Citrus Sinensis ID: 011250

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490
Protein Sequence
MGLSPESVKVKNWEVNNSDNNNNSKSRKVKKKKDGGAEQEEEEEIGCWVRFRFIESCMPSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPLRTLSHPNGPHASPYRHPQQSPKPNGKQ
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccccccccccccccHHHHccccccEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHccccccccccHHHHHHHHcccccccccccccccEEEEEEEccccccccccccccEEEEEEcccccccHHHHHHHHHHHHHcccccccccEEEEEccccEEEEEEEEcccccHHHHcccccccccHHHHHHHHHHHHHHHHHHHccccccEEEcccccccccccccccccccccccccccccccccccccccccccccccHHHHcccccccccccccHHHHHHHHHHcccccccccccccccHHHcccccccccccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccEEEEEEEEcccccccccccccccccccccccccccccccEEEEEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHHHccccccccEEEEEEEcccccccccccccEEEEEEEEccccccccHHHHHHHHHHHHHcccccEEEEEEEEccccEEEEEEEcccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHHcccccEEcccccHHHEEEcccccEEEcccccccccccccccEEEEEEEcccccccHHHHHccccccccHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
mglspesvkvknwevnnsdnnnnsksrkvkkkkdggaeqeeeeEIGCWVRFRFiescmpsrskvdssmsgtstnyadgkssnekrrdrpvvpvsstttsnaesasstpkfSEELKVASQLRKFMFNDLKlatrnfrpesllgeggfgcvfkgwveengtapvkpgtgLTVAVKTLNHDGLQGHKEWLAEVNFlgnllhpnLVKLVGYcieddqrllvyefmprgslenhlfrrslplpwSIRMKIALGAAKGLAFLheeaekpviyrdfktsnilldadynaklsdfglakdapedgkthvstrvmgtygyaapeyvmtghltsksdVYSFGVVLLEMLTgrrsmdknrpngehnlvewarphlgdkrrfyrlldprleghfsikgsQKATQLAAQClsrdpkarprMSEVVETLKplqnlkdmassSYYFQTmqadntwsirnskngirtqggfmtrngqplrtlshpngphaspyrhpqqspkpngkq
Flexible Loop (DISEMBL)
mglspesvkvknwevnnsdnnnnsksrkvkkkkdggaeqeeeeeigcwvrFRFIESCMPsrskvdssmsgtstnyadgkssnekrrdrpvvpvsstttsnaesasstpkfsEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFglakdapedgkthvstrVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTgrrsmdknrpngehnlvewarphlgdkRRFYRLLDPRLEGHfsikgsqkaTQLAAQCLsrdpkarprMSEVVEtlkplqnlkDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPLRTLSHPNGphaspyrhpqqspkpngkq
Low Complexity Region (SEG)
MGLSPESVKvknwevnnsdnnnnsksrkvkkkkDGGAeqeeeeeIGCWVRFRFIESCMPSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPVsstttsnaesasstPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPLRTLSHPNGPHASPYRHPQQSPKPNGKQ
Disordered region (IsUnstruct)
********************************************IGCWVRFRFIESC*************************************************************QLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD*****KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG*************NLVEWARPHLGDKRRFYRLLDPRLEGHFSI********************************************YYFQTMQADNTWSI************************************************
Disordered Region (DISOPRED)
*********************************************GCWVRFR********************************************************************RKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL************************************************************************
Disordered Region (DISEMBL)
MGLSPESVKVKNWEVNNSDNNNN********************EIGCWVRFRFIESCM******************************************************ELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIK************************EVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPLRTLSHPNGP******************
Disordered Region (DISPRO)
***SPESVKVKNWEVNN**************************EIGCWVRFRFIESCM***********************************************************SQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL*********************************************************************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGLSPESVKVKNWEVNNSDNNNNSKSRKVKKKKDGGAEQEEEEEIGCWVRFRFIESCMPSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPLRTLSHPNGPHASPYRHPQQSPKPNGKQ
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	490	2.2.26 [Sep-21-2011]
Q9LFP7	493	Probable receptor-like pr	yes	no	0.975	0.969	0.766	0.0
Q9SRH7	490	Receptor-like serine/thre	no	no	0.912	0.912	0.791	0.0
Q06548	410	Protein kinase APK1A, chl	no	no	0.714	0.853	0.586	1e-124
P46573	412	Protein kinase APK1B, chl	no	no	0.646	0.769	0.641	1e-122
Q8GXZ3	410	Serine/threonine-protein	no	no	0.646	0.773	0.661	1e-122
P43293	389	Probable serine/threonine	no	no	0.661	0.832	0.621	1e-122
O49840	426	Protein kinase 2B, chloro	no	no	0.744	0.856	0.592	1e-120
O48814	395	Serine/threonine-protein	no	no	0.712	0.883	0.562	1e-117
O49839	426	Protein kinase 2A, chloro	no	no	0.744	0.856	0.571	1e-115
Q8H186	389	Probable receptor-like pr	no	no	0.626	0.789	0.599	1e-112

>sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1

 Score =  744 bits (1920), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 383/500 (76%), Positives = 414/500 (82%), Gaps = 22/500 (4%)

Query: 1   MGLSPESVKVK-NW--EVNNSDNNNNSKSRKVKKKKDGGAEQEEEEEIGCWVRFRFIESC 57
           MGL  ++VK K NW  E      N N K +     K    E+EE E  GCWV+FRF+  C
Sbjct: 1   MGL--DAVKAKGNWKSEKPKETENKNHKKKNGDDNKSRNEEEEEGEASGCWVKFRFMIGC 58

Query: 58  MPSRSKVDSSMSG-----TSTNYADGKSSNEKRRDRPVVPVSSTTT-SNAESASSTPKFS 111
           +PS+S +D+S S       +    + KS+NEK  D+PV  VSSTTT SNAES+SSTP  S
Sbjct: 59  IPSKSDLDASSSSIYGSNCTVTTMESKSANEKSNDQPVGQVSSTTTTSNAESSSSTPVIS 118

Query: 112 EELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVA 171
           EEL ++S LRKF FNDLKL+TRNFRPESLLGEGGFGCVFKGW+EENGTAPVKPGTGLTVA
Sbjct: 119 EELNISSHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVA 178

Query: 172 VKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF 231
           VKTLN DGLQGHKEWLAE+NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF
Sbjct: 179 VKTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF 238

Query: 232 RRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK 291
           RRSLPLPWSIRMKIALGAAKGL+FLHEEA KPVIYRDFKTSNILLDADYNAKLSDFGLAK
Sbjct: 239 RRSLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAK 298

Query: 292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN 351
           DAP++GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN
Sbjct: 299 DAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN 358

Query: 352 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
           GEHNLVEWARPHL DKRRFYRLLDPRLEGHFSIKG+QK TQLAAQCLSRDPK RP+MS+V
Sbjct: 359 GEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDV 418

Query: 412 VETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQ---PLRTLSH 468
           VE LKPL +LKDMASSSYYFQTMQA+        KNG     GF +RNGQ     RTLS 
Sbjct: 419 VEALKPLPHLKDMASSSYYFQTMQAERL------KNGSGRSQGFGSRNGQHQPVFRTLSS 472

Query: 469 PNGPHASPYRHPQQSPKPNG 488
           P+G  +SPYRH   SPKP G
Sbjct: 473 PHG--SSPYRHQIPSPKPKG 490

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1

 Score =  717 bits (1851), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 360/455 (79%), Positives = 394/455 (86%), Gaps = 8/455 (1%)

Query: 37  AEQEEEEEIGCWVRFRFIESCMPSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPVSST 96
           +E  EEE  GCWV+FR+I  C  S S V++S++  ST+    +S+  +  D+PV PVSST
Sbjct: 38  SEHYEEEANGCWVKFRYIVCCASSTSDVETSLT-LSTSTVGSQSAIVQSNDQPVGPVSST 96

Query: 97  TT-SNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVE 155
           TT SNAES+ STP  SEEL + S L+KF F DLKLATRNFRPESLLGEGGFGCVFKGWVE
Sbjct: 97  TTTSNAESSLSTPIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVE 156

Query: 156 ENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL 215
           ENGTAPVKPGTGLTVAVKTLN DGLQGHKEWLAE+N+LGNLLHPNLVKLVGYCIEDDQRL
Sbjct: 157 ENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRL 216

Query: 216 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL 275
           LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL+FLHEEA KPVIYRDFKTSNIL
Sbjct: 217 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNIL 276

Query: 276 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVL 335
           LD +YNAKLSDFGLAKDAP++GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVL
Sbjct: 277 LDGEYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVL 336

Query: 336 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA 395
           LEMLTGRRSMDKNRPNGEHNLVEWARPHL DKRRFYRLLDPRLEGHFS+KG+QK TQLAA
Sbjct: 337 LEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAA 396

Query: 396 QCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGF 455
           QCLSRD K RP+MSEVVE LKPL +LKDMAS+SYYFQTMQA+       + +G  +  GF
Sbjct: 397 QCLSRDSKIRPKMSEVVEVLKPLPHLKDMASASYYFQTMQAERL----KAGSGSGSGRGF 452

Query: 456 MTRNGQPL-RTLSHPNG-PHASPYRHPQQSPKPNG 488
            +RNGQP+ RTLS P+G   +SPYRH   SPKP G
Sbjct: 453 GSRNGQPVFRTLSSPHGQAGSSPYRHQIPSPKPKG 487

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1

 Score =  446 bits (1146), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 216/368 (58%), Positives = 274/368 (74%), Gaps = 18/368 (4%)

Query: 57  CMPSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKV 116
           C+ ++ K +SS + T  +  D  S   K     V P              +P+   E+  
Sbjct: 4   CLSAQVKAESSGASTKYDAKDIGSLGSKASSVSVRP--------------SPRTEGEILQ 49

Query: 117 ASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN 176
           +  L+ F F +LK ATRNFRP+S+LGEGGFGCVFKGW++E      +PGTGL +AVK LN
Sbjct: 50  SPNLKSFSFAELKSATRNFRPDSVLGEGGFGCVFKGWIDEKSLTASRPGTGLVIAVKKLN 109

Query: 177 HDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL- 235
            DG QGH+EWLAEVN+LG   H +LVKL+GYC+ED+ RLLVYEFMPRGSLENHLFRR L 
Sbjct: 110 QDGWQGHQEWLAEVNYLGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGLY 169

Query: 236 --PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 293
             PL W +R+K+ALGAAKGLAFLH  +E  VIYRDFKTSNILLD++YNAKLSDFGLAKD 
Sbjct: 170 FQPLSWKLRLKVALGAAKGLAFLHS-SETRVIYRDFKTSNILLDSEYNAKLSDFGLAKDG 228

Query: 294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 353
           P   K+HVSTRVMGT+GYAAPEY+ TGHLT+KSDVYSFGVVLLE+L+GRR++DKNRP+GE
Sbjct: 229 PIGDKSHVSTRVMGTHGYAAPEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKNRPSGE 288

Query: 354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
            NLVEWA+P+L +KR+ +R++D RL+  +S++ + K   L+ +CL+ + K RP MSEVV 
Sbjct: 289 RNLVEWAKPYLVNKRKIFRVIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNMSEVVS 348

Query: 414 TLKPLQNL 421
            L+ +Q+L
Sbjct: 349 HLEHIQSL 356

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2

 Score =  440 bits (1131), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 206/321 (64%), Positives = 255/321 (79%), Gaps = 4/321 (1%)

Query: 106 STPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPG 165
           + P+   E+  +  L+ F F +LK ATRNFRP+S+LGEGGFG VFKGW++E      KPG
Sbjct: 40  TNPRTEGEILQSPNLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPG 99

Query: 166 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGS 225
           TG+ +AVK LN DG QGH+EWLAEVN+LG   HPNLVKL+GYC+ED+ RLLVYEFMPRGS
Sbjct: 100 TGVVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGS 159

Query: 226 LENHLFRRS---LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA 282
           LENHLFRR     PL W++R+K+ALGAAKGLAFLH  AE  VIYRDFKTSNILLD++YNA
Sbjct: 160 LENHLFRRGSYFQPLSWTLRLKVALGAAKGLAFLHN-AETSVIYRDFKTSNILLDSEYNA 218

Query: 283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           KLSDFGLAKD P   K+HVSTR+MGTYGYAAPEY+ TGHLT+KSDVYS+GVVLLE+L+GR
Sbjct: 219 KLSDFGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGR 278

Query: 343 RSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDP 402
           R++DKNRP GE  LVEWARP L +KR+ +R++D RL+  +S++ + K   LA +CL+ + 
Sbjct: 279 RAVDKNRPPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEI 338

Query: 403 KARPRMSEVVETLKPLQNLKD 423
           K RP M+EVV  L+ +Q L +
Sbjct: 339 KLRPNMNEVVSHLEHIQTLNE 359

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1

 Score =  439 bits (1130), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 215/325 (66%), Positives = 260/325 (80%), Gaps = 8/325 (2%)

Query: 103 SASSTPKFSEELKVA---SQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGT 159
           S  STP+F ++ +     +Q+  F   +L+  T++FRP+ +LGEGGFG V+KG++++N  
Sbjct: 34  SDPSTPRFRDDSRTPISYAQVIPFTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLR 93

Query: 160 APVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYE 219
             +K    L VAVK LN +GLQGH+EWL EVNFLG L HPNLVKL+GYC EDD RLLVYE
Sbjct: 94  VGLK---SLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYE 150

Query: 220 FMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA 278
           FM RGSLENHLFR++  PL WS RM IALGAAKGLAFLH  AE+PVIYRDFKTSNILLD+
Sbjct: 151 FMLRGSLENHLFRKTTAPLSWSRRMMIALGAAKGLAFLHN-AERPVIYRDFKTSNILLDS 209

Query: 279 DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 338
           DY AKLSDFGLAK  P+  +THVSTRVMGTYGYAAPEYVMTGHLT++SDVYSFGVVLLEM
Sbjct: 210 DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEM 269

Query: 339 LTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCL 398
           LTGR+S+DK RP+ E NLV+WARP L DKR+  +++DPRLE  +S++ +QKA  LA  CL
Sbjct: 270 LTGRKSVDKTRPSKEQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCL 329

Query: 399 SRDPKARPRMSEVVETLKPLQNLKD 423
           S++PKARP MS+VVETL+PLQ   D
Sbjct: 330 SQNPKARPLMSDVVETLEPLQCTGD 354

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2

 Score =  439 bits (1129), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 204/328 (62%), Positives = 261/328 (79%), Gaps = 4/328 (1%)

Query: 99  SNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENG 158
           S+  S S  P+   E+   + L+ F  ++LK ATRNFRP+S++GEGGFGCVFKGW++E+ 
Sbjct: 32  SSTASFSYMPRTEGEILQNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESS 91

Query: 159 TAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVY 218
            AP KPGTG+ +AVK LN +G QGH+EWLAE+N+LG L HPNLVKL+GYC+E++ RLLVY
Sbjct: 92  LAPSKPGTGIVIAVKRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVY 151

Query: 219 EFMPRGSLENHLFRRSL---PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL 275
           EFM RGSLENHLFRR     PL W+ R+++ALGAA+GLAFLH  A+  VIYRDFK SNIL
Sbjct: 152 EFMTRGSLENHLFRRGTFYQPLSWNTRVRMALGAARGLAFLHN-AQPQVIYRDFKASNIL 210

Query: 276 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVL 335
           LD++YNAKLSDFGLA+D P    +HVSTRVMGT GYAAPEY+ TGHL+ KSDVYSFGVVL
Sbjct: 211 LDSNYNAKLSDFGLARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVL 270

Query: 336 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA 395
           LE+L+GRR++DKN+P GEHNLV+WARP+L +KRR  R++DPRL+G +S+  + K   LA 
Sbjct: 271 LELLSGRRAIDKNQPVGEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLAL 330

Query: 396 QCLSRDPKARPRMSEVVETLKPLQNLKD 423
            C+S D K+RP M+E+V+T++ L   K+
Sbjct: 331 DCISIDAKSRPTMNEIVKTMEELHIQKE 358

May play a role in the regulation of plant growth and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1

 Score =  434 bits (1115), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 218/368 (59%), Positives = 271/368 (73%), Gaps = 3/368 (0%)

Query: 57  CMPSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPVSSTTTSNAESAS-STPKFSEELK 115
           C+ S +KVDSS      N A   S    +  R  VP S +  S +   S  TP+   E+ 
Sbjct: 4   CLDSSAKVDSSSHSPHANSASLSSRVSSKTSRSTVPSSLSINSYSSVESLPTPRTEGEIL 63

Query: 116 VASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL 175
            +  L+ F FN+LK ATRNFRP+SLLGEGGFG VFKGW++       KPG+G+ VAVK L
Sbjct: 64  SSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAVKKL 123

Query: 176 NHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRR-S 234
             +G QGHKEWL EVN+LG L HPNLVKLVGYC+E + RLLVYEFMP+GSLENHLFRR +
Sbjct: 124 KTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFRRGA 183

Query: 235 LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 294
            PL W+IRMK+A+GAAKGL FLH+ A+  VIYRDFK +NILLDA++N+KLSDFGLAK  P
Sbjct: 184 QPLTWAIRMKVAIGAAKGLTFLHD-AKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGP 242

Query: 295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
              KTHVST+VMGT+GYAAPEYV TG LT+KSDVYSFGVVLLE+L+GRR++DK++   E 
Sbjct: 243 TGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGMEQ 302

Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET 414
           +LV+WA P+LGDKR+ +R++D RL G +  KG+  A  LA QCL+ D K RP+MSEV+  
Sbjct: 303 SLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLAK 362

Query: 415 LKPLQNLK 422
           L  L++ K
Sbjct: 363 LDQLESTK 370

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1

 Score =  422 bits (1086), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 207/368 (56%), Positives = 265/368 (72%), Gaps = 19/368 (5%)

Query: 56  SCMPSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELK 115
           SC  SR K D   +G S++      S+ K        V++   +  E  SSTP       
Sbjct: 3   SCFSSRVKADIFHNGKSSDLYGLSLSSRKSS----STVAAAQKTEGEILSSTP------- 51

Query: 116 VASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL 175
               ++ F FN+LKLATRNFRP+S++GEGGFGCVFKGW++E+   P KPGTGL +AVK L
Sbjct: 52  ----VKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIAVKKL 107

Query: 176 NHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL 235
           N +G QGH+EWL E+N+LG L HPNLVKL+GYC+ED+ RLLVYEFM +GSLENHLFRR  
Sbjct: 108 NQEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLFRRGA 167

Query: 236 ---PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD 292
              PLPW +R+ +AL AAKGLAFLH +  K VIYRD K SNILLDADYNAKLSDFGLA+D
Sbjct: 168 YFKPLPWFLRVNVALDAAKGLAFLHSDPVK-VIYRDIKASNILLDADYNAKLSDFGLARD 226

Query: 293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG 352
            P    ++VSTRVMGTYGYAAPEY+ +GHL ++SDVYSFGV+LLE+L+G+R++D NRP  
Sbjct: 227 GPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNRPAK 286

Query: 353 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
           E NLV+WARP+L  KR+   ++D RL+  +  + + +   +A QCLS +PK+RP M +VV
Sbjct: 287 EENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMDQVV 346

Query: 413 ETLKPLQN 420
             L+ LQ+
Sbjct: 347 RALQQLQD 354

Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1

 Score =  416 bits (1069), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 212/371 (57%), Positives = 271/371 (73%), Gaps = 6/371 (1%)

Query: 56  SCMPSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVP--VSSTTTSNAESASSTPKFSEE 113
           +C+ S +KVD+S      N A   S    +  R   P  +S+T+ S   S    P    E
Sbjct: 3   NCLDSSAKVDNSNHSPHANSASSGSKVSSKTSRSTGPSGLSTTSYSTDSSFGPLPTLRTE 62

Query: 114 LKVAS--QLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVA 171
            ++ S   L+ F FN+LK AT+NFR ++LLGEGGFGCVFKGW+++      +PG+G+ VA
Sbjct: 63  GEILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVA 122

Query: 172 VKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF 231
           VK L  +G QGHKEWL EVN+LG L HPNLV LVGYC E + RLLVYEFMP+GSLENHLF
Sbjct: 123 VKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLF 182

Query: 232 RR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA 290
           RR + PL W+IRMK+A+GAAKGL FLHE A+  VIYRDFK +NILLDAD+NAKLSDFGLA
Sbjct: 183 RRGAQPLTWAIRMKVAVGAAKGLTFLHE-AKSQVIYRDFKAANILLDADFNAKLSDFGLA 241

Query: 291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           K  P    THVST+V+GT+GYAAPEYV TG LT+KSDVYSFGVVLLE+++GRR+MD +  
Sbjct: 242 KAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNG 301

Query: 351 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 410
             E++LV+WA P+LGDKR+ +R++D +L G +  KG+  A  LA QCL+ D K RP+MSE
Sbjct: 302 GNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSE 361

Query: 411 VVETLKPLQNL 421
           V+ TL+ L+++
Sbjct: 362 VLVTLEQLESV 372

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1

 Score =  405 bits (1041), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 187/312 (59%), Positives = 241/312 (77%), Gaps = 5/312 (1%)

Query: 113 ELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAV 172
           E+  ++ ++ F FN+LKLATRNFR +S++GEGGFGCVF+GW++E    P K  +GL +AV
Sbjct: 39  EILSSTTVKSFSFNELKLATRNFRSDSVVGEGGFGCVFRGWLDETTLTPTKSSSGLVIAV 98

Query: 173 KTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF- 231
           K LN DG QGH+EWL E+N+LG L HPNLVKL+GYC+ED+QRLLVYEFM +GSLENHLF 
Sbjct: 99  KRLNPDGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFMHKGSLENHLFA 158

Query: 232 ---RRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG 288
              +   PL W +R+K+AL AAKGLAFLH +  K VIYRD K SNILLD+D+NAKLSDFG
Sbjct: 159 NGNKDFKPLSWILRIKVALDAAKGLAFLHSDPVK-VIYRDIKASNILLDSDFNAKLSDFG 217

Query: 289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN 348
           LA+D P   +++VSTRVMGT+GYAAPEYV TGHL ++SDVYSFGVVLLE+L GR+++D N
Sbjct: 218 LARDGPMGEQSYVSTRVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLLELLCGRQALDHN 277

Query: 349 RPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM 408
           RP  E NLV+WARP+L  +R+   ++D RL   +  +G+ +   +A QCLS +PK+RP M
Sbjct: 278 RPAKEQNLVDWARPYLTSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQCLSFEPKSRPTM 337

Query: 409 SEVVETLKPLQN 420
            +VV  L  LQ+
Sbjct: 338 DQVVRALVQLQD 349

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	490
224077698	480	predicted protein [Populus trichocarpa]	0.971	0.991	0.822	0.0
255552850	479	Protein kinase APK1B, chloroplast precur	0.971	0.993	0.821	0.0
359473277	481	PREDICTED: probable receptor-like protei	0.969	0.987	0.799	0.0
255558222	495	Protein kinase APK1B, chloroplast precur	0.981	0.971	0.787	0.0
147857978	495	hypothetical protein VITISV_008843 [Viti	0.971	0.961	0.781	0.0
359488899	475	PREDICTED: probable receptor-like protei	0.963	0.993	0.797	0.0
356567562	487	PREDICTED: probable receptor-like protei	0.904	0.909	0.847	0.0
356526888	487	PREDICTED: probable receptor-like protei	0.904	0.909	0.843	0.0
351722951	485	serine/threonine protein kinase-like pro	0.912	0.921	0.830	0.0
356498172	491	PREDICTED: probable receptor-like protei	0.902	0.900	0.834	0.0

>gi|224077698|ref|XP_002305368.1| predicted protein [Populus trichocarpa] gi|222848332|gb|EEE85879.1| predicted protein [Populus trichocarpa]

 Score =  813 bits (2100), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 404/491 (82%), Positives = 431/491 (87%), Gaps = 15/491 (3%)

Query: 1   MGLSPESVKVKNWEVNNSDNNNNSKSRKVKKKKDGGAEQEEEEEIGCWVRFRFIESCMPS 60
           MGLSP+SVKVKN            +  K KK K     +++EE+IGCW +FR   SCMPS
Sbjct: 1   MGLSPDSVKVKN----------FKEKSKSKKNKKNQGNEKDEEDIGCWFKFRSTGSCMPS 50

Query: 61  RSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPV--SSTTTSNAESASSTPKFSEELKVAS 118
           RSKVDSS+SG ST+Y   KS NEK +D+P+VP   S+TTTSNAESASS P FSEELK+AS
Sbjct: 51  RSKVDSSLSGISTHYVPSKSKNEKNKDQPIVPAMSSTTTTSNAESASSLPTFSEELKLAS 110

Query: 119 QLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD 178
           QLRKF FNDLKLATRNFRPESLLGEGGFGCVFKGW+EENGTAPVKPGTGLTVAVKTLNHD
Sbjct: 111 QLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD 170

Query: 179 GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP 238
           GLQGHKEWLAEV+FLGNLLH NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP
Sbjct: 171 GLQGHKEWLAEVSFLGNLLHKNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP 230

Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
           WSIRMKIALGAA+GLAFLHEEA++PVIYRDFKTSNILLDADYNAKLSDFGLAKDAP+ GK
Sbjct: 231 WSIRMKIALGAAQGLAFLHEEADRPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDGGK 290

Query: 299 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 358
           THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE
Sbjct: 291 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 350

Query: 359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
           WARPH GDKRRFYRLLDPRLEGHFSIKG+QK  QLAAQCLSRDPKARP+MSEVVE LKPL
Sbjct: 351 WARPHFGDKRRFYRLLDPRLEGHFSIKGAQKGIQLAAQCLSRDPKARPQMSEVVEALKPL 410

Query: 419 QNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPLRTLSHPNGPHASPYR 478
            NLKDMASSSYYFQ+MQAD   S  N+KNG RTQ GF+TRNGQPLR+LS      ASPY 
Sbjct: 411 PNLKDMASSSYYFQSMQADRNKSNMNAKNGTRTQAGFVTRNGQPLRSLSD---VRASPYN 467

Query: 479 HPQQSPKPNGK 489
            PQQSPKP G+
Sbjct: 468 QPQQSPKPKGR 478

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255552850|ref|XP_002517468.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] gi|223543479|gb|EEF45010.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis]

 Score =  813 bits (2100), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 404/492 (82%), Positives = 432/492 (87%), Gaps = 16/492 (3%)

Query: 1   MGLSPESVKVKNWEVNNSDNNNNSKSRKVKKKKDGGAEQEEEEEIGCWVRFRFIESCMPS 60
           MGL P+S+KVKN E  +    N               + EEE+EIGCW + R I  CMPS
Sbjct: 1   MGLGPDSLKVKNLEDKSKKKKN--------------KKDEEEKEIGCWPKLRLIGGCMPS 46

Query: 61  RSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPV-SSTTTSNAESASSTPKFSEELKVASQ 119
           RSKVD+S+SGT+  Y + KS+ EK +D+PVVPV SSTTTSN ESASSTPKFSEELK+ASQ
Sbjct: 47  RSKVDNSLSGTTAQYVESKSTEEKSKDQPVVPVISSTTTSNGESASSTPKFSEELKLASQ 106

Query: 120 LRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG 179
           LR F FNDLKLATRNFRPESLLGEGGFGCVFKGW+EENGTAPVKPGTGLTVAVKTLNHDG
Sbjct: 107 LRIFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG 166

Query: 180 LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLP 238
           LQGHKEWLAEV+FLGNLLHPNLVKL+GYCIEDDQRLLVYEFMPRGSLENHLFR+ SLPLP
Sbjct: 167 LQGHKEWLAEVSFLGNLLHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP 226

Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
           WSIRMKIALGAAKGLAFLHEEAE+ VIYRDFKTSNILLDADYNAKLSDFGLAKD PE GK
Sbjct: 227 WSIRMKIALGAAKGLAFLHEEAERSVIYRDFKTSNILLDADYNAKLSDFGLAKDGPESGK 286

Query: 299 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 358
           THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE
Sbjct: 287 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 346

Query: 359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
           WARPH GD+RRFYRLLDPRLEGHFSIKG+QKA QLA+QCLSRDPKARPRMSEVVETLKPL
Sbjct: 347 WARPHFGDRRRFYRLLDPRLEGHFSIKGAQKAIQLASQCLSRDPKARPRMSEVVETLKPL 406

Query: 419 QNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPLRTLSHPNGPHASPYR 478
            NLKDMASSSYYFQTMQAD   S  ++KNGIRTQ GF+TRNGQPLR+LS  +   ASPY 
Sbjct: 407 PNLKDMASSSYYFQTMQADRNKSNMHTKNGIRTQAGFVTRNGQPLRSLSSLSDTRASPYN 466

Query: 479 HPQQSPKPNGKQ 490
            P QSPKPNGK+
Sbjct: 467 QPYQSPKPNGKK 478

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359473277|ref|XP_003631281.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Vitis vinifera] gi|296086431|emb|CBI32020.3| unnamed protein product [Vitis vinifera]

 Score =  801 bits (2069), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 395/494 (79%), Positives = 432/494 (87%), Gaps = 19/494 (3%)

Query: 1   MGLSPESVKVKNWEVNNSDNNNNSKSRKVKKKKDGGAEQEEEEEIGCWVRFRFIESCMPS 60
           MGL    VKV++WEV  S         K +KKKDGG    EEE   CWV+ RF+ SC+ S
Sbjct: 1   MGLGGNDVKVESWEVGKS---------KGRKKKDGG----EEETGCCWVKLRFMASCISS 47

Query: 61  RSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPV-SSTTTSNAESASSTPKFSEELKVASQ 119
           RSKVDSS+SGTST+Y + +S+N+  RD+PV PV SSTTTSNAES SST K  EELKVAS+
Sbjct: 48  RSKVDSSISGTSTHY-ENRSTNDTSRDQPVAPVVSSTTTSNAESNSSTSKLEEELKVASR 106

Query: 120 LRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG 179
           LRKF FNDLK+ATRNFRPESLLGEGGFGCVFKGW+EENGTAPVKPGTGLTVAVKTLNHDG
Sbjct: 107 LRKFSFNDLKMATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG 166

Query: 180 LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 239
           LQGHKEWLAEVNFLG+L+HPNLVKL+GYCIEDDQRLLVYEFMPRGSLENHLFRR+LPLPW
Sbjct: 167 LQGHKEWLAEVNFLGDLIHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRALPLPW 226

Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
           +IRMKIALGAAKGLAFLHEEAE+PVIYRDFKTSNILLDA+YNAKLSDFGLAKD PE  KT
Sbjct: 227 AIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNAKLSDFGLAKDGPEGDKT 286

Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 359
           HVSTRVMGTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW
Sbjct: 287 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 346

Query: 360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ 419
           ARPHLG++RRFYRL+DPRLEGHFSIKG+QKA QLAA CLSRDPK RP MSEVVE LKPL 
Sbjct: 347 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKVRPLMSEVVEALKPLP 406

Query: 420 NLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNG-QPLRTLSHPNGPHASPY- 477
           NLKDMASSSYYFQTMQA+   S  N++NG+RTQ G ++RNG Q  R+LS PNG HASPY 
Sbjct: 407 NLKDMASSSYYFQTMQAERIGSSPNARNGVRTQQGILSRNGHQQQRSLSIPNGSHASPYH 466

Query: 478 --RHPQQSPKPNGK 489
             ++P QSPKPNGK
Sbjct: 467 QNQYPYQSPKPNGK 480

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255558222|ref|XP_002520138.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] gi|223540630|gb|EEF42193.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis]

 Score =  793 bits (2049), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 397/504 (78%), Positives = 428/504 (84%), Gaps = 23/504 (4%)

Query: 1   MGLSPES---VKVKNWEVNNSDNNNNSKSRKVKKKKD-----GGA---EQEEEEEIGCWV 49
           MGL  E     K  +WEV      N       KKK+D     GGA   +  EE E GCW 
Sbjct: 1   MGLGSEDGNRAKASSWEVCKPKGRN-------KKKQDVSNSSGGASPGDVVEEAETGCWF 53

Query: 50  RFRFIESCMPSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVP-VSSTTTSNAESASSTP 108
           +FRFI SC+ SRSKVDSS+SGTST + + KS+N+  RD+P  P +SSTTTSNAES SST 
Sbjct: 54  KFRFIGSCISSRSKVDSSVSGTST-HCESKSTNDTSRDQPTAPTISSTTTSNAESNSSTS 112

Query: 109 KFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGL 168
           K  EELK+AS+LRKF FNDLKLATRNFRPESLLGEGGFGCVFKGW+EENGTAPVKPGTGL
Sbjct: 113 KLEEELKIASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGL 172

Query: 169 TVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLEN 228
           TVAVKTLNHDGLQGHKEWLAEVN+LG+L+HPNLVKL+GYCIEDDQRLLVYEFMPRGSLEN
Sbjct: 173 TVAVKTLNHDGLQGHKEWLAEVNYLGDLVHPNLVKLIGYCIEDDQRLLVYEFMPRGSLEN 232

Query: 229 HLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG 288
           HLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE+PVIYRDFKTSNILLDADYNAKLSDFG
Sbjct: 233 HLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 292

Query: 289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN 348
           LAKD PE  KTHVSTRVMGTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEM+TGRRSMDKN
Sbjct: 293 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMITGRRSMDKN 352

Query: 349 RPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM 408
           RP GEHNLVEWARPHLG++RRFYRL+DPRLEGHFSIKG+QKA QLAA CLSRDPKARP M
Sbjct: 353 RPIGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 412

Query: 409 SEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPLRTLSH 468
           SEVVE LKPL NLKDMASSSYYFQ+MQAD   S  N+K+  RTQGG + RNGQ  R+LS 
Sbjct: 413 SEVVEVLKPLPNLKDMASSSYYFQSMQADKIASSPNAKSSNRTQGGLL-RNGQQQRSLSI 471

Query: 469 PNGPHASPYRH--PQQSPKPNGKQ 490
           PNG HASPY H  P QSPKPNGKQ
Sbjct: 472 PNGSHASPYHHQYPFQSPKPNGKQ 495

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147857978|emb|CAN82516.1| hypothetical protein VITISV_008843 [Vitis vinifera]

 Score =  787 bits (2033), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 396/507 (78%), Positives = 430/507 (84%), Gaps = 31/507 (6%)

Query: 1   MGLSPESVKVKNWEVNNSDNNNNSKSRKVKKKKDGGAEQEEEEEIGCWVRFRFIESCMPS 60
           MGL    VKV++WEV  S         K +KKKDGG    EEE   CWV+ RF+ SC+ S
Sbjct: 1   MGLGGNDVKVESWEVGKS---------KGRKKKDGG----EEETGCCWVKLRFMASCISS 47

Query: 61  RSKVDSSMSGTSTNYADGKSSN-EKR------------RDRPVVPV-SSTTTSNAESASS 106
           RSKVDSS+SGTST+Y  G   + E R            RD+PV PV SSTTTSNAES SS
Sbjct: 48  RSKVDSSISGTSTHYDLGVXFDVEPRSLNVFWCDFGLCRDQPVAPVVSSTTTSNAESNSS 107

Query: 107 TPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGT 166
           T K  EELKVAS+LRKF FNDLK+ATRNFRPESLLGEGGFGCVFKGW+EENGTAPVKPGT
Sbjct: 108 TSKLEEELKVASRLRKFSFNDLKMATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGT 167

Query: 167 GLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL 226
           GLTVAVKTLNHDGLQGHKEWLAEVNFLG+L+HPNLVKL+GYCIEDDQRLLVYEFMPRGSL
Sbjct: 168 GLTVAVKTLNHDGLQGHKEWLAEVNFLGDLIHPNLVKLIGYCIEDDQRLLVYEFMPRGSL 227

Query: 227 ENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD 286
           ENHLFRR+LPLPW+IRMKIALGAAKGLAFLHEEAE+PVIYRDFKTSNILLDA+YNAKLSD
Sbjct: 228 ENHLFRRALPLPWAIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNAKLSD 287

Query: 287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD 346
           FGLAKD PE  KTHVSTRVMGTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEMLTGRRSMD
Sbjct: 288 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 347

Query: 347 KNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
           KNRPNGEHNLVEWARPHLG++RRFYRL+DPRLEGHFSIKG+QKA QLAA CLSRDPK RP
Sbjct: 348 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKVRP 407

Query: 407 RMSEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNG-QPLRT 465
            MSEVVE LKPL NLKDMASSSYYFQTMQA+   S  N++NG+RTQ G ++RNG Q  R+
Sbjct: 408 LMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNARNGVRTQQGILSRNGHQQQRS 467

Query: 466 LSHPNGPHASPY---RHPQQSPKPNGK 489
           LS PNG HASPY   ++P QSPKPNGK
Sbjct: 468 LSIPNGSHASPYHQNQYPYQSPKPNGK 494

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359488899|ref|XP_003633841.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Vitis vinifera]

 Score =  787 bits (2033), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 390/489 (79%), Positives = 425/489 (86%), Gaps = 17/489 (3%)

Query: 1   MGLSPESVKVKNWEVNNSDNNNNSKSRKVKKKKDGGAEQEEEEEIGCWVRFRFIESCMPS 60
           MGL P++++V NWEV NS         K +KKKD     +EEE  GCW++FRF+ SCM +
Sbjct: 1   MGLGPDAIQVGNWEVGNS---------KGRKKKD-----DEEEATGCWIKFRFMGSCMSA 46

Query: 61  RSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPV-SSTTTSNAESASSTPKFSEELKVASQ 119
           RSKV+SS+S +ST YA+ KS+N+  RD+PV PV SS+TTSN ES  STP   EELKVASQ
Sbjct: 47  RSKVESSVSSSSTQYAESKSTNDTSRDQPVAPVVSSSTTSNGESTPSTPNTGEELKVASQ 106

Query: 120 LRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG 179
           LRKF FN+LK ATRNFRPESLLGEGGFGCVFKGW+   GT PVKPGTGLTVAVKTLNHDG
Sbjct: 107 LRKFTFNELKSATRNFRPESLLGEGGFGCVFKGWINGTGTTPVKPGTGLTVAVKTLNHDG 166

Query: 180 LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 239
           LQGHKEWLAEVNFLG+LLHPNLVKL+GYCIEDDQRLLVYEFMPRGSLENHLFRR+LPLPW
Sbjct: 167 LQGHKEWLAEVNFLGDLLHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRALPLPW 226

Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
           SIRMKIALGAAKGLAFLHEEAE+PVIYRDFKTSNILLD DYNAKLSDFGLAKD PE  KT
Sbjct: 227 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDVDYNAKLSDFGLAKDGPEGDKT 286

Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 359
           HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW
Sbjct: 287 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 346

Query: 360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ 419
           ARPHLG++RRFYRLLDPRLEG FSIKG+QKA QLAA CLSRDPKARP MSEVVE LKPL 
Sbjct: 347 ARPHLGERRRFYRLLDPRLEGRFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 406

Query: 420 NLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPLRTLSHPNGPHASPYRH 479
           NLKDMASSS +FQTMQA+ T S  NS++GIR Q GF++RNGQP R+LS PNGPHASPY H
Sbjct: 407 NLKDMASSSSFFQTMQAERTGSTPNSRSGIRAQAGFLSRNGQPNRSLSMPNGPHASPYNH 466

Query: 480 --PQQSPKP 486
             P +SPKP
Sbjct: 467 NNPHRSPKP 475

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356567562|ref|XP_003551987.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Glycine max]

 Score =  785 bits (2027), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 379/447 (84%), Positives = 406/447 (90%), Gaps = 4/447 (0%)

Query: 46  GCWVRFRFIESCMPSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVP-VSSTTTSNAESA 104
           GCW R RFI SC+ SRSKVDSS+SGTSTNYA+ KS+ +  RD+P VP VSSTTTSNAES 
Sbjct: 41  GCWFRLRFIGSCISSRSKVDSSVSGTSTNYAESKSTIDTSRDQPTVPVVSSTTTSNAESN 100

Query: 105 SSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKP 164
           SST K  EE KV+S+LRKF FNDLKLATRNFRPESLLGEGGFGCVFKGW+EENGTAPVKP
Sbjct: 101 SSTSKLEEEFKVSSRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP 160

Query: 165 GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRG 224
           GTGLTVAVKTLNHDGLQGHKEWLAEVN+LG+L+HP+LVKL+GYCIEDDQRLLVYEFMPRG
Sbjct: 161 GTGLTVAVKTLNHDGLQGHKEWLAEVNYLGDLVHPHLVKLIGYCIEDDQRLLVYEFMPRG 220

Query: 225 SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL 284
           SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE+PVIYRDFKTSNILLDA+YNAKL
Sbjct: 221 SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNAKL 280

Query: 285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRS 344
           SDFGLAKD PE  KTHVSTRVMGTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEMLTGRRS
Sbjct: 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 340

Query: 345 MDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA 404
           MDKNRPNGEHNLVEWARPHLG++RRFYRL+DPRLEGHFSIKG+QKA  LAA CLSRDPKA
Sbjct: 341 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAHLAAHCLSRDPKA 400

Query: 405 RPRMSEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPLR 464
           RP MSEVVE LKPL NLKDMASSSYYFQTMQAD   +  N++NG RTQG  +TRNGQ  R
Sbjct: 401 RPLMSEVVEALKPLPNLKDMASSSYYFQTMQADRFSASPNTRNG-RTQGALLTRNGQQQR 459

Query: 465 TLSHPNGPHASPYRH--PQQSPKPNGK 489
           +LS P+G HASPY H  PQ SPKPNGK
Sbjct: 460 SLSIPHGTHASPYHHQFPQPSPKPNGK 486

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356526888|ref|XP_003532048.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Glycine max]

 Score =  779 bits (2012), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 377/447 (84%), Positives = 405/447 (90%), Gaps = 4/447 (0%)

Query: 46  GCWVRFRFIESCMPSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVV-PVSSTTTSNAESA 104
           GCW R RFI SC+ SRSKVDSS+SGTSTNYA+ KS+ +  RD+P +  VSSTTTSNAES 
Sbjct: 41  GCWFRLRFIGSCISSRSKVDSSVSGTSTNYAESKSTIDTSRDQPTLRVVSSTTTSNAESN 100

Query: 105 SSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKP 164
           SST K  EELKVAS+LRKF FNDLKLATRNFRPESLLGEGGFGCVFKGW+EENGTAPVKP
Sbjct: 101 SSTSKLEEELKVASRLRKFAFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP 160

Query: 165 GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRG 224
           GTGLTVAVKTLNHDGLQGHKEWLAEVN+LG+L+HP+LVKL+GYCIEDDQRLLVYEFMPRG
Sbjct: 161 GTGLTVAVKTLNHDGLQGHKEWLAEVNYLGDLVHPHLVKLIGYCIEDDQRLLVYEFMPRG 220

Query: 225 SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL 284
           SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE+PVIYRDFKTSNILLDA+YN+KL
Sbjct: 221 SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNSKL 280

Query: 285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRS 344
           SDFGLAKD PE  KTHVSTRVMGTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEMLTGRRS
Sbjct: 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 340

Query: 345 MDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA 404
           MDKNRPNGEHNLVEWARPHLG++RRFY+L+DPRLEGHFSIKG+QKA  LAA CLSRDPKA
Sbjct: 341 MDKNRPNGEHNLVEWARPHLGERRRFYKLIDPRLEGHFSIKGAQKAAHLAAHCLSRDPKA 400

Query: 405 RPRMSEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPLR 464
           RP MSEVVE LKPL NLKDMASSSYYFQTMQAD      N++NG RTQG  +TRNGQ  R
Sbjct: 401 RPLMSEVVEALKPLPNLKDMASSSYYFQTMQADRFSVSPNTRNG-RTQGALLTRNGQQQR 459

Query: 465 TLSHPNGPHASPYRH--PQQSPKPNGK 489
           +LS P+G HASPY H  PQ SPKPNGK
Sbjct: 460 SLSIPHGTHASPYHHQFPQPSPKPNGK 486

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|351722951|ref|NP_001235470.1| serine/threonine protein kinase-like protein [Glycine max] gi|223452506|gb|ACM89580.1| serine/threonine protein kinase-like protein [Glycine max]

 Score =  775 bits (2000), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 377/454 (83%), Positives = 408/454 (89%), Gaps = 7/454 (1%)

Query: 42  EEEIGCWVRFRFIESCMPSRSKVDSSMSG--TSTNYADGKSSNEKRRDRPVVP-VSSTTT 98
           E E GCWVR RFI SC+ SRSKVD+S+SG  TST+YA+ KS+N+  RD+P  P VSSTTT
Sbjct: 32  EAEAGCWVRLRFIGSCISSRSKVDTSVSGSGTSTHYAESKSTNDTSRDQPTAPAVSSTTT 91

Query: 99  SNAES-ASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEEN 157
           SNAES +SST K  EELK+AS+LRKF FN+LKLATRNFRPES LGEGGFGCVFKGW+EEN
Sbjct: 92  SNAESNSSSTSKLEEELKIASRLRKFSFNELKLATRNFRPESFLGEGGFGCVFKGWIEEN 151

Query: 158 GTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV 217
           GTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG+L+HPNLVKLVGYCIE+DQRLLV
Sbjct: 152 GTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHPNLVKLVGYCIEEDQRLLV 211

Query: 218 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD 277
           YEFMPRGSLENHLFRRS+PLPWSIRMKIALGAAKGLAFLHEEAE+PVIYRDFKTSNILLD
Sbjct: 212 YEFMPRGSLENHLFRRSIPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 271

Query: 278 ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLE 337
           A+YNAKLSDFGLAKD PE  KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLE
Sbjct: 272 AEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLE 331

Query: 338 MLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQC 397
           MLTGRRSMDK+RPNGEHNLVEWARPHLG++RRFYRL+DPRLEGHFS+KG+QKA  LAA C
Sbjct: 332 MLTGRRSMDKHRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSVKGAQKAALLAAHC 391

Query: 398 LSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMT 457
           LSRDPKARP MSEVVE LKPL NLKDMASSSYYFQ MQAD   +  N++NG R QG  +T
Sbjct: 392 LSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQAMQADRIGASPNTRNG-RMQGALLT 450

Query: 458 RNGQPLRTLSHPNGPHASPYRH--PQQSPKPNGK 489
           RNGQ  R+LS PNG +ASPY H  PQ SPKPNGK
Sbjct: 451 RNGQQQRSLSIPNGTYASPYHHQFPQPSPKPNGK 484

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356498172|ref|XP_003517927.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Glycine max]

 Score =  772 bits (1993), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 374/448 (83%), Positives = 403/448 (89%), Gaps = 6/448 (1%)

Query: 47  CWVRFRFIESCMPSRSKVDSSMS--GTSTNYADGKSSNEKRRDRPVVP-VSSTTTSNAES 103
           CWVR RFI SC+ SRSKVD+S+S  G ST+YA+ KS+N+  RD+P  P VSSTTTSNAES
Sbjct: 44  CWVRLRFIGSCISSRSKVDTSVSASGISTHYAESKSTNDTSRDQPTAPAVSSTTTSNAES 103

Query: 104 ASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVK 163
            SST K  EELK+AS+LRKF FNDLK ATRNFRPES LGEGGFGCVFKGW+EENGTAPVK
Sbjct: 104 NSSTSKLEEELKIASRLRKFSFNDLKSATRNFRPESFLGEGGFGCVFKGWIEENGTAPVK 163

Query: 164 PGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR 223
           PGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG+L+HPNLVKLVGYCIEDDQRLLVYEFMPR
Sbjct: 164 PGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHPNLVKLVGYCIEDDQRLLVYEFMPR 223

Query: 224 GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK 283
           GSLENHLFRRS+PLPWSIRMKIALGAAKGLAFLHEEAE+PVIYRDFKTSNILLDADYNAK
Sbjct: 224 GSLENHLFRRSMPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 283

Query: 284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 343
           LSDFGLAKD PE  KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR
Sbjct: 284 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 343

Query: 344 SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPK 403
           SMDK+RPNGEHNLVEWARPHLG++RRFYRL+DPRLEGHFS+KG+QKA QLAA CLSRDPK
Sbjct: 344 SMDKHRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSVKGAQKAAQLAAHCLSRDPK 403

Query: 404 ARPRMSEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPL 463
           +RP MSEVVE LKPL +LKDMASSSYYFQ MQAD   +  N++NG R QG  +TRNGQ  
Sbjct: 404 SRPLMSEVVEALKPLPSLKDMASSSYYFQAMQADRFGASPNTRNG-RMQGALLTRNGQQQ 462

Query: 464 RTLSHPNGPHASPYRH--PQQSPKPNGK 489
           R+LS PNG +ASPY H  PQ SPKPNGK
Sbjct: 463 RSLSIPNGTYASPYHHQFPQPSPKPNGK 490

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	490
TAIR|locus:2147805	493	AT5G15080 [Arabidopsis thalian	0.887	0.882	0.785	9.1e-187
TAIR|locus:2100282	490	AT3G01300 [Arabidopsis thalian	0.893	0.893	0.775	6.8e-182
TAIR|locus:2095517	453	AT3G28690 [Arabidopsis thalian	0.885	0.958	0.764	5.5e-180
TAIR|locus:2058847	426	APK2B "protein kinase 2B" [Ara	0.746	0.859	0.579	2.6e-111
TAIR|locus:2053240	423	PK1B "protein kinase 1B" [Arab	0.642	0.744	0.645	2.6e-111
TAIR|locus:2180127	389	NAK [Arabidopsis thaliana (tax	0.671	0.845	0.613	3.3e-111
TAIR|locus:2150019	410	AT5G01020 [Arabidopsis thalian	0.628	0.751	0.667	1.1e-110
TAIR|locus:2012492	426	APK2A "protein kinase 2A" [Ara	0.744	0.856	0.557	7e-109
TAIR|locus:2039772	395	BIK1 "botrytis-induced kinase1	0.634	0.787	0.612	8.3e-106
TAIR|locus:2205050	387	AT1G69790 [Arabidopsis thalian	0.748	0.948	0.523	2.3e-103

TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)]

 Score = 1811 (642.6 bits), Expect = 9.1e-187, P = 9.1e-187
 Identities = 355/452 (78%), Positives = 383/452 (84%)

Query:    46 GCWVRFRFIESCMPSRSKVDSSMS---GTSTNYA--DGKSSNEKRRDRPVVPVXXXXXXX 100
             GCWV+FRF+  C+PS+S +D+S S   G++      + KS+NEK  D+PV  V       
Sbjct:    47 GCWVKFRFMIGCIPSKSDLDASSSSIYGSNCTVTTMESKSANEKSNDQPVGQVSSTTTTS 106

Query:   101 XX-XXXXXPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGT 159
                     P  SEEL ++S LRKF FNDLKL+TRNFRPESLLGEGGFGCVFKGW+EENGT
Sbjct:   107 NAESSSSTPVISEELNISSHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGT 166

Query:   160 APVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYE 219
             APVKPGTGLTVAVKTLN DGLQGHKEWLAE+NFLGNLLHPNLVKLVGYCIEDDQRLLVYE
Sbjct:   167 APVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYE 226

Query:   220 FMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD 279
             FMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL+FLHEEA KPVIYRDFKTSNILLDAD
Sbjct:   227 FMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDAD 286

Query:   280 YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 339
             YNAKLSDFGLAKDAP++GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML
Sbjct:   287 YNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 346

Query:   340 TGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLS 399
             TGRRSMDKNRPNGEHNLVEWARPHL DKRRFYRLLDPRLEGHFSIKG+QK TQLAAQCLS
Sbjct:   347 TGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLS 406

Query:   400 RDPKARPRMSEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRN 459
             RDPK RP+MS+VVE LKPL +LKDMASSSYYFQTMQA+        KNG     GF +RN
Sbjct:   407 RDPKIRPKMSDVVEALKPLPHLKDMASSSYYFQTMQAERL------KNGSGRSQGFGSRN 460

Query:   460 GQ--PL-RTLSHPNGPHASPYRHPQQSPKPNG 488
             GQ  P+ RTLS P+G  +SPYRH   SPKP G
Sbjct:   461 GQHQPVFRTLSSPHG--SSPYRHQIPSPKPKG 490

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)]

 Score = 1765 (626.4 bits), Expect = 6.8e-182, P = 6.8e-182
 Identities = 346/446 (77%), Positives = 377/446 (84%)

Query:    46 GCWVRFRFIESCMPSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPVXXXXXXXXXXXX 105
             GCWV+FR+I  C  S S V++S++  ST+    +S+  +  D+PV PV            
Sbjct:    47 GCWVKFRYIVCCASSTSDVETSLT-LSTSTVGSQSAIVQSNDQPVGPVSSTTTTSNAESS 105

Query:   106 -XXPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKP 164
                P  SEEL + S L+KF F DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKP
Sbjct:   106 LSTPIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKP 165

Query:   165 GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRG 224
             GTGLTVAVKTLN DGLQGHKEWLAE+N+LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRG
Sbjct:   166 GTGLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRG 225

Query:   225 SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL 284
             SLENHLFRRSLPLPWSIRMKIALGAAKGL+FLHEEA KPVIYRDFKTSNILLD +YNAKL
Sbjct:   226 SLENHLFRRSLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKL 285

Query:   285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRS 344
             SDFGLAKDAP++GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRS
Sbjct:   286 SDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRS 345

Query:   345 MDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA 404
             MDKNRPNGEHNLVEWARPHL DKRRFYRLLDPRLEGHFS+KG+QK TQLAAQCLSRD K 
Sbjct:   346 MDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKI 405

Query:   405 RPRMSEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPL- 463
             RP+MSEVVE LKPL +LKDMAS+SYYFQTMQA+   +   S +G R   GF +RNGQP+ 
Sbjct:   406 RPKMSEVVEVLKPLPHLKDMASASYYFQTMQAERLKAGSGSGSG-R---GFGSRNGQPVF 461

Query:   464 RTLSHPNGPH-ASPYRHPQQSPKPNG 488
             RTLS P+G   +SPYRH   SPKP G
Sbjct:   462 RTLSSPHGQAGSSPYRHQIPSPKPKG 487

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)]

 Score = 1747 (620.0 bits), Expect = 5.5e-180, P = 5.5e-180
 Identities = 341/446 (76%), Positives = 379/446 (84%)

Query:    46 GCWVRFRFIESCMPSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPVXXXXXXXXXXXX 105
             G W RF+FI SC+ SRSKVDSSM+ T+   A+ K   EK    P  P             
Sbjct:    18 GFWFRFKFIFSCISSRSKVDSSMNATAV-IAEPKKVIEKLEGHPA-PTKDTGCAESGSST 75

Query:   106 XXPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPG 165
               P  S ELK +S+LR FMFNDLKLATRNFRPESLLGEGGFGCVFKGW+EENGTAPVKPG
Sbjct:    76 --PLMSGELKYSSKLRIFMFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPG 133

Query:   166 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGS 225
             TGLTVAVKTLN DGLQGHKEWLAE+NFLGNL+HP+LVKLVGYC+E+DQRLLVYEFMPRGS
Sbjct:   134 TGLTVAVKTLNPDGLQGHKEWLAEINFLGNLVHPSLVKLVGYCMEEDQRLLVYEFMPRGS 193

Query:   226 LENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS 285
             LENHLFRR+LPLPWS+RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD +YNAKLS
Sbjct:   194 LENHLFRRTLPLPWSVRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLS 253

Query:   286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM 345
             DFGLAKDAP++ K+HVSTRVMGTYGYAAPEYVMTGHLT+KSDVYSFGVVLLE+LTGRRS+
Sbjct:   254 DFGLAKDAPDEKKSHVSTRVMGTYGYAAPEYVMTGHLTTKSDVYSFGVVLLEILTGRRSV 313

Query:   346 DKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
             DK+RPNGE NLVEW RPHL DK+RFYRLLDPRLEGH+SIKG+QKATQ+AAQCL+RD KAR
Sbjct:   314 DKSRPNGEQNLVEWVRPHLLDKKRFYRLLDPRLEGHYSIKGAQKATQVAAQCLNRDSKAR 373

Query:   406 PRMSEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGG-FMTRNGQPLR 464
             P+MSEVVE LKPL NLKD ASSS  FQTMQ         +KNG+RTQGG F++RNG P+R
Sbjct:   374 PKMSEVVEALKPLPNLKDFASSSSSFQTMQPV-------AKNGVRTQGGGFVSRNGPPMR 426

Query:   465 TLSHPNGPHASPYRHPQQSPKPNGKQ 490
             +LS  N P ASPYR+ +QSPKP GK+
Sbjct:   427 SLSSLNLPQASPYRYARQSPKPKGKE 452

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2058847 APK2B "protein kinase 2B" [Arabidopsis thaliana (taxid:3702)]

 Score = 1099 (391.9 bits), Expect = 2.6e-111, P = 2.6e-111
 Identities = 214/369 (57%), Positives = 265/369 (71%)

Query:    56 SCMPSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPVXXXXXXXXXXXXX-XPKFSEEL 114
             +C+ S +KVDSS      N A   S    +  R  VP                P+   E+
Sbjct:     3 NCLDSSAKVDSSSHSPHANSASLSSRVSSKTSRSTVPSSLSINSYSSVESLPTPRTEGEI 62

Query:   115 KVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT 174
               +  L+ F FN+LK ATRNFRP+SLLGEGGFG VFKGW++       KPG+G+ VAVK 
Sbjct:    63 LSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAVKK 122

Query:   175 LNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS 234
             L  +G QGHKEWL EVN+LG L HPNLVKLVGYC+E + RLLVYEFMP+GSLENHLFRR 
Sbjct:   123 LKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFRRG 182

Query:   235 L-PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 293
               PL W+IRMK+A+GAAKGL FLH+ A+  VIYRDFK +NILLDA++N+KLSDFGLAK  
Sbjct:   183 AQPLTWAIRMKVAIGAAKGLTFLHD-AKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAG 241

Query:   294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 353
             P   KTHVST+VMGT+GYAAPEYV TG LT+KSDVYSFGVVLLE+L+GRR++DK++   E
Sbjct:   242 PTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGME 301

Query:   354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
              +LV+WA P+LGDKR+ +R++D RL G +  KG+  A  LA QCL+ D K RP+MSEV+ 
Sbjct:   302 QSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLA 361

Query:   414 TLKPLQNLK 422
              L  L++ K
Sbjct:   362 KLDQLESTK 370

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2053240 PK1B "protein kinase 1B" [Arabidopsis thaliana (taxid:3702)]

 Score = 1099 (391.9 bits), Expect = 2.6e-111, P = 2.6e-111
 Identities = 206/319 (64%), Positives = 254/319 (79%)

Query:   108 PKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTG 167
             P+   E+  +  L+ F F +LK ATRNFRP+S+LGEGGFG VFKGW++E      KPGTG
Sbjct:    53 PRTEGEILQSPNLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTG 112

Query:   168 LTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLE 227
             + +AVK LN DG QGH+EWLAEVN+LG   HPNLVKL+GYC+ED+ RLLVYEFMPRGSLE
Sbjct:   113 VVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLE 172

Query:   228 NHLFRRSL---PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL 284
             NHLFRR     PL W++R+K+ALGAAKGLAFLH  AE  VIYRDFKTSNILLD++YNAKL
Sbjct:   173 NHLFRRGSYFQPLSWTLRLKVALGAAKGLAFLHN-AETSVIYRDFKTSNILLDSEYNAKL 231

Query:   285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRS 344
             SDFGLAKD P   K+HVSTR+MGTYGYAAPEY+ TGHLT+KSDVYS+GVVLLE+L+GRR+
Sbjct:   232 SDFGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRA 291

Query:   345 MDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA 404
             +DKNRP GE  LVEWARP L +KR+ +R++D RL+  +S++ + K   LA +CL+ + K 
Sbjct:   292 VDKNRPPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKL 351

Query:   405 RPRMSEVVETLKPLQNLKD 423
             RP M+EVV  L+ +Q L +
Sbjct:   352 RPNMNEVVSHLEHIQTLNE 370

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2180127 NAK [Arabidopsis thaliana (taxid:3702)]

 Score = 1098 (391.6 bits), Expect = 3.3e-111, P = 3.3e-111
 Identities = 205/334 (61%), Positives = 262/334 (78%)

Query:   108 PKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTG 167
             P+   E+   + L+ F  ++LK ATRNFRP+S++GEGGFGCVFKGW++E+  AP KPGTG
Sbjct:    41 PRTEGEILQNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTG 100

Query:   168 LTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLE 227
             + +AVK LN +G QGH+EWLAE+N+LG L HPNLVKL+GYC+E++ RLLVYEFM RGSLE
Sbjct:   101 IVIAVKRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLE 160

Query:   228 NHLFRRSL---PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL 284
             NHLFRR     PL W+ R+++ALGAA+GLAFLH  A+  VIYRDFK SNILLD++YNAKL
Sbjct:   161 NHLFRRGTFYQPLSWNTRVRMALGAARGLAFLHN-AQPQVIYRDFKASNILLDSNYNAKL 219

Query:   285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRS 344
             SDFGLA+D P    +HVSTRVMGT GYAAPEY+ TGHL+ KSDVYSFGVVLLE+L+GRR+
Sbjct:   220 SDFGLARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRA 279

Query:   345 MDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA 404
             +DKN+P GEHNLV+WARP+L +KRR  R++DPRL+G +S+  + K   LA  C+S D K+
Sbjct:   280 IDKNQPVGEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKS 339

Query:   405 RPRMSEVVETLKPLQNLKDMASSSYYFQTMQADN 438
             RP M+E+V+T++ L   K+ AS       +  DN
Sbjct:   340 RPTMNEIVKTMEELHIQKE-ASKEQQNPQISIDN 372

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009617 "response to bacterium" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

TAIR|locus:2150019 AT5G01020 [Arabidopsis thaliana (taxid:3702)]

 Score = 1093 (389.8 bits), Expect = 1.1e-110, P = 1.1e-110
 Identities = 211/316 (66%), Positives = 256/316 (81%)

Query:   108 PKFSEELKVA---SQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKP 164
             P+F ++ +     +Q+  F   +L+  T++FRP+ +LGEGGFG V+KG++++N    +K 
Sbjct:    39 PRFRDDSRTPISYAQVIPFTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLK- 97

Query:   165 GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRG 224
                L VAVK LN +GLQGH+EWL EVNFLG L HPNLVKL+GYC EDD RLLVYEFM RG
Sbjct:    98 --SLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRG 155

Query:   225 SLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK 283
             SLENHLFR++  PL WS RM IALGAAKGLAFLH  AE+PVIYRDFKTSNILLD+DY AK
Sbjct:   156 SLENHLFRKTTAPLSWSRRMMIALGAAKGLAFLHN-AERPVIYRDFKTSNILLDSDYTAK 214

Query:   284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 343
             LSDFGLAK  P+  +THVSTRVMGTYGYAAPEYVMTGHLT++SDVYSFGVVLLEMLTGR+
Sbjct:   215 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRK 274

Query:   344 SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPK 403
             S+DK RP+ E NLV+WARP L DKR+  +++DPRLE  +S++ +QKA  LA  CLS++PK
Sbjct:   275 SVDKTRPSKEQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPK 334

Query:   404 ARPRMSEVVETLKPLQ 419
             ARP MS+VVETL+PLQ
Sbjct:   335 ARPLMSDVVETLEPLQ 350

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000394 "RNA splicing, via endonucleolytic cleavage and ligation" evidence=RCA

GO:0009086 "methionine biosynthetic process" evidence=RCA

GO:0032880 "regulation of protein localization" evidence=RCA

TAIR|locus:2012492 APK2A "protein kinase 2A" [Arabidopsis thaliana (taxid:3702)]

 Score = 1076 (383.8 bits), Expect = 7.0e-109, P = 7.0e-109
 Identities = 207/371 (55%), Positives = 263/371 (70%)

Query:    56 SCMPSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPVXXXXXXXXXXXXXXP----KFS 111
             +C+ S +KVD+S      N A   S    +  R   P               P    +  
Sbjct:     3 NCLDSSAKVDNSNHSPHANSASSGSKVSSKTSRSTGPSGLSTTSYSTDSSFGPLPTLRTE 62

Query:   112 EELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVA 171
              E+  +  L+ F FN+LK AT+NFR ++LLGEGGFGCVFKGW+++      +PG+G+ VA
Sbjct:    63 GEILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVA 122

Query:   172 VKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF 231
             VK L  +G QGHKEWL EVN+LG L HPNLV LVGYC E + RLLVYEFMP+GSLENHLF
Sbjct:   123 VKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLF 182

Query:   232 RRSL-PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA 290
             RR   PL W+IRMK+A+GAAKGL FLHE A+  VIYRDFK +NILLDAD+NAKLSDFGLA
Sbjct:   183 RRGAQPLTWAIRMKVAVGAAKGLTFLHE-AKSQVIYRDFKAANILLDADFNAKLSDFGLA 241

Query:   291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
             K  P    THVST+V+GT+GYAAPEYV TG LT+KSDVYSFGVVLLE+++GRR+MD +  
Sbjct:   242 KAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNG 301

Query:   351 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 410
               E++LV+WA P+LGDKR+ +R++D +L G +  KG+  A  LA QCL+ D K RP+MSE
Sbjct:   302 GNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSE 361

Query:   411 VVETLKPLQNL 421
             V+ TL+ L+++
Sbjct:   362 VLVTLEQLESV 372

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2039772 BIK1 "botrytis-induced kinase1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1047 (373.6 bits), Expect = 8.3e-106, P = 8.3e-106
 Identities = 193/315 (61%), Positives = 247/315 (78%)

Query:   109 KFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGL 168
             K   E+  ++ ++ F FN+LKLATRNFRP+S++GEGGFGCVFKGW++E+   P KPGTGL
Sbjct:    41 KTEGEILSSTPVKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGL 100

Query:   169 TVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLEN 228
              +AVK LN +G QGH+EWL E+N+LG L HPNLVKL+GYC+ED+ RLLVYEFM +GSLEN
Sbjct:   101 VIAVKKLNQEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLEN 160

Query:   229 HLFRRSL---PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS 285
             HLFRR     PLPW +R+ +AL AAKGLAFLH +  K VIYRD K SNILLDADYNAKLS
Sbjct:   161 HLFRRGAYFKPLPWFLRVNVALDAAKGLAFLHSDPVK-VIYRDIKASNILLDADYNAKLS 219

Query:   286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM 345
             DFGLA+D P    ++VSTRVMGTYGYAAPEY+ +GHL ++SDVYSFGV+LLE+L+G+R++
Sbjct:   220 DFGLARDGPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRAL 279

Query:   346 DKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
             D NRP  E NLV+WARP+L  KR+   ++D RL+  +  + + +   +A QCLS +PK+R
Sbjct:   280 DHNRPAKEENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSR 339

Query:   406 PRMSEVVETLKPLQN 420
             P M +VV  L+ LQ+
Sbjct:   340 PTMDQVVRALQQLQD 354

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005730 "nucleolus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009620 "response to fungus" evidence=IEP

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

GO:0050832 "defense response to fungus" evidence=RCA;IMP

GO:0052033 "pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response" evidence=IMP

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006865 "amino acid transport" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

TAIR|locus:2205050 AT1G69790 [Arabidopsis thaliana (taxid:3702)]

 Score = 1024 (365.5 bits), Expect = 2.3e-103, P = 2.3e-103
 Identities = 198/378 (52%), Positives = 265/378 (70%)

Query:    56 SCMPSRSKV---DSSMSGTSTNYADGKSSNEKRRDRPVVPVXXXXXXXXXX-XXXXPKFS 111
             +C+ S ++V   +S+  G+S      K +   R     +P                P+  
Sbjct:     3 NCLDSSARVGNRESTFGGSSR--ISRKPNQSSRLSSLTIPSYSNNSFTTSSWSNLTPRSE 60

Query:   112 EELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVA 171
              EL  +  L+ F FN+LK ATRNF+P S++GEGGFGCV+KGW+ E   +P KPG+G+ VA
Sbjct:    61 GELLPSPTLKAFTFNELKTATRNFKPNSMIGEGGFGCVYKGWIGERSLSPSKPGSGMVVA 120

Query:   172 VKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF 231
             VK L  +G QGHKEWL EV++LG L H NLVKL+GYC+E ++RLLVYE+MP+GSLENHLF
Sbjct:   121 VKKLKSEGFQGHKEWLTEVHYLGRLHHMNLVKLIGYCLEGEKRLLVYEYMPKGSLENHLF 180

Query:   232 RRSL-PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA 290
             RR   P+PW  RMK+A  AA+GL+FLHE     VIYRDFK SNILLD D+NAKLSDFGLA
Sbjct:   181 RRGAEPIPWKTRMKVAFSAARGLSFLHEAK---VIYRDFKASNILLDVDFNAKLSDFGLA 237

Query:   291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
             K  P   +THV+T+V+GT GYAAPEY+ TG LTSKSDVYSFGVVLLE+L+GR ++DK++ 
Sbjct:   238 KAGPTGDRTHVTTQVIGTQGYAAPEYIATGRLTSKSDVYSFGVVLLELLSGRPTLDKSKV 297

Query:   351 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 410
               E NLV+WA P+L D+R+ +R++D +L G +  KG+  A  +A +CL+ +PK RP M++
Sbjct:   298 GVERNLVDWAIPYLVDRRKVFRIMDTKLGGQYPHKGACAAANIALRCLNTEPKLRPDMAD 357

Query:   411 VVETLKPLQ-NLKDMASS 427
             V+ TL+ L+ + K M S+
Sbjct:   358 VLSTLQQLETSSKKMGST 375

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9LFP7	Y5158_ARATH	2, ., 7, ., 1, 1, ., 1	0.766	0.9755	0.9695	yes	no
Q9SRH7	Y3130_ARATH	2, ., 7, ., 1, 1, ., 1	0.7912	0.9122	0.9122	no	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.979
3rd Layer	2.7.11	0.983

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00028989001 SubName- Full=Chromosome chr1 scaffold_46, whole genome shotgun sequence; (481 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	490
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-57
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-57
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-56
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-56
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	8e-55
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-53
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-51
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-40
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-37
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	8e-36
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	6e-35
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	5e-33
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-31
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-31
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-30
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-29
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-29
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-29
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-29
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-29
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	7e-29
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-28
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-28
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-27
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-27
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-27
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-27
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-27
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	7e-27
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	7e-27
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-26
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-26
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-26
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-25
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-25
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-25
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	6e-25
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	7e-25
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	8e-25
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-24
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-24
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-24
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-24
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-24
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	7e-24
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	8e-24
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-23
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-23
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-23
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-23
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-23
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	7e-23
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	7e-23
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-22
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-22
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-22
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-22
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-22
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-22
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-22
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-22
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	7e-22
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	7e-22
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-21
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-21
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-21
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-21
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-21
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-21
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-21
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-20
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-20
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-20
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-20
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-20
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-20
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-20
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-20
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-20
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-20
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	6e-20
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	6e-20
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	7e-20
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-19
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-19
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-19
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-19
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-19
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-19
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	6e-19
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	6e-19
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-19
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	8e-19
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-18
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-18
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-18
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-18
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-18
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-18
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	6e-18
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	6e-18
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	6e-18
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	7e-18
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	8e-18
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	8e-18
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	8e-18
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	9e-18
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-17
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-17
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-17
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-17
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-17
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-17
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-17
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	8e-17
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	9e-17
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	9e-17
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	9e-17
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-16
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-16
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-16
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-16
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-16
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-16
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-16
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-16
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-16
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-16
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-16
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-16
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-16
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-16
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-16
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-16
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-16
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	5e-16
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	8e-16
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-15
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-15
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-15
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-15
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-15
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-15
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-15
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-15
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-15
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-15
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-15
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-15
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-15
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-15
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-15
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-15
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	6e-15
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-15
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	6e-15
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-14
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-14
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-14
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-14
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-14
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-14
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-14
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-14
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-14
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-14
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-14
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-14
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	6e-14
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-14
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	7e-14
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	7e-14
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	8e-14
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-13
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-13
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-13
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-13
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-13
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	6e-13
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	7e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	7e-13
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	8e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	8e-13
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-12
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-12
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-12
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-12
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-12
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-12
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-12
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-12
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-12
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-12
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-12
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-12
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	6e-12
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	7e-12
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	7e-12
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	8e-12
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-11
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-11
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-11
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-11
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-11
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-11
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-11
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	3e-11
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	5e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	6e-11
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	6e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	7e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	7e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-10
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-10
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-10
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-10
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-10
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-10
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-10
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	5e-10
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	6e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	6e-10
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	6e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	6e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-10
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	7e-10
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	7e-10
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-09
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-09
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-09
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-09
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-09
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	6e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	7e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-08
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-08
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-08
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-08
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	4e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	6e-08
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	7e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	7e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-07
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	5e-07
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	9e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	4e-06
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-06
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	5e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	8e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	4e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	0.003
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	0.004

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  190 bits (485), Expect = 2e-57
 Identities = 93/279 (33%), Positives = 133/279 (47%), Gaps = 26/279 (9%)

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNL 196
              LGEG FG V+KG ++            + VAVKTL  D   Q  +E+L E   +  L
Sbjct: 4   GKKLGEGAFGEVYKGKLK-----GKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL 58

Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 256
            HPN+VKL+G C E++   +V E+M  G L ++L +    L  S  +  AL  A+G+ +L
Sbjct: 59  DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118

Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
                K  I+RD    N L+  +   K+SDFGL++D  +D   +          + APE 
Sbjct: 119 E---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD-DYYRKRGGKLPIRWMAPES 174

Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP 376
           +  G  TSKSDV+SFGV+L E+ T         P    +  E    +L   +  YRL  P
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTLGEQ-----PYPGMSNEE-VLEYL---KNGYRLPQP 225

Query: 377 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
                       +   L  QC + DP+ RP  SE+VE L
Sbjct: 226 P-------NCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  188 bits (480), Expect = 3e-57
 Identities = 80/278 (28%), Positives = 119/278 (42%), Gaps = 66/278 (23%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 199
           LGEGGFG V+    ++ G           VA+K +  +      E  L E+  L  L HP
Sbjct: 1   LGEGGFGTVYLARDKKTGK---------KVAIKIIKKEDSSSLLEELLREIEILKKLNHP 51

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           N+VKL G   +++   LV E+   GSL++ L      L     ++I L   +GL +LH  
Sbjct: 52  NIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH-- 109

Query: 260 AEKPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
               +I+RD K  NILLD+D    KL+DFGL+K    D        ++GT  Y APE ++
Sbjct: 110 -SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVLL 166

Query: 319 -TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPR 377
             G+ + KSD++S GV+L E+                                       
Sbjct: 167 GKGYYSEKSDIWSLGVILYEL--------------------------------------- 187

Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
                      +   L  + L +DP+ RP   E++E L
Sbjct: 188 ----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  188 bits (481), Expect = 1e-56
 Identities = 97/280 (34%), Positives = 138/280 (49%), Gaps = 27/280 (9%)

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNL 196
              LGEG FG V+KG ++         G  + VAVKTL  D   Q  +E+L E   +  L
Sbjct: 4   GKKLGEGAFGEVYKGTLK-----GKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL 58

Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAF 255
            HPN+VKL+G C E++  ++V E+MP G L ++L   R   L  S  +  AL  A+G+ +
Sbjct: 59  DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
           L     K  I+RD    N L+  +   K+SDFGL++D  +D    V         + APE
Sbjct: 119 LE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG-KLPIRWMAPE 174

Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 375
            +  G  TSKSDV+SFGV+L E+ T         P    +  E    +L   ++ YRL  
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFTLGEE-----PYPGMSNAE-VLEYL---KKGYRLPK 225

Query: 376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           P            +  +L  QC + DP+ RP  SE+VE L
Sbjct: 226 PP-------NCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  188 bits (479), Expect = 2e-56
 Identities = 93/284 (32%), Positives = 130/284 (45%), Gaps = 33/284 (11%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNF 192
           +     LG G FG V+K             GTG  VAVK L       +  +    E+  
Sbjct: 1   YELLRKLGSGSFGTVYKA---------KHKGTGKIVAVKILKKRSEKSKKDQTARREIRI 51

Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
           L  L HPN+V+L+    + D   LV E+   G L      R  PL      KIAL   +G
Sbjct: 52  LRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDL-FDYLSRGGPLSEDEAKKIALQILRG 110

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L +LH      +I+RD K  NILLD +   K++DFGLAK   +   + ++T V GT  Y 
Sbjct: 111 LEYLHSNG---IIHRDLKPENILLDENGVVKIADFGLAKKLLKSS-SSLTTFV-GTPWYM 165

Query: 313 APEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 371
           APE ++ G     K DV+S GV+L E+LTG+                     L   +   
Sbjct: 166 APEVLLGGNGYGPKVDVWSLGVILYELLTGK-------------PPFSGENILDQLQLIR 212

Query: 372 RLLDPRLEGHF--SIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
           R+L P LE        GS++A  L  +CL++DP  RP   E+++
Sbjct: 213 RILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  183 bits (468), Expect = 8e-55
 Identities = 94/282 (33%), Positives = 134/282 (47%), Gaps = 37/282 (13%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           LGEG FG V+KG ++         GT   VAVKTL      +  +E+L E + +  L HP
Sbjct: 7   LGEGAFGEVYKGTLK-----GDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           N+V+L+G C + +   +V E+MP G L + L +    L     +++AL  AKG+ +L   
Sbjct: 62  NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE-- 119

Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST------RVMGTYGYAA 313
             K  ++RD    N L+  +   K+SDFGL++D  ED             + M      A
Sbjct: 120 -SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM------A 172

Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 373
           PE +  G  TSKSDV+SFGV+L E+ T         P    +  E     L D    YRL
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFTLGEQ-----PYPGMSNEE-VLELLEDG---YRL 223

Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
             P            +  +L  QC + DP+ RP  SE+VE L
Sbjct: 224 PRPE-------NCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  180 bits (459), Expect = 2e-53
 Identities = 96/295 (32%), Positives = 133/295 (45%), Gaps = 54/295 (18%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHP 199
           LGEG FG V+KG          K G    VAVKTL  D   +  K++L E   +  L HP
Sbjct: 3   LGEGAFGEVYKG------KLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHP 56

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP--------LPWSIRMKIALGAAK 251
           N+V+L+G C E++   LV E+M  G L ++L +            L     +  A+  AK
Sbjct: 57  NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED------GKTHVSTRV 305
           G+ +L     K  ++RD    N L+  D   K+SDFGL++D  +D          +  R 
Sbjct: 117 GMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRW 173

Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE---HNL-VEWAR 361
           M      APE +  G  TSKSDV+SFGV+L E+ T           G      L  E   
Sbjct: 174 M------APESLKDGIFTSKSDVWSFGVLLWEIFT----------LGATPYPGLSNEEVL 217

Query: 362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
            +L   R+ YRL  P            +  +L   C   DP+ RP  SE+VE L+
Sbjct: 218 EYL---RKGYRLPKPEY-------CPDELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  175 bits (445), Expect = 2e-51
 Identities = 84/282 (29%), Positives = 122/282 (43%), Gaps = 35/282 (12%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFL 193
           +     LGEG FG V+               TG  VA+K +    ++  +E  L E+  L
Sbjct: 1   YEILEKLGEGSFGKVYLA---------RDKKTGKLVAIKVIKKKKIKKDRERILREIKIL 51

Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKG 252
             L HPN+V+L     ++D+  LV E+   G L + L  R  L      R          
Sbjct: 52  KKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE-AR-FYLRQILSA 109

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L +LH    K +++RD K  NILLD D + KL+DFGLA+      K    T V GT  Y 
Sbjct: 110 LEYLHS---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT--TFV-GTPEYM 163

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFY 371
           APE ++        D++S GV+L E+LTG+       P  G+  L+E  +     K  F 
Sbjct: 164 APEVLLGKGYGKAVDIWSLGVILYELLTGK------PPFPGDDQLLELFKKIGKPKPPFP 217

Query: 372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                          S +A  L  + L +DP+ R    E ++
Sbjct: 218 P---------PEWDISPEAKDLIRKLLVKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  144 bits (365), Expect = 5e-40
 Identities = 76/281 (27%), Positives = 123/281 (43%), Gaps = 48/281 (17%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 194
           F     +G+GGFG V+K   +          TG  VA+K +  +  +  ++ + E+  L 
Sbjct: 2   FEILEKIGKGGFGEVYKARHKR---------TGKEVAIKVIKLESKEKKEKIINEIQILK 52

Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
              HPN+VK  G  ++ D+  +V EF   GSL++ L   +  L  S    +     KGL 
Sbjct: 53  KCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLE 112

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           +LH      +I+RD K +NILL +D   KL DFGL+     D K   +   +GT  + AP
Sbjct: 113 YLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQL-SDTKARNTM--VGTPYWMAP 166

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGR---------RSMDKNRPNGEHNLVEWARPHLG 365
           E +       K+D++S G+  +E+  G+         +++ K   NG             
Sbjct: 167 EVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG------------- 213

Query: 366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
                  L +P        K S +      +CL ++P+ RP
Sbjct: 214 ----PPGLRNPE-------KWSDEFKDFLKKCLQKNPEKRP 243

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  138 bits (350), Expect = 1e-37
 Identities = 82/272 (30%), Positives = 128/272 (47%), Gaps = 34/272 (12%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVNFLGNLL 197
           LLG G FG V+    +          TG  +AVK+  L+ D  +  +    E+  L +L 
Sbjct: 7   LLGRGSFGSVYLALDK---------DTGELMAVKSVELSGDSEEELEALEREIRILSSLQ 57

Query: 198 HPNLVKLVGYCIEDDQR-LLVY-EFMPRGSLENHLFRRSLPLPWS-IRMKIALGAAKGLA 254
           HPN+V+  G   ++++  L ++ E++  GSL + L ++   LP   IR K      +GLA
Sbjct: 58  HPNIVRYYGSERDEEKNTLNIFLEYVSGGSL-SSLLKKFGKLPEPVIR-KYTRQILEGLA 115

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           +LH      +++RD K +NIL+D+D   KL+DFG AK   +      +  V GT  + AP
Sbjct: 116 YLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL 374
           E +        +D++S G  ++EM TG+       P  E      A   +G         
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMATGK------PPWSELGNPMAALYKIG-----SSGE 221

Query: 375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            P +  H     S++A     +CL RDPK RP
Sbjct: 222 PPEIPEHL----SEEAKDFLRKCLRRDPKKRP 249

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  134 bits (338), Expect = 8e-36
 Identities = 73/205 (35%), Positives = 104/205 (50%), Gaps = 14/205 (6%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLHP 199
           LGEG FG V     +  G       TG  VAVK+LNH G + H  ++  E+  L  L H 
Sbjct: 12  LGEGHFGKVELCRYDPLGD-----NTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHE 66

Query: 200 NLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 257
           N+VK  G C +   R   L+ E++P GSL ++L R    +     +  +    KG+ +L 
Sbjct: 67  NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG 126

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST--RVMGTYGYAAPE 315
               +  I+RD    NIL++++   K+SDFGLAK  PED   +          + Y APE
Sbjct: 127 S---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182

Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLT 340
            + T   +S SDV+SFGV L E+ T
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  130 bits (330), Expect = 6e-35
 Identities = 72/206 (34%), Positives = 106/206 (51%), Gaps = 19/206 (9%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVNFLGNLL 197
           L+G G FG V+KG   E         TG  VA+K   L     +  K  + E++ L NL 
Sbjct: 7   LIGRGAFGVVYKGLNLE---------TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK 57

Query: 198 HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 256
           HPN+VK +G  IE    L ++ E+   GSL   + ++  P P S+         +GLA+L
Sbjct: 58  HPNIVKYIG-SIETSDSLYIILEYAENGSLRQ-IIKKFGPFPESLVAVYVYQVLQGLAYL 115

Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           HE+    VI+RD K +NIL   D   KL+DFG+A    +  K      V+GT  + APE 
Sbjct: 116 HEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEV 170

Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTGR 342
           +     ++ SD++S G  ++E+LTG 
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  129 bits (323), Expect = 5e-33
 Identities = 99/378 (26%), Positives = 149/378 (39%), Gaps = 46/378 (12%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEV 190
           ++R    LGEG FG V+     +             VA+K L        KE    L E+
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRK------------LVALKVLAKKLESKSKEVERFLREI 48

Query: 191 NFLGNLLHP-NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIAL 247
             L +L HP N+VKL  +  ++    LV E++  GSLE+ L    R  PL  S  + I  
Sbjct: 49  QILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILA 108

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN-AKLSDFGLAKDAPEDGKT----HVS 302
                L +LH    K +I+RD K  NILLD D    KL DFGLAK  P+ G T     + 
Sbjct: 109 QILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALP 165

Query: 303 TRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRR-SMDKNRPNGEHNLVE 358
           +  +GT GY APE ++     + +S SD++S G+ L E+LTG      +   +     ++
Sbjct: 166 STSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK 225

Query: 359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE----- 413
                          L   L        S+ A+ L  + L++DPK R   S  +      
Sbjct: 226 IIL------ELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279

Query: 414 ----TLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPLRTLSHP 469
                   L +L     S+    ++       I +  +   +       +         P
Sbjct: 280 HLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDD-SNFSKELAP 338

Query: 470 NGPHASPYRHPQQSPKPN 487
           NG  +SP+          
Sbjct: 339 NGVSSSPHNSSSLLLSTA 356

Length = 384

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  120 bits (302), Expect = 4e-31
 Identities = 79/280 (28%), Positives = 130/280 (46%), Gaps = 34/280 (12%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLH 198
            +G+G FG V+KG ++              VAVKT         K  +L E   L    H
Sbjct: 2   KIGKGNFGDVYKGVLK----------GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDH 51

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 258
           PN+VKL+G C++     +V E +P GSL   L ++   L     ++++L AA G+ +L  
Sbjct: 52  PNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE- 110

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT--YGYAAPEY 316
              K  I+RD    N L+  +   K+SDFG++++  E+G  +  +  +      + APE 
Sbjct: 111 --SKNCIHRDLAARNCLVGENNVLKISDFGMSRE--EEGGIYTVSDGLKQIPIKWTAPEA 166

Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP 376
           +  G  TS+SDV+S+G++L E  +   +      N +       R  +      YR+  P
Sbjct: 167 LNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ------TRERI---ESGYRMPAP 217

Query: 377 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
           +L          +  +L  QC + DP+ RP  SE+   L+
Sbjct: 218 QLCPE-------EIYRLMLQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  120 bits (303), Expect = 4e-31
 Identities = 70/209 (33%), Positives = 109/209 (52%), Gaps = 28/209 (13%)

Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH 198
           + +G+G FG V  G              G  VAVK L  D       +LAE + +  L H
Sbjct: 12  ATIGKGEFGDVMLGDYR-----------GQKVAVKCLKDDSTAAQA-FLAEASVMTTLRH 59

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLAFLH 257
           PNLV+L+G  ++ +   +V E+M +GSL ++L  R    +  + ++  AL   +G+ +L 
Sbjct: 60  PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE 119

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP---EDGKTHVSTRVMGTYGYAAP 314
              EK  ++RD    N+L+  D  AK+SDFGLAK+A    + GK  V         + AP
Sbjct: 120 ---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK--------WTAP 168

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLT-GR 342
           E +     ++KSDV+SFG++L E+ + GR
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  116 bits (294), Expect = 6e-30
 Identities = 88/274 (32%), Positives = 124/274 (45%), Gaps = 48/274 (17%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGNLL 197
           LG+G FG V    V +  T       G   A+K L    +   KE    L E N L  + 
Sbjct: 1   LGKGSFGKVLL--VRKKDT-------GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN 51

Query: 198 HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRR-SLPLPWSIRM--KIALGAAKGL 253
           HP +VKL  Y  + +++L LV E+ P G L +HL +        +     +I L     L
Sbjct: 52  HPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLA----L 106

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
            +LH      +IYRD K  NILLDAD + KL+DFGLAK+   +G +  +T   GT  Y A
Sbjct: 107 EYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC-GTPEYLA 161

Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR--FY 371
           PE ++        D +S GV+L EMLTG+                   P   + R+  + 
Sbjct: 162 PEVLLGKGYGKAVDWWSLGVLLYEMLTGK------------------PPFYAEDRKEIYE 203

Query: 372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           ++L   L   F    S +A  L +  L +DP  R
Sbjct: 204 KILKDPLR--FPEFLSPEARDLISGLLQKDPTKR 235

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  116 bits (292), Expect = 1e-29
 Identities = 70/296 (23%), Positives = 117/296 (39%), Gaps = 62/296 (20%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVN 191
            +     +G+G FG V+   V            G    +K   L++   +  ++ L EV 
Sbjct: 1   KYEIIKQIGKGSFGKVYL--VRRKSD-------GKLYVLKEIDLSNMSEKEREDALNEVK 51

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLL-VYEFMPRGSLENHLFRRSL---PLP----WSIRM 243
            L  L HPN++K      E+  +L  V E+   G L   + ++     P P        +
Sbjct: 52  ILKKLNHPNIIKYYE-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV 110

Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
           ++ L     L +LH    + +++RD K  NI L ++   KL DFG++K           T
Sbjct: 111 QLCLA----LKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISK-VLSSTVDLAKT 162

Query: 304 RVMGTYGYAAPE------YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 357
            V GT  Y +PE      Y        KSD++S G VL E+ T +   +           
Sbjct: 163 VV-GTPYYLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHPFEGENLLE----- 210

Query: 358 EWARPHLGDK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
                 L  K  +  Y    P +   +    S +   L +  L +DP+ RP ++++
Sbjct: 211 ------LALKILKGQY----PPIPSQY----SSELRNLVSSLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  116 bits (292), Expect = 2e-29
 Identities = 87/302 (28%), Positives = 128/302 (42%), Gaps = 63/302 (20%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLHP 199
           LG+G FG V++G         VK      VA+KT+N +     + E+L E + +      
Sbjct: 14  LGQGSFGMVYEG----LAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH 69

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--------FRRSLPLPWSIRM-KIALGAA 250
           ++V+L+G        L+V E M +G L+++L            L  P   +  ++A   A
Sbjct: 70  HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE------DGKTHVSTR 304
            G+A+L   A K  ++RD    N ++  D   K+ DFG+ +D  E       GK  +  R
Sbjct: 130 DGMAYL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
            M      APE +  G  T+KSDV+SFGVVL EM T               L E  +P+ 
Sbjct: 187 WM------APESLKDGVFTTKSDVWSFGVVLWEMAT---------------LAE--QPYQ 223

Query: 365 GDKRRFYRLLDPRLEGHFSIKGS---------QKATQLAAQCLSRDPKARPRMSEVVETL 415
           G        L       F I G           K  +L   C   +PK RP   E+V +L
Sbjct: 224 G--------LSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275

Query: 416 KP 417
           K 
Sbjct: 276 KD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  115 bits (290), Expect = 2e-29
 Identities = 71/211 (33%), Positives = 103/211 (48%), Gaps = 24/211 (11%)

Query: 135 FRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           F  E  LG G FG V++G W              + VA+K L  D L   +++  EV  L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWK-----------NRVRVAIKILKSDDLLKQQDFQKEVQAL 56

Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR----RSLPLPWSIRMKIALGA 249
             L H +L+ L   C   +   ++ E M +GSL     R    + LP+   I M  A   
Sbjct: 57  KRLRHKHLISLFAVCSVGEPVYIITELMEKGSLL-AFLRSPEGQVLPVASLIDM--ACQV 113

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           A+G+A+L    E+  I+RD    NIL+  D   K++DFGLA+   ED       ++   Y
Sbjct: 114 AEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PY 168

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            + APE    G  ++KSDV+SFG++L EM T
Sbjct: 169 KWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  115 bits (290), Expect = 3e-29
 Identities = 82/282 (29%), Positives = 120/282 (42%), Gaps = 34/282 (12%)

Query: 140 LLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNLL 197
            LG+G FG V +G W    G         + VAVK L  D L     ++L E   + +L 
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKV-------IPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD 54

Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLAFL 256
           H NL++L G  +     ++V E  P GSL + L + +L     S     A+  A G+ +L
Sbjct: 55  HENLIRLYG-VVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYL 113

Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST---RVMGTYGYAA 313
                K  I+RD    NILL +D   K+ DFGL +  P++   +V     +V   + + A
Sbjct: 114 ES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCA 168

Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 373
           PE + T   +  SDV+ FGV L EM T          +G   L         D +   RL
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-SGSQIL------KKID-KEGERL 220

Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
             P           Q    +  QC + +P  RP  + + E L
Sbjct: 221 ERPE-------ACPQDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  116 bits (291), Expect = 3e-29
 Identities = 90/293 (30%), Positives = 133/293 (45%), Gaps = 18/293 (6%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVN 191
           R  +   +LGEG FG V     +     P   GTG  VAVKTL  +  Q +   W  E+N
Sbjct: 4   RYLKKIRVLGEGHFGKVSLYCYD-----PANDGTGEMVAVKTLKRECGQQNTSGWKKEIN 58

Query: 192 FLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 249
            L  L H N+VK  G C E   +   L+ E++P GSL ++L +  L L  +  +  A   
Sbjct: 59  ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNL--AQLLLFAQQI 116

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
            +G+A+LH    +  I+RD    N+LLD D   K+ DFGLAK  PE G  +   R  G  
Sbjct: 117 CEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVREDGDS 172

Query: 310 G--YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
              + A E +     +  SDV+SFGV L E+LT      ++ P     ++   +  +   
Sbjct: 173 PVFWYAVECLKENKFSYASDVWSFGVTLYELLT-HCDSKQSPPKKFEEMIGPKQGQM-TV 230

Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN 420
            R   LL+  +         Q+   L   C   + K RP    ++  LK + +
Sbjct: 231 VRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  114 bits (286), Expect = 7e-29
 Identities = 82/276 (29%), Positives = 129/276 (46%), Gaps = 33/276 (11%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +G G FG V+ G W+E+             VA+KT+  +G    ++++ E   +  L HP
Sbjct: 12  IGSGQFGLVWLGYWLEKR-----------KVAIKTI-REGAMSEEDFIEEAQVMMKLSHP 59

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
            LV+L G C E     LV+EFM  G L ++L  +         + + L   +G+A+L   
Sbjct: 60  KLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS 119

Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
               VI+RD    N L+  +   K+SDFG+ +   +D  T  ST       +++PE    
Sbjct: 120 N---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS-STGTKFPVKWSSPEVFSF 175

Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
              +SKSDV+SFGV++ E+ +  ++  +NR N E  +VE            +RL  PRL 
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE--VVE-------TINAGFRLYKPRL- 225

Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
                  SQ   +L   C    P+ RP  S ++  L
Sbjct: 226 ------ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  113 bits (285), Expect = 1e-28
 Identities = 84/278 (30%), Positives = 122/278 (43%), Gaps = 35/278 (12%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG G  G V K           +P TG  +AVKT+  +      K+ L E++ L     P
Sbjct: 9   LGAGNSGVVSK--------VLHRP-TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSP 59

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
            +V   G    +    +  E+M  GSL+  L      +P  I  KIA+   KGL +LHE+
Sbjct: 60  YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119

Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED-GKTHVSTRVMGTYGYAAPEYVM 318
            +  +I+RD K SNIL+++    KL DFG++        KT V     GT  Y APE + 
Sbjct: 120 HK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPERIQ 172

Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD--- 375
               + KSD++S G+ L+E+ TGR                   P  G       +++   
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGRFPYPP-----------ENDPPDGIFELLQYIVNEPP 221

Query: 376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
           PRL      K S         CL +DP+ RP   E++E
Sbjct: 222 PRLPSG---KFSPDFQDFVNLCLIKDPRERPSYKELLE 256

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  112 bits (283), Expect = 3e-28
 Identities = 90/272 (33%), Positives = 126/272 (46%), Gaps = 42/272 (15%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V+ G W   NGT  V        AVKTL   G    + +L E   +  L H 
Sbjct: 14  LGAGQFGEVWMGTW---NGTTKV--------AVKTLK-PGTMSPEAFLQEAQIMKKLRHD 61

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
            LV+L   C E++   +V E+M +GSL + L     + L LP  + M  A   A+G+A+L
Sbjct: 62  KLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM--AAQIAEGMAYL 119

Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPE 315
                +  I+RD    NIL+  +   K++DFGLA+   +D  T     +      + APE
Sbjct: 120 E---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF--PIKWTAPE 174

Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLL 374
               G  T KSDV+SFG++L E++T  R      P  G  N     R  L    R YR+ 
Sbjct: 175 AANYGRFTIKSDVWSFGILLTEIVTYGRV-----PYPGMTN-----REVLEQVERGYRM- 223

Query: 375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            PR          ++   L  QC  +DP+ RP
Sbjct: 224 -PRPPNC-----PEELYDLMLQCWDKDPEERP 249

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  110 bits (278), Expect = 1e-27
 Identities = 84/285 (29%), Positives = 130/285 (45%), Gaps = 48/285 (16%)

Query: 140 LLGEGGFGCVFKGWVEENGT-APVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH 198
           LLG G FG V++G   ++G    VK      V++      G +  K+   E+  L  L H
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVK-----EVSLADDGQTGQEAVKQLEQEIALLSKLQH 61

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWS-IRM---KIALGAAKGLA 254
           PN+V+ +G   E+D   +  E +P GSL   L ++    P   IR+   +I LG    L 
Sbjct: 62  PNIVQYLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLG----LE 116

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM-----GTY 309
           +LH+   +  ++RD K +NIL+D +   KL+DFG+AK         V          G+ 
Sbjct: 117 YLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSP 165

Query: 310 GYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
            + APE +   G     +D++S G  +LEM TG+       P  +   V  A   +G  +
Sbjct: 166 YWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK------PPWSQLEGVA-AVFKIGRSK 218

Query: 369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                  P +  H     S +A     +CL RDP  RP  +E++E
Sbjct: 219 EL-----PPIPDHL----SDEAKDFILKCLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  111 bits (279), Expect = 1e-27
 Identities = 70/215 (32%), Positives = 98/215 (45%), Gaps = 23/215 (10%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLT-VAVKTLNHDGL-QGHKEWLAEVNFLGNLLH 198
           LGEG FG VF G         ++P      VAVKTL         K++  E   L N  H
Sbjct: 13  LGEGAFGKVFLGECYH-----LEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQH 67

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRRSL-------PLPWSIRMKI 245
            N+VK  G C E D  ++V+E+M  G L   L                   L  S  ++I
Sbjct: 68  ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127

Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
           A+  A G+ +L   A +  ++RD  T N L+  D   K+ DFG+++D        V    
Sbjct: 128 AVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHT 184

Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           M    +  PE +M    T++SDV+SFGVVL E+ T
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  110 bits (278), Expect = 1e-27
 Identities = 75/283 (26%), Positives = 125/283 (44%), Gaps = 34/283 (12%)

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW--LAEVNFLGN 195
           E ++G G FG V +G ++  G   +       VA+KTL   G    +    L E + +G 
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEI------DVAIKTL-KAGSSDKQRLDFLTEASIMGQ 61

Query: 196 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 255
             HPN+++L G   +    +++ E+M  GSL+  L            + +  G A G+ +
Sbjct: 62  FDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKY 121

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTHVSTRVMGTYGYAA 313
           L   +E   ++RD    NIL++++   K+SDFGL++  +  E   T    ++     + A
Sbjct: 122 L---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWTA 176

Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK-RRFYR 372
           PE +     TS SDV+SFG+V+ E+++           GE    + +   +       YR
Sbjct: 177 PEAIAYRKFTSASDVWSFGIVMWEVMS----------YGERPYWDMSNQDVIKAVEDGYR 226

Query: 373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           L  P               QL   C  +D   RP  S++V TL
Sbjct: 227 LPPPM-------DCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  111 bits (279), Expect = 1e-27
 Identities = 68/227 (29%), Positives = 116/227 (51%), Gaps = 25/227 (11%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLH 198
           LG G FG V+KG W+ E     VK    + VA+K L  +   + +KE L E   + ++ H
Sbjct: 15  LGSGAFGTVYKGVWIPEG--EKVK----IPVAIKVLREETSPKANKEILDEAYVMASVDH 68

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRRSLPLPWSIRMKIALGAAKG 252
           P++V+L+G C+   Q  L+ + MP G L +++            L W +++      AKG
Sbjct: 69  PHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKG 121

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           +++L E   K +++RD    N+L+    + K++DFGLAK    D K + +        + 
Sbjct: 122 MSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVE 358
           A E ++    T KSDV+S+GV + E++T G +  +        +L+E
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  108 bits (273), Expect = 6e-27
 Identities = 85/280 (30%), Positives = 128/280 (45%), Gaps = 33/280 (11%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V KG          K G  + VAVKTL       G KE+L E + +  L HP
Sbjct: 3   LGHGNFGSVVKGVYLM------KSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHP 56

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
            +V+L+G C  +   +LV E  P G L  +L +R   +P S   ++A   A G+A+L   
Sbjct: 57  CIVRLIGVCKGE-PLMLVMELAPLGPLLKYLKKRRE-IPVSDLKELAHQVAMGMAYLES- 113

Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY--GYAAPEYV 317
             K  ++RD    N+LL   + AK+SDFG+++ A   G  +      G +   + APE +
Sbjct: 114 --KHFVHRDLAARNVLLVNRHQAKISDFGMSR-ALGAGSDYYRATTAGRWPLKWYAPECI 170

Query: 318 MTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP 376
             G  +SKSDV+S+GV L E  + G +   + +      ++E             RL  P
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG----------ERLPRP 220

Query: 377 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
                   +  Q+   +   C    P+ RP  SE+  T +
Sbjct: 221 E-------ECPQEIYSIMLSCWKYRPEDRPTFSELESTFR 253

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  108 bits (272), Expect = 7e-27
 Identities = 76/276 (27%), Positives = 117/276 (42%), Gaps = 33/276 (11%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V  G W  +           + VA+K +  +G     +++ E   +  L HP
Sbjct: 12  LGSGQFGVVHLGKWRGK-----------IDVAIKMI-REGAMSEDDFIEEAKVMMKLSHP 59

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           NLV+L G C +     +V E+M  G L N+L  R   L     + +     + + +L   
Sbjct: 60  NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE-- 117

Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
                I+RD    N L+  D   K+SDFGLA+   +D  T  S        +A PE    
Sbjct: 118 -SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQGTKFPVKWAPPEVFDY 175

Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
              +SKSDV+SFGV++ E+ +  +   +   N E  +VE      G     YRL  P+L 
Sbjct: 176 SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVE--SVSAG-----YRLYRPKL- 225

Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
                    +   +   C    P+ RP   +++  L
Sbjct: 226 ------APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  108 bits (272), Expect = 7e-27
 Identities = 80/287 (27%), Positives = 128/287 (44%), Gaps = 48/287 (16%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 198
           +G+G FG VFK          V+       A+K ++   +     +E + E   L  L  
Sbjct: 8   IGKGSFGVVFKV---------VRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDS 58

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLP----WSIRMKIALGAAKGL 253
             +++     ++  +  +V E+   G L   L  +R  PLP    W   ++I LG    L
Sbjct: 59  SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----L 114

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
           A LH    K +++RD K+ N+ LDA  N K+ D G+AK       T+ +  ++GT  Y +
Sbjct: 115 AHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL--SDNTNFANTIVGTPYYLS 169

Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 373
           PE         KSDV++ GVVL E  TG+   D    N +  L+           +  R 
Sbjct: 170 PELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA---NNQGALI----------LKIIRG 216

Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN 420
           + P +   +    SQ+  QL  QCL++D + RP      +T + L+N
Sbjct: 217 VFPPVSQMY----SQQLAQLIDQCLTKDYRQRP------DTFQLLRN 253

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  108 bits (272), Expect = 1e-26
 Identities = 75/277 (27%), Positives = 124/277 (44%), Gaps = 44/277 (15%)

Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLL 197
            +LG+G  G V+K              TG   A+K ++ DG  +  K+ L E+  L +  
Sbjct: 7   KVLGQGSSGVVYKV---------RHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE 57

Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 257
            P +VK  G   ++ +  +V E+M  GSL + L ++   +P  +   IA    KGL +LH
Sbjct: 58  SPYVVKCYGAFYKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQILKGLDYLH 116

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
              ++ +I+RD K SN+L+++    K++DFG++K   E+     +T V GT  Y +PE +
Sbjct: 117 --TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL-ENTLDQCNTFV-GTVTYMSPERI 172

Query: 318 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD-- 375
                +  +D++S G+ LLE   G+                           F+ L+   
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS-----------------FFELMQAI 215

Query: 376 -----PRL-EGHFSIKGSQKATQLAAQCLSRDPKARP 406
                P L    F    S +     + CL +DPK RP
Sbjct: 216 CDGPPPSLPAEEF----SPEFRDFISACLQKDPKKRP 248

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  113 bits (284), Expect = 2e-26
 Identities = 90/300 (30%), Positives = 141/300 (47%), Gaps = 35/300 (11%)

Query: 121 RKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDG 179
           +    ND+  + +    E+++  G  G  +KG   +NG   V         VK +N  + 
Sbjct: 681 KSITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFV---------VKEINDVNS 728

Query: 180 LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 239
           +       +E+  +G L HPN+VKL+G C  +    L++E++   +L   L      L W
Sbjct: 729 IP-----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL----RNLSW 779

Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
             R KIA+G AK L FLH      V+  +     I++D      L    L      D K 
Sbjct: 780 ERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKC 838

Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLVE 358
            +S+       Y APE   T  +T KSD+Y FG++L+E+LTG+   D     G H ++VE
Sbjct: 839 FISS------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE--FGVHGSIVE 890

Query: 359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQ--KATQLAAQCLSRDPKARPRMSEVVETLK 416
           WAR    D       +DP + G  S+  ++  +   LA  C + DP ARP  ++V++TL+
Sbjct: 891 WARYCYSDC-HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949

Length = 968

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  107 bits (269), Expect = 2e-26
 Identities = 96/297 (32%), Positives = 137/297 (46%), Gaps = 52/297 (17%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTG-LTVAVKTLNHDGL-QGHKEWLAEVNFLGNLL 197
            LG G FG V++G      T  + PG+G + VAVKTL      Q  KE+L E + + N  
Sbjct: 2   FLGSGAFGEVYEG----TATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFN 57

Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-------FRRSLPLPWSIRMKIALGAA 250
           HPN+VKL+G C+ ++ + ++ E M  G L ++L       F   L L     + I L  A
Sbjct: 58  HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPL-LTLKELLDICLDVA 116

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILL-----DADYNAKLSDFGLAKDA------PEDGKT 299
           KG  +L +      I+RD    N L+     DAD   K+ DFGLA+D        ++G+ 
Sbjct: 117 KGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173

Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVE 358
            +  R M      APE ++ G  T++SDV+SFGV++ E+LT G       +P    N  E
Sbjct: 174 LLPVRWM------APESLLDGKFTTQSDVWSFGVLMWEILTLG------QQPYPALNNQE 221

Query: 359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
                L       RL  P            K  QL   C ++DP  RP    + E L
Sbjct: 222 V----LQHVTAGGRLQKPE-------NCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  104 bits (262), Expect = 2e-25
 Identities = 73/208 (35%), Positives = 105/208 (50%), Gaps = 25/208 (12%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V++G W   N T PV        AVKTL    +   K++LAE   +  L HP
Sbjct: 14  LGAGQFGEVWEGLW---NNTTPV--------AVKTLKPGTMDP-KDFLAEAQIMKKLRHP 61

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
            L++L   C  ++   +V E M  GSL  +L     R+L LP  I M  A   A G+A+L
Sbjct: 62  KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDM--AAQVASGMAYL 119

Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPE 315
             +     I+RD    N+L+  +   K++DFGLA+   ED        +      + APE
Sbjct: 120 EAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF--PIKWTAPE 174

Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLT-GR 342
             +    + KSDV+SFG++L E++T GR
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  104 bits (261), Expect = 2e-25
 Identities = 85/295 (28%), Positives = 123/295 (41%), Gaps = 62/295 (21%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQG-HKEWLAEVNFLGNLLH 198
           +G G FG V+           V   TG  +AVK +   D      KE   E+  L  L H
Sbjct: 8   IGGGTFGKVYTA---------VNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKH 58

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 258
           PNLVK  G  +  ++  +  E+   G+LE  L      L   +     L   +GLA+LH 
Sbjct: 59  PNLVKYYGVEVHREKVYIFMEYCSGGTLEE-LLEHGRILDEHVIRVYTLQLLEGLAYLHS 117

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV---MGTYGYAAPE 315
                +++RD K +NI LD +   KL DFG A    ++  T +   V    GT  Y APE
Sbjct: 118 ---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKL-KNNTTTMGEEVQSLAGTPAYMAPE 173

Query: 316 YV----MTGHLTSKSDVYSFGVVLLEMLTGRR---SMDKNRPNGEHNLVEWA-------- 360
            +      GH  + +D++S G V+LEM TG+R    +D           E+         
Sbjct: 174 VITGGKGKGHGRA-ADIWSLGCVVLEMATGKRPWSELDN----------EFQIMFHVGAG 222

Query: 361 -RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET 414
            +P + D       L    EG   +           +CL  DPK RP  SE+++ 
Sbjct: 223 HKPPIPDS------LQLSPEGKDFLD----------RCLESDPKKRPTASELLQH 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  104 bits (261), Expect = 3e-25
 Identities = 67/219 (30%), Positives = 105/219 (47%), Gaps = 33/219 (15%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGNLLH 198
           LGEG FG V+KG  E  G       T  +VA+KTL  N +  +  +E+  E   + +L H
Sbjct: 13  LGEGAFGKVYKG--ELTGPNERLSAT--SVAIKTLKENAEP-KVQQEFRQEAELMSDLQH 67

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRM 243
           PN+V L+G C ++    +++E++  G L   L R S                 L  S  +
Sbjct: 68  PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127

Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
            IA+  A G+ +L   +    ++RD    N L+      K+SDFGL++    D  +    
Sbjct: 128 HIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR----DIYSADYY 180

Query: 304 RVMGT----YGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 338
           RV         +  PE ++ G  T++SD++SFGVVL E+
Sbjct: 181 RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  103 bits (259), Expect = 6e-25
 Identities = 84/291 (28%), Positives = 121/291 (41%), Gaps = 43/291 (14%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHP 199
           LG G FG V++G         V+    L VAVKTL      Q   ++L E   +    H 
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVE----LQVAVKTLPESCSEQDESDFLMEALIMSKFNHQ 69

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL---PWSIRMK----IALGAAKG 252
           N+V+L+G   E   R ++ E M  G L++ L R + P    P S+ MK     A   AKG
Sbjct: 70  NIVRLIGVSFERLPRFILLELMAGGDLKSFL-RENRPRPERPSSLTMKDLLFCARDVAKG 128

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLD---ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
             +L E      I+RD    N LL        AK++DFG+A+D           R M   
Sbjct: 129 CKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HNLVEWAR--PHLG 365
            +  PE  + G  TSK+DV+SFGV+L E+ +        R N E    +    R  P  G
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKG 245

Query: 366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
                YR++                      C    P+ RP  + ++E ++
Sbjct: 246 CPGPVYRIM--------------------TDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  103 bits (259), Expect = 7e-25
 Identities = 66/235 (28%), Positives = 104/235 (44%), Gaps = 41/235 (17%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNF 192
           N      +G+G FG VF+      G  P +P T   VAVK L  +       ++  E   
Sbjct: 6   NIEYVRDIGQGAFGRVFQA--RAPGLLPYEPFT--MVAVKMLKEEASADMQADFQREAAL 61

Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS------------------ 234
           +    HPN+VKL+G C       L++E+M  G L   L  RS                  
Sbjct: 62  MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121

Query: 235 ---LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK 291
              LPL  + ++ IA   A G+A+L   +E+  ++RD  T N L+  +   K++DFGL++
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 178

Query: 292 DA------PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +              +  R M       PE +     T++SDV+++GVVL E+ +
Sbjct: 179 NIYSADYYKASENDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  103 bits (257), Expect = 8e-25
 Identities = 84/282 (29%), Positives = 131/282 (46%), Gaps = 35/282 (12%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGNLLH 198
           +LG+G +G V+ G   +     VK      V + T N    +   E L  EV+ L +L H
Sbjct: 7   VLGKGAYGTVYCGLTNQGQLIAVK-----QVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 258
            N+V+ +G C++D+   +  EF+P GS+ + L  R  PLP  +  K       G+A+LH 
Sbjct: 62  VNIVQYLGTCLDDNTISIFMEFVPGGSISSIL-NRFGPLPEPVFCKYTKQILDGVAYLHN 120

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG----KTHVSTRVMGTYGYAAP 314
                V++RD K +N++L  +   KL DFG A+     G     +++   + GT  + AP
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGR---RSMDKNRPNGEHNLVEWARPHLGDKRRFY 371
           E +       KSD++S G  + EM TG+    SMD+            A  ++G     +
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA----------AMFYIGA----H 223

Query: 372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
           R L PRL   F    S  A      CL+RD   RP   +++ 
Sbjct: 224 RGLMPRLPDSF----SAAAIDFVTSCLTRDQHERPSALQLLR 261

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score =  102 bits (256), Expect = 2e-24
 Identities = 86/300 (28%), Positives = 135/300 (45%), Gaps = 43/300 (14%)

Query: 141 LGEGGFGCVFKGWVEENGTAP-------VKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNF 192
           LGEG FG V    V      P       V+ G  L VAVK L  D  +  + ++L EV  
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72

Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL---------------PL 237
           L  L  PN+++L+G C+++D   ++ E+M  G L   L    L                L
Sbjct: 73  LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132

Query: 238 P---WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 294
           P   +S  + +AL  A G+ +L   +    ++RD  T N L+  +   K++DFG++++  
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189

Query: 295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE- 353
                 +  R +    + A E ++ G  T+ SDV++FGV L E+L     + K +P GE 
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL----MLCKEQPYGEL 245

Query: 354 --HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
               ++E A     D+ R   L  P           Q   +L  QC SRD + RP  S++
Sbjct: 246 TDEQVIENAGEFFRDQGRQVYLFRPPP-------CPQGLYELMLQCWSRDCRERPSFSDI 298

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  102 bits (256), Expect = 2e-24
 Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 23/208 (11%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN----HDGLQGHKEWLAEVNFLGNL 196
           +GEG  G VFK    E         TG TVA+K +       G+    + L E+  L   
Sbjct: 8   IGEGAHGIVFKAKDRE---------TGETVALKKVALRRLEGGIP--NQALREIKALQAC 56

Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 256
            HP +VKL+         +LV E+MP   L   L     PLP +          KG+A++
Sbjct: 57  QHPYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115

Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +++RD K +N+L+ AD   K++DFGLA+   E+     S +V  T  Y APE 
Sbjct: 116 HANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPE- 170

Query: 317 VMTG--HLTSKSDVYSFGVVLLEMLTGR 342
           ++ G        D+++ G +  E+L G 
Sbjct: 171 LLYGARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  101 bits (255), Expect = 3e-24
 Identities = 64/213 (30%), Positives = 107/213 (50%), Gaps = 22/213 (10%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAEV 190
           +     LGEG +G V+K   ++ G           VA+K +      +G+      L E+
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGE---------IVALKKIRLDNEEEGIP--STALREI 49

Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 250
           + L  L HPN+VKL+     + +  LV+E+     L+ +L +R  PL  ++   I     
Sbjct: 50  SLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLL 108

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
           +GLA+ H      +++RD K  NIL++ D   KL+DFGLA+      +T+ +  V+ T  
Sbjct: 109 RGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-TLW 163

Query: 311 YAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
           Y APE ++     S + D++S G +  EM+TG+
Sbjct: 164 YRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  102 bits (254), Expect = 4e-24
 Identities = 71/216 (32%), Positives = 101/216 (46%), Gaps = 24/216 (11%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LGEG FG VF    E    +P K    + VAVK L    L   K++  E   L NL H +
Sbjct: 13  LGEGAFGKVF--LAECYNLSPTK--DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP----------------LPWSIRMK 244
           +VK  G C + D  ++V+E+M  G L N   R   P                L  S  + 
Sbjct: 69  IVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127

Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           IA   A G+ +L   A +  ++RD  T N L+ A+   K+ DFG+++D        V   
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 184

Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            M    +  PE +M    T++SDV+SFGV+L E+ T
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  101 bits (253), Expect = 5e-24
 Identities = 73/213 (34%), Positives = 108/213 (50%), Gaps = 15/213 (7%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  E+  
Sbjct: 4   RHLKFIQQLGKGNFGSV-----ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEI 58

Query: 193 LGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 250
           L +L H N+VK  G C    +R   LV E++P GSL ++L +    L     +  A    
Sbjct: 59  LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQIC 118

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG--- 307
           KG+ +L     K  ++RD  T NIL++++   K+ DFGL K  P+D K +   R  G   
Sbjct: 119 KGMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD-KEYYKVREPGESP 174

Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            + Y APE +     +  SDV+SFGVVL E+ T
Sbjct: 175 IFWY-APESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  100 bits (249), Expect = 7e-24
 Identities = 85/278 (30%), Positives = 134/278 (48%), Gaps = 33/278 (11%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLH 198
           LLG+G FG VFKG +++             VAVKT   D  Q  K ++L+E   L    H
Sbjct: 2   LLGKGNFGEVFKGTLKDK----------TPVAVKTCKEDLPQELKIKFLSEARILKQYDH 51

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 258
           PN+VKL+G C +     +V E +P G   + L ++   L     +K AL AA G+A+L  
Sbjct: 52  PNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE- 110

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT-YGYAAPEYV 317
              K  I+RD    N L+  +   K+SDFG+++   ED   + S+ +      + APE +
Sbjct: 111 --SKNCIHRDLAARNCLVGENNVLKISDFGMSRQ--EDDGIYSSSGLKQIPIKWTAPEAL 166

Query: 318 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPR 377
             G  +S+SDV+S+G++L E      S+      G  N  + AR  +    + YR+  P+
Sbjct: 167 NYGRYSSESDVWSYGILLWETF----SLGVCPYPGMTN--QQAREQV---EKGYRMSCPQ 217

Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
                  K      ++  +C    P+ RP+ SE+ + L
Sbjct: 218 -------KCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  100 bits (250), Expect = 8e-24
 Identities = 80/286 (27%), Positives = 134/286 (46%), Gaps = 45/286 (15%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           LG G +G V++G W + +          LTVAVKTL  D ++   E+L E   +  + HP
Sbjct: 14  LGGGQYGEVYEGVWKKYS----------LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHP 62

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGLAFLH 257
           NLV+L+G C  +    ++ EFM  G+L ++L    R   +   + + +A   +  + +L 
Sbjct: 63  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLE 121

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEY 316
              +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE 
Sbjct: 122 ---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPES 176

Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLD 375
           +     + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLE 219

Query: 376 P--RLEGHFSIKG-SQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
              R+E     +G   K  +L   C   +P  RP  +E+ +  + +
Sbjct: 220 KGYRMERP---EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 99.6 bits (249), Expect = 2e-23
 Identities = 63/238 (26%), Positives = 96/238 (40%), Gaps = 49/238 (20%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH---------K 184
           +F+   ++GEG F  V             +  T    A+K L+   L            K
Sbjct: 2   DFKFGKIIGEGSFSTVVLAK---------EKETNKEYAIKILDKRQLIKEKKVKYVKIEK 52

Query: 185 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHL-FRRSLPLPWSIR 242
           E L  +N      HP ++KL  Y  +D++ L  V E+ P G L  ++    SL      R
Sbjct: 53  EVLTRLN-----GHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC-TR 105

Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
              A      L +LH    K +I+RD K  NILLD D + K++DFG AK    +     +
Sbjct: 106 FYAAE-ILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESN 161

Query: 303 TRVM------------------GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
                                 GT  Y +PE +        SD+++ G ++ +MLTG+
Sbjct: 162 KGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 99.5 bits (248), Expect = 2e-23
 Identities = 79/295 (26%), Positives = 129/295 (43%), Gaps = 44/295 (14%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNLL 197
           +LGEG FG V +G + ++  + +K      VAVKT+  D       +E+L+E   + +  
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLK------VAVKTMKLDIHTYSEIEEFLSEAACMKDFD 59

Query: 198 HPNLVKLVGYCIEDDQR------LLVYEFMPRGSLENHLFRRSLP-----LPWSIRMKIA 246
           HPN++KL+G C E          +++  FM  G L + L    L      LP    +K  
Sbjct: 60  HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           +  A G+ +L   + +  I+RD    N +L  D    ++DFGL+K     G  +   R+ 
Sbjct: 120 VDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKI-YSGDYYRQGRIA 175

Query: 307 GT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
                + A E +     TSKSDV++FGV + E+ T  R          H + ++      
Sbjct: 176 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT--RGQTPYPGVENHEIYDYL----- 228

Query: 366 DKRRFYRLLDPR--LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
             R   RL  P   L+  + +            C   DPK RP  +++ E L+ +
Sbjct: 229 --RHGNRLKQPEDCLDELYDL---------MYSCWRADPKDRPTFTKLREVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 99.4 bits (248), Expect = 2e-23
 Identities = 80/280 (28%), Positives = 120/280 (42%), Gaps = 40/280 (14%)

Query: 139 SLLGEGGFGCVFKGWVEENGTAPVK-PGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNL 196
           S LGEG  G V K           +   TG+  A+KT+  D      K+ L E+    + 
Sbjct: 7   SRLGEGAGGSVTK----------CRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC 56

Query: 197 LHPNLVKLVGYCIEDDQRLL--VYEFMPRGSLEN---HLFRRSLPLPWSIRMKIALGAAK 251
             P +VK  G  +++    +    E+   GSL++    + +R   +   +  KIA    K
Sbjct: 57  KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLK 116

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG-KTHVSTRVMGTYG 310
           GL++LH    + +I+RD K SNILL      KL DFG++ +       T       GT  
Sbjct: 117 GLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSF 168

Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM--DKNRPNGEHNLVEWARPHLGDKR 368
           Y APE +     +  SDV+S G+ LLE+   R     +   P G   L+ +         
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY--------- 219

Query: 369 RFYRLLDPRL--EGHFSIKGSQKATQLAAQCLSRDPKARP 406
               + +P L  E    IK S++      QCL +DP  RP
Sbjct: 220 -IVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRP 258

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 99.3 bits (247), Expect = 3e-23
 Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 12/213 (5%)

Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWL 187
           L     R   LLG G FG V KG W+ E  +  +       VA+KT+ +  G Q  +E  
Sbjct: 4   LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIP------VAIKTIQDRSGRQTFQEIT 57

Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
             +  +G+L H  +V+L+G C       LV +  P GSL +H+ +    L     +   +
Sbjct: 58  DHMLAMGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCV 116

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             AKG+ +L E     +++R+    NILL +D   +++DFG+A     D K +  +    
Sbjct: 117 QIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT 173

Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + A E ++ G  T +SDV+S+GV + EM++
Sbjct: 174 PIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 99.3 bits (248), Expect = 3e-23
 Identities = 82/295 (27%), Positives = 125/295 (42%), Gaps = 41/295 (13%)

Query: 141 LGEGGFGCV-------FKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNF 192
           LGEG FG V        + + E+           + VAVK L  D      +++L EV  
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72

Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRR----------SLPLPWSIR 242
           L  L  PN+ +L+G C  D    ++ E+M  G L   L +           S  L +S  
Sbjct: 73  LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132

Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
           + +A   A G+ +L        ++RD  T N L+  +Y  K++DFG++++        V 
Sbjct: 133 LYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189

Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGE---HNLVE 358
            R      + A E V+ G  T+KSDV++FGV L E+LT  R      +P        ++E
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE-----QPYEHLTDQQVIE 244

Query: 359 WA-RPHLGDKRRFYRLLDPRLEGHFSIKGSQKAT-QLAAQCLSRDPKARPRMSEV 411
            A      D R+ Y L  P            K   +L  +C  RD + RP   E+
Sbjct: 245 NAGHFFRDDGRQIY-LPRP--------PNCPKDIYELMLECWRRDEEDRPTFREI 290

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 98.1 bits (245), Expect = 7e-23
 Identities = 75/276 (27%), Positives = 119/276 (43%), Gaps = 50/276 (18%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA--EVNFLGNLLH 198
           +GEG  G V+K              TG  VA+K +    L+   + L   E+  + +  H
Sbjct: 27  IGEGASGEVYKA---------TDRATGKEVAIKKMR---LRKQNKELIINEILIMKDCKH 74

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 258
           PN+V      +  D+  +V E+M  GSL + + +  + +       +     +GL +LH 
Sbjct: 75  PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS 134

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR--VMGTYGYAAPEY 316
              + VI+RD K+ NILL  D + KL+DFG A           S R  V+GT  + APE 
Sbjct: 135 ---QNVIHRDIKSDNILLSKDGSVKLADFGFAA----QLTKEKSKRNSVVGTPYWMAPE- 186

Query: 317 VMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK--RRFYRL 373
           V+       K D++S G++ +EM  G        P           P+L +   R  + +
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEG-------EP-----------PYLREPPLRALFLI 228

Query: 374 LD---PRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
                P L+     K S +      +CL +DP+ RP
Sbjct: 229 TTKGIPPLKN--PEKWSPEFKDFLNKCLVKDPEKRP 262

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 97.4 bits (243), Expect = 7e-23
 Identities = 73/254 (28%), Positives = 112/254 (44%), Gaps = 27/254 (10%)

Query: 169 TVAVKTLNHDGLQGH-KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLE 227
            VA+K ++ +  Q    E   EV  +    HPN+VK     +  D+  LV  ++  GSL 
Sbjct: 28  KVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLL 87

Query: 228 NHLFRRSLP---LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL 284
             + + S P   L  +I   +     KGL +LH   +   I+RD K  NILL  D + K+
Sbjct: 88  -DIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKI 143

Query: 285 SDFGLAKDAPEDGKTHVSTR--VMGTYGYAAPEYVMTGH--LTSKSDVYSFGVVLLEMLT 340
           +DFG++    + G      R   +GT  + APE VM        K+D++SFG+  +E+ T
Sbjct: 144 ADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-VMEQVHGYDFKADIWSFGITAIELAT 202

Query: 341 GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKA-TQLAAQCLS 399
           G     K  P     L     P             P LE     K   K+  ++ + CL 
Sbjct: 203 GAAPYSKYPPMKVLMLTLQNDP-------------PSLETGADYKKYSKSFRKMISLCLQ 249

Query: 400 RDPKARPRMSEVVE 413
           +DP  RP   E+++
Sbjct: 250 KDPSKRPTAEELLK 263

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 96.8 bits (241), Expect = 1e-22
 Identities = 68/207 (32%), Positives = 109/207 (52%), Gaps = 17/207 (8%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLH 198
           ++G+G FGCV+ G + ++    +        AVK+LN    L+  +++L E   + +  H
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIH------CAVKSLNRITDLEEVEQFLKEGIIMKDFSH 55

Query: 199 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLAF 255
           PN++ L+G C+  +   L+V  +M  G L N  F RS     +++  I  G   AKG+ +
Sbjct: 56  PNVLSLLGICLPSEGSPLVVLPYMKHGDLRN--FIRSETHNPTVKDLIGFGLQVAKGMEY 113

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYAA 313
           L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + A
Sbjct: 114 L---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170

Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            E + T   T+KSDV+SFGV+L E++T
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 96.4 bits (240), Expect = 2e-22
 Identities = 71/216 (32%), Positives = 109/216 (50%), Gaps = 25/216 (11%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLA--- 188
           N+R   LLG+G FG V+               TG  +AVK +  D       KE  A   
Sbjct: 3   NWRRGKLLGQGAFGRVY---------LCYDVDTGRELAVKQVPFDPDSPETKKEVNALEC 53

Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
           E+  L NL H  +V+  G C+ DD+ L ++ E+MP GS+++ L +    L  ++  K   
Sbjct: 54  EIQLLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTRKYTR 111

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTHVSTRV 305
              +G+ +LH      +++RD K +NIL D+  N KL DFG +K         T + + V
Sbjct: 112 QILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-V 167

Query: 306 MGTYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEMLT 340
            GT  + +PE V++G     K+DV+S G  ++EMLT
Sbjct: 168 TGTPYWMSPE-VISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 96.1 bits (239), Expect = 2e-22
 Identities = 76/286 (26%), Positives = 133/286 (46%), Gaps = 31/286 (10%)

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNL 196
           E ++G G FG V +G ++  G   +       VA+KTL      +  +++L+E + +G  
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREI------FVAIKTLKSGYTEKQRRDFLSEASIMGQF 62

Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 256
            HPN++ L G   +    +++ EFM  G+L++ L +          + +  G A G+ +L
Sbjct: 63  DHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 122

Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG---TYGYAA 313
              +E   ++RD    NIL++++   K+SDFGL++   +D      T  +G      + A
Sbjct: 123 ---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179

Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR 372
           PE +     TS SDV+S+G+V+ E+++ G R           N +E          + YR
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE----------QDYR 229

Query: 373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
           L  P       +       QL   C  +D  ARP+  ++V TL  +
Sbjct: 230 LPPP-------MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 96.0 bits (239), Expect = 2e-22
 Identities = 80/287 (27%), Positives = 133/287 (46%), Gaps = 39/287 (13%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL--------NHDGLQGH--KEWLAE 189
           L+G+G +G V+      N T      TG  +AVK +         HD  Q    K   +E
Sbjct: 8   LIGKGTYGRVYLAL---NVT------TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSE 58

Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 249
           +  L +L H N+V+ +G+   ++   +  E++P GS+ +   R        +        
Sbjct: 59  IETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGS-CLRTYGRFEEQLVRFFTEQV 117

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM-GT 308
            +GLA+LH    K +++RD K  N+L+DAD   K+SDFG++K + +D   +     M G+
Sbjct: 118 LEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKS-DDIYDNDQNMSMQGS 173

Query: 309 YGYAAPEYVMTGH--LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
             + APE + +     ++K D++S G V+LEM  GR      RP  +   +  A   LG+
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR------RPWSDEEAIA-AMFKLGN 226

Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
           KR       P +    S+  S  A      C + +P  RP   E+++
Sbjct: 227 KRS-----APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 96.3 bits (239), Expect = 3e-22
 Identities = 70/213 (32%), Positives = 99/213 (46%), Gaps = 21/213 (9%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LGEG FG VF    E     P +    + VAVKTL        K++  E   L NL H +
Sbjct: 13  LGEGAFGKVF--LAECYNLCPEQ--DKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-------------LPWSIRMKIAL 247
           +VK  G C+E D  ++V+E+M  G L N   R   P             L  S  + IA 
Sbjct: 69  IVKFYGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A G+ +L   A +  ++RD  T N L+  +   K+ DFG+++D        V    M 
Sbjct: 128 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 184

Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              +  PE +M    T++SDV+S GVVL E+ T
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 96.2 bits (240), Expect = 3e-22
 Identities = 76/289 (26%), Positives = 111/289 (38%), Gaps = 39/289 (13%)

Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGNL 196
            ++GEG +G V K   +          TG  VA+K    + D     K  L EV  L  L
Sbjct: 7   GVVGEGAYGVVLKCRNKA---------TGEIVAIKKFKESEDDEDVKKTALREVKVLRQL 57

Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLEN-HLFRRSLPLPWSIRMKIALGAAKGLAF 255
            H N+V L        +  LV+E++ R  LE        LP P ++R        + +A+
Sbjct: 58  RHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLP-PDAVR-SYIWQLLQAIAY 115

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
            H      +I+RD K  NIL+      KL DFG A+       + ++  V  T  Y APE
Sbjct: 116 CHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPE 171

Query: 316 YVMTGHLTSKS-DVYSFGVVLLEMLTGR----------------RSMDKNRPNGEHNLVE 358
            ++      K  DV++ G ++ E+L G                 + +    P   H  + 
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPP--SHQELF 229

Query: 359 WARPHLGDKRRFYRLLDPR-LEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            + P       F     P  LE  +  K S  A      CL  DPK R 
Sbjct: 230 SSNPRFA-GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL 277

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 95.5 bits (238), Expect = 3e-22
 Identities = 73/287 (25%), Positives = 114/287 (39%), Gaps = 38/287 (13%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN---HDGLQGHKEWLAEV 190
           +F    ++G+G FG V    V++  T           A+K +N          +  L E 
Sbjct: 1   HFELLRVIGKGAFGKVCI--VQKRDT-------KKMFAMKYMNKQKCVEKGSVRNVLNER 51

Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 249
             L  L HP LV L  Y  +D++ + LV + +  G L  HL ++       ++  I    
Sbjct: 52  RILQELNHPFLVNLW-YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC-EI 109

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
              L +LH    K +I+RD K  NILLD   +  ++DF +A     D  T   T   GT 
Sbjct: 110 VLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTP 163

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
           GY APE +     +   D +S GV   E L G+R    +       + +  R        
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS----RTIRDQIRAKQETADV 219

Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
                       +    S +A     + L RDP+   R+ + ++ LK
Sbjct: 220 -----------LYPATWSTEAIDAINKLLERDPQK--RLGDNLKDLK 253

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 94.6 bits (236), Expect = 5e-22
 Identities = 74/286 (25%), Positives = 118/286 (41%), Gaps = 59/286 (20%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 194
           F     LGEG +G V+K   +E G           VA+K +  +     +E + E++ L 
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQ---------VVAIKVVPVEE--DLQEIIKEISILK 53

Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
               P +VK  G   ++    +V E+   GS+ + +   +  L       I     KGL 
Sbjct: 54  QCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLE 113

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA---KDAPEDGKTHVSTRVMGTYGY 311
           +LH       I+RD K  NILL+ +  AKL+DFG++    D      T     V+GT  +
Sbjct: 114 YLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-----VIGTPFW 165

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR---------RS--MDKNRPNGEHNLVEWA 360
            APE +      +K+D++S G+  +EM  G+         R+  M  N+P          
Sbjct: 166 MAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPP--------- 216

Query: 361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            P L D  ++                S +      +CL +DP+ RP
Sbjct: 217 -PTLSDPEKW----------------SPEFNDFVKKCLVKDPEERP 245

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 95.4 bits (237), Expect = 7e-22
 Identities = 80/286 (27%), Positives = 129/286 (45%), Gaps = 34/286 (11%)

Query: 141 LGEGGFG----CVFKGWVEENG-TAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLG 194
           LGEG FG    C  +G  E  G  AP   G  + VAVK L  D  +    ++L E+  + 
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI--------- 245
            L +PN+++L+G C+ DD   ++ E+M  G L   L +R +   ++    I         
Sbjct: 73  RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132

Query: 246 --ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
             A+  A G+ +L   A    ++RD  T N L+   Y  K++DFG++++        +  
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189

Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG---EHNLVEWA 360
           R +    + A E ++ G  T+ SDV++FGV L EM T    + K +P     +  ++E  
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT----LCKEQPYSLLSDEQVIENT 245

Query: 361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
                ++ R   L    L             +L  +C SRD K RP
Sbjct: 246 GEFFRNQGRQIYLSQTPL-------CPSPVFKLMMRCWSRDIKDRP 284

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 95.1 bits (237), Expect = 7e-22
 Identities = 82/295 (27%), Positives = 124/295 (42%), Gaps = 58/295 (19%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGN 195
           +GEG +G V+K   +          TG  VA+K +    L+   E      L E+  L  
Sbjct: 7   IGEGTYGVVYKARDKL---------TGEIVAIKKIK---LRFESEGIPKTALREIKLLKE 54

Query: 196 LLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
           L HPN++KL+         L LV+EFM    L   +  R   LP S+         +GLA
Sbjct: 55  LNHPNIIKLLD-VFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLA 112

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTH-VSTRVMGTYGY 311
           F H      +++RD K  N+L++ +   KL+DFGLA+   +P    TH V TR      Y
Sbjct: 113 FCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW-----Y 164

Query: 312 AAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP--NGEHNLVEWARPH--LGD 366
            APE ++     ++  D++S G +  E+L+ R       P   G+  + +  +    LG 
Sbjct: 165 RAPELLLGDKGYSTPVDIWSVGCIFAELLSRR-------PLFPGKSEIDQLFKIFRTLGT 217

Query: 367 -----------KRRFYRLLDPRLEG----HFSIKGSQKATQLAAQCLSRDPKARP 406
                        R Y+   P+  G          S +A  L +Q L  DP  R 
Sbjct: 218 PDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRI 272

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 94.3 bits (234), Expect = 2e-21
 Identities = 83/311 (26%), Positives = 134/311 (43%), Gaps = 51/311 (16%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLT-VAVKTLNHDGLQGH-KEWLAEVN 191
           N      LGEG FG V K          +K   G T VAVK L  +      ++ L+E N
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFR-----LKGRAGYTTVAVKMLKENASSSELRDLLSEFN 55

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL---------------FRRSLP 236
            L  + HP+++KL G C +D   LL+ E+   GSL + L                R S  
Sbjct: 56  LLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115

Query: 237 L------PWSIRMKI--ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG 288
           L        ++   I  A   ++G+ +L   AE  +++RD    N+L+      K+SDFG
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFG 172

Query: 289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDK 347
           L++D  E+      ++      + A E +     T++SDV+SFGV+L E++T G      
Sbjct: 173 LSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232

Query: 348 NRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR 407
             P    NL++            YR+  P          S++   L   C  ++P  RP 
Sbjct: 233 IAPERLFNLLKTG----------YRMERPE-------NCSEEMYNLMLTCWKQEPDKRPT 275

Query: 408 MSEVVETLKPL 418
            +++ + L+ +
Sbjct: 276 FADISKELEKM 286

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 93.3 bits (232), Expect = 2e-21
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 12/201 (5%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLH 198
            +GEG FG V++G               + VAVKT  +      +E +L E   +    H
Sbjct: 13  CIGEGQFGDVYQG------VYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDH 66

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 258
           P++VKL+G    ++   +V E  P G L ++L      L  +  +  +   +  LA+L  
Sbjct: 67  PHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE- 124

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
              K  ++RD    N+L+ +    KL DFGL++   ED   + +++      + APE + 
Sbjct: 125 --SKRFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKLPIKWMAPESIN 181

Query: 319 TGHLTSKSDVYSFGVVLLEML 339
               TS SDV+ FGV + E+L
Sbjct: 182 FRRFTSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 93.3 bits (232), Expect = 3e-21
 Identities = 65/207 (31%), Positives = 87/207 (42%), Gaps = 21/207 (10%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLL 197
           LG+GGFG V          A     TG   A K L+   L   +G +  L E   L  + 
Sbjct: 1   LGKGGFGEVC---------ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS 51

Query: 198 HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLAF 255
              +V L  Y  E    L LV   M  G L+ H++    P  P +  +  A     GL  
Sbjct: 52  SRFIVSL-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEH 110

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
           LH+     ++YRD K  N+LLD   N ++SD GLA +     K        GT GY APE
Sbjct: 111 LHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPE 164

Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGR 342
            +         D ++ G  L EM+ GR
Sbjct: 165 VLQGEVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 92.5 bits (230), Expect = 4e-21
 Identities = 74/303 (24%), Positives = 128/303 (42%), Gaps = 50/303 (16%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLA 188
             NF+ E  +G+G F  V+K     +G           VA+K +    +   K   + L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDG---------RVVALKKVQIFEMMDAKARQDCLK 51

Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLE---NHLFRRSLPLP----WSI 241
           E++ L  L HPN++K +   IE+++  +V E    G L     H  ++   +P    W  
Sbjct: 52  EIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY 111

Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
            +++       L  +H    K +++RD K +N+ + A    KL D GL +      KT  
Sbjct: 112 FVQL----CSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTA 162

Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 361
           +  ++GT  Y +PE +       KSD++S G +L EM                       
Sbjct: 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM------------------AALQS 204

Query: 362 PHLGDKRRFYRLLDPRLEGHF----SIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP 417
           P  GDK   Y L     +  +    +   S++   L ++C++ DP+ RP +S V++  K 
Sbjct: 205 PFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKE 264

Query: 418 LQN 420
           +  
Sbjct: 265 MHA 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 92.0 bits (228), Expect = 5e-21
 Identities = 81/296 (27%), Positives = 130/296 (43%), Gaps = 53/296 (17%)

Query: 130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 189
           L  +  +    +G+G FG V  G              G  VAVK + +D     + +LAE
Sbjct: 3   LNMKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDATA--QAFLAE 49

Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLP-LPWSIRMKIAL 247
            + +  L H NLV+L+G  +E+   L +V E+M +GSL ++L  R    L     +K +L
Sbjct: 50  ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 109

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP---EDGKTHVSTR 304
              + + +L        ++RD    N+L+  D  AK+SDFGL K+A    + GK  V   
Sbjct: 110 DVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-- 164

Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
                 + APE +     ++KSDV+SFG++L E+ +  R             V + R  L
Sbjct: 165 ------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR-------------VPYPRIPL 205

Query: 365 GDKRRFYRLLDPRLEGHFSIKGSQKAT----QLAAQCLSRDPKARPRMSEVVETLK 416
            D       + PR+E  + +            +  QC   D   RP   ++ E L+
Sbjct: 206 KD-------VVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 92.6 bits (231), Expect = 5e-21
 Identities = 70/221 (31%), Positives = 101/221 (45%), Gaps = 39/221 (17%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAE 189
            +F     LG G FG V    V   G+           A+K L+   +   K+    L E
Sbjct: 1   DDFEFIKTLGTGSFGRVML--VRHKGSGKY-------YALKILSKAKIVKLKQVEHVLNE 51

Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRM---K 244
              L ++ HP LV L G   +DD  L LV E++P G L +HL +    P P + R    +
Sbjct: 52  KRILQSIRHPFLVNLYG-SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVA-RFYAAQ 109

Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           + L     L +LH      ++YRD K  N+LLD+D   K++DFG AK         V  R
Sbjct: 110 VVLA----LEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKGR 154

Query: 305 VM---GTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTG 341
                GT  Y APE ++  G+     D ++ G+++ EML G
Sbjct: 155 TYTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 91.8 bits (228), Expect = 5e-21
 Identities = 75/275 (27%), Positives = 124/275 (45%), Gaps = 31/275 (11%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V  G          K    + VA+K +N +G    ++++ E   +  L HP 
Sbjct: 12  LGSGQFGVVHLG----------KWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPK 60

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           LV+L G C +     +V EFM  G L N+L +R   L   + + +     +G+ +L   +
Sbjct: 61  LVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS 120

Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG 320
               I+RD    N L+ +    K+SDFG+ +   +D  T  S+       ++ PE     
Sbjct: 121 ---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS-SSGAKFPVKWSPPEVFNFS 176

Query: 321 HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEG 380
             +SKSDV+SFGV++ E+ T  +   + + N E  +VE          R +RL  P+L  
Sbjct: 177 KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE--VVEMI-------SRGFRLYRPKL-- 225

Query: 381 HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
                 S    ++   C    P+ RP  +E++  +
Sbjct: 226 -----ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 91.2 bits (226), Expect = 1e-20
 Identities = 84/278 (30%), Positives = 127/278 (45%), Gaps = 41/278 (14%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +GEG FG V +G             TG  VAVK +  D     + +L E   +  L H N
Sbjct: 14  IGEGEFGAVLQGEY-----------TGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKN 60

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM-KIALGAAKGLAFLHEE 259
           LV+L+G  I  +   +V E M +G+L N L  R   L   I++ + +L  A+G+ +L   
Sbjct: 61  LVRLLG-VILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES- 118

Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             K +++RD    NIL+  D  AK+SDFGLA+          ++++     + APE +  
Sbjct: 119 --KKLVHRDLAARNILVSEDGVAKVSDFGLARVGS---MGVDNSKL--PVKWTAPEALKH 171

Query: 320 GHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRL 378
              +SKSDV+S+GV+L E+ + GR    K         VE          + YR+  P  
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE----------KGYRMEPP-- 219

Query: 379 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
           EG            L   C   +PK RP   ++ E L+
Sbjct: 220 EG-----CPADVYVLMTSCWETEPKKRPSFHKLREKLE 252

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 91.9 bits (228), Expect = 1e-20
 Identities = 71/205 (34%), Positives = 104/205 (50%), Gaps = 14/205 (6%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGNLLHP 199
           LGEG FG      VE     P    TG  VAVK+L  +    H   L  E+  L NL H 
Sbjct: 12  LGEGHFG-----KVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 66

Query: 200 NLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 257
           N+VK  G C ED      L+ EF+P GSL+ +L R    +    ++K A+   KG+ +L 
Sbjct: 67  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL- 125

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR--VMGTYGYAAPE 315
               +  ++RD    N+L+++++  K+ DFGL K A E  K + + +  +     + APE
Sbjct: 126 --GSRQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDLDSPVFWYAPE 182

Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLT 340
            ++       SDV+SFGV L E+LT
Sbjct: 183 CLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 91.8 bits (229), Expect = 1e-20
 Identities = 80/298 (26%), Positives = 127/298 (42%), Gaps = 62/298 (20%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGN 195
           +GEG +G V+K     N        TG  VA+K +    ++  KE      + E+  L  
Sbjct: 7   IGEGTYGQVYKA---RNKK------TGELVALKKIR---MENEKEGFPITAIREIKLLQK 54

Query: 196 LLHPNLVKLVGYCIEDDQR--LLVYEFMP---RGSLENHLFRRSLPLPWSIR--MKIALG 248
           L HPN+V+L        +    +V+E+M     G L++   + +      I+  MK  L 
Sbjct: 55  LRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTES---QIKCYMKQLL- 110

Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
             +GL +LH      +++RD K SNIL++ D   KL+DFGLA+   +      + RV+ T
Sbjct: 111 --EGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-T 164

Query: 309 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR---------RSMDK-----NRPNGE 353
             Y  PE ++       + D++S G +L E+  G+           ++K       P  E
Sbjct: 165 LWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDE 224

Query: 354 HNLVEWARPHLGDKRRFYRLLDP------RLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
                W  P +  K  ++  L P      RL   F       A  L  + L+ DPK R
Sbjct: 225 ----NW--PGV-SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKR 275

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 90.8 bits (226), Expect = 1e-20
 Identities = 65/220 (29%), Positives = 98/220 (44%), Gaps = 38/220 (17%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVK-PGTGLTVAVKTLNHDGLQGH-KEWL-AEVNFLGNLL 197
           +G+G FG V K          V+    G  +  K +++  +    K+ L +EVN L  L 
Sbjct: 8   IGKGSFGTVRK----------VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK 57

Query: 198 HPNLVKLVGYCIEDDQRLL--VYEFMPRGSLENHLFRRS----LPLP----WSIRMKIAL 247
           HPN+V+     I+   + L  V E+   G L   L ++       +     W I  ++ L
Sbjct: 58  HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQ-LIQKCKKERKYIEEEFIWRILTQLLL 116

Query: 248 GAAKGLAFLH--EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED---GKTHVS 302
                L   H   +    V++RD K +NI LDA+ N KL DFGLAK    D    KT+V 
Sbjct: 117 A----LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV- 171

Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
               GT  Y +PE +       KSD++S G ++ E+    
Sbjct: 172 ----GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 91.3 bits (226), Expect = 2e-20
 Identities = 61/203 (30%), Positives = 108/203 (53%), Gaps = 12/203 (5%)

Query: 140 LLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLL 197
           +LG G FG V+KG WV E  T  +       VA+K LN   G + + E++ E   + ++ 
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIP------VAIKILNETTGPKANVEFMDEALIMASMD 67

Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 257
           HP+LV+L+G C+    +L V + MP G L +++      +   + +   +  AKG+ +L 
Sbjct: 68  HPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 126

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
           E   + +++RD    N+L+ +  + K++DFGLA+    D K + +        + A E +
Sbjct: 127 E---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183

Query: 318 MTGHLTSKSDVYSFGVVLLEMLT 340
                T +SDV+S+GV + E++T
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 91.1 bits (226), Expect = 2e-20
 Identities = 75/293 (25%), Positives = 132/293 (45%), Gaps = 29/293 (9%)

Query: 141 LGEGGFG----CVFKG---WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNF 192
           LGEG FG    C  +G   +++++ +  V     + VAVK L  D  +  + ++L E+  
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72

Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP----------WSIR 242
           +  L  PN+++L+  CI  D   ++ E+M  G L   L R                +S  
Sbjct: 73  MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132

Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
           + +A   A G+ +L   +    ++RD  T N L+  +Y  K++DFG++++        + 
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189

Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 362
            R +    + + E ++ G  T+ SDV++FGV L E+LT  +    ++ + E  ++E    
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ-VIENTGE 248

Query: 363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
              D+ R   L  P L             +L   C  R+ K RP   E+  TL
Sbjct: 249 FFRDQGRQVYLPKPAL-------CPDSLYKLMLSCWRRNAKERPSFQEIHATL 294

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 90.3 bits (224), Expect = 2e-20
 Identities = 85/293 (29%), Positives = 126/293 (43%), Gaps = 62/293 (21%)

Query: 126 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 185
             LKL  +       LG G FG V+ G+   +            VA+K+L   G    + 
Sbjct: 6   ETLKLVKK-------LGAGQFGEVWMGYYNGH----------TKVAIKSLK-QGSMSPEA 47

Query: 186 WLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIR 242
           +LAE N +  L HP LV+L    +  +   ++ E+M  GSL + L       L +   I 
Sbjct: 48  FLAEANLMKQLQHPRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLID 106

Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DAPE 295
           M  A   A+G+AF+     K  I+RD + +NIL+      K++DFGLA+        A E
Sbjct: 107 M--AAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTARE 161

Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-- 353
             K  +         + APE +  G  T KSDV+SFG++L E++T  R       N E  
Sbjct: 162 GAKFPIK--------WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI 213

Query: 354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            NL            R YR+  PR +        ++  +L   C    P+ RP
Sbjct: 214 QNL-----------ERGYRM--PRPDN-----CPEELYELMRLCWKEKPEERP 248

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 90.4 bits (224), Expect = 3e-20
 Identities = 65/215 (30%), Positives = 94/215 (43%), Gaps = 23/215 (10%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LGEG FG VF    E +   P +      VAVK L        +++  E   L  L H +
Sbjct: 13  LGEGAFGKVF--LAECHNLLPEQDKM--LVAVKALKEASESARQDFQREAELLTVLQHQH 68

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRMKI 245
           +V+  G C E    L+V+E+M  G L N   R   P               L     + I
Sbjct: 69  IVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
           A   A G+ +L   A    ++RD  T N L+      K+ DFG+++D        V  R 
Sbjct: 128 ASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 184

Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           M    +  PE ++    T++SD++SFGVVL E+ T
Sbjct: 185 MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 90.3 bits (224), Expect = 3e-20
 Identities = 80/290 (27%), Positives = 131/290 (45%), Gaps = 51/290 (17%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW----------LAE 189
            LG G FGCV+K   + NG           +A+K +N       K+           ++E
Sbjct: 7   HLGSGAFGCVYKVRKKNNG--------QNLLALKEINVHNPAFGKDKRERDKSIGDIVSE 58

Query: 190 VNFLG-NLLHPNLVKLVGYCIEDDQRLLVYEFM---PRGSLENHLFRRSLPLP----WSI 241
           V  +   L HPN+V+     +E+D+  +V + +   P G   N L  +         W+I
Sbjct: 59  VTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNI 118

Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
            +++ L     L +LH+E  K +++RD   +NI+L  D    ++DFGLAK    + K   
Sbjct: 119 FVQMVLA----LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL-- 170

Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 361
            T V+GT  Y+ PE V       K+DV++FG +L +M T         P    N++  A 
Sbjct: 171 -TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLSLA- 222

Query: 362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
                 +    + +P  EG +    S+  T +   CL+ D +ARP + +V
Sbjct: 223 -----TKIVEAVYEPLPEGMY----SEDVTDVITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 89.8 bits (223), Expect = 3e-20
 Identities = 72/289 (24%), Positives = 122/289 (42%), Gaps = 50/289 (17%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEV 190
           +F+    LG+G +G V+K  V+               A+K ++  G    KE    + E+
Sbjct: 1   DFKVLKKLGKGSYGSVYK--VKRLSD-------NQFYALKEVDL-GSMSQKEREDAVNEI 50

Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL---PLPWSIRMKIAL 247
             L ++ HPN++      ++ ++  +V E+ P G L   + +R      +P     +I +
Sbjct: 51  RILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI 110

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
              +GL  LHE+    +++RD K++NILL A+   K+ D G++K      K +++   +G
Sbjct: 111 QLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIG 163

Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR-----RSMDKNRPNGEHNLVEWARP 362
           T  Y APE       + KSD++S G +L EM T       RSM   R             
Sbjct: 164 TPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR------------- 210

Query: 363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
                 +  R   P +   +    SQ         L   PK RP   ++
Sbjct: 211 -----YKVQRGKYPPIPPIY----SQDLQNFIRSMLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 89.3 bits (221), Expect = 6e-20
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 31/285 (10%)

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNL 196
           + ++G G FG VF+G ++  G   V       VA+KTL     +  + ++L+E + +G  
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEV------AVAIKTLKPGYTEKQRQDFLSEASIMGQF 63

Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 256
            H N+++L G   +    +++ E+M  G+L+ +L            + +  G A G+ +L
Sbjct: 64  SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123

Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK---DAPEDGKTHVSTRVMGTYGYAA 313
              ++   ++RD    NIL++++   K+SDFGL++   D PE   T    ++     + A
Sbjct: 124 ---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTA 178

Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 373
           PE +     TS SDV+SFG+V+ E+++        RP  + +  E  +  + D    +RL
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSF-----GERPYWDMSNHEVMKA-INDG---FRL 229

Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
             P       +       QL  QC  +D   RPR  ++V  L  L
Sbjct: 230 PAP-------MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 89.5 bits (222), Expect = 6e-20
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 22/215 (10%)

Query: 134 NFRPESL-----LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWL 187
           + R E L     LG G  G V K  V+   T       G  +A K ++        K+ L
Sbjct: 1   DLRNEDLETISDLGAGNGGSVSK--VKHIPT-------GTVMAKKVVHIGAKSSVRKQIL 51

Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E+  +     P +V   G  + ++   +  EFM  GSL+  ++++  P+P  I  KIA+
Sbjct: 52  RELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDR-IYKKGGPIPVEILGKIAV 110

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
              +GL +L+      +++RD K SNIL+++    KL DFG++ +        ++   +G
Sbjct: 111 AVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS----IADTFVG 164

Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           T  Y +PE +  G  T KSDV+S G+ ++E+  G+
Sbjct: 165 TSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 89.4 bits (222), Expect = 7e-20
 Identities = 74/282 (26%), Positives = 120/282 (42%), Gaps = 42/282 (14%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG+G FG V+K              TGL  A K +  +  +  ++++ E++ L    HPN
Sbjct: 13  LGDGAFGKVYKA---------QHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           +V L      +++  ++ EF   G+L++ +      L       +     + L FLH   
Sbjct: 64  IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS-- 121

Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
              VI+RD K  NILL  D + KL+DFG+ AK+     K       +GT  + APE V  
Sbjct: 122 -HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---FIGTPYWMAPEVVAC 177

Query: 320 GHLTS-----KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL 374
                     K+D++S G+ L+E+           P+ E N +          R   ++L
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIELAQME------PPHHELNPM----------RVLLKIL 221

Query: 375 D---PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
               P L+     K S         CL +DP  RP  +E+++
Sbjct: 222 KSEPPTLDQ--PSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 88.4 bits (220), Expect = 1e-19
 Identities = 73/292 (25%), Positives = 116/292 (39%), Gaps = 63/292 (21%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFL 193
           F     +G+G FG V+K          +   T   VA+K ++ +  +   E +  E+ FL
Sbjct: 3   FTLLECIGKGSFGEVYKA---------IDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFL 53

Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 253
                P + K  G  ++  +  ++ E+   GS  + L  +   L  +    I      GL
Sbjct: 54  SQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILREVLLGL 111

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA---KDAPEDGKTHVSTRVMGTYG 310
            +LHEE     I+RD K +NILL  + + KL+DFG++           T V     GT  
Sbjct: 112 EYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-----GTPF 163

Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG---RRSMD---------KNRPNGEHNLVE 358
           + APE +       K+D++S G+  +E+  G      +          KN P        
Sbjct: 164 WMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP-------- 215

Query: 359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 410
                            P LEG+   K S+      + CL++DPK RP   E
Sbjct: 216 -----------------PSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKE 247

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 87.5 bits (217), Expect = 3e-19
 Identities = 76/291 (26%), Positives = 119/291 (40%), Gaps = 32/291 (10%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNF 192
           N +  + LG G FG VF    +         G    V VK L          E+  E++ 
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEE----GGETLVLVKALQKTKDENLQSEFRRELDM 61

Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRRSLPLPWSIRMKIA 246
              L H N+V+L+G C E +   ++ E+   G L+  L        +  P P S + K+A
Sbjct: 62  FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121

Query: 247 LGA--AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           L    A G+  L   +    ++RD    N L+ +    K+S   L+KD        +   
Sbjct: 122 LCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNA 178

Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
           ++    + APE V     ++KSDV+SFGV++ E+ T                 E     L
Sbjct: 179 LI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT---------------QGELPFYGL 222

Query: 365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
            D+    RL   +LE         +  +L  +C + +PK RP  SE+V  L
Sbjct: 223 SDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 87.6 bits (218), Expect = 3e-19
 Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 44/218 (20%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGN 195
           LG+G FG V+    +E G           VA+K +     +    W     L EV  L  
Sbjct: 7   LGDGTFGSVYLARNKETGE---------LVAIKKMK----KKFYSWEECMNLREVKSLRK 53

Query: 196 L-LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF-----RRSLPLPWSIRMKIALGA 249
           L  HPN+VKL     E+D+   V+E+M     E +L+     R+  P   S+   I    
Sbjct: 54  LNEHPNIVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQI 108

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD----APEDGKTHVSTRV 305
            +GLA +H+       +RD K  N+L+      K++DFGLA++     P     +VSTR 
Sbjct: 109 LQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY--TDYVSTR- 162

Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
                Y APE ++ +   +S  D+++ G ++ E+ T R
Sbjct: 163 ----WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 87.9 bits (218), Expect = 3e-19
 Identities = 67/203 (33%), Positives = 94/203 (46%), Gaps = 10/203 (4%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGNL-LH 198
           LG G FG V    VE       K    + VAVK L        +E L +E+  + +L  H
Sbjct: 43  LGAGAFGKV----VEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLH 257
            N+V L+G C      L++ E+   G L N L R R   L     +  +   AKG+AFL 
Sbjct: 99  ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL- 157

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
             A K  I+RD    N+LL      K+ DFGLA+D   D    V         + APE +
Sbjct: 158 --ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI 215

Query: 318 MTGHLTSKSDVYSFGVVLLEMLT 340
                T +SDV+S+G++L E+ +
Sbjct: 216 FNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 86.5 bits (214), Expect = 4e-19
 Identities = 74/280 (26%), Positives = 125/280 (44%), Gaps = 41/280 (14%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V  G W  +             VA+K +  +G     E++ E   +  L H 
Sbjct: 12  LGTGQFGVVKYGKWRGQY-----------DVAIKMIK-EGSMSEDEFIEEAKVMMKLSHE 59

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
            LV+L G C +     +V E+M  G L N+L         S  +++     +G+A+L   
Sbjct: 60  KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE-- 117

Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT---YGYAAPEY 316
             K  I+RD    N L+D     K+SDFGL++   +D   + S+  +G+     ++ PE 
Sbjct: 118 -SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD--EYTSS--VGSKFPVRWSPPEV 172

Query: 317 VMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 375
           ++    +SKSDV++FGV++ E+ + G+   ++   N E   VE     +    R YR   
Sbjct: 173 LLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN-NSE--TVE----KVSQGLRLYR--- 222

Query: 376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           P L        S+K   +   C     + RP   +++ ++
Sbjct: 223 PHL-------ASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 86.2 bits (213), Expect = 6e-19
 Identities = 84/270 (31%), Positives = 122/270 (45%), Gaps = 39/270 (14%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V+ G W   NG           VAVKTL   G    + +L E   +  L H 
Sbjct: 14  LGNGQFGEVWMGTW---NGNT--------KVAVKTLK-PGTMSPESFLEEAQIMKKLRHD 61

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
            LV+L    + ++   +V E+M +GSL + L     R+L LP  + M  A   A G+A++
Sbjct: 62  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDM--AAQVAAGMAYI 118

Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
                   I+RD +++NIL+      K++DFGLA+   ED +            + APE 
Sbjct: 119 ER---MNYIHRDLRSANILVGDGLVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEA 174

Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP 376
            + G  T KSDV+SFG++L E++T  R       N         R  L    R YR+  P
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---------REVLEQVERGYRMPCP 225

Query: 377 RLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
           +              +L  QC  +DP+ RP
Sbjct: 226 Q-------DCPISLHELMLQCWKKDPEERP 248

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 86.6 bits (214), Expect = 6e-19
 Identities = 80/289 (27%), Positives = 131/289 (45%), Gaps = 39/289 (13%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G    N    +K      VAVKT+N    L+   E+L E + +      
Sbjct: 14  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 69

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL----------PLPWSIRMKIALGA 249
           ++V+L+G   +    L+V E M  G L+++L  RSL          P P +++  I + A
Sbjct: 70  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPP-TLQEMIQMAA 126

Query: 250 --AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A G+A+L+    K  ++RD    N ++  D+  K+ DFG+ +D  E        + + 
Sbjct: 127 EIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL 183

Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
              + APE +  G  T+ SD++SFGVVL E+ +               L E     L ++
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNE 228

Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
           +    ++D            ++ T L   C   +PK RP   E+V  LK
Sbjct: 229 QVLKFVMDGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 86.9 bits (216), Expect = 6e-19
 Identities = 68/223 (30%), Positives = 102/223 (45%), Gaps = 37/223 (16%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT--LNH-----DGLQGHKEW 186
            +     LGEG +  V+K   +E G           VA+K   L       DG+  +   
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGR---------IVAIKKIKLGERKEAKDGI--NFTA 49

Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-PWSIR--M 243
           L E+  L  L HPN++ L+          LV+EFM    LE  +  +S+ L P  I+  M
Sbjct: 50  LREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYM 108

Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD--APEDGKTH- 300
            + L   +GL +LH      +++RD K +N+L+ +D   KL+DFGLA+   +P    TH 
Sbjct: 109 LMTL---RGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQ 162

Query: 301 VSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
           V TR      Y APE +    H     D++S G +  E+L   
Sbjct: 163 VVTRW-----YRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 86.3 bits (213), Expect = 6e-19
 Identities = 84/282 (29%), Positives = 126/282 (44%), Gaps = 39/282 (13%)

Query: 129 KLATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL 187
           ++   + R +  LG+G FG V+ G W   NGT          VA+KTL   G    + +L
Sbjct: 2   EIPRESLRLDVKLGQGCFGEVWMGTW---NGTT--------KVAIKTLK-PGTMMPEAFL 49

Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMK 244
            E   +  L H  LV L    + ++   +V EFM +GSL + L     + L LP  + M 
Sbjct: 50  QEAQIMKKLRHDKLVPLYA-VVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDM- 107

Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
            A   A G+A++        I+RD + +NIL+  +   K++DFGLA+   ED +      
Sbjct: 108 -AAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLAR-LIEDNEYTARQG 162

Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
                 + APE  + G  T KSDV+SFG++L E++T  R       N         R  L
Sbjct: 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---------REVL 213

Query: 365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
               R YR+  P+          +   +L   C  +DP  RP
Sbjct: 214 EQVERGYRMPCPQ-------GCPESLHELMKLCWKKDPDERP 248

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 86.2 bits (213), Expect = 8e-19
 Identities = 80/291 (27%), Positives = 135/291 (46%), Gaps = 43/291 (14%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G  +  G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 14  LGQGSFGMVYEGIAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 69

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 248
           ++V+L+G   +    L++ E M RG L+++L  RSL           P      +++A  
Sbjct: 70  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVQAPPSLKKMIQMAGE 127

Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            A G+A+L+  A K  ++RD    N ++  D+  K+ DFG+ +D  E        + +  
Sbjct: 128 IADGMAYLN--ANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
             + +PE +  G  T+ SDV+SFGVVL E+ T               L E  +P+ G   
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGMSN 227

Query: 369 RFYRLLDPRLEGHFSIKGSQ---KATQLAAQCLSRDPKARPRMSEVVETLK 416
              ++L   +EG    K         +L   C   +PK RP   E++ ++K
Sbjct: 228 E--QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 86.0 bits (213), Expect = 1e-18
 Identities = 77/290 (26%), Positives = 122/290 (42%), Gaps = 47/290 (16%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFL 193
           ++   L+G G +G V++G             TG  VA+K +N D       +   EV  L
Sbjct: 3   YQRLELIGRGAYGAVYRG---------KHVPTGRVVALKIINLDTPDDDVSDIQREVALL 53

Query: 194 GNLLH---PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK----I 245
             L     PN+ K  G       RL ++ E+   GS+      R+L     I  K    I
Sbjct: 54  SQLRQSQPPNITKYYG-SYLKGPRLWIIMEYAEGGSV------RTLMKAGPIAEKYISVI 106

Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                  L ++H+     VI+RD K +NIL+    N KL DFG+A  A  +  +   +  
Sbjct: 107 IREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVA--ALLNQNSSKRSTF 161

Query: 306 MGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
           +GT  + APE +  G    +K+D++S G+ + EM TG              L+  ++P  
Sbjct: 162 VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP-- 219

Query: 365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET 414
                      PRLE +     S+   +  A CL  +PK R    E++++
Sbjct: 220 -----------PRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 84.9 bits (210), Expect = 2e-18
 Identities = 54/188 (28%), Positives = 94/188 (50%), Gaps = 15/188 (7%)

Query: 165 GTGLTVAVKTL----NHDGLQGH--KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVY 218
            TG  +AVK +    N    Q    +    E+  +  L HP++++++G   ED    L  
Sbjct: 23  KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV 82

Query: 219 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA 278
           E+M  GS+ +HL  +      ++ +       +GL++LHE     +I+RD K +N+L+D+
Sbjct: 83  EWMAGGSV-SHLLSKYGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDS 138

Query: 279 D-YNAKLSDFGLAKDAPED--GKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVV 334
                +++DFG A        G      +++GT  + APE V+ G    +S DV+S G V
Sbjct: 139 TGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE-VLRGEQYGRSCDVWSVGCV 197

Query: 335 LLEMLTGR 342
           ++EM T +
Sbjct: 198 IIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 85.5 bits (211), Expect = 2e-18
 Identities = 66/204 (32%), Positives = 97/204 (47%), Gaps = 25/204 (12%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGNLL 197
           +G G FG V+      N        T   VAVK +++ G Q +++W   + EV FL  L 
Sbjct: 29  IGHGSFGAVY---FATNSH------TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK 79

Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 257
           HPN ++  G  +++    LV E+   GS  + L     PL       I  GA +GLA+LH
Sbjct: 80  HPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 138

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
                 +I+RD K  NILL      KL+DFG A       K+  +   +GT  + APE +
Sbjct: 139 SHN---MIHRDIKAGNILLTEPGQVKLADFGSAS------KSSPANSFVGTPYWMAPEVI 189

Query: 318 MT---GHLTSKSDVYSFGVVLLEM 338
           +    G    K DV+S G+  +E+
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 84.3 bits (208), Expect = 3e-18
 Identities = 83/277 (29%), Positives = 125/277 (45%), Gaps = 39/277 (14%)

Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 7   SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 54

Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 249
           +  L H  LV+L    + ++   +V E+M +GSL + L     + L LP  + M  A   
Sbjct: 55  MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM--AAQI 111

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +           
Sbjct: 112 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPI 167

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L    R
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 218

Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            YR+  P        +  +    L  QC  ++P+ RP
Sbjct: 219 GYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 248

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 85.1 bits (211), Expect = 3e-18
 Identities = 70/217 (32%), Positives = 100/217 (46%), Gaps = 39/217 (17%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD---------GLQGHKEWLAEV 190
           +LG+G FG V          A +K GT    AVK L  D              K  LA  
Sbjct: 2   VLGKGSFGKVL--------LAELK-GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALA 52

Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSI--RMKIA 246
                  HP L +L   C +   RL  V E++  G L  H+ R      P +     +I 
Sbjct: 53  G-----KHPFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIV 106

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           LG    L FLHE   + +IYRD K  N+LLD++ + K++DFG+ K+    G T  ++   
Sbjct: 107 LG----LQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFC 157

Query: 307 GTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
           GT  Y APE +++      + D ++ GV+L EML G+
Sbjct: 158 GTPDYIAPE-ILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 83.9 bits (207), Expect = 3e-18
 Identities = 65/203 (32%), Positives = 101/203 (49%), Gaps = 20/203 (9%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V+ G+   N T          VAVKTL   G    + +L E N +  L H  
Sbjct: 14  LGAGQFGEVWMGYYN-NST---------KVAVKTLK-PGTMSVQAFLEEANLMKTLQHDK 62

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLH 257
           LV+L     +++   ++ E+M +GSL + L       + LP  I     +  A+G+A++ 
Sbjct: 63  LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAYIE 120

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
               K  I+RD + +N+L+      K++DFGLA+   ED +            + APE +
Sbjct: 121 R---KNYIHRDLRAANVLVSESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAI 176

Query: 318 MTGHLTSKSDVYSFGVVLLEMLT 340
             G  T KSDV+SFG++L E++T
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 83.8 bits (207), Expect = 4e-18
 Identities = 59/211 (27%), Positives = 107/211 (50%), Gaps = 15/211 (7%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNF 192
             + E ++G G FG V  G ++  G   +       VA+KTL     +  + ++L+E + 
Sbjct: 5   CIKIEKVIGAGEFGEVCSGRLKLPGKREI------PVAIKTLKAGYTEKQRRDFLSEASI 58

Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
           +G   HPN++ L G   +    ++V E+M  GSL+  L +          + +  G A G
Sbjct: 59  MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASG 118

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK---DAPEDGKTHVSTRVMGTY 309
           + +L   ++   ++RD    NIL++++   K+SDFGL++   D PE   T    ++    
Sbjct: 119 MKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PI 173

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            + APE +     TS SDV+S+G+V+ E+++
Sbjct: 174 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 83.4 bits (206), Expect = 6e-18
 Identities = 76/286 (26%), Positives = 123/286 (43%), Gaps = 41/286 (14%)

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE--WLAEVNFLGN 195
           E +LG G FG + +G ++     P K    L VA+ TL   G    +   +LAE   LG 
Sbjct: 10  ERILGTGRFGELCRGCLK----LPSK--RELPVAIHTL-RAGCSDKQRRGFLAEALTLGQ 62

Query: 196 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 255
             H N+V+L G     +  ++V E+M  G+L++ L +    L     M +  G A G+ +
Sbjct: 63  FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKY 122

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG--YAA 313
           L   +E   +++      +L+++D   K+S F       ED    + T + G     +AA
Sbjct: 123 L---SEMGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPVLWAA 176

Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF-- 370
           PE +   H +S SDV+SFG+V+ E+++ G R               W        +    
Sbjct: 177 PEAIQYHHFSSASDVWSFGIVMWEVMSYGERPY-------------WDMSGQDVIKAVED 223

Query: 371 -YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
            +RL  PR              QL   C  ++   RPR S++   L
Sbjct: 224 GFRLPAPR-------NCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 83.1 bits (206), Expect = 6e-18
 Identities = 71/214 (33%), Positives = 93/214 (43%), Gaps = 37/214 (17%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-----GLQGH----KEWLAEVN 191
           LG GGFG V    V+             T A+K +        G Q H    KE L E N
Sbjct: 1   LGVGGFGRVEL--VKVKSK-------NRTFALKCVKKRHIVETGQQEHIFSEKEILEECN 51

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVY---EFMPRGSLENHLFRRSLPLPWSIRMKIALG 248
                 HP +VKL  Y    D++  +Y   E+   G L   L  R L   ++ R  IA  
Sbjct: 52  ------HPFIVKL--YRTFKDKKY-IYMLMEYCLGGELWTILRDRGLFDEYTARFYIA-C 101

Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
                 +LH    + +IYRD K  N+LLD++   KL DFG AK      KT       GT
Sbjct: 102 VVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGT 155

Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
             Y APE ++        D +S G++L E+LTGR
Sbjct: 156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 82.9 bits (205), Expect = 6e-18
 Identities = 60/240 (25%), Positives = 104/240 (43%), Gaps = 39/240 (16%)

Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRM 243
           L E+  L  L HPN++    + ++D+  L+  E+   G+L + + R+          +  
Sbjct: 47  LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY 106

Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
              + +A  ++++H+     +++RD KT NI L      KL DFG++K    +  +   T
Sbjct: 107 LFQIVSA--VSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE-YSMAET 160

Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV------ 357
            V+GT  Y +PE         KSD+++ G VL E+LT +R+ D   P    NLV      
Sbjct: 161 -VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLVVKIVQG 216

Query: 358 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP 417
            +                P +  +     S +   L    L +DP+ RP   EV++    
Sbjct: 217 NYT---------------PVVSVY-----SSELISLVHSLLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 83.6 bits (207), Expect = 7e-18
 Identities = 67/218 (30%), Positives = 100/218 (45%), Gaps = 24/218 (11%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-L 197
            LGEG FG V K   E  G     P    TVAVK L  D   +   + ++E+  +  +  
Sbjct: 19  PLGEGAFGQVVKA--EAVGL--DNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 74

Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRR-------SLPLPWSIRMKI----- 245
           H N++ L+G C ++    +V E+   G+L + L  R       S   P      +     
Sbjct: 75  HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134

Query: 246 ---ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
              A   A+G+ FL   A K  I+RD    N+L+  D+  K++DFGLA+D         +
Sbjct: 135 VSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191

Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           T       + APE +     T +SDV+SFGV+L E+ T
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 83.6 bits (207), Expect = 8e-18
 Identities = 87/313 (27%), Positives = 130/313 (41%), Gaps = 56/313 (17%)

Query: 114 LKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK 173
           L +  Q      NDL+           +G G  G V+K   ++ G           +AVK
Sbjct: 3   LTIDGQKYPADLNDLEN-------LGEIGSGTCGQVYKMRFKKTGH---------VMAVK 46

Query: 174 TLNHDG-LQGHKEWLAEVNFLGNLLH--PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL 230
            +   G  + +K  L +++ +    H  P +VK  GY I D    +  E M    L+  L
Sbjct: 47  QMRRTGNKEENKRILMDLDVV-LKSHDCPYIVKCYGYFITDSDVFICMELMST-CLDKLL 104

Query: 231 FRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA 290
            R   P+P  I  K+ +   K L +L E+    VI+RD K SNILLDA  N KL DFG++
Sbjct: 105 KRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGIS 162

Query: 291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSK----SDVYSFGVVLLEMLTGRRSMD 346
                D K    TR  G   Y APE +       K    +DV+S G+ L+E+ TG+    
Sbjct: 163 GRLV-DSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQF--- 216

Query: 347 KNRPNGEHNLVEWARPHLGDKRRF---YRLLD---PRLEGHFSIKGSQKATQLAAQCLSR 400
                          P+   K  F    ++L    P L  +     S         CL++
Sbjct: 217 ---------------PYKNCKTEFEVLTKILQEEPPSLPPNEGF--SPDFCSFVDLCLTK 259

Query: 401 DPKARPRMSEVVE 413
           D + RP+  E+++
Sbjct: 260 DHRKRPKYRELLQ 272

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 83.1 bits (205), Expect = 8e-18
 Identities = 63/231 (27%), Positives = 108/231 (46%), Gaps = 27/231 (11%)

Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKE 185
           +L L+   F  E  LGE  FG ++KG +   G    +      VA+KTL + +  Q   E
Sbjct: 1   ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQ-----LVAIKTLKDINNPQQWGE 53

Query: 186 WLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS----------- 234
           +  E + +  L HPN+V L+G   ++    +++E++ +G L   L  RS           
Sbjct: 54  FQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDE 113

Query: 235 -----LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL 289
                  L     + IA+  A G+ +L   +    +++D    NIL+    + K+SD GL
Sbjct: 114 DGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGL 170

Query: 290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +++        V  + +    +  PE +M G  +S SD++SFGVVL E+ +
Sbjct: 171 SREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 83.6 bits (207), Expect = 8e-18
 Identities = 67/245 (27%), Positives = 108/245 (44%), Gaps = 43/245 (17%)

Query: 196 LLH----PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 251
           +LH    P +V   G    D +  +  E M  GSL+  L +++  +P +I  KI++   +
Sbjct: 52  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPENILGKISIAVLR 110

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS--TRVMGTY 309
           GL +L E+ +  +++RD K SNIL+++    KL DFG++      G+   S     +GT 
Sbjct: 111 GLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS------GQLIDSMANSFVGTR 162

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM-------------DKNRPNGEHNL 356
            Y +PE +   H T +SD++S G+ L+EM  GR  +                        
Sbjct: 163 SYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKES 222

Query: 357 VEWARPHLGDKRR---FYRLLD-------PRLE-GHFSIKGSQKATQLAAQCLSRDPKAR 405
                 H  D  R    + LLD       P+L  G F    S +      +CL ++PK R
Sbjct: 223 HRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAF----SDEFQDFVDKCLKKNPKER 278

Query: 406 PRMSE 410
             + E
Sbjct: 279 ADLKE 283

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 83.7 bits (207), Expect = 9e-18
 Identities = 85/283 (30%), Positives = 132/283 (46%), Gaps = 58/283 (20%)

Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL------QGHKEWLAEVNF 192
            +LG+GG+G VF+  V +   A     TG   A+K L    +        H +  AE N 
Sbjct: 2   KVLGKGGYGKVFQ--VRKVTGA----DTGKIFAMKVLKKATIVRNQKDTAHTK--AERNI 53

Query: 193 LGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP-----WSIRMKIA 246
           L  + HP +V L+ Y  +   +L L+ E++  G L  HL R  + +      +   + +A
Sbjct: 54  LEAVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA 112

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG-KTHVSTRV 305
           L        LH++    +IYRD K  NILLDA  + KL+DFGL K++  +G  TH     
Sbjct: 113 LE------HLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---F 160

Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
            GT  Y APE +M +GH     D +S G ++ +MLTG                  A P  
Sbjct: 161 CGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTG------------------APPFT 201

Query: 365 GDKRRFYRLLDPRLEGHFSIKG--SQKATQLAAQCLSRDPKAR 405
            + R+  + +D  L+G  ++    + +A  L  + L R+P +R
Sbjct: 202 AENRK--KTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPSSR 242

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 82.9 bits (205), Expect = 1e-17
 Identities = 79/302 (26%), Positives = 126/302 (41%), Gaps = 57/302 (18%)

Query: 128 LKLATRNFRPESLL------GEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ 181
           L+L      P S L      GEG  G V                TG  VAVK ++    Q
Sbjct: 8   LQLVVDPGDPRSYLDNFVKIGEGSTGIV---------CIATDKSTGRQVAVKKMDLRKQQ 58

Query: 182 GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI 241
             +    EV  + +  HPN+V++    +  D+  +V EF+  G+L +        +    
Sbjct: 59  RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD--------IVTHT 110

Query: 242 RMK------IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG----LAK 291
           RM       + L   K L+FLH +    VI+RD K+ +ILL +D   KLSDFG    ++K
Sbjct: 111 RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK 167

Query: 292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN 351
           + P          ++GT  + APE +      ++ D++S G++++EM+ G        P 
Sbjct: 168 EVPR------RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP- 220

Query: 352 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
                       L   +R    L P+L+     K S +      + L RDP  R   +E+
Sbjct: 221 ------------LQAMKRIRDNLPPKLKNL--HKVSPRLRSFLDRMLVRDPAQRATAAEL 266

Query: 412 VE 413
           + 
Sbjct: 267 LN 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 81.8 bits (202), Expect = 2e-17
 Identities = 64/254 (25%), Positives = 109/254 (42%), Gaps = 41/254 (16%)

Query: 170 VAVKTLNHDGLQGHKEWLA--EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLE 227
           V +K +  + +   +   A  E   L  L HPN+++     +ED   ++V E+ P G+L 
Sbjct: 28  VIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLA 87

Query: 228 -------NHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY 280
                  N L      L + +++ +A         LH    K +++RD KT NILLD   
Sbjct: 88  EYIQKRCNSLLDEDTILHFFVQILLA---------LHHVHTKLILHRDLKTQNILLDKHK 138

Query: 281 N-AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 339
              K+ DFG++K      K +    V+GT  Y +PE         KSD+++ G VL E+ 
Sbjct: 139 MVVKIGDFGISKILSSKSKAYT---VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELA 195

Query: 340 TGRRSMD-KNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCL 398
           + +R+ +  N P     ++      + D+                   S    QL    L
Sbjct: 196 SLKRAFEAANLPALVLKIMSGTFAPISDRY------------------SPDLRQLILSML 237

Query: 399 SRDPKARPRMSEVV 412
           + DP  RP++S+++
Sbjct: 238 NLDPSKRPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 81.9 bits (203), Expect = 2e-17
 Identities = 63/210 (30%), Positives = 91/210 (43%), Gaps = 28/210 (13%)

Query: 144 GGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGNLLHPN 200
           G +G VF            K  TG   A+K +    +       + L E + L     P 
Sbjct: 4   GAYGRVFLA---------KKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPY 54

Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           +VKL  Y  +  + L LV E++P G L   L      L   +           L +LH  
Sbjct: 55  VVKLY-YSFQGKKNLYLVMEYLPGGDLA-SLLENVGSLDEDVARIYIAEIVLALEYLHSN 112

Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DAPEDGKTHVSTRVMGTYGYA 312
               +I+RD K  NIL+D++ + KL+DFGL+K           D +     R++GT  Y 
Sbjct: 113 G---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE-DKRIVGTPDYI 168

Query: 313 APEYVMTGHLTSKS-DVYSFGVVLLEMLTG 341
           APE V+ G   SK+ D +S G +L E L G
Sbjct: 169 APE-VILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 58/166 (34%), Positives = 83/166 (50%), Gaps = 20/166 (12%)

Query: 198 HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLP----WSIRMKIALGAAK 251
           HP LV L   C + + RL  V EF+  G L  H+ R R LP      +S  + +AL    
Sbjct: 55  HPFLVGLHS-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALN--- 110

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
              FLHE   + +IYRD K  N+LLDA+ + KL+D+G+ K+    G T  ++   GT  Y
Sbjct: 111 ---FLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT--TSTFCGTPNY 162

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD--KNRPNGEHN 355
            APE +         D ++ GV++ EM+ GR   D      N + N
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 81.6 bits (201), Expect = 2e-17
 Identities = 76/300 (25%), Positives = 122/300 (40%), Gaps = 50/300 (16%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEV 190
           NFR E  +G G F  V++     +G           VA+K +    L   +   + + E+
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGV---------PVALKKVQIFDLMDAKARADCIKEI 53

Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLEN---HLFRRSLPLPWSIRMKIAL 247
           + L  L HPN++K     IED++  +V E    G L     H  ++   +P     K  +
Sbjct: 54  DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV 113

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
                L  +H    + V++RD K +N+ + A    KL D GL +      KT  +  ++G
Sbjct: 114 QLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVG 168

Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  Y +PE +       KSD++S G +L EM                       P  GDK
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEM------------------AALQSPFYGDK 210

Query: 368 RRFYRLLD--------PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ 419
              Y L          P    H+    S++  QL   C++ DP+ RP ++ V +  K + 
Sbjct: 211 MNLYSLCKKIEQCDYPPLPSDHY----SEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 81.4 bits (201), Expect = 3e-17
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 28/218 (12%)

Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK-----TLNHDGLQGHKEWLA----E 189
           +L+G G FG V+ G         +   +G  +AVK     +++       +  L     E
Sbjct: 6   ALIGSGSFGSVYLG---------MNASSGELMAVKQVELPSVSASSKDRKRSMLDALARE 56

Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 249
           +  L  L H N+V+ +G  ++ D   +  E++P GS+   L         ++        
Sbjct: 57  IALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAA-LLNNYGAFEETLVRNFVRQI 115

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR----- 304
            KGL +LH    + +I+RD K +NIL+D     K+SDFG++K   E       T      
Sbjct: 116 LKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKL-EANSLSTKTNGARPS 171

Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           + G+  + APE V     T K+D++S G +++EMLTG+
Sbjct: 172 LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 81.4 bits (201), Expect = 5e-17
 Identities = 75/212 (35%), Positives = 106/212 (50%), Gaps = 30/212 (14%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--------GHKEWLAEVN 191
           +LG+G FG VF   V +       P  G   A+K L    L+          ++ LAEVN
Sbjct: 3   VLGQGSFGKVF--LVRK----ITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN 56

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 250
                 HP +VKL  Y  + + +L L+ +F+  G L   L +  +     ++  +A   A
Sbjct: 57  ------HPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELA 108

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
             L  LH      +IYRD K  NILLD + + KL+DFGL+K++ +  K   S    GT  
Sbjct: 109 LALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVE 163

Query: 311 YAAPEYV-MTGHLTSKSDVYSFGVVLLEMLTG 341
           Y APE V   GH T  +D +SFGV++ EMLTG
Sbjct: 164 YMAPEVVNRRGH-TQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 80.8 bits (199), Expect = 8e-17
 Identities = 83/295 (28%), Positives = 123/295 (41%), Gaps = 44/295 (14%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP     VAVK L  D  +    + ++E+  +  +  H
Sbjct: 26  LGEGCFGQVVMA--EAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 243
            N++ L+G C +D    ++ E+  +G+L  +L  R  P               L +   +
Sbjct: 84  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143

Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
             A   A+G+ +L   A K  I+RD    N+L+  D   K++DFGLA+D         +T
Sbjct: 144 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200

Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV+L E+ T   S     P  E          
Sbjct: 201 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---------- 250

Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQL---AAQCLSRDPKARPRMSEVVETL 415
                  ++LL    EGH   K S    +L      C    P  RP   ++VE L
Sbjct: 251 ------LFKLLK---EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 80.1 bits (197), Expect = 9e-17
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 23/205 (11%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG+G FG V+K   +E         TG+  A K ++    +  ++++ E++ L +  HPN
Sbjct: 13  LGDGAFGKVYKAQNKE---------TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 63

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           +VKL+     ++   ++ EF   G+++  +     PL       +     + L +LHE  
Sbjct: 64  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK 123

Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG 320
              +I+RD K  NIL   D + KL+DFG++  A            +GT  + APE VM  
Sbjct: 124 ---IIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMCE 178

Query: 321 HLTS-------KSDVYSFGVVLLEM 338
             TS       K+DV+S G+ L+EM
Sbjct: 179 --TSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 80.8 bits (199), Expect = 9e-17
 Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 22/217 (10%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP   +TVAVK L  D   +   + ++E+  +  +  H
Sbjct: 20  LGEGCFGQVVMA--EAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 243
            N++ L+G C +D    ++ E+  +G+L  +L  R  P               L +   +
Sbjct: 78  KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137

Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
             A   A+G+ +L   A +  I+RD    N+L+  D   K++DFGLA+D         +T
Sbjct: 138 SCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194

Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                  + APE +     T +SDV+SFGV+L E+ T
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 80.5 bits (198), Expect = 9e-17
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 23/205 (11%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG+G FG V+K   +E         TG   A K +     +  ++++ E+  L    HP 
Sbjct: 20  LGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYMVEIEILATCNHPY 70

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGLAFLHE 258
           +VKL+G    D +  ++ EF P G+++  +    R L  P  I++ I     + L +LH 
Sbjct: 71  IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-QIQV-ICRQMLEALQYLHS 128

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +I+RD K  N+LL  D + KL+DFG++  A            +GT  + APE VM
Sbjct: 129 ---MKIIHRDLKAGNVLLTLDGDIKLADFGVS--AKNVKTLQRRDSFIGTPYWMAPEVVM 183

Query: 319 TGHLTS-----KSDVYSFGVVLLEM 338
              +       K+D++S G+ L+EM
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 70/212 (33%), Positives = 97/212 (45%), Gaps = 34/212 (16%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK--TLNHDGLQGHKEWLAEVNFLGNLLH 198
           +GEG +G VFK    E         TG  VA+K    + D     K  L E+  L  L H
Sbjct: 9   IGEGSYGVVFKCRNRE---------TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKH 59

Query: 199 PNLVKLVGYCIE---DDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
           PNLV L    IE     ++L LV+E+    ++ N L +    +P  +  KI     + + 
Sbjct: 60  PNLVNL----IEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVN 114

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKT-HVSTRVMGTYGY 311
           F H+      I+RD K  NIL+      KL DFG A+    P D  T +V+TR      Y
Sbjct: 115 FCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WY 166

Query: 312 AAPEYVMTGHLT--SKSDVYSFGVVLLEMLTG 341
            APE ++ G        DV++ G V  E+LTG
Sbjct: 167 RAPE-LLVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 80.7 bits (200), Expect = 1e-16
 Identities = 61/235 (25%), Positives = 98/235 (41%), Gaps = 59/235 (25%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNF 192
           +     +G G +G V            V   TG  VA+K +++  D L   K  L E+  
Sbjct: 2   YELLKPIGSGAYGVVCSA---------VDKRTGRKVAIKKISNVFDDLIDAKRILREIKL 52

Query: 193 LGNLLHPNLVKL--VGYCIEDDQRL------LVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
           L +L H N++ L  +   +            +V E M     E  L +        I+  
Sbjct: 53  LRHLRHENIIGLLDI---LRPPSPEDFNDVYIVTELM-----ETDLHK-------VIKSP 97

Query: 245 IALGAA----------KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 294
             L             +GL +LH      VI+RD K SNIL++++ + K+ DFGLA+   
Sbjct: 98  QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVD 154

Query: 295 EDGKT------HVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            D         +V TR      Y APE +++    +K+ D++S G +  E+LT +
Sbjct: 155 PDEDEKGFLTEYVVTRW-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 67/214 (31%), Positives = 107/214 (50%), Gaps = 21/214 (9%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-LAEVNF 192
           NF+    LGEG +  V+KG    N T      TG  VA+K ++ D  +G     + E++ 
Sbjct: 1   NFKQLEKLGEGTYATVYKG---RNRT------TGEIVALKEIHLDAEEGTPSTAIREISL 51

Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMP---RGSLENHLFRRSLPLPWSIRMKIALGA 249
           +  L H N+V+L      +++ +LV+E+M    +  ++ H  R +L           L  
Sbjct: 52  MKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQL-- 109

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
            KG+AF HE     V++RD K  N+L++     KL+DFGLA+       T  +  V  T 
Sbjct: 110 LKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TL 164

Query: 310 GYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            Y AP+ ++     S S D++S G ++ EM+TGR
Sbjct: 165 WYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 80.4 bits (198), Expect = 1e-16
 Identities = 61/220 (27%), Positives = 111/220 (50%), Gaps = 26/220 (11%)

Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+      P      + VA+K L      + +KE L
Sbjct: 4   LKETEFKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEIL 57

Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-------ENHLFRRSLPLPWS 240
            E   + ++ +P++ +L+G C+    +L + + MP G L       ++++  + L L W 
Sbjct: 58  DEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL-LNWC 115

Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH 300
           +++      AKG+ +L E   + +++RD    N+L+    + K++DFGLAK    D K +
Sbjct: 116 VQI------AKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEY 166

Query: 301 VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 167 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 73/245 (29%), Positives = 102/245 (41%), Gaps = 57/245 (23%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEV 190
           +F    ++G G FG V+               TG   A+K L    +    +     AE 
Sbjct: 2   DFEVIKVIGRGAFGEVWLVR---------DKDTGQVYAMKVLRKSDMIKRNQIAHVRAER 52

Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MK 244
           + L +   P +VKL  Y  +D++ L LV E+MP G L N L R+ +    + R     + 
Sbjct: 53  DILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELV 111

Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT----- 299
           +AL +   L F+H         RD K  NIL+DAD + KL+DFGL K   +         
Sbjct: 112 LALDSVHKLGFIH---------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLN 162

Query: 300 -----------------HVSTRVM-----GTYGYAAPEYVMTGH-LTSKSDVYSFGVVLL 336
                            H   RV      GT  Y APE V+ G     + D +S GV+L 
Sbjct: 163 DSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVILY 221

Query: 337 EMLTG 341
           EML G
Sbjct: 222 EMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 79.4 bits (195), Expect = 2e-16
 Identities = 78/302 (25%), Positives = 133/302 (44%), Gaps = 39/302 (12%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGNLLHP 199
           +G+G FG VFKG   +N T  V       VA+K ++ +  +   E +  E+  L     P
Sbjct: 12  IGKGSFGEVFKGI--DNRTQKV-------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
            + K  G  ++D +  ++ E++  GS  + L     PL  +    I     KGL +LH E
Sbjct: 63  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSE 120

Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS-TRVMGTYGYAAPEYVM 318
            +   I+RD K +N+LL      KL+DFG+A    +   T +     +GT  + APE + 
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD---TQIKRNTFVGTPFWMAPEVIK 174

Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRL 378
                SK+D++S G+  +E+  G     +  P     L+    P             P L
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------------PTL 221

Query: 379 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQTMQADN 438
           EG++    S+   +    CL+++P  RP   E+++    ++  K    +SY  + +    
Sbjct: 222 EGNY----SKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAK---KTSYLTELIDRYK 274

Query: 439 TW 440
            W
Sbjct: 275 RW 276

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 71/237 (29%), Positives = 104/237 (43%), Gaps = 43/237 (18%)

Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK-TLNHDGLQG-HKEWLA 188
             R++     LGEG FG V+K           +  TG  VA+K  L H+   G     L 
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKA---------RQIKTGRVVALKKILMHNEKDGFPITALR 56

Query: 189 EVNFLGNLLHPNLVKLVGYCIE-----DDQRLLVYEFMP------RGSLENHLFRRSLPL 237
           E+  L  L HPN+V L+   +E       +R  VY   P       G LEN   + +   
Sbjct: 57  EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTES- 115

Query: 238 PWSIR--MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK---D 292
              I+  M   L   +G+ +LHE     +++RD K +NIL+D     K++DFGLA+    
Sbjct: 116 --QIKCYMLQLL---EGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDG 167

Query: 293 APEDGK------THVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
            P + K      T   T ++ T  Y  PE ++     T+  D++  G V  EM T R
Sbjct: 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 79.5 bits (196), Expect = 2e-16
 Identities = 63/205 (30%), Positives = 93/205 (45%), Gaps = 27/205 (13%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGNLL 197
           +G G FG V+                   VA+K +++ G Q +++W   + EV FL  L 
Sbjct: 23  IGHGSFGAVYFARDVRTNE---------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR 73

Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 257
           HPN ++  G  + +    LV E+   GS  + L     PL       I  GA +GLA+LH
Sbjct: 74  HPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH 132

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK-DAPEDGKTHVSTRVMGTYGYAAPEY 316
                  I+RD K  NILL      KL+DFG A   +P       +   +GT  + APE 
Sbjct: 133 SHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSP-------ANSFVGTPYWMAPEV 182

Query: 317 VMT---GHLTSKSDVYSFGVVLLEM 338
           ++    G    K DV+S G+  +E+
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 78.8 bits (194), Expect = 2e-16
 Identities = 66/219 (30%), Positives = 94/219 (42%), Gaps = 36/219 (16%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           +G G FG V  G     G +  +      V VK L           +L EV     L HP
Sbjct: 3   IGNGWFGKVLLGEAH-RGMSKAR------VVVKELRASATPDEQLLFLQEVQPYRELNHP 55

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALGAAKGLA 254
           N+++ +G CIE    LLV EF P G L+N+L         +     +  ++A   A GL 
Sbjct: 56  NVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK-DVLQRMACEVASGLL 114

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PED-----GKTHVSTRVMGT 308
           +LH+      I+ D    N  L AD + K+ D+GLA +  PED         V  R    
Sbjct: 115 WLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR---- 167

Query: 309 YGYAAPEYV-------MTGHLTSKSDVYSFGVVLLEMLT 340
             + APE V       +    T KS+++S GV + E+ T
Sbjct: 168 --WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 78.9 bits (195), Expect = 3e-16
 Identities = 79/301 (26%), Positives = 121/301 (40%), Gaps = 69/301 (22%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-H 198
           ++GEG +G V+K    +         TG  VA+K ++       +E   E N L     H
Sbjct: 13  VIGEGTYGKVYKA-RHKK--------TGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNH 62

Query: 199 PNLVKLVG------YCIEDDQRLLVYEFMPRGSLEN-----HLFRRSLPLPWSIRMKIAL 247
           PN+    G          DDQ  LV E    GS+ +         + L   W     IA 
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-----IAY 117

Query: 248 ---GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD-APEDGKTHVST 303
                 +GLA+LHE     VI+RD K  NILL  +   KL DFG++       G+ +   
Sbjct: 118 ILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI 174

Query: 304 RVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 358
              GT  + APE +           ++SDV+S G+  +E+  G                 
Sbjct: 175 ---GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG----------------- 214

Query: 359 WARPHLGDK---RRFYRLL---DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
             +P L D    R  +++     P L+       S+K     ++CL ++ + RP M E++
Sbjct: 215 --KPPLCDMHPMRALFKIPRNPPPTLKS--PENWSKKFNDFISECLIKNYEQRPFMEELL 270

Query: 413 E 413
           E
Sbjct: 271 E 271

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 79.3 bits (195), Expect = 3e-16
 Identities = 87/272 (31%), Positives = 117/272 (43%), Gaps = 41/272 (15%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNL 196
           LLG+G FG V    V+E  T       G   A+K L  + +    E    L E   L N 
Sbjct: 2   LLGKGTFGKVI--LVKEKAT-------GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 52

Query: 197 LHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA--AKGL 253
            HP L  L  Y  +   RL  V E+   G L  HL R  +   +S       GA     L
Sbjct: 53  RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERV---FSEDRARFYGAEIVSAL 108

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
            +LH  +EK V+YRD K  N++LD D + K++DFGL K+  +DG T  +    GT  Y A
Sbjct: 109 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLA 164

Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 373
           PE +         D +  GVV+ EM+ GR             L+      L ++ RF R 
Sbjct: 165 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LMEEIRFPRT 218

Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           L P            +A  L +  L +DPK R
Sbjct: 219 LSP------------EAKSLLSGLLKKDPKQR 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 15/203 (7%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNLLHP 199
           LG G FGCV KG  +            + VA+K L ++  +    E + E   +  L +P
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQ-------IDVAIKVLKNENEKSVRDEMMREAEIMHQLDNP 55

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
            +V+++G C E +  +LV E    G L   L  +   +  S  +++    + G+ +L   
Sbjct: 56  YIVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG- 113

Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY--GYAAPEYV 317
             K  ++RD    N+LL   + AK+SDFGL+K    D  ++   R  G +   + APE +
Sbjct: 114 --KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGAD-DSYYKARSAGKWPLKWYAPECI 170

Query: 318 MTGHLTSKSDVYSFGVVLLEMLT 340
                +S+SDV+S+G+ + E  +
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 78/279 (27%), Positives = 117/279 (41%), Gaps = 35/279 (12%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLHP 199
           +G G FG VF G +  + T          VAVK+         K ++L E   L    HP
Sbjct: 3   IGRGNFGEVFSGRLRADNTP---------VAVKSCRETLPPDLKAKFLQEARILKQYSHP 53

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           N+V+L+G C +     +V E +  G     L      L     +++   AA G+ +L   
Sbjct: 54  NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE-- 111

Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT--YGYAAPEYV 317
             K  I+RD    N L+      K+SDFG++++  EDG  + ST  M      + APE +
Sbjct: 112 -SKHCIHRDLAARNCLVTEKNVLKISDFGMSREE-EDG-VYASTGGMKQIPVKWTAPEAL 168

Query: 318 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRLLDP 376
             G  +S+SDV+SFG++L E  +       N  N +    +E          +  RL  P
Sbjct: 169 NYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE----------QGVRLPCP 218

Query: 377 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
            L             +L  +C   DP  RP  S V + L
Sbjct: 219 EL-------CPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 81.4 bits (201), Expect = 3e-16
 Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 18/193 (9%)

Query: 166 TGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNLLHPNLVKLV--GYCIEDDQRLLVYEF 220
           TG  VA+K L  D  +   +   +  E      L HPN+V L+  G          V+E+
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEY 60

Query: 221 MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---D 277
           +P  +L   L      LP     ++ L     LA  H +    +++RD K  NI++    
Sbjct: 61  VPGRTLREVLAADG-ALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTG 116

Query: 278 ADYNAKLSDFGLAKDAPEDGKTHV-----STRVMGTYGYAAPEYVMTGHLTSKSDVYSFG 332
              +AK+ DFG+    P      V     +T V+GT  Y APE +    +T  SD+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176

Query: 333 VVLLEMLTGRRSM 345
           ++ LE LTG+R +
Sbjct: 177 LIFLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 70/289 (24%), Positives = 126/289 (43%), Gaps = 30/289 (10%)

Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWL 187
           L     +   +LG G FG V+KG W       P      + VA+K L  +   + +KE L
Sbjct: 4   LKETELKKVKVLGSGAFGTVYKGIW------IPDGENVKIPVAIKVLRENTSPKANKEIL 57

Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E   +  +  P + +L+G C+    +L V + MP G L +++      +     +   +
Sbjct: 58  DEAYVMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCV 116

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             AKG+++L E     +++RD    N+L+ +  + K++DFGLA+    D   + +     
Sbjct: 117 QIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV 173

Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGD 366
              + A E ++    T +SDV+S+GV + E++T G +  D        +L+E        
Sbjct: 174 PIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE----- 228

Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
                RL  P +        +     +  +C   D + RPR  E+V+  
Sbjct: 229 -----RLPQPPI-------CTIDVYMIMVKCWMIDSECRPRFRELVDEF 265

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 78.5 bits (193), Expect = 4e-16
 Identities = 84/276 (30%), Positives = 116/276 (42%), Gaps = 35/276 (12%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVN 191
           FR   +LG+GGFG V    V           TG   A K L    ++   G    L E  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGESMALNEKQ 52

Query: 192 FLGNLLHPNLVKLVGYCIE-DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGA 249
            L  + +   V  + Y  E  D   LV   M  G L+ H++            +  A   
Sbjct: 53  ILEKV-NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEI 111

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
             GL  LH+E    ++YRD K  NILLD   + ++SD GLA   PE G+T +  RV GT 
Sbjct: 112 CCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE-GQT-IKGRV-GTV 165

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
           GY APE V     T   D ++ G +L EM+ G+    + +   +   VE           
Sbjct: 166 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE----------- 214

Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
             RL+   ++  +S K S  A  L    L +DPK R
Sbjct: 215 --RLVK-EVQEEYSEKFSPDARSLCKMLLCKDPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 78.9 bits (194), Expect = 4e-16
 Identities = 68/210 (32%), Positives = 99/210 (47%), Gaps = 21/210 (10%)

Query: 198 HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 256
           +P LV L   C +   RL LV E++  G L  H+ +R   LP       A      L FL
Sbjct: 55  NPFLVGLHS-CFQTTSRLFLVIEYVNGGDLMFHM-QRQRKLPEEHARFYAAEICIALNFL 112

Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           HE   + +IYRD K  N+LLDAD + KL+D+G+ K+    G T  ++   GT  Y APE 
Sbjct: 113 HE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNYIAPEI 167

Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR-RFYRLLD 375
           +         D ++ GV++ EM+ GR   D    N + N  ++    + +K  R  R L 
Sbjct: 168 LRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFL- 226

Query: 376 PRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
                      S KA+ +    L++DPK R
Sbjct: 227 -----------SVKASHVLKGFLNKDPKER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 78.9 bits (194), Expect = 4e-16
 Identities = 57/217 (26%), Positives = 101/217 (46%), Gaps = 22/217 (10%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LH 198
           LGEG FG V +   E  G    +P   +TVAVK L  +   +   + ++E+  +  +  H
Sbjct: 20  LGEGCFGQVVRA--EAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP---------------WSIRM 243
            N++ L+G C ++    ++ E+  +G+L   L  R  P P               +   +
Sbjct: 78  KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137

Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
             A   A+G+ +L     +  I+RD    N+L+  D   K++DFGLA+   +      ++
Sbjct: 138 SCAYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194

Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                  + APE +     T +SDV+SFG+++ E+ T
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 78.5 bits (193), Expect = 4e-16
 Identities = 63/223 (28%), Positives = 108/223 (48%), Gaps = 36/223 (16%)

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL 196
           E ++GEG FG V +  ++       K G  +  A+K L     +  H+++  E+  L  L
Sbjct: 7   EDVIGEGNFGQVIRAMIK-------KDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKL 59

Query: 197 -LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL---PWSIR---------- 242
             HPN++ L+G C       +  E+ P G+L + L R+S  L   P   +          
Sbjct: 60  GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFL-RKSRVLETDPAFAKEHGTASTLTS 118

Query: 243 ---MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
              ++ A   A G+ +L   +EK  I+RD    N+L+  +  +K++DFGL++     G+ 
Sbjct: 119 QQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR-----GEE 170

Query: 300 HVSTRVMGTYG--YAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
               + MG     + A E +     T+KSDV+SFGV+L E+++
Sbjct: 171 VYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 78.0 bits (192), Expect = 5e-16
 Identities = 72/283 (25%), Positives = 121/283 (42%), Gaps = 49/283 (17%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           LG G  G V+K +            T   +AVK +  D  ++  K+ ++E+  L     P
Sbjct: 9   LGHGNGGTVYKAYH---------LLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSP 59

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
            ++   G    +++  +  EFM  GSL+  ++R+   +P  +  +IA+   KGL +L   
Sbjct: 60  YIIGFYGAFFVENRISICTEFMDGGSLD--VYRK---IPEHVLGRIAVAVVKGLTYLWS- 113

Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED-GKTHVSTRVMGTYGYAAPEYVM 318
               +++RD K SN+L++     KL DFG++        KT+V     GT  Y APE + 
Sbjct: 114 --LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV-----GTNAYMAPERIS 166

Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE--------HNLVEWARPHLGDKRRF 370
                  SDV+S G+  +E+  GR    + + N            +V+   P L      
Sbjct: 167 GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPV---- 222

Query: 371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                    G F    S+K      QC+ + PK RP    +++
Sbjct: 223 ---------GQF----SEKFVHFITQCMRKQPKERPAPENLMD 252

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 77.3 bits (190), Expect = 8e-16
 Identities = 70/209 (33%), Positives = 94/209 (44%), Gaps = 25/209 (11%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLL 197
           LG+GGFG V    V+          TG   A K L+   L+   G K  L E   L  + 
Sbjct: 1   LGKGGFGEVCAVQVKN---------TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN 51

Query: 198 HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGL 253
            P +V L  Y  E    L LV   M  G L+ H++    R L +   I     +    G+
Sbjct: 52  SPFIVNL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQI--TCGI 108

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
             LH      ++YRD K  N+LLD   N +LSD GLA +   DGKT   T+  GT GY A
Sbjct: 109 LHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELK-DGKT--ITQRAGTNGYMA 162

Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           PE +     +   D ++ G  + EM+ GR
Sbjct: 163 PEILKEEPYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 77.9 bits (192), Expect = 1e-15
 Identities = 73/208 (35%), Positives = 95/208 (45%), Gaps = 25/208 (12%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVN-FLGNL 196
           +G+G FG V     +           G   AVK L    +   KE    +AE N  L N+
Sbjct: 3   IGKGSFGKVLLAKHKA---------DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV 53

Query: 197 LHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMKI-ALGAAKGL 253
            HP LV L  Y  +   +L  V +++  G L  HL R RS P P   R +  A   A  L
Sbjct: 54  KHPFLVGL-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP---RARFYAAEIASAL 109

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
            +LH      +IYRD K  NILLD+  +  L+DFGL K+  E  KT  ++   GT  Y A
Sbjct: 110 GYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLA 164

Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           PE +         D +  G VL EML G
Sbjct: 165 PEVLRKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 25/214 (11%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLLH 198
           LGEG FG V +G + ++ +        L VAVKT+          +++L+E   +    H
Sbjct: 7   LGEGEFGSVMEGQLNQDDSI-------LKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDH 59

Query: 199 PNLVKLVGYCIEDDQR------LLVYEFMPRGSLENHLFRRSLP-----LPWSIRMKIAL 247
           PN+++L+G C++  +       +++  FM  G L + L    L      LP  + +K   
Sbjct: 60  PNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT 119

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A G+ +L   + K  I+RD    N +L+ + N  ++DFGL+K    +G  +   R+  
Sbjct: 120 DIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI-YNGDYYRQGRIAK 175

Query: 308 T-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
               + A E +     T+KSDV+SFGV + E+ T
Sbjct: 176 MPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 77.4 bits (190), Expect = 1e-15
 Identities = 72/235 (30%), Positives = 108/235 (45%), Gaps = 33/235 (14%)

Query: 118 SQLRKFMFNDLKLATRNFR--PESL------LGEGGFGCVFKGWVEENGTAPVKPGTGLT 169
           S  R     D ++A   F+  PE L      +G G FG V+  +  +  T  V       
Sbjct: 2   STSRAGSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVY--FARDVRTNEV------- 52

Query: 170 VAVKTLNHDGLQGHKEW---LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL 226
           VA+K +++ G Q +++W   + EV FL  + HPN ++  G  + +    LV E+   GS 
Sbjct: 53  VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSA 111

Query: 227 ENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD 286
            + L     PL       I  GA +GLA+LH      +I+RD K  NILL      KL+D
Sbjct: 112 SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLAD 168

Query: 287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEM 338
           FG A  A        +   +GT  + APE ++    G    K DV+S G+  +E+
Sbjct: 169 FGSASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 65/231 (28%), Positives = 106/231 (45%), Gaps = 27/231 (11%)

Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HK 184
           ++ L+T  F  E  LGE  FG V+KG +   GTAP +      VA+KTL  D  +G   +
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHL--FGTAPGEQTQ--AVAIKTLK-DKAEGPLRE 53

Query: 185 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------- 234
           E+  E      L HPN+V L+G   ++    +++ +     L   L  RS          
Sbjct: 54  EFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDD 113

Query: 235 -----LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL 289
                  L  +  + I    A G+ FL   +   V+++D  T N+L+    N K+SD GL
Sbjct: 114 DKTVKSTLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGL 170

Query: 290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            ++        +    +    + +PE +M G  +  SD++S+GVVL E+ +
Sbjct: 171 FREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 81/311 (26%), Positives = 137/311 (44%), Gaps = 47/311 (15%)

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL 196
           + ++GEG FG V K  ++       K G  +  A+K +     +  H+++  E+  L  L
Sbjct: 12  QDVIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 64

Query: 197 -LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA------LGA 249
             HPN++ L+G C       L  E+ P G+L + L R+S  L       IA      L +
Sbjct: 65  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSS 123

Query: 250 AKGLAFLHEEA-------EKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
            + L F  + A       +K  I+RD    NIL+  +Y AK++DFGL++     G+    
Sbjct: 124 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYV 178

Query: 303 TRVMGTYG--YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 360
            + MG     + A E +     T+ SDV+S+GV+L E++    S+      G      + 
Sbjct: 179 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV----SLGGTPYCGMTCAELYE 234

Query: 361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL-KPLQ 419
           +   G     YRL  P       +    +   L  QC    P  RP  ++++ +L + L+
Sbjct: 235 KLPQG-----YRLEKP-------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282

Query: 420 NLKDMASSSYY 430
             K   +++ Y
Sbjct: 283 ERKTYVNTTLY 293

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 76.3 bits (187), Expect = 2e-15
 Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 19/216 (8%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EV 190
           N+R   LLG+G FG V+  +        V  G  L       + +  +  KE  A   E+
Sbjct: 3   NWRRGKLLGQGAFGRVYLCY-------DVDTGRELAAKQVQFDPESPETSKEVSALECEI 55

Query: 191 NFLGNLLHPNLVKLVGYCIED--DQRLLVY-EFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
             L NL H  +V+  G C+ D  ++ L ++ E+MP GS+++ L +    L  S+  K   
Sbjct: 56  QLLKNLQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTR 113

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR-VM 306
              +G+++LH      +++RD K +NIL D+  N KL DFG +K       +    R V 
Sbjct: 114 QILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT 170

Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           GT  + +PE +       K+DV+S G  ++EMLT +
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 70/298 (23%), Positives = 120/298 (40%), Gaps = 46/298 (15%)

Query: 134 NFRPESLLGEGGFGCVFKGWVE-ENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           NF+ E  +G G F  V++     +     +K        V+       +  ++ + E++ 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALK-------KVQIFEMMDAKARQDCVKEIDL 55

Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLEN---HLFRRSLPLPWSIRMKIALGA 249
           L  L HPN++K +   IED++  +V E    G L     +  ++   +P     K  +  
Sbjct: 56  LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQL 115

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
              +  +H    + V++RD K +N+ + A    KL D GL +      KT  +  ++GT 
Sbjct: 116 CSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTP 170

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            Y +PE +       KSD++S G +L EM                       P  GDK  
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEM------------------AALQSPFYGDKMN 212

Query: 370 FYRLLD-------PRLEG-HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ 419
            + L         P L   H+    S+K  +L + C+  DP  RP +  V +  K + 
Sbjct: 213 LFSLCQKIEQCDYPPLPTEHY----SEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 88/275 (32%), Positives = 115/275 (41%), Gaps = 48/275 (17%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNL 196
           LLG+G FG V    V E  T       G   A+K L  + +    E    + E   L N 
Sbjct: 2   LLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 52

Query: 197 LHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA--AKGL 253
            HP L  L  Y  +   RL  V E+   G L  HL R  +      R     GA     L
Sbjct: 53  RHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF---YGAEIVSAL 108

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
            +LH    + V+YRD K  N++LD D + K++DFGL K+   DG T  +    GT  Y A
Sbjct: 109 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLA 163

Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGR---RSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           PE +         D +  GVV+ EM+ GR    + D  R      L E     L ++ RF
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELI---LMEEIRF 214

Query: 371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
            R L P            +A  L A  L +DPK R
Sbjct: 215 PRTLSP------------EAKSLLAGLLKKDPKQR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 75.5 bits (185), Expect = 2e-15
 Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 21/217 (9%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLA--- 188
           N+R   LLG+G FG V+  +  +         TG  +AVK +  + +  +  KE  A   
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDAD---------TGRELAVKQVQFDPESPETSKEVNALEC 53

Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLL--VYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
           E+  L NLLH  +V+  G   +  +R L    E MP GS+++ L +    L  ++  K  
Sbjct: 54  EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYT 112

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR-V 305
               +G+++LH      +++RD K +NIL D+  N KL DFG +K       +    + V
Sbjct: 113 RQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV 169

Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
            GT  + +PE +       K+D++S G  ++EMLT +
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 76.5 bits (188), Expect = 3e-15
 Identities = 67/207 (32%), Positives = 97/207 (46%), Gaps = 21/207 (10%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLG-N 195
           +LG+G FG V    ++E+G            AVK L  D +    +    + E   L   
Sbjct: 2   VLGKGSFGKVMLARLKESGR---------LYAVKVLKKDVILQDDDVECTMTEKRILSLA 52

Query: 196 LLHPNLVKLVGYCIEDDQRLL-VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
             HP L +L   C +   RL  V EF+  G L  H+ ++S     +     A      L 
Sbjct: 53  RNHPFLTQLY-CCFQTPDRLFFVMEFVNGGDLMFHI-QKSRRFDEARARFYAAEITSALM 110

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           FLH+   K +IYRD K  N+LLD + + KL+DFG+ K+   +GKT  ++   GT  Y AP
Sbjct: 111 FLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIAP 165

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           E +         D ++ GV+L EML G
Sbjct: 166 EILQEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 3e-15
 Identities = 72/293 (24%), Positives = 115/293 (39%), Gaps = 78/293 (26%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G G +G V+K      G           VA+K +  +     +    E++ L    HPN
Sbjct: 11  IGSGTYGDVYKARDIATGE---------LVAIKVIKLEPGDDFEIIQQEISMLKECRHPN 61

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLEN--HLFRRSLPLPWSIRMKIAL---GAAKGLAF 255
           +V   G  +  D+  +V E+   GSL++   + R  L        +IA       KGLA+
Sbjct: 62  IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL-----QIAYVCRETLKGLAY 116

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR--VMGTYGYAA 313
           LHE      I+RD K +NILL  D + KL+DFG++    +   T ++ R   +GT  + A
Sbjct: 117 LHE---TGKIHRDIKGANILLTEDGDVKLADFGVSA---QLTAT-IAKRKSFIGTPYWMA 169

Query: 314 PEYV---MTGHLTSKSDVYSFGVVLLEM-----------------LTGRRSMDKNRPNGE 353
           PE       G    K D+++ G+  +E+                 L  + +         
Sbjct: 170 PEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP------ 223

Query: 354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
                   P L DK ++                S        +CL++DPK RP
Sbjct: 224 --------PKLKDKEKW----------------SPVFHDFIKKCLTKDPKKRP 252

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 75.8 bits (186), Expect = 3e-15
 Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 22/217 (10%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 23  LGEGCFGQVVMA--EALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRM-------------- 243
            N++ L+G C +D    ++ E+  +G+L  +L  RR   + +S  +              
Sbjct: 81  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140

Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 141 SCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197

Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                  + APE +     T +SDV+SFGV++ E+ T
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 75.2 bits (185), Expect = 4e-15
 Identities = 66/222 (29%), Positives = 109/222 (49%), Gaps = 32/222 (14%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 189
           NF+    +GEG +G V+K   +          TG  VA+K +  D    G+      + E
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKL---------TGEVVALKKIRLDTETEGVPSTA--IRE 49

Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIA 246
           ++ L  L HPN+VKL+     +++  LV+EF+     +   F  + P   +P  +     
Sbjct: 50  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL---HQDLKKFMDASPLSGIPLPLIKSYL 106

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTHVSTR 304
               +GLAF H      V++RD K  N+L++ +   KL+DFGLA+    P    TH    
Sbjct: 107 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---E 160

Query: 305 VMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSM 345
           V+ T  Y APE ++   + ++  D++S G +  EM+T RR++
Sbjct: 161 VV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 75.1 bits (184), Expect = 4e-15
 Identities = 63/221 (28%), Positives = 106/221 (47%), Gaps = 36/221 (16%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-L 197
           ++GEG FG V K  ++       K G  +  A+K +     +  H+++  E+  L  L  
Sbjct: 2   VIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 54

Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL---PWSIR------------ 242
           HPN++ L+G C       L  E+ P G+L + L R+S  L   P                
Sbjct: 55  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQ 113

Query: 243 -MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
            +  A   A+G+ +L   ++K  I+RD    NIL+  +Y AK++DFGL++     G+   
Sbjct: 114 LLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVY 165

Query: 302 STRVMGTYG--YAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
             + MG     + A E +     T+ SDV+S+GV+L E+++
Sbjct: 166 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 74.6 bits (183), Expect = 4e-15
 Identities = 63/201 (31%), Positives = 97/201 (48%), Gaps = 17/201 (8%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 198
           LG G FG V KG  +   +         TVAVK L +D        E L E N +  L +
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEK-------TVAVKILKNDNNDPALKDELLREANVMQQLDN 55

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 258
           P +V+++G C E +  +LV E    G L   L +       +I  ++    + G+ +L E
Sbjct: 56  PYIVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNI-TELVHQVSMGMKYLEE 113

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY--GYAAPEY 316
                 ++RD    N+LL   + AK+SDFGL+K    D + +   +  G +   + APE 
Sbjct: 114 TN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD-ENYYKAKTHGKWPVKWYAPEC 169

Query: 317 VMTGHLTSKSDVYSFGVVLLE 337
           +     +SKSDV+SFGV++ E
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 74.8 bits (184), Expect = 5e-15
 Identities = 65/224 (29%), Positives = 109/224 (48%), Gaps = 35/224 (15%)

Query: 135 FRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLAEVNF 192
                LL EG FG +F G  ++E      KPG    V VKT+ +H         L E   
Sbjct: 8   VTLSDLLQEGTFGRIFYGILIDE------KPGKEEEVFVKTVKDHASEIQVTLLLQESCL 61

Query: 193 LGNLLHPNLVKLVGYCIED-DQRLLVYEFMPRGSLENHLFRRSLPL-----PWSIRMK-- 244
           L  L H N++ ++  CIED +   ++Y +M  G+L+  LF +   L     P ++  +  
Sbjct: 62  LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLK--LFLQQCRLGEANNPQALSTQQL 119

Query: 245 --IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PED----- 296
             +A+  A G+++LH+   + VI++D    N ++D +   K++D  L++D  P D     
Sbjct: 120 VHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG 176

Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              +   + M      A E ++    +S SDV+SFGV+L E++T
Sbjct: 177 DNENRPVKWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 75.3 bits (185), Expect = 5e-15
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 20/211 (9%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVN 191
           + +     +G+G  G V+        TA +   TG  VA+K +N    Q  KE +  E+ 
Sbjct: 19  KKYTRFEKIGQGASGTVY--------TA-IDVATGQEVAIKQMNLQQ-QPKKELIINEIL 68

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 251
            +    HPN+V  +   +  D+  +V E++  GSL + +    +         +     +
Sbjct: 69  VMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE--GQIAAVCRECLQ 126

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTYG 310
            L FLH      VI+RD K+ NILL  D + KL+DFG  A+  PE  K    + ++GT  
Sbjct: 127 ALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPY 180

Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           + APE V       K D++S G++ +EM+ G
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 74.7 bits (183), Expect = 5e-15
 Identities = 69/209 (33%), Positives = 104/209 (49%), Gaps = 21/209 (10%)

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL 197
           E  LG G FG V+     ++            VAVKT+   G    + +LAE N +  L 
Sbjct: 11  EKKLGAGQFGEVWMATYNKH----------TKVAVKTMK-PGSMSVEAFLAEANVMKTLQ 59

Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLA 254
           H  LVKL    +  +   ++ EFM +GSL + L        PLP  I     +  A+G+A
Sbjct: 60  HDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMA 116

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           F+ +   +  I+RD + +NIL+ A    K++DFGLA+   ED +            + AP
Sbjct: 117 FIEQ---RNYIHRDLRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAP 172

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGRR 343
           E +  G  T KSDV+SFG++L+E++T  R
Sbjct: 173 EAINFGSFTIKSDVWSFGILLMEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 75.6 bits (186), Expect = 6e-15
 Identities = 89/273 (32%), Positives = 113/273 (41%), Gaps = 44/273 (16%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNL 196
           LLG+G FG V    V E  T       G   A+K L  + +    E    L E   L N 
Sbjct: 2   LLGKGTFGKVI--LVREKAT-------GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT 52

Query: 197 LHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA--AKGL 253
            HP L  L  Y  +   RL  V E+   G L  HL R  +      R     GA     L
Sbjct: 53  RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF---YGAEIVSAL 108

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
            +LH      V+YRD K  N++LD D + K++DFGL K+   DG T       GT  Y A
Sbjct: 109 GYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLA 163

Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPHLGDKRRFYR 372
           PE +         D +  GVV+ EM+ GR        N +H  L E     L ++ RF R
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF----YNQDHEKLFELI---LMEEIRFPR 216

Query: 373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
            L            S +A  L A  L +DPK R
Sbjct: 217 TL------------SPEAKSLLAGLLKKDPKQR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 75.5 bits (186), Expect = 6e-15
 Identities = 66/218 (30%), Positives = 88/218 (40%), Gaps = 32/218 (14%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH---------DGLQGHKE 185
           FR  ++LG G FG V     E   T       G   A+K L           + L   K 
Sbjct: 1   FRCLAVLGRGHFGKVL--LAEYKKT-------GELYAIKALKKGDIIARDEVESLMCEKR 51

Query: 186 WLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
                N      HP LV L   C + +  +  V E+   G L  H+       P   R  
Sbjct: 52  IFETANSER---HPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP---RAV 104

Query: 245 I-ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
             A     GL +LHE     ++YRD K  N+LLD +   K++DFGL K+    G    ST
Sbjct: 105 FYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR-TST 160

Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
              GT  + APE +     T   D +  GV++ EML G
Sbjct: 161 -FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 75.1 bits (184), Expect = 6e-15
 Identities = 67/215 (31%), Positives = 97/215 (45%), Gaps = 33/215 (15%)

Query: 137 PESL------LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---L 187
           PE L      +G G FG V+      N            VA+K +++ G Q +++W   +
Sbjct: 13  PEKLFSDLREIGHGSFGAVYFARDVRNSE---------VVAIKKMSYSGKQSNEKWQDII 63

Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            EV FL  L HPN ++  G  + +    LV E+   GS  + L     PL       +  
Sbjct: 64  KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTH 122

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK-DAPEDGKTHVSTRVM 306
           GA +GLA+LH      +I+RD K  NILL      KL DFG A   AP       +   +
Sbjct: 123 GALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFV 172

Query: 307 GTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEM 338
           GT  + APE ++    G    K DV+S G+  +E+
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 17/215 (7%)

Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWL 187
           +L   +F   S LG G  G VFK           KP +GL +A K ++ +       + +
Sbjct: 1   ELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLIMARKLIHLEIKPAIRNQII 51

Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E+  L     P +V   G    D +  +  E M  GSL+  + +++  +P  I  K+++
Sbjct: 52  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGRIPEQILGKVSI 110

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
              KGL +L E+ +  +++RD K SNIL+++    KL DFG++    +     ++   +G
Sbjct: 111 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVG 164

Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           T  Y +PE +   H + +SD++S G+ L+EM  GR
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 74.6 bits (183), Expect = 1e-14
 Identities = 65/223 (29%), Positives = 102/223 (45%), Gaps = 31/223 (13%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEV 190
           +F    +LG+G FG V          A  K GT    A+K L  D +    +    + E 
Sbjct: 1   DFNFLMVLGKGSFGKVM--------LAERK-GTDELYAIKILKKDVVIQDDDVECTMVEK 51

Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHL-----FRRSLPLPWSIRMK 244
             L     P  +  +  C +   RL  V E++  G L  H+     F+    + ++  + 
Sbjct: 52  RVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEIS 111

Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           +      GL FLH    + +IYRD K  N++LD++ + K++DFG+ K+   DG   V+TR
Sbjct: 112 V------GLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG---VTTR 159

Query: 305 VM-GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD 346
              GT  Y APE +         D +++GV+L EML G+   D
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 73/274 (26%), Positives = 124/274 (45%), Gaps = 34/274 (12%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGNLLHP 199
           +G+G FG V+KG   +N T  V       VA+K ++ +  +   E +  E+  L     P
Sbjct: 12  IGKGSFGEVYKGI--DNRTKEV-------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
            + +  G  ++  +  ++ E++  GS  + L  +  PL  +    I     KGL +LH E
Sbjct: 63  YITRYYGSYLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSE 120

Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
            +   I+RD K +N+LL    + KL+DFG+A     D +   +T V GT  + APE +  
Sbjct: 121 RK---IHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNTFV-GTPFWMAPEVIKQ 175

Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
                K+D++S G+  +E+  G        P     L+    P             P LE
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------PTLE 222

Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
           G +    S+   +    CL++DP+ RP   E+++
Sbjct: 223 GQY----SKPFKEFVEACLNKDPRFRPTAKELLK 252

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 74.5 bits (183), Expect = 1e-14
 Identities = 55/181 (30%), Positives = 85/181 (46%), Gaps = 14/181 (7%)

Query: 165 GTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFM 221
           GTG   A+K L    +   K+      E + L  L HP +V ++    ++++   + EF+
Sbjct: 41  GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFV 100

Query: 222 PRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN 281
             G L  HL R++   P  +             +LH    K +IYRD K  N+LLD   +
Sbjct: 101 VGGELFTHL-RKAGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGH 156

Query: 282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLT 340
            K++DFG AK  P+   T     + GT  Y APE + + GH     D ++ GV+L E + 
Sbjct: 157 VKVTDFGFAKKVPDRTFT-----LCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIA 210

Query: 341 G 341
           G
Sbjct: 211 G 211

Length = 329

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 84/295 (28%), Positives = 126/295 (42%), Gaps = 41/295 (13%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGNLL 197
           L+GEG +G V K   +E         TG  VA+K    + D     K  + E+  L  L 
Sbjct: 8   LVGEGSYGMVMKCKHKE---------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR 58

Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 257
           H NLV L+       +  LV+EF+    L + L +    L  S   K      +G+ F H
Sbjct: 59  HENLVNLIEVFRRKKRLYLVFEFVDHTVL-DDLEKYPNGLDESRVRKYLFQILRGIEFCH 117

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKT-HVSTRVMGTYGYAAP 314
                 +I+RD K  NIL+      KL DFG A+   AP +  T +V+TR      Y AP
Sbjct: 118 SHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WYRAP 169

Query: 315 EYVMTGHLTSKS-DVYSFGVVLLEMLTGR------RSMDK---------NRPNGEHNLVE 358
           E ++      ++ D+++ G ++ EMLTG         +D+         N       + +
Sbjct: 170 ELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQ 229

Query: 359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                 G +    + ++P LE  F  K S     LA QCL  DP  RP  S+++ 
Sbjct: 230 KNPLFAGMRLPEVKEIEP-LEKRFP-KLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 66/216 (30%), Positives = 104/216 (48%), Gaps = 31/216 (14%)

Query: 198 HPNLVKLVGYCIEDDQRLL-VYEFMPRGSLENHLFR-RSLPLP----WSIRMKIALGAAK 251
           HP LV L   C + + RL  V E++  G L  H+ R R LP      +S  + +AL    
Sbjct: 55  HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN--- 110

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
              +LHE     +IYRD K  N+LLD++ + KL+D+G+ K+    G T  ++   GT  Y
Sbjct: 111 ---YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNY 162

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD--KNRPNGEHNLVEWARPHLGDKRR 369
            APE +         D ++ GV++ EM+ GR   D   +  N + N  ++          
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL--------- 213

Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           F  +L+ ++    S+  S KA  +    L++DPK R
Sbjct: 214 FQVILEKQIRIPRSL--SVKAASVLKSFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 67/218 (30%), Positives = 99/218 (45%), Gaps = 31/218 (14%)

Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGN 195
            +LG+G FG V     E  GT  +        A+K L  D +    +    + E   L  
Sbjct: 6   MVLGKGSFGKVMLA--ERKGTDEL-------YAIKILKKDVIIQDDDVECTMVEKRVLAL 56

Query: 196 LLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALGA 249
              P  +  +  C +   RL  V E++  G L  H+     F+    + ++  + I    
Sbjct: 57  PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAI---- 112

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM-GT 308
             GL FLH    K +IYRD K  N++LDA+ + K++DFG+ K+    GKT   TR   GT
Sbjct: 113 --GLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGT 164

Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD 346
             Y APE +         D ++FGV+L EML G+   D
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 74.4 bits (183), Expect = 2e-14
 Identities = 72/255 (28%), Positives = 97/255 (38%), Gaps = 56/255 (21%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN-------FL 193
           +G+GG+G VF            K  TG  VA+K +    L      L EV         L
Sbjct: 9   VGQGGYGQVF---------LAKKKDTGEIVALKRMKKSLLF----KLNEVRHVLTERDIL 55

Query: 194 GNLLHPNLVKLVGYCIEDDQRL-LVYEFMP----------RGSLENHLFRRSLPLPWSIR 242
                  LVKL+ Y  +DD+ L L  E++P           G L     R  +       
Sbjct: 56  TTTKSEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYM-----AE 109

Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
           M  A+ A   L ++H         RD K  N L+DA  + KL+DFGL+K       +   
Sbjct: 110 MFEAVDALHELGYIH---------RDLKPENFLIDASGHIKLTDFGLSKGIVTYANS--- 157

Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLVEWA- 360
             V+G+  Y APE +         D +S G +L E L G      + PN    NL  W  
Sbjct: 158 --VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE 215

Query: 361 ---RPHLGDKRRFYR 372
              RP   D R    
Sbjct: 216 TLQRPVYDDPRFNLS 230

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 83/281 (29%), Positives = 116/281 (41%), Gaps = 45/281 (16%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVN 191
           FR   +LG+GGFG V    V           TG   A K L    ++   G    L E  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVR---------ATGKMYACKRLEKKRIKKRKGESMALNEKQ 52

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 251
            L  +    +V L       D   LV   M  G L+ H++  ++  P     +    AA+
Sbjct: 53  ILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIY--NMGNPGFEEERALFYAAE 110

Query: 252 ---GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
              GL  LH E     +YRD K  NILLD   + ++SD GLA   PE     +  RV GT
Sbjct: 111 ILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--ESIRGRV-GT 164

Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
            GY APE +     T   D +  G ++ EM+ G+                   P  G K 
Sbjct: 165 VGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ------------------SPFRGRKE 206

Query: 369 RFYR-LLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKAR 405
           +  R  +D R+   E  +S K S++A  +    L++DPK R
Sbjct: 207 KVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 73.2 bits (179), Expect = 2e-14
 Identities = 84/311 (27%), Positives = 134/311 (43%), Gaps = 43/311 (13%)

Query: 137 PESL------LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-E 189
           PE L      +G+G FG VFKG   +N T  V       VA+K ++ +  +   E +  E
Sbjct: 2   PEELFTKLERIGKGSFGEVFKGI--DNRTQQV-------VAIKIIDLEEAEDEIEDIQQE 52

Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 249
           +  L     P + K  G  ++  +  ++ E++  GS  + L  R+ P        +    
Sbjct: 53  ITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL--RAGPFDEFQIATMLKEI 110

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
            KGL +LH E +   I+RD K +N+LL    + KL+DFG+A     D +   +T V GT 
Sbjct: 111 LKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNTFV-GTP 165

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            + APE +      SK+D++S G+  +E+  G        P     L+    P       
Sbjct: 166 FWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP------- 218

Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSY 429
                 P L G F    S+   +    CL++DP  RP   E+   LK    +K+   +SY
Sbjct: 219 ------PTLTGEF----SKPFKEFIDACLNKDPSFRPTAKEL---LKHKFIVKNAKKTSY 265

Query: 430 YFQTMQADNTW 440
             + +     W
Sbjct: 266 LTELIDRFKRW 276

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 44/166 (26%), Positives = 69/166 (41%), Gaps = 15/166 (9%)

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 258
           P + KL       D   LV E++  G   + L +    LP     +       G+  LH+
Sbjct: 57  PYVAKLYYSFQSKDYLYLVMEYLNGGDCAS-LIKTLGGLPEDWAKQYIAEVVLGVEDLHQ 115

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +I+RD K  N+L+D   + KL+DFGL+++         + + +GT  Y APE ++
Sbjct: 116 RG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETIL 166

Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-----NGEHNLVEW 359
                  SD +S G V+ E L G        P     N     + W
Sbjct: 167 GVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINW 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 72.8 bits (179), Expect = 3e-14
 Identities = 56/204 (27%), Positives = 84/204 (41%), Gaps = 54/204 (26%)

Query: 229 HLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG 288
            ++ + L +P  I  KIA+   K L +LH +    VI+RD K SN+L++ +   KL DFG
Sbjct: 92  KVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFG 149

Query: 289 --------LAKDAPEDGKTHVSTRVMGTYGYAAPEYV----MTGHLTSKSDVYSFGVVLL 336
                   +AK           T   G   Y APE +           KSDV+S G+ ++
Sbjct: 150 ISGYLVDSVAK-----------TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMI 198

Query: 337 EMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD------PRL-EGHFSIKGSQK 389
           E+ TGR   D            W  P       F +L        P+L    FS     +
Sbjct: 199 ELATGRFPYDS-----------WKTP-------FQQLKQVVEEPSPQLPAEKFSP----E 236

Query: 390 ATQLAAQCLSRDPKARPRMSEVVE 413
                 +CL ++ K RP   E+++
Sbjct: 237 FQDFVNKCLKKNYKERPNYPELLQ 260

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 73.2 bits (179), Expect = 3e-14
 Identities = 60/215 (27%), Positives = 106/215 (49%), Gaps = 17/215 (7%)

Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWL 187
           +L   +F   S LG G  G V K           KP +GL +A K ++ +       + +
Sbjct: 1   ELKDDDFERISELGAGNGGVVTK--------VQHKP-SGLIMARKLIHLEIKPAIRNQII 51

Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E+  L     P +V   G    D +  +  E M  GSL+  + + +  +P  I  K+++
Sbjct: 52  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKEAKRIPEEILGKVSI 110

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
              +GLA+L E+ +  +++RD K SNIL+++    KL DFG++    +     ++   +G
Sbjct: 111 AVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVG 164

Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           T  Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 72.8 bits (179), Expect = 3e-14
 Identities = 82/292 (28%), Positives = 120/292 (41%), Gaps = 48/292 (16%)

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK--TLNHDGLQGHKEWLAEVNFLGN 195
              +G G FG V K   + +GT          +AVK      D  +  K  L +++ +  
Sbjct: 9   LGEIGRGAFGTVNKMLHKPSGT---------IMAVKRIRSTVDEKE-QKRLLMDLDVVMR 58

Query: 196 LLH-PNLVKLVGYCIEDDQRLLVYEFMPRGSLEN-----HLFRRSLPLPWSIRMKIALGA 249
               P +VK  G    +    +  E M   SL+      +   +S+ +P  I  KIA+  
Sbjct: 59  SSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSV-IPEEILGKIAVAT 116

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS---TRVM 306
            K L +L EE +  +I+RD K SNILLD + N KL DFG++      G+   S   TR  
Sbjct: 117 VKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS------GQLVDSIAKTRDA 168

Query: 307 GTYGYAAPEYVMTGHLTS---KSDVYSFGVVLLEMLTGRRSMDK-NRPNGEHNLVEWARP 362
           G   Y APE +          +SDV+S G+ L E+ TG+    K N         +  + 
Sbjct: 169 GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV-----FDQLTQV 223

Query: 363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET 414
             GD       L    E  FS             CL +D   RP+  E++E 
Sbjct: 224 VKGDPPI----LSNSEEREFSP----SFVNFINLCLIKDESKRPKYKELLEH 267

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 72.6 bits (178), Expect = 3e-14
 Identities = 78/272 (28%), Positives = 116/272 (42%), Gaps = 36/272 (13%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLL 197
           LG+GGFG V          A     TG   A K LN   L   +G++  + E   L  + 
Sbjct: 1   LGKGGFGEVS---------ACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV- 50

Query: 198 HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK---GL 253
           H   +  + Y  +    L LV   M  G L  H++      P     +     A+   GL
Sbjct: 51  HSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGL 110

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
             LH+   + +IYRD K  N+LLD D N ++SD GLA +  +DG++  +    GT G+ A
Sbjct: 111 EHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVEL-KDGQSK-TKGYAGTPGFMA 165

Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 373
           PE +         D ++ GV L EM+  R      R  GE   VE       +K    R+
Sbjct: 166 PELLQGEEYDFSVDYFALGVTLYEMIAARGPF---RARGEK--VE-------NKELKQRI 213

Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           L+  +   +  K S  +       L++DP+ R
Sbjct: 214 LNDSVT--YPDKFSPASKSFCEALLAKDPEKR 243

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 72.3 bits (177), Expect = 4e-14
 Identities = 83/281 (29%), Positives = 119/281 (42%), Gaps = 45/281 (16%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVN 191
           FR   +LG+GGFG V    V           TG   A K L    ++   G    L E  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGEAMALNEKR 52

Query: 192 FLGNLLHPNLVKLVGYCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 250
            L  +    +V L  Y  E  D   LV   M  G L+ H++  ++  P     +    AA
Sbjct: 53  ILEKVNSRFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIY--NMGNPGFDEQRAIFYAA 109

Query: 251 K---GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
           +   GL  L  E    ++YRD K  NILLD   + ++SD GLA   PE G+T V  RV G
Sbjct: 110 ELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE-GET-VRGRV-G 163

Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T GY APE +     T   D +  G ++ EM+ G+    K +       V+         
Sbjct: 164 TVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER-----VKREE------ 212

Query: 368 RRFYRLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKAR 405
                 +D R+   +  +S K S+ A  +    L+++PK R
Sbjct: 213 ------VDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 72.7 bits (178), Expect = 4e-14
 Identities = 71/213 (33%), Positives = 97/213 (45%), Gaps = 31/213 (14%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLG-N 195
           +LG+G FG VF         A +K GT    A+K L  D +    +    + E   L   
Sbjct: 2   MLGKGSFGKVF--------LAELK-GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 52

Query: 196 LLHPNLVKLVGYCI--EDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGAA 250
             HP L  L  YC     +    V E++  G L  H+    +  LP       +I  G  
Sbjct: 53  WEHPFLTHL--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICG-- 108

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP-EDGKTHVSTRVMGTY 309
             L FLH    K ++YRD K  NILLD D + K++DFG+ K+    D KT       GT 
Sbjct: 109 --LQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT---CTFCGTP 160

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
            Y APE ++     +  D +SFGV+L EML G+
Sbjct: 161 DYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 72.6 bits (179), Expect = 6e-14
 Identities = 71/217 (32%), Positives = 107/217 (49%), Gaps = 36/217 (16%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-----EVNFLGN 195
           LG+G +G V+K          +   T   VA+K +  D  +   +  A     E+ FL  
Sbjct: 15  LGKGAYGIVWKA---------IDRRTKEVVALKKI-FDAFRNATD--AQRTFREIMFLQE 62

Query: 196 LL-HPNLVKLVG-YCIEDDQRL-LVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 249
           L  HPN+VKL+     E+D+ + LV+E+M     E  L    R ++      R  I    
Sbjct: 63  LGDHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY-IMYQL 116

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK---DAPEDGKTHVSTRVM 306
            K L ++H      VI+RD K SNILL++D   KL+DFGLA+   +  E+ +  V T  +
Sbjct: 117 LKALKYIHS-GN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173

Query: 307 GTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            T  Y APE ++     +K  D++S G +L EML G+
Sbjct: 174 ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 72.1 bits (177), Expect = 6e-14
 Identities = 55/162 (33%), Positives = 82/162 (50%), Gaps = 27/162 (16%)

Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLL--VYEFMPRGSLENHL-----FRRSLPLPWSI 241
           E   L  + HP +++L  +  E DQR L  + E++P G L ++L     F  S  L ++ 
Sbjct: 51  EKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYAS 108

Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
            +  AL       +LH    K ++YRD K  NILLD + + KL+DFG AK      K   
Sbjct: 109 EIVCAL------EYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK------KLRD 153

Query: 302 STRVM-GTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTG 341
            T  + GT  Y APE +   GH  +  D ++ G+++ EML G
Sbjct: 154 RTWTLCGTPEYLAPEVIQSKGHNKA-VDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 72.6 bits (178), Expect = 7e-14
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 23/207 (11%)

Query: 163 KPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMP 222
           KPG    V +K     G +G    L E   L N+ HP+++++    +      +V   +P
Sbjct: 87  KPGQPDPVVLKI----GQKGTT--LIEAMLLQNVNHPSVIRMKDTLVSGAITCMV---LP 137

Query: 223 --RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY 280
                L  +L +RS PLP    + I     +GL +LH +    +I+RD KT NI ++   
Sbjct: 138 HYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVD 194

Query: 281 NAKLSDFGLAK---DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLE 337
              + D G A+    AP          + GT    APE +      SK+D++S G+VL E
Sbjct: 195 QVCIGDLGAAQFPVVAPAF------LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFE 248

Query: 338 MLTGRRSMDKNRPNGEHNLVEWARPHL 364
           ML    ++ ++ P+     V+    HL
Sbjct: 249 MLAYPSTIFEDPPSTPEEYVKSCHSHL 275

Length = 357

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 71.6 bits (175), Expect = 7e-14
 Identities = 65/216 (30%), Positives = 109/216 (50%), Gaps = 23/216 (10%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLA--- 188
           N+R   LLG G FG V+  +  +         TG  +AVK +  + D  +  KE  A   
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDAD---------TGRELAVKQVPFDPDSQETSKEVNALEC 53

Query: 189 EVNFLGNLLHPNLVKLVGYCIED--DQRLLVY-EFMPRGSLENHLFRRSLPLPWSIRMKI 245
           E+  L NL H  +V+  G C+ D  +++L ++ E+MP GS+++ L +    L  ++  + 
Sbjct: 54  EIQLLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRY 111

Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR- 304
                +G+++LH      +++RD K +NIL D+  N KL DFG +K       +    + 
Sbjct: 112 TRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS 168

Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           V GT  + +PE +       K+DV+S    ++EMLT
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 72.5 bits (178), Expect = 8e-14
 Identities = 64/229 (27%), Positives = 100/229 (43%), Gaps = 34/229 (14%)

Query: 126 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 185
             L++   +F    ++G G FG V    V    +  V        A+K L+   +    +
Sbjct: 36  TKLRMKAEDFDVIKVIGRGAFGEV--QLVRHKSSKQV-------YAMKLLSKFEMIKRSD 86

Query: 186 ----WLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWS 240
               W  E + + +     +V+L  Y  +DD+ L +V E+MP G L N +    +P  W+
Sbjct: 87  SAFFW-EERDIMAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWA 144

Query: 241 I----RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED 296
                 + +AL A   + F+H         RD K  N+LLD   + KL+DFG       +
Sbjct: 145 RFYTAEVVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195

Query: 297 GKTHVSTRVMGTYGYAAPEYVMT----GHLTSKSDVYSFGVVLLEMLTG 341
           G     T V GT  Y +PE + +    G+   + D +S GV L EML G
Sbjct: 196 GMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 70.7 bits (173), Expect = 1e-13
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 22/214 (10%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNLL 197
           +LG+G FG V +  ++         G+   VAVK L  D       +E+L E   +    
Sbjct: 6   MLGKGEFGSVREAQLKSED------GSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD 59

Query: 198 HPNLVKLVGYCIED--DQRL----LVYEFMPRGSLENHLFRRSL-----PLPWSIRMKIA 246
           HPN++KL+G  +      RL    ++  FM  G L   L    +      LP    ++  
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           +  A G+ +L   + K  I+RD    N +L+ +    ++DFGL+K               
Sbjct: 120 IDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176

Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
               + A E +     T+ SDV++FGV + E++T
Sbjct: 177 LPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 72/208 (34%), Positives = 97/208 (46%), Gaps = 23/208 (11%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVN-FLGN 195
           ++G+G FG V     + +G            AVK L    +   KE    +AE N  L N
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKC---------YAVKVLQKKIVLNRKEQKHIMAERNVLLKN 52

Query: 196 LLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGL 253
           + HP LV L  Y  +  ++L  V +F+  G L  HL R RS P P + R   A   A  L
Sbjct: 53  VKHPFLVGL-HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRA-RFYAA-EIASAL 109

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
            +LH      ++YRD K  NILLD+  +  L+DFGL K+      T  +T   GT  Y A
Sbjct: 110 GYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLA 164

Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           PE +      +  D +  G VL EML G
Sbjct: 165 PEVIRKQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 53/149 (35%), Positives = 78/149 (52%), Gaps = 15/149 (10%)

Query: 199 PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 257
           P LV L  Y  + D +L L+ +++  G L  HL++R       +R+ IA      L  LH
Sbjct: 65  PFLVTL-HYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLH 122

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD--APEDGKTHVSTRVMGTYGYAAPE 315
           +     +IYRD K  NILLD++ +  L+DFGL+K+  A E+ + +      GT  Y APE
Sbjct: 123 QLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTIEYMAPE 176

Query: 316 YVMT---GHLTSKSDVYSFGVVLLEMLTG 341
            +     GH     D +S GV+  E+LTG
Sbjct: 177 VIRGGSGGH-DKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 49/221 (22%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGN 195
           +GEG +G V+K   +          TG  VA+K +    L+   E      + E++ L  
Sbjct: 7   IGEGTYGVVYKARDKL---------TGEIVALKKIR---LETEDEGVPSTAIREISLLKE 54

Query: 196 LLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA---- 250
           L HPN+V+L+   +  + +L LV+EF+    L+   +  S P          L       
Sbjct: 55  LNHPNIVRLLD-VVHSENKLYLVFEFL---DLDLKKYMDSSP-------LTGLDPPLIKS 103

Query: 251 ------KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTHVS 302
                 +G+A+ H      V++RD K  N+L+D +   KL+DFGLA+    P    TH  
Sbjct: 104 YLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH-- 158

Query: 303 TRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
             V+ T  Y APE ++     S   D++S G +  EM+  R
Sbjct: 159 -EVV-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 69.9 bits (171), Expect = 3e-13
 Identities = 86/278 (30%), Positives = 122/278 (43%), Gaps = 39/278 (14%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLA--EVN 191
           FR   +LG+GGFG V    V           TG   A K L    ++  K E +A  E  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGEAMALNEKQ 52

Query: 192 FLGNLLHPNLVKLVGYCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 250
            L  +    +V L  Y  E  D   LV   M  G L+ H++  ++  P     +    AA
Sbjct: 53  ILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIY--NMGNPGFDEERAVFYAA 109

Query: 251 K---GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
           +   GL  LH E    ++YRD K  NILLD   + ++SD GLA + PE G+T +  RV G
Sbjct: 110 EITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPE-GET-IRGRV-G 163

Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T GY APE V     T   D +  G ++ EM+ G+    + +   +   VE         
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE--------- 214

Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           RR         +  +S K S+ A  +  Q L++DP  R
Sbjct: 215 RRV-----KEDQEEYSEKFSEAARSICRQLLTKDPGFR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 68.9 bits (169), Expect = 6e-13
 Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 52/230 (22%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAE 189
            F   + +GEG +G V++              +G  VA+K +      DG+      L E
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTT---------SGEIVALKKVRMDNERDGIPISS--LRE 56

Query: 190 VNFLGNLLHPNLVKL---------------VGYCIEDDQRLLVYEFMPRGSLENHLFRRS 234
           +  L NL HPN+V+L               + YC +D   LL  + MP            
Sbjct: 57  ITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPT----------- 103

Query: 235 LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 294
            P   S    + L   +GL +LHE     +I+RD K SN+LL      K++DFGLA+   
Sbjct: 104 -PFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR-TY 158

Query: 295 EDGKTHVSTRVMGTYGYAAPEYV--MTGHLTSKSDVYSFGVVLLEMLTGR 342
                 ++ +V+ T  Y APE +   T + T+  D+++ G +L E+L  +
Sbjct: 159 GLPAKPMTPKVV-TLWYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 69.2 bits (169), Expect = 6e-13
 Identities = 69/207 (33%), Positives = 95/207 (45%), Gaps = 21/207 (10%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVN-FLGN 195
           ++G+G FG V     + +G+           AVK L    +   KE    +AE N  L N
Sbjct: 2   VIGKGSFGKVLLAKRKSDGS---------FYAVKVLQKKTILKKKEQNHIMAERNVLLKN 52

Query: 196 LLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
           L HP LV L  Y  +  ++L  V +++  G L  HL R    L    R   A   A  + 
Sbjct: 53  LKHPFLVGL-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIG 110

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           +LH      +IYRD K  NILLD+  +  L+DFGL K+  E  +T  ++   GT  Y AP
Sbjct: 111 YLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAP 165

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           E +         D +  G VL EML G
Sbjct: 166 EVLRKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 69.3 bits (169), Expect = 7e-13
 Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 31/217 (14%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNL 196
           +LG+G FG V             + GT    A+K L  D +    +    + E   L   
Sbjct: 7   VLGKGSFGKV---------MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALS 57

Query: 197 LHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALGAA 250
             P  +  +  C +   RL  V E++  G L   +     F+    + ++  + I     
Sbjct: 58  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI----- 112

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM-GTY 309
            GL FLH    K +IYRD K  N++LD++ + K++DFG+ K+   DG   V+T+   GT 
Sbjct: 113 -GLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG---VTTKTFCGTP 165

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD 346
            Y APE +         D ++FGV+L EML G+   +
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 69.1 bits (169), Expect = 7e-13
 Identities = 40/91 (43%), Positives = 54/91 (59%), Gaps = 5/91 (5%)

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL FLH+   K +IYRD K  N+LLD D + K++DFG+ K+   +G+   ST   GT  Y
Sbjct: 108 GLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKEN-MNGEGKAST-FCGTPDY 162

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
            APE +         D +SFGV+L EML G+
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 68.6 bits (168), Expect = 8e-13
 Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 34/214 (15%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-----EVNFLGN 195
           +GEG +G V+KG             TG  VA+K +    L+  +E +      E++ L  
Sbjct: 8   IGEGTYGVVYKG---------RNKKTGQIVAMKKIR---LESEEEGVPSTAIREISLLKE 55

Query: 196 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI---RMKIAL-GAAK 251
           L HPN+V L    +++ +  L++EF+    L+ +L   SLP    +    +K  L    +
Sbjct: 56  LQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYL--DSLPKGQYMDAELVKSYLYQILQ 112

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTHVSTRVMGTY 309
           G+ F H    + V++RD K  N+L+D     KL+DFGLA+    P      V T  + T 
Sbjct: 113 GILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP----VRVYTHEVVTL 165

Query: 310 GYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            Y APE ++     S   D++S G +  EM T +
Sbjct: 166 WYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 68.9 bits (169), Expect = 8e-13
 Identities = 60/241 (24%), Positives = 98/241 (40%), Gaps = 64/241 (26%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVN 191
            ++P   +G G +G V            +   +G  VA+K + H  D     K  L E+ 
Sbjct: 6   RYKPIENIGSGAYGVVCSA---------IDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK 56

Query: 192 FLGNLLHPNLVKLVGYCIEDDQR---------LLVYEFM---------PRGSLENHLFRR 233
            L +  H N++      I D  R          +V + M             L     R 
Sbjct: 57  ILRHFKHDNII-----AIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRY 111

Query: 234 SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK-- 291
            L   + +         +GL ++H      VI+RD K SN+L++ D   ++ DFG+A+  
Sbjct: 112 FL---YQL--------LRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157

Query: 292 -DAPEDGKT----HVSTRVMGTYGYAAPE--YVMTGHLTSKSDVYSFGVVLLEMLTGRRS 344
             +P + K     +V+TR      Y APE    +  + T+  D++S G +  EML GRR 
Sbjct: 158 SSSPTEHKYFMTEYVATR-----WYRAPELLLSLPEY-TTAIDMWSVGCIFAEML-GRRQ 210

Query: 345 M 345
           +
Sbjct: 211 L 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 37/90 (41%), Positives = 51/90 (56%), Gaps = 5/90 (5%)

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L FLH      VIYRD K  NILLDA+ + KL+DFG+ K+   +G T  +T   GT  Y 
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYI 163

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           APE +         D ++ GV++ EM+ G+
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 64/258 (24%), Positives = 113/258 (43%), Gaps = 42/258 (16%)

Query: 166 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGS 225
           TG  VAVK ++    Q  +    EV  + +  H N+V +    +  D+  +V EF+  G+
Sbjct: 46  TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105

Query: 226 LENHLFRRSLPLPWSIRMK------IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD 279
           L +        +    RM       + L   + L++LH +    VI+RD K+ +ILL +D
Sbjct: 106 LTD--------IVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSD 154

Query: 280 YNAKLSDFG----LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVL 335
              KLSDFG    ++K+ P+         ++GT  + APE +      ++ D++S G+++
Sbjct: 155 GRIKLSDFGFCAQVSKEVPK------RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMV 208

Query: 336 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA 395
           +EM+ G                 +  P L   RR    L PR++    +    +      
Sbjct: 209 IEMIDGEPPY-------------FNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRG--FLD 253

Query: 396 QCLSRDPKARPRMSEVVE 413
             L R+P  R    E+++
Sbjct: 254 LMLVREPSQRATAQELLQ 271

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 67/261 (25%), Positives = 118/261 (45%), Gaps = 43/261 (16%)

Query: 89  PVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGC 148
           P+ P SS+++S++ S++S    S              ++L+   R       +G G  G 
Sbjct: 46  PLPPPSSSSSSSSSSSASGSAPSAAKS---------LSELERVNR-------IGSGAGGT 89

Query: 149 VFKGWVEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGNLLHPNLVKLVG 206
           V+K          +   TG   A+K +  NH+     ++   E+  L ++ HPN+VK   
Sbjct: 90  VYK---------VIHRPTGRLYALKVIYGNHED-TVRRQICREIEILRDVNHPNVVKCHD 139

Query: 207 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIY 266
               + +  ++ EFM  GSLE         L       +A     G+A+LH    + +++
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-----DVARQILSGIAYLHR---RHIVH 191

Query: 267 RDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSK- 325
           RD K SN+L+++  N K++DFG+++   +      S+  +GT  Y +PE + T       
Sbjct: 192 RDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VGTIAYMSPERINTDLNHGAY 249

Query: 326 ----SDVYSFGVVLLEMLTGR 342
                D++S GV +LE   GR
Sbjct: 250 DGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 67.8 bits (165), Expect = 2e-12
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 18/202 (8%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G+G  G VF           +   TG  VA+K +N       +  + E+  +  L +PN
Sbjct: 27  IGQGASGTVFTA---------IDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPN 77

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           +V  +   +  D+  +V E++  GSL + +    +    +    +     + L FLH   
Sbjct: 78  IVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMD--EAQIAAVCRECLQALEFLHANQ 135

Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
              VI+RD K+ N+LL  D + KL+DFG  A+  PE  K    + ++GT  + APE V  
Sbjct: 136 ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTR 189

Query: 320 GHLTSKSDVYSFGVVLLEMLTG 341
                K D++S G++ +EM+ G
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 69.4 bits (170), Expect = 2e-12
 Identities = 62/252 (24%), Positives = 100/252 (39%), Gaps = 58/252 (23%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG----HKEWLAEVNFLGN 195
           L+G+GG G V+  +          P     VA+K +  D L       K +L E     +
Sbjct: 9   LIGKGGMGEVYLAY---------DPVCSRRVALKKIRED-LSENPLLKKRFLREAKIAAD 58

Query: 196 LLHPNLVKLVGYCIEDDQRLLVYEFMP--RGSLENHLFR-----RSLPLPWSIR------ 242
           L+HP +V +  Y I  D    VY  MP   G     L +      SL    + +      
Sbjct: 59  LIHPGIVPV--YSICSDGDP-VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF 115

Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK----------- 291
           + I       + ++H    K V++RD K  NILL       + D+G A            
Sbjct: 116 LSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172

Query: 292 -DAPEDGKTH----VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT------ 340
            D  E    +    +  +++GT  Y APE ++    +  +D+Y+ GV+L +MLT      
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232

Query: 341 ---GRRSMDKNR 349
              GR+   ++ 
Sbjct: 233 RKKGRKISYRDV 244

Length = 932

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 72/279 (25%), Positives = 120/279 (43%), Gaps = 43/279 (15%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +GEG  G V          A VK  +G  VAVK ++    Q  +    EV  + +  H N
Sbjct: 28  IGEGSTGIVC--------IATVK-SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 78

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK------IALGAAKGLA 254
           +V++    +  D+  +V EF+  G+L +        +    RM       + L   K L+
Sbjct: 79  VVEMYNSYLVGDELWVVMEFLEGGALTD--------IVTHTRMNEEQIAAVCLAVLKALS 130

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
            LH +    VI+RD K+ +ILL  D   KLSDFG      ++     S  ++GT  + AP
Sbjct: 131 VLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAP 185

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL 374
           E +       + D++S G++++EM+ G        P     ++   R +L  K +    +
Sbjct: 186 ELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPKLKNLHKV 242

Query: 375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
            P L+G               + L RDP  R   +E+++
Sbjct: 243 SPSLKGFLD------------RLLVRDPAQRATAAELLK 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 21/209 (10%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +LG+G +G V+         A     T + +A+K +     +  +    E+     L H 
Sbjct: 15  VLGKGTYGIVY---------AARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA--KGLAFLH 257
           N+V+ +G   E+    +  E +P GSL   L  +  PL  + +  I       +GL +LH
Sbjct: 66  NIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH 125

Query: 258 EEAEKPVIYRDFKTSNILLDADYNA--KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
           +     +++RD K  N+L++  Y+   K+SDFG +K     G    +    GT  Y APE
Sbjct: 126 DNQ---IVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLA--GINPCTETFTGTLQYMAPE 179

Query: 316 YVMTGH--LTSKSDVYSFGVVLLEMLTGR 342
            +  G     + +D++S G  ++EM TG+
Sbjct: 180 VIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 67.8 bits (165), Expect = 2e-12
 Identities = 67/207 (32%), Positives = 90/207 (43%), Gaps = 20/207 (9%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNL 196
           LLG+G FG V    V E  +       G   A+K L  + +    E    L E   L N 
Sbjct: 2   LLGKGTFGKVI--LVREKAS-------GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT 52

Query: 197 LHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 255
            HP L  L  Y  +   RL  V E++  G L  HL R  +      R   A      L +
Sbjct: 53  RHPFLTSL-KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGA-EIVSALDY 110

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
           LH      ++YRD K  N++LD D + K++DFGL K+   D  T  +    GT  Y APE
Sbjct: 111 LHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPE 165

Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGR 342
            +         D +  GVV+ EM+ GR
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 24/224 (10%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAE---VNFL 193
           ++G GGFG V+            K  TG   A+K L+   +   QG    L E   ++ +
Sbjct: 1   IIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 51

Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 253
                P +V +       D+   + + M  G L  HL +  +     +R   A     GL
Sbjct: 52  STGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGL 110

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
             +H    + V+YRD K +NILLD   + ++SD GLA D  +  K H S   +GT+GY A
Sbjct: 111 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHAS---VGTHGYMA 163

Query: 314 PEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 356
           PE +  G    S +D +S G +L ++L G     +++   +H +
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 67.3 bits (165), Expect = 3e-12
 Identities = 65/234 (27%), Positives = 103/234 (44%), Gaps = 57/234 (24%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL---NHDGLQGHKEWLAEV 190
            ++  S +GEG +G V         +A  KP TG+ VA+K +    H      +  L E+
Sbjct: 6   RYQNLSYIGEGAYGMVC--------SATHKP-TGVKVAIKKISPFEHQTFC--QRTLREI 54

Query: 191 NFLGNLLHPNLVKLVGYCIEDDQR----------LLVYEFMPRGSLENHLFR--RSLPLP 238
             L    H N++      I D  R           +V E M     E  L++  ++  L 
Sbjct: 55  KILRRFKHENIIG-----ILDIIRPPSFESFNDVYIVQELM-----ETDLYKLIKTQHLS 104

Query: 239 --------WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA 290
                   + I         +GL ++H      V++RD K SN+LL+ + + K+ DFGLA
Sbjct: 105 NDHIQYFLYQI--------LRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLA 153

Query: 291 K-DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
           +   PE   T   T  + T  Y APE ++     +K+ D++S G +L EML+ R
Sbjct: 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 66.5 bits (163), Expect = 4e-12
 Identities = 79/312 (25%), Positives = 110/312 (35%), Gaps = 75/312 (24%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAE 189
           ++F+   LLG+G  G VF   V   GT  +        A+K L+   +    +    L E
Sbjct: 1   KHFKKIKLLGKGDVGRVF--LVRLKGTGKL-------FALKVLDKKEMIKRNKVKRVLTE 51

Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIA 246
              L  L HP L  L      +    LV ++ P G L      +  P   L   +     
Sbjct: 52  QEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGEL--FRLLQRQPGKCLSEEV---AR 106

Query: 247 LGAAK---GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV-- 301
             AA+    L +LH      ++YRD K  NILL    +  LSDF L+K +  +       
Sbjct: 107 FYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKA 163

Query: 302 ----------------------STRVM---GTYGYAAPEYVM-TGHLTSKSDVYSFGVVL 335
                                 S R     GT  Y APE +   GH  S  D ++ G++L
Sbjct: 164 LRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILL 222

Query: 336 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR--FYRLLDPRLEGHFSIKGSQKATQL 393
            EML G                    P  G  R   F  +L   +    S   S  A  L
Sbjct: 223 YEMLYGT------------------TPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDL 264

Query: 394 AAQCLSRDPKAR 405
             + L +DP  R
Sbjct: 265 IRKLLVKDPSKR 276

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 66.7 bits (162), Expect = 4e-12
 Identities = 67/255 (26%), Positives = 113/255 (44%), Gaps = 23/255 (9%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G+G  G V+           +   TG  VA+K +N       +  + E+  +    +PN
Sbjct: 27  IGQGASGTVYTA---------IDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPN 77

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           +V  +   +  D+  +V E++  GSL + +    +         +     + L FLH   
Sbjct: 78  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQALDFLHSNQ 135

Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
              VI+RD K+ NILL  D + KL+DFG  A+  PE  K    + ++GT  + APE V  
Sbjct: 136 ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTR 189

Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRS-MDKNRPNGEHNLVEWARPHLGDKRR----FYRLL 374
                K D++S G++ +EM+ G    +++N     + +     P L +  R    F   L
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFL 249

Query: 375 DPRLEGHFSIKGSQK 389
           +  LE     +GS K
Sbjct: 250 NRCLEMDVDRRGSAK 264

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 66.0 bits (161), Expect = 4e-12
 Identities = 73/282 (25%), Positives = 121/282 (42%), Gaps = 46/282 (16%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 198
           +GEG FG       +E+G   V         +K +N   +     +E   EV  L N+ H
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYV---------IKEINISKMSPKEREESRKEVAVLSNMKH 58

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSL-------ENHLFRRSLPLPWSIRMKIALGAAK 251
           PN+V+      E+    +V ++   G L          LF     L W +++ +AL    
Sbjct: 59  PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL---- 114

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
               +H+   + +++RD K+ NI L  D   KL DFG+A+    +    ++   +GT  Y
Sbjct: 115 --KHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVL--NSTVELARTCIGTPYY 167

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 371
            +PE        +KSD+++ G VL EM T + + +        NLV      L   R  Y
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA---GNMKNLV------LKIIRGSY 218

Query: 372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
               P +  H+    S     L +Q   R+P+ RP ++ ++E
Sbjct: 219 ----PPVSSHY----SYDLRNLVSQLFKRNPRDRPSVNSILE 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 67.0 bits (163), Expect = 5e-12
 Identities = 48/144 (33%), Positives = 70/144 (48%), Gaps = 19/144 (13%)

Query: 207 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW----SIRMKIALGAAKGLAFLHEEAE 261
           Y  +DD+ L +V E+MP G L N +    +P  W    +  + +AL A   + F+H    
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH---- 165

Query: 262 KPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-- 319
                RD K  N+LLD   + KL+DFG      ++G     T V GT  Y +PE + +  
Sbjct: 166 -----RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQG 219

Query: 320 --GHLTSKSDVYSFGVVLLEMLTG 341
             G+   + D +S GV L EML G
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 66.3 bits (161), Expect = 6e-12
 Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 18/202 (8%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G+G  G V+           +   TG  VA++ +N       +  + E+  +    +PN
Sbjct: 28  IGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           +V  +   +  D+  +V E++  GSL + +    +         +     + L FLH   
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQALEFLHSNQ 136

Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
              VI+RD K+ NILL  D + KL+DFG  A+  PE  K    + ++GT  + APE V  
Sbjct: 137 ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTR 190

Query: 320 GHLTSKSDVYSFGVVLLEMLTG 341
                K D++S G++ +EM+ G
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 66.1 bits (161), Expect = 7e-12
 Identities = 40/91 (43%), Positives = 52/91 (57%), Gaps = 5/91 (5%)

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL FLH    K +IYRD K  N++LD D + K++DFG+ K+    G    ST   GT  Y
Sbjct: 108 GLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF-GDNRAST-FCGTPDY 162

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
            APE +     T   D +SFGV+L EML G+
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 66.6 bits (162), Expect = 7e-12
 Identities = 51/153 (33%), Positives = 74/153 (48%), Gaps = 22/153 (14%)

Query: 199 PNLVKLVGYC-IEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW----SIRMKIALGAAKG 252
           P +V+L  +C  +DD+ L +V E+MP G L N +    +P  W    +  + +AL A   
Sbjct: 103 PWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHS 160

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           +  +H         RD K  N+LLD   + KL+DFG      E G     T V GT  Y 
Sbjct: 161 MGLIH---------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYI 210

Query: 313 APEYVMT----GHLTSKSDVYSFGVVLLEMLTG 341
           +PE + +    G+   + D +S GV L EML G
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 65.8 bits (160), Expect = 8e-12
 Identities = 50/183 (27%), Positives = 92/183 (50%), Gaps = 21/183 (11%)

Query: 166 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGS 225
           +G  VAVK ++    Q  +    EV  + +  H N+V++    +  ++  ++ EF+  G+
Sbjct: 45  SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104

Query: 226 LENHLFRRSLPLPWSIRMKIAL---GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA 282
           L + + +  L        +IA       + L +LH +    VI+RD K+ +ILL  D   
Sbjct: 105 LTDIVSQTRLN-----EEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRV 156

Query: 283 KLSDFG----LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 338
           KLSDFG    ++KD P+         ++GT  + APE +      ++ D++S G++++EM
Sbjct: 157 KLSDFGFCAQISKDVPK------RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEM 210

Query: 339 LTG 341
           + G
Sbjct: 211 VDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 11/94 (11%)

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
           +GL ++H      +I+RD K SNI ++ D   K+ DFGLA+   ++   +V+TR      
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 180

Query: 311 YAAPEYVMT--GHLTSKSDVYSFGVVLLEMLTGR 342
           Y APE +M    H     D++S G ++ E+LTG+
Sbjct: 181 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 83/270 (30%), Positives = 114/270 (42%), Gaps = 40/270 (14%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNLL 197
           +G+G FG V +  V +  T  +        A+KT+    +    E    LAE   L  + 
Sbjct: 1   IGKGSFGKVMQ--VRKRDTQRI-------YALKTIRKAHIVSRSEVTHTLAERTVLAQVN 51

Query: 198 HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 256
            P +V L  +  +  ++L LV  F+  G L +HL R         R   A    + L  L
Sbjct: 52  CPFIVPL-KFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTA----ELLCAL 106

Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK-DAPEDGKTHVSTRVMGTYGYAAPE 315
               +  VIYRD K  NILLD   +  L DFGL K +  +D KT+      GT  Y APE
Sbjct: 107 ENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT---FCGTPEYLAPE 163

Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 375
            ++    T   D ++ GV+L EMLTG        P  + N+ E  R  L +  RF    D
Sbjct: 164 LLLGHGYTKAVDWWTLGVLLYEMLTGL------PPFYDENVNEMYRKILQEPLRFPDGFD 217

Query: 376 PRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
                       + A  L    LSRDP  R
Sbjct: 218 ------------RDAKDLLIGLLSRDPTRR 235

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 64.9 bits (158), Expect = 1e-11
 Identities = 84/302 (27%), Positives = 137/302 (45%), Gaps = 49/302 (16%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK--EWLAEVNFLGNLLH 198
           LG+G +G V+K           +P TG+T+A+K +  + L   K  + + E++ L   + 
Sbjct: 9   LGKGNYGSVYK--------VLHRP-TGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVS 58

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIALGAAKGLAF 255
           P +V   G    +    +  E+M  GSL+  L+   +    +P  +  +I     KGL F
Sbjct: 59  PYIVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKF 117

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED-GKTHVSTRVMGTYGYAAP 314
           L EE    +I+RD K +N+L++ +   KL DFG++ +      KT++     G   Y AP
Sbjct: 118 LKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAP 170

Query: 315 EYVMTGHL------TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL-GDK 367
           E + +G        T +SDV+S G+ +LEM  GR       P    N+       + GD 
Sbjct: 171 ERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP---PETYANIFAQLSAIVDGDP 227

Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPLQNLK-DM 424
                   P L   +    S  A    A+CL++ P  RP  ++++E   L   +N   DM
Sbjct: 228 --------PTLPSGY----SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADVDM 275

Query: 425 AS 426
           A 
Sbjct: 276 AE 277

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 48/183 (26%), Positives = 84/183 (45%), Gaps = 19/183 (10%)

Query: 170 VAVKTLNHDGLQGHKEWLA----EVNFLGNLLHPNLVKLVGYCIEDDQRL----LVYEFM 221
           V ++T      +GHK  +     E+  L  +   N++K+ G+ I+    L    L+ E+ 
Sbjct: 46  VIIRTFKKFH-KGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104

Query: 222 PRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN 281
            RG L   L  +   L +  ++ +A+   KGL  L++   KP  Y++  + + L+  +Y 
Sbjct: 105 TRGYLREVL-DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYK 161

Query: 282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEML 339
            K+   GL K        +V+  V     Y + + +       T K D+YS GVVL E+ 
Sbjct: 162 LKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIF 216

Query: 340 TGR 342
           TG+
Sbjct: 217 TGK 219

Length = 283

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 75/301 (24%), Positives = 125/301 (41%), Gaps = 41/301 (13%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNF 192
           ++ + ++G+G +G V          + +   TG  VA+K +N   + +      L E+  
Sbjct: 2   YKIQEVIGKGSYGVV---------CSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKL 52

Query: 193 LGNLLHPNLVKLVGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
           L  L HP++V++    +   +R      +V+E M   S  + + + +  L          
Sbjct: 53  LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM--ESDLHQVIKANDDLTPEHHQFFLY 110

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS-TRVM 306
              + L ++H      V +RD K  NIL +AD   K+ DFGLA+ A  D  T +  T  +
Sbjct: 111 QLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 167

Query: 307 GTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH------NLVE 358
            T  Y APE   +     T   D++S G +  E+LTG+        N  H      +L+ 
Sbjct: 168 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK--NVVHQLDLITDLLG 225

Query: 359 WARPHLGDK------RRFYRLLDPRLEGHFSIK---GSQKATQLAAQCLSRDPKARPRMS 409
              P    +      RR+   +  +    FS K       A +L  + L+ DPK RP   
Sbjct: 226 TPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAE 285

Query: 410 E 410
           E
Sbjct: 286 E 286

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 39/217 (17%)

Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT----LNHDGLQGHKEWLAEVNFLG 194
           + +GEG +G V+K              TG  VA+K     L+ +G+      L E+  L 
Sbjct: 5   AEIGEGAYGTVYKA---------RDLNTGRFVALKKVRVPLSEEGIP--LSTLREIALLK 53

Query: 195 NLL---HPNLVKLVGYC--IEDDQRL---LVYEFMPR---GSLENHLFRRSLPLPWSIR- 242
            L    HPN+V+L+  C     D+ L   LV+E + +     L     +  LP P +I+ 
Sbjct: 54  QLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCP-KPGLP-PETIKD 111

Query: 243 -MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
            M+  L   +G+ FLH      +++RD K  NIL+ +D   K++DFGLA+    +     
Sbjct: 112 LMRQLL---RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL-- 163

Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 338
            T V+ T  Y APE ++     +  D++S G +  E+
Sbjct: 164 -TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 71/287 (24%), Positives = 104/287 (36%), Gaps = 61/287 (21%)

Query: 166 TGLTVAVKTLNHDGLQGHKEWL---AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMP 222
           T   VAVK +N D     ++      E+     L HPN++  V   I D +  +V   M 
Sbjct: 24  TNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82

Query: 223 RGSLENHLFRRSLP--LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY 280
            GS E+ L +   P  LP      I       L ++H    K  I+R  K S+ILL  D 
Sbjct: 83  YGSCED-LLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDG 138

Query: 281 NAKLSDFGLAKDAPEDGKTHV--------STRVMGTYGYAAPEYV---MTGHLTSKSDVY 329
              LS    +    + GK           S + +    + +PE +   + G+   KSD+Y
Sbjct: 139 KVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL---PWLSPEVLQQNLQGY-NEKSDIY 194

Query: 330 SFGVVLLEMLTG--------RRSMDKNRPNGEHNLVEWAR---PHLGDKRRFYRLLDPRL 378
           S G+   E+  G           M          L+E  R   P L DK  +    D   
Sbjct: 195 SVGITACELANGHVPFKDMPATQM----------LLEKVRGTVPCLLDKSTYPLYEDSMS 244

Query: 379 EGHFSIKGSQKAT---------------QLAAQCLSRDPKARPRMSE 410
           +   S +                     Q    CL RDP++RP  S+
Sbjct: 245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQ 291

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 64/219 (29%), Positives = 101/219 (46%), Gaps = 33/219 (15%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAEV 190
           + P + +G G +G V+K            P +G  VA+K++    N DGL      + EV
Sbjct: 2   YEPVAEIGVGAYGTVYKA---------RDPHSGHFVALKSVRVQTNEDGLP--LSTVREV 50

Query: 191 NFLGNLL---HPNLVKLVGYC--IEDDQRL---LVYEFMPRGSLENHLFRRSLP-LPWSI 241
             L  L    HPN+V+L+  C     D+     LV+E + +  L  +L +   P LP   
Sbjct: 51  ALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAET 109

Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
              +     +GL FLH      +++RD K  NIL+ +    KL+DFGLA+         +
Sbjct: 110 IKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY----SCQM 162

Query: 302 S-TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 339
           + T V+ T  Y APE ++     +  D++S G +  EM 
Sbjct: 163 ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 64.9 bits (158), Expect = 3e-11
 Identities = 51/179 (28%), Positives = 78/179 (43%), Gaps = 26/179 (14%)

Query: 189 EVNFLGNLLHPNLVKLV-GYCIEDDQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMK 244
           E++ L  + H  ++ L+  Y      +  V   MP+   +  LF    RS PLP    + 
Sbjct: 136 EIDILKTISHRAIINLIHAY----RWKSTVCMVMPKYKCD--LFTYVDRSGPLPLEQAIT 189

Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           I     + LA+LH    + +I+RD KT NI LD   NA L DFG A       K      
Sbjct: 190 IQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAA------CKLDAHPD 240

Query: 305 VMGTYGYA------APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM-DKNRPNGEHNL 356
               YG++      +PE +      +K+D++S G+VL EM     ++  K   +    L
Sbjct: 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQL 299

Length = 392

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 61/224 (27%), Positives = 99/224 (44%), Gaps = 32/224 (14%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL----- 187
           + +   + +GEG +G VFK    +NG        G  VA+K +    +Q  +E +     
Sbjct: 1   QQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVR---VQTGEEGMPLSTI 49

Query: 188 ---AEVNFLGNLLHPNLVKLVGYCI-----EDDQRLLVYEFMPRGSLENHLFRRSLP-LP 238
              A +  L    HPN+V+L   C       + +  LV+E + +  L  +L +   P +P
Sbjct: 50  REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVP 108

Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
                 +     +GL FLH      V++RD K  NIL+ +    KL+DFGLA+       
Sbjct: 109 TETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 165

Query: 299 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
               T V+ T  Y APE ++     +  D++S G +  EM   +
Sbjct: 166 L---TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 60/175 (34%), Positives = 79/175 (45%), Gaps = 10/175 (5%)

Query: 171 AVKTLNHDGLQGHKE---WLAEVN-FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL 226
           AVK L    +   KE    ++E N  L N+ HP LV L       D+   V +++  G L
Sbjct: 24  AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 83

Query: 227 ENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD 286
             HL R    L    R   A   A  L +LH      ++YRD K  NILLD+  +  L+D
Sbjct: 84  FYHLQRERCFLEPRARF-YAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTD 139

Query: 287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           FGL K+  E   T  ++   GT  Y APE +         D +  G VL EML G
Sbjct: 140 FGLCKENIEHNGT--TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 62.9 bits (153), Expect = 3e-11
 Identities = 45/160 (28%), Positives = 72/160 (45%), Gaps = 22/160 (13%)

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP------WSIRMKIALGAAKG 252
           PN+V L  Y + +D   LV +    G L +H+ +  L +P      W+  M +AL A   
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF-LNIPEECVKRWAAEMVVALDA--- 100

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
              LH E    ++ RD   +NILLD   + +L+ F    +  +         +     Y 
Sbjct: 101 ---LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YC 149

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG 352
           APE       T   D +S G +L E+LTG +++ +  P+G
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSG 188

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 63.6 bits (155), Expect = 4e-11
 Identities = 66/223 (29%), Positives = 97/223 (43%), Gaps = 39/223 (17%)

Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFL 193
             +GEG +G V+K              TG  VA+K +    L   KE      + E+  L
Sbjct: 13  GQIGEGTYGQVYKA---------RDKDTGELVALKKVR---LDNEKEGFPITAIREIKIL 60

Query: 194 GNLLHPNLVKLVGYCIEDDQRL----------LVYEFMPR---GSLENHLFRRSLPLPWS 240
             L H N+V L     +    L          LV+E+M     G LE+ L   S     S
Sbjct: 61  RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS 120

Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH 300
             MK  L   +GL + H+   K  ++RD K SNILL+     KL+DFGLA+    +    
Sbjct: 121 F-MKQLL---EGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173

Query: 301 VSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            + +V+ T  Y  PE ++       + DV+S G +L E+ T +
Sbjct: 174 YTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 63.8 bits (155), Expect = 5e-11
 Identities = 65/219 (29%), Positives = 101/219 (46%), Gaps = 27/219 (12%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           NF    +LG G +G VF   V +         TG   A+K L    L    + +      
Sbjct: 1   NFELLKVLGTGAYGKVF--LVRKVT----GHDTGKLYAMKVLQKAALVQKAKTVEHTRTE 54

Query: 194 GNLLH-----PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM---K 244
            N+L      P LV L  Y  + + +L L+ +++  G +  HL++R       +R    +
Sbjct: 55  RNVLEHVRQSPFLVTL-HYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGE 113

Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           I L     L  LH+     ++YRD K  NILLD++ +  L+DFGL+K+   + K    + 
Sbjct: 114 IILA----LEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS- 165

Query: 305 VMGTYGYAAPEYV--MTGHLTSKSDVYSFGVVLLEMLTG 341
             GT  Y APE +    GH     D +S G+++ E+LTG
Sbjct: 166 FCGTIEYMAPEIIRGKGGH-GKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 63.0 bits (153), Expect = 5e-11
 Identities = 38/106 (35%), Positives = 59/106 (55%), Gaps = 8/106 (7%)

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL  +H    + V+YRD K +NILLD   + ++SD GLA D  +  K H S   +GT+GY
Sbjct: 109 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHAS---VGTHGY 161

Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 356
            APE +  G    S +D +S G +L ++L G     +++   +H +
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 64.1 bits (156), Expect = 6e-11
 Identities = 51/159 (32%), Positives = 75/159 (47%), Gaps = 17/159 (10%)

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
           +H    K +I+RD K++NILL ++   KL DFG +K         V     GT  Y APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215

Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 375
                  + K+D++S GV+L E+LT +R  D     GE N+ E     L  +   Y  L 
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFD-----GE-NMEEVMHKTLAGR---YDPLP 266

Query: 376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET 414
           P +        S +  ++    LS DPK RP  S+++  
Sbjct: 267 PSI--------SPEMQEIVTALLSSDPKRRPSSSKLLNM 297

Length = 496

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 62.9 bits (153), Expect = 6e-11
 Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 38/216 (17%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGN 195
           +GEG +G V+K              T  T+A+K +    L+   E      + E++ L  
Sbjct: 10  IGEGTYGVVYKARDRV---------TNETIALKKIR---LEQEDEGVPSTAIREISLLKE 57

Query: 196 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALGAA 250
           + H N+V+L      + +  LV+E++    L+ H+     F ++  L  +   +I     
Sbjct: 58  MQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQI----L 112

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAK--DAPEDGKTHVSTRVMG 307
           +G+A+ H      V++RD K  N+L+D   NA KL+DFGLA+    P    TH       
Sbjct: 113 RGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV---- 165

Query: 308 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
           T  Y APE ++ + H ++  D++S G +  EM+  +
Sbjct: 166 TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 63.1 bits (153), Expect = 7e-11
 Identities = 51/169 (30%), Positives = 72/169 (42%), Gaps = 18/169 (10%)

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           A+G+ FL   A +  I+RD    NILL  +   K+ DFGLA+D  +D             
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            + APE +     T++SDV+SFGV+L E+ +   S     P  + N     R   G + R
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGAS---PYPGVQINEEFCQRLKDGTRMR 297

Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                 P +              +   C   DPK RP  S +VE L  L
Sbjct: 298 APENATPEIYR------------IMLACWQGDPKERPTFSALVEILGDL 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 62.7 bits (152), Expect = 7e-11
 Identities = 50/147 (34%), Positives = 75/147 (51%), Gaps = 11/147 (7%)

Query: 199 PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 257
           P LV L  Y  + D +L L+ +++  G L  HL +R       +++         L  LH
Sbjct: 65  PFLVTL-HYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSG-EIVLALEHLH 122

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
           +     +IYRD K  NILLD++ +  L+DFGL+K+  ED +   +    GT  Y AP+ V
Sbjct: 123 KLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHED-EVERAYSFCGTIEYMAPDIV 178

Query: 318 M---TGHLTSKSDVYSFGVVLLEMLTG 341
                GH     D +S GV++ E+LTG
Sbjct: 179 RGGDGGH-DKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 66/214 (30%), Positives = 101/214 (47%), Gaps = 28/214 (13%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           +G G FG V  G V  +G  P +      V VK L     +Q   ++L E     +L H 
Sbjct: 3   IGNGWFGKVILGEVN-SGYTPAQ------VVVKELRVSASVQEQMKFLEEAQPYRSLQHS 55

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS-------LPLPWSIRMKIALGAAKG 252
           NL++ +G C E    LLV EF P G L+ +L  RS        P P +++ ++A   A G
Sbjct: 56  NLLQCLGQCTEVTPYLLVMEFCPLGDLKGYL--RSCRKAELMTPDPTTLQ-RMACEIALG 112

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L  LH+      I+ D    N LL AD   K+ D+GL+ +  ++       ++     + 
Sbjct: 113 LLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWI 169

Query: 313 APEYV--MTGHL-----TSKSDVYSFGVVLLEML 339
           APE V  + G+L     T +S+V+S GV + E+ 
Sbjct: 170 APELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 19/168 (11%)

Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENH-------LFRRSLPLPWSI 241
           EV  L  + HPN+V       E+ +  +V E+   G L          LF     L W +
Sbjct: 49  EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV 108

Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDAPEDGKTH 300
             +I+LG    L  +H+   + +++RD K+ NI L  +   AKL DFG+A+    +    
Sbjct: 109 --QISLG----LKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL--NDSME 157

Query: 301 VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN 348
           ++   +GT  Y +PE        +K+D++S G VL E+ T +   + N
Sbjct: 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 61.9 bits (151), Expect = 1e-10
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 46/218 (21%)

Query: 143 EGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGNLL 197
           EG +G V++   ++         TG  VA+K L  +     KE      L E+N L  L 
Sbjct: 15  EGTYGVVYRARDKK---------TGEIVALKKLKMEK---EKEGFPITSLREINILLKLQ 62

Query: 198 HPNLVKL----VGYCIEDDQRLLVYEFMP---RGSLENHLFRRSLPLPWSIR-----MKI 245
           HPN+V +    VG  +  D+  +V E++    +  +E          P+        M  
Sbjct: 63  HPNIVTVKEVVVGSNL--DKIYMVMEYVEHDLKSLMETM------KQPFLQSEVKCLMLQ 114

Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
            L    G+A LH+     +++RD KTSN+LL+     K+ DFGLA++     K +  T++
Sbjct: 115 LL---SGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--TQL 166

Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
           + T  Y APE ++     ++  D++S G +  E+LT +
Sbjct: 167 VVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 52/181 (28%), Positives = 81/181 (44%), Gaps = 15/181 (8%)

Query: 166 TGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMP 222
           TG  VA+K +          K    E+  L +L H N++ L    I   + +  V E + 
Sbjct: 34  TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL- 92

Query: 223 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA 282
               + H    S PL             +GL ++H      V++RD K SNIL++ + + 
Sbjct: 93  --GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDL 147

Query: 283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEMLTG 341
           K+ DFGLA+        +VSTR      Y APE ++T      + D++S G +  EML G
Sbjct: 148 KICDFGLARIQDPQMTGYVSTRY-----YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202

Query: 342 R 342
           +
Sbjct: 203 K 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 63/223 (28%), Positives = 100/223 (44%), Gaps = 47/223 (21%)

Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL--PWSIRMKIALGAAKGLAF 255
           H ++V L G C+ D + ++V EF+  G L+  + R+S  L  PW  + K+A   A  L++
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120

Query: 256 LHEEAEKPVIYRDFKTSNILL-----DADYNA--KLSDFGLAKDAPEDGKTHVSTR--VM 306
           L    +K +++ +  T NILL     D +     KLSD G+           V +R   +
Sbjct: 121 LE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP--------ITVLSRQECV 169

Query: 307 GTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
               + APE V  + +L+  +D +SFG  L E+            NGE  L +     L 
Sbjct: 170 ERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICY----------NGEIPLKD---KTLA 216

Query: 366 DKRRFYRLLDPRLEGHFSI--KGSQKATQLAAQCLSRDPKARP 406
           +K RFY       EG   +     ++   L   C++ DP  RP
Sbjct: 217 EKERFY-------EGQCMLVTPSCKELADLMTHCMNYDPNQRP 252

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 61.5 bits (150), Expect = 2e-10
 Identities = 59/233 (25%), Positives = 92/233 (39%), Gaps = 64/233 (27%)

Query: 142 GEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGNLLH 198
           G G +G V+K               G   A+K    D  Q     +    E+  L  L H
Sbjct: 9   GRGTYGRVYKAK-------RKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 199 PNLVKLVGYCIEDDQRL--LVYEFMPRGSLENHLF----------RRSLP------LPWS 240
            N+V LV   +E   +   L++++      E+ L+          R S+P      L W 
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYA-----EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116

Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA----KLSDFGLAK--DAP 294
           I          G+ +LH      V++RD K +NIL+  +       K+ D GLA+  +AP
Sbjct: 117 I--------LNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165

Query: 295 ------EDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLT 340
                  D        V+ T  Y APE ++   H T   D+++ G +  E+LT
Sbjct: 166 LKPLADLDP-------VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 5/93 (5%)

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
           +GL +LH      +++RD K  N+L++++   K+ DFGLA+    D   H++  V+  Y 
Sbjct: 114 RGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169

Query: 311 YAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
           Y APE +M + H TS  D++S G +  E+L  R
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 61.1 bits (148), Expect = 3e-10
 Identities = 62/225 (27%), Positives = 92/225 (40%), Gaps = 20/225 (8%)

Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           K+   +F     LG G FG V          A  K      VA+K      +   K+   
Sbjct: 26  KMKYEDFNFIRTLGTGSFGRVI--------LATYKNEDFPPVAIKRFEKSKIIKQKQVDH 77

Query: 187 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 245
             +E   L  + HP  V L G   ++    LV EF+  G     L RR+   P  +    
Sbjct: 78  VFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL-RRNKRFPNDVG--- 133

Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
              AA+ +          ++YRD K  N+LLD D   K++DFG AK    D +T+    +
Sbjct: 134 CFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV--DTRTYT---L 188

Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
            GT  Y APE ++       +D ++ G+ + E+L G      N P
Sbjct: 189 CGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233

Length = 340

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 59/216 (27%), Positives = 91/216 (42%), Gaps = 38/216 (17%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK--TLNHDGLQGHKEWLAEVNFLGNLLH 198
           +GEG +G VFK    E         T   VA+K   L+ D        L E+  L  L H
Sbjct: 8   IGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKH 58

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMP----------RGSLENHLFRRSLPLPWSIRMKIALG 248
            N+V+L      D +  LV+E+             G ++  + +  +             
Sbjct: 59  KNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFM-----------FQ 107

Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
             KGLAF H      V++RD K  N+L++ +   KL+DFGLA+      + + S  V+ T
Sbjct: 108 LLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY-SAEVV-T 162

Query: 309 YGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRR 343
             Y  P+ +    L S S D++S G +  E+    R
Sbjct: 163 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 61.0 bits (148), Expect = 4e-10
 Identities = 37/111 (33%), Positives = 56/111 (50%), Gaps = 3/111 (2%)

Query: 234 SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 293
           S PL     ++ +   A+G+ FL   A K  I+RD    N+LL     AK+ DFGLA+D 
Sbjct: 206 SWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDI 262

Query: 294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRS 344
             D    V         + APE +     T +SDV+S+G++L E+ +  +S
Sbjct: 263 MNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 61.2 bits (148), Expect = 5e-10
 Identities = 66/243 (27%), Positives = 103/243 (42%), Gaps = 33/243 (13%)

Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIA 246
           +E++ L    H  +VK       DD+ LL+ E+   G L   + +R    LP+    ++ 
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQ-EYEVG 172

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           L   + +  L E   + +++RD K++NI L      KL DFG +K   +     V++   
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC 232

Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           GT  Y APE       + K+D++S GV+L E+LT                    RP  G 
Sbjct: 233 GTPYYLAPELWERKRYSKKADMWSLGVILYELLT------------------LHRPFKGP 274

Query: 367 KRR------FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPL 418
            +R       Y   DP     F    S     L    LS++P  RP   +++ T  LK +
Sbjct: 275 SQREIMQQVLYGKYDP-----FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329

Query: 419 QNL 421
            NL
Sbjct: 330 ANL 332

Length = 478

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 59.7 bits (144), Expect = 6e-10
 Identities = 81/294 (27%), Positives = 121/294 (41%), Gaps = 48/294 (16%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 194
           F    L+G G +G V+KG         VK  TG   A+K ++  G +  +E   E+N L 
Sbjct: 8   FELVELVGNGTYGQVYKG-------RHVK--TGQLAAIKVMDVTGDE-EEEIKQEINMLK 57

Query: 195 NLLH-PNLVKLVGYCIE------DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMK 244
              H  N+    G  I+      DDQ  LV EF   GS+ + +      +L   W     
Sbjct: 58  KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AY 115

Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           I     +GL+ LH+     VI+RD K  N+LL  +   KL DFG++  A  D        
Sbjct: 116 ICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNT 170

Query: 305 VMGTYGYAAPEYVMTGH-----LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 359
            +GT  + APE +            KSD++S G+  +EM  G   +    P     L+  
Sbjct: 171 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP- 229

Query: 360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                       R   PRL+   S K S+K       CL ++   RP   ++++
Sbjct: 230 ------------RNPAPRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 60.0 bits (145), Expect = 6e-10
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 17/204 (8%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLHP 199
           LGEG +  VFKG  +          T   VA+K +  +  +G     + EV+ L NL H 
Sbjct: 13  LGEGTYATVFKGRSKL---------TENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHA 63

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           N+V L      +    LV+E++    L+ +L      +             +GL++ H+ 
Sbjct: 64  NIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK- 121

Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM- 318
             + +++RD K  N+L++     KL+DFGLA+      KT+ +  V  T  Y  P+ ++ 
Sbjct: 122 --RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLG 177

Query: 319 TGHLTSKSDVYSFGVVLLEMLTGR 342
           +   ++  D++  G +L EM TGR
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 59.4 bits (144), Expect = 6e-10
 Identities = 74/279 (26%), Positives = 119/279 (42%), Gaps = 45/279 (16%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EVNFLGNL 196
           LG+G F  ++KG    ++    V PG  ++V +K L       H++ LA     + +  L
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG----SDHRDSLAFFETASLMSQL 58

Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 256
            H +LVKL G C+ D + ++V E++  G L+  L R    +    ++ +A   A  L +L
Sbjct: 59  SHKHLVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL 117

Query: 257 HEEAEKPVIYRDFKTSNILL-DADYN------AKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
               +K +++ +    NIL+     N       KLSD G+              RV    
Sbjct: 118 E---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI-----TVLSREERVERI- 168

Query: 310 GYAAPEYVMTGH--LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
            + APE +  G   LT  +D +SFG  LLE+ +          NGE  L   +     +K
Sbjct: 169 PWIAPECIRNGQASLTIAADKWSFGTTLLEICS----------NGEEPLSTLSS---SEK 215

Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            RFY     + +    +    +   L  QC + DP  RP
Sbjct: 216 ERFY-----QDQHRLPMPDCAELANLINQCWTYDPTKRP 249

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 60.4 bits (146), Expect = 6e-10
 Identities = 50/169 (29%), Positives = 69/169 (40%), Gaps = 18/169 (10%)

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           AKG+ FL   A +  I+RD    NILL  +   K+ DFGLA+D  +D             
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            + APE +     T +SDV+SFGV+L E+ +               L     P +     
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------------LGASPYPGVKIDEE 290

Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
           F R L            + +  Q    C   +P  RP  SE+VE L  L
Sbjct: 291 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 59.2 bits (143), Expect = 6e-10
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 24/226 (10%)

Query: 189 EVNFLGNLLHPNLVKLV-GYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIA 246
           E   L  L HPN+V     +  ED    +V  F   G L + L  ++   LP +  ++  
Sbjct: 49  EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWF 108

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           +  A  L +LHE   K +++RD KT N+ L      K+ D G+A+    + +  +++ ++
Sbjct: 109 VQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVL--ENQCDMASTLI 163

Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           GT  Y +PE         KSDV++ G  + EM T + + +    N   +LV         
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN---SLV--------- 211

Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
               YR+++ +L        S +  +L A  LS+ P+ RP +  ++
Sbjct: 212 ----YRIIEGKLP-PMPKDYSPELGELIATMLSKRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 59.6 bits (145), Expect = 7e-10
 Identities = 61/221 (27%), Positives = 95/221 (42%), Gaps = 42/221 (19%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 194
           ++    +GEG F  V K    + G            A+K +       H + L +VN L 
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGK---------YYAIKCMKK-----HFKSLEQVNNLR 46

Query: 195 NLL-------HPNLVKLVGYCIEDDQ--RL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
            +        HPN+++L+   + D +  RL LV+E M   +L   +  R  PLP      
Sbjct: 47  EIQALRRLSPHPNILRLIE-VLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKS 104

Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK----TH 300
                 K L  +H      + +RD K  NIL+  D   KL+DFG  +      K     +
Sbjct: 105 YMYQLLKSLDHMHR---NGIFHRDIKPENILIK-DDILKLADFGSCRGI--YSKPPYTEY 158

Query: 301 VSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLT 340
           +STR      Y APE ++T G+   K D+++ G V  E+L+
Sbjct: 159 ISTR-----WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 59.6 bits (144), Expect = 7e-10
 Identities = 83/296 (28%), Positives = 126/296 (42%), Gaps = 62/296 (20%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGNLL-H 198
           +G+G +G V+K   +++G+           AVK L  D +    E + AE N L +L  H
Sbjct: 30  IGKGTYGKVYKVTNKKDGS---------LAAVKIL--DPISDVDEEIEAEYNILQSLPNH 78

Query: 199 PNLVKLVGYCIEDD-----QRLLVYEFMPRGS---LENHLFRRSLPLPWSIRMKIALGAA 250
           PN+VK  G   + D     Q  LV E    GS   L   L      L  ++   I  GA 
Sbjct: 79  PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGAL 138

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV----- 305
            GL  LH      +I+RD K +NILL  +   KL DFG++           STR+     
Sbjct: 139 LGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQL-------TSTRLRRNTS 188

Query: 306 MGTYGYAAPEYVMTGH-----LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 360
           +GT  + APE +           ++ DV+S G+  +E+  G   +    P     L +  
Sbjct: 189 VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP--VKTLFKIP 246

Query: 361 R---PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
           R   P L    ++ R  +     HF            +QCL +D +ARP ++ ++E
Sbjct: 247 RNPPPTLLHPEKWCRSFN-----HF-----------ISQCLIKDFEARPSVTHLLE 286

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 47/170 (27%), Positives = 76/170 (44%), Gaps = 24/170 (14%)

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           AKG++FL   A K  I+RD    NILL      K+ DFGLA+D   D    V        
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            + APE +     T +SDV+S+G++L E+ +               L     P +    +
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFS---------------LGSSPYPGMPVDSK 325

Query: 370 FYRLLDPRLEGH--FSIKGS-QKATQLAAQCLSRDPKARPRMSEVVETLK 416
           FY+++    EG+   S + +  +   +   C   DP  RP   ++V+ ++
Sbjct: 326 FYKMIK---EGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 19/205 (9%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLHP 199
           LGEG +  V+KG    NG           VA+K ++    +G     + E + L  L H 
Sbjct: 13  LGEGSYATVYKGISRINGQ---------LVALKVISMKTEEGVPFTAIREASLLKGLKHA 63

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-PWSIRMKIALGAAKGLAFLHE 258
           N+V L       +    V+E+M    L  ++ +    L P+++R+       +GLA++H 
Sbjct: 64  NIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHG 121

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
           +    +++RD K  N+L+      KL+DFGLA+      +T+ S  V  T  Y  P+ ++
Sbjct: 122 QH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLL 176

Query: 319 -TGHLTSKSDVYSFGVVLLEMLTGR 342
                +S  D++  G + +EML G+
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 66/209 (31%), Positives = 93/209 (44%), Gaps = 24/209 (11%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNLL 197
           +G+G FG V++           K  T    A+K L+   +   KE    + E N L   L
Sbjct: 1   IGKGTFGQVYQ---------VRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTL 51

Query: 198 HPNLVKLVG--YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
                 +VG  +  + D  L LV ++M  G L  HL +         +  IA      L 
Sbjct: 52  LDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALE 110

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
            LH+     ++YRD K  NILLDA  +  L DFGL+K    D KT  +    GT  Y AP
Sbjct: 111 HLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLAP 165

Query: 315 EYVM--TGHLTSKSDVYSFGVVLLEMLTG 341
           E ++   G+ T   D +S GV++ EM  G
Sbjct: 166 EVLLDEKGY-TKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 32/93 (34%), Positives = 53/93 (56%), Gaps = 9/93 (9%)

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
           +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      
Sbjct: 131 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 182

Query: 311 YAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 33/93 (35%), Positives = 51/93 (54%), Gaps = 9/93 (9%)

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
           KGL ++H      +I+RD K  N+ ++ D   K+ DFGLA+    +   +V TR      
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----W 180

Query: 311 YAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           Y APE ++   H T   D++S G ++ EMLTG+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 9/93 (9%)

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            GL ++H      +I+RD K  N+ ++ D   K+ DFGLA+ A  +   +V TR      
Sbjct: 128 CGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----W 179

Query: 311 YAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           Y APE ++   H     D++S G ++ EMLTG+
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 58.9 bits (143), Expect = 2e-09
 Identities = 78/302 (25%), Positives = 118/302 (39%), Gaps = 58/302 (19%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGN 195
           +G+G FG VFK        A  K  T   VA+K +    ++  KE      L E+  L  
Sbjct: 20  IGQGTFGEVFK--------ARHKK-TKQIVALKKVL---MENEKEGFPITALREIKILQL 67

Query: 196 LLHPNLVKLVGYCIEDDQR--------LLVYEFMPR---GSLENHLFRRSLPLPWSIRMK 244
           L H N+V L+  C               LV+EF      G L N   + +L     + MK
Sbjct: 68  LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKV-MK 126

Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTHVS 302
           + L    GL ++H      +++RD K +NIL+  D   KL+DFGLA+     ++ K +  
Sbjct: 127 MLL---NGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180

Query: 303 TRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE--- 358
           T  + T  Y  PE ++         D++  G ++ EM T    M  N    +  L+    
Sbjct: 181 TNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC 240

Query: 359 -------W---ARPHLGDKRRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA 404
                  W    +  L  K        R +  RL+ +        A  L  + L  DP  
Sbjct: 241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVK---DPHALDLIDKLLVLDPAK 297

Query: 405 RP 406
           R 
Sbjct: 298 RI 299

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 53/179 (29%), Positives = 79/179 (44%), Gaps = 38/179 (21%)

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED------GKTHVST 303
           A+G+ FL   A +  I+RD    NILL  +   K+ DFGLA+D  +D      G   +  
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239

Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
           + M      APE +     T++SDV+SFGV+L E+ +               L     P 
Sbjct: 240 KWM------APESIFDKVYTTQSDVWSFGVLLWEIFS---------------LGASPYPG 278

Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKAT----QLAAQCLSRDPKARPRMSEVVETLKPL 418
           +     F R    RL+    ++  + AT     +   C   +P+ RP  SE+VE L  L
Sbjct: 279 VQIDEEFCR----RLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDL 333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 80/290 (27%), Positives = 122/290 (42%), Gaps = 50/290 (17%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLAEVNFLGNLL- 197
           +G+G +G VFK   ++NG+           AVK L+  HD     +E  AE N L  L  
Sbjct: 26  IGKGTYGKVFKVLNKKNGS---------KAAVKILDPIHDI---DEEIEAEYNILKALSD 73

Query: 198 HPNLVKLVG-YCIED----DQRLLVYEFMPRGS---LENHLFRRSLPLPWSIRMKIALGA 249
           HPN+VK  G Y  +D    DQ  LV E    GS   L     +R   +   I   I   A
Sbjct: 74  HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
             GL  LH       I+RD K +NILL  +   KL DFG++  A            +GT 
Sbjct: 134 LMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRRNTSVGTP 188

Query: 310 GYAAPEYV-----MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
            + APE +     +     ++ DV+S G+  +E+  G   +    P              
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP-------------- 234

Query: 365 GDKRRFYRL-LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
              R  +++  +P    H     S +      +CL++D + RP +S++++
Sbjct: 235 --MRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 50/167 (29%), Positives = 71/167 (42%), Gaps = 18/167 (10%)

Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-------ENHLFRRSLPLPWSI 241
           E   L  + HPN+V        D    +V E+   G L          LF     L W +
Sbjct: 48  EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107

Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           +M +      G+  +HE   K V++RD K+ NI L  +   KL DFG A+     G  + 
Sbjct: 108 QMCL------GVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AYA 157

Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN 348
            T V GT  Y  PE        +KSD++S G +L E+ T +     N
Sbjct: 158 CTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 58.1 bits (141), Expect = 4e-09
 Identities = 67/255 (26%), Positives = 101/255 (39%), Gaps = 68/255 (26%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNF 192
           +F    ++G G FG V             K  TG   A+K L   + L+  KE +A V  
Sbjct: 2   DFESIKVIGRGAFGEV---------RLVQKKDTGHIYAMKKLRKSEMLE--KEQVAHVRA 50

Query: 193 LGNLL----HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKI-- 245
             ++L    +P +VKL  Y  +D+  L L+ E++P G +   L ++        R  I  
Sbjct: 51  ERDILAEADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAE 109

Query: 246 ---ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL------------- 289
              A+ +   L ++H         RD K  N+LLDA  + KLSDFGL             
Sbjct: 110 TILAIDSIHKLGYIH---------RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160

Query: 290 ---AKDAPEDGKTHVST---------------RVM-----GTYGYAAPEYVMTGHLTSKS 326
              +   P +    +S                R +     GT  Y APE  +      + 
Sbjct: 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKEC 220

Query: 327 DVYSFGVVLLEMLTG 341
           D +S GV++ EML G
Sbjct: 221 DWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 57.9 bits (140), Expect = 4e-09
 Identities = 65/245 (26%), Positives = 102/245 (41%), Gaps = 59/245 (24%)

Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 186
           DL     + RP   LG G  G VF         + V       VAVK +     Q  K  
Sbjct: 2   DLGSRYMDLRP---LGCGSNGLVF---------SAVDSDCDKRVAVKKIVLTDPQSVKHA 49

Query: 187 LAEVNFLGNLLHPNLVKL--------------VGYCIEDDQRLLVYEFMP--------RG 224
           L E+  +  L H N+VK+              VG   E +   +V E+M         +G
Sbjct: 50  LREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQG 109

Query: 225 SL-ENH--LFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DY 280
            L E H  LF   L               +GL ++H      V++RD K +N+ ++  D 
Sbjct: 110 PLSEEHARLFMYQL--------------LRGLKYIHSAN---VLHRDLKPANVFINTEDL 152

Query: 281 NAKLSDFGLAK--DAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLE 337
             K+ DFGLA+  D     K ++S  ++  + Y +P  +++  + T   D+++ G +  E
Sbjct: 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAE 211

Query: 338 MLTGR 342
           MLTG+
Sbjct: 212 MLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 57.3 bits (138), Expect = 5e-09
 Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 23/207 (11%)

Query: 141 LGEGGFGCVFKGW--VEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLL 197
           LGEG +  VFKG   + EN            VA+K +  +  +G     + EV+ L +L 
Sbjct: 14  LGEGTYATVFKGRSKLTEN-----------LVALKEIRLEHEEGAPCTAIREVSLLKDLK 62

Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL-GAAKGLAFL 256
           H N+V L      D    LV+E++ +  L+ ++      +     +KI L    +GLA+ 
Sbjct: 63  HANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMH-NVKIFLYQILRGLAYC 120

Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H    + V++RD K  N+L++     KL+DFGLA+      KT+ +  V  T  Y  P+ 
Sbjct: 121 HR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDV 175

Query: 317 VM-TGHLTSKSDVYSFGVVLLEMLTGR 342
           ++ +   +++ D++  G +  EM +GR
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 56.8 bits (137), Expect = 6e-09
 Identities = 61/258 (23%), Positives = 107/258 (41%), Gaps = 36/258 (13%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLT-VAVKTLNHD-GLQGHKEWLAEVNFLGNLLH 198
           +G G FG V            +   TG+  V VK L  +   +   E+L + +    L H
Sbjct: 3   IGNGWFGKVLLS--------EIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQH 54

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRRSLPLPWSIRMKIALGAAKG 252
           PN+++ +G C+E    LLV+E+   G L+++L       R S  L   +  ++A   A G
Sbjct: 55  PNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLL---LLQRMACEIAAG 111

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           +  +H+      ++ D    N  L +D   K+ D+G+     ++              + 
Sbjct: 112 VTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL 168

Query: 313 APEYV-------MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
           APE V       +T   T  S+V++ GV L E+        +N      +L +    +  
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELF-------ENAAQPYSHLSDREVLNHV 221

Query: 366 DKRRFYRLLDPRLEGHFS 383
            K +  +L  P+LE  +S
Sbjct: 222 IKDQQVKLFKPQLELPYS 239

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 57.0 bits (138), Expect = 7e-09
 Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 34/224 (15%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 189
              + P   +G G +G V          +     T   VA+K + +  D     K  L E
Sbjct: 4   DTKYVPIKPIGRGAYGIV---------CSAKNSETNEKVAIKKIANAFDNRIDAKRTLRE 54

Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQR------LLVYEFMPRGSLENH-LFRRSLPLPWSIR 242
           +  L +L H N++ +    +    R       +VYE M     + H + R S  L     
Sbjct: 55  IKLLRHLDHENVIAIKD-IMPPPHREAFNDVYIVYELM---DTDLHQIIRSSQTLSDDHC 110

Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK---T 299
                   +GL ++H      V++RD K SN+LL+A+ + K+ DFGLA+   E G     
Sbjct: 111 QYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTE 167

Query: 300 HVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGR 342
           +V TR      Y APE ++     T+  DV+S G +  E+L  +
Sbjct: 168 YVVTR-----WYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 46/175 (26%), Positives = 77/175 (44%), Gaps = 29/175 (16%)

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           A+G+ FL   A K  ++RD    N+LL      K+ DFGLA+D   D             
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            + APE +     T+ SDV+S+G++L E+ +               L     P +     
Sbjct: 304 KWMAPESIFDNLYTTLSDVWSYGILLWEIFS---------------LGGTPYPGMIVDST 348

Query: 370 FYRLLDPRLEGHFSIKGSQKATQ----LAAQCLSRDPKARPR---MSEVVETLKP 417
           FY     +++  + +     ATQ    +  +C + +P+ RP    +S++VE+L P
Sbjct: 349 FYN----KIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 57/225 (25%), Positives = 108/225 (48%), Gaps = 35/225 (15%)

Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEV 190
             ++++  +++G G FG V++          +   T   VA+K +  D    ++E L   
Sbjct: 64  PNKSYKLGNIIGNGSFGVVYEA---------ICIDTSEKVAIKKVLQDPQYKNRELL--- 111

Query: 191 NFLGNLLHPNLVKLVGY----CIEDDQRLL----VYEFMPRG--SLENHLFRRSLPLPWS 240
             + NL H N++ L  Y    C + +++ +    V EF+P+       H  R +  LP  
Sbjct: 112 -IMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLF 170

Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAKLSDFGLAKD--APEDG 297
           +    +    + LA++H    K + +RD K  N+L+D + +  KL DFG AK+  A +  
Sbjct: 171 LVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS 227

Query: 298 KTHVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTG 341
            +++ +R      Y APE ++   + T+  D++S G ++ EM+ G
Sbjct: 228 VSYICSRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 55.1 bits (133), Expect = 3e-08
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 37/214 (17%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK--TLNHDGLQGHK-EWLAEVNFLGNLL 197
           LGEG +  V+KG  +  G           VA+K   L H+  +G     + E + L +L 
Sbjct: 13  LGEGSYATVYKGRSKLTGQL---------VALKEIRLEHE--EGAPFTAIREASLLKDLK 61

Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRG---SLENHLFRRSLPLPWSIRM---KIAL-GAA 250
           H N+V L           LV+E++       +++            + M   ++ L    
Sbjct: 62  HANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDC--------GGGLSMHNVRLFLFQLL 113

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
           +GLA+ H+   + V++RD K  N+L+      KL+DFGLA+      KT+ +  V  T  
Sbjct: 114 RGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLW 168

Query: 311 YAAPEYVM--TGHLTSKSDVYSFGVVLLEMLTGR 342
           Y  P+ ++  T + TS  D++  G +  EM TGR
Sbjct: 169 YRPPDVLLGSTEYSTS-LDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 78/294 (26%), Positives = 120/294 (40%), Gaps = 48/294 (16%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 194
           F    ++G G +G V+KG         VK  TG   A+K ++    +  +E   E+N L 
Sbjct: 18  FELVEVVGNGTYGQVYKG-------RHVK--TGQLAAIKVMDVTEDE-EEEIKLEINMLK 67

Query: 195 NLLH-PNLVKLVGYCIE------DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMK 244
              H  N+    G  I+      DDQ  LV EF   GS+ + +      +L   W     
Sbjct: 68  KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI--AY 125

Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           I     +GLA LH      VI+RD K  N+LL  +   KL DFG++  A  D        
Sbjct: 126 ICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNT 180

Query: 305 VMGTYGYAAPEYVMTGH-----LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 359
            +GT  + APE +            +SD++S G+  +EM  G   +    P     L+  
Sbjct: 181 FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 240

Query: 360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
             P             P+L+   S K S+K       CL ++  +RP   ++++
Sbjct: 241 NPP-------------PKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 55.1 bits (133), Expect = 3e-08
 Identities = 35/102 (34%), Positives = 59/102 (57%), Gaps = 9/102 (8%)

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK---DAPEDGKTHVSTRVMGT 308
           GL ++H      V++RD K  N+L++AD   K+ DFGLA+   + P +    + T  + T
Sbjct: 117 GLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVAT 172

Query: 309 YGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNR 349
             Y APE +++    +K+ DV+S G +L E+L GR+ + K +
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGK 213

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 55.1 bits (132), Expect = 3e-08
 Identities = 30/93 (32%), Positives = 53/93 (56%), Gaps = 9/93 (9%)

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
           +GL ++H      +I+RD K SN+ ++ D   ++ DFGLA+ A ++   +V+TR      
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180

Query: 311 YAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           Y APE ++   H     D++S G ++ E+L G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 27/208 (12%)

Query: 141 LGEGGFGCVF----KGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEVNFLGN 195
           LG+G FG V+    K  V E     +K      + V  LN ++ +Q ++E       L  
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLK-----EIPVGELNPNETVQANQE----AQLLSK 58

Query: 196 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-----RSLPLPWSIRMKIALGAA 250
           L HP +VK     +E D   ++ E+     L+  L       ++L         I L   
Sbjct: 59  LDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL--L 116

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            G+ ++H+   + +++RD K  NI L  +   K+ DFG+++     G   ++T   GT  
Sbjct: 117 LGVHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM--GSCDLATTFTGTPY 170

Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEM 338
           Y +PE +      SKSD++S G +L EM
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 41/160 (25%), Positives = 72/160 (45%), Gaps = 12/160 (7%)

Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKI 245
           E + L  + HP++++L G    +    L+   +PR   + + +   +R++ +     + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAI--CDILAI 187

Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                + + +LHE     +I+RD K  NI ++   +  L DFG A   P D   +     
Sbjct: 188 ERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGW 243

Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM 345
            GT    APE +         D++S G+VL EM T   S+
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283

Length = 391

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 54.3 bits (130), Expect = 3e-08
 Identities = 63/279 (22%), Positives = 115/279 (41%), Gaps = 37/279 (13%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G G +G V+K              TG   A+K +  +  +       E+  + +  H N
Sbjct: 17  IGSGTYGDVYKA---------RNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSN 67

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           +V   G  +  D+  +  EF   GSL++ ++  + PL  S    ++    +GL +LH + 
Sbjct: 68  IVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLHSKG 126

Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT- 319
           +   ++RD K +NILL  + + KL+DFG++  A            +GT  + APE     
Sbjct: 127 K---MHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKSFIGTPYWMAPEVAAVE 181

Query: 320 --GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV---EWARPHLGDKRRFYRLL 374
             G      D+++ G+  +E+   +  M    P     L+    +  P L DK       
Sbjct: 182 RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDK------- 234

Query: 375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                    +K S          L+++PK RP   ++++
Sbjct: 235 ---------MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 55.1 bits (132), Expect = 4e-08
 Identities = 73/312 (23%), Positives = 110/312 (35%), Gaps = 52/312 (16%)

Query: 52  RFIESCMPSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPVSSTTTSNAES--ASSTPK 109
           R +E   P+   +    +      A    S  +  D      S      A    A   P 
Sbjct: 81  RALEDAAPAGELLVPRSNADLFASAGDGPSGAEDSD-----ASHLDFDEAPPDAAGPVPL 135

Query: 110 FSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFG----CVFKGWVEE-------NG 158
              +LK   +              +FR    L  G FG    C  +   EE       N 
Sbjct: 136 AQAKLKHDDEF-----------LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNS 184

Query: 159 TAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKL--------VGYCIE 210
           T   KP     +A +           E   E+  LG L H N++K+          Y I 
Sbjct: 185 TNQGKPKCERLIAKRVKAGSRAAIQLE--NEILALGRLNHENILKIEEILRSEANTYMIT 242

Query: 211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR--MKIALGAAKGLAFLHEEAEKPVIYRD 268
                 +Y FM   + +     +  PL    R  MK  L A   + ++H+   K +I+RD
Sbjct: 243 QKYDFDLYSFMYDEAFD----WKDRPLLKQTRAIMKQLLCA---VEYIHD---KKLIHRD 292

Query: 269 FKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDV 328
            K  NI L+ D    L DFG A    E  +       +GT    +PE +        +D+
Sbjct: 293 IKLENIFLNCDGKIVLGDFGTAMPF-EKEREAFDYGWVGTVATNSPEILAGDGYCEITDI 351

Query: 329 YSFGVVLLEMLT 340
           +S G++LL+ML+
Sbjct: 352 WSCGLILLDMLS 363

Length = 501

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 54.1 bits (130), Expect = 6e-08
 Identities = 42/143 (29%), Positives = 63/143 (44%), Gaps = 11/143 (7%)

Query: 207 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVI 265
           Y  +D   L LV E+ P G L + L R        +        A+ +  +H   +   +
Sbjct: 68  YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM---AQFYLAELVLAIHSVHQMGYV 124

Query: 266 YRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSK 325
           +RD K  N+L+D   + KL+DFG A     +     S   +GT  Y APE + T +   K
Sbjct: 125 HRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGK 183

Query: 326 S------DVYSFGVVLLEMLTGR 342
                  D +S GV+  EM+ GR
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 53.9 bits (129), Expect = 7e-08
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 17/204 (8%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLHP 199
           LGEG +  V+KG  +          T   VA+K +  +  +G     + EV+ L +L H 
Sbjct: 14  LGEGTYATVYKGRSKL---------TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           N+V L      +    LV+E++ +  L+ +L      +             +GL + H  
Sbjct: 65  NIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR- 122

Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM- 318
             + V++RD K  N+L++     KL+DFGLA+      KT+ +  V  T  Y  P+ ++ 
Sbjct: 123 --RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLG 178

Query: 319 TGHLTSKSDVYSFGVVLLEMLTGR 342
           +   +++ D++  G +  EM TGR
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 53.9 bits (129), Expect = 7e-08
 Identities = 52/176 (29%), Positives = 74/176 (42%), Gaps = 28/176 (15%)

Query: 207 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP------WSIRMKIALGAAKGLAFLHEE 259
           Y  +D+  L LV ++   G L   L +    LP      +   M IA+ +   L ++H  
Sbjct: 68  YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVH-- 125

Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
                  RD K  NIL+D + + +L+DFG      EDG    S  V GT  Y +PE +  
Sbjct: 126 -------RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQA 177

Query: 320 -----GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
                G    + D +S GV + EML G        P    +LVE     +  K RF
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGE------TPFYAESLVETYGKIMNHKERF 227

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 22/213 (10%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEW-LAEVNF 192
           F    ++GEG +G V K   +E         T   VA+K   + +  +  KE  L E+  
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKE---------TKEIVAIKKFKDSEENEEVKETTLRELKM 53

Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIALGA 249
           L  L   N+V+L        +  LV+E++ +  LE       +P    P  +R  I    
Sbjct: 54  LRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE---LLEEMPNGVPPEKVRSYI-YQL 109

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
            K + + H+     +++RD K  N+L+  +   KL DFG A++  E G     T  + T 
Sbjct: 110 IKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSE-GSNANYTEYVATR 165

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
            Y +PE ++        D++S G +L E+  G+
Sbjct: 166 WYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 31/91 (34%), Positives = 45/91 (49%), Gaps = 3/91 (3%)

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           A G+ FL   A K  ++RD    N+L+      K+ DFGLA+D   D             
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPL 305

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            + APE +     T+ SDV+SFG++L E+ T
Sbjct: 306 KWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 53.2 bits (127), Expect = 1e-07
 Identities = 51/187 (27%), Positives = 85/187 (45%), Gaps = 32/187 (17%)

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 184

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEML------TGRRSMDK-NR---------PNGEHN 355
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244

Query: 356 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 406
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 303

Query: 407 RMSEVVE 413
            + E ++
Sbjct: 304 SVDEALQ 310

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 35/218 (16%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK----TLNHDGLQGHKEWLAEVNFLGNL 196
           +GEG +G V+K              TG  VA+K     ++ +G+      L E++ L  L
Sbjct: 9   IGEGTYGKVYKA---------RDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLLQML 57

Query: 197 LH-PNLVKL--VGYCIEDDQRL---LVYEFMP---RGSLENHLFRRSLPLPWSIRMKIAL 247
                +V+L  V +  E + +    LV+E++    +  ++++      PLP         
Sbjct: 58  SESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMY 117

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAK--DAPEDGKTHVSTR 304
              KG+A  H+     V++RD K  N+L+D      K++D GL +    P    TH    
Sbjct: 118 QLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH---- 170

Query: 305 VMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTG 341
            + T  Y APE ++   H ++  D++S G +  EM   
Sbjct: 171 EIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 61/220 (27%), Positives = 91/220 (41%), Gaps = 23/220 (10%)

Query: 141 LGEGGFGCVFKGWVEENGT----APVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGN 195
           LGEG +G V K +    G       VK         K     G+ G H   L E+  +  
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 196 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 255
           + H N++ LV   +E D   LV + M    L+  +  R + L  S    I L    GL  
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQILNGLNV 134

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--------DAPEDGKTHVSTRVMG 307
           LH+      ++RD   +NI +++    K++DFGLA+        D     +T      M 
Sbjct: 135 LHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT 191

Query: 308 ----TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
               T  Y APE +M         D++S G +  E+LTG+
Sbjct: 192 SKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 52.0 bits (125), Expect = 3e-07
 Identities = 31/91 (34%), Positives = 49/91 (53%), Gaps = 6/91 (6%)

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 183

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
            APE ++        D++S G ++ EM+ G 
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 51.6 bits (123), Expect = 4e-07
 Identities = 31/91 (34%), Positives = 49/91 (53%), Gaps = 6/91 (6%)

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
            APE ++        D++S G ++ EM+ G 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 50/204 (24%), Positives = 99/204 (48%), Gaps = 19/204 (9%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLHP 199
           LGEG +  V+KG  + NG           VA+K +     +G     + E + L  L H 
Sbjct: 13  LGEGSYATVYKGKSKVNGK---------LVALKVIRLQEEEGTPFTAIREASLLKGLKHA 63

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-PWSIRMKIALGAAKGLAFLHE 258
           N+V L       +   LV+E++    L  ++ +    L P ++++ +     +GL+++H+
Sbjct: 64  NIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFL-FQLLRGLSYIHQ 121

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
              + +++RD K  N+L+      KL+DFGLA+   +   +H  +  + T  Y  P+ ++
Sbjct: 122 ---RYILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDVLL 176

Query: 319 -TGHLTSKSDVYSFGVVLLEMLTG 341
            +   ++  D++  G + +EM+ G
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 51.6 bits (123), Expect = 5e-07
 Identities = 47/174 (27%), Positives = 68/174 (39%), Gaps = 48/174 (27%)

Query: 207 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKI-----ALGAAKGLAFLHEEA 260
           Y  +D + L L+ EF+P G +   L ++      + +  I     A+ A   L F+H   
Sbjct: 68  YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIH--- 124

Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGL----------------AKDAPED-------- 296
                 RD K  N+LLDA  + KLSDFGL                  + P D        
Sbjct: 125 ------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178

Query: 297 ---------GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
                     +  ++   +GT  Y APE  M        D +S GV++ EML G
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 50.6 bits (121), Expect = 9e-07
 Identities = 53/167 (31%), Positives = 74/167 (44%), Gaps = 30/167 (17%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           +F    ++G+G FG V    V+       K  TG   A+KTL    +   K+ LA V   
Sbjct: 2   DFHTVKVIGKGAFGEV--RLVQ-------KKDTGKIYAMKTLLKSEMF-KKDQLAHVKAE 51

Query: 194 GNLL----HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA-- 246
            ++L     P +V L  Y  +D Q L L+ EF+P G L   L +         R  +A  
Sbjct: 52  RDVLAESDSPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAEC 110

Query: 247 ---LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA 290
              + A   L F+H         RD K  NIL+D   + KLSDFGL+
Sbjct: 111 VLAIEAVHKLGFIH---------RDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 6/90 (6%)

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A  +    + T  + T  Y
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN---FMMTPYVVTRYY 188

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            APE ++        D++S G ++ E++ G
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 49.8 bits (119), Expect = 2e-06
 Identities = 54/221 (24%), Positives = 88/221 (39%), Gaps = 60/221 (27%)

Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHL-----FRRSLPLPWSI 241
           AE + L    +  +VKL  Y  +D   L  V +++P G + + L     F   L   +  
Sbjct: 50  AERDILAEADNEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA 108

Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA----------- 290
            +  A+ +   + F+H         RD K  NIL+D D + KL+DFGL            
Sbjct: 109 ELTCAIESVHKMGFIH---------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159

Query: 291 --------KDA--PEDGKTHVSTRVM--------------------GTYGYAAPEYVM-T 319
                   +D+  P +  + +    +                    GT  Y APE ++ T
Sbjct: 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT 219

Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG-EHNLVEW 359
           G+ T   D +S GV+L EML G+     + P   +  ++ W
Sbjct: 220 GY-TQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINW 259

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 43/147 (29%), Positives = 65/147 (44%), Gaps = 22/147 (14%)

Query: 207 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP------WSIRMKIALGAAKGLAFLHEE 259
           Y  +D+  L LV ++   G L   L +    LP      +   M +A+ +   L ++H  
Sbjct: 68  YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVH-- 125

Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
                  RD K  N+LLD + + +L+DFG      +DG    S  V GT  Y +PE +  
Sbjct: 126 -------RDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTPDYISPEILQA 177

Query: 320 -----GHLTSKSDVYSFGVVLLEMLTG 341
                G    + D +S GV + EML G
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 48.0 bits (114), Expect = 4e-06
 Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 43/230 (18%)

Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 257
           H +L  + G C+   + ++V EF+  G L+  L +    +P + ++ +A   A  L++L 
Sbjct: 75  HIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE 134

Query: 258 EEAEKPVIYRDFKTSNILLD----ADYNA---KLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
              +K +++ +    NILL     A+  +   KLSD G++  A    +     R+     
Sbjct: 135 ---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS--REERVERI----P 185

Query: 311 YAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
           + APE V  G  L++ +D +SFG  LLE+            +GE  L E       +K R
Sbjct: 186 WIAPECVPGGNSLSTAADKWSFGTTLLEICF----------DGEVPLKERTPS---EKER 232

Query: 370 FY----RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           FY    RL +P           ++   L +QCL+ +P  RP    ++  L
Sbjct: 233 FYEKKHRLPEP---------SCKELATLISQCLTYEPTQRPSFRTILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 47.9 bits (114), Expect = 4e-06
 Identities = 71/295 (24%), Positives = 126/295 (42%), Gaps = 60/295 (20%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG+G F  +FKG   E G       T   V +K L+       + +    + +  L H +
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKT--EVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF-LHEE 259
           LV   G C+  D+ ++V E++  GSL+ +L +    +  S ++++    AK LA+ LH  
Sbjct: 61  LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEV----AKQLAWALHFL 116

Query: 260 AEKPVIYRDFKTSNILLDADYNA--------KLSDFG-----LAKDAPEDGKTHVSTRVM 306
            +K + + +    N+LL  + +         KLSD G     L K+   +       R+ 
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLE-------RI- 168

Query: 307 GTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
               +  PE +    +L+  +D +SFG  L E+ +G      ++P    + ++  +    
Sbjct: 169 ---PWVPPECIENPQNLSLAADKWSFGTTLWEIFSG-----GDKP---LSALDSQK---- 213

Query: 366 DKRRFY--RLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETL 415
            K +FY  R   P          + K T+LA    QC+  +P  RP    ++  L
Sbjct: 214 -KLQFYEDRHQLP----------APKWTELANLINQCMDYEPDFRPSFRAIIRDL 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 47.7 bits (113), Expect = 5e-06
 Identities = 54/222 (24%), Positives = 95/222 (42%), Gaps = 25/222 (11%)

Query: 120 LRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG 179
           LR+   +D +L  R       +G G +G V+K              TG   AVK +  + 
Sbjct: 3   LRRNPQHDYELIQR-------VGSGTYGDVYKA---------RNLHTGELAAVKIIKLEP 46

Query: 180 LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 239
                    E+  +    H N+V   G  +  ++  +  E+   GSL++ ++  + PL  
Sbjct: 47  GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSE 105

Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
                +     +GLA+LH + +   ++RD K +NILL  + + KL+DFG+A  A      
Sbjct: 106 LQIAYVCRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVA--AKITATI 160

Query: 300 HVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEM 338
                 +GT  + APE       G      D+++ G+  +E+
Sbjct: 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 48.2 bits (115), Expect = 5e-06
 Identities = 43/147 (29%), Positives = 65/147 (44%), Gaps = 22/147 (14%)

Query: 207 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSI------RMKIALGAAKGLAFLHEE 259
           Y  +D+  L LV ++   G L   L +    LP  +       M +A+ +   L ++H  
Sbjct: 68  YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVH-- 125

Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM- 318
                  RD K  N+LLD + + +L+DFG       DG T  S   +GT  Y +PE +  
Sbjct: 126 -------RDIKPDNVLLDKNGHIRLADFGSCLRLLADG-TVQSNVAVGTPDYISPEILQA 177

Query: 319 ----TGHLTSKSDVYSFGVVLLEMLTG 341
                G    + D +S GV + EML G
Sbjct: 178 MEDGKGRYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 48.1 bits (114), Expect = 5e-06
 Identities = 47/174 (27%), Positives = 67/174 (38%), Gaps = 48/174 (27%)

Query: 207 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA-----LGAAKGLAFLHEEA 260
           Y  +D   L L+ EF+P G +   L ++        +  IA     + +   L F+H   
Sbjct: 68  YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIH--- 124

Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGLA---KDA-------------PED-------- 296
                 RD K  N+LLD+  + KLSDFGL    K A             P D        
Sbjct: 125 ------RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178

Query: 297 ---------GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
                     +  ++   +GT  Y APE  M        D +S GV++ EML G
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 47.9 bits (114), Expect = 6e-06
 Identities = 41/151 (27%), Positives = 68/151 (45%), Gaps = 21/151 (13%)

Query: 207 YCIEDDQRLL--VYEFMPRGSLENHLFRRSLPLPWSI-RMKIALGAAKGLAFLHEEAEKP 263
           +C  + +R L  V E++  G     L +    LP  + RM  A      L +LH      
Sbjct: 67  FCSFETKRHLCMVMEYVEGGDCAT-LLKNIGALPVDMARMYFA-ETVLALEYLHNYG--- 121

Query: 264 VIYRDFKTSNILLDADYNAKLSDFGLAK-------------DAPEDGKTHVSTRVMGTYG 310
           +++RD K  N+L+ +  + KL+DFGL+K                +D +  +  +V GT  
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181

Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           Y APE ++        D ++ G++L E L G
Sbjct: 182 YIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 65/256 (25%), Positives = 96/256 (37%), Gaps = 73/256 (28%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL---AEVNFLGNLL 197
           LG G FG V             K  T    A+KTL    +    +     AE + L    
Sbjct: 9   LGIGAFGEV---------CLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD 59

Query: 198 HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR-----RSLPLPWSIRMKIALGAAK 251
           +  +VKL  Y  +D   L  V +++P G + + L R       L   +   + +A+ +  
Sbjct: 60  NEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVH 118

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA-------------------KD 292
            + F+H         RD K  NIL+D D + KL+DFGL                    +D
Sbjct: 119 KMGFIH---------RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQD 169

Query: 293 A--PEDGKTHVST------------------------RVMGTYGYAAPEYVMTGHLTSKS 326
           +  P D    VS                          ++GT  Y APE ++    T   
Sbjct: 170 SMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLC 229

Query: 327 DVYSFGVVLLEMLTGR 342
           D +S GV+L EML G+
Sbjct: 230 DWWSVGVILFEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 45.7 bits (108), Expect = 4e-05
 Identities = 34/115 (29%), Positives = 52/115 (45%), Gaps = 3/115 (2%)

Query: 223 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA 282
           R  L  +L  R  PL  +    +A      + ++H E    +I+RD KT N+L++   + 
Sbjct: 243 RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDI 299

Query: 283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLE 337
            L DFG A  A     T     + GT    APE +     T   D++S G+V+ E
Sbjct: 300 CLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 44.3 bits (104), Expect = 8e-05
 Identities = 44/171 (25%), Positives = 79/171 (46%), Gaps = 26/171 (15%)

Query: 189 EVNFLGNLLHPNLVKL--VGYCIEDDQRLLVYEFMP----------RGSLENHLFRRSLP 236
           E+  L  L HPN++ L  V     D +  L++++            R S  N   ++ + 
Sbjct: 48  EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPMQ 104

Query: 237 LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY----NAKLSDFGLAK- 291
           LP S+   +      G+ +LH      V++RD K +NIL+  +       K++D G A+ 
Sbjct: 105 LPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 161

Query: 292 -DAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLT 340
            ++P      +   V+ T+ Y APE ++   H T   D+++ G +  E+LT
Sbjct: 162 FNSPLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 43.0 bits (101), Expect = 3e-04
 Identities = 33/97 (34%), Positives = 44/97 (45%), Gaps = 10/97 (10%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE----VNFLGNL 196
           LG G FG V    VE       K    +TVAVK L        +E L      +++LGN 
Sbjct: 43  LGAGAFGKV----VEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 97

Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRR 233
            H N+V L+G C      L++ E+   G L N L R+
Sbjct: 98  -HINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRK 133

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 42.7 bits (100), Expect = 3e-04
 Identities = 44/187 (23%), Positives = 67/187 (35%), Gaps = 60/187 (32%)

Query: 207 YCIED-DQRLLVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           Y  +D D    V +++P G + + L     F   L   +   +  A+ +   + F+H   
Sbjct: 68  YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIH--- 124

Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGL--------------AKDAPEDGKTHVSTR-- 304
                 RD K  NIL+D D + KL+DFGL              + D         S    
Sbjct: 125 ------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178

Query: 305 -----------------------------VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVL 335
                                        ++GT  Y APE ++    T   D +S GV+L
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238

Query: 336 LEMLTGR 342
            EML G+
Sbjct: 239 YEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 42.4 bits (99), Expect = 3e-04
 Identities = 43/171 (25%), Positives = 78/171 (45%), Gaps = 26/171 (15%)

Query: 189 EVNFLGNLLHPNLVKL--VGYCIEDDQRLLVYEFMP----------RGSLENHLFRRSLP 236
           E+  L  L HPN++ L  V     D +  L++++            R S  N   ++ + 
Sbjct: 48  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQ 104

Query: 237 LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY----NAKLSDFGLAK- 291
           LP  +   +      G+ +LH      V++RD K +NIL+  +       K++D G A+ 
Sbjct: 105 LPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 161

Query: 292 -DAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLT 340
            ++P      +   V+ T+ Y APE ++   H T   D+++ G +  E+LT
Sbjct: 162 FNSPLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 42.3 bits (99), Expect = 4e-04
 Identities = 50/192 (26%), Positives = 82/192 (42%), Gaps = 23/192 (11%)

Query: 166 TGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPR 223
           TG  V V+  + +   + H + L     L +   HPN++             ++  FM  
Sbjct: 24  TGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83

Query: 224 GSLENHLFRRSLP--LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN 281
           GS  N L +   P  +  ++   I  GA +GL +LH+      I+R+ K S+IL+  D  
Sbjct: 84  GS-ANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGL 139

Query: 282 AKLSDFGLAKDAPEDGKTH--------VSTRVMGTYGYAAPEYV---MTGHLTSKSDVYS 330
             LS          +G+           ST V+    + +PE +   + G+   KSD+YS
Sbjct: 140 VSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP---WLSPELLRQDLYGY-NVKSDIYS 195

Query: 331 FGVVLLEMLTGR 342
            G+   E+ TGR
Sbjct: 196 VGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 47/215 (21%), Positives = 88/215 (40%), Gaps = 21/215 (9%)

Query: 138 ESLLGEGGFGCVFK------GWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 191
           + L+G GGFGCV++        +     A ++     T+ ++TL ++ +    + +A   
Sbjct: 17  DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIY-DIDKIALWK 75

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL---ENHLFRRSLPLPWSIRMKIALG 248
            + N+ H  + K  G C    +  + Y F+    L      +F+R       +   I   
Sbjct: 76  NIHNIDHLGIPKYYG-CGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKD 134

Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV--- 305
               L ++HE     + + D K  NI++D +    + D+G+A      GK H+       
Sbjct: 135 MLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGK-HIEYSKEQK 190

Query: 306 ---MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLE 337
               GT  YA  +      +T + D+ S G  +L+
Sbjct: 191 DLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225

Length = 294

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 39.2 bits (91), Expect = 0.004
 Identities = 26/107 (24%), Positives = 41/107 (38%), Gaps = 13/107 (12%)

Query: 59  PSRSKVDSSMSGTSTNY--ADGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKV 116
            SRS   +  SG+  +   A    S   +           TT+   +    P   ++ KV
Sbjct: 44  TSRSTNSARRSGSKRDRETATSTDSGRTKSHEGAATTKQATTTPTTNVEVAPP-PKKKKV 102

Query: 117 ASQLRK----------FMFNDLKLATRNFRPESLLGEGGFGCVFKGW 153
              L             +  D+ ++T+ F+  SLLGEG FG V + W
Sbjct: 103 TYALPNQSREEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAW 149

Length = 467

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	490
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.98
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.98
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.98
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.98
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.98
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.94
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.89
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.86
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.86
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.86
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.85
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.85
PRK10345	210	hypothetical protein; Provisional	99.85
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.84
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.81
smart00090	237	RIO RIO-like kinase.	99.81
PRK14879	211	serine/threonine protein kinase; Provisional	99.81
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.8
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.78
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.77
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.71
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.71
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.69
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.63
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.55
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.52
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.48
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.46
KOG1243	690	consensus Protein kinase [General function predict	99.43
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.4
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.38
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.38
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.31
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.28
KOG3087	229	consensus Serine/threonine protein kinase [General	99.26
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.22
COG4248	637	Uncharacterized protein with protein kinase and he	99.18
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.05
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.01
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.85
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.82
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.79
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.71
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.67
PRK09902	216	hypothetical protein; Provisional	98.62
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.56
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.55
PF01636	239	APH: Phosphotransferase enzyme family This family	98.46
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.43
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.42
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.37
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.28
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.27
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.25
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.21
PLN02876	822	acyl-CoA dehydrogenase	98.16
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.09
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.99
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.95
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.94
PRK10593	297	hypothetical protein; Provisional	97.93
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.89
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.67
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.67
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.61
PRK05231	319	homoserine kinase; Provisional	97.58
KOG2270	520	consensus Serine/threonine protein kinase involved	97.39
PLN02236	344	choline kinase	97.37
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.36
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.34
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.21
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.87
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.86
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.84
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.78
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.64
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.51
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.5
PLN02756	418	S-methyl-5-thioribose kinase	96.48
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.3
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.22
PRK12396	409	5-methylribose kinase; Reviewed	96.19
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.74
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.7
PTZ00384	383	choline kinase; Provisional	95.63
PRK11768	325	serine/threonine protein kinase; Provisional	95.54
PRK06148	1013	hypothetical protein; Provisional	95.4
COG2334	331	Putative homoserine kinase type II (protein kinase	95.38
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.23

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-54  Score=434.40  Aligned_cols=290  Identities=57%  Similarity=0.984  Sum_probs=255.8

Q ss_pred             hhchhhhhhHHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCC
Q 011250          119 QLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH  198 (490)
Q Consensus       119 ~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~H  198 (490)
                      ..+.|.+.++..+|++|....+||+|+||.||+|...+          |..||||++.....+..++|.+|+.++.+++|
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~----------~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H  130 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD----------GTVVAVKRLSSNSGQGEREFLNEVEILSRLRH  130 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC----------CCEEEEEEecCCCCcchhHHHHHHHHHhcCCC
Confidence            45779999999999999999999999999999999874          46899998876543315669999999999999


Q ss_pred             CCeeceeeEEEeCC-ceEEEEEecCCCChhHHhhhcCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE
Q 011250          199 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL  276 (490)
Q Consensus       199 pnIv~l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl  276 (490)
                      ||||+|+|||.+.+ ..+||||||++|+|.++|+.... .++|..+++||.++|+||+|||+...++|||||||++||||
T Consensus       131 ~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL  210 (361)
T KOG1187|consen  131 PNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL  210 (361)
T ss_pred             cCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE
Confidence            99999999999998 49999999999999999987766 89999999999999999999999887789999999999999


Q ss_pred             cCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchh
Q 011250          277 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL  356 (490)
Q Consensus       277 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~  356 (490)
                      |+++++||+|||+|+..+.. .....+...||.+|+|||++..+..+.|+|||||||+|+||+||+.+.+...+.....+
T Consensus       211 D~~~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l  289 (361)
T KOG1187|consen  211 DEDFNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSL  289 (361)
T ss_pred             CCCCCEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccH
Confidence            99999999999999776542 22222211799999999999999999999999999999999999999988777777779


Q ss_pred             hHhhhcccCCcchhhhccCCccC-CCCCh-hhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          357 VEWARPHLGDKRRFYRLLDPRLE-GHFSI-KGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~l~-~~~~~-~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                      ++|+.+.+.+. .+.+++|+.+. ..++. .....+..++.+|++.+|.+||+|.+|++.|+.+..
T Consensus       290 ~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  290 VEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            99998777666 78899999987 66665 577889999999999999999999999999966543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.1e-53  Score=426.82  Aligned_cols=249  Identities=29%  Similarity=0.471  Sum_probs=215.4

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      .+|...++||+|||+.||++++.+         +|..||+|++.+...   ...+.+.+||+|.+.|.|||||+++++|+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~---------tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE   88 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLD---------TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFE   88 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcC---------CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEee
Confidence            469999999999999999999976         788999999987533   33466889999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +.+++|||+|+|..++|..++. +...+++.+++.++.||+.||.|||+.+   |||||||..||||+++.+|||+||||
T Consensus        89 Ds~nVYivLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGL  164 (592)
T KOG0575|consen   89 DSNNVYIVLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGL  164 (592)
T ss_pred             cCCceEEEEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccce
Confidence            9999999999999999999885 5678999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      |..+..++...  .++||||.|+|||++....++..+||||+||+||-||.|++||+...-.+..+-+....        
T Consensus       165 At~le~~~Erk--~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~--------  234 (592)
T KOG0575|consen  165 ATQLEYDGERK--KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE--------  234 (592)
T ss_pred             eeeecCccccc--ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC--------
Confidence            99987554433  35899999999999999999999999999999999999999998653322222221111        


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                                -.+|...+.++.+||.++|+.||.+|||+++||.+
T Consensus       235 ----------Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  235 ----------YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             ----------cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                      11222348899999999999999999999999975

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-52  Score=401.76  Aligned_cols=252  Identities=28%  Similarity=0.418  Sum_probs=211.4

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      +.+.++.||+|..|+||+++++.         +++.+|+|++.... ....+++.+|+++++..+||+||.+||+|..+.
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~---------t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~  150 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKP---------TGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG  150 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcC---------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence            45566889999999999999987         78899999995442 344578999999999999999999999999999


Q ss_pred             -ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          213 -QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       213 -~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                       .+.|+||||++|+|++++... +.+++.....|+.+|++||.|||+ .+   ||||||||+||||+..|.|||||||.+
T Consensus       151 ~~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS  226 (364)
T KOG0581|consen  151 EEISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVS  226 (364)
T ss_pred             ceEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEecccccc
Confidence             499999999999999988544 579999999999999999999996 55   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCC--CCcchhhHhhhcccCCcc
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP--NGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~--~~~~~~~~~~~~~~~~~~  368 (490)
                      ..+.+.    ....++||..|||||.+.+..|+.++||||||++++|+.+|+.||....+  .....+..++-.      
T Consensus       227 ~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~------  296 (364)
T KOG0581|consen  227 GILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD------  296 (364)
T ss_pred             HHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc------
Confidence            887553    34568999999999999999999999999999999999999999976411  122222222111      


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                          -..|.+...   .+++++.+||..||++||.+||++.++++|-
T Consensus       297 ----~ppP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp  336 (364)
T KOG0581|consen  297 ----EPPPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQHP  336 (364)
T ss_pred             ----CCCCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence                011222221   3589999999999999999999999999863

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-52  Score=401.55  Aligned_cols=251  Identities=29%  Similarity=0.463  Sum_probs=206.9

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .+|.+.+.||.|+||+||+|+++.         ++..||||.+.+..  ....+.+..|+.||+.|+|||||.+++++..
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~---------~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~   80 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKK---------SGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED   80 (429)
T ss_pred             ccceehhhccCcceEEEEEeEecc---------CCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec
Confidence            478999999999999999999987         56799999998774  3345668899999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC------CCeEE
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD------YNAKL  284 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~------~~vkL  284 (490)
                      ++.+|||||||.||+|.++|.+++ .+++..+..++.||+.||++||+++   ||||||||.||||+.+      -.+||
T Consensus        81 ~~~i~lVMEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKI  156 (429)
T KOG0595|consen   81 DDFIYLVMEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKI  156 (429)
T ss_pred             CCeEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEe
Confidence            999999999999999999997665 7999999999999999999999988   9999999999999764      46899


Q ss_pred             ecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc
Q 011250          285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      +|||+|+.+....   .....||++.|||||+++...|+.|+|+||+|+|||+|++|+.||+...+.+....++....  
T Consensus       157 ADFGfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~--  231 (429)
T KOG0595|consen  157 ADFGFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNE--  231 (429)
T ss_pred             cccchhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccc--
Confidence            9999999987543   34568999999999999999999999999999999999999999986654332222211111  


Q ss_pred             CCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                                   +...++...+..+.+|+...|.++|.+|.++.+.+.+
T Consensus       232 -------------~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~  268 (429)
T KOG0595|consen  232 -------------IVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDH  268 (429)
T ss_pred             -------------ccCchhhhccCchhhhhhHHHhcCccccCchHHhhhh
Confidence                         1111222224455677777788888777776665543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.3e-52  Score=400.93  Aligned_cols=255  Identities=29%  Similarity=0.413  Sum_probs=208.9

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-------HHHHHHHHHHHhccCCCCeece
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-------HKEWLAEVNFLGNLLHPNLVKL  204 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~Ei~il~~l~HpnIv~l  204 (490)
                      .+.|.+.+.||+|+||.|-+|..+.         +|+.||||++++.....       ...+.+|++||++|+|||||++
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~---------tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~  241 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKK---------TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRI  241 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcc---------cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEE
Confidence            3468899999999999999998876         78899999998653322       2345799999999999999999


Q ss_pred             eeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC---CC
Q 011250          205 VGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD---YN  281 (490)
Q Consensus       205 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~---~~  281 (490)
                      +++|...+..||||||+.||+|.+.+..++ .+.+.....++.|++.||.|||++|   |+||||||+|||+..+   ..
T Consensus       242 ~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~l  317 (475)
T KOG0615|consen  242 KDFFEVPDSSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCL  317 (475)
T ss_pred             eeeeecCCceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceE
Confidence            999999999999999999999999997654 6888888999999999999999999   9999999999999765   77


Q ss_pred             eEEecccCcccCCCCCcceeeeccccCCCccCcchhccCC---CCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhH
Q 011250          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE  358 (490)
Q Consensus       282 vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~---~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~  358 (490)
                      +||+|||+|+...+   .....+.|||+.|.|||++.+..   +..++|+||+||+||-+|+|.+||.......  .+.+
T Consensus       318 lKItDFGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~e  392 (475)
T KOG0615|consen  318 LKITDFGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKE  392 (475)
T ss_pred             EEecccchhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHH
Confidence            99999999998753   34456799999999999998653   3458899999999999999999997643322  1111


Q ss_pred             hhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                      ..   ......+..        ....+.++++.+||.+||..||++|||+.|+|+|-
T Consensus       393 QI---~~G~y~f~p--------~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hp  438 (475)
T KOG0615|consen  393 QI---LKGRYAFGP--------LQWDRISEEALDLINWMLVVDPENRPSADEALNHP  438 (475)
T ss_pred             HH---hcCcccccC--------hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcCh
Confidence            11   011111111        11234489999999999999999999999999764

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-51  Score=390.49  Aligned_cols=243  Identities=31%  Similarity=0.433  Sum_probs=205.5

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      .++|++.++||+|+||+||+++.++         +++.+|+|++++.....   .+...+|..||..++||+||+++..|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~d---------t~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF   94 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKD---------TGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF   94 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcc---------cCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec
Confidence            3479999999999999999999886         78899999998775433   35678899999999999999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      ++.+.+|||+||+.||.|..+|.+. ..+++..+..++.+|+.||.|||+.+   ||||||||+|||||.+|+++|+|||
T Consensus        95 Qt~~kLylVld~~~GGeLf~hL~~e-g~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFg  170 (357)
T KOG0598|consen   95 QTEEKLYLVLDYLNGGELFYHLQRE-GRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFG  170 (357)
T ss_pred             ccCCeEEEEEeccCCccHHHHHHhc-CCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccc
Confidence            9999999999999999999999655 47999999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +++.....+.  ....+|||+.|||||++.+..|+.++|+|||||++||||+|.+||......      ++....+..+.
T Consensus       171 L~k~~~~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------~~~~~I~~~k~  242 (357)
T KOG0598|consen  171 LCKEDLKDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------KMYDKILKGKL  242 (357)
T ss_pred             cchhcccCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH------HHHHHHhcCcC
Confidence            9986544322  234489999999999999999999999999999999999999999765322      12111111110


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCC
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP  406 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP  406 (490)
                                 ..++.-.+.++.+|++++|.+||.+|.
T Consensus       243 -----------~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  243 -----------PLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             -----------CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence                       011112378899999999999999996

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-50  Score=400.53  Aligned_cols=256  Identities=36%  Similarity=0.591  Sum_probs=212.7

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcE-EEEEEecCCCccc--HHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLT-VAVKTLNHDGLQG--HKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~-vaiK~~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      +.+.+.||.|+||+||+|.+.           |.. ||||++.......  .++|.+|+.+|.+|+|||||+++|++.+.
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~-----------g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~  111 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWR-----------GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP  111 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeC-----------CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            445566999999999999996           345 9999998654322  45899999999999999999999999988


Q ss_pred             C-ceEEEEEecCCCChhHHhhh-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-CeEEeccc
Q 011250          212 D-QRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG  288 (490)
Q Consensus       212 ~-~~~lV~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-~vkL~DFG  288 (490)
                      . ..+|||||+++|+|.+++.+ ....+++..++.|+.||++||.|||+++.  ||||||||+||||+.++ ++||+|||
T Consensus       112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFG  189 (362)
T KOG0192|consen  112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFG  189 (362)
T ss_pred             CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCc
Confidence            7 79999999999999999987 46789999999999999999999999774  99999999999999997 99999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhc--cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVM--TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~--~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      +++......  ...+...||+.|||||++.  ...|+.|+|||||||+||||+||+.||...........          
T Consensus       190 lsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~----------  257 (362)
T KOG0192|consen  190 LSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASA----------  257 (362)
T ss_pred             cceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHH----------
Confidence            998765422  2223368999999999999  56999999999999999999999999976543111110          


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccc
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~~  421 (490)
                            +........++..++..+..|+.+||..||..||++.+++..|+.+...
T Consensus       258 ------v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~  306 (362)
T KOG0192|consen  258 ------VVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH  306 (362)
T ss_pred             ------HHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence                  1111122233344688999999999999999999999999999877553

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.1e-51  Score=377.38  Aligned_cols=251  Identities=27%  Similarity=0.417  Sum_probs=206.7

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceee-EEEe
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVG-YCIE  210 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~-~~~~  210 (490)
                      +|+++++||+|+||.||++.+..         +|..||.|.+..+..  ...+.+..|+.+|++|+|||||++++ .|.+
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~---------~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~   90 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLL---------DGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIE   90 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeecc---------CcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhc
Confidence            58899999999999999999876         677899999986543  33457899999999999999999999 5555


Q ss_pred             CCc-eEEEEEecCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeeecCCCCCcEEEcCCCCeEEe
Q 011250          211 DDQ-RLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAE-KPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       211 ~~~-~~lV~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~~-~~iiHrDlkp~NILl~~~~~vkL~  285 (490)
                      +.. ++||||||++|+|..+|..   ....+++..+++++.|++.||..+|+.-. .-|+||||||.||+|+.+|.|||+
T Consensus        91 ~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLG  170 (375)
T KOG0591|consen   91 DNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLG  170 (375)
T ss_pred             cchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeec
Confidence            555 8999999999999998853   45679999999999999999999999331 129999999999999999999999


Q ss_pred             cccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011250          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      |||+++.+...  .......+|||+||+||.+....|+.+|||||+||++|||+.-++||.+.      ++.+.....  
T Consensus       171 DfGL~r~l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI--  240 (375)
T KOG0591|consen  171 DFGLGRFLSSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKI--  240 (375)
T ss_pred             cchhHhHhcch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHH--
Confidence            99999988653  33445689999999999999999999999999999999999999999765      222111110  


Q ss_pred             CcchhhhccCCccCCCC---C-hhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          366 DKRRFYRLLDPRLEGHF---S-IKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~---~-~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                                  -.+++   + .-.+.++..||.-|+..||..||+...++..+
T Consensus       241 ------------~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  241 ------------EQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             ------------HcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence                        11111   1 23488999999999999999999855554443

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4.9e-50  Score=374.29  Aligned_cols=265  Identities=27%  Similarity=0.367  Sum_probs=213.6

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      .|+.+.++|+|+||+||+|++++         +|+.||||++.....  .-.+-.++||++|++|.|+|+|.++++|...
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~---------TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrk   73 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKD---------TGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRK   73 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCC---------cccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhc
Confidence            57888999999999999999987         889999999865432  2335578999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      ..++||+|||+. ++.+.|.+....++...+..++.|++.|+.|+|+++   +|||||||+||||+.+|.+||||||+|+
T Consensus        74 rklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR  149 (396)
T KOG0593|consen   74 RKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFAR  149 (396)
T ss_pred             ceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhH
Confidence            999999999976 555556677778999999999999999999999998   9999999999999999999999999999


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc------
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL------  364 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~------  364 (490)
                      .+...  ....+..+.|.+|.|||++.+ ..|+..+||||+||++.||++|.+.|.+....+...++......+      
T Consensus       150 ~L~~p--gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~  227 (396)
T KOG0593|consen  150 TLSAP--GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQS  227 (396)
T ss_pred             hhcCC--cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHH
Confidence            88643  233467889999999999987 689999999999999999999999998876555443332211111      


Q ss_pred             --CCcchhhhccCCc------cCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          365 --GDKRRFYRLLDPR------LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       365 --~~~~~~~~~~~~~------l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                        .....|..+-=|.      ++..|+ +.+.-+.+|++.||..||.+|++.++++.+
T Consensus       228 iF~~N~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  228 IFSSNPFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             HhccCCceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence              1111111111111      122222 335688999999999999999999999864

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-49  Score=393.87  Aligned_cols=256  Identities=27%  Similarity=0.377  Sum_probs=216.2

Q ss_pred             HHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcc-CCCCeece
Q 011250          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNL-LHPNLVKL  204 (490)
Q Consensus       129 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~Ei~il~~l-~HpnIv~l  204 (490)
                      +....+|.+++.||+|+|++||+|+...         +++.||||++.+.-..   ..+-+..|-.+|.+| .||.|++|
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~---------t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkL  139 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKA---------TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKL  139 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecC---------CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEE
Confidence            3445689999999999999999999887         7889999999766332   224567899999999 69999999


Q ss_pred             eeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 011250          205 VGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       205 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL  284 (490)
                      +..|+++..+|+|+||+++|+|.++|.+. +.|++..++.++.+|+.||+|||++|   ||||||||+|||||+||++||
T Consensus       140 y~TFQD~~sLYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikI  215 (604)
T KOG0592|consen  140 YFTFQDEESLYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKI  215 (604)
T ss_pred             EEEeecccceEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEE
Confidence            99999999999999999999999999666 47999999999999999999999999   999999999999999999999


Q ss_pred             ecccCcccCCCCCcc---------eee--eccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCc
Q 011250          285 SDFGLAKDAPEDGKT---------HVS--TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE  353 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~---------~~~--~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~  353 (490)
                      +|||.|+.+......         ...  ..++||..|++||+|..+..+..+|+|+||||||+|+.|.+||....+.-.
T Consensus       216 TDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli  295 (604)
T KOG0592|consen  216 TDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI  295 (604)
T ss_pred             eeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH
Confidence            999999877543211         111  448999999999999999999999999999999999999999976532211


Q ss_pred             chhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                                      |.++++  +.-.|+...++.+.+||+++|..||.+|+|..+|.+|.
T Consensus       296 ----------------FqkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  296 ----------------FQKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             ----------------HHHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence                            122221  22344555578999999999999999999999998874

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=4e-48  Score=360.77  Aligned_cols=238  Identities=29%  Similarity=0.385  Sum_probs=205.6

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      .++|++.+.||.|+||.|.+++.+.         +|..+|+|++++...-.   .+...+|..+|+.+.||+++++++.|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~---------~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~  113 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKH---------SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF  113 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEcc---------CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee
Confidence            3579999999999999999999987         57799999998775433   34567899999999999999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      .+.+.+||||||++||.|..++.+ .+++++..++.++.||+.||+|||+.+   |++|||||+|||||.+|.+||+|||
T Consensus       114 ~d~~~lymvmeyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFG  189 (355)
T KOG0616|consen  114 KDNSNLYMVMEYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFG  189 (355)
T ss_pred             ccCCeEEEEEeccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEecc
Confidence            999999999999999999999954 458999999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +|+.....     .-..||||.|+|||++....|+.++|+|||||++|||+.|.+||....+....+.            
T Consensus       190 FAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~K------------  252 (355)
T KOG0616|consen  190 FAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEK------------  252 (355)
T ss_pred             ceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHH------------
Confidence            99987543     2348999999999999999999999999999999999999999987655222111            


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCC
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR  405 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~R  405 (490)
                          ++...  -.||...+.++.+|+.++|+.|-.+|
T Consensus       253 ----I~~~~--v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  253 ----ILEGK--VKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ----HHhCc--ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence                11111  12333447889999999999999998

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-48  Score=387.99  Aligned_cols=257  Identities=32%  Similarity=0.458  Sum_probs=214.1

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      .+.+.+++.||+|.||.||+|++...          ..||+|.++... ...+.|.+|+++|+.|+|+|||+++++|..+
T Consensus       205 r~~l~l~~~LG~G~FG~V~~g~~~~~----------~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~  273 (468)
T KOG0197|consen  205 REELKLIRELGSGQFGEVWLGKWNGS----------TKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ  273 (468)
T ss_pred             HHHHHHHHHhcCCccceEEEEEEcCC----------CcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecC
Confidence            34456678899999999999999753          369999998764 3457899999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhh-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          212 DQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      +.+|||||||+.|+|.++|.. .+..+...+.+.++.|||+|++||++++   +|||||..+||||+++..+||+|||+|
T Consensus       274 ~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLA  350 (468)
T KOG0197|consen  274 EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLA  350 (468)
T ss_pred             CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccc
Confidence            899999999999999999976 5667999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +...+ +.+.......-...|.|||.+..+.++.|||||||||+||||+| |+.|+......+.   ++           
T Consensus       351 r~~~d-~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev---~~-----------  415 (468)
T KOG0197|consen  351 RLIGD-DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV---LE-----------  415 (468)
T ss_pred             cccCC-CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH---HH-----------
Confidence            95443 33333333334678999999999999999999999999999999 7777765432222   21           


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                         .++.-..-.-|..|+.++.+|+..||..+|++|||++.+...|+.+..
T Consensus       416 ---~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  416 ---LLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             ---HHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence               112222223445679999999999999999999999999999887644

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-47  Score=375.04  Aligned_cols=258  Identities=31%  Similarity=0.453  Sum_probs=208.1

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC-
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD-  212 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-  212 (490)
                      +|...+.||+|+||.||++.+.+         +|...|||.+........+.+.+|+.+|.+|+|||||+++|...... 
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~---------~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~   88 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKK---------TGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN   88 (313)
T ss_pred             hhhhhccccCccceEEEEEEecC---------CCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC
Confidence            57778999999999999999876         46789999987654333667899999999999999999999754444 


Q ss_pred             -ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-CCCeEEecccCc
Q 011250          213 -QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYNAKLSDFGLA  290 (490)
Q Consensus       213 -~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~-~~~vkL~DFG~a  290 (490)
                       .++|+|||+++|+|.+++.+.+..|++..+..+++||++||.|||+++   ||||||||+||||+. ++.+||+|||++
T Consensus        89 ~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a  165 (313)
T KOG0198|consen   89 DEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLA  165 (313)
T ss_pred             eeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccc
Confidence             689999999999999999877668999999999999999999999988   999999999999999 799999999999


Q ss_pred             ccCCCC-CcceeeeccccCCCccCcchhccC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          291 KDAPED-GKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       291 ~~~~~~-~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ...... ..........||+.|||||++..+ ....++|||||||++.||+||.+||...  ...   ..+..       
T Consensus       166 ~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~---~~~~~-------  233 (313)
T KOG0198|consen  166 KKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEE---AEALL-------  233 (313)
T ss_pred             cccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cch---HHHHH-------
Confidence            876531 111222347899999999999864 3345999999999999999999999753  111   11100       


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                         .+........++...+.++.+|+.+||.+||.+|||+.++|++.--.
T Consensus       234 ---~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~  280 (313)
T KOG0198|consen  234 ---LIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK  280 (313)
T ss_pred             ---HHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence               01101111234444589999999999999999999999999886543

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-47  Score=384.17  Aligned_cols=251  Identities=28%  Similarity=0.372  Sum_probs=209.3

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC----Cc-ccHHHHHHHHHHHhccC-CCCeece
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GL-QGHKEWLAEVNFLGNLL-HPNLVKL  204 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~----~~-~~~~~~~~Ei~il~~l~-HpnIv~l  204 (490)
                      ..+.|.+.+.||+|+||+|++|++..         ++..||||++...    .. ...+.+.+|+.+++.++ ||||+++
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~---------t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l   85 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRL---------TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRL   85 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeecc---------CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEE
Confidence            45689999999999999999999987         6679999987764    11 22345678999999999 9999999


Q ss_pred             eeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-CCeE
Q 011250          205 VGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAK  283 (490)
Q Consensus       205 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~-~~vk  283 (490)
                      ++++.....+|+|||||.||+|++++.+ ..++.+..+..+++||+.||+|||+.+   |+||||||+|||++.+ +++|
T Consensus        86 ~ev~~t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~K  161 (370)
T KOG0583|consen   86 LEVFATPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLK  161 (370)
T ss_pred             EEEEecCCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEE
Confidence            9999999999999999999999999987 668999999999999999999999998   9999999999999999 9999


Q ss_pred             EecccCcccCCCCCcceeeeccccCCCccCcchhccCC-CC-ccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011250          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH-LT-SKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~~-~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~  361 (490)
                      |+|||++.....  ........|||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.....   .+...  
T Consensus       162 l~DFG~s~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~---~l~~k--  234 (370)
T KOG0583|consen  162 LSDFGLSAISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP---NLYRK--  234 (370)
T ss_pred             EeccccccccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH---HHHHH--
Confidence            999999998741  122335589999999999999876 76 7899999999999999999999863211   11111  


Q ss_pred             cccCCcchhhhccCCccCCCCChhh-HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          362 PHLGDKRRFYRLLDPRLEGHFSIKG-SQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       362 ~~~~~~~~~~~~~~~~l~~~~~~~~-~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                       .....            -.++... +.++..|+.+||..||.+|+++.+|+++
T Consensus       235 -i~~~~------------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h  275 (370)
T KOG0583|consen  235 -IRKGE------------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH  275 (370)
T ss_pred             -HhcCC------------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence             11110            1122233 7889999999999999999999999954

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-48  Score=382.70  Aligned_cols=265  Identities=27%  Similarity=0.385  Sum_probs=216.4

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHH--HHHHHHHHhccC-CCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE--WLAEVNFLGNLL-HPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~--~~~Ei~il~~l~-HpnIv~l~~~~~  209 (490)
                      ++|.+++.||.|+||.||+|+...         +|..||||.++..-.. .++  -++|++.|++|+ |||||+|.+++.
T Consensus        10 ~RY~~i~klGDGTfGsV~la~~~~---------~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~   79 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYLAKSKE---------TGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIR   79 (538)
T ss_pred             HHHHHHHHhcCCcceeEEEeeecC---------CCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhh
Confidence            479999999999999999999887         6678999999765332 333  368999999999 999999999999


Q ss_pred             eCC-ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          210 EDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       210 ~~~-~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      +.+ .+|+||||| ..+|+.++..+...|++..++.|+.||++||+|+|.+|   +.||||||+|||+..+..+||+|||
T Consensus        80 d~~~~L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFG  155 (538)
T KOG0661|consen   80 DNDRILYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFG  155 (538)
T ss_pred             ccCceEeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccc
Confidence            988 999999999 45999999988899999999999999999999999999   9999999999999989999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhc-cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh--hcc--
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA--RPH--  363 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~--~~~--  363 (490)
                      +||.......   .+..+-|..|.|||++. .+.|+.++|+||+|||++|+.+-++.|.+..+.++...+-..  .+.  
T Consensus       156 LARev~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~  232 (538)
T KOG0661|consen  156 LAREVRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKD  232 (538)
T ss_pred             cccccccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccc
Confidence            9998765432   35578899999999876 578999999999999999999999999987665543322111  111  


Q ss_pred             -cCCcchhhhccCCcc--------CCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          364 -LGDKRRFYRLLDPRL--------EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       364 -~~~~~~~~~~~~~~l--------~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                       +.+...+...++-.+        ..-++ .++.++.+||.+||..||.+|||+.++|++-
T Consensus       233 ~~~eg~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  233 SWPEGYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             cchhHHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence             111112222222221        11222 3688999999999999999999999999864

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-47  Score=377.70  Aligned_cols=269  Identities=26%  Similarity=0.345  Sum_probs=215.6

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      ..+.|+.++.||+|.||.||+|++..         +|+.||+|++..+..  ....-..+||.||++|.||||++|.+..
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~---------tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eiv  185 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLE---------TGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIV  185 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecc---------cCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEE
Confidence            34568889999999999999999987         788999999987753  3345678999999999999999999998


Q ss_pred             EeC--CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEec
Q 011250          209 IED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       209 ~~~--~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~D  286 (490)
                      .+.  ..+|||+|||+. +|.-++...+..|++.++..|+.||+.||.|||.++   |+|||||.+|||||.+|.+||+|
T Consensus       186 t~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaD  261 (560)
T KOG0600|consen  186 TSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIAD  261 (560)
T ss_pred             EecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEecc
Confidence            876  689999999965 999998777788999999999999999999999988   99999999999999999999999


Q ss_pred             ccCcccCCCCCcceeeeccccCCCccCcchhccC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--cc
Q 011250          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--PH  363 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~--~~  363 (490)
                      ||||+.+....... .+..+-|..|.|||+|.+. .|+.++|+||+||||.||++|++.|.+....+....+-..-  +.
T Consensus       262 FGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~  340 (560)
T KOG0600|consen  262 FGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPT  340 (560)
T ss_pred             ccceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCC
Confidence            99999776544332 3556789999999999864 89999999999999999999999998876655443332110  10


Q ss_pred             cCCcc--hh--hhccCC------ccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          364 LGDKR--RF--YRLLDP------RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       364 ~~~~~--~~--~~~~~~------~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ...+.  .+  ...+.+      .+.+. -...+..+.+|+..+|..||.+|.|+.++|+.
T Consensus       341 e~~W~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  341 EDYWPVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             hhccccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            00000  00  111111      11111 11226788999999999999999999999864

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-47  Score=385.11  Aligned_cols=251  Identities=26%  Similarity=0.388  Sum_probs=215.7

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      ..|.....||+|+.|.||.|....         ++..||||.+........+-+++|+.+|+.++|+|||.+++.|...+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~---------~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d  343 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKIS---------TKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGD  343 (550)
T ss_pred             hhhcchhhhccccccceeeeeecc---------CCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccc
Confidence            468888999999999999998876         67789999998887666677899999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      .+|+|||||+||+|.+.+...  .+++.++..|++++++||+|||.++   |||||||.+|||++.+|.+||+|||++..
T Consensus       344 eLWVVMEym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaq  418 (550)
T KOG0578|consen  344 ELWVVMEYMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQ  418 (550)
T ss_pred             eeEEEEeecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeec
Confidence            999999999999999988543  5999999999999999999999998   99999999999999999999999999998


Q ss_pred             CCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhh
Q 011250          293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR  372 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (490)
                      +.....  ....++||++|||||++....|+.++||||||++++||+.|.+||-...+.....++.    ..        
T Consensus       419 i~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa----~n--------  484 (550)
T KOG0578|consen  419 ISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA----TN--------  484 (550)
T ss_pred             cccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh----hc--------
Confidence            865433  3356899999999999999999999999999999999999999996543332222211    00        


Q ss_pred             ccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       373 ~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                         ....-..+...+..+.+|+.+||+.|+.+|+++.|+|+|
T Consensus       485 ---g~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  485 ---GTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             ---CCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence               111122334458999999999999999999999999986

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.1e-46  Score=346.39  Aligned_cols=266  Identities=27%  Similarity=0.413  Sum_probs=214.8

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc--HHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .+|..++.||+|.||+||+|++..         +|+.||||+++.....+  ....++||+.|+.++|+||+.++++|-+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~---------t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~   72 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTE---------TGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH   72 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecC---------CCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC
Confidence            368888999999999999999877         78899999998764332  2457899999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      .+.+.||+||++ .+|+..|..+...++..++..++.++++||+|||.+.   |+||||||.|+||+.+|.+||+|||+|
T Consensus        73 ~~~l~lVfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLA  148 (318)
T KOG0659|consen   73 KSNLSLVFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLA  148 (318)
T ss_pred             CCceEEEEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccch
Confidence            999999999995 5999999888889999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh--------h
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA--------R  361 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~--------~  361 (490)
                      +.+.......  +..+-|..|.|||++.+ ..|+..+|+||.|||+.||+.|.+-|.+....+....+-.+        +
T Consensus       149 r~f~~p~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~W  226 (318)
T KOG0659|consen  149 RFFGSPNRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQW  226 (318)
T ss_pred             hccCCCCccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccC
Confidence            9887554332  22367999999999886 47999999999999999999999988876544333222110        1


Q ss_pred             cccC---CcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          362 PHLG---DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       362 ~~~~---~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      +.+.   +-..+.....+.+..-| ..++.++.+|+.+||..||.+|+++.|++++
T Consensus       227 P~~~~lpdY~~~~~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  227 PEMTSLPDYVKIQQFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             ccccccccHHHHhcCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            1111   11111111222222222 3446777999999999999999999999865

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=5.3e-47  Score=378.54  Aligned_cols=256  Identities=26%  Similarity=0.365  Sum_probs=210.2

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhccCCCCeeceee
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVG  206 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~  206 (490)
                      ...++|+++..||+|+||.||+|+-+.         ||..+|+|++++....   ..+.++.|-.||....+|.||+||.
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~---------Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyY  208 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKD---------TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYY  208 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEcc---------CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEE
Confidence            445799999999999999999999887         7889999999987543   3456788999999999999999999


Q ss_pred             EEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEec
Q 011250          207 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~D  286 (490)
                      .|++.+.+||||||++||++..+|.+. ..|++..+..++.+++.|+..||..|   ||||||||+|+|||..|++||+|
T Consensus       209 sFQD~~~LYLiMEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSD  284 (550)
T KOG0605|consen  209 SFQDKEYLYLIMEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSD  284 (550)
T ss_pred             EecCCCeeEEEEEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeecc
Confidence            999999999999999999999999655 48999999999999999999999999   99999999999999999999999


Q ss_pred             ccCcccCCCC-----------------------Cc-----ce-----------------eeeccccCCCccCcchhccCC
Q 011250          287 FGLAKDAPED-----------------------GK-----TH-----------------VSTRVMGTYGYAAPEYVMTGH  321 (490)
Q Consensus       287 FG~a~~~~~~-----------------------~~-----~~-----------------~~~~~~Gt~~y~aPE~l~~~~  321 (490)
                      |||+.-+...                       ..     ..                 .....+|||.|||||++.+..
T Consensus       285 FGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg  364 (550)
T KOG0605|consen  285 FGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG  364 (550)
T ss_pred             ccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC
Confidence            9998532110                       00     00                 011258999999999999999


Q ss_pred             CCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchh-hHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhc
Q 011250          322 LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL-VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSR  400 (490)
Q Consensus       322 ~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~  400 (490)
                      |+..+|+|||||||||||.|.+||....+.....- +.|. ..+.              -.-...++.++.+||.+||. 
T Consensus       365 Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr-~~l~--------------fP~~~~~s~eA~DLI~rll~-  428 (550)
T KOG0605|consen  365 YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWR-ETLK--------------FPEEVDLSDEAKDLITRLLC-  428 (550)
T ss_pred             CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-hhcc--------------CCCcCcccHHHHHHHHHHhc-
Confidence            99999999999999999999999987766543222 2221 1111              00112236899999999999 


Q ss_pred             CCCCCCC---HHHHHHH
Q 011250          401 DPKARPR---MSEVVET  414 (490)
Q Consensus       401 dP~~RPt---~~evl~~  414 (490)
                      ||.+|.-   +.||-+|
T Consensus       429 d~~~RLG~~G~~EIK~H  445 (550)
T KOG0605|consen  429 DPENRLGSKGAEEIKKH  445 (550)
T ss_pred             CHHHhcCcccHHHHhcC
Confidence            9999965   6666654

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-47  Score=386.38  Aligned_cols=248  Identities=28%  Similarity=0.395  Sum_probs=210.9

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cc--cHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      -|++++.||.|+-|.|-+|++..         ||+.+|||++.+.. ..  ....+.+||.||+.|.||||+.+|++|++
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~---------TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~   83 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAE---------TGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN   83 (786)
T ss_pred             ceeccccccCCCCceehhhhccc---------ccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc
Confidence            48899999999999999999987         89999999997762 21  23457899999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      ..++|||.||++||.|++++.+++ ++++.++.++++||+.|+.|||..+   ||||||||+|+|||..+++||+|||+|
T Consensus        84 ~~~lylvlEyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMA  159 (786)
T KOG0588|consen   84 KQHLYLVLEYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMA  159 (786)
T ss_pred             CceEEEEEEecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeecccee
Confidence            999999999999999999997765 7999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCC-ccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLT-SKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~-~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      .....+..   -.+.||++.|.|||++.+..|+ .++||||+|||||.||+|+.||++...   ..+.......      
T Consensus       160 sLe~~gkl---LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi---r~LLlKV~~G------  227 (786)
T KOG0588|consen  160 SLEVPGKL---LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI---RVLLLKVQRG------  227 (786)
T ss_pred             ecccCCcc---ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH---HHHHHHHHcC------
Confidence            87655432   3457999999999999998875 689999999999999999999985421   1121111110      


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                               .-+.|...+.++++||.+||..||.+|.|+.||++|-
T Consensus       228 ---------~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  228 ---------VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             ---------cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence                     0012234488999999999999999999999999974

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-46  Score=366.31  Aligned_cols=263  Identities=28%  Similarity=0.397  Sum_probs=214.4

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccH-HHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ..+|++...||.|.-++||+|+...         ++..||||+++.+..... +.+.+|+..|+.++||||++++..|..
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p---------~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv   95 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIP---------TNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV   95 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecc---------cCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe
Confidence            3579999999999999999999876         667999999988765544 789999999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +..+|+||.||.+|++.+++... ...+++..+..|++++++||.|||.+|   .||||||+.||||+.+|.|||+|||.
T Consensus        96 ~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgv  172 (516)
T KOG0582|consen   96 DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGV  172 (516)
T ss_pred             cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCcee
Confidence            99999999999999999998653 345999999999999999999999999   99999999999999999999999999


Q ss_pred             cccCCCCCcceee--eccccCCCccCcchhcc--CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011250          290 AKDAPEDGKTHVS--TRVMGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       290 a~~~~~~~~~~~~--~~~~Gt~~y~aPE~l~~--~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      +..+...+.....  ..++||++|||||+++.  ..|+.|+|||||||+..||.+|..||....+.....+.-...+.. 
T Consensus       173 sa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~-  251 (516)
T KOG0582|consen  173 SASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPT-  251 (516)
T ss_pred             eeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCC-
Confidence            8776554422211  45799999999999653  579999999999999999999999998776543322211111110 


Q ss_pred             CcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                             .....+..+-....+..+..+|..||.+||.+|||+++++++
T Consensus       252 -------~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  252 -------LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             -------cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence                   000011111112235689999999999999999999999974

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=5.3e-47  Score=378.44  Aligned_cols=248  Identities=29%  Similarity=0.404  Sum_probs=213.6

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ++|.+.+.||+|+||+||+|+.+.         +.+.||||.+.+...  .+.+.+.+|++|++.|+|||||.++++|+.
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~---------t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt   72 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKY---------TIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET   72 (808)
T ss_pred             cchhHHHHhcCCccceeeeccccc---------ceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc
Confidence            468899999999999999998876         778999999976643  345678999999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      ..++|+|.|||.| +|..+|.. ...++++.+..|+.+++.||.|||+++   |+|||+||.||||+.+|.+|+||||+|
T Consensus        73 ~~~~~vVte~a~g-~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~A  147 (808)
T KOG0597|consen   73 SAHLWVVTEYAVG-DLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLA  147 (808)
T ss_pred             cceEEEEehhhhh-hHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhh
Confidence            9999999999966 99999854 457999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      +.+..  .+.+.+.+.|||.|||||++.+..|+..+|+||||||||||++|++||....   ...++   ...+.+.   
T Consensus       148 r~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s---i~~Lv---~~I~~d~---  216 (808)
T KOG0597|consen  148 RAMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS---ITQLV---KSILKDP---  216 (808)
T ss_pred             hhccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH---HHHHH---HHHhcCC---
Confidence            98755  4566678899999999999999999999999999999999999999995431   11122   1111111   


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                               ..++.+.+..+..|+..+|.+||..|.+..+++.|
T Consensus       217 ---------v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  217 ---------VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             ---------CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence                     12334568899999999999999999999999875

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-47  Score=373.04  Aligned_cols=249  Identities=28%  Similarity=0.442  Sum_probs=216.0

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      .|...++||+|+||.||+|.+..         +++.||||++..+... ..+++.+|+.+|..++++||.++|+.|..+.
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~---------t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~   84 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNK---------TKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT   84 (467)
T ss_pred             ccccchhccccccceeeeeeecc---------ccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecc
Confidence            47778999999999999999887         7889999999877543 4577889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      .++++||||.||++.++| +.+..+.+..+..++++++.||.|||.++   .+|||||+.|||+..+|.+||+|||.+..
T Consensus        85 ~LwiiMey~~gGsv~~lL-~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~q  160 (467)
T KOG0201|consen   85 KLWIIMEYCGGGSVLDLL-KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQ  160 (467)
T ss_pred             cHHHHHHHhcCcchhhhh-ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeee
Confidence            999999999999999998 44445688888999999999999999988   99999999999999999999999999988


Q ss_pred             CCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhh
Q 011250          293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR  372 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (490)
                      ........  .+++||+.|||||++....|+.|+||||||++.|||++|.+|+....+.....++             .+
T Consensus       161 l~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI-------------pk  225 (467)
T KOG0201|consen  161 LTNTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI-------------PK  225 (467)
T ss_pred             eechhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec-------------cC
Confidence            76643332  5689999999999999889999999999999999999999999877664332221             22


Q ss_pred             ccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       373 ~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      -..|.+.+.|    +..+++|+..||.+||+.||++.++|++
T Consensus       226 ~~PP~L~~~~----S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  226 SAPPRLDGDF----SPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             CCCCcccccc----CHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            3345555544    7889999999999999999999999975

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-46  Score=382.54  Aligned_cols=246  Identities=28%  Similarity=0.434  Sum_probs=209.6

Q ss_pred             HHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccC-CCCeece
Q 011250          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLL-HPNLVKL  204 (490)
Q Consensus       129 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~-HpnIv~l  204 (490)
                      .+..++|.++++||+|+||+|+++..+.         +++.+|||+++++..   .+.+..+.|.+|+.... ||.++.+
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~---------~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L  434 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKG---------TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNL  434 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcC---------CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeec
Confidence            4455789999999999999999999986         677999999998854   33466788999988876 9999999


Q ss_pred             eeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 011250          205 VGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       205 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL  284 (490)
                      +.+|+..+++|+||||+.||++..++  +...|++..+..|+..|+.||+|||+++   |||||||.+|||||.+|.+||
T Consensus       435 ~~~fQT~~~l~fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~ki  509 (694)
T KOG0694|consen  435 FSCFQTKEHLFFVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKI  509 (694)
T ss_pred             ccccccCCeEEEEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEe
Confidence            99999999999999999999955433  4457999999999999999999999999   999999999999999999999


Q ss_pred             ecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc
Q 011250          285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      +|||+++.....+.  ...++|||+.|||||++.+..|+.++|+|||||+|||||.|..||.+..+.+..+.+      +
T Consensus       510 ADFGlcKe~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI------~  581 (694)
T KOG0694|consen  510 ADFGLCKEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI------V  581 (694)
T ss_pred             cccccccccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH------h
Confidence            99999997653333  346699999999999999999999999999999999999999999876433221111      1


Q ss_pred             CCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCH
Q 011250          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM  408 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~  408 (490)
                      .+            ...||...+.++..|++++|.+||.+|.-+
T Consensus       582 ~d------------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  582 ND------------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             cC------------CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            11            224556669999999999999999999765

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.5e-45  Score=372.11  Aligned_cols=266  Identities=29%  Similarity=0.431  Sum_probs=207.4

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcc-CCCCeeceeeEE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKLVGYC  208 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~  208 (490)
                      ..++|++.+.||+|+||.||+|.+....    ...++..||||++..... ...+.+.+|+.+|..+ +||||+++++++
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGID----KKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGAC   80 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccC----CcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence            4567999999999999999999864211    112456899999875432 3345789999999999 899999999988


Q ss_pred             EeC-CceEEEEEecCCCChhHHhhhcC-----------------------------------------------------
Q 011250          209 IED-DQRLLVYEFMPRGSLENHLFRRS-----------------------------------------------------  234 (490)
Q Consensus       209 ~~~-~~~~lV~E~~~~gsL~~~l~~~~-----------------------------------------------------  234 (490)
                      ... ..+++||||+++|+|.+++....                                                     
T Consensus        81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (338)
T cd05102          81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP  160 (338)
T ss_pred             cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence            765 45889999999999999986421                                                     


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCCCcceeeeccc
Q 011250          235 --------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM  306 (490)
Q Consensus       235 --------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~  306 (490)
                              ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...............
T Consensus       161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~  237 (338)
T cd05102         161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR  237 (338)
T ss_pred             hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCC
Confidence                    24778889999999999999999988   9999999999999999999999999998654332222222345


Q ss_pred             cCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChh
Q 011250          307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIK  385 (490)
Q Consensus       307 Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  385 (490)
                      ++..|+|||++.+..++.++|||||||+||||++ |..||.......  .+....    ....          ....+..
T Consensus       238 ~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~~~~----~~~~----------~~~~~~~  301 (338)
T cd05102         238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFCQRL----KDGT----------RMRAPEN  301 (338)
T ss_pred             CCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHHHHH----hcCC----------CCCCCCC
Confidence            6789999999998999999999999999999997 999997543211  111110    0000          0011223


Q ss_pred             hHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011250          386 GSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       386 ~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~  419 (490)
                      .+..+.+|+.+||+.||.+|||+.+|++.|+.+.
T Consensus       302 ~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         302 ATPEIYRIMLACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            4678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-46  Score=340.19  Aligned_cols=250  Identities=27%  Similarity=0.407  Sum_probs=213.4

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      .++|++++.||+|.||.||+|+.+.         ++..||+|++.+...   +...++.+|++|-..|+||||+++|++|
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekk---------s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f   91 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKK---------SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF   91 (281)
T ss_pred             hhhccccccccCCccccEeEeeecc---------CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe
Confidence            3579999999999999999999987         667999999977643   2346789999999999999999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhh-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DF  287 (490)
                      .++...||++||..+|+|+..|.. ....+++.....++.|++.||.|+|..+   ||||||||+|+|++..+.+||+||
T Consensus        92 hd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdf  168 (281)
T KOG0580|consen   92 HDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADF  168 (281)
T ss_pred             eccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCC
Confidence            999999999999999999999963 3456999999999999999999999977   999999999999999999999999


Q ss_pred             cCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011250          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      |.+...+..    .....|||..|.+||.+.+..++..+|+|++|++.||++.|.+||..........-           
T Consensus       169 GwsV~~p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkr-----------  233 (281)
T KOG0580|consen  169 GWSVHAPSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKR-----------  233 (281)
T ss_pred             CceeecCCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHH-----------
Confidence            999876532    22458999999999999999999999999999999999999999976542111111           


Q ss_pred             chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                           +..  +.-.++...+..+.+||.+||..+|.+|....|++++-
T Consensus       234 -----I~k--~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp  274 (281)
T KOG0580|consen  234 -----IRK--VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHP  274 (281)
T ss_pred             -----HHH--ccccCCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence                 110  11123344588999999999999999999999999874

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.3e-45  Score=354.41  Aligned_cols=259  Identities=28%  Similarity=0.351  Sum_probs=211.4

Q ss_pred             HHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccH---HHHHHHHHHHhccCCCCeece
Q 011250          128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGNLLHPNLVKL  204 (490)
Q Consensus       128 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~Ei~il~~l~HpnIv~l  204 (490)
                      ..+..++|++++.||.|.-|+||++.+..         ++..+|+|++.+......   .+...|-+||+.++||.++.|
T Consensus        72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~---------t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTL  142 (459)
T KOG0610|consen   72 GSLGLRHFRLLKRLGCGDIGTVYLVELRG---------TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTL  142 (459)
T ss_pred             CccCHHHHHHHHHcCCCCceeEEEEEecC---------CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchh
Confidence            34455678999999999999999999986         567899999988765543   456779999999999999999


Q ss_pred             eeEEEeCCceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeE
Q 011250          205 VGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       205 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vk  283 (490)
                      |+.|+.+...|||||||+||+|..+++++ +..|++..++.++.+|+-||+|||-.|   ||+|||||+||||.++|++.
T Consensus       143 Ya~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIM  219 (459)
T KOG0610|consen  143 YASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIM  219 (459)
T ss_pred             hheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEE
Confidence            99999999999999999999999988764 467999999999999999999999999   99999999999999999999


Q ss_pred             EecccCcccCCC---------------------------------CCcc---------------------eeeeccccCC
Q 011250          284 LSDFGLAKDAPE---------------------------------DGKT---------------------HVSTRVMGTY  309 (490)
Q Consensus       284 L~DFG~a~~~~~---------------------------------~~~~---------------------~~~~~~~Gt~  309 (490)
                      |+||.|+..+..                                 ....                     .....++||-
T Consensus       220 LsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGTh  299 (459)
T KOG0610|consen  220 LSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTH  299 (459)
T ss_pred             eeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccc
Confidence            999999754311                                 0000                     0112368999


Q ss_pred             CccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHH
Q 011250          310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQK  389 (490)
Q Consensus       310 ~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  389 (490)
                      .|+|||++.+...+.++|+|+|||+|||||.|..||.+......                +..++-..+.-......+..
T Consensus       300 EYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T----------------l~NIv~~~l~Fp~~~~vs~~  363 (459)
T KOG0610|consen  300 EYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET----------------LRNIVGQPLKFPEEPEVSSA  363 (459)
T ss_pred             ccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh----------------HHHHhcCCCcCCCCCcchhH
Confidence            99999999999999999999999999999999999987543321                11111111111111244789


Q ss_pred             HHHHHHHhhhcCCCCCCC----HHHHHHH
Q 011250          390 ATQLAAQCLSRDPKARPR----MSEVVET  414 (490)
Q Consensus       390 l~~Li~~cL~~dP~~RPt----~~evl~~  414 (490)
                      +.+||+++|.+||.+|.-    +.||-+|
T Consensus       364 akDLIr~LLvKdP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  364 AKDLIRKLLVKDPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             HHHHHHHHhccChhhhhccccchHHhhcC
Confidence            999999999999999998    7777654

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.3e-46  Score=360.87  Aligned_cols=248  Identities=23%  Similarity=0.376  Sum_probs=212.0

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHH---HHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      .+|++.+.||+|.||.|-+|+...         .|+.||||.|+++...+..   .+.+||+||..|+||||+.+|++|+
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~---------sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFE  123 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHK---------SGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFE  123 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhcc---------CCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhc
Confidence            468899999999999999998765         7889999999988665544   4678999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      ..+.++|||||..+|.|++++.+++ .|++.++..+++||..|+.|+|.++   ++|||||.+|||||.|+++||+|||+
T Consensus       124 NkdKIvivMEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGL  199 (668)
T KOG0611|consen  124 NKDKIVIVMEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGL  199 (668)
T ss_pred             CCceEEEEEEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccch
Confidence            9999999999999999999996654 7999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCC-ccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLT-SKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~-~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +..+....   ..+.+||++.|.+||++++..|. +.+|.|||||+||.|+.|..||++...   ..++..+...     
T Consensus       200 SNly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k~lvrQIs~G-----  268 (668)
T KOG0611|consen  200 SNLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---KRLVRQISRG-----  268 (668)
T ss_pred             hhhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---HHHHHHhhcc-----
Confidence            98775543   33569999999999999998875 789999999999999999999987532   2222221110     


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                                 ..+.+.-+..+.-||++||..||++|.|+.+|..|-
T Consensus       269 -----------aYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  269 -----------AYREPETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             -----------cccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence                       001112256788999999999999999999998875

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-45  Score=361.08  Aligned_cols=263  Identities=26%  Similarity=0.361  Sum_probs=208.8

Q ss_pred             HHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--------------cHHHHHHHHHHH
Q 011250          128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--------------GHKEWLAEVNFL  193 (490)
Q Consensus       128 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------------~~~~~~~Ei~il  193 (490)
                      .....+.|++++.||+|.||.|-+|++..         +++.||||++.+....              ..+.+.+||.||
T Consensus        92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~---------~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIail  162 (576)
T KOG0585|consen   92 DRKQLNQYELIKEIGSGQYGKVKLARDEV---------DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAIL  162 (576)
T ss_pred             cceehhheehhhhhcCCccceEEEEeecC---------CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHH
Confidence            34455789999999999999999999987         6779999999754321              235788999999


Q ss_pred             hccCCCCeeceeeEEEeC--CceEEEEEecCCCChhHHhhhcCCC-CCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 011250          194 GNLLHPNLVKLVGYCIED--DQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFK  270 (490)
Q Consensus       194 ~~l~HpnIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~-l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlk  270 (490)
                      ++|+|||||+|+++..+.  +.+|||+|||..|.+...  ....+ +++.++++|+++++.||+|||.++   |||||||
T Consensus       163 Kkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~--p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIK  237 (576)
T KOG0585|consen  163 KKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC--PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIK  237 (576)
T ss_pred             HhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccC--CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccc
Confidence            999999999999998764  579999999999987543  23334 999999999999999999999999   9999999


Q ss_pred             CCcEEEcCCCCeEEecccCcccCCCC---CcceeeeccccCCCccCcchhccCC----CCccchhhHHHHHHHHHHhCCC
Q 011250          271 TSNILLDADYNAKLSDFGLAKDAPED---GKTHVSTRVMGTYGYAAPEYVMTGH----LTSKSDVYSFGVVLLEMLTGRR  343 (490)
Q Consensus       271 p~NILl~~~~~vkL~DFG~a~~~~~~---~~~~~~~~~~Gt~~y~aPE~l~~~~----~~~~sDvwSlGv~l~elltG~~  343 (490)
                      |+|+||+++|+|||+|||.+......   +......+.+|||.|||||.+.++.    .+.+.||||+||+||.|+.|+.
T Consensus       238 PsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~  317 (576)
T KOG0585|consen  238 PSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQL  317 (576)
T ss_pred             hhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccC
Confidence            99999999999999999999866322   1111223478999999999988632    3568999999999999999999


Q ss_pred             CCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          344 SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       344 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                      ||-.......                +..+.+..+.-....+....+.+||.+||.+||..|.++.+|..|..-...
T Consensus       318 PF~~~~~~~l----------------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  318 PFFDDFELEL----------------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             CcccchHHHH----------------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            9965422111                112222222222223447889999999999999999999999988865444

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-46  Score=373.85  Aligned_cols=267  Identities=26%  Similarity=0.449  Sum_probs=217.7

Q ss_pred             hhhHHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhccCCCCee
Q 011250          125 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLV  202 (490)
Q Consensus       125 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~Ei~il~~l~HpnIv  202 (490)
                      ..++.+..+.+.+...||+|.||+||+|.|..            .||||+++.+...  ..+.|.+|+.++++-+|.||+
T Consensus       384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG------------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIl  451 (678)
T KOG0193|consen  384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG------------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENIL  451 (678)
T ss_pred             ccccccCHHHhhccceeccccccceeeccccc------------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhhe
Confidence            35666777788889999999999999999976            5999999877543  457899999999999999999


Q ss_pred             ceeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCe
Q 011250          203 KLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       203 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~v  282 (490)
                      -++|||..... .||+.+|+|-+|+.+|+.....|.....+.|++||++|+.|||.++   |||||||..||+|.++++|
T Consensus       452 LFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kV  527 (678)
T KOG0193|consen  452 LFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKV  527 (678)
T ss_pred             eeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcE
Confidence            99999988776 9999999999999999887788999999999999999999999988   9999999999999999999


Q ss_pred             EEecccCcccCCCCCcceeeeccccCCCccCcchhcc---CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 011250          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW  359 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~---~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~  359 (490)
                      ||+|||++................|...|||||+++.   ..|+..+||||||||+|||++|..||........  +  |
T Consensus       528 kIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI--i--f  603 (678)
T KOG0193|consen  528 KIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI--I--F  603 (678)
T ss_pred             EEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe--E--E
Confidence            9999999975443322222234568899999999974   4789999999999999999999999973322111  1  1


Q ss_pred             hhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                      .   .+...     +.+.+ .....+++.++++|+..||..++++||.+.+|+..|+.+..
T Consensus       604 m---VGrG~-----l~pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  604 M---VGRGY-----LMPDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             E---ecccc-----cCccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            1   11110     00111 11223568899999999999999999999999998887655

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-45  Score=353.95  Aligned_cols=280  Identities=27%  Similarity=0.367  Sum_probs=220.1

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEec--CCCcccHHHHHHHHHHHhccCCCCeeceeeE
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  207 (490)
                      .....|...+.||+|+||.|..|.+..         +|..||||++.  .......++.++|+++|+.++|+||+.++++
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~---------t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di   89 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKR---------TGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDI   89 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcC---------CCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEee
Confidence            344567778999999999999999887         67899999997  4455566889999999999999999999998


Q ss_pred             EEe-----CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCe
Q 011250          208 CIE-----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       208 ~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~v  282 (490)
                      +..     -..+|+|+|+| +.+|...| +.+..|+...+..++.||+.||.|+|+.+   |+||||||+|+|++.+..+
T Consensus        90 ~~p~~~~~f~DvYiV~elM-etDL~~ii-k~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~l  164 (359)
T KOG0660|consen   90 FRPPSRDKFNDVYLVFELM-ETDLHQII-KSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDL  164 (359)
T ss_pred             cccccccccceeEEehhHH-hhHHHHHH-HcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCE
Confidence            875     24689999999 67898887 44556999999999999999999999999   9999999999999999999


Q ss_pred             EEecccCcccCCCCCcceeeeccccCCCccCcchhc-cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011250          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~  361 (490)
                      ||||||+|+...........+..+-|..|.|||++. ...|+.+.||||+||||.|||+|++.|.+........++....
T Consensus       165 KI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~l  244 (359)
T KOG0660|consen  165 KICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELL  244 (359)
T ss_pred             EeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhc
Confidence            999999999886543334446678899999999876 4689999999999999999999999998876554444332221


Q ss_pred             cccCC----------cchhhhccCCc----cCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH--hhcCcccccc
Q 011250          362 PHLGD----------KRRFYRLLDPR----LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPLQNLKDM  424 (490)
Q Consensus       362 ~~~~~----------~~~~~~~~~~~----l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~--L~~l~~~~~~  424 (490)
                      ..-.+          .+.+..-+...    +...|+ ..++.+.+|+.+||..||.+|+|++|+|+|  |..+.+..+-
T Consensus       245 GtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dE  322 (359)
T KOG0660|consen  245 GTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDE  322 (359)
T ss_pred             CCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccC
Confidence            11100          00011111111    111122 447899999999999999999999999986  4555554443

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.9e-45  Score=347.79  Aligned_cols=267  Identities=24%  Similarity=0.324  Sum_probs=213.8

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc--HHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ++|+.+..|++|+||+||+|+++.         +++.||+|+++.+....  --..++||.+|.+++|||||.+..+...
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~---------t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG  146 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKK---------TDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVG  146 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCC---------cceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEec
Confidence            358888999999999999999887         77799999998664211  1235799999999999999999998764


Q ss_pred             C--CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          211 D--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       211 ~--~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      .  +.+|||||||+. +|..++.....+|...++..++.|+++||+|||.+.   |+|||||++|+|++..|.+||+|||
T Consensus       147 ~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFG  222 (419)
T KOG0663|consen  147 SNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFG  222 (419)
T ss_pred             cccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccc
Confidence            3  579999999965 999999888889999999999999999999999999   9999999999999999999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh-------
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-------  360 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~-------  360 (490)
                      +||.+....  ...+..+-|..|.|||++.+ ..|+.++|+||+|||+.||+++++.|.+....+..+.+-..       
T Consensus       223 LAR~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~  300 (419)
T KOG0663|consen  223 LAREYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEA  300 (419)
T ss_pred             hhhhhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccc
Confidence            999887652  23456788999999999886 47999999999999999999999999887665544332111       


Q ss_pred             -hcccCCc-----chhhhccCCccCCCCChh-hHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          361 -RPHLGDK-----RRFYRLLDPRLEGHFSIK-GSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       361 -~~~~~~~-----~~~~~~~~~~l~~~~~~~-~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                       ++.+...     ..+....-..+...|... .++...+|+..+|..||.+|.|+++.|++
T Consensus       301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             cCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence             1111110     011111112233334333 46889999999999999999999999865

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4.5e-44  Score=355.87  Aligned_cols=273  Identities=28%  Similarity=0.444  Sum_probs=209.9

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCc-------cccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeec
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTA-------PVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVK  203 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~-------~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~  203 (490)
                      .++|++.+.||+|+||.||+|.+......       ....+++..||+|.+..... ....++.+|+.+|..++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            35799999999999999999987543211       12234566899999876532 23457899999999999999999


Q ss_pred             eeeEEEeCCceEEEEEecCCCChhHHhhhcC------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 011250          204 LVGYCIEDDQRLLVYEFMPRGSLENHLFRRS------------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVI  265 (490)
Q Consensus       204 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~------------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ii  265 (490)
                      +++++.+.+..+|||||+++|+|.+++....                  ..+++..++.++.||+.||.|||+.+   |+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence            9999999999999999999999999885421                  24678889999999999999999988   99


Q ss_pred             ecCCCCCcEEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh--CCC
Q 011250          266 YRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT--GRR  343 (490)
Q Consensus       266 HrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt--G~~  343 (490)
                      ||||||+|||++.++.+||+|||+++...............++..|+|||++....++.++|||||||++|||++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            999999999999999999999999987654433333334556889999999988899999999999999999987  456


Q ss_pred             CCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011250          344 SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  417 (490)
Q Consensus       344 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~  417 (490)
                      ||......   .............       ........+..++..+.+|+.+||..||.+|||+.+|.+.|++
T Consensus       241 p~~~~~~~---~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         241 PYGELTDE---QVIENAGEFFRDQ-------GRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCcCCHH---HHHHHHHHHhhhc-------cccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            66543221   1111111100000       0000111123447889999999999999999999999988863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-45  Score=359.20  Aligned_cols=246  Identities=25%  Similarity=0.333  Sum_probs=204.1

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|++.+.||+|+||.||+|.+..         ++..||||++.....   ...+.+.+|+.+++.++||||+++++++.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   71 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRI---------SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH   71 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcC---------CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc
Confidence            368999999999999999999876         567899999865432   23456788999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +++..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~  147 (291)
T cd05612          72 DQRFLYMLMEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGF  147 (291)
T ss_pred             cCCeEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCc
Confidence            999999999999999999998654 47899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      ++......     ...+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   .....   ....  
T Consensus       148 ~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~---~~~~i---~~~~--  214 (291)
T cd05612         148 AKKLRDRT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG---IYEKI---LAGK--  214 (291)
T ss_pred             chhccCCc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH---HhCC--
Confidence            98764321     23579999999999998899999999999999999999999997543211   11110   0000  


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt-----~~evl~~  414 (490)
                                ..++...+..+.+||.+||+.||.+||+     +++++++
T Consensus       215 ----------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         215 ----------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             ----------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence                      0122223678999999999999999995     8888865

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.9e-44  Score=354.17  Aligned_cols=251  Identities=29%  Similarity=0.407  Sum_probs=204.7

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      |++.+.||+|+||.||+|.+..         ++..||+|.+.....   .....+.+|+.++..++|+||+++++++.++
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~   72 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK   72 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEec---------CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC
Confidence            7788999999999999999876         577899999875432   2234578899999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      +..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.++|+|||++
T Consensus        73 ~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~  149 (285)
T cd05631          73 DALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLA  149 (285)
T ss_pred             CeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCc
Confidence            9999999999999998887543 346899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ........   .....||..|+|||++.+..++.++|||||||+||||++|+.||..............   ..      
T Consensus       150 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~---~~------  217 (285)
T cd05631         150 VQIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR---RV------  217 (285)
T ss_pred             EEcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHH---Hh------
Confidence            87543221   2345799999999999999999999999999999999999999976543221111100   00      


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  414 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt-----~~evl~~  414 (490)
                         ..  ....++...+.++.+|+.+||+.||.+||+     +++++++
T Consensus       218 ---~~--~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         218 ---KE--DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             ---hc--ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence               00  011223334788999999999999999997     7888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1e-44  Score=365.06  Aligned_cols=246  Identities=27%  Similarity=0.388  Sum_probs=204.4

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      .+|++.+.||+|+||.||+|++..         ++..||||++.....   ...+.+.+|+.++..++||||+++++++.
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   88 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKG---------TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ   88 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            468999999999999999999876         567899999875422   23456889999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +++..|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus        89 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~  164 (329)
T PTZ00263         89 DENRVYFLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGF  164 (329)
T ss_pred             cCCEEEEEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccC
Confidence            999999999999999999998654 47899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      ++......     ...+||+.|+|||++.+..++.++|||||||++|||++|..||......   ...+..   .     
T Consensus       165 ~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~i---~-----  228 (329)
T PTZ00263        165 AKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF---RIYEKI---L-----  228 (329)
T ss_pred             ceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH---HHHHHH---h-----
Confidence            98764322     2357999999999999989999999999999999999999999653221   111110   0     


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt-----~~evl~~  414 (490)
                           ...  ..++...+..+.+||.+||+.||.+||+     +.++++|
T Consensus       229 -----~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        229 -----AGR--LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             -----cCC--cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                 000  0112223678899999999999999986     6888766

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.8e-44  Score=362.27  Aligned_cols=243  Identities=32%  Similarity=0.412  Sum_probs=199.9

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEEEeCCceE
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL  215 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  215 (490)
                      ++||+|+||.||+|++..         +|..||||++.....   .....+.+|+.+++.++||||+++++++...+..|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~   71 (323)
T cd05571           1 KLLGKGTFGKVILVREKA---------TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLC   71 (323)
T ss_pred             CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEE
Confidence            469999999999999876         577899999975422   23356788999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCC
Q 011250          216 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE  295 (490)
Q Consensus       216 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~  295 (490)
                      |||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++....
T Consensus        72 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  147 (323)
T cd05571          72 FVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIS  147 (323)
T ss_pred             EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccccc
Confidence            999999999999988654 47899999999999999999999988   99999999999999999999999999875432


Q ss_pred             CCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccC
Q 011250          296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD  375 (490)
Q Consensus       296 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  375 (490)
                      ...  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+....   ....        
T Consensus       148 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~~---~~~~--------  211 (323)
T cd05571         148 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELI---LMEE--------  211 (323)
T ss_pred             CCC--cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---HHHHHH---HcCC--------
Confidence            221  123467999999999999999999999999999999999999999653211   111111   0000        


Q ss_pred             CccCCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011250          376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  414 (490)
Q Consensus       376 ~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----t~~evl~~  414 (490)
                          ..++...+.++.+||.+||+.||.+||     ++.+++++
T Consensus       212 ----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         212 ----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence                112233478899999999999999999     79999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.5e-45  Score=383.11  Aligned_cols=266  Identities=30%  Similarity=0.462  Sum_probs=224.0

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      .+.+....+.||+|+||+||+|......    .......||||.++..... ..++|.+|+.+|..|+|||||+|+|+|.
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~----p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~  559 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLL----PGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR  559 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCC----CCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence            3456677789999999999999876432    1124568999999887655 6789999999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcC---------CC----CCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRS---------LP----LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL  276 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~---------~~----l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl  276 (490)
                      +++..|+|+|||..|||.++|..++         ..    |+..+.+.||.|||.|+.||-++.   +|||||-.+|+||
T Consensus       560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLV  636 (774)
T KOG1026|consen  560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLV  636 (774)
T ss_pred             cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhcee
Confidence            9999999999999999999996431         23    888999999999999999999988   9999999999999


Q ss_pred             cCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcch
Q 011250          277 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHN  355 (490)
Q Consensus       277 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~  355 (490)
                      .++..|||+|||+++.....+++.......-.++|||||.++.++|+.+||||||||+|||+++ |..||.+....+   
T Consensus       637 ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E---  713 (774)
T KOG1026|consen  637 GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE---  713 (774)
T ss_pred             ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH---
Confidence            9999999999999999888777766545556789999999999999999999999999999998 778886654332   


Q ss_pred             hhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                      .++..+.             ..+ -..+..|+.+++.|+..||+.+|.+||+++||-..|+.+..
T Consensus       714 VIe~i~~-------------g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  714 VIECIRA-------------GQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             HHHHHHc-------------CCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence            2222221             111 23456789999999999999999999999999999987644

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.8e-44  Score=367.12  Aligned_cols=264  Identities=26%  Similarity=0.410  Sum_probs=208.7

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcc-CCCCeeceeeEEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~  209 (490)
                      .++|.+.+.||+|+||.||+|++...+.    ..++..||||++..... .....+.+|+.+++.+ +|+|||++++++.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~  112 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGK----EDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT  112 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCc----ccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence            4579999999999999999998754221    12456799999975532 2345688999999999 7999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcC-------------------------------------------------------
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRS-------------------------------------------------------  234 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~-------------------------------------------------------  234 (490)
                      ..+..++|||||++|+|.+++....                                                       
T Consensus       113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (374)
T cd05106         113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS  192 (374)
T ss_pred             CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence            9999999999999999999885421                                                       


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCCCcce
Q 011250          235 --------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH  300 (490)
Q Consensus       235 --------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  300 (490)
                                    ..+++..++.|+.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.........
T Consensus       193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~  269 (374)
T cd05106         193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV  269 (374)
T ss_pred             ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence                          24788889999999999999999988   9999999999999999999999999998764433222


Q ss_pred             eeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccC
Q 011250          301 VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE  379 (490)
Q Consensus       301 ~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  379 (490)
                      ......++..|||||++.+..++.++|||||||++|||++ |+.||........  ......              ....
T Consensus       270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~~~~~--------------~~~~  333 (374)
T cd05106         270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FYKMVK--------------RGYQ  333 (374)
T ss_pred             eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HHHHHH--------------cccC
Confidence            2222345678999999998899999999999999999997 9999975432111  111110              0011


Q ss_pred             CCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          380 GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       380 ~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                      ...+...+.++.+|+.+||+.||.+||++.+|++.|+++
T Consensus       334 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            111122367899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.9e-44  Score=351.69  Aligned_cols=268  Identities=23%  Similarity=0.292  Sum_probs=205.6

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ++|++.+.||+|+||.||+|++..         ++..||||++.....  ...+.+.+|+.+++.++||||+++++++..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   71 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKE---------TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR   71 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECC---------CCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec
Confidence            369999999999999999999876         567899999875432  234567899999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      ++..++||||++++.|..+ ......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        72 ~~~~~lv~e~~~~~~l~~~-~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~  147 (287)
T cd07848          72 RGKLYLVFEYVEKNMLELL-EEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFA  147 (287)
T ss_pred             CCEEEEEEecCCCCHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCc
Confidence            9999999999988766544 344557999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC-----
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-----  365 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~-----  365 (490)
                      ......... ......||+.|+|||++.+..++.++|||||||++|||++|++||...........+......+.     
T Consensus       148 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  226 (287)
T cd07848         148 RNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMK  226 (287)
T ss_pred             ccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHH
Confidence            876432221 12345799999999999988999999999999999999999999976432221111111000000     


Q ss_pred             ---CcchhhhccCCcc------CCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          366 ---DKRRFYRLLDPRL------EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 ---~~~~~~~~~~~~l------~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                         ....+.....+..      ...+....+..+.+||++||+.||.+|||++++++|
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         227 LFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             hhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence               0000000000000      001111246789999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=8e-44  Score=351.57  Aligned_cols=267  Identities=24%  Similarity=0.342  Sum_probs=206.0

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      ++|.+.+.||.|+||.||+|++..         ++..||+|.+..... .....+.+|+.+++.++||||+++++++..+
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   75 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKL---------TENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE   75 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECC---------CCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            469999999999999999998876         567899999875432 2335678999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      +..++||||++ |+|.+++......+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        76 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~  151 (288)
T cd07871          76 RCLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLAR  151 (288)
T ss_pred             CeEEEEEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCccee
Confidence            99999999996 5999988766667899999999999999999999988   9999999999999999999999999997


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh--------hc
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA--------RP  362 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~--------~~  362 (490)
                      ........  .....|++.|+|||++.+ ..++.++|||||||++|+|++|++||...........+...        .+
T Consensus       152 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  229 (288)
T cd07871         152 AKSVPTKT--YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWP  229 (288)
T ss_pred             eccCCCcc--ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhh
Confidence            65332211  233568999999998865 56899999999999999999999999765432221111100        00


Q ss_pred             ccCCcchhhhccCCccCC----CCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          363 HLGDKRRFYRLLDPRLEG----HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~----~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .......+....-+....    ......+.++.+||.+||+.||.+|||++|+++|
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         230 GITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             ccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            011111111111111100    0011236788999999999999999999999865

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-44  Score=375.87  Aligned_cols=265  Identities=25%  Similarity=0.309  Sum_probs=214.8

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccC-CCCeeceeeE-
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGY-  207 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~-  207 (490)
                      +...+++|.+.|.+|||+.||+|.+..         .|..||+|++...+....+.+.+||.+|+.|. |+|||.+++. 
T Consensus        34 Vg~~~v~V~~vLAEGGFa~VYla~~~~---------~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss  104 (738)
T KOG1989|consen   34 VGSHRVTVEKVLAEGGFAQVYLAQDVK---------GGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSS  104 (738)
T ss_pred             ECCEEEEEEEEEccCCcEEEEEEEecC---------CCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccc
Confidence            345578899999999999999999876         34689999987777777888999999999998 9999999993 


Q ss_pred             EEeC------CceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC
Q 011250          208 CIED------DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY  280 (490)
Q Consensus       208 ~~~~------~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~  280 (490)
                      ....      -+++|+||||.||.|-+++..+ ...|++.++++|+.++++||++||... .+|||||||-+||||+.++
T Consensus       105 ~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g  183 (738)
T KOG1989|consen  105 AINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADG  183 (738)
T ss_pred             cccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCC
Confidence            2211      2568999999999999999743 345999999999999999999999987 7899999999999999999


Q ss_pred             CeEEecccCcccCCCCCccee-------eeccccCCCccCcchhc---cCCCCccchhhHHHHHHHHHHhCCCCCCCCCC
Q 011250          281 NAKLSDFGLAKDAPEDGKTHV-------STRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP  350 (490)
Q Consensus       281 ~vkL~DFG~a~~~~~~~~~~~-------~~~~~Gt~~y~aPE~l~---~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~  350 (490)
                      ..||||||.|......-....       .-...-|+.|.|||++.   +...+.|+|||+|||+||-|+....||+....
T Consensus       184 ~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~  263 (738)
T KOG1989|consen  184 NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK  263 (738)
T ss_pred             CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc
Confidence            999999999875432211100       00124589999999875   56889999999999999999999999976532


Q ss_pred             CCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcccccc
Q 011250          351 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDM  424 (490)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~~~~~  424 (490)
                      .                    .+++..+.-.-....+..+.+||+.||+.||.+||++-+|++.+..+.+....
T Consensus       264 l--------------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~  317 (738)
T KOG1989|consen  264 L--------------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP  317 (738)
T ss_pred             e--------------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence            2                    12222222222245689999999999999999999999999999887775544

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=5.9e-44  Score=365.86  Aligned_cols=263  Identities=27%  Similarity=0.407  Sum_probs=207.0

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcc-CCCCeeceeeEEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~  209 (490)
                      .++|++.+.||+|+||.||+|++...    ....++..||||+++... ....+.+.+|+.+|..+ +||||+++++++.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~----~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~  109 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGL----FKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT  109 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEecc----ccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence            34789999999999999999976321    111256689999997543 23345788999999999 8999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcC-------------------------------------------------------
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRS-------------------------------------------------------  234 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~-------------------------------------------------------  234 (490)
                      +.+..++|||||++|+|.+++....                                                       
T Consensus       110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence            9999999999999999999885421                                                       


Q ss_pred             -------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCC
Q 011250          235 -------------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE  295 (490)
Q Consensus       235 -------------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~  295 (490)
                                         ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence                               24788889999999999999999988   99999999999999999999999999987654


Q ss_pred             CCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcchhhhcc
Q 011250          296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  374 (490)
Q Consensus       296 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (490)
                      ...........++..|+|||++.+..++.++|||||||++|||++ |..||.......  .........           
T Consensus       267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~~~-----------  333 (375)
T cd05104         267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIKEG-----------  333 (375)
T ss_pred             cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHHhC-----------
Confidence            332222222345678999999999999999999999999999998 888886532211  111111110           


Q ss_pred             CCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011250          375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  417 (490)
Q Consensus       375 ~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~  417 (490)
                         .....+...+.++.+||.+||+.||++||++.+|++.|++
T Consensus       334 ---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         334 ---YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             ---ccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence               0001111236789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.1e-43  Score=349.87  Aligned_cols=246  Identities=21%  Similarity=0.326  Sum_probs=200.9

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhccCCCCeeceeeEEEe----C
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIE----D  211 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~  211 (490)
                      ..||+|++|.||+|.+           +|..||||.+.......   .+.+.+|+.+|.+++|||||++++++.+    .
T Consensus        26 ~~i~~g~~~~v~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~   94 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-----------NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL   94 (283)
T ss_pred             eEEeeCCceEEEEEEE-----------CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence            5799999999999987           35689999997654333   3567899999999999999999999877    3


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      ...++||||+++|+|.+++... ..+++.....++.|++.||.|||.. +   ++||||||+|||++.++.+||+|||++
T Consensus        95 ~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~  170 (283)
T PHA02988         95 PRLSLILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLE  170 (283)
T ss_pred             CceEEEEEeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchH
Confidence            4688999999999999998654 4789999999999999999999984 6   889999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhcc--CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +......     ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||.......   +....   .    
T Consensus       171 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---~~~~i---~----  235 (283)
T PHA02988        171 KILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---IYDLI---I----  235 (283)
T ss_pred             hhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---HHHHH---H----
Confidence            8654321     23468999999999876  689999999999999999999999997543211   11110   0    


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                            .......++..++..+.+|+.+||+.||.+|||+.+|++.|+.++.
T Consensus       236 ------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        236 ------NKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             ------hcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence                  0000112233457889999999999999999999999999987753

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-44  Score=361.20  Aligned_cols=254  Identities=26%  Similarity=0.344  Sum_probs=207.2

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|++.+.||+|+||.||+|++..         ++..||||++.....   .....+..|+.++..++||||+++++++.
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~   71 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKD---------TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ   71 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence            368999999999999999999876         567899999975422   23456889999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +.+..||||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~  147 (333)
T cd05600          72 DDEYLYLAMEYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGL  147 (333)
T ss_pred             cCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcC
Confidence            999999999999999999998544 47899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +.....     .....+||+.|+|||++.+..++.++|||||||+||||++|..||...........+......+.    
T Consensus       148 a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----  218 (333)
T cd05600         148 SKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ----  218 (333)
T ss_pred             Cccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc----
Confidence            986543     22346799999999999988999999999999999999999999976433221111110000000    


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                           .+.. .......+.++.+||.+||..+|.+||++.+++++
T Consensus       219 -----~~~~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         219 -----RPVY-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             -----CCCC-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence                 0000 00002337889999999999999999999999987

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-44  Score=359.90  Aligned_cols=253  Identities=26%  Similarity=0.336  Sum_probs=215.4

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhccC-CCCeeceeeE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGNLL-HPNLVKLVGY  207 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~Ei~il~~l~-HpnIv~l~~~  207 (490)
                      ...|.+.+.||+|.||.||+|+.+.         +|..+|+|++.+.....   ...+.+|+.||++|. |||||.++++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~---------tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~  104 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKS---------TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDA  104 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecC---------CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            3468999999999999999999886         68899999998776543   357899999999999 9999999999


Q ss_pred             EEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC----CCCeE
Q 011250          208 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA----DYNAK  283 (490)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~----~~~vk  283 (490)
                      |++...++||||+|.||.|.+.|...  .+++..+..++.||+.+++|||+.|   |+||||||+|||+..    ++.+|
T Consensus       105 ~e~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik  179 (382)
T KOG0032|consen  105 FEDPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIK  179 (382)
T ss_pred             EEcCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEE
Confidence            99999999999999999999999776  3999999999999999999999988   999999999999953    35799


Q ss_pred             EecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011250          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      ++|||++......   ......+||+.|+|||++....|+..+||||+||++|.|++|.+||...........+...   
T Consensus       180 ~~DFGla~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~---  253 (382)
T KOG0032|consen  180 LIDFGLAKFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG---  253 (382)
T ss_pred             EeeCCCceEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC---
Confidence            9999999987662   2335689999999999999999999999999999999999999999876543332211111   


Q ss_pred             cCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                                 +..+........+..+.++|++||..||.+|+|+.++|+|-
T Consensus       254 -----------~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~Hp  294 (382)
T KOG0032|consen  254 -----------DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHP  294 (382)
T ss_pred             -----------CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCc
Confidence                       11122233344489999999999999999999999999974

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.5e-43  Score=345.32  Aligned_cols=260  Identities=25%  Similarity=0.410  Sum_probs=209.3

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .++|++.+.||+|+||.||+|++....      ..+..||+|.++.... .....+.+|+.++..++||||+++++++..
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~------~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   77 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPS------KRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR   77 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCC------CceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec
Confidence            346899999999999999999876432      2567899999976532 234568899999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      ++..+|||||+++|+|.+++......+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.++|+|||.+
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~  154 (266)
T cd05064          78 GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRL  154 (266)
T ss_pred             CCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccc
Confidence            99999999999999999999776667999999999999999999999988   999999999999999999999999987


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      ......... ......++..|+|||++.+..++.++|||||||++|||++ |..||.......   ......    +.  
T Consensus       155 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~----~~--  224 (266)
T cd05064         155 QEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIKAVE----DG--  224 (266)
T ss_pred             ccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHH----CC--
Confidence            654322111 1112345678999999999999999999999999999775 999997543221   111110    00  


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                              .....+..++..+.+++.+||+.+|.+||++.+|++.|..+
T Consensus       225 --------~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         225 --------FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             --------CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                    00111233477899999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-45  Score=363.63  Aligned_cols=244  Identities=30%  Similarity=0.488  Sum_probs=205.3

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCCc
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQ  213 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  213 (490)
                      ....++-||.|+.|.||+|++.           ++.||||+++.-       -..+|+-|++|+||||+.|.|+|.....
T Consensus       125 ~IsELeWlGSGaQGAVF~Grl~-----------netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPc  186 (904)
T KOG4721|consen  125 EISELEWLGSGAQGAVFLGRLH-----------NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPC  186 (904)
T ss_pred             HhhhhhhhccCcccceeeeecc-----------CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCce
Confidence            3444677999999999999985           458999987522       2357999999999999999999999999


Q ss_pred             eEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccC
Q 011250          214 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       214 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~  293 (490)
                      +|||||||..|-|...| +.+..+.......|..+||.|+.|||.+.   |||||||.-||||..+..|||+|||.++..
T Consensus       187 yCIiMEfCa~GqL~~VL-ka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~  262 (904)
T KOG4721|consen  187 YCIIMEFCAQGQLYEVL-KAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKEL  262 (904)
T ss_pred             eEEeeeccccccHHHHH-hccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhh
Confidence            99999999999999998 55668899999999999999999999988   999999999999999999999999999876


Q ss_pred             CCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhc
Q 011250          294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  373 (490)
Q Consensus       294 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (490)
                      .+. .+  .-.++||..|||||++.+...+.|+|||||||||||||||..||..-....    +-|.            +
T Consensus       263 ~~~-ST--kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIwG------------V  323 (904)
T KOG4721|consen  263 SDK-ST--KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIWG------------V  323 (904)
T ss_pred             hhh-hh--hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEEe------------c
Confidence            543 11  224899999999999999999999999999999999999999996432211    1111            1


Q ss_pred             cCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       374 ~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                      -.-.|.-..+..|++-++-||++||.-.|..||++.+|+.||+-.
T Consensus       324 GsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  324 GSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             cCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            111233345667789999999999999999999999999999743

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.3e-43  Score=358.58  Aligned_cols=249  Identities=24%  Similarity=0.361  Sum_probs=196.5

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      .+|++.+.||+|+||.||+|++..         +++.||||++..... ...+.+.+|+.+++.++|+||+++++++.+.
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  144 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRP---------TGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHN  144 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECC---------CCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC
Confidence            356778899999999999998875         567899999865432 2345788999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      +.+++||||+++|+|.+..     .+.+..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus       145 ~~~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~  216 (353)
T PLN00034        145 GEIQVLLEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSR  216 (353)
T ss_pred             CeEEEEEecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccce
Confidence            9999999999999986532     4567788899999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhcc-----CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMT-----GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      .......  ......||..|+|||++..     ...+.++|||||||+||||++|+.||..........+.....  .. 
T Consensus       217 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~--~~-  291 (353)
T PLN00034        217 ILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC--MS-  291 (353)
T ss_pred             ecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh--cc-
Confidence            7643211  1233579999999998743     234568999999999999999999997432221111111000  00 


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                                 .....+...+.++.+||.+||+.||++||++.||+++
T Consensus       292 -----------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        292 -----------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             -----------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                       0011122346789999999999999999999999975

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.6e-43  Score=356.63  Aligned_cols=265  Identities=25%  Similarity=0.373  Sum_probs=207.3

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .++|++.+.||+|+||.||++++..         ++..||+|.+..... ...+.+.+|+++|+.++||||+++++++..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   74 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKP---------SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS   74 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECC---------CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence            4689999999999999999999876         677899999876532 234578999999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      ++..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+  +|+||||||+|||++.++.+||+|||++
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  151 (331)
T cd06649          75 DGEISICMEHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVS  151 (331)
T ss_pred             CCEEEEEeecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccc
Confidence            99999999999999999998554 46899999999999999999999853  2999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh-cccCCc--
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR-PHLGDK--  367 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~-~~~~~~--  367 (490)
                      .......    .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +..... +.....  
T Consensus       152 ~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~  224 (331)
T cd06649         152 GQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEG  224 (331)
T ss_pred             ccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccC
Confidence            7664321    233579999999999998899999999999999999999999996433211   100000 000000  


Q ss_pred             --------------------------chhhhccC----CccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          368 --------------------------RRFYRLLD----PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       368 --------------------------~~~~~~~~----~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                                                ......++    ...........+.++.+||.+||+.||++|||+.+|+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         225 EPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             CccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                                      00000000    0000000112467899999999999999999999999764

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.6e-43  Score=346.17  Aligned_cols=262  Identities=28%  Similarity=0.489  Sum_probs=211.6

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      .+|++.+.||+|+||.||+|.+.....    ......||+|.+..... ....++.+|+.++..++||||+++++++...
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   80 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNE----RLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE   80 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCC----CcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence            368899999999999999998865321    11346799999875432 2345688999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL  276 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl  276 (490)
                      ...+++|||+++++|.+++....               ..+++..++.++.||+.||.|||+.+   |+||||||+|||+
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~  157 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLV  157 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEE
Confidence            99999999999999999986532               45788999999999999999999988   9999999999999


Q ss_pred             cCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcch
Q 011250          277 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHN  355 (490)
Q Consensus       277 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~  355 (490)
                      +.++.++|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||......   .
T Consensus       158 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~  234 (283)
T cd05048         158 GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---E  234 (283)
T ss_pred             cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---H
Confidence            9999999999999986644333333344567889999999988899999999999999999998 99999754322   1


Q ss_pred             hhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                      +......              ......+..++.++.+|+.+||+.||.+||++.+|+++|+.+
T Consensus       235 ~~~~i~~--------------~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         235 VIEMIRS--------------RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             HHHHHHc--------------CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            1111110              001112334578999999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-45  Score=334.51  Aligned_cols=255  Identities=25%  Similarity=0.345  Sum_probs=209.9

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      .+.|++.+.||+|.|+.||++.+..         +|+.+|+|+++....  .+.+++.+|++|-+.|+|||||+|.+.+.
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~---------tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~   80 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKT---------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ   80 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhcc---------chHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhc
Confidence            3568888999999999999997765         788999999875432  35678999999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CCCeEEec
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSD  286 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~---~~~vkL~D  286 (490)
                      +....|||+|+|.|++|..-|..+ ..+++..+-.+++||++||.|+|.++   |||||+||+|+||..   ..-+||+|
T Consensus        81 ~~~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~  156 (355)
T KOG0033|consen   81 EESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLAD  156 (355)
T ss_pred             ccceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecc
Confidence            999999999999999998777655 46888889999999999999999999   999999999999953   34699999


Q ss_pred             ccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011250          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      ||+|..+...   ......+|||.|||||++....|+..+|||+.||+||-||.|.+||.+....   .+.+.+...   
T Consensus       157 FGvAi~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye~I~~g---  227 (355)
T KOG0033|consen  157 FGLAIEVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYEQIKAG---  227 (355)
T ss_pred             cceEEEeCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHHHHhcc---
Confidence            9999988632   2334578999999999999999999999999999999999999999763221   222211111   


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~  416 (490)
                      ..    .    +...+....++++++|+++||..||.+|.|+.|.|+|-.
T Consensus       228 ~y----d----~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpW  269 (355)
T KOG0033|consen  228 AY----D----YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPW  269 (355)
T ss_pred             cc----C----CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence            00    1    111122344789999999999999999999999997643

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.3e-43  Score=356.91  Aligned_cols=244  Identities=29%  Similarity=0.387  Sum_probs=200.1

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEEEeCCceE
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL  215 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  215 (490)
                      +.||+|+||.||+|.+..         ++..||||++.....   .....+.+|+.+++.++||||+++++++...+..+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   71 (328)
T cd05593           1 KLLGKGTFGKVILVREKA---------SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLC   71 (328)
T ss_pred             CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEE
Confidence            369999999999999876         577899999975422   23456788999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCC
Q 011250          216 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE  295 (490)
Q Consensus       216 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~  295 (490)
                      |||||+++|+|..++... ..+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++....
T Consensus        72 lv~Ey~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~  147 (328)
T cd05593          72 FVMEYVNGGELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGIT  147 (328)
T ss_pred             EEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCC
Confidence            999999999999888544 47999999999999999999999988   99999999999999999999999999876432


Q ss_pred             CCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccC
Q 011250          296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD  375 (490)
Q Consensus       296 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  375 (490)
                      ...  .....+||+.|+|||++.+..++.++|||||||+||+|++|+.||......   .....   .....        
T Consensus       148 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~---~~~~~---~~~~~--------  211 (328)
T cd05593         148 DAA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFEL---ILMED--------  211 (328)
T ss_pred             ccc--ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH---HHHHH---hccCC--------
Confidence            211  123467999999999999889999999999999999999999999653221   11110   00000        


Q ss_pred             CccCCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHh
Q 011250          376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVETL  415 (490)
Q Consensus       376 ~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----t~~evl~~L  415 (490)
                          ..++...+.++.+||.+||..||.+|+     ++.+++++-
T Consensus       212 ----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~  252 (328)
T cd05593         212 ----IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHS  252 (328)
T ss_pred             ----ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCC
Confidence                112223477899999999999999997     899998763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.3e-44  Score=359.06  Aligned_cols=251  Identities=27%  Similarity=0.400  Sum_probs=213.5

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ++|..++.||+|+||.+++++++.+         +..|++|.+......  ..+....|+.+++++.|||||.+++.|++
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~---------~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~   74 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSD---------DKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE   74 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccC---------CceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc
Confidence            4689999999999999999998874         458999999876543  33467899999999999999999999999


Q ss_pred             CCc-eEEEEEecCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          211 DDQ-RLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       211 ~~~-~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      ++. .+|||+||+||+|.+.|.+.. ..++++.+..|+.|++.||.|||++.   |+|||||+.|||++.++.|+|+|||
T Consensus        75 ~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfG  151 (426)
T KOG0589|consen   75 DGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFG  151 (426)
T ss_pred             CCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchh
Confidence            988 999999999999999997654 67999999999999999999999877   9999999999999999999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +|+.+....  ......+||+.||.||++.+..|+.|+|||||||++|||++-+++|......   .++......     
T Consensus       152 laK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---~Li~ki~~~-----  221 (426)
T KOG0589|consen  152 LAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---ELILKINRG-----  221 (426)
T ss_pred             hhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH---HHHHHHhhc-----
Confidence            999886653  2334578999999999999999999999999999999999999999765322   222111111     


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                               .....+...+.++..||..||..+|..||++.++|.+
T Consensus       222 ---------~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  222 ---------LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ---------cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                     1122333448899999999999999999999999976

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.2e-43  Score=349.72  Aligned_cols=266  Identities=22%  Similarity=0.320  Sum_probs=202.9

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .++|.+.+.||+|+||.||+|++..         ++..||||++..... .....+.+|+.+++.++||||+++++++.+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   74 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKV---------NGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT   74 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECC---------CCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec
Confidence            3679999999999999999999875         567899999875432 223467889999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      ++..++||||+. ++|.+++......+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        75 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~  150 (303)
T cd07869          75 KETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLA  150 (303)
T ss_pred             CCeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcc
Confidence            999999999994 6888888776667999999999999999999999988   999999999999999999999999998


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC--c
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD--K  367 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~--~  367 (490)
                      ........  ......||+.|+|||++.+ ..++.++|||||||++|||++|..||.......  .........+..  .
T Consensus       151 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~  226 (303)
T cd07869         151 RAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNE  226 (303)
T ss_pred             eeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCCh
Confidence            75432221  1233578999999998865 468899999999999999999999997542211  111100000000  0


Q ss_pred             c---hhhh--ccCC---------ccCCCCC-hhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          368 R---RFYR--LLDP---------RLEGHFS-IKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       368 ~---~~~~--~~~~---------~l~~~~~-~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .   ....  .+.+         .+...++ ...+..+.+|+.+||+.||.+|||+.++++|
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         227 DTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             hhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence            0   0000  0000         0000000 0124678899999999999999999999965

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.3e-43  Score=356.02  Aligned_cols=243  Identities=32%  Similarity=0.407  Sum_probs=199.0

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEEEeCCceE
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL  215 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  215 (490)
                      +.||+|+||.||++++..         +|..||+|++.....   .....+.+|+.+++.++||||+++++++...+..|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~   71 (323)
T cd05595           1 KLLGKGTFGKVILVREKA---------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   71 (323)
T ss_pred             CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEE
Confidence            469999999999999876         577899999975422   23345778999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCC
Q 011250          216 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE  295 (490)
Q Consensus       216 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~  295 (490)
                      |||||+++|+|..++... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        72 lv~E~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  147 (323)
T cd05595          72 FVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  147 (323)
T ss_pred             EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccC
Confidence            999999999999888544 47899999999999999999999988   99999999999999999999999999875432


Q ss_pred             CCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccC
Q 011250          296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD  375 (490)
Q Consensus       296 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  375 (490)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   .....   ....        
T Consensus       148 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~~~~~---~~~~--------  211 (323)
T cd05595         148 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFELI---LMEE--------  211 (323)
T ss_pred             CCC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHH---hcCC--------
Confidence            211  1234679999999999998999999999999999999999999996542211   11100   0000        


Q ss_pred             CccCCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011250          376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  414 (490)
Q Consensus       376 ~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----t~~evl~~  414 (490)
                          ..++...+.++.+||.+||..||.+|+     ++.+++++
T Consensus       212 ----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         212 ----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence                012223478899999999999999998     89998876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1e-43  Score=359.31  Aligned_cols=247  Identities=26%  Similarity=0.332  Sum_probs=203.6

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|.+.+.||+|+||.||+|.+...        .+..||+|.+....   ....+.+.+|+.+++.++||||+++++++.
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~  101 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNE--------DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK  101 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECC--------CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence            4699999999999999999987642        23579999986542   223456888999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +++..||||||+.+|+|.+++... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~~~lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~  177 (340)
T PTZ00426        102 DESYLYLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGF  177 (340)
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCC
Confidence            999999999999999999998654 47999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +......     ....+||+.|+|||++.+..++.++|||||||++|||++|..||.......   .....   .     
T Consensus       178 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---~~~~i---~-----  241 (340)
T PTZ00426        178 AKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL---IYQKI---L-----  241 (340)
T ss_pred             CeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH---HHHHH---h-----
Confidence            9875432     123579999999999998889999999999999999999999997543211   11100   0     


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----t~~evl~~  414 (490)
                           ...  ..++...+..+.+||++||+.||.+|+     ++++++++
T Consensus       242 -----~~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        242 -----EGI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             -----cCC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                 000  012223367789999999999999995     89998876

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-44  Score=352.01  Aligned_cols=249  Identities=25%  Similarity=0.376  Sum_probs=215.7

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccH--HHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .-|.+++.||+|.|.+|-+|++..         +|..||||++.+..+...  -.+.+|++.|+.++|||||+||++...
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVF---------TGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT   88 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVF---------TGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT   88 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhc---------ccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc
Confidence            458899999999999999999876         788999999988766543  468899999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE-cCCCCeEEecccC
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL-DADYNAKLSDFGL  289 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl-~~~~~vkL~DFG~  289 (490)
                      ...+|||+|+-++|+|+++|.++...+.+..+.+++.||+.|+.|+|+..   +|||||||+||.+ .+-|-|||.|||+
T Consensus        89 QTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGF  165 (864)
T KOG4717|consen   89 QTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGF  165 (864)
T ss_pred             cceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccc
Confidence            99999999999999999999999889999999999999999999999988   9999999999977 4568999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCC-ccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLT-SKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~-~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +..+..+..   .+..||+..|-|||++.+..|+ +++||||||||||.|++|++||......+.               
T Consensus       166 SNkf~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------  227 (864)
T KOG4717|consen  166 SNKFQPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------  227 (864)
T ss_pred             cccCCCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------
Confidence            988765533   2457999999999999999887 589999999999999999999976533222               


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                       +..++|-..  ..+...+.++.+||..||.+||.+|.+.+||..+
T Consensus       228 -LTmImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  228 -LTMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             -hhhhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence             222333222  2344558999999999999999999999999864

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-43  Score=353.53  Aligned_cols=241  Identities=31%  Similarity=0.350  Sum_probs=197.4

Q ss_pred             cccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhccCCCCeeceeeEEEeCCceEEE
Q 011250          141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  217 (490)
Q Consensus       141 LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  217 (490)
                      ||+|+||.||+|++..         ++..||+|++....   ......+.+|+.++..++||||+++++++.+.+..|+|
T Consensus         1 lg~G~~g~Vy~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   71 (312)
T cd05585           1 IGKGSFGKVMQVRKRD---------TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLV   71 (312)
T ss_pred             CCcCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEE
Confidence            7999999999999876         56789999987532   23345678899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCCC
Q 011250          218 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG  297 (490)
Q Consensus       218 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~  297 (490)
                      |||+++|+|.+++... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        72 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  147 (312)
T cd05585          72 LAFINGGELFHHLQRE-GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD  147 (312)
T ss_pred             EcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC
Confidence            9999999999998654 46999999999999999999999988   9999999999999999999999999998643322


Q ss_pred             cceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCc
Q 011250          298 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPR  377 (490)
Q Consensus       298 ~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  377 (490)
                      .  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.....      .+.....+...          
T Consensus       148 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~~~~~----------  209 (312)
T cd05585         148 D--KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKILQEP----------  209 (312)
T ss_pred             C--ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCC----------
Confidence            1  22346799999999999999999999999999999999999999965321      11111111110          


Q ss_pred             cCCCCChhhHHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 011250          378 LEGHFSIKGSQKATQLAAQCLSRDPKARPR---MSEVVET  414 (490)
Q Consensus       378 l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt---~~evl~~  414 (490)
                        ..++...+..+.+||.+||..||.+||+   +.+++.+
T Consensus       210 --~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         210 --LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             --CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence              1122334678999999999999999975   6677655

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=5.9e-43  Score=350.02  Aligned_cols=261  Identities=24%  Similarity=0.396  Sum_probs=208.4

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      .+|++.+.||+|+||.||+|.+..++..     ....||||.+.... ....+++..|+.+++.++||||+++++++...
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~   81 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS   81 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCc-----cceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence            4699999999999999999998653321     23469999987543 23456788999999999999999999998764


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                       ..++|+||+++|+|.+++......+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~  157 (316)
T cd05108          82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAK  157 (316)
T ss_pred             -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccc
Confidence             578999999999999999776667899999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ...............++..|+|||++.+..++.++|||||||++|||++ |..||.......   +.....    ..   
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~~~~~~----~~---  227 (316)
T cd05108         158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILE----KG---  227 (316)
T ss_pred             cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHh----CC---
Confidence            7654332222222345678999999999999999999999999999998 999986532111   111110    00   


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~  419 (490)
                             .....+..++..+.+|+.+||..||.+||++.+++..|..+.
T Consensus       228 -------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~  269 (316)
T cd05108         228 -------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  269 (316)
T ss_pred             -------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                   000112234678899999999999999999999999987664

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.9e-43  Score=369.94  Aligned_cols=253  Identities=24%  Similarity=0.293  Sum_probs=206.4

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCCc
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQ  213 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  213 (490)
                      .|.+.+.||+|+||.||+|....+        .+..||+|.+..........+.+|+.+|+.++|||||++++++..++.
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~--------~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~  139 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSD--------PKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDK  139 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCC--------CCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCE
Confidence            488999999999999999987652        255789998765554445567889999999999999999999999999


Q ss_pred             eEEEEEecCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          214 RLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       214 ~~lV~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      .||||||+++|+|.+++..   ....+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla  216 (478)
T PTZ00267        140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFS  216 (478)
T ss_pred             EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCc
Confidence            9999999999999988753   2346899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      +..............+||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+...   .+.     
T Consensus       217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~---~~~~~---~~~-----  285 (478)
T PTZ00267        217 KQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR---EIMQQ---VLY-----  285 (478)
T ss_pred             eecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH---HHh-----
Confidence            8765433323334567999999999999999999999999999999999999999653211   11110   000     


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                           ... ..++...+..+.+||.+||..||.+||++.+++.+
T Consensus       286 -----~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        286 -----GKY-DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             -----CCC-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence                 000 01122346789999999999999999999999753

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-42  Score=338.00  Aligned_cols=260  Identities=27%  Similarity=0.450  Sum_probs=210.6

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      ++|++.+.||+|+||.||+|.+...+.      +...||||.+...... ...++.+|+.+++.++||||+++++++...
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   77 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGK------KEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS   77 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCC------CcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC
Confidence            579999999999999999999865321      3457999998755332 345788999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      +..++||||+++++|.+++......+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||+++
T Consensus        78 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~  154 (266)
T cd05033          78 RPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSR  154 (266)
T ss_pred             CceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhh
Confidence            9999999999999999999776667999999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ...............++..|+|||.+.+..++.++||||||+++|+|++ |..||......   .........       
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~~~-------  224 (266)
T cd05033         155 RLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIKAVEDG-------  224 (266)
T ss_pred             cccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHHHHHcC-------
Confidence            7752222222222345678999999988899999999999999999998 99998643211   111111100       


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                             .....+..++..+.+|+.+||+.||++||++.+|+++|+.+
T Consensus       225 -------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         225 -------YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             -------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                   00011223467899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.7e-43  Score=353.39  Aligned_cols=267  Identities=26%  Similarity=0.383  Sum_probs=199.9

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC--CcccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      +|++.+.||+|+||.||+|++..         ++..||||++...  .......+.+|+.+++.++||||+++++++...
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   71 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTH---------TGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP   71 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECC---------CCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEecc
Confidence            48889999999999999999876         5778999998643  223345688999999999999999999988654


Q ss_pred             C-----ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEec
Q 011250          212 D-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       212 ~-----~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~D  286 (490)
                      .     ..|+||||| +++|.+++... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        72 ~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~D  146 (338)
T cd07859          72 SRREFKDIYVVFELM-ESDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICD  146 (338)
T ss_pred             CCCCCceEEEEEecC-CCCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEcc
Confidence            3     479999999 57899888544 46999999999999999999999988   99999999999999999999999


Q ss_pred             ccCcccCCCCCcc-eeeeccccCCCccCcchhcc--CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011250          287 FGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       287 FG~a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~--~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      ||+++........ ......+||+.|+|||++.+  ..++.++|||||||++|||++|++||...........+......
T Consensus       147 fg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~  226 (338)
T cd07859         147 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGT  226 (338)
T ss_pred             CccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC
Confidence            9999865332211 12234679999999999875  67899999999999999999999999754321111100000000


Q ss_pred             --------c--CCcchhhhccCCccCCCCC---hhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          364 --------L--GDKRRFYRLLDPRLEGHFS---IKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       364 --------~--~~~~~~~~~~~~~l~~~~~---~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                              +  .....+...+.......+.   ...+..+.+|+.+||+.||.+||++++++++
T Consensus       227 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         227 PSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             CCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                    0  0000000000000000000   1235678999999999999999999999975

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=7.9e-43  Score=351.89  Aligned_cols=266  Identities=26%  Similarity=0.401  Sum_probs=204.9

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .++|++.+.||+|+||.||+|.+..         ++..||+|.+..... .....+.+|+++++.++|+||++++++|.+
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   74 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKP---------SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS   74 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECC---------CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence            4689999999999999999998875         567899998876532 234568899999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      ++..+|||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||+
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~  150 (333)
T cd06650          75 DGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGV  150 (333)
T ss_pred             CCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCc
Confidence            99999999999999999998654 4689999999999999999999974 5   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh---c-cc-
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR---P-HL-  364 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~---~-~~-  364 (490)
                      +.......    .....||..|+|||++.+..++.++|||||||++|+|++|+.||................   . .. 
T Consensus       151 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  226 (333)
T cd06650         151 SGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESE  226 (333)
T ss_pred             chhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccc
Confidence            87653321    123578999999999998889999999999999999999999997543211110000000   0 00 


Q ss_pred             ----------------CCcc---hhhhccCCccC---CCCC-hhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          365 ----------------GDKR---RFYRLLDPRLE---GHFS-IKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       365 ----------------~~~~---~~~~~~~~~l~---~~~~-~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                                      ...+   ......+....   ..++ ...+.++.+|+.+||+.||.+|||+.+++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         227 TSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             cCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence                            0000   00000000000   0000 1135779999999999999999999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.4e-43  Score=358.75  Aligned_cols=255  Identities=25%  Similarity=0.331  Sum_probs=200.2

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|++.+.||+|+||+||+|.+..         ++..||||++.....   .....+..|+.++..++|+||+++++++.
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~   71 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKD---------TGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ   71 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECC---------CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            478999999999999999998876         577999999975422   22346788999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +...+|||||||++|+|.+++.+. ..+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus        72 ~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGl  147 (363)
T cd05628          72 DKLNLYLIMEFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGL  147 (363)
T ss_pred             cCCeEEEEEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccC
Confidence            999999999999999999998654 47999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcc---------------------------------eeeeccccCCCccCcchhccCCCCccchhhHHHHHHH
Q 011250          290 AKDAPEDGKT---------------------------------HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLL  336 (490)
Q Consensus       290 a~~~~~~~~~---------------------------------~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~  336 (490)
                      ++........                                 ......+||+.|+|||++.+..++.++|||||||+||
T Consensus       148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~  227 (363)
T cd05628         148 CTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY  227 (363)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHH
Confidence            8754321100                                 0012357999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhh--cCCCCCCCHHHHHHH
Q 011250          337 EMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLS--RDPKARPRMSEVVET  414 (490)
Q Consensus       337 elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~--~dP~~RPt~~evl~~  414 (490)
                      ||++|+.||...........+   .. ......    +.+      ....+.++.+||.+|+.  .++..||++++|+++
T Consensus       228 ell~G~~Pf~~~~~~~~~~~i---~~-~~~~~~----~p~------~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         228 EMLIGYPPFCSETPQETYKKV---MN-WKETLI----FPP------EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             HHHhCCCCCCCCCHHHHHHHH---Hc-CcCccc----CCC------cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            999999999754322111100   00 000000    000      01236788999998664  233356899999876

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4e-43  Score=360.56  Aligned_cols=254  Identities=25%  Similarity=0.300  Sum_probs=200.5

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .|.+++.||+|+||+||+|++..         ++..||||++.....   .....+.+|+.+++.++||||+++++++.+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~   72 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVD---------THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD   72 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec
Confidence            58899999999999999998876         677999999975432   234568899999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      .+.+||||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~  148 (381)
T cd05626          73 KDNLYFVMDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLC  148 (381)
T ss_pred             CCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCC
Confidence            99999999999999999998654 46899999999999999999999988   999999999999999999999999997


Q ss_pred             ccCCCCCc---------------------------------------------ceeeeccccCCCccCcchhccCCCCcc
Q 011250          291 KDAPEDGK---------------------------------------------THVSTRVMGTYGYAAPEYVMTGHLTSK  325 (490)
Q Consensus       291 ~~~~~~~~---------------------------------------------~~~~~~~~Gt~~y~aPE~l~~~~~~~~  325 (490)
                      ........                                             .......+||+.|+|||++.+..++.+
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~  228 (381)
T cd05626         149 TGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL  228 (381)
T ss_pred             cccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc
Confidence            64311000                                             001123579999999999998899999


Q ss_pred             chhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhh--hcCCC
Q 011250          326 SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCL--SRDPK  403 (490)
Q Consensus       326 sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL--~~dP~  403 (490)
                      +|||||||++|||++|..||...........  ..  ...          ..+........+.++.+||.+|+  ..++.
T Consensus       229 ~DiwSlG~il~elltG~~Pf~~~~~~~~~~~--i~--~~~----------~~~~~~~~~~~s~~~~dli~~ll~~~~~~~  294 (381)
T cd05626         229 CDWWSVGVILFEMLVGQPPFLAPTPTETQLK--VI--NWE----------NTLHIPPQVKLSPEAVDLITKLCCSAEERL  294 (381)
T ss_pred             cceeehhhHHHHHHhCCCCCcCCCHHHHHHH--HH--ccc----------cccCCCCCCCCCHHHHHHHHHHccCccccc
Confidence            9999999999999999999976432211100  00  000          00000011123678999999954  55666


Q ss_pred             CCCCHHHHHHH
Q 011250          404 ARPRMSEVVET  414 (490)
Q Consensus       404 ~RPt~~evl~~  414 (490)
                      .|+++.++++|
T Consensus       295 ~R~~~~~~l~h  305 (381)
T cd05626         295 GRNGADDIKAH  305 (381)
T ss_pred             CCCCHHHHhcC
Confidence            69999999976

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-43  Score=359.34  Aligned_cols=254  Identities=25%  Similarity=0.337  Sum_probs=202.9

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|++.+.||+|+||+||+|++..         ++..||||++.....   .....+.+|+.+|..++||||+++++++.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~   71 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKD---------TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ   71 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence            379999999999999999999876         577899999975421   23345788999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +++..|||||||++|+|.+++... ..+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.++|+|||+
T Consensus        72 ~~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~  147 (364)
T cd05599          72 DENYLYLIMEYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGL  147 (364)
T ss_pred             cCCeEEEEECCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeeccc
Confidence            999999999999999999998654 46999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcce------------------------------------eeeccccCCCccCcchhccCCCCccchhhHHHH
Q 011250          290 AKDAPEDGKTH------------------------------------VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGV  333 (490)
Q Consensus       290 a~~~~~~~~~~------------------------------------~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv  333 (490)
                      +..........                                    .....+||+.|+|||++....++.++|||||||
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~  227 (364)
T cd05599         148 CTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV  227 (364)
T ss_pred             ceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchh
Confidence            87543211000                                    011246999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCC---HHH
Q 011250          334 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR---MSE  410 (490)
Q Consensus       334 ~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt---~~e  410 (490)
                      ++|||++|..||........   ....   +....        .+........+.++.+||.+||. +|.+|++   +.+
T Consensus       228 il~el~~G~~Pf~~~~~~~~---~~~i---~~~~~--------~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~  292 (364)
T cd05599         228 IMYEMLVGYPPFCSDNPQET---YRKI---INWKE--------TLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNE  292 (364)
T ss_pred             HHHHhhcCCCCCCCCCHHHH---HHHH---HcCCC--------ccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHH
Confidence            99999999999975432111   1100   00000        00000011236789999999996 9999997   999


Q ss_pred             HHHH
Q 011250          411 VVET  414 (490)
Q Consensus       411 vl~~  414 (490)
                      ++++
T Consensus       293 ll~h  296 (364)
T cd05599         293 IKSH  296 (364)
T ss_pred             HhcC
Confidence            8876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=6.1e-43  Score=352.31  Aligned_cols=257  Identities=29%  Similarity=0.381  Sum_probs=203.6

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc----ccHHHHHHHHHHHhccC-CCCeeceeeEE
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGNLL-HPNLVKLVGYC  208 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~Ei~il~~l~-HpnIv~l~~~~  208 (490)
                      +|++.+.||+|+||.||+++.....      .++..||+|++.....    ...+.+..|+.++..+. |+||+++++++
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~   74 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGH------DTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF   74 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccC------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE
Confidence            4889999999999999999875422      2678999999865321    22356788999999995 99999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      ..++..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        75 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG  150 (332)
T cd05614          75 QTEAKLHLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFG  150 (332)
T ss_pred             ecCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCc
Confidence            9999999999999999999998654 46899999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhccC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      +++........ .....+||+.|+|||++.+. .++.++|||||||+||||++|..||...........+  .....   
T Consensus       151 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~--~~~~~---  224 (332)
T cd05614         151 LSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV--SRRIL---  224 (332)
T ss_pred             CCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH--HHHHh---
Confidence            99865432221 12346799999999998765 4788999999999999999999999754322211111  00000   


Q ss_pred             chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHh
Q 011250          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVETL  415 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----t~~evl~~L  415 (490)
                           ..++    .++...+..+.+|+.+||+.||++||     ++++++++-
T Consensus       225 -----~~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~  268 (332)
T cd05614         225 -----KCDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP  268 (332)
T ss_pred             -----cCCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence                 0111    12223477899999999999999999     788888763

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.9e-43  Score=355.03  Aligned_cols=244  Identities=31%  Similarity=0.404  Sum_probs=198.7

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEEEeCCceE
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL  215 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  215 (490)
                      +.||+|+||.||+|.+..         ++..||+|++.....   .....+..|++++..++||||+++++++...+..|
T Consensus         1 ~~lG~G~~g~V~~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~   71 (325)
T cd05594           1 KLLGKGTFGKVILVKEKA---------TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC   71 (325)
T ss_pred             CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEE
Confidence            469999999999998875         677999999975422   23356778999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCC
Q 011250          216 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       216 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~  294 (490)
                      |||||+++|+|..++... ..+++..+..++.||+.||.|||+ .+   |+||||||+|||++.++.+||+|||+++...
T Consensus        72 lv~E~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~  147 (325)
T cd05594          72 FVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  147 (325)
T ss_pred             EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence            999999999999888544 479999999999999999999997 57   9999999999999999999999999987543


Q ss_pred             CCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhcc
Q 011250          295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  374 (490)
Q Consensus       295 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (490)
                      ....  .....+||+.|+|||++.+..++.++|||||||+||||++|..||.......   .....   ...        
T Consensus       148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~---~~~~i---~~~--------  211 (325)
T cd05594         148 KDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFELI---LME--------  211 (325)
T ss_pred             CCCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH---HHHHH---hcC--------
Confidence            2221  1233579999999999998999999999999999999999999996532211   11110   000        


Q ss_pred             CCccCCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHh
Q 011250          375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVETL  415 (490)
Q Consensus       375 ~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----t~~evl~~L  415 (490)
                          ...++...+.++.+||.+||+.||.+|+     ++.+++++-
T Consensus       212 ----~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~  253 (325)
T cd05594         212 ----EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK  253 (325)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence                0012223367899999999999999996     899999763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.9e-43  Score=351.97  Aligned_cols=246  Identities=28%  Similarity=0.417  Sum_probs=197.5

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHH---hccCCCCeeceeeEE
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFL---GNLLHPNLVKLVGYC  208 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il---~~l~HpnIv~l~~~~  208 (490)
                      |++.+.||+|+||.||+|.+..         ++..||||++....   ....+.+.+|++++   +.+.||||+++++++
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~   71 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKK---------TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF   71 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE
Confidence            6788999999999999998876         57789999997542   12234566676655   566799999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      .+.+..|+||||+++|+|..++..  ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~~lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg  146 (324)
T cd05589          72 QTEDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFG  146 (324)
T ss_pred             EcCCEEEEEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCccc
Confidence            999999999999999999988743  46999999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......   .....   ...  
T Consensus       147 ~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~---~~~~i---~~~--  216 (324)
T cd05589         147 LCKEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE---VFDSI---VND--  216 (324)
T ss_pred             CCccCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH---HHHHH---HhC--
Confidence            9875432211  1234679999999999999899999999999999999999999997543211   11100   000  


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  414 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----t~~evl~~  414 (490)
                                ...++...+..+.+||.+||+.||.+||     ++.+++++
T Consensus       217 ----------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         217 ----------EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence                      0012223477889999999999999999     57777665

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.2e-42  Score=358.25  Aligned_cols=266  Identities=23%  Similarity=0.369  Sum_probs=209.4

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccC-CCCeeceeeEE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLL-HPNLVKLVGYC  208 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~-HpnIv~l~~~~  208 (490)
                      ..++|.+.++||+|+||.||+|.+.....    ...+..||||++..... ...+.+.+|+.+|..+. ||||+++++++
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~----~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~  110 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSR----SQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC  110 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCC----CCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence            35679999999999999999998753211    11345799999975433 23457899999999996 99999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcC------------------------------------------------------
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRS------------------------------------------------------  234 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~------------------------------------------------------  234 (490)
                      .+.+..|||||||++|+|.++|....                                                      
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence            99999999999999999999885421                                                      


Q ss_pred             -----------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 011250          235 -----------------------------------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN  273 (490)
Q Consensus       235 -----------------------------------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~N  273 (490)
                                                               ..+++..+..++.||+.||.|||+.+   |+||||||+|
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~N  267 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARN  267 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHh
Confidence                                                     24778888999999999999999988   9999999999


Q ss_pred             EEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCC
Q 011250          274 ILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNG  352 (490)
Q Consensus       274 ILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~  352 (490)
                      ||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||+||||++ |..||.......
T Consensus       268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~  347 (400)
T cd05105         268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS  347 (400)
T ss_pred             EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence            9999999999999999986643322222233457889999999998899999999999999999997 999986532211


Q ss_pred             cchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011250          353 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~  419 (490)
                      .  .......              ......+...+..+.+|+.+||+.||++||++.+|.+.|+.+.
T Consensus       348 ~--~~~~~~~--------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         348 T--FYNKIKS--------------GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             H--HHHHHhc--------------CCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            1  1110000              0001112234778999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.1e-43  Score=351.70  Aligned_cols=246  Identities=30%  Similarity=0.431  Sum_probs=199.0

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc----ccHHHHHHHHHHHhccCCCCeeceeeEEEeCCce
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQR  214 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  214 (490)
                      +.||+|+||.||+++.....      .++..||||++.....    .....+..|+.+|+.++||||+++++++..++..
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~------~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~   75 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGA------DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKL   75 (323)
T ss_pred             ceeeecCCeEEEEEEEcccC------CCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeE
Confidence            67999999999999875422      2577999999875422    2234567899999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCC
Q 011250          215 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~  294 (490)
                      |+||||+++++|.+++... ..+.+..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        76 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  151 (323)
T cd05584          76 YLILEYLSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESI  151 (323)
T ss_pred             EEEEeCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecc
Confidence            9999999999999988554 46888999999999999999999988   9999999999999999999999999987543


Q ss_pred             CCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhcc
Q 011250          295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  374 (490)
Q Consensus       295 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (490)
                      ....  .....+||+.|+|||++.+..++.++|||||||+||||++|+.||.......   ....             +.
T Consensus       152 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~---~~~~-------------~~  213 (323)
T cd05584         152 HEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK---TIDK-------------IL  213 (323)
T ss_pred             cCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH---HHHH-------------HH
Confidence            2221  1234679999999999998889999999999999999999999997543211   1110             00


Q ss_pred             CCccCCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011250          375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  414 (490)
Q Consensus       375 ~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----t~~evl~~  414 (490)
                      ...  ..++...+..+.+||.+||+.||.+||     ++.+++++
T Consensus       214 ~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         214 KGK--LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             cCC--CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence            000  112223467899999999999999999     88888875

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.2e-42  Score=340.64  Aligned_cols=260  Identities=30%  Similarity=0.452  Sum_probs=209.5

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      ++|.+.+.||+|+||.||+|.+.....    ..++..||||.+...... ..+.+.+|+++|+.+.|+||+++++++...
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   80 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEP----ENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG   80 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccC----cCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence            468889999999999999998754210    124568999999765443 456889999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcC-------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRS-------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA  278 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~  278 (490)
                      ...++||||+++++|.+++...+             ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~  157 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGY  157 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcC
Confidence            99999999999999999986532             34788899999999999999999988   999999999999999


Q ss_pred             CCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhh
Q 011250          279 DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLV  357 (490)
Q Consensus       279 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~  357 (490)
                      ++.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......   ...
T Consensus       158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~  234 (280)
T cd05049         158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVI  234 (280)
T ss_pred             CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHH
Confidence            99999999999986543322222233456789999999999999999999999999999998 99998654321   111


Q ss_pred             HhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011250          358 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~  416 (490)
                      +.....              .....+...+..+.+|+.+||..||.+||++.||++.|+
T Consensus       235 ~~~~~~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         235 ECITQG--------------RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HHHHcC--------------CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            111100              001112234788999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-43  Score=358.76  Aligned_cols=255  Identities=29%  Similarity=0.354  Sum_probs=207.1

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|.+.+.||+|+||.||+|.+..         ++..||||++.....   .....+..|+.++..++|+||+++++++.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   71 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKD---------TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ   71 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECC---------CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee
Confidence            368999999999999999999876         577999999975422   33456888999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +++..++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~  147 (350)
T cd05573          72 DEEHLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGL  147 (350)
T ss_pred             cCCeEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCC
Confidence            999999999999999999999665 57999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCC---------------------------cceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCC
Q 011250          290 AKDAPEDG---------------------------KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR  342 (490)
Q Consensus       290 a~~~~~~~---------------------------~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~  342 (490)
                      +.......                           .........||+.|+|||++.+..++.++|||||||+||||++|+
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~  227 (350)
T cd05573         148 CKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF  227 (350)
T ss_pred             CccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCC
Confidence            98765432                           001123357999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCC-HHHHHHHh
Q 011250          343 RSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-MSEVVETL  415 (490)
Q Consensus       343 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt-~~evl~~L  415 (490)
                      .||...........      .....        ..+........+.++.+||.+||. ||.+||+ +.+++++.
T Consensus       228 ~Pf~~~~~~~~~~~------i~~~~--------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp  286 (350)
T cd05573         228 PPFYSDTLQETYNK------IINWK--------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP  286 (350)
T ss_pred             CCCCCCCHHHHHHH------HhccC--------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence            99976532111100      00000        000000011137889999999997 9999999 99999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.1e-42  Score=340.96  Aligned_cols=263  Identities=25%  Similarity=0.425  Sum_probs=207.8

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      +..++|++.+.||+|+||.||+|.+...    .....+..||||.+.... .....++.+|+.+++.++||||+++++++
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~----~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~   78 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   78 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccC----CCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            3456899999999999999999987532    112246689999986543 23345688999999999999999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcC---------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD  279 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~  279 (490)
                      .+....++||||+++++|.+++....         ..+++..+..++.|++.||.|||+.+   ++||||||+|||++++
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~  155 (277)
T cd05062          79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED  155 (277)
T ss_pred             cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCC
Confidence            99999999999999999999986432         23577888999999999999999988   9999999999999999


Q ss_pred             CCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhH
Q 011250          280 YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVE  358 (490)
Q Consensus       280 ~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~  358 (490)
                      +.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......   ....
T Consensus       156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~  232 (277)
T cd05062         156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLR  232 (277)
T ss_pred             CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH
Confidence            9999999999986644332222223456788999999998899999999999999999999 78888654221   1111


Q ss_pred             hhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011250          359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~  416 (490)
                      ....   ..           ....+..++..+.+|+.+||+.||++||++.++++.|+
T Consensus       233 ~~~~---~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         233 FVME---GG-----------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHHc---CC-----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            1100   00           00112234678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.6e-42  Score=365.30  Aligned_cols=270  Identities=22%  Similarity=0.325  Sum_probs=199.0

Q ss_pred             hhhHHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCC------
Q 011250          125 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH------  198 (490)
Q Consensus       125 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~H------  198 (490)
                      .+++....++|++.++||+|+||+||+|++..         ++..||||+++... ....++..|+.++..+.|      
T Consensus       121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~---------~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~  190 (467)
T PTZ00284        121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRK---------RKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADR  190 (467)
T ss_pred             CCccccCCCcEEEEEEEEeccCEEEEEEEEcC---------CCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccC
Confidence            34455567899999999999999999999876         56789999996432 223445667777776654      


Q ss_pred             CCeeceeeEEEeC-CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEE
Q 011250          199 PNLVKLVGYCIED-DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNILL  276 (490)
Q Consensus       199 pnIv~l~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlkp~NILl  276 (490)
                      .+|+++++++..+ ..+|||||++ +++|.+++.+. ..+++..+..|+.||+.||.|||+ .+   ||||||||+||||
T Consensus       191 ~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl  265 (467)
T PTZ00284        191 FPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILM  265 (467)
T ss_pred             cceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence            4588999988765 4688999998 78999988654 479999999999999999999997 47   9999999999999


Q ss_pred             cCCC----------------CeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh
Q 011250          277 DADY----------------NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT  340 (490)
Q Consensus       277 ~~~~----------------~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt  340 (490)
                      +.++                .+||+|||++.....     .....+||+.|+|||++.+..|+.++|||||||+||||++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ellt  340 (467)
T PTZ00284        266 ETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYT  340 (467)
T ss_pred             ecCCcccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHh
Confidence            8765                499999998864322     1234689999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCcchhhHhhhcccCC----------cchhhhc---cCCccC---------C--CCChhhHHHHHHHHHH
Q 011250          341 GRRSMDKNRPNGEHNLVEWARPHLGD----------KRRFYRL---LDPRLE---------G--HFSIKGSQKATQLAAQ  396 (490)
Q Consensus       341 G~~pf~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~---~~~~l~---------~--~~~~~~~~~l~~Li~~  396 (490)
                      |+.||+..........+......+..          ...++..   +.+...         .  .........+.+||.+
T Consensus       341 G~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~  420 (467)
T PTZ00284        341 GKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYG  420 (467)
T ss_pred             CCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHH
Confidence            99999765432222221111000000          0000000   000000         0  0000124568899999


Q ss_pred             hhhcCCCCCCCHHHHHHH
Q 011250          397 CLSRDPKARPRMSEVVET  414 (490)
Q Consensus       397 cL~~dP~~RPt~~evl~~  414 (490)
                      ||+.||.+|||+.|+|+|
T Consensus       421 mL~~dP~~R~ta~e~L~H  438 (467)
T PTZ00284        421 LLHYDRQKRLNARQMTTH  438 (467)
T ss_pred             hCCcChhhCCCHHHHhcC
Confidence            999999999999999976

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.8e-42  Score=334.38  Aligned_cols=249  Identities=26%  Similarity=0.402  Sum_probs=200.0

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEeCCceEEE
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  217 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  217 (490)
                      +.||+|+||.||+|.+..         ++..||+|.+..... .....+.+|+++++.++||||+++++++......+||
T Consensus         1 ~~lg~g~~g~vy~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   71 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRA---------DNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV   71 (252)
T ss_pred             CccCcccCccEEEEEEec---------CCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEE
Confidence            469999999999999876         566899998865432 3345689999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCCC
Q 011250          218 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG  297 (490)
Q Consensus       218 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~  297 (490)
                      |||+++++|.+++......+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus        72 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  148 (252)
T cd05084          72 MELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV  148 (252)
T ss_pred             EeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccc
Confidence            9999999999999766667899999999999999999999988   9999999999999999999999999987654321


Q ss_pred             cceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCC
Q 011250          298 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP  376 (490)
Q Consensus       298 ~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (490)
                      .........++..|+|||.+.++.++.++|||||||++|||++ |..||........   ....              ..
T Consensus       149 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~---~~~~--------------~~  211 (252)
T cd05084         149 YASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT---REAI--------------EQ  211 (252)
T ss_pred             ccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH---HHHH--------------Hc
Confidence            1111111223467999999998899999999999999999998 8888864322111   0000              00


Q ss_pred             ccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011250          377 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       377 ~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~  416 (490)
                      .....++...+..+.+|+.+||+.||++||++.+|++.|+
T Consensus       212 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         212 GVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            0111222334678999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-43  Score=377.70  Aligned_cols=265  Identities=30%  Similarity=0.450  Sum_probs=219.5

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC-CcccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .....+.+.||+|.||.||.|.........    ....||||.+... ..+...+|++|..+|+.++|||||+++|++.+
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~----~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~  766 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSV----SPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD  766 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCc----cceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence            345677889999999999999988643210    1346999998765 34556789999999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhc------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRR------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL  284 (490)
                      ....+|++|||.||+|..+|.+.      ...++....+.++.|||+|+.||++++   +|||||..+|+||++...|||
T Consensus       767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKI  843 (1025)
T KOG1095|consen  767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKI  843 (1025)
T ss_pred             CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEE
Confidence            99999999999999999999876      567999999999999999999999988   999999999999999999999


Q ss_pred             ecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcc
Q 011250          285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      +|||+|+.+.....+.......-...|||||.+..+.++.|+|||||||+|||++| |..||...........+      
T Consensus       844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~------  917 (1025)
T KOG1095|consen  844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV------  917 (1025)
T ss_pred             cccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH------
Confidence            99999997766655554433233578999999999999999999999999999999 88888765433222211      


Q ss_pred             cCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                      +...           +-..+..|+..+++||.+||+.+|++||++..|++.+..+.+
T Consensus       918 ~~gg-----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~  963 (1025)
T KOG1095|consen  918 LEGG-----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN  963 (1025)
T ss_pred             HhCC-----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence            1111           113345679999999999999999999999999997776544

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-43  Score=360.99  Aligned_cols=271  Identities=29%  Similarity=0.458  Sum_probs=218.1

Q ss_pred             hhHHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhccCCCCee
Q 011250          126 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLV  202 (490)
Q Consensus       126 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv  202 (490)
                      ..+.+.-++..+.++||+|+||.||+|.+...+..     ....||||..+...   ....+++++|+++|+.++|||||
T Consensus       150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~-----~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVV  224 (474)
T KOG0194|consen  150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGF-----KVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVV  224 (474)
T ss_pred             cccEEeccCccccceeecccccEEEEEEEEecCCc-----eeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEE
Confidence            34445556777789999999999999999864221     11228999988532   34567899999999999999999


Q ss_pred             ceeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCe
Q 011250          203 KLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       203 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~v  282 (490)
                      ++||++..+..++||||+|.||+|.++|.+....++..+...++.+++.||+|||+++   +|||||-.+|+|++.++.+
T Consensus       225 r~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~v  301 (474)
T KOG0194|consen  225 RFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVV  301 (474)
T ss_pred             EEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeE
Confidence            9999999999999999999999999999888778999999999999999999999988   9999999999999999999


Q ss_pred             EEecccCcccCCCCCcceeee-ccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 011250          283 KLSDFGLAKDAPEDGKTHVST-RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~-~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~  360 (490)
                      ||+|||+++.....   .... ...-...|+|||.+..+.|+.++|||||||++||+++ |..||.+.........+   
T Consensus       302 KISDFGLs~~~~~~---~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI---  375 (474)
T KOG0194|consen  302 KISDFGLSRAGSQY---VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKI---  375 (474)
T ss_pred             EeCccccccCCcce---eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHH---
Confidence            99999999876411   1111 1124579999999999999999999999999999999 78888765332111111   


Q ss_pred             hcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccccc
Q 011250          361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKD  423 (490)
Q Consensus       361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~~~~  423 (490)
                                   .........+...+.++..++.+||..||++||+|.++.+.|+.+.....
T Consensus       376 -------------~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  376 -------------VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             -------------HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence                         00111112233458899999999999999999999999999988765543

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=7.1e-43  Score=350.79  Aligned_cols=248  Identities=28%  Similarity=0.376  Sum_probs=199.9

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhccCC-CCeeceeeEEE
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLH-PNLVKLVGYCI  209 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~  209 (490)
                      +|++.+.||+|+||.||+|++..         ++..||||++....   ....+.+..|+.++..+.| ++|+.+++++.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~   71 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKG---------TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ   71 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE
Confidence            58899999999999999999875         56789999997542   2234567889999999976 56888999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +.+..|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~  147 (324)
T cd05587          72 TMDRLYFVMEYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGM  147 (324)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCc
Confidence            999999999999999999988554 46899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +........  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......   .......   ..   
T Consensus       148 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i~---~~---  216 (324)
T cd05587         148 CKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQSIM---EH---  216 (324)
T ss_pred             ceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHH---cC---
Confidence            875422211  123467999999999999999999999999999999999999999754321   1111110   00   


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM-----SEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~-----~evl~~  414 (490)
                               ...++...+.++.+|+.+||..||.+|++.     .+++++
T Consensus       217 ---------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         217 ---------NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                     111222346789999999999999999986     555544

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.5e-42  Score=339.50  Aligned_cols=260  Identities=27%  Similarity=0.458  Sum_probs=207.9

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      .+|++.+.||+|+||.||+|.+...+.     ..+..||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   79 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGM-----DHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE   79 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCC-----CCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence            468889999999999999998753221     1567899999875432 3346788999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRS----------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  275 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~----------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NIL  275 (490)
                      +..|+||||+++++|.+++....                ..+++..+..++.|++.||.|||+.+   |+||||||+|||
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nil  156 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNIL  156 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEE
Confidence            99999999999999999985321                24788899999999999999999988   999999999999


Q ss_pred             EcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcc
Q 011250          276 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEH  354 (490)
Q Consensus       276 l~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~  354 (490)
                      ++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......   
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---  233 (283)
T cd05090         157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---  233 (283)
T ss_pred             EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---
Confidence            99999999999999987644332222334456788999999988889999999999999999998 99898653221   


Q ss_pred             hhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011250          355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  417 (490)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~  417 (490)
                      .+.+......              ....+..++..+.+++.+||+.||.+||++.+|+++|..
T Consensus       234 ~~~~~~~~~~--------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         234 EVIEMVRKRQ--------------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHHcCC--------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            1111111100              001122346789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=9.6e-43  Score=351.83  Aligned_cols=265  Identities=27%  Similarity=0.409  Sum_probs=207.4

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcc-CCCCeeceeeEE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKLVGYC  208 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~  208 (490)
                      ..++|++.+.||+|+||.||+|.....+.    ..+++.||+|++..... ...+.+..|+.++.++ +|+||+++++++
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~----~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~   80 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEK----SASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGAC   80 (337)
T ss_pred             CHHHhhhhcccccCcCceEEecccccccc----ccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence            34579999999999999999997643211    12567899999875432 2345678899999999 799999999988


Q ss_pred             EeC-CceEEEEEecCCCChhHHhhhcC-----------------------------------------------------
Q 011250          209 IED-DQRLLVYEFMPRGSLENHLFRRS-----------------------------------------------------  234 (490)
Q Consensus       209 ~~~-~~~~lV~E~~~~gsL~~~l~~~~-----------------------------------------------------  234 (490)
                      ... ..+++||||+++++|.+++....                                                     
T Consensus        81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (337)
T cd05054          81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE  160 (337)
T ss_pred             ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence            654 56889999999999999885321                                                     


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCCCcceeeecccc
Q 011250          235 -------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG  307 (490)
Q Consensus       235 -------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~G  307 (490)
                             ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.++|+|||+++...............+
T Consensus       161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~  237 (337)
T cd05054         161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  237 (337)
T ss_pred             hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCC
Confidence                   25789999999999999999999988   99999999999999999999999999987644322222233456


Q ss_pred             CCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhh
Q 011250          308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKG  386 (490)
Q Consensus       308 t~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  386 (490)
                      +..|+|||++.+..++.++|||||||+||||++ |..||........  +.....    ..          .....+...
T Consensus       238 ~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~~~~----~~----------~~~~~~~~~  301 (337)
T cd05054         238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCRRLK----EG----------TRMRAPEYA  301 (337)
T ss_pred             CccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHHHHh----cc----------CCCCCCccC
Confidence            788999999999999999999999999999998 9999965322111  111110    00          000111223


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          387 SQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       387 ~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                      +.++.+|+.+||+.+|++||++.+|+++|+.+
T Consensus       302 ~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~  333 (337)
T cd05054         302 TPEIYSIMLDCWHNNPEDRPTFSELVEILGDL  333 (337)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            67899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-43  Score=360.16  Aligned_cols=255  Identities=23%  Similarity=0.307  Sum_probs=200.5

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|.+.+.||+|+||.||+|.+..         ++..||||++.....   ...+.+.+|+.++..+.||||+++++++.
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~   71 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKD---------TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ   71 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECC---------CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence            368999999999999999998876         677899999865421   23356788999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +.+..||||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus        72 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGl  147 (377)
T cd05629          72 DAQYLYLIMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGL  147 (377)
T ss_pred             cCCeeEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccc
Confidence            999999999999999999998654 57899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcc---------------------------------------------eeeeccccCCCccCcchhccCCCCc
Q 011250          290 AKDAPEDGKT---------------------------------------------HVSTRVMGTYGYAAPEYVMTGHLTS  324 (490)
Q Consensus       290 a~~~~~~~~~---------------------------------------------~~~~~~~Gt~~y~aPE~l~~~~~~~  324 (490)
                      ++........                                             ......+||+.|+|||++.+..++.
T Consensus       148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  227 (377)
T cd05629         148 STGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ  227 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCC
Confidence            9643211000                                             0001247999999999999889999


Q ss_pred             cchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCC
Q 011250          325 KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA  404 (490)
Q Consensus       325 ~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~  404 (490)
                      ++|||||||+||||++|..||..........   ..   ......+      .+..  ....+.++.+||.+||. +|.+
T Consensus       228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~---~i---~~~~~~~------~~p~--~~~~s~~~~dli~~lL~-~~~~  292 (377)
T cd05629         228 ECDWWSLGAIMFECLIGWPPFCSENSHETYR---KI---INWRETL------YFPD--DIHLSVEAEDLIRRLIT-NAEN  292 (377)
T ss_pred             ceeeEecchhhhhhhcCCCCCCCCCHHHHHH---HH---HccCCcc------CCCC--CCCCCHHHHHHHHHHhc-CHhh
Confidence            9999999999999999999996543211100   00   0000000      0000  01236789999999997 7776


Q ss_pred             C---CCHHHHHHHh
Q 011250          405 R---PRMSEVVETL  415 (490)
Q Consensus       405 R---Pt~~evl~~L  415 (490)
                      |   +++.+++++-
T Consensus       293 r~~r~~~~~~l~hp  306 (377)
T cd05629         293 RLGRGGAHEIKSHP  306 (377)
T ss_pred             cCCCCCHHHHhcCC
Confidence            5   5999998763

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2e-42  Score=336.61  Aligned_cols=255  Identities=27%  Similarity=0.414  Sum_probs=208.5

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      .+|.+.+.||+|+||.||+|.+..         ++..||+|.+..+. ....++.+|+++++.++|+||+++++++..++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~---------~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP   75 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEec---------CCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCC
Confidence            468888999999999999999876         56689999987543 34567899999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          213 QRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      ..++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~  152 (263)
T cd05052          76 PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR  152 (263)
T ss_pred             CcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccc
Confidence            999999999999999998653 346899999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||......   .......         
T Consensus       153 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~~~~~~---------  219 (263)
T cd05052         153 LMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELLE---------  219 (263)
T ss_pred             ccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHH---------
Confidence            76543221 1112234678999999998899999999999999999998 99998653211   1111110         


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                           .......+...+.++.+|+.+||..||++||++.++++.|+.+
T Consensus       220 -----~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         220 -----KGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             -----CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence                 1111122334478899999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=7.2e-43  Score=349.61  Aligned_cols=243  Identities=29%  Similarity=0.421  Sum_probs=194.4

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhc-cCCCCeeceeeEEEeCCce
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGN-LLHPNLVKLVGYCIEDDQR  214 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~  214 (490)
                      ++||+|+||.||+|++..         ++..||||+++....   ...+.+..|..++.. +.||||+++++++..++..
T Consensus         1 ~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~   71 (316)
T cd05592           1 KVLGKGSFGKVMLAELKG---------TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHL   71 (316)
T ss_pred             CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence            369999999999999875         567899999975421   223455667777765 4799999999999999999


Q ss_pred             EEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCC
Q 011250          215 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~  294 (490)
                      ++||||+++|+|..++... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        72 ~lv~e~~~gg~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~  147 (316)
T cd05592          72 FFVMEYLNGGDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENM  147 (316)
T ss_pred             EEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence            9999999999999988554 47999999999999999999999988   9999999999999999999999999997653


Q ss_pred             CCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhcc
Q 011250          295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  374 (490)
Q Consensus       295 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (490)
                      ...  ......+||+.|+|||++.+..++.++|||||||++|||++|..||......   .+....   ...        
T Consensus       148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---~~~~~i---~~~--------  211 (316)
T cd05592         148 NGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---ELFDSI---LND--------  211 (316)
T ss_pred             CCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---HHHHHH---HcC--------
Confidence            322  1223467999999999999889999999999999999999999999754321   111110   000        


Q ss_pred             CCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHH-HHHHH
Q 011250          375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS-EVVET  414 (490)
Q Consensus       375 ~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~-evl~~  414 (490)
                          ...++...+.++.+|+.+||+.||.+||++. +++++
T Consensus       212 ----~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05592         212 ----RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH  248 (316)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence                0112223467889999999999999999875 55443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.9e-43  Score=354.35  Aligned_cols=254  Identities=25%  Similarity=0.283  Sum_probs=205.5

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|.+.+.||+|+||.||+|.+..         ++..||||+++....   ...+.+.+|+.+++.+.|+||+++++++.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~   71 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKA---------TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ   71 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe
Confidence            368999999999999999998876         567899999975432   23456788999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +.+..+|||||+++|+|.+++.+....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~  148 (330)
T cd05601          72 DKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGS  148 (330)
T ss_pred             cCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCC
Confidence            999999999999999999999776568999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhc------cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVM------TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      +......... ......||+.|+|||++.      ...++.++|||||||++|||++|..||........      ....
T Consensus       149 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i  221 (330)
T cd05601         149 AARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT------YNNI  221 (330)
T ss_pred             CeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH------HHHH
Confidence            9876543222 223357999999999986      45678999999999999999999999975432111      0000


Q ss_pred             cCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      +... ..       +.-......+..+.+|+.+||. ||.+||++.+++++
T Consensus       222 ~~~~-~~-------~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         222 MNFQ-RF-------LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             HcCC-Cc-------cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            0000 00       0000111237789999999997 99999999999865

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-43  Score=350.83  Aligned_cols=271  Identities=27%  Similarity=0.443  Sum_probs=227.1

Q ss_pred             hhhhHHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC-CcccHHHHHHHHHHHhccCCCCee
Q 011250          124 MFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHPNLV  202 (490)
Q Consensus       124 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv  202 (490)
                      ...++.+..+...+.++||+|.||.||+|......     ++....||||..+.+ .....+.|+.|..+|+.++|||||
T Consensus       380 ~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~-----kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIi  454 (974)
T KOG4257|consen  380 TVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPE-----KGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHII  454 (974)
T ss_pred             CCCcceeehhhccHHHhhcCCcccceeeeEecccc-----cCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchh
Confidence            33445556667778899999999999999987642     335667999999875 445567799999999999999999


Q ss_pred             ceeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCe
Q 011250          203 KLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       203 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~v  282 (490)
                      +++|+|.+. ..|||||+++-|.|..+|..+...|+......++.||+.||.|||+..   +|||||..+|||+.....|
T Consensus       455 kLIGv~~e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CV  530 (974)
T KOG4257|consen  455 KLIGVCVEQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCV  530 (974)
T ss_pred             heeeeeecc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCccee
Confidence            999998764 689999999999999999988889999999999999999999999977   9999999999999999999


Q ss_pred             EEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhh
Q 011250          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~  361 (490)
                      ||+|||+++.+.+...+... ...-.+.|||||.++-..++.++|||.|||++||++. |..||.+-...+..-.++   
T Consensus       531 KLaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE---  606 (974)
T KOG4257|consen  531 KLADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE---  606 (974)
T ss_pred             eecccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec---
Confidence            99999999999877666543 3445678999999999999999999999999999765 999997654443322111   


Q ss_pred             cccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccc
Q 011250          362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~~  421 (490)
                          ..          -....+++|++.++.|+.+||+.||.+||.+.+|...|..+...
T Consensus       607 ----nG----------eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe  652 (974)
T KOG4257|consen  607 ----NG----------ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE  652 (974)
T ss_pred             ----CC----------CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence                11          12245677899999999999999999999999999999776543

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=6.5e-43  Score=350.53  Aligned_cols=243  Identities=29%  Similarity=0.427  Sum_probs=196.4

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcc-CCCCeeceeeEEEeCCce
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIEDDQR  214 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~  214 (490)
                      ++||+|+||.||+|++..         ++..||||++....   ....+.+..|+.++..+ .||||+++++++...+..
T Consensus         1 ~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   71 (320)
T cd05590           1 RVLGKGSFGKVMLARLKE---------SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRL   71 (320)
T ss_pred             CeeeeCCCeEEEEEEEcC---------CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEE
Confidence            469999999999999876         56789999987542   22345677888888876 699999999999999999


Q ss_pred             EEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCC
Q 011250          215 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~  294 (490)
                      ||||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        72 ~iv~Ey~~~g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~  147 (320)
T cd05590          72 FFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  147 (320)
T ss_pred             EEEEcCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecC
Confidence            9999999999999988554 47999999999999999999999988   9999999999999999999999999987643


Q ss_pred             CCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhcc
Q 011250          295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  374 (490)
Q Consensus       295 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (490)
                      ....  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +....   ....       
T Consensus       148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~~~~i---~~~~-------  212 (320)
T cd05590         148 FNGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD---LFEAI---LNDE-------  212 (320)
T ss_pred             cCCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HHHHH---hcCC-------
Confidence            2211  1234679999999999998899999999999999999999999997543211   11111   1000       


Q ss_pred             CCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 011250          375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM------SEVVET  414 (490)
Q Consensus       375 ~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~------~evl~~  414 (490)
                           ..++...+.++.+||.+||+.||.+||++      ++++++
T Consensus       213 -----~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         213 -----VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence                 01122236789999999999999999998      566544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-44  Score=358.55  Aligned_cols=254  Identities=26%  Similarity=0.418  Sum_probs=212.7

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      +.|.|+..||.|+||.||+|..++         ++...|.|+|........++++-||.||..+.||+||+|++.|+.++
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nke---------t~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en  102 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKE---------TKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN  102 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhccc---------chhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC
Confidence            458889999999999999998876         55577889988777777889999999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      .+||+.|||.||-++..+..-+..|.+.++..+++|++.||.|||+++   |||||||..|||++-+|.++|+|||.+..
T Consensus       103 kLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAK  179 (1187)
T KOG0579|consen  103 KLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAK  179 (1187)
T ss_pred             ceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeeccccccc
Confidence            999999999999999999888889999999999999999999999988   99999999999999999999999999865


Q ss_pred             CCCCCcceeeeccccCCCccCcchhc-----cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011250          293 APEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      ...  .......+.|||+|||||+++     ...|++++|||||||+|.||..+.+|-....+...  ++..+...-   
T Consensus       180 n~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV--llKiaKSeP---  252 (1187)
T KOG0579|consen  180 NKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIAKSEP---  252 (1187)
T ss_pred             chh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH--HHHHhhcCC---
Confidence            422  122234589999999999886     35899999999999999999999999765433222  222221110   


Q ss_pred             chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                         +.++.       +...+..+.+|+.+||.+||..||+++++++|-
T Consensus       253 ---PTLlq-------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp  290 (1187)
T KOG0579|consen  253 ---PTLLQ-------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP  290 (1187)
T ss_pred             ---CcccC-------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence               01111       223478899999999999999999999999864

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=5.3e-43  Score=359.71  Aligned_cols=253  Identities=26%  Similarity=0.315  Sum_probs=200.0

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      +|.+++.||+|+||.||+|++..         ++..||+|++.....   .....+.+|+.+++.+.|+||+++++++.+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~   72 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVD---------TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD   72 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECC---------CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe
Confidence            58899999999999999999876         567899999875422   233567889999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      ++..|||||||++|+|.+++.+. ..+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla  148 (382)
T cd05625          73 KDNLYFVMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLC  148 (382)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCC
Confidence            99999999999999999998654 46899999999999999999999988   999999999999999999999999997


Q ss_pred             ccCCCCC---------------------------------------------cceeeeccccCCCccCcchhccCCCCcc
Q 011250          291 KDAPEDG---------------------------------------------KTHVSTRVMGTYGYAAPEYVMTGHLTSK  325 (490)
Q Consensus       291 ~~~~~~~---------------------------------------------~~~~~~~~~Gt~~y~aPE~l~~~~~~~~  325 (490)
                      .......                                             ........+||+.|+|||++.+..++.+
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~  228 (382)
T cd05625         149 TGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL  228 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe
Confidence            5321000                                             0001123579999999999999999999


Q ss_pred             chhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCC
Q 011250          326 SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR  405 (490)
Q Consensus       326 sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~R  405 (490)
                      +|||||||+||||++|++||....+......+  .  ..          ...+........+.++.+||.+|+ .||.+|
T Consensus       229 ~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i--~--~~----------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R  293 (382)
T cd05625         229 CDWWSVGVILYEMLVGQPPFLAQTPLETQMKV--I--NW----------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDR  293 (382)
T ss_pred             eeEEechHHHHHHHhCCCCCCCCCHHHHHHHH--H--cc----------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHc
Confidence            99999999999999999999754322111000  0  00          000000011123678899999976 599999


Q ss_pred             CC---HHHHHHH
Q 011250          406 PR---MSEVVET  414 (490)
Q Consensus       406 Pt---~~evl~~  414 (490)
                      ++   +.++++|
T Consensus       294 ~~~~~~~ei~~h  305 (382)
T cd05625         294 LGKNGADEIKAH  305 (382)
T ss_pred             CCCCCHHHHhcC
Confidence            87   8888865

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.6e-42  Score=340.62  Aligned_cols=264  Identities=29%  Similarity=0.446  Sum_probs=211.8

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      .+|.+.+.||+|+||.||++.+....    ...++..||+|.+........+.+.+|+.+++.+.||||+++++++...+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~----~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLC----PEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   80 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCC----CCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            46899999999999999999864310    11245679999987665555667999999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcC------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC
Q 011250          213 QRLLVYEFMPRGSLENHLFRRS------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY  280 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~  280 (490)
                      ..++||||+++++|.+++....            ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~  157 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENL  157 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCC
Confidence            9999999999999999986432            24899999999999999999999988   99999999999999999


Q ss_pred             CeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHh
Q 011250          281 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEW  359 (490)
Q Consensus       281 ~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~  359 (490)
                      .++|+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||.......   ....
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~~  234 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIEC  234 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH
Confidence            999999999986644332222233456789999999998899999999999999999998 899986543211   1111


Q ss_pred             hhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                      .....     .     .    ..+...+.++.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus       235 i~~~~-----~-----~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         235 ITQGR-----V-----L----QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             HHcCC-----c-----C----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            11000     0     0    0111236789999999999999999999999999987753

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.6e-42  Score=341.98  Aligned_cols=265  Identities=25%  Similarity=0.363  Sum_probs=198.2

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcc---CCCCeeceeeE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNL---LHPNLVKLVGY  207 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l---~HpnIv~l~~~  207 (490)
                      ++|++.+.||+|+||.||+|.+...        .+..||||.+.....  .....+.+|+.+++.+   .||||++++++
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~   72 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKN--------GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV   72 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCC--------CCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEE
Confidence            3689999999999999999987542        356899999865432  2234566777777765   69999999998


Q ss_pred             EEe-----CCceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCC
Q 011250          208 CIE-----DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       208 ~~~-----~~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                      +..     ....++||||++ ++|.+++... ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus        73 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~  148 (290)
T cd07862          73 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQ  148 (290)
T ss_pred             EecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCC
Confidence            852     356899999995 6999888653 345899999999999999999999988   999999999999999999


Q ss_pred             eEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhh-Hhh
Q 011250          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWA  360 (490)
Q Consensus       282 vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~-~~~  360 (490)
                      +||+|||+++.....   .......||+.|+|||++....++.++|||||||++|||++|.+||...........+ ...
T Consensus       149 ~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~  225 (290)
T cd07862         149 IKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI  225 (290)
T ss_pred             EEEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh
Confidence            999999999865432   1223457899999999998889999999999999999999999999765432211111 000


Q ss_pred             hcccCCcchhh-------hccCCccC---CCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          361 RPHLGDKRRFY-------RLLDPRLE---GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       361 ~~~~~~~~~~~-------~~~~~~l~---~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .  ......+.       ..+.+...   ..+....+..+.+|+.+||+.||++|||+.+++++
T Consensus       226 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         226 G--LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             C--CCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            0  00000000       00000000   00112236778999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.6e-42  Score=341.05  Aligned_cols=264  Identities=28%  Similarity=0.441  Sum_probs=213.5

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      ++|.+.+.||+|+||.||+|.+.....    ..++..|++|.+........+.+.+|+.+++.++|+||+++++++...+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~----~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSP----TKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD   80 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCC----CCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence            468889999999999999998654211    1245679999987766655678999999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD  277 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~  277 (490)
                      ..++||||+++++|.+++....               ..+++..++.++.||+.||+|||+.+   |+||||||+|||++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~  157 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVG  157 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEc
Confidence            9999999999999999986432               34889999999999999999999988   99999999999999


Q ss_pred             CCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchh
Q 011250          278 ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNL  356 (490)
Q Consensus       278 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~  356 (490)
                      .++.++|+|||++................|+..|+|||++.+..++.++|||||||++|||++ |..||.......   .
T Consensus       158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~  234 (291)
T cd05094         158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---V  234 (291)
T ss_pred             cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H
Confidence            999999999999986654333333334567889999999998999999999999999999998 999986543211   1


Q ss_pred             hHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                      .+......              ....+...+..+.+|+.+||+.||.+||++.+|++.|+.+..
T Consensus       235 ~~~~~~~~--------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         235 IECITQGR--------------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             HHHHhCCC--------------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            11111000              001112236789999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.4e-42  Score=338.26  Aligned_cols=262  Identities=26%  Similarity=0.393  Sum_probs=206.7

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      .+|++.+.||+|+||+||+|.+..++..     ....|++|.+..... ....++..|+.++..+.||||+++++++. .
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~   80 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDS-----IKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G   80 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCc-----eeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence            4688999999999999999998653221     123588888764422 23356788899999999999999999875 4


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      ...++|+||+++|+|.+++......+++..+..++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~  157 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVAD  157 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccce
Confidence            5678999999999999999776678999999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ...............|+..|+|||.+.+..++.++|||||||++|||++ |..||.......   ..+....    ..  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~~~~----~~--  228 (279)
T cd05111         158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VPDLLEK----GE--  228 (279)
T ss_pred             eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHC----CC--
Confidence            7644332222234567889999999998899999999999999999998 999997543221   1111110    00  


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                              ....+..++..+.+++.+||..||.+||++.|+++.|..+.+
T Consensus       229 --------~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         229 --------RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             --------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence                    000111235678899999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.2e-43  Score=340.85  Aligned_cols=259  Identities=26%  Similarity=0.375  Sum_probs=201.4

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC-
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD-  212 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-  212 (490)
                      .|...+++|.|+||.||+|....         ++..||||+.-.+..    .-.+|+++|+.+.|||||+|..+|.... 
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e---------~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~   91 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRE---------TEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTE   91 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcC---------CCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCC
Confidence            47778999999999999999987         466899998865432    2247999999999999999998887532 


Q ss_pred             ----ceEEEEEecCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-CCeEE
Q 011250          213 ----QRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAKL  284 (490)
Q Consensus       213 ----~~~lV~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~-~~vkL  284 (490)
                          ...||||||+. +|.+.+..   ....++...+.-+.+||++||.|||+.+   |+||||||.|||+|.+ |.+||
T Consensus        92 ~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKi  167 (364)
T KOG0658|consen   92 SDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKI  167 (364)
T ss_pred             CchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEe
Confidence                34589999975 99988863   3567888889999999999999999988   9999999999999976 99999


Q ss_pred             ecccCcccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011250          285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      ||||.|+.+......   .....|..|.|||++.+ ..|+.+.||||.||++.||+-|++.|.+....+.  +++.+.-.
T Consensus       168 cDFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ--L~eIik~l  242 (364)
T KOG0658|consen  168 CDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ--LVEIIKVL  242 (364)
T ss_pred             ccCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH--HHHHHHHh
Confidence            999999987654332   33567999999999886 4899999999999999999999999987544333  33322211


Q ss_pred             cCCcchhhhccCCc--------c-----CCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          364 LGDKRRFYRLLDPR--------L-----EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       364 ~~~~~~~~~~~~~~--------l-----~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      -.........+++.        +     ...+....++++.+|+.++|..+|.+|.++.|++.+
T Consensus       243 G~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  243 GTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             CCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence            11111111111111        1     112334558999999999999999999999999864

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-42  Score=357.63  Aligned_cols=263  Identities=21%  Similarity=0.244  Sum_probs=200.2

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ...+|.+.+.||+|+||.||+|.+..         +++.||||....      ..+.+|+++|+.|+|||||++++++..
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~---------~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~  154 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNK---------TCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTY  154 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECC---------CCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEE
Confidence            34579999999999999999999876         677899997532      346789999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      ....++|||++ +++|..++... ..+++..++.|+.||+.||.|||+.+   ||||||||+|||++.++.+||+|||++
T Consensus       155 ~~~~~lv~e~~-~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a  229 (391)
T PHA03212        155 NKFTCLILPRY-KTDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAA  229 (391)
T ss_pred             CCeeEEEEecC-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcc
Confidence            99999999999 57898888554 46899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCc-----chhhHhhhcc--
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-----HNLVEWARPH--  363 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~-----~~~~~~~~~~--  363 (490)
                      +....... ......+||+.|+|||++.+..++.++|||||||+||||++|..||........     ..+.......  
T Consensus       230 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~  308 (391)
T PHA03212        230 CFPVDINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGT  308 (391)
T ss_pred             cccccccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcC
Confidence            75432211 122346799999999999988999999999999999999999988754321110     0010000000  


Q ss_pred             ----cC--Cc---chhh-hcc-----CCccCCCC--ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          364 ----LG--DK---RRFY-RLL-----DPRLEGHF--SIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       364 ----~~--~~---~~~~-~~~-----~~~l~~~~--~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                          ..  ..   ...+ ...     .+.....+  ....+.++.+||.+||+.||.+|||+.|++++
T Consensus       309 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        309 HPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             ChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence                00  00   0000 000     00000000  01236689999999999999999999999964

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=8.9e-43  Score=349.63  Aligned_cols=243  Identities=28%  Similarity=0.412  Sum_probs=197.3

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcc-CCCCeeceeeEEEeCCce
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNL-LHPNLVKLVGYCIEDDQR  214 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~  214 (490)
                      ++||+|+||.||+|++..         ++..||||++.....   .....+..|+.++..+ +||||+++++++.+.+..
T Consensus         1 ~~lG~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~   71 (321)
T cd05591           1 KVLGKGSFGKVMLAELKG---------TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRL   71 (321)
T ss_pred             CccccCCCeEEEEEEECC---------CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeE
Confidence            469999999999999875         567899999975422   2334577899998866 799999999999999999


Q ss_pred             EEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCC
Q 011250          215 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~  294 (490)
                      ||||||+++|+|..++... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        72 ~lv~E~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~  147 (321)
T cd05591          72 FFVMEYVNGGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGI  147 (321)
T ss_pred             EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecc
Confidence            9999999999999888544 47899999999999999999999988   9999999999999999999999999987643


Q ss_pred             CCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhcc
Q 011250          295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  374 (490)
Q Consensus       295 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (490)
                      ....  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......   ......   ....       
T Consensus       148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---~~~~~i---~~~~-------  212 (321)
T cd05591         148 LNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---DLFESI---LHDD-------  212 (321)
T ss_pred             cCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH---HHHHHH---HcCC-------
Confidence            2221  123467999999999999889999999999999999999999999754321   111111   0000       


Q ss_pred             CCccCCCCChhhHHHHHHHHHHhhhcCCCCCC-------CHHHHHHH
Q 011250          375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-------RMSEVVET  414 (490)
Q Consensus       375 ~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-------t~~evl~~  414 (490)
                           ..++...+.++.+|+.+||+.||.+||       ++.+++++
T Consensus       213 -----~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         213 -----VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence                 011222367899999999999999999       78888866

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.5e-43  Score=360.23  Aligned_cols=253  Identities=25%  Similarity=0.281  Sum_probs=201.5

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      +|++.+.||+|+||.||+|++..         ++..||||++.....   .....+.+|+.+|+.+.|+||+++++++.+
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~   72 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVD---------TNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD   72 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECC---------CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc
Confidence            69999999999999999999876         577899999865422   223567889999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      ++.+|||||||++|+|.+++.+. ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        73 ~~~~~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a  148 (376)
T cd05598          73 KDNLYFVMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLC  148 (376)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCC
Confidence            99999999999999999998654 46899999999999999999999988   999999999999999999999999997


Q ss_pred             ccCCCCC-----------------------------------------cceeeeccccCCCccCcchhccCCCCccchhh
Q 011250          291 KDAPEDG-----------------------------------------KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVY  329 (490)
Q Consensus       291 ~~~~~~~-----------------------------------------~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvw  329 (490)
                      ..+....                                         ........+||+.|||||++.+..++.++|||
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw  228 (376)
T cd05598         149 TGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW  228 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeee
Confidence            5321000                                         00001235799999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCC---
Q 011250          330 SFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP---  406 (490)
Q Consensus       330 SlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP---  406 (490)
                      ||||+||||++|+.||....+......+.      ...        ..+........+.++.+||.+|+ .+|.+|+   
T Consensus       229 SlGvilyell~G~~Pf~~~~~~~~~~~i~------~~~--------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~  293 (376)
T cd05598         229 SVGVILYEMLVGQPPFLADTPAETQLKVI------NWE--------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKN  293 (376)
T ss_pred             eccceeeehhhCCCCCCCCCHHHHHHHHh------ccC--------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCC
Confidence            99999999999999997654321111000      000        00000111223678899999976 5999999   


Q ss_pred             CHHHHHHH
Q 011250          407 RMSEVVET  414 (490)
Q Consensus       407 t~~evl~~  414 (490)
                      ++.+++++
T Consensus       294 t~~ell~h  301 (376)
T cd05598         294 GADEIKAH  301 (376)
T ss_pred             CHHHHhCC
Confidence            89999977

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.6e-42  Score=349.04  Aligned_cols=250  Identities=26%  Similarity=0.400  Sum_probs=198.1

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcc-CCCCeeceeeEEEeCCce
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNL-LHPNLVKLVGYCIEDDQR  214 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~  214 (490)
                      ++||+|+||.||+|++..         ++..||||+++....   .....+..|+.++..+ +||||+++++++.+.+..
T Consensus         1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~   71 (329)
T cd05588           1 RVIGRGSYAKVLLVELKK---------TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRL   71 (329)
T ss_pred             CeEeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEE
Confidence            469999999999999876         567899999975422   2334578899999988 699999999999999999


Q ss_pred             EEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCC
Q 011250          215 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~  294 (490)
                      ||||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        72 ~lv~e~~~~g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~  147 (329)
T cd05588          72 FFVIEFVSGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI  147 (329)
T ss_pred             EEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccc
Confidence            9999999999999888544 57999999999999999999999988   9999999999999999999999999987532


Q ss_pred             CCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCC--cchhhHhhhcccCCcchhhh
Q 011250          295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG--EHNLVEWARPHLGDKRRFYR  372 (490)
Q Consensus       295 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~  372 (490)
                      ....  .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||+......  .....++....         
T Consensus       148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~---------  216 (329)
T cd05588         148 RPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV---------  216 (329)
T ss_pred             cCCC--ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH---------
Confidence            2211  1234689999999999999999999999999999999999999997432211  11111111000         


Q ss_pred             ccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCC------HHHHHHH
Q 011250          373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR------MSEVVET  414 (490)
Q Consensus       373 ~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt------~~evl~~  414 (490)
                      +....  ..++...+..+.+||.+||+.||.+|++      +.+++++
T Consensus       217 ~~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         217 ILEKQ--IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             HHcCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence            00100  0122234678999999999999999997      6677655

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1e-42  Score=349.53  Aligned_cols=242  Identities=26%  Similarity=0.374  Sum_probs=197.1

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcc-CCCCeeceeeEEE
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  209 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~  209 (490)
                      +|.+.+.||+|+||.||+|++..         ++..||||++.....   ...+.+..|..++..+ .|++|+++++++.
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~   71 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKG---------TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ   71 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe
Confidence            58889999999999999998875         567899999976432   2234567788888877 4899999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +.+..||||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~  147 (323)
T cd05616          72 TMDRLYFVMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGM  147 (323)
T ss_pred             cCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCC
Confidence            999999999999999999988554 46899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      ++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+.....        
T Consensus       148 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~i~--------  214 (323)
T cd05616         148 CKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQSIM--------  214 (323)
T ss_pred             ceecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHHHHHH--------
Confidence            975432221  123467999999999999999999999999999999999999999754321   1111110        


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCH
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM  408 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~  408 (490)
                           ..  ...++...+.++.+|+.+||+.||.+|++.
T Consensus       215 -----~~--~~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         215 -----EH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             -----hC--CCCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence                 00  011223347889999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.4e-42  Score=367.14  Aligned_cols=255  Identities=26%  Similarity=0.331  Sum_probs=206.1

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      ..++|.+.+.||+|+||+||+|++..         ++..||||++.....  .....+.+|+.++..++|+||+++++.+
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~---------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~  100 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVS---------DGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDF  100 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcC---------CCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecce
Confidence            34689999999999999999998876         577999999876533  3345678899999999999999998877


Q ss_pred             EeCC--------ceEEEEEecCCCChhHHhhhc---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc
Q 011250          209 IEDD--------QRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD  277 (490)
Q Consensus       209 ~~~~--------~~~lV~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~  277 (490)
                      ...+        .+++||||+++|+|.++|...   ...+++..+..++.|++.||.|||+.+   |+||||||+||||+
T Consensus       101 ~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~  177 (496)
T PTZ00283        101 AKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLC  177 (496)
T ss_pred             ecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEe
Confidence            5432        367999999999999988643   346899999999999999999999988   99999999999999


Q ss_pred             CCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 011250          278 ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV  357 (490)
Q Consensus       278 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~  357 (490)
                      .++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||+||||++|+.||......      
T Consensus       178 ~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------  251 (496)
T PTZ00283        178 SNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------  251 (496)
T ss_pred             CCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------
Confidence            99999999999998764332222334568999999999999989999999999999999999999999653211      


Q ss_pred             HhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          358 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      +.....+...           ...++...+.++.+|+.+||+.||.+||++.+++++
T Consensus       252 ~~~~~~~~~~-----------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        252 EVMHKTLAGR-----------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHHHHHhcCC-----------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            1111111000           011223347889999999999999999999999875

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.1e-42  Score=348.25  Aligned_cols=243  Identities=28%  Similarity=0.410  Sum_probs=195.3

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcc-CCCCeeceeeEEEeCCce
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNL-LHPNLVKLVGYCIEDDQR  214 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~  214 (490)
                      ++||+|+||.||+|++..         +|..||+|+++....   .....+..|..++..+ +||||+++++++.+.+..
T Consensus         1 ~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~   71 (316)
T cd05620           1 KVLGKGSFGKVLLAELKG---------KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHL   71 (316)
T ss_pred             CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEE
Confidence            469999999999999876         677899999975421   2334567788888754 799999999999999999


Q ss_pred             EEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCC
Q 011250          215 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~  294 (490)
                      ||||||+.+|+|..++... ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.++|+|||+++...
T Consensus        72 ~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~  147 (316)
T cd05620          72 FFVMEFLNGGDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENV  147 (316)
T ss_pred             EEEECCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecc
Confidence            9999999999999988654 46899999999999999999999988   9999999999999999999999999987532


Q ss_pred             CCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhcc
Q 011250          295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  374 (490)
Q Consensus       295 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (490)
                      ....  .....+||+.|+|||++.+..++.++|||||||++|||++|..||......   .+.+....           .
T Consensus       148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~~~~~~-----------~  211 (316)
T cd05620         148 FGDN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELFESIRV-----------D  211 (316)
T ss_pred             cCCC--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHh-----------C
Confidence            2211  223467999999999999999999999999999999999999999754321   11111110           0


Q ss_pred             CCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHH-HHHHH
Q 011250          375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS-EVVET  414 (490)
Q Consensus       375 ~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~-evl~~  414 (490)
                      .+    .++...+.++.+||.+||+.||.+||++. +++++
T Consensus       212 ~~----~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h  248 (316)
T cd05620         212 TP----HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGH  248 (316)
T ss_pred             CC----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence            01    11222367899999999999999999984 56544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-42  Score=334.52  Aligned_cols=258  Identities=28%  Similarity=0.454  Sum_probs=205.1

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      |.+.+.||+|+||.||+|.+..++.      ++..||||.+.....  .....+.+|+.+++.++||||+++++++....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   74 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDG------SQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS   74 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCC------CcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence            5678999999999999998865322      456899999875432  23457899999999999999999999887655


Q ss_pred             c------eEEEEEecCCCChhHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCC
Q 011250          213 Q------RLLVYEFMPRGSLENHLFRR-----SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       213 ~------~~lV~E~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                      .      .++||||+++|+|..++...     ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.
T Consensus        75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~  151 (273)
T cd05035          75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMT  151 (273)
T ss_pred             ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCe
Confidence            4      79999999999999888542     236899999999999999999999988   999999999999999999


Q ss_pred             eEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 011250          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       282 vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~  360 (490)
                      +||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......   ...+..
T Consensus       152 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~  228 (273)
T cd05035         152 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYL  228 (273)
T ss_pred             EEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH
Confidence            99999999987654332222222345778999999988899999999999999999999 88888653221   111111


Q ss_pred             hcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                      ...              .....+..++..+.+++.+||+.||.+||++.++++.|+++
T Consensus       229 ~~~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         229 RHG--------------NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             HcC--------------CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            100              00112233477899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.4e-43  Score=326.56  Aligned_cols=254  Identities=27%  Similarity=0.392  Sum_probs=207.6

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc----cc----HHHHHHHHHHHhccC-CCCee
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----QG----HKEWLAEVNFLGNLL-HPNLV  202 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~----~~~~~~Ei~il~~l~-HpnIv  202 (490)
                      ...|...+.||+|..++|.++.++.         +|..+|+|++.....    ..    .++-.+|+.||+++. ||+|+
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~---------t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II   86 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKE---------TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYII   86 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcc---------cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEE
Confidence            3468888999999999999998776         777899999864321    11    234567999999996 99999


Q ss_pred             ceeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCe
Q 011250          203 KLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       203 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~v  282 (490)
                      ++.++|+.+..+++|+|.|+.|.|+|+|.. ...+++.....|++|+++|+.|||..+   ||||||||+|||++++.++
T Consensus        87 ~l~D~yes~sF~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i  162 (411)
T KOG0599|consen   87 DLQDVYESDAFVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNI  162 (411)
T ss_pred             EeeeeccCcchhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccce
Confidence            999999999999999999999999999954 457999999999999999999999988   9999999999999999999


Q ss_pred             EEecccCcccCCCCCcceeeeccccCCCccCcchhcc------CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchh
Q 011250          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT------GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL  356 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~  356 (490)
                      ||+|||+++.+..+...   ...||||+|+|||.+..      ..|+..+|+|++|||||.||.|.+||........   
T Consensus       163 ~isDFGFa~~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlM---  236 (411)
T KOG0599|consen  163 KISDFGFACQLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLM---  236 (411)
T ss_pred             EEeccceeeccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHH---
Confidence            99999999998765443   45899999999998853      4688899999999999999999999965422111   


Q ss_pred             hHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                         .+..+.....|        ...-..+.+..+++||.+||+.||.+|.|++|+|.|-
T Consensus       237 ---LR~ImeGkyqF--------~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp  284 (411)
T KOG0599|consen  237 ---LRMIMEGKYQF--------RSPEWADISATVKDLISRLLQVDPTKRITAKEALAHP  284 (411)
T ss_pred             ---HHHHHhccccc--------CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence               11111111111        1111234478899999999999999999999999863

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-42  Score=338.08  Aligned_cols=254  Identities=35%  Similarity=0.579  Sum_probs=199.1

Q ss_pred             CCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEeCCceE
Q 011250          137 PESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL  215 (490)
Q Consensus       137 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  215 (490)
                      +.+.||.|.||.||+|.+...     ....+..|+||.++.... ...+.+.+|+++++.++||||++++|++...+..+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~-----~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~   77 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQK-----DNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF   77 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEEST-----TTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred             EeeEEccCCCcEEEEEEEEcc-----cCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccc
Confidence            457899999999999999831     122567899999965432 34678999999999999999999999999888899


Q ss_pred             EEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCC
Q 011250          216 LVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       216 lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~  294 (490)
                      +||||+++|+|.++|... ...+++..++.|+.||+.||.|||+.+   |+|+||+++|||++.++.+||+|||++....
T Consensus        78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~  154 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPIS  154 (259)
T ss_dssp             EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence            999999999999999876 568999999999999999999999988   9999999999999999999999999998774


Q ss_pred             CCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcchhhhc
Q 011250          295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  373 (490)
Q Consensus       295 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (490)
                      ............+...|+|||.+....++.++||||||+++|||++ |+.||....   ...+......    ..     
T Consensus       155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~---~~~~~~~~~~----~~-----  222 (259)
T PF07714_consen  155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD---NEEIIEKLKQ----GQ-----  222 (259)
T ss_dssp             TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC---HHHHHHHHHT----TE-----
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccc----cc-----
Confidence            3333333333457789999999999899999999999999999999 678875442   1111111110    00     


Q ss_pred             cCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       374 ~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                           ....+..++..+.+||.+||..||.+||++.+|++.|
T Consensus       223 -----~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  223 -----RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -----ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -----cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                 0112223478899999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.8e-42  Score=333.13  Aligned_cols=251  Identities=28%  Similarity=0.461  Sum_probs=203.2

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      .+|++.+.||+|+||.||+|.+..          +..+|+|.+.... .....+.+|+.+++.++||||+++++++...+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   72 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA----------QIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK   72 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc----------CceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence            358888999999999999998753          3479999886543 23467889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      ..++||||+++|+|.+++......+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        73 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~  149 (256)
T cd05114          73 PLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRY  149 (256)
T ss_pred             CEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccc
Confidence            999999999999999998765557899999999999999999999988   99999999999999999999999999986


Q ss_pred             CCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcchhh
Q 011250          293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  371 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (490)
                      ....... ......++..|+|||++.+..++.++||||||+++|||++ |+.||......   .........   .    
T Consensus       150 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~---~~~~~i~~~---~----  218 (256)
T cd05114         150 VLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY---EVVEMISRG---F----  218 (256)
T ss_pred             cCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHCC---C----
Confidence            5432221 1122345678999999988889999999999999999999 89999654321   111111110   0    


Q ss_pred             hccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       372 ~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                      ....       +...+..+.+|+.+||..||.+||++.++++.|
T Consensus       219 ~~~~-------~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         219 RLYR-------PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CCCC-------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            0001       111256789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=9.4e-43  Score=356.33  Aligned_cols=258  Identities=24%  Similarity=0.294  Sum_probs=205.6

Q ss_pred             HHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeecee
Q 011250          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLV  205 (490)
Q Consensus       129 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~  205 (490)
                      ....++|++.+.||+|+||.||+|++..         ++..||+|++.....   .....+..|+.+++.++||||++++
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~  109 (370)
T cd05596          39 RMKAEDFDVIKVIGRGAFGEVQLVRHKS---------SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLH  109 (370)
T ss_pred             CCCHHHcEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEE
Confidence            3455689999999999999999999876         577899999965321   2234577899999999999999999


Q ss_pred             eEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEe
Q 011250          206 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       206 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~  285 (490)
                      +++.+++..||||||+++|+|.+++...  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus       110 ~~~~~~~~~~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~  184 (370)
T cd05596         110 YAFQDDKYLYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLA  184 (370)
T ss_pred             EEEecCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEE
Confidence            9999999999999999999999988543  5888999999999999999999988   9999999999999999999999


Q ss_pred             cccCcccCCCCCcceeeeccccCCCccCcchhccC----CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011250          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG----HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~----~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~  361 (490)
                      |||++......... .....+||+.|+|||++.+.    .++.++|||||||+||||++|..||........   .... 
T Consensus       185 DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~~~i-  259 (370)
T cd05596         185 DFGTCMKMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---YSKI-  259 (370)
T ss_pred             eccceeeccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH---HHHH-
Confidence            99999876433221 12346799999999998653    478999999999999999999999975432111   1100 


Q ss_pred             cccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCC--CCCHHHHHHHh
Q 011250          362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA--RPRMSEVVETL  415 (490)
Q Consensus       362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~--RPt~~evl~~L  415 (490)
                        .....        .+.-......+.++.+||.+||..+|.+  |+++.+++++-
T Consensus       260 --~~~~~--------~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~  305 (370)
T cd05596         260 --MDHKN--------SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP  305 (370)
T ss_pred             --HcCCC--------cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence              00000        0000011124789999999999999988  99999999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.3e-42  Score=335.22  Aligned_cols=255  Identities=31%  Similarity=0.480  Sum_probs=210.9

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      ..+|.+.+.||.|+||.||+|.+..          +..||+|.+..........+..|+.+++.++|+||+++++++.+.
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~----------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   74 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN----------RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG   74 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC----------CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecC
Confidence            4568999999999999999998864          457999999877655667889999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      +..++||||+++++|.+++... ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~  151 (261)
T cd05148          75 EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLA  151 (261)
T ss_pred             CCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccch
Confidence            9999999999999999999653 356899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      .........  .....++..|+|||.+....++.++||||||+++|+|++ |+.||......   ........       
T Consensus       152 ~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~~~~~-------  219 (261)
T cd05148         152 RLIKEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYDQITA-------  219 (261)
T ss_pred             hhcCCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHHHh-------
Confidence            876443221  123346778999999988899999999999999999998 89999654311   11111110       


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                             ......+..++..+.++|.+||..||.+|||+.++++.|+.+
T Consensus       220 -------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         220 -------GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             -------CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence                   011112234478899999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-42  Score=333.10  Aligned_cols=256  Identities=27%  Similarity=0.409  Sum_probs=207.0

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ..++|++.+.||+|+||.||+|.+..          +..||+|.+.... ...+++.+|+.+++.++|+||+++++++..
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~----------~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   72 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNN----------TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTL   72 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecC----------CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEec
Confidence            34579999999999999999998643          4579999987654 335678999999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      .+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||+
T Consensus        73 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~  149 (261)
T cd05068          73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGL  149 (261)
T ss_pred             CCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcce
Confidence            999999999999999999986543 46899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +......... ......++..|+|||++.+..++.++||||||+++|||++ |+.||.......   +......      
T Consensus       150 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~------  219 (261)
T cd05068         150 ARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQQVDQ------  219 (261)
T ss_pred             EEEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHc------
Confidence            9876532211 1111223457999999988899999999999999999999 999996542111   1111000      


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                              ......+...+..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus       220 --------~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         220 --------GYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             --------CCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence                    000111223467899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.4e-42  Score=345.89  Aligned_cols=242  Identities=28%  Similarity=0.426  Sum_probs=194.5

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhc-cCCCCeeceeeEEEeCCce
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGN-LLHPNLVKLVGYCIEDDQR  214 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~  214 (490)
                      +.||+|+||+||+|++..         ++..||||++.....   .....+..|..++.. +.||||+++++++.+.+..
T Consensus         1 ~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~   71 (316)
T cd05619           1 KMLGKGSFGKVFLAELKG---------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENL   71 (316)
T ss_pred             CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEE
Confidence            469999999999999876         567899999975421   223456678888875 4899999999999999999


Q ss_pred             EEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCC
Q 011250          215 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~  294 (490)
                      +|||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        72 ~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~  147 (316)
T cd05619          72 FFVMEYLNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENM  147 (316)
T ss_pred             EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECC
Confidence            9999999999999988543 46899999999999999999999988   9999999999999999999999999987543


Q ss_pred             CCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhcc
Q 011250          295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  374 (490)
Q Consensus       295 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (490)
                      ....  .....+||+.|+|||++.+..++.++|||||||++|||++|..||......   .+......           .
T Consensus       148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~i~~-----------~  211 (316)
T cd05619         148 LGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQSIRM-----------D  211 (316)
T ss_pred             CCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh-----------C
Confidence            2211  123467999999999999889999999999999999999999999754321   11111100           0


Q ss_pred             CCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHH-HHHH
Q 011250          375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS-EVVE  413 (490)
Q Consensus       375 ~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~-evl~  413 (490)
                      .+    .++...+.++.+|+.+||+.||.+||++. ++++
T Consensus       212 ~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         212 NP----CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CC----CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            01    11222367889999999999999999997 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-42  Score=339.69  Aligned_cols=252  Identities=31%  Similarity=0.402  Sum_probs=203.7

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      +|++.++||+|+||.||++.+..         ++..||||++......   ....+.+|+.+++.++||||+++++++..
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   71 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET   71 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcC---------CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC
Confidence            47888999999999999998865         5678999998654322   23457789999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      ++..++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||+
T Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~  148 (285)
T cd05605          72 KDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGL  148 (285)
T ss_pred             CCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCC
Confidence            999999999999999998886543 46899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +........   .....|++.|+|||++.+..++.++|||||||++|||++|..||...........+..  ....    
T Consensus       149 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~--~~~~----  219 (285)
T cd05605         149 AVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER--RVKE----  219 (285)
T ss_pred             ceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHH--Hhhh----
Confidence            987543221   1235789999999999988999999999999999999999999975432211111100  0000    


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----t~~evl~~  414 (490)
                              ....++...+..+.+||.+||..||.+||     ++++++++
T Consensus       220 --------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         220 --------DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             --------cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence                    01112223477899999999999999999     78888765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.4e-42  Score=352.02  Aligned_cols=266  Identities=23%  Similarity=0.270  Sum_probs=204.5

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      ..+|.+.+.||+|+||.||+|......       ++..||+|.+...     +.+.+|+++|+.|+||||+++++++...
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~-------~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~  158 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDE-------QRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWK  158 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCc-------cceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeC
Confidence            457999999999999999999765321       4668999988643     2356899999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      ...++|||++ +++|.+++ .....+++..++.|+.||+.||.|||+.+   ||||||||+||||+.++.++|+|||+++
T Consensus       159 ~~~~lv~e~~-~~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~  233 (392)
T PHA03207        159 STVCMVMPKY-KCDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAAC  233 (392)
T ss_pred             CEEEEEehhc-CCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCcccc
Confidence            9999999999 46898888 44467999999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC------
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG------  365 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~------  365 (490)
                      ...............||+.|+|||++....++.++|||||||+||||++|+.||..................+.      
T Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~  313 (392)
T PHA03207        234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF  313 (392)
T ss_pred             ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence            76543333333346799999999999989999999999999999999999999976543321111110000000      


Q ss_pred             -Cc--chh---hhccCCccCCCCC-------hhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          366 -DK--RRF---YRLLDPRLEGHFS-------IKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 -~~--~~~---~~~~~~~l~~~~~-------~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                       ..  ..+   +..+.......+.       ...+.++.+||.+||..||++||++.+++.+
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence             00  000   0000000000010       1125678899999999999999999999976

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4.8e-42  Score=337.49  Aligned_cols=246  Identities=28%  Similarity=0.396  Sum_probs=197.7

Q ss_pred             cccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhccCCCCeeceeeEEEeCCceEEE
Q 011250          141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  217 (490)
Q Consensus       141 LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  217 (490)
                      ||+|+||+||+|.+..         ++..||+|.+......   ..+.+..|+.+++.++|+||+++++++......++|
T Consensus         1 lg~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv   71 (280)
T cd05608           1 LGKGGFGEVSACQMRA---------TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLV   71 (280)
T ss_pred             CCCCCceeEEEEEEcc---------CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEE
Confidence            7999999999998876         5678999998754322   235677899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCC
Q 011250          218 YEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       218 ~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~  294 (490)
                      |||+++|+|..++..   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.++|+|||++....
T Consensus        72 ~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  148 (280)
T cd05608          72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELK  148 (280)
T ss_pred             EeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecC
Confidence            999999999887743   3346899999999999999999999988   9999999999999999999999999997654


Q ss_pred             CCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhcc
Q 011250          295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  374 (490)
Q Consensus       295 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (490)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........  ......          +
T Consensus       149 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~----------~  214 (280)
T cd05608         149 DGQS--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELKQRI----------L  214 (280)
T ss_pred             CCCc--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH--HHHHhh----------c
Confidence            4322  1233579999999999999999999999999999999999999997543221110  000000          0


Q ss_pred             CCccCCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011250          375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  414 (490)
Q Consensus       375 ~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----t~~evl~~  414 (490)
                      ..  ...++...+..+.+|+.+||+.||.+||     ++++++++
T Consensus       215 ~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         215 ND--SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             cc--CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            00  0112233478899999999999999999     66777754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3.4e-42  Score=346.66  Aligned_cols=250  Identities=25%  Similarity=0.389  Sum_probs=197.1

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcc-CCCCeeceeeEEEeCCce
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIEDDQR  214 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~  214 (490)
                      +.||+|+||.||+|++..         ++..||+|++....   ....+.+..|+.++..+ +||||+++++++...+..
T Consensus         1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~   71 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKK---------TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL   71 (329)
T ss_pred             CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEE
Confidence            469999999999999876         56789999997642   22334577899988776 799999999999999999


Q ss_pred             EEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCC
Q 011250          215 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~  294 (490)
                      +|||||+++|+|..++... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        72 ~lv~E~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~  147 (329)
T cd05618          72 FFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  147 (329)
T ss_pred             EEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCcccccc
Confidence            9999999999999887544 47999999999999999999999988   9999999999999999999999999987543


Q ss_pred             CCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCc--chhhHhhhcccCCcchhhh
Q 011250          295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HNLVEWARPHLGDKRRFYR  372 (490)
Q Consensus       295 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~  372 (490)
                      ....  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........  .....+....         
T Consensus       148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~---------  216 (329)
T cd05618         148 RPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV---------  216 (329)
T ss_pred             CCCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH---------
Confidence            2211  12346799999999999999999999999999999999999999964221111  1111111000         


Q ss_pred             ccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCC------HHHHHHH
Q 011250          373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR------MSEVVET  414 (490)
Q Consensus       373 ~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt------~~evl~~  414 (490)
                      +...  ...++...+..+.+||.+||+.||.+||+      +.+++++
T Consensus       217 i~~~--~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         217 ILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             HhcC--CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            0000  01123334778999999999999999998      4666654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.6e-42  Score=333.36  Aligned_cols=266  Identities=26%  Similarity=0.351  Sum_probs=205.5

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhccCCCC-eeceeeEEEe
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPN-LVKLVGYCIE  210 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~  210 (490)
                      .|...++||+|+||+||+|+...         +|..||+|+++.....  .-....+|+.+|+.|+|+| ||.+++++..
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~---------~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~   82 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKR---------TGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHT   82 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEec---------CCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeee
Confidence            46667889999999999999987         6779999999866432  2245689999999999999 9999999998


Q ss_pred             CC------ceEEEEEecCCCChhHHhhhcC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCC
Q 011250          211 DD------QRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       211 ~~------~~~lV~E~~~~gsL~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                      .+      .++|||||+ ..+|..++....   ..++...+..++.||+.||+|||+++   |+||||||.||||+++|.
T Consensus        83 ~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~  158 (323)
T KOG0594|consen   83 SNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGV  158 (323)
T ss_pred             cccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCc
Confidence            87      789999999 569999997655   35888899999999999999999999   999999999999999999


Q ss_pred             eEEecccCcccCCCCCcceeeeccccCCCccCcchhccC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011250          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       282 vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~  360 (490)
                      +||+|||+|+...-....  .+..++|..|.|||++.+. .|+..+||||+|||++||+++++.|.+.........+-..
T Consensus       159 lKlaDFGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~  236 (323)
T KOG0594|consen  159 LKLADFGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRL  236 (323)
T ss_pred             EeeeccchHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHH
Confidence            999999999976533222  3456789999999999876 8999999999999999999999999876553221111000


Q ss_pred             --hcccCCcc----------hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          361 --RPHLGDKR----------RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       361 --~~~~~~~~----------~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                        .+......          .++..-.+..-...-........+|+.+||+.+|.+|.|++.+++|
T Consensus       237 lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  237 LGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence              01000000          1111110100000001113588999999999999999999999976

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.8e-42  Score=354.03  Aligned_cols=257  Identities=24%  Similarity=0.334  Sum_probs=204.2

Q ss_pred             hHHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhccCCCCeec
Q 011250          127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVK  203 (490)
Q Consensus       127 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~  203 (490)
                      .+....++|++.+.||+|+||.||+|++..         ++..||+|++.+..   ......+.+|+.+++.++||||++
T Consensus        37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~  107 (370)
T cd05621          37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKS---------SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ  107 (370)
T ss_pred             hcCCCHHHCeEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEee
Confidence            344556789999999999999999999876         56789999986432   122345778999999999999999


Q ss_pred             eeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeE
Q 011250          204 LVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       204 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vk  283 (490)
                      +++++.+++..|+|||||++|+|.+++...  .+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+|
T Consensus       108 ~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~k  182 (370)
T cd05621         108 LFCAFQDDKYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLK  182 (370)
T ss_pred             EEEEEEcCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEE
Confidence            999999999999999999999999988543  5889999999999999999999988   99999999999999999999


Q ss_pred             EecccCcccCCCCCcceeeeccccCCCccCcchhccC----CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 011250          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG----HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW  359 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~----~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~  359 (490)
                      |+|||++......... .....+||+.|+|||++.+.    .++.++|||||||+||||++|+.||........   .. 
T Consensus       183 L~DFG~a~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~---~~-  257 (370)
T cd05621         183 LADFGTCMKMDETGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT---YS-  257 (370)
T ss_pred             EEecccceecccCCce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH---HH-
Confidence            9999999876432221 12346799999999998753    378899999999999999999999975432111   00 


Q ss_pred             hhcccCCcchhhhccCCccCCCCC--hhhHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 011250          360 ARPHLGDKRRFYRLLDPRLEGHFS--IKGSQKATQLAAQCLSRDPKA--RPRMSEVVET  414 (490)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~l~~~~~--~~~~~~l~~Li~~cL~~dP~~--RPt~~evl~~  414 (490)
                                  .+++......++  ...+..+.+|+.+||..++.+  |+++.+++++
T Consensus       258 ------------~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         258 ------------KIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             ------------HHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence                        011100000111  123778999999999865544  8999999987

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=7.9e-42  Score=335.32  Aligned_cols=263  Identities=24%  Similarity=0.395  Sum_probs=207.5

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .++|++.+.||+|+||+||+|.+..++..     ....||+|.+..... ...+++.+|+.++..+.|+||+++++++..
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~-----~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGEN-----VKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT   80 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCc-----cceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence            35789999999999999999997654321     123589999875432 334678899999999999999999999875


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                       ...+++|||+++|+|.+++......+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        81 -~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~  156 (279)
T cd05109          81 -STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLA  156 (279)
T ss_pred             -CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCce
Confidence             4578999999999999999766667999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +...............++..|+|||.+.+..++.++|||||||++|||++ |..||......   .+..+....      
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~~~------  227 (279)
T cd05109         157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPDLLEKG------  227 (279)
T ss_pred             eecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHCC------
Confidence            87643322211222345678999999988899999999999999999998 89998643221   111111110      


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                              .....+..++..+.+++.+||..||++||++.++++.|..+..
T Consensus       228 --------~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         228 --------ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             --------CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                    0001112346789999999999999999999999999876643

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.5e-42  Score=340.07  Aligned_cols=266  Identities=27%  Similarity=0.405  Sum_probs=211.1

Q ss_pred             HHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcc-CCCCeeceee
Q 011250          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKLVG  206 (490)
Q Consensus       129 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~  206 (490)
                      .+..++|++.+.||+|+||.||+|.+.....    ......||+|.+..... ....++.+|+.++..+ +|+||+++++
T Consensus         8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~----~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   83 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDN----PNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG   83 (293)
T ss_pred             ccCHhHeEEeeEecccccccEEEEEEecCCC----CCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            3455679999999999999999998864321    12446899999875432 3345688999999999 7999999999


Q ss_pred             EEEeCCceEEEEEecCCCChhHHhhhc---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 011250          207 YCIEDDQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKT  271 (490)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp  271 (490)
                      ++..++..++||||+++|+|..++...               ...+++..++.++.||+.||.|||+.+   |+||||||
T Consensus        84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp  160 (293)
T cd05053          84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAA  160 (293)
T ss_pred             EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccce
Confidence            999999999999999999999998532               346889999999999999999999988   99999999


Q ss_pred             CcEEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCC
Q 011250          272 SNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRP  350 (490)
Q Consensus       272 ~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~  350 (490)
                      +|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus       161 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  240 (293)
T cd05053         161 RNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  240 (293)
T ss_pred             eeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence            999999999999999999987654332222222345678999999988899999999999999999997 9999864322


Q ss_pred             CCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          351 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                      ...   ....              ........+..++..+.+|+.+||..||.+|||+.++++.|+.+
T Consensus       241 ~~~---~~~~--------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         241 EEL---FKLL--------------KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             HHH---HHHH--------------HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence            111   1100              00011112334467899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=9.9e-42  Score=336.65  Aligned_cols=262  Identities=28%  Similarity=0.417  Sum_probs=207.9

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      +|++.+.||+|+||.||+|+......    ......+|+|.+..... .....+.+|+.+++.+.||||+++++.+...+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~----~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   76 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKG----RAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG   76 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCC----CCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence            47889999999999999998754221    11335789998875532 23467889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhc-----------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCC
Q 011250          213 QRLLVYEFMPRGSLENHLFRR-----------------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDF  269 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~-----------------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDl  269 (490)
                      ..++||||+.+++|.+++...                       ...+++..++.++.|++.||.|||+.+   |+||||
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~di  153 (290)
T cd05045          77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDL  153 (290)
T ss_pred             CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhh
Confidence            999999999999999987532                       134788999999999999999999988   999999


Q ss_pred             CCCcEEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCC
Q 011250          270 KTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKN  348 (490)
Q Consensus       270 kp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~  348 (490)
                      ||+|||++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus       154 kp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  233 (290)
T cd05045         154 AARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  233 (290)
T ss_pred             hhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999999986543322222223456788999999988899999999999999999998 99999654


Q ss_pred             CCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011250          349 RPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~  419 (490)
                      .+..   +.+....              ......+...+.++.+|+.+||+.||.+||++.++++.|+++.
T Consensus       234 ~~~~---~~~~~~~--------------~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         234 APER---LFNLLKT--------------GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             CHHH---HHHHHhC--------------CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence            3221   1111110              0111112234678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1e-41  Score=334.95  Aligned_cols=260  Identities=27%  Similarity=0.420  Sum_probs=208.3

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      ++|.+.+.||+|+||.||++.....    ....++..||+|.+..........+.+|+++++.++|+||+++++++.+.+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNL----LPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGR   80 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecC----CCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence            4688899999999999999976431    112356689999987665555678999999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcC--------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC
Q 011250          213 QRLLVYEFMPRGSLENHLFRRS--------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA  278 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~  278 (490)
                      ..++||||+++++|.+++....              ..+++..++.++.||+.||+|||+.+   |+||||||+|||+++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~  157 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQ  157 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcC
Confidence            9999999999999999986542              24889999999999999999999988   999999999999999


Q ss_pred             CCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhh
Q 011250          279 DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLV  357 (490)
Q Consensus       279 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~  357 (490)
                      ++.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |.+||........   .
T Consensus       158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~  234 (280)
T cd05092         158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA---I  234 (280)
T ss_pred             CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH---H
Confidence            99999999999976543322222223446788999999998999999999999999999998 8999864322111   1


Q ss_pred             HhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011250          358 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~  416 (490)
                      .....    .          .....+..++..+.+|+.+||+.||.+||++.+|++.|+
T Consensus       235 ~~~~~----~----------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         235 ECITQ----G----------RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHHHc----C----------ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            11000    0          000111234678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=6.5e-42  Score=336.43  Aligned_cols=260  Identities=25%  Similarity=0.380  Sum_probs=207.0

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      +|++.+.||+|+||.||+|.+.....    ...+..||||++...... ....+.+|+.++..++||||+++++++.+.+
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~   81 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAP----GEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ   81 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCC----CCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence            47788999999999999998764211    114568999999765432 2356889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhc---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc
Q 011250          213 QRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD  277 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~  277 (490)
                      ..++++||+.+++|.+++...               ...+++..+..++.|++.||.|||+.+   |+||||||+|||++
T Consensus        82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~  158 (283)
T cd05091          82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVF  158 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEec
Confidence            999999999999999998532               134788889999999999999999988   99999999999999


Q ss_pred             CCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchh
Q 011250          278 ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNL  356 (490)
Q Consensus       278 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~  356 (490)
                      .++.+||+|||+++...............+++.|+|||.+.++.++.++|||||||++|||++ |..||......   ..
T Consensus       159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~  235 (283)
T cd05091         159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DV  235 (283)
T ss_pred             CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---HH
Confidence            999999999999887644333222233456789999999988899999999999999999998 88888653221   11


Q ss_pred             hHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011250          357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  417 (490)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~  417 (490)
                      .+....             .. ...++..++..+.+|+.+||+.+|.+||++.+|+..|+.
T Consensus       236 ~~~i~~-------------~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         236 IEMIRN-------------RQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHHc-------------CC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            111110             00 011233457889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.5e-42  Score=346.00  Aligned_cols=243  Identities=28%  Similarity=0.410  Sum_probs=197.4

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcc-CCCCeeceeeEEEeCCce
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIEDDQR  214 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~  214 (490)
                      +.||+|+||+||+|++..         ++..||||++....   ......+..|+.++..+ .||||+++++++...+..
T Consensus         1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~   71 (318)
T cd05570           1 KVLGKGSFGKVLLAELKG---------TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRL   71 (318)
T ss_pred             CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence            469999999999999875         56789999997542   22345577899999888 699999999999999999


Q ss_pred             EEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCC
Q 011250          215 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~  294 (490)
                      |+||||+++|+|..++.+. ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        72 ~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  147 (318)
T cd05570          72 FFVMEYVNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGI  147 (318)
T ss_pred             EEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecC
Confidence            9999999999999888554 47999999999999999999999988   9999999999999999999999999987532


Q ss_pred             CCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhcc
Q 011250          295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  374 (490)
Q Consensus       295 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (490)
                      ....  .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||......   ......   ....       
T Consensus       148 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---~~~~~i---~~~~-------  212 (318)
T cd05570         148 LGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---ELFQSI---LEDE-------  212 (318)
T ss_pred             cCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---HHHHHH---HcCC-------
Confidence            2211  123357999999999999999999999999999999999999999654211   111110   0000       


Q ss_pred             CCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 011250          375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM-----SEVVET  414 (490)
Q Consensus       375 ~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~-----~evl~~  414 (490)
                           ..++...+..+.+||.+||..||.+||++     .+++++
T Consensus       213 -----~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         213 -----VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             -----CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence                 01222346789999999999999999999     777765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.3e-41  Score=334.48  Aligned_cols=274  Identities=27%  Similarity=0.381  Sum_probs=208.5

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeC-
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED-  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-  211 (490)
                      .+|++.+.||+|+||.||+|.....     ...++..||+|.+........+.+.+|+++++.++||||+++++++... 
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~-----~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   78 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPL-----QDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG   78 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCC-----cCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence            4789999999999999999986421     1226778999999876655567889999999999999999999987543 


Q ss_pred             -CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          212 -DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       212 -~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                       ...++||||+++++|.+++......+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~  155 (284)
T cd05081          79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLT  155 (284)
T ss_pred             CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccc
Confidence             4688999999999999999766567999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCccee-eeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC---C
Q 011250          291 KDAPEDGKTHV-STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG---D  366 (490)
Q Consensus       291 ~~~~~~~~~~~-~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~---~  366 (490)
                      +.......... .....++..|+|||++.+..++.++|||||||++|||++|..++......    ..........   .
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~~~~~~  231 (284)
T cd05081         156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMGNDKQGQMI  231 (284)
T ss_pred             ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhcccccccccc
Confidence            87654322211 11223455699999998889999999999999999999988765432110    0000000000   0


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                      ...+...+........+...+.++.+|+.+||..+|++|||+.+|++.|+.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         232 VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             hHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            0000111111111112233467899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.1e-41  Score=336.92  Aligned_cols=272  Identities=27%  Similarity=0.409  Sum_probs=211.7

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCcc-------ccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeec
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAP-------VKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVK  203 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~-------~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~  203 (490)
                      ..+|++.+.||+|+||.||+|.+...+...       .....+..||+|.+..... ...+.+.+|++++..++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            357999999999999999999887543211       1223456799999876543 34567889999999999999999


Q ss_pred             eeeEEEeCCceEEEEEecCCCChhHHhhhcC----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 011250          204 LVGYCIEDDQRLLVYEFMPRGSLENHLFRRS----------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN  273 (490)
Q Consensus       204 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~N  273 (490)
                      +++++..++..++||||+++++|.+++....          ..+++..++.++.|++.||.|||+.+   |+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            9999999999999999999999999986543          26899999999999999999999988   9999999999


Q ss_pred             EEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh--CCCCCCCCCCC
Q 011250          274 ILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT--GRRSMDKNRPN  351 (490)
Q Consensus       274 ILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt--G~~pf~~~~~~  351 (490)
                      ||++.++.++|+|||+++...............+++.|+|||++....++.++|||||||++|||++  |..||..... 
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~-  239 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD-  239 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence            9999999999999999986644333333334567889999999988899999999999999999998  6677754321 


Q ss_pred             CcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011250          352 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~  416 (490)
                        .............       .........+..++.++.+|+.+||+.||.+|||+.+|++.|+
T Consensus       240 --~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         240 --QQVIENAGHFFRD-------DGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             --HHHHHHHHhcccc-------ccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence              1111111111000       0011111122234678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.4e-42  Score=360.86  Aligned_cols=263  Identities=23%  Similarity=0.363  Sum_probs=196.8

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      .++|.+.+.||+|+||.||+|.+..         ++..||||++....    ....+|+.+|+.++|||||++++++...
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~---------~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~  131 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICID---------TSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTE  131 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECC---------CCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeec
Confidence            4579999999999999999999875         56789999886442    2345799999999999999999987542


Q ss_pred             --------CceEEEEEecCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC
Q 011250          212 --------DQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY  280 (490)
Q Consensus       212 --------~~~~lV~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~  280 (490)
                              ..+++||||++ ++|.+++..   ....+++..++.++.||+.||+|||+.+   ||||||||+||||+.++
T Consensus       132 ~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~  207 (440)
T PTZ00036        132 CFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNT  207 (440)
T ss_pred             ccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCC
Confidence                    24679999996 477776642   3457999999999999999999999988   99999999999998664


Q ss_pred             -CeEEecccCcccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhh-
Q 011250          281 -NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-  357 (490)
Q Consensus       281 -~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~-  357 (490)
                       .+||+|||+++.......   .....||+.|+|||++.+ ..|+.++|||||||+||||++|.+||...........+ 
T Consensus       208 ~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~  284 (440)
T PTZ00036        208 HTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII  284 (440)
T ss_pred             CceeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence             799999999987643222   123578999999998875 46999999999999999999999999764332111110 


Q ss_pred             Hhh-hcccC---------CcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          358 EWA-RPHLG---------DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       358 ~~~-~~~~~---------~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ... .+...         ....+.......+...++...+.++.+||.+||..||.+|||+.+++++
T Consensus       285 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        285 QVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            000 00000         0000000111111222333457889999999999999999999999975

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=7.6e-42  Score=332.92  Aligned_cols=255  Identities=24%  Similarity=0.349  Sum_probs=204.6

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      .+|++.+.||+|+||.||+|++..         ++..||+|++..........+.+|+.++..++||||+++++++..++
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~   79 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLH---------TGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE   79 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECC---------CCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Confidence            479999999999999999999865         56789999997654445566889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      ..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++..
T Consensus        80 ~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~  155 (267)
T cd06646          80 KLWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAK  155 (267)
T ss_pred             EEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCcccee
Confidence            999999999999999988544 47899999999999999999999988   99999999999999999999999999986


Q ss_pred             CCCCCcceeeeccccCCCccCcchhc---cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          293 APEDGKTHVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      ......  ......|+..|+|||.+.   ...++.++|||||||++|||++|..||....+.......  ....      
T Consensus       156 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~--~~~~------  225 (267)
T cd06646         156 ITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--SKSN------  225 (267)
T ss_pred             eccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee--ecCC------
Confidence            543211  112356899999999874   345788999999999999999999998644322111000  0000      


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                         ...+...  .....+..+.+||.+||..||++||++++|+++|
T Consensus       226 ---~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         226 ---FQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ---CCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence               0001110  0112367899999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.5e-41  Score=330.70  Aligned_cols=259  Identities=24%  Similarity=0.355  Sum_probs=208.6

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|++.+.||+|+||.||+|++..         ++..||||.+....   ......+.+|+.+++.++||||+++++++.
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   72 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLL---------DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI   72 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeC---------CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE
Confidence            479999999999999999999876         56789999876432   223356889999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEec
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~D  286 (490)
                      +.+..++||||+++++|.+++..   ....+++..++.++.||+.||.|||+.+   |+|+||||+|||++.++.++|+|
T Consensus        73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d  149 (267)
T cd08228          73 EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGD  149 (267)
T ss_pred             ECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECc
Confidence            99999999999999999988753   2345889999999999999999999988   99999999999999999999999


Q ss_pred             ccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011250          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      ||++........  ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ..+.......   
T Consensus       150 ~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~~~~~---  223 (267)
T cd08228         150 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLCQKIEQC---  223 (267)
T ss_pred             cccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHHHHHhcC---
Confidence            999887643221  1123568899999999988889999999999999999999999986432211 1111111000   


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~  419 (490)
                                ..........+..+.+|+.+||..+|++||++.+|++.|++++
T Consensus       224 ----------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         224 ----------DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             ----------CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                      0000111233678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=8.9e-42  Score=334.72  Aligned_cols=261  Identities=28%  Similarity=0.420  Sum_probs=206.0

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .++|.+.+.||+|+||.||+|.+.....    ..++..||+|.+..... .....+.+|+.+++.++|+||+++++++.+
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~----~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDG----DAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE   80 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCC----CCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            4579999999999999999998865210    11456899998875432 234568999999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcC------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC---C
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRS------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY---N  281 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~---~  281 (490)
                      .+..++||||+++++|.+++....      ..+++..++.++.||+.||+|||+.+   ++||||||+|||++.++   .
T Consensus        81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~  157 (277)
T cd05036          81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRV  157 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcc
Confidence            999999999999999999986543      25899999999999999999999988   99999999999998654   5


Q ss_pred             eEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 011250          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       282 vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~  360 (490)
                      +||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......   .....
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~~~~  234 (277)
T cd05036         158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VMEFV  234 (277)
T ss_pred             eEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH
Confidence            99999999987643222221222334568999999998999999999999999999997 999997543221   11111


Q ss_pred             hcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011250          361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~  416 (490)
                      ..              .....++...+..+.+|+.+||+.||++||++.+|+++|.
T Consensus       235 ~~--------------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         235 TG--------------GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             Hc--------------CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            00              0011122334678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.7e-41  Score=333.56  Aligned_cols=273  Identities=32%  Similarity=0.438  Sum_probs=207.6

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEeC--
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED--  211 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--  211 (490)
                      |.+.+.||+|+||+||++.....     ...++..||+|.+..... .....+.+|+++++.++||||+++++++...  
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPA-----NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccc-----cCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            48899999999999999865431     122577899999876532 2346788999999999999999999987654  


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      ...++||||+++++|.+++...  .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||+++
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~  155 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK  155 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccc
Confidence            3578999999999999998553  5999999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCcce-eeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          292 DAPEDGKTH-VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       292 ~~~~~~~~~-~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ......... ......++..|+|||.+....++.++|||||||++|||++|..||........ ......... .....+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~-~~~~~~  233 (283)
T cd05080         156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQ-MTVVRL  233 (283)
T ss_pred             ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccc-cchhhh
Confidence            765432211 11223456789999999888899999999999999999999999864322110 111110000 000111


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~  419 (490)
                      ...++.......+...+..+.+|+.+||+.||++|||+++|++.|+.+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            1111111222233445789999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-41  Score=329.90  Aligned_cols=250  Identities=27%  Similarity=0.421  Sum_probs=203.0

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCCc
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQ  213 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  213 (490)
                      +|++.+.||+|+||.||+|.+..          +..+|+|++..... ....+.+|+.+++.++|+||+++++++...+.
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~----------~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRG----------KIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRP   73 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecC----------CccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            58889999999999999998753          34699999865432 34568899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccC
Q 011250          214 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       214 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~  293 (490)
                      .++||||+++++|.+++......+++..++.++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+++..
T Consensus        74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~  150 (256)
T cd05059          74 IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYV  150 (256)
T ss_pred             eEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceec
Confidence            99999999999999999766567899999999999999999999988   999999999999999999999999999865


Q ss_pred             CCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcchhhh
Q 011250          294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR  372 (490)
Q Consensus       294 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (490)
                      .+.... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......   ........         
T Consensus       151 ~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~~---------  217 (256)
T cd05059         151 LDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVESVSAG---------  217 (256)
T ss_pred             cccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHHHHHcC---------
Confidence            432211 1111234568999999998899999999999999999999 899986543211   11111100         


Q ss_pred             ccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       373 ~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                           .....+...+..+.+|+.+||..+|++|||+.++++.|
T Consensus       218 -----~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         218 -----YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             -----CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence                 01111223478899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5.5e-42  Score=344.88  Aligned_cols=250  Identities=27%  Similarity=0.389  Sum_probs=198.3

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcc-CCCCeeceeeEEEeCCce
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNL-LHPNLVKLVGYCIEDDQR  214 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~  214 (490)
                      ++||+|+||.||+|++..         ++..||+|++.....   ...+.+..|+.++..+ .||||+.+++++.+.+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~   71 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKK---------NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRL   71 (327)
T ss_pred             CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEE
Confidence            469999999999999876         567899999976432   2334578899999888 599999999999999999


Q ss_pred             EEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCC
Q 011250          215 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~  294 (490)
                      ||||||+++|+|..++... ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        72 ~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~  147 (327)
T cd05617          72 FLVIEYVNGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGL  147 (327)
T ss_pred             EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceecc
Confidence            9999999999999888544 47999999999999999999999988   9999999999999999999999999987533


Q ss_pred             CCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhcc
Q 011250          295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  374 (490)
Q Consensus       295 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (490)
                      ....  .....+||+.|+|||++.+..++.++|||||||+||||++|..||............++.....         .
T Consensus       148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~---------~  216 (327)
T cd05617         148 GPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI---------L  216 (327)
T ss_pred             CCCC--ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH---------H
Confidence            2211  1234679999999999999999999999999999999999999997543322222111111110         0


Q ss_pred             CCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 011250          375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM------SEVVET  414 (490)
Q Consensus       375 ~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~------~evl~~  414 (490)
                      ..  ...++...+..+.+|+.+||+.||.+|+++      .+++++
T Consensus       217 ~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         217 EK--PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             hC--CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence            00  011222336788999999999999999984      566554

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=8.2e-42  Score=331.57  Aligned_cols=255  Identities=24%  Similarity=0.403  Sum_probs=206.8

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      .++|++.++||+|+||.||+|.+..          +..||+|.+..... ..+.+.+|+.+++.++|+||+++++++.+.
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~----------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   73 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNN----------STKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKE   73 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecC----------CceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            3579999999999999999998653          44799999865432 356789999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      +..++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++
T Consensus        74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~  150 (261)
T cd05072          74 EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLA  150 (261)
T ss_pred             CCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccc
Confidence            9999999999999999998653 456889999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      ......... ......++..|+|||++....++.++|||||||++|+|++ |..||.......   .........     
T Consensus       151 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~~~~-----  221 (261)
T cd05072         151 RVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSALQRGY-----  221 (261)
T ss_pred             eecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHHHcCC-----
Confidence            876543221 1223446778999999988889999999999999999998 999996532211   111111000     


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                           ..    ......+.++.+|+.+||..||++||+++++++.|+.+
T Consensus       222 -----~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         222 -----RM----PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             -----CC----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                 00    01112367899999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-43  Score=364.49  Aligned_cols=261  Identities=27%  Similarity=0.471  Sum_probs=223.0

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .....|+++||.|.||.|++|+++..++      ....||||.++..... ...+|+.|+.||.+++||||++|.|+...
T Consensus       628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgk------re~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk  701 (996)
T KOG0196|consen  628 PSCVKIEKVIGAGEFGEVCSGRLKLPGK------REITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK  701 (996)
T ss_pred             hhheEEEEEEecccccceecccccCCCC------cceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec
Confidence            3456788999999999999999987664      4568999999876543 45689999999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      ...++||.|||++|+|+.+|..+...|++.+..-+++.|+.|++||-+.+   +|||||..+|||++.+...|++|||++
T Consensus       702 s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLS  778 (996)
T KOG0196|consen  702 SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLS  778 (996)
T ss_pred             CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccce
Confidence            99999999999999999999988889999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeecccc--CCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCc
Q 011250          291 KDAPEDGKTHVSTRVMG--TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~G--t~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      |.+.++..... +...|  ..+|.|||.+...+++.+||||||||+|||.++ |.+||......+..+.++         
T Consensus       779 Rvledd~~~~y-tt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe---------  848 (996)
T KOG0196|consen  779 RVLEDDPEAAY-TTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE---------  848 (996)
T ss_pred             eecccCCCccc-cccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH---------
Confidence            98866543222 22223  579999999999999999999999999999776 999997654443333222         


Q ss_pred             chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011250          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~  419 (490)
                              ..+.-.-|.+|+..+.+|+..||++|-.+||.+.+|+.+|.++.
T Consensus       849 --------~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI  892 (996)
T KOG0196|consen  849 --------QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI  892 (996)
T ss_pred             --------hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence                    11222345678999999999999999999999999999998764

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=5.4e-42  Score=344.25  Aligned_cols=238  Identities=31%  Similarity=0.414  Sum_probs=191.0

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHH-HHhccCCCCeeceeeEEEeCCce
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVN-FLGNLLHPNLVKLVGYCIEDDQR  214 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~  214 (490)
                      ++||+|+||+||+|++..         +|..||||++.....   ...+.+..|.. +++.++||||+++++++.+.+..
T Consensus         1 ~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~   71 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKA---------DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKL   71 (323)
T ss_pred             CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEE
Confidence            469999999999999876         577899999875422   22344555555 56789999999999999999999


Q ss_pred             EEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCC
Q 011250          215 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~  294 (490)
                      |+||||+++|+|..++... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        72 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~  147 (323)
T cd05575          72 YFVLDYVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGI  147 (323)
T ss_pred             EEEEcCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccc
Confidence            9999999999999988554 47899999999999999999999988   9999999999999999999999999987543


Q ss_pred             CCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhcc
Q 011250          295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  374 (490)
Q Consensus       295 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (490)
                      ....  .....+||+.|+|||++.+..++.++|||||||++|||++|..||......   .+.   ...+..        
T Consensus       148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---~~~---~~i~~~--------  211 (323)
T cd05575         148 EHSK--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA---EMY---DNILNK--------  211 (323)
T ss_pred             cCCC--ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH---HHH---HHHHcC--------
Confidence            2211  223467999999999999999999999999999999999999999653211   111   111100        


Q ss_pred             CCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHH
Q 011250          375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS  409 (490)
Q Consensus       375 ~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~  409 (490)
                        .+  .++...+..+.+||.+||+.||.+||++.
T Consensus       212 --~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         212 --PL--RLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             --CC--CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence              00  11122377899999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=8.1e-42  Score=339.70  Aligned_cols=270  Identities=25%  Similarity=0.397  Sum_probs=211.9

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcc-CCCCeeceeeE
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGY  207 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~  207 (490)
                      ...++|.+.+.||+|+||.||+|++...+..  ....+..||+|.+.... ......+.+|+.++..+ .||||++++++
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~--~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   89 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKD--KPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA   89 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCC--CCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence            3445789999999999999999986432110  11245689999987542 23446788999999999 79999999999


Q ss_pred             EEeCCceEEEEEecCCCChhHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 011250          208 CIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTS  272 (490)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~  272 (490)
                      +......++||||+++|+|.+++....               ..+++..++.++.||+.||.|||+.+   |+||||||+
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~  166 (304)
T cd05101          90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAAR  166 (304)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccc
Confidence            999999999999999999999986532               34788889999999999999999988   999999999


Q ss_pred             cEEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCC
Q 011250          273 NILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPN  351 (490)
Q Consensus       273 NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~  351 (490)
                      |||++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus       167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~  246 (304)
T cd05101         167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  246 (304)
T ss_pred             eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence            99999999999999999987654332222223456788999999988889999999999999999998 78888643211


Q ss_pred             CcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccc
Q 011250          352 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~~  421 (490)
                      .   +.....    ..          .....+..++..+.+|+.+||..+|.+||++.++++.|..+...
T Consensus       247 ~---~~~~~~----~~----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         247 E---LFKLLK----EG----------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             H---HHHHHH----cC----------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence            1   111110    00          00111234478899999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.1e-42  Score=348.38  Aligned_cols=242  Identities=30%  Similarity=0.378  Sum_probs=196.0

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEeCCceEE
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLL  216 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  216 (490)
                      +.||+|+||.||+++.....      .+|..||+|++.....  .....+..|+++|+.++||||+++++++.+++..|+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   75 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGP------DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYL   75 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccC------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEE
Confidence            57999999999999875321      2678999999975432  233457789999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCC
Q 011250          217 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  296 (490)
Q Consensus       217 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~  296 (490)
                      ||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        76 v~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  151 (318)
T cd05582          76 ILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  151 (318)
T ss_pred             EEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence            99999999999998554 46999999999999999999999988   999999999999999999999999999865433


Q ss_pred             CcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCC
Q 011250          297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP  376 (490)
Q Consensus       297 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (490)
                      ..  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......   ......   ....         
T Consensus       152 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~~~~i---~~~~---------  214 (318)
T cd05582         152 EK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK---ETMTMI---LKAK---------  214 (318)
T ss_pred             CC--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH---HHHHHH---HcCC---------
Confidence            21  123467999999999999888999999999999999999999999754221   111110   0000         


Q ss_pred             ccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHH
Q 011250          377 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE  410 (490)
Q Consensus       377 ~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~e  410 (490)
                         ..++...+..+.+||.+||+.||.+||++.+
T Consensus       215 ---~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         215 ---LGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             ---CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence               0122233678999999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=7e-42  Score=340.71  Aligned_cols=267  Identities=26%  Similarity=0.386  Sum_probs=209.0

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcc-CCCCeeceeeEEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~  209 (490)
                      .++|.+.+.||+|+||.||+|.+...+..  ...+...||+|.+.... .....++..|+.++..+ +|+||+++++++.
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~--~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKE--KPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   94 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCc--ccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            45799999999999999999987542210  11134579999997643 23345688899999999 7999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcE
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI  274 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NI  274 (490)
                      ..+..|+||||+++|+|.+++....               ..+++..++.++.||+.||+|||+.+   |+||||||+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni  171 (307)
T cd05098          95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV  171 (307)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHhe
Confidence            9999999999999999999996532               24888999999999999999999988   99999999999


Q ss_pred             EEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCc
Q 011250          275 LLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGE  353 (490)
Q Consensus       275 Ll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~  353 (490)
                      |++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......  
T Consensus       172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~--  249 (307)
T cd05098         172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--  249 (307)
T ss_pred             EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH--
Confidence            999999999999999976643221111122234578999999998899999999999999999998 88888643211  


Q ss_pred             chhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                       .+......              ......+...+.++.+|+.+||..+|.+||++.+|++.|+.+..
T Consensus       250 -~~~~~~~~--------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         250 -ELFKLLKE--------------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             -HHHHHHHc--------------CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence             11111100              00111223346889999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=7.7e-42  Score=340.73  Aligned_cols=267  Identities=23%  Similarity=0.343  Sum_probs=204.5

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      ++|.+.+.||+|+||.||+|++..         ++..||+|.+..... .....+.+|+.+++.++||||+++++++..+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   76 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKL---------TENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD   76 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecC---------CCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence            469999999999999999998875         566899999875432 2234677899999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      +..++||||++ ++|.+++......+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        77 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~  152 (309)
T cd07872          77 KSLTLVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLAR  152 (309)
T ss_pred             CeEEEEEeCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccce
Confidence            99999999996 5898888766667899999999999999999999988   9999999999999999999999999997


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--------c
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--------P  362 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~--------~  362 (490)
                      .......  ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||...........+....        +
T Consensus       153 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  230 (309)
T cd07872         153 AKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWP  230 (309)
T ss_pred             ecCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Confidence            6533221  1223568999999998865 468999999999999999999999997654332221111100        0


Q ss_pred             ccCCcchhhhccCCccCC----CCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          363 HLGDKRRFYRLLDPRLEG----HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~----~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .+.....+.....+....    ......+.++.+||.+||+.||.+|||+.|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         231 GISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             hhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence            000000000000000000    0011236788999999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.2e-41  Score=338.42  Aligned_cols=265  Identities=26%  Similarity=0.387  Sum_probs=209.6

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcc-CCCCeeceeeEE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKLVGYC  208 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~  208 (490)
                      ..++|.+.+.||+|+||.||+|.+....    ...++..||||.++.... ...+.+.+|+.+++++ +|+||+++++++
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  108 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLS----KSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC  108 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCC----CCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence            3457999999999999999999864211    112566899999875532 3345788999999999 799999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DF  287 (490)
                      ...+..++||||+++|+|.+++.... ..+++.++..++.||+.||+|||+.+   |+|+||||+|||++.++.++|+||
T Consensus       109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~df  185 (302)
T cd05055         109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDF  185 (302)
T ss_pred             ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCC
Confidence            99999999999999999999986543 34899999999999999999999988   999999999999999999999999


Q ss_pred             cCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCC
Q 011250          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      |++................++..|+|||.+....++.++|||||||++|||++ |..||........  ......     
T Consensus       186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~~~~-----  258 (302)
T cd05055         186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYKLIK-----  258 (302)
T ss_pred             cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHHHHH-----
Confidence            99987654332222223456788999999998899999999999999999998 9999865432111  111110     


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                               .......+...+..+.+|+.+||..+|++||++.+|++.|+++
T Consensus       259 ---------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         259 ---------EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             ---------cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                     0000011122367899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.9e-42  Score=333.75  Aligned_cols=262  Identities=27%  Similarity=0.433  Sum_probs=209.5

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ..++|.+.+.||+|+||.||+|.+.....    ..++..||+|.+.... ......+.+|+.++..+.|+||+++++++.
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~----~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   79 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVK----GEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCC----CCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence            34579999999999999999998865321    1245789999986553 233456889999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcC---------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY  280 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~  280 (490)
                      .....++||||+++|+|.+++....         ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~  156 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDL  156 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCC
Confidence            9999999999999999999986422         24688899999999999999999988   99999999999999999


Q ss_pred             CeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHh
Q 011250          281 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEW  359 (490)
Q Consensus       281 ~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~  359 (490)
                      .+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......   ....
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~  233 (277)
T cd05032         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLKF  233 (277)
T ss_pred             CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHHH
Confidence            999999999986644332222233457889999999988889999999999999999998 999986543211   1111


Q ss_pred             hhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011250          360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~  416 (490)
                      ..    ..          ....++..++..+.+|+.+||+.+|.+|||+.++++.|+
T Consensus       234 ~~----~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         234 VI----DG----------GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             Hh----cC----------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            11    00          001122234788999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=8.6e-42  Score=351.84  Aligned_cols=266  Identities=24%  Similarity=0.385  Sum_probs=208.4

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhccC-CCCeeceeeE
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLL-HPNLVKLVGY  207 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~Ei~il~~l~-HpnIv~l~~~  207 (490)
                      ...++|.+.+.||+|+||.||+|++....    ....+..||||+++..... ..+.+.+|+.+|..+. |||||+++++
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~----~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~  109 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLS----HSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGA  109 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCC----CCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence            33456888999999999999999976421    1124568999999765322 2356889999999997 9999999999


Q ss_pred             EEeCCceEEEEEecCCCChhHHhhhcC-----------------------------------------------------
Q 011250          208 CIEDDQRLLVYEFMPRGSLENHLFRRS-----------------------------------------------------  234 (490)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------------------------------------------------  234 (490)
                      +...+..+||||||++|+|.+++.+..                                                     
T Consensus       110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence            999999999999999999999986431                                                     


Q ss_pred             --------------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 011250          235 --------------------------------------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFK  270 (490)
Q Consensus       235 --------------------------------------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlk  270 (490)
                                                                  ..+++..++.|+.||+.||.|||+.+   |+|||||
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlk  266 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLA  266 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCC
Confidence                                                        13567788899999999999999987   9999999


Q ss_pred             CCcEEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCC
Q 011250          271 TSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNR  349 (490)
Q Consensus       271 p~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~  349 (490)
                      |+|||++.++.+||+|||+++...............|+..|+|||.+....++.++|||||||++|||++ |..||....
T Consensus       267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~  346 (401)
T cd05107         267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP  346 (401)
T ss_pred             cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999999999999999999986543222111223467889999999988889999999999999999998 888986542


Q ss_pred             CCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          350 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                      ....  +.....              .......+..++.++.+|+.+||..+|.+||++.+|++.|+.+
T Consensus       347 ~~~~--~~~~~~--------------~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         347 MNEQ--FYNAIK--------------RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             chHH--HHHHHH--------------cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            2111  111000              0001112223478899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=316.03  Aligned_cols=266  Identities=28%  Similarity=0.383  Sum_probs=212.0

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      +..++|++.+.||+|||+.||+++...         ++..+|+|++.....++.+..++|++..++++||||++++++..
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s---------~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l   88 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLS---------TGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQL   88 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccC---------cccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHH
Confidence            345689999999999999999998655         56789999998777777888999999999999999999999876


Q ss_pred             eCC-----ceEEEEEecCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCC
Q 011250          210 EDD-----QRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       210 ~~~-----~~~lV~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                      .+.     ..||+++|...|+|.+.+..   .+..+++.+++.|+.+|++||++||+.. .+++||||||.|||+.+.+.
T Consensus        89 ~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~  167 (302)
T KOG2345|consen   89 REEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGL  167 (302)
T ss_pred             HhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCc
Confidence            544     48999999999999999864   3457999999999999999999999987 57999999999999999999


Q ss_pred             eEEecccCcccCCCCCcce-------eeeccccCCCccCcchhc---cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCC
Q 011250          282 AKLSDFGLAKDAPEDGKTH-------VSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN  351 (490)
Q Consensus       282 vkL~DFG~a~~~~~~~~~~-------~~~~~~Gt~~y~aPE~l~---~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~  351 (490)
                      ++|.|||.++...-.-...       .......|..|.|||++.   +...+.++|||||||+||+|+.|..||+..-..
T Consensus       168 ~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~  247 (302)
T KOG2345|consen  168 PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ  247 (302)
T ss_pred             eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc
Confidence            9999999988654211110       001134689999999886   456789999999999999999999999753321


Q ss_pred             CcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011250          352 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~  419 (490)
                      +. .+.             ..+.++.+.-.-....+..+.+||+.||+.||.+||++.+++..+..+.
T Consensus       248 Gg-Sla-------------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  248 GG-SLA-------------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             CC-eEE-------------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            11 100             0111111111111224889999999999999999999999999988663

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.6e-41  Score=336.47  Aligned_cols=260  Identities=25%  Similarity=0.411  Sum_probs=205.0

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC-CcccHHHHHHHHHHHhcc-CCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~  210 (490)
                      ++|++.++||+|+||.||+|++...+       ....+++|.++.. .....+.+.+|+.++.++ +||||+++++++..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~   74 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDG-------LKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN   74 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCC-------CcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc
Confidence            47899999999999999999887632       2235788888743 223446788999999999 69999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  275 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NIL  275 (490)
                      .+..++||||+++++|.+++....               ..+++..++.++.||+.||+|||+.+   |+||||||+|||
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil  151 (297)
T cd05089          75 RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVL  151 (297)
T ss_pred             CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEE
Confidence            999999999999999999986432               25888999999999999999999988   999999999999


Q ss_pred             EcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcc
Q 011250          276 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEH  354 (490)
Q Consensus       276 l~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~  354 (490)
                      ++.++.+||+|||++.......   .......+..|+|||++.+..++.++|||||||++|||++ |..||.......  
T Consensus       152 l~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--  226 (297)
T cd05089         152 VGENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--  226 (297)
T ss_pred             ECCCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--
Confidence            9999999999999986432111   1111223567999999988889999999999999999997 999996543211  


Q ss_pred             hhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcccc
Q 011250          355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLK  422 (490)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~~~  422 (490)
                       +....              ........+..++..+.+|+.+||..||.+||++.++++.|+.+.+..
T Consensus       227 -~~~~~--------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         227 -LYEKL--------------PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             -HHHHH--------------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence             11110              000111122234678999999999999999999999999998765543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.7e-41  Score=328.98  Aligned_cols=252  Identities=25%  Similarity=0.394  Sum_probs=203.8

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      .+|.+.+.||+|+||.||+|.+..          +..||||.+.... .....+.+|+.++..++||||+++++++.+.+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   72 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG----------QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR   72 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC----------CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            358889999999999999997753          2359999987554 33467899999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      ..++||||+.+|+|.+++......+++..++.++.||+.||.|||+.+   |+|+||||+|||++.++.+||+|||+++.
T Consensus        73 ~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~  149 (256)
T cd05113          73 PIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRY  149 (256)
T ss_pred             CcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCcccee
Confidence            999999999999999999765557899999999999999999999988   99999999999999999999999999886


Q ss_pred             CCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcchhh
Q 011250          293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  371 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (490)
                      ...... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......   .......   ..    
T Consensus       150 ~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~---~~----  218 (256)
T cd05113         150 VLDDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVEKVSQ---GL----  218 (256)
T ss_pred             cCCCce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHhc---CC----
Confidence            543321 11122345678999999988889999999999999999998 999986433211   1111100   00    


Q ss_pred             hccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011250          372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       372 ~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~  416 (490)
                             ....+...+..+.+++.+||+.||.+||++.+|++.|+
T Consensus       219 -------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         219 -------RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             -------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                   00111123678999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.7e-42  Score=357.87  Aligned_cols=264  Identities=24%  Similarity=0.294  Sum_probs=201.1

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      ...|.+.+.||+|+||.||+|.+..         ++..||||....      ..+.+|+++|++|+|+|||++++++..+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~---------~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~  232 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPD---------YPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVG  232 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECC---------CCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence            4479999999999999999999876         567899996432      2456899999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      +..+||||++ .++|.+++......+++..++.|+.||+.||.|||+.+   ||||||||+||||+.++.+||+|||+++
T Consensus       233 ~~~~lv~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~  308 (461)
T PHA03211        233 GLTCLVLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAAC  308 (461)
T ss_pred             CEEEEEEEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCce
Confidence            9999999999 57999988766667999999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCC-----cchhhHhhh---cc
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG-----EHNLVEWAR---PH  363 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~-----~~~~~~~~~---~~  363 (490)
                      ..............+||+.|+|||++.+..++.++|||||||+||||++|..++.......     ...+.....   ..
T Consensus       309 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~  388 (461)
T PHA03211        309 FARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVH  388 (461)
T ss_pred             ecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccc
Confidence            7644322222334679999999999999999999999999999999999886653221111     011111111   00


Q ss_pred             cCCcc-----hhhhc--------cCCccCC-CCC--hhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          364 LGDKR-----RFYRL--------LDPRLEG-HFS--IKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       364 ~~~~~-----~~~~~--------~~~~l~~-~~~--~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .....     .+...        ..+.... .+.  ...+..+.+||.+||+.||.+|||+.|||++
T Consensus       389 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        389 VDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             cccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            00000     00000        0000000 000  0224578999999999999999999999986

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-41  Score=335.12  Aligned_cols=272  Identities=26%  Similarity=0.431  Sum_probs=206.1

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCc-----cccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceee
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTA-----PVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVG  206 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~-----~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~  206 (490)
                      ++|++.+.||+|+||.||+|++...+..     ....+....||+|.+..... .....+.+|++++..++|+||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            5799999999999999999987542110     01112344699999876532 23456889999999999999999999


Q ss_pred             EEEeCCceEEEEEecCCCChhHHhhhcC-----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 011250          207 YCIEDDQRLLVYEFMPRGSLENHLFRRS-----------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  275 (490)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NIL  275 (490)
                      ++...+..++||||+++++|.+++....           ..+++..++.++.|++.||+|||+.+   |+||||||+|||
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence            9999999999999999999999985432           23688899999999999999999988   999999999999


Q ss_pred             EcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh--CCCCCCCCCCCCc
Q 011250          276 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT--GRRSMDKNRPNGE  353 (490)
Q Consensus       276 l~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt--G~~pf~~~~~~~~  353 (490)
                      ++.++.+||+|||++................++..|+|||++..+.++.++|||||||++|+|++  |..||......  
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~--  239 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE--  239 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH--
Confidence            99999999999999986544322222233456789999999998899999999999999999998  56677543221  


Q ss_pred             chhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011250          354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  417 (490)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~  417 (490)
                       ..+.........       .........+...+..+.+|+.+||+.||.+||++.+|++.|++
T Consensus       240 -~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         240 -QVIENTGEFFRN-------QGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             -HHHHHHHHhhhh-------ccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence             111111000000       00000001112236789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-41  Score=328.42  Aligned_cols=254  Identities=27%  Similarity=0.392  Sum_probs=205.5

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-----cHHHHHHHHHHHhccCCCCeeceeeE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-----GHKEWLAEVNFLGNLLHPNLVKLVGY  207 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~l~~~  207 (490)
                      ++|.+.+.||+|+||.||+|....         ++..||+|.+......     ..+.+.+|+.+++.++||||++++++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~---------~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   72 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVD---------TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGC   72 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcC---------CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEE
Confidence            468999999999999999998765         5678999998654221     23467889999999999999999999


Q ss_pred             EEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecc
Q 011250          208 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DF  287 (490)
                      +.+++..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.++|+||
T Consensus        73 ~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~df  148 (263)
T cd06625          73 LRDDETLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDF  148 (263)
T ss_pred             EccCCeEEEEEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence            99999999999999999999988554 46899999999999999999999988   999999999999999999999999


Q ss_pred             cCcccCCCCCccee-eeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011250          288 GLAKDAPEDGKTHV-STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       288 G~a~~~~~~~~~~~-~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      |+++.......... .....|+..|+|||++.+..++.++||||||+++|||++|+.||........   ...       
T Consensus       149 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~-------  218 (263)
T cd06625         149 GASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA---IFK-------  218 (263)
T ss_pred             ccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH---HHH-------
Confidence            99976543211111 1235688999999999988899999999999999999999999964321100   000       


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                            .........++...+..+.+||.+||..+|.+|||+.+++++.
T Consensus       219 ------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  261 (263)
T cd06625         219 ------IATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF  261 (263)
T ss_pred             ------HhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence                  0000011122334477899999999999999999999999763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.1e-41  Score=330.05  Aligned_cols=261  Identities=26%  Similarity=0.447  Sum_probs=208.8

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .++|+..+.||+|+||.||+|.+...+.      ....||+|.+.... ....+.+..|+++++.++|+||+++++++..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   77 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGR------KEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK   77 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCC------CceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc
Confidence            3468888999999999999999875322      23479999987553 2334678899999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      .+..++||||+++++|.+++......+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~  154 (268)
T cd05063          78 FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLS  154 (268)
T ss_pred             CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccc
Confidence            99999999999999999999766667999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceee-eccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          291 KDAPEDGKTHVS-TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       291 ~~~~~~~~~~~~-~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ............ .....+..|+|||++....++.++|||||||++|||++ |..||......   .........     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~---~~~~~i~~~-----  226 (268)
T cd05063         155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH---EVMKAINDG-----  226 (268)
T ss_pred             eecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHHHHHhcC-----
Confidence            866433221111 11223567999999988889999999999999999997 99999654321   111111100     


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                               .........+..+.+|+.+||..||++||++.+|++.|+++
T Consensus       227 ---------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         227 ---------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                     00111223467889999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-42  Score=349.79  Aligned_cols=245  Identities=26%  Similarity=0.408  Sum_probs=206.3

Q ss_pred             ccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCCceEEEEE
Q 011250          140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYE  219 (490)
Q Consensus       140 ~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E  219 (490)
                      +||+|.||+||-|++..         +...+|||.+........+-+..||.+.++|+|.|||+++|.+.+++.+-|.||
T Consensus       582 VLGKGTYG~VYA~RD~~---------tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFME  652 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMD---------TQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFME  652 (1226)
T ss_pred             EeecCceeEEEeecccc---------ceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEee
Confidence            59999999999999987         667899999987766666778899999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhhcCCCC--CHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-CCCCeEEecccCcccCCCC
Q 011250          220 FMPRGSLENHLFRRSLPL--PWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD-ADYNAKLSDFGLAKDAPED  296 (490)
Q Consensus       220 ~~~~gsL~~~l~~~~~~l--~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~-~~~~vkL~DFG~a~~~~~~  296 (490)
                      -++||+|.++|...-+++  .+.+.-.+..||++||.|||++.   |||||||-+||||+ -.|.+||+|||.++.+.. 
T Consensus       653 qVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-  728 (1226)
T KOG4279|consen  653 QVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-  728 (1226)
T ss_pred             cCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc-
Confidence            999999999998776777  78888999999999999999988   99999999999996 568999999999987643 


Q ss_pred             CcceeeeccccCCCccCcchhccC--CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhcc
Q 011250          297 GKTHVSTRVMGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  374 (490)
Q Consensus       297 ~~~~~~~~~~Gt~~y~aPE~l~~~--~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (490)
                       .......+.||..|||||++..+  .|+.++|||||||++.||.||++||-.......   .            ++++-
T Consensus       729 -inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---A------------MFkVG  792 (1226)
T KOG4279|consen  729 -INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---A------------MFKVG  792 (1226)
T ss_pred             -CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---h------------hhhhc
Confidence             23345668899999999999865  689999999999999999999999964321100   0            00110


Q ss_pred             CCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 011250          375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE  413 (490)
Q Consensus       375 ~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~  413 (490)
                      --......|...+.+++.+|.+|+..||.+||++.++|+
T Consensus       793 myKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  793 MYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             ceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            111223345566899999999999999999999999986

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.6e-41  Score=331.25  Aligned_cols=259  Identities=27%  Similarity=0.459  Sum_probs=207.3

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      +|++.+.||+|+||.||+|.+...+.      .+..||||.+.... .....+|..|+.+++.+.||||+++++++.++.
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   78 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGK------REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR   78 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCC------CceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC
Confidence            58889999999999999999876432      23479999987542 233567999999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      ..++||||+++++|.+++......+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++..
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~  155 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRF  155 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccc
Confidence            999999999999999998766667899999999999999999999988   99999999999999999999999999876


Q ss_pred             CCCCCcceeeec-cc--cCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          293 APEDGKTHVSTR-VM--GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       293 ~~~~~~~~~~~~-~~--Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ............ ..  ++..|+|||.+.+..++.++|||||||++|||++ |..||......   ....+....     
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~~~-----  227 (269)
T cd05065         156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIEQD-----  227 (269)
T ss_pred             cccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHHcC-----
Confidence            543222111111 11  2457999999998899999999999999999886 99999654321   111111100     


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                               .....+..++..+.+++.+||..+|.+||++.+|+..|+.+
T Consensus       228 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         228 ---------YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ---------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                     00011223467889999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=6.7e-42  Score=343.65  Aligned_cols=242  Identities=26%  Similarity=0.381  Sum_probs=196.3

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccC-CCCeeceeeEEE
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLL-HPNLVKLVGYCI  209 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~  209 (490)
                      +|++.+.||+|+||.||+|.+..         ++..||||++.....   ...+.+..|+.++..+. |++|+++++++.
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~   71 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKG---------TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ   71 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe
Confidence            47788999999999999999876         577899999975421   23356778999998886 577888999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +.+..||||||+++|+|.+++... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~~lv~Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~  147 (323)
T cd05615          72 TVDRLYFVMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGM  147 (323)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEecccc
Confidence            999999999999999999988554 46999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      ++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......   .......        
T Consensus       148 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i~--------  214 (323)
T cd05615         148 CKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELFQSIM--------  214 (323)
T ss_pred             ccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHH--------
Confidence            876433221  123467999999999999889999999999999999999999999754321   1111110        


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCH
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM  408 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~  408 (490)
                           ..  ...++...+.++.+|+.+||+.||.+|++.
T Consensus       215 -----~~--~~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         215 -----EH--NVSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             -----hC--CCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence                 00  011222346788999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-42  Score=344.29  Aligned_cols=256  Identities=23%  Similarity=0.285  Sum_probs=201.3

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|++.+.||+|+||.||++++..         ++..||||++....   ....+.+.+|+.++..++|+||+++++++.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   71 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKN---------TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ   71 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence            479999999999999999999876         56789999986432   123355788999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +++..|+||||+++|+|.+++.+....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~  148 (331)
T cd05597          72 DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGS  148 (331)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCc
Confidence            999999999999999999999765667999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhcc-----CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-----GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      +......... .....+||+.|+|||++..     ..++.++|||||||++|||++|+.||.......      ......
T Consensus       149 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~------~~~~i~  221 (331)
T cd05597         149 CLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIM  221 (331)
T ss_pred             eeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH------HHHHHH
Confidence            8765433221 1223569999999999863     467889999999999999999999996532211      110000


Q ss_pred             CCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 011250          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA--RPRMSEVVET  414 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~--RPt~~evl~~  414 (490)
                      .....+ .+ .+     .....+..+.+||.+||..++.+  |+++.+++++
T Consensus       222 ~~~~~~-~~-~~-----~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         222 NHKEHF-QF-PP-----DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             cCCCcc-cC-CC-----ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            000000 00 00     01124778999999988654443  7899999987

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.6e-41  Score=329.86  Aligned_cols=257  Identities=26%  Similarity=0.418  Sum_probs=200.3

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhccCCCCeeceeeEEEeC-
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED-  211 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-  211 (490)
                      |.+.+.||+|+||.||+|++...+       ....||+|.++...  ....+.+..|+.+++.++|+||+++++++... 
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~-------~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   73 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDD-------SILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTV   73 (272)
T ss_pred             CccccccCcccCceEEEeEEccCC-------CeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCC
Confidence            456789999999999999986532       12369999887542  23346788999999999999999999987532 


Q ss_pred             -----CceEEEEEecCCCChhHHhhh-----cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCC
Q 011250          212 -----DQRLLVYEFMPRGSLENHLFR-----RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       212 -----~~~~lV~E~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                           ...++||||+.+|+|.+++..     ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.
T Consensus        74 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~  150 (272)
T cd05075          74 ESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMN  150 (272)
T ss_pred             cccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCC
Confidence                 246899999999999988742     2245889999999999999999999988   999999999999999999


Q ss_pred             eEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 011250          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       282 vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~  360 (490)
                      +||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||......   ...+..
T Consensus       151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~  227 (272)
T cd05075         151 VCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIYDYL  227 (272)
T ss_pred             EEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH
Confidence            99999999987644322221222346778999999998899999999999999999999 88898653221   111111


Q ss_pred             hcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                      ..    ...          ...+...+..+.+||.+||+.||++|||+.+|++.|+.+
T Consensus       228 ~~----~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         228 RQ----GNR----------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             Hc----CCC----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            10    000          011223467799999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-44  Score=331.53  Aligned_cols=250  Identities=28%  Similarity=0.403  Sum_probs=214.4

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCCce
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQR  214 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  214 (490)
                      |.++.+||+|+||.||+|.+++         +|..||||.+..+  .+.+++..|+.||+++..|++|++||.|.....+
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~E---------sG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDL  103 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRE---------SGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDL  103 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhc---------cCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCce
Confidence            6677899999999999999987         7889999998765  4568899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCC
Q 011250          215 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~  294 (490)
                      |||||||..|++.+.+.-+..+|++.++..+++..++||+|||...   =||||||..||||+.+|.+||+|||.|-.+.
T Consensus       104 WIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLT  180 (502)
T KOG0574|consen  104 WIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLT  180 (502)
T ss_pred             EeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhh
Confidence            9999999999999999888889999999999999999999999987   8999999999999999999999999998765


Q ss_pred             CCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhcc
Q 011250          295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  374 (490)
Q Consensus       295 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (490)
                      +.-  .....+.||+.|||||++..-.|+.++||||||++..||..|++||....+......+    +.           
T Consensus       181 DTM--AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI----PT-----------  243 (502)
T KOG0574|consen  181 DTM--AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI----PT-----------  243 (502)
T ss_pred             hhH--HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec----cC-----------
Confidence            421  2234578999999999999999999999999999999999999999766554322111    10           


Q ss_pred             CCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       375 ~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                      +|...-.-+...+.++.++++.||-++|++|-|+.++++|-
T Consensus       244 ~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~  284 (502)
T KOG0574|consen  244 KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT  284 (502)
T ss_pred             CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence            11111122344588999999999999999999999999863

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.2e-42  Score=351.17  Aligned_cols=254  Identities=26%  Similarity=0.354  Sum_probs=200.7

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|++.+.||+|+||.||+|.+..         ++..||||++....   ......+..|+.++..++|+||+++++++.
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~   71 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKD---------TGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ   71 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            368899999999999999999876         57789999997532   223456788999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +.+.+|||||||++|+|.+++.+. ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.++|+|||+
T Consensus        72 ~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~  147 (360)
T cd05627          72 DKRNLYLIMEFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGL  147 (360)
T ss_pred             cCCEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccC
Confidence            999999999999999999998654 46899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcc---------------------------------eeeeccccCCCccCcchhccCCCCccchhhHHHHHHH
Q 011250          290 AKDAPEDGKT---------------------------------HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLL  336 (490)
Q Consensus       290 a~~~~~~~~~---------------------------------~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~  336 (490)
                      +.........                                 ......+||+.|+|||++.+..++.++|||||||+||
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvily  227 (360)
T cd05627         148 CTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY  227 (360)
T ss_pred             CcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceee
Confidence            8754321100                                 0012357999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 011250          337 EMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR---MSEVVE  413 (490)
Q Consensus       337 elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt---~~evl~  413 (490)
                      ||++|+.||....+......+      ......+  .+.+      ....+.++.+||.+|+ .||.+|++   +.++++
T Consensus       228 el~tG~~Pf~~~~~~~~~~~i------~~~~~~~--~~p~------~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         228 EMLIGYPPFCSETPQETYRKV------MNWKETL--VFPP------EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             ecccCCCCCCCCCHHHHHHHH------HcCCCce--ecCC------CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            999999999765432111110      0000000  0000      0113678999999987 49999985   677775


Q ss_pred             H
Q 011250          414 T  414 (490)
Q Consensus       414 ~  414 (490)
                      |
T Consensus       293 h  293 (360)
T cd05627         293 H  293 (360)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=9.5e-42  Score=348.99  Aligned_cols=262  Identities=24%  Similarity=0.308  Sum_probs=205.3

Q ss_pred             hhhHHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCe
Q 011250          125 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNL  201 (490)
Q Consensus       125 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnI  201 (490)
                      +.++....++|++.+.||+|+||.||+|.+..         ++..||+|++.....   .....+.+|+.+++.++||||
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~i  105 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---------TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV  105 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECC---------CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCC
Confidence            34455666899999999999999999999876         677899999864321   223457789999999999999


Q ss_pred             eceeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCC
Q 011250          202 VKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       202 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                      +++++++.+++..++||||+++|+|.+++...  .+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.
T Consensus       106 v~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~  180 (371)
T cd05622         106 VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGH  180 (371)
T ss_pred             CeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCC
Confidence            99999999999999999999999999988543  5889999999999999999999988   999999999999999999


Q ss_pred             eEEecccCcccCCCCCcceeeeccccCCCccCcchhccC----CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 011250          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG----HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV  357 (490)
Q Consensus       282 vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~----~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~  357 (490)
                      +||+|||+++........ .....+||+.|+|||++...    .++.++|||||||+||||++|..||........   .
T Consensus       181 ikL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~  256 (371)
T cd05622         181 LKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---Y  256 (371)
T ss_pred             EEEEeCCceeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH---H
Confidence            999999999876432221 12346799999999998753    378999999999999999999999975432111   1


Q ss_pred             HhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCC--CCCHHHHHHHh
Q 011250          358 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA--RPRMSEVVETL  415 (490)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~--RPt~~evl~~L  415 (490)
                         ...+....        .+.-......+..+.+||.+||..++.+  |+++.+++++.
T Consensus       257 ---~~i~~~~~--------~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         257 ---SKIMNHKN--------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             ---HHHHcCCC--------cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence               00000000        0000011134788999999999844433  78999999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.2e-41  Score=341.30  Aligned_cols=238  Identities=29%  Similarity=0.373  Sum_probs=190.3

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHH-HHhccCCCCeeceeeEEEeCCce
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVN-FLGNLLHPNLVKLVGYCIEDDQR  214 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~  214 (490)
                      ++||+|+||.||+|++..         ++..||+|++.....   .....+..|+. +++.++||||+++++++.+.+..
T Consensus         1 ~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~   71 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKS---------DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKL   71 (321)
T ss_pred             CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEE
Confidence            469999999999999876         567899999875422   22334555554 67889999999999999999999


Q ss_pred             EEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCC
Q 011250          215 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~  294 (490)
                      ||||||+++|+|..++.. ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++...
T Consensus        72 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  147 (321)
T cd05603          72 YFVLDYVNGGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGV  147 (321)
T ss_pred             EEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCC
Confidence            999999999999988854 346889999999999999999999988   9999999999999999999999999987542


Q ss_pred             CCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhcc
Q 011250          295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  374 (490)
Q Consensus       295 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (490)
                      ....  .....+||+.|+|||++.+..++.++|||||||++|||++|..||......   .+.+.   ..          
T Consensus       148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~---i~----------  209 (321)
T cd05603         148 EPEE--TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QMYDN---IL----------  209 (321)
T ss_pred             CCCC--ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH---HHHHH---Hh----------
Confidence            2211  223467999999999999889999999999999999999999999654211   11111   00          


Q ss_pred             CCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHH
Q 011250          375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS  409 (490)
Q Consensus       375 ~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~  409 (490)
                      ...  ..++...+..+.+++.+||+.||.+||++.
T Consensus       210 ~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         210 HKP--LQLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             cCC--CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            000  112223467899999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.1e-41  Score=334.07  Aligned_cols=265  Identities=26%  Similarity=0.408  Sum_probs=207.0

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      +..++|++.+.||+|+||.||+|.+....    ....+..||+|.+..... .....+.+|+.+++.++||||+++++++
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   78 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDII----KGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV   78 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccC----CCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            34568999999999999999999876421    111355899999865432 2334678899999999999999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcC---------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD  279 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~  279 (490)
                      .+.+..++||||+++|+|.+++....         ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.+
T Consensus        79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~  155 (288)
T cd05061          79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHD  155 (288)
T ss_pred             cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCC
Confidence            99999999999999999999996422         23567788899999999999999988   9999999999999999


Q ss_pred             CCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhH
Q 011250          280 YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVE  358 (490)
Q Consensus       280 ~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~  358 (490)
                      +.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......   ...
T Consensus       156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~  232 (288)
T cd05061         156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLK  232 (288)
T ss_pred             CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH
Confidence            9999999999986543322222223346778999999998899999999999999999998 788886432211   111


Q ss_pred             hhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                      ...             +.. ....+..++..+.+|+.+||+.||++|||+.++++.|+..
T Consensus       233 ~~~-------------~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         233 FVM-------------DGG-YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             HHH-------------cCC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            100             000 0011223367899999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.8e-41  Score=329.31  Aligned_cols=260  Identities=26%  Similarity=0.448  Sum_probs=208.7

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      .+|++.+.||+|+||.||+|.+...+.      .+..||+|.+..... ...+.+.+|+.++..++||||+++++++..+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   77 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGK------REIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS   77 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCC------CceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            468899999999999999998865322      344799999875432 2346788999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      +..++||||+++++|.+++......+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++.
T Consensus        78 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~  154 (267)
T cd05066          78 KPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSR  154 (267)
T ss_pred             CccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccc
Confidence            9999999999999999999776667899999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCccee-eeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          292 DAPEDGKTHV-STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       292 ~~~~~~~~~~-~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      .......... .....++..|+|||.+.+..++.++|||||||++||+++ |..||.......   ........    . 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~~~----~-  226 (267)
T cd05066         155 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAIEEG----Y-  226 (267)
T ss_pred             ccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHHhCC----C-
Confidence            7654322111 112234568999999998899999999999999999886 999996543221   11111100    0 


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                               ....+...+..+.+|+.+||+.+|.+||++.++++.|+.+
T Consensus       227 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         227 ---------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ---------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                     0011123367889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.4e-41  Score=347.89  Aligned_cols=263  Identities=25%  Similarity=0.386  Sum_probs=202.1

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC--CcccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      +|++.+.||+|+||.||+|.+..         ++..||||.+...  .....+.+.+|+.+++.++|+||+++++++...
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   71 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPR---------DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPP   71 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECC---------CCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCC
Confidence            48889999999999999998865         5678999998653  223446788999999999999999999999877


Q ss_pred             C-----ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEec
Q 011250          212 D-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       212 ~-----~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~D  286 (490)
                      +     ..|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        72 ~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~D  146 (372)
T cd07853          72 HIDPFEEIYVVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICD  146 (372)
T ss_pred             CccccceEEEEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEecc
Confidence            6     7899999995 688887744 457999999999999999999999988   99999999999999999999999


Q ss_pred             ccCcccCCCCCcceeeeccccCCCccCcchhccC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011250          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      ||+++....... .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||....+......+..   .++
T Consensus       147 fg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~---~~g  222 (372)
T cd07853         147 FGLARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITD---LLG  222 (372)
T ss_pred             ccceeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHH---HcC
Confidence            999986543221 122335689999999998764 589999999999999999999999976543322111110   000


Q ss_pred             Cc--chh-------hh-c----cC-CccCC--CCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          366 DK--RRF-------YR-L----LD-PRLEG--HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 ~~--~~~-------~~-~----~~-~~l~~--~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ..  ..+       .. +    .. +....  .+....+.++.+||.+||+.||.+|||+.+++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         223 TPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             CCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            00  000       00 0    00 00000  1112236789999999999999999999999976

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-43  Score=350.72  Aligned_cols=245  Identities=30%  Similarity=0.444  Sum_probs=205.6

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccH---HHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      |.-++.||.|+||.||-|++..         +...||||++.....+..   .+++.|+.+|+.|.|||+|.+.|+|..+
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~---------n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre   98 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE   98 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccC---------ccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc
Confidence            5556789999999999999887         566899999987665543   5689999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      ...||||||| -|+-.|++.-...++.+..+..|..+.+.||+|||+.+   .||||||..||||++.|.|||+|||.|.
T Consensus        99 ~TaWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAs  174 (948)
T KOG0577|consen   99 HTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSAS  174 (948)
T ss_pred             chHHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchh
Confidence            9999999999 67999998877789999999999999999999999999   9999999999999999999999999987


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhc---cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      .....      ..++|||+|||||++.   .+.|+-++|||||||+..||...++|+-..........+  +.       
T Consensus       175 i~~PA------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI--AQ-------  239 (948)
T KOG0577|consen  175 IMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--AQ-------  239 (948)
T ss_pred             hcCch------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH--Hh-------
Confidence            65432      4589999999999986   578999999999999999999999997543222111110  00       


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                          .-.|.+.   ....+..+..|+..||++-|.+|||.++++.|
T Consensus       240 ----NesPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  240 ----NESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             ----cCCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence                0111121   23458899999999999999999999998875

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.3e-41  Score=342.46  Aligned_cols=263  Identities=23%  Similarity=0.301  Sum_probs=198.4

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ....+|++.+.||+|+||.||+|.+..         ++..||+|+....      ....|+.+++.++|+||+++++++.
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~  127 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPG---------QPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLV  127 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECC---------CCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEE
Confidence            334579999999999999999999875         5668999985433      2346899999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      .....++||||+ .++|.+++......+++..++.|+.||+.||.|||+.+   ||||||||+|||++.++.+||+|||+
T Consensus       128 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~  203 (357)
T PHA03209        128 SGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGA  203 (357)
T ss_pred             eCCeeEEEEEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcc
Confidence            999999999999 56899988777778999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcc--------hhhHhhh
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH--------NLVEWAR  361 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~--------~~~~~~~  361 (490)
                      ++......   ......||+.|+|||++.+..++.++|||||||++|||+++..++....+....        .+.....
T Consensus       204 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~  280 (357)
T PHA03209        204 AQFPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIS  280 (357)
T ss_pred             ccccccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHH
Confidence            97543221   123357999999999999999999999999999999999866554322221100        0111000


Q ss_pred             cccCCcchhh---------hccCC--ccCCCC-------ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          362 PHLGDKRRFY---------RLLDP--RLEGHF-------SIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       362 ~~~~~~~~~~---------~~~~~--~l~~~~-------~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ........+.         ..++.  .....+       ....+..+.+||.+||+.||.+|||+.||++|
T Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        281 TLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             HhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence            0000000000         00000  000000       01235667889999999999999999999976

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.5e-41  Score=341.40  Aligned_cols=241  Identities=30%  Similarity=0.376  Sum_probs=192.1

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHH-HHhccCCCCeeceeeEEEeCCce
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVN-FLGNLLHPNLVKLVGYCIEDDQR  214 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~  214 (490)
                      +.||+|+||+||+|.+..         +|..||||++....   ......+..|.. +++.++||||+++++++...+..
T Consensus         1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~   71 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKL---------DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKL   71 (325)
T ss_pred             CceeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEE
Confidence            469999999999999876         57789999986542   122345556655 56779999999999999999999


Q ss_pred             EEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCC
Q 011250          215 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~  294 (490)
                      ||||||+++|+|..++.. ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++...
T Consensus        72 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~  147 (325)
T cd05604          72 YFVLDFVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGI  147 (325)
T ss_pred             EEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCC
Confidence            999999999999988854 457999999999999999999999988   9999999999999999999999999987543


Q ss_pred             CCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhcc
Q 011250          295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  374 (490)
Q Consensus       295 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (490)
                      ....  .....+||+.|+|||++.+..++.++|||||||++|||++|..||.......   +.   ...+..        
T Consensus       148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~---~~~~~~--------  211 (325)
T cd05604         148 AQSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE---MY---DNILHK--------  211 (325)
T ss_pred             CCCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH---HH---HHHHcC--------
Confidence            2211  1234679999999999999999999999999999999999999996542211   11   111100        


Q ss_pred             CCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 011250          375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV  412 (490)
Q Consensus       375 ~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl  412 (490)
                        .+  .+....+..+.+++.+||+.||.+||++.+.+
T Consensus       212 --~~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         212 --PL--VLRPGASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             --Cc--cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence              00  11122367889999999999999999876433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3.9e-41  Score=327.72  Aligned_cols=259  Identities=27%  Similarity=0.399  Sum_probs=208.7

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|++.+.||.|+||.||+|.+..         ++..||||.+.....   ....++.+|+.+++.+.|+||+++++++.
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~   72 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLL---------DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI   72 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecC---------CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE
Confidence            368889999999999999999866         566899998865322   23357889999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEec
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~D  286 (490)
                      +++..++||||+++++|.+++..   ....+++..++.++.||+.||.|||+.+   |+|+||||+||+++.++.++|+|
T Consensus        73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~d  149 (267)
T cd08229          73 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGD  149 (267)
T ss_pred             eCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECc
Confidence            99999999999999999998853   2346899999999999999999999988   99999999999999999999999


Q ss_pred             ccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011250          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      ||++........  ......|+..|+|||.+.+..++.++||||||+++|+|++|..||...... .........     
T Consensus       150 fg~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~-----  221 (267)
T cd08229         150 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIE-----  221 (267)
T ss_pred             chhhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhhhhh-----
Confidence            999876643322  122356899999999998888999999999999999999999999643221 011111000     


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~  419 (490)
                           ....+.+   .....+..+.+|+.+||..||.+|||+.+|++.++++.
T Consensus       222 -----~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         222 -----QCDYPPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             -----cCCCCCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence                 0000100   11224678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=7.4e-42  Score=343.56  Aligned_cols=243  Identities=28%  Similarity=0.357  Sum_probs=192.5

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHH-HHhccCCCCeeceeeEEEeCCce
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVN-FLGNLLHPNLVKLVGYCIEDDQR  214 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~  214 (490)
                      +.||+|+||+||+|++..         ++..||+|++.....   .....+..|.. +++.+.||||+++++++...+..
T Consensus         1 ~~lg~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~   71 (325)
T cd05602           1 KVIGKGSFGKVLLARHKA---------EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL   71 (325)
T ss_pred             CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeE
Confidence            369999999999999876         566899999875421   22234455544 56788999999999999999999


Q ss_pred             EEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCC
Q 011250          215 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~  294 (490)
                      |+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        72 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~  147 (325)
T cd05602          72 YFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI  147 (325)
T ss_pred             EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccc
Confidence            9999999999999988654 46888899999999999999999988   9999999999999999999999999997543


Q ss_pred             CCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhcc
Q 011250          295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  374 (490)
Q Consensus       295 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (490)
                      ....  .....+||+.|+|||++.+..++.++|||||||++|||++|..||.......   .....   ..         
T Consensus       148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i---~~---------  210 (325)
T cd05602         148 EHNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYDNI---LN---------  210 (325)
T ss_pred             cCCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH---HHHHH---Hh---------
Confidence            2211  1234679999999999999999999999999999999999999997543211   11111   00         


Q ss_pred             CCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       375 ~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                       ..  ..+....+..+.+||.+||+.||.+||++.+.+..
T Consensus       211 -~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~  247 (325)
T cd05602         211 -KP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME  247 (325)
T ss_pred             -CC--cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence             00  01122347789999999999999999998754433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.1e-41  Score=324.56  Aligned_cols=252  Identities=35%  Similarity=0.529  Sum_probs=207.1

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-HHHHHHHHHHHhccCCCCeeceeeEEEeCCceEEE
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  217 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  217 (490)
                      +.||+|+||.||+|.+....      ..+..||+|.+....... .+.+.+|+.++..++|+||+++++++......++|
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   74 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKD------GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLV   74 (262)
T ss_pred             CccccCCceEEEEEEEecCC------CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEE
Confidence            46999999999999987531      136689999997664433 57789999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhc--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          218 YEFMPRGSLENHLFRR--------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       218 ~E~~~~gsL~~~l~~~--------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      |||+++++|.+++...        ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||.
T Consensus        75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~  151 (262)
T cd00192          75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGL  151 (262)
T ss_pred             EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccc
Confidence            9999999999999765        467999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +................++..|+|||.+....++.++|||||||++|+|++ |..||......   .+......      
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~~------  222 (262)
T cd00192         152 SRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EVLEYLRK------  222 (262)
T ss_pred             ccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHc------
Confidence            987765432222334567899999999988899999999999999999999 69999765221   11111110      


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~  416 (490)
                              ......+...+.++.+++.+||..||.+||++.+++++|+
T Consensus       223 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         223 --------GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             --------CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                    0011122334788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.5e-41  Score=324.84  Aligned_cols=250  Identities=28%  Similarity=0.411  Sum_probs=206.1

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      +|.+.+.||+|+||.||+|.+..         ++..|++|.+....  .....++.+|+.+++.++||||+++++++.+.
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   71 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKA---------DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK   71 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcC---------CCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC
Confidence            47888999999999999999876         56789999986542  23456788999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      +..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++
T Consensus        72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~  148 (256)
T cd08529          72 GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVA  148 (256)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccc
Confidence            9999999999999999998764 457899999999999999999999988   999999999999999999999999998


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ........  ......|++.|+|||++.+..++.++|||||||++|+|++|+.||......   ........   .    
T Consensus       149 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~---~----  216 (256)
T cd08529         149 KLLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALILKIIR---G----  216 (256)
T ss_pred             eeccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHc---C----
Confidence            87654322  123357899999999999889999999999999999999999999654311   11111100   0    


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                        .     ...++...+..+.+++.+||+.+|++||++.+++++
T Consensus       217 --~-----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         217 --V-----FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             --C-----CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence              0     001111336789999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.1e-41  Score=337.24  Aligned_cols=267  Identities=24%  Similarity=0.393  Sum_probs=208.2

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcc-CCCCeeceeeEEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~  209 (490)
                      .++|.+.+.||+|+||.||+|.+.....  ........||+|.+.... ......+..|+.+++.+ .||||+++++++.
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDK--SRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCC--ccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            4578899999999999999998643111  111245579999987543 23345688999999999 5999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcE
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI  274 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NI  274 (490)
                      +.+..++||||+++|+|.+++....               ..+++..+..++.||+.||.|||+.+   |+||||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni  165 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNV  165 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeE
Confidence            9999999999999999999986532               35888999999999999999999988   99999999999


Q ss_pred             EEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCc
Q 011250          275 LLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGE  353 (490)
Q Consensus       275 Ll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~  353 (490)
                      |++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||....... 
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-  244 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE-  244 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH-
Confidence            999999999999999987643222111122234568999999998899999999999999999999 888886542211 


Q ss_pred             chhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                        +......    .          .....+..++.++.+|+.+||..||.+||++.++++.|..+..
T Consensus       245 --~~~~~~~----~----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         245 --LFKLLRE----G----------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             --HHHHHHc----C----------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence              1111110    0          0011223346788999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=7.3e-41  Score=324.85  Aligned_cols=250  Identities=24%  Similarity=0.407  Sum_probs=199.6

Q ss_pred             cccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEeCCceEEEEE
Q 011250          141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYE  219 (490)
Q Consensus       141 LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E  219 (490)
                      ||+|+||.||+|.+...+       .+..||+|++..... ...+.+.+|+.+++.++|+||+++++++. .+..++|||
T Consensus         3 ig~G~~g~v~~~~~~~~~-------~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e   74 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRK-------KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVME   74 (257)
T ss_pred             cCCCCcccEEEEEEecCC-------CceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEE
Confidence            899999999999876421       355799999876532 23456889999999999999999999875 457899999


Q ss_pred             ecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCCCcc
Q 011250          220 FMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT  299 (490)
Q Consensus       220 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~  299 (490)
                      |+++++|.+++......+++..++.++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||++.........
T Consensus        75 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  151 (257)
T cd05115          75 MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY  151 (257)
T ss_pred             eCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccc
Confidence            99999999998766668999999999999999999999988   999999999999999999999999999865433221


Q ss_pred             ee-eeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCc
Q 011250          300 HV-STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPR  377 (490)
Q Consensus       300 ~~-~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  377 (490)
                      .. .....++..|+|||++....++.++|||||||++|||++ |..||........   .....              ..
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~--------------~~  214 (257)
T cd05115         152 YKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV---MSFIE--------------QG  214 (257)
T ss_pred             eeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHHHH--------------CC
Confidence            11 111233578999999988889999999999999999996 9999965432111   11110              00


Q ss_pred             cCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       378 l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                      .....+..++.++.+|+.+||..||++||++.+|++.|+.+
T Consensus       215 ~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         215 KRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            11122334578999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.5e-41  Score=342.38  Aligned_cols=266  Identities=28%  Similarity=0.396  Sum_probs=204.6

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcc-CCCCeeceeeEEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~  209 (490)
                      .++|++.+.||+|+||+||+|.+...+    ...+++.||||+++.... .....+.+|+.++..+ +||||+++++++.
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT   81 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCC----ccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence            457999999999999999999864311    112567899999976432 2345688999999999 6899999999886


Q ss_pred             eC-CceEEEEEecCCCChhHHhhhcC------------------------------------------------------
Q 011250          210 ED-DQRLLVYEFMPRGSLENHLFRRS------------------------------------------------------  234 (490)
Q Consensus       210 ~~-~~~~lV~E~~~~gsL~~~l~~~~------------------------------------------------------  234 (490)
                      .. ...++|||||++|+|.+++....                                                      
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence            54 46789999999999999985421                                                      


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCCCcceee
Q 011250          235 ------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS  302 (490)
Q Consensus       235 ------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~  302 (490)
                                  ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++............
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  238 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK  238 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence                        23678888999999999999999988   999999999999999999999999999865432222222


Q ss_pred             eccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCC
Q 011250          303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGH  381 (490)
Q Consensus       303 ~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  381 (490)
                      ....++..|+|||.+.+..++.++|||||||++|+|++ |..||.......  .......    ...          ...
T Consensus       239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~----~~~----------~~~  302 (343)
T cd05103         239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLK----EGT----------RMR  302 (343)
T ss_pred             CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHHHHHh----ccC----------CCC
Confidence            22345678999999988899999999999999999997 999986532211  1111100    000          000


Q ss_pred             CChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          382 FSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       382 ~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                      .+...+.++.+++.+||+.||.+||++.+|+++|+.+.+
T Consensus       303 ~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            111225678999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=5.2e-41  Score=332.64  Aligned_cols=272  Identities=26%  Similarity=0.420  Sum_probs=206.6

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCc-------cccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeece
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTA-------PVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKL  204 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~-------~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l  204 (490)
                      ++|++.+.||+|+||.||++.+......       ....+++..||+|.+..... .....+.+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            4699999999999999999875431110       01223456799999975532 334678999999999999999999


Q ss_pred             eeEEEeCCceEEEEEecCCCChhHHhhhcC----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcE
Q 011250          205 VGYCIEDDQRLLVYEFMPRGSLENHLFRRS----------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI  274 (490)
Q Consensus       205 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NI  274 (490)
                      ++++...+..++||||+++++|.+++....          ..+++..+..++.||+.||+|||+.+   |+||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence            999999999999999999999999986532          24778889999999999999999988   99999999999


Q ss_pred             EEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh--CCCCCCCCCCCC
Q 011250          275 LLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT--GRRSMDKNRPNG  352 (490)
Q Consensus       275 Ll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt--G~~pf~~~~~~~  352 (490)
                      |++.++.++|+|||+++...............++..|+|||.+..+.++.++|||||||++|||++  |..||.......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999986644322222223445678999999888899999999999999999998  677886432211


Q ss_pred             cchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011250          353 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  417 (490)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~  417 (490)
                      .   +..........       ........+..++..+.+|+.+||+.||.+||++.+|++.|++
T Consensus       242 ~---~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         242 V---IENTGEFFRDQ-------GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             H---HHHHHHHHhhc-------cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            1   11000000000       0000001112346789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=6.9e-41  Score=324.66  Aligned_cols=250  Identities=28%  Similarity=0.390  Sum_probs=199.3

Q ss_pred             ccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEeCCceEEE
Q 011250          140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  217 (490)
Q Consensus       140 ~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  217 (490)
                      .||+|+||.||+|.+...+       ++..||+|++.....  ...+++..|+.+++.+.||||+++++++. .+..++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv   73 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKK-------SEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLV   73 (257)
T ss_pred             cCCCcCCcceEEeEEecCC-------CceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEE
Confidence            5899999999999875322       567899999865432  23467889999999999999999999875 4567899


Q ss_pred             EEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCCC
Q 011250          218 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG  297 (490)
Q Consensus       218 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~  297 (490)
                      |||+++|+|.+++... ..+++..+..++.|++.||+|||+.+   |+||||||.|||++.++.+||+|||+++......
T Consensus        74 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~  149 (257)
T cd05116          74 MELAELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE  149 (257)
T ss_pred             EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCC
Confidence            9999999999998544 46899999999999999999999988   9999999999999999999999999998764432


Q ss_pred             ccee-eeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcchhhhccC
Q 011250          298 KTHV-STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD  375 (490)
Q Consensus       298 ~~~~-~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  375 (490)
                      .... .....++..|+|||.+....++.++|||||||++|||++ |..||......   .+......             
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~i~~-------------  213 (257)
T cd05116         150 NYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQMIES-------------  213 (257)
T ss_pred             CeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHC-------------
Confidence            2111 122344679999999988889999999999999999998 99999754322   11111111             


Q ss_pred             CccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       376 ~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                       ......+..++.++.+||.+||+.||++||++.+|.+.|+..
T Consensus       214 -~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         214 -GERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             -CCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence             001112234478899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=5.2e-41  Score=329.78  Aligned_cols=252  Identities=26%  Similarity=0.393  Sum_probs=201.3

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      ++|++.++||+|+||.||+|.+..         ++..||+|.+.... ....+++.+|++++..++||||+++++++...
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   71 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLL---------TRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE   71 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcC---------CCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC
Confidence            368889999999999999998865         56789999987553 23345788999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      +..++||||+++++|..+.     .+++..+..++.|++.||.|||+.+   |+|+||||+|||++.++.++|+|||++.
T Consensus        72 ~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~  143 (279)
T cd06619          72 NRISICTEFMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVST  143 (279)
T ss_pred             CEEEEEEecCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcce
Confidence            9999999999999996542     5788899999999999999999988   9999999999999999999999999997


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcch-hhHhhhcccCCcchh
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPHLGDKRRF  370 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~  370 (490)
                      ......    ....+||..|+|||++.+..++.++|||||||++|+|++|..||.......... ...........    
T Consensus       144 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----  215 (279)
T cd06619         144 QLVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE----  215 (279)
T ss_pred             eccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc----
Confidence            654321    233579999999999998899999999999999999999999996532211110 00000000000    


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                         ..+.+   .....+.++.+|+.+||+.||.+||++.+++++.
T Consensus       216 ---~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~  254 (279)
T cd06619         216 ---DPPVL---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP  254 (279)
T ss_pred             ---CCCCC---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence               00000   0112357889999999999999999999999764

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.5e-41  Score=329.33  Aligned_cols=254  Identities=24%  Similarity=0.377  Sum_probs=203.9

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      ++|.+.+.||+|+||.||+|++..         ++..||+|.++.........+.+|+.+++.++||||+++++++...+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~   79 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVN---------TGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD   79 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcC---------CCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence            468888999999999999998875         56789999987665445566788999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      ..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++..
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~  155 (267)
T cd06645          80 KLWICMEFCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQ  155 (267)
T ss_pred             EEEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeE
Confidence            999999999999999988544 47999999999999999999999988   99999999999999999999999999876


Q ss_pred             CCCCCcceeeeccccCCCccCcchhc---cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          293 APEDGKTHVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      .....  .......|+..|+|||++.   ...++.++|||||||++|+|++|..||....+........  ...      
T Consensus       156 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~--~~~------  225 (267)
T cd06645         156 ITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT--KSN------  225 (267)
T ss_pred             ccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh--ccC------
Confidence            54321  1123457999999999874   4568899999999999999999999986543221111000  000      


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                         ...+.+..  ....+..+.+||.+||..||++||++++|+++
T Consensus       226 ---~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         226 ---FQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             ---CCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence               00000100  01235678999999999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4e-41  Score=330.44  Aligned_cols=248  Identities=28%  Similarity=0.402  Sum_probs=196.8

Q ss_pred             cccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhccCCCCeeceeeEEEeCCceEEE
Q 011250          141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  217 (490)
Q Consensus       141 LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  217 (490)
                      ||+|+||.||++....         +|..||+|.+......   ....+..|+++++.++||||+++++++.++...++|
T Consensus         1 lg~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv   71 (277)
T cd05607           1 LGKGGFGEVCAVQVKN---------TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLV   71 (277)
T ss_pred             CCCCCceEEEEEEEcc---------CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEE
Confidence            7999999999999876         5778999998654321   234456799999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCC
Q 011250          218 YEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  296 (490)
Q Consensus       218 ~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~  296 (490)
                      |||+++++|.+++.... ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.++|+|||++......
T Consensus        72 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~  148 (277)
T cd05607          72 MSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG  148 (277)
T ss_pred             EecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence            99999999998885433 35889999999999999999999988   999999999999999999999999999876442


Q ss_pred             CcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCC
Q 011250          297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP  376 (490)
Q Consensus       297 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (490)
                      ..   .....|+..|+|||++.+..++.++|||||||++|||++|..||........  ..+........          
T Consensus       149 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~----------  213 (277)
T cd05607         149 KT---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTLED----------  213 (277)
T ss_pred             ce---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhhcc----------
Confidence            21   2335789999999999988899999999999999999999999965322111  11111111100          


Q ss_pred             ccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011250          377 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       377 ~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~  416 (490)
                      .+.. .....+.++.+|+.+||+.||.+||++.|+++.+.
T Consensus       214 ~~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         214 EVKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR  252 (277)
T ss_pred             cccc-ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence            0000 00123678999999999999999999987765443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=6.4e-41  Score=334.15  Aligned_cols=266  Identities=26%  Similarity=0.384  Sum_probs=205.1

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      ++|++.+.||+|+||.||+|.+..         ++..||+|.+..... .....+.+|++++..++||||+++++++.++
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   71 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRP---------SGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD   71 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcC---------CCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence            368999999999999999998875         567899999875432 2335688999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      +..++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+ .+   |+||||||+|||++.++.++|+|||++
T Consensus        72 ~~~~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~  147 (308)
T cd06615          72 GEISICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS  147 (308)
T ss_pred             CEEEEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCc
Confidence            9999999999999999998654 578999999999999999999997 46   999999999999999999999999998


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc---
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK---  367 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~---  367 (490)
                      .......    .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||......................   
T Consensus       148 ~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (308)
T cd06615         148 GQLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESH  223 (308)
T ss_pred             ccccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCc
Confidence            7653321    233578999999999988889999999999999999999999996543211111110000000000   


Q ss_pred             -------------chhhhccCCcc---CCCCC-hhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          368 -------------RRFYRLLDPRL---EGHFS-IKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       368 -------------~~~~~~~~~~l---~~~~~-~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                                   .......+...   ....+ ...+.++.+|+.+||..||++||++.+|+++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             ccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                         00000000000   00001 11366799999999999999999999999774

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.2e-40  Score=323.95  Aligned_cols=258  Identities=25%  Similarity=0.391  Sum_probs=209.2

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|++.+.||+|+||.||+|.+..         +|..||+|.++...   ....+.+.+|+++++.++|+||+++++++.
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~   72 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLL---------DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI   72 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcC---------CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee
Confidence            579999999999999999999875         56789999886432   223467889999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEec
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~D  286 (490)
                      +.+..++||||+++++|.+++..   ....+++..++.++.+|+.||.|||+.+   |+||||+|+||+++.++.++|+|
T Consensus        73 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d  149 (267)
T cd08224          73 ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGD  149 (267)
T ss_pred             cCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEec
Confidence            99999999999999999998853   2346899999999999999999999988   99999999999999999999999


Q ss_pred             ccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011250          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      ||++.........  .....|+..|+|||.+.+..++.++|||||||++|+|++|..||...... ...+.+.....   
T Consensus       150 ~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~---  223 (267)
T cd08224         150 LGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEKC---  223 (267)
T ss_pred             cceeeeccCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHHHHhhhhcC---
Confidence            9998765432211  22356899999999998888999999999999999999999998643211 00111110000   


Q ss_pred             cchhhhccCCccCCCCC-hhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011250          367 KRRFYRLLDPRLEGHFS-IKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~-~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~  419 (490)
                            ..     ...+ ...+..+.++|.+||..+|++||++.+|++.|+.+.
T Consensus       224 ------~~-----~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         224 ------DY-----PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             ------CC-----CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                  00     0111 133678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.3e-41  Score=329.77  Aligned_cols=249  Identities=23%  Similarity=0.403  Sum_probs=194.6

Q ss_pred             ccccCCceEEEEEEEccCCCcc---------------ccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeece
Q 011250          140 LLGEGGFGCVFKGWVEENGTAP---------------VKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKL  204 (490)
Q Consensus       140 ~LG~G~fg~Vy~~~~~~~~~~~---------------~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l  204 (490)
                      .||+|+||.||+|.+...+...               ........||+|++.........++.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            6999999999999875322110               0122345789999876544445678899999999999999999


Q ss_pred             eeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC----
Q 011250          205 VGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY----  280 (490)
Q Consensus       205 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~----  280 (490)
                      ++++.+....+|||||+++|+|..++......+++..+..++.||+.||+|||+.+   |+||||||+|||++..+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccC
Confidence            99999999999999999999999998766667999999999999999999999987   99999999999997643    


Q ss_pred             ---CeEEecccCcccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHH-hCCCCCCCCCCCCcch
Q 011250          281 ---NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEML-TGRRSMDKNRPNGEHN  355 (490)
Q Consensus       281 ---~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~ell-tG~~pf~~~~~~~~~~  355 (490)
                         .+||+|||++......      ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||....+.....
T Consensus       159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~  232 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER  232 (274)
T ss_pred             ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence               3899999988654321      12357889999998865 56899999999999999985 7999987543322111


Q ss_pred             hhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011250          356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~  416 (490)
                      .   ...    .        .    .++......+.+||.+||+.+|.+||++.+|++.|.
T Consensus       233 ~---~~~----~--------~----~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         233 F---YEK----K--------H----RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             H---HHh----c--------c----CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            1   000    0        0    011112457899999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4.2e-41  Score=330.14  Aligned_cols=265  Identities=26%  Similarity=0.406  Sum_probs=211.0

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ..++|.+.++||+|+||.||+|.+...+     ..++..|++|.+.... ....+.+.+|+.+++.+.|+||+++++++.
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~-----~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~   78 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEK-----PGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCI   78 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCC-----CCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            4567999999999999999999987532     1245689999987542 233466889999999999999999999877


Q ss_pred             e-CCceEEEEEecCCCChhHHhhhcC-------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCC
Q 011250          210 E-DDQRLLVYEFMPRGSLENHLFRRS-------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       210 ~-~~~~~lV~E~~~~gsL~~~l~~~~-------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                      . ....++++||+++++|.+++....       ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.
T Consensus        79 ~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~  155 (280)
T cd05043          79 EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQ  155 (280)
T ss_pred             cCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCc
Confidence            6 467899999999999999986532       45899999999999999999999988   999999999999999999


Q ss_pred             eEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 011250          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       282 vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~  360 (490)
                      +||+|||+++.+.............++..|+|||++.+..++.++|||||||++||+++ |+.||....+.   .+..+.
T Consensus       156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~  232 (280)
T cd05043         156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMAAYL  232 (280)
T ss_pred             EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHHHHH
Confidence            99999999986644332222233456788999999988889999999999999999999 99999754322   111111


Q ss_pred             hcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                      ....              ....+..++..+.+++.+||..||++|||+.++++.|+.+..
T Consensus       233 ~~~~--------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         233 KDGY--------------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             HcCC--------------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            1100              001112346789999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=5.8e-41  Score=325.59  Aligned_cols=253  Identities=28%  Similarity=0.422  Sum_probs=203.1

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      .++|++.+.||+|+||.||+|.+..          +..||+|.+..... ..+.+.+|+.+++.++|+||+++++++. .
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~----------~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~   72 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNG----------NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-E   72 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecC----------CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-C
Confidence            3478999999999999999997653          44699999876543 3467899999999999999999999875 4


Q ss_pred             CceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      ...++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~  149 (260)
T cd05070          73 EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLA  149 (260)
T ss_pred             CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceee
Confidence            5689999999999999998653 345899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      ......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||......   ........       
T Consensus       150 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~~-------  218 (260)
T cd05070         150 RLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLEQVER-------  218 (260)
T ss_pred             eeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHc-------
Confidence            765432211 1122345678999999988899999999999999999999 89999653211   11111110       


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  417 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~  417 (490)
                             ......+...+..+.+|+.+||..||++|||+.++++.|++
T Consensus       219 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         219 -------GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -------CCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                   00111223346789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.7e-41  Score=329.70  Aligned_cols=274  Identities=29%  Similarity=0.437  Sum_probs=207.2

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      +.|++.+.||+|+||.||+|.+...+.     .++..||+|.+.... ......+.+|+.+++.+.||||+++++++...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~-----~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   78 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGD-----NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED   78 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCC-----CccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence            357889999999999999998653221     257789999987543 23346788999999999999999999998875


Q ss_pred             --CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          212 --DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       212 --~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                        ...++||||+++++|.+++.+....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.++|+|||+
T Consensus        79 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~  155 (284)
T cd05079          79 GGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGL  155 (284)
T ss_pred             CCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcc
Confidence              5688999999999999998766557899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcc-eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC--
Q 011250          290 AKDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD--  366 (490)
Q Consensus       290 a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~--  366 (490)
                      ++........ .......|+..|+|||++.+..++.++|||||||++|||++++.|+......    ......+....  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~----~~~~~~~~~~~~~  231 (284)
T cd05079         156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTL----FLKMIGPTHGQMT  231 (284)
T ss_pred             ccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccch----hhhhccccccccc
Confidence            9876433221 1122355778899999998888999999999999999999987765321100    00000000000  


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                      .......+........+..++..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         232 VTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            0000000000001111223478899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.8e-41  Score=339.64  Aligned_cols=269  Identities=26%  Similarity=0.380  Sum_probs=210.0

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcc-CCCCeeceeeE
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGY  207 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~  207 (490)
                      +...+|.+.+.||+|+||.||+|++...+.  .....+..||+|.+.... ....+++.+|+++++++ .||||++++++
T Consensus         9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (334)
T cd05100           9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDK--DKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA   86 (334)
T ss_pred             cCHhHeeecceeccccCCcEEEEEEeccCC--ccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence            344579999999999999999998754221  011234579999887543 23346789999999999 79999999999


Q ss_pred             EEeCCceEEEEEecCCCChhHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 011250          208 CIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTS  272 (490)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~  272 (490)
                      +..++..++||||+++|+|.+++....               ..+++..++.++.||+.||.|||+.+   |+||||||+
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~  163 (334)
T cd05100          87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAAR  163 (334)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccc
Confidence            999999999999999999999986532               24788899999999999999999988   999999999


Q ss_pred             cEEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCC
Q 011250          273 NILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPN  351 (490)
Q Consensus       273 NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~  351 (490)
                      |||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||+||||++ |..||......
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  243 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  243 (334)
T ss_pred             eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            99999999999999999987644322222222344678999999999999999999999999999998 88888653211


Q ss_pred             CcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          352 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                      .      ......           .......+..++..+.+|+.+||+.+|.+||++.++++.|+.+..
T Consensus       244 ~------~~~~~~-----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         244 E------LFKLLK-----------EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             H------HHHHHH-----------cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence            1      111000           000111222346789999999999999999999999999987754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4.6e-41  Score=330.37  Aligned_cols=252  Identities=26%  Similarity=0.414  Sum_probs=204.7

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCCce
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQR  214 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  214 (490)
                      |++.+.||.|+||.||+|.+..         ++..+++|.+........+.+.+|+.+++.++||||+++++++..++..
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~   77 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKE---------TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNL   77 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECC---------CCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEE
Confidence            6788899999999999998875         5678999999766555567788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCC
Q 011250          215 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~  294 (490)
                      ++||||+++++|..++.+....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        78 ~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  154 (282)
T cd06643          78 WILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT  154 (282)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccc
Confidence            9999999999999988665667999999999999999999999988   9999999999999999999999999987653


Q ss_pred             CCCcceeeeccccCCCccCcchhc-----cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          295 EDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       295 ~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      ...  .......|+..|+|||++.     +..++.++|||||||++|||++|.+||.......  ........       
T Consensus       155 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~~~~~-------  223 (282)
T cd06643         155 RTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--VLLKIAKS-------  223 (282)
T ss_pred             ccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--HHHHHhhc-------
Confidence            321  1123357899999999884     3457889999999999999999999996532211  01111000       


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                          ..+.  ...+...+.++.+||.+||+.||.+||++.+++++-
T Consensus       224 ----~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  263 (282)
T cd06643         224 ----EPPT--LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP  263 (282)
T ss_pred             ----CCCC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence                0000  011122367899999999999999999999998764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.6e-41  Score=323.47  Aligned_cols=250  Identities=30%  Similarity=0.496  Sum_probs=205.9

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      .++|++.+.||.|+||.||+|...           |..||||.+..... ..+++.+|+.+++.++|+||+++++++.+.
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-----------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   72 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-----------GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQG   72 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-----------CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCC
Confidence            357899999999999999999763           45799999976643 467889999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      +..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++
T Consensus        73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~  149 (256)
T cd05039          73 NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLA  149 (256)
T ss_pred             CCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccc
Confidence            99999999999999999986543 36899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +.......     ...++..|+|||.+....++.++||||||+++|||++ |..||.......   +......       
T Consensus       150 ~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~-------  214 (256)
T cd05039         150 KEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPHVEK-------  214 (256)
T ss_pred             cccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHhc-------
Confidence            87633211     2335678999999988899999999999999999997 999986442211   1111100       


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                             ......+...+..+.+||.+||..+|++||++.++++.|+.+
T Consensus       215 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         215 -------GYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             -------CCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence                   000111223468899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=8.1e-42  Score=349.95  Aligned_cols=263  Identities=24%  Similarity=0.344  Sum_probs=206.5

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccC-C-----CCeeceeeE
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-H-----PNLVKLVGY  207 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~-H-----pnIv~l~~~  207 (490)
                      +|.+.++||+|+||.|.+|++..         +++.||||+++... .-..+...|+.||..|+ |     -|||+++++
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~---------T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~  256 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHK---------TGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY  256 (586)
T ss_pred             EEEEEEEecccccceeEEEEecC---------CCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec
Confidence            78999999999999999999987         78899999997653 33456678999999997 4     489999999


Q ss_pred             EEeCCceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC--CCeEE
Q 011250          208 CIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD--YNAKL  284 (490)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~--~~vkL  284 (490)
                      |...++.|||+|++ ..+|+++|..+ ...|+...++.|+.||+.||.+||+.+   |||+||||+||||..-  ..|||
T Consensus       257 F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKV  332 (586)
T KOG0667|consen  257 FYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKV  332 (586)
T ss_pred             cccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeE
Confidence            99999999999999 67999999754 356999999999999999999999988   9999999999999643  47999


Q ss_pred             ecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc--
Q 011250          285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP--  362 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~--  362 (490)
                      +|||.|+.......     ..+-+..|.|||++.+..|+.+.||||||||++||++|.+.|.+..+.+....+.-...  
T Consensus       333 IDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~P  407 (586)
T KOG0667|consen  333 IDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLP  407 (586)
T ss_pred             EecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCC
Confidence            99999987654322     35678899999999999999999999999999999999999987765543322110000  


Q ss_pred             ------ccCCcchhhhc------------------------------cC---C----ccCCCCChhhHHHHHHHHHHhhh
Q 011250          363 ------HLGDKRRFYRL------------------------------LD---P----RLEGHFSIKGSQKATQLAAQCLS  399 (490)
Q Consensus       363 ------~~~~~~~~~~~------------------------------~~---~----~l~~~~~~~~~~~l~~Li~~cL~  399 (490)
                            .......|+.-                              .+   |    .+...+.......+.+|+++||.
T Consensus       408 p~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~  487 (586)
T KOG0667|consen  408 PPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLE  487 (586)
T ss_pred             CHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhc
Confidence                  00000000000                              00   0    00011111235678999999999


Q ss_pred             cCCCCCCCHHHHHHHh
Q 011250          400 RDPKARPRMSEVVETL  415 (490)
Q Consensus       400 ~dP~~RPt~~evl~~L  415 (490)
                      .||.+|+|..++|+|-
T Consensus       488 ~dP~~R~tp~qal~Hp  503 (586)
T KOG0667|consen  488 WDPAERITPAQALNHP  503 (586)
T ss_pred             cCchhcCCHHHHhcCc
Confidence            9999999999999873

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4.6e-41  Score=331.45  Aligned_cols=252  Identities=32%  Similarity=0.434  Sum_probs=203.1

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .|++.++||+|+||.||+|.+..         +++.||||.+......   ....+.+|+.+++.++|+||+.+++++.+
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~   71 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET   71 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcC---------CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec
Confidence            37788999999999999999876         6779999998654322   23457789999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      .+..++||||+.+++|.+++... ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||+
T Consensus        72 ~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~  148 (285)
T cd05630          72 KDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGL  148 (285)
T ss_pred             CCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccc
Confidence            99999999999999999988543 346899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +........   .....|+..|+|||++.+..++.++|||||||++|+|++|..||...............   ..    
T Consensus       149 ~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~---~~----  218 (285)
T cd05630         149 AVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL---VK----  218 (285)
T ss_pred             eeecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhh---hh----
Confidence            876543221   12347999999999999889999999999999999999999999754321111111000   00    


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt-----~~evl~~  414 (490)
                             .....++...+.++.+|+.+||+.||.+|||     +.+++++
T Consensus       219 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         219 -------EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             -------hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence                   0011122234678899999999999999999     8888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.4e-41  Score=335.38  Aligned_cols=258  Identities=26%  Similarity=0.440  Sum_probs=203.1

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcc-CCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~  210 (490)
                      ++|++.+.||+|+||.||+|.+..++       ....+|+|.+.... ......+.+|+.++.++ +|+||+++++++.+
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~   79 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDG-------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH   79 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCC-------ceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC
Confidence            47899999999999999999986532       12356888776432 23345788999999999 89999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  275 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NIL  275 (490)
                      ++..++||||+++++|.+++....               ..+++..++.++.||+.||+|||+.+   |+||||||+|||
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nil  156 (303)
T cd05088          80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNIL  156 (303)
T ss_pred             CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEE
Confidence            999999999999999999986432               25789999999999999999999988   999999999999


Q ss_pred             EcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcc
Q 011250          276 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEH  354 (490)
Q Consensus       276 l~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~  354 (490)
                      ++.++.+||+|||++......   .......++..|+|||++.+..++.++|||||||++|||++ |..||......   
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---  230 (303)
T cd05088         157 VGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---  230 (303)
T ss_pred             ecCCCcEEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---
Confidence            999999999999998643211   01111234678999999988889999999999999999998 99999643221   


Q ss_pred             hhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                      .......              .......+...+..+.+|+.+||+.||++||++.++++.|+.+..
T Consensus       231 ~~~~~~~--------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~  282 (303)
T cd05088         231 ELYEKLP--------------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  282 (303)
T ss_pred             HHHHHHh--------------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            1111110              000111122236788999999999999999999999999986544

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.5e-41  Score=342.24  Aligned_cols=257  Identities=23%  Similarity=0.278  Sum_probs=201.6

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|.+.+.||+|+||.||++++..         ++..||+|++....   ......+.+|+.++..+.|+||+++++++.
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~   71 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKH---------TERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ   71 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            479999999999999999998876         56789999986532   122345778999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +++..||||||+++|+|.+++.+....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~  148 (331)
T cd05624          72 DENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGS  148 (331)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccc
Confidence            999999999999999999999775567999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhcc-----CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-----GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      +......... .....+||+.|+|||++.+     +.++.++|||||||+||||++|+.||.......   ....   ..
T Consensus       149 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~~~~---i~  221 (331)
T cd05624         149 CLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE---TYGK---IM  221 (331)
T ss_pred             eeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH---HHHH---HH
Confidence            9766443221 1233579999999999875     568899999999999999999999996542211   1110   00


Q ss_pred             CCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCC--CCCHHHHHHHh
Q 011250          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA--RPRMSEVVETL  415 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~--RPt~~evl~~L  415 (490)
                      .....+      .+... ....+.++.+|+.+||..++.+  |+++++++++-
T Consensus       222 ~~~~~~------~~p~~-~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~  267 (331)
T cd05624         222 NHEERF------QFPSH-ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHA  267 (331)
T ss_pred             cCCCcc------cCCCc-cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence            000000      00000 0123678999999999876554  46888888763

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2e-41  Score=341.53  Aligned_cols=256  Identities=22%  Similarity=0.276  Sum_probs=201.4

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|++.+.||+|+||.||++++..         ++..||+|++.+...   .....+..|+.++..++|+||+++++++.
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   71 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKN---------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ   71 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECC---------CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence            368999999999999999999876         566899999864321   22345778999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +.+..||||||+++|+|.+++.+....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~  148 (332)
T cd05623          72 DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGS  148 (332)
T ss_pred             cCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecch
Confidence            999999999999999999999775667999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhc-----cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      +........ ......+||+.|+|||++.     ...++.++|||||||+||||++|+.||.......      ......
T Consensus       149 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~  221 (332)
T cd05623         149 CLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIM  221 (332)
T ss_pred             heecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH------HHHHHh
Confidence            876543222 1223357999999999986     3468899999999999999999999997542211      111111


Q ss_pred             CCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 011250          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA--RPRMSEVVET  414 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~--RPt~~evl~~  414 (490)
                      .....+      .+. ......+.++.+|+.+||..++.+  |+++.+++++
T Consensus       222 ~~~~~~------~~p-~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         222 NHKERF------QFP-AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             CCCccc------cCC-CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            000000      000 001234788999999999765544  6899999977

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=6.4e-41  Score=324.34  Aligned_cols=252  Identities=29%  Similarity=0.452  Sum_probs=203.5

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEeCCceEEE
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  217 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  217 (490)
                      ++||+|+||.||+|.+...+      +....||||.+..... ...+.+.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v   73 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSG------GKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMV   73 (257)
T ss_pred             CcCCccCcccEEeeeEecCC------CCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEE
Confidence            46899999999999986531      1344799999987766 556789999999999999999999999988 889999


Q ss_pred             EEecCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCC
Q 011250          218 YEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  296 (490)
Q Consensus       218 ~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~  296 (490)
                      |||+++++|.+++.... ..+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||++......
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~  150 (257)
T cd05040          74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQN  150 (257)
T ss_pred             EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccc
Confidence            99999999999997654 57899999999999999999999988   999999999999999999999999999876542


Q ss_pred             Ccc-eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcchhhhcc
Q 011250          297 GKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  374 (490)
Q Consensus       297 ~~~-~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (490)
                      ... .......++..|+|||++.+..++.++|||||||++|||++ |..||.......   .......   ..       
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~---~~-------  217 (257)
T cd05040         151 EDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILKKIDK---EG-------  217 (257)
T ss_pred             ccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHh---cC-------
Confidence            221 11223457889999999998899999999999999999998 999996432211   1111100   00       


Q ss_pred             CCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011250          375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       375 ~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~  416 (490)
                       .  ....+...+..+.+|+.+||..+|.+||++.++++.|.
T Consensus       218 -~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         218 -E--RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             -C--cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence             0  00111223678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=4.5e-41  Score=342.48  Aligned_cols=264  Identities=24%  Similarity=0.330  Sum_probs=198.5

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      .++|++.+.||+|+||.||+|.+..         +|..||||++....  ......+.+|+.+++.++||||+++++++.
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   90 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTV---------LGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFT   90 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcC---------CCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeec
Confidence            4679999999999999999998875         67799999986542  233467889999999999999999999986


Q ss_pred             eCC------ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeE
Q 011250          210 EDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       210 ~~~------~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vk  283 (490)
                      ...      ..|+||||+++ +|...+.   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+|
T Consensus        91 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~k  163 (359)
T cd07876          91 PQKSLEEFQDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK  163 (359)
T ss_pred             cCCCccccceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEE
Confidence            543      46999999964 6766653   24888999999999999999999988   99999999999999999999


Q ss_pred             EecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchh-hHh---
Q 011250          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL-VEW---  359 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~-~~~---  359 (490)
                      |+|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........... ...   
T Consensus       164 l~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  240 (359)
T cd07876         164 ILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGT  240 (359)
T ss_pred             EecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99999997643321   12345789999999999999999999999999999999999999975432110000 000   


Q ss_pred             ------------hhcccCCc-----chhhhccCCcc---CCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          360 ------------ARPHLGDK-----RRFYRLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       360 ------------~~~~~~~~-----~~~~~~~~~~l---~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                                  ........     ..+...+....   ........+..+.+||.+||..||.+|||+.|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         241 PSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             CcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                        00000000     00000000000   000111225678999999999999999999999976

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.2e-41  Score=328.08  Aligned_cols=262  Identities=25%  Similarity=0.402  Sum_probs=209.7

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      .+|++.+.||+|+||.||+|.+..++..     ....||+|.+..... ....++.+|+.++..+.||||+++++++.. 
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~-----~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-   80 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEK-----VKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-   80 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCC-----cceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence            4688999999999999999998754321     234699998876643 334678899999999999999999999887 


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      ...++||||+++|+|.+++......+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~  157 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAK  157 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccc
Confidence            7889999999999999999776667999999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ...............++..|+|||.+....++.++|||||||++|||++ |..||.......   +......    .   
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~----~---  227 (279)
T cd05057         158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---IPDLLEK----G---  227 (279)
T ss_pred             cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHHhC----C---
Confidence            7654322221122234678999999988899999999999999999998 999997543211   1111110    0   


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                             .....+..++..+.+++.+||..||.+||++.++++.|+.+.+
T Consensus       228 -------~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         228 -------ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             -------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                   0011122235788999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3.8e-41  Score=331.71  Aligned_cols=263  Identities=25%  Similarity=0.373  Sum_probs=196.7

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcc---CCCCeeceeeEE
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNL---LHPNLVKLVGYC  208 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~Ei~il~~l---~HpnIv~l~~~~  208 (490)
                      +|++.+.||+|+||.||+|++..         ++..||+|.+......  ....+.+|+.+++.+   .||||+++++++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~   71 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPH---------SGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVC   71 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECC---------CCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeee
Confidence            48889999999999999999876         6778999998754222  223456777777665   699999999988


Q ss_pred             EeC-----CceEEEEEecCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCe
Q 011250          209 IED-----DQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       209 ~~~-----~~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~v  282 (490)
                      ...     ...++||||+. ++|.+++.... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus        72 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~  147 (288)
T cd07863          72 ATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQV  147 (288)
T ss_pred             ccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence            652     45789999996 58988886543 35899999999999999999999988   9999999999999999999


Q ss_pred             EEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcch-hhHhhh
Q 011250          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWAR  361 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~-~~~~~~  361 (490)
                      ||+|||+++.......   .....||..|+|||++.+..++.++|||||||++|+|++|++||.......... ......
T Consensus       148 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~  224 (288)
T cd07863         148 KLADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG  224 (288)
T ss_pred             EECccCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhC
Confidence            9999999986643211   233578999999999998899999999999999999999999996543221110 000000


Q ss_pred             cccCCcchhhh-------ccCCc---cCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          362 PHLGDKRRFYR-------LLDPR---LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       362 ~~~~~~~~~~~-------~~~~~---l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                        ......+..       .+.+.   .........+..+.+||.+||+.||.+|||+.+++.+
T Consensus       225 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         225 --LPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             --CCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence              000000000       00000   0001112346788999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=6.3e-41  Score=324.22  Aligned_cols=250  Identities=24%  Similarity=0.339  Sum_probs=204.3

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      +|++.+.||.|+||.||++.+..         ++..||+|.++... ....+.+.+|+.+++.++|+||+++++++.+++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   71 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVN---------SDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG   71 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcC---------CCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC
Confidence            47889999999999999998875         56789999986543 234467888999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhh-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          213 QRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      ..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+   |+|+||||+|||++.++.++|+|||++.
T Consensus        72 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~  148 (255)
T cd08219          72 HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSAR  148 (255)
T ss_pred             EEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcce
Confidence            99999999999999998854 3456899999999999999999999988   9999999999999999999999999997


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhh
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  371 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (490)
                      .......  ......|++.|+|||++.+..++.++||||||+++|+|++|..||......   .......   ...    
T Consensus       149 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~~~~~---~~~----  216 (255)
T cd08219         149 LLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK---NLILKVC---QGS----  216 (255)
T ss_pred             eeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH---HHHHHHh---cCC----
Confidence            6643322  123357899999999998888999999999999999999999999753211   1111000   000    


Q ss_pred             hccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       372 ~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                             ....+...+..+.+||.+||+.||.+||++.+|+..
T Consensus       217 -------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         217 -------YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -------CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                   001122336778999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-40  Score=322.41  Aligned_cols=253  Identities=30%  Similarity=0.472  Sum_probs=201.5

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhccCCCCeeceeeEEEeCCceEEE
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  217 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  217 (490)
                      +.||+|+||.||+|.+...+      +++..||+|.+...... ..+++.+|+.+++.+.|+||+++++++. .+..++|
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v   73 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKS------GKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLV   73 (257)
T ss_pred             CccCccCceeEEEeEeeccC------CCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEE
Confidence            46999999999999876532      13468999999766542 4467899999999999999999999876 4568999


Q ss_pred             EEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCCC
Q 011250          218 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG  297 (490)
Q Consensus       218 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~  297 (490)
                      |||+++|+|.+++.... .+++..++.++.|++.||+|||..+   |+||||||+|||++.++.+||+|||+++......
T Consensus        74 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~  149 (257)
T cd05060          74 MELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS  149 (257)
T ss_pred             EEeCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCC
Confidence            99999999999996554 7899999999999999999999988   9999999999999999999999999998764432


Q ss_pred             ccee-eeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcchhhhccC
Q 011250          298 KTHV-STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD  375 (490)
Q Consensus       298 ~~~~-~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  375 (490)
                      .... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||......   .+........           
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~~~~-----------  215 (257)
T cd05060         150 DYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLESGE-----------  215 (257)
T ss_pred             cccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHcCC-----------
Confidence            2211 111224568999999998899999999999999999998 99999654321   1222111110           


Q ss_pred             CccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011250          376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       376 ~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~  419 (490)
                         ....+..++..+.+||.+||..||.+||++.+|++.|+.+.
T Consensus       216 ---~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         216 ---RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             ---cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence               00112234678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=7.6e-41  Score=331.72  Aligned_cols=251  Identities=25%  Similarity=0.360  Sum_probs=206.4

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      .+|++.+.||.|+||.||+|.+..         ++..||+|.+........+.+.+|+.+++.+.|+||+++++++..+.
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~   90 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVA---------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD   90 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECC---------CCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC
Confidence            579999999999999999998765         56789999998766555677889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      ..++||||+++++|.+++..  ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++..
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~  165 (296)
T cd06654          91 ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ  165 (296)
T ss_pred             EEEEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchh
Confidence            99999999999999998854  35889999999999999999999988   99999999999999999999999999876


Q ss_pred             CCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhh
Q 011250          293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR  372 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (490)
                      ......  ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||....+...  .......          
T Consensus       166 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~~~~~----------  231 (296)
T cd06654         166 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLIATN----------  231 (296)
T ss_pred             cccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHHHhcC----------
Confidence            543221  11235789999999999888899999999999999999999999965432111  1111000          


Q ss_pred             ccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       373 ~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                         .......+...+..+.+|+.+||..||.+||++.+|+++
T Consensus       232 ---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         232 ---GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             ---CCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence               000001112336778999999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6.8e-41  Score=328.59  Aligned_cols=276  Identities=29%  Similarity=0.391  Sum_probs=211.6

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhccCCCCeeceeeEEEe-
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIE-  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-  210 (490)
                      ++|.+.+.||+|+||.||+|.+...+     .+++..||||.+...... ..+.+.+|+.+++.+.|+||+++++++.. 
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~   78 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLG-----DNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP   78 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCC-----CCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC
Confidence            46888899999999999999876432     125779999999766443 45679999999999999999999999887 


Q ss_pred             -CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          211 -DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       211 -~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                       ....++||||+++++|.+++......+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.++|+|||+
T Consensus        79 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~  155 (284)
T cd05038          79 GGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGL  155 (284)
T ss_pred             CCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccc
Confidence             55789999999999999999776657999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcc-eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          290 AKDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +......... .......++..|+|||.+.+..++.++||||||+++|||++|..||.............  ........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~  233 (284)
T cd05038         156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI--AQGQMIVT  233 (284)
T ss_pred             ccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc--ccccccHH
Confidence            9877533221 11112345667999999988899999999999999999999999986432211000000  00000000


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                      .+...+........+..++.++.+|+.+||..||.+||++.+|++.|+.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         234 RLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            01111111111112233467899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=8e-41  Score=330.51  Aligned_cols=253  Identities=27%  Similarity=0.417  Sum_probs=205.8

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      +.|++.+.||.|+||.||+|.+..         ++..||+|.+........+.+.+|+.+++.+.|+||+++++++..+.
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   82 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG   82 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECC---------CCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC
Confidence            569999999999999999998876         56789999998766566678899999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      ..++||||+++++|..++.+....+++..+..++.|++.+|.|||+.+   |+||||||+||+++.++.++|+|||++..
T Consensus        83 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~  159 (292)
T cd06644          83 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAK  159 (292)
T ss_pred             eEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCcccee
Confidence            999999999999999888666667999999999999999999999988   99999999999999999999999999876


Q ss_pred             CCCCCcceeeeccccCCCccCcchhc-----cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011250          293 APEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      .....  .......|++.|+|||++.     ...++.++|||||||++|||++|..||.......  ........     
T Consensus       160 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~-----  230 (292)
T cd06644         160 NVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLLKIAKS-----  230 (292)
T ss_pred             ccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH--HHHHHhcC-----
Confidence            43221  1123356889999999884     3457889999999999999999999996543211  11111100     


Q ss_pred             chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                            ..+.+  ..+...+.++.+||.+||..||++||++.+++++
T Consensus       231 ------~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         231 ------EPPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             ------CCccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence                  00000  1112336788999999999999999999999865

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=8.5e-41  Score=324.40  Aligned_cols=255  Identities=27%  Similarity=0.443  Sum_probs=205.0

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ..++|++.++||+|+||.||+|...          ++..||+|.+..... ....+.+|+.+++.++|+||+++++++. 
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~----------~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-   71 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYN----------GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-   71 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecC----------CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-
Confidence            3457999999999999999999864          356799999876543 3467899999999999999999999864 


Q ss_pred             CCceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      .+..++||||+.+++|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+|||+
T Consensus        72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~  148 (260)
T cd05067          72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGL  148 (260)
T ss_pred             cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcc
Confidence            56789999999999999988643 356899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +......... ......++..|+|||++....++.++||||||+++|||++ |+.||......   .........     
T Consensus       149 ~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~-----  219 (260)
T cd05067         149 ARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQNLERG-----  219 (260)
T ss_pred             eeecCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHHHHHcC-----
Confidence            9776532211 1223446788999999988899999999999999999999 99999654321   111111000     


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                               .....+...+.++.+|+.+||..||++||+++++++.|+.+
T Consensus       220 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  260 (260)
T cd05067         220 ---------YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF  260 (260)
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence                     00011122367899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.3e-41  Score=325.14  Aligned_cols=249  Identities=22%  Similarity=0.358  Sum_probs=194.4

Q ss_pred             cccccCCceEEEEEEEccCCCc---cccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCCceE
Q 011250          139 SLLGEGGFGCVFKGWVEENGTA---PVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL  215 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~---~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  215 (490)
                      +.||+|+||.||+|+.......   .........||+|.+..........+..|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            3689999999999986532110   0011234568999887655444567888999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCC-------eEEeccc
Q 011250          216 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN-------AKLSDFG  288 (490)
Q Consensus       216 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~-------vkL~DFG  288 (490)
                      +||||+++|+|..++......+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.       ++|+|||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999988766667999999999999999999999988   999999999999987664       8999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhc-cCCCCccchhhHHHHHHHHHH-hCCCCCCCCCCCCcchhhHhhhcccCC
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEML-TGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-~~~~~~~sDvwSlGv~l~ell-tG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      ++......      ....|+..|+|||++. +..++.++|||||||+||||+ +|..||.........    ...   ..
T Consensus       158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~----~~~---~~  224 (262)
T cd05077         158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE----RFY---EG  224 (262)
T ss_pred             CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH----HHH---hc
Confidence            98765321      2245788999999886 467899999999999999998 588887543211110    000   00


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                                ..  ........++.+||.+||+.||.+||++.+|++.|
T Consensus       225 ----------~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         225 ----------QC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             ----------Cc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence                      00  00111256789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-41  Score=330.20  Aligned_cols=253  Identities=27%  Similarity=0.421  Sum_probs=207.0

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      ++|++.+.||.|+||.||+|.+..         ++..||+|.+........+.+..|+.+++.++|+||+++++++..+.
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKE---------TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN   75 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcC---------CCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC
Confidence            468999999999999999998875         56689999997665556678899999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      ..++||||+++++|.+++.+....+++..++.++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++..
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~  152 (280)
T cd06611          76 KLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAK  152 (280)
T ss_pred             eEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchh
Confidence            999999999999999998776668999999999999999999999988   99999999999999999999999999876


Q ss_pred             CCCCCcceeeeccccCCCccCcchhc-----cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011250          293 APEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      ......  ......|++.|+|||++.     ...++.++|||||||++|+|++|+.||.......  .......      
T Consensus       153 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~------  222 (280)
T cd06611         153 NKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--VLLKILK------  222 (280)
T ss_pred             hccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--HHHHHhc------
Confidence            543221  123356899999999875     3457789999999999999999999996542211  1111100      


Q ss_pred             chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                           ...+.+  ..+...+.++.+||.+||..||.+||++.+++++
T Consensus       223 -----~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         223 -----SEPPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             -----CCCCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence                 000000  1112236789999999999999999999999876

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.1e-40  Score=322.05  Aligned_cols=251  Identities=27%  Similarity=0.408  Sum_probs=207.9

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      ++|++.+.||.|+||.||+|.+..         ++..|++|.+.....  .+++.+|+.+++.++|+||+++++++.+..
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~   71 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKE---------TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNT   71 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcC---------CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence            579999999999999999999875         456899999875532  678999999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      ..|++|||+++++|.+++......+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.++|+|||++..
T Consensus        72 ~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~  148 (256)
T cd06612          72 DLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQ  148 (256)
T ss_pred             cEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchh
Confidence            999999999999999999766678999999999999999999999988   99999999999999999999999999987


Q ss_pred             CCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhh
Q 011250          293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR  372 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (490)
                      ......  ......|+..|+|||++.+..++.++|||||||++|+|++|+.||....+.......   ..          
T Consensus       149 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~---~~----------  213 (256)
T cd06612         149 LTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI---PN----------  213 (256)
T ss_pred             cccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh---cc----------
Confidence            654321  123356889999999999889999999999999999999999999754322111000   00          


Q ss_pred             ccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       373 ~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ...+  ....+...+..+.+||.+||+.||.+||++.+|+++
T Consensus       214 ~~~~--~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         214 KPPP--TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             CCCC--CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            0000  001122235789999999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=4.7e-41  Score=328.05  Aligned_cols=253  Identities=29%  Similarity=0.412  Sum_probs=201.5

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcc-CCCCeeceeeEEE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  209 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~  209 (490)
                      +++.|++.+.||+|+||.||+|.+..         ++..||+|++.... .....+..|+.++..+ +|+||+++++++.
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   73 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVK---------TGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI   73 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcC---------CCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEe
Confidence            45678899999999999999998875         56789999986543 3446788999999998 6999999999987


Q ss_pred             eC------CceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCe
Q 011250          210 ED------DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       210 ~~------~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~v  282 (490)
                      ..      ...|+||||+++++|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+
T Consensus        74 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~  150 (272)
T cd06637          74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV  150 (272)
T ss_pred             ecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCE
Confidence            53      4578999999999999998653 356899999999999999999999988   9999999999999999999


Q ss_pred             EEecccCcccCCCCCcceeeeccccCCCccCcchhc-----cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 011250          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV  357 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~  357 (490)
                      +|+|||++........  ......|+..|+|||++.     ...++.++|||||||++|||++|..||............
T Consensus       151 ~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~  228 (272)
T cd06637         151 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI  228 (272)
T ss_pred             EEccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH
Confidence            9999999986543211  123467999999999886     346888999999999999999999999643221111000


Q ss_pred             HhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          358 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                          .         ....   ........+..+.+|+.+||..||.+|||+.+++++
T Consensus       229 ----~---------~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         229 ----P---------RNPA---PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             ----h---------cCCC---CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence                0         0000   001112236789999999999999999999999865

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6.5e-41  Score=330.30  Aligned_cols=251  Identities=31%  Similarity=0.433  Sum_probs=201.3

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      |+..+.||+|+||+||+|.+..         +++.||+|.+......   ....+.+|+++|+.++|+||+.+++++..+
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~   72 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRA---------TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK   72 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECC---------CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC
Confidence            6777899999999999999876         5778999998654322   234577899999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      +..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~  149 (285)
T cd05632          73 DALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLA  149 (285)
T ss_pred             CEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcc
Confidence            99999999999999998886543 46999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ........   .....|+..|+|||++.+..++.++|||||||++|+|++|..||.............  . ..      
T Consensus       150 ~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~--~-~~------  217 (285)
T cd05632         150 VKIPEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD--R-RV------  217 (285)
T ss_pred             eecCCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--H-hh------
Confidence            76543211   123578999999999998899999999999999999999999997543211111110  0 00      


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  414 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt-----~~evl~~  414 (490)
                         ...  ...++...+..+.+|+.+||+.||.+||+     +.+++.+
T Consensus       218 ---~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         218 ---LET--EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             ---hcc--ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence               000  01122233678899999999999999999     6666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-40  Score=323.64  Aligned_cols=256  Identities=29%  Similarity=0.439  Sum_probs=207.2

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      +..++|.+.+.||+|+||.||+|.+..          +..||||.+..... ..+++.+|+.+++.++|+||+++++++.
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~----------~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~   71 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNG----------TTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCS   71 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcC----------CceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeee
Confidence            345689999999999999999998753          35699999876543 4567899999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      .....++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||
T Consensus        72 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g  148 (261)
T cd05034          72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFG  148 (261)
T ss_pred             cCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccc
Confidence            9899999999999999999996543 46899999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCc
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      ++........ .......++..|+|||.+.+..++.++|||||||++|+|++ |+.||......   .........    
T Consensus       149 ~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~~~~----  220 (261)
T cd05034         149 LARLIEDDEY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLEQVERG----  220 (261)
T ss_pred             cceeccchhh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcC----
Confidence            9987643211 11112234678999999998899999999999999999998 99999643211   111111000    


Q ss_pred             chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011250          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  417 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~  417 (490)
                                .....+...+.++.+++.+||..||++||+++++++.|+.
T Consensus       221 ----------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         221 ----------YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ----------CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                      0011112236789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-41  Score=324.16  Aligned_cols=255  Identities=26%  Similarity=0.383  Sum_probs=208.7

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      ++|++.+.||.|+||.||+|.+..         ++..+++|.+........+.+.+|+.+++.++||||+++++++.+.+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   73 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIA---------TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD   73 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecC---------CCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC
Confidence            478999999999999999998865         45689999998765556678999999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      ..+++|||+++++|.+++......+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.++|+|||++..
T Consensus        74 ~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~  150 (262)
T cd06613          74 KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQ  150 (262)
T ss_pred             EEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchh
Confidence            999999999999999988766567999999999999999999999988   99999999999999999999999999976


Q ss_pred             CCCCCcceeeeccccCCCccCcchhccC---CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          293 APEDGKTHVSTRVMGTYGYAAPEYVMTG---HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~---~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      ......  ......|+..|+|||.+...   .++.++|||||||++|+|++|..||.........  .......+     
T Consensus       151 ~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~--~~~~~~~~-----  221 (262)
T cd06613         151 LTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL--FLISKSNF-----  221 (262)
T ss_pred             hhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhccC-----
Confidence            543211  12235789999999998776   8899999999999999999999999754322111  00000000     


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                          ..+.  .......+.++.+|+.+||..||.+|||+.+|+.+
T Consensus       222 ----~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         222 ----PPPK--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             ----CCcc--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                0000  01122346789999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.2e-40  Score=324.16  Aligned_cols=254  Identities=27%  Similarity=0.413  Sum_probs=203.3

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      ..+|++.+.||+|+||.||+|.+..          ...||+|++..... ..+.+.+|+++++.++|+||+++++++. .
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~----------~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~   72 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-E   72 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecC----------CceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-C
Confidence            3469999999999999999998753          23599999975432 3467899999999999999999999874 4


Q ss_pred             CceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      +..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+|||++
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~  149 (262)
T cd05071          73 EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLA  149 (262)
T ss_pred             CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCce
Confidence            5689999999999999999653 345889999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +........ ......++..|+|||++.+..++.++|||||||++|||++ |..||.......   ........      
T Consensus       150 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~~~~~~~~------  219 (262)
T cd05071         150 RLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQVERG------  219 (262)
T ss_pred             eeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---HHHHHhcC------
Confidence            866433221 1122346778999999988899999999999999999999 888886543211   11100000      


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                              .....+...+..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus       220 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         220 --------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             --------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence                    00011223467889999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1e-40  Score=323.89  Aligned_cols=255  Identities=27%  Similarity=0.457  Sum_probs=197.5

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC-CcccHHHHHHHHHHHhccCCCCeeceeeEEE-eCCceEE
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI-EDDQRLL  216 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~l  216 (490)
                      +.||+|+||.||+|.+.....      ....||||.+... .....+.+.+|+.+++.++||||+++++++. .++..++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~l   74 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDG------QKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLV   74 (262)
T ss_pred             CcccccCCceEEEEEEecCCC------ceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEE
Confidence            468999999999998764221      3457999998543 2334567889999999999999999999776 4556899


Q ss_pred             EEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCC
Q 011250          217 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  296 (490)
Q Consensus       217 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~  296 (490)
                      ||||+.+|+|.+++.+....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~  151 (262)
T cd05058          75 VLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDK  151 (262)
T ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCC
Confidence            99999999999999766556788888999999999999999988   999999999999999999999999999865432


Q ss_pred             Ccce--eeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhC-CCCCCCCCCCCcchhhHhhhcccCCcchhhhc
Q 011250          297 GKTH--VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG-RRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  373 (490)
Q Consensus       297 ~~~~--~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (490)
                      ....  ......++..|+|||.+.+..++.++|||||||++|||++| .+||.....   ..+......    ..     
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~----~~-----  219 (262)
T cd05058         152 EYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITVYLLQ----GR-----  219 (262)
T ss_pred             cceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHhc----CC-----
Confidence            2111  11234567789999999888999999999999999999995 556653221   111111100    00     


Q ss_pred             cCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011250          374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       374 ~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~  419 (490)
                       .+    ..+...+..+.+|+.+||..+|++||++.+|++.|+.+.
T Consensus       220 -~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         220 -RL----LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             -CC----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence             00    011123578999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.3e-40  Score=322.38  Aligned_cols=248  Identities=29%  Similarity=0.443  Sum_probs=200.7

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEE-eC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI-ED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~  211 (490)
                      .+|.+.+.||+|+||.||+|...           |..||+|.+....  ..+.+.+|+.+++.++|+||+++++++. .+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-----------~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK   72 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-----------CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC
Confidence            46899999999999999999763           4579999986543  3467889999999999999999999765 45


Q ss_pred             CceEEEEEecCCCChhHHhhhcCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      +..++||||+++++|.+++..... .+++..++.++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~  149 (256)
T cd05082          73 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLT  149 (256)
T ss_pred             CceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccc
Confidence            678999999999999999875443 4889999999999999999999988   999999999999999999999999998


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      .......     ....++..|+|||++.+..++.++|||||||++|||++ |+.||.....   ..+.......      
T Consensus       150 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~~~------  215 (256)
T cd05082         150 KEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEKG------  215 (256)
T ss_pred             eeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhcC------
Confidence            7653321     12345678999999988899999999999999999997 9999864321   1111111100      


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                              .....+..++..+.+|+.+||+.||++|||+.++++.|+.+
T Consensus       216 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         216 --------YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             --------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                    01112223478899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=7.7e-41  Score=332.20  Aligned_cols=267  Identities=22%  Similarity=0.327  Sum_probs=203.7

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      ++|.+.+.||.|+||.||+|++..         ++..||+|.+..... .....+.+|+.+++.++||||+++++++..+
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~   76 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKL---------TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE   76 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcC---------CCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecC
Confidence            469999999999999999998875         567899999875432 2334677899999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      +..++||||++ ++|.+++......+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.++|+|||++.
T Consensus        77 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~  152 (301)
T cd07873          77 KSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLAR  152 (301)
T ss_pred             CeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchh
Confidence            99999999996 6999988776667999999999999999999999988   9999999999999999999999999997


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--------c
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--------P  362 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~--------~  362 (490)
                      ........  .....+++.|+|||++.+ ..++.++|||||||++|||++|++||...........+....        +
T Consensus       153 ~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  230 (301)
T cd07873         153 AKSIPTKT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWP  230 (301)
T ss_pred             ccCCCCCc--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhch
Confidence            65332211  123457899999998865 457889999999999999999999997543221111000000        0


Q ss_pred             ccCCcchhhhccCCccCC----CCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          363 HLGDKRRFYRLLDPRLEG----HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~----~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .+.....+.....+....    ......+..+.+||.+||+.||.+|||+.+++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         231 GILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             hhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            000000000000000000    1112346788999999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.3e-40  Score=332.88  Aligned_cols=264  Identities=22%  Similarity=0.357  Sum_probs=190.9

Q ss_pred             CcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEe--CCceE
Q 011250          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE--DDQRL  215 (490)
Q Consensus       138 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~  215 (490)
                      ..+||+|+||+||+|++....       ++..||+|.+.....  ...+.+|+.+|+.++||||+++++++..  +...+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~-------~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   76 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGK-------DDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVW   76 (317)
T ss_pred             ccccccCCCeEEEEEEEccCC-------CCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEE
Confidence            468999999999999875421       456899999875432  3457889999999999999999998865  35678


Q ss_pred             EEEEecCCCChhHHhhhc--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE----cCCCCeE
Q 011250          216 LVYEFMPRGSLENHLFRR--------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL----DADYNAK  283 (490)
Q Consensus       216 lV~E~~~~gsL~~~l~~~--------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl----~~~~~vk  283 (490)
                      +||||+ +++|.+++...        ...+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+|
T Consensus        77 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~k  152 (317)
T cd07868          77 LLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK  152 (317)
T ss_pred             EEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEE
Confidence            999999 45888877422        235899999999999999999999988   9999999999999    4567899


Q ss_pred             EecccCcccCCCCCcc-eeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcc------h
Q 011250          284 LSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH------N  355 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~------~  355 (490)
                      |+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|++||.........      .
T Consensus       153 l~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~  232 (317)
T cd07868         153 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD  232 (317)
T ss_pred             EeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHH
Confidence            9999999876432211 11234678999999999876 46899999999999999999999999754322110      0


Q ss_pred             hhHhhhcccC--------------CcchhhhccCCc------cC---CCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 011250          356 LVEWARPHLG--------------DKRRFYRLLDPR------LE---GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV  412 (490)
Q Consensus       356 ~~~~~~~~~~--------------~~~~~~~~~~~~------l~---~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl  412 (490)
                      ........++              ........+...      +.   .......+..+.+||.+||+.||.+|||++|++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l  312 (317)
T cd07868         233 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM  312 (317)
T ss_pred             HHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHh
Confidence            0000000000              000000000000      00   000011245688999999999999999999998


Q ss_pred             HH
Q 011250          413 ET  414 (490)
Q Consensus       413 ~~  414 (490)
                      ++
T Consensus       313 ~h  314 (317)
T cd07868         313 QD  314 (317)
T ss_pred             cC
Confidence            75

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.6e-40  Score=324.36  Aligned_cols=255  Identities=28%  Similarity=0.392  Sum_probs=195.1

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEeCCceEEE
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  217 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  217 (490)
                      +.||+|+||.||+|.+....       ++..+|+|.+..... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   73 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGY-------TPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLV   73 (269)
T ss_pred             CcccccCCceEEEEEEcCCC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEE
Confidence            35999999999999875421       456799999876532 3345788999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhcC----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccC
Q 011250          218 YEFMPRGSLENHLFRRS----LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       218 ~E~~~~gsL~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~  293 (490)
                      |||+++|+|.+++....    ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++...
T Consensus        74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~  150 (269)
T cd05087          74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNK  150 (269)
T ss_pred             EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccc
Confidence            99999999999986432    24667788899999999999999988   999999999999999999999999999765


Q ss_pred             CCCCcceeeeccccCCCccCcchhccC-------CCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccC
Q 011250          294 PEDGKTHVSTRVMGTYGYAAPEYVMTG-------HLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       294 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~-------~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      .............|+..|+|||++...       .++.++|||||||++|||++ |..||........   .....  ..
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~~~--~~  225 (269)
T cd05087         151 YKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTYTV--RE  225 (269)
T ss_pred             cCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHHHh--hc
Confidence            433322222345678899999988632       35789999999999999996 9999965432211   11100  00


Q ss_pred             CcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011250          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~  416 (490)
                      ..   ....++.+    ....+..+.+|+.+|| .+|++|||+.+|+..|+
T Consensus       226 ~~---~~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         226 QQ---LKLPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             cc---CCCCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            00   01111111    1123567889999999 68999999999998774

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=8.6e-41  Score=326.20  Aligned_cols=261  Identities=25%  Similarity=0.388  Sum_probs=208.3

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ..+|.+.+.||+|+||.||+|.+....      +....||||.+.... ....+.+.+|+.+++.+.||||+++++++.+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~------~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   78 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPE------NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE   78 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCC------CCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC
Confidence            346889999999999999999876431      133469999987654 3445678999999999999999999998875


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                       +..++||||+++|+|.+++......+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++
T Consensus        79 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~  154 (270)
T cd05056          79 -NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLS  154 (270)
T ss_pred             -CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCcee
Confidence             5678999999999999999766567899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +........ ......++..|+|||.+....++.++|||||||++|||++ |..||........   ......    .. 
T Consensus       155 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~~~~~----~~-  225 (270)
T cd05056         155 RYLEDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IGRIEN----GE-  225 (270)
T ss_pred             eecccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHc----CC-
Confidence            876543221 1222345578999999988889999999999999999986 9999965432211   111100    00 


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                               ....+..++..+.+||.+||..+|.+|||+.++++.|..+.+
T Consensus       226 ---------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         226 ---------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             ---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                     001122346789999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.4e-41  Score=342.87  Aligned_cols=265  Identities=23%  Similarity=0.306  Sum_probs=199.8

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      ..++|++.+.||+|+||.||+|++..         ++..||||.+....  ....+.+.+|+.+++.++||||+++++++
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~   85 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAV---------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF   85 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecC---------CCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeee
Confidence            44689999999999999999998765         56789999987542  23345778999999999999999999988


Q ss_pred             EeCC------ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCe
Q 011250          209 IEDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       209 ~~~~------~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~v  282 (490)
                      ....      ..++||||+++ +|.+.+..   .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+
T Consensus        86 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~  158 (355)
T cd07874          86 TPQKSLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL  158 (355)
T ss_pred             eccccccccceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCE
Confidence            6543      46999999964 67766632   4888999999999999999999988   9999999999999999999


Q ss_pred             EEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhh-Hhh-
Q 011250          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWA-  360 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~-~~~-  360 (490)
                      ||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||............ ... 
T Consensus       159 kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (355)
T cd07874         159 KILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG  235 (355)
T ss_pred             EEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            999999998654321   123457899999999999889999999999999999999999999754321111000 000 


Q ss_pred             --------------hcccCCcch-----hhhccCCcc---CCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          361 --------------RPHLGDKRR-----FYRLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       361 --------------~~~~~~~~~-----~~~~~~~~l---~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                                    .........     +...+...+   ........+..+.+||.+||..||.+|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             CCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                          000000000     000000000   001112235678999999999999999999999976

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.1e-40  Score=328.74  Aligned_cols=262  Identities=27%  Similarity=0.428  Sum_probs=205.7

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .++|++.+.||+|+||.||+|.+...    ....++..||+|.+..... ....++.+|+.+++.+.||||+++++++.+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~   79 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV   79 (288)
T ss_pred             hHhceecccccccccccEEEEEEccc----CCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence            45799999999999999999987531    1112466899999875532 334678899999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcC---------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCC
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRS---------------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDF  269 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~---------------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDl  269 (490)
                      ++..++||||+++|+|.+++....                     ..+++..++.++.||+.||.|||+.+   ++||||
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl  156 (288)
T cd05050          80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDL  156 (288)
T ss_pred             CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccc
Confidence            999999999999999999986431                     24788889999999999999999988   999999


Q ss_pred             CCCcEEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCC
Q 011250          270 KTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKN  348 (490)
Q Consensus       270 kp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~  348 (490)
                      ||+|||++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus       157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~  236 (288)
T cd05050         157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM  236 (288)
T ss_pred             cHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999876543322221222345678999999988899999999999999999997 88888543


Q ss_pred             CCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011250          349 RPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  417 (490)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~  417 (490)
                      ...   ........             ... ...+...+.++.+|+.+||+.||.+||++.||++.|+.
T Consensus       237 ~~~---~~~~~~~~-------------~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         237 AHE---EVIYYVRD-------------GNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             CHH---HHHHHHhc-------------CCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            221   11111100             000 01112336789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-42  Score=324.14  Aligned_cols=250  Identities=30%  Similarity=0.401  Sum_probs=209.3

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHH---HHHHHHHHhccCCCCeeceeeEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~---~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      -++|..+++||+|.||+|.+++-+.         +++.+|||++++.......+   -+.|-++|+..+||.+..|.-.|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKa---------t~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF  237 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKA---------TGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF  237 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecc---------cCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh
Confidence            3578899999999999999998876         78899999999886554444   46799999999999999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      +..+.+|+||||..||.|+-+|.+ ...+++.....+...|+.||.|||+.+   ||+||||.+|+|||++|++||+|||
T Consensus       238 Qt~drlCFVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFG  313 (516)
T KOG0690|consen  238 QTQDRLCFVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFG  313 (516)
T ss_pred             ccCceEEEEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecc
Confidence            999999999999999999998854 457999999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +++.....+.  ....+||||.|+|||++....|+.++|+|.+||++|||++|+.||..........++      +-+  
T Consensus       314 LCKE~I~~g~--t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI------l~e--  383 (516)
T KOG0690|consen  314 LCKEEIKYGD--TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI------LME--  383 (516)
T ss_pred             cchhcccccc--eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH------Hhh--
Confidence            9986544333  345699999999999999999999999999999999999999999754322221111      111  


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  414 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt-----~~evl~~  414 (490)
                                ...|+...++++..|+..+|.+||.+|..     +.||.++
T Consensus       384 ----------d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  384 ----------DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             ----------hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence                      11344455899999999999999999953     5555543

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.1e-40  Score=319.36  Aligned_cols=247  Identities=30%  Similarity=0.457  Sum_probs=199.1

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-HHHHHHHHHHHhccCCCCeeceeeEEEeCCceEEE
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  217 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  217 (490)
                      ++||+|+||.||+|...          .+..||+|.+....... ...+.+|+.+++.++||||+++++++...+..++|
T Consensus         1 ~~ig~g~~g~vy~~~~~----------~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   70 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK----------DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIV   70 (250)
T ss_pred             CccCCCCCceEEEEEec----------CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEE
Confidence            36999999999999864          34579999987654332 34688999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCCC
Q 011250          218 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG  297 (490)
Q Consensus       218 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~  297 (490)
                      |||+++++|.+++......+++..++.++.|++.+|.|||+.+   ++||||||+||+++.++.+||+|||++.......
T Consensus        71 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  147 (250)
T cd05085          71 MELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI  147 (250)
T ss_pred             EECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccc
Confidence            9999999999998766667899999999999999999999988   9999999999999999999999999987643321


Q ss_pred             cceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCC
Q 011250          298 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP  376 (490)
Q Consensus       298 ~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (490)
                      . .......++..|+|||++.+..++.++||||||+++|+|++ |..||.......   .......              
T Consensus       148 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~~~~~~~--------------  209 (250)
T cd05085         148 Y-SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---AREQVEK--------------  209 (250)
T ss_pred             c-ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHHHc--------------
Confidence            1 11112344678999999998899999999999999999998 999996542211   1111100              


Q ss_pred             ccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011250          377 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       377 ~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~  416 (490)
                      ......+...+..+.+|+.+||..+|++||++.++++.|.
T Consensus       210 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         210 GYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            0011122234688999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-40  Score=319.38  Aligned_cols=248  Identities=29%  Similarity=0.450  Sum_probs=200.8

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhccCCCCeeceeeEEEeCCceEEE
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  217 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  217 (490)
                      ++||.|+||.||+|.+..          +..||+|.+...... ..+.+.+|+++++.+.|+||+++++++.+....++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~----------~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   70 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG----------NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIV   70 (251)
T ss_pred             CccccCCCceEEEEEEeC----------CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEE
Confidence            469999999999998753          457999998765443 456789999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCCC
Q 011250          218 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG  297 (490)
Q Consensus       218 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~  297 (490)
                      |||+++++|.+++......+++..+..++.+++.+|.|||+++   |+||||||+|||++.++.++|+|||++.......
T Consensus        71 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  147 (251)
T cd05041          71 MELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGI  147 (251)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCc
Confidence            9999999999999766667899999999999999999999988   9999999999999999999999999998654322


Q ss_pred             cceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCC
Q 011250          298 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP  376 (490)
Q Consensus       298 ~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (490)
                      .........++..|+|||.+.++.++.++|||||||++|||++ |..||........   ......              
T Consensus       148 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~---~~~~~~--------------  210 (251)
T cd05041         148 YTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT---RERIES--------------  210 (251)
T ss_pred             ceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH---HHHHhc--------------
Confidence            2111112234667999999988899999999999999999999 8888865432111   111100              


Q ss_pred             ccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011250          377 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       377 ~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~  416 (490)
                      ......+...+.++.+|+.+||..+|.+||++.+|++.|.
T Consensus       211 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         211 GYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            0011112234678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=9.4e-41  Score=332.10  Aligned_cols=262  Identities=25%  Similarity=0.427  Sum_probs=206.6

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .++|+..+.||+|+||.||+|.+...+..     ....||+|.+..... ....++.+|+.+++.+.||||+++++++..
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~   80 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGET-----VKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS   80 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCc-----ceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC
Confidence            35688899999999999999998764321     123689998875533 223468899999999999999999999875


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      . ..++|+||+++|+|.+++......+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        81 ~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~  156 (303)
T cd05110          81 P-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLA  156 (303)
T ss_pred             C-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccc
Confidence            4 567999999999999999776667899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +...............++..|+|||.+.+..++.++|||||||++|||++ |..||......   ....+...    ...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~---~~~~~~~~----~~~  229 (303)
T cd05110         157 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---EIPDLLEK----GER  229 (303)
T ss_pred             ccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHC----CCC
Confidence            87643322212223446788999999998899999999999999999997 88998653211   11111110    000


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~  419 (490)
                                ...+..++..+.+++.+||..||++||++.++++.|..+.
T Consensus       230 ----------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~  269 (303)
T cd05110         230 ----------LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA  269 (303)
T ss_pred             ----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                      0011223578899999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-41  Score=342.87  Aligned_cols=242  Identities=28%  Similarity=0.348  Sum_probs=189.9

Q ss_pred             cccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcc---CCCCeeceeeEEEeCCce
Q 011250          141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNL---LHPNLVKLVGYCIEDDQR  214 (490)
Q Consensus       141 LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~~  214 (490)
                      ||+|+||+||+|++..         ++..||||++......   ....+..|..++..+   .||||+++++++.+.+..
T Consensus         1 lG~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~   71 (330)
T cd05586           1 IGKGTFGQVYQVRKKD---------TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDL   71 (330)
T ss_pred             CCCCCceEEEEEEECC---------CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeE
Confidence            7999999999999876         5778999998654222   223455677777655   699999999999999999


Q ss_pred             EEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCC
Q 011250          215 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~  294 (490)
                      ||||||+++|+|..++.+. ..+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||++....
T Consensus        72 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~  147 (330)
T cd05586          72 YLVTDYMSGGELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANL  147 (330)
T ss_pred             EEEEcCCCCChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCC
Confidence            9999999999999888554 57999999999999999999999988   9999999999999999999999999987643


Q ss_pred             CCCcceeeeccccCCCccCcchhccC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhc
Q 011250          295 EDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  373 (490)
Q Consensus       295 ~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (490)
                      ....  .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.......   .....   .....     
T Consensus       148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~---~~~~i---~~~~~-----  214 (330)
T cd05586         148 TDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ---MYRNI---AFGKV-----  214 (330)
T ss_pred             CCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH---HHHHH---HcCCC-----
Confidence            2221  12346799999999998754 58999999999999999999999996532211   11000   00000     


Q ss_pred             cCCccCCCCChhhHHHHHHHHHHhhhcCCCCCC----CHHHHHHH
Q 011250          374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP----RMSEVVET  414 (490)
Q Consensus       374 ~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP----t~~evl~~  414 (490)
                         .+.   ....+.++.+||.+||..||.+||    ++.+++++
T Consensus       215 ---~~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         215 ---RFP---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             ---CCC---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence               000   011367889999999999999998    57777764

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.5e-40  Score=324.10  Aligned_cols=256  Identities=23%  Similarity=0.350  Sum_probs=204.7

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      .+++++.....||+|+||.||+|.+..         ++..||+|.+........+.+.+|+.+++.++|+||+++++++.
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   75 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLS---------TQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS   75 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecC---------CCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec
Confidence            445566666789999999999998865         56689999988766566678999999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCC--CHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-CCCeEEec
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPL--PWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYNAKLSD  286 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l--~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~-~~~vkL~D  286 (490)
                      .++..++||||+++++|.+++......+  ++..+..++.||+.||.|||+.+   |+||||||+||+++. ++.++|+|
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~d  152 (268)
T cd06624          76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISD  152 (268)
T ss_pred             cCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEec
Confidence            9999999999999999999997654455  88889999999999999999988   999999999999976 67999999


Q ss_pred             ccCcccCCCCCcceeeeccccCCCccCcchhccC--CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc
Q 011250          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~--~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      ||++........  ......|+..|+|||++...  .++.++||||||+++|+|++|+.||........   ..+.....
T Consensus       153 fg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~  227 (268)
T cd06624         153 FGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMF  227 (268)
T ss_pred             chhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhh
Confidence            999876543221  12234689999999998654  378899999999999999999999964321111   00100000


Q ss_pred             CCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                                  .....++...+.++.+|+.+||..+|.+|||+.+++++
T Consensus       228 ------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         228 ------------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             ------------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence                        00111223346789999999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.6e-41  Score=326.03  Aligned_cols=254  Identities=32%  Similarity=0.530  Sum_probs=202.8

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHH--HHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK--EWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      |++.+.||+|+||+||+|....         ++..||+|++.........  ....|+.++++++||||+++++++.+..
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~   71 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKK---------NGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN   71 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETT---------TTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS
T ss_pred             CEEeEEEEeCCCEEEEEEEECC---------CCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc
Confidence            6778999999999999999886         5678999999877544332  3456999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      ..++||||+.+++|.+++. ....+++..++.++.||++||.|||+.+   |+|+||||+|||++.++.++|+|||.+..
T Consensus        72 ~~~~v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~  147 (260)
T PF00069_consen   72 YLYIVMEYCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVK  147 (260)
T ss_dssp             EEEEEEEEETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEE
T ss_pred             ccccccccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence            9999999999999999996 3347899999999999999999999988   99999999999999999999999999976


Q ss_pred             CCCCCcceeeeccccCCCccCcchhc-cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhh
Q 011250          293 APEDGKTHVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  371 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~-~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (490)
                      ....  ........|+..|+|||++. +..++.++||||||+++|+|++|..||.............   ......... 
T Consensus       148 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~---~~~~~~~~~-  221 (260)
T PF00069_consen  148 LSEN--NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE---KILKRPLPS-  221 (260)
T ss_dssp             STST--TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH---HHHHTHHHH-
T ss_pred             cccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh---hcccccccc-
Confidence            4221  12234567899999999998 7889999999999999999999999997541111111111   100000000 


Q ss_pred             hccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       372 ~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                       .    .  .........+.+||.+||+.||++||++.+++++
T Consensus       222 -~----~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  222 -S----S--QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             -H----T--TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             -c----c--cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             0    0  0000114789999999999999999999999864

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=6.7e-41  Score=341.87  Aligned_cols=264  Identities=22%  Similarity=0.291  Sum_probs=199.1

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      .++|.+.+.||+|+||.||+|++..         ++..||||++....  ....+.+.+|+.+++.++||||+++++++.
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~   93 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAI---------LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT   93 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECC---------CCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeec
Confidence            4579999999999999999998875         56789999987542  233467889999999999999999999876


Q ss_pred             eC------CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeE
Q 011250          210 ED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       210 ~~------~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vk  283 (490)
                      ..      ...|+||||++ ++|.+.+..   .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+|
T Consensus        94 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~k  166 (364)
T cd07875          94 PQKSLEEFQDVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK  166 (364)
T ss_pred             ccccccccCeEEEEEeCCC-CCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEE
Confidence            43      35799999995 577777632   4888999999999999999999988   99999999999999999999


Q ss_pred             EecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhh-Hhhhc
Q 011250          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWARP  362 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~-~~~~~  362 (490)
                      |+|||+++......   ......||..|+|||++.+..++.++|||||||+||+|++|+.||...........+ .....
T Consensus       167 L~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  243 (364)
T cd07875         167 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT  243 (364)
T ss_pred             EEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99999998654321   123457899999999999999999999999999999999999999754322111100 00000


Q ss_pred             ---------------ccCCcch-----hhhccCCc---cCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          363 ---------------HLGDKRR-----FYRLLDPR---LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       363 ---------------~~~~~~~-----~~~~~~~~---l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                                     .......     +...+...   .........+..+.+||.+||+.||.+|||+.+++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         244 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             CCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                           0000000     00000000   0001111225678999999999999999999999875

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-41  Score=336.31  Aligned_cols=263  Identities=29%  Similarity=0.462  Sum_probs=217.7

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-HHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      ....+.++||+|.||.|.+|....          +..||||+++.+.... .++|.+||++|.+|+|||||.++|+|..+
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg----------~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D  607 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEG----------PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD  607 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecC----------ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC
Confidence            456788999999999999998753          4689999998775443 47899999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCC-CHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPL-PWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l-~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      +.+++|+|||++|+|..+|..+..+. .......|+.||+.|++||.+.+   +|||||.+.|+|++.++++||+|||++
T Consensus       608 ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgms  684 (807)
T KOG1094|consen  608 DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMS  684 (807)
T ss_pred             CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccc
Confidence            99999999999999999998774433 45566789999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh--CCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT--GRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt--G~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +.+.....+....+.+-.++|||+|.+..++++.++|||+||++|||+++  ...||......   ..++.....+.+. 
T Consensus       685 R~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~-  760 (807)
T KOG1094|consen  685 RNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQ-  760 (807)
T ss_pred             cccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCC-
Confidence            98888877777777788899999999999999999999999999999755  66777543221   2222222222111 


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                            .......-|.-|+..+.+|+.+||..|-.+||+++++..+|.+.
T Consensus       761 ------~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  761 ------GRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ------CcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence                  11222233455689999999999999999999999999888653

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.8e-40  Score=326.14  Aligned_cols=266  Identities=23%  Similarity=0.335  Sum_probs=200.2

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      +|++.+.||+|+||.||+|++..         ++..||||.+.....  ...+.+.+|+.+++.++||||+++++++.++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   71 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKK---------TGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE   71 (285)
T ss_pred             CceEeeEecccCceEEEEEEECC---------CCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC
Confidence            48889999999999999999876         567899999865432  2345688999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +..++||||+. ++|.+++....  ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.++|+|||+
T Consensus        72 ~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~  147 (285)
T cd07861          72 SRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGL  147 (285)
T ss_pred             CeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccc
Confidence            99999999996 68888875432  56899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcch-hhHhh-h-----
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWA-R-----  361 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~-~~~~~-~-----  361 (490)
                      +.......  .......+++.|+|||++.+. .++.++|||||||++|+|++|++||.......... ..... .     
T Consensus       148 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (285)
T cd07861         148 ARAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDV  225 (285)
T ss_pred             eeecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            87653321  112234678999999988654 57899999999999999999999997543211100 00000 0     


Q ss_pred             -cccCCcchhhhccCCccC---CCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          362 -PHLGDKRRFYRLLDPRLE---GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       362 -~~~~~~~~~~~~~~~~l~---~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                       +.......+.........   .......+.++.+||.+||..||.+|||+.+|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         226 WPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             hhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence             000000000000000000   00111246788999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2e-40  Score=322.73  Aligned_cols=251  Identities=25%  Similarity=0.406  Sum_probs=202.9

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---------HHHHHHHHHHHhccCCCCeece
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---------HKEWLAEVNFLGNLLHPNLVKL  204 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~~Ei~il~~l~HpnIv~l  204 (490)
                      +|.+...||.|+||.||+|.+..         ++..||+|.+.......         .+.+.+|+.+++.++||||+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~   71 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNAS---------SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQY   71 (267)
T ss_pred             CccccceeecCCCeEEEEEEecC---------CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence            47888999999999999998765         46689999886543221         2457889999999999999999


Q ss_pred             eeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 011250          205 VGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       205 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL  284 (490)
                      ++++.+.+..++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+   |+||||+|+|||++.++.++|
T Consensus        72 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l  147 (267)
T cd06628          72 LGSSLDADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKI  147 (267)
T ss_pred             EEEEEeCCccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEe
Confidence            99999999999999999999999998554 56899999999999999999999988   999999999999999999999


Q ss_pred             ecccCcccCCCCCcc----eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011250          285 SDFGLAKDAPEDGKT----HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~----~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~  360 (490)
                      +|||+++........    .......|+..|+|||.+.+..++.++|||||||++|+|++|+.||.......   .+...
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~  224 (267)
T cd06628         148 SDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ---AIFKI  224 (267)
T ss_pred             cccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH---HHHHH
Confidence            999999876532111    11123568899999999988889999999999999999999999997532110   00000


Q ss_pred             hcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                                ...    ....++...+..+.++|.+||+.||.+||++.+|+++
T Consensus       225 ----------~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         225 ----------GEN----ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             ----------hcc----CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence                      000    1111223347889999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.5e-41  Score=367.74  Aligned_cols=259  Identities=24%  Similarity=0.354  Sum_probs=202.4

Q ss_pred             hHHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeece
Q 011250          127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKL  204 (490)
Q Consensus       127 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l  204 (490)
                      +.....++|.+++.||.|+||+||+|++..         ++..||+|++.....  .....+..|+.+|..|.|||||++
T Consensus         7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~---------tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl   77 (1021)
T PTZ00266          7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKR---------TQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRY   77 (1021)
T ss_pred             CCccccCCEEEEEEEecCCCeEEEEEEECC---------CCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeE
Confidence            334455689999999999999999999876         567899999875432  234568899999999999999999


Q ss_pred             eeEEEeC--CceEEEEEecCCCChhHHhhhc---CCCCCHHHHHHHHHHHHHHHHHhhhcCC----CCeeecCCCCCcEE
Q 011250          205 VGYCIED--DQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAE----KPVIYRDFKTSNIL  275 (490)
Q Consensus       205 ~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~~----~~iiHrDlkp~NIL  275 (490)
                      +++|.+.  ..+||||||+++|+|.++|...   ...+++..++.|+.||+.||.|||+.+.    ++||||||||+|||
T Consensus        78 ~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNIL  157 (1021)
T PTZ00266         78 IDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIF  157 (1021)
T ss_pred             EEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeE
Confidence            9988654  5689999999999999998642   3469999999999999999999998541    34999999999999


Q ss_pred             EcC-----------------CCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhcc--CCCCccchhhHHHHHHH
Q 011250          276 LDA-----------------DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLL  336 (490)
Q Consensus       276 l~~-----------------~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~~~~sDvwSlGv~l~  336 (490)
                      |+.                 .+.+||+|||++........   ....+||+.|+|||++..  ..++.++||||||||||
T Consensus       158 L~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILY  234 (1021)
T PTZ00266        158 LSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY  234 (1021)
T ss_pred             eecCccccccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHH
Confidence            964                 23589999999987643221   234579999999999864  45889999999999999


Q ss_pred             HHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          337 EMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       337 elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ||++|..||.......  .+.....    ..        +.+.   ....+.++.+||.+||..+|.+||++.++|.+
T Consensus       235 ELLTGk~PF~~~~~~~--qli~~lk----~~--------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        235 ELCSGKTPFHKANNFS--QLISELK----RG--------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             HHHHCCCCCCcCCcHH--HHHHHHh----cC--------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            9999999996432111  1111100    00        0000   01126789999999999999999999999953

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2e-40  Score=328.85  Aligned_cols=251  Identities=25%  Similarity=0.380  Sum_probs=206.5

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      .+|.+.+.||.|+||.||+|....         ++..||+|.+........+.+.+|+.+++.++|+||+++++++..++
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIA---------TGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD   89 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECC---------CCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            579999999999999999998765         56789999997665555677889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      ..++||||+++++|.+++.+  ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++..
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~  164 (297)
T cd06656          90 ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ  164 (297)
T ss_pred             EEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceE
Confidence            99999999999999998854  35889999999999999999999988   99999999999999999999999999876


Q ss_pred             CCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhh
Q 011250          293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR  372 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (490)
                      ......  ......|++.|+|||.+.+..++.++|||||||++|+|++|..||....+.......  ..    ..     
T Consensus       165 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~--~~----~~-----  231 (297)
T cd06656         165 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--AT----NG-----  231 (297)
T ss_pred             ccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee--cc----CC-----
Confidence            543321  122356899999999999888999999999999999999999999654322111000  00    00     


Q ss_pred             ccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       373 ~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                        .+  ....+...+..+.+|+.+||..||.+||++.+++++
T Consensus       232 --~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         232 --TP--ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             --CC--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              00  001112236778999999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-40  Score=324.16  Aligned_cols=250  Identities=27%  Similarity=0.413  Sum_probs=205.9

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      ++|++.+.||.|+||.||+|.+..         ++..||+|.+.... ......+.+|+.+++.++|+||+++++++.++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   71 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKR---------TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG   71 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECC---------CCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC
Confidence            368889999999999999999875         56789999987654 33346788999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      ...++|+||+++++|.+++...  .+++..++.++.|++.||.|||+.+   |+||||+|+||+++.++.++|+|||+++
T Consensus        72 ~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~  146 (274)
T cd06609          72 SKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSG  146 (274)
T ss_pred             CeEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccce
Confidence            9999999999999999998544  7899999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhh
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  371 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (490)
                      ......  .......|+..|+|||++.+..++.++|||||||++|+|++|..||....+...   ......         
T Consensus       147 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~---~~~~~~---------  212 (274)
T cd06609         147 QLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV---LFLIPK---------  212 (274)
T ss_pred             eecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH---HHHhhh---------
Confidence            765432  122345789999999999988899999999999999999999999965432111   100000         


Q ss_pred             hccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       372 ~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                       ...+.+...   ..+..+.+++.+||..||++||++++++++
T Consensus       213 -~~~~~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         213 -NNPPSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             -cCCCCCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence             001111111   136788999999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-40  Score=322.60  Aligned_cols=250  Identities=26%  Similarity=0.449  Sum_probs=196.5

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcc-CCCCeeceeeEEEeCCceEE
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIEDDQRLL  216 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l  216 (490)
                      ++||+|+||.||+|++..++       ....+|+|.+.... ....+.+.+|+.++.++ .||||+++++++...+..++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l   73 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDG-------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   73 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCC-------CeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceE
Confidence            36999999999999987532       12357889887533 23446788999999999 79999999999999999999


Q ss_pred             EEEecCCCChhHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCC
Q 011250          217 VYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       217 V~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                      ||||+++|+|.+++....               ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.
T Consensus        74 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~  150 (270)
T cd05047          74 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  150 (270)
T ss_pred             EEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCe
Confidence            999999999999986432               24789999999999999999999988   999999999999999999


Q ss_pred             eEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 011250          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       282 vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~  360 (490)
                      +||+|||++......   ........+..|+|||++....++.++|||||||++|||++ |..||......   ......
T Consensus       151 ~kl~dfgl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~  224 (270)
T cd05047         151 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEKL  224 (270)
T ss_pred             EEECCCCCccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---HHHHHH
Confidence            999999998643211   11111234567999999988899999999999999999997 99999643211   111111


Q ss_pred             hcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                      .              .......+...+.++.+|+.+||..||.+||++.+++..|+.+
T Consensus       225 ~--------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         225 P--------------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             h--------------CCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence            0              0001111223467889999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7e-41  Score=324.94  Aligned_cols=248  Identities=23%  Similarity=0.391  Sum_probs=195.3

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCCceEEEE
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVY  218 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~  218 (490)
                      +.||.|+||.||+|.....+..  ..-....||+|.+........+.+..|+.+++.+.||||+++++++..++..++||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~--~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDY--GELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCCcccchhheeeeecccccc--cccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence            4699999999999988653221  00123468889886655445567889999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCC--------eEEecccCc
Q 011250          219 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN--------AKLSDFGLA  290 (490)
Q Consensus       219 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~--------vkL~DFG~a  290 (490)
                      ||+++|+|..++......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.        ++|+|||++
T Consensus        79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            999999999999776667899999999999999999999988   999999999999987765        699999998


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCC-CCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGR-RSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~-~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ......      ....|+..|+|||++.+ ..++.++|||||||++|||++|. .||........   ....    ..  
T Consensus       156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~---~~~~----~~--  220 (258)
T cd05078         156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK---LQFY----ED--  220 (258)
T ss_pred             cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH---HHHH----Hc--
Confidence            754321      23568899999999876 45899999999999999999995 55543221110   0000    00  


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~  416 (490)
                                ...++.....++.+|+.+||+.||++|||+++|++.|+
T Consensus       221 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 ----------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ----------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                      01122223577899999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2e-40  Score=323.12  Aligned_cols=255  Identities=30%  Similarity=0.483  Sum_probs=200.5

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEeCCceEEE
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  217 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  217 (490)
                      +.||+|+||.||+|++.....   ....+..||||.+..... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~---~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILG---PGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII   77 (269)
T ss_pred             CccccccceeEEeeeeccccc---CcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence            369999999999998865321   011346799998865432 3456788999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhc------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-----CeEEec
Q 011250          218 YEFMPRGSLENHLFRR------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-----NAKLSD  286 (490)
Q Consensus       218 ~E~~~~gsL~~~l~~~------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-----~vkL~D  286 (490)
                      |||+++++|.+++...      ...+++..++.++.||+.||.|||+.+   ++|+||||+|||++.++     .++|+|
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~d  154 (269)
T cd05044          78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGD  154 (269)
T ss_pred             EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECC
Confidence            9999999999998642      234788999999999999999999987   99999999999999877     899999


Q ss_pred             ccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccC
Q 011250          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      ||++................++..|+|||++.+..++.++|||||||++|||++ |..||......   ........   
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~~~~~---  228 (269)
T cd05044         155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQHVTA---  228 (269)
T ss_pred             cccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHHHHhc---
Confidence            999976643322222223456789999999999999999999999999999998 99998643211   11111100   


Q ss_pred             CcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011250          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~  416 (490)
                       .          .....+...+..+.+||.+||..+|.+||++.+|++.|+
T Consensus       229 -~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         229 -G----------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             -C----------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence             0          000112234788999999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.8e-40  Score=329.05  Aligned_cols=251  Identities=26%  Similarity=0.405  Sum_probs=206.9

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      .+|++.+.||.|+||.||+|.+..         ++..||||.+........+.+.+|+.+++.++||||+++++++...+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVA---------TGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD   89 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcC---------CCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence            469999999999999999998765         57789999997665555677899999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      ..++||||+++++|..++...  .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++..
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~  164 (296)
T cd06655          90 ELFVVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQ  164 (296)
T ss_pred             eEEEEEEecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchh
Confidence            999999999999999988543  5899999999999999999999988   99999999999999999999999999886


Q ss_pred             CCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhh
Q 011250          293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR  372 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (490)
                      ......  ......|+..|+|||.+.+..++.++|||||||++|+|++|..||............  ....         
T Consensus       165 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~--~~~~---------  231 (296)
T cd06655         165 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--ATNG---------  231 (296)
T ss_pred             cccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HhcC---------
Confidence            543321  122356899999999998888999999999999999999999999764332111110  0000         


Q ss_pred             ccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       373 ~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                        .+.+  ..+...+..+.+||.+||..||.+||++.+|+++
T Consensus       232 --~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         232 --TPEL--QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             --Cccc--CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence              0000  1122336789999999999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.2e-41  Score=337.98  Aligned_cols=263  Identities=24%  Similarity=0.361  Sum_probs=198.3

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      ..++|.+.+.||.|+||.||+|.+..         ++..||||++.....  ...+.+.+|+.+|+.++||||+++++++
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   83 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTR---------LRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVF   83 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECC---------CCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhh
Confidence            35689999999999999999998865         567899999875422  2345677899999999999999999987


Q ss_pred             EeC------CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCe
Q 011250          209 IED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       209 ~~~------~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~v  282 (490)
                      ...      ...|++||++ +++|.+++.  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus        84 ~~~~~~~~~~~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~  157 (343)
T cd07878          84 TPATSIENFNEVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCEL  157 (343)
T ss_pred             cccccccccCcEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCE
Confidence            643      3468999998 789988774  346999999999999999999999988   9999999999999999999


Q ss_pred             EEecccCcccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhh-Hhh
Q 011250          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWA  360 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~-~~~  360 (490)
                      ||+|||+++.....     ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||............ ...
T Consensus       158 kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  232 (343)
T cd07878         158 RILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVV  232 (343)
T ss_pred             EEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHh
Confidence            99999999875432     123578999999999876 57899999999999999999999999754321110000 000


Q ss_pred             hc-------ccCC--cchhhhccC----CccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          361 RP-------HLGD--KRRFYRLLD----PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       361 ~~-------~~~~--~~~~~~~~~----~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ..       .+..  ...+...+.    ..+...+ ...+..+.+||.+||..||.+|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         233 GTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             CCCCHHHHHhcchhhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00       0000  000000000    0000000 1124568899999999999999999999976

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.2e-40  Score=318.44  Aligned_cols=251  Identities=26%  Similarity=0.385  Sum_probs=206.5

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      +|++.+.||.|+||.||.++...         ++..|++|.+....  ....+++.+|+.++++++|+||+++++++.+.
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   71 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTE---------DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD   71 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcC---------CCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC
Confidence            58899999999999999998876         56789999986543  23446788999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      +..++||||+++++|.+++... ...+++..+..++.|++.+|.|||+.+   ++||||+|+||+++.++.+||+|||++
T Consensus        72 ~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~  148 (256)
T cd08221          72 NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGIS  148 (256)
T ss_pred             CeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcce
Confidence            9999999999999999998664 456899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ........  ......|++.|+|||++.+..++.++||||||+++|||++|..||.......   .....   ..     
T Consensus       149 ~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~---~~~~~---~~-----  215 (256)
T cd08221         149 KILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN---LVVKI---VQ-----  215 (256)
T ss_pred             EEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH---HHHHH---Hc-----
Confidence            87644321  2234578999999999988889999999999999999999999996532211   11100   00     


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                           ..+. ......+.++.+++.+||..||.+||++.++++++
T Consensus       216 -----~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         216 -----GNYT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             -----CCCC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence                 0000 01123367899999999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=5.1e-40  Score=319.11  Aligned_cols=252  Identities=28%  Similarity=0.412  Sum_probs=201.3

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      ++|.+.+.||+|+||.||+|.+..          +..||+|.+.... ...+.+.+|+.+++.+.|+||+++++++. .+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~----------~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~   73 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNG----------TTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EE   73 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcC----------CceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CC
Confidence            468899999999999999998753          2358999886543 23467889999999999999999999875 45


Q ss_pred             ceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          213 QRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      ..++||||+.+++|.+++... ...+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.++|+|||++.
T Consensus        74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~  150 (260)
T cd05069          74 PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLAR  150 (260)
T ss_pred             CcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccce
Confidence            689999999999999998653 345889999999999999999999988   9999999999999999999999999997


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||......   .........       
T Consensus       151 ~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~~~-------  219 (260)
T cd05069         151 LIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLEQVERG-------  219 (260)
T ss_pred             EccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcC-------
Confidence            65432211 1122346778999999988899999999999999999999 89998653221   111111100       


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  417 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~  417 (490)
                             .....+...+..+.+|+.+||..||.+||++.+|++.|+.
T Consensus       220 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         220 -------YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -------CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                   0001122336789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.8e-40  Score=325.33  Aligned_cols=252  Identities=27%  Similarity=0.443  Sum_probs=201.7

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      ++|++.+.||+|+||.||+|.+..         ++..||+|.+.... ......+.+|+.+++.++|+||+++++++...
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRP---------TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE   71 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcC---------CCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC
Confidence            368899999999999999998875         56789999887542 22346788999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhc--CCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEE-AEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      +..++||||+++++|..++...  ...+++..+..++.||+.||.|||+. +   |+||||||+|||++.++.++|+|||
T Consensus        72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg  148 (286)
T cd06622          72 GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFG  148 (286)
T ss_pred             CeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecC
Confidence            9999999999999999888553  23689999999999999999999973 6   9999999999999999999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhccC------CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG------HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~------~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      ++.......    .....|+..|+|||++.+.      .++.++|||||||++|+|++|..||..............   
T Consensus       149 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~---  221 (286)
T cd06622         149 VSGNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSA---  221 (286)
T ss_pred             CcccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHH---
Confidence            987653321    1234688999999988543      358899999999999999999999965322111111100   


Q ss_pred             ccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                                +.+. ....++...+.++.+||.+||+.+|.+||++.+++++
T Consensus       222 ----------~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         222 ----------IVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             ----------Hhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence                      0000 0011223347889999999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.7e-40  Score=326.28  Aligned_cols=264  Identities=23%  Similarity=0.306  Sum_probs=200.1

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      +|++.+.||+|+||.||+|++..         +|..||+|.+......  ....+.+|+.+++.++||||+++++++.+.
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~---------~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   71 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD   71 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECC---------CCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC
Confidence            48888999999999999999876         5778999998654221  234677899999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      ...++||||++ ++|.+++......+++..++.++.||++||.|||+.+   |+||||||+||+++.++.++|+|||+++
T Consensus        72 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~  147 (284)
T cd07839          72 KKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLAR  147 (284)
T ss_pred             CceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhh
Confidence            99999999996 5888887665667999999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhccC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc--------
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP--------  362 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~--------  362 (490)
                      ........  .....++..|+|||++.+. .++.++|||||||++|+|++|..||.......  ........        
T Consensus       148 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~  223 (284)
T cd07839         148 AFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEE  223 (284)
T ss_pred             ccCCCCCC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChH
Confidence            65432211  1234678999999988764 47899999999999999999998864322111  00000000        


Q ss_pred             ---ccCCcchh--hhccCCccC-CCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          363 ---HLGDKRRF--YRLLDPRLE-GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       363 ---~~~~~~~~--~~~~~~~l~-~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                         .+.....+  ......... .......+.++.+||.+||+.||.+|||+++++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         224 SWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             HhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence               00000000  000000000 01112346789999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-41  Score=309.49  Aligned_cols=254  Identities=30%  Similarity=0.449  Sum_probs=205.8

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC-CcccHHHHHHHHHHHhccC-CCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~  210 (490)
                      ++.+++..||.|+.|+|++++++.         +|..+|||.+... +..+.++++..+.++..-+ .|.||+.+|||..
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs---------~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~  162 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRS---------TGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT  162 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcc---------cceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence            345667889999999999999987         6779999999765 4455577888888776654 8999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      +..++|.||.| ...++.++.+-..++++..+-++...++.||.||.+..  +|||||+||+|||||+.|++||||||++
T Consensus       163 n~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIs  239 (391)
T KOG0983|consen  163 NTDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGIS  239 (391)
T ss_pred             CchHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeeccccc
Confidence            99999999998 56778888777788999999999999999999998865  4999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhc---cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      -.+.+..   ..++..|.+.|||||.+.   ...|+.++|||||||+|+||.||+.||......-+  .....   +.  
T Consensus       240 GrlvdSk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe--~ltkv---ln--  309 (391)
T KOG0983|consen  240 GRLVDSK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE--VLTKV---LN--  309 (391)
T ss_pred             ceeeccc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH--HHHHH---Hh--
Confidence            8775532   345678999999999986   35799999999999999999999999986532211  11111   10  


Q ss_pred             chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                           ...|.|....  ..++.+.+|+..||++|+.+||...+++++-
T Consensus       310 -----~ePP~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~  350 (391)
T KOG0983|consen  310 -----EEPPLLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEHP  350 (391)
T ss_pred             -----cCCCCCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence                 0112222211  1378999999999999999999999999863

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.2e-40  Score=318.44  Aligned_cols=252  Identities=29%  Similarity=0.500  Sum_probs=203.3

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      .+|++.+.||.|+||.||+|.+..          +..+|+|.+..... ....+.+|+++++.+.||||+++++++....
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~----------~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLE----------KRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERS   72 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeC----------CCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCC
Confidence            368888999999999999998752          44799999875433 3457889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      ..++||||+.+++|.+++......+++..+..++.|++.+|+|||+.+   |+||||||+||+++.++.++|+|||+++.
T Consensus        73 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~  149 (256)
T cd05112          73 PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRF  149 (256)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceee
Confidence            999999999999999998766667899999999999999999999988   99999999999999999999999999876


Q ss_pred             CCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcchhh
Q 011250          293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  371 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (490)
                      ...... .......++..|+|||++.+..++.++|||||||++|||++ |..||......   ...+.....       .
T Consensus       150 ~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~-------~  218 (256)
T cd05112         150 VLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---EVVETINAG-------F  218 (256)
T ss_pred             cccCcc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHHhCC-------C
Confidence            543221 11122345678999999988899999999999999999998 99998643211   111111000       0


Q ss_pred             hccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011250          372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       372 ~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~  416 (490)
                      ....+       ...+..+.+|+.+||+.+|++||++.++++.|.
T Consensus       219 ~~~~~-------~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         219 RLYKP-------RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             CCCCC-------CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            00111       113678999999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-41  Score=339.79  Aligned_cols=264  Identities=27%  Similarity=0.427  Sum_probs=220.9

Q ss_pred             hhHHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeecee
Q 011250          126 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLV  205 (490)
Q Consensus       126 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~  205 (490)
                      ++++....+.....+||.|.||.||.|.|+..         ...||||.++.+. ...++|+.|+.+|+.+.|||+|+|+
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKky---------slTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLL  329 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKY---------SLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLL  329 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeecc---------ceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHh
Confidence            45555566777888999999999999999873         4579999998765 4568999999999999999999999


Q ss_pred             eEEEeCCceEEEEEecCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 011250          206 GYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       206 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL  284 (490)
                      |+|..+..+|||+|||..|+|.++|.+.. ..++....++++.||..|+.||...+   +|||||...|+|+.++..|||
T Consensus       330 GVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKv  406 (1157)
T KOG4278|consen  330 GVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKV  406 (1157)
T ss_pred             hhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEe
Confidence            99999999999999999999999997643 34777788999999999999999877   999999999999999999999


Q ss_pred             ecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcc
Q 011250          285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      +|||+++.+..+.++. .....-.+.|.|||-+....++.|+|||+|||+|||+.| |-.||.+....            
T Consensus       407 ADFGLsRlMtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS------------  473 (1157)
T KOG4278|consen  407 ADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------------  473 (1157)
T ss_pred             eccchhhhhcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH------------
Confidence            9999999987654432 111223578999999999999999999999999999988 66777654221            


Q ss_pred             cCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                           ..+.++...+.-.-+..|++.+++|++.||+.+|.+||++.|+-+.|+.+..
T Consensus       474 -----qVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  474 -----QVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             -----HHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence                 2233444444445566789999999999999999999999999999876543

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-41  Score=338.14  Aligned_cols=255  Identities=24%  Similarity=0.333  Sum_probs=210.7

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC--CcccHHHHHHHHHHHhccC-CCCeeceee
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLL-HPNLVKLVG  206 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~Ei~il~~l~-HpnIv~l~~  206 (490)
                      +..+.|++++.||.||.+.||++...+          ...||+|.+...  +.+...-|..|+.+|.+|. |.+||+||+
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~----------~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~D  427 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSD----------KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYD  427 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCC----------CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEee
Confidence            445679999999999999999997653          345777776543  3344567999999999997 999999999


Q ss_pred             EEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEec
Q 011250          207 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~D  286 (490)
                      |-..++.+||||||= ..+|..+|.+.....+...++.+..|++.|+.++|.+|   |||-||||.|+|+- .|.+||+|
T Consensus       428 YEv~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLID  502 (677)
T KOG0596|consen  428 YEVTDGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLID  502 (677)
T ss_pred             eeccCceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeee
Confidence            999999999999985 56999999877666665588899999999999999999   99999999999985 57999999


Q ss_pred             ccCcccCCCCCcceeeeccccCCCccCcchhccCC-----------CCccchhhHHHHHHHHHHhCCCCCCCCCCCCcch
Q 011250          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH-----------LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN  355 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-----------~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~  355 (490)
                      ||+|..+..+...-.....+||+.||+||.+....           .+.++||||||||||+|+.|++||....      
T Consensus       503 FGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~------  576 (677)
T KOG0596|consen  503 FGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII------  576 (677)
T ss_pred             echhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH------
Confidence            99999998877776677789999999999886432           4578999999999999999999996321      


Q ss_pred             hhHhhhcccCCcchhhhccCCccCCCCChhh-HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKG-SQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~-~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                               .....+..+.+|.-+.+|+.-. ..++.++++.||.+||.+||++.|+|++
T Consensus       577 ---------n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  577 ---------NQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             ---------HHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence                     0122355677776666665433 3349999999999999999999999976

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-41  Score=343.51  Aligned_cols=254  Identities=28%  Similarity=0.449  Sum_probs=210.0

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhccCCCCeeceeeEEEeCCc
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQ  213 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  213 (490)
                      ..+.++||+|.||+|++|.|...+      ++-..||||+++.+.+. ...+|++|+.+|.+|+|+|+++|||+..+ ..
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~ps------gk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp  184 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPS------GKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QP  184 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCC------CcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence            445688999999999999998643      24568999999887665 56789999999999999999999999887 67


Q ss_pred             eEEEEEecCCCChhHHhhh-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          214 RLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       214 ~~lV~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      ..||||++++|+|.+.|.+ ....|.......++.||+.||.||..++   +|||||...||||.....||||||||.+.
T Consensus       185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRa  261 (1039)
T KOG0199|consen  185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRA  261 (1039)
T ss_pred             hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceec
Confidence            8899999999999999987 4456888889999999999999999987   99999999999999999999999999998


Q ss_pred             CCCCCcc-eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          293 APEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       293 ~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      +...... .+.....-.+.|+|||.+....++.++|||+|||+||||++ |..||.+.........              
T Consensus       262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~--------------  327 (1039)
T KOG0199|consen  262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKN--------------  327 (1039)
T ss_pred             cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHh--------------
Confidence            8654333 22233334678999999999999999999999999999998 6778866543222222              


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                         +|..-.-.-+..|++++++++++||..+|.+|||+..|.+.+
T Consensus       328 ---iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  328 ---IDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             ---ccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence               221112233456799999999999999999999999997543

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.6e-40  Score=318.16  Aligned_cols=250  Identities=25%  Similarity=0.350  Sum_probs=202.3

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      +|++.+.||+|+||.||++.+..         ++..||+|.+.....  ...+.+.+|+++++.++|+||+++++.+...
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRT---------DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE   71 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcC---------CCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC
Confidence            48899999999999999999876         566899999865432  3345688899999999999999999987644


Q ss_pred             -CceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          212 -DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       212 -~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                       ...++||||+++++|.+++... ...+++.++..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||+
T Consensus        72 ~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~  148 (257)
T cd08223          72 DGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGI  148 (257)
T ss_pred             CCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccc
Confidence             4678999999999999998653 346899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +.......  .......|++.|+|||++.+..++.++|||||||++|+|++|+.||......      ..........  
T Consensus       149 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~~~~~~~--  218 (257)
T cd08223         149 ARVLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYRIIEGK--  218 (257)
T ss_pred             eEEecccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHhcC--
Confidence            97664322  1223457899999999999989999999999999999999999999643211      1110000000  


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                          +     ...+...+..+.+|+.+||+.||.+||++.+++++
T Consensus       219 ----~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         219 ----L-----PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ----C-----CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                0     01122346789999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=6.3e-40  Score=316.72  Aligned_cols=255  Identities=34%  Similarity=0.515  Sum_probs=205.0

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhccCCCCeeceeeEEEeCCc
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQ  213 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  213 (490)
                      |.+.+.||.|+||.||+|.+...+.     ..+..||+|.+...... ..+.+..|+.++..++|+||+++++++.+.+.
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   75 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSG-----EKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEP   75 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCC-----CCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCe
Confidence            4577899999999999999876321     13478999999766433 45788999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhHHhhhcCCC-CCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          214 RLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       214 ~~lV~E~~~~gsL~~~l~~~~~~-l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      .++||||+++++|.+++...... +++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+|||++..
T Consensus        76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~  152 (258)
T smart00219       76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRD  152 (258)
T ss_pred             eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCcee
Confidence            99999999999999998654433 999999999999999999999988   99999999999999999999999999987


Q ss_pred             CCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcchhh
Q 011250          293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  371 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (490)
                      ......... ....+++.|+|||.+.+..++.++||||||+++|+|++ |.+||......   ........   ..    
T Consensus       153 ~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~---~~~~~~~~---~~----  221 (258)
T smart00219      153 LYDDDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE---EVLEYLKK---GY----  221 (258)
T ss_pred             ccccccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHhc---CC----
Confidence            654422221 12337889999999988889999999999999999998 78888653211   11111100   00    


Q ss_pred             hccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       372 ~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                             ....+...+.++.+++.+||..||.+|||+.++++.|
T Consensus       222 -------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      222 -------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                   0011122477899999999999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4.4e-40  Score=330.87  Aligned_cols=264  Identities=22%  Similarity=0.275  Sum_probs=197.0

Q ss_pred             CCcccccC--CceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          137 PESLLGEG--GFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       137 ~~~~LG~G--~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      ++++||+|  +|++||++....         +|..||+|.+.....  ...+.+.+|+.+++.++||||+++++++..++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~   72 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKP---------TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN   72 (327)
T ss_pred             hhhhccccccceEEEEEEeecc---------cCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC
Confidence            56789999  789999999876         677999999976532  22345778999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          213 QRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      ..++||||+++|+|.+++... ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.++|+||+.+.
T Consensus        73 ~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~  149 (327)
T cd08227          73 ELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNL  149 (327)
T ss_pred             EEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhh
Confidence            999999999999999998653 345899999999999999999999988   9999999999999999999999998754


Q ss_pred             cCCCCCcc-----eeeeccccCCCccCcchhcc--CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc
Q 011250          292 DAPEDGKT-----HVSTRVMGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       292 ~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~--~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      ........     .......++..|+|||++.+  ..++.++|||||||++|||++|..||.......  ..........
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~  227 (327)
T cd08227         150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTV  227 (327)
T ss_pred             ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHHhcCCc
Confidence            43221110     01112356788999999875  468999999999999999999999996432111  0000000000


Q ss_pred             C---Cc------------------chhhh---------ccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          365 G---DK------------------RRFYR---------LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       365 ~---~~------------------~~~~~---------~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .   +.                  ..+..         .........+....+..+.+|+.+||+.||.+|||+++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         228 PCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             cccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence            0   00                  00000         000000001122336789999999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.5e-40  Score=325.56  Aligned_cols=262  Identities=28%  Similarity=0.384  Sum_probs=204.6

Q ss_pred             hhhhHHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcc-CCCCee
Q 011250          124 MFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLV  202 (490)
Q Consensus       124 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv  202 (490)
                      .++.+....++|++.+.||+|+||.||+|.+..         ++..||+|++.... ....++..|+.+++.+ +||||+
T Consensus         9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~   78 (286)
T cd06638           9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKK---------NGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVV   78 (286)
T ss_pred             EeecCCCcccceeeeeeeccCCCcEEEEEEECC---------CCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCee
Confidence            345556677899999999999999999999876         56689999886532 2235678899999999 699999


Q ss_pred             ceeeEEE-----eCCceEEEEEecCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcE
Q 011250          203 KLVGYCI-----EDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI  274 (490)
Q Consensus       203 ~l~~~~~-----~~~~~~lV~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NI  274 (490)
                      ++++++.     .++..++||||+++++|.+++..   ....+++..+..++.|++.||.|||+.+   |+||||||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~ni  155 (286)
T cd06638          79 KFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNI  155 (286)
T ss_pred             eeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhE
Confidence            9999874     34568999999999999988753   3356889999999999999999999988   99999999999


Q ss_pred             EEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhcc-----CCCCccchhhHHHHHHHHHHhCCCCCCCCC
Q 011250          275 LLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-----GHLTSKSDVYSFGVVLLEMLTGRRSMDKNR  349 (490)
Q Consensus       275 Ll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~~~~~sDvwSlGv~l~elltG~~pf~~~~  349 (490)
                      +++.++.++|+|||+++.......  ......|++.|+|||++..     ..++.++|||||||++|||++|..||....
T Consensus       156 li~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~  233 (286)
T cd06638         156 LLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH  233 (286)
T ss_pred             EECCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence            999999999999999986643221  1123468999999998753     457889999999999999999999996543


Q ss_pred             CCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          350 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                      ....  +.....     . ......       .+...+..+.+||.+||+.||++||++.||++++
T Consensus       234 ~~~~--~~~~~~-----~-~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         234 PMRA--LFKIPR-----N-PPPTLH-------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             hhHH--Hhhccc-----c-CCCccc-------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            2111  000000     0 000000       1112356799999999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.6e-40  Score=317.71  Aligned_cols=248  Identities=25%  Similarity=0.459  Sum_probs=194.9

Q ss_pred             cccccCCceEEEEEEEccCCCccc-cCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCCceEEE
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPV-KPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  217 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  217 (490)
                      +.||+|+||.||+|.+...+.... .......|++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            469999999999999976431100 0112246888887655433 5778999999999999999999999988 778999


Q ss_pred             EEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-------CeEEecccCc
Q 011250          218 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-------NAKLSDFGLA  290 (490)
Q Consensus       218 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-------~vkL~DFG~a  290 (490)
                      |||+++|+|.+++......+++..++.++.||+.||+|||+.+   |+||||||+|||++.++       .+||+|||++
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            9999999999999766557999999999999999999999988   99999999999999887       7999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccC--CCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCc
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~--~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      .....      .....++..|+|||++...  .++.++|||||||++|||++ |..||..........   +..    ..
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~---~~~----~~  222 (259)
T cd05037         156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER---FYQ----DQ  222 (259)
T ss_pred             ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH---HHh----cC
Confidence            87543      1224577889999998876  78999999999999999999 577775543211111   100    00


Q ss_pred             chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011250          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~  416 (490)
                                  ...+......+.+|+.+||..||.+||++.+|++.|+
T Consensus       223 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         223 ------------HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             ------------CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                        0001111378899999999999999999999998773

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.7e-40  Score=324.39  Aligned_cols=261  Identities=27%  Similarity=0.416  Sum_probs=207.8

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .++|++.+.||+|+||+||+|.+..         ++..||+|++.... ....+.+.+|+++++.++||||+++++++..
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   74 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIP---------TGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN   74 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcC---------CCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec
Confidence            3568889999999999999999876         56789999886543 2335678999999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      .+.+++||||+++++|.+++.+. ..+++..+..++.+++.+|.|||+ .+   |+||||||+||+++.++.++|+|||+
T Consensus        75 ~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl  150 (284)
T cd06620          75 ENNICMCMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGV  150 (284)
T ss_pred             CCEEEEEEecCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCc
Confidence            99999999999999999988553 478999999999999999999997 45   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCc-----chhhHhhhccc
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-----HNLVEWARPHL  364 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~-----~~~~~~~~~~~  364 (490)
                      +.......    .....|+..|+|||++.+..++.++|||||||++|+|++|..||........     ..+.++.....
T Consensus       151 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  226 (284)
T cd06620         151 SGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV  226 (284)
T ss_pred             ccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh
Confidence            87543221    1235789999999999888999999999999999999999999975433211     11111111111


Q ss_pred             CCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011250          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~  419 (490)
                      ...       .+.+.   ....+.++.+|+.+||..||.+||++.|++++..-++
T Consensus       227 ~~~-------~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~  271 (284)
T cd06620         227 QEP-------PPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ  271 (284)
T ss_pred             hcc-------CCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence            000       00110   1123678999999999999999999999998754443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.7e-40  Score=359.86  Aligned_cols=259  Identities=23%  Similarity=0.352  Sum_probs=203.2

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|++.++||+|+||.||+|++..         ++..||||++.....   ...+++.+|+.+++.++||||+++++++.
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~---------tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~   72 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPV---------CSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS   72 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECC---------CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe
Confidence            479999999999999999999875         577899999975422   22457899999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhc----------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRR----------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD  279 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~----------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~  279 (490)
                      +++..++||||++||+|.+++...          ...+++..++.++.||+.||+|||+.+   |+||||||+|||++.+
T Consensus        73 d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~d  149 (932)
T PRK13184         73 DGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLF  149 (932)
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCC
Confidence            999999999999999999988531          123566778899999999999999988   9999999999999999


Q ss_pred             CCeEEecccCcccCCCCCc----------------ceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCC
Q 011250          280 YNAKLSDFGLAKDAPEDGK----------------THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR  343 (490)
Q Consensus       280 ~~vkL~DFG~a~~~~~~~~----------------~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~  343 (490)
                      +.++|+|||+++.......                .......+||+.|||||++.+..++.++|||||||++|||++|+.
T Consensus       150 g~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~  229 (932)
T PRK13184        150 GEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSF  229 (932)
T ss_pred             CCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCC
Confidence            9999999999986521100                001123579999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCC-CHHHHHHHhhcC
Q 011250          344 SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-RMSEVVETLKPL  418 (490)
Q Consensus       344 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-t~~evl~~L~~l  418 (490)
                      ||........   . . .........    +.+      ....+..+.+++.+||+.||++|| +++++++.|+.+
T Consensus       230 PF~~~~~~ki---~-~-~~~i~~P~~----~~p------~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~  290 (932)
T PRK13184        230 PYRRKKGRKI---S-Y-RDVILSPIE----VAP------YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH  290 (932)
T ss_pred             CCCCcchhhh---h-h-hhhccChhh----ccc------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            9965322111   0 0 000000000    000      012367789999999999999995 567777777654

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.7e-40  Score=323.09  Aligned_cols=248  Identities=25%  Similarity=0.393  Sum_probs=202.6

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      .|+..+.||+|+||.||+|.+..         ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++..++
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNR---------TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT   75 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcC---------CCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC
Confidence            36677889999999999998865         566899999875532 33457889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      ..++||||+++++|.+++..  ..+++..+..++.||+.||.|||+.+   |+|+||+|+||+++.++.++|+|||++..
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~  150 (277)
T cd06642          76 KLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQ  150 (277)
T ss_pred             ceEEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEcccccccc
Confidence            99999999999999998843  46899999999999999999999988   99999999999999999999999999976


Q ss_pred             CCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhh
Q 011250          293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR  372 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (490)
                      ......  ......|+..|+|||++.+..++.++|||||||++|||++|..||....+....   ..    ...      
T Consensus       151 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~~----~~~------  215 (277)
T cd06642         151 LTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---FL----IPK------  215 (277)
T ss_pred             ccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH---hh----hhc------
Confidence            643221  112346889999999999889999999999999999999999998643221110   00    000      


Q ss_pred             ccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       373 ~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ...+    ......+..+.+||.+||..+|.+||++.+++++
T Consensus       216 ~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         216 NSPP----TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CCCC----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            0011    1122346789999999999999999999999986

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=8.2e-40  Score=317.77  Aligned_cols=257  Identities=28%  Similarity=0.407  Sum_probs=207.2

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      ++|++.+.||.|+||+||+|....         ++..||+|++..... ...+.+.+|+.+++.++|+||+++++.+...
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLP---------NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG   71 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcC---------CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC
Confidence            468999999999999999998765         466899999875532 3456789999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          212 DQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +..++||||+++++|.+++...  ...+++..+..++.|++.||.|||+.+   |+||||+|+||++++++.++|+|||+
T Consensus        72 ~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~  148 (267)
T cd06610          72 DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGV  148 (267)
T ss_pred             CEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccch
Confidence            9999999999999999998653  246899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcce--eeeccccCCCccCcchhccC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011250          290 AKDAPEDGKTH--VSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       290 a~~~~~~~~~~--~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      +..........  ......|+..|+|||++... .++.++|||||||++|+|++|+.||........  .......   .
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~~---~  223 (267)
T cd06610         149 SASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLTLQN---D  223 (267)
T ss_pred             HHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHHhcC---C
Confidence            87665432221  22345789999999998876 789999999999999999999999975433211  1111110   0


Q ss_pred             cchhhhccCCccCCCC-ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          367 KRRFYRLLDPRLEGHF-SIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~-~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                              .+.+.... ....+..+.+|+.+||..||++||++.+|+++
T Consensus       224 --------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         224 --------PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             --------CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                    00011100 11336788999999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=7.4e-40  Score=319.45  Aligned_cols=254  Identities=30%  Similarity=0.402  Sum_probs=191.4

Q ss_pred             ccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEeCCceEEEE
Q 011250          140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVY  218 (490)
Q Consensus       140 ~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~  218 (490)
                      .||+|+||.||+|......       ....+|+|.+..... .....+.+|+.+++.++|+||+++++++.+....++||
T Consensus         2 ~lg~G~fg~v~~~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~   74 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGM-------SKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVL   74 (269)
T ss_pred             cCCccCCceEEEEEEecCC-------CCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEE
Confidence            5999999999999764321       345789998765432 23456889999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhcC----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCC
Q 011250          219 EFMPRGSLENHLFRRS----LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       219 E~~~~gsL~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~  294 (490)
                      ||+++|+|.+++....    ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  151 (269)
T cd05042          75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQY  151 (269)
T ss_pred             EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccc
Confidence            9999999999986543    23467788899999999999999988   9999999999999999999999999987643


Q ss_pred             CCCcceeeeccccCCCccCcchhcc-------CCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCC
Q 011250          295 EDGKTHVSTRVMGTYGYAAPEYVMT-------GHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       295 ~~~~~~~~~~~~Gt~~y~aPE~l~~-------~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      ............++..|+|||++..       ..++.++|||||||++|||++ |..||.......  .+......   .
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~~~~~~---~  226 (269)
T cd05042         152 PEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ--VLKQVVRE---Q  226 (269)
T ss_pred             cchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HHHHHhhc---c
Confidence            3322222223456778999998753       356789999999999999999 788886442211  01110000   0


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~  416 (490)
                         ......+.    .+...+..+.+++..|| .||++||++++|++.|.
T Consensus       227 ---~~~~~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         227 ---DIKLPKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             ---CccCCCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence               00111121    12234677888999998 59999999999998863

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6.3e-40  Score=322.26  Aligned_cols=267  Identities=28%  Similarity=0.375  Sum_probs=203.0

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ++|++.+.||+|+||.||+|.+..         ++..||+|++.....  ...+.+.+|+.+++.++|+||+++++++..
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   71 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRE---------TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR   71 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECC---------CCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee
Confidence            368899999999999999999875         567899998864422  233567899999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      ....++||||++++.|..++. ....+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.++|+|||++
T Consensus        72 ~~~~~~v~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~  147 (286)
T cd07847          72 KRKLHLVFEYCDHTVLNELEK-NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFA  147 (286)
T ss_pred             CCEEEEEEeccCccHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccc
Confidence            999999999999888877663 4446999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh-hcccC---
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-RPHLG---  365 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~-~~~~~---  365 (490)
                      ........  ......++..|+|||++.+ ..++.++|||||||++|+|++|..||............... .....   
T Consensus       148 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  225 (286)
T cd07847         148 RILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQ  225 (286)
T ss_pred             eecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence            87654322  1123467899999999875 56889999999999999999999999754432211111000 00000   


Q ss_pred             ---Ccchhh-hccCCccCCCCC-----hhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          366 ---DKRRFY-RLLDPRLEGHFS-----IKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 ---~~~~~~-~~~~~~l~~~~~-----~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                         ....+. ....+......+     ...+..+.+|+.+||+.||++||++.+++.+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         226 QIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             hhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence               000000 000010000000     1236788999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=8.9e-40  Score=326.54  Aligned_cols=262  Identities=23%  Similarity=0.363  Sum_probs=190.1

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEe--CCceEE
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE--DDQRLL  216 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~l  216 (490)
                      .+||+|+||.||+|+.....       ++..||+|.+.....  ...+.+|+.+++.++||||+++++++..  +...++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~-------~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l   77 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGK-------DEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWL   77 (317)
T ss_pred             eEeccCCCeeEEEEEecCCC-------ccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEE
Confidence            57999999999999875422       456899999875432  3467889999999999999999998854  457799


Q ss_pred             EEEecCCCChhHHhhhc--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE----cCCCCeEE
Q 011250          217 VYEFMPRGSLENHLFRR--------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL----DADYNAKL  284 (490)
Q Consensus       217 V~E~~~~gsL~~~l~~~--------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl----~~~~~vkL  284 (490)
                      ||||+. ++|.+++...        ...+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+||
T Consensus        78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl  153 (317)
T cd07867          78 LFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI  153 (317)
T ss_pred             EEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEE
Confidence            999995 5787776421        235889999999999999999999988   9999999999999    56679999


Q ss_pred             ecccCcccCCCCCcc-eeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcc-------h
Q 011250          285 SDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-------N  355 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~-------~  355 (490)
                      +|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|.+||.........       .
T Consensus       154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~  233 (317)
T cd07867         154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQ  233 (317)
T ss_pred             eeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHH
Confidence            999999876433211 11234578999999999876 46899999999999999999999999754321110       0


Q ss_pred             hhHhhhcccC-----Ccc------hhhhcc---------CCcc---CCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 011250          356 LVEWARPHLG-----DKR------RFYRLL---------DPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV  412 (490)
Q Consensus       356 ~~~~~~~~~~-----~~~------~~~~~~---------~~~l---~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl  412 (490)
                      +..... .++     ...      .+....         ...+   ........+..+.+|+.+||+.||.+|||+.|++
T Consensus       234 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l  312 (317)
T cd07867         234 LDRIFS-VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQAL  312 (317)
T ss_pred             HHHHHH-hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHh
Confidence            000000 000     000      000000         0000   0001112256788999999999999999999998


Q ss_pred             HH
Q 011250          413 ET  414 (490)
Q Consensus       413 ~~  414 (490)
                      ++
T Consensus       313 ~h  314 (317)
T cd07867         313 QD  314 (317)
T ss_pred             cC
Confidence            65

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.8e-40  Score=323.69  Aligned_cols=258  Identities=28%  Similarity=0.400  Sum_probs=202.8

Q ss_pred             hhHHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcc-CCCCeece
Q 011250          126 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKL  204 (490)
Q Consensus       126 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l  204 (490)
                      .++....+.|++.+.||.|+||.||+|.+..         ++..||+|++.... ....++..|+.++..+ +|+||+++
T Consensus         9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~   78 (282)
T cd06636           9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVK---------TGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATY   78 (282)
T ss_pred             hhhcChhhhhhhheeeccCCCeEEEEEEEcC---------CCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEE
Confidence            3444556789999999999999999999876         56689999986543 2345678899999998 69999999


Q ss_pred             eeEEEe------CCceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc
Q 011250          205 VGYCIE------DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD  277 (490)
Q Consensus       205 ~~~~~~------~~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~  277 (490)
                      ++++..      .+..++||||+++|+|.+++... ...+++..++.++.||+.||.|||+.+   |+||||+|+||+++
T Consensus        79 ~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~  155 (282)
T cd06636          79 YGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLT  155 (282)
T ss_pred             eeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEC
Confidence            999863      45789999999999999988653 345888899999999999999999988   99999999999999


Q ss_pred             CCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhc-----cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCC
Q 011250          278 ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG  352 (490)
Q Consensus       278 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~  352 (490)
                      .++.++|+|||++........  ......|+..|+|||.+.     ...++.++|||||||++|||++|..||....+..
T Consensus       156 ~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~  233 (282)
T cd06636         156 ENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR  233 (282)
T ss_pred             CCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh
Confidence            999999999999876532211  122357899999999875     3468889999999999999999999996543221


Q ss_pred             cchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          353 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ......             ....+.   ......+.++.+||.+||..||.+||++.+|+++
T Consensus       234 ~~~~~~-------------~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         234 ALFLIP-------------RNPPPK---LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             hhhhHh-------------hCCCCC---CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence            111000             000000   0111236789999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=7.4e-40  Score=320.29  Aligned_cols=260  Identities=26%  Similarity=0.400  Sum_probs=206.6

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      ++|++.+.||.|+||.||+|+......    .+....|++|.+...... ..+++.+|+++++.++|+||+++++++.+.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~----~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   80 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEE----EGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA   80 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCc----CCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence            468899999999999999999865321    224568999988655433 346789999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcC--------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeE
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRS--------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~--------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vk  283 (490)
                      +..++||||+++|+|.+++....        ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.++
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~  157 (275)
T cd05046          81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVK  157 (275)
T ss_pred             CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEE
Confidence            99999999999999999986443        15899999999999999999999988   99999999999999999999


Q ss_pred             EecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhc
Q 011250          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      |+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   .......
T Consensus       158 l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~~~~  233 (275)
T cd05046         158 VSLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNRLQA  233 (275)
T ss_pred             EcccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHHHHc
Confidence            999999875432211 11223456788999999988889999999999999999998 788885432211   1111100


Q ss_pred             ccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011250          363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~  416 (490)
                                   ..+....+...+..+.+++.+||..||.+||++.+++..|.
T Consensus       234 -------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         234 -------------GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             -------------CCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                         00001112234678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=7.4e-40  Score=317.98  Aligned_cols=255  Identities=27%  Similarity=0.421  Sum_probs=203.8

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ..++|++.+.||+|+||.||+|.+..          +..||+|.+.... .....+.+|+.+++.++|+||+++++++.+
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~----------~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   72 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNK----------HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK   72 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecC----------CccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC
Confidence            34679999999999999999997643          3469999887543 234678899999999999999999999887


Q ss_pred             CCceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                       ...++||||+++++|.+++.+. ...+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||+
T Consensus        73 -~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~  148 (260)
T cd05073          73 -EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGL  148 (260)
T ss_pred             -CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcc
Confidence             7789999999999999999653 446888999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +........ .......++..|+|||++....++.++|||||||++|+|++ |..||......   ..........    
T Consensus       149 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~~~~----  220 (260)
T cd05073         149 ARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRALERGY----  220 (260)
T ss_pred             eeeccCCCc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHhCCC----
Confidence            976543222 11222346678999999988889999999999999999998 99999653221   1111111000    


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                                ....+...+.++.+++.+||+.||++||++.++++.|+.+
T Consensus       221 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         221 ----------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             ----------CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence                      0011122367899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.2e-39  Score=319.56  Aligned_cols=249  Identities=26%  Similarity=0.381  Sum_probs=205.5

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      .|+..+.||.|+||.||+|.+..         ++..||||.+.... ......+.+|+.+++.+.|+||+++++++.++.
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNR---------TQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT   75 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEcc---------CCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            57788999999999999998875         56789999987543 234567889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      ..++||||+++++|.+++..  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        76 ~~~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~  150 (277)
T cd06640          76 KLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQ  150 (277)
T ss_pred             EEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEccccccee
Confidence            99999999999999998853  46889999999999999999999988   99999999999999999999999999976


Q ss_pred             CCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhh
Q 011250          293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR  372 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (490)
                      ......  ......++..|+|||++.+..++.++|||||||++|||++|..||....+.......               
T Consensus       151 ~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~---------------  213 (277)
T cd06640         151 LTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI---------------  213 (277)
T ss_pred             ccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh---------------
Confidence            643221  122356889999999998888999999999999999999999999654322111100               


Q ss_pred             ccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       373 ~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                        .......+....+..+.+|+.+||..+|++||++.+++.+-
T Consensus       214 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  254 (277)
T cd06640         214 --PKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK  254 (277)
T ss_pred             --hcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence              00001122334578899999999999999999999999774

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=6.1e-40  Score=319.16  Aligned_cols=252  Identities=29%  Similarity=0.474  Sum_probs=201.1

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc------ccHHHHHHHHHHHhccCCCCeeceeeE
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL------QGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~~~  207 (490)
                      +|.+.+.||.|+||.||+|...          ++..+|+|.+.....      .....+.+|+.+++.++|+||++++++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~----------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   70 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN----------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGT   70 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc----------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeE
Confidence            4888999999999999999763          456899998864421      122457889999999999999999999


Q ss_pred             EEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecc
Q 011250          208 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DF  287 (490)
                      +.+.+..++||||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+   |+|+||+|+||+++.++.++|+||
T Consensus        71 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df  146 (265)
T cd06631          71 CLDDNTISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDF  146 (265)
T ss_pred             eecCCeEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccc
Confidence            99999999999999999999998654 46899999999999999999999988   999999999999999999999999


Q ss_pred             cCcccCCCCC----cceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011250          288 GLAKDAPEDG----KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       288 G~a~~~~~~~----~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      |++.......    .........|+..|+|||++.+..++.++|||||||++|+|++|..||.............     
T Consensus       147 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-----  221 (265)
T cd06631         147 GCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG-----  221 (265)
T ss_pred             hhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhh-----
Confidence            9987653211    1111223568999999999998889999999999999999999999996432211100000     


Q ss_pred             cCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                        ...    ...+    ..+...+.++.++|.+||..+|.+||++.+++++
T Consensus       222 --~~~----~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         222 --AHR----GLMP----RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             --hcc----CCCC----CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence              000    0001    1122346789999999999999999999999864

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=4.4e-40  Score=323.42  Aligned_cols=264  Identities=27%  Similarity=0.366  Sum_probs=204.9

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      +|++.+.||.|+||.||+|.+..         +|..||+|++.....  ...+.+.+|+.+++.++||||+++++++..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRE---------TGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG   71 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECC---------CCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC
Confidence            48889999999999999999876         567899999876542  2346788999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      ...++||||+ +++|.+++......+++..++.++.||+.||.|||+.+   |+|+||||+||+++.++.++|+|||++.
T Consensus        72 ~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~  147 (286)
T cd07832          72 SGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLAR  147 (286)
T ss_pred             CeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecc
Confidence            9999999999 99999998766678999999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhccC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC-----
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-----  365 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~-----  365 (490)
                      ....... .......|+..|+|||++.+. .++.++|||||||++|||++|.++|........   .......+.     
T Consensus       148 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~  223 (286)
T cd07832         148 LFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEE  223 (286)
T ss_pred             cccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChH
Confidence            7654322 112235689999999988654 568999999999999999999888865432111   111100000     


Q ss_pred             ------CcchhhhccCCcc----CCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          366 ------DKRRFYRLLDPRL----EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 ------~~~~~~~~~~~~l----~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                            +......+..+..    ......+.+..+.+||.+||..||.+||++++++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         224 TWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             HHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                  0000000000000    000111236889999999999999999999999976

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=8.6e-40  Score=319.31  Aligned_cols=258  Identities=25%  Similarity=0.429  Sum_probs=202.2

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      |.+.+.||+|+||.||+|.+..++      +++..||||++....  ....+++.+|+++++.++||||+++++++....
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   74 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSED------GSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSR   74 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccC------CCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence            667889999999999999886532      267899999987543  233467889999999999999999999886542


Q ss_pred             ------ceEEEEEecCCCChhHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCC
Q 011250          213 ------QRLLVYEFMPRGSLENHLFRR-----SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       213 ------~~~lV~E~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                            ..++++||+.+|+|.+++...     ...+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.
T Consensus        75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~  151 (273)
T cd05074          75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMT  151 (273)
T ss_pred             CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCC
Confidence                  247899999999998887432     225788999999999999999999988   999999999999999999


Q ss_pred             eEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 011250          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       282 vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~  360 (490)
                      +||+|||+++...............++..|++||.+....++.++|||||||++|||++ |.+||......   .+..+.
T Consensus       152 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~  228 (273)
T cd05074         152 VCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYL  228 (273)
T ss_pred             EEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHH
Confidence            99999999987643322222223446678999999998889999999999999999999 88888643221   111111


Q ss_pred             hcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                      ..    ...          ...+...+..+.+|+.+||..+|++||++.++++.|+.+
T Consensus       229 ~~----~~~----------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         229 IK----GNR----------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             Hc----CCc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            10    000          011123367899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-40  Score=324.14  Aligned_cols=267  Identities=27%  Similarity=0.358  Sum_probs=204.4

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      +|++.+.||+|+||.||+|.+..         ++..||+|.++...  ....+.+.+|+++++.+.|+||+++++++..+
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~---------~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   72 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKA---------TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRK   72 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCC---------CCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEEC
Confidence            68899999999999999998876         56789999986542  23346789999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      +..++||||++++.|..++ .....+++..+..++.||+.||.|||+.+   |+||||+|+||+++.++.+||+|||++.
T Consensus        73 ~~~~iv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~  148 (288)
T cd07833          73 GRLYLVFEYVERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFAR  148 (288)
T ss_pred             CEEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeeccc
Confidence            9999999999886666554 44456899999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhccC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC----
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD----  366 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~----  366 (490)
                      ....... .......|+..|+|||++.+. .++.++||||||+++|+|++|++||..................+..    
T Consensus       149 ~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (288)
T cd07833         149 ALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQE  227 (288)
T ss_pred             ccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhh
Confidence            7654432 122346788999999999887 8899999999999999999999999754321111100000000000    


Q ss_pred             ----cc-----hhhhccCC-ccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          367 ----KR-----RFYRLLDP-RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       367 ----~~-----~~~~~~~~-~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                          ..     .+....++ .+...++...+.++.+||++||..||++||++++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         228 LFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             hcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence                00     00000000 00111222347889999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4.1e-40  Score=325.23  Aligned_cols=246  Identities=29%  Similarity=0.423  Sum_probs=203.7

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|++.+.||+|+||.||++.+..         ++..||+|++.....   ...+.+.+|+++++.+.||||+++++++.
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   71 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKG---------SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ   71 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE
Confidence            368899999999999999999876         567899999865432   23456889999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +++..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+   |+||||+|+|||++.++.+||+|||+
T Consensus        72 ~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~  147 (290)
T cd05580          72 DDSNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGF  147 (290)
T ss_pred             cCCeEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCC
Confidence            999999999999999999998655 57999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +......     .....|++.|+|||.+.+..++.++||||||+++|+|++|..||......   ......   ....  
T Consensus       148 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~---~~~~--  214 (290)
T cd05580         148 AKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---QIYEKI---LEGK--  214 (290)
T ss_pred             ccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH---hcCC--
Confidence            9876543     23357899999999998888899999999999999999999999654311   111100   0000  


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----t~~evl~~  414 (490)
                                ..++...+..+.++|.+||..||.+|+     ++++++++
T Consensus       215 ----------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         215 ----------VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             ----------ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence                      011222367889999999999999998     77777754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.5e-40  Score=317.93  Aligned_cols=255  Identities=24%  Similarity=0.409  Sum_probs=204.0

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc------ccHHHHHHHHHHHhccCCCCeeceeeE
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL------QGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~~~  207 (490)
                      +|+..+.||+|+||.||+|....         ++..||+|.+.....      ...+.+.+|+.+++.++|+||++++++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   71 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVK---------TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGA   71 (268)
T ss_pred             CccccceecCcCceEEEEEEEcC---------CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhce
Confidence            47888999999999999998765         567899999875431      124578899999999999999999999


Q ss_pred             EEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-CeEEec
Q 011250          208 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSD  286 (490)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-~vkL~D  286 (490)
                      +.+.+..++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+   |+||||+|+||+++.++ .++|+|
T Consensus        72 ~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~d  147 (268)
T cd06630          72 TCEDSHFNLFVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIAD  147 (268)
T ss_pred             eccCCeEEEEEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcc
Confidence            99999999999999999999998554 47899999999999999999999988   99999999999998776 599999


Q ss_pred             ccCcccCCCCCcc--eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc
Q 011250          287 FGLAKDAPEDGKT--HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       287 FG~a~~~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      ||++.........  .......|+..|+|||++.+..++.++||||||+++|+|++|..||.............      
T Consensus       148 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------  221 (268)
T cd06630         148 FGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF------  221 (268)
T ss_pred             cccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHH------
Confidence            9998776432111  11223568999999999988889999999999999999999999996433211111110      


Q ss_pred             CCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                             ..........++...+.++.+++.+||..||.+||++.+++++
T Consensus       222 -------~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         222 -------KIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             -------HHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence                   0000011122333447889999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.1e-39  Score=317.93  Aligned_cols=252  Identities=27%  Similarity=0.397  Sum_probs=198.4

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-----ccHHHHHHHHHHHhccCCCCeeceeeE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~  207 (490)
                      .+|.+.+.||+|+||.||+|.+..         ++..||+|.+.....     ...+.+.+|+.+++.++||||++++++
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   72 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVD---------TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGC   72 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcC---------CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEE
Confidence            368999999999999999998865         567899998864421     223467889999999999999999998


Q ss_pred             EEeC--CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEe
Q 011250          208 CIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       208 ~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~  285 (490)
                      +.+.  ...+++|||+++++|.+++... ..+++...+.++.|++.||.|||+.+   |+||||||+||+++.++.++|+
T Consensus        73 ~~~~~~~~~~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~  148 (266)
T cd06651          73 LRDRAEKTLTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLG  148 (266)
T ss_pred             EEcCCCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEc
Confidence            8763  5678999999999999998654 36899999999999999999999988   9999999999999999999999


Q ss_pred             cccCcccCCCCCcc-eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc
Q 011250          286 DFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       286 DFG~a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      |||+++........ .......|+..|+|||++.+..++.++|||||||++|||++|+.||........     ...   
T Consensus       149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~-----~~~---  220 (266)
T cd06651         149 DFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA-----IFK---  220 (266)
T ss_pred             cCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH-----HHH---
Confidence            99998765321111 111235689999999999888899999999999999999999999964321110     000   


Q ss_pred             CCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                              .........++...+..+.+|+ +||..+|++||++++|+++
T Consensus       221 --------~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         221 --------IATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             --------HhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence                    0000001122233466778888 6888999999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-40  Score=326.98  Aligned_cols=254  Identities=29%  Similarity=0.377  Sum_probs=204.0

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|++.+.||+|+||.||+|....         ++..||||.+......   ..+.+..|+++++.+.|+||+++++++.
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   71 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKG---------TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ   71 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcC---------CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee
Confidence            368899999999999999998875         5678999999765433   3456889999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      +....++||||+.+++|.+++... ...+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.++|+|||
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg  148 (316)
T cd05574          72 TETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFD  148 (316)
T ss_pred             cCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecc
Confidence            999999999999999999998653 357899999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCcc---------------------------eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhC
Q 011250          289 LAKDAPEDGKT---------------------------HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG  341 (490)
Q Consensus       289 ~a~~~~~~~~~---------------------------~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG  341 (490)
                      ++.........                           .......||..|+|||++.+..++.++||||||+++|+|++|
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g  228 (316)
T cd05574         149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG  228 (316)
T ss_pred             hhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhC
Confidence            98754322110                           011234689999999999988899999999999999999999


Q ss_pred             CCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCC----HHHHHHH
Q 011250          342 RRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR----MSEVVET  414 (490)
Q Consensus       342 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt----~~evl~~  414 (490)
                      ..||........  +..              +.............+..+.+||.+||..||++||+    +.+++.+
T Consensus       229 ~~pf~~~~~~~~--~~~--------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         229 TTPFKGSNRDET--FSN--------------ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             CCCCCCCchHHH--HHH--------------HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            999965432111  110              11100000001113788999999999999999999    7776654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.9e-40  Score=320.00  Aligned_cols=256  Identities=26%  Similarity=0.422  Sum_probs=201.6

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc----------cHHHHHHHHHHHhccCCCCeec
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ----------GHKEWLAEVNFLGNLLHPNLVK  203 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~~Ei~il~~l~HpnIv~  203 (490)
                      +|.+.+.||.|+||.||+|....         ++..||+|.+......          ..+.+..|+.+++.++|+||++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~   72 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVT---------TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQ   72 (272)
T ss_pred             ceeecceecccCceEEEEEeecC---------CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcce
Confidence            47888999999999999998765         5678999988542110          1245778999999999999999


Q ss_pred             eeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeE
Q 011250          204 LVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       204 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vk  283 (490)
                      +++++...+..++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+   ++||||+|+||+++.++.++
T Consensus        73 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~  148 (272)
T cd06629          73 YLGFETTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICK  148 (272)
T ss_pred             EEEEeccCCceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEE
Confidence            999999999999999999999999998655 47899999999999999999999988   99999999999999999999


Q ss_pred             EecccCcccCCCCCcceeeeccccCCCccCcchhccCC--CCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011250          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH--LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~--~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~  361 (490)
                      |+|||++................|+..|+|||.+....  ++.++||||||+++|+|++|..||.......  ...+...
T Consensus       149 l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~  226 (272)
T cd06629         149 ISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA--AMFKLGN  226 (272)
T ss_pred             EeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH--HHHHhhc
Confidence            99999997654322111223356899999999987654  8899999999999999999999995322110  0000000


Q ss_pred             cccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                          .      ...+.+........+..+.+|+.+||..||.+||++.+|+++
T Consensus       227 ----~------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         227 ----K------RSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             ----c------ccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence                0      000111111112336889999999999999999999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-41  Score=328.90  Aligned_cols=256  Identities=31%  Similarity=0.447  Sum_probs=213.1

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceee
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVG  206 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~  206 (490)
                      +..+.|+.-++||+|+||.||-++.+.         +|+.+|+|.+.+...   ....-.++|-.||..++.+.||.+--
T Consensus       182 vt~n~F~~~RvlGkGGFGEV~acqvra---------TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaY  252 (591)
T KOG0986|consen  182 VTKNTFRVYRVLGKGGFGEVCACQVRA---------TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAY  252 (591)
T ss_pred             ccccceeeeEEEecccccceeEEEEec---------chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEee
Confidence            334679999999999999999998886         888999999865533   23345788999999999999999999


Q ss_pred             EEEeCCceEEEEEecCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEe
Q 011250          207 YCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~  285 (490)
                      +|+..+.+||||..|.||+|.-+|...+ ..|++..+..++.+|+.||++||...   ||+|||||+|||||+.|+++|+
T Consensus       253 AfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRIS  329 (591)
T KOG0986|consen  253 AFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRIS  329 (591)
T ss_pred             eecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEee
Confidence            9999999999999999999999987654 46999999999999999999999988   9999999999999999999999


Q ss_pred             cccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011250          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      |+|+|..+.+....   ...+||.+|||||+++++.|+...|+|||||+||||+.|+.||..........-++  +..+.
T Consensus       330 DLGLAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd--rr~~~  404 (591)
T KOG0986|consen  330 DLGLAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD--RRTLE  404 (591)
T ss_pred             ccceEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH--HHHhc
Confidence            99999988765332   33489999999999999999999999999999999999999997654433221111  11111


Q ss_pred             CcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011250          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  414 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt-----~~evl~~  414 (490)
                      +            ...|+.+.++++.+|++.+|++||.+|.-     +.+|.+|
T Consensus       405 ~------------~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H  446 (591)
T KOG0986|consen  405 D------------PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH  446 (591)
T ss_pred             c------------hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence            1            23455556899999999999999999965     4455554

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-40  Score=337.52  Aligned_cols=249  Identities=24%  Similarity=0.341  Sum_probs=210.5

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc--HHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      ....|.+...||+|.|++|.+|++..         ++..||||.+.+.....  ...+.+|+++|..|+|||||+++.+.
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~---------t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~  124 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHIL---------TGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI  124 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecC---------CCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence            34579999999999999999999987         67799999998875543  24588999999999999999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      +....+|+||||+.+|.++++|.+.+ ...+..+..++.|+..|++|||+++   |||||||++||||+.+.++||+|||
T Consensus       125 ~t~~~lylV~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfg  200 (596)
T KOG0586|consen  125 ETEATLYLVMEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFG  200 (596)
T ss_pred             eecceeEEEEEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccc
Confidence            99999999999999999999997776 4555888999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhccCCC-CccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      ++..+...   ......||++.|.|||++++..| ++.+|+||+|++||-|+.|..||++..-.....            
T Consensus       201 fS~~~~~~---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~------------  265 (596)
T KOG0586|consen  201 FSTFFDYG---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP------------  265 (596)
T ss_pred             cceeeccc---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc------------
Confidence            99987643   33456899999999999998766 478999999999999999999998653221111            


Q ss_pred             chhhhccCCccCCCC--ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          368 RRFYRLLDPRLEGHF--SIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~--~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                              +.+.+.+  +.-.+.++.+||+++|..+|.+|++++++.++-
T Consensus       266 --------rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~  307 (596)
T KOG0586|consen  266 --------RVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR  307 (596)
T ss_pred             --------hheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence                    1111111  122377899999999999999999999987653

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.4e-39  Score=316.87  Aligned_cols=252  Identities=26%  Similarity=0.370  Sum_probs=199.4

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-----cccHHHHHHHHHHHhccCCCCeeceeeE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~l~~~  207 (490)
                      .+|++.+.||+|+||.||+|.+..         ++..||||.+....     ....+.+.+|+.+++.+.||||++++++
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   72 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDAD---------TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGC   72 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcC---------CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeE
Confidence            478999999999999999998875         57789999886432     1223567889999999999999999998


Q ss_pred             EEeC--CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEe
Q 011250          208 CIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       208 ~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~  285 (490)
                      +.+.  ..+++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+   |+|+||||+|||++.++.++|+
T Consensus        73 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~  148 (265)
T cd06652          73 LRDPMERTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLG  148 (265)
T ss_pred             eccCCCceEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEEC
Confidence            8764  4678999999999999998654 46889999999999999999999988   9999999999999999999999


Q ss_pred             cccCcccCCCCCcc-eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc
Q 011250          286 DFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       286 DFG~a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      |||+++........ .......|+..|+|||++.+..++.++|||||||++|||++|+.||......     ..... . 
T Consensus       149 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~~~~-~-  221 (265)
T cd06652         149 DFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-----AAIFK-I-  221 (265)
T ss_pred             cCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-----HHHHH-H-
Confidence            99998765321111 1112356899999999998888999999999999999999999999643111     00000 0 


Q ss_pred             CCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                               .........+...+..+.+++.+|| .+|.+||++++|+++
T Consensus       222 ---------~~~~~~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~  261 (265)
T cd06652         222 ---------ATQPTNPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLRH  261 (265)
T ss_pred             ---------hcCCCCCCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhcC
Confidence                     0000111223344678899999999 499999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=9e-40  Score=322.54  Aligned_cols=265  Identities=24%  Similarity=0.364  Sum_probs=200.1

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      ++|++.+.||.|+||.||+|....         ++..||||.+...... ....+.+|+.+++.++|+||+++++++.++
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   75 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKL---------TGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTK   75 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcC---------CCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecC
Confidence            579999999999999999998865         5668999998654322 234567899999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      +..++||||+. ++|.+++.+....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        76 ~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~  151 (291)
T cd07844          76 KTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLAR  151 (291)
T ss_pred             CeEEEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccc
Confidence            99999999997 5999988766667899999999999999999999988   9999999999999999999999999987


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC--cc
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD--KR  368 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~--~~  368 (490)
                      ........  .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||........  ........+..  ..
T Consensus       152 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~  227 (291)
T cd07844         152 AKSVPSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTEE  227 (291)
T ss_pred             ccCCCCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCChh
Confidence            54322111  122357889999998875 4688999999999999999999999965431110  00000000000  00


Q ss_pred             hh-------------hhccC-CccCCCC-ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          369 RF-------------YRLLD-PRLEGHF-SIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       369 ~~-------------~~~~~-~~l~~~~-~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .+             ..... ..+.... .......+.+++.+||+.||.+||++.+++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         228 TWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             hhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence            00             00000 0000000 01113778999999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.4e-40  Score=326.50  Aligned_cols=249  Identities=27%  Similarity=0.394  Sum_probs=201.8

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCCce
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQR  214 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  214 (490)
                      |.....||+|+||.||++.+..         ++..||||.+........+.+.+|+.+++.++|+||+++++.+...+..
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~   94 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKH---------TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDEL   94 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECC---------CCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeE
Confidence            4445679999999999998765         5678999998765555566788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCC
Q 011250          215 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~  294 (490)
                      ++||||+++++|.+++..  ..+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.++|+|||++....
T Consensus        95 ~lv~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~  169 (292)
T cd06658          95 WVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVS  169 (292)
T ss_pred             EEEEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcc
Confidence            999999999999998743  35899999999999999999999988   9999999999999999999999999987653


Q ss_pred             CCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhcc
Q 011250          295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  374 (490)
Q Consensus       295 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (490)
                      ....  ......|+..|+|||++.+..++.++|||||||++|||++|..||........   .....          ..+
T Consensus       170 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~~~~~----------~~~  234 (292)
T cd06658         170 KEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA---MRRIR----------DNL  234 (292)
T ss_pred             cccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH----------hcC
Confidence            3221  12235689999999999888899999999999999999999999965322111   11000          011


Q ss_pred             CCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       375 ~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .+.+..  ....+..+.+++.+||..||.+|||+.+++++
T Consensus       235 ~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         235 PPRVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             CCcccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            111111  11236678999999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=7.3e-40  Score=318.23  Aligned_cols=255  Identities=31%  Similarity=0.430  Sum_probs=206.1

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      ++|++.+.||.|+||.||+|.+..         ++..||+|.+..... ...+++.+|+++++.+.||||+++++++..+
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRP---------TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN   71 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcC---------CCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC
Confidence            367888999999999999999875         567899999876532 3446788999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      ...++||||+++++|.+++......+++..+..++.|++.||.|||+ .+   ++|+||||+||+++.++.++|+|||.+
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~  148 (265)
T cd06605          72 GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVS  148 (265)
T ss_pred             CEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence            99999999999999999997655689999999999999999999999 77   999999999999999999999999998


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ........    ....|+..|+|||.+.+..++.++||||||+++|+|++|..||......... ..+........    
T Consensus       149 ~~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~----  219 (265)
T cd06605         149 GQLVNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-IFELLQYIVNE----  219 (265)
T ss_pred             hhhHHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-HHHHHHHHhcC----
Confidence            76532211    1267899999999999889999999999999999999999999654221111 11111111100    


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                         ..+.+..   ...+..+.+||.+||..||.+|||+.+++.+
T Consensus       220 ---~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         220 ---PPPRLPS---GKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             ---CCCCCCh---hhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence               0001100   1146789999999999999999999999865

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.8e-40  Score=324.05  Aligned_cols=267  Identities=28%  Similarity=0.377  Sum_probs=202.0

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ++|++.+.||+|+||.||+|.+..         ++..||+|.+......  ..+.+.+|+++++.++||||+++++++..
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   71 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKE---------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR   71 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECC---------CCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc
Confidence            368899999999999999999875         5678999998654322  34568899999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      ++..++||||+++++|..+... ...+++..++.++.||+.||.|||+.+   |+||||+|+||++++++.++|+|||++
T Consensus        72 ~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~  147 (286)
T cd07846          72 KKRLYLVFEFVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFA  147 (286)
T ss_pred             CCeEEEEEecCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeee
Confidence            9999999999999888876643 345899999999999999999999988   999999999999999999999999998


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcch-hhHhhhcccCCcc
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPHLGDKR  368 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~-~~~~~~~~~~~~~  368 (490)
                      ........  ......|+..|+|||++.+ ..++.++|||||||++|||++|++||.......... +..+.........
T Consensus       148 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (286)
T cd07846         148 RTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQ  225 (286)
T ss_pred             eeccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhH
Confidence            86544321  1233568899999998875 457889999999999999999999996543211100 0000000000000


Q ss_pred             hh-------hhccCCccCC-----CCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          369 RF-------YRLLDPRLEG-----HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       369 ~~-------~~~~~~~l~~-----~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ..       .....+....     ......+..+.+|+.+||..||.+||++.+++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         226 EIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             HHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            00       0000000000     0011336789999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.2e-39  Score=314.93  Aligned_cols=249  Identities=30%  Similarity=0.452  Sum_probs=203.0

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-----ccHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      +|+..+.||+|+||.||+|....         ++..|++|.+.....     ...+.+.+|+.+++.++|+||+++++++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~   71 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLD---------DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE   71 (258)
T ss_pred             CccccceeeecCCceEEEEEEcC---------CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE
Confidence            47788999999999999998875         466899999865431     2346788999999999999999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      .++...++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+   |+|+||+|+||+++.++.+||+|||
T Consensus        72 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~  147 (258)
T cd06632          72 REEDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFG  147 (258)
T ss_pred             ecCCeEEEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCc
Confidence            9999999999999999999998654 46899999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhccCC-CCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      ++.......   ......|+..|+|||.+.... ++.++|+|||||++|+|++|+.||........  ......  ..  
T Consensus       148 ~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~--~~--  218 (258)
T cd06632         148 MAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA--VFKIGR--SK--  218 (258)
T ss_pred             cceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH--HHHHHh--cc--
Confidence            988764432   123456899999999987766 89999999999999999999999965431111  000000  00  


Q ss_pred             chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                                ....++...+..+.+|+.+||..||.+||++.+++.+
T Consensus       219 ----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         219 ----------ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             ----------cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence                      0011222346888999999999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.6e-39  Score=314.98  Aligned_cols=250  Identities=25%  Similarity=0.367  Sum_probs=203.3

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEe-
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE-  210 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-  210 (490)
                      +|++.+.||.|+||.||+|.+..         ++..||+|.+.....  ...+.+..|+.+++.++|+||+++++++.. 
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKS---------DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR   71 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecC---------CCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC
Confidence            48889999999999999998876         566899999875433  234568889999999999999999998764 


Q ss_pred             -CCceEEEEEecCCCChhHHhhhc---CCCCCHHHHHHHHHHHHHHHHHhh-----hcCCCCeeecCCCCCcEEEcCCCC
Q 011250          211 -DDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLH-----EEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       211 -~~~~~lV~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH-----~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                       ....+++|||+++++|.+++...   ...+++..++.++.||+.||.|||     +.+   |+|+||+|+||+++.++.
T Consensus        72 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~  148 (265)
T cd08217          72 SNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNN  148 (265)
T ss_pred             CCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCC
Confidence             34678999999999999998653   457999999999999999999999     655   999999999999999999


Q ss_pred             eEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011250          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       282 vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~  361 (490)
                      +||+|||++.........  .....|+..|+|||.+....++.++||||||+++|+|++|..||.....   ..+.....
T Consensus       149 ~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~  223 (265)
T cd08217         149 VKLGDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLASKIK  223 (265)
T ss_pred             EEEecccccccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHHHHHh
Confidence            999999999876543321  2335689999999999988899999999999999999999999975431   11111111


Q ss_pred             cccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .              .....++...+..+.+|+.+||..+|.+||++.+|+++
T Consensus       224 ~--------------~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         224 E--------------GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             c--------------CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            0              00111223346889999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.5e-39  Score=315.96  Aligned_cols=254  Identities=23%  Similarity=0.367  Sum_probs=191.6

Q ss_pred             ccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEEEeCCceEEEE
Q 011250          140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVY  218 (490)
Q Consensus       140 ~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~  218 (490)
                      .||+|+||.||+|......       ....+++|.+.... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~   74 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDT-------GVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVF   74 (268)
T ss_pred             cCCCCcCceEEEEEEEcCC-------CcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEE
Confidence            5999999999999765422       23457788776543 234567999999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhcC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCC
Q 011250          219 EFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE  295 (490)
Q Consensus       219 E~~~~gsL~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~  295 (490)
                      ||+++|+|.+++.+..   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.++|+|||++.....
T Consensus        75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~  151 (268)
T cd05086          75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK  151 (268)
T ss_pred             ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCc
Confidence            9999999999986532   34667778899999999999999988   99999999999999999999999999865332


Q ss_pred             CCcceeeeccccCCCccCcchhcc-------CCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCc
Q 011250          296 DGKTHVSTRVMGTYGYAAPEYVMT-------GHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       296 ~~~~~~~~~~~Gt~~y~aPE~l~~-------~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      ..........+|+..|+|||++..       ..++.++|||||||++|||++ |..||......   ......   +.. 
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~~~---~~~-  224 (268)
T cd05086         152 EDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR---EVLNHV---IKD-  224 (268)
T ss_pred             chhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH---Hhh-
Confidence            222222234678999999998753       245789999999999999997 56677543221   111110   000 


Q ss_pred             chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011250          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~  416 (490)
                       ......++.+...    .+..+.+|+..|| .+|++||++.+|++.|.
T Consensus       225 -~~~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         225 -QQVKLFKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             -cccccCCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence             0111222322222    3677889999999 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.3e-39  Score=314.97  Aligned_cols=250  Identities=26%  Similarity=0.381  Sum_probs=204.4

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      +|++.+.||+|+||.||++....         ++..||+|.+....  ....+++.+|+.+++.++||||+++++++...
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKE---------DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN   71 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcC---------CCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC
Confidence            48889999999999999999876         56689999986542  23346788999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      +..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+   ++|+||+|+|||++.++.++|+|||++
T Consensus        72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~  148 (256)
T cd08218          72 GNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIA  148 (256)
T ss_pred             CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccce
Confidence            9999999999999999988653 346899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      .........  .....|++.|+|||++.+..++.++|||||||++|+|++|..||......   ....   ......   
T Consensus       149 ~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~---~~~~---~~~~~~---  217 (256)
T cd08218         149 RVLNSTVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK---NLVL---KIIRGS---  217 (256)
T ss_pred             eecCcchhh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH---HHHH---HHhcCC---
Confidence            765432211  12346889999999998888999999999999999999999998643211   1110   000000   


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                              ....+...+.++.++|.+||+.+|.+||++.+|+++
T Consensus       218 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         218 --------YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             --------CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence                    001122346789999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.3e-39  Score=315.08  Aligned_cols=246  Identities=30%  Similarity=0.466  Sum_probs=198.5

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      .+|.+.+.||+|+||.||+|..           ++..||+|.+....  ....+.+|+.+++.++||||+++++++..+ 
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-----------~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-   71 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-----------TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-   71 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-----------CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-
Confidence            4588999999999999999864           35579999986543  345788999999999999999999998764 


Q ss_pred             ceEEEEEecCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      ..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.
T Consensus        72 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~  148 (254)
T cd05083          72 GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLAR  148 (254)
T ss_pred             CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccce
Confidence            5799999999999999986543 35899999999999999999999988   9999999999999999999999999987


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ......     .....+..|+|||.+.+..++.++|||||||++|||++ |+.||.......   .......    .   
T Consensus       149 ~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~----~---  213 (254)
T cd05083         149 VGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE---VKECVEK----G---  213 (254)
T ss_pred             eccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH---HHHHHhC----C---
Confidence            643221     12234578999999988899999999999999999997 999996543221   1111100    0   


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  417 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~  417 (490)
                             .....+...+..+.+|+.+||+.+|.+||++.++++.|+.
T Consensus       214 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         214 -------YRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -------CCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence                   0011122346788999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.2e-39  Score=322.75  Aligned_cols=263  Identities=26%  Similarity=0.358  Sum_probs=201.9

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-----cHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-----GHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      +|.+.+.||+|+||.||+|.+..         ++..||||.+......     ....+..|+.+++.++|+||+++++++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~   71 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKE---------TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF   71 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECC---------CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee
Confidence            47888999999999999999875         5678999999765432     234577899999999999999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      .+.+..++||||+ +++|.+++......+++..++.++.||++||.|||+.+   |+|+||||+|||++.++.++|+|||
T Consensus        72 ~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg  147 (298)
T cd07841          72 GHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFG  147 (298)
T ss_pred             ecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccce
Confidence            9999999999999 99999998655447999999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC-
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD-  366 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~-  366 (490)
                      ++.........  .....+++.|+|||.+.+ ..++.++|||||||++|||++|.++|.........  ..... .+.. 
T Consensus       148 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~--~~~~~-~~~~~  222 (298)
T cd07841         148 LARSFGSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL--GKIFE-ALGTP  222 (298)
T ss_pred             eeeeccCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH--HHHHH-HcCCC
Confidence            99876543221  122456889999998864 46789999999999999999998888654322111  00000 0000 


Q ss_pred             -cchh---h---hccCCccC-----CCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          367 -KRRF---Y---RLLDPRLE-----GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       367 -~~~~---~---~~~~~~l~-----~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                       ...+   .   ........     .......+..+.+||.+||..||++||++.+++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         223 TEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             chhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence             0000   0   00000000     00112236789999999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=7.2e-40  Score=324.95  Aligned_cols=249  Identities=25%  Similarity=0.387  Sum_probs=201.9

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCCce
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQR  214 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  214 (490)
                      |.....||+|+||.||+|.+..         ++..||+|.+........+.+.+|+.++..+.||||+++++++..++..
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~   93 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKH---------SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEEL   93 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcC---------CCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeE
Confidence            4455679999999999998865         5668999998765545566788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCC
Q 011250          215 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~  294 (490)
                      ++||||+++++|..++..  ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++....
T Consensus        94 ~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~  168 (297)
T cd06659          94 WVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQIS  168 (297)
T ss_pred             EEEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcc
Confidence            999999999999987743  36899999999999999999999988   9999999999999999999999999987654


Q ss_pred             CCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhcc
Q 011250          295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  374 (490)
Q Consensus       295 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (490)
                      ....  ......|+..|+|||++.+..++.++|||||||++|||++|..||........   ........          
T Consensus       169 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~~~~~~~~----------  233 (297)
T cd06659         169 KDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MKRLRDSP----------  233 (297)
T ss_pred             cccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHhccC----------
Confidence            3221  12335789999999999988999999999999999999999999964332111   11110000          


Q ss_pred             CCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       375 ~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .+..  ......+..+.++|.+||+.+|.+||++.+++++
T Consensus       234 ~~~~--~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         234 PPKL--KNAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCCc--cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0000  0111235778999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.9e-39  Score=313.39  Aligned_cols=249  Identities=26%  Similarity=0.386  Sum_probs=203.4

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      +|++.+.||+|+||.||+|....         ++..||||.+.....  ...+.+.+|+.+++.++||||+++++.+..+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKA---------DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED   71 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcC---------CCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC
Confidence            48889999999999999998876         567899999876532  3346788999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-CCeEEecccC
Q 011250          212 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAKLSDFGL  289 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~-~~vkL~DFG~  289 (490)
                      +..++||||+++++|.+++... ...+++..+..++.|++.+|.|||+++   |+|+||+|+||+++.+ +.++|+|||+
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~  148 (256)
T cd08220          72 KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGI  148 (256)
T ss_pred             CEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCC
Confidence            9999999999999999999764 345899999999999999999999988   9999999999999855 4689999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +........   .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||.......   ........      
T Consensus       149 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~~~~------  216 (256)
T cd08220         149 SKILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LVLKIMSG------  216 (256)
T ss_pred             ceecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HHHHHHhc------
Confidence            987654322   123568999999999988889999999999999999999999996543211   11111000      


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                              ....++...+..+.+++.+||..||.+|||+.+++++
T Consensus       217 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         217 --------TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             --------CCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                    0001122346789999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.4e-39  Score=321.39  Aligned_cols=268  Identities=24%  Similarity=0.330  Sum_probs=200.6

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      +.+|.+.+.||+|+||.||+|....         ++..||+|.+...... ....+.+|+.+++.++|+||+++++++..
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~   74 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRI---------NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT   74 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcC---------CCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec
Confidence            4679999999999999999998876         5668999998755322 23467789999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      ++..++||||+. ++|.+++......+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.++|+|||++
T Consensus        75 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~  150 (291)
T cd07870          75 KETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLA  150 (291)
T ss_pred             CCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccc
Confidence            999999999995 7887777665556888899999999999999999988   999999999999999999999999998


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc-
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR-  368 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~-  368 (490)
                      +........  .....++..|+|||++.+ ..++.++|||||||++|+|++|..||.......+.....+......... 
T Consensus       151 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  228 (291)
T cd07870         151 RAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDT  228 (291)
T ss_pred             cccCCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhh
Confidence            764332211  123457899999998875 3578899999999999999999999975432111000000000000000 


Q ss_pred             ------------hhhhccCC-ccCCCC-ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          369 ------------RFYRLLDP-RLEGHF-SIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       369 ------------~~~~~~~~-~l~~~~-~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                                  .+.....+ .+.... ....+..+.+|+.+||..||.+|||+.+++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         229 WPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             hhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence                        00000000 000000 01125678999999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.2e-39  Score=324.38  Aligned_cols=256  Identities=23%  Similarity=0.325  Sum_probs=201.4

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|.+.+.||+|+||.||++.+..         ++..||+|.+.....   .....+.+|+++++.++||||+++++++.
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   71 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKE---------TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE   71 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECC---------CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe
Confidence            368899999999999999999876         567899999876532   23356789999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      .++..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||+
T Consensus        72 ~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~  147 (305)
T cd05609          72 TKRHLCMVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGL  147 (305)
T ss_pred             cCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCC
Confidence            999999999999999999998554 47899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCc-------------ceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchh
Q 011250          290 AKDAPEDGK-------------THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL  356 (490)
Q Consensus       290 a~~~~~~~~-------------~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~  356 (490)
                      ++.......             ........|+..|+|||.+....++.++|||||||++|||++|..||.......   +
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~---~  224 (305)
T cd05609         148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---L  224 (305)
T ss_pred             ccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H
Confidence            864211100             001122467889999999988889999999999999999999999996432211   1


Q ss_pred             hHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011250          357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~  416 (490)
                      ....   ....     ...+..    ....+..+.+||.+||+.||++||++.++++.|+
T Consensus       225 ~~~~---~~~~-----~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         225 FGQV---ISDD-----IEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             HHHH---Hhcc-----cCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence            1100   0000     000100    0123678999999999999999999655555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.8e-39  Score=313.52  Aligned_cols=253  Identities=27%  Similarity=0.403  Sum_probs=209.5

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      ++|++.+.||.|+||.||+|.+..         ++..|+||++..... .....+.+|+.++..++|+||+++++++...
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKP---------TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE   71 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcC---------CCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC
Confidence            368899999999999999999876         577899999876644 3456789999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      +..++||||+++++|.+++... ..+++..++.++.|+++||.|||+ .+   ++||||+|+||+++.++.++|+|||++
T Consensus        72 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~  147 (264)
T cd06623          72 GEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGIS  147 (264)
T ss_pred             CeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccc
Confidence            9999999999999999998654 579999999999999999999999 88   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ..........  ....|+..|+|||.+.+..++.++||||||+++|+|++|..||..........+.......       
T Consensus       148 ~~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-------  218 (264)
T cd06623         148 KVLENTLDQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG-------  218 (264)
T ss_pred             eecccCCCcc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC-------
Confidence            8765432221  2356899999999999889999999999999999999999999765431211222111100       


Q ss_pred             hhccCCccCCCCChh-hHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          371 YRLLDPRLEGHFSIK-GSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~-~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                             .....+.. .+..+.++|.+||..+|++||++.+++++
T Consensus       219 -------~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         219 -------PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             -------CCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                   00111122 46789999999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.9e-39  Score=320.34  Aligned_cols=260  Identities=29%  Similarity=0.398  Sum_probs=203.6

Q ss_pred             hhhHHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcc-CCCCeec
Q 011250          125 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVK  203 (490)
Q Consensus       125 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~  203 (490)
                      ..++....++|.+.+.||+|+||.||+|....         ++..+|+|++.... .....+.+|+.++..+ .||||++
T Consensus        14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~---------~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~   83 (291)
T cd06639          14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKK---------DGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVK   83 (291)
T ss_pred             cccCCCCCCCeEEEEEeecCCCeEEEEEEECC---------CCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEE
Confidence            34445567889999999999999999998865         56789999986542 2235677899999999 7999999


Q ss_pred             eeeEEEeC-----CceEEEEEecCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 011250          204 LVGYCIED-----DQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  275 (490)
Q Consensus       204 l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NIL  275 (490)
                      +++++...     +..++||||+++++|.+++..   ....+++..++.++.|++.||.|||+.+   |+||||||+||+
T Consensus        84 ~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nil  160 (291)
T cd06639          84 FYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNIL  160 (291)
T ss_pred             EEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEE
Confidence            99998754     358999999999999998753   3457899999999999999999999988   999999999999


Q ss_pred             EcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccC-----CCCccchhhHHHHHHHHHHhCCCCCCCCCC
Q 011250          276 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-----HLTSKSDVYSFGVVLLEMLTGRRSMDKNRP  350 (490)
Q Consensus       276 l~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-----~~~~~sDvwSlGv~l~elltG~~pf~~~~~  350 (490)
                      ++.++.+||+|||++.........  .....|+..|+|||++...     .++.++|||||||++|||++|+.||.....
T Consensus       161 i~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~  238 (291)
T cd06639         161 LTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP  238 (291)
T ss_pred             EcCCCCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH
Confidence            999999999999998865432211  1235689999999987643     368899999999999999999999965322


Q ss_pred             CCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          351 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ..  .+..+....           .+.+  ..+......+.+||.+||+.||++||++.+++++
T Consensus       239 ~~--~~~~~~~~~-----------~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         239 VK--TLFKIPRNP-----------PPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             HH--HHHHHhcCC-----------CCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            11  111111000           0000  0112235679999999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.6e-39  Score=321.22  Aligned_cols=267  Identities=26%  Similarity=0.370  Sum_probs=203.1

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ++|++.+.||.|+||.||+|.+..         ++..||+|.++.....  ....+.+|+.++..++||||+++++++..
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~   75 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKK---------TGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG   75 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECC---------CCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEe
Confidence            468899999999999999999875         5678999999754322  22356789999999999999999999988


Q ss_pred             C--CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          211 D--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       211 ~--~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      .  +..||||||+. ++|.+++......+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.++|+|||
T Consensus        76 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g  151 (293)
T cd07843          76 SNLDKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFG  151 (293)
T ss_pred             cCCCcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecC
Confidence            7  88999999996 5999988766557999999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhccC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhh-Hhhh-c---
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWAR-P---  362 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~-~~~~-~---  362 (490)
                      ++.........  .....+++.|+|||.+.+. .++.++||||||+++|+|++|.+||...........+ .... +   
T Consensus       152 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  229 (293)
T cd07843         152 LAREYGSPLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEK  229 (293)
T ss_pred             ceeeccCCccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Confidence            99876543211  1234678999999988754 4689999999999999999999999754321111000 0000 0   


Q ss_pred             ------ccCCc--chhhhccCCccCCCCChh-hHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          363 ------HLGDK--RRFYRLLDPRLEGHFSIK-GSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       363 ------~~~~~--~~~~~~~~~~l~~~~~~~-~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                            .+...  ..+.......+...++.. .+..+.+||.+||+.||++|||+.|++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         230 IWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             HHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence                  00000  000000111112222222 37789999999999999999999999865

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=9.1e-40  Score=316.65  Aligned_cols=249  Identities=26%  Similarity=0.346  Sum_probs=205.6

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      +|++.+.||.|+||.||+|.+..         ++..||+|.+.....   ...+.+.+|++++++++||||+++++++.+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   71 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRD---------TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD   71 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEcc---------CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC
Confidence            48889999999999999998875         567899999975432   335678999999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      +...++||||+.+++|.+++... ..+++..+..++.||++||.|||+.+   |+|+||+|+||++++++.++|+|||++
T Consensus        72 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~  147 (258)
T cd05578          72 EENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIA  147 (258)
T ss_pred             CCeEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccc
Confidence            99999999999999999998655 57999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ........   .....|+..|+|||++.+..++.++|+||||+++|+|++|..||..........+.....    .    
T Consensus       148 ~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----~----  216 (258)
T cd05578         148 TKVTPDTL---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE----T----  216 (258)
T ss_pred             cccCCCcc---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc----c----
Confidence            87654321   233568899999999988889999999999999999999999997654321111111100    0    


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCH--HHHHH
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM--SEVVE  413 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~--~evl~  413 (490)
                             ....++...+..+.++|.+||..||.+||++  +++++
T Consensus       217 -------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         217 -------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             -------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence                   1112223346889999999999999999999  66654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-39  Score=316.90  Aligned_cols=254  Identities=30%  Similarity=0.418  Sum_probs=201.6

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcc-CCCCeeceeeEEE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  209 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~  209 (490)
                      ..++|++.+.||.|+||.||+|.+..         ++..|++|++..... ..+.+.+|+.+++.+ .|+||+++++++.
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   73 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKK---------TGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFI   73 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECC---------CCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEE
Confidence            35789999999999999999999865         566899999876543 346788999999999 6999999999997


Q ss_pred             eCC------ceEEEEEecCCCChhHHhhhc---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC
Q 011250          210 EDD------QRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY  280 (490)
Q Consensus       210 ~~~------~~~lV~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~  280 (490)
                      ...      ..++||||+++++|.+++...   ...+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++
T Consensus        74 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~  150 (275)
T cd06608          74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNA  150 (275)
T ss_pred             ecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCC
Confidence            654      489999999999999988642   357899999999999999999999988   99999999999999999


Q ss_pred             CeEEecccCcccCCCCCcceeeeccccCCCccCcchhcc-----CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcch
Q 011250          281 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-----GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN  355 (490)
Q Consensus       281 ~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~  355 (490)
                      .++|+|||++........  ......|+..|+|||++..     ..++.++|||||||+||+|++|..||.......  .
T Consensus       151 ~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~  226 (275)
T cd06608         151 EVKLVDFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--A  226 (275)
T ss_pred             eEEECCCccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--H
Confidence            999999999876543221  1233568999999998753     357789999999999999999999996432111  1


Q ss_pred             hhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ......           ...+.+  ..+...+..+.+||.+||..||.+|||+.+++++
T Consensus       227 ~~~~~~-----------~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         227 LFKIPR-----------NPPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             HHHhhc-----------cCCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            111000           000001  1112246789999999999999999999999864

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.4e-39  Score=316.25  Aligned_cols=257  Identities=30%  Similarity=0.408  Sum_probs=203.8

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      ++|...+.||.|+||.||+|.+..         ++..||+|.+..... .....+.+|+++++.++||||+++++++.+.
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   71 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKN---------TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE   71 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECC---------CCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc
Confidence            368888999999999999999875         567899999875432 3346789999999999999999999988654


Q ss_pred             --CceEEEEEecCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEec
Q 011250          212 --DQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       212 --~~~~lV~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~D  286 (490)
                        +.+++||||+++++|.+++..   ....+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d  148 (287)
T cd06621          72 SSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCD  148 (287)
T ss_pred             CCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEee
Confidence              468999999999999887643   3456889999999999999999999988   99999999999999999999999


Q ss_pred             ccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCC--CCcchhhHhhhccc
Q 011250          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP--NGEHNLVEWARPHL  364 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~--~~~~~~~~~~~~~~  364 (490)
                      ||++........    ....++..|+|||.+.+..++.++|||||||++|+|++|..||.....  .....+..+.... 
T Consensus       149 fg~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-  223 (287)
T cd06621         149 FGVSGELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM-  223 (287)
T ss_pred             cccccccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC-
Confidence            999876543211    235678899999999988999999999999999999999999975532  1111122221110 


Q ss_pred             CCcchhhhccCCccCCCCC--hhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          365 GDKRRFYRLLDPRLEGHFS--IKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~--~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                               ..+.+.....  ...+..+.+|+.+||..||.+|||+.|++++-
T Consensus       224 ---------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~  267 (287)
T cd06621         224 ---------PNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP  267 (287)
T ss_pred             ---------CchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence                     0001111111  12367899999999999999999999999864

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-39  Score=316.26  Aligned_cols=249  Identities=28%  Similarity=0.435  Sum_probs=201.5

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccC---CCCeeceeeEEE
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLL---HPNLVKLVGYCI  209 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~  209 (490)
                      .|++.+.||.|+||.||+|.+..         ++..||+|.+.... .....++.+|+.+++.+.   ||||+++++++.
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~   72 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVP---------TGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL   72 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcC---------CCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee
Confidence            47788999999999999999865         56789999987543 234467889999999997   999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      .+...++||||+++++|.+++..  ..+++..++.++.|++.||.|||+.+   |+|+||+|+||+++.++.++|+|||+
T Consensus        73 ~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~  147 (277)
T cd06917          73 KGPRLWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGV  147 (277)
T ss_pred             eCCEEEEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCc
Confidence            99999999999999999998844  37899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +........  ......|+..|+|||.+.++ .++.++|||||||++|+|++|..||............       ..  
T Consensus       148 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~-------~~--  216 (277)
T cd06917         148 AALLNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI-------PK--  216 (277)
T ss_pred             eeecCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc-------cc--
Confidence            987654332  12335789999999988754 5789999999999999999999999754322111000       00  


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                          ...+.+...   ..+.++.+++.+||..||++||++.+++++
T Consensus       217 ----~~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         217 ----SKPPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             ----CCCCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence                000111110   136789999999999999999999999874

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.4e-39  Score=319.42  Aligned_cols=251  Identities=26%  Similarity=0.398  Sum_probs=205.0

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      ++|.+.+.||.|+||.||+|....         ++..||+|.+........+.+.+|+.+++.++||||+++++++...+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~   89 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVA---------TGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD   89 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcC---------CCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCC
Confidence            579999999999999999998765         45689999987654455567889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      ..|+||||+++++|.+++.+.  .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++..
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~  164 (293)
T cd06647          90 ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ  164 (293)
T ss_pred             cEEEEEecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceec
Confidence            999999999999999988543  5889999999999999999999988   99999999999999999999999999876


Q ss_pred             CCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhh
Q 011250          293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR  372 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (490)
                      ......  ......|++.|+|||.+....++.++|||||||++|+|++|+.||............  ..    ..     
T Consensus       165 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~--~~----~~-----  231 (293)
T cd06647         165 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--AT----NG-----  231 (293)
T ss_pred             cccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh--hc----CC-----
Confidence            543322  122356899999999998888999999999999999999999999754332111100  00    00     


Q ss_pred             ccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       373 ~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                        .+.+  ..+...+..+.+||.+||..+|.+||++.+++.+
T Consensus       232 --~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         232 --TPEL--QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             --CCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              0000  0111235678999999999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-40  Score=356.08  Aligned_cols=260  Identities=26%  Similarity=0.323  Sum_probs=217.3

Q ss_pred             hhhHHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCe
Q 011250          125 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNL  201 (490)
Q Consensus       125 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnI  201 (490)
                      ..+++...++|.++++||+|+||.|.+++++.         +++.||+|++++...   ....-|..|-.||..-+.+-|
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~---------t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wi  137 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKS---------TEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWI  137 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeec---------cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHH
Confidence            45666777899999999999999999999987         778999999987422   233457889999998899999


Q ss_pred             eceeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCC
Q 011250          202 VKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       202 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                      +.++-+|.++.++|+|||||+||+|..++.+.. .+++..+.+|+..|+.||.-||+.|   +|||||||+|||||..|+
T Consensus       138 v~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GH  213 (1317)
T KOG0612|consen  138 VQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGH  213 (1317)
T ss_pred             HHHHHHhcCccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCc
Confidence            999999999999999999999999999997776 8999999999999999999999999   999999999999999999


Q ss_pred             eEEecccCcccCCCCCcceeeeccccCCCccCcchhc----c-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchh
Q 011250          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM----T-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL  356 (490)
Q Consensus       282 vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~----~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~  356 (490)
                      +||+|||.+-.+..++.. .....+|||.|++||++.    + +.|+..+|+||+||++||||.|..||...      .+
T Consensus       214 ikLADFGsClkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad------sl  286 (1317)
T KOG0612|consen  214 IKLADFGSCLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD------SL  286 (1317)
T ss_pred             EeeccchhHHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH------HH
Confidence            999999999888755443 345578999999999986    2 67999999999999999999999999643      23


Q ss_pred             hHhhhcccCCcchhhhccCCccCCCCC--hhhHHHHHHHHHHhhhcCCCCCCC---HHHHHHHh
Q 011250          357 VEWARPHLGDKRRFYRLLDPRLEGHFS--IKGSQKATQLAAQCLSRDPKARPR---MSEVVETL  415 (490)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~l~~~~~--~~~~~~l~~Li~~cL~~dP~~RPt---~~evl~~L  415 (490)
                      ++....          +++-.-.-.||  .+.+.++.+||++.+ -+|..|..   ++++-.|.
T Consensus       287 veTY~K----------Im~hk~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~Hp  339 (1317)
T KOG0612|consen  287 VETYGK----------IMNHKESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHP  339 (1317)
T ss_pred             HHHHHH----------HhchhhhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCc
Confidence            332222          22221122233  345899999999988 58888988   89888764

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.8e-39  Score=317.35  Aligned_cols=251  Identities=29%  Similarity=0.407  Sum_probs=195.9

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHH-HhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNF-LGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~  210 (490)
                      ++|++.+.||+|+||.||+|.+..         +|..||||.+..... .....+..|+.+ ++.++||||+++++++..
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~   71 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVP---------TGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR   71 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcC---------CCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec
Confidence            368999999999999999999875         677999999876532 233456667665 666789999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEcCCCCeEEec
Q 011250          211 DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEE-AEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiHrDlkp~NILl~~~~~vkL~D  286 (490)
                      ++..++||||++ |+|.+++..   ....+++..++.++.||+.||+|||++ +   ++||||||+|||++.++.+||+|
T Consensus        72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~d  147 (283)
T cd06617          72 EGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCD  147 (283)
T ss_pred             CCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEee
Confidence            999999999995 688877753   235689999999999999999999986 6   99999999999999999999999


Q ss_pred             ccCcccCCCCCcceeeeccccCCCccCcchhcc----CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011250          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT----GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~----~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      ||++.......   ..+...|+..|+|||++.+    ..++.++|+|||||++|+|++|+.||....... ..+..... 
T Consensus       148 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~-  222 (283)
T cd06617         148 FGISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQLKQVVE-  222 (283)
T ss_pred             ccccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HHHHHHHh-
Confidence            99998654321   1223568999999998864    456889999999999999999999996422110 00100000 


Q ss_pred             ccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                                ...+.+   .....+.++.+||.+||..+|.+||++.+++++
T Consensus       223 ----------~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         223 ----------EPSPQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             ----------cCCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                      000000   011236789999999999999999999999875

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=5.9e-39  Score=312.90  Aligned_cols=253  Identities=26%  Similarity=0.427  Sum_probs=201.5

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC----------cccHHHHHHHHHHHhc-cCCCCee
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG----------LQGHKEWLAEVNFLGN-LLHPNLV  202 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~Ei~il~~-l~HpnIv  202 (490)
                      +|++.+.||+|+||.||+|.+...        .+..+|+|.+....          .....++..|+.++.. ++||||+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~--------~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~   72 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNN--------GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIV   72 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCC--------CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCee
Confidence            478889999999999999998652        35689999886432          1123457788988875 7899999


Q ss_pred             ceeeEEEeCCceEEEEEecCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEEcC
Q 011250          203 KLVGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNILLDA  278 (490)
Q Consensus       203 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlkp~NILl~~  278 (490)
                      ++++++.+++..++||||+++++|.+++..   ....+++..++.++.|++.+|.|||+ .+   |+|+||+|+|||++.
T Consensus        73 ~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~  149 (269)
T cd08528          73 RYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGE  149 (269)
T ss_pred             eEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECC
Confidence            999999999999999999999999988743   34578999999999999999999996 55   999999999999999


Q ss_pred             CCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhH
Q 011250          279 DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE  358 (490)
Q Consensus       279 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~  358 (490)
                      ++.++|+|||++.......   ......|+..|+|||.+.+..++.++||||||+++|+|++|..||.......   ...
T Consensus       150 ~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~---~~~  223 (269)
T cd08528         150 DDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS---LAT  223 (269)
T ss_pred             CCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH---HHH
Confidence            9999999999998764432   2234678999999999998889999999999999999999999986432111   111


Q ss_pred             hhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011250          359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~  416 (490)
                      ....   .      ...+..    ....+..+.+||.+||+.||++||++.|+..+|+
T Consensus       224 ~~~~---~------~~~~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         224 KIVE---A------VYEPLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             HHhh---c------cCCcCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            0000   0      000100    1123678999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.2e-40  Score=310.42  Aligned_cols=274  Identities=23%  Similarity=0.317  Sum_probs=203.2

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ..|+++..||+|.||.||+|.-.+.+.     ...+.+|||.++....  .-.....+|+.+++.|+||||+.|..+|..
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~-----kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~   98 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTND-----KRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLS   98 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCc-----ccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc
Confidence            358999999999999999996554321     1244799999975521  223567899999999999999999999988


Q ss_pred             -CCceEEEEEecCCCChhHHhhhc----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC----CC
Q 011250          211 -DDQRLLVYEFMPRGSLENHLFRR----SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD----YN  281 (490)
Q Consensus       211 -~~~~~lV~E~~~~gsL~~~l~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~----~~  281 (490)
                       +..++|++||.+. +|...|.-+    ...++...+..|++||+.|+.|||++-   |+||||||.|||+..+    |.
T Consensus        99 ~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~  174 (438)
T KOG0666|consen   99 HDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGR  174 (438)
T ss_pred             cCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCe
Confidence             7789999999965 898888532    356999999999999999999999999   9999999999999877    89


Q ss_pred             eEEecccCcccCCCCCcce-eeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcch----
Q 011250          282 AKLSDFGLAKDAPEDGKTH-VSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN----  355 (490)
Q Consensus       282 vkL~DFG~a~~~~~~~~~~-~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~----  355 (490)
                      |||+|||+++.+.+.-... ....++-|+.|.|||++.+ ..||.+.|||++|||+.|||+-.+.|..........    
T Consensus       175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq  254 (438)
T KOG0666|consen  175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQ  254 (438)
T ss_pred             eEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCch
Confidence            9999999999886554332 2234677999999999886 589999999999999999999999996543221111    


Q ss_pred             --hhHhhhcccC-----CcchhhhccCC-----ccCCCCChh------------hHHHHHHHHHHhhhcCCCCCCCHHHH
Q 011250          356 --LVEWARPHLG-----DKRRFYRLLDP-----RLEGHFSIK------------GSQKATQLAAQCLSRDPKARPRMSEV  411 (490)
Q Consensus       356 --~~~~~~~~~~-----~~~~~~~~~~~-----~l~~~~~~~------------~~~~l~~Li~~cL~~dP~~RPt~~ev  411 (490)
                        ..+.+...++     +...+....+-     .+...+-..            -++.+.+|+.+||+.||.+|.|++++
T Consensus       255 ~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA  334 (438)
T KOG0666|consen  255 HDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA  334 (438)
T ss_pred             HHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH
Confidence              0111101111     00000000000     000000000            14558999999999999999999999


Q ss_pred             HHHh
Q 011250          412 VETL  415 (490)
Q Consensus       412 l~~L  415 (490)
                      +++.
T Consensus       335 leh~  338 (438)
T KOG0666|consen  335 LEHP  338 (438)
T ss_pred             hccc
Confidence            9875

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=7.4e-39  Score=307.22  Aligned_cols=251  Identities=28%  Similarity=0.438  Sum_probs=207.4

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCCc
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQ  213 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  213 (490)
                      +|.+.+.||.|+||.||++.+..         ++..|++|++..........+.+|+.+++.+.|+||+++++++..+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   71 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKR---------TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE   71 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECC---------CCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence            47888999999999999999875         466899999987655556789999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccC
Q 011250          214 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       214 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~  293 (490)
                      .+++|||+++++|.+++......+++..+..++.|++.||.|||..+   ++||||+|+||+++.++.++|+|||.+...
T Consensus        72 ~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~  148 (253)
T cd05122          72 LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQL  148 (253)
T ss_pred             EEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeeccccccc
Confidence            99999999999999998766567999999999999999999999988   999999999999999999999999999876


Q ss_pred             CCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhc
Q 011250          294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  373 (490)
Q Consensus       294 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (490)
                      .....   .....|+..|+|||++....++.++||||||+++|+|++|+.||.........   .....  ..   ....
T Consensus       149 ~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~--~~---~~~~  217 (253)
T cd05122         149 SDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL---FKIAT--NG---PPGL  217 (253)
T ss_pred             ccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH---HHHHh--cC---CCCc
Confidence            54322   23457899999999998888999999999999999999999999654321111   00000  00   0000


Q ss_pred             cCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       374 ~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .       .....+..+.++|.+||..||.+|||+.+++++
T Consensus       218 ~-------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         218 R-------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             C-------cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0       011125789999999999999999999999865

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-39  Score=344.60  Aligned_cols=278  Identities=19%  Similarity=0.251  Sum_probs=191.8

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCcccc-C-----CCCcE----EEEEEecCCCcccHHHHHHHHHHHhccCCCC
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVK-P-----GTGLT----VAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN  200 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~-~-----~~~~~----vaiK~~~~~~~~~~~~~~~Ei~il~~l~Hpn  200 (490)
                      ..++|++++.||+|+||+||+|.++........ .     ..+..    ++.|.+.. .......+.+|+.+|+.++|||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCC
Confidence            346899999999999999999987542111000 0     00001    11111111 1122356789999999999999


Q ss_pred             eeceeeEEEeCCceEEEEEecCCCChhHHhhhcC----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE
Q 011250          201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS----LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL  276 (490)
Q Consensus       201 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl  276 (490)
                      ||++++++...+..|+|||++ +++|..++....    .......+..|+.||+.||.|||+.+   ||||||||+||||
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence            999999999999999999999 567877775432    22345667889999999999999988   9999999999999


Q ss_pred             cCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCC-CCCCCCCcch
Q 011250          277 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM-DKNRPNGEHN  355 (490)
Q Consensus       277 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf-~~~~~~~~~~  355 (490)
                      +.++.+||+|||+++.+..... ......+||..|+|||++.+..++.++|||||||+||||++|..++ ..........
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            9999999999999987654322 1223467999999999999999999999999999999999988644 3322222122


Q ss_pred             hhHhhhcc------cCC-cchhhhccCCc-c---CCCC-----ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          356 LVEWARPH------LGD-KRRFYRLLDPR-L---EGHF-----SIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       356 ~~~~~~~~------~~~-~~~~~~~~~~~-l---~~~~-----~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      +.+.....      +.+ ...++..++.. +   ...+     ....+..+.++|.+||+.||.+|||+.|+|.+
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            22111100      000 00011111000 0   0000     01124567889999999999999999999975

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=8.2e-39  Score=313.68  Aligned_cols=248  Identities=26%  Similarity=0.399  Sum_probs=202.4

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      -|++.+.||.|+||.||+|.+..         ++..||||.+..... .....+.+|+.++..++||||+++++++..++
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   75 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNR---------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT   75 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECC---------CCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC
Confidence            37788999999999999998765         566899999865432 33456889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      ..++||||+++++|.+++..  ..+++..+..++.|++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        76 ~~~lv~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~  150 (277)
T cd06641          76 KLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQ  150 (277)
T ss_pred             eEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeeccccee
Confidence            99999999999999998853  36899999999999999999999988   99999999999999999999999999876


Q ss_pred             CCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhh
Q 011250          293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR  372 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (490)
                      ......  ......|+..|+|||.+.+..++.++|||||||++|+|++|..||.......   ......    ..     
T Consensus       151 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~----~~-----  216 (277)
T cd06641         151 LTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK---VLFLIP----KN-----  216 (277)
T ss_pred             cccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH---HHHHHh----cC-----
Confidence            543221  1223568899999999988889999999999999999999999996432211   111000    00     


Q ss_pred             ccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       373 ~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                           ....+....+.++.+++.+||..+|.+||++.+++++
T Consensus       217 -----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         217 -----NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             -----CCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                 0011122336789999999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=6.2e-39  Score=314.55  Aligned_cols=260  Identities=25%  Similarity=0.337  Sum_probs=197.7

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccC-CCCeeceeeEEEeC-
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLL-HPNLVKLVGYCIED-  211 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~-  211 (490)
                      |++.+.||+|+||.||+|.+..         ++..||+|+++.... .......+|+.++.++. |+||+++++++.+. 
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~---------~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   71 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRK---------TGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK   71 (282)
T ss_pred             CceEeeccccccceEEEEEEcC---------CCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC
Confidence            6778899999999999999876         566899999875422 22234567999999886 99999999999987 


Q ss_pred             -CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          212 -DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       212 -~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                       +..++||||+. ++|.+.+......+++..++.++.||+.||+|||+.+   |+||||+|+||+++. +.+||+|||++
T Consensus        72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~  146 (282)
T cd07831          72 TGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSC  146 (282)
T ss_pred             CCcEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccc
Confidence             88999999996 5888888665567999999999999999999999988   999999999999999 99999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      .........   ....++..|+|||++.. ..++.++|||||||++|||++|..||......+   .+......++....
T Consensus       147 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~  220 (282)
T cd07831         147 RGIYSKPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDA  220 (282)
T ss_pred             cccccCCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCH
Confidence            876433221   23468899999997654 567889999999999999999999997643321   11111111100000


Q ss_pred             -hh------hccCCccCC-------CCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          370 -FY------RLLDPRLEG-------HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       370 -~~------~~~~~~l~~-------~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                       ..      ...+.....       ......+..+.+||.+||..||.+||++.+++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         221 EVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             HHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence             00      000000000       0011337899999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=5.5e-39  Score=316.58  Aligned_cols=250  Identities=28%  Similarity=0.412  Sum_probs=202.9

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCCc
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQ  213 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  213 (490)
                      .|...+.||+|+||.||+|.+..         ++..|++|.+........+.+.+|+.+++.+.||||+++++++...+.
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~   90 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKS---------TGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE   90 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECC---------CCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCe
Confidence            35556799999999999998765         566899999876554555678899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccC
Q 011250          214 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       214 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~  293 (490)
                      .++|+||+++++|.+++..  ..+++..+..++.|++.||+|||+.+   |+||||+|+||+++.++.++|+|||++...
T Consensus        91 ~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~  165 (285)
T cd06648          91 LWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQV  165 (285)
T ss_pred             EEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhh
Confidence            9999999999999998865  46899999999999999999999988   999999999999999999999999988765


Q ss_pred             CCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhc
Q 011250          294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  373 (490)
Q Consensus       294 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (490)
                      .....  ......|+..|+|||.+.+..++.++|||||||++|+|++|..||....+..   ........          
T Consensus       166 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~---~~~~~~~~----------  230 (285)
T cd06648         166 SKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ---AMKRIRDN----------  230 (285)
T ss_pred             ccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH---HHHHHHhc----------
Confidence            43221  1123568999999999988889999999999999999999999996533211   11111100          


Q ss_pred             cCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       374 ~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ..+.+.  .....+..+.+|+.+||..||.+||++.+++++
T Consensus       231 ~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         231 LPPKLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             CCCCCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence            000110  111236789999999999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=4.4e-39  Score=327.13  Aligned_cols=265  Identities=23%  Similarity=0.304  Sum_probs=200.6

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC--CcccHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      ..++|++.+.||+|+||.||+|.+..         ++..||||.+...  .......+.+|+.+++.++|+||+++++++
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   84 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTV---------TGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVF   84 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECC---------CCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeee
Confidence            34679999999999999999999876         5678999998643  223345678899999999999999999988


Q ss_pred             EeC------CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCe
Q 011250          209 IED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       209 ~~~------~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~v  282 (490)
                      ...      ...|+||||+. ++|.+.+...   +++..+..++.|++.||+|||..+   |+||||||+|||++.++.+
T Consensus        85 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~  157 (353)
T cd07850          85 TPQKSLEEFQDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL  157 (353)
T ss_pred             ccCCCccccCcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCE
Confidence            644      34699999995 5888877432   889999999999999999999988   9999999999999999999


Q ss_pred             EEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhh-H---
Q 011250          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-E---  358 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~-~---  358 (490)
                      ||+|||+++.......   .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+ .   
T Consensus       158 kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  234 (353)
T cd07850         158 KILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLG  234 (353)
T ss_pred             EEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcC
Confidence            9999999987643221   22356899999999999999999999999999999999999999754321110000 0   


Q ss_pred             --------hhh----cccC-----CcchhhhccCC----ccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          359 --------WAR----PHLG-----DKRRFYRLLDP----RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       359 --------~~~----~~~~-----~~~~~~~~~~~----~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                              ...    ....     ....+...+..    ..........+..+.+||.+||+.||.+|||+.++|++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         235 TPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             CCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                    000    0000     00000011100    00011112336778999999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=8.1e-39  Score=310.49  Aligned_cols=254  Identities=31%  Similarity=0.460  Sum_probs=204.0

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      +|.+.+.||+|+||.||+|....         ++..||+|.+......  ..+.+..|+.+++.++|+||+++++++...
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~   71 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLD---------TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR   71 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECC---------CCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC
Confidence            48889999999999999998865         5678999998766543  456789999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      +..++|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.+||+|||++.
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~  147 (264)
T cd06626          72 EKVYIFMEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAV  147 (264)
T ss_pred             CEEEEEEecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccccccc
Confidence            9999999999999999998654 45889999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCccee--eeccccCCCccCcchhccCC---CCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011250          292 DAPEDGKTHV--STRVMGTYGYAAPEYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       292 ~~~~~~~~~~--~~~~~Gt~~y~aPE~l~~~~---~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      ..........  .....++..|+|||++....   ++.++||||||+++|+|++|+.||........  .. +... ...
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~~-~~~~-~~~  223 (264)
T cd06626         148 KLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--IM-FHVG-AGH  223 (264)
T ss_pred             ccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--HH-HHHh-cCC
Confidence            7654322211  11356889999999988765   88999999999999999999999964321110  00 0000 000


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                              .+.+.  .....+..+.+||.+||+.||.+||++.+++.+
T Consensus       224 --------~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         224 --------KPPIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             --------CCCCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                    00010  011236788999999999999999999998854

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5e-39  Score=320.16  Aligned_cols=248  Identities=29%  Similarity=0.434  Sum_probs=200.2

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ..|.+.+.||+|+||.||+|.+..         ++..||+|.+.....   ...+++.+|+.+++.++||||+++++++.
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~   85 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVR---------TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL   85 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcC---------CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE
Confidence            458899999999999999998875         567899999865432   23356889999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +++..++||||+. |+|.+++......+++..+..++.||+.||.|||+.+   |+||||+|+||+++.++.++|+|||+
T Consensus        86 ~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~  161 (307)
T cd06607          86 REHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGS  161 (307)
T ss_pred             eCCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCc
Confidence            9999999999996 6887777655567999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhc---cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      +......      ....|+..|+|||++.   ...++.++||||||+++|||++|..||........   .....  ...
T Consensus       162 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~---~~~~~--~~~  230 (307)
T cd06607         162 ASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHIA--QND  230 (307)
T ss_pred             ceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH---HHHHh--cCC
Confidence            8765332      2346889999999874   45688999999999999999999999864321110   00000  000


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                              .+.+   .....+..+.+||.+||..||.+||++.+|+.+.
T Consensus       231 --------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         231 --------SPTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             --------CCCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence                    0000   1122467899999999999999999999999764

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=5e-39  Score=315.95  Aligned_cols=265  Identities=26%  Similarity=0.368  Sum_probs=199.0

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      +|++.+.||.|+||.||+|.+..         ++..||||.+.....  .....+.+|++++++++||||+++++++.++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   71 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKL---------TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE   71 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECC---------CCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC
Confidence            48889999999999999998875         567899999875432  2235688999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      +..++||||+. ++|.+++... ...+++..+..++.|++.||+|||+.+   ++||||+|+||+++.++.+||+|||++
T Consensus        72 ~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~  147 (284)
T cd07860          72 NKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLA  147 (284)
T ss_pred             CcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccch
Confidence            99999999995 6898887543 356899999999999999999999988   999999999999999999999999998


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcc-hhhHhhhccc----
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLVEWARPHL----  364 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~-~~~~~~~~~~----  364 (490)
                      .........  .....++..|+|||++.+. .++.++|||||||++|||+||+.||......... ..........    
T Consensus       148 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  225 (284)
T cd07860         148 RAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW  225 (284)
T ss_pred             hhcccCccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Confidence            765432111  1234578899999988654 4688999999999999999999999654321110 0000000000    


Q ss_pred             ---CCc----chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          365 ---GDK----RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       365 ---~~~----~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                         ...    ..+.......+. ......+.++.+||.+||+.||.+||++.+++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         226 PGVTSLPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             hhhhHHHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence               000    000000000000 0011235678899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.3e-38  Score=306.88  Aligned_cols=253  Identities=29%  Similarity=0.440  Sum_probs=207.8

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      +|.+.+.||+|+||.||+|.+..         ++..|++|++.....  ...+.+.+|+.++++++|+||+++++++.+.
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKD---------TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE   71 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECC---------CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC
Confidence            47788999999999999998875         567899999876543  3456788999999999999999999999988


Q ss_pred             --CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          212 --DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       212 --~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                        ...++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||.
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~  147 (260)
T cd06606          72 EKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGC  147 (260)
T ss_pred             CCCeEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccccc
Confidence              88999999999999999986654 8999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +................++..|+|||.+....++.++||||||+++|+|++|..||.....     ......        
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~--------  214 (260)
T cd06606         148 AKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALY--------  214 (260)
T ss_pred             EEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHH--------
Confidence            9877554321112345789999999999888899999999999999999999999975430     000000        


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                        ..........++...+..+.+||.+||+.||.+||++.+++.+
T Consensus       215 --~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         215 --KIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             --hccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence              0000011112223337889999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=5.9e-39  Score=319.06  Aligned_cols=269  Identities=24%  Similarity=0.350  Sum_probs=199.0

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ++|++.+.||+|+||.||+|....         ++..||||.+.....  .....+.+|+.+++.++||||+++++++..
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   82 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKK---------TKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT   82 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECC---------CCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEec
Confidence            469999999999999999998875         577899999865422  223456789999999999999999999876


Q ss_pred             CC--------ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCe
Q 011250          211 DD--------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       211 ~~--------~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~v  282 (490)
                      ..        ..++||||+. ++|.+++......+++..++.++.||+.||.|||+.+   |+|+||||+|||++.++.+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~  158 (310)
T cd07865          83 KATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGIL  158 (310)
T ss_pred             ccccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcE
Confidence            54        3499999995 5888888666567999999999999999999999988   9999999999999999999


Q ss_pred             EEecccCcccCCCCCcc--eeeeccccCCCccCcchhccC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 011250          283 KLSDFGLAKDAPEDGKT--HVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW  359 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~  359 (490)
                      ||+|||++.........  .......++..|+|||++.+. .++.++||||||+++|||++|+.||...........+..
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~  238 (310)
T cd07865         159 KLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQ  238 (310)
T ss_pred             EECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            99999999765432211  111234678899999988654 478899999999999999999999976543222111111


Q ss_pred             hhcccC-----Ccc--hhhhccC-C-----ccCCCC-ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          360 ARPHLG-----DKR--RFYRLLD-P-----RLEGHF-SIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       360 ~~~~~~-----~~~--~~~~~~~-~-----~l~~~~-~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ......     ...  .....+. +     ...... +...+..+.+||.+||..||.+|||+++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         239 LCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             HhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            110000     000  0000000 0     000000 00124567899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=5.1e-39  Score=320.32  Aligned_cols=266  Identities=28%  Similarity=0.361  Sum_probs=200.2

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ++|++.+.||+|+||.||+|.+..         +|..||+|.+......  ....+.+|+.+++.++|+||+++++++..
T Consensus         7 ~~y~~~~~ig~g~~~~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   77 (309)
T cd07845           7 TEFEKLNRIGEGTYGIVYRARDTT---------SGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVG   77 (309)
T ss_pred             cceeEeeeeeecCCEEEEEEEECC---------CCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEec
Confidence            579999999999999999999875         5778999998654322  12346789999999999999999999876


Q ss_pred             C--CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          211 D--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       211 ~--~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      .  +..++||||+. ++|.+++......+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        78 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg  153 (309)
T cd07845          78 KHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFG  153 (309)
T ss_pred             CCCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccc
Confidence            5  46899999995 5898888765567999999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHh-hhcccCC
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW-ARPHLGD  366 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~-~~~~~~~  366 (490)
                      ++.........  .....++..|+|||++.+ ..++.++|||||||++|||++|.+||...........+.. .......
T Consensus       154 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  231 (309)
T cd07845         154 LARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNES  231 (309)
T ss_pred             eeeecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence            99876543211  122346888999998865 5688999999999999999999999975433221111110 0000000


Q ss_pred             cc-h--------hhhccCCc---cCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          367 KR-R--------FYRLLDPR---LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       367 ~~-~--------~~~~~~~~---l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .. .        ........   +...+ ...+..+.+||.+||+.||.+|||+.+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         232 IWPGFSDLPLVGKFTLPKQPYNNLKHKF-PWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             hchhhhcccccccccccCCCCCchHHhc-cccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            00 0        00000000   00000 1136778999999999999999999999965

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.5e-40  Score=336.20  Aligned_cols=246  Identities=24%  Similarity=0.415  Sum_probs=198.6

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC----CcccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .+...+||+|+|-+||+|.+..         +|..||--.++..    .....++|..|+.+|+.|+|||||++|.+|.+
T Consensus        42 ~k~~evLGrGafKtVYka~De~---------~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d  112 (632)
T KOG0584|consen   42 LKFDEVLGRGAFKTVYKAFDEE---------EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVD  112 (632)
T ss_pred             eehhhhcccccceeeeeccccc---------cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheec
Confidence            3455789999999999999876         6777875433322    22344789999999999999999999999998


Q ss_pred             CCc--eEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-CCeEEecc
Q 011250          211 DDQ--RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAKLSDF  287 (490)
Q Consensus       211 ~~~--~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~-~~vkL~DF  287 (490)
                      ...  +.+|+|++..|+|..|+.+. +.+....+..|++||++||.|||++. +||||||||.+||+|+.+ |.|||+|+
T Consensus       113 ~~n~~in~iTEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDL  190 (632)
T KOG0584|consen  113 TDNKTINFITELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDL  190 (632)
T ss_pred             CCCceeeeeeecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecch
Confidence            765  77999999999999999655 47889999999999999999999987 789999999999999765 89999999


Q ss_pred             cCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011250          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      |||........    ...+|||.|||||++. ..|+..+||||||++|+||+|+..||....     +-.+..+......
T Consensus       191 GLAtl~r~s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-----n~AQIYKKV~SGi  260 (632)
T KOG0584|consen  191 GLATLLRKSHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT-----NPAQIYKKVTSGI  260 (632)
T ss_pred             hHHHHhhcccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC-----CHHHHHHHHHcCC
Confidence            99998754332    2378999999999776 899999999999999999999999996543     2222222211111


Q ss_pred             --chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          368 --RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       368 --~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                        ..|.++-            .+++++||.+||.. ..+|||+.|+|++
T Consensus       261 KP~sl~kV~------------dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  261 KPAALSKVK------------DPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             CHHHhhccC------------CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence              1122221            57889999999999 9999999999974

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4.3e-39  Score=317.23  Aligned_cols=253  Identities=29%  Similarity=0.386  Sum_probs=197.7

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccC-CCCeeceeeEEEeC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLL-HPNLVKLVGYCIED  211 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~  211 (490)
                      +|...+.||+|+||.||++.+..         ++..||+|.+..... .....+.+|+.++.++. |+||+++++++..+
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~   75 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKP---------SGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE   75 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECC---------CCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC
Confidence            56677889999999999999876         567899999875432 33457889999999996 99999999999999


Q ss_pred             CceEEEEEecCCCChhHHhh---h-cCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEcCCCCeEEec
Q 011250          212 DQRLLVYEFMPRGSLENHLF---R-RSLPLPWSIRMKIALGAAKGLAFLHEE-AEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~---~-~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiHrDlkp~NILl~~~~~vkL~D  286 (490)
                      ...+++|||+. ++|.++..   . ....+++..+..++.|++.||+|||+. +   |+||||||+|||++.++.++|+|
T Consensus        76 ~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~d  151 (288)
T cd06616          76 GDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCD  151 (288)
T ss_pred             CcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEee
Confidence            99999999985 46655432   2 235799999999999999999999974 6   99999999999999999999999


Q ss_pred             ccCcccCCCCCcceeeeccccCCCccCcchhccC---CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011250          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG---HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~---~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      ||+++.......   .....|+..|+|||++.+.   .++.++|||||||++|+|++|+.||....     ...+.....
T Consensus       152 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~  223 (288)
T cd06616         152 FGISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQV  223 (288)
T ss_pred             cchhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhh
Confidence            999976543221   1234689999999998765   68999999999999999999999996542     111111110


Q ss_pred             cCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ..       ...+.+........+.++.+||.+||+.||.+|||+.+|+++
T Consensus       224 ~~-------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         224 VK-------GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             cC-------CCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00       001112222223347789999999999999999999999976

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.1e-38  Score=313.37  Aligned_cols=266  Identities=24%  Similarity=0.357  Sum_probs=201.3

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      +|++.+.||.|+||.||+|++..         +|..||||.+...... ....+.+|+.+++.++|+||+++++++.+.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   71 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRT---------TGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN   71 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECC---------CCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC
Confidence            58889999999999999999875         5778999998765432 3456778999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      ..+|||||++ ++|.+++....  ..+++..+..++.||+.||.|||+.+   |+||||||+||++++++.++|+|||++
T Consensus        72 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~  147 (284)
T cd07836          72 KLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLA  147 (284)
T ss_pred             cEEEEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchh
Confidence            9999999997 48888886543  46899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchh-hHhhh-cc----
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL-VEWAR-PH----  363 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~-~~~~~-~~----  363 (490)
                      ........  ......++..|++||.+.+ ..++.++|||||||++|+|++|..||........... ..... +.    
T Consensus       148 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (284)
T cd07836         148 RAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTW  225 (284)
T ss_pred             hhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhH
Confidence            76533211  1123467899999998865 4578999999999999999999999975432211100 00000 00    


Q ss_pred             --cCCcchhhhccCC---ccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          364 --LGDKRRFYRLLDP---RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       364 --~~~~~~~~~~~~~---~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                        +.....+......   .....+....+..+.+++.+||+.||.+||++.+++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         226 PGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             HHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence              0000000000000   00001112236788999999999999999999999864

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.7e-38  Score=317.88  Aligned_cols=252  Identities=29%  Similarity=0.414  Sum_probs=202.3

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .|...+.||+|+||.||+|++..         ++..||+|.+.....   .....+.+|+++++.++|+||+++++++.+
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   96 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVR---------TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR   96 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcC---------CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            37788899999999999999865         567899999875432   223568899999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      ++..+|||||+. |+|.+++......+++..+..++.||+.||.|||+.+   |+||||+|+||+++.++.++|+|||++
T Consensus        97 ~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~  172 (317)
T cd06635          97 EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSA  172 (317)
T ss_pred             CCeEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCc
Confidence            999999999996 5888887666667999999999999999999999988   999999999999999999999999998


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhc---cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      ......      ....|++.|+|||++.   .+.++.++|||||||++|||++|..||.........  ..+...     
T Consensus       173 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--~~~~~~-----  239 (317)
T cd06635         173 SIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YHIAQN-----  239 (317)
T ss_pred             cccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH--HHHHhc-----
Confidence            754322      2346899999999874   457889999999999999999999998643211100  000000     


Q ss_pred             chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                               ..........+..+.+|+.+||+.+|.+||++.++++++..+..
T Consensus       240 ---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         240 ---------ESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             ---------cCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence                     00000111236779999999999999999999999998765443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.2e-38  Score=313.27  Aligned_cols=244  Identities=28%  Similarity=0.392  Sum_probs=190.5

Q ss_pred             ccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHH---hccCCCCeeceeeEEEeCCc
Q 011250          140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFL---GNLLHPNLVKLVGYCIEDDQ  213 (490)
Q Consensus       140 ~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~Ei~il---~~l~HpnIv~l~~~~~~~~~  213 (490)
                      +||+|+||.||++.+..         ++..||+|.+......   ....+.+|..++   ....||||+.+++++..++.
T Consensus         1 ~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~   71 (279)
T cd05633           1 IIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDK   71 (279)
T ss_pred             CcccCCCeEEEEEEECC---------CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe
Confidence            48999999999998865         5678999998654321   122344454433   34479999999999999999


Q ss_pred             eEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccC
Q 011250          214 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       214 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~  293 (490)
                      .++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++...
T Consensus        72 ~~lv~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~  147 (279)
T cd05633          72 LCFILDLMNGGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  147 (279)
T ss_pred             EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceec
Confidence            99999999999999988654 46999999999999999999999988   999999999999999999999999998765


Q ss_pred             CCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhh
Q 011250          294 PEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR  372 (490)
Q Consensus       294 ~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (490)
                      ....    .....||..|+|||.+.+ ..++.++|||||||++|+|++|..||..........+....   .        
T Consensus       148 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---~--------  212 (279)
T cd05633         148 SKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---L--------  212 (279)
T ss_pred             cccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh---h--------
Confidence            3321    123468999999998864 56899999999999999999999999754322211111100   0        


Q ss_pred             ccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHh
Q 011250          373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVETL  415 (490)
Q Consensus       373 ~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----t~~evl~~L  415 (490)
                          .....++...+.++.++|.+||..||.+||     ++++++++.
T Consensus       213 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~  256 (279)
T cd05633         213 ----TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV  256 (279)
T ss_pred             ----cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence                011122233478899999999999999999     599988763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.5e-38  Score=306.56  Aligned_cols=250  Identities=25%  Similarity=0.400  Sum_probs=207.4

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      +|.+.+.||.|+||.||++.+..         ++..||+|++.....  ...+.+.+|+++++.++|+|++++++.+...
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~   71 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKS---------DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK   71 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcC---------CCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC
Confidence            58889999999999999999875         566899999976543  4456788999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhc---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      +..++||||+++++|.+++...   ...+++..+..++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||
T Consensus        72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~  148 (258)
T cd08215          72 GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFG  148 (258)
T ss_pred             CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCcc
Confidence            9999999999999999998764   367999999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ++.......  .......|++.|+|||.+....++.++||||||+++|+|++|..||......   .+....   ...  
T Consensus       149 ~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~~---~~~--  218 (258)
T cd08215         149 ISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL---ELALKI---LKG--  218 (258)
T ss_pred             ceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH---HHHHHH---hcC--
Confidence            998765432  1223357899999999998888999999999999999999999999654321   111110   000  


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                               ....++...+..+.+++.+||..+|++||++.+++++
T Consensus       219 ---------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         219 ---------QYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                     0011122336789999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=8e-39  Score=309.28  Aligned_cols=250  Identities=22%  Similarity=0.379  Sum_probs=202.4

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      +|.+.+.||.|+||.||+|....         +|..||+|.+.....  ...+.+.+|+.+++.++|+||+++++++...
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~   71 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKS---------DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN   71 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcC---------CCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC
Confidence            47888999999999999999876         566899999865432  2345678999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-CeEEecccC
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFGL  289 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-~vkL~DFG~  289 (490)
                      +..++||||+++++|.+++.+.. ..+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++ .++|+|||.
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~  148 (257)
T cd08225          72 GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGI  148 (257)
T ss_pred             CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEeccccc
Confidence            99999999999999999986543 35899999999999999999999988   99999999999998885 469999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +.........  .....|++.|+|||++.+..++.++|||||||++|||++|..||......      +........   
T Consensus       149 ~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~---  217 (257)
T cd08225         149 ARQLNDSMEL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLKICQG---  217 (257)
T ss_pred             chhccCCccc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHhcc---
Confidence            9876443221  12346899999999998888999999999999999999999999643211      111110000   


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                             .+ .......+..+.+++.+||..+|++|||+.+++++
T Consensus       218 -------~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         218 -------YF-APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             -------cC-CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                   00 01112236789999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.3e-38  Score=313.53  Aligned_cols=254  Identities=27%  Similarity=0.425  Sum_probs=207.2

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ..+.|++...||.|+||.||+|.+..         ++..|++|++..... ..+.+.+|+.+++.++|+||+++++++..
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   86 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRA---------TGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV   86 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEcc---------CCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE
Confidence            45678999999999999999999875         466899999976544 45678899999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      .+..++||||+++++|.+++......+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.++|+|||++
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~  163 (286)
T cd06614          87 GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFA  163 (286)
T ss_pred             CCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchh
Confidence            99999999999999999999766557999999999999999999999988   999999999999999999999999998


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ........  ......|+..|+|||++.+..++.++|||||||++|+|++|..||........  .........      
T Consensus       164 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~--~~~~~~~~~------  233 (286)
T cd06614         164 AQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA--LFLITTKGI------  233 (286)
T ss_pred             hhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhcCC------
Confidence            76543221  11234688999999999888899999999999999999999999864322111  110000000      


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                           +.+.  .....+..+.+||.+||+.+|.+||++.+++++
T Consensus       234 -----~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         234 -----PPLK--NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             -----CCCc--chhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                 0000  011136789999999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.4e-38  Score=308.98  Aligned_cols=244  Identities=27%  Similarity=0.366  Sum_probs=199.1

Q ss_pred             cccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEEEeCCceEEE
Q 011250          141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  217 (490)
Q Consensus       141 LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  217 (490)
                      ||.|+||.||+|++..         ++..||+|++.....   ...+.+.+|+.+++.++||||+++++++.++...++|
T Consensus         1 lg~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   71 (262)
T cd05572           1 LGVGGFGRVELVKVKS---------KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYML   71 (262)
T ss_pred             CCCCCceEEEEEEECC---------CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEE
Confidence            7999999999999865         567899999875432   2346788999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCCC
Q 011250          218 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG  297 (490)
Q Consensus       218 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~  297 (490)
                      |||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        72 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~  147 (262)
T cd05572          72 MEYCLGGELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ  147 (262)
T ss_pred             EecCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc
Confidence            9999999999998654 46899999999999999999999988   9999999999999999999999999998765432


Q ss_pred             cceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCc
Q 011250          298 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPR  377 (490)
Q Consensus       298 ~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  377 (490)
                         ......|+..|++||.+....++.++|+||||+++|+|++|..||....... ....   .          ......
T Consensus       148 ---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~---~----------~~~~~~  210 (262)
T cd05572         148 ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-MEIY---N----------DILKGN  210 (262)
T ss_pred             ---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-HHHH---H----------HHhccC
Confidence               1223578999999999988889999999999999999999999997553211 1111   0          011101


Q ss_pred             cCCCCChhhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011250          378 LEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  414 (490)
Q Consensus       378 l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt-----~~evl~~  414 (490)
                      ....++...+.++.++|.+||+.||.+||+     +.|++++
T Consensus       211 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~  252 (262)
T cd05572         211 GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH  252 (262)
T ss_pred             CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence            112233333678999999999999999999     7887763

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.4e-38  Score=321.29  Aligned_cols=270  Identities=26%  Similarity=0.377  Sum_probs=202.7

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC--CcccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      .++|.+.+.||+|+||.||+|++..         ++..||||.+...  .......+.+|+.+++.++|+||+++++++.
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~   74 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSE---------TNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMP   74 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecC---------CCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHhee
Confidence            3579999999999999999998865         6779999998653  2233456788999999999999999999886


Q ss_pred             eCC-----ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 011250          210 EDD-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       210 ~~~-----~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL  284 (490)
                      ...     ..+|||||+. ++|.+++... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||
T Consensus        75 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL  149 (337)
T cd07858          75 PPHREAFNDVYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKI  149 (337)
T ss_pred             cccccccCcEEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEE
Confidence            543     4799999995 7898888543 57999999999999999999999988   999999999999999999999


Q ss_pred             ecccCcccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhH-hhhc
Q 011250          285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE-WARP  362 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~-~~~~  362 (490)
                      +|||++.......  .......|+..|+|||.+.. ..++.++|||||||++|+|++|++||............. ....
T Consensus       150 ~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  227 (337)
T cd07858         150 CDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGS  227 (337)
T ss_pred             CcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC
Confidence            9999998764432  11233568999999998865 468899999999999999999999996542111100000 0000


Q ss_pred             -------ccC--Ccchhhhc----cCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH--hhcC
Q 011250          363 -------HLG--DKRRFYRL----LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPL  418 (490)
Q Consensus       363 -------~~~--~~~~~~~~----~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~--L~~l  418 (490)
                             ...  ....+...    .++.+. ......+.++.+||.+||+.||.+|||+.+++++  +..+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         228 PSEEDLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             CChHHhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence                   000  00000000    000000 0112347889999999999999999999999987  5544

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.8e-38  Score=311.21  Aligned_cols=245  Identities=31%  Similarity=0.434  Sum_probs=195.6

Q ss_pred             cccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEEEeCCceEEE
Q 011250          141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  217 (490)
Q Consensus       141 LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  217 (490)
                      ||+|+||.||+|.+..         +|..||+|.+.....   .....+..|+.+++.++||||+++++++...+..|+|
T Consensus         1 lg~g~~g~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   71 (277)
T cd05577           1 LGKGGFGEVCACQVKA---------TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLV   71 (277)
T ss_pred             CCCCCceeEEEEEEcC---------CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEE
Confidence            6999999999998776         567899999865422   2234567899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCC
Q 011250          218 YEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  296 (490)
Q Consensus       218 ~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~  296 (490)
                      |||+++++|.+++.... ..+++..+..++.|++.||.|||+.+   |+||||+|+|||++.++.++|+|||++......
T Consensus        72 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~  148 (277)
T cd05577          72 MTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG  148 (277)
T ss_pred             EecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC
Confidence            99999999999986544 36899999999999999999999988   999999999999999999999999998765432


Q ss_pred             CcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCC
Q 011250          297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP  376 (490)
Q Consensus       297 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (490)
                      ..   .....|+..|+|||++.+..++.++|||||||++|+|++|+.||.............  .....           
T Consensus       149 ~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~-----------  212 (277)
T cd05577         149 KK---IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK--RRTLE-----------  212 (277)
T ss_pred             Cc---cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH--hcccc-----------
Confidence            11   123467889999999988889999999999999999999999996543311111110  00000           


Q ss_pred             ccCCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011250          377 RLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  414 (490)
Q Consensus       377 ~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----t~~evl~~  414 (490)
                       ....++...+..+.++|.+||+.||.+||     ++.+++++
T Consensus       213 -~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         213 -MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             -ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence             01112223377899999999999999999     66667653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-38  Score=313.63  Aligned_cols=265  Identities=23%  Similarity=0.333  Sum_probs=199.3

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      |++.+.||.|++|.||+|.+..         +|..||+|++.....  .....+.+|+.+++.++||||+++++++.+++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~   71 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKL---------TGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN   71 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcC---------CCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC
Confidence            6778899999999999999876         567899999875532  22356888999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      ..++||||+ +++|.+++.... ..+++..++.++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++.
T Consensus        72 ~~~iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~  147 (283)
T cd07835          72 KLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLAR  147 (283)
T ss_pred             eEEEEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence            999999999 468999886543 36899999999999999999999987   9999999999999999999999999997


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhccC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcc-hhhHhhhcc------
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLVEWARPH------  363 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~-~~~~~~~~~------  363 (490)
                      ........  .....++..|+|||++.+. .++.++|||||||++|+|++|..||......... .........      
T Consensus       148 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  225 (283)
T cd07835         148 AFGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWP  225 (283)
T ss_pred             ccCCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhh
Confidence            65332111  1223578899999987654 5788999999999999999999999754321110 000000000      


Q ss_pred             -cCCcchhhhccC---CccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          364 -LGDKRRFYRLLD---PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       364 -~~~~~~~~~~~~---~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                       ......+...+.   ...........+..+.+||.+||+.||.+||++.+++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         226 GVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence             000000000000   000001112235789999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.7e-38  Score=314.60  Aligned_cols=265  Identities=18%  Similarity=0.219  Sum_probs=190.5

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccH-----------HHHHHHHHHHhccCCC
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-----------KEWLAEVNFLGNLLHP  199 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~Ei~il~~l~Hp  199 (490)
                      ..++|.+.++||+|+||.||+|.+...+.      .+..+|+|+.........           .....++..+..+.|+
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~------~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~   83 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHC------INNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHL   83 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcc------cccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCC
Confidence            34579999999999999999999865321      144677776543321111           1123344556677899


Q ss_pred             CeeceeeEEEeCC----ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 011250          200 NLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  275 (490)
Q Consensus       200 nIv~l~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NIL  275 (490)
                      ||+++++++....    ..+++||++ ..++.+.+.. ....++..+..++.|++.||.|||+.+   |+||||||+|||
T Consensus        84 ~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nil  158 (294)
T PHA02882         84 GIPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIM  158 (294)
T ss_pred             CCCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence            9999999776554    346888887 4467666643 334678889999999999999999988   999999999999


Q ss_pred             EcCCCCeEEecccCcccCCCCCcc-----eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCC
Q 011250          276 LDADYNAKLSDFGLAKDAPEDGKT-----HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP  350 (490)
Q Consensus       276 l~~~~~vkL~DFG~a~~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~  350 (490)
                      ++.++.++|+|||+|+........     .......||+.|+|||++.+..++.++|||||||+||||++|..||.....
T Consensus       159 l~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~  238 (294)
T PHA02882        159 VDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH  238 (294)
T ss_pred             EcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence            999999999999999876432211     111234699999999999999999999999999999999999999976532


Q ss_pred             CCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011250          351 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~  416 (490)
                      .......  .....     ...+....+   ....++..+.+++..||..+|++||++.+|++.|+
T Consensus       239 ~~~~~~~--~~~~~-----~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        239 NGNLIHA--AKCDF-----IKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             chHHHHH--hHHHH-----HHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            2211100  00000     000111110   01123678999999999999999999999998763

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-38  Score=307.67  Aligned_cols=252  Identities=25%  Similarity=0.370  Sum_probs=200.6

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-----cccHHHHHHHHHHHhccCCCCeeceeeE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~l~~~  207 (490)
                      .+|++.+.||+|+||.||+|.+..         ++..||+|.+....     ......+.+|+.+++.++|+||++++++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~   72 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDAD---------TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGC   72 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcC---------CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEE
Confidence            479999999999999999998865         57789999875321     2233568899999999999999999999


Q ss_pred             EEeC--CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEe
Q 011250          208 CIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       208 ~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~  285 (490)
                      +.+.  ...++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+   |+|+||||+||+++.++.++|+
T Consensus        73 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~  148 (264)
T cd06653          73 LRDPEEKKLSIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLG  148 (264)
T ss_pred             EEcCCCCEEEEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEC
Confidence            8764  45789999999999999986543 5889999999999999999999988   9999999999999999999999


Q ss_pred             cccCcccCCCCCcc-eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc
Q 011250          286 DFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       286 DFG~a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      |||+++........ .......|+..|+|||++.+..++.++|||||||++|+|++|+.||........  ...      
T Consensus       149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~------  220 (264)
T cd06653         149 DFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA--IFK------  220 (264)
T ss_pred             ccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH--HHH------
Confidence            99999865321111 111235689999999999888899999999999999999999999964321110  000      


Q ss_pred             CCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                              .........++...+..+.+++.+||. +|..||++.+++.|
T Consensus       221 --------~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         221 --------IATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             --------HHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence                    000111122333447889999999998 57999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-38  Score=317.23  Aligned_cols=269  Identities=24%  Similarity=0.324  Sum_probs=199.8

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      +|.+.+.||+|+||.||+|.+...       +++..||+|.+....   ....+.+.+|+.++..++||||+++++++.+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~-------~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   73 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNG-------KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE   73 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCC-------CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC
Confidence            478889999999999999998652       146789999998643   2334567889999999999999999999998


Q ss_pred             C--CceEEEEEecCCCChhHHhhhc----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC----CC
Q 011250          211 D--DQRLLVYEFMPRGSLENHLFRR----SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA----DY  280 (490)
Q Consensus       211 ~--~~~~lV~E~~~~gsL~~~l~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~----~~  280 (490)
                      .  ...++||||+. ++|.+++...    ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.    ++
T Consensus        74 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~  149 (316)
T cd07842          74 HADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERG  149 (316)
T ss_pred             CCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccc
Confidence            8  78999999996 4777766432    236889999999999999999999988   999999999999999    89


Q ss_pred             CeEEecccCcccCCCCCc-ceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcc----
Q 011250          281 NAKLSDFGLAKDAPEDGK-THVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH----  354 (490)
Q Consensus       281 ~vkL~DFG~a~~~~~~~~-~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~----  354 (490)
                      .+||+|||++........ ........++..|+|||++.+ ..++.++|||||||+||+|++|++||.........    
T Consensus       150 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~  229 (316)
T cd07842         150 VVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPF  229 (316)
T ss_pred             eEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchh
Confidence            999999999987644322 111233578999999998876 45889999999999999999999999755433200    


Q ss_pred             ---hhhHhhhcccCC-----------cchhhhccCCccCCCCC---------h--hhHHHHHHHHHHhhhcCCCCCCCHH
Q 011250          355 ---NLVEWARPHLGD-----------KRRFYRLLDPRLEGHFS---------I--KGSQKATQLAAQCLSRDPKARPRMS  409 (490)
Q Consensus       355 ---~~~~~~~~~~~~-----------~~~~~~~~~~~l~~~~~---------~--~~~~~l~~Li~~cL~~dP~~RPt~~  409 (490)
                         .+.... ..+..           ...+....+......++         .  ..+..+.+++.+||+.||++|||+.
T Consensus       230 ~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~  308 (316)
T cd07842         230 QRDQLERIF-EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAE  308 (316)
T ss_pred             HHHHHHHHH-HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHH
Confidence               000000 00000           00000000000000010         1  3356789999999999999999999


Q ss_pred             HHHHH
Q 011250          410 EVVET  414 (490)
Q Consensus       410 evl~~  414 (490)
                      +++++
T Consensus       309 eil~~  313 (316)
T cd07842         309 EALEH  313 (316)
T ss_pred             HHhcC
Confidence            99865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-39  Score=324.51  Aligned_cols=265  Identities=24%  Similarity=0.326  Sum_probs=198.6

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .++|.+.+.||+|+||.||+|.+..         +|..||||.+.... ......+.+|+.+++.++|+||+++++++..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   74 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKP---------TGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRP   74 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcC---------CCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeec
Confidence            4689999999999999999998875         57789999986432 2334567889999999999999999998765


Q ss_pred             CC-----ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEe
Q 011250          211 DD-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       211 ~~-----~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~  285 (490)
                      ..     ..++||||+. ++|.+++..  ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+
T Consensus        75 ~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~  148 (336)
T cd07849          75 PSFESFNDVYIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKIC  148 (336)
T ss_pred             ccccccceEEEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEC
Confidence            43     4799999995 588887733  46999999999999999999999988   9999999999999999999999


Q ss_pred             cccCcccCCCCCcc-eeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011250          286 DFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       286 DFG~a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      |||++......... .......||..|+|||++.+ ..++.++|||||||++|+|++|+.||.........   ......
T Consensus       149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~---~~~~~~  225 (336)
T cd07849         149 DFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQL---NLILGV  225 (336)
T ss_pred             cccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHH
Confidence            99999765432211 11233578999999998754 56899999999999999999999999654321110   000000


Q ss_pred             cCC--cchhh-----------hccCCccCCC---CChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          364 LGD--KRRFY-----------RLLDPRLEGH---FSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       364 ~~~--~~~~~-----------~~~~~~l~~~---~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      +..  ...+.           ..........   .....+.++.+||.+||+.||.+|||+.+++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         226 LGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             cCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000  00000           0000000000   001236778999999999999999999999987

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=304.86  Aligned_cols=257  Identities=26%  Similarity=0.393  Sum_probs=202.3

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccC-CCCeeceeeEEEeCCceEEE
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIEDDQRLLV  217 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV  217 (490)
                      ++||+|+|+.|--|....         +|.+||||++.+...-...++.+|++++.+.+ |+||+.|+++|+++..+|||
T Consensus        84 e~LGeGAyasVqtcv~i~---------t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLV  154 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQ---------TGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLV  154 (463)
T ss_pred             HHhcCccceeeeeeeeec---------cchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEE
Confidence            679999999999988776         78899999998876666788999999999987 99999999999999999999


Q ss_pred             EEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC---CeEEecccCcccCC
Q 011250          218 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY---NAKLSDFGLAKDAP  294 (490)
Q Consensus       218 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~---~vkL~DFG~a~~~~  294 (490)
                      ||-|.||.|..+|.++. .|++.++..+..+|+.||.|||..|   |.||||||+|||.....   -||||||.+..-..
T Consensus       155 fEKm~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k  230 (463)
T KOG0607|consen  155 FEKMRGGPLLSHIQKRK-HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIK  230 (463)
T ss_pred             EecccCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccc
Confidence            99999999999997664 6999999999999999999999988   99999999999996554   48999999875432


Q ss_pred             CCCc-----ceeeeccccCCCccCcchhc-----cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc
Q 011250          295 EDGK-----THVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       295 ~~~~-----~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      ....     +......+|+..|||||++.     ...|+.++|.||||||||.||+|.+||.+.--.+    ..|.+...
T Consensus       231 ~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d----CGWdrGe~  306 (463)
T KOG0607|consen  231 LNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD----CGWDRGEV  306 (463)
T ss_pred             cCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc----CCccCCCc
Confidence            2111     11123478999999999874     3478999999999999999999999997543211    11211111


Q ss_pred             C---CcchhhhccCCccCCCCC----hhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          365 G---DKRRFYRLLDPRLEGHFS----IKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       365 ~---~~~~~~~~~~~~l~~~~~----~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .   ....|..+.+-..  +||    ...+.++.+||..+|.+|+.+|.++.+++++
T Consensus       307 Cr~CQ~~LFesIQEGkY--eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh  361 (463)
T KOG0607|consen  307 CRVCQNKLFESIQEGKY--EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH  361 (463)
T ss_pred             cHHHHHHHHHHHhccCC--cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence            0   0011112221111  122    2238899999999999999999999999874

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-40  Score=305.62  Aligned_cols=253  Identities=24%  Similarity=0.290  Sum_probs=198.9

Q ss_pred             hhcCCCCC-cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcc-CCCCeeceeeEE
Q 011250          131 ATRNFRPE-SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGYC  208 (490)
Q Consensus       131 ~~~~y~~~-~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~  208 (490)
                      .+++|.+. ++||-|-.|.|..|.++.         ++..+|+|++...     ....+|+++.-.. .|||||.++++|
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~---------T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVy  124 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKR---------TQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVY  124 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEecc---------chhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhh
Confidence            45567665 579999999999999887         7889999998643     3456788876555 499999999988


Q ss_pred             Ee----CCceEEEEEecCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CC
Q 011250          209 IE----DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DY  280 (490)
Q Consensus       209 ~~----~~~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~---~~  280 (490)
                      ..    ...+++|||.|+||.|+..|..++ ..+++.++..|+.||+.|+.|||+.+   |.||||||+|+|...   |.
T Consensus       125 eNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na  201 (400)
T KOG0604|consen  125 ENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNA  201 (400)
T ss_pred             hhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCc
Confidence            64    345789999999999999998765 47999999999999999999999988   999999999999954   56


Q ss_pred             CeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011250          281 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       281 ~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~  360 (490)
                      .+||+|||+|+......   .....|-|++|.|||++....|+..+|+||+||++|-||+|.+||....-..       .
T Consensus       202 ~lKLtDfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-------i  271 (400)
T KOG0604|consen  202 PLKLTDFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-------I  271 (400)
T ss_pred             ceEecccccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-------C
Confidence            79999999998764321   2234788999999999999999999999999999999999999996432110       0


Q ss_pred             hcccCCcc--hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          361 RPHLGDKR--RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       361 ~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                      .+.+..+.  ..+...+     .-....++.++++|+.+|..+|.+|.|+.+++++-
T Consensus       272 spgMk~rI~~gqy~FP~-----pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp  323 (400)
T KOG0604|consen  272 SPGMKRRIRTGQYEFPE-----PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP  323 (400)
T ss_pred             ChhHHhHhhccCccCCC-----hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence            01110000  0001111     11123489999999999999999999999999864

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.4e-38  Score=314.54  Aligned_cols=265  Identities=22%  Similarity=0.290  Sum_probs=197.4

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccC-CCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLL-HPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~  209 (490)
                      ++|++.+.||+|+||.||+|.+..         ++..||||.+.....  .....+.+|+.+++.+. |+||+++++++.
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~   71 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKN---------TGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEH   71 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECC---------CCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEe
Confidence            368899999999999999999876         567899999865432  22356888999999995 699999999988


Q ss_pred             eCCc-----eEEEEEecCCCChhHHhhhc----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-C
Q 011250          210 EDDQ-----RLLVYEFMPRGSLENHLFRR----SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-D  279 (490)
Q Consensus       210 ~~~~-----~~lV~E~~~~gsL~~~l~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~-~  279 (490)
                      ..+.     .|+||||+++ +|.+++...    ...+++..++.++.||+.||.|||+.+   |+||||||+||+++. +
T Consensus        72 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~  147 (295)
T cd07837          72 VEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQK  147 (295)
T ss_pred             ecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCC
Confidence            7665     8999999975 898887543    245899999999999999999999988   999999999999998 8


Q ss_pred             CCeEEecccCcccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhH
Q 011250          280 YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE  358 (490)
Q Consensus       280 ~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~  358 (490)
                      +.+||+|||++.........  .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||.........  ..
T Consensus       148 ~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~--~~  223 (295)
T cd07837         148 GLLKIADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL--LH  223 (295)
T ss_pred             CeEEEeecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH--HH
Confidence            99999999998765332111  122357889999998865 46789999999999999999999999754321110  00


Q ss_pred             hhhcc-cCCcchhhhc--------c---CCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          359 WARPH-LGDKRRFYRL--------L---DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       359 ~~~~~-~~~~~~~~~~--------~---~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ..... ......+...        .   .+..........+.++.+||.+||..||.+||++.+++.+
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         224 IFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             HHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            00000 0000000000        0   0000000112246789999999999999999999999865

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=4.7e-38  Score=308.80  Aligned_cols=243  Identities=28%  Similarity=0.403  Sum_probs=190.7

Q ss_pred             ccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHH---HHHhccCCCCeeceeeEEEeCCc
Q 011250          140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEV---NFLGNLLHPNLVKLVGYCIEDDQ  213 (490)
Q Consensus       140 ~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~Ei---~il~~l~HpnIv~l~~~~~~~~~  213 (490)
                      +||+|+||.||+|.+..         +++.||+|.+......   ....+..|.   .+++...||||+.+++++.+.+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~   71 (278)
T cd05606           1 IIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK   71 (278)
T ss_pred             CcccCCCeEEEEEEEec---------CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCE
Confidence            48999999999998865         5778999998764322   112233443   34455679999999999999999


Q ss_pred             eEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccC
Q 011250          214 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       214 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~  293 (490)
                      .++||||+.||+|..++... ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++...
T Consensus        72 ~~~v~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~  147 (278)
T cd05606          72 LSFILDLMNGGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  147 (278)
T ss_pred             EEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCcccc
Confidence            99999999999999888543 47999999999999999999999988   999999999999999999999999998765


Q ss_pred             CCCCcceeeeccccCCCccCcchhccC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhh
Q 011250          294 PEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR  372 (490)
Q Consensus       294 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (490)
                      ....    .....|+..|+|||++.++ .++.++|||||||++|||++|+.||...............   .        
T Consensus       148 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~--------  212 (278)
T cd05606         148 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---L--------  212 (278)
T ss_pred             CccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh---h--------
Confidence            3321    1235799999999998754 6899999999999999999999999754322211111000   0        


Q ss_pred             ccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011250          373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  414 (490)
Q Consensus       373 ~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----t~~evl~~  414 (490)
                      ..    ...++...+..+.+++.+||..||.+||     ++.+++++
T Consensus       213 ~~----~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         213 TM----AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             cc----CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            00    1112223378899999999999999999     99999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.3e-38  Score=311.98  Aligned_cols=267  Identities=22%  Similarity=0.325  Sum_probs=198.1

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ++|++.+.||+|+||.||+|.+..         ++..||+|.+.....  ...+.+.+|+++++.++||||+++++++.+
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   72 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRV---------TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS   72 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecC---------CCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec
Confidence            468999999999999999999865         567899999865432  223568889999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-CCCeEEeccc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYNAKLSDFG  288 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~-~~~vkL~DFG  288 (490)
                      ....++||||++ ++|.+++.... ..+++..+..++.||+.||+|||+.+   |+||||+|+||+++. ++.+||+|||
T Consensus        73 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg  148 (294)
T PLN00009         73 EKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFG  148 (294)
T ss_pred             CCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccc
Confidence            999999999995 58888775433 34678888999999999999999988   999999999999985 5679999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchh-hHhh-hcccC
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL-VEWA-RPHLG  365 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~-~~~~-~~~~~  365 (490)
                      ++........  ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||......+.... .... .+...
T Consensus       149 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  226 (294)
T PLN00009        149 LARAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEE  226 (294)
T ss_pred             cccccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            9976533211  1123467899999998865 4578999999999999999999999975432211110 0000 00000


Q ss_pred             ------Ccchhhhcc---CCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          366 ------DKRRFYRLL---DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 ------~~~~~~~~~---~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                            ....+....   .+..........+.++.+++.+||+.||.+||++.+++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        227 TWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             hccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  000000000   0000001112336778999999999999999999999964

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-38  Score=311.37  Aligned_cols=266  Identities=25%  Similarity=0.348  Sum_probs=202.1

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhccCCCCeeceeeEEEeC-
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED-  211 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-  211 (490)
                      |++.+.||.|+||.||+|.+..         ++..||+|.+....  ......+.+|+.+++.+.|+||+++++++... 
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   71 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKK---------TGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG   71 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECC---------CCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC
Confidence            6778899999999999999876         56789999997653  23345688999999999999999999999988 


Q ss_pred             -CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          212 -DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       212 -~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                       +..++||||++ ++|.+++......+++..++.++.||+.||+|||+.+   ++|+||+|+|||+++++.++|+|||++
T Consensus        72 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~  147 (287)
T cd07840          72 KGSIYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLA  147 (287)
T ss_pred             CCcEEEEecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccce
Confidence             88999999996 5899888666567999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHh-hh-cccCCc
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW-AR-PHLGDK  367 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~-~~-~~~~~~  367 (490)
                      ......... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.. .. +.....
T Consensus       148 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  226 (287)
T cd07840         148 RPYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENW  226 (287)
T ss_pred             eeccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhc
Confidence            876543211 1223467889999997764 4678999999999999999999999975443211111100 00 000000


Q ss_pred             chh-----hhcc------CCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          368 RRF-----YRLL------DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       368 ~~~-----~~~~------~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ..+     ....      ...+...+...++..+.+++.+||..||.+||++.+++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         227 PGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             cccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            000     0000      0001111111136789999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.3e-38  Score=308.41  Aligned_cols=244  Identities=27%  Similarity=0.392  Sum_probs=196.7

Q ss_pred             cccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEEEeCCceEEE
Q 011250          141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  217 (490)
Q Consensus       141 LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  217 (490)
                      ||.|+||.||+|++..         ++..|++|.+.....   ...+.+.+|+++++.+.|+||+++++.+..+...|+|
T Consensus         1 lg~g~~~~vy~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   71 (265)
T cd05579           1 ISKGAYGRVFLAKKKS---------TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLV   71 (265)
T ss_pred             CCCCCceEEEEEEECC---------CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEE
Confidence            6899999999999875         567899999976543   3345788999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCCC
Q 011250          218 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG  297 (490)
Q Consensus       218 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~  297 (490)
                      |||+++++|.+++.+.. .+++..+..++.||+.||+|||+.+   |+||||+|+||+++.++.++|+|||++.......
T Consensus        72 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~  147 (265)
T cd05579          72 MEYLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRR  147 (265)
T ss_pred             EecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCc
Confidence            99999999999986544 7899999999999999999999988   9999999999999999999999999987654331


Q ss_pred             c------ceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhh
Q 011250          298 K------THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  371 (490)
Q Consensus       298 ~------~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (490)
                      .      ........++..|+|||.+....++.++||||||+++|+|++|..||.......   ......   ....   
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~~~~---~~~~---  218 (265)
T cd05579         148 QINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE---IFQNIL---NGKI---  218 (265)
T ss_pred             ccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHh---cCCc---
Confidence            1      112233568899999999988889999999999999999999999996543211   111100   0000   


Q ss_pred             hccCCccCCCCChh--hHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          372 RLLDPRLEGHFSIK--GSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       372 ~~~~~~l~~~~~~~--~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                               .++..  .+..+.+|+.+||+.+|.+|||+.++.+.|
T Consensus       219 ---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         219 ---------EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             ---------CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence                     01111  267889999999999999999995444444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=6.1e-38  Score=306.24  Aligned_cols=245  Identities=22%  Similarity=0.260  Sum_probs=192.3

Q ss_pred             hcCCCCCccc--ccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcc-CCCCeeceeeEE
Q 011250          132 TRNFRPESLL--GEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGYC  208 (490)
Q Consensus       132 ~~~y~~~~~L--G~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~  208 (490)
                      .++|.+.+.+  |.|+||.||+++...         ++..+|+|.+........     |+.+...+ +|+||+++++++
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~   78 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKP---------TQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSV   78 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcC---------CCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEE
Confidence            3467777776  999999999998876         567899999875432221     22222222 699999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-CeEEecc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDF  287 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-~vkL~DF  287 (490)
                      ...+..++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+   |+||||||+||+++.++ .++|+||
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~df  154 (267)
T PHA03390         79 TTLKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDY  154 (267)
T ss_pred             ecCCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecC
Confidence            99999999999999999999986553 8999999999999999999999988   99999999999999988 9999999


Q ss_pred             cCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011250          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      |++......      ....|+..|+|||++.+..++.++|||||||++|+|++|..||...... ......+.... .. 
T Consensus       155 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~-~~-  225 (267)
T PHA03390        155 GLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQ-QK-  225 (267)
T ss_pred             ccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhh-cc-
Confidence            998765432      1246899999999999889999999999999999999999999743221 11111111110 00 


Q ss_pred             chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCC-HHHHHHH
Q 011250          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-MSEVVET  414 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt-~~evl~~  414 (490)
                                 ........+..+.+||.+||+.||.+||+ +++++++
T Consensus       226 -----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        226 -----------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             -----------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence                       00111134788999999999999999996 6998864

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-38  Score=302.62  Aligned_cols=249  Identities=31%  Similarity=0.504  Sum_probs=205.8

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      +|++.+.||+|+||.||+|.+..         ++..|++|.+.....  .....+.+|++++..++|+||+++++++.++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLE---------TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS   71 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcC---------CCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Confidence            47889999999999999998865         566899999987654  3456789999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      ...++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.++|+|||++.
T Consensus        72 ~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~  147 (254)
T cd06627          72 DSLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVAT  147 (254)
T ss_pred             CEEEEEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccce
Confidence            9999999999999999998654 57999999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhh
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  371 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (490)
                      ........  .....|+..|+|||.+.+..++.++||||||+++|+|++|..||......   ... +. ....      
T Consensus       148 ~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~---~~~-~~-~~~~------  214 (254)
T cd06627         148 KLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM---AAL-FR-IVQD------  214 (254)
T ss_pred             ecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH---HHH-HH-Hhcc------
Confidence            76543321  23356899999999998888899999999999999999999999643211   000 00 0000      


Q ss_pred             hccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       372 ~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                            ....++...+..+.+++.+||..+|++||++.+++.+
T Consensus       215 ------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         215 ------DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             ------CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence                  0111222336789999999999999999999999853

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.9e-38  Score=304.97  Aligned_cols=248  Identities=25%  Similarity=0.381  Sum_probs=204.2

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      +|++.+.||+|+||.||++.+..         ++..+|+|.+.....  .....+.+|+.+++.++|+||+++++++.+.
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLS---------DNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG   71 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECC---------CCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC
Confidence            48889999999999999998765         567899999875432  2345678899999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhc---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      ...++||||+++++|.+++.+.   ...+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||
T Consensus        72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g  148 (256)
T cd08530          72 NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLG  148 (256)
T ss_pred             CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeecc
Confidence            9999999999999999988652   346899999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ++......    ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||......   .+.....       
T Consensus       149 ~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~-------  214 (256)
T cd08530         149 ISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLRYKVQ-------  214 (256)
T ss_pred             chhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHh-------
Confidence            99876543    122346889999999999889999999999999999999999999654321   1111000       


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                             .......+...+.++.+++.+||..+|.+||++.+++++
T Consensus       215 -------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         215 -------RGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             -------cCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                   000011122346789999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.8e-38  Score=316.93  Aligned_cols=263  Identities=23%  Similarity=0.296  Sum_probs=194.9

Q ss_pred             cccccC--CceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEeCCce
Q 011250          139 SLLGEG--GFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQR  214 (490)
Q Consensus       139 ~~LG~G--~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  214 (490)
                      ..||+|  +||+||+|++..         +|..||+|++.....  ...+.+.+|+.+++.++||||++++++|..++..
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~   74 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTP---------TGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL   74 (328)
T ss_pred             HHhCCcccCceeEEEEEEcC---------CCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCce
Confidence            456766  999999999876         677999999875432  2346688899999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccC
Q 011250          215 LLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~  293 (490)
                      ++||||+.+++|.+++... ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.++++||+.+...
T Consensus        75 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~  151 (328)
T cd08226          75 WVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSL  151 (328)
T ss_pred             EEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence            9999999999999988654 245899999999999999999999988   999999999999999999999999865433


Q ss_pred             CCCCcce-----eeeccccCCCccCcchhccC--CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc-c--
Q 011250          294 PEDGKTH-----VSTRVMGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP-H--  363 (490)
Q Consensus       294 ~~~~~~~-----~~~~~~Gt~~y~aPE~l~~~--~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~-~--  363 (490)
                      .......     ......++..|+|||++.+.  .++.++|||||||++|||++|..||........  ....... .  
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~  229 (328)
T cd08226         152 VRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYS  229 (328)
T ss_pred             hccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCC
Confidence            2211110     01112356779999998763  578999999999999999999999975432111  0000000 0  


Q ss_pred             ------cCCcc--------hh--------------hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          364 ------LGDKR--------RF--------------YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       364 ------~~~~~--------~~--------------~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                            .....        .+              .......+........+..+.+|+++||+.||.+|||+.+++++-
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~  309 (328)
T cd08226         230 PLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA  309 (328)
T ss_pred             CccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence                  00000        00              000001111122234578899999999999999999999999763

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.1e-38  Score=312.51  Aligned_cols=246  Identities=27%  Similarity=0.401  Sum_probs=199.4

Q ss_pred             CcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCCceEEE
Q 011250          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  217 (490)
Q Consensus       138 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  217 (490)
                      ..+||+|+||.||+|....         ++..||||.+..........+.+|+.+++.++|+||+++++++...+..++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   95 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKS---------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV   95 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcC---------CCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEE
Confidence            4679999999999998876         5778999998665545556788999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCCC
Q 011250          218 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG  297 (490)
Q Consensus       218 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~  297 (490)
                      |||+++++|.+++..  ..+++..+..++.|++.+|+|||+.+   |+||||+|+||+++.++.++|+|||++.......
T Consensus        96 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~  170 (292)
T cd06657          96 MEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  170 (292)
T ss_pred             EecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc
Confidence            999999999987743  35899999999999999999999988   9999999999999999999999999987654322


Q ss_pred             cceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCc
Q 011250          298 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPR  377 (490)
Q Consensus       298 ~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  377 (490)
                      .  ......|++.|+|||.+.+..++.++||||||+++|+|++|..||........   .......+          .+.
T Consensus       171 ~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~---~~~~~~~~----------~~~  235 (292)
T cd06657         171 P--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMIRDNL----------PPK  235 (292)
T ss_pred             c--cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhhC----------Ccc
Confidence            1  12335689999999999888899999999999999999999999864322111   11111101          111


Q ss_pred             cCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       378 l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      +..  ....+..+.+++.+||..||.+||++.+++++
T Consensus       236 ~~~--~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         236 LKN--LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             cCC--cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            100  01235678999999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.5e-38  Score=312.70  Aligned_cols=269  Identities=26%  Similarity=0.341  Sum_probs=201.8

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeE
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~  207 (490)
                      ...++|++.+.||+|+||.||+|.+..         ++..||||.++....  .....+.+|+.+++.++||||++++++
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~   74 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKD---------TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI   74 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECC---------CCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeehe
Confidence            345689999999999999999999876         567899999975432  223567789999999999999999999


Q ss_pred             EEeCC----------ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc
Q 011250          208 CIEDD----------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD  277 (490)
Q Consensus       208 ~~~~~----------~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~  277 (490)
                      +.+..          ..+|||||+++ +|...+......+++..+..++.||+.||+|||+.+   |+||||||+||+++
T Consensus        75 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~  150 (302)
T cd07864          75 VTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLN  150 (302)
T ss_pred             ecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence            87655          78999999975 777777665557999999999999999999999988   99999999999999


Q ss_pred             CCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchh
Q 011250          278 ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL  356 (490)
Q Consensus       278 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~  356 (490)
                      .++.+||+|||++......... ......++..|+|||.+.+ ..++.++|||||||++|||++|++||...........
T Consensus       151 ~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~  229 (302)
T cd07864         151 NKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLEL  229 (302)
T ss_pred             CCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            9999999999999876543221 1122356889999998864 4578999999999999999999999975432111111


Q ss_pred             hHhhh--------cccCCcchhhhccCC------ccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          357 VEWAR--------PHLGDKRRFYRLLDP------RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       357 ~~~~~--------~~~~~~~~~~~~~~~------~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      +....        +.+..... +...+.      .....+ ...+..+.+|+.+||..||.+||++.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         230 ISRLCGSPCPAVWPDVIKLPY-FNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             HHHHhCCCChhhccccccccc-ccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11000        00000000 000000      000001 1236789999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-38  Score=310.23  Aligned_cols=262  Identities=27%  Similarity=0.365  Sum_probs=203.6

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      |.+.+.||.|++|.||+|....         ++..+++|.+......  ....+.+|+.+++.++|+||+++++++..++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   71 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKL---------TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG   71 (283)
T ss_pred             CccceeeecCCCceEEEEEcCC---------CCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC
Confidence            5677899999999999998865         5678999998765433  3457888999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      ..++||||+++ +|.+++......+++..+..++.||+.||.|||+.+   |+|+||||+||+++.++.++|+|||.+..
T Consensus        72 ~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~  147 (283)
T cd05118          72 DLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARS  147 (283)
T ss_pred             CEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEe
Confidence            99999999964 898888776668999999999999999999999988   99999999999999999999999999987


Q ss_pred             CCCCCcceeeeccccCCCccCcchhccC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc--ch
Q 011250          293 APEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK--RR  369 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~--~~  369 (490)
                      ......  ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||............   ...+...  ..
T Consensus       148 ~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~---~~~~~~~~~~~  222 (283)
T cd05118         148 FGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI---FRTLGTPDPEV  222 (283)
T ss_pred             cCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHcCCCchHh
Confidence            654331  12234688899999998876 7899999999999999999999999654322111110   0000000  00


Q ss_pred             hhhcc-----------CC--ccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          370 FYRLL-----------DP--RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       370 ~~~~~-----------~~--~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      +....           ..  ..........+.++.+||.+||..||.+||++.+++.+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         223 WPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             cccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            00000           00  00001112347889999999999999999999999864

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.3e-38  Score=321.18  Aligned_cols=269  Identities=24%  Similarity=0.349  Sum_probs=201.6

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ++|++.+.||.|+||.||+|....         ++..||+|++....  ....+.+.+|+.+|+.++||||+++++++..
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   75 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTR---------SGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRP   75 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcC---------CCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccc
Confidence            679999999999999999998876         57789999987542  2344677889999999999999999998763


Q ss_pred             ----CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEec
Q 011250          211 ----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       211 ----~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~D  286 (490)
                          ....++||||+. ++|.+++... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        76 ~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~d  150 (334)
T cd07855          76 PGADFKDVYVVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGD  150 (334)
T ss_pred             cCCCCceEEEEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecc
Confidence                346899999994 6898888544 46999999999999999999999988   99999999999999999999999


Q ss_pred             ccCcccCCCCCcc--eeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011250          287 FGLAKDAPEDGKT--HVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       287 FG~a~~~~~~~~~--~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      ||++.........  .......|+..|+|||.+.. ..++.++|||||||++|||++|+.||...........+......
T Consensus       151 fg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~  230 (334)
T cd07855         151 FGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGS  230 (334)
T ss_pred             cccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCC
Confidence            9999765432211  11234578999999998865 46889999999999999999999999754322111110000000


Q ss_pred             ---------cCC-cchhhhccCCccC---CCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          364 ---------LGD-KRRFYRLLDPRLE---GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       364 ---------~~~-~~~~~~~~~~~l~---~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                               ..+ .......+.....   ..+....+.++.++|++||+.||.+||++.+++.+-
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~  295 (334)
T cd07855         231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP  295 (334)
T ss_pred             ChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence                     000 0000000000000   001122368899999999999999999999999763

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.2e-38  Score=319.80  Aligned_cols=267  Identities=29%  Similarity=0.366  Sum_probs=199.7

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC--CcccHHHHHHHHHHHhcc-CCCCeeceeeEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNL-LHPNLVKLVGYC  208 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~  208 (490)
                      .++|.+.+.||+|+||.||+|.+..         ++..||||.+...  .......+.+|+.+++.+ +||||+++++++
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~   76 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRR---------TKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVI   76 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcC---------CCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeee
Confidence            4578999999999999999998865         5678999988543  223345677899999999 999999999998


Q ss_pred             EeCC--ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEec
Q 011250          209 IEDD--QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       209 ~~~~--~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~D  286 (490)
                      ...+  ..++||||+. ++|..++...  .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|
T Consensus        77 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d  150 (337)
T cd07852          77 KAENDKDIYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLAD  150 (337)
T ss_pred             ccCCCceEEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEee
Confidence            6543  6799999996 5998888543  7889999999999999999999988   99999999999999999999999


Q ss_pred             ccCcccCCCCCcc---eeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011250          287 FGLAKDAPEDGKT---HVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       287 FG~a~~~~~~~~~---~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      ||++.........   .......||..|+|||++.+ ..++.++|||||||++|+|++|+.||.................
T Consensus       151 ~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~  230 (337)
T cd07852         151 FGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIG  230 (337)
T ss_pred             ccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            9999876443221   12234578999999998754 5678899999999999999999999965432211110000000


Q ss_pred             ccC----------Ccchhhh-cc---CCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          363 HLG----------DKRRFYR-LL---DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       363 ~~~----------~~~~~~~-~~---~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ...          ....+.. ..   ...+.. .....+.++.+||.+||+.||.+|||+.+++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         231 PPSAEDIESIKSPFAATMLDSLPSRPRKPLDE-LLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             CCCHHHHHHHHhhhHHHhhhhcccccccchhh-hccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            000          0000000 00   000001 111247889999999999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=7.2e-38  Score=357.86  Aligned_cols=262  Identities=31%  Similarity=0.532  Sum_probs=208.3

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      ..|...++||+|+||.||+|++..         ++..||||.+......    ...|++++++++|||||++++++.+++
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~  756 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIK---------NGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEK  756 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECC---------CCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCC
Confidence            457778899999999999999865         5678999998654322    235688999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      ..|+||||+++|+|.+++.    .++|..+..|+.||+.||+|||....++|+||||||+||+++.++..++. ||....
T Consensus       757 ~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~  831 (968)
T PLN00113        757 GAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL  831 (968)
T ss_pred             CCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence            9999999999999999984    38899999999999999999996644569999999999999999888876 665543


Q ss_pred             CCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhh
Q 011250          293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR  372 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (490)
                      ....      ....||+.|||||++.+..++.++|||||||++|||++|+.||+.... ....+++|.+..... .....
T Consensus       832 ~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~-~~~~~  903 (968)
T PLN00113        832 LCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSD-CHLDM  903 (968)
T ss_pred             cccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCc-cchhh
Confidence            3211      223689999999999999999999999999999999999999954322 233455555433222 12233


Q ss_pred             ccCCccCCC--CChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          373 LLDPRLEGH--FSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       373 ~~~~~l~~~--~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                      .+++.+...  .+.....++.+++.+||+.||++||+|.+|++.|+.+..
T Consensus       904 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             eeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            455555332  334556778999999999999999999999999987644

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.2e-38  Score=315.05  Aligned_cols=269  Identities=28%  Similarity=0.351  Sum_probs=198.6

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      .++|++.+.||.|+||.||+|.+..         ++..||||.+......  ....+.+|+++++.++||||+++++++.
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   77 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIK---------TGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAV   77 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECC---------CCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhhee
Confidence            3689999999999999999999876         5678999988654322  2345678999999999999999999876


Q ss_pred             eCC--------ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCC
Q 011250          210 EDD--------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       210 ~~~--------~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                      +..        .+++||||+. ++|...+......+++..+..++.||++||.|||+.+   |+||||||+|||++.++.
T Consensus        78 ~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~  153 (311)
T cd07866          78 ERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGI  153 (311)
T ss_pred             cccccccccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCC
Confidence            543        4699999995 5787777666667999999999999999999999988   999999999999999999


Q ss_pred             eEEecccCcccCCCCCcc---------eeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCC
Q 011250          282 AKLSDFGLAKDAPEDGKT---------HVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN  351 (490)
Q Consensus       282 vkL~DFG~a~~~~~~~~~---------~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~  351 (490)
                      ++|+|||+++........         ...+...|++.|+|||++.+ ..++.++|||||||++|||++|++||......
T Consensus       154 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~  233 (311)
T cd07866         154 LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI  233 (311)
T ss_pred             EEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH
Confidence            999999999765432211         11123467889999998765 45889999999999999999999999754332


Q ss_pred             CcchhhHhh-hc----ccCCcchhhh--------ccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          352 GEHNLVEWA-RP----HLGDKRRFYR--------LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       352 ~~~~~~~~~-~~----~~~~~~~~~~--------~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .....+... ..    .+........        ...+.+...+ ......+.+||.+||+.||.+|||+.+++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         234 DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            111111000 00    0000000000        0001110000 1123678999999999999999999999864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=9.6e-38  Score=312.04  Aligned_cols=245  Identities=30%  Similarity=0.456  Sum_probs=197.2

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      |...+.||+|+||.||+|++..         ++..||+|.+.....   .....+.+|+.+++.++||||+++++++.+.
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   93 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSH---------TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE   93 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECC---------CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC
Confidence            6667889999999999998865         567899999875432   2235678899999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      ...|+||||+. |+|.+++......+++..++.++.||+.||.|||+.+   |+||||+|+||+++.++.++|+|||++.
T Consensus        94 ~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~  169 (313)
T cd06633          94 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSAS  169 (313)
T ss_pred             CEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCc
Confidence            99999999995 6888888666667999999999999999999999988   9999999999999999999999999986


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhc---cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ....      .....|+..|+|||++.   ...++.++|||||||++|+|++|..||............  ..   ..  
T Consensus       170 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~--~~---~~--  236 (313)
T cd06633         170 KSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--AQ---ND--  236 (313)
T ss_pred             ccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--Hh---cC--
Confidence            5322      12357899999999874   456888999999999999999999998654321111100  00   00  


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                            .+.   ......+..+.+|+.+||+.+|.+||++.+++.+
T Consensus       237 ------~~~---~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         237 ------SPT---LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             ------CCC---CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  000   0111225678999999999999999999999975

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-40  Score=355.25  Aligned_cols=254  Identities=29%  Similarity=0.401  Sum_probs=206.3

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      +-+|.-...||.|.||.||-|...+         +|...|+|.++...  ....+.+.+|..++..|.|||||++||+-.
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~---------tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv 1304 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLD---------TGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEV 1304 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCC---------ccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceee
Confidence            3467888899999999999998876         67789999886543  233466889999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +.+..+|.||||++|+|.+++ .++.-.++.....+..|++.||.|||+.|   ||||||||+||||+.+|.+|++|||.
T Consensus      1305 HRekv~IFMEyC~~GsLa~ll-~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGs 1380 (1509)
T KOG4645|consen 1305 HREKVYIFMEYCEGGSLASLL-EHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGS 1380 (1509)
T ss_pred             cHHHHHHHHHHhccCcHHHHH-HhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccc
Confidence            999999999999999999988 55556777788888999999999999999   99999999999999999999999999


Q ss_pred             cccCCCCCcc--eeeeccccCCCccCcchhccC---CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc
Q 011250          290 AKDAPEDGKT--HVSTRVMGTYGYAAPEYVMTG---HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       290 a~~~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~---~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      |..+.....+  ......+||+.|||||++.+.   ....+.||||||||+.||+||+.||.........    ...-..
T Consensus      1381 a~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aI----My~V~~ 1456 (1509)
T KOG4645|consen 1381 AVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAI----MYHVAA 1456 (1509)
T ss_pred             eeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHH----HhHHhc
Confidence            9887654211  112347899999999999753   4567899999999999999999999654322110    000001


Q ss_pred             CCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      +.            ...+|...+.+..++|.+||..||.+|.++.|++++
T Consensus      1457 gh------------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1457 GH------------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             cC------------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            11            112333458899999999999999999999999876

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.3e-38  Score=309.84  Aligned_cols=251  Identities=27%  Similarity=0.374  Sum_probs=205.4

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccC-CCCeeceeeEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLL-HPNLVKLVGYC  208 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~-HpnIv~l~~~~  208 (490)
                      ++|.+.+.||.|+||.||+|....         ++..||+|++.....   ...+.+.+|+.+++.+. |+||+++++++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~   71 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKE---------TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF   71 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcC---------CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh
Confidence            368999999999999999999876         567899999876422   23356888999999999 99999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      ..++..++||||+++++|.+++.+. ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||
T Consensus        72 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~  147 (280)
T cd05581          72 QDEENLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFG  147 (280)
T ss_pred             cCCceEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCc
Confidence            9999999999999999999998654 47999999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCcc------------------eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCC
Q 011250          289 LAKDAPEDGKT------------------HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP  350 (490)
Q Consensus       289 ~a~~~~~~~~~------------------~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~  350 (490)
                      ++.........                  .......|+..|+|||++....++.++||||||+++|+|++|..||.....
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~  227 (280)
T cd05581         148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE  227 (280)
T ss_pred             cccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH
Confidence            98866433211                  112235688999999999888899999999999999999999999975531


Q ss_pred             CCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCH----HHHHHH
Q 011250          351 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM----SEVVET  414 (490)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~----~evl~~  414 (490)
                      .   .......               .....++...+..+.+||.+||+.||.+||++    .+++++
T Consensus       228 ~---~~~~~~~---------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         228 Y---LTFQKIL---------------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             H---HHHHHHH---------------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence            1   1111000               01112222336789999999999999999999    888764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-39  Score=312.47  Aligned_cols=243  Identities=29%  Similarity=0.420  Sum_probs=203.0

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccH---HHHHHHHHHHhccC-CCCeeceeeE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGNLL-HPNLVKLVGY  207 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~Ei~il~~l~-HpnIv~l~~~  207 (490)
                      ..+|..+.+||+|+||.|.+|..+.         +.+.+|||+++++.....   +--+.|-++|.... -|.+++++.+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkg---------tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc  418 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKG---------TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC  418 (683)
T ss_pred             ecccceEEEeccCccceeeeecccC---------cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH
Confidence            3479999999999999999997654         677899999998754322   23456888888664 7899999999


Q ss_pred             EEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecc
Q 011250          208 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DF  287 (490)
                      |+.-+.+|+||||+.||+|.-+|..-+ .+.+..+..+|.+|+-||-|||+.|   ||+||||.+||||+.+|++||+||
T Consensus       419 FQTmDRLyFVMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DF  494 (683)
T KOG0696|consen  419 FQTMDRLYFVMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADF  494 (683)
T ss_pred             hhhhhheeeEEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeec
Confidence            999999999999999999999886554 6889999999999999999999988   999999999999999999999999


Q ss_pred             cCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011250          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      |+++.-.-++.+  ...+|||+.|+|||++....|+..+|+|||||+|||||.|++||++..+..   +           
T Consensus       495 GmcKEni~~~~T--TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e---l-----------  558 (683)
T KOG0696|consen  495 GMCKENIFDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---L-----------  558 (683)
T ss_pred             ccccccccCCcc--eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH---H-----------
Confidence            999865444333  345899999999999999999999999999999999999999998754321   1           


Q ss_pred             chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCC
Q 011250          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR  407 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt  407 (490)
                        |..+++..  ..|+...+.++..+++..|.+.|.+|..
T Consensus       559 --F~aI~ehn--vsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  559 --FQAIMEHN--VSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             --HHHHHHcc--CcCcccccHHHHHHHHHHhhcCCccccC
Confidence              12222222  2345555899999999999999999954

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=6.3e-38  Score=312.57  Aligned_cols=251  Identities=28%  Similarity=0.401  Sum_probs=200.4

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .|...+.||+|+||.||+|++..         ++..||+|.+.....   ...+++.+|+++++.++|+||+++++++..
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   86 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR   86 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcC---------CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc
Confidence            47778899999999999999875         566899999864322   233567889999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      ....++||||+. |+|.+++......+++..+..++.|++.||.|||+.+   ++||||+|+|||++.++.++|+|||++
T Consensus        87 ~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~  162 (308)
T cd06634          87 EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA  162 (308)
T ss_pred             CCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccc
Confidence            999999999996 6888877665667899999999999999999999988   999999999999999999999999998


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhc---cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      ......      ....|+..|+|||++.   ...++.++|||||||++|+|++|..||.........  ..+....    
T Consensus       163 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~~~~----  230 (308)
T cd06634         163 SIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YHIAQNE----  230 (308)
T ss_pred             eeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH--HHHhhcC----
Confidence            765332      2356889999999875   356788999999999999999999998643211110  0000000    


Q ss_pred             chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011250          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~  419 (490)
                             .+.   ......+..+.+||.+||..+|.+||++.+++++.....
T Consensus       231 -------~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         231 -------SPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             -------CCC---cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence                   000   011123677899999999999999999999998865443

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=327.77  Aligned_cols=267  Identities=29%  Similarity=0.430  Sum_probs=201.6

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEEEeCC-
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD-  212 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-  212 (490)
                      |...+.||+|+||.||+|+++.         +|+.||||.++... ....+.+.+|+++|++|+|+|||+++++-++.. 
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnke---------tG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~   85 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKE---------TGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFL   85 (732)
T ss_pred             eeehhhhcCCccceeeeecccc---------cccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCcccc
Confidence            5566889999999999999887         88899999998653 345677899999999999999999999755433 


Q ss_pred             -----ceEEEEEecCCCChhHHhhh--cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE--cCCC--C
Q 011250          213 -----QRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL--DADY--N  281 (490)
Q Consensus       213 -----~~~lV~E~~~~gsL~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl--~~~~--~  281 (490)
                           ...+|||||.||||+..|.+  +...|++.+.+.++.+++.||.|||+++   ||||||||.||++  .++|  .
T Consensus        86 ~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~I  162 (732)
T KOG4250|consen   86 GLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSI  162 (732)
T ss_pred             CcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceE
Confidence                 45799999999999999965  3457999999999999999999999988   9999999999998  3334  4


Q ss_pred             eEEecccCcccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011250          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       282 vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~  360 (490)
                      .||+|||.|+...++.   ..+.++||..|.+||++.. ..|+..+|.|||||++|+..||..||..........-+.|.
T Consensus       163 yKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~  239 (732)
T KOG4250|consen  163 YKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWH  239 (732)
T ss_pred             EeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhh
Confidence            7999999999987654   4466899999999999984 88999999999999999999999999644322110001111


Q ss_pred             hcc-------------cCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCC--CHHHHHHHhhcC
Q 011250          361 RPH-------------LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP--RMSEVVETLKPL  418 (490)
Q Consensus       361 ~~~-------------~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP--t~~evl~~L~~l  418 (490)
                      ...             ......+...+..  ..+........+..++..+|..+|.+|-  .+.+....+..+
T Consensus       240 ~~tkkp~~v~i~~~~~eNgpv~~s~~lP~--p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI  310 (732)
T KOG4250|consen  240 IITKKPSGVAIGAQEEENGPVEWSSTLPQ--PNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI  310 (732)
T ss_pred             hhccCCCceeEeeecccCCceeeeccCCC--cccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence            000             0000001111110  1122223345667788889999999998  555555544443

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.2e-37  Score=307.43  Aligned_cols=256  Identities=29%  Similarity=0.376  Sum_probs=200.0

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc----ccHHHHHHHHHHHhcc-CCCCeeceeeEE
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGNL-LHPNLVKLVGYC  208 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~Ei~il~~l-~HpnIv~l~~~~  208 (490)
                      +|++.+.||.|+||.||+|+.....      .+|..||+|++.....    ...+.+.+|++++..+ +|+||+++++++
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~------~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~   74 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGH------DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF   74 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCC------CCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe
Confidence            4788999999999999999875321      1577899999875422    2235678899999999 599999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      ..+...++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+   ++||||+|+|||++.++.+||+|||
T Consensus        75 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg  150 (290)
T cd05613          75 QTDTKLHLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFG  150 (290)
T ss_pred             ecCCeEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCc
Confidence            9999999999999999999998654 46889999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhccC--CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~--~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      ++......... ......|+..|+|||.+...  .++.++||||||+++|+|++|..||........  ...........
T Consensus       151 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~  227 (290)
T cd05613         151 LSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKS  227 (290)
T ss_pred             cceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhcc
Confidence            99865432211 12235689999999988753  477899999999999999999999964322111  11111111000


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  414 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----t~~evl~~  414 (490)
                                  ...++...+..+.+|+.+||+.||.+||     ++.+++++
T Consensus       228 ------------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         228 ------------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             ------------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence                        0112233467889999999999999997     67777654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-38  Score=303.67  Aligned_cols=242  Identities=25%  Similarity=0.323  Sum_probs=188.8

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHH-hccCCCCeeceeeEEEeCCce
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFL-GNLLHPNLVKLVGYCIEDDQR  214 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~Ei~il-~~l~HpnIv~l~~~~~~~~~~  214 (490)
                      +.||.|+||.||+|.+..         ++..||||.+.......   ...+..|..++ ..+.|+||+++++++..++..
T Consensus         2 ~~l~~g~~~~v~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~   72 (260)
T cd05611           2 KPISKGAFGSVYLAKKRS---------TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYL   72 (260)
T ss_pred             ccCCcCCCeeEEEEEecC---------CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeE
Confidence            569999999999998876         56789999987653322   22344555444 455899999999999999999


Q ss_pred             EEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCC
Q 011250          215 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~  294 (490)
                      |+||||+++++|.+++... ..+++..+..++.||+.||.|||+.+   |+||||+|+|||++.++.++|+|||++....
T Consensus        73 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  148 (260)
T cd05611          73 YLVMEYLNGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL  148 (260)
T ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecc
Confidence            9999999999999988544 46899999999999999999999988   9999999999999999999999999987643


Q ss_pred             CCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhcc
Q 011250          295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  374 (490)
Q Consensus       295 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (490)
                      .      .....|+..|+|||.+.+..++.++||||||+++|+|++|..||.......   ......   ...       
T Consensus       149 ~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~---~~~-------  209 (260)
T cd05611         149 E------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA---VFDNIL---SRR-------  209 (260)
T ss_pred             c------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHH---hcc-------
Confidence            3      123568899999999988889999999999999999999999996543211   111000   000       


Q ss_pred             CCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 011250          375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE  413 (490)
Q Consensus       375 ~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~  413 (490)
                       ...........+..+.++|.+||+.||++||++.++.+
T Consensus       210 -~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~  247 (260)
T cd05611         210 -INWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE  247 (260)
T ss_pred             -cCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence             00011111234788999999999999999997654433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=7.2e-38  Score=310.10  Aligned_cols=255  Identities=30%  Similarity=0.450  Sum_probs=198.8

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccC-CCCeeceeeEE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLL-HPNLVKLVGYC  208 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~-HpnIv~l~~~~  208 (490)
                      ..++|.+.+.||.|+||.||+|.+..         ++..||||.+..... ....++..|+.++..+. |+||+++++++
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~   83 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKK---------TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYF   83 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECC---------CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheee
Confidence            34578999999999999999999875         567899999975432 23456777887776665 99999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEEcCCCCeEEecc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlkp~NILl~~~~~vkL~DF  287 (490)
                      .++...++||||+ +++|.+++......+++..+..++.||+.||+|||+ .+   |+||||+|+||+++.++.+||+||
T Consensus        84 ~~~~~~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~df  159 (296)
T cd06618          84 ITDSDVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDF  159 (296)
T ss_pred             ecCCeEEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECcc
Confidence            9999999999998 458888776655689999999999999999999997 46   999999999999999999999999


Q ss_pred             cCcccCCCCCcceeeeccccCCCccCcchhccCC----CCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011250          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH----LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~----~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      |++........   .....|+..|+|||.+.+..    ++.++||||||+++|+|++|+.||...... ...+.....  
T Consensus       160 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~--  233 (296)
T cd06618         160 GISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVLTKILQ--  233 (296)
T ss_pred             ccchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHHHHHhc--
Confidence            99876543221   12345788999999987543    788999999999999999999999643211 000111110  


Q ss_pred             cCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                        ...       +.+  ......+.++.+|+.+||..||.+||++.+++++.
T Consensus       234 --~~~-------~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         234 --EEP-------PSL--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             --CCC-------CCC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence              000       000  00112367899999999999999999999999764

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.2e-38  Score=314.41  Aligned_cols=267  Identities=26%  Similarity=0.359  Sum_probs=203.3

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      +|.+.+.||.|+||.||+|....         ++..||||.+....  ....+.+.+|+.+++.++|+||+++++++...
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKR---------TGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPP   71 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCC---------CCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhccc
Confidence            58899999999999999999865         56789999987643  33446788999999999999999999998877


Q ss_pred             C-----ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEec
Q 011250          212 D-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       212 ~-----~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~D  286 (490)
                      .     ..|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.++|+|
T Consensus        72 ~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~d  146 (330)
T cd07834          72 SPEDFNDVYIVTELME-TDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICD  146 (330)
T ss_pred             CcccccceEEEecchh-hhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcc
Confidence            5     7899999996 5898888544 48999999999999999999999988   99999999999999999999999


Q ss_pred             ccCcccCCCCCcc-eeeeccccCCCccCcchhccC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc--
Q 011250          287 FGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP--  362 (490)
Q Consensus       287 FG~a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~--  362 (490)
                      ||++......... .......++..|+|||++.+. .++.++||||||+++|+|++|.+||...........+.....  
T Consensus       147 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  226 (330)
T cd07834         147 FGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTP  226 (330)
T ss_pred             cCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCC
Confidence            9999876543210 112335689999999999877 889999999999999999999999976542211110000000  


Q ss_pred             --------ccCCcchhhhccCCccC---CCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          363 --------HLGDKRRFYRLLDPRLE---GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       363 --------~~~~~~~~~~~~~~~l~---~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                              .......+.........   .......+..+.+||.+||+.||.+||++.+++.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             ChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                    00000000000000000   00111236789999999999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=8.9e-38  Score=315.01  Aligned_cols=268  Identities=25%  Similarity=0.313  Sum_probs=198.2

Q ss_pred             cCCC-CCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc--------------HHHHHHHHHHHhccC
Q 011250          133 RNFR-PESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--------------HKEWLAEVNFLGNLL  197 (490)
Q Consensus       133 ~~y~-~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--------------~~~~~~Ei~il~~l~  197 (490)
                      ++|. +.+.||.|+||+||+|.+..         ++..||||++.......              ...+.+|+.+++.++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~   78 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTL---------TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK   78 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECC---------CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC
Confidence            3454 45789999999999998865         56789999986543221              125778999999999


Q ss_pred             CCCeeceeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc
Q 011250          198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD  277 (490)
Q Consensus       198 HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~  277 (490)
                      |+||+++++++..++..++||||+. |+|.+++.. ...+++..+..++.||+.||.|||+.+   |+||||+|+|||++
T Consensus        79 h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~  153 (335)
T PTZ00024         79 HENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFIN  153 (335)
T ss_pred             CcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEEC
Confidence            9999999999999999999999996 699988854 446899999999999999999999988   99999999999999


Q ss_pred             CCCCeEEecccCcccCCCCCc------------ceeeeccccCCCccCcchhccC-CCCccchhhHHHHHHHHHHhCCCC
Q 011250          278 ADYNAKLSDFGLAKDAPEDGK------------THVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRS  344 (490)
Q Consensus       278 ~~~~vkL~DFG~a~~~~~~~~------------~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGv~l~elltG~~p  344 (490)
                      .++.++|+|||++........            ........++..|+|||.+.+. .++.++|||||||++|||++|.+|
T Consensus       154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p  233 (335)
T PTZ00024        154 SKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPL  233 (335)
T ss_pred             CCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            999999999999976541110            0111223568899999988754 478999999999999999999999


Q ss_pred             CCCCCCCCcchhh-Hhhhcc----cCCcc------hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 011250          345 MDKNRPNGEHNLV-EWARPH----LGDKR------RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE  413 (490)
Q Consensus       345 f~~~~~~~~~~~~-~~~~~~----~~~~~------~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~  413 (490)
                      |...........+ ......    +....      .+.....+.+.. .....+..+.+||.+||+.||++||++++++.
T Consensus       234 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        234 FPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             CCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            9755322111100 000000    00000      000000000000 01123678899999999999999999999996


Q ss_pred             Hh
Q 011250          414 TL  415 (490)
Q Consensus       414 ~L  415 (490)
                      +-
T Consensus       313 ~~  314 (335)
T PTZ00024        313 HE  314 (335)
T ss_pred             Cc
Confidence            53

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-37  Score=303.04  Aligned_cols=261  Identities=25%  Similarity=0.338  Sum_probs=197.1

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcc---CCCCeeceeeEEE
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNL---LHPNLVKLVGYCI  209 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~Ei~il~~l---~HpnIv~l~~~~~  209 (490)
                      |++.+.||.|+||.||+|.+..         ++..||+|.+......  ....+.+|+.++..+   .|+||+++++++.
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~   71 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLN---------TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCH   71 (287)
T ss_pred             CeEEEEecccCceEEEEEEECC---------CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEe
Confidence            6778899999999999999875         4668999999754322  234566788777666   5999999999999


Q ss_pred             eCCc-----eEEEEEecCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeE
Q 011250          210 EDDQ-----RLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       210 ~~~~-----~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vk  283 (490)
                      ..+.     .+++|||+. ++|.+++.... ..+++..++.++.||+.||.|||+.+   |+|+||+|+||+++.++.++
T Consensus        72 ~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~  147 (287)
T cd07838          72 GPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVK  147 (287)
T ss_pred             eccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEE
Confidence            8876     899999996 58988886543 36899999999999999999999988   99999999999999999999


Q ss_pred             EecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011250          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      |+|||++........   .....++..|+|||++.+..++.++|||||||++|||++|.+||........  +..+....
T Consensus       148 l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~  222 (287)
T cd07838         148 IADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDKIFDVI  222 (287)
T ss_pred             EeccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHHHHHHc
Confidence            999999977643321   1234578999999999988999999999999999999999999975432211  11111000


Q ss_pred             cC-C-----------cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          364 LG-D-----------KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       364 ~~-~-----------~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .. .           ...+........ .......+..+.+||.+||+.||.+||++.+++.+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         223 GLPSEEEWPRNVSLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             CCCChHhcCCCcccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence            00 0           000000000000 11112336788999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.6e-37  Score=306.21  Aligned_cols=258  Identities=28%  Similarity=0.362  Sum_probs=201.4

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc----ccHHHHHHHHHHHhcc-CCCCeeceeeEE
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGNL-LHPNLVKLVGYC  208 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~Ei~il~~l-~HpnIv~l~~~~  208 (490)
                      +|++.+.||+|+||.||+++......      ++..||||++.....    ...+.+..|+.++..+ +||||+++++++
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~------~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~   74 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHD------AGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF   74 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEecccc------CCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee
Confidence            47888999999999999998754321      567899999875422    2235678899999999 599999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      ..+...++||||+++|+|.+++... ..+++..+..++.|++.+|.|||+.+   ++||||+|+||+++.++.++|+|||
T Consensus        75 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg  150 (288)
T cd05583          75 QTDTKLHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFG  150 (288)
T ss_pred             ecCCEEEEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECc
Confidence            9999999999999999999988654 46899999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhccCC--CCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH--LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~--~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      +++........ ......|+..|+|||.+.+..  .+.++||||||+++|||++|..||........  ..+........
T Consensus       151 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~  227 (288)
T cd05583         151 LSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILKS  227 (288)
T ss_pred             ccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHcc
Confidence            98875433221 122356899999999987654  78899999999999999999999964322111  11111110000


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~  416 (490)
                              .    ...+...+..+.+++.+||+.||++|||+.++.+.|+
T Consensus       228 --------~----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~  265 (288)
T cd05583         228 --------K----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN  265 (288)
T ss_pred             --------C----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence                    0    1112223678899999999999999999887776664

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=5.4e-38  Score=317.77  Aligned_cols=267  Identities=23%  Similarity=0.303  Sum_probs=198.1

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeC-
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED-  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-  211 (490)
                      .+|.+.+.||.|+||.||+|....         ++..||+|.+........+.+.+|+.+++.++||||+++++++... 
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~---------~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~   75 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSD---------CDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSG   75 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECC---------CCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccc
Confidence            579999999999999999998876         6778999998776656667788999999999999999999876654 


Q ss_pred             -------------CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-
Q 011250          212 -------------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD-  277 (490)
Q Consensus       212 -------------~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~-  277 (490)
                                   ...++||||+. ++|.+++..  ..+++..++.++.||+.||.|||+.+   |+||||||+|||++ 
T Consensus        76 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~  149 (342)
T cd07854          76 SDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINT  149 (342)
T ss_pred             cccccccccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcC
Confidence                         35789999996 589887743  36899999999999999999999988   99999999999997 


Q ss_pred             CCCCeEEecccCcccCCCCCcc-eeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcch
Q 011250          278 ADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN  355 (490)
Q Consensus       278 ~~~~vkL~DFG~a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~  355 (490)
                      .++.++|+|||++......... .......|+..|+|||++.. ..++.++|||||||++|+|++|+.||..........
T Consensus       150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~  229 (342)
T cd07854         150 EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ  229 (342)
T ss_pred             CCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            4567899999999765322111 11122467899999998754 568889999999999999999999997554322111


Q ss_pred             hhHhhhcccCC--cchhhhccCC-----ccCC-----CCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          356 LVEWARPHLGD--KRRFYRLLDP-----RLEG-----HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       356 ~~~~~~~~~~~--~~~~~~~~~~-----~l~~-----~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ......+....  ...+......     ....     .+....+.++.+||.+||..||.+||++.+++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         230 LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             HHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            11100000000  0000000000     0000     0011236788999999999999999999999965

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.1e-37  Score=307.87  Aligned_cols=263  Identities=25%  Similarity=0.300  Sum_probs=192.7

Q ss_pred             CCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC--CcccHHHHHHHHHHHhccCCCCeeceeeEEEeCCc
Q 011250          136 RPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQ  213 (490)
Q Consensus       136 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  213 (490)
                      .+.+.+|.|+++  |.++...         ++..||||++...  .....+.+.+|+.+++.++|+||+++++++.+.+.
T Consensus         5 ~i~~~~~~~~~v--~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~   73 (314)
T cd08216           5 LIGKCFEDLMIV--HLAKHKP---------TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSE   73 (314)
T ss_pred             hhhHhhcCCceE--EEEEecC---------CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCe
Confidence            344445555554  4444443         5678999999765  23345678999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          214 RLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       214 ~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      .+++|||+++|+|.+++... ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||.+..
T Consensus        74 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~  150 (314)
T cd08216          74 LYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVS  150 (314)
T ss_pred             EEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCcccee
Confidence            99999999999999998753 346899999999999999999999988   99999999999999999999999998875


Q ss_pred             CCCCCcc-----eeeeccccCCCccCcchhcc--CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011250          293 APEDGKT-----HVSTRVMGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       293 ~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~--~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      .......     .......++..|+|||++..  ..++.++|||||||++|||++|..||.......  .+.+.......
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~  228 (314)
T cd08216         151 MIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVP  228 (314)
T ss_pred             eccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCc
Confidence            5332111     11123457889999999875  358899999999999999999999997542211  11111100000


Q ss_pred             ---Ccchhhh-----------ccCCc----cCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          366 ---DKRRFYR-----------LLDPR----LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 ---~~~~~~~-----------~~~~~----l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                         .......           ..++.    .........+.++.+|+.+||..||++|||+.+++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         229 CLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             cccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence               0000000           00000    0111222336789999999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-37  Score=303.89  Aligned_cols=263  Identities=28%  Similarity=0.395  Sum_probs=198.8

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccC-CCCeeceeeEEEeCC
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLL-HPNLVKLVGYCIEDD  212 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~  212 (490)
                      |.+.+.||.|+||.||+|....         ++..||||.+..... .......+|+..+..+. |+||+++++++.+++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   71 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKE---------TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND   71 (283)
T ss_pred             CeeheeeccCCceEEEEEEECC---------CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC
Confidence            6778899999999999999865         466899999865432 22234567999999999 999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      ..++||||+ +|+|.+++.... ..+++..+..++.|++.+|.|||+.+   |+|+||+|+||+++.++.++|+|||++.
T Consensus        72 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~  147 (283)
T cd07830          72 ELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAR  147 (283)
T ss_pred             cEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccce
Confidence            999999999 889999886553 47899999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhc-cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhh-Hhhhccc----C
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWARPHL----G  365 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~-~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~-~~~~~~~----~  365 (490)
                      .......   .....|+..|+|||++. ...++.++|+||||+++|||++|++||............ .......    .
T Consensus       148 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (283)
T cd07830         148 EIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWP  224 (283)
T ss_pred             eccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhh
Confidence            6643222   12356889999999875 446789999999999999999999999655332111100 0000000    0


Q ss_pred             CcchhhhccC--------CccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          366 DKRRFYRLLD--------PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 ~~~~~~~~~~--------~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      +........+        ..+...+ ...+..+.+||++||+.||.+||++.|++.+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         225 EGYKLASKLGFRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             hHhhhhccccccccccccccHHHHc-ccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            0000000000        0010001 1125789999999999999999999999864

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-37  Score=314.10  Aligned_cols=273  Identities=24%  Similarity=0.362  Sum_probs=203.7

Q ss_pred             hhhhhhHHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhccCCC
Q 011250          122 KFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHP  199 (490)
Q Consensus       122 ~~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~Ei~il~~l~Hp  199 (490)
                      .....++....++|.+.+.||+|+||.||+|.+..         ++..||+|++....  ....+.+.+|+.++..++||
T Consensus         6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~   76 (345)
T cd07877           6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE   76 (345)
T ss_pred             hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcC---------CCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCC
Confidence            33445566677899999999999999999998765         57789999987542  22345678899999999999


Q ss_pred             CeeceeeEEEeC------CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 011250          200 NLVKLVGYCIED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN  273 (490)
Q Consensus       200 nIv~l~~~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~N  273 (490)
                      ||+++++++...      ...+++++++ +++|.+++..  ..+++..+..++.||+.||+|||+.+   |+||||||+|
T Consensus        77 ~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~N  150 (345)
T cd07877          77 NVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSN  150 (345)
T ss_pred             cccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHH
Confidence            999999988643      3468888887 7899887743  36899999999999999999999988   9999999999


Q ss_pred             EEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCC
Q 011250          274 ILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG  352 (490)
Q Consensus       274 ILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~  352 (490)
                      |+++.++.+||+|||+++.....     .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus       151 Ill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~  225 (345)
T cd07877         151 LAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID  225 (345)
T ss_pred             EEEcCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999999999999998865332     123568999999998866 568899999999999999999999996543211


Q ss_pred             cchhh-Hhh-------hcccCCc--chhhhccCCccCCCC---ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          353 EHNLV-EWA-------RPHLGDK--RRFYRLLDPRLEGHF---SIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       353 ~~~~~-~~~-------~~~~~~~--~~~~~~~~~~l~~~~---~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ....+ ...       ...+...  ..+...+.......+   ....+.++.+||.+||+.||.+||++.+++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         226 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            11100 000       0000000  000000000000000   01236678999999999999999999999976

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.4e-37  Score=311.68  Aligned_cols=266  Identities=26%  Similarity=0.322  Sum_probs=195.0

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhccC-CCCeeceeeEEEe
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIE  210 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~  210 (490)
                      +|.+.+.||+|+||.||+|++....       .+..||||.+....  ....+.+.+|+.+++++. ||||+++++++..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   73 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETS-------EEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIV   73 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCC-------cCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeee
Confidence            4788899999999999999986521       16689999986432  223456889999999994 9999999987543


Q ss_pred             C----CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEec
Q 011250          211 D----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       211 ~----~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~D  286 (490)
                      .    ...+++|||+. ++|.+++.. ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        74 ~~~~~~~~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~D  148 (332)
T cd07857          74 FPGNFNELYLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICD  148 (332)
T ss_pred             ccccCCcEEEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCc
Confidence            2    45789999984 689888854 457999999999999999999999988   99999999999999999999999


Q ss_pred             ccCcccCCCCCcc--eeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011250          287 FGLAKDAPEDGKT--HVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       287 FG~a~~~~~~~~~--~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      ||+++........  .......||..|+|||++.+ ..++.++|||||||++|+|++|.+||........   .......
T Consensus       149 fg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~---~~~~~~~  225 (332)
T cd07857         149 FGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQ---LNQILQV  225 (332)
T ss_pred             CCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHH---HHHHHHH
Confidence            9999865432211  11233578999999998765 4689999999999999999999999975432110   0000000


Q ss_pred             cC-----------Cc--chhhhccCCccCC---CCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          364 LG-----------DK--RRFYRLLDPRLEG---HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       364 ~~-----------~~--~~~~~~~~~~l~~---~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ++           ..  ..+...+......   ......+..+.+|+.+||+.||.+|||+.+++.+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         226 LGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             hCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            00           00  0000000000000   0111236789999999999999999999999854

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-37  Score=315.12  Aligned_cols=267  Identities=25%  Similarity=0.359  Sum_probs=198.1

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      .++|.+.+.||+|+||.||+|.+..         ++..||||.+.....  .....+.+|+.+++.+.||||+++++++.
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~   84 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKR---------TGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFT   84 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCC---------CCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheec
Confidence            3689999999999999999998865         577899999875422  22356789999999999999999999987


Q ss_pred             eCC------ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeE
Q 011250          210 EDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       210 ~~~------~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vk  283 (490)
                      ...      ..++||||+. .+|..++   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.++
T Consensus        85 ~~~~~~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~k  157 (342)
T cd07879          85 SAVSGDEFQDFYLVMPYMQ-TDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELK  157 (342)
T ss_pred             ccccCCCCceEEEEecccc-cCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence            543      4689999995 4776654   236899999999999999999999988   99999999999999999999


Q ss_pred             EecccCcccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011250          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      |+|||+++.....     .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...........+.....
T Consensus       158 L~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~  232 (342)
T cd07879         158 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG  232 (342)
T ss_pred             EeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            9999998765332     123467899999998876 4688999999999999999999999976432211111000000


Q ss_pred             --------ccCC--cchhhhccCCccCCCC---ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH--hhcCc
Q 011250          363 --------HLGD--KRRFYRLLDPRLEGHF---SIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPLQ  419 (490)
Q Consensus       363 --------~~~~--~~~~~~~~~~~l~~~~---~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~--L~~l~  419 (490)
                              ....  ...+...+.......+   ....+..+.+||.+||+.||.+||++.+++.+  ++.+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         233 VPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             CCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence                    0000  0000000000000000   01235678999999999999999999999976  55443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-37  Score=303.71  Aligned_cols=264  Identities=28%  Similarity=0.402  Sum_probs=201.9

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      |++.+.||+|+||.||+|....         ++..||+|.+....  ....+.+..|+.+++.++|+||+++++++.+.+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   71 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKK---------TGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER   71 (282)
T ss_pred             CeeehcccccCcceEEEeeecC---------CCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC
Confidence            5677889999999999999876         56789999997653  223467788999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      ..++||||+. ++|.+++......+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.++|+|||++..
T Consensus        72 ~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~  147 (282)
T cd07829          72 KLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARA  147 (282)
T ss_pred             ceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccc
Confidence            9999999996 5999999766457999999999999999999999988   99999999999999999999999999987


Q ss_pred             CCCCCcceeeeccccCCCccCcchhccC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhh-Hhhh-------cc
Q 011250          293 APEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWAR-------PH  363 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~-~~~~-------~~  363 (490)
                      ......  ......++..|+|||.+.+. .++.++|||||||++|||++|.+||...........+ ....       ..
T Consensus       148 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (282)
T cd07829         148 FGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPG  225 (282)
T ss_pred             cCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHh
Confidence            644322  11234567889999998766 8899999999999999999999999654321111000 0000       00


Q ss_pred             cCCc----chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          364 LGDK----RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       364 ~~~~----~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ....    ..+...........+ ...+..+.++|.+||..||.+||++.+++.+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         226 VTKLPDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             hcccccccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            0000    000000000000011 1126789999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.7e-38  Score=339.99  Aligned_cols=254  Identities=29%  Similarity=0.422  Sum_probs=192.6

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      -..+|+.+++||+||||.||+++.+-         +|..||||+|.... ......+.+|+.+|++|+|||||+++..|.
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKl---------DGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWV  547 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKL---------DGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWV  547 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecc---------cchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhh
Confidence            34578999999999999999999987         57799999997664 223356889999999999999999987654


Q ss_pred             eC------------------------------------------------------------------------------
Q 011250          210 ED------------------------------------------------------------------------------  211 (490)
Q Consensus       210 ~~------------------------------------------------------------------------------  211 (490)
                      +.                                                                              
T Consensus       548 Es~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg  627 (1351)
T KOG1035|consen  548 ESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDG  627 (1351)
T ss_pred             ccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccc
Confidence            20                                                                              


Q ss_pred             -----------------------------------------CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHH
Q 011250          212 -----------------------------------------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA  250 (490)
Q Consensus       212 -----------------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~  250 (490)
                                                               ..+||-||||+...|.+++.++...-.....+.++++|+
T Consensus       628 ~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIl  707 (1351)
T KOG1035|consen  628 RNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREIL  707 (1351)
T ss_pred             cccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHH
Confidence                                                     013788999988777776644432214677899999999


Q ss_pred             HHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCC----------------CCCcceeeeccccCCCccCc
Q 011250          251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP----------------EDGKTHVSTRVMGTYGYAAP  314 (490)
Q Consensus       251 ~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~----------------~~~~~~~~~~~~Gt~~y~aP  314 (490)
                      +||.|+|+.|   ||||||||.||+|+++..|||+|||+|....                ........+..+||.-|+||
T Consensus       708 EGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP  784 (1351)
T KOG1035|consen  708 EGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAP  784 (1351)
T ss_pred             HHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecH
Confidence            9999999999   9999999999999999999999999998721                01111134568899999999


Q ss_pred             chhccC---CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccC--CCCChhhHHH
Q 011250          315 EYVMTG---HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE--GHFSIKGSQK  389 (490)
Q Consensus       315 E~l~~~---~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~--~~~~~~~~~~  389 (490)
                      |++.+.   .|+.|+|+|||||||+||+.   ||....  +....+...+             +..+.  ..|..+....
T Consensus       785 Ell~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa~iL~~LR-------------~g~iP~~~~f~~~~~~~  846 (1351)
T KOG1035|consen  785 ELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERASILTNLR-------------KGSIPEPADFFDPEHPE  846 (1351)
T ss_pred             HHhcccccccccchhhhHHHHHHHHHHhc---cCCchH--HHHHHHHhcc-------------cCCCCCCcccccccchH
Confidence            998754   59999999999999999995   565321  1111111111             11111  1222333566


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          390 ATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       390 l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      -..+|++||+.||.+|||+.|+|+.
T Consensus       847 e~slI~~Ll~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  847 EASLIRWLLSHDPSKRPTATELLNS  871 (1351)
T ss_pred             HHHHHHHHhcCCCccCCCHHHHhhc
Confidence            6889999999999999999999863

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.1e-37  Score=311.64  Aligned_cols=265  Identities=25%  Similarity=0.339  Sum_probs=200.9

Q ss_pred             HHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhccCCCCeecee
Q 011250          128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLV  205 (490)
Q Consensus       128 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~  205 (490)
                      +...+++|.+.+.||.|+||.||+|.+..         ++..||||++....  ....+.+.+|+.++..++||||++++
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~   75 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQL---------TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLS   75 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECC---------CCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEe
Confidence            34567889999999999999999998876         57789999886432  22346788999999999999999999


Q ss_pred             eEEEe-CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 011250          206 GYCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       206 ~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL  284 (490)
                      +++.. ....++||||+ +++|..++..  ..+++..+..++.||+.||.|||+.+   |+||||+|+|||++.++.++|
T Consensus        76 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l  149 (328)
T cd07856          76 DIFISPLEDIYFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKI  149 (328)
T ss_pred             eeEecCCCcEEEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEe
Confidence            99876 45789999999 6789887743  36888889999999999999999988   999999999999999999999


Q ss_pred             ecccCcccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhh-Hh---
Q 011250          285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EW---  359 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~-~~---  359 (490)
                      +|||++.......     ....++..|+|||++.+ ..++.++|||||||++|+|++|+.||............ +.   
T Consensus       150 ~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~  224 (328)
T cd07856         150 CDFGLARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGT  224 (328)
T ss_pred             CccccccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            9999987643221     23467889999998765 57899999999999999999999999754321111000 00   


Q ss_pred             -----hhcccC-CcchhhhccCCccCCCCC-----hhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          360 -----ARPHLG-DKRRFYRLLDPRLEGHFS-----IKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       360 -----~~~~~~-~~~~~~~~~~~~l~~~~~-----~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                           ...... ....+...+  ......+     ...+..+.++|.+||+.+|.+||++.+++.+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         225 PPDDVINTICSENTLRFVQSL--PKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             CCHHHHHhccchhhHHHHhhc--cccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                 000000 000000000  0000111     1236789999999999999999999999876

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3e-37  Score=299.29  Aligned_cols=249  Identities=23%  Similarity=0.320  Sum_probs=195.8

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC---C--cccHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD---G--LQGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      +|.+.+.||+|+||.||++.+...         +..+++|+++..   .  ......+..|+.+++.++||||+++++++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   71 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKA---------VAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF   71 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCC---------CCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH
Confidence            488899999999999999988652         334555554431   1  12334567899999999999999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEe
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~  285 (490)
                      .+....++||||+++++|.+++..   ....+++..++.++.|++.||.|||+.+   |+|+||+|+||+++. +.++|+
T Consensus        72 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~  147 (260)
T cd08222          72 LERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIG  147 (260)
T ss_pred             hcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeec
Confidence            999999999999999999988853   3457999999999999999999999988   999999999999975 579999


Q ss_pred             cccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011250          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      |||++........  ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.....   ......   ...
T Consensus       148 d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~---~~~~~~---~~~  219 (260)
T cd08222         148 DFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---LSVVLR---IVE  219 (260)
T ss_pred             ccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHHH---HHc
Confidence            9999876643322  12235688999999999888899999999999999999999999964321   111110   000


Q ss_pred             CcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                             ...+    .++...+.++.++|.+||..||++||++.+++++
T Consensus       220 -------~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         220 -------GPTP----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             -------CCCC----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence                   0011    1223446789999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-38  Score=304.56  Aligned_cols=274  Identities=23%  Similarity=0.339  Sum_probs=208.9

Q ss_pred             hhhhhhHHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccC-C-C
Q 011250          122 KFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-H-P  199 (490)
Q Consensus       122 ~~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~-H-p  199 (490)
                      .+.+......+.+|.+.++||+|.||.|-++++..         ++..||||+++.-. ...+..+-|+++|.+|. + |
T Consensus        78 H~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~---------~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP  147 (415)
T KOG0671|consen   78 HYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRE---------TKEHVALKIIKNVD-KYREAALIEIEVLQKINESDP  147 (415)
T ss_pred             eEEEEeccccccceehhhhhcCCcccceEEEeecC---------CCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCC
Confidence            34455555568899999999999999999999987         56789999986432 33455677999999994 2 2


Q ss_pred             ----CeeceeeEEEeCCceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcE
Q 011250          200 ----NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI  274 (490)
Q Consensus       200 ----nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NI  274 (490)
                          -+|.+.+||.-.++.|||+|.+ |-+++++|..+ ..+++..++..|+.|++++++|||+.+   ++|-||||+||
T Consensus       148 ~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENI  223 (415)
T KOG0671|consen  148 NGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENI  223 (415)
T ss_pred             CCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheE
Confidence                3788889999999999999998 77999999763 467999999999999999999999988   99999999999


Q ss_pred             EEcC--------------------CCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHH
Q 011250          275 LLDA--------------------DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVV  334 (490)
Q Consensus       275 Ll~~--------------------~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~  334 (490)
                      |+..                    +..|+|+|||.|+......     +.++-|..|.|||++.+-.++..+||||+|||
T Consensus       224 Lfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCI  298 (415)
T KOG0671|consen  224 LFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCI  298 (415)
T ss_pred             EEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeE
Confidence            9832                    2358999999998765443     34677999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc----c---hh-----------------hhccCCc--cC--CCCChhh
Q 011250          335 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK----R---RF-----------------YRLLDPR--LE--GHFSIKG  386 (490)
Q Consensus       335 l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~----~---~~-----------------~~~~~~~--l~--~~~~~~~  386 (490)
                      |+||++|...|......+...+.+.+...++..    .   .+                 ...+++.  +.  -.-....
T Consensus       299 L~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e  378 (415)
T KOG0671|consen  299 LVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLE  378 (415)
T ss_pred             EEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHH
Confidence            999999999998776333222222211111000    0   00                 0000000  00  0011233


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          387 SQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       387 ~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ..++.+|+++||..||.+|+|+.|+|.+
T Consensus       379 ~~~LfDLl~~mL~fDP~~RiTl~EAL~H  406 (415)
T KOG0671|consen  379 HVQLFDLLRRMLEFDPARRITLREALSH  406 (415)
T ss_pred             HhHHHHHHHHHHccCccccccHHHHhcC
Confidence            6779999999999999999999999975

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.5e-37  Score=312.02  Aligned_cols=262  Identities=24%  Similarity=0.335  Sum_probs=198.5

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      ..++|.+.+.||+|+||.||+|.+..         ++..||||.+.....  ...+.+.+|+.+|+.++||||+++++++
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   83 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRR---------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVF   83 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECC---------CCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeee
Confidence            45689999999999999999998765         567899999864321  2235688999999999999999999998


Q ss_pred             EeCC------ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCe
Q 011250          209 IEDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       209 ~~~~------~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~v  282 (490)
                      ..+.      ..++||||+ +++|.+++..  ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+
T Consensus        84 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~  157 (343)
T cd07880          84 TPDLSLDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCEL  157 (343)
T ss_pred             cCCccccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCE
Confidence            7654      358999999 7899888743  46899999999999999999999988   9999999999999999999


Q ss_pred             EEecccCcccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011250          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~  361 (490)
                      +|+|||++......     .....+++.|+|||.+.+ ..++.++|||||||++|+|++|..||........  ......
T Consensus       158 kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~--~~~~~~  230 (343)
T cd07880         158 KILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ--LMEIMK  230 (343)
T ss_pred             EEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHH
Confidence            99999999865432     123467899999998875 4688999999999999999999999975432111  000000


Q ss_pred             cccCC------------cchhhhccCCccC---CCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          362 PHLGD------------KRRFYRLLDPRLE---GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       362 ~~~~~------------~~~~~~~~~~~l~---~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .....            ...+...+.....   .......+..+.++|.+||+.||.+|||+.+++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         231 VTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             hcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000            0000000000000   01112346678999999999999999999999964

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=4.4e-37  Score=336.00  Aligned_cols=146  Identities=26%  Similarity=0.335  Sum_probs=131.3

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|.+.+.||+|+||.||+|++..         ++..||||++......   ....+..|+.++..++||||+++++++.
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~---------~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~   74 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKN---------NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ   74 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE
Confidence            579999999999999999999875         5678999999754322   2356888999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      ..+..||||||+.+++|.+++... ..+++..++.|+.||+.||.|||..+   ||||||||+||||+.++.+||+|||+
T Consensus        75 ~~~~~~lVmEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGl  150 (669)
T cd05610          75 SANNVYLVMEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGL  150 (669)
T ss_pred             ECCEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCC
Confidence            999999999999999999998554 46899999999999999999999988   99999999999999999999999999


Q ss_pred             cc
Q 011250          290 AK  291 (490)
Q Consensus       290 a~  291 (490)
                      ++
T Consensus       151 s~  152 (669)
T cd05610         151 SK  152 (669)
T ss_pred             Cc
Confidence            86

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-37  Score=313.59  Aligned_cols=264  Identities=24%  Similarity=0.358  Sum_probs=200.0

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      ..++|.+.+.||+|+||.||+|++..         ++..||||++....  ....+.+.+|+.+++.+.|+||+++++++
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   83 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTK---------TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVF   83 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECC---------CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHh
Confidence            45689999999999999999999876         56789999986532  22335678899999999999999999988


Q ss_pred             EeCCc------eEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCe
Q 011250          209 IEDDQ------RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       209 ~~~~~------~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~v  282 (490)
                      ...+.      .++|+||+ +++|.+++..  ..+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+
T Consensus        84 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~  157 (343)
T cd07851          84 TPASSLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCEL  157 (343)
T ss_pred             hccccccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCE
Confidence            76654      89999999 6799998854  46999999999999999999999988   9999999999999999999


Q ss_pred             EEecccCcccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhh-Hhh
Q 011250          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWA  360 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~-~~~  360 (490)
                      +|+|||++......     .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+ ...
T Consensus       158 kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~  232 (343)
T cd07851         158 KILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLV  232 (343)
T ss_pred             EEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Confidence            99999999876432     223468899999998865 36789999999999999999999999754322111100 000


Q ss_pred             hc-------ccC--CcchhhhccCCccCCCC---ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          361 RP-------HLG--DKRRFYRLLDPRLEGHF---SIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       361 ~~-------~~~--~~~~~~~~~~~~l~~~~---~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ..       .+.  ....+...+.......+   ....+..+.+||.+||..||.+|||+.+|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         233 GTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             CCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            00       000  00000000000000000   01236789999999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-38  Score=310.36  Aligned_cols=246  Identities=26%  Similarity=0.373  Sum_probs=201.5

Q ss_pred             CcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEeCCceE
Q 011250          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL  215 (490)
Q Consensus       138 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  215 (490)
                      .++||.|.||+||-|.++.         +|+.||||+|.+-..  .....+.+|+.||..+.||.||.+...|+..+.++
T Consensus       569 devLGSGQFG~VYgg~hRk---------tGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervF  639 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRK---------TGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVF  639 (888)
T ss_pred             HhhccCCcceeeecceecc---------cCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEE
Confidence            4789999999999999987         788999999976543  23456889999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhh-hcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC---CCeEEecccCcc
Q 011250          216 LVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD---YNAKLSDFGLAK  291 (490)
Q Consensus       216 lV~E~~~~gsL~~~l~-~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~---~~vkL~DFG~a~  291 (490)
                      +|||-+. |++.+.|. .....|++.....++.||+.||.|||..+   |+|.||||+||||...   ..+||||||+|+
T Consensus       640 VVMEKl~-GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfAR  715 (888)
T KOG4236|consen  640 VVMEKLH-GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFAR  715 (888)
T ss_pred             EEehhhc-chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeecccccee
Confidence            9999994 56555554 45568999999999999999999999988   9999999999999654   469999999999


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhh
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  371 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (490)
                      .+.+..   .....+||+.|+|||++.+..|...-|+||+|||+|--|+|..||.......+  .++.+. .        
T Consensus       716 iIgEks---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd--QIQNAa-F--------  781 (888)
T KOG4236|consen  716 IIGEKS---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND--QIQNAA-F--------  781 (888)
T ss_pred             ecchhh---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH--Hhhccc-c--------
Confidence            987643   33458999999999999999999999999999999999999999965422111  111110 0        


Q ss_pred             hccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       372 ~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                       ...+..    ..+.+..+.+||..+|+..-.+|-+....+.+.
T Consensus       782 -MyPp~P----W~eis~~AidlIn~LLqVkm~kRysvdk~lsh~  820 (888)
T KOG4236|consen  782 -MYPPNP----WSEISPEAIDLINNLLQVKMRKRYSVDKSLSHP  820 (888)
T ss_pred             -ccCCCc----hhhcCHHHHHHHHHHHHHHHHHhcchHhhccch
Confidence             011111    123478899999999999999999999888764

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-37  Score=294.28  Aligned_cols=241  Identities=33%  Similarity=0.437  Sum_probs=196.6

Q ss_pred             cccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhccCCCCeeceeeEEEeCCceEEE
Q 011250          141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  217 (490)
Q Consensus       141 LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  217 (490)
                      ||.|+||.||++.+..         ++..||+|.+......   ....+..|+.+++.++|+||+++++.+..+...++|
T Consensus         1 lg~G~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   71 (250)
T cd05123           1 LGKGSFGKVLLVRKKD---------TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLV   71 (250)
T ss_pred             CCCCCceEEEEEEECC---------CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEE
Confidence            7999999999998865         4668999998765432   345788999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCCC
Q 011250          218 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG  297 (490)
Q Consensus       218 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~  297 (490)
                      |||+++++|.+++... ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        72 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~  147 (250)
T cd05123          72 LEYAPGGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG  147 (250)
T ss_pred             EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC
Confidence            9999999999998654 36899999999999999999999988   9999999999999999999999999998764432


Q ss_pred             cceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCc
Q 011250          298 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPR  377 (490)
Q Consensus       298 ~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  377 (490)
                      .  ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.....   ........   ..           
T Consensus       148 ~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~---~~-----------  208 (250)
T cd05123         148 S--RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKIL---KD-----------  208 (250)
T ss_pred             C--cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHh---cC-----------
Confidence            1  12345689999999999888889999999999999999999999965432   11111110   00           


Q ss_pred             cCCCCChhhHHHHHHHHHHhhhcCCCCCCCH---HHHHHH
Q 011250          378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRM---SEVVET  414 (490)
Q Consensus       378 l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~---~evl~~  414 (490)
                       ...++...+..+.+++.+||..||++||++   .+++++
T Consensus       209 -~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~  247 (250)
T cd05123         209 -PLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH  247 (250)
T ss_pred             -CCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence             111222336788999999999999999999   565543

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-38  Score=319.57  Aligned_cols=243  Identities=27%  Similarity=0.299  Sum_probs=198.7

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcc-CCCCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~  210 (490)
                      ++.|.+...||.|+|+.|-.+.+..         ++...++|++.+...    +..+|+.++... .||||+++.+++.+
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~---------t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~  387 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSP---------TDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYED  387 (612)
T ss_pred             chhhccccccCCCCccceeeeeccc---------cccchhheecccccc----ccccccchhhhhcCCCcceeecceecC
Confidence            4568888889999999999998876         677899999976622    233567666555 59999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE-cCCCCeEEecccC
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL-DADYNAKLSDFGL  289 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl-~~~~~vkL~DFG~  289 (490)
                      +.+.|+|||++.|+.|.+.+....  .....+..|+.+|+.|+.|||++|   ||||||||+|||+ +..++++|+|||.
T Consensus       388 ~~~~~~v~e~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~  462 (612)
T KOG0603|consen  388 GKEIYLVMELLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGF  462 (612)
T ss_pred             CceeeeeehhccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEech
Confidence            999999999999999988885543  223777889999999999999988   9999999999999 5889999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      ++.....     ....+-|..|.|||++....|+.++||||||++||+||+|+.||......  ..+             
T Consensus       463 a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei-------------  522 (612)
T KOG0603|consen  463 WSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEI-------------  522 (612)
T ss_pred             hhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHH-------------
Confidence            9887654     12246688999999999999999999999999999999999999754322  111             


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~  416 (490)
                          +.....+.++...+..+++|+.+||+.||.+|+++.+++.+-.
T Consensus       523 ----~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w  565 (612)
T KOG0603|consen  523 ----HTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPW  565 (612)
T ss_pred             ----HHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcc
Confidence                1111122333455899999999999999999999999987643

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=314.95  Aligned_cols=244  Identities=25%  Similarity=0.325  Sum_probs=207.9

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      ..+++++..||-|+||.|=++.....         ...+|+|++++...   ...+.+..|-+||...+.|.||++|-.|
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~---------~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf  489 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQ---------KATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF  489 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEeccc---------chHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh
Confidence            34677788899999999999887653         22589999876533   3345688899999999999999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      .++..+|++||-|-||.|...|.+++ .|+...+..++..+++|++|||..+   ||+|||||+|+||+.+|-+||.|||
T Consensus       490 rd~kyvYmLmEaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFG  565 (732)
T KOG0614|consen  490 RDSKYVYMLMEACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFG  565 (732)
T ss_pred             ccchhhhhhHHhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehh
Confidence            99999999999999999999996654 7999999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +|+.+.....+   -++|||+.|.|||++.+...+.++|.|||||++||||+|.+||....+....+++-....      
T Consensus       566 FAKki~~g~KT---wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid------  636 (732)
T KOG0614|consen  566 FAKKIGSGRKT---WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID------  636 (732)
T ss_pred             hHHHhccCCce---eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh------
Confidence            99998765443   358999999999999999999999999999999999999999998777655554422111      


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCC
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR  407 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt  407 (490)
                                .-.+|...+..+.+||+++...+|.+|.-
T Consensus       637 ----------~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  637 ----------KIEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             ----------hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence                      11334444788999999999999999975

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-39  Score=296.23  Aligned_cols=252  Identities=29%  Similarity=0.394  Sum_probs=196.9

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHh-ccCCCCeeceeeEEEeCC
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLG-NLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~~~  212 (490)
                      .+-+..||.|+||+|++-.++.         +|+..|||.++.... .+.++++.|..... .-+.||||++||++..++
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~---------sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG  136 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKP---------SGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG  136 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCc---------cCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC
Confidence            3345679999999999998876         788999999987654 45567888887654 446999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhh----cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          213 QRLLVYEFMPRGSLENHLFR----RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      ..||.||+| ..+|+.+...    ....+++.....|..-.+.||.||-..-  .||||||||+||||+..|.+||||||
T Consensus       137 dcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFG  213 (361)
T KOG1006|consen  137 DCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFG  213 (361)
T ss_pred             ceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeeccc
Confidence            999999999 5577665431    3457999999999999999999998854  39999999999999999999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhcc--CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh-cccC
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR-PHLG  365 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~-~~~~  365 (490)
                      ++-.+.+.   ...+..+|...|||||.+..  ..|+.+|||||||++|||+.||+.|+.....     ..+... -..+
T Consensus       214 IcGqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~g  285 (361)
T KOG1006|consen  214 ICGQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVIG  285 (361)
T ss_pred             chHhHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHcC
Confidence            99776543   22344689999999999863  3589999999999999999999999976532     111111 1111


Q ss_pred             CcchhhhccCCccCC-CCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          366 DKRRFYRLLDPRLEG-HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~-~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      +.        |.+.. .-....+..+..+|..||.+|-..||.+.+++++
T Consensus       286 dp--------p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  286 DP--------PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             CC--------CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            11        11111 1112347889999999999999999999998754

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-37  Score=290.47  Aligned_cols=254  Identities=27%  Similarity=0.397  Sum_probs=205.3

Q ss_pred             HHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcc-CCCCeec
Q 011250          128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNL-LHPNLVK  203 (490)
Q Consensus       128 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l-~HpnIv~  203 (490)
                      ..+..++|.++++||+|+|.+|.++++..         +.+.+|+|++++.-.   .+...+..|-.+...- +||.+|.
T Consensus       245 ~~l~l~df~ll~vigrgsyakvl~~~~~~---------t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvg  315 (593)
T KOG0695|consen  245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKK---------TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVG  315 (593)
T ss_pred             cccccccceeeeeecCcchhhhhheehcc---------cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEe
Confidence            34566789999999999999999999876         677999999986533   2334456777777766 5999999


Q ss_pred             eeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeE
Q 011250          204 LVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       204 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vk  283 (490)
                      ++.+|..+..+++|.||++||+|.-++.+ ...++++.+..+...|+-||.|||+.|   ||+||||.+|+|||..|.+|
T Consensus       316 lhscfqtesrlffvieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghik  391 (593)
T KOG0695|consen  316 LHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIK  391 (593)
T ss_pred             hhhhhcccceEEEEEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCcee
Confidence            99999999999999999999999877754 457999999999999999999999998   99999999999999999999


Q ss_pred             EecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCC-CCCcchhhHhhhc
Q 011250          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR-PNGEHNLVEWARP  362 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~-~~~~~~~~~~~~~  362 (490)
                      |.|+|+++.....+..  ...+|||+.|+|||++.+..|+..+|+|+|||+++||+.|+.||+.-. .+.+.+..++.. 
T Consensus       392 ltdygmcke~l~~gd~--tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylf-  468 (593)
T KOG0695|consen  392 LTDYGMCKEGLGPGDT--TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLF-  468 (593)
T ss_pred             ecccchhhcCCCCCcc--cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHH-
Confidence            9999999875544332  356999999999999999999999999999999999999999998432 222333333321 


Q ss_pred             ccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCC
Q 011250          363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR  407 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt  407 (490)
                              ..++...+.  ++-..+..+..+++..|.+||.+|..
T Consensus       469 --------qvilekqir--iprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  469 --------QVILEKQIR--IPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             --------HHHhhhccc--ccceeehhhHHHHHHhhcCCcHHhcC
Confidence                    122222211  12222667788999999999999964

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-37  Score=301.22  Aligned_cols=271  Identities=29%  Similarity=0.462  Sum_probs=200.4

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhc--cCCCCeeceeeEEEeC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGN--LLHPNLVKLVGYCIED  211 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~  211 (490)
                      ...+.++||+|.||+||+|.+.           ++.||||++...   ....|.+|-+|.+.  +.|+||++++++-...
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~-----------~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~  276 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD-----------NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRG  276 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc-----------CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccC
Confidence            4566788999999999999985           468999999743   44568888888775  4699999999987665


Q ss_pred             C----ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcC------CCCeeecCCCCCcEEEcCCCC
Q 011250          212 D----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA------EKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       212 ~----~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------~~~iiHrDlkp~NILl~~~~~  281 (490)
                      .    .++||++|.+.|+|.++|..+  .++|.....|+..+++||+|||+.-      +++|+|||||..||||..|++
T Consensus       277 t~~~~eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT  354 (534)
T KOG3653|consen  277 TADRMEYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT  354 (534)
T ss_pred             CccccceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc
Confidence            5    789999999999999999554  7999999999999999999999863      357999999999999999999


Q ss_pred             eEEecccCcccCCCCCcceeeeccccCCCccCcchhccC-CCC-----ccchhhHHHHHHHHHHhCCCCCCCCCCCCcch
Q 011250          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLT-----SKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN  355 (490)
Q Consensus       282 vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~-----~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~  355 (490)
                      ..|+|||+|..+.........-..+||.+|||||++.+. .+.     .+.||||+|.|||||++...-++. .+..+..
T Consensus       355 ccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~-~~vp~Yq  433 (534)
T KOG3653|consen  355 CCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP-GPVPEYQ  433 (534)
T ss_pred             EEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC-CCCCccc
Confidence            999999999987654433333347899999999998754 222     368999999999999997665532 1111111


Q ss_pred             h--hHh--hhcccCCcchh--hhccCCccCCCCC-hhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccc
Q 011250          356 L--VEW--ARPHLGDKRRF--YRLLDPRLEGHFS-IKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       356 ~--~~~--~~~~~~~~~~~--~~~~~~~l~~~~~-~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~~  421 (490)
                      +  ...  ..|.+.+-+.+  .+...|.+...+- ......+.+.+..||..||+.|.|+.=+-+.+.++...
T Consensus       434 lpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~  506 (534)
T KOG3653|consen  434 LPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML  506 (534)
T ss_pred             CchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence            1  000  00111100000  0011111111110 12367789999999999999999999998888877543

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-38  Score=304.67  Aligned_cols=258  Identities=28%  Similarity=0.398  Sum_probs=202.5

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-c------ccHHHHHHHHHHHhccCCCCeec
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-L------QGHKEWLAEVNFLGNLLHPNLVK  203 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~------~~~~~~~~Ei~il~~l~HpnIv~  203 (490)
                      ..++|-++.+||+|||+.||+|.+..         ..+.||||+-.... .      ...+...+|.+|.+.|+||.||+
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~---------EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVK  531 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLT---------EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVK  531 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccc---------hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeee
Confidence            34578999999999999999998876         45689999864331 1      12345788999999999999999


Q ss_pred             eeeEEE-eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---C
Q 011250          204 LVGYCI-EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---D  279 (490)
Q Consensus       204 l~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~---~  279 (490)
                      +|+||. +.+.+|-|+|||+|.+|+-+|. ....+++.++..|+.||+.||.||.+.. .+|||-||||.||||-.   -
T Consensus       532 lYDyfslDtdsFCTVLEYceGNDLDFYLK-QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~Gtac  609 (775)
T KOG1151|consen  532 LYDYFSLDTDSFCTVLEYCEGNDLDFYLK-QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTAC  609 (775)
T ss_pred             eeeeeeeccccceeeeeecCCCchhHHHH-hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCccc
Confidence            999986 5578899999999999988884 4457999999999999999999999876 78999999999999943   4


Q ss_pred             CCeEEecccCcccCCCCCcc-----eeeeccccCCCccCcchhccC----CCCccchhhHHHHHHHHHHhCCCCCCCCCC
Q 011250          280 YNAKLSDFGLAKDAPEDGKT-----HVSTRVMGTYGYAAPEYVMTG----HLTSKSDVYSFGVVLLEMLTGRRSMDKNRP  350 (490)
Q Consensus       280 ~~vkL~DFG~a~~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~~----~~~~~sDvwSlGv~l~elltG~~pf~~~~~  350 (490)
                      |.+||.|||+++.+.++...     .......||++|++||.+.-+    ..+.++||||+|||+|..|.|+.||..+..
T Consensus       610 GeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs  689 (775)
T KOG1151|consen  610 GEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS  689 (775)
T ss_pred             ceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence            78999999999988765443     234557899999999987533    578899999999999999999999975432


Q ss_pred             CCcchhhHhhhcccCCcchhhhccCCccCCCCC--hhhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 011250          351 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFS--IKGSQKATQLAAQCLSRDPKARPRMSEVVE  413 (490)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~--~~~~~~l~~Li~~cL~~dP~~RPt~~evl~  413 (490)
                      ..  .+.+..           .++... +-.|+  +..+.++.+||++||+.--++|.+..++..
T Consensus       690 QQ--dILqeN-----------TIlkAt-EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  690 QQ--DILQEN-----------TILKAT-EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             HH--HHHhhh-----------chhcce-eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            11  111110           011100 11222  224789999999999999999998887753

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-37  Score=319.27  Aligned_cols=257  Identities=28%  Similarity=0.397  Sum_probs=210.4

Q ss_pred             HHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccC-CCCeeceee
Q 011250          128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVG  206 (490)
Q Consensus       128 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~  206 (490)
                      +...++-|++.++||.|.+|.||+++...         +++.+|+|++..+. ...+++..|.+||+.+. |||++.+||
T Consensus        14 lpdp~d~~ei~evig~Gtygkv~k~k~~~---------~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg   83 (953)
T KOG0587|consen   14 LPDPADIFEIIEVIGNGTYGKVYKGRHVK---------TGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYG   83 (953)
T ss_pred             CCCCCCccEEEEEEeeccceeEEEEeeee---------cCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEE
Confidence            33455679999999999999999999987         45678888887654 33467788999999885 999999999


Q ss_pred             EEEe-----CCceEEEEEecCCCChhHHhhh-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC
Q 011250          207 YCIE-----DDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY  280 (490)
Q Consensus       207 ~~~~-----~~~~~lV~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~  280 (490)
                      +|..     ++++|||||||.+|+..|++.. .+..+.|..+..|++.++.||++||.+.   +||||||-.|||++.++
T Consensus        84 ~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~  160 (953)
T KOG0587|consen   84 AFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENA  160 (953)
T ss_pred             EEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccC
Confidence            9874     5689999999999999999864 2567999999999999999999999988   99999999999999999


Q ss_pred             CeEEecccCcccCCCCCcceeeeccccCCCccCcchhcc-----CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcch
Q 011250          281 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-----GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN  355 (490)
Q Consensus       281 ~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~  355 (490)
                      .|||+|||++..+....  ......+||+.|||||++..     ..|+..+|+||||++..||--|.+|+-...+.-.. 
T Consensus       161 ~VKLvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL-  237 (953)
T KOG0587|consen  161 EVKLVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL-  237 (953)
T ss_pred             cEEEeeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh-
Confidence            99999999998775432  22345789999999999864     35788999999999999999999998654432111 


Q ss_pred             hhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                                    |...-+|.....-+.+.+.++.++|..||.+|..+||++.++|+|
T Consensus       238 --------------F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  238 --------------FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             --------------ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence                          111112222233345668999999999999999999999999976

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-37  Score=267.24  Aligned_cols=266  Identities=24%  Similarity=0.310  Sum_probs=204.7

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      +|.-.++||+|.||+||+|+..+         +++.||+|.++.+..  ..-...++||-+|+.|.|.|||+++++...+
T Consensus         3 ~ydkmekigegtygtvfkarn~~---------t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd   73 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD   73 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCC---------ccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC
Confidence            46667899999999999999887         677999999876532  2235678999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      ..+-+|+|||+ -+|..+...-...++.+.+..++.|+++||.|+|+++   +.||||||.|+||+.+|.+||+|||+++
T Consensus        74 kkltlvfe~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglar  149 (292)
T KOG0662|consen   74 KKLTLVFEFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLAR  149 (292)
T ss_pred             ceeEEeHHHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhh
Confidence            99999999994 5898888777778999999999999999999999988   9999999999999999999999999999


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhccC-CCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhh--cccCCc
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWAR--PHLGDK  367 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~--~~~~~~  367 (490)
                      .+.-..  ......+-|..|.+|.++.+. -|+...|+||.|||+.|+.. |++.|.+....+....+-+..  +.....
T Consensus       150 afgipv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~w  227 (292)
T KOG0662|consen  150 AFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQW  227 (292)
T ss_pred             hcCCce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccC
Confidence            775431  122334679999999998865 68899999999999999986 777777665443322221111  111111


Q ss_pred             chhhhccCCccCCCCC---------hhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          368 RRFYRLLDPRLEGHFS---------IKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~---------~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ..+..+.|-..-..|+         ++....-.+|++++|.-+|.+|.++++.+++
T Consensus       228 ps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  228 PSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             CccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            1111111211111111         1223456789999999999999999998865

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.7e-36  Score=289.31  Aligned_cols=220  Identities=25%  Similarity=0.275  Sum_probs=178.6

Q ss_pred             CCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCCceEEEEEecCC
Q 011250          144 GGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR  223 (490)
Q Consensus       144 G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~  223 (490)
                      |.||.||++++..         ++..||+|.+....     .+..|...+....||||+++++++.+.+..++||||+++
T Consensus         4 g~~~~v~~~~~~~---------~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   69 (237)
T cd05576           4 GVIDKVLLVMDTR---------TQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEG   69 (237)
T ss_pred             cccceEEEEEEcc---------CCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCC
Confidence            8999999999876         67789999997643     233455555566799999999999999999999999999


Q ss_pred             CChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCCCcceeee
Q 011250          224 GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST  303 (490)
Q Consensus       224 gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~  303 (490)
                      |+|.+++.+. ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++......     ..
T Consensus        70 ~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~  140 (237)
T cd05576          70 GKLWSHISKF-LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CD  140 (237)
T ss_pred             CCHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cc
Confidence            9999998654 36999999999999999999999988   999999999999999999999999988665332     12


Q ss_pred             ccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCC
Q 011250          304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFS  383 (490)
Q Consensus       304 ~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  383 (490)
                      ...++..|+|||.+....++.++||||+||++|||++|..||........            ..          ....++
T Consensus       141 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------~~----------~~~~~~  198 (237)
T cd05576         141 GEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------TH----------TTLNIP  198 (237)
T ss_pred             cCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------cc----------cccCCc
Confidence            24567889999999888899999999999999999999988753211000            00          000112


Q ss_pred             hhhHHHHHHHHHHhhhcCCCCCCCH
Q 011250          384 IKGSQKATQLAAQCLSRDPKARPRM  408 (490)
Q Consensus       384 ~~~~~~l~~Li~~cL~~dP~~RPt~  408 (490)
                      ...+..+.+||.+||+.||++||++
T Consensus       199 ~~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         199 EWVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             ccCCHHHHHHHHHHccCCHHHhcCC
Confidence            2236788999999999999999996

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-37  Score=317.98  Aligned_cols=257  Identities=27%  Similarity=0.399  Sum_probs=214.4

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC-CcccHHHHHHHHHHHhccCCCCeeceeeEEEeCCc
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQ  213 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  213 (490)
                      .+..++||.|+||+||+|.+...++.     -..+||||++... ..+...+++.|+.+|.+|+||||++|++++.... 
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~-----vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-  771 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGEN-----VKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-  771 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCce-----ecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-
Confidence            44567899999999999998765432     3458999998655 3445688999999999999999999999998775 


Q ss_pred             eEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccC
Q 011250          214 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       214 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~  293 (490)
                      +.||++|+++|+|.+++..+...+.....+.|..||++||.|||.+.   +|||||-.+|||+.+-..+||.|||+++..
T Consensus       772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll  848 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLL  848 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence            88999999999999999888888999999999999999999999877   999999999999999999999999999987


Q ss_pred             CCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcchhhh
Q 011250          294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR  372 (490)
Q Consensus       294 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (490)
                      ..+..........-.+.|||-|.+....|+.++|||||||++||+|| |..|++.....+..++.+..            
T Consensus       849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~g------------  916 (1177)
T KOG1025|consen  849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKG------------  916 (1177)
T ss_pred             CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcc------------
Confidence            65544332222334678999999999999999999999999999998 88888776544333333221            


Q ss_pred             ccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011250          373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  417 (490)
Q Consensus       373 ~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~  417 (490)
                           ..-.-++.++.++..++.+||..|+..||+++++...+..
T Consensus       917 -----eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~  956 (1177)
T KOG1025|consen  917 -----ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR  956 (1177)
T ss_pred             -----ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence                 1123456679999999999999999999999999887753

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-36  Score=323.60  Aligned_cols=267  Identities=30%  Similarity=0.462  Sum_probs=212.7

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccC-CCCeeceeeE
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLL-HPNLVKLVGY  207 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~-HpnIv~l~~~  207 (490)
                      ...++..+.+.||+|.||.|++|.........  ......||||.++.... ...+.+..|+++|+.+. |+||+.++|+
T Consensus       293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~--~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKAL--LSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             echhhccccceeecccccceEeEEEeeccccc--ccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            33445566679999999999999876432210  11256899999976543 44577999999999995 9999999999


Q ss_pred             EEeCCceEEEEEecCCCChhHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 011250          208 CIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTS  272 (490)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~  272 (490)
                      +...+..++|+||+..|+|.++|....               ..++....+.++.||+.|++||++..   +|||||-.+
T Consensus       371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaR  447 (609)
T KOG0200|consen  371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAAR  447 (609)
T ss_pred             eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhh
Confidence            999999999999999999999997665               34889999999999999999999977   999999999


Q ss_pred             cEEEcCCCCeEEecccCcccCCCCCcceeeecccc--CCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCC
Q 011250          273 NILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG--TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNR  349 (490)
Q Consensus       273 NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~G--t~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~  349 (490)
                      |||+.++..+||+|||+|+........... ...|  ...|||||.+....|+.++|||||||+|||+++ |..||.+..
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            999999999999999999977655444322 1222  346999999999999999999999999999998 777886521


Q ss_pred             CCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          350 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                      .  ...+.++.+              .-.....|..|+.++.+|++.||+.+|++||++.++.+.|+..
T Consensus       527 ~--~~~l~~~l~--------------~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  527 P--TEELLEFLK--------------EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             c--HHHHHHHHh--------------cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            1  112222221              1112234456689999999999999999999999999999873

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.8e-37  Score=309.55  Aligned_cols=244  Identities=26%  Similarity=0.329  Sum_probs=195.5

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      -|..++.||-|+||.|.++.-.+         +...||.|.+.+.+.-.   ...+..|-.||..-+.+-||+||-.|.+
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvD---------T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD  700 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVD---------TRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD  700 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecc---------hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc
Confidence            57788899999999999997765         56689999997764332   2346779999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      .+.+|+||+|++||++..+|.+.+ -|++..+..++.++..|++++|..|   +|||||||+|||||.+|++||.||||+
T Consensus       701 kdnLYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLC  776 (1034)
T KOG0608|consen  701 KDNLYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLC  776 (1034)
T ss_pred             CCceEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccc
Confidence            999999999999999999998765 6899999999999999999999999   999999999999999999999999998


Q ss_pred             ccCC---------CCCcc-------------------------------eeeeccccCCCccCcchhccCCCCccchhhH
Q 011250          291 KDAP---------EDGKT-------------------------------HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYS  330 (490)
Q Consensus       291 ~~~~---------~~~~~-------------------------------~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwS  330 (490)
                      +-+.         +++..                               ......+||+.|+|||++....|+.-+|+||
T Consensus       777 TGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws  856 (1034)
T KOG0608|consen  777 TGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWS  856 (1034)
T ss_pred             ccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhH
Confidence            5321         10000                               0011257999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCCCcchhh-HhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCC
Q 011250          331 FGVVLLEMLTGRRSMDKNRPNGEHNLV-EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP  406 (490)
Q Consensus       331 lGv~l~elltG~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP  406 (490)
                      .|||||||+.|++||-...+.+.+..+ .|.           ..++-    .+..+.+.++.+||.+++ .+++.|.
T Consensus       857 ~gvil~em~~g~~pf~~~tp~~tq~kv~nw~-----------~~l~~----~~~~~ls~e~~~li~kLc-~sad~RL  917 (1034)
T KOG0608|consen  857 VGVILYEMLVGQPPFLADTPGETQYKVINWR-----------NFLHI----PYQGNLSKEALDLIQKLC-CSADSRL  917 (1034)
T ss_pred             hhHHHHHHhhCCCCccCCCCCcceeeeeehh-----------hcccc----ccccccCHHHHHHHHHHh-cChhhhh
Confidence            999999999999999887776543322 221           11111    122233777888887755 4666664

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.3e-38  Score=285.85  Aligned_cols=271  Identities=25%  Similarity=0.375  Sum_probs=206.1

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      .|.-..+||+|.||.||+|+..+         +|+.||+|++-.+..  .--...++|+.+|..|.|+|++.++++|...
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n---------~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk   88 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKN---------TGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK   88 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcC---------ccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhc
Confidence            46667889999999999999876         677899987644321  1224568999999999999999999987542


Q ss_pred             --------CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeE
Q 011250          212 --------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       212 --------~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vk  283 (490)
                              ..+||||.+|+. +|.-+|......++..++..++.++..||.|+|...   |+|||+|++|+||+.+|.+|
T Consensus        89 ~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilk  164 (376)
T KOG0669|consen   89 ATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILK  164 (376)
T ss_pred             cCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEE
Confidence                    247999999965 999999777778999999999999999999999988   99999999999999999999


Q ss_pred             EecccCcccCCCCCc--ceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011250          284 LSDFGLAKDAPEDGK--THVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       284 L~DFG~a~~~~~~~~--~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~  360 (490)
                      |+|||+++.+.....  ....+..+-|..|.+||.+.+ ..|+...|||..||||.||+|+.+-|.++.......++...
T Consensus       165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~L  244 (376)
T KOG0669|consen  165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQL  244 (376)
T ss_pred             eeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHH
Confidence            999999986643222  112234566999999998886 58999999999999999999999999877655444333221


Q ss_pred             --------hcccCCcchhhhcc--CCccCCCCC--------hhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          361 --------RPHLGDKRRFYRLL--DPRLEGHFS--------IKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       361 --------~~~~~~~~~~~~~~--~~~l~~~~~--------~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                              ++..... .++..+  .|-..+.+.        ..-.+++.+|+.++|..||.+|+++++++.+.--.
T Consensus       245 cGs~tkevWP~~d~l-pL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~  319 (376)
T KOG0669|consen  245 CGSITKEVWPNVDNL-PLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFW  319 (376)
T ss_pred             hccCCcccCCCcccc-hHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhh
Confidence                    1111111 111111  111111111        11156889999999999999999999999886433

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-35  Score=288.00  Aligned_cols=267  Identities=29%  Similarity=0.439  Sum_probs=200.9

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhc--cCCCCeeceeeEEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGN--LLHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~  209 (490)
                      .+...+.+.||+|.||.||+|.++           |..||||++...   +...+.+|.+|++.  |+|+||+.+++.-.
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wr-----------Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~  275 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWR-----------GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADN  275 (513)
T ss_pred             hheeEEEEEecCccccceeecccc-----------CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccc
Confidence            356788899999999999999995           668999999754   34567788887764  58999999998765


Q ss_pred             eCC----ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhc-----CCCCeeecCCCCCcEEEcCCC
Q 011250          210 EDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-----AEKPVIYRDFKTSNILLDADY  280 (490)
Q Consensus       210 ~~~----~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-----~~~~iiHrDlkp~NILl~~~~  280 (490)
                      .+.    ++|||++|-+.|+|+|+|.+  ..++....+++++.+|.||++||..     |++.|.|||||..|||+.+++
T Consensus       276 ~~~gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~  353 (513)
T KOG2052|consen  276 KDNGSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG  353 (513)
T ss_pred             cCCCceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence            443    68999999999999999966  4799999999999999999999974     556799999999999999999


Q ss_pred             CeEEecccCcccCCCCCcc--eeeeccccCCCccCcchhccC----CC--CccchhhHHHHHHHHHHhC----------C
Q 011250          281 NAKLSDFGLAKDAPEDGKT--HVSTRVMGTYGYAAPEYVMTG----HL--TSKSDVYSFGVVLLEMLTG----------R  342 (490)
Q Consensus       281 ~vkL~DFG~a~~~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~----~~--~~~sDvwSlGv~l~elltG----------~  342 (490)
                      ...|+|+|||.........  ......+||.+|||||++...    .+  -..+||||||++|||+.-.          +
T Consensus       354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~  433 (513)
T KOG2052|consen  354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ  433 (513)
T ss_pred             cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence            9999999999876554322  122347899999999998643    12  2369999999999998752          3


Q ss_pred             CCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCC-ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccc
Q 011250          343 RSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHF-SIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       343 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~~  421 (490)
                      +||....+.+.. ..+ .+.....     +.+.|.+...+ +..+...+.+|++.||..||.-|.|+-.|-+.|.++.+.
T Consensus       434 ~Pyyd~Vp~DPs-~ee-MrkVVCv-----~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~  506 (513)
T KOG2052|consen  434 LPYYDVVPSDPS-FEE-MRKVVCV-----QKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS  506 (513)
T ss_pred             CCcccCCCCCCC-HHH-Hhcceee-----cccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence            565443332210 000 0111000     01111111111 234467788999999999999999999999999888753

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=6.6e-35  Score=311.88  Aligned_cols=267  Identities=21%  Similarity=0.266  Sum_probs=173.3

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeE---
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGY---  207 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~---  207 (490)
                      ..++|.+.+.||+|+||.||+|++..+..     ..+..||||++.....  .+.+..|  .+....+.+++.++..   
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~-----~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~  200 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQS-----KKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLE  200 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCcc-----ccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhc
Confidence            45789999999999999999999876311     1267899998864321  1112221  1222223333332222   


Q ss_pred             ---EEeCCceEEEEEecCCCChhHHhhhcCCC-------------------CCHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 011250          208 ---CIEDDQRLLVYEFMPRGSLENHLFRRSLP-------------------LPWSIRMKIALGAAKGLAFLHEEAEKPVI  265 (490)
Q Consensus       208 ---~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-------------------l~~~~~~~i~~qi~~aL~yLH~~~~~~ii  265 (490)
                         ...+...+|||||+.+++|.+++......                   .....+..++.||+.||.|||+.+   ||
T Consensus       201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---Ii  277 (566)
T PLN03225        201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IV  277 (566)
T ss_pred             ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence               23556789999999999999988643211                   123345679999999999999988   99


Q ss_pred             ecCCCCCcEEEcC-CCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccC----------------------CC
Q 011250          266 YRDFKTSNILLDA-DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG----------------------HL  322 (490)
Q Consensus       266 HrDlkp~NILl~~-~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~----------------------~~  322 (490)
                      ||||||+||||+. ++.+||+|||+|+....... ......+||+.|||||.+...                      .+
T Consensus       278 HRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~  356 (566)
T PLN03225        278 HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL  356 (566)
T ss_pred             eCcCCHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence            9999999999985 58999999999986543322 223457899999999966422                      24


Q ss_pred             CccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCcc----CCCCC--hhhHHHHHHHHHH
Q 011250          323 TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRL----EGHFS--IKGSQKATQLAAQ  396 (490)
Q Consensus       323 ~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l----~~~~~--~~~~~~l~~Li~~  396 (490)
                      +.++|||||||+||||+++..+++...    ..+.........+...+.....+..    ...+.  ........+||.+
T Consensus       357 ~~k~DVwSlGviL~el~~~~~~~~~~~----~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~  432 (566)
T PLN03225        357 PDRFDIYSAGLIFLQMAFPNLRSDSNL----IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKS  432 (566)
T ss_pred             CCCcccHHHHHHHHHHHhCcCCCchHH----HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHH
Confidence            456799999999999999776653210    0000000000000000001111110    00000  0013345689999


Q ss_pred             hhhcCCCCCCCHHHHHHH
Q 011250          397 CLSRDPKARPRMSEVVET  414 (490)
Q Consensus       397 cL~~dP~~RPt~~evl~~  414 (490)
                      ||+.||.+|||+.++++|
T Consensus       433 mL~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        433 MMRFKGRQRISAKAALAH  450 (566)
T ss_pred             HccCCcccCCCHHHHhCC
Confidence            999999999999999987

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=4.2e-34  Score=272.09  Aligned_cols=239  Identities=31%  Similarity=0.439  Sum_probs=194.6

Q ss_pred             CceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-HHHHHHHHHHHhccCCCCeeceeeEEEeCCceEEEEEecCC
Q 011250          145 GFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR  223 (490)
Q Consensus       145 ~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~  223 (490)
                      +||.||+|.+..         ++..||+|++....... .+.+.+|+++++.++|+||+++++++......++||||+++
T Consensus         1 ~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   71 (244)
T smart00220        1 SFGKVYLARDKK---------TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDG   71 (244)
T ss_pred             CceEEEEEEECC---------CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCC
Confidence            589999999875         56789999998765544 67899999999999999999999999999999999999999


Q ss_pred             CChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCCCcceeee
Q 011250          224 GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST  303 (490)
Q Consensus       224 gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~  303 (490)
                      ++|.+++.... .+++..++.++.+++.+|.|||..+   |+|+||+|+||+++.++.++|+|||.+.......   ...
T Consensus        72 ~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~  144 (244)
T smart00220       72 GDLFDLLKKRG-RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLT  144 (244)
T ss_pred             CCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccc
Confidence            99999986543 3899999999999999999999988   9999999999999999999999999998765432   223


Q ss_pred             ccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCC
Q 011250          304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFS  383 (490)
Q Consensus       304 ~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  383 (490)
                      ...|+..|++||.+....++.++||||||+++|+|++|..||....  ......+.........            ....
T Consensus       145 ~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~--~~~~~~~~~~~~~~~~------------~~~~  210 (244)
T smart00220      145 TFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD--QLLELFKKIGKPKPPF------------PPPE  210 (244)
T ss_pred             cccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHhccCCCC------------cccc
Confidence            4568999999999988889999999999999999999999996531  1111111111100000            0000


Q ss_pred             hhhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 011250          384 IKGSQKATQLAAQCLSRDPKARPRMSEVVE  413 (490)
Q Consensus       384 ~~~~~~l~~Li~~cL~~dP~~RPt~~evl~  413 (490)
                      ...+.++.+++.+||..||++||++.++++
T Consensus       211 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      211 WKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             ccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            003678999999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.8e-34  Score=299.32  Aligned_cols=271  Identities=19%  Similarity=0.279  Sum_probs=187.1

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCcc-------ccCCCCcEEEEEEecCCCcccHHH--------------HHH
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAP-------VKPGTGLTVAVKTLNHDGLQGHKE--------------WLA  188 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~-------~~~~~~~~vaiK~~~~~~~~~~~~--------------~~~  188 (490)
                      ...++|.+.++||+|+||+||+|.+...+...       .....++.||||.+........++              ...
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            34678999999999999999999864322111       112345689999987553322222              334


Q ss_pred             HHHHHhccCCCCe-----eceeeEEEe--------CCceEEEEEecCCCChhHHhhhcC---------------------
Q 011250          189 EVNFLGNLLHPNL-----VKLVGYCIE--------DDQRLLVYEFMPRGSLENHLFRRS---------------------  234 (490)
Q Consensus       189 Ei~il~~l~HpnI-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~---------------------  234 (490)
                      |+.++.+++|.++     ++++++|..        .+..+|||||+++++|.+++....                     
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            7777777776554     677777653        356899999999999999886421                     


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCcc
Q 011250          235 --LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA  312 (490)
Q Consensus       235 --~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~  312 (490)
                        ..+++..+..++.|++.+|.|||+.+   |+||||||+|||++.++.+||+|||++.......... .....+|+.|+
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~  377 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYS  377 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCccee
Confidence              12456778899999999999999988   9999999999999999999999999997654322111 11234588999


Q ss_pred             CcchhccCC--------------------CC--ccchhhHHHHHHHHHHhCCC-CCCCCCCCCc------chhhHhhhcc
Q 011250          313 APEYVMTGH--------------------LT--SKSDVYSFGVVLLEMLTGRR-SMDKNRPNGE------HNLVEWARPH  363 (490)
Q Consensus       313 aPE~l~~~~--------------------~~--~~sDvwSlGv~l~elltG~~-pf~~~~~~~~------~~~~~~~~~~  363 (490)
                      |||.+....                    |+  .+.||||+||+||+|++|.. ||........      ..+..|..  
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--  455 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--  455 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--
Confidence            999875432                    11  24799999999999999875 6643211110      00111100  


Q ss_pred             cCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCC---CCCCCHHHHHHHh
Q 011250          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDP---KARPRMSEVVETL  415 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP---~~RPt~~evl~~L  415 (490)
                               .......-......+..+.+|+.+||..+|   .+|+|++|+|+|-
T Consensus       456 ---------~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp  501 (507)
T PLN03224        456 ---------YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHR  501 (507)
T ss_pred             ---------hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence                     000000001112347889999999999876   6899999999874

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-34  Score=274.62  Aligned_cols=270  Identities=25%  Similarity=0.345  Sum_probs=220.1

Q ss_pred             hhhHHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeec
Q 011250          125 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVK  203 (490)
Q Consensus       125 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~  203 (490)
                      ..++.+..+++++..++-+|.||.||.|.+++.++.    .+.+.|-+|.++.... .....++.|.-.+..+.|||++.
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~----n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~  351 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTY----NDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLS  351 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCc----chHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccc
Confidence            456777778899999999999999999988875443    2445677787765432 33456889999999999999999


Q ss_pred             eeeEEEeC-CceEEEEEecCCCChhHHhhh-------cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 011250          204 LVGYCIED-DQRLLVYEFMPRGSLENHLFR-------RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  275 (490)
Q Consensus       204 l~~~~~~~-~~~~lV~E~~~~gsL~~~l~~-------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NIL  275 (490)
                      +.+++.++ ...+.++.++.-|+|..+|..       ....++..+...++.|++.|+.|||.++   |||.||..+|++
T Consensus       352 V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCv  428 (563)
T KOG1024|consen  352 VLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCV  428 (563)
T ss_pred             eeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcce
Confidence            99988765 567888999988999999962       1245777788899999999999999999   999999999999


Q ss_pred             EcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcc
Q 011250          276 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEH  354 (490)
Q Consensus       276 l~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~  354 (490)
                      |++...+||+|=.++|.+-..+........--...||+||.+.+..|+.++|||||||+||||+| |+.|+....+.+..
T Consensus       429 Idd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~  508 (563)
T KOG1024|consen  429 IDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME  508 (563)
T ss_pred             ehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH
Confidence            99999999999999998877666655544445778999999999999999999999999999998 88888766554332


Q ss_pred             hhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                      ...       .+..          .-.-|.+|++++..++.-||+.+|++||++++++..|.+.
T Consensus       509 ~yl-------kdGy----------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  509 HYL-------KDGY----------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             HHH-------hccc----------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence            221       1111          1223457899999999999999999999999999998765

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-36  Score=276.52  Aligned_cols=268  Identities=22%  Similarity=0.358  Sum_probs=205.6

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC--CcccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      +.+..+.||-|+||+||.+++..         +|+.||+|++..-  .+...+.+.+|+++|..++|.|++..+++..-.
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPR---------dgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPp  124 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPR---------SGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPA  124 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCC---------CccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCC
Confidence            56778999999999999987765         6889999988543  444567899999999999999999999876644


Q ss_pred             C-----ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEec
Q 011250          212 D-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       212 ~-----~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~D  286 (490)
                      .     ++|+|+|+| ..+|...|. ....++...+..++.||++||+|||+.+   |.||||||.|+|++.|..+||||
T Consensus       125 h~dfFqEiYV~TELm-QSDLHKIIV-SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICD  199 (449)
T KOG0664|consen  125 NPSFFQELYVLTELM-QSDLHKIIV-SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICD  199 (449)
T ss_pred             CchHHHHHHHHHHHH-Hhhhhheec-cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecc
Confidence            3     467899998 568887774 4457999999999999999999999998   99999999999999999999999


Q ss_pred             ccCcccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--cc
Q 011250          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--PH  363 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~--~~  363 (490)
                      ||+++....+...+ .+..+-|.+|.|||++++ ..|+.++||||+|||+.|||..+..|....+.....++....  +.
T Consensus       200 FGLARvee~d~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs  278 (449)
T KOG0664|consen  200 FGLARTWDQRDRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPS  278 (449)
T ss_pred             cccccccchhhhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCc
Confidence            99999765544333 345567899999999986 489999999999999999999999998877665544432211  10


Q ss_pred             cC------Ccch--h-hh-ccCCccCCCCC----hhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011250          364 LG------DKRR--F-YR-LLDPRLEGHFS----IKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       364 ~~------~~~~--~-~~-~~~~~l~~~~~----~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~  416 (490)
                      +.      +..+  + .. .-.|.+..-|.    .....+...++.++|..||++|.+..+.+.++.
T Consensus       279 ~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  279 QEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             HHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence            00      0000  0 00 00111111111    122456788999999999999999999998763

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-35  Score=258.93  Aligned_cols=204  Identities=28%  Similarity=0.383  Sum_probs=170.9

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC-CcccHHHHHHHHHHHhcc-CCCCeeceeeE
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNL-LHPNLVKLVGY  207 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~  207 (490)
                      +..++...+..||+|+||.|=+-++..         +|...|+|.+... ..+..+.+++|+.+..+. .+|.+|.+||.
T Consensus        43 V~ad~L~~i~elGrGayG~vekmrh~~---------sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa  113 (282)
T KOG0984|consen   43 VPADDLVGIEELGRGAYGVVEKMRHIQ---------SGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGA  113 (282)
T ss_pred             cchhhhhhhhhhcCCccchhhheeecc---------CCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehh
Confidence            334445556779999999999888887         6779999999765 334557788899876655 59999999999


Q ss_pred             EEeCCceEEEEEecCCCChhHHhh---hcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 011250          208 CIEDDQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL  284 (490)
                      +..+...||.||.| ..+|+.+..   +.+..+++..+-+|+..++.||.|||++-  .|||||+||+||||+.+|.||+
T Consensus       114 ~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKi  190 (282)
T KOG0984|consen  114 LFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKI  190 (282)
T ss_pred             hhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEE
Confidence            99999999999999 458876543   46788999999999999999999999965  4999999999999999999999


Q ss_pred             ecccCcccCCCCCcceeeeccccCCCccCcchhcc----CCCCccchhhHHHHHHHHHHhCCCCCCCC
Q 011250          285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT----GHLTSKSDVYSFGVVLLEMLTGRRSMDKN  348 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~----~~~~~~sDvwSlGv~l~elltG~~pf~~~  348 (490)
                      ||||++-.+.+.-.   .+-..|...|||||.+..    ..|+.++||||||+++.||.+++.||+..
T Consensus       191 CDFGIsG~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  191 CDFGISGYLVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             cccccceeehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            99999987754322   222568999999998863    47899999999999999999999999754

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=2.9e-34  Score=284.79  Aligned_cols=269  Identities=24%  Similarity=0.281  Sum_probs=208.3

Q ss_pred             HHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccC------CCCe
Q 011250          128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL------HPNL  201 (490)
Q Consensus       128 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~------HpnI  201 (490)
                      ..+...+|.+....|+|-|++|..|.+..         .|..||||+|..... -++.=+.|++||+.|.      .-|+
T Consensus       427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~---------r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hc  496 (752)
T KOG0670|consen  427 GELLDSRYEVQGYTGKGVFSTVVRARDQA---------RGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHC  496 (752)
T ss_pred             hhhhcceeEEEeccccceeeeeeeccccC---------CCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHH
Confidence            34556789999999999999999998876         466899999987643 3456678999999996      3589


Q ss_pred             eceeeEEEeCCceEEEEEecCCCChhHHhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC
Q 011250          202 VKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD  279 (490)
Q Consensus       202 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~  279 (490)
                      ++|+-.|...+++|||+|-+ ..+|.++|.+.+  ..|....+..++.|++-||..|-..+   |+|.||||+|||+++.
T Consensus       497 lrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~  572 (752)
T KOG0670|consen  497 LRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNES  572 (752)
T ss_pred             HHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccC
Confidence            99999999999999999998 679999997755  35778899999999999999999999   9999999999999865


Q ss_pred             -CCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhH
Q 011250          280 -YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE  358 (490)
Q Consensus       280 -~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~  358 (490)
                       ..+||||||.|....+...+    .+.-+..|.|||++.+-.|+...|+||+||+||||.||+..|.+.+.+....+.-
T Consensus       573 k~iLKLCDfGSA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~m  648 (752)
T KOG0670|consen  573 KNILKLCDFGSASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFM  648 (752)
T ss_pred             cceeeeccCcccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHH
Confidence             56899999999877654332    2345678999999999999999999999999999999999998876654333221


Q ss_pred             hhh---------------cccCCcchhh----------------hccCC------ccCC--CCC---hhhHHHHHHHHHH
Q 011250          359 WAR---------------PHLGDKRRFY----------------RLLDP------RLEG--HFS---IKGSQKATQLAAQ  396 (490)
Q Consensus       359 ~~~---------------~~~~~~~~~~----------------~~~~~------~l~~--~~~---~~~~~~l~~Li~~  396 (490)
                      -..               .++.....|.                ..+.|      .|..  .++   ...-..+.+|+.+
T Consensus       649 e~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdk  728 (752)
T KOG0670|consen  649 ELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDK  728 (752)
T ss_pred             HhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHH
Confidence            110               0111000000                00011      0111  122   2235678999999


Q ss_pred             hhhcCCCCCCCHHHHHHH
Q 011250          397 CLSRDPKARPRMSEVVET  414 (490)
Q Consensus       397 cL~~dP~~RPt~~evl~~  414 (490)
                      ||..||++|.|..++|.|
T Consensus       729 ml~LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  729 MLILDPEKRITVNQALKH  746 (752)
T ss_pred             HhccChhhcCCHHHHhcC
Confidence            999999999999999876

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.1e-33  Score=255.29  Aligned_cols=260  Identities=21%  Similarity=0.300  Sum_probs=198.3

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccC-CCCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~  210 (490)
                      .++|++.+++|+|.|+.||.|....         ++..++||+++.-   ..+.+.+|+.||..|. ||||++++++..+
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~---------~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~D  104 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINIT---------NNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKD  104 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccC---------CCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence            3579999999999999999998765         4557999999743   3457889999999998 9999999999877


Q ss_pred             CC--ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-CCeEEecc
Q 011250          211 DD--QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAKLSDF  287 (490)
Q Consensus       211 ~~--~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~-~~vkL~DF  287 (490)
                      ..  ...||+||+.+.+...+.    ..|+...+..++.+++.||.|||+.|   |+|||+||.|++||.. -.++|+|+
T Consensus       105 p~SktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDW  177 (338)
T KOG0668|consen  105 PESKTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDW  177 (338)
T ss_pred             ccccCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeec
Confidence            54  567999999887766544    35777889999999999999999999   9999999999999854 57999999


Q ss_pred             cCcccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc----
Q 011250          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP----  362 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~----  362 (490)
                      |+|.+........+   .+.+..|--||++-. ..|+..-|+|||||+|..|+..+.||-....+.. .++..+.-    
T Consensus       178 GLAEFYHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D-QLVkIakVLGt~  253 (338)
T KOG0668|consen  178 GLAEFYHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVKIAKVLGTD  253 (338)
T ss_pred             chHhhcCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH-HHHHHHHHhChH
Confidence            99998766544432   356788999998764 6789999999999999999999999965544332 22222111    


Q ss_pred             ---------ccCCcchhhhccCCccCC---CC-----ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          363 ---------HLGDKRRFYRLLDPRLEG---HF-----SIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       363 ---------~~~~~~~~~~~~~~~l~~---~~-----~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                               .+.-...+..++......   .|     ..-.++++.+|+.++|..|-.+|+|+.|++.|
T Consensus       254 el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  254 ELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             HHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence                     011111111111111100   01     01126899999999999999999999999865

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.1e-31  Score=265.35  Aligned_cols=131  Identities=24%  Similarity=0.360  Sum_probs=112.3

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccC-----C---CCeece
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-----H---PNLVKL  204 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~-----H---pnIv~l  204 (490)
                      .+|.+.++||-|.|++||+|++..         ..+.||+|+.+... ...+..+.||.+|++++     |   ..||+|
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq---------~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L  147 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQ---------NKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQL  147 (590)
T ss_pred             ceEEEEEeccccccceeEEEeecc---------CCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence            689999999999999999999987         45689999987542 23356789999999985     2   369999


Q ss_pred             eeEEEe----CCceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE
Q 011250          205 VGYCIE----DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL  276 (490)
Q Consensus       205 ~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl  276 (490)
                      ++.|..    +.++|||+|++ |-+|..+|.+. .+.++...+.+|++||+.||.|||....  |||-||||+|||+
T Consensus       148 lD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl  221 (590)
T KOG1290|consen  148 LDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLL  221 (590)
T ss_pred             eccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeee
Confidence            999975    45789999999 78999998754 3569999999999999999999999764  9999999999998

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.98  E-value=2e-33  Score=292.97  Aligned_cols=246  Identities=29%  Similarity=0.423  Sum_probs=187.2

Q ss_pred             CCCCcccccCCceE-EEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccC-CCCeeceeeEEEeCC
Q 011250          135 FRPESLLGEGGFGC-VFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIEDD  212 (490)
Q Consensus       135 y~~~~~LG~G~fg~-Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~  212 (490)
                      |.-.+++|.|+-|+ ||+|...           |+.||||.+-...   .....+||..|+.-+ |||||++|+.-.+..
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-----------~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~q  576 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-----------GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQ  576 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-----------CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCc
Confidence            44557899998876 8999884           5699999885432   234578999999875 999999999988889


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCC---CHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---C--CCeEE
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPL---PWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---D--YNAKL  284 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l---~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~---~--~~vkL  284 (490)
                      ..||..|+| ..+|.+++......+   .....+.++.|++.||++||+.+   ||||||||.||||+.   +  ..++|
T Consensus       577 F~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~i  652 (903)
T KOG1027|consen  577 FLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKI  652 (903)
T ss_pred             eEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEe
Confidence            999999999 569999996531111   11345778899999999999988   999999999999965   2  57899


Q ss_pred             ecccCcccCCCCCcc-eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhC-CCCCCCCCCCCcchhhHhhhc
Q 011250          285 SDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG-RRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG-~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      +|||+++....+... .......||-+|+|||++.....+.++|||||||++|+.++| .+||........ ++      
T Consensus       653 SDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-NI------  725 (903)
T KOG1027|consen  653 SDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-NI------  725 (903)
T ss_pred             cccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-hh------
Confidence            999999987654322 123457799999999999998889999999999999998886 899975422111 00      


Q ss_pred             ccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                       +.....+. .+.+        ....++.+||.+|++.||..||++.+||.|-
T Consensus       726 -l~~~~~L~-~L~~--------~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HP  768 (903)
T KOG1027|consen  726 -LTGNYTLV-HLEP--------LPDCEAKDLISRMLNPDPQLRPSATDVLNHP  768 (903)
T ss_pred             -hcCcccee-eecc--------CchHHHHHHHHHhcCCCcccCCCHHHHhCCC
Confidence             00110000 0000        0012899999999999999999999999763

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.98  E-value=4e-31  Score=245.10  Aligned_cols=212  Identities=37%  Similarity=0.602  Sum_probs=184.9

Q ss_pred             cccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhccCCCCeeceeeEEEeCCceEEEEE
Q 011250          141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYE  219 (490)
Q Consensus       141 LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E  219 (490)
                      ||+|++|.||++....         ++..+++|++...... ....+.+|+++++.+.|++|+++++++......+++||
T Consensus         1 l~~g~~~~v~~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e   71 (215)
T cd00180           1 LGEGGFGTVYLARDKK---------TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVME   71 (215)
T ss_pred             CCcCCceEEEEEEecC---------CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEe
Confidence            6899999999998865         4678999999866433 34678899999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-CCCeEEecccCcccCCCCCc
Q 011250          220 FMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDAPEDGK  298 (490)
Q Consensus       220 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~-~~~vkL~DFG~a~~~~~~~~  298 (490)
                      |+++++|.+++......+++..+..++.+++.+|.|||+.+   ++|+||+|.||+++. ++.++|+|||.+........
T Consensus        72 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~  148 (215)
T cd00180          72 YCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS  148 (215)
T ss_pred             cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc
Confidence            99999999998665457899999999999999999999988   999999999999999 89999999999987654321


Q ss_pred             ceeeeccccCCCccCcchhccC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCc
Q 011250          299 THVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPR  377 (490)
Q Consensus       299 ~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  377 (490)
                        ......+...|++||.+... .++.++|+|+||+++|+|                                       
T Consensus       149 --~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------  187 (215)
T cd00180         149 --LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------  187 (215)
T ss_pred             --hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------
Confidence              12235678899999998877 888999999999999999                                       


Q ss_pred             cCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       378 l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                                ..+.+++.+||..||.+||++.+++++|
T Consensus       188 ----------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ----------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ----------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                      2467899999999999999999998764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.98  E-value=1.1e-33  Score=288.17  Aligned_cols=253  Identities=24%  Similarity=0.364  Sum_probs=206.7

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      .++|.+...+|.|+||.||+|++..         +++..|+|+++........-+..|+-+++..+|||||.+++.+...
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~---------s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~   84 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKR---------SGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR   84 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccc---------cCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhh
Confidence            3579999999999999999999987         6778999999887666677788899999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      +.+||+||||.||+|.+..+- ..++++.++....+..+++|+|||+.+   =+|||||-.|||+++.|.+||+|||.+-
T Consensus        85 dklwicMEycgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsa  160 (829)
T KOG0576|consen   85 DKLWICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSA  160 (829)
T ss_pred             cCcEEEEEecCCCcccceeee-cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchh
Confidence            999999999999999986643 458999999999999999999999988   7999999999999999999999999987


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhc---cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      .+...-  .....+.||++|||||+..   .+.|...+|||++|++..|+-.-++|.....+.....+...         
T Consensus       161 qitati--~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTk---------  229 (829)
T KOG0576|consen  161 QITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTK---------  229 (829)
T ss_pred             hhhhhh--hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhc---------
Confidence            664321  2224588999999999764   57899999999999999999888887644333222111110         


Q ss_pred             hhhhccC-CccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 011250          369 RFYRLLD-PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE  413 (490)
Q Consensus       369 ~~~~~~~-~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~  413 (490)
                         ..++ |.+.+  ..+.+..+.+|++.||.++|++||+++.+|.
T Consensus       230 ---S~~qpp~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  230 ---SGFQPPTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             ---cCCCCCcccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence               0111 11111  1233788999999999999999999987765

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.98  E-value=1e-32  Score=260.31  Aligned_cols=262  Identities=23%  Similarity=0.313  Sum_probs=198.4

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC--CcccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .+|.-.+.+|.|.- .|.-|.+.-         .+..||+|.+...  .....++..+|+.++..+.|+||++++.+|.-
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v---------~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP   86 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQV---------LGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTP   86 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhh---------ccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCc
Confidence            35777788999987 566665544         5778999987644  23445778899999999999999999999864


Q ss_pred             C------CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 011250          211 D------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       211 ~------~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL  284 (490)
                      .      ...|+||||| ..+|...+.   ..++-..+..|..|++.|++|||+.+   |+||||||+||++..++.+||
T Consensus        87 ~~~l~~~~e~y~v~e~m-~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi  159 (369)
T KOG0665|consen   87 QKTLEEFQEVYLVMELM-DANLCQVIL---MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKI  159 (369)
T ss_pred             cccHHHHHhHHHHHHhh-hhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheee
Confidence            3      3579999999 569988886   35778889999999999999999999   999999999999999999999


Q ss_pred             ecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh----
Q 011250          285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA----  360 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~----  360 (490)
                      +|||+|+.....   -..+..+.|..|.|||++.+..|...+||||+||++.||++|.-.|.+....+....+...    
T Consensus       160 ~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtp  236 (369)
T KOG0665|consen  160 LDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTP  236 (369)
T ss_pred             ccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCC
Confidence            999999875433   3456688999999999999888999999999999999999999999754332221111000    


Q ss_pred             ------------hcccCC-----cchhhhccCCc-c--CCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          361 ------------RPHLGD-----KRRFYRLLDPR-L--EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       361 ------------~~~~~~-----~~~~~~~~~~~-l--~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                                  +.....     ...+.+.+... .  ..+.+......+.+|+.+||..||++|.+++++|+|
T Consensus       237 d~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  237 DPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             CHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                        000000     01111111110 0  001112235678999999999999999999999987

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-32  Score=275.88  Aligned_cols=196  Identities=23%  Similarity=0.330  Sum_probs=168.9

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccH--------HHHHHHHHHHhccC---CCCee
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--------KEWLAEVNFLGNLL---HPNLV  202 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~Ei~il~~l~---HpnIv  202 (490)
                      +|..++.||+|+||.|++|.++.         ....|+||.+.+...-..        -.+-.||+||..|+   |+||+
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~---------n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIl  632 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKE---------NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENIL  632 (772)
T ss_pred             cceeeeeccccccceEEEeeecc---------cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchh
Confidence            68999999999999999999987         356899999987542111        12456999999998   99999


Q ss_pred             ceeeEEEeCCceEEEEEec-CCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCC
Q 011250          203 KLVGYCIEDDQRLLVYEFM-PRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       203 ~l~~~~~~~~~~~lV~E~~-~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                      +++++|++++.+||+||-- ++-+|+++|. ....+++.++..|+.||+.|+++||+.+   |||||||-+|+.++.+|-
T Consensus       633 KlLdfFEddd~yyl~te~hg~gIDLFd~IE-~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~  708 (772)
T KOG1152|consen  633 KLLDFFEDDDYYYLETEVHGEGIDLFDFIE-FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGF  708 (772)
T ss_pred             hhhheeecCCeeEEEecCCCCCcchhhhhh-ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCe
Confidence            9999999999999999974 4569999984 4457999999999999999999999999   999999999999999999


Q ss_pred             eEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCC-CccchhhHHHHHHHHHHhCCCCCC
Q 011250          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMD  346 (490)
Q Consensus       282 vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~sDvwSlGv~l~elltG~~pf~  346 (490)
                      +||+|||.|.....+.    ...++||..|.|||++.+..| +..-|||+|||+||.++....||.
T Consensus       709 ~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  709 VKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             EEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9999999987764432    234789999999999998776 456899999999999999888874

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-31  Score=247.36  Aligned_cols=252  Identities=22%  Similarity=0.335  Sum_probs=190.9

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccC-CCCeeceeeE-EEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGY-CIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~-~~~  210 (490)
                      +.|.+.+.||+|.||.+-+|.++.         +...+++|.+.... ...++|.+|...--.|. |.||+.-|++ |+.
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~---------s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt   93 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQ---------SKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQT   93 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccC---------CceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence            469999999999999999999987         56689999987653 44678999998776675 9999998874 667


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc--CCCCeEEeccc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD--ADYNAKLSDFG  288 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~--~~~~vkL~DFG  288 (490)
                      .+.++++|||++.|+|..-+...  .+.+.....++.|++.||.|+|+.+   +||||||.+||||-  +..+|||||||
T Consensus        94 ~d~YvF~qE~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG  168 (378)
T KOG1345|consen   94 SDAYVFVQEFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFG  168 (378)
T ss_pred             CceEEEeeccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecc
Confidence            78888999999999999887543  5888889999999999999999988   99999999999993  33589999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhccC-----CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-----HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-----~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      +.+......     ...--+..|.+||++...     ...+.+|||.|||++|.+|||..||..... ......+|..-.
T Consensus       169 ~t~k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-~d~~Y~~~~~w~  242 (378)
T KOG1345|consen  169 LTRKVGTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-MDKPYWEWEQWL  242 (378)
T ss_pred             cccccCcee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc-cCchHHHHHHHh
Confidence            988653321     122346679999987532     245679999999999999999999984432 223333333221


Q ss_pred             cCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .......++.+.+         .+..+..+.++-|..++++|-...++.+.
T Consensus       243 ~rk~~~~P~~F~~---------fs~~a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  243 KRKNPALPKKFNP---------FSEKALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             cccCccCchhhcc---------cCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence            1111112222221         26788999999999999999555555443

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=5.5e-30  Score=241.59  Aligned_cols=200  Identities=34%  Similarity=0.449  Sum_probs=174.1

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhccCCCCeeceeeEEEeCCc
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQ  213 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  213 (490)
                      |.+.+.||.|+||.||+|.+..         ++..+|+|.+...... ..+.+.+|+..++.++|+||+++++++.....
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~   71 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKG---------TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEP   71 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcC---------CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCc
Confidence            5677899999999999998875         4668999999876554 56788999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccC
Q 011250          214 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       214 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~  293 (490)
                      .++++||+++++|.+++......+++..+..++.+++.+|.|||..+   ++|+||+|.||+++.++.++|+|||++...
T Consensus        72 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~  148 (225)
T smart00221       72 LYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFI  148 (225)
T ss_pred             eEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEe
Confidence            99999999999999998654433899999999999999999999987   999999999999999999999999999877


Q ss_pred             CCCCcceeeeccccCCCccCcchh-ccCCCCccchhhHHHHHHHHHHhCCCCCCC
Q 011250          294 PEDGKTHVSTRVMGTYGYAAPEYV-MTGHLTSKSDVYSFGVVLLEMLTGRRSMDK  347 (490)
Q Consensus       294 ~~~~~~~~~~~~~Gt~~y~aPE~l-~~~~~~~~sDvwSlGv~l~elltG~~pf~~  347 (490)
                      ...... ......++..|++||.+ ....++.++|||+||+++|+|++|+.||..
T Consensus       149 ~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      149 HRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            544211 12335688899999998 666788899999999999999999999954

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=6e-31  Score=256.97  Aligned_cols=273  Identities=25%  Similarity=0.328  Sum_probs=202.1

Q ss_pred             hHHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccC-CCCeecee
Q 011250          127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLV  205 (490)
Q Consensus       127 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~  205 (490)
                      .+....+.|.++.+||+|+|++||+|.+...      ......||+|.+......  ..+..|+++|..+. +.||+++.
T Consensus        30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~------~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~  101 (418)
T KOG1167|consen   30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQ------DTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLN  101 (418)
T ss_pred             hhhhhhhhhhhhccccccchhhhhhhhHhhh------ccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcch
Confidence            3444556799999999999999999998763      125678999999766433  46889999999996 99999999


Q ss_pred             eEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-CCCeEE
Q 011250          206 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYNAKL  284 (490)
Q Consensus       206 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~-~~~vkL  284 (490)
                      +++..+++..+||||++.....+++.    .++...+..+++.++.||.++|.+|   ||||||||+|+|.+. .+.-.|
T Consensus       102 ~~~rnnd~v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~L  174 (418)
T KOG1167|consen  102 GCFRNNDQVAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVL  174 (418)
T ss_pred             hhhccCCeeEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceE
Confidence            99999999999999999988888773    4668889999999999999999999   999999999999974 578999


Q ss_pred             ecccCcccCCCC----------------------------------Ccc--------eeeeccccCCCccCcchhcc-CC
Q 011250          285 SDFGLAKDAPED----------------------------------GKT--------HVSTRVMGTYGYAAPEYVMT-GH  321 (490)
Q Consensus       285 ~DFG~a~~~~~~----------------------------------~~~--------~~~~~~~Gt~~y~aPE~l~~-~~  321 (490)
                      +|||+|......                                  +..        .......||++|.|||++.. ..
T Consensus       175 vDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~  254 (418)
T KOG1167|consen  175 VDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPR  254 (418)
T ss_pred             EechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccC
Confidence            999999721000                                  000        01112579999999999875 57


Q ss_pred             CCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh----------cc------cCC---------cchhhhccC-
Q 011250          322 LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR----------PH------LGD---------KRRFYRLLD-  375 (490)
Q Consensus       322 ~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~----------~~------~~~---------~~~~~~~~~-  375 (490)
                      .+.++||||.|||+.-+++++.||-..... ...+.+.+.          ..      +.+         ...-++-++ 
T Consensus       255 QttaiDiws~GVI~Lslls~~~PFf~a~dd-~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~  333 (418)
T KOG1167|consen  255 QTTAIDIWSAGVILLSLLSRRYPFFKAKDD-ADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHI  333 (418)
T ss_pred             cCCccceeeccceeehhhccccccccCccc-cchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccCh
Confidence            889999999999999999999999643221 111111110          00      000         000011110 


Q ss_pred             -CccC-------CC-CChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          376 -PRLE-------GH-FSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       376 -~~l~-------~~-~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                       ....       .. .....+..+.+|+.+||+.||.+|.|++++|+|-
T Consensus       334 ~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp  382 (418)
T KOG1167|consen  334 ESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP  382 (418)
T ss_pred             hhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence             0000       00 1111255899999999999999999999999763

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=1.1e-29  Score=283.96  Aligned_cols=197  Identities=20%  Similarity=0.278  Sum_probs=142.2

Q ss_pred             ccCC-CCeeceeeEE-------EeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 011250          195 NLLH-PNLVKLVGYC-------IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIY  266 (490)
Q Consensus       195 ~l~H-pnIv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH  266 (490)
                      .+.| +||+.++++|       .+...++++|||+ +++|.++|......+++..++.|+.||++||.|||+++   |||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---IvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---IVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence            3445 5788888877       3334677889988 67999999765567999999999999999999999988   999


Q ss_pred             cCCCCCcEEEcC-------------------CCCeEEecccCcccCCCCCc--------------ceeeeccccCCCccC
Q 011250          267 RDFKTSNILLDA-------------------DYNAKLSDFGLAKDAPEDGK--------------THVSTRVMGTYGYAA  313 (490)
Q Consensus       267 rDlkp~NILl~~-------------------~~~vkL~DFG~a~~~~~~~~--------------~~~~~~~~Gt~~y~a  313 (490)
                      |||||+||||+.                   ++.+||+|||+++.......              .......+||+.|||
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            999999999954                   44566666666654211000              000112468999999


Q ss_pred             cchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHH
Q 011250          314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQL  393 (490)
Q Consensus       314 PE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~L  393 (490)
                      ||++.+..|+.++|||||||+||||++|.+|+.....    .......          ..+.+..     ......+.++
T Consensus       184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~----------~~~~~~~-----~~~~~~~~~~  244 (793)
T PLN00181        184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRH----------RVLPPQI-----LLNWPKEASF  244 (793)
T ss_pred             hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHH----------hhcChhh-----hhcCHHHHHH
Confidence            9999999999999999999999999999888643210    0000000          0111110     0113456788


Q ss_pred             HHHhhhcCCCCCCCHHHHHHH
Q 011250          394 AAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       394 i~~cL~~dP~~RPt~~evl~~  414 (490)
                      +.+||+.||.+||++.+|+++
T Consensus       245 ~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        245 CLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHhCCCChhhCcChHHHhhc
Confidence            999999999999999999875

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=6.3e-27  Score=222.04  Aligned_cols=282  Identities=18%  Similarity=0.242  Sum_probs=214.6

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccC-CCCeeceeeEEEeCC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIEDD  212 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~  212 (490)
                      +|+++++||+|+||++|+|...-         +++.||||.-....  ..-++..|.+..+.|. .++|...|-+..++-
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~---------nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~   97 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLY---------NNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGK   97 (449)
T ss_pred             cceeccccccCcceeeecccccc---------cCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccc
Confidence            69999999999999999998876         56799999865432  2345677888888886 799999998888888


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-----CCeEEecc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-----YNAKLSDF  287 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~-----~~vkL~DF  287 (490)
                      +..||||++ |-+|+|++.-.+..|+..+++.+|.|++.-++|+|++.   +|+|||||+|+||...     ..+.|+||
T Consensus        98 ~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDF  173 (449)
T KOG1165|consen   98 YNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDF  173 (449)
T ss_pred             hhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEec
Confidence            889999999 89999999888889999999999999999999999988   9999999999999644     35899999


Q ss_pred             cCcccCCCCCcc-e----eeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011250          288 GLAKDAPEDGKT-H----VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       288 G~a~~~~~~~~~-~----~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      |+|+...+.... +    ......||.+||+--...+.+.+.+.|+-|||-+++++|-|..||.+..........+.+  
T Consensus       174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI--  251 (449)
T KOG1165|consen  174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI--  251 (449)
T ss_pred             cchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh--
Confidence            999987654322 1    223478999999999999999999999999999999999999999876543332222211  


Q ss_pred             ccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccccc-ccccchhhhhcccCCCc
Q 011250          363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKD-MASSSYYFQTMQADNTW  440 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~~~~-~~~~~~~~~~~~~~~~~  440 (490)
                        ++.++...+      ..+....+.++...+.-.-..+-.+-|+.+-+...+..+..... ..+-.|.|--......|
T Consensus       252 --Ge~Kr~T~i------~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln~g~gw  322 (449)
T KOG1165|consen  252 --GETKRSTPI------EVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLNNGKGW  322 (449)
T ss_pred             --ccccccCCH------HHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccCCCCCC
Confidence              111110000      00111227788888888888899999999887777665444332 33444555444433344

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=1.9e-27  Score=216.96  Aligned_cols=167  Identities=26%  Similarity=0.280  Sum_probs=127.3

Q ss_pred             CChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCCCcceeee
Q 011250          224 GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST  303 (490)
Q Consensus       224 gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~  303 (490)
                      |+|.+++..++..+++..++.|+.||+.||.|||+.+         ||+|||++.++.+|+  ||++......       
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~-------   62 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE-------   62 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc-------
Confidence            6899999776778999999999999999999999855         999999999999999  9998865432       


Q ss_pred             ccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCC
Q 011250          304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFS  383 (490)
Q Consensus       304 ~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  383 (490)
                      ...||+.|||||++.+..++.++|||||||++|||++|+.||.......  .............       .+. .....
T Consensus        63 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~-------~~~-~~~~~  132 (176)
T smart00750       63 QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPAD-------DPR-DRSNL  132 (176)
T ss_pred             cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccC-------Ccc-ccccH
Confidence            1268999999999999999999999999999999999999996432211  1111111000000       000 00011


Q ss_pred             hhhHH--HHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          384 IKGSQ--KATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       384 ~~~~~--~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                      .....  ++.++|.+||..||.+||++.++++++..+
T Consensus       133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            11233  699999999999999999999999998654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=1.9e-26  Score=231.30  Aligned_cols=263  Identities=22%  Similarity=0.234  Sum_probs=199.9

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCC----CCeeceeeEE-
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH----PNLVKLVGYC-  208 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~H----pnIv~l~~~~-  208 (490)
                      +|.+.+.||+|+||.||+|.....+        ...+|+|............+..|+.++..+.+    .++..+++.+ 
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~--------~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~   90 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEK--------NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR   90 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCC--------CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence            7999999999999999999987531        34789998876533322367788898888873    6899999988 


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-----CCe
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-----YNA  282 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~-----~~v  282 (490)
                      ..+...+|||+.+ |.+|.++..... ..++..++..|+.|++.+|++||+.|   +|||||||+|+++...     ..+
T Consensus        91 ~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~  166 (322)
T KOG1164|consen   91 STEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTL  166 (322)
T ss_pred             CCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceE
Confidence            4777889999998 899999875554 68999999999999999999999998   9999999999999754     469


Q ss_pred             EEecccCcc--cCCCCCcc---ee---eeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcc
Q 011250          283 KLSDFGLAK--DAPEDGKT---HV---STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH  354 (490)
Q Consensus       283 kL~DFG~a~--~~~~~~~~---~~---~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~  354 (490)
                      +|.|||+++  ........   ..   .....||..|+++....+...+.+.|+||++.++.||+.|..||.........
T Consensus       167 ~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~  246 (322)
T KOG1164|consen  167 YLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK  246 (322)
T ss_pred             EEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH
Confidence            999999998  33222211   11   12355999999999999999999999999999999999999999654432221


Q ss_pred             hhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccc
Q 011250          355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~~  421 (490)
                      .........             .....+....+.++.++...+-..+...+|....+...|+.+...
T Consensus       247 ~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  247 SKFEKDPRK-------------LLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             HHHHHHhhh-------------hccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence            111110000             000001122356777787777789999999999999988765443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=3.3e-26  Score=230.21  Aligned_cols=167  Identities=19%  Similarity=0.137  Sum_probs=129.2

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-----cccHHHHHHHHHHHhccCCCCeecee
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLGNLLHPNLVKLV  205 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~l~  205 (490)
                      ..++|.+.+.||+|+||+||+|++...        ++..||||++....     ....+.+.+|+++|..|.|+||+..+
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~--------~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l   87 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGD--------PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQL   87 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCC--------CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEE
Confidence            345799999999999999999987642        35578999875331     12245688999999999999998533


Q ss_pred             eEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCC-CCCcEEEcCCCCeEE
Q 011250          206 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDF-KTSNILLDADYNAKL  284 (490)
Q Consensus       206 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDl-kp~NILl~~~~~vkL  284 (490)
                      ..   .+..|||||||+|++|.. +..    ..   ...++.|++++|.|||+.+   |+|||| ||+|||++.++.+||
T Consensus        88 ~~---~~~~~LVmE~~~G~~L~~-~~~----~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikL  153 (365)
T PRK09188         88 LA---TGKDGLVRGWTEGVPLHL-ARP----HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAV  153 (365)
T ss_pred             EE---cCCcEEEEEccCCCCHHH-hCc----cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEE
Confidence            22   246799999999999963 211    11   1467889999999999988   999999 999999999999999


Q ss_pred             ecccCcccCCCCCccee------eeccccCCCccCcchhcc
Q 011250          285 SDFGLAKDAPEDGKTHV------STRVMGTYGYAAPEYVMT  319 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~------~~~~~Gt~~y~aPE~l~~  319 (490)
                      +|||+|+..........      .+...+++.|+|||.+..
T Consensus       154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            99999997654332111      134678999999998863

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=1.3e-26  Score=211.19  Aligned_cols=264  Identities=19%  Similarity=0.210  Sum_probs=208.0

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCC-CCeeceeeEEE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH-PNLVKLVGYCI  209 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~  209 (490)
                      ....|+++++||.|+||.+|+|....         +|..||||+-+...  .+..+..|..+.+.|++ ..|..+..++.
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~---------~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~   81 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISIT---------SGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGT   81 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeecc---------CCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhcc
Confidence            44679999999999999999998876         67899999976553  23467789999999985 67888888888


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC---CCeEEec
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD---YNAKLSD  286 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~---~~vkL~D  286 (490)
                      +.....|||+++ |-+|.+++.-....++..+++-++-|++.-++|+|..+   +|||||||+|+|..-+   ..+.|+|
T Consensus        82 e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LID  157 (341)
T KOG1163|consen   82 EKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLID  157 (341)
T ss_pred             ccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEe
Confidence            889999999999 89999998766778999999999999999999999988   9999999999998533   4699999


Q ss_pred             ccCcccCCCCCcc-----eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011250          287 FGLAKDAPEDGKT-----HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       287 FG~a~~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~  361 (490)
                      ||+|+...+....     .......||.+|.+--...+...+.+.|+-|+|.+|.++.-|..||.+..........+.+.
T Consensus       158 FGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~  237 (341)
T KOG1163|consen  158 FGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKIS  237 (341)
T ss_pred             ccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHH
Confidence            9999876543221     12244789999999988888888999999999999999999999998876654443332221


Q ss_pred             cccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011250          362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~  419 (490)
                      ...-          ......+....+.++.-.+.-|-..--++-|+..-+.+.+.-|.
T Consensus       238 EkK~----------s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf  285 (341)
T KOG1163|consen  238 EKKM----------STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF  285 (341)
T ss_pred             Hhhc----------CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence            1000          00000111122678888999999999999999888877766543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=1.1e-24  Score=214.50  Aligned_cols=259  Identities=33%  Similarity=0.455  Sum_probs=198.4

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhccCCC-CeeceeeEEEe
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHP-NLVKLVGYCIE  210 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~  210 (490)
                      |.+.+.||.|+||.||++.+.            ..+++|.+......   ....+.+|+.++..+.|+ +|+++++++..
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~------------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~   69 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR------------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD   69 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec------------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec
Confidence            677889999999999999886            26899998765433   356789999999999988 79999999977


Q ss_pred             CCceEEEEEecCCCChhHHhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-CeEEecc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDF  287 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-~vkL~DF  287 (490)
                      ....+++++++.+++|.+++....  ..+.......++.|++.++.|+|..+   ++||||||+||+++..+ .++++||
T Consensus        70 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~df  146 (384)
T COG0515          70 EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDF  146 (384)
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEecc
Confidence            777899999999999997665443  26899999999999999999999988   99999999999999988 7999999


Q ss_pred             cCcccCCCCCcce----eeeccccCCCccCcchhcc---CCCCccchhhHHHHHHHHHHhCCCCCCCCCCC-CcchhhHh
Q 011250          288 GLAKDAPEDGKTH----VSTRVMGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN-GEHNLVEW  359 (490)
Q Consensus       288 G~a~~~~~~~~~~----~~~~~~Gt~~y~aPE~l~~---~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~-~~~~~~~~  359 (490)
                      |++..........    ......||..|+|||.+..   ..+....|+||+|++++++++|..||...... ........
T Consensus       147 g~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~  226 (384)
T COG0515         147 GLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI  226 (384)
T ss_pred             CcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHH
Confidence            9998654433221    2345789999999999987   57889999999999999999999997654321 01111111


Q ss_pred             hhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .......      .................+.+++.+|+..+|..|.+..+....
T Consensus       227 ~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         227 ILELPTP------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             HHhcCCc------ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            1111000      000000000001223678999999999999999998887764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=1.8e-26  Score=246.52  Aligned_cols=255  Identities=21%  Similarity=0.282  Sum_probs=189.8

Q ss_pred             CCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecC---CCccc---HHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          136 RPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH---DGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       136 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~---~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ....++|.|+||.|+.+.......         .++.|.+..   .....   ...+..|+-+-..|.|+|++..+..+.
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~---------~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~  391 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLK---------SFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQ  391 (601)
T ss_pred             CccceeeecccCceEEEEecCCCc---------cchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHh
Confidence            456789999999888777654322         233333221   11111   122566888888899999999888887


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +....+-+||||++ +|+.++... ..+....+..++.|++.||+|||..|   |.|||||++|+++..+|.+||+|||.
T Consensus       392 ~~~~~~~~mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~  466 (601)
T KOG0590|consen  392 EIDGILQSMEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGA  466 (601)
T ss_pred             hcccchhhhhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCc
Confidence            77776667999999 999998554 46888889999999999999999999   99999999999999999999999999


Q ss_pred             cccCCCCCcc--eeeeccccCCCccCcchhccCCCCc-cchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011250          290 AKDAPEDGKT--HVSTRVMGTYGYAAPEYVMTGHLTS-KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       290 a~~~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~~~-~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      +.........  .....++|+..|+|||++....|+. ..||||.||+++.|++|+.||......+......    ....
T Consensus       467 ~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~----~~~~  542 (601)
T KOG0590|consen  467 ASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN----NYSD  542 (601)
T ss_pred             ceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh----cccc
Confidence            9876554443  5566789999999999999999886 5899999999999999999997655443321000    0000


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE  413 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~  413 (490)
                      ....  ...+   .......+.....+|.+||+.||.+|.|+++|++
T Consensus       543 ~~~~--~~~~---~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  543 QRNI--FEGP---NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cccc--ccCh---HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            0000  0000   0001122677899999999999999999999985

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.3e-24  Score=201.02  Aligned_cols=246  Identities=23%  Similarity=0.361  Sum_probs=191.8

Q ss_pred             CCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhccCCCCeeceeeEEEeCCc
Q 011250          136 RPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQ  213 (490)
Q Consensus       136 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  213 (490)
                      .+..+|.+...|..|+|++..+           .+++|+++.....  ..++|..|.-.|+.+.||||+.+++.|.....
T Consensus       193 nl~tkl~e~hsgelwrgrwqgn-----------divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppn  261 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQGN-----------DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPN  261 (448)
T ss_pred             hhhhhhccCCCcccccccccCc-----------chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCC
Confidence            3445688999999999999753           5778888765433  23678899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee-cCCCCCcEEEcCCCCeEEe--cccC
Q 011250          214 RLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIY-RDFKTSNILLDADYNAKLS--DFGL  289 (490)
Q Consensus       214 ~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH-rDlkp~NILl~~~~~vkL~--DFG~  289 (490)
                      +.++..||+.|+|+.+|+... ..++..++..++.+|++|++|||+...  +|- --|....++||++.+.+|.  |--+
T Consensus       262 lv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep--~ipr~~lns~hvmidedltarismad~kf  339 (448)
T KOG0195|consen  262 LVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP--MIPRFYLNSKHVMIDEDLTARISMADTKF  339 (448)
T ss_pred             ceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch--hhhhhhcccceEEecchhhhheeccccee
Confidence            999999999999999997653 346778899999999999999999763  444 3688999999999888775  3222


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCC---ccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLT---SKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~---~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      +...         ....-.+.||+||.+....-+   .++|+|||+++||||.|...||....+.+..-.+         
T Consensus       340 sfqe---------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki---------  401 (448)
T KOG0195|consen  340 SFQE---------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI---------  401 (448)
T ss_pred             eeec---------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh---------
Confidence            2111         112347899999999865433   4799999999999999999999876554321111         


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~  419 (490)
                             .-..+...+++..+..+..|+.-|+..||.+||.+..|+-.|+.++
T Consensus       402 -------aleglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  402 -------ALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             -------hhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence                   1112334455566889999999999999999999999998888653

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=5.7e-24  Score=199.76  Aligned_cols=172  Identities=10%  Similarity=0.089  Sum_probs=134.4

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHH---------HHHHHHHHhccCCCC
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---------WLAEVNFLGNLLHPN  200 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~---------~~~Ei~il~~l~Hpn  200 (490)
                      ...++|++.++||.|+||.||++.. .          +..+|||++..........         +.+|++.+.++.|++
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~----------~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~G   96 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-D----------YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEG   96 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-C----------CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCC
Confidence            4567899999999999999998644 2          3369999997543322222         578999999999999


Q ss_pred             eeceeeEEEeC--------CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 011250          201 LVKLVGYCIED--------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTS  272 (490)
Q Consensus       201 Iv~l~~~~~~~--------~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~  272 (490)
                      |..+.+++...        ...+|||||++|.+|.++.     .++.    ....+++.+|..||..|   |+||||||+
T Consensus        97 I~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~  164 (232)
T PRK10359         97 LASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLHQHG---MVSGDPHKG  164 (232)
T ss_pred             CCcceEeeeecccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHHHcC---CccCCCChH
Confidence            99999886644        3578999999999998763     2332    24568999999999988   999999999


Q ss_pred             cEEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHH
Q 011250          273 NILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML  339 (490)
Q Consensus       273 NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ell  339 (490)
                      ||+++.++ ++|+|||...........              -.++....|+.++|+|+||+++..+.
T Consensus       165 Nili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        165 NFIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             HEEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            99999988 999999988765322111              11355566778999999999987665

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=7.9e-23  Score=189.15  Aligned_cols=140  Identities=16%  Similarity=0.169  Sum_probs=108.7

Q ss_pred             CcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--c------------------------HHHHHHHHH
Q 011250          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--G------------------------HKEWLAEVN  191 (490)
Q Consensus       138 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~------------------------~~~~~~Ei~  191 (490)
                      ...||+|+||.||+|.+.          +|..||||+++.....  .                        ......|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~----------~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~   71 (190)
T cd05147           2 NGCISTGKEANVYHATTA----------NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMR   71 (190)
T ss_pred             CCccccccceEEEEEECC----------CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHH
Confidence            468999999999999874          4678999999754211  1                        012235999


Q ss_pred             HHhccCCCCeeceeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCCeeecCCC
Q 011250          192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL-HEEAEKPVIYRDFK  270 (490)
Q Consensus       192 il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yL-H~~~~~~iiHrDlk  270 (490)
                      +|..+.++++.....+..  ...+|||||+++++|...+.. ...++...+..++.|++.+|.|| |+.+   |+|||||
T Consensus        72 ~l~~l~~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlk  145 (190)
T cd05147          72 NLKRLVTAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLS  145 (190)
T ss_pred             HHHHHHHCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence            999998887744333322  233899999988877655433 34789999999999999999999 6878   9999999


Q ss_pred             CCcEEEcCCCCeEEecccCcccCC
Q 011250          271 TSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       271 p~NILl~~~~~vkL~DFG~a~~~~  294 (490)
                      |+|||++ ++.++|+|||+|....
T Consensus       146 P~NIli~-~~~v~LiDFG~a~~~~  168 (190)
T cd05147         146 EYNLLYH-DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             HHHEEEE-CCcEEEEEccccccCC
Confidence            9999998 5789999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.89  E-value=2.7e-24  Score=220.36  Aligned_cols=229  Identities=30%  Similarity=0.381  Sum_probs=183.0

Q ss_pred             ccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccH--HHHHHHHHHHhccC-CCCeeceeeEEEeCCceEE
Q 011250          140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNLL-HPNLVKLVGYCIEDDQRLL  216 (490)
Q Consensus       140 ~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~l  216 (490)
                      ++|.|+||.|++++-.....      .|..+|+|++++......  .....|..++..++ ||.+|++.-.++.+...++
T Consensus         1 vlg~g~~gkvfLvrk~~g~d------a~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l   74 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGAD------AGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYL   74 (612)
T ss_pred             CCCcCCCcchHHHHHhcccc------ccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhH
Confidence            47999999999875443221      466789998876543221  13456888888887 9999999999999999999


Q ss_pred             EEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCC
Q 011250          217 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  296 (490)
Q Consensus       217 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~  296 (490)
                      +++|..||+|...+.+. ..+.+.....+...++-++.++|..+   |+|||+|++||+++.+|++++.|||+++.....
T Consensus        75 ~ld~~rgg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~  150 (612)
T KOG0603|consen   75 ILDFLRGGDLFTRLSKE-VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE  150 (612)
T ss_pred             hhhhcccchhhhccccC-CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhh
Confidence            99999999999888544 45777777888889999999999999   999999999999999999999999999876543


Q ss_pred             CcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCC
Q 011250          297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP  376 (490)
Q Consensus       297 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (490)
                      ..      .|||..|||||+++  ....++|.||||++++||+||..||..    +      ....          ++. 
T Consensus       151 ~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~------~~~~----------Il~-  201 (612)
T KOG0603|consen  151 KI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----D------TMKR----------ILK-  201 (612)
T ss_pred             hh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----H------HHHH----------Hhh-
Confidence            22      28999999999987  677899999999999999999999965    1      1111          110 


Q ss_pred             ccCCCCChhhHHHHHHHHHHhhhcCCCCCCCH
Q 011250          377 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRM  408 (490)
Q Consensus       377 ~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~  408 (490)
                       ..-.++...+..+.+++..++..+|..|.-.
T Consensus       202 -~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  202 -AELEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             -hccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence             1122334457889999999999999999654

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.88  E-value=5.2e-22  Score=192.00  Aligned_cols=232  Identities=22%  Similarity=0.295  Sum_probs=149.8

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCC----------CC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLH----------PN  200 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~H----------pn  200 (490)
                      .+...+.||.|+|+.||.+++.+         +++.+|+|++.....   ...+++.+|......+.+          -.
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~---------t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r   83 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVE---------TGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLR   83 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-
T ss_pred             EEEEccccccCCceEEEEEEEcc---------CCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhce
Confidence            35567889999999999999987         788999999864432   234566666655555332          12


Q ss_pred             eeceeeEEE---------eCC--------ceEEEEEecCCCChhHHhh---hcCC---CCCHHHHHHHHHHHHHHHHHhh
Q 011250          201 LVKLVGYCI---------EDD--------QRLLVYEFMPRGSLENHLF---RRSL---PLPWSIRMKIALGAAKGLAFLH  257 (490)
Q Consensus       201 Iv~l~~~~~---------~~~--------~~~lV~E~~~~gsL~~~l~---~~~~---~l~~~~~~~i~~qi~~aL~yLH  257 (490)
                      ++..++...         ...        ..+++|+-+ .++|.+++.   ....   .+....++.+..|+++.+++||
T Consensus        84 ~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh  162 (288)
T PF14531_consen   84 FLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH  162 (288)
T ss_dssp             B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh
Confidence            222222221         111        236788887 568887753   2221   2334555677799999999999


Q ss_pred             hcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhcc--------CCCCccchhh
Q 011250          258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT--------GHLTSKSDVY  329 (490)
Q Consensus       258 ~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--------~~~~~~sDvw  329 (490)
                      ..|   |||+||+|+|+|++.+|.++|+||+........    ... ...+..|.+||....        -.++.+.|.|
T Consensus       163 ~~G---lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW  234 (288)
T PF14531_consen  163 SYG---LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR----YRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAW  234 (288)
T ss_dssp             HTT---EEEST-SGGGEEE-TTS-EEE--GGGEEETTEE----EEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHH
T ss_pred             hcc---eEecccceeeEEEcCCCCEEEcChHHHeecCce----eec-cCCCcccCChhhhhhhcccCcccceeeeccCHH
Confidence            999   999999999999999999999999987764321    111 334678999997643        2478899999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCC
Q 011250          330 SFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR  405 (490)
Q Consensus       330 SlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~R  405 (490)
                      +||+++|.|++|..||...........            .|        . ... +.++.++.||..+|+.||.+|
T Consensus       235 ~LG~~ly~lWC~~lPf~~~~~~~~~~~------------~f--------~-~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  235 QLGITLYSLWCGRLPFGLSSPEADPEW------------DF--------S-RCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHHHHHSS-STCCCGGGSTSGG------------GG--------T-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHHHHHHccCCCCCCCccccccc------------cc--------h-hcC-CcCHHHHHHHHHHccCCcccC
Confidence            999999999999999975432211110            01        0 111 348899999999999999988

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=8.8e-22  Score=182.42  Aligned_cols=142  Identities=17%  Similarity=0.164  Sum_probs=111.4

Q ss_pred             CCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--c------------------------HHHHHHHH
Q 011250          137 PESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--G------------------------HKEWLAEV  190 (490)
Q Consensus       137 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~------------------------~~~~~~Ei  190 (490)
                      +.+.||+|+||.||+|.+.          +|..||||+++.....  .                        ...+..|+
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~----------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~   70 (190)
T cd05145           1 INGCISTGKEANVYHARTG----------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEF   70 (190)
T ss_pred             CCceeecCCCcEEEEEEcC----------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHH
Confidence            3578999999999999865          3668999998765211  0                        11235789


Q ss_pred             HHHhccCCCCeeceeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCC
Q 011250          191 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDF  269 (490)
Q Consensus       191 ~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDl  269 (490)
                      ..+.++.|++|.....+...  ..+|||||++|+++...+.. ...++......++.|++.+|.+||+ .|   |+||||
T Consensus        71 ~~l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDl  144 (190)
T cd05145          71 RNLKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDL  144 (190)
T ss_pred             HHHHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCC
Confidence            99999999988555444333  24899999988765443222 2467888899999999999999999 88   999999


Q ss_pred             CCCcEEEcCCCCeEEecccCcccCCC
Q 011250          270 KTSNILLDADYNAKLSDFGLAKDAPE  295 (490)
Q Consensus       270 kp~NILl~~~~~vkL~DFG~a~~~~~  295 (490)
                      ||+|||++ ++.++|+|||++.....
T Consensus       145 kP~NIll~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         145 SEYNILYH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             ChhhEEEE-CCCEEEEEcccceecCC
Confidence            99999998 88999999999987643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=2.9e-21  Score=177.86  Aligned_cols=189  Identities=17%  Similarity=0.090  Sum_probs=140.3

Q ss_pred             CCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc----HHHHHHHHHHHhccC-CCCeeceeeEEEe
Q 011250          136 RPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG----HKEWLAEVNFLGNLL-HPNLVKLVGYCIE  210 (490)
Q Consensus       136 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~Ei~il~~l~-HpnIv~l~~~~~~  210 (490)
                      .+...|++|+||+||++..           .+..++.+.+.....-.    ...+.+|+++|++|. |++|++++++   
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-----------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---   70 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-----------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---   70 (218)
T ss_pred             ccceeecCCCcceEEEeec-----------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---
Confidence            4567899999999997644           24467777776553311    124788999999996 5889999886   


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCC-CCCcEEEcCCCCeEEecccC
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDF-KTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDl-kp~NILl~~~~~vkL~DFG~  289 (490)
                       +..+++|||+.|.+|...+..       . ...++.|++.+|.++|..|   |+|||| ||+|||++.++.++|+|||+
T Consensus        71 -~~~~lvmeyI~G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~  138 (218)
T PRK12274         71 -DGRHLDRSYLAGAAMYQRPPR-------G-DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQL  138 (218)
T ss_pred             -cCEEEEEeeecCccHHhhhhh-------h-hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCC
Confidence             456999999999998754311       1 2357789999999999998   999999 79999999999999999999


Q ss_pred             cccCCCCCcc----ee-------eeccccCCCccCcchhccC-CCC-ccchhhHHHHHHHHHHhCCCCCCCCCC
Q 011250          290 AKDAPEDGKT----HV-------STRVMGTYGYAAPEYVMTG-HLT-SKSDVYSFGVVLLEMLTGRRSMDKNRP  350 (490)
Q Consensus       290 a~~~~~~~~~----~~-------~~~~~Gt~~y~aPE~l~~~-~~~-~~sDvwSlGv~l~elltG~~pf~~~~~  350 (490)
                      |.........    ..       .....+++.|++|+.-.-- ..+ ...++++.|+-+|.++|++.++....+
T Consensus       139 A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        139 AVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             ceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence            9865543310    00       0012368889999854321 223 568999999999999999988765443

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.86  E-value=1.2e-22  Score=217.62  Aligned_cols=248  Identities=24%  Similarity=0.304  Sum_probs=179.8

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC----cccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG----LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      +|...+.||.+.|=+|.+|++.+          | .|+||++-+..    +...++.+.|++ ...++|||.+++.-+..
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e----------G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~   91 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE----------G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLV   91 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC----------c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHH
Confidence            57778999999999999998874          4 48899986543    233445555666 56678999999999888


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      .+...|||-+|+.+ +|+|.|.-+ ..+...+.+.|+.||+.||.-+|..|   |+|+|||.+||||+.-.=+.|+||..
T Consensus        92 t~kAAylvRqyvkh-nLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAs  166 (1431)
T KOG1240|consen   92 TDKAAYLVRQYVKH-NLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFAS  166 (1431)
T ss_pred             hhHHHHHHHHHHhh-hhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccc
Confidence            88888999999954 999998543 35777788889999999999999988   99999999999999988899999976


Q ss_pred             ccc--CCCCCcce---eeeccccCCCccCcchhccC-----------CCCccchhhHHHHHHHHHHh-CCCCCCCCCCCC
Q 011250          290 AKD--APEDGKTH---VSTRVMGTYGYAAPEYVMTG-----------HLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNG  352 (490)
Q Consensus       290 a~~--~~~~~~~~---~~~~~~Gt~~y~aPE~l~~~-----------~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~  352 (490)
                      -+.  +++++...   ...+-.--..|+|||.+...           ..+++-||||+||+++||++ |+++|...    
T Consensus       167 FKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----  242 (1431)
T KOG1240|consen  167 FKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----  242 (1431)
T ss_pred             cCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----
Confidence            542  22221111   11111122479999987541           25678999999999999987 68888532    


Q ss_pred             cchhhHhhhcccCCcch-hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011250          353 EHNLVEWARPHLGDKRR-FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       353 ~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~  416 (490)
                        .+..+....-.+... +..+-            ...+..||..|++.||.+|.++++.|+.-.
T Consensus       243 --QL~aYr~~~~~~~e~~Le~Ie------------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yr  293 (1431)
T KOG1240|consen  243 --QLLAYRSGNADDPEQLLEKIE------------DVSLRNLILSMIQRDPSKRLSAEDYLQKYR  293 (1431)
T ss_pred             --HHHhHhccCccCHHHHHHhCc------------CccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence              122221111001111 11111            346789999999999999999999997643

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=2.3e-21  Score=211.68  Aligned_cols=252  Identities=19%  Similarity=0.200  Sum_probs=185.3

Q ss_pred             HHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccC---CCCeece
Q 011250          128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL---HPNLVKL  204 (490)
Q Consensus       128 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l  204 (490)
                      ..+....|.|.+.||+|+||.||+|...+          |+.||+|+-+....-.   |.-=.+++.+|+   -+-|..+
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~----------~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~  759 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSN----------GKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHI  759 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCC----------CcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHH
Confidence            33455678999999999999999998763          6789999977654332   222233444443   4556777


Q ss_pred             eeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC------
Q 011250          205 VGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA------  278 (490)
Q Consensus       205 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~------  278 (490)
                      ..++.-.+..+||+||.+.|+|.+++. ....+++..++.++.|++..|..||..+   |||+||||+|+||..      
T Consensus       760 ~~a~~~~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~  835 (974)
T KOG1166|consen  760 SSAHVFQNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADS  835 (974)
T ss_pred             HHHHccCCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCC
Confidence            777777788899999999999999996 5567999999999999999999999999   999999999999942      


Q ss_pred             -CCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 011250          279 -DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV  357 (490)
Q Consensus       279 -~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~  357 (490)
                       ...++|+|||.+..+.--.........++|-.+-.+|+..+..+++.+|.|.|+-++|-||.|+..-.           
T Consensus       836 ~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~-----------  904 (974)
T KOG1166|consen  836 DSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEV-----------  904 (974)
T ss_pred             cccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHh-----------
Confidence             34699999999977643322233455788999999999999999999999999999999999975310           


Q ss_pred             HhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011250          358 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~  419 (490)
                       +....+.-...+.+..+           -....+|+..+|..|-..=|...++...|+.+.
T Consensus       905 -~~g~~~~~~~~~~Ry~~-----------~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~  954 (974)
T KOG1166|consen  905 -KNGSSWMVKTNFPRYWK-----------RDMWNKFFDLLLNPDCDTLPNLQELRTELEEVL  954 (974)
T ss_pred             -cCCcceeccccchhhhh-----------HHHHHHHHHHHhCcCcccchhHHHHHHHHHHHH
Confidence             00000000000111111           234567888888844444478888887776543

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=3.1e-21  Score=187.31  Aligned_cols=259  Identities=21%  Similarity=0.284  Sum_probs=171.6

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCcc-c----------c---------------CCCCcEEEEEEecCCCc-ccH--
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAP-V----------K---------------PGTGLTVAVKTLNHDGL-QGH--  183 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~-~----------~---------------~~~~~~vaiK~~~~~~~-~~~--  183 (490)
                      ++|+++..||+|.-..||.|+...++... .          -               .....+.|||.+-.-.. ...  
T Consensus       157 ddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~~  236 (598)
T KOG4158|consen  157 DDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDAH  236 (598)
T ss_pred             hhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchHH
Confidence            46999999999999999999887533210 0          0               01112567776532111 111  


Q ss_pred             --HHHHHHH------------H--HHhc--------cCCCCeeceeeEEEeC---------------------------C
Q 011250          184 --KEWLAEV------------N--FLGN--------LLHPNLVKLVGYCIED---------------------------D  212 (490)
Q Consensus       184 --~~~~~Ei------------~--il~~--------l~HpnIv~l~~~~~~~---------------------------~  212 (490)
                        +...+|.            .  ..+.        -.|||||++.++|.+.                           .
T Consensus       237 iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~  316 (598)
T KOG4158|consen  237 ILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPK  316 (598)
T ss_pred             HHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCc
Confidence              1111221            0  1111        2499999999987652                           2


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE--cCCC--CeEEeccc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL--DADY--NAKLSDFG  288 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl--~~~~--~vkL~DFG  288 (490)
                      .+|+||..++ .+|..++..+  ..+.....-++.|+++|+.|||.+|   |.|||+|.+||||  ++|+  .+.|+|||
T Consensus       317 tlylvMkrY~-~tLr~yl~~~--~~s~r~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFG  390 (598)
T KOG4158|consen  317 TLYLVMKRYR-QTLREYLWTR--HRSYRTGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFG  390 (598)
T ss_pred             eEEEehhcch-hhHHHHHhcC--CCchHHHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccc
Confidence            4689999885 4999988544  4566677788899999999999999   9999999999998  3443  47899999


Q ss_pred             CcccCCCCCc----ceeeeccccCCCccCcchhccCC------CCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhH
Q 011250          289 LAKDAPEDGK----THVSTRVMGTYGYAAPEYVMTGH------LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE  358 (490)
Q Consensus       289 ~a~~~~~~~~----~~~~~~~~Gt~~y~aPE~l~~~~------~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~  358 (490)
                      ++-.....+-    ........|.-.-||||+.....      --.++|.|+.|.+.||+++...||....+.. .+...
T Consensus       391 CcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~r~  469 (598)
T KOG4158|consen  391 CCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDTRT  469 (598)
T ss_pred             eeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-echhh
Confidence            8754332111    11122356888999999876421      1248999999999999999999997632211 11111


Q ss_pred             hhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 011250          359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE  413 (490)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~  413 (490)
                      +....           -|    ..+..++..+.+|+..+|+.||.+|++..-..+
T Consensus       470 Yqe~q-----------LP----alp~~vpp~~rqlV~~lL~r~pskRvsp~iAAN  509 (598)
T KOG4158|consen  470 YQESQ-----------LP----ALPSRVPPVARQLVFDLLKRDPSKRVSPNIAAN  509 (598)
T ss_pred             hhhhh-----------CC----CCcccCChHHHHHHHHHhcCCccccCCccHHHh
Confidence            11111           11    123345788999999999999999998654433

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.85  E-value=6.1e-22  Score=212.26  Aligned_cols=209  Identities=26%  Similarity=0.390  Sum_probs=150.1

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      .+|..+++|..|+||.||+.+++.         +.+.+|+ .++++++.-     +-  |+.....|.+|          
T Consensus        83 ~df~~IklisngAygavylvrh~~---------trqrfa~-kiNkq~lil-----Rn--ilt~a~npfvv----------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKE---------TRQRFAM-KINKQNLIL-----RN--ILTFAGNPFVV----------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccc---------cccchhh-cccccchhh-----hc--cccccCCccee----------
Confidence            478999999999999999999886         5668898 454443211     10  33333344444          


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                                 |+-..++ +....++...        +.+++|||+.+   |+|||+||+|+||+.-|++|+.|||+++.
T Consensus       136 -----------gDc~tll-k~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~  192 (1205)
T KOG0606|consen  136 -----------GDCATLL-KNIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKK  192 (1205)
T ss_pred             -----------chhhhhc-ccCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhh
Confidence                       4444444 3333455333        78999999988   99999999999999999999999999875


Q ss_pred             CCCCCcc-------------eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 011250          293 APEDGKT-------------HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW  359 (490)
Q Consensus       293 ~~~~~~~-------------~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~  359 (490)
                      ......+             ......|||+.|.|||++....|+..+|+|++|+|+||++.|..||.+.++......+  
T Consensus       193 GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v--  270 (1205)
T KOG0606|consen  193 GLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV--  270 (1205)
T ss_pred             hhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh--
Confidence            4321111             1123469999999999999999999999999999999999999999887654322111  


Q ss_pred             hhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCC
Q 011250          360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP  406 (490)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP  406 (490)
                          +.+...+.+-         ....+.+++++|.++|+.+|..|-
T Consensus       271 ----isd~i~wpE~---------dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  271 ----ISDDIEWPEE---------DEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             ----hhhhcccccc---------CcCCCHHHHHHHHHHHHhChHhhc
Confidence                1111111111         122378899999999999999994

>PRK10345 hypothetical protein; Provisional

Probab=99.85  E-value=9.1e-21  Score=177.31  Aligned_cols=136  Identities=19%  Similarity=0.214  Sum_probs=106.5

Q ss_pred             CCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcc-----CCCCeeceeeEEEe
Q 011250          136 RPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-----LHPNLVKLVGYCIE  210 (490)
Q Consensus       136 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l~~~~~~  210 (490)
                      .-.++||+|+||.||.  +..         ++.. +||++........+.+.+|+.+++.|     .||||+++++++.+
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~---------~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et   72 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPE---------DAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVET   72 (210)
T ss_pred             CCcceecCCCceEEEE--CCC---------CcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEe
Confidence            3457899999999995  433         2333 69988765555567899999999999     57999999999988


Q ss_pred             CC---ceE-EEEEe--cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHH-HHhhhcCCCCeeecCCCCCcEEEcC----C
Q 011250          211 DD---QRL-LVYEF--MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL-AFLHEEAEKPVIYRDFKTSNILLDA----D  279 (490)
Q Consensus       211 ~~---~~~-lV~E~--~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL-~yLH~~~~~~iiHrDlkp~NILl~~----~  279 (490)
                      +.   ..+ +||||  +.+|+|.+++.+.  .+++.  ..++.+++.++ +|||+++   ||||||||+|||++.    +
T Consensus        73 ~~g~g~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~  145 (210)
T PRK10345         73 DCGTGYVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESE  145 (210)
T ss_pred             CCCCeEEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCC
Confidence            74   333 78999  5579999999543  46555  35677888777 9999998   999999999999974    3


Q ss_pred             CCeEEecccCc
Q 011250          280 YNAKLSDFGLA  290 (490)
Q Consensus       280 ~~vkL~DFG~a  290 (490)
                      +.++|+||+.+
T Consensus       146 ~~~~LiDg~G~  156 (210)
T PRK10345        146 VIPVVCDNIGE  156 (210)
T ss_pred             CcEEEEECCCC
Confidence            47999995544

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.84  E-value=8.6e-21  Score=194.62  Aligned_cols=218  Identities=26%  Similarity=0.441  Sum_probs=166.8

Q ss_pred             HhccCCCCeeceeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe-eecCCCC
Q 011250          193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPV-IYRDFKT  271 (490)
Q Consensus       193 l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~i-iHrDlkp  271 (490)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+......+++.-...++++|+.||+|||.-.   | .|+.|+.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeeecc
Confidence            46788999999999999999999999999999999999887788999999999999999999999855   4 9999999


Q ss_pred             CcEEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccC-------CCCccchhhHHHHHHHHHHhCCCC
Q 011250          272 SNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-------HLTSKSDVYSFGVVLLEMLTGRRS  344 (490)
Q Consensus       272 ~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-------~~~~~sDvwSlGv~l~elltG~~p  344 (490)
                      .|++++....+||+|||+.................-...|.|||.+...       ..+.+.||||||+++||+++...|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            9999999999999999998776431111111122345679999988753       146779999999999999999999


Q ss_pred             CCCCCCCCc-chhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccc
Q 011250          345 MDKNRPNGE-HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       345 f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~~  421 (490)
                      |+....... ..++.....  ...    ..+.|.+....  ...+++..++.+||..+|.+||+++.|...++.+...
T Consensus       158 ~~~~~~~~~~~eii~~~~~--~~~----~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKK--GGS----NPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             cccccccCChHHHHHHHHh--cCC----CCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            986443332 222222211  000    11112111111  2345789999999999999999999999988876654

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.81  E-value=6.7e-21  Score=192.07  Aligned_cols=172  Identities=26%  Similarity=0.419  Sum_probs=129.4

Q ss_pred             ceEEEEEecCCCChhHHhhhc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          213 QRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      .+||.|++|...+|.++|.++  ....++...+.++.|++.++.|   ++   .+|||+||.||++..+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            578999999999999999533  4567888899999999999999   55   999999999999999999999999999


Q ss_pred             ccCCCCC----cceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccC
Q 011250          291 KDAPEDG----KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       291 ~~~~~~~----~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      .......    .....+..+||..||+||.+.+..|+.++||||||++|+||+. -...|+...      ..    ..+.
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~------t~----~d~r  473 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA------TL----TDIR  473 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH------hh----hhhh
Confidence            8776544    1223356789999999999999999999999999999999997 222221110      00    0000


Q ss_pred             CcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHH
Q 011250          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE  410 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~e  410 (490)
                      +     ..+++.....     -++-..|+.++|...|.+||++.+
T Consensus       474 ~-----g~ip~~~~~d-----~p~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  474 D-----GIIPPEFLQD-----YPEEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             c-----CCCChHHhhc-----CcHHHHHHHHhcCCCcccCchHHH
Confidence            0     0111111111     234468999999999999994443

>smart00090 RIO RIO-like kinase

Probab=99.81  E-value=2.1e-19  Score=171.85  Aligned_cols=145  Identities=17%  Similarity=0.164  Sum_probs=111.1

Q ss_pred             cCCCCCcccccCCceEEEEEE-EccCCCccccCCCCcEEEEEEecCCCcc------------------------cHHHHH
Q 011250          133 RNFRPESLLGEGGFGCVFKGW-VEENGTAPVKPGTGLTVAVKTLNHDGLQ------------------------GHKEWL  187 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~-~~~~~~~~~~~~~~~~vaiK~~~~~~~~------------------------~~~~~~  187 (490)
                      ..|.+.+.||+|+||.||+|. +..         +|..||||++......                        ....+.
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~---------~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   98 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDG---------SGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAE   98 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCC---------CCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHH
Confidence            358899999999999999998 333         5779999998754211                        012356


Q ss_pred             HHHHHHhccCCCC--eeceeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 011250          188 AEVNFLGNLLHPN--LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVI  265 (490)
Q Consensus       188 ~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ii  265 (490)
                      .|+.++..+.+.+  +.+++++    ...+|||||++|++|...+... ..+....+..++.||+.+|.+||..+.  |+
T Consensus        99 ~E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g~--ii  171 (237)
T smart00090       99 KEFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEGE--LV  171 (237)
T ss_pred             HHHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcCC--EE
Confidence            7999999997633  3333332    2358999999998887654332 346666778999999999999998653  99


Q ss_pred             ecCCCCCcEEEcCCCCeEEecccCcccCC
Q 011250          266 YRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       266 HrDlkp~NILl~~~~~vkL~DFG~a~~~~  294 (490)
                      ||||||+||+++ ++.++|+|||.+....
T Consensus       172 H~Dikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      172 HGDLSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             eCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence            999999999999 8899999999987543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=4e-19  Score=167.07  Aligned_cols=134  Identities=18%  Similarity=0.262  Sum_probs=112.3

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--------cHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--------GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      +.||+|++|.||+|.+.           |..|++|+.......        ....+.+|+.++..+.|++|.....++..
T Consensus         2 ~~l~~G~~~~vy~~~~~-----------~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~   70 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFL-----------GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD   70 (211)
T ss_pred             cccccCceEEEEEEeeC-----------CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe
Confidence            57999999999999872           446889986543221        12357789999999999999888878778


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      .+..++||||++|++|.+++....    . .+..++.+++.+|.+||+.+   ++|||++|.|||++ ++.++|+|||++
T Consensus        71 ~~~~~lv~e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a  141 (211)
T PRK14879         71 PENFIIVMEYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLA  141 (211)
T ss_pred             CCCCEEEEEEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcc
Confidence            888999999999999999885432    2 77889999999999999988   99999999999999 789999999988


Q ss_pred             cc
Q 011250          291 KD  292 (490)
Q Consensus       291 ~~  292 (490)
                      ..
T Consensus       142 ~~  143 (211)
T PRK14879        142 EF  143 (211)
T ss_pred             cC
Confidence            65

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.80  E-value=3.9e-19  Score=165.64  Aligned_cols=131  Identities=21%  Similarity=0.322  Sum_probs=107.2

Q ss_pred             ccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--------cHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--------GHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       140 ~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      +||+|+||.||+|.+           .+..|++|........        ...++.+|++++..+.|+++.....++...
T Consensus         1 ~ig~G~~~~vy~~~~-----------~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~   69 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-----------LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP   69 (199)
T ss_pred             CCCCCceEEEEEeec-----------CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC
Confidence            489999999999985           3457999986543211        124577899999999998876666666677


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      +..+|||||++|++|.+++.....        .++.+++.+|.+||+.+   ++|||++|.|||++ ++.++|+|||++.
T Consensus        70 ~~~~lv~e~~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~  137 (199)
T TIGR03724        70 DNKTIVMEYIEGKPLKDVIEEGND--------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGK  137 (199)
T ss_pred             CCCEEEEEEECCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCc
Confidence            788999999999999988744211        78899999999999988   99999999999999 8899999999987


Q ss_pred             cC
Q 011250          292 DA  293 (490)
Q Consensus       292 ~~  293 (490)
                      ..
T Consensus       138 ~~  139 (199)
T TIGR03724       138 YS  139 (199)
T ss_pred             CC
Confidence            64

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.78  E-value=1.6e-18  Score=161.68  Aligned_cols=141  Identities=16%  Similarity=0.075  Sum_probs=109.5

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc----------------------cHHHHHH
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ----------------------GHKEWLA  188 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~----------------------~~~~~~~  188 (490)
                      ....|.+.+.||+|+||.||+|...          +|..||||++......                      ....+..
T Consensus        13 ~~~~~~~~~~i~~G~~g~Vy~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (198)
T cd05144          13 RGVVESLGNQIGVGKESDVYLALDP----------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQK   82 (198)
T ss_pred             cCchhhcCCccccCcceEEEEEEcC----------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHH
Confidence            3344888999999999999999764          4678999987643210                      0113567


Q ss_pred             HHHHHhccCCCC--eeceeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 011250          189 EVNFLGNLLHPN--LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIY  266 (490)
Q Consensus       189 Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH  266 (490)
                      |+.++..+.|++  ++..++    ....++||||++|++|..+...       .....++.+++.++.++|+.+   |+|
T Consensus        83 E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~g---i~H  148 (198)
T cd05144          83 EFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHG---IIH  148 (198)
T ss_pred             HHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCC---CCc
Confidence            899999998874  444433    2456899999999998765421       335678899999999999988   999


Q ss_pred             cCCCCCcEEEcCCCCeEEecccCcccCCC
Q 011250          267 RDFKTSNILLDADYNAKLSDFGLAKDAPE  295 (490)
Q Consensus       267 rDlkp~NILl~~~~~vkL~DFG~a~~~~~  295 (490)
                      |||||+||++++++.++|+|||++.....
T Consensus       149 ~Dl~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         149 GDLSEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCCCcccEEEcCCCcEEEEECCccccCCC
Confidence            99999999999999999999999976544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.78  E-value=1.7e-18  Score=185.32  Aligned_cols=138  Identities=23%  Similarity=0.289  Sum_probs=111.9

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC--C---c---ccHHHHHHHHHHHhccCCCCeec
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--G---L---QGHKEWLAEVNFLGNLLHPNLVK  203 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~---~---~~~~~~~~Ei~il~~l~HpnIv~  203 (490)
                      ...|...++||+|+||.||+|.+...           .+++|+....  .   .   ...+.+.+|++++..++|++|+.
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-----------~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~  400 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGR-----------DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPT  400 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCc-----------cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCe
Confidence            34567789999999999999987532           3444432211  1   0   11246789999999999999998


Q ss_pred             eeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeE
Q 011250          204 LVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       204 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vk  283 (490)
                      .+.++.+....++||||++|++|.+++.         ....++.+++.+|.|||+.+   |+||||||+|||+ .++.++
T Consensus       401 p~~~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~  467 (535)
T PRK09605        401 PVIYDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLY  467 (535)
T ss_pred             eEEEEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEE
Confidence            8888887778899999999999999874         35678999999999999988   9999999999999 678999


Q ss_pred             EecccCcccC
Q 011250          284 LSDFGLAKDA  293 (490)
Q Consensus       284 L~DFG~a~~~  293 (490)
                      |+|||+++..
T Consensus       468 liDFGla~~~  477 (535)
T PRK09605        468 LIDFGLGKYS  477 (535)
T ss_pred             EEeCcccccC
Confidence            9999998764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.77  E-value=5.1e-20  Score=197.11  Aligned_cols=256  Identities=26%  Similarity=0.323  Sum_probs=196.0

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhccC-CCCeeceeeEEEe
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIE  210 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~  210 (490)
                      .|.+.+.||+|+|+.|-+.....+        ....+|+|.+....  ....+....|..+-..+. |.|++.+++...+
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~--------~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~   92 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRD--------PESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS   92 (601)
T ss_pred             cccccccccccccchhhhhhhcCC--------CcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC
Confidence            367778899999999988776543        23467777776553  222344556888888887 9999999999999


Q ss_pred             CCceEEEEEecCCCChhHHh-hhcCCCCCHHHHHHHHHHHHHHHHHhh-hcCCCCeeecCCCCCcEEEcCCC-CeEEecc
Q 011250          211 DDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLH-EEAEKPVIYRDFKTSNILLDADY-NAKLSDF  287 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l-~~~~~~l~~~~~~~i~~qi~~aL~yLH-~~~~~~iiHrDlkp~NILl~~~~-~vkL~DF  287 (490)
                      .+..+++++|..|+++.+.+ .......+...+..++.|+..++.|+| ..+   +.||||||+|.+++..+ .++++||
T Consensus        93 ~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df  169 (601)
T KOG0590|consen   93 PRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADF  169 (601)
T ss_pred             CcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCc
Confidence            99999999999999999988 433335667778889999999999999 877   99999999999999999 9999999


Q ss_pred             cCcccCCC-CCcceeeecccc-CCCccCcchhccC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc
Q 011250          288 GLAKDAPE-DGKTHVSTRVMG-TYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       288 G~a~~~~~-~~~~~~~~~~~G-t~~y~aPE~l~~~-~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      |+|..... .+........+| ++.|+|||...+. ......|+||.|+++.-+++|..|++........ ...|..   
T Consensus       170 ~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~---  245 (601)
T KOG0590|consen  170 GLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKS---  245 (601)
T ss_pred             hhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecc---
Confidence            99998876 555555556789 9999999988874 5567899999999999999999999755433211 111111   


Q ss_pred             CCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 011250          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE  413 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~  413 (490)
                       ....+...        ........+.+++.+++..+|..|.+.+++..
T Consensus       246 -~~~~~~~~--------~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  246 -NKGRFTQL--------PWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             -cccccccC--------ccccCChhhhhcccccccCCchhccccccccc
Confidence             00000011        11122667889999999999999999887753

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.71  E-value=8.8e-17  Score=141.50  Aligned_cols=136  Identities=21%  Similarity=0.122  Sum_probs=114.0

Q ss_pred             CCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCC--CCeeceeeEEEeCCce
Q 011250          137 PESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH--PNLVKLVGYCIEDDQR  214 (490)
Q Consensus       137 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~  214 (490)
                      +.+.||.|.++.||++....           ..+++|.......  ...+.+|+.++..+.|  .+++++++++...+..
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-----------~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~   68 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-----------EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWS   68 (155)
T ss_pred             cceecccccccceEEEEecC-----------CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCcc
Confidence            45789999999999998742           4689999865533  4578899999999986  5899999888888889


Q ss_pred             EEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccC
Q 011250          215 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~  293 (490)
                      +++|||++++.+..+        +......++.+++++|.+||.....+++|+||+|+|||++..+.++|+|||.++..
T Consensus        69 ~~v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          69 YLLMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             EEEEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            999999988877653        55666788899999999999864445999999999999999899999999988753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.71  E-value=6.5e-17  Score=149.05  Aligned_cols=138  Identities=20%  Similarity=0.172  Sum_probs=97.7

Q ss_pred             CcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc--HHH----------------------HHHHHHHH
Q 011250          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKE----------------------WLAEVNFL  193 (490)
Q Consensus       138 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~----------------------~~~Ei~il  193 (490)
                      .+.||+|+||.||+|.+.          ++..||||++.......  ...                      ...|...+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~----------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l   71 (187)
T cd05119           2 GGPIGTGKEADVYLALDG----------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNL   71 (187)
T ss_pred             CcccccccceeEEEEECC----------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHH
Confidence            567999999999999865          35689999987542211  111                      13466666


Q ss_pred             hccCCCC--eeceeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCC
Q 011250          194 GNLLHPN--LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFK  270 (490)
Q Consensus       194 ~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlk  270 (490)
                      ..+.+..  +.+.+++    ...+|||||++++.+........ ... ..+..++.+++.++.++|. .+   |+|||||
T Consensus        72 ~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~  142 (187)
T cd05119          72 KRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAG---LVHGDLS  142 (187)
T ss_pred             HHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCC
Confidence            6665433  4444433    24589999999854432111111 011 5678899999999999999 77   9999999


Q ss_pred             CCcEEEcCCCCeEEecccCcccCCC
Q 011250          271 TSNILLDADYNAKLSDFGLAKDAPE  295 (490)
Q Consensus       271 p~NILl~~~~~vkL~DFG~a~~~~~  295 (490)
                      |+||+++ ++.++|+|||.+.....
T Consensus       143 p~Nili~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119         143 EYNILVD-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             hhhEEEE-CCcEEEEECcccccccC
Confidence            9999999 89999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.69  E-value=2.8e-16  Score=150.66  Aligned_cols=135  Identities=21%  Similarity=0.242  Sum_probs=102.7

Q ss_pred             cccc-cCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-------------ccHHHHHHHHHHHhccCCCCe--e
Q 011250          139 SLLG-EGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-------------QGHKEWLAEVNFLGNLLHPNL--V  202 (490)
Q Consensus       139 ~~LG-~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~Ei~il~~l~HpnI--v  202 (490)
                      ..|| .|+.|+||.+...           +..++||.+.....             .....+.+|+.++..|.|++|  +
T Consensus        37 ~~lg~~~g~gtv~~v~~~-----------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP  105 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-----------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVP  105 (239)
T ss_pred             ceeecCCCCccEEEEEeC-----------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCc
Confidence            4577 7888888887663           44788998854221             122457889999999998885  6


Q ss_pred             ceeeEEEeCCc----eEEEEEecCC-CChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc
Q 011250          203 KLVGYCIEDDQ----RLLVYEFMPR-GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD  277 (490)
Q Consensus       203 ~l~~~~~~~~~----~~lV~E~~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~  277 (490)
                      ..+++......    .+|||||++| .+|.+++..  ..++..    .+.+|+.+|.+||+.|   |+||||||+|||++
T Consensus       106 ~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~  176 (239)
T PRK01723        106 RPIAARVVRHGLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLD  176 (239)
T ss_pred             eeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEc
Confidence            67766444322    2599999997 689888743  245544    3568999999999998   99999999999999


Q ss_pred             CCCCeEEecccCcccC
Q 011250          278 ADYNAKLSDFGLAKDA  293 (490)
Q Consensus       278 ~~~~vkL~DFG~a~~~  293 (490)
                      .++.++|+|||.+...
T Consensus       177 ~~~~v~LIDfg~~~~~  192 (239)
T PRK01723        177 PDGKFWLIDFDRGELR  192 (239)
T ss_pred             CCCCEEEEECCCcccC
Confidence            9899999999988753

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.63  E-value=1.1e-15  Score=157.31  Aligned_cols=249  Identities=26%  Similarity=0.302  Sum_probs=188.5

Q ss_pred             CCCCCccccc--CCceEEEEEEE--ccCCCccccCCCCcEEEEEEecCC--CcccHHHHHHHHHHHhccC-CCCeeceee
Q 011250          134 NFRPESLLGE--GGFGCVFKGWV--EENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLL-HPNLVKLVG  206 (490)
Q Consensus       134 ~y~~~~~LG~--G~fg~Vy~~~~--~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~Ei~il~~l~-HpnIv~l~~  206 (490)
                      .|.+...+|.  |.+|.||.+..  ..         ++..+|+|.-+..  .......-++|+...+.++ |+|.++.+.
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~---------s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~  185 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSE---------SPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSP  185 (524)
T ss_pred             hcccccccccCCCCCceeecccCCccc---------CCcccccccccCCCCCccccccccchhhcccccCccccccccCc
Confidence            5777888999  99999999987  44         5667899873322  2233334456777777775 999999999


Q ss_pred             EEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHH----HHHHhhhcCCCCeeecCCCCCcEEEcCC-CC
Q 011250          207 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK----GLAFLHEEAEKPVIYRDFKTSNILLDAD-YN  281 (490)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~----aL~yLH~~~~~~iiHrDlkp~NILl~~~-~~  281 (490)
                      .+...+..++-+|+| +.+|..+.......++....+.+..+...    ||.++|..+   ++|-|+||.||++..+ ..
T Consensus       186 ~~e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s  261 (524)
T KOG0601|consen  186 AWEGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTS  261 (524)
T ss_pred             ccccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccce
Confidence            999999999999999 57888888766666888889999999999    999999988   9999999999999999 88


Q ss_pred             eEEecccCcccCCCCCcce---eeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhH
Q 011250          282 AKLSDFGLAKDAPEDGKTH---VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE  358 (490)
Q Consensus       282 vkL~DFG~a~~~~~~~~~~---~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~  358 (490)
                      .+++|||+...+.+.....   ...+..|...|++||.+ .+-++.+.|+|++|.++.+..++-.++......      .
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~  334 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS------S  334 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC------C
Confidence            9999999998887654222   22334688899999955 578999999999999999999987765432100      1


Q ss_pred             hhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 011250          359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE  413 (490)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~  413 (490)
                      |..     .+..      .+..+|....+.++...+..|+..+|..|++...++.
T Consensus       335 W~~-----~r~~------~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  335 WSQ-----LRQG------YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ccc-----cccc------cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            110     0000      0122222223556666999999999999999887765

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.55  E-value=2.1e-14  Score=149.32  Aligned_cols=142  Identities=20%  Similarity=0.159  Sum_probs=99.1

Q ss_pred             CcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccH----------------------------------
Q 011250          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH----------------------------------  183 (490)
Q Consensus       138 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~----------------------------------  183 (490)
                      .+.||.|++|.||+|++.          +|+.||||+.+.......                                  
T Consensus       122 ~~plasaSigQVh~A~l~----------~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~  191 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV----------DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFE  191 (437)
T ss_pred             CcceeeeehhheEEEEec----------CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHH
Confidence            367999999999999985          467999999865421100                                  


Q ss_pred             ------HHHHHHHHHHhccC----CCCeeceeeEEE-eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHH-
Q 011250          184 ------KEWLAEVNFLGNLL----HPNLVKLVGYCI-EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK-  251 (490)
Q Consensus       184 ------~~~~~Ei~il~~l~----HpnIv~l~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~-  251 (490)
                            -++.+|+..+.++.    |.+-+.+-.++. .....+|||||++|++|.++.......+.   ...++..++. 
T Consensus       192 ~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~  268 (437)
T TIGR01982       192 KTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARS  268 (437)
T ss_pred             HHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHH
Confidence                  02445555555552    333333333332 23457999999999999887643222222   3456666665 


Q ss_pred             HHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCC
Q 011250          252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE  295 (490)
Q Consensus       252 aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~  295 (490)
                      .+..+|..|   ++|+|++|.||+++.++.++|+|||++..+..
T Consensus       269 ~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       269 FLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            478889888   99999999999999999999999999977643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.52  E-value=1.6e-14  Score=138.03  Aligned_cols=203  Identities=23%  Similarity=0.307  Sum_probs=140.3

Q ss_pred             HHhccCCCCeeceeeEEEeCC-----ceEEEEEecCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 011250          192 FLGNLLHPNLVKLVGYCIEDD-----QRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAEKP  263 (490)
Q Consensus       192 il~~l~HpnIv~l~~~~~~~~-----~~~lV~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~  263 (490)
                      -|-.+.|.|||+++.||.+..     ...++.|||..|+|..+|.+   ....+....-.+|+.||+.||.|||+.. .+
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Cc
Confidence            344567999999999987654     46899999999999999964   3356778888899999999999999987 78


Q ss_pred             eeecCCCCCcEEEcCCCCeEEecccCcccCC--CCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhC
Q 011250          264 VIYRDFKTSNILLDADYNAKLSDFGLAKDAP--EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG  341 (490)
Q Consensus       264 iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~--~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG  341 (490)
                      |+|+++..+.|++..+|-+||.----.....  ............|-++|.+||.=.....+.++|||+||.+..||..|
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            9999999999999999988885211110000  00001111223567899999987777788899999999999999887


Q ss_pred             CCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          342 RRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       342 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                      ..--.......+ .-.......++.       -            ...-..++.+||+..|..||+|.+++-|.
T Consensus       279 Eiq~tnseS~~~-~ee~ia~~i~~l-------e------------n~lqr~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  279 EIQSTNSESKVE-VEENIANVIIGL-------E------------NGLQRGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             eeccCCCcceee-hhhhhhhheeec-------c------------CccccCcCcccccCCCCCCcchhhhhcCc
Confidence            643111100000 000000000000       0            01113578899999999999999998764

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.48  E-value=2e-13  Score=123.56  Aligned_cols=131  Identities=19%  Similarity=0.070  Sum_probs=96.3

Q ss_pred             CcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeec-eeeEEEeCCceEE
Q 011250          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVK-LVGYCIEDDQRLL  216 (490)
Q Consensus       138 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~-l~~~~~~~~~~~l  216 (490)
                      .+.|+.|.++.||++...           +..|++|....... ....+..|+.++..+.+.++++ ++.+  .....++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-----------~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~l   68 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-----------NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVL   68 (170)
T ss_pred             eeecCCcccCceEEEEEC-----------CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeE
Confidence            356899999999998763           45799999765432 1234678999999987655543 4443  3334589


Q ss_pred             EEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          217 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA--EKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       217 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      ||||++|.++....      .   ....++.+++++|+.||..+  ...++|+|++|.||+++ ++.++|+|||.+..
T Consensus        69 v~e~i~G~~l~~~~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          69 ITEFIEGSELLTED------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             EEEecCCCcccccc------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            99999998876430      1   11345678999999999976  22359999999999999 67899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.46  E-value=1.5e-13  Score=144.81  Aligned_cols=144  Identities=17%  Similarity=0.134  Sum_probs=95.4

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-----------------------------
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-----------------------------  182 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----------------------------  182 (490)
                      ..+|.. +.||.|++|+||+|++..         +|+.||||+.+......                             
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~---------~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~  188 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKD---------NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPRE  188 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECC---------CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHH
Confidence            345776 789999999999999875         47799999997542110                             


Q ss_pred             -----HH------HHHHHHHHHhccC----CCCeeceeeEEEe-CCceEEEEEecCCCChhHHh--hhcCC---CCCHHH
Q 011250          183 -----HK------EWLAEVNFLGNLL----HPNLVKLVGYCIE-DDQRLLVYEFMPRGSLENHL--FRRSL---PLPWSI  241 (490)
Q Consensus       183 -----~~------~~~~Ei~il~~l~----HpnIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l--~~~~~---~l~~~~  241 (490)
                           .+      ++.+|+..+.++.    +.+.+.+-.++.+ ....+|||||++|+.|.++.  ...+.   .+....
T Consensus       189 ~v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~  268 (537)
T PRK04750        189 VVAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERG  268 (537)
T ss_pred             HHHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHH
Confidence                 01      1334444444442    3344444444332 34568999999999998742  22221   133333


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC----CeEEecccCcccCCC
Q 011250          242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY----NAKLSDFGLAKDAPE  295 (490)
Q Consensus       242 ~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~----~vkL~DFG~a~~~~~  295 (490)
                      +..++.|++       ..|   ++|+|+||.||+++.++    .++++|||++..+..
T Consensus       269 v~~~~~Qif-------~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        269 VEVFFTQVF-------RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHHHHHH-------hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            334444443       456   99999999999999888    999999999987754

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.43  E-value=3.6e-12  Score=132.75  Aligned_cols=164  Identities=18%  Similarity=0.202  Sum_probs=124.6

Q ss_pred             CCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHH
Q 011250          166 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI  245 (490)
Q Consensus       166 ~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i  245 (490)
                      ++.+|.|..++...........+-++.|+.|+||||+++++.++.++..|||+|.+  ..|..++.+.+    ...+...
T Consensus        36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~----~~~v~~G  109 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG----KEEVCLG  109 (690)
T ss_pred             cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH----HHHHHHH
Confidence            56688888887665433345677889999999999999999999999999999997  36777775433    5667778


Q ss_pred             HHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCcc
Q 011250          246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSK  325 (490)
Q Consensus       246 ~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~  325 (490)
                      +.||+.||.|||+.+.  ++|++|.-..|+|+..|..||++|.++.........  .....---.|..|+.+....  -.
T Consensus       110 l~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~--~~~~~~~~s~~~P~~~~~s~--~s  183 (690)
T KOG1243|consen  110 LFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP--AKSLYLIESFDDPEEIDPSE--WS  183 (690)
T ss_pred             HHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc--cccchhhhcccChhhcCccc--cc
Confidence            8999999999986543  999999999999999999999999988655332210  01111122456666443222  45


Q ss_pred             chhhHHHHHHHHHHhC
Q 011250          326 SDVYSFGVVLLEMLTG  341 (490)
Q Consensus       326 sDvwSlGv~l~elltG  341 (490)
                      .|.|-|||+++|++.|
T Consensus       184 ~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  184 IDSWGLGCLIEELFNG  199 (690)
T ss_pred             hhhhhHHHHHHHHhCc
Confidence            6999999999999999

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.40  E-value=2.6e-13  Score=139.90  Aligned_cols=251  Identities=23%  Similarity=0.179  Sum_probs=179.9

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHH--HHHHHHHHhccC-CCCeeceee
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE--WLAEVNFLGNLL-HPNLVKLVG  206 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~--~~~Ei~il~~l~-HpnIv~l~~  206 (490)
                      ....+|..+..||.|.|+.||....+..        .+..|++|.+.........+  -+.|+.+...+. |.+++.++.
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~--------~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~  333 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPE--------GDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNS  333 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCC--------CCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCC
Confidence            3445799999999999999999874422        45578999876654333332  245777777664 999999999


Q ss_pred             EEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-CCeEEe
Q 011250          207 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAKLS  285 (490)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~-~~vkL~  285 (490)
                      .|....+.||-.|||.++++...+ .-...+.+...+.+..|++.++.++|+..   ++|+|+||+||++..+ +..++.
T Consensus       334 ~W~~~r~~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~  409 (524)
T KOG0601|consen  334 SWSQLRQGYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLG  409 (524)
T ss_pred             CccccccccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcc
Confidence            888888889999999999887666 33345777888999999999999999877   9999999999999876 788999


Q ss_pred             cccCcccCCCCCcceeeeccccCCCcc--CcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011250          286 DFGLAKDAPEDGKTHVSTRVMGTYGYA--APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~--aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      |||++..+.-...     ...+.-+++  +++......+..+.|++|||..+++.++|...-...        ..|....
T Consensus       410 ~~~~~t~~~~~~~-----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~--------~~~~~i~  476 (524)
T KOG0601|consen  410 DFGCWTRLAFSSG-----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG--------VQSLTIR  476 (524)
T ss_pred             ccccccccceecc-----cccccccccccchhhccccccccccccccccccccccccCcccCccc--------ccceeee
Confidence            9999875321111     112233344  454445567888999999999999999987533211        1111000


Q ss_pred             cCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                      -+        .-+.+    + .....+..+.+.+...++..||.+.++..+....
T Consensus       477 ~~--------~~p~~----~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  477 SG--------DTPNL----P-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             cc--------cccCC----C-chHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence            00        00001    1 1136778899999999999999999887665544

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.38  E-value=6.6e-12  Score=115.71  Aligned_cols=145  Identities=14%  Similarity=0.096  Sum_probs=100.5

Q ss_pred             CcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---------------------c-HHHH----HHHHH
Q 011250          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---------------------G-HKEW----LAEVN  191 (490)
Q Consensus       138 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---------------------~-~~~~----~~Ei~  191 (490)
                      ...||.|--+.||.|.......   ....+..+|||+.+.....                     . .+.+    .+|++
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~---~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r   78 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNET---EQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMH   78 (197)
T ss_pred             CCccccCcceEEEEEecCcccc---cccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHH
Confidence            4579999999999997543110   0113468999998632110                     0 1122    37999


Q ss_pred             HHhccCC--CCeeceeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCCeeecC
Q 011250          192 FLGNLLH--PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL-HEEAEKPVIYRD  268 (490)
Q Consensus       192 il~~l~H--pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yL-H~~~~~~iiHrD  268 (490)
                      .|.++..  -++...+++    ...+|||||+.+..+..-..+. ..++......+..+++.+|..| |..+   |||+|
T Consensus        79 ~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD  150 (197)
T cd05146          79 NLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD  150 (197)
T ss_pred             HHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence            9999863  455666654    4568999999665442221121 2355556677889999999999 8878   99999


Q ss_pred             CCCCcEEEcCCCCeEEecccCcccCC
Q 011250          269 FKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       269 lkp~NILl~~~~~vkL~DFG~a~~~~  294 (490)
                      |++.|||++ ++.++|+|||.+....
T Consensus       151 Ls~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         151 LSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCHHHEEEE-CCcEEEEECCCceeCC
Confidence            999999997 4689999999887653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.38  E-value=1.2e-13  Score=149.35  Aligned_cols=248  Identities=22%  Similarity=0.224  Sum_probs=173.6

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .|.+.+-+-.|+|+.++.+.-..         +|-..++|+......   ...+....+-.++-..++|.++...-.+..
T Consensus       805 ~~~i~~p~qS~sp~ss~p~~pa~---------sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~  875 (1205)
T KOG0606|consen  805 GFEITKPSQSGSPSSSFPASPAG---------SGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPC  875 (1205)
T ss_pred             cceecccccCCCCcccccCCccc---------cccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCC
Confidence            46666778888999888765443         333445554433211   122333444444444556777766655556


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      ....+|||+|+.+++|...|+..+ ..+.+....++..+..+++|||...   ++|||++|.|+|+..++..++.|||..
T Consensus       876 rsP~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~  951 (1205)
T KOG0606|consen  876 RSPLPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTL  951 (1205)
T ss_pred             CCCcchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccc
Confidence            678899999999999999886654 5666666777788999999999976   899999999999999999999999843


Q ss_pred             ccCCCC-----------------------------CcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhC
Q 011250          291 KDAPED-----------------------------GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG  341 (490)
Q Consensus       291 ~~~~~~-----------------------------~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG  341 (490)
                      ......                             ..........||+.|.+||.+.+......+|+|++|++++|.++|
T Consensus       952 ~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen  952 SKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred             cccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcC
Confidence            221100                             000112236799999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHH
Q 011250          342 RRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS  409 (490)
Q Consensus       342 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~  409 (490)
                      .+||....+.....      ..+...     +.    ...-+...+.++.+++.+.|..+|.+|..+.
T Consensus      1032 ~pp~na~tpq~~f~------ni~~~~-----~~----~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1032 IPPFNAETPQQIFE------NILNRD-----IP----WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCCCcchhhhhh------ccccCC-----CC----CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            99997655432211      000000     00    0112233478899999999999999997766

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.31  E-value=3.4e-11  Score=107.64  Aligned_cols=131  Identities=22%  Similarity=0.302  Sum_probs=99.7

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC-----Cccc---HHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-----GLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .++++|+-+.+|.+.+.           |..+++|.-...     .+..   ...-.+|+++|..+.--.|..-+=+..+
T Consensus         2 ~~i~~GAEa~i~~~~~~-----------g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD   70 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-----------GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD   70 (204)
T ss_pred             chhhCCcceeEEeeecc-----------CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc
Confidence            46889999999998663           335666653222     1111   1345789999999876666555556677


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      .+...|+|||++|-.|.+.+...        ...++..+-..+.-||..+   |||+||.++||++..+ .+.++|||++
T Consensus        71 ~~~~~I~me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~-~i~~IDfGLg  138 (204)
T COG3642          71 PDNGLIVMEYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGG-RIYFIDFGLG  138 (204)
T ss_pred             CCCCEEEEEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCC-cEEEEECCcc
Confidence            88889999999998888888544        2456777788888999999   9999999999999766 4999999998


Q ss_pred             cc
Q 011250          291 KD  292 (490)
Q Consensus       291 ~~  292 (490)
                      ..
T Consensus       139 ~~  140 (204)
T COG3642         139 EF  140 (204)
T ss_pred             cc
Confidence            74

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.28  E-value=3.7e-11  Score=113.33  Aligned_cols=143  Identities=20%  Similarity=0.217  Sum_probs=108.8

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCC--CCeeceeeEEEeC---C
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLH--PNLVKLVGYCIED---D  212 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~---~  212 (490)
                      +.|+.|.++.||++...+          |..+++|....... .....+..|+.++..+.+  .++.+++.+....   +
T Consensus         4 ~~l~~G~~n~~~~v~~~~----------g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~   73 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG----------GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLG   73 (223)
T ss_pred             eecCCCccceEEEEEecC----------CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccC
Confidence            568999999999987642          35799999765432 134567899999999975  3456677766553   2


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcC--------------------------------
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA--------------------------------  260 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--------------------------------  260 (490)
                      ..++||||++|.+|.+.+..  ..++......++.+++++|.+||+..                                
T Consensus        74 ~~~~v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (223)
T cd05154          74 TPFYVMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRT  151 (223)
T ss_pred             CceEEEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcc
Confidence            56899999999988776532  35777778888888888888888531                                


Q ss_pred             ---------------------CCCeeecCCCCCcEEEcC--CCCeEEecccCcccC
Q 011250          261 ---------------------EKPVIYRDFKTSNILLDA--DYNAKLSDFGLAKDA  293 (490)
Q Consensus       261 ---------------------~~~iiHrDlkp~NILl~~--~~~vkL~DFG~a~~~  293 (490)
                                           ...+||+|+.+.|||++.  ++.+.|+||+.+...
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g  207 (223)
T cd05154         152 DEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG  207 (223)
T ss_pred             cccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence                                 234799999999999988  567899999987653

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.26  E-value=6.6e-11  Score=105.31  Aligned_cols=142  Identities=22%  Similarity=0.237  Sum_probs=106.2

Q ss_pred             CCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEe-----cCCCcc---cHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          137 PESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL-----NHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       137 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~-----~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      .+.+|-+|+-+.|+++.+.           |+.+.||.-     ++..+.   ..++..+|+++|.++.--.|.--.-++
T Consensus        11 ~l~likQGAEArv~~~~~~-----------Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~   79 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-----------GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIF   79 (229)
T ss_pred             cceeeeccceeeEeeeccC-----------CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEE
Confidence            5678899999999999874           556667643     222221   235678899999998755655555567


Q ss_pred             EeCCceEEEEEecCC-CChhHHhhhcCCCCCHHHH-HHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC---CeE
Q 011250          209 IEDDQRLLVYEFMPR-GSLENHLFRRSLPLPWSIR-MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY---NAK  283 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~-gsL~~~l~~~~~~l~~~~~-~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~---~vk  283 (490)
                      .+...-.|+|||++| .++.+++......-..... ..++..|-+.|.-||.++   |||+||..+||+|..++   .+.
T Consensus        80 ~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~  156 (229)
T KOG3087|consen   80 IDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPI  156 (229)
T ss_pred             EecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceE
Confidence            777778899999976 4788888665433333333 788899999999999999   99999999999996554   458


Q ss_pred             EecccCccc
Q 011250          284 LSDFGLAKD  292 (490)
Q Consensus       284 L~DFG~a~~  292 (490)
                      |+|||++..
T Consensus       157 lIdfgls~~  165 (229)
T KOG3087|consen  157 LIDFGLSSV  165 (229)
T ss_pred             EEeecchhc
Confidence            999999754

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.22  E-value=3.7e-10  Score=114.52  Aligned_cols=213  Identities=17%  Similarity=0.256  Sum_probs=151.9

Q ss_pred             eEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEe----CCceEEEEEecC
Q 011250          147 GCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE----DDQRLLVYEFMP  222 (490)
Q Consensus       147 g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lV~E~~~  222 (490)
                      .+.|+++...         +|..|++|++..+..+.......-+++++++.|+|||++.++|..    +..++|||+|++
T Consensus       290 ~Ttyk~~s~~---------DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP  360 (655)
T KOG3741|consen  290 ITTYKATSNV---------DGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYP  360 (655)
T ss_pred             ceeEeeeecc---------CCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCC
Confidence            5689998877         566899999965544443334456889999999999999998873    456899999988


Q ss_pred             C-CChhHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecc
Q 011250          223 R-GSLENHLFRR--------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       223 ~-gsL~~~l~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DF  287 (490)
                      + ++|.++.+..              +...++...|.++.|+..||.++|+.|   +.-+-|.+.+||++.+.+++|...
T Consensus       361 ~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C  437 (655)
T KOG3741|consen  361 SSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGC  437 (655)
T ss_pred             CCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecc
Confidence            6 6888776432              234778999999999999999999999   888999999999999999999988


Q ss_pred             cCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchh-hHhhhcccCC
Q 011250          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL-VEWARPHLGD  366 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~-~~~~~~~~~~  366 (490)
                      |+......+..                |.+..   -.+-|.=.||.+++.|.||..--....  ..... .+        
T Consensus       438 ~i~Dvl~~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d--~~~~s~~~--------  488 (655)
T KOG3741|consen  438 GIMDVLQEDPT----------------EPLES---QQQNDLRDLGLLLLALATGTENSNRTD--STQSSHLT--------  488 (655)
T ss_pred             cceeeecCCCC----------------cchhH---HhhhhHHHHHHHHHHHhhccccccccc--chHHHHHH--------
Confidence            87765544320                11111   235689999999999999964211000  00000 00        


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                                    ......+.++.+++.-+...++++ -++.+++.++
T Consensus       489 --------------~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  489 --------------RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI  522 (655)
T ss_pred             --------------HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence                          011122677778888888878776 5666666543

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.18  E-value=3.6e-09  Score=104.98  Aligned_cols=261  Identities=16%  Similarity=0.168  Sum_probs=161.0

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcc-CCCCeeceeeE------
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGY------  207 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~------  207 (490)
                      ....+.||+|+-+.+|-.-.-            ...+.|++.........+.   +..|... .||-+-.-+.+      
T Consensus        13 i~~gr~LgqGgea~ly~l~e~------------~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~   77 (637)
T COG4248          13 IPPGRPLGQGGEADLYTLGEV------------RDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLH   77 (637)
T ss_pred             cCCCccccCCccceeeecchh------------hchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhh
Confidence            345678999999999954221            1244588776544332222   2233333 35543321111      


Q ss_pred             EEeC-CceEEEEEecCCCChhHHhhh------cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC
Q 011250          208 CIED-DQRLLVYEFMPRGSLENHLFR------RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY  280 (490)
Q Consensus       208 ~~~~-~~~~lV~E~~~~gsL~~~l~~------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~  280 (490)
                      .-+. ....++|..+.+..--..+.+      ......|.-.+..++.++.+.+.||..|   .+-+|+.++|+|+.+++
T Consensus        78 G~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~  154 (637)
T COG4248          78 GGRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDS  154 (637)
T ss_pred             CCCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCc
Confidence            1112 236688988877533222221      1234778999999999999999999999   88999999999999999


Q ss_pred             CeEEecccCcccCCCCCcceeeeccccCCCccCcchhc-----cCCCCccchhhHHHHHHHHHHhC-CCCCCCCCCCCc-
Q 011250          281 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTG-RRSMDKNRPNGE-  353 (490)
Q Consensus       281 ~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~sDvwSlGv~l~elltG-~~pf~~~~~~~~-  353 (490)
                      .|.|.|=..-....++   ....-.+|...|.+||...     +..-+...|.|.|||++++||.| ++||.+...... 
T Consensus       155 ~V~LVdsDsfqi~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~a  231 (637)
T COG4248         155 KVVLVDSDSFQINANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDA  231 (637)
T ss_pred             eEEEEcccceeeccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCC
Confidence            9999975433222221   1122357899999999654     23456679999999999999887 999975432211 


Q ss_pred             -----chhhHhhhcccCCcchhhhccCCccCCCCChh-hHHHHHHHHHHhhhc--CCCCCCCHHHHHHHhhcCcc
Q 011250          354 -----HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIK-GSQKATQLAAQCLSR--DPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       354 -----~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~-~~~~l~~Li~~cL~~--dP~~RPt~~evl~~L~~l~~  420 (490)
                           ..+.......-.+.+ ..... +  ....+.. .+..+..|..+|+..  ++.-|||++.++..|..+..
T Consensus       232 p~p~E~~Ia~g~f~ya~~~~-~g~~p-~--P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~  302 (637)
T COG4248         232 PNPLETDIAHGRFAYASDQR-RGLKP-P--PRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ  302 (637)
T ss_pred             CCcchhhhhcceeeechhcc-CCCCC-C--CCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence                 011100000000000 00000 0  0111211 267889999999975  46789999999998877654

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.05  E-value=3.5e-09  Score=102.90  Aligned_cols=123  Identities=17%  Similarity=0.101  Sum_probs=90.1

Q ss_pred             CcEEEEEEecCCCcc-cHH----------HHHHHHHHHhccCCCCe--eceeeEEEe-----CCceEEEEEecCCC-Chh
Q 011250          167 GLTVAVKTLNHDGLQ-GHK----------EWLAEVNFLGNLLHPNL--VKLVGYCIE-----DDQRLLVYEFMPRG-SLE  227 (490)
Q Consensus       167 ~~~vaiK~~~~~~~~-~~~----------~~~~Ei~il~~l~HpnI--v~l~~~~~~-----~~~~~lV~E~~~~g-sL~  227 (490)
                      |+.|.||........ ..+          .+.+|...+..|..-+|  +..++++..     ....+||||++++. +|.
T Consensus        45 g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~  124 (268)
T PRK15123         45 GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLE  124 (268)
T ss_pred             CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHH
Confidence            557999977543311 011          36789998888854333  344555543     23468999999876 788


Q ss_pred             HHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-------CCCeEEecccCccc
Q 011250          228 NHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-------DYNAKLSDFGLAKD  292 (490)
Q Consensus       228 ~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~-------~~~vkL~DFG~a~~  292 (490)
                      +++... ....+......++.+++..+.-||..|   |+|+||++.|||++.       ++.+.|+||+.+..
T Consensus       125 ~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        125 DYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            887432 234566777889999999999999999   999999999999975       46899999998753

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.01  E-value=3.3e-09  Score=97.38  Aligned_cols=126  Identities=21%  Similarity=0.215  Sum_probs=79.8

Q ss_pred             EEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--------------------------cHHHHHHHHHHHhccCCC--
Q 011250          148 CVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--------------------------GHKEWLAEVNFLGNLLHP--  199 (490)
Q Consensus       148 ~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------------------------~~~~~~~Ei~il~~l~Hp--  199 (490)
                      .||.|...          .|..+|||+.+.....                          ......+|++.|..+..-  
T Consensus         1 ~Vy~~~~~----------~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv   70 (188)
T PF01163_consen    1 DVYHAIDP----------DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGV   70 (188)
T ss_dssp             EEEEEEEC----------TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-
T ss_pred             CEEEEECC----------CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCc
Confidence            37888764          4668999998742110                          012357899999999865  


Q ss_pred             CeeceeeEEEeCCceEEEEEecC--CCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHH-hhhcCCCCeeecCCCCCcEEE
Q 011250          200 NLVKLVGYCIEDDQRLLVYEFMP--RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF-LHEEAEKPVIYRDFKTSNILL  276 (490)
Q Consensus       200 nIv~l~~~~~~~~~~~lV~E~~~--~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~y-LH~~~~~~iiHrDlkp~NILl  276 (490)
                      ++.+.+++.    ..+|||||++  |..+..+. ...  ++......++.+++..+.. +|..|   |||+||.+.|||+
T Consensus        71 ~vP~p~~~~----~~~ivME~I~~~G~~~~~l~-~~~--~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv  140 (188)
T PF01163_consen   71 PVPKPYDYN----RNVIVMEYIGEDGVPLPRLK-DVD--LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILV  140 (188)
T ss_dssp             SS--EEEEE----TTEEEEE--EETTEEGGCHH-HCG--GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEE
T ss_pred             cCCcEEEEe----CCEEEEEecCCCccchhhHH-hcc--ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEe
Confidence            456665442    3489999998  54554433 221  1133455677778775555 57877   9999999999999


Q ss_pred             cCCCCeEEecccCcccCC
Q 011250          277 DADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       277 ~~~~~vkL~DFG~a~~~~  294 (490)
                      +++ .+.|+|||.+....
T Consensus       141 ~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  141 DDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             ETT-CEEE--GTTEEETT
T ss_pred             ecc-eEEEEecCcceecC
Confidence            887 99999999887653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.85  E-value=2.4e-08  Score=94.67  Aligned_cols=136  Identities=18%  Similarity=0.108  Sum_probs=96.9

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc----------------------cHHHHHHHHHH
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ----------------------GHKEWLAEVNF  192 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~----------------------~~~~~~~Ei~i  192 (490)
                      +.+...||.|--+.||.|...          .|..+|||.-+.....                      ......+|.++
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~----------~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~  162 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP----------KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEA  162 (304)
T ss_pred             HhhccccccCccceEEEEECC----------CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHH
Confidence            456788999999999999875          4678999976532111                      11235789999


Q ss_pred             HhccCCC--CeeceeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 011250          193 LGNLLHP--NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFK  270 (490)
Q Consensus       193 l~~l~Hp--nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlk  270 (490)
                      |.+|...  .|.+.+++    +.-.+||||++|-.|...-      +..+..-.++..|++-+.-+-..|   |||+|+.
T Consensus       163 L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~G---iVHGDlS  229 (304)
T COG0478         163 LQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRG---IVHGDLS  229 (304)
T ss_pred             HHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCc
Confidence            9998644  56666654    4558999999887765432      123333444455555555455666   9999999


Q ss_pred             CCcEEEcCCCCeEEecccCcccC
Q 011250          271 TSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       271 p~NILl~~~~~vkL~DFG~a~~~  293 (490)
                      +-|||++++|.++++||--+...
T Consensus       230 efNIlV~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         230 EFNILVTEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             hheEEEecCCCEEEEeCcccccC
Confidence            99999999999999999766543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.82  E-value=6e-08  Score=90.93  Aligned_cols=106  Identities=25%  Similarity=0.226  Sum_probs=83.0

Q ss_pred             HHHHHHHHHHhccCCC--CeeceeeEEEeCC----ceEEEEEecCCC-ChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHh
Q 011250          184 KEWLAEVNFLGNLLHP--NLVKLVGYCIEDD----QRLLVYEFMPRG-SLENHLFRRSLPLPWSIRMKIALGAAKGLAFL  256 (490)
Q Consensus       184 ~~~~~Ei~il~~l~Hp--nIv~l~~~~~~~~----~~~lV~E~~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yL  256 (490)
                      ....+|...+..|..-  .+...+++.....    ..+||+|++++. +|.+++.... .++......++.+++..+.-|
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-~~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-QLDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-ccchhhHHHHHHHHHHHHHHH
Confidence            3577888888877533  3455566555432    348999999884 7988885533 266677889999999999999


Q ss_pred             hhcCCCCeeecCCCCCcEEEcCCC---CeEEecccCcccC
Q 011250          257 HEEAEKPVIYRDFKTSNILLDADY---NAKLSDFGLAKDA  293 (490)
Q Consensus       257 H~~~~~~iiHrDlkp~NILl~~~~---~vkL~DFG~a~~~  293 (490)
                      |..|   |+|+|+++.|||++.++   .+.|+||+.++..
T Consensus       135 H~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  135 HDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999   99999999999998887   8999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.79  E-value=3.3e-09  Score=111.42  Aligned_cols=151  Identities=23%  Similarity=0.320  Sum_probs=105.3

Q ss_pred             HHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCCCcceee-------eccccCCCccCcchhcc
Q 011250          247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS-------TRVMGTYGYAAPEYVMT  319 (490)
Q Consensus       247 ~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~-------~~~~Gt~~y~aPE~l~~  319 (490)
                      .+++.||.|+|...+  +||+.|.|++|.++.++..||+.|+++............       .-..-...|.|||++..
T Consensus       106 ~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            455699999998654  999999999999999999999999998765442221110       01223568999999999


Q ss_pred             CCCCccchhhHHHHHHHHHH-hCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhh
Q 011250          320 GHLTSKSDVYSFGVVLLEML-TGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCL  398 (490)
Q Consensus       320 ~~~~~~sDvwSlGv~l~ell-tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL  398 (490)
                      ...+.++|+|||||++|.+. .|+.-+............    ....+.          -...++.+.+.++.+=+.++|
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~----~~~~~~----------~~~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS----RNLLNA----------GAFGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh----hccccc----------ccccccccCcHHHHHHHHHHh
Confidence            88899999999999999999 555544432211111100    000000          011223445889999999999


Q ss_pred             hcCCCCCCCHHHHHH
Q 011250          399 SRDPKARPRMSEVVE  413 (490)
Q Consensus       399 ~~dP~~RPt~~evl~  413 (490)
                      ..++.-||++.+++.
T Consensus       250 ~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLS  264 (700)
T ss_pred             cCCcccCcchhhhhc
Confidence            999999998777643

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.71  E-value=7.1e-08  Score=101.44  Aligned_cols=142  Identities=17%  Similarity=0.173  Sum_probs=94.5

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc------------------------------HH----
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG------------------------------HK----  184 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~------------------------------~~----  184 (490)
                      ..|+.++-|.||+|++.          +|+.||||+.+..-...                              .+    
T Consensus       131 ~PiAsASIaQVH~A~L~----------sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~  200 (517)
T COG0661         131 EPIASASIAQVHRAVLK----------SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK  200 (517)
T ss_pred             CchhhhhHhhheeEEec----------CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence            67999999999999997          47899999987532110                              00    


Q ss_pred             ------HHHHHHHHHhccC-----CCCeeceeeE-EEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHH
Q 011250          185 ------EWLAEVNFLGNLL-----HPNLVKLVGY-CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG  252 (490)
Q Consensus       185 ------~~~~Ei~il~~l~-----HpnIv~l~~~-~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~a  252 (490)
                            ++.+|..-+.++.     .++| .+-.+ +.-.....|+|||++|-.+.+........++...+.....++.  
T Consensus       201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--  277 (517)
T COG0661         201 RLREELDYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--  277 (517)
T ss_pred             HHHHHhCHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--
Confidence                  2345655555553     2333 23233 3335667999999999998887533334455443333322222  


Q ss_pred             HHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCC
Q 011250          253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  296 (490)
Q Consensus       253 L~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~  296 (490)
                      +..+-..|   ++|.|..|.||+++.+|.+.+.|||+...+...
T Consensus       278 ~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         278 LRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             HHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            22222235   999999999999999999999999999877543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.67  E-value=4.3e-07  Score=86.33  Aligned_cols=138  Identities=16%  Similarity=0.132  Sum_probs=84.1

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCC--eeceeeEEEeCCceEE
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN--LVKLVGYCIEDDQRLL  216 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~l  216 (490)
                      ..||+|..+.||+..             +..+++|......  ......+|.++++.+..-+  +.+.+++....+...+
T Consensus         7 ~~i~~G~t~~~y~~~-------------~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~gl   71 (226)
T TIGR02172         7 TQTGEGGNGESYTHK-------------TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGL   71 (226)
T ss_pred             eeecCCCCcceeEec-------------CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeee
Confidence            568999999999831             2247788876432  3345788999999886433  4667777777778889


Q ss_pred             EEEecCCCC-hhHHhh--------------h-----cC---CCCCHHHHH-HHHH----------HHHH-HHHHhhhc-C
Q 011250          217 VYEFMPRGS-LENHLF--------------R-----RS---LPLPWSIRM-KIAL----------GAAK-GLAFLHEE-A  260 (490)
Q Consensus       217 V~E~~~~gs-L~~~l~--------------~-----~~---~~l~~~~~~-~i~~----------qi~~-aL~yLH~~-~  260 (490)
                      |||+++|.+ +...+.              +     +.   ......... .+..          .+.. ...+|... .
T Consensus        72 v~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~  151 (226)
T TIGR02172        72 IYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPD  151 (226)
T ss_pred             eeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCC
Confidence            999998863 211110              0     00   001111000 0000          0011 11122111 1


Q ss_pred             CCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          261 EKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       261 ~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      ...++|+|+.|.||++++++ +.|+||+.+..
T Consensus       152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            23478999999999999888 99999998754

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PRK09902 hypothetical protein; Provisional

Probab=98.62  E-value=6.3e-07  Score=83.10  Aligned_cols=137  Identities=18%  Similarity=0.158  Sum_probs=99.9

Q ss_pred             cccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC---C---cccHHHHHHHHHHHhccCCCC--eeceeeEEE-eC
Q 011250          141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD---G---LQGHKEWLAEVNFLGNLLHPN--LVKLVGYCI-ED  211 (490)
Q Consensus       141 LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~---~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~-~~  211 (490)
                      -|+||.+-|+.....           |..+-+|.-..-   .   ......|.+|+..|..|..-+  +.+.. ++. ..
T Consensus        26 ~~rgG~SgV~r~~~~-----------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k   93 (216)
T PRK09902         26 YRRNGMSGVQCVERN-----------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVK   93 (216)
T ss_pred             cCCCCcceEEEEEeC-----------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeec
Confidence            467999999987653           335777765311   1   224567999999999986433  44444 222 11


Q ss_pred             ----CceEEEEEecCC-CChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCC--eE
Q 011250          212 ----DQRLLVYEFMPR-GSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN--AK  283 (490)
Q Consensus       212 ----~~~~lV~E~~~~-gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~--vk  283 (490)
                          -.-+||+|-++| -+|.+++.... .+.+......++.+|+..|.-||..|   +.|+|+.+.|||++.++.  ++
T Consensus        94 ~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~  170 (216)
T PRK09902         94 IEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAG  170 (216)
T ss_pred             cCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEE
Confidence                135799998854 58888875432 24577777899999999999999998   999999999999986667  99


Q ss_pred             EecccCccc
Q 011250          284 LSDFGLAKD  292 (490)
Q Consensus       284 L~DFG~a~~  292 (490)
                      ++||.-++.
T Consensus       171 lIDlEk~r~  179 (216)
T PRK09902        171 FLDLEKSRR  179 (216)
T ss_pred             EEEhhccch
Confidence            999987764

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.56  E-value=6.7e-07  Score=83.25  Aligned_cols=139  Identities=11%  Similarity=0.098  Sum_probs=91.7

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHH---------HHHHHHHHhccCC--
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---------WLAEVNFLGNLLH--  198 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~---------~~~Ei~il~~l~H--  198 (490)
                      ....+|.+.+++-.....-|.+-..           .|..+++|..+.......+.         ..+++..+..+..  
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei-----------~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g   96 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEI-----------DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEG   96 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEE-----------CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcC
Confidence            4556788888888877777766554           35678999887554322221         2344444444432  


Q ss_pred             -CCeeceeeEEEe-----CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 011250          199 -PNLVKLVGYCIE-----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTS  272 (490)
Q Consensus       199 -pnIv~l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~  272 (490)
                       -.+..++.+...     ....+|||||++|..|.++.     .+++    .++..|.+++.-||..|   ++|+|+.|.
T Consensus        97 ~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~-----~i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpg  164 (229)
T PF06176_consen   97 FTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIE-----DIDE----DLAEKIVEAIKQLHKHG---FYHGDPHPG  164 (229)
T ss_pred             ccccccceeeeeeeeccceeEEEEEEEEecCeecccch-----hcCH----HHHHHHHHHHHHHHHcC---CccCCCCcC
Confidence             222333332222     23456899999998887654     1332    24456778899999999   999999999


Q ss_pred             cEEEcCCCCeEEecccCccc
Q 011250          273 NILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       273 NILl~~~~~vkL~DFG~a~~  292 (490)
                      |++++.+ .++++||+..+.
T Consensus       165 NFlv~~~-~i~iID~~~k~~  183 (229)
T PF06176_consen  165 NFLVSNN-GIRIIDTQGKRM  183 (229)
T ss_pred             cEEEECC-cEEEEECccccc
Confidence            9999865 599999986653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.55  E-value=6.6e-09  Score=107.99  Aligned_cols=187  Identities=18%  Similarity=0.119  Sum_probs=136.2

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCC-eeceeeEEEeCC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN-LVKLVGYCIEDD  212 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~  212 (490)
                      .+....-+++|+++.+++.+....          +....+.+...     ....-++++|.+++||| .+..++-+..++
T Consensus       243 ws~~fh~fvK~altknpKkRptae----------klL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~  307 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAE----------KLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGED  307 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChh----------hheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCccc
Confidence            344445588999999998765431          12234444322     34456899999999999 777777777788


Q ss_pred             ceEEEEEecCCC-ChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          213 QRLLVYEFMPRG-SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       213 ~~~lV~E~~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      ..+++|+++.++ +-..........+...+...+.+.-+++|+|||+..   =+|||    |||..+ +..++.||+...
T Consensus       308 ~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~  379 (829)
T KOG0576|consen  308 YLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPP  379 (829)
T ss_pred             ccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCc
Confidence            899999999877 322222122223444455667777788999999854   48999    887755 689999999988


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCC
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD  346 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~  346 (490)
                      .+....   ......+|+.++|||+.....+....|+|++|+-..+|--|-+|-.
T Consensus       380 ~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  380 QLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             ccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            775532   2344779999999999999999999999999998778877777653

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.46  E-value=1.4e-06  Score=82.39  Aligned_cols=140  Identities=18%  Similarity=0.158  Sum_probs=82.4

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCC--eeceeeEEEe---CCc
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN--LVKLVGYCIE---DDQ  213 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~---~~~  213 (490)
                      +.|+.|..+.||+.....           ..+++|.....  .....+..|+.+++.|....  +..++.+...   ...
T Consensus         3 ~~l~~G~~n~~~~v~~~~-----------~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~   69 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-----------GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGF   69 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-----------SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSE
T ss_pred             ccCCCCCeeeEEEEEECC-----------cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccccccc
Confidence            568999999999987753           37899997654  34567788999998886333  4566654432   234


Q ss_pred             eEEEEEecCCCChhH----------------Hhh---hc---CCCCCHHH---------HHHH------------HHHHH
Q 011250          214 RLLVYEFMPRGSLEN----------------HLF---RR---SLPLPWSI---------RMKI------------ALGAA  250 (490)
Q Consensus       214 ~~lV~E~~~~gsL~~----------------~l~---~~---~~~l~~~~---------~~~i------------~~qi~  250 (490)
                      .+++|++++|..+..                .+.   ..   ...+....         ....            ...+.
T Consensus        70 ~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (239)
T PF01636_consen   70 PYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELE  149 (239)
T ss_dssp             EEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHH
T ss_pred             ceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHH
Confidence            689999999988877                110   11   01111100         0000            11122


Q ss_pred             H-HHHHhhhc----CCCCeeecCCCCCcEEEc-CCCCeEEecccCcc
Q 011250          251 K-GLAFLHEE----AEKPVIYRDFKTSNILLD-ADYNAKLSDFGLAK  291 (490)
Q Consensus       251 ~-aL~yLH~~----~~~~iiHrDlkp~NILl~-~~~~vkL~DFG~a~  291 (490)
                      . .+..++..    ....++|+|+.+.|||++ .++.+.|+||+.+.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  150 ERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            2 33333321    234599999999999999 66667899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.43  E-value=2.9e-06  Score=81.59  Aligned_cols=138  Identities=20%  Similarity=0.148  Sum_probs=81.9

Q ss_pred             cccCCc-eEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccC-CCCeeceeeEEEeCCceEEEE
Q 011250          141 LGEGGF-GCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIEDDQRLLVY  218 (490)
Q Consensus       141 LG~G~f-g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~  218 (490)
                      |-.|.. ..||+....           +..+.||+.....   ...+.+|+++++.+. +--+.+++++....+..++||
T Consensus         6 ~~~g~~~~~v~~~~~~-----------~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~   71 (244)
T cd05150           6 VTEGQSGATVYRLDGK-----------NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLT   71 (244)
T ss_pred             cCCCCCcCeEEEEcCC-----------CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEE
Confidence            344544 789988542           2357788875443   235678999988885 434556777776666789999


Q ss_pred             EecCCCChhHHhh----------------h-cCC-----CCCHH--HHHHHHH--------------------HHHHHHH
Q 011250          219 EFMPRGSLENHLF----------------R-RSL-----PLPWS--IRMKIAL--------------------GAAKGLA  254 (490)
Q Consensus       219 E~~~~gsL~~~l~----------------~-~~~-----~l~~~--~~~~i~~--------------------qi~~aL~  254 (490)
                      |+++|.+|.....                + +..     .+...  .......                    .+...+.
T Consensus        72 e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (244)
T cd05150          72 SAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYA  151 (244)
T ss_pred             EeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHH
Confidence            9999987764321                0 000     11100  0000000                    0111112


Q ss_pred             Hhhh----cCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          255 FLHE----EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       255 yLH~----~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      .|-.    .....++|+|+.|.|||++++..+.|+||+.+..
T Consensus       152 ~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         152 ELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             HHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            2211    0123489999999999999987788999997753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.42  E-value=4.4e-06  Score=78.69  Aligned_cols=154  Identities=18%  Similarity=0.152  Sum_probs=99.6

Q ss_pred             chhhhhhHHHhhcCCCCCcccc---cCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---------------
Q 011250          121 RKFMFNDLKLATRNFRPESLLG---EGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---------------  182 (490)
Q Consensus       121 ~~~~~~~~~~~~~~y~~~~~LG---~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~---------------  182 (490)
                      ...+...+....++..+..+.|   .|--+.||+|...          .+..||+|+++......               
T Consensus        33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~----------~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~  102 (268)
T COG1718          33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETG----------DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRN  102 (268)
T ss_pred             hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC----------CCceEEEEEEehhhhhhhhHHHHHhcChhhhc
Confidence            3445555555556666666555   5666679998653          46689999987542211               


Q ss_pred             ----HH-----HHHHHHHHHhccC--CCCeeceeeEEEeCCceEEEEEecCCCC-hhHHhhhcCCCCCHHHHHHHHHHHH
Q 011250          183 ----HK-----EWLAEVNFLGNLL--HPNLVKLVGYCIEDDQRLLVYEFMPRGS-LENHLFRRSLPLPWSIRMKIALGAA  250 (490)
Q Consensus       183 ----~~-----~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~lV~E~~~~gs-L~~~l~~~~~~l~~~~~~~i~~qi~  250 (490)
                          .+     ...+|+.-|.++.  +-.+.+-+++.    ...|||||+.... -.-.|  ....+.......+..+++
T Consensus       103 ~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L--kDv~~e~~e~~~~~~~~v  176 (268)
T COG1718         103 SRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL--KDVPLELEEAEGLYEDVV  176 (268)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc--ccCCcCchhHHHHHHHHH
Confidence                11     1345777777774  44444445432    3479999995431 11111  112233335666777888


Q ss_pred             HHHHHhhh-cCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCC
Q 011250          251 KGLAFLHE-EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       251 ~aL~yLH~-~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~  294 (490)
                      +.+.-|-. .+   +||+||..=|||+. ++.+.|+|||-|....
T Consensus       177 ~~~~~l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         177 EYMRRLYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             HHHHHHHHhcC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence            88887776 55   99999999999999 8899999999887654

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.37  E-value=2.8e-06  Score=75.83  Aligned_cols=129  Identities=19%  Similarity=0.186  Sum_probs=89.3

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeec-eeeEEEeCCc
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVK-LVGYCIEDDQ  213 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~-l~~~~~~~~~  213 (490)
                      .++.+.||+|.+|.||+|.+.           |..+|+|+-+.+..  ...+..|+++|..+.--++-+ +|.|..    
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~-----------~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~----   86 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR-----------GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGE----   86 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc-----------CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEech----
Confidence            345678999999999999985           45899998776643  467889999999988665543 444322    


Q ss_pred             eEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC--CcEEEcCCCCeEEecccCcc
Q 011250          214 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKT--SNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       214 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp--~NILl~~~~~vkL~DFG~a~  291 (490)
                      .++.|||+.|-.|.+.....    +..+    ...+++.---|-..|   |-|..|.-  .||++ .+..+.|+||.-|+
T Consensus        87 ~~i~me~i~G~~L~~~~~~~----~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv-~~~~~~iIDFd~At  154 (201)
T COG2112          87 DFIRMEYIDGRPLGKLEIGG----DRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLV-NDRDVYIIDFDSAT  154 (201)
T ss_pred             hhhhhhhhcCcchhhhhhcc----cHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEe-cCCcEEEEEccchh
Confidence            24669999988887765321    2222    234555544555556   88888863  45555 44599999999887


Q ss_pred             c
Q 011250          292 D  292 (490)
Q Consensus       292 ~  292 (490)
                      .
T Consensus       155 ~  155 (201)
T COG2112         155 F  155 (201)
T ss_pred             h
Confidence            4

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.28  E-value=1.5e-05  Score=73.37  Aligned_cols=102  Identities=28%  Similarity=0.280  Sum_probs=81.8

Q ss_pred             HHHHHHhccCC-CCeeceeeEEEeCCceEEEEEecCCCChhHHh--hhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 011250          188 AEVNFLGNLLH-PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPV  264 (490)
Q Consensus       188 ~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l--~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~i  264 (490)
                      .|.-+|..+.+ +++.+++|+|-    .++|.||...+++....  ...-...+|..+.+||.++++.+.+|+......+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            58888998986 69999999983    37889999877664210  0112357899999999999999999998554448


Q ss_pred             eecCCCCCcEEEcCCCCeEEecccCcccC
Q 011250          265 IYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       265 iHrDlkp~NILl~~~~~vkL~DFG~a~~~  293 (490)
                      .-.|++++|+-+++++++|++|...+...
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcchh
Confidence            88999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.27  E-value=5.5e-06  Score=87.15  Aligned_cols=143  Identities=17%  Similarity=0.107  Sum_probs=92.0

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-------------------------------HH---
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-------------------------------HK---  184 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-------------------------------~~---  184 (490)
                      +.||.-+.|.||+|+.+.          |..||||+=+..-...                               .+   
T Consensus       167 ~piaaASlaQVhrA~L~~----------G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~  236 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN----------GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLP  236 (538)
T ss_pred             chhhhcchhheEEEEecC----------CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhH
Confidence            579999999999999874          7789999865431110                               01   


Q ss_pred             ---HHHHHHHHHhc----cCCCCe---eceeeEEE-eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHH
Q 011250          185 ---EWLAEVNFLGN----LLHPNL---VKLVGYCI-EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL  253 (490)
Q Consensus       185 ---~~~~Ei~il~~----l~HpnI---v~l~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL  253 (490)
                         +|.+|++-..+    +.|-++   |.+-.++. -.....|+||||+|..+.++-.-....++...+..-+.++..-+
T Consensus       237 ~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~q  316 (538)
T KOG1235|consen  237 QELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQ  316 (538)
T ss_pred             hhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHH
Confidence               23445443333    335551   11222222 23467899999999887766543334566555554444443333


Q ss_pred             HHhhhcCCCCeeecCCCCCcEEEcC----CCCeEEecccCcccCCCC
Q 011250          254 AFLHEEAEKPVIYRDFKTSNILLDA----DYNAKLSDFGLAKDAPED  296 (490)
Q Consensus       254 ~yLH~~~~~~iiHrDlkp~NILl~~----~~~vkL~DFG~a~~~~~~  296 (490)
                      -+.|  |   ++|.|=.|.||++..    ++.+.+.|||+.......
T Consensus       317 If~~--G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  317 IFKT--G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             HHhc--C---CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            3333  4   999999999999983    678999999999876543

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.25  E-value=1.6e-05  Score=73.70  Aligned_cols=128  Identities=17%  Similarity=0.242  Sum_probs=90.7

Q ss_pred             CcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC----------------cccHHHHHHHHHHHhccC----
Q 011250          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG----------------LQGHKEWLAEVNFLGNLL----  197 (490)
Q Consensus       138 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~Ei~il~~l~----  197 (490)
                      ...||.|+.-.||.  +..++          ...||++....                ....++..+|+.....+.    
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp----------~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~   73 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDP----------NLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRG   73 (199)
T ss_pred             CcccccCCCceEEE--CCCCC----------CeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccC
Confidence            46799999999996  33322          46789887665                123456677777666665    


Q ss_pred             --CCCeeceeeEEEeCCceEEEEEecCC------CChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCC
Q 011250          198 --HPNLVKLVGYCIEDDQRLLVYEFMPR------GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDF  269 (490)
Q Consensus       198 --HpnIv~l~~~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDl  269 (490)
                        +.+|.+++|+.+++....+|+|.+.+      -+|.+++...  .++. ....   .+-+-..||-..+   |+.+||
T Consensus        74 ~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~-~~~~---~L~~f~~~l~~~~---Iv~~dl  144 (199)
T PF10707_consen   74 VDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE-ELRQ---ALDEFKRYLLDHH---IVIRDL  144 (199)
T ss_pred             CcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH-HHHH---HHHHHHHHHHHcC---CeecCC
Confidence              88999999999999999999998654      2677777333  3554 3333   3344456666666   999999


Q ss_pred             CCCcEEEcCC--C--CeEEec
Q 011250          270 KTSNILLDAD--Y--NAKLSD  286 (490)
Q Consensus       270 kp~NILl~~~--~--~vkL~D  286 (490)
                      +|.||++..+  +  .+.|+|
T Consensus       145 ~~~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  145 NPHNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             CcccEEEEecCCCceEEEEEe
Confidence            9999999533  2  577777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.21  E-value=1.3e-05  Score=73.83  Aligned_cols=125  Identities=28%  Similarity=0.413  Sum_probs=90.3

Q ss_pred             cCCCCCcccccCCc-eEEEEEEEccCCCccccCCCCcEEEEEEecC---CCc-------c-----------cHHHHHHHH
Q 011250          133 RNFRPESLLGEGGF-GCVFKGWVEENGTAPVKPGTGLTVAVKTLNH---DGL-------Q-----------GHKEWLAEV  190 (490)
Q Consensus       133 ~~y~~~~~LG~G~f-g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~---~~~-------~-----------~~~~~~~Ei  190 (490)
                      .+++.++.||.|.- |.||++..           .|..+|+|++..   ...       .           ...-|..|.
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-----------~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~EC  105 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-----------DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCEC  105 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-----------CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHH
Confidence            67889999999999 99999988           466899999432   100       0           012477888


Q ss_pred             HHHhccC---CCCe--eceeeEEEeCC------------------ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHH
Q 011250          191 NFLGNLL---HPNL--VKLVGYCIEDD------------------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL  247 (490)
Q Consensus       191 ~il~~l~---HpnI--v~l~~~~~~~~------------------~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~  247 (490)
                      +...+|.   +.++  |+++||..-..                  ...||.||++...          .+.    ..-+.
T Consensus       106 RAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~----~~~~~  171 (207)
T PF13095_consen  106 RAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQ----IRDIP  171 (207)
T ss_pred             HhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccc----hhHHH
Confidence            8888775   4566  99999874321                  1357888876533          122    23345


Q ss_pred             HHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       248 qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      +|.+-|..+|..|   |+-+|+++.|..     .-+|+|||.+
T Consensus       172 ~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  172 QMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            6778888999998   999999999986     5689999864

>PLN02876 acyl-CoA dehydrogenase

Probab=98.16  E-value=2.6e-05  Score=88.06  Aligned_cols=82  Identities=18%  Similarity=0.215  Sum_probs=57.0

Q ss_pred             CcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccC-CCCe--eceeeEEEeC--
Q 011250          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLL-HPNL--VKLVGYCIED--  211 (490)
Q Consensus       138 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~-HpnI--v~l~~~~~~~--  211 (490)
                      .+.|+.|.+..+|+......+       ....+++|+..... ......+.+|+++|+.|. |.+|  .+++.++.+.  
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~-------~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v  115 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGG-------SVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV  115 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCC-------cceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc
Confidence            467899999999998664311       11357777764432 233456889999999996 6665  7777777654  


Q ss_pred             -CceEEEEEecCCCCh
Q 011250          212 -DQRLLVYEFMPRGSL  226 (490)
Q Consensus       212 -~~~~lV~E~~~~gsL  226 (490)
                       +..|+||||++|..+
T Consensus       116 ~G~~flVME~v~G~~~  131 (822)
T PLN02876        116 IGTAFYIMEYLEGRIF  131 (822)
T ss_pred             CCCceEEEEecCCccc
Confidence             467899999987643

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.09  E-value=2.7e-05  Score=74.40  Aligned_cols=73  Identities=14%  Similarity=0.097  Sum_probs=44.9

Q ss_pred             cccccCCce-EEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCC---CeeceeeEEEeC---
Q 011250          139 SLLGEGGFG-CVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP---NLVKLVGYCIED---  211 (490)
Q Consensus       139 ~~LG~G~fg-~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~~~~~~~---  211 (490)
                      +.|+.|+.. .||+..              ..+++|.....  .....+.+|+++|..|...   -+..+++.....   
T Consensus         3 ~~~~~gG~~n~vy~~~--------------~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~   66 (235)
T cd05155           3 EPVDSGGTDNATFRLG--------------DDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGY   66 (235)
T ss_pred             eeccCCCcccceEEcC--------------CceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCC
Confidence            457767666 588751              14677875542  2235788899999887532   233344333222   


Q ss_pred             CceEEEEEecCCCChh
Q 011250          212 DQRLLVYEFMPRGSLE  227 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~  227 (490)
                      ...++||++++|.++.
T Consensus        67 ~~~~~l~~~i~G~~l~   82 (235)
T cd05155          67 PWPWSVYRWLEGETAT   82 (235)
T ss_pred             CcceEEEEeecCCCCC
Confidence            2348899999997764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.99  E-value=8.3e-05  Score=70.87  Aligned_cols=75  Identities=21%  Similarity=0.157  Sum_probs=46.4

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCe-eceeeEEEeCCceEEE
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNL-VKLVGYCIEDDQRLLV  217 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV  217 (490)
                      +.|..|-...+|+......        .+..|++|+....... .-...+|+.++..+...++ .++++.+.    ..+|
T Consensus         4 ~~l~gG~tN~~~~v~~~~~--------~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l   70 (235)
T cd05157           4 KRFTGGITNKLVKVSNKED--------NQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLI   70 (235)
T ss_pred             EEcCCcccceEEEEEcCCC--------CCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEE
Confidence            4577788889998864310        1346888977543221 1233478888888864333 44443322    2489


Q ss_pred             EEecCCCCh
Q 011250          218 YEFMPRGSL  226 (490)
Q Consensus       218 ~E~~~~gsL  226 (490)
                      |||++|.++
T Consensus        71 ~e~i~G~~l   79 (235)
T cd05157          71 YEFIPGRTL   79 (235)
T ss_pred             EEeeCCCcC
Confidence            999998766

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.95  E-value=5.5e-05  Score=74.83  Aligned_cols=141  Identities=16%  Similarity=0.123  Sum_probs=83.7

Q ss_pred             CcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCC--eeceeeE------EE
Q 011250          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN--LVKLVGY------CI  209 (490)
Q Consensus       138 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~------~~  209 (490)
                      .+.|..|....+|+....           +..+++|+...   .....+..|+.++..|.+-+  +.+++..      ..
T Consensus        19 i~~i~~G~~n~~y~v~~~-----------~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~   84 (296)
T cd05153          19 FEGISAGIENTNYFVTTD-----------SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSE   84 (296)
T ss_pred             eecccCccccceEEEEeC-----------CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeee
Confidence            456777887899987543           22588898764   23355677888888885433  3444331      22


Q ss_pred             eCCceEEEEEecCCCChhH----Hh----------hhcCC----------CCCHHHHH----------HHHHHHHHHHHH
Q 011250          210 EDDQRLLVYEFMPRGSLEN----HL----------FRRSL----------PLPWSIRM----------KIALGAAKGLAF  255 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~----~l----------~~~~~----------~l~~~~~~----------~i~~qi~~aL~y  255 (490)
                      .++..++||+|++|..+..    .+          +....          ...|....          .....+..++.+
T Consensus        85 ~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  164 (296)
T cd05153          85 LAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELAR  164 (296)
T ss_pred             eCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHH
Confidence            3456789999999876532    11          10000          01111110          011123334444


Q ss_pred             hhh----cCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          256 LHE----EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       256 LH~----~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      +..    .....+||+|+.|.|||++.++.+.|+||+.+..
T Consensus       165 l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         165 QDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             HHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            443    1123499999999999999887778999997754

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.94  E-value=8.2e-05  Score=72.06  Aligned_cols=137  Identities=15%  Similarity=0.105  Sum_probs=76.8

Q ss_pred             cccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCe-eceeeEEEeCCceEEEEE
Q 011250          141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNL-VKLVGYCIEDDQRLLVYE  219 (490)
Q Consensus       141 LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~E  219 (490)
                      +..|-.+.+|+...           .+..+++|........-.-...+|..+++.+..-++ .+++...  .  .++|||
T Consensus         4 ~~~G~tn~~y~~~~-----------~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e   68 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-----------PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVE   68 (256)
T ss_pred             CCCcCcCCeEEEEe-----------CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEE
Confidence            55677889998753           344688887654322211134678889988864433 3333332  2  379999


Q ss_pred             ecCCCChhHH----------h-------hhc---CCCCCHHH-HHHHHHHH---------HHHHHHhhhc-----CCCCe
Q 011250          220 FMPRGSLENH----------L-------FRR---SLPLPWSI-RMKIALGA---------AKGLAFLHEE-----AEKPV  264 (490)
Q Consensus       220 ~~~~gsL~~~----------l-------~~~---~~~l~~~~-~~~i~~qi---------~~aL~yLH~~-----~~~~i  264 (490)
                      |++|..+...          +       +..   ...++... ...+..++         ...+..+-..     ....+
T Consensus        69 ~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  148 (256)
T TIGR02721        69 WLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAP  148 (256)
T ss_pred             eccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCee
Confidence            9998765421          0       100   11122111 11111111         1112222111     12348


Q ss_pred             eecCCCCCcEEEcCCCCeEEecccCcccC
Q 011250          265 IYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       265 iHrDlkp~NILl~~~~~vkL~DFG~a~~~  293 (490)
                      +|+|+.|.||+++.++ +.|+||..+...
T Consensus       149 ~H~Dl~~~Nil~~~~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       149 LHMDVHAYNLVVTPQG-LKLIDWEYASDG  176 (256)
T ss_pred             ecCCCCcCcEEEeCCC-CEEEeccccCcC
Confidence            9999999999999876 789999987643

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK10593 hypothetical protein; Provisional

Probab=97.93  E-value=0.00017  Score=71.59  Aligned_cols=77  Identities=12%  Similarity=0.059  Sum_probs=54.6

Q ss_pred             CCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCC---CCeeceeeEEEeC--
Q 011250          137 PESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH---PNLVKLVGYCIED--  211 (490)
Q Consensus       137 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~H---pnIv~l~~~~~~~--  211 (490)
                      -.+.||.|..+.||+....+          + .+.+|..+..  .....+..|...|+.|..   -.+.++++++..+  
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~----------~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~   84 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQ----------G-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS   84 (297)
T ss_pred             eeeecCCccceeEEEEEcCC----------C-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc
Confidence            34679999999999975432          2 4667774331  123467889999998853   3577788777543  


Q ss_pred             -CceEEEEEecCCCCh
Q 011250          212 -DQRLLVYEFMPRGSL  226 (490)
Q Consensus       212 -~~~~lV~E~~~~gsL  226 (490)
                       +..+||||+++|+++
T Consensus        85 ~g~~~LVmE~i~G~~~  100 (297)
T PRK10593         85 PGPDVLLLERLRGVSV  100 (297)
T ss_pred             CCCeEEEEeccCCEec
Confidence             568999999998765

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.89  E-value=4.1e-05  Score=85.33  Aligned_cols=196  Identities=21%  Similarity=0.243  Sum_probs=136.6

Q ss_pred             HHHHHHHHhccCCCCeeceeeEEEeCCce----EEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 011250          186 WLAEVNFLGNLLHPNLVKLVGYCIEDDQR----LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE  261 (490)
Q Consensus       186 ~~~Ei~il~~l~HpnIv~l~~~~~~~~~~----~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~  261 (490)
                      ...|+..+..+.|+|++.++.|..+....    .+..++|..-++...+. .-..++....+.+..++.+||.|+|+.. 
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q-~v~~i~~~~~r~~~~~~~~GL~~~h~~~-  306 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ-SVGSIPLETLRILHQKLLEGLAYLHSLS-  306 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh-hccccCHHHHHHHHHHHhhhHHHHHHhc-
Confidence            34567778888999999999987765433    24457888888888774 3457888999999999999999999975 


Q ss_pred             CCeeecCCCCC---cEEEcCCCCeEEe--cccCcccCCCCCcceeeeccccCCCccCcchhccCCCCcc--chhhHHHHH
Q 011250          262 KPVIYRDFKTS---NILLDADYNAKLS--DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSK--SDVYSFGVV  334 (490)
Q Consensus       262 ~~iiHrDlkp~---NILl~~~~~vkL~--DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~--sDvwSlGv~  334 (490)
                        ..|.-|..+   +...+..+.+.++  ||+.+....+.....   ...-+..|.++|......+..+  .|+|.+|.+
T Consensus       307 --l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll  381 (1351)
T KOG1035|consen  307 --LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL  381 (1351)
T ss_pred             --cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHHHHH
Confidence              555544444   3444566677777  999888765543321   1233556788887776655554  799999999


Q ss_pred             HHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          335 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       335 l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      +..+..|..+-.....                   ...+++.        .......++..+|+..++++|+++.+++.+
T Consensus       382 ~~~~~~~~~i~~~~~~-------------------~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~  434 (1351)
T KOG1035|consen  382 LLQLSQGEDISEKSAV-------------------PVSLLDV--------LSTSELLDALPKCLDEDSEERLSALELLTH  434 (1351)
T ss_pred             HhhhhhcCcccccccc-------------------hhhhhcc--------ccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence            9999988754321100                   0001110        011256788899999999999999999976


Q ss_pred             h
Q 011250          415 L  415 (490)
Q Consensus       415 L  415 (490)
                      .
T Consensus       435 ~  435 (1351)
T KOG1035|consen  435 P  435 (1351)
T ss_pred             h
Confidence            4

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.67  E-value=0.00037  Score=69.22  Aligned_cols=146  Identities=23%  Similarity=0.251  Sum_probs=82.8

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCe-eceeeEEEeCCceEEE
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNL-VKLVGYCIEDDQRLLV  217 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV  217 (490)
                      +.|..|-...||+........   ....+..+++|+..... ....+..+|+.++..+...++ .++++++. +   .+|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~---~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v   75 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDA---LSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRI   75 (302)
T ss_pred             EEecCcccceeEEEEcCCccc---ccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cch
Confidence            345667777899886542100   11235678899976543 222345678888888864333 34454443 2   468


Q ss_pred             EEecCCCChhHHh-----------------hhcCCC--------CC--HHHHHH--------------------------
Q 011250          218 YEFMPRGSLENHL-----------------FRRSLP--------LP--WSIRMK--------------------------  244 (490)
Q Consensus       218 ~E~~~~gsL~~~l-----------------~~~~~~--------l~--~~~~~~--------------------------  244 (490)
                      |||++|..+....                 +.....        .+  +.....                          
T Consensus        76 ~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (302)
T cd05156          76 EEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSL  155 (302)
T ss_pred             hheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHH
Confidence            9999887664311                 010001        01  001000                          


Q ss_pred             HHHHHHHHHHHhhh------cCCCCeeecCCCCCcEEEcCC----CCeEEecccCccc
Q 011250          245 IALGAAKGLAFLHE------EAEKPVIYRDFKTSNILLDAD----YNAKLSDFGLAKD  292 (490)
Q Consensus       245 i~~qi~~aL~yLH~------~~~~~iiHrDlkp~NILl~~~----~~vkL~DFG~a~~  292 (490)
                      +...+...+.+|-.      .....++|+|+.+.|||++.+    +.+.|+||..|..
T Consensus       156 ~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         156 FLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            11122223334432      123459999999999999875    8899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.67  E-value=0.0012  Score=67.67  Aligned_cols=76  Identities=20%  Similarity=0.172  Sum_probs=52.3

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecC------CC-cccHHHHHHHHHHHhccC---CCCeeceeeEE
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH------DG-LQGHKEWLAEVNFLGNLL---HPNLVKLVGYC  208 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~------~~-~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~  208 (490)
                      +.||.|.+..||++....         .++.|+||.-..      .. ....+.+..|.+.|..+.   ..++.+++.+ 
T Consensus        32 ~elggGn~N~VyrV~~~~---------g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~-  101 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTE---------GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY-  101 (401)
T ss_pred             eEcCCCceEEEEEEEeCC---------CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE-
Confidence            569999999999998753         124789998431      11 123456677888888763   3456677765 


Q ss_pred             EeCCceEEEEEecCCCC
Q 011250          209 IEDDQRLLVYEFMPRGS  225 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gs  225 (490)
                       +.+..++||||+++..
T Consensus       102 -D~~~~~lVME~L~~~~  117 (401)
T PRK09550        102 -DEELAVTVMEDLSDHK  117 (401)
T ss_pred             -CCCCCEEEEecCCCcc
Confidence             4466789999998643

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.61  E-value=0.00055  Score=68.18  Aligned_cols=142  Identities=18%  Similarity=0.187  Sum_probs=81.3

Q ss_pred             CcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCC--eeceeeE------EE
Q 011250          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN--LVKLVGY------CI  209 (490)
Q Consensus       138 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~------~~  209 (490)
                      .+.|+.|....+|+....          +| .+++|+.....  ....+..|++++..|...+  +.+++..      ..
T Consensus        27 i~~~~~G~~n~~y~v~t~----------~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~   93 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTD----------VG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLST   93 (307)
T ss_pred             ccccCCccccceEEEEeC----------CC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehh
Confidence            566777877899987542          22 47788775421  2345566777777775322  3333331      12


Q ss_pred             eCCceEEEEEecCCCChhH----H----------hhhcCCCC-----------CHHHHH------------HHHHHHHHH
Q 011250          210 EDDQRLLVYEFMPRGSLEN----H----------LFRRSLPL-----------PWSIRM------------KIALGAAKG  252 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~----~----------l~~~~~~l-----------~~~~~~------------~i~~qi~~a  252 (490)
                      ..+..++||+|++|..+..    .          ++.....+           .|....            .....+...
T Consensus        94 ~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~  173 (307)
T TIGR00938        94 LAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKE  173 (307)
T ss_pred             cCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHH
Confidence            2456789999998865421    0          11100101           011000            001123334


Q ss_pred             HHHhhh----cCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          253 LAFLHE----EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       253 L~yLH~----~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      ++++..    .....+||+|+.+.||+++.++.+.|+||+.+..
T Consensus       174 ~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       174 LDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             HHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            555532    1235599999999999999887778999997753

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=97.58  E-value=0.0021  Score=64.23  Aligned_cols=141  Identities=17%  Similarity=0.136  Sum_probs=76.0

Q ss_pred             CcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCC--eeceee------EEE
Q 011250          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN--LVKLVG------YCI  209 (490)
Q Consensus       138 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~------~~~  209 (490)
                      .+.|+.|....+|+....          .| .+++|++..   ...+.+..|+.++..|...+  +.+.+.      +..
T Consensus        27 ~~~l~~G~~n~~y~v~t~----------~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~   92 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTT----------QG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGE   92 (319)
T ss_pred             cchhccccccceEEEEeC----------CC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeee
Confidence            345777877889987643          22 578898752   12234445666666664222  223232      122


Q ss_pred             eCCceEEEEEecCCCChhH-----------Hh---hhcCC----------CCCH-HHHHH------------HHHH-HHH
Q 011250          210 EDDQRLLVYEFMPRGSLEN-----------HL---FRRSL----------PLPW-SIRMK------------IALG-AAK  251 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~-----------~l---~~~~~----------~l~~-~~~~~------------i~~q-i~~  251 (490)
                      ..+..+++|+|++|..+..           .|   +....          .+.+ .....            .+.+ +..
T Consensus        93 ~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  172 (319)
T PRK05231         93 LAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAA  172 (319)
T ss_pred             eCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHH
Confidence            3456789999998875421           11   11000          0111 11110            1111 111


Q ss_pred             HHHHhhhc----CCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          252 GLAFLHEE----AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       252 aL~yLH~~----~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      .+..+...    -..++||+|+.+.|||++.+...-|+||+.+..
T Consensus       173 ~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        173 QLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             HHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            22233211    234599999999999998665568999998754

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.39  E-value=0.0016  Score=64.96  Aligned_cols=142  Identities=16%  Similarity=0.113  Sum_probs=93.7

Q ss_pred             CCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---------c-------------H----HHHHHH
Q 011250          136 RPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---------G-------------H----KEWLAE  189 (490)
Q Consensus       136 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---------~-------------~----~~~~~E  189 (490)
                      .+...|..|--+-||.|.-.          .|..+|||+++..-+.         +             .    -....|
T Consensus       147 ~inGCiSTGKEANVYHat~~----------dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE  216 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEE----------DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKE  216 (520)
T ss_pred             ecccccccCccceeEeeecC----------CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHH
Confidence            34567888999999998654          4678999998742110         0             0    123568


Q ss_pred             HHHHhccCCCCeeceeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCC
Q 011250          190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDF  269 (490)
Q Consensus       190 i~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDl  269 (490)
                      ++-|.+|+.-.|.----+..  ..-+|||+|+. ++=+-.=.-....++...+..+-.|++.-+.-|...+.  +||.||
T Consensus       217 ~RNLkRl~~aGIP~PePIlL--k~hVLVM~FlG-rdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADL  291 (520)
T KOG2270|consen  217 MRNLKRLNNAGIPCPEPILL--KNHVLVMEFLG-RDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADL  291 (520)
T ss_pred             HHHHHHHHhcCCCCCCceee--ecceEeeeecc-CCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccch
Confidence            88888887655432222222  13379999994 33221111123357777777777888888887766553  999999


Q ss_pred             CCCcEEEcCCCCeEEecccCcccC
Q 011250          270 KTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       270 kp~NILl~~~~~vkL~DFG~a~~~  293 (490)
                      .--|+|+. +|.++|+|-+-+...
T Consensus       292 SEfN~Lyh-dG~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  292 SEFNLLYH-DGKLYIIDVSQSVEH  314 (520)
T ss_pred             hhhhheEE-CCEEEEEEccccccC
Confidence            99999985 569999998877644

>PLN02236 choline kinase

Probab=97.37  E-value=0.002  Score=65.22  Aligned_cols=144  Identities=17%  Similarity=0.115  Sum_probs=80.9

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCe-eceeeEEEeCCceEEE
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNL-VKLVGYCIEDDQRLLV  217 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV  217 (490)
                      ..|-.|-.-.+|++.......     ..+..|++|+......... +-.+|+.++..+..-++ .++++.+..    ..|
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~-----~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~----g~v  111 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEG-----NLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPN----GRV  111 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCC-----CCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECC----ceE
Confidence            345458888999987543211     1245788998865432221 23578888888864444 345555432    268


Q ss_pred             EEecCCCChhHH-----------------hhhcC---C--CCCHHHHHHHHHHH-----------------HHHHHHh--
Q 011250          218 YEFMPRGSLENH-----------------LFRRS---L--PLPWSIRMKIALGA-----------------AKGLAFL--  256 (490)
Q Consensus       218 ~E~~~~gsL~~~-----------------l~~~~---~--~l~~~~~~~i~~qi-----------------~~aL~yL--  256 (490)
                      ++|+++.+|...                 ++...   .  ...+..+..+..++                 ...+..|  
T Consensus       112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~  191 (344)
T PLN02236        112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK  191 (344)
T ss_pred             EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence            999987766421                 01100   0  11122222332111                 1111122  


Q ss_pred             --hh-cCCCCeeecCCCCCcEEEcC-CCCeEEecccCccc
Q 011250          257 --HE-EAEKPVIYRDFKTSNILLDA-DYNAKLSDFGLAKD  292 (490)
Q Consensus       257 --H~-~~~~~iiHrDlkp~NILl~~-~~~vkL~DFG~a~~  292 (490)
                        .. .....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus       192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence              21 11235899999999999986 46899999987753

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.36  E-value=0.00023  Score=69.64  Aligned_cols=135  Identities=16%  Similarity=0.098  Sum_probs=91.8

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc----------------------cHHHHHHHHHH
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ----------------------GHKEWLAEVNF  192 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~----------------------~~~~~~~Ei~i  192 (490)
                      +.++..||-|--+.||.+-+.          .|...++|.-+.....                      ..-...+|+..
T Consensus        94 ~svGnqIGVGKESDIY~v~d~----------~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfaf  163 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE----------EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAF  163 (465)
T ss_pred             hhhccccccccccceEEEecC----------CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHH
Confidence            678889999999999999775          3667888864322110                      01124678889


Q ss_pred             HhccC-CCC-eeceeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 011250          193 LGNLL-HPN-LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFK  270 (490)
Q Consensus       193 l~~l~-Hpn-Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlk  270 (490)
                      |+.|. |-. +.+.++    .+.-++|||++.|-.|...-.    .....   .+...+..-+.-|-.+|   +||+|+.
T Consensus       164 mkaL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~----v~d~~---~ly~~lm~~Iv~la~~G---lIHgDFN  229 (465)
T KOG2268|consen  164 MKALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVRH----VEDPP---TLYDDLMGLIVRLANHG---LIHGDFN  229 (465)
T ss_pred             HHHHHHcCCCCCCccc----ccceeeHHHhhcccceeeeee----cCChH---HHHHHHHHHHHHHHHcC---ceecccc
Confidence            98885 433 333333    356689999999888765431    12222   23334444455666777   9999999


Q ss_pred             CCcEEEcCCCCeEEecccCcccC
Q 011250          271 TSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       271 p~NILl~~~~~vkL~DFG~a~~~  293 (490)
                      -=||++++++.++++||--+...
T Consensus       230 EFNimv~dd~~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  230 EFNIMVKDDDKIVVIDFPQMVST  252 (465)
T ss_pred             hheeEEecCCCEEEeechHhhcc
Confidence            99999999999999999765443

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.34  E-value=3.6e-05  Score=87.60  Aligned_cols=174  Identities=13%  Similarity=-0.002  Sum_probs=121.2

Q ss_pred             EEEEEecCCCcccHH-----HHHHHHHHHhccCCCCeeceeeEEEe--CCceEEEEEecCCCChhHHhhhcCC---CCCH
Q 011250          170 VAVKTLNHDGLQGHK-----EWLAEVNFLGNLLHPNLVKLVGYCIE--DDQRLLVYEFMPRGSLENHLFRRSL---PLPW  239 (490)
Q Consensus       170 vaiK~~~~~~~~~~~-----~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~---~l~~  239 (490)
                      +-+|+.+.-..+..-     -.+.|..-++...|+++...+.-...  ....|.+++|+.+|.+.+.|.+...   .+..
T Consensus      1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~ 1334 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR 1334 (2724)
T ss_pred             eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh
Confidence            455655543333322     23445555666789988876654332  3456899999999999999976433   3333


Q ss_pred             HHHHHHHHHHHHHHHHhhhcC--CCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchh
Q 011250          240 SIRMKIALGAAKGLAFLHEEA--EKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV  317 (490)
Q Consensus       240 ~~~~~i~~qi~~aL~yLH~~~--~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l  317 (490)
                      .-+.....+.+.+..-+|...  ..-.+|++||+.|.+|..+..+|++++|+.+.....  .......++++.|+.+++.
T Consensus      1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~ 1412 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIK 1412 (2724)
T ss_pred             chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHH
Confidence            333333334355555555542  234789999999999999999999999999833221  1222345788899999988


Q ss_pred             ccCCCCccchhhHHHHHHHHHHhCCCCC
Q 011250          318 MTGHLTSKSDVYSFGVVLLEMLTGRRSM  345 (490)
Q Consensus       318 ~~~~~~~~sDvwSlGv~l~elltG~~pf  345 (490)
                      +.-.++.++|+|..|+.+|++.-|..+|
T Consensus      1413 N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1413 NEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             HHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence            8888999999999999999999888776

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.21  E-value=0.005  Score=60.40  Aligned_cols=31  Identities=29%  Similarity=0.394  Sum_probs=25.9

Q ss_pred             CeeecCCCCCcEEEcCCCC-eEEecccCcccC
Q 011250          263 PVIYRDFKTSNILLDADYN-AKLSDFGLAKDA  293 (490)
Q Consensus       263 ~iiHrDlkp~NILl~~~~~-vkL~DFG~a~~~  293 (490)
                      .+||+|+.+.|||++.++. .-|+||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            4899999999999987555 469999988654

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.87  E-value=0.012  Score=58.57  Aligned_cols=30  Identities=23%  Similarity=0.321  Sum_probs=25.7

Q ss_pred             CCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          262 KPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       262 ~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      .++||+|+.+.|||++. +.+.|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            45999999999999987 6789999997653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.86  E-value=0.0043  Score=58.15  Aligned_cols=30  Identities=33%  Similarity=0.403  Sum_probs=21.2

Q ss_pred             CeeecCCCCCcEEE-cCCCCeEEecccCccc
Q 011250          263 PVIYRDFKTSNILL-DADYNAKLSDFGLAKD  292 (490)
Q Consensus       263 ~iiHrDlkp~NILl-~~~~~vkL~DFG~a~~  292 (490)
                      .++|.||.+.|||+ +.++.++|+||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            48999999999999 8889999999987753

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.84  E-value=0.016  Score=57.62  Aligned_cols=34  Identities=18%  Similarity=0.348  Sum_probs=29.6

Q ss_pred             CCeeecCCCCCcEEEcCCCCeEEecccCcccCCC
Q 011250          262 KPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE  295 (490)
Q Consensus       262 ~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~  295 (490)
                      ..++|+|+.+.||+|+.++-+=|+||+++.....
T Consensus       198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             ceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence            4499999999999999888899999999876543

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.78  E-value=0.018  Score=58.12  Aligned_cols=74  Identities=16%  Similarity=0.140  Sum_probs=46.8

Q ss_pred             ccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecC------CC-cccHHHHHHHHHHHhccC--CC-CeeceeeEEE
Q 011250          140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH------DG-LQGHKEWLAEVNFLGNLL--HP-NLVKLVGYCI  209 (490)
Q Consensus       140 ~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~------~~-~~~~~~~~~Ei~il~~l~--Hp-nIv~l~~~~~  209 (490)
                      .||.|-...||++....         .+..|+||.-..      .. .-...+..-|...|....  -| .+.++|.  .
T Consensus         2 EigdGnlN~VfrV~~~~---------g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~   70 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQE---------GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--F   70 (370)
T ss_pred             cCCCCceEEEEEEEcCC---------CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--E
Confidence            47999999999998632         224788987431      11 223345566777776654  34 3444543  4


Q ss_pred             eCCceEEEEEecCCC
Q 011250          210 EDDQRLLVYEFMPRG  224 (490)
Q Consensus       210 ~~~~~~lV~E~~~~g  224 (490)
                      +.+...+|||+++..
T Consensus        71 D~e~~~~vMEdL~~~   85 (370)
T TIGR01767        71 DTEMAVTVMEDLSHH   85 (370)
T ss_pred             ccccceehHhhCccc
Confidence            556678999998653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.64  E-value=0.014  Score=58.80  Aligned_cols=142  Identities=17%  Similarity=0.183  Sum_probs=77.8

Q ss_pred             ccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCe-eceeeEEEeCCceEEEE
Q 011250          140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNL-VKLVGYCIEDDQRLLVY  218 (490)
Q Consensus       140 ~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~  218 (490)
                      .|..|=...+|+.......      +++..|++|+....... .-+-.+|+.+++.+..-++ .++++++. .+   +|.
T Consensus        21 ~l~gGlTN~~~~v~~~~~~------~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~   89 (330)
T PLN02421         21 RISGGITNLLLKVSVKEEN------GNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQ   89 (330)
T ss_pred             EeCCcccceEEEEEecCCC------CCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eee
Confidence            3444777889988654311      12336889987654321 1223578888888875444 34555542 22   589


Q ss_pred             EecCCCChhHH-------h----------hhcC----CCC-CHHHHHHHHHHH----------------------HHHHH
Q 011250          219 EFMPRGSLENH-------L----------FRRS----LPL-PWSIRMKIALGA----------------------AKGLA  254 (490)
Q Consensus       219 E~~~~gsL~~~-------l----------~~~~----~~l-~~~~~~~i~~qi----------------------~~aL~  254 (490)
                      +|+++..|...       +          +...    ... .+..+..+..++                      ..-+.
T Consensus        90 ~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  169 (330)
T PLN02421         90 SFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIV  169 (330)
T ss_pred             hhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHH
Confidence            99977655221       1          1100    001 122222222111                      11121


Q ss_pred             Hh---h-hc-CCCCeeecCCCCCcEEEcC-CCCeEEecccCccc
Q 011250          255 FL---H-EE-AEKPVIYRDFKTSNILLDA-DYNAKLSDFGLAKD  292 (490)
Q Consensus       255 yL---H-~~-~~~~iiHrDlkp~NILl~~-~~~vkL~DFG~a~~  292 (490)
                      .+   . .. .+.-++|.|+.+.|||+++ ++.++++||..|..
T Consensus       170 ~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        170 ELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            11   1 11 1234799999999999975 57899999998754

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.51  E-value=0.033  Score=55.46  Aligned_cols=31  Identities=16%  Similarity=0.173  Sum_probs=28.0

Q ss_pred             CCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          262 KPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       262 ~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      ..+||+|+.+.|||++.++.+.|+||..+..
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            4599999999999999999999999998764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.50  E-value=0.026  Score=55.60  Aligned_cols=73  Identities=21%  Similarity=0.252  Sum_probs=45.6

Q ss_pred             CcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccC---CCCeeceeeEEEeCCce
Q 011250          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL---HPNLVKLVGYCIEDDQR  214 (490)
Q Consensus       138 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~  214 (490)
                      .+.|+.|....+|+...           ++..+.||+-...   ....|..|+.-|+.|.   --.+.+.+++...++..
T Consensus        22 ~~~v~GG~i~~a~~~~~-----------~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~   87 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLDT-----------DGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDA   87 (288)
T ss_dssp             EEEE--SSSSEEEEEET-----------TS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCC
T ss_pred             eEecCCCChhheEEEEC-----------CCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCc
Confidence            45688899999998762           4567889987622   2245677888887773   45577888888877788


Q ss_pred             EEEEEecCCC
Q 011250          215 LLVYEFMPRG  224 (490)
Q Consensus       215 ~lV~E~~~~g  224 (490)
                      +|||||++.+
T Consensus        88 fLlle~l~~~   97 (288)
T PF03881_consen   88 FLLLEFLEMG   97 (288)
T ss_dssp             EEEEE-----
T ss_pred             eEEEEeecCC
Confidence            9999999876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.48  E-value=0.05  Score=55.92  Aligned_cols=73  Identities=10%  Similarity=0.025  Sum_probs=47.5

Q ss_pred             CcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-------ccHHHHHHHHHHHhccC---CCCeeceeeE
Q 011250          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-------QGHKEWLAEVNFLGNLL---HPNLVKLVGY  207 (490)
Q Consensus       138 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~Ei~il~~l~---HpnIv~l~~~  207 (490)
                      .+.||.|....||+....           +..|+||.-.....       -...+...|+..|+.+.   ..++.+++.+
T Consensus        37 ~~eiggGn~N~VyrV~~~-----------~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~  105 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-----------SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHF  105 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-----------CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEE
Confidence            467899999999997652           22588887541110       12233445566666553   3467778877


Q ss_pred             EEeCCceEEEEEecCC
Q 011250          208 CIEDDQRLLVYEFMPR  223 (490)
Q Consensus       208 ~~~~~~~~lV~E~~~~  223 (490)
                      +.  +..++||||+++
T Consensus       106 de--d~~vlvME~L~~  119 (418)
T PLN02756        106 DR--TMALIGMRYLEP  119 (418)
T ss_pred             CC--CCCEEEEeecCC
Confidence            66  456889999977

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.30  E-value=0.003  Score=65.41  Aligned_cols=166  Identities=23%  Similarity=0.319  Sum_probs=92.6

Q ss_pred             cHHHHHHHHHHHhccCCCCeeceeeEEEeC-CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcC
Q 011250          182 GHKEWLAEVNFLGNLLHPNLVKLVGYCIED-DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA  260 (490)
Q Consensus       182 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~  260 (490)
                      ....++-..++++.+.|+|+..++++-... ....+|||++ +.+|++.+..+.  +-...       +   +  -|.  
T Consensus        25 ~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~--l~~~s-------~---~--~~~--   87 (725)
T KOG1093|consen   25 NSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN--LKDES-------L---L--AHG--   87 (725)
T ss_pred             cHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc--cchhh-------h---c--ccc--
Confidence            345677788999999999999999876543 3578899999 789999885443  21111       1   1  121  


Q ss_pred             CCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh
Q 011250          261 EKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT  340 (490)
Q Consensus       261 ~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt  340 (490)
                         +.|-     |       .++++| -++...         ....|                +|+||||+|.++.|+..
T Consensus        88 ---~~~~-----~-------~~~~td-~~~t~~---------~~~~~----------------pKsdVwsl~~i~~el~L  126 (725)
T KOG1093|consen   88 ---VLHL-----N-------IIYITD-HFLTKY---------PSPIG----------------PKSDVWSLGFIILELYL  126 (725)
T ss_pred             ---ccee-----h-------hhhccc-cccccC---------CCCCC----------------cchhhhhHHHHHHHHHH
Confidence               3332     1       233333 111000         00111                49999999999999999


Q ss_pred             CCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHH
Q 011250          341 GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV  411 (490)
Q Consensus       341 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~ev  411 (490)
                      |...+......   +..+................   .+..+-..++....++...|+-..|..||...++
T Consensus       127 ~~~l~~~~~~s---~~l~~i~k~~~~d~~~~~~a---~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~  191 (725)
T KOG1093|consen  127 GISLEAELTES---EYLEILLKYYTDDQELLSTA---MEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMEL  191 (725)
T ss_pred             hhHHHHHHHHH---HHHHHHHHhccCchhHHHHH---HHHHHHHhhhHhHHHHhccCCccccccccchhHH
Confidence            98665432111   11111111111100000000   0001223446778889999999999988865544

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.22  E-value=0.025  Score=56.53  Aligned_cols=103  Identities=17%  Similarity=0.185  Sum_probs=68.6

Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      .+.|++|++- |++|.. +    ....++++..|+++.+..+.-+...  .++-|||+...||||+ +|+|.|+||-++|
T Consensus       299 ~y~yl~~kdh-gt~is~-i----k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfklsR  369 (488)
T COG5072         299 LYLYLHFKDH-GTPISI-I----KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLSR  369 (488)
T ss_pred             eEEEEEEecC-Cceeee-e----ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeeee
Confidence            3456777775 555532 2    2356788899999988877777653  4589999999999999 9999999999999


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHH
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSF  331 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSl  331 (490)
                      .-...+.-.       -...--|-.+. +.-+..-|||-+
T Consensus       370 l~~~q~~is-------y~rldhp~lF~-G~dd~QFeIYrl  401 (488)
T COG5072         370 LSYSQGIIS-------YNRLDHPDLFN-GVDDYQFEIYRL  401 (488)
T ss_pred             cccCCceee-------ccccCchhhhc-CccceeeeHHHH
Confidence            543322111       11233444444 333666677654

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.19  E-value=0.034  Score=56.89  Aligned_cols=75  Identities=21%  Similarity=0.257  Sum_probs=49.0

Q ss_pred             CcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecC-----CC-cccHHHHHHHHHHHhccC--CC-CeeceeeEE
Q 011250          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-----DG-LQGHKEWLAEVNFLGNLL--HP-NLVKLVGYC  208 (490)
Q Consensus       138 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~-----~~-~~~~~~~~~Ei~il~~l~--Hp-nIv~l~~~~  208 (490)
                      .+.||.|--.-||++.+..         .+..|+||.-..     .. .-..++..-|..+|+.+.  -| .+.++|.  
T Consensus        34 ~~eigdGnlN~VfrV~~~~---------~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--  102 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQ---------KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--  102 (409)
T ss_pred             eeEcCCCceEEEEEEeeCC---------CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--
Confidence            4578999999999998732         134688886421     11 223456667888887664  34 4444554  


Q ss_pred             EeCCceEEEEEecCC
Q 011250          209 IEDDQRLLVYEFMPR  223 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~  223 (490)
                      .+.....+|||+++.
T Consensus       103 ~D~e~~~~vMEdL~~  117 (409)
T PRK12396        103 FDSVMNCCVMEDLSD  117 (409)
T ss_pred             ECcHHhhHHHHhCcc
Confidence            456677899999864

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.74  E-value=0.05  Score=50.84  Aligned_cols=101  Identities=14%  Similarity=0.091  Sum_probs=66.4

Q ss_pred             EEEEEecCCCcc-cHHHHHHHHHHHhccCCCCeeceeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHH
Q 011250          170 VAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG  248 (490)
Q Consensus       170 vaiK~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~q  248 (490)
                      ..+|++..-... ...-|..+.++++++.  .|+++..-  ..-.+.+++|+|..-..          .    ...++..
T Consensus        88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i----------~----~~N~i~a  149 (308)
T PF07387_consen   88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI----------N----FSNFITA  149 (308)
T ss_pred             hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc----------c----hhHHHHH
Confidence            345555433333 4456778899988864  47777631  33345699999843111          0    1122222


Q ss_pred             HHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       249 i~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      =+.+|.-.|+.. ...+|+|..|+||+-|..|.+||.|=+.
T Consensus       150 gi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  150 GIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             hHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence            257788889654 4599999999999999999999999764

The function of this family is unknown.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.70  E-value=0.027  Score=57.08  Aligned_cols=60  Identities=17%  Similarity=0.140  Sum_probs=40.8

Q ss_pred             EEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC
Q 011250          215 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA  278 (490)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~  278 (490)
                      .||=+|..|-++..++...  ..++.....++.--+.||--+---.  +++|.|+.|.||++..
T Consensus       321 vl~E~~~~Gl~v~~~v~~~--~~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  321 VLVETYERGLSVLRFVKWK--SQPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIRF  380 (565)
T ss_pred             eeeeeccccccHHhhhhcc--cChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEEe
Confidence            5666788888888888544  3555566666665555554333222  2999999999999943

>PTZ00384 choline kinase; Provisional

Probab=95.63  E-value=0.093  Score=53.89  Aligned_cols=81  Identities=12%  Similarity=0.083  Sum_probs=45.1

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCe-eceeeEEEeCCceEEE
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNL-VKLVGYCIEDDQRLLV  217 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV  217 (490)
                      +.|..|-...+|++..........   ..+.|.+....... ...-+-.+|+++++.|...++ .++++.+.    -++|
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~---~~k~Vl~R~~g~~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l  127 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRY---PIKSVCIKKSSTYN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTI  127 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCcc---ccceEEEEeccCCC-ceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEE
Confidence            445558889999987643210000   01124444432211 111123568999999975554 44555543    2699


Q ss_pred             EEecCCCChh
Q 011250          218 YEFMPRGSLE  227 (490)
Q Consensus       218 ~E~~~~gsL~  227 (490)
                      +||++|..|.
T Consensus       128 ~efIeGr~l~  137 (383)
T PTZ00384        128 QEWVEGNTMG  137 (383)
T ss_pred             EEEeccccCC
Confidence            9999987764

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.54  E-value=0.26  Score=49.55  Aligned_cols=71  Identities=17%  Similarity=0.085  Sum_probs=42.8

Q ss_pred             CCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCC--eece---ee--EEEeCCceEE
Q 011250          144 GGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN--LVKL---VG--YCIEDDQRLL  216 (490)
Q Consensus       144 G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l---~~--~~~~~~~~~l  216 (490)
                      +.-..||+....          .+..+++|+..... ....++..|+.++..|....  ++..   -|  +...++..+.
T Consensus        36 s~eN~vy~v~~~----------~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~  104 (325)
T PRK11768         36 SYENRVYQFGDE----------DGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFA  104 (325)
T ss_pred             cccceEEEEecC----------CCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEE
Confidence            445678887653          34568899875332 24456777888887774211  2221   12  2233456788


Q ss_pred             EEEecCCCC
Q 011250          217 VYEFMPRGS  225 (490)
Q Consensus       217 V~E~~~~gs  225 (490)
                      |+++++|..
T Consensus       105 l~~~~~G~~  113 (325)
T PRK11768        105 LFPRRGGRA  113 (325)
T ss_pred             EEeeeCCCC
Confidence            999998764

>PRK06148 hypothetical protein; Provisional

Probab=95.40  E-value=0.27  Score=56.99  Aligned_cols=31  Identities=45%  Similarity=0.495  Sum_probs=26.2

Q ss_pred             CCeeecCCCCCcEEEcCCC--CeE-EecccCccc
Q 011250          262 KPVIYRDFKTSNILLDADY--NAK-LSDFGLAKD  292 (490)
Q Consensus       262 ~~iiHrDlkp~NILl~~~~--~vk-L~DFG~a~~  292 (490)
                      ..+||+|+.+.|||++.++  .+. |+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            4599999999999998775  555 999998764

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.38  E-value=0.25  Score=49.65  Aligned_cols=138  Identities=22%  Similarity=0.279  Sum_probs=79.9

Q ss_pred             cccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCC------eeceeeEE--EeCC
Q 011250          141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN------LVKLVGYC--IEDD  212 (490)
Q Consensus       141 LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~~~~--~~~~  212 (490)
                      |.. .-..||+....+          | .+++|+....  ....++..|+..|..|.-.+      |..+-|-.  .-..
T Consensus        34 l~s-~eN~~f~~~~~~----------g-~~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~   99 (331)
T COG2334          34 LNS-EENSNFRVQTED----------G-RYILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSG   99 (331)
T ss_pred             ccc-ccCceEEEEecC----------C-CeEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccC
Confidence            444 456788876653          3 3488888765  34566777888888885222      22222211  1123


Q ss_pred             --ceEEEEEecCCCChhH-H----h----------hhcCC-----------CCCHHH-------------HHHHHHHHHH
Q 011250          213 --QRLLVYEFMPRGSLEN-H----L----------FRRSL-----------PLPWSI-------------RMKIALGAAK  251 (490)
Q Consensus       213 --~~~lV~E~~~~gsL~~-~----l----------~~~~~-----------~l~~~~-------------~~~i~~qi~~  251 (490)
                        ..+-|++|++|..+.. .    +          +....           ...|..             ......++..
T Consensus       100 ~~r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~  179 (331)
T COG2334         100 GPRPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLA  179 (331)
T ss_pred             CceeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHH
Confidence              6678999999987772 1    0          10000           122220             0112233444


Q ss_pred             HHHHhhhcC----C---CCeeecCCCCCcEEEcCCCC-eEEecccCccc
Q 011250          252 GLAFLHEEA----E---KPVIYRDFKTSNILLDADYN-AKLSDFGLAKD  292 (490)
Q Consensus       252 aL~yLH~~~----~---~~iiHrDlkp~NILl~~~~~-vkL~DFG~a~~  292 (490)
                      .+..+...-    .   ..+||+|+.|.|||++.+.. +-++|||-+..
T Consensus       180 ~~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         180 ALDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             HHHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence            444444321    1   22999999999999998874 89999997753

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.23  E-value=0.19  Score=47.38  Aligned_cols=70  Identities=26%  Similarity=0.376  Sum_probs=47.8

Q ss_pred             eEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccC---CCCeeceeeEEEeCCceEEEEEecCC
Q 011250          147 GCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL---HPNLVKLVGYCIEDDQRLLVYEFMPR  223 (490)
Q Consensus       147 g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lV~E~~~~  223 (490)
                      |.|..|+...++.        ..+-||+-...   ....|..|+.-|..|.   .-++.+++.+..+.+..||||||++-
T Consensus        27 G~inea~~v~dg~--------~~~FvK~n~~~---~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~   95 (286)
T COG3001          27 GDINEAWRLRDGT--------DPFFVKCNQRE---QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPT   95 (286)
T ss_pred             ccccceeEeecCC--------cceEEEecchh---hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccC
Confidence            5666666555432        35777864322   2345667777666664   45678888888889999999999998


Q ss_pred             CChh
Q 011250          224 GSLE  227 (490)
Q Consensus       224 gsL~  227 (490)
                      |.+.
T Consensus        96 ~~~d   99 (286)
T COG3001          96 GPLD   99 (286)
T ss_pred             CCCC
Confidence            7665

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	490
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-53
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-52
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-49
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-48
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-43
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-43
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-42
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-40
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-25
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-25
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		8e-25
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-24
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-24
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		4e-24
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-24
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		7e-24
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-23
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-23
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-23
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-23
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-21
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-21
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-21
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-21
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-21
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		6e-21
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		6e-21
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		8e-21
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-20
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-20
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-20
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-20
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-20
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-20
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-20
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-20
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-20
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-20
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-20
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-20
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-20
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-20
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-20
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-20
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-20
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-20
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-20
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-20
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-20
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-20
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-20
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-20
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-20
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-20
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-20
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-20
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		6e-20
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		6e-20
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		6e-20
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		7e-20
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		7e-20
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		7e-20
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		7e-20
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		7e-20
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		8e-20
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-19
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-19
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-19
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-19
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-19
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-19
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-19
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-19
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		8e-19
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-19
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-18
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-18
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-18
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-18
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-18
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-18
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-18
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-18
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-18
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-18
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-18
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-18
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-18
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-18
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-18
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-18
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-18
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-18
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-18
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-18
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-18
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-18
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-18
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-18
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-18
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-18
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-18
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		4e-18
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-18
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-18
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-18
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-18
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-18
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-18
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-18
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		4e-18
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-18
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-18
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-18
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-18
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-18
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-18
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		5e-18
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		5e-18
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-18
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		6e-18
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		6e-18
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		6e-18
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		6e-18
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		6e-18
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		6e-18
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		6e-18
2pl0_A	289	Lck Bound To Imatinib Length = 289		7e-18
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		7e-18
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		8e-18
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		8e-18
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		8e-18
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		8e-18
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		8e-18
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		8e-18
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		9e-18
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		9e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		9e-18
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		9e-18
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		9e-18
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-17
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-17
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-17
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-17
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-17
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-17
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-17
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-17
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-17
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-17
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-17
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-17
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-17
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-17
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-17
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-17
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-17
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-17
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-17
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-17
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-17
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-17
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-17
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-17
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-17
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-17
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-17
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-17
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-17
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-17
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-17
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-17
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-17
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-17
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-17
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-17
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-17
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-17
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-17
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-17
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-17
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-17
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-17
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-17
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-17
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-17
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		5e-17
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-17
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-17
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-17
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-17
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		5e-17
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		5e-17
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		5e-17
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		5e-17
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		6e-17
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		6e-17
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		6e-17
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-17
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		6e-17
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		7e-17
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		8e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-17
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		8e-17
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		9e-17
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-16
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-16
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-16
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-16
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-16
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-16
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-16
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-16
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-16
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-16
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-16
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-16
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-16
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-16
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-16
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-16
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-16
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-16
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-16
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-16
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-16
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-16
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-16
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-16
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-16
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-16
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-16
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-16
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		5e-16
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-16
3b2t_A	311	Structure Of Phosphotransferase Length = 311		5e-16
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		6e-16
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		6e-16
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		7e-16
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		7e-16
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-16
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		8e-16
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		9e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		9e-16
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		9e-16
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-15
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-15
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-15
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-15
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-15
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-15
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-15
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-15
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-15
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-15
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-15
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-15
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-15
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-15
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-15
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-15
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-15
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-15
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-15
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-15
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-15
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-15
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-15
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-15
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-15
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-15
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-15
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-15
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-15
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-15
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-15
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-15
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-15
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-15
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-15
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-15
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-15
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-15
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-15
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-15
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-15
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-15
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-15
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-15
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-15
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-15
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-15
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-15
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-15
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-15
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-15
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-15
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-15
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-15
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-15
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-15
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-15
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-15
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-15
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-15
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-15
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-15
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		5e-15
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		6e-15
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-15
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-15
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		6e-15
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-15
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		7e-15
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		7e-15
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-15
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		8e-15
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		8e-15
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		9e-15
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		9e-15
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		9e-15
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-14
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-14
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-14
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-14
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-14
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-14
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-14
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-14
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-14
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-14
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-14
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-14
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-14
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-14
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-14
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-14
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-14
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-14
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-14
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-14
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-14
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-14
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-14
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-14
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-14
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-14
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-14
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-14
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-14
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-14
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-14
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-14
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-14
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-14
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-14
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-14
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-14
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-14
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-14
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-14
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-14
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-14
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-14
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-14
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-14
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-14
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-14
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-14
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-14
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-14
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-14
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-14
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-14
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-14
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-14
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-14
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		5e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-14
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-14
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		5e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		5e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-14
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		6e-14
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		7e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		7e-14
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		7e-14
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		7e-14
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		7e-14
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		7e-14
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-14
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		8e-14
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		8e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-13
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-13
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-13
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-13
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-13
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-13
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-13
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-13
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-13
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-13
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-13
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-13
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-13
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-13
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-13
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-13
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-13
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-13
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-13
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-13
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-13
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-13
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-13
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-13
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		6e-13
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		6e-13
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-13
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		7e-13
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		7e-13
4fie_A	423	Full-Length Human Pak4 Length = 423		7e-13
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		8e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		9e-13
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		9e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-12
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-12
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-12
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-12
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-12
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-12
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-12
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-12
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-12
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-12
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-12
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-12
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-12
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-12
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-12
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-12
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-12
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		6e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		7e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		7e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-12
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		7e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-12
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		7e-12
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		8e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		8e-12
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		9e-12
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-12
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-11
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-11
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-11
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-11
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-11
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-11
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-11
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-11
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		4e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-11
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-11
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-11
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-11
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-11
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		4e-11
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		4e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		4e-11
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-11
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-11
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-11
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-11
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-11
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-11
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-11
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-11
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-11
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-11
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-11
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-11
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-11
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		6e-11
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-11
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		6e-11
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		7e-11
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		7e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		9e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-10
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-10
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-10
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-10
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-10
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-10
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-10
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-10
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-10
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-10
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-10
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-10
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-10
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-10
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-10
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-10
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-10
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-10
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-10
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-10
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-10
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-10
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-10
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-10
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-10
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-10
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-10
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-10
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-10
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-10
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-10
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-10
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-10
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-10
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-10
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		5e-10
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-10
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-10
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-10
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		5e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		5e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		5e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		5e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		5e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		5e-10
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		5e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		5e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		6e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		6e-10
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		7e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		7e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		7e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		7e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		8e-10
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		8e-10
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		9e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		9e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-09
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-09
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-09
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-09
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-09
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-09
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-09
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-09
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-09
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-09
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-09
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-09
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-09
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-09
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		5e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-09
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		5e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		6e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		6e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		6e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-09
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		6e-09
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		6e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		6e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		6e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		7e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		7e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		7e-09
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		7e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		8e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		8e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		8e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		8e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		9e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		9e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-08
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-08
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-08
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-08
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-08
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-08
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		4e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-08
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-08
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-08
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		5e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		5e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		5e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		6e-08
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		6e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		6e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		6e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		6e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		7e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		7e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		9e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		9e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		9e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		9e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-07
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-07
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-07
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-07
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-07
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-07
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-07
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-07
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-07
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		4e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		5e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		5e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		6e-07
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		6e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		6e-07
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		6e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		7e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		8e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		9e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-06
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-06
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-06
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-06
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-06
3soa_A	444	Full-Length Human Camkii Length = 444		2e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-06
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-06
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		5e-06
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		5e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		5e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		6e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		6e-06
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		7e-06
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		7e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		8e-06
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		8e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		9e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		9e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-05
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		2e-05
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-05
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-05
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-05
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-05
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-05
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-05
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-05
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-05
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		4e-05
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		4e-05
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		4e-05
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		4e-05
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		4e-05
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		4e-05
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		4e-05
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		4e-05
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		4e-05
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-05
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		4e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-05
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-05
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-05
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		5e-05
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-05
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-05
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		5e-05
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		5e-05
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		5e-05
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		5e-05
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-05
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		5e-05
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-05
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-05
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		5e-05
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-05
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-05
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-05
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		6e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		6e-05
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		6e-05
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		6e-05
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		7e-05
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		7e-05
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		8e-05
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		9e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-04
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		4e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  206 bits (523), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 117/304 (38%), Positives = 183/304 (60%), Gaps = 18/304 (5%)
Query: 119 QLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD 178
           QL++F   +L++A+ NF  +++LG GGFG V+KG          +   G  VAVK L  +
Sbjct: 24  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKG----------RLADGTLVAVKRLKEE 73
Query: 179 GLQGHK-EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRR---S 234
             QG + ++  EV  +   +H NL++L G+C+   +RLLVY +M  GS+ + L  R    
Sbjct: 74  RXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 133
Query: 235 LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 294
            PL W  R +IALG+A+GLA+LH+  +  +I+RD K +NILLD ++ A + DFGLAK   
Sbjct: 134 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LM 192
Query: 295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
           +    HV   V GT G+ APEY+ TG  + K+DV+ +GV+LLE++TG+R+ D  R   + 
Sbjct: 193 DYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 252
Query: 355 N--LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
           +  L++W +  L +K +   L+D  L+G++  +  ++  Q+A  C    P  RP+MSEVV
Sbjct: 253 DVMLLDWVKGLLKEK-KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 311
Query: 413 ETLK 416
             L+
Sbjct: 312 RMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  204 bits (519), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 116/304 (38%), Positives = 182/304 (59%), Gaps = 18/304 (5%)
Query: 119 QLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD 178
           QL++F   +L++A+ NF  +++LG GGFG V+KG          +   G  VAVK L  +
Sbjct: 16  QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKG----------RLADGXLVAVKRLKEE 65
Query: 179 GLQGHK-EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRR---S 234
             QG + ++  EV  +   +H NL++L G+C+   +RLLVY +M  GS+ + L  R    
Sbjct: 66  RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 125
Query: 235 LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 294
            PL W  R +IALG+A+GLA+LH+  +  +I+RD K +NILLD ++ A + DFGLAK   
Sbjct: 126 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LM 184
Query: 295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
           +    HV   V G  G+ APEY+ TG  + K+DV+ +GV+LLE++TG+R+ D  R   + 
Sbjct: 185 DYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244
Query: 355 N--LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
           +  L++W +  L +K +   L+D  L+G++  +  ++  Q+A  C    P  RP+MSEVV
Sbjct: 245 DVMLLDWVKGLLKEK-KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303
Query: 413 ETLK 416
             L+
Sbjct: 304 RMLE 307

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  192 bits (489), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 114/301 (37%), Positives = 175/301 (58%), Gaps = 19/301 (6%)
Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 186
           DL+ AT NF  + L+G G FG V+KG + +          G  VA+K    +  QG +E+
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRD----------GAKVALKRRTPESSQGIEEF 82
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRM 243
             E+  L    HP+LV L+G+C E ++ +L+Y++M  G+L+ HL+   LP   + W  R+
Sbjct: 83  ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
           +I +GAA+GL +LH  A   +I+RD K+ NILLD ++  K++DFG++K   E G+TH+  
Sbjct: 143 EICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXX 199
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-RP 362
            V GT GY  PEY + G LT KSDVYSFGVVL E+L  R ++ ++ P    NL EWA   
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259
Query: 363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLK 422
           H  +  +  +++DP L      +  +K    A +CL+   + RP M +V+  L+    L+
Sbjct: 260 H--NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317
Query: 423 D 423
           +
Sbjct: 318 E 318

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  190 bits (483), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 113/301 (37%), Positives = 174/301 (57%), Gaps = 19/301 (6%)
Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 186
           DL+ AT NF  + L+G G FG V+KG + +          G  VA+K    +  QG +E+
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRD----------GAKVALKRRTPESSQGIEEF 82
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRM 243
             E+  L    HP+LV L+G+C E ++ +L+Y++M  G+L+ HL+   LP   + W  R+
Sbjct: 83  ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
           +I +GAA+GL +LH  A   +I+RD K+ NILLD ++  K++DFG++K   E  +TH+  
Sbjct: 143 EICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXX 199
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-RP 362
            V GT GY  PEY + G LT KSDVYSFGVVL E+L  R ++ ++ P    NL EWA   
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259
Query: 363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLK 422
           H  +  +  +++DP L      +  +K    A +CL+   + RP M +V+  L+    L+
Sbjct: 260 H--NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317
Query: 423 D 423
           +
Sbjct: 318 E 318

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 109/309 (35%), Positives = 171/309 (55%), Gaps = 22/309 (7%)
Query: 118 SQLRKFMFNDLKLATRNF--RPESL----LGEGGFGCVFKGWVEENGTAPVKPGTGLTVA 171
           ++   F F +LK  T NF  RP S+    +GEGGFG V+KG+V     A  K    + + 
Sbjct: 10  TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDIT 69
Query: 172 VKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL- 230
            + L        +++  E+  +    H NLV+L+G+  + D   LVY +MP GSL + L 
Sbjct: 70  TEELK-------QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 122
Query: 231 -FRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL 289
               + PL W +R KIA GAA G+ FLHE      I+RD K++NILLD  + AK+SDFGL
Sbjct: 123 CLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGL 179
Query: 290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR 349
           A+ + +  +T + +R++GT  Y APE  + G +T KSD+YSFGVVLLE++TG  ++D++R
Sbjct: 180 ARASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 238
Query: 350 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS 409
                 L++       +++     +D ++    S    +    +A+QCL      RP + 
Sbjct: 239 E--PQLLLDIKEEIEDEEKTIEDYIDKKMNDADS-TSVEAMYSVASQCLHEKKNKRPDIK 295
Query: 410 EVVETLKPL 418
           +V + L+ +
Sbjct: 296 KVQQLLQEM 304

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  173 bits (439), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 109/309 (35%), Positives = 170/309 (55%), Gaps = 22/309 (7%)
Query: 118 SQLRKFMFNDLKLATRNF--RPESL----LGEGGFGCVFKGWVEENGTAPVKPGTGLTVA 171
           ++   F F +LK  T NF  RP S+    +GEGGFG V+KG+V     A  K    + + 
Sbjct: 10  TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDIT 69
Query: 172 VKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL- 230
            + L        +++  E+  +    H NLV+L+G+  + D   LVY +MP GSL + L 
Sbjct: 70  TEELK-------QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 122
Query: 231 -FRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL 289
               + PL W +R KIA GAA G+ FLHE      I+RD K++NILLD  + AK+SDFGL
Sbjct: 123 CLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGL 179
Query: 290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR 349
           A+ + +  +T +  R++GT  Y APE  + G +T KSD+YSFGVVLLE++TG  ++D++R
Sbjct: 180 ARASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 238
Query: 350 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS 409
                 L++       +++     +D ++    S    +    +A+QCL      RP + 
Sbjct: 239 E--PQLLLDIKEEIEDEEKTIEDYIDKKMNDADS-TSVEAMYSVASQCLHEKKNKRPDIK 295
Query: 410 EVVETLKPL 418
           +V + L+ +
Sbjct: 296 KVQQLLQEM 304

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  171 bits (432), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 108/309 (34%), Positives = 169/309 (54%), Gaps = 22/309 (7%)
Query: 118 SQLRKFMFNDLKLATRNF--RPESL----LGEGGFGCVFKGWVEENGTAPVKPGTGLTVA 171
           ++   F F +LK  T NF  RP S+    +GEGGFG V+KG+V     A  K    + + 
Sbjct: 4   TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDIT 63
Query: 172 VKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL- 230
            + L        +++  E+  +    H NLV+L+G+  + D   LVY +MP GSL + L 
Sbjct: 64  TEELK-------QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 116
Query: 231 -FRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL 289
               + PL W +R KIA GAA G+ FLHE      I+RD K++NILLD  + AK+SDFGL
Sbjct: 117 CLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGL 173
Query: 290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR 349
           A+ + +  +  +  R++GT  Y APE  + G +T KSD+YSFGVVLLE++TG  ++D++R
Sbjct: 174 ARASEKFAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 232
Query: 350 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS 409
                 L++       +++     +D ++    S    +    +A+QCL      RP + 
Sbjct: 233 E--PQLLLDIKEEIEDEEKTIEDYIDKKMNDADS-TSVEAMYSVASQCLHEKKNKRPDIK 289
Query: 410 EVVETLKPL 418
           +V + L+ +
Sbjct: 290 KVQQLLQEM 298

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 107/307 (34%), Positives = 163/307 (53%), Gaps = 22/307 (7%)
Query: 118 SQLRKFMFNDLKLATRNF--RPESL----LGEGGFGCVFKGWVEENGTAPVKPGTGLTVA 171
           ++   F F +LK  T NF  RP S+     GEGGFG V+KG+V     A  K    + + 
Sbjct: 1   TRFHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDIT 60
Query: 172 VKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL- 230
            + L        +++  E+       H NLV+L+G+  + D   LVY + P GSL + L 
Sbjct: 61  TEELK-------QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLS 113
Query: 231 -FRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL 289
               + PL W  R KIA GAA G+ FLHE      I+RD K++NILLD  + AK+SDFGL
Sbjct: 114 CLDGTPPLSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGL 170
Query: 290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR 349
           A+ + +  +    +R++GT  Y APE  + G +T KSD+YSFGVVLLE++TG  ++D++R
Sbjct: 171 ARASEKFAQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 229
Query: 350 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS 409
                 L++       +++     +D +     S    +    +A+QCL      RP + 
Sbjct: 230 E--PQLLLDIKEEIEDEEKTIEDYIDKKXNDADS-TSVEAXYSVASQCLHEKKNKRPDIK 286
Query: 410 EVVETLK 416
           +V + L+
Sbjct: 287 KVQQLLQ 293

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 85/297 (28%), Positives = 143/297 (48%), Gaps = 33/297 (11%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 188
           LA      E  +G+GGFG V KG  V++     +K    L +       + ++  +E+  
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIK---SLILGDSEGETEMIEKFQEFQR 72
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 248
           EV  + NL HPN+VKL G  +  +   +V EF+P G L + L  ++ P+ WS+++++ L 
Sbjct: 73  EVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLD 130
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILL-----DADYNAKLSDFGLAKDAPEDGKTHVST 303
            A G+ ++  +   P+++RD ++ NI L     +A   AK++DFGL++ +      H  +
Sbjct: 131 IALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS-----VHSVS 184
Query: 304 RVMGTYGYAAPEYVMTGH--LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 361
            ++G + + APE +       T K+D YSF ++L  +LTG    D+    G+   +   R
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS-YGKIKFINMIR 243
Query: 362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
              G +        PRL     +            C S DPK RP  S +V+ L  L
Sbjct: 244 EE-GLRPTIPEDCPPRLRNVIEL------------CWSGDPKKRPHFSYIVKELSEL 287

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 142/297 (47%), Gaps = 33/297 (11%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 188
           LA      E  +G+GGFG V KG  V++     +K    L +       + ++  +E+  
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIK---SLILGDSEGETEMIEKFQEFQR 72
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 248
           EV  + NL HPN+VKL G  +  +   +V EF+P G L + L  ++ P+ WS+++++ L 
Sbjct: 73  EVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLD 130
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILL-----DADYNAKLSDFGLAKDAPEDGKTHVST 303
            A G+ ++  +   P+++RD ++ NI L     +A   AK++DFG ++ +      H  +
Sbjct: 131 IALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQS-----VHSVS 184
Query: 304 RVMGTYGYAAPEYVMTGH--LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 361
            ++G + + APE +       T K+D YSF ++L  +LTG    D+    G+   +   R
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS-YGKIKFINMIR 243
Query: 362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
              G +        PRL     +            C S DPK RP  S +V+ L  L
Sbjct: 244 EE-GLRPTIPEDCPPRLRNVIEL------------CWSGDPKKRPHFSYIVKELSEL 287

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 142/297 (47%), Gaps = 33/297 (11%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 188
           LA      E  +G+GGFG V KG  V++     +K    L +       + ++  +E+  
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIK---SLILGDSEGETEMIEKFQEFQR 72
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 248
           EV  + NL HPN+VKL G  +  +   +V EF+P G L + L  ++ P+ WS+++++ L 
Sbjct: 73  EVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLD 130
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILL-----DADYNAKLSDFGLAKDAPEDGKTHVST 303
            A G+ ++  +   P+++RD ++ NI L     +A   AK++DF L++ +      H  +
Sbjct: 131 IALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQS-----VHSVS 184
Query: 304 RVMGTYGYAAPEYVMTGH--LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 361
            ++G + + APE +       T K+D YSF ++L  +LTG    D+    G+   +   R
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS-YGKIKFINMIR 243
Query: 362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
              G +        PRL     +            C S DPK RP  S +V+ L  L
Sbjct: 244 EE-GLRPTIPEDCPPRLRNVIEL------------CWSGDPKKRPHFSYIVKELSEL 287

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 131/279 (46%), Gaps = 33/279 (11%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +G G FG V  G W+ ++            VA+KT+  +G    ++++ E   +  L HP
Sbjct: 15  IGSGQFGLVHLGYWLNKD-----------KVAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 62
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
            LV+L G C+E     LV+EFM  G L ++L  +         + + L   +G+A+L E 
Sbjct: 63  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 122
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
           +   VI+RD    N L+  +   K+SDFG+ +   +D  T  ST       +A+PE    
Sbjct: 123 S---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSF 178
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
              +SKSDV+SFGV++ E+ +  +   +NR N E  +VE       D    +RL  PRL 
Sbjct: 179 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVE-------DISTGFRLYKPRL- 228
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                  S    Q+   C    P+ RP  S ++  L  +
Sbjct: 229 ------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAAI 261

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 130/279 (46%), Gaps = 33/279 (11%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +G G FG V  G W+ ++            VA+KT+  +G    ++++ E   +  L HP
Sbjct: 15  IGSGQFGLVHLGYWLNKD-----------KVAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 62
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
            LV+L G C+E     LV+EFM  G L ++L  +         + + L   +G+A+L E 
Sbjct: 63  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 122
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
               VI+RD    N L+  +   K+SDFG+ +   +D  T  ST       +A+PE    
Sbjct: 123 C---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSF 178
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
              +SKSDV+SFGV++ E+ +  +   +NR N E  +VE       D    +RL  PRL 
Sbjct: 179 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVE-------DISTGFRLYKPRL- 228
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                  S    Q+   C    P+ RP  S ++  L  +
Sbjct: 229 ------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 261

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 130/279 (46%), Gaps = 33/279 (11%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +G G FG V  G W+ ++            VA+KT+  +G    ++++ E   +  L HP
Sbjct: 18  IGSGQFGLVHLGYWLNKD-----------KVAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 65
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
            LV+L G C+E     LV+EFM  G L ++L  +         + + L   +G+A+L E 
Sbjct: 66  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 125
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
               VI+RD    N L+  +   K+SDFG+ +   +D  T  ST       +A+PE    
Sbjct: 126 C---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSF 181
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
              +SKSDV+SFGV++ E+ +  +   +NR N E  +VE       D    +RL  PRL 
Sbjct: 182 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVE-------DISTGFRLYKPRL- 231
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                  S    Q+   C    P+ RP  S ++  L  +
Sbjct: 232 ------ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 130/279 (46%), Gaps = 33/279 (11%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +G G FG V  G W+ ++            VA+KT+  +G    ++++ E   +  L HP
Sbjct: 13  IGSGQFGLVHLGYWLNKD-----------KVAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 60
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
            LV+L G C+E     LV+EFM  G L ++L  +         + + L   +G+A+L E 
Sbjct: 61  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
               VI+RD    N L+  +   K+SDFG+ +   +D  T  ST       +A+PE    
Sbjct: 121 C---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSF 176
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
              +SKSDV+SFGV++ E+ +  +   +NR N E  +VE       D    +RL  PRL 
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVE-------DISTGFRLYKPRL- 226
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                  S    Q+   C    P+ RP  S ++  L  +
Sbjct: 227 ------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 129/279 (46%), Gaps = 33/279 (11%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +G G FG V  G W+ ++            VA+KT+  +G     +++ E   +  L HP
Sbjct: 35  IGSGQFGLVHLGYWLNKD-----------KVAIKTIK-EGSMSEDDFIEEAEVMMKLSHP 82
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
            LV+L G C+E     LV+EFM  G L ++L  +         + + L   +G+A+L E 
Sbjct: 83  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 142
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
               VI+RD    N L+  +   K+SDFG+ +   +D  T  ST       +A+PE    
Sbjct: 143 C---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSF 198
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
              +SKSDV+SFGV++ E+ +  +   +NR N E  +VE       D    +RL  PRL 
Sbjct: 199 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVE-------DISTGFRLYKPRL- 248
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                  S    Q+   C    P+ RP  S ++  L  +
Sbjct: 249 ------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 281

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 88/291 (30%), Positives = 140/291 (48%), Gaps = 42/291 (14%)
Query: 133 RNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 191
           +    E ++G G FG V K  W  ++            VA+K +  +  +  K ++ E+ 
Sbjct: 9   KEIEVEEVVGRGAFGVVCKAKWRAKD------------VAIKQIESESER--KAFIVELR 54
Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW---SIRMKIALG 248
            L  + HPN+VKL G C+  +   LV E+   GSL N +   + PLP+   +  M   L 
Sbjct: 55  QLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYN-VLHGAEPLPYYTAAHAMSWCLQ 111
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 307
            ++G+A+LH    K +I+RD K  N+LL A     K+ DFG A D     +TH+ T   G
Sbjct: 112 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHM-TNNKG 166
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           +  + APE     + + K DV+S+G++L E++T R+  D+    G    + WA  H G +
Sbjct: 167 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI--GGPAFRIMWAV-HNGTR 223
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
               + L   +E             L  +C S+DP  RP M E+V+ +  L
Sbjct: 224 PPLIKNLPKPIES------------LMTRCWSKDPSQRPSMEEIVKIMTHL 262

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 129/279 (46%), Gaps = 33/279 (11%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +G G FG V  G W+ ++            VA+KT+  +G    ++++ E   +  L HP
Sbjct: 16  IGSGQFGLVHLGYWLNKD-----------KVAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 63
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
            LV+L G C+E     LV EFM  G L ++L  +         + + L   +G+A+L E 
Sbjct: 64  KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 123
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
               VI+RD    N L+  +   K+SDFG+ +   +D  T  ST       +A+PE    
Sbjct: 124 C---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSF 179
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
              +SKSDV+SFGV++ E+ +  +   +NR N E  +VE       D    +RL  PRL 
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVE-------DISTGFRLYKPRL- 229
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                  S    Q+   C    P+ RP  S ++  L  +
Sbjct: 230 ------ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 88/291 (30%), Positives = 140/291 (48%), Gaps = 42/291 (14%)
Query: 133 RNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 191
           +    E ++G G FG V K  W  ++            VA+K +  +  +  K ++ E+ 
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWRAKD------------VAIKQIESESER--KAFIVELR 53
Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW---SIRMKIALG 248
            L  + HPN+VKL G C+  +   LV E+   GSL N +   + PLP+   +  M   L 
Sbjct: 54  QLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYN-VLHGAEPLPYYTAAHAMSWCLQ 110
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 307
            ++G+A+LH    K +I+RD K  N+LL A     K+ DFG A D     +TH+ T   G
Sbjct: 111 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHM-TNNKG 165
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           +  + APE     + + K DV+S+G++L E++T R+  D+    G    + WA  H G +
Sbjct: 166 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI--GGPAFRIMWAV-HNGTR 222
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
               + L   +E             L  +C S+DP  RP M E+V+ +  L
Sbjct: 223 PPLIKNLPKPIES------------LMTRCWSKDPSQRPSMEEIVKIMTHL 261

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 72/217 (33%), Positives = 111/217 (51%), Gaps = 31/217 (14%)
Query: 138 ESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----EVNF 192
           E ++G GGFG V++  W+            G  VAVK   HD  +   + +     E   
Sbjct: 12  EEIIGIGGFGKVYRAFWI------------GDEVAVKAARHDPDEDISQTIENVRQEAKL 59
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
              L HPN++ L G C+++    LV EF   G L   L  + +P    I +  A+  A+G
Sbjct: 60  FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPP--DILVNWAVQIARG 117
Query: 253 LAFLHEEAEKPVIYRDFKTSNILL-----DADYN---AKLSDFGLAKDAPEDGKTHVSTR 304
           + +LH+EA  P+I+RD K+SNIL+     + D +    K++DFGLA++     K   +  
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA-- 175
Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
             G Y + APE +     +  SDV+S+GV+L E+LTG
Sbjct: 176 --GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG 210

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 76/205 (37%), Positives = 104/205 (50%), Gaps = 16/205 (7%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           LGEG FG      V      P   GTG  VAVK L  D G Q    W  E++ L  L H 
Sbjct: 22  LGEGHFG-----KVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHE 76
Query: 200 NLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 257
           +++K  G C +  ++   LV E++P GSL ++L R S+ L  +  +  A    +G+A+LH
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGL--AQLLLFAQQICEGMAYLH 134
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT--YGYAAPE 315
            +     I+R+    N+LLD D   K+ DFGLAK  PE G  +   R  G     + APE
Sbjct: 135 SQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVREDGDSPVFWYAPE 190
Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLT 340
            +        SDV+SFGV L E+LT
Sbjct: 191 CLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 76/205 (37%), Positives = 104/205 (50%), Gaps = 16/205 (7%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           LGEG FG      V      P   GTG  VAVK L  D G Q    W  E++ L  L H 
Sbjct: 22  LGEGHFG-----KVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHE 76
Query: 200 NLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 257
           +++K  G C +  ++   LV E++P GSL ++L R S+ L  +  +  A    +G+A+LH
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGL--AQLLLFAQQICEGMAYLH 134
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT--YGYAAPE 315
            +     I+R+    N+LLD D   K+ DFGLAK  PE G  +   R  G     + APE
Sbjct: 135 AQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVREDGDSPVFWYAPE 190
Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLT 340
            +        SDV+SFGV L E+LT
Sbjct: 191 CLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/297 (28%), Positives = 137/297 (46%), Gaps = 34/297 (11%)
Query: 126 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK- 184
           +D+ +   +   +  +G G FG V +   E +G+          VAVK L        + 
Sbjct: 30  DDMDIPWCDLNIKEKIGAGSFGTVHRA--EWHGS---------DVAVKILMEQDFHAERV 78
Query: 185 -EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL--PLPWSI 241
            E+L EV  +  L HPN+V  +G   +     +V E++ RGSL   L +      L    
Sbjct: 79  NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR 138
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           R+ +A   AKG+ +LH     P+++RD K+ N+L+D  Y  K+ DFGL++   +      
Sbjct: 139 RLSMAYDVAKGMNYLHNR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKASXFLX 195
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 361
           S    GT  + APE +       KSDVYSFGV+L E+ T +      +P G  N  +   
Sbjct: 196 SKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ------QPWGNLNPAQ-VV 248
Query: 362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
             +G K +  RL  PR         + +   +   C + +P  RP  + +++ L+PL
Sbjct: 249 AAVGFKCK--RLEIPR-------NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 36/298 (12%)
Query: 126 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK- 184
           +D+ +   +   +  +G G FG V +   E +G+          VAVK L        + 
Sbjct: 30  DDMDIPWCDLNIKEKIGAGSFGTVHRA--EWHGS---------DVAVKILMEQDFHAERV 78
Query: 185 -EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL--PLPWSI 241
            E+L EV  +  L HPN+V  +G   +     +V E++ RGSL   L +      L    
Sbjct: 79  NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR 138
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           R+ +A   AKG+ +LH     P+++R+ K+ N+L+D  Y  K+ DFGL++       T +
Sbjct: 139 RLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR---LKASTFL 194
Query: 302 STR-VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 360
           S++   GT  + APE +       KSDVYSFGV+L E+ T +      +P G  N  +  
Sbjct: 195 SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ------QPWGNLNPAQ-V 247
Query: 361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
              +G K +  RL  PR         + +   +   C + +P  RP  + +++ L+PL
Sbjct: 248 VAAVGFKCK--RLEIPR-------NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 79/206 (38%), Positives = 102/206 (49%), Gaps = 18/206 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           LGEG FG      V      P   GTG  VAVK L  D G Q    W  E++ L  L H 
Sbjct: 39  LGEGHFG-----KVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHE 93
Query: 200 NLVKLVGYCIEDD---QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 256
           +++K  G C ED       LV E++P GSL ++L R S+ L  +  +  A    +G+A+L
Sbjct: 94  HIIKYKG-CCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGL--AQLLLFAQQICEGMAYL 150
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT--YGYAAP 314
           H +     I+RD    N+LLD D   K+ DFGLAK  PE G      R  G     + AP
Sbjct: 151 HAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE-GHEXYRVREDGDSPVFWYAP 206
Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLT 340
           E +        SDV+SFGV L E+LT
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 87/324 (26%), Positives = 144/324 (44%), Gaps = 44/324 (13%)
Query: 123 FMFNDLKLATRNF---------RPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK 173
           F F D   A R F         + E ++G G FG V  G ++  G   +       VA+K
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREI------FVAIK 67
Query: 174 TLNHDGLQGHK-EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR 232
           TL     +  + ++L+E + +G   HPN++ L G   +    +++ EFM  GSL++ L +
Sbjct: 68  TLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ 127
Query: 233 RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD 292
                     + +  G A G+ +L   A+   ++RD    NIL++++   K+SDFGL++ 
Sbjct: 128 NDGQFTVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 184
Query: 293 APEDGKTHVSTRVMG---TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKN 348
             +D      T  +G      + APE +     TS SDV+S+G+V+ E+++ G R     
Sbjct: 185 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 244
Query: 349 RPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM 408
                 N +E          + YRL  P       +       QL   C  +D   RP+ 
Sbjct: 245 TNQDVINAIE----------QDYRLPPP-------MDCPSALHQLMLDCWQKDRNHRPKF 287
Query: 409 SEVVETLKPL----QNLKDMASSS 428
            ++V TL  +     +LK MA  S
Sbjct: 288 GQIVNTLDKMIRNPNSLKAMAPLS 311

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 71/216 (32%), Positives = 101/216 (46%), Gaps = 24/216 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LGEG FG VF    E    +P K    + VAVK L    L   K++  E   L NL H +
Sbjct: 23  LGEGAFGKVFLA--ECYNLSPTK--DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP----------------LPWSIRMK 244
           +VK  G C + D  ++V+E+M  G L N   R   P                L  S  + 
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           IA   A G+ +L   A +  ++RD  T N L+ A+   K+ DFG+++D        V   
Sbjct: 138 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194
Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            M    +  PE +M    T++SDV+SFGV+L E+ T
Sbjct: 195 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 100/203 (49%), Gaps = 11/203 (5%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG+G FG V     E     P++  TG  VAVK L H   +  +++  E+  L +L H N
Sbjct: 21  LGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 75
Query: 201 LVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 258
           +VK  G C    +R   L+ EF+P GSL  +L +    +     ++      KG+ +L  
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYL-- 133
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTRVMGTYGYAAPEYV 317
              K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V         + APE +
Sbjct: 134 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 318 MTGHLTSKSDVYSFGVVLLEMLT 340
                +  SDV+SFGVVL E+ T
Sbjct: 193 TESKFSVASDVWSFGVVLYELFT 215

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 106/218 (48%), Gaps = 11/218 (5%)
Query: 126 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 185
           N  +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  ++
Sbjct: 21  NMTQFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD 75
Query: 186 WLAEVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRM 243
           +  E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +    +     +
Sbjct: 76  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 135
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVS 302
           +      KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V 
Sbjct: 136 QYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 192
Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                   + APE +     +  SDV+SFGVVL E+ T
Sbjct: 193 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 106/218 (48%), Gaps = 11/218 (5%)
Query: 126 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 185
           N  +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  ++
Sbjct: 21  NMTQFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD 75
Query: 186 WLAEVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRM 243
           +  E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +    +     +
Sbjct: 76  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 135
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVS 302
           +      KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V 
Sbjct: 136 QYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 192
Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                   + APE +     +  SDV+SFGVVL E+ T
Sbjct: 193 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 105/215 (48%), Gaps = 11/215 (5%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 188
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 13  QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 67
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +    +     ++  
Sbjct: 68  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 127
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTRV 305
               KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V    
Sbjct: 128 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 184
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                + APE +     +  SDV+SFGVVL E+ T
Sbjct: 185 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 105/215 (48%), Gaps = 11/215 (5%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 188
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 6   QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +    +     ++  
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTRV 305
               KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V    
Sbjct: 121 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 177
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                + APE +     +  SDV+SFGVVL E+ T
Sbjct: 178 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 105/215 (48%), Gaps = 11/215 (5%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 188
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 11  QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 65
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +    +     ++  
Sbjct: 66  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 125
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTRV 305
               KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V    
Sbjct: 126 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 182
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                + APE +     +  SDV+SFGVVL E+ T
Sbjct: 183 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 105/215 (48%), Gaps = 11/215 (5%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 188
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 10  QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 64
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +    +     ++  
Sbjct: 65  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 124
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTRV 305
               KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V    
Sbjct: 125 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 181
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                + APE +     +  SDV+SFGVVL E+ T
Sbjct: 182 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 105/215 (48%), Gaps = 11/215 (5%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 188
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 9   QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 63
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +    +     ++  
Sbjct: 64  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 123
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTRV 305
               KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V    
Sbjct: 124 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 180
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                + APE +     +  SDV+SFGVVL E+ T
Sbjct: 181 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 105/215 (48%), Gaps = 11/215 (5%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 188
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 5   QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 59
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +    +     ++  
Sbjct: 60  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 119
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTRV 305
               KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V    
Sbjct: 120 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 176
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                + APE +     +  SDV+SFGVVL E+ T
Sbjct: 177 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 106/216 (49%), Gaps = 13/216 (6%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 188
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 6   QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +    +     ++  
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
               KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D K     +  
Sbjct: 121 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEFFKVKEP 176
Query: 307 GT--YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           G     + APE +     +  SDV+SFGVVL E+ T
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 105/215 (48%), Gaps = 11/215 (5%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 188
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 4   QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 58
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +    +     ++  
Sbjct: 59  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 118
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTRV 305
               KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V    
Sbjct: 119 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 175
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                + APE +     +  SDV+SFGVVL E+ T
Sbjct: 176 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 105/215 (48%), Gaps = 11/215 (5%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 188
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 12  QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 66
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +    +     ++  
Sbjct: 67  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 126
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTRV 305
               KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V    
Sbjct: 127 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 183
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                + APE +     +  SDV+SFGVVL E+ T
Sbjct: 184 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 105/215 (48%), Gaps = 11/215 (5%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 188
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 37  QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 91
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +    +     ++  
Sbjct: 92  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 151
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTRV 305
               KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V    
Sbjct: 152 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 208
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                + APE +     +  SDV+SFGVVL E+ T
Sbjct: 209 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 99/213 (46%), Gaps = 21/213 (9%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LGEG FG VF    E     P +    + VAVKTL        K++  E   L NL H +
Sbjct: 21  LGEGAFGKVFLA--ECYNLCPEQ--DKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 76
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-------------LPWSIRMKIAL 247
           +VK  G C+E D  ++V+E+M  G L N   R   P             L  S  + IA 
Sbjct: 77  IVKFYGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQ 135
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A G+ +L   A +  ++RD  T N L+  +   K+ DFG+++D        V    M 
Sbjct: 136 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 192
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              +  PE +M    T++SDV+S GVVL E+ T
Sbjct: 193 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 105/215 (48%), Gaps = 11/215 (5%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 188
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 6   QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +    +     ++  
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTRV 305
               KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V    
Sbjct: 121 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 177
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                + APE +     +  SDV+SFGVVL E+ T
Sbjct: 178 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/207 (33%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 198
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 42  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 95
Query: 199 PNLVKLVGYCIEDDQR-LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLAF 255
           PN++ L+G C+  +   L+V  +M  G L N  F R+     +++  I  G   AKG+ F
Sbjct: 96  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKF 153
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYAA 313
           L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + A
Sbjct: 154 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 210
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            E + T   T+KSDV+SFGV+L E++T
Sbjct: 211 LESLQTQKFTTKSDVWSFGVLLWELMT 237

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/207 (33%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 198
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 35  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 88
Query: 199 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLAF 255
           PN++ L+G C+  +   L+V  +M  G L N  F R+     +++  I  G   AKG+ F
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKF 146
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYAA 313
           L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + A
Sbjct: 147 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 203
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            E + T   T+KSDV+SFGV+L E++T
Sbjct: 204 LESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/207 (33%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 198
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 38  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 91
Query: 199 PNLVKLVGYCIEDDQR-LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLAF 255
           PN++ L+G C+  +   L+V  +M  G L N  F R+     +++  I  G   AKG+ F
Sbjct: 92  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKF 149
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYAA 313
           L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + A
Sbjct: 150 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 206
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            E + T   T+KSDV+SFGV+L E++T
Sbjct: 207 LESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/207 (33%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 198
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 96  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 149
Query: 199 PNLVKLVGYCIEDDQR-LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLAF 255
           PN++ L+G C+  +   L+V  +M  G L N  F R+     +++  I  G   AKG+ F
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKF 207
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYAA 313
           L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + A
Sbjct: 208 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            E + T   T+KSDV+SFGV+L E++T
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/207 (33%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 198
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 37  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 199 PNLVKLVGYCIEDDQR-LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLAF 255
           PN++ L+G C+  +   L+V  +M  G L N  F R+     +++  I  G   AKG+ F
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKF 148
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYAA 313
           L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + A
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            E + T   T+KSDV+SFGV+L E++T
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/205 (35%), Positives = 103/205 (50%), Gaps = 14/205 (6%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGNLLHP 199
           LGEG FG      VE     P    TG  VAVK+L  +    H   L  E+  L NL H 
Sbjct: 29  LGEGHFG-----KVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 83
Query: 200 NLVKLVGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 257
           N+VK  G C ED  +   L+ EF+P GSL+ +L +    +    ++K A+   KG+ +L 
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL- 142
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK--THVSTRVMGTYGYAAPE 315
               +  ++RD    N+L+++++  K+ DFGL K    D +  T    R    + Y APE
Sbjct: 143 --GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APE 199
Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLT 340
            +M       SDV+SFGV L E+LT
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/207 (33%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 198
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 37  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 199 PNLVKLVGYCIEDDQR-LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLAF 255
           PN++ L+G C+  +   L+V  +M  G L N  F R+     +++  I  G   AKG+ F
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKF 148
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYAA 313
           L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + A
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            E + T   T+KSDV+SFGV+L E++T
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/207 (33%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 198
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 38  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 91
Query: 199 PNLVKLVGYCIEDDQR-LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLAF 255
           PN++ L+G C+  +   L+V  +M  G L N  F R+     +++  I  G   AKG+ F
Sbjct: 92  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKF 149
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYAA 313
           L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + A
Sbjct: 150 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMA 206
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            E + T   T+KSDV+SFGV+L E++T
Sbjct: 207 LESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 107/216 (49%), Gaps = 13/216 (6%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 188
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 7   QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 61
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +    +     ++  
Sbjct: 62  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 121
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
               KG+ +L     K  I+R+  T NIL++ +   K+ DFGL K  P+D K +   +  
Sbjct: 122 SQICKGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQD-KEYYKVKEP 177
Query: 307 GT--YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           G     + APE +     +  SDV+SFGVVL E+ T
Sbjct: 178 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 105/215 (48%), Gaps = 11/215 (5%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 188
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 9   QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 63
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L   +  +     ++  
Sbjct: 64  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYT 123
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTRV 305
               KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V    
Sbjct: 124 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 180
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                + APE +     +  SDV+SFGVVL E+ T
Sbjct: 181 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 198
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 36  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 89
Query: 199 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLAF 255
           PN++ L+G C+  +   L+V  +M  G L N  F R+     +++  I  G   AKG+ +
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKY 147
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYAA 313
           L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + A
Sbjct: 148 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMA 204
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            E + T   T+KSDV+SFGV+L E++T
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 72/205 (35%), Positives = 103/205 (50%), Gaps = 14/205 (6%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGNLLHP 199
           LGEG FG      VE     P    TG  VAVK+L  +    H   L  E+  L NL H 
Sbjct: 17  LGEGHFG-----KVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 71
Query: 200 NLVKLVGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 257
           N+VK  G C ED  +   L+ EF+P GSL+ +L +    +    ++K A+   KG+ +L 
Sbjct: 72  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL- 130
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK--THVSTRVMGTYGYAAPE 315
               +  ++RD    N+L+++++  K+ DFGL K    D +  T    R    + Y APE
Sbjct: 131 --GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APE 187
Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLT 340
            +M       SDV+SFGV L E+LT
Sbjct: 188 CLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 75/205 (36%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           LGEG FG      V      P   GTG  VAVK L    G Q    W  E+  L  L H 
Sbjct: 17  LGEGHFG-----KVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHE 71
Query: 200 NLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 257
           ++VK  G C +  ++   LV E++P GSL ++L R  + L  +  +  A    +G+A+LH
Sbjct: 72  HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGL--AQLLLFAQQICEGMAYLH 129
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT--YGYAAPE 315
            +     I+R     N+LLD D   K+ DFGLAK  PE G  +   R  G     + APE
Sbjct: 130 AQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVREDGDSPVFWYAPE 185
Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLT 340
            +        SDV+SFGV L E+LT
Sbjct: 186 CLKECKFYYASDVWSFGVTLYELLT 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 75/205 (36%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           LGEG FG      V      P   GTG  VAVK L    G Q    W  E+  L  L H 
Sbjct: 16  LGEGHFG-----KVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHE 70
Query: 200 NLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 257
           ++VK  G C +  ++   LV E++P GSL ++L R  + L  +  +  A    +G+A+LH
Sbjct: 71  HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGL--AQLLLFAQQICEGMAYLH 128
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT--YGYAAPE 315
            +     I+R     N+LLD D   K+ DFGLAK  PE G  +   R  G     + APE
Sbjct: 129 AQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVREDGDSPVFWYAPE 184
Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLT 340
            +        SDV+SFGV L E+LT
Sbjct: 185 CLKECKFYYASDVWSFGVTLYELLT 209

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 198
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 55  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 108
Query: 199 PNLVKLVGYCIEDDQR-LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLAF 255
           PN++ L+G C+  +   L+V  +M  G L N  F R+     +++  I  G   AKG+ +
Sbjct: 109 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKY 166
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYAA 313
           L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + A
Sbjct: 167 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 223
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            E + T   T+KSDV+SFGV+L E++T
Sbjct: 224 LESLQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 198
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 37  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 199 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLAF 255
           PN++ L+G C+  +   L+V  +M  G L N  F R+     +++  I  G   AKG+ +
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKY 148
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYAA 313
           L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + A
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            E + T   T+KSDV+SFGV+L E++T
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 198
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 36  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 89
Query: 199 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLAF 255
           PN++ L+G C+  +   L+V  +M  G L N  F R+     +++  I  G   AKG+ +
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKY 147
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYAA 313
           L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + A
Sbjct: 148 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 204
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            E + T   T+KSDV+SFGV+L E++T
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 198
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 56  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 109
Query: 199 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLAF 255
           PN++ L+G C+  +   L+V  +M  G L N  F R+     +++  I  G   AKG+ +
Sbjct: 110 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKY 167
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYAA 313
           L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + A
Sbjct: 168 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 224
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            E + T   T+KSDV+SFGV+L E++T
Sbjct: 225 LESLQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 198
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 29  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 82
Query: 199 PNLVKLVGYCIEDDQR-LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLAF 255
           PN++ L+G C+  +   L+V  +M  G L N  F R+     +++  I  G   AKG+ +
Sbjct: 83  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKY 140
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYAA 313
           L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + A
Sbjct: 141 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 197
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            E + T   T+KSDV+SFGV+L E++T
Sbjct: 198 LESLQTQKFTTKSDVWSFGVLLWELMT 224

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 198
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 37  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 199 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLAF 255
           PN++ L+G C+  +   L+V  +M  G L N  F R+     +++  I  G   AKG+ +
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKY 148
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYAA 313
           L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + A
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            E + T   T+KSDV+SFGV+L E++T
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 198
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 35  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 88
Query: 199 PNLVKLVGYCIEDDQR-LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLAF 255
           PN++ L+G C+  +   L+V  +M  G L N  F R+     +++  I  G   AKG+ +
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKY 146
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYAA 313
           L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + A
Sbjct: 147 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 203
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            E + T   T+KSDV+SFGV+L E++T
Sbjct: 204 LESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 198
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 32  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 85
Query: 199 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLAF 255
           PN++ L+G C+  +   L+V  +M  G L N  F R+     +++  I  G   AKG+ +
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKY 143
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYAA 313
           L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + A
Sbjct: 144 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 200
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            E + T   T+KSDV+SFGV+L E++T
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 198
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 34  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 199 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLAF 255
           PN++ L+G C+  +   L+V  +M  G L N  F R+     +++  I  G   AKG+ +
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKY 145
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYAA 313
           L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + A
Sbjct: 146 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 202
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            E + T   T+KSDV+SFGV+L E++T
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 131/286 (45%), Gaps = 31/286 (10%)
Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNL 196
           E ++G G FG V +G ++    AP K  +   VA+KTL     +  + E+L+E + +G  
Sbjct: 21  EEVIGAGEFGEVCRGRLK----APGKKES--CVAIKTLKGGYTERQRREFLSEASIMGQF 74
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 256
            HPN+++L G        +++ EFM  G+L++ L            + +  G A G+ +L
Sbjct: 75  EHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYL 134
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG---TYGYAA 313
              AE   ++RD    NIL++++   K+SDFGL++   E+      T  +G      + A
Sbjct: 135 ---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTA 191
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR 372
           PE +     TS SD +S+G+V+ E+++ G R           N +E          + YR
Sbjct: 192 PEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIE----------QDYR 241
Query: 373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
           L  P               QL   C  +D  ARPR  +VV  L  +
Sbjct: 242 LPPPP-------DCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKM 280

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 114/225 (50%), Gaps = 19/225 (8%)
Query: 118 SQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLN 176
           +QLR     +LK          +LG G FG V+KG WV E  T  +       VA+K LN
Sbjct: 30  AQLRILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKI------PVAIKILN 76
Query: 177 HD-GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL 235
              G + + E++ E   + ++ HP+LV+L+G C+    +L V + MP G L  ++     
Sbjct: 77  ETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKD 135
Query: 236 PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE 295
            +   + +   +  AKG+ +L E   + +++RD    N+L+ +  + K++DFGLA+    
Sbjct: 136 NIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 192
Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           D K + +        + A E +     T +SDV+S+GV + E++T
Sbjct: 193 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 107/203 (52%), Gaps = 12/203 (5%)
Query: 140 LLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLL 197
           +LG G FG V+KG WV E  T  +       VA+K LN   G + + E++ E   + ++ 
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETVKI------PVAIKILNETTGPKANVEFMDEALIMASMD 75
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 257
           HP+LV+L+G C+    +L V + MP G L  ++      +   + +   +  AKG+ +L 
Sbjct: 76  HPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 134
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
           E   + +++RD    N+L+ +  + K++DFGLA+    D K + +        + A E +
Sbjct: 135 E---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 191
Query: 318 MTGHLTSKSDVYSFGVVLLEMLT 340
                T +SDV+S+GV + E++T
Sbjct: 192 HYRKFTHQSDVWSYGVTIWELMT 214

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 131/286 (45%), Gaps = 31/286 (10%)
Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNL 196
           E ++G G FG V +G ++    AP K  +   VA+KTL     +  + E+L+E + +G  
Sbjct: 19  EEVIGAGEFGEVCRGRLK----APGKKES--CVAIKTLKGGYTERQRREFLSEASIMGQF 72
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 256
            HPN+++L G        +++ EFM  G+L++ L            + +  G A G+ +L
Sbjct: 73  EHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYL 132
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG---TYGYAA 313
              AE   ++RD    NIL++++   K+SDFGL++   E+      T  +G      + A
Sbjct: 133 ---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTA 189
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR 372
           PE +     TS SD +S+G+V+ E+++ G R           N +E          + YR
Sbjct: 190 PEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIE----------QDYR 239
Query: 373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
           L  P               QL   C  +D  ARPR  +VV  L  +
Sbjct: 240 LPPPP-------DCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKM 278

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 41/290 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G    N    +K      VAVKT+N    L+   E+L E + +      
Sbjct: 22  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 77
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 248
           ++V+L+G   +    L+V E M  G L+++L  RSL           P      +++A  
Sbjct: 78  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAE 135
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            A G+A+L+    K  ++RD    N ++  D+  K+ DFG+ +D  E        + +  
Sbjct: 136 IADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 192
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
             + APE +  G  T+ SD++SFGVVL E+ +               L E     L +++
Sbjct: 193 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQ 237
Query: 369 RFYRLLDPRLEGHFSIKGS--QKATQLAAQCLSRDPKARPRMSEVVETLK 416
               ++D    G+     +  ++ T L   C   +PK RP   E+V  LK
Sbjct: 238 VLKFVMDG---GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 284

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 41/290 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G    N    +K      VAVKT+N    L+   E+L E + +      
Sbjct: 25  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 248
           ++V+L+G   +    L+V E M  G L+++L  RSL           P      +++A  
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            A G+A+L+    K  ++RD    N ++  D+  K+ DFG+ +D  E        + +  
Sbjct: 139 IADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 195
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
             + APE +  G  T+ SD++SFGVVL E+ +               L E     L +++
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQ 240
Query: 369 RFYRLLDPRLEGHFSIKGS--QKATQLAAQCLSRDPKARPRMSEVVETLK 416
               ++D    G+     +  ++ T L   C   +PK RP   E+V  LK
Sbjct: 241 VLKFVMDG---GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 136/299 (45%), Gaps = 35/299 (11%)
Query: 136 RPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLG 194
           + E ++G G FG V  G ++  G   +       VA+KTL     +  + ++L+E + +G
Sbjct: 10  KIEQVIGAGEFGEVCSGHLKLPGKREI------FVAIKTLKSGYTEKQRRDFLSEASIMG 63
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
              HPN++ L G   +    +++ EFM  GSL++ L +          + +  G A G+ 
Sbjct: 64  QFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 123
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG---TYGY 311
           +L   A+   ++R     NIL++++   K+SDFGL++   +D      T  +G      +
Sbjct: 124 YL---ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW 180
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
            APE +     TS SDV+S+G+V+ E+++ G R           N +E          + 
Sbjct: 181 TAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE----------QD 230
Query: 371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL----QNLKDMA 425
           YRL  P       +       QL   C  +D   RP+  ++V TL  +     +LK MA
Sbjct: 231 YRLPPP-------MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLKAMA 282

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 136/292 (46%), Gaps = 27/292 (9%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 187
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSK--KEISVAIKTLKVGYTEKQRRDFL 94
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E + +G   HPN+++L G   +    ++V E+M  GSL++ L +          + +  
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
           G A G+ +L   ++   ++RD    NIL++++   K+SDFGLA+   +D +   +TR   
Sbjct: 155 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGK 211
Query: 308 T-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
               + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  +  
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIKA 262
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
               YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 263 VDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 41/290 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G    N    +K      VAVKT+N    L+   E+L E + +      
Sbjct: 25  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 248
           ++V+L+G   +    L+V E M  G L+++L  RSL           P      +++A  
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            A G+A+L+    K  ++RD    N ++  D+  K+ DFG+ +D  E        + +  
Sbjct: 139 IADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLP 195
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
             + APE +  G  T+ SD++SFGVVL E+ +               L E     L +++
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQ 240
Query: 369 RFYRLLDPRLEGHFSIKGS--QKATQLAAQCLSRDPKARPRMSEVVETLK 416
               ++D    G+     +  ++ T L   C   +PK RP   E+V  LK
Sbjct: 241 VLKFVMDG---GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 132/281 (46%), Gaps = 35/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 19  LGGGQFGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 68
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 69  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 126
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 127 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF--PIKWTAPESLA 183
Query: 319 TGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T G        P+  + L+E          + YR+  P 
Sbjct: 184 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE----------KDYRMERP- 232
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
            EG       +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 233 -EG-----CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 136/292 (46%), Gaps = 27/292 (9%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 187
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSK--KEISVAIKTLKVGYTEKQRRDFL 94
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E + +G   HPN+++L G   +    ++V E+M  GSL++ L +          + +  
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
           G A G+ +L   ++   ++RD    NIL++++   K+SDFGL++   +D +   +TR   
Sbjct: 155 GIASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 308 T-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
               + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  +  
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIKA 262
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
               YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 263 VDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 136/292 (46%), Gaps = 27/292 (9%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 187
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSKKE--ISVAIKTLKVGYTEKQRRDFL 65
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E + +G   HPN+++L G   +    ++V E+M  GSL++ L +          + +  
Sbjct: 66  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 125
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
           G A G+ +L   ++   ++RD    NIL++++   K+SDFGL++   +D +   +TR   
Sbjct: 126 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 182
Query: 308 T-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
               + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  +  
Sbjct: 183 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIKA 233
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
               YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 234 VDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 278

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 136/292 (46%), Gaps = 27/292 (9%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 187
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSK--KEISVAIKTLKVGYTEKQRRDFL 94
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E + +G   HPN+++L G   +    ++V E+M  GSL++ L +          + +  
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
           G A G+ +L   ++   ++RD    NIL++++   K+SDFGL++   +D +   +TR   
Sbjct: 155 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 308 T-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
               + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  +  
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIKA 262
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
               YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 263 VDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 136/292 (46%), Gaps = 27/292 (9%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 187
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSK--KEISVAIKTLKVGYTEKQRRDFL 94
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E + +G   HPN+++L G   +    ++V E+M  GSL++ L +          + +  
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
           G A G+ +L   ++   ++RD    NIL++++   K+SDFGL++   +D +   +TR   
Sbjct: 155 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 308 T-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
               + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  +  
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIKA 262
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
               YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 263 VDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 136/292 (46%), Gaps = 27/292 (9%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 187
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSK--KEISVAIKTLKVGYTEKQRRDFL 94
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E + +G   HPN+++L G   +    ++V E+M  GSL++ L +          + +  
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
           G A G+ +L   ++   ++RD    NIL++++   K+SDFGL++   +D +   +TR   
Sbjct: 155 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 308 T-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
               + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  +  
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIKA 262
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
               YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 263 VDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 41/290 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G    N    +K      VAVKT+N    L+   E+L E + +      
Sbjct: 25  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 248
           ++V+L+G   +    L+V E M  G L+++L  RSL           P      +++A  
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            A G+A+L+    K  ++RD    N ++  D+  K+ DFG+ +D  E        + +  
Sbjct: 139 IADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 195
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
             + APE +  G  T+ SD++SFGVVL E+ +               L E     L +++
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQ 240
Query: 369 RFYRLLDPRLEGHFSIKGS--QKATQLAAQCLSRDPKARPRMSEVVETLK 416
               ++D    G+     +  ++ T L   C   +PK RP   E+V  LK
Sbjct: 241 VLKFVMDG---GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 136/292 (46%), Gaps = 27/292 (9%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 187
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSK--KEISVAIKTLKVGYTEKQRRDFL 94
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E + +G   HPN+++L G   +    ++V E+M  GSL++ L +          + +  
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
           G A G+ +L   ++   ++RD    NIL++++   K+SDFGL++   +D +   +TR   
Sbjct: 155 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 308 T-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
               + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  +  
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIKA 262
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
               YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 263 VDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 136/292 (46%), Gaps = 27/292 (9%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 187
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 29  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSKKE--ISVAIKTLKVGYTEKQRRDFL 82
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E + +G   HPN+++L G   +    ++V E+M  GSL++ L +          + +  
Sbjct: 83  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 142
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
           G A G+ +L   ++   ++RD    NIL++++   K+SDFGL++   +D +   +TR   
Sbjct: 143 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 199
Query: 308 T-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
               + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  +  
Sbjct: 200 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIKA 250
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
               YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 251 VDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 295

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 136/292 (46%), Gaps = 27/292 (9%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 187
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 39  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSK--KEISVAIKTLKVGYTEKQRRDFL 92
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E + +G   HPN+++L G   +    ++V E+M  GSL++ L +          + +  
Sbjct: 93  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 152
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
           G A G+ +L   ++   ++RD    NIL++++   K+SDFGL++   +D +   +TR   
Sbjct: 153 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 209
Query: 308 T-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
               + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  +  
Sbjct: 210 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIKA 260
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
               YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 261 VDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 305

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 130/290 (44%), Gaps = 41/290 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G    N    +K      VAVKT+N    L+   E+L E + +      
Sbjct: 25  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 248
           ++V+L+G   +    L+V E M  G L+++L  RSL           P      +++A  
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            A G+A+L+    K  ++RD    N ++  D+  K+ DFG+ +D  E        + +  
Sbjct: 139 IADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 195
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
             + APE +  G  T+ SD++SFGVVL E+ +               L E     L +++
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQ 240
Query: 369 RFYRLLDPRLEGHFSIKGS--QKATQLAAQCLSRDPKARPRMSEVVETLK 416
               ++D    G+     +  ++ T L   C   +P  RP   E+V  LK
Sbjct: 241 VLKFVMDG---GYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 41/290 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G    N    +K      VAVKT+N    L+   E+L E + +      
Sbjct: 24  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 79
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 248
           ++V+L+G   +    L+V E M  G L+++L  RSL           P      +++A  
Sbjct: 80  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAE 137
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            A G+A+L+    K  ++RD    N ++  D+  K+ DFG+ +D  E        + +  
Sbjct: 138 IADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 194
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
             + APE +  G  T+ SD++SFGVVL E+ +               L E     L +++
Sbjct: 195 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQ 239
Query: 369 RFYRLLDPRLEGHFSIKGS--QKATQLAAQCLSRDPKARPRMSEVVETLK 416
               ++D    G+     +  ++ T L   C   +PK RP   E+V  LK
Sbjct: 240 VLKFVMDG---GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 286

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 132/281 (46%), Gaps = 35/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 19  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 68
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 69  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 126
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 127 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF--PIKWTAPESLA 183
Query: 319 TGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T G        P+  + L+E          + YR+  P 
Sbjct: 184 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE----------KDYRMERP- 232
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
            EG       +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 233 -EG-----CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 135/292 (46%), Gaps = 27/292 (9%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 187
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSK--KEISVAIKTLKVGYTEKQRRDFL 94
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E + +G   HPN+++L G   +    ++V E+M  GSL++ L +          + +  
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
           G A G+ +L   ++   ++RD    NIL++++   K+SDFGL +   +D +   +TR   
Sbjct: 155 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGK 211
Query: 308 T-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
               + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  +  
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIKA 262
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
               YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 263 VDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 35/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 22  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 71
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 72  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 129
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 130 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF--PIKWTAPESLA 186
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 187 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 229
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 230 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 270

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 35/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 21  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 70
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 71  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 128
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 185
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 228
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 35/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 21  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 70
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 71  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 128
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 185
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 228
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 35/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 26  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 75
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 133
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 134 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 190
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 233
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 234 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 35/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 26  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 75
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           LV+L+G C  +    ++ EFM  G+L ++L   +      +   + L  A  ++   E  
Sbjct: 76  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ---EVNAVVLLYMATQISSAMEYL 132
Query: 261 EKP-VIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
           EK   I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 133 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 190
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 233
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 234 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 128/287 (44%), Gaps = 35/287 (12%)
Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNL 196
           E ++G G  G V  G +   G   V       VA+K L     +  + ++L+E + +G  
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVP------VAIKALKAGYTERQRRDFLSEASIMGQF 107
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL--GAAKGLA 254
            HPN+++L G        ++V E+M  GSL+   F R+    ++I   + +  G   G+ 
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT--FLRTHDGQFTIMQLVGMLRGVGAGMR 165
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK---DAPEDGKTHVSTRVMGTYGY 311
           +L   ++   ++RD    N+L+D++   K+SDFGL++   D P+   T    ++     +
Sbjct: 166 YL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKI--PIRW 220
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 371
            APE +     +S SDV+SFGVV+ E+L        N  N         R  +      Y
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN---------RDVISSVEEGY 271
Query: 372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
           RL  P       +       QL   C  +D   RPR S++V  L  L
Sbjct: 272 RLPAP-------MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 128/288 (44%), Gaps = 43/288 (14%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 194
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 32  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 75
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
              H N++  +GY  +  Q  +V ++    SL +HL            + IA   A+G+ 
Sbjct: 76  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMD 134
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           +LH    K +I+RD K++NI L  D   K+ DFGLA +      +H   ++ G+  + AP
Sbjct: 135 YLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191
Query: 315 EYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-RPHLGDKRRF 370
           E +    +   + +SDVY+FG+VL E++TG+  +  +  N    ++E   R  L      
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIEMVGRGSLSPDLSK 249
Query: 371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
            R   P+           +  +L A+CL +    RP    ++  ++ L
Sbjct: 250 VRSNCPK-----------RMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 35/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 26  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 75
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           LV+L+G C  +    ++ EFM  G+L ++L   +      +   + L  A  ++   E  
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ---EVNAVVLLYMATQISSAMEYL 132
Query: 261 EKP-VIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
           EK   I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 133 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF--PIKWTAPESLA 190
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 233
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 234 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 35/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 21  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 70
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 128
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 185
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 228
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 35/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 21  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 70
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 128
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 185
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 228
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 135/289 (46%), Gaps = 31/289 (10%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLH 198
           +LGEG FG V++G V  N       G  + VAVKT   D    +KE +++E   + NL H
Sbjct: 31  ILGEGFFGEVYEG-VYTN-----HKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 84
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 258
           P++VKL+G  IE++   ++ E  P G L ++L R    L     +  +L   K +A+L  
Sbjct: 85  PHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE- 142
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                 ++RD    NIL+ +    KL DFGL++   ED   + ++       + +PE + 
Sbjct: 143 --SINCVHRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMSPESIN 199
Query: 319 TGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPR 377
               T+ SDV+ F V + E+L+ G++            ++E      GD+     L  P 
Sbjct: 200 FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-----KGDRLPKPDLCPPV 254
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL-KDMA 425
           L              L  +C   DP  RPR +E+V +L  +  + KD+A
Sbjct: 255 L------------YTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIA 291

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 35/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 26  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 75
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 133
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 134 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 190
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 233
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 234 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 66
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 249
           +  L H  LV+L    + ++   +V E+M +GSL + L     + L LP  + M  A   
Sbjct: 67  MKKLRHEKLVQLYA-VVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDM--AAQI 123
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +           
Sbjct: 124 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEXTARQGAKFPI 179
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L    R
Sbjct: 180 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 230
Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            YR+  P        +  +    L  QC  +DP+ RP
Sbjct: 231 GYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 260

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 35/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 26  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 75
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           LV+L+G C  +    ++ EFM  G+L ++L   +      +   + L  A  ++   E  
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ---EVNAVVLLYMATQISSAMEYL 132
Query: 261 EKP-VIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
           EK   I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 133 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 190
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 233
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 234 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 35/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 25  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 74
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           LV+L+G C  +    ++ EFM  G+L ++L   +      +   + L  A  ++   E  
Sbjct: 75  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ---EVNAVVLLYMATQISSAMEYL 131
Query: 261 EKP-VIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
           EK   I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 132 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 189
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 232
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 233 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 128/287 (44%), Gaps = 35/287 (12%)
Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNL 196
           E ++G G  G V  G +   G   V       VA+K L     +  + ++L+E + +G  
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVP------VAIKALKAGYTERQRRDFLSEASIMGQF 107
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL--GAAKGLA 254
            HPN+++L G        ++V E+M  GSL+   F R+    ++I   + +  G   G+ 
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT--FLRTHDGQFTIMQLVGMLRGVGAGMR 165
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK---DAPEDGKTHVSTRVMGTYGY 311
           +L   ++   ++RD    N+L+D++   K+SDFGL++   D P+   T    ++     +
Sbjct: 166 YL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI--PIRW 220
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 371
            APE +     +S SDV+SFGVV+ E+L        N  N         R  +      Y
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN---------RDVISSVEEGY 271
Query: 372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
           RL  P       +       QL   C  +D   RPR S++V  L  L
Sbjct: 272 RLPAP-------MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 135/292 (46%), Gaps = 27/292 (9%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 187
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSKKE--ISVAIKTLKVGYTEKQRRDFL 94
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E + +G   HPN+++L G   +    ++V E M  GSL++ L +          + +  
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
           G A G+ +L   ++   ++RD    NIL++++   K+SDFGL++   +D +   +TR   
Sbjct: 155 GIASGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 308 T-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
               + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  +  
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIKA 262
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
               YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 263 VDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/233 (30%), Positives = 108/233 (46%), Gaps = 34/233 (14%)
Query: 133 RNFRPESL-----LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL 187
           R FRP  L     LG+G FG   K    E         TG  + +K L     +  + +L
Sbjct: 5   RIFRPSDLIHGEVLGKGCFGQAIKVTHRE---------TGEVMVMKELIRFDEETQRTFL 55
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            EV  +  L HPN++K +G   +D +   + E++  G+L   +       PWS R+  A 
Sbjct: 56  KEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAK 115
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA------KDAPE------ 295
             A G+A+LH      +I+RD  + N L+  + N  ++DFGLA      K  PE      
Sbjct: 116 DIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLK 172
Query: 296 --DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD 346
             D K   +  V+G   + APE +       K DV+SFG+VL E++ GR + D
Sbjct: 173 KPDRKKRYT--VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNAD 222

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 136/303 (44%), Gaps = 43/303 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 267 LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 316
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 317 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 374
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+R+    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 375 -KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 431
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 432 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 474
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL--------QNLKDMASSSY 429
                     +K  +L   C   +P  RP  +E+ +  + +        +  K++   + 
Sbjct: 475 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKENL 534
Query: 430 YFQ 432
           YFQ
Sbjct: 535 YFQ 537

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 134/290 (46%), Gaps = 30/290 (10%)
Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNL 196
           + ++G G FG V+KG ++ +      P     VA+KTL     +  + ++L E   +G  
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVP-----VAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 256
            H N+++L G   +    +++ E+M  G+L+  L  +         + +  G A G+ +L
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 163
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK---DAPEDGKTHVSTRVMGTYGYAA 313
              A    ++RD    NIL++++   K+SDFGL++   D PE   T    ++     + A
Sbjct: 164 ---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI--PIRWTA 218
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 373
           PE +     TS SDV+SFG+V+ E++T        RP  E +  E  +  + D    +RL
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMTY-----GERPYWELSNHEVMKA-INDG---FRL 269
Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKD 423
             P       +       QL  QC  ++   RP+ +++V  L  L    D
Sbjct: 270 PTP-------MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 35/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 34  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 83
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 84  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 141
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 142 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 198
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 199 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 241
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 242 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 282

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 135/289 (46%), Gaps = 31/289 (10%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLH 198
           +LGEG FG V++G V  N       G  + VAVKT   D    +KE +++E   + NL H
Sbjct: 19  ILGEGFFGEVYEG-VYTN-----HKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 72
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 258
           P++VKL+G  IE++   ++ E  P G L ++L R    L     +  +L   K +A+L  
Sbjct: 73  PHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE- 130
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                 ++RD    NIL+ +    KL DFGL++   ED   + ++       + +PE + 
Sbjct: 131 --SINCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESIN 187
Query: 319 TGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPR 377
               T+ SDV+ F V + E+L+ G++            ++E      GD+     L  P 
Sbjct: 188 FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-----KGDRLPKPDLCPPV 242
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL-KDMA 425
           L              L  +C   DP  RPR +E+V +L  +  + KD+A
Sbjct: 243 L------------YTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIA 279

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 35/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 23  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 72
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 130
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 131 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 187
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 188 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 230
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 231 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 35/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 23  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 72
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 130
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 131 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 187
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 188 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 230
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 231 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 35/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 21  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 70
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           LV+L+G C  +    ++ EFM  G+L ++L   +      +   + L  A  ++   E  
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ---EVNAVVLLYMATQISSAMEYL 127
Query: 261 EKP-VIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
           EK   I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 185
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 228
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 103/212 (48%), Gaps = 13/212 (6%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           R+ +  S LG+G FG V     E     P+   TG  VAVK L H G    +++  E+  
Sbjct: 10  RHLKYISQLGKGNFGSV-----ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 64
Query: 193 LGNLLHPNLVKL--VGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 250
           L  L    +VK   V Y        LV E++P G L + L R    L  S  +  +    
Sbjct: 65  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 124
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT-- 308
           KG+ +L     +  ++RD    NIL++++ + K++DFGLAK  P D K +   R  G   
Sbjct: 125 KGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD-KDYYVVREPGQSP 180
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
             + APE +     + +SDV+SFGVVL E+ T
Sbjct: 181 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 135/289 (46%), Gaps = 31/289 (10%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLH 198
           +LGEG FG V++G V  N       G  + VAVKT   D    +KE +++E   + NL H
Sbjct: 15  ILGEGFFGEVYEG-VYTN-----HKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 68
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 258
           P++VKL+G  IE++   ++ E  P G L ++L R    L     +  +L   K +A+L  
Sbjct: 69  PHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE- 126
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                 ++RD    NIL+ +    KL DFGL++   ED   + ++       + +PE + 
Sbjct: 127 --SINCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESIN 183
Query: 319 TGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPR 377
               T+ SDV+ F V + E+L+ G++            ++E      GD+     L  P 
Sbjct: 184 FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-----KGDRLPKPDLCPPV 238
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL-KDMA 425
           L              L  +C   DP  RPR +E+V +L  +  + KD+A
Sbjct: 239 L------------YTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIA 275

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 35/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 19  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 68
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 69  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 126
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 127 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKF--PIKWTAPESLA 183
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 184 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDPSQVYELLEKD 226
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 227 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 66
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 249
           +  L H  LV+L    + ++   +V E+M +GSL + L     + L LP  + M  A   
Sbjct: 67  MKKLRHEKLVQLYA-VVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDM--AAQI 123
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +           
Sbjct: 124 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPI 179
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L    R
Sbjct: 180 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 230
Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            YR+  P        +  +    L  QC  +DP+ RP
Sbjct: 231 GYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 260

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 103/212 (48%), Gaps = 13/212 (6%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           R+ +  S LG+G FG V     E     P+   TG  VAVK L H G    +++  E+  
Sbjct: 11  RHLKYISQLGKGNFGSV-----ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 65
Query: 193 LGNLLHPNLVKL--VGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 250
           L  L    +VK   V Y        LV E++P G L + L R    L  S  +  +    
Sbjct: 66  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 125
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT-- 308
           KG+ +L     +  ++RD    NIL++++ + K++DFGLAK  P D K +   R  G   
Sbjct: 126 KGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD-KDYYVVREPGQSP 181
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
             + APE +     + +SDV+SFGVVL E+ T
Sbjct: 182 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 35/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 21  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 70
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           LV+L+G C  +    ++ EFM  G+L ++L   +      +   + L  A  ++   E  
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ---EVNAVVLLYMATQISSAMEYL 127
Query: 261 EKP-VIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
           EK   I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 185
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 228
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 135/292 (46%), Gaps = 27/292 (9%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 187
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSKKE--ISVAIKTLKVGYTEKQRRDFL 65
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E + +G   HPN+++L G   +    ++V E M  GSL++ L +          + +  
Sbjct: 66  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR 125
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
           G A G+ +L   ++   ++RD    NIL++++   K+SDFGL++   +D +   +TR   
Sbjct: 126 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 182
Query: 308 T-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
               + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  +  
Sbjct: 183 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIKA 233
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
               YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 234 VDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 278

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 135/292 (46%), Gaps = 27/292 (9%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 187
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSK--KEISVAIKTLKVGYTEKQRRDFL 94
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E + +G   HPN+++L G   +    ++V E M  GSL++ L +          + +  
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
           G A G+ +L   ++   ++RD    NIL++++   K+SDFGL++   +D +   +TR   
Sbjct: 155 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 308 T-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
               + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  +  
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIKA 262
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
               YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 263 VDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 127/288 (44%), Gaps = 43/288 (14%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 194
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 32  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 75
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
              H N++  +GY     Q  +V ++    SL +HL            + IA   A+G+ 
Sbjct: 76  KTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMD 134
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           +LH    K +I+RD K++NI L  D   K+ DFGLA +      +H   ++ G+  + AP
Sbjct: 135 YLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191
Query: 315 EYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-RPHLGDKRRF 370
           E +    +   + +SDVY+FG+VL E++TG+  +  +  N    ++E   R  L      
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIEMVGRGSLSPDLSK 249
Query: 371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
            R   P+           +  +L A+CL +    RP    ++  ++ L
Sbjct: 250 VRSNCPK-----------RMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 117/297 (39%), Gaps = 45/297 (15%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE----VNFLGNL 196
           LG G FG V    VE      +K    +TVAVK L        +E L      +++LGN 
Sbjct: 47  LGAGAFGKV----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 101
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWS---------------- 240
            H N+V L+G C      L++ E+   G L N L R+      S                
Sbjct: 102 -HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 160
Query: 241 -IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
              +  +   AKG+AFL   A K  I+RD    NILL      K+ DFGLA+D   D   
Sbjct: 161 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 217
Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 359
            V         + APE +     T +SDV+S+G+ L E+ +   S               
Sbjct: 218 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------------- 262
Query: 360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
             P +    +FY+++              +   +   C   DP  RP   ++V+ ++
Sbjct: 263 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 319

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 103/212 (48%), Gaps = 13/212 (6%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           R+ +  S LG+G FG V     E     P+   TG  VAVK L H G    +++  E+  
Sbjct: 23  RHLKYISQLGKGNFGSV-----ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 77
Query: 193 LGNLLHPNLVKL--VGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 250
           L  L    +VK   V Y        LV E++P G L + L R    L  S  +  +    
Sbjct: 78  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 137
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT-- 308
           KG+ +L     +  ++RD    NIL++++ + K++DFGLAK  P D K +   R  G   
Sbjct: 138 KGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD-KDYYVVREPGQSP 193
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
             + APE +     + +SDV+SFGVVL E+ T
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 10  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 57
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 249
           +  L H  LV+L    + ++   +V E+M +GSL + L     + L LP  + M  A   
Sbjct: 58  MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM--AAQI 114
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +           
Sbjct: 115 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPI 170
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L    R
Sbjct: 171 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 221
Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            YR+  P        +  +    L  QC  +DP+ RP
Sbjct: 222 GYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 251

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 66
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 249
           +  L H  LV+L    + ++   +V E+M +GSL + L     + L LP  + M  A   
Sbjct: 67  MKKLRHEKLVQLYA-VVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDM--AAQI 123
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +           
Sbjct: 124 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPI 179
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L    R
Sbjct: 180 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 230
Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            YR+  P        +  +    L  QC  +DP+ RP
Sbjct: 231 GYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 260

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 123/267 (46%), Gaps = 33/267 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 27  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 75
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L    +  +   ++ E+M  GSL + L   S + L  +  + +A   A+G+AF+ E 
Sbjct: 76  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 133
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 134 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINY 190
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 191 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 239
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARP 406
                   ++  QL   C    P+ RP
Sbjct: 240 -----NCPEELYQLMRLCWKERPEDRP 261

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 128/281 (45%), Gaps = 35/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 228 LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 277
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 335
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+R+    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 336 -KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 392
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 435
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 436 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 8   SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 55
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 249
           +  L H  LV+L    + ++   +V E+M +GSL + L     + L LP  + M  A   
Sbjct: 56  MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM--AAQI 112
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +           
Sbjct: 113 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPI 168
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L    R
Sbjct: 169 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 219
Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            YR+  P        +  +    L  QC  +DP+ RP
Sbjct: 220 GYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 249

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 66
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 249
           +  L H  LV+L    + ++   +V E+M +GSL + L     + L LP  + M  A   
Sbjct: 67  MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM--AAQI 123
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +           
Sbjct: 124 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPI 179
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L    R
Sbjct: 180 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 230
Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            YR+  P        +  +    L  QC  +DP+ RP
Sbjct: 231 GYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 260

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 123/294 (41%), Gaps = 33/294 (11%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNF 192
           N +    LG G FG V    VE       K    L VAVK L        KE L +E+  
Sbjct: 47  NLQFGKTLGAGAFGKV----VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 193 LGNL-LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIR 242
           + +L  H N+V L+G C      L++ E+   G L N L R++          PL     
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDL 162
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
           +  +   A+G+AFL   A K  I+RD    N+LL   + AK+ DFGLA+D   D    V 
Sbjct: 163 LHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 219
Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 362
                   + APE +     T +SDV+S+G++L E+     S+  N             P
Sbjct: 220 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLN-----------PYP 264
Query: 363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
            +    +FY+L+    +        +    +   C + +P  RP   ++   L+
Sbjct: 265 GILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 318

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 123/267 (46%), Gaps = 33/267 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 29  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 77
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L    +  +   ++ E+M  GSL + L   S + L  +  + +A   A+G+AF+ E 
Sbjct: 78  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 135
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 136 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINY 192
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 193 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 241
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARP 406
                   ++  QL   C    P+ RP
Sbjct: 242 -----NCPEELYQLMRLCWKERPEDRP 263

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 123/267 (46%), Gaps = 33/267 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 30  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 78
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L    +  +   ++ E+M  GSL + L   S + L  +  + +A   A+G+AF+ E 
Sbjct: 79  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 136
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 137 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINY 193
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 194 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 242
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARP 406
                   ++  QL   C    P+ RP
Sbjct: 243 -----NCPEELYQLMRLCWKERPEDRP 264

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 117/297 (39%), Gaps = 45/297 (15%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE----VNFLGNL 196
           LG G FG V    VE      +K    +TVAVK L        +E L      +++LGN 
Sbjct: 54  LGAGAFGKV----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 108
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWS---------------- 240
            H N+V L+G C      L++ E+   G L N L R+      S                
Sbjct: 109 -HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 167
Query: 241 -IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
              +  +   AKG+AFL   A K  I+RD    NILL      K+ DFGLA+D   D   
Sbjct: 168 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 224
Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 359
            V         + APE +     T +SDV+S+G+ L E+ +   S               
Sbjct: 225 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------------- 269
Query: 360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
             P +    +FY+++              +   +   C   DP  RP   ++V+ ++
Sbjct: 270 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 123/294 (41%), Gaps = 33/294 (11%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNF 192
           N +    LG G FG V    VE       K    L VAVK L        KE L +E+  
Sbjct: 39  NLQFGKTLGAGAFGKV----VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 94
Query: 193 LGNL-LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIR 242
           + +L  H N+V L+G C      L++ E+   G L N L R++          PL     
Sbjct: 95  MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDL 154
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
           +  +   A+G+AFL   A K  I+RD    N+LL   + AK+ DFGLA+D   D    V 
Sbjct: 155 LHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 211
Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 362
                   + APE +     T +SDV+S+G++L E+     S+  N             P
Sbjct: 212 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLN-----------PYP 256
Query: 363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
            +    +FY+L+    +        +    +   C + +P  RP   ++   L+
Sbjct: 257 GILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 310

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 117/297 (39%), Gaps = 45/297 (15%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE----VNFLGNL 196
           LG G FG V    VE      +K    +TVAVK L        +E L      +++LGN 
Sbjct: 49  LGAGAFGKV----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 103
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWS---------------- 240
            H N+V L+G C      L++ E+   G L N L R+      S                
Sbjct: 104 -HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 162
Query: 241 -IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
              +  +   AKG+AFL   A K  I+RD    NILL      K+ DFGLA+D   D   
Sbjct: 163 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 219
Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 359
            V         + APE +     T +SDV+S+G+ L E+ +   S               
Sbjct: 220 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------------- 264
Query: 360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
             P +    +FY+++              +   +   C   DP  RP   ++V+ ++
Sbjct: 265 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 321

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 124/283 (43%), Gaps = 37/283 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V  G          K      VAVK +  +G     E+  E   +  L HP 
Sbjct: 16  LGSGQFGVVKLG----------KWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPK 64
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           LVK  G C ++    +V E++  G L N+L      L  S  +++     +G+AFL    
Sbjct: 65  LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ 124
Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT---YGYAAPEYV 317
               I+RD    N L+D D   K+SDFG+ +   +D   +VS+  +GT     ++APE  
Sbjct: 125 ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD--QYVSS--VGTKFPVKWSAPEVF 177
Query: 318 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPR 377
                +SKSDV++FG+++ E+ +  +       N E  L       +    R YR   P 
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL------KVSQGHRLYR---PH 228
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN 420
           L        S    Q+   C    P+ RP   +++ +++PL+ 
Sbjct: 229 L-------ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 117/297 (39%), Gaps = 45/297 (15%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE----VNFLGNL 196
           LG G FG V    VE      +K    +TVAVK L        +E L      +++LGN 
Sbjct: 31  LGAGAFGKV----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 85
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWS---------------- 240
            H N+V L+G C      L++ E+   G L N L R+      S                
Sbjct: 86  -HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 241 -IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
              +  +   AKG+AFL   A K  I+RD    NILL      K+ DFGLA+D   D   
Sbjct: 145 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 359
            V         + APE +     T +SDV+S+G+ L E+ +   S               
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------------- 246
Query: 360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
             P +    +FY+++              +   +   C   DP  RP   ++V+ ++
Sbjct: 247 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 123/267 (46%), Gaps = 33/267 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 21  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 69
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L    +  +   ++ E+M  GSL + L   S + L  +  + +A   A+G+AF+ E 
Sbjct: 70  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 127
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 128 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINY 184
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 233
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARP 406
                   ++  QL   C    P+ RP
Sbjct: 234 -----NCPEELYQLMRLCWKERPEDRP 255

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 123/267 (46%), Gaps = 33/267 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 31  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 79
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L    +  +   ++ E+M  GSL + L   S + L  +  + +A   A+G+AF+ E 
Sbjct: 80  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 137
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 138 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINY 194
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 195 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 243
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARP 406
                   ++  QL   C    P+ RP
Sbjct: 244 -----NCPEELYQLMRLCWKERPEDRP 265

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 127/287 (44%), Gaps = 41/287 (14%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 194
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 44  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 87
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
              H N++  +GY  +  Q  +V ++    SL +HL            + IA   A+G+ 
Sbjct: 88  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 146
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           +LH    K +I+RD K++NI L  D   K+ DFGLA +      +H   ++ G+  + AP
Sbjct: 147 YLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 203
Query: 315 EYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 371
           E +        + +SDVY+FG+VL E++TG+     N  N +  +    R +L       
Sbjct: 204 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKV 262
Query: 372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
           R   P+              +L A+CL +    RP   +++ +++ L
Sbjct: 263 RSNCPK-----------AMKRLMAECLKKKRDERPLFPQILASIELL 298

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 127/287 (44%), Gaps = 41/287 (14%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 194
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 36  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 79
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
              H N++  +GY  +  Q  +V ++    SL +HL            + IA   A+G+ 
Sbjct: 80  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 138
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           +LH    K +I+RD K++NI L  D   K+ DFGLA +      +H   ++ G+  + AP
Sbjct: 139 YLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 195
Query: 315 EYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 371
           E +        + +SDVY+FG+VL E++TG+     N  N +  +    R +L       
Sbjct: 196 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKV 254
Query: 372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
           R   P+              +L A+CL +    RP   +++ +++ L
Sbjct: 255 RSNCPK-----------AMKRLMAECLKKKRDERPLFPQILASIELL 290

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 66
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 249
           +  + H  LV+L    + ++   +V E+M +GSL + L     + L LP  + M  A   
Sbjct: 67  MKKIRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM--AAQI 123
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +           
Sbjct: 124 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPI 179
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L    R
Sbjct: 180 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 230
Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            YR+  P        +  +    L  QC  +DP+ RP
Sbjct: 231 GYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 260

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 123/267 (46%), Gaps = 33/267 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 23  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 71
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L    +  +   ++ E+M  GSL + L   S + L  +  + +A   A+G+AF+ E 
Sbjct: 72  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 129
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 130 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINY 186
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 187 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 235
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARP 406
                   ++  QL   C    P+ RP
Sbjct: 236 -----NCPEELYQLMRLCWKERPEDRP 257

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 123/267 (46%), Gaps = 33/267 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 27  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 75
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L    +  +   ++ E+M  GSL + L   S + L  +  + +A   A+G+AF+ E 
Sbjct: 76  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 133
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 134 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINY 190
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 191 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 239
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARP 406
                   ++  QL   C    P+ RP
Sbjct: 240 -----NCPEELYQLMRLCWKERPEDRP 261

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 123/267 (46%), Gaps = 33/267 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 26  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 74
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L    +  +   ++ E+M  GSL + L   S + L  +  + +A   A+G+AF+ E 
Sbjct: 75  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 132
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 133 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINY 189
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 190 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 238
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARP 406
                   ++  QL   C    P+ RP
Sbjct: 239 -----NCPEELYQLMRLCWKERPEDRP 260

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 103/212 (48%), Gaps = 13/212 (6%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           R+ +  S LG+G FG V     E     P+   TG  VAVK L H G    +++  E+  
Sbjct: 7   RHLKYISQLGKGNFGSV-----ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 61
Query: 193 LGNLLHPNLVKL--VGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 250
           L  L    +VK   V Y     +  LV E++P G L + L R    L  S  +  +    
Sbjct: 62  LKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 121
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT-- 308
           KG+ +L     +  ++RD    NIL++++ + K++DFGLAK  P D    V  R  G   
Sbjct: 122 KGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXV-VREPGQSP 177
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
             + APE +     + +SDV+SFGVVL E+ T
Sbjct: 178 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 123/267 (46%), Gaps = 33/267 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 22  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 70
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L    +  +   ++ E+M  GSL + L   S + L  +  + +A   A+G+AF+ E 
Sbjct: 71  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 128
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 129 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINY 185
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 186 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 234
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARP 406
                   ++  QL   C    P+ RP
Sbjct: 235 -----NCPEELYQLMRLCWKERPEDRP 256

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 127/288 (44%), Gaps = 43/288 (14%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 194
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 20  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 63
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
              H N++  +GY  +  Q  +V ++    SL +HL            + IA   A+G+ 
Sbjct: 64  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMD 122
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           +LH    K +I+RD K++NI L  D   K+ DFGLA        +H   ++ G+  + AP
Sbjct: 123 YLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 179
Query: 315 EYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-RPHLGDKRRF 370
           E +    +   + +SDVY+FG+VL E++TG+  +  +  N    ++E   R  L      
Sbjct: 180 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIEMVGRGSLSPDLSK 237
Query: 371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
            R   P+           +  +L A+CL +    RP    ++  ++ L
Sbjct: 238 VRSNCPK-----------RMKRLMAECLKKKRDERPSFPRILAEIEEL 274

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 120/291 (41%), Gaps = 37/291 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGNL-LH 198
           LG G FG V    VE       K    L VAVK L        KE L +E+  + +L  H
Sbjct: 54  LGAGAFGKV----VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG---------- 248
            N+V L+G C      L++ E+   G L N L R+S  L       IA            
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 249 ---AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
               A+G+AFL   A K  I+RD    N+LL   + AK+ DFGLA+D   D    V    
Sbjct: 170 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
                + APE +     T +SDV+S+G++L E+     S+  N             P + 
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLN-----------PYPGIL 271
Query: 366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
              +FY+L+    +        +    +   C + +P  RP   ++   L+
Sbjct: 272 VNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 322

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 123/267 (46%), Gaps = 33/267 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 21  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 69
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L    +  +   ++ E+M  GSL + L   S + L  +  + +A   A+G+AF+ E 
Sbjct: 70  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 127
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 128 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINY 184
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 233
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARP 406
                   ++  QL   C    P+ RP
Sbjct: 234 -----NCPEELYQLMRLCWKERPEDRP 255

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 127/287 (44%), Gaps = 41/287 (14%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 194
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 16  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 59
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
              H N++  +GY  +  Q  +V ++    SL +HL            + IA   A+G+ 
Sbjct: 60  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           +LH    K +I+RD K++NI L  D   K+ DFGLA +      +H   ++ G+  + AP
Sbjct: 119 YLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 175
Query: 315 EYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 371
           E +        + +SDVY+FG+VL E++TG+     N  N +  +    R +L       
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKV 234
Query: 372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
           R   P+              +L A+CL +    RP   +++ +++ L
Sbjct: 235 RSNCPK-----------AMKRLMAECLKKKRDERPLFPQILASIELL 270

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 134/291 (46%), Gaps = 43/291 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G  +  G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 18  LGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 73
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 248
           ++V+L+G   +    L++ E M RG L+++L  RSL           P   S  +++A  
Sbjct: 74  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQMAGE 131
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            A G+A+L+       ++RD    N ++  D+  K+ DFG+ +D  E        + +  
Sbjct: 132 IADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 188
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
             + +PE +  G  T+ SDV+SFGVVL E+ T               L E  +P+ G   
Sbjct: 189 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSN 231
Query: 369 RFYRLLDPRLEGHFSIKGSQ---KATQLAAQCLSRDPKARPRMSEVVETLK 416
              ++L   +EG    K         +L   C   +PK RP   E++ ++K
Sbjct: 232 E--QVLRFVMEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIK 280

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 120/291 (41%), Gaps = 37/291 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGNL-LH 198
           LG G FG V    VE       K    L VAVK L        KE L +E+  + +L  H
Sbjct: 54  LGAGAFGKV----VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG---------- 248
            N+V L+G C      L++ E+   G L N L R+S  L       IA            
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHF 169
Query: 249 ---AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
               A+G+AFL   A K  I+RD    N+LL   + AK+ DFGLA+D   D    V    
Sbjct: 170 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
                + APE +     T +SDV+S+G++L E+     S+  N             P + 
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLN-----------PYPGIL 271
Query: 366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
              +FY+L+    +        +    +   C + +P  RP   ++   L+
Sbjct: 272 VNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 322

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 127/280 (45%), Gaps = 33/280 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 22  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 71
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 72  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 129
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
            +K  I+RD    N L+  ++  K++DFGL++    D  T  +        + APE +  
Sbjct: 130 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI-KWTAPESLAY 187
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPRL 378
              + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+   
Sbjct: 188 NKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKDY 230
Query: 379 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                    +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 231 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 270

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 129/283 (45%), Gaps = 27/283 (9%)
Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNL 196
           E ++G G FG V  G ++  G         L VA+KTL     +  + ++L E + +G  
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRE------LPVAIKTLKVGYTEKQRRDFLGEASIMGQF 80
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 256
            HPN++ L G   +    ++V E+M  GSL+  L +          + +  G + G+ +L
Sbjct: 81  DHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYL 140
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT-YGYAAPE 315
              ++   ++RD    NIL++++   K+SDFGL++   +D +   +TR       + APE
Sbjct: 141 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 197
Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 375
            +     TS SDV+S+G+V+ E+++        RP  E       +  +      YRL  
Sbjct: 198 AIAFRKFTSASDVWSYGIVMWEVVSY-----GERPYWEMT----NQDVIKAVEEGYRLPS 248
Query: 376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
           P       +       QL   C  ++  +RP+  E+V  L  L
Sbjct: 249 P-------MDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKL 284

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 134/291 (46%), Gaps = 43/291 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G  +  G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 27  LGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 82
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 248
           ++V+L+G   +    L++ E M RG L+++L  RSL           P   S  +++A  
Sbjct: 83  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQMAGE 140
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            A G+A+L+       ++RD    N ++  D+  K+ DFG+ +D  E        + +  
Sbjct: 141 IADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 197
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
             + +PE +  G  T+ SDV+SFGVVL E+ T               L E  +P+ G   
Sbjct: 198 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSN 240
Query: 369 RFYRLLDPRLEGHFSIKGSQ---KATQLAAQCLSRDPKARPRMSEVVETLK 416
              ++L   +EG    K         +L   C   +PK RP   E++ ++K
Sbjct: 241 E--QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 289

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 124/277 (44%), Gaps = 39/277 (14%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 66
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 249
           +  L H  LV+L    + ++   +V E+M +GSL + L     + L LP  + M  A   
Sbjct: 67  MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM--AAQI 123
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           A G+A++        ++RD   +NIL+  +   K++DFGLA+   ED +           
Sbjct: 124 ASGMAYVER---MNYVHRDLAAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPI 179
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L    R
Sbjct: 180 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 230
Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            YR+  P        +  +    L  QC  +DP+ RP
Sbjct: 231 GYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 260

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 124/277 (44%), Gaps = 39/277 (14%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 66
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 249
           +  L H  LV+L    + ++   +V E+M +G L + L     + L LP  + M  A   
Sbjct: 67  MKKLRHEKLVQLYA-VVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDM--AAQI 123
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +           
Sbjct: 124 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPI 179
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L    R
Sbjct: 180 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 230
Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            YR+  P        +  +    L  QC  +DP+ RP
Sbjct: 231 GYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 260

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 123/267 (46%), Gaps = 33/267 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 21  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 69
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L    +  +   ++ E+M  GSL + L   S + L  +  + +A   A+G+AF+ E 
Sbjct: 70  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 127
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 128 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 233
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARP 406
                   ++  QL   C    P+ RP
Sbjct: 234 -----NCPEELYQLMRLCWKERPEDRP 255

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 127/280 (45%), Gaps = 33/280 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 23  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 72
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 130
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
            +K  I+RD    N L+  ++  K++DFGL++    D  T  +        + APE +  
Sbjct: 131 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI-KWTAPESLAY 188
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPRL 378
              + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+   
Sbjct: 189 NKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKDY 231
Query: 379 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                    +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 232 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 123/267 (46%), Gaps = 33/267 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 16  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 64
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L    +  +   ++ E+M  GSL + L   S + L  +  + +A   A+G+AF+ E 
Sbjct: 65  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 122
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 123 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINY 179
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 180 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 228
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARP 406
                   ++  QL   C    P+ RP
Sbjct: 229 -----NCPEELYQLMRLCWKERPEDRP 250

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 124/277 (44%), Gaps = 39/277 (14%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 66
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 249
           +  L H  LV+L    + ++   +V E+M +G L + L     + L LP  + M  A   
Sbjct: 67  MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDM--AAQI 123
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +           
Sbjct: 124 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPI 179
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L    R
Sbjct: 180 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 230
Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            YR+  P        +  +    L  QC  +DP+ RP
Sbjct: 231 GYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 260

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 130/290 (44%), Gaps = 41/290 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G    N    +K      VAVKT+N    L+   E+L E + +      
Sbjct: 25  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 248
           ++V+L+G   +    L+V E M  G L+++L  RSL           P      +++A  
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            A G+A+L+    K  ++R+    N ++  D+  K+ DFG+ +D  E        + +  
Sbjct: 139 IADGMAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 195
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
             + APE +  G  T+ SD++SFGVVL E+ +               L E     L +++
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQ 240
Query: 369 RFYRLLDPRLEGHFSIKGS--QKATQLAAQCLSRDPKARPRMSEVVETLK 416
               ++D    G+     +  ++ T L   C   +P  RP   E+V  LK
Sbjct: 241 VLKFVMDG---GYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 130/290 (44%), Gaps = 41/290 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G    N    +K      VAVKT+N    L+   E+L E + +      
Sbjct: 26  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 81
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 248
           ++V+L+G   +    L+V E M  G L+++L  RSL           P      +++A  
Sbjct: 82  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAE 139
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            A G+A+L+    K  ++R+    N ++  D+  K+ DFG+ +D  E        + +  
Sbjct: 140 IADGMAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 196
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
             + APE +  G  T+ SD++SFGVVL E+ +               L E     L +++
Sbjct: 197 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQ 241
Query: 369 RFYRLLDPRLEGHFSIKGS--QKATQLAAQCLSRDPKARPRMSEVVETLK 416
               ++D    G+     +  ++ T L   C   +P  RP   E+V  LK
Sbjct: 242 VLKFVMDG---GYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 288

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           + + E  LG G FG V+     ++            VAVKT+   G    + +LAE N +
Sbjct: 189 SLKLEKKLGAGQFGEVWMATYNKH----------TKVAVKTMK-PGSMSVEAFLAEANVM 237
Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAA 250
             L H  LVKL    +  +   ++ EFM +GSL + L        PLP  I     +  A
Sbjct: 238 KTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--A 294
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
           +G+AF+ +   +  I+RD + +NIL+ A    K++DFGLA+   ED +            
Sbjct: 295 EGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIK 350
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 343
           + APE +  G  T KSDV+SFG++L+E++T  R
Sbjct: 351 WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 383

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 126/287 (43%), Gaps = 41/287 (14%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 194
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 43  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 86
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
              H N++  +GY  +  Q  +V ++    SL +HL            + IA   A+G+ 
Sbjct: 87  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 145
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           +LH    K +I+RD K++NI L  D   K+ DFGLA        +H   ++ G+  + AP
Sbjct: 146 YLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 202
Query: 315 EYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 371
           E +        + +SDVY+FG+VL E++TG+     N  N +  +    R +L       
Sbjct: 203 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKV 261
Query: 372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
           R   P+              +L A+CL +    RP   +++ +++ L
Sbjct: 262 RSNCPK-----------AMKRLMAECLKKKRDERPLFPQILASIELL 297

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 122/293 (41%), Gaps = 39/293 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGNL-LH 198
           LG G FG V    VE       K    L VAVK L        KE L +E+  + +L  H
Sbjct: 54  LGAGAFGKV----VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIR--------------M 243
            N+V L+G C      L++ E+   G L N L R+  P L +S                +
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLL 169
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
             +   A+G+AFL   A K  I+RD    N+LL   + AK+ DFGLA+D   D    V  
Sbjct: 170 HFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 226
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+S+G++L E+     S+  N             P 
Sbjct: 227 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLN-----------PYPG 271
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
           +    +FY+L+    +        +    +   C + +P  RP   ++   L+
Sbjct: 272 ILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 324

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 126/287 (43%), Gaps = 41/287 (14%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 194
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 44  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 87
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
              H N++  +GY  +  Q  +V ++    SL +HL            + IA   A+G+ 
Sbjct: 88  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 146
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           +LH    K +I+RD K++NI L  D   K+ DFGLA        +H   ++ G+  + AP
Sbjct: 147 YLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 203
Query: 315 EYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 371
           E +        + +SDVY+FG+VL E++TG+     N  N +  +    R +L       
Sbjct: 204 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKV 262
Query: 372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
           R   P+              +L A+CL +    RP   +++ +++ L
Sbjct: 263 RSNCPK-----------AMKRLMAECLKKKRDERPLFPQILASIELL 298

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 9   SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 56
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 249
           +  L H  LV+L    + ++   +V E+M +GSL + L     + L LP  + M  A   
Sbjct: 57  MKKLRHEKLVQLYA-VVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM--AAQI 113
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +           
Sbjct: 114 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEXTARQGAKFPI 169
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L    R
Sbjct: 170 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 220
Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            YR+  P        +  +    L  QC  ++P+ RP
Sbjct: 221 GYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 250

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 126/287 (43%), Gaps = 41/287 (14%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 194
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 18  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 61
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
              H N++  +GY  +  Q  +V ++    SL +HL            + IA   A+G+ 
Sbjct: 62  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 120
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           +LH    K +I+RD K++NI L  D   K+ DFGLA        +H   ++ G+  + AP
Sbjct: 121 YLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 177
Query: 315 EYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 371
           E +        + +SDVY+FG+VL E++TG+     N  N +  +    R +L       
Sbjct: 178 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKV 236
Query: 372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
           R   P+              +L A+CL +    RP   +++ +++ L
Sbjct: 237 RSNCPK-----------AMKRLMAECLKKKRDERPLFPQILASIELL 272

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 126/287 (43%), Gaps = 41/287 (14%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 194
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 21  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 64
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
              H N++  +GY  +  Q  +V ++    SL +HL            + IA   A+G+ 
Sbjct: 65  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 123
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           +LH    K +I+RD K++NI L  D   K+ DFGLA        +H   ++ G+  + AP
Sbjct: 124 YLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 180
Query: 315 EYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 371
           E +        + +SDVY+FG+VL E++TG+     N  N +  +    R +L       
Sbjct: 181 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKV 239
Query: 372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
           R   P+              +L A+CL +    RP   +++ +++ L
Sbjct: 240 RSNCPK-----------AMKRLMAECLKKKRDERPLFPQILASIELL 275

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 112/229 (48%), Gaps = 20/229 (8%)
Query: 123 FMFNDLKLATRNF---------RPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK 173
           F F D   A R F         + E ++G G FG V  G ++  G   +       VA+K
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREI------CVAIK 63
Query: 174 TLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR 232
           TL      +  +++L+E + +G   HPN++ L G   +    +++ E+M  GSL+  L +
Sbjct: 64  TLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRK 123
Query: 233 RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD 292
                     + +  G   G+ +L   ++   ++RD    NIL++++   K+SDFG+++ 
Sbjct: 124 NDGRFTVIQLVGMLRGIGSGMKYL---SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRV 180
Query: 293 APEDGKTHVSTRVMGT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
             +D +   +TR       + APE +     TS SDV+S+G+V+ E+++
Sbjct: 181 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           + + E  LG G FG V+     ++            VAVKT+   G    + +LAE N +
Sbjct: 16  SLKLEKKLGAGQFGEVWMATYNKHTK----------VAVKTMK-PGSMSVEAFLAEANVM 64
Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAA 250
             L H  LVKL    +  +   ++ EFM +GSL + L        PLP  I     +  A
Sbjct: 65  KTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--A 121
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
           +G+AF+ +   +  I+RD + +NIL+ A    K++DFGLA+   ED +            
Sbjct: 122 EGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIK 177
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 343
           + APE +  G  T KSDV+SFG++L+E++T  R
Sbjct: 178 WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 210

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 15/216 (6%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 187
           +L     + E ++G G FG V  G ++  G   V       VA+KTL     +  + ++L
Sbjct: 39  ELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDV------AVAIKTLKVGYTEKQRRDFL 92
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E + +G   HPN+V L G        ++V EFM  G+L+  L +          + +  
Sbjct: 93  CEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLR 152
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK---DAPEDGKTHVSTR 304
           G A G+ +L   A+   ++RD    NIL++++   K+SDFGL++   D PE   T    +
Sbjct: 153 GIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGK 209
Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +     + APE +     TS SDV+S+G+V+ E+++
Sbjct: 210 I--PVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 131 ATRNFRPESL------LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK 184
            TR+  PE        LG+G FG V+K   +E         T +  A K ++    +  +
Sbjct: 29  VTRDLNPEDFWEIIGELGDGAFGKVYKAQNKE---------TSVLAAAKVIDTKSEEELE 79
Query: 185 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
           +++ E++ L +  HPN+VKL+     ++   ++ EF   G+++  +     PL  S    
Sbjct: 80  DYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV 139
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           +       L +LH   +  +I+RD K  NIL   D + KL+DFG++  A           
Sbjct: 140 VCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRXIQRRDX 194
Query: 305 VMGTYGYAAPEYVMTGH-----LTSKSDVYSFGVVLLEM 338
            +GT  + APE VM           K+DV+S G+ L+EM
Sbjct: 195 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 126/287 (43%), Gaps = 41/287 (14%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 194
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 21  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 64
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
              H N++  +GY  +  Q  +V ++    SL +HL            + IA   A+G+ 
Sbjct: 65  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 123
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           +LH    K +I+RD K++NI L  D   K+ DFGLA        +H   ++ G+  + AP
Sbjct: 124 YLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 180
Query: 315 EYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 371
           E +        + +SDVY+FG+VL E++TG+     N  N +  +    R +L       
Sbjct: 181 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKV 239
Query: 372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
           R   P+              +L A+CL +    RP   +++ +++ L
Sbjct: 240 RSNCPK-----------AMKRLMAECLKKKRDERPLFPQILASIELL 275

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 131 ATRNFRPESL------LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK 184
            TR+  PE        LG+G FG V+K   +E         T +  A K ++    +  +
Sbjct: 29  VTRDLNPEDFWEIIGELGDGAFGKVYKAQNKE---------TSVLAAAKVIDTKSEEELE 79
Query: 185 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
           +++ E++ L +  HPN+VKL+     ++   ++ EF   G+++  +     PL  S    
Sbjct: 80  DYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV 139
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           +       L +LH   +  +I+RD K  NIL   D + KL+DFG++  A           
Sbjct: 140 VCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDS 194
Query: 305 VMGTYGYAAPEYVMTGH-----LTSKSDVYSFGVVLLEM 338
            +GT  + APE VM           K+DV+S G+ L+EM
Sbjct: 195 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 141/309 (45%), Gaps = 43/309 (13%)
Query: 123 FMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQ 181
           F+ ++ ++A         LG+G FG V++G  +  G    +P T   VA+KT+N    ++
Sbjct: 6   FVPDEWEVAREKITMSRELGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMR 61
Query: 182 GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL------ 235
              E+L E + +      ++V+L+G   +    L++ E M RG L+++L  RSL      
Sbjct: 62  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMEN 119
Query: 236 -----PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA 290
                P   S  +++A   A G+A+L+       ++RD    N ++  D+  K+ DFG+ 
Sbjct: 120 NPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMT 176
Query: 291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +D  E        + +    + +PE +  G  T+ SDV+SFGVVL E+ T          
Sbjct: 177 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------- 226
Query: 351 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQ---KATQLAAQCLSRDPKARPR 407
                L E  +P+ G      ++L   +EG    K         +L   C   +PK RP 
Sbjct: 227 -----LAE--QPYQGLSNE--QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPS 277
Query: 408 MSEVVETLK 416
             E++ ++K
Sbjct: 278 FLEIISSIK 286

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 268 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 315
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 249
           +  L H  LV+L    + ++   +V E+M +GSL + L     + L LP  + M  A   
Sbjct: 316 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM--AAQI 372
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +           
Sbjct: 373 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPI 428
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L    R
Sbjct: 429 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 479
Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            YR+  P        +  +    L  QC  ++P+ RP
Sbjct: 480 GYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 509

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 83/313 (26%), Positives = 141/313 (45%), Gaps = 43/313 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G  +  G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 26  LGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 81
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 248
           ++V+L+G   +    L++ E M RG L+++L  RSL           P   S  +++A  
Sbjct: 82  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQMAGE 139
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            A G+A+L+       ++RD    N ++  D+  K+ DFG+ +D  E        + +  
Sbjct: 140 IADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 196
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
             + +PE +  G  T+ SDV+SFGVVL E+ T               L E  +P+ G   
Sbjct: 197 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSN 239
Query: 369 RFYRLLDPRLEGHFSIKGSQ---KATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMA 425
              ++L   +EG    K         +L   C   +PK RP   E++ ++K         
Sbjct: 240 E--QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 297
Query: 426 SSSYYFQTMQADN 438
            S YY +  + +N
Sbjct: 298 VSFYYSEENKMEN 310

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 131 ATRNFRPESL------LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK 184
            TR+  PE        LG+G FG V+K   +E         T +  A K ++    +  +
Sbjct: 29  VTRDLNPEDFWEIIGELGDGAFGKVYKAQNKE---------TSVLAAAKVIDTKSEEELE 79
Query: 185 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
           +++ E++ L +  HPN+VKL+     ++   ++ EF   G+++  +     PL  S    
Sbjct: 80  DYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV 139
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           +       L +LH   +  +I+RD K  NIL   D + KL+DFG++  A           
Sbjct: 140 VCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRXIQRRDS 194
Query: 305 VMGTYGYAAPEYVMTGH-----LTSKSDVYSFGVVLLEM 338
            +GT  + APE VM           K+DV+S G+ L+EM
Sbjct: 195 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 12  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 59
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 249
           +  L H  LV+L    + ++   +V E+M +GSL + L     + L LP  + M  A   
Sbjct: 60  MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM--AAQI 116
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +           
Sbjct: 117 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPI 172
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L    R
Sbjct: 173 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 223
Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            YR+  P        +  +    L  QC  ++P+ RP
Sbjct: 224 GYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 253

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 134/291 (46%), Gaps = 43/291 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G  +  G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 20  LGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 75
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 248
           ++V+L+G   +    L++ E M RG L+++L  RSL           P   S  +++A  
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQMAGE 133
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            A G+A+L+       ++RD    N ++  D+  K+ DFG+ +D  E        + +  
Sbjct: 134 IADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 190
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
             + +PE +  G  T+ SDV+SFGVVL E+ T               L E  +P+ G   
Sbjct: 191 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSN 233
Query: 369 RFYRLLDPRLEGHFSIKGSQ---KATQLAAQCLSRDPKARPRMSEVVETLK 416
              ++L   +EG    K         +L   C   +PK RP   E++ ++K
Sbjct: 234 E--QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 282

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 232
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 249
           +  L H  LV+L    + ++   +V E+M +GSL + L     + L LP  + M  A   
Sbjct: 233 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM--AAQI 289
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +           
Sbjct: 290 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPI 345
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L    R
Sbjct: 346 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 396
Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            YR+  P        +  +    L  QC  ++P+ RP
Sbjct: 397 GYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 426

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 126/287 (43%), Gaps = 41/287 (14%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 194
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 16  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 59
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
              H N++  +GY  +  Q  +V ++    SL +HL            + IA   A+G+ 
Sbjct: 60  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           +LH    K +I+RD K++NI L  D   K+ DFGLA        +H   ++ G+  + AP
Sbjct: 119 YLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 315 EYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 371
           E +        + +SDVY+FG+VL E++TG+     N  N +  +    R +L       
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKV 234
Query: 372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
           R   P+              +L A+CL +    RP   +++ +++ L
Sbjct: 235 RSNCPK-----------AMKRLMAECLKKKRDERPLFPQILASIELL 270

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 232
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 249
           +  L H  LV+L    + ++   +V E+M +GSL + L     + L LP  + M  A   
Sbjct: 233 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM--AAQI 289
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +           
Sbjct: 290 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPI 345
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L    R
Sbjct: 346 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 396
Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            YR+  P        +  +    L  QC  ++P+ RP
Sbjct: 397 GYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 426

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 134/291 (46%), Gaps = 43/291 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G  +  G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 23  LGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 78
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 248
           ++V+L+G   +    L++ E M RG L+++L  RSL           P   S  +++A  
Sbjct: 79  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPAMANNPVLAPPSLSKMIQMAGE 136
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            A G+A+L+       ++RD    N ++  D+  K+ DFG+ +D  E        + +  
Sbjct: 137 IADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 193
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
             + +PE +  G  T+ SDV+SFGVVL E+ T               L E  +P+ G   
Sbjct: 194 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSN 236
Query: 369 RFYRLLDPRLEGHFSIKGSQ---KATQLAAQCLSRDPKARPRMSEVVETLK 416
              ++L   +EG    K         +L   C   +PK RP   E++ ++K
Sbjct: 237 E--QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 285

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 134/291 (46%), Gaps = 43/291 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G  +  G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 27  LGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 82
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 248
           ++V+L+G   +    L++ E M RG L+++L  RSL           P   S  +++A  
Sbjct: 83  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQMAGE 140
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            A G+A+L+       ++RD    N ++  D+  K+ DFG+ +D  E        + +  
Sbjct: 141 IADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 197
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
             + +PE +  G  T+ SDV+SFGVVL E+ T               L E  +P+ G   
Sbjct: 198 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSN 240
Query: 369 RFYRLLDPRLEGHFSIKGSQ---KATQLAAQCLSRDPKARPRMSEVVETLK 416
              ++L   +EG    K         +L   C   +PK RP   E++ ++K
Sbjct: 241 E--QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 289

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 124/277 (44%), Gaps = 39/277 (14%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 186 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGNMSPEAFLQEAQV 233
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 249
           +  L H  LV+L    + ++   +V E+M +GSL + L     + L LP  + M  A   
Sbjct: 234 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM--AAQI 290
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           A G+A++        ++RD + +NIL+  +   K++DFGL +   ED +           
Sbjct: 291 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLGR-LIEDNEYTARQGAKFPI 346
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L    R
Sbjct: 347 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 397
Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            YR+  P        +  +    L  QC  +DP+ RP
Sbjct: 398 GYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 427

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 124/295 (42%), Gaps = 44/295 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP     VAVK L  D  +    + ++E+  +  +  H
Sbjct: 36  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIR--------------M 243
            N++ L+G C +D    ++ E+  +G+L  +L  R  P L +S                +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLV 153
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
             A   A+G+ +L   A K  I+RD    N+L+  D   K++DFGLA+D         +T
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTT 210
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV+L E+ T   S     P  E          
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---------- 260
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETL 415
                  ++LL    EGH   K S    +L      C    P  RP   ++VE L
Sbjct: 261 ------LFKLLK---EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 136/291 (46%), Gaps = 43/291 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G  +  G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 33  LGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 248
           ++V+L+G   +    L++ E M RG L+++L  RSL           P   S  +++A  
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQMAGE 146
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            A G+A+L+  A K  ++RD    N ++  D+  K+ DFG+ +D  E        + +  
Sbjct: 147 IADGMAYLN--ANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 203
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
             + +PE +  G  T+ SDV+SFGVVL E+ T               L E  +P+ G   
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSN 246
Query: 369 RFYRLLDPRLEGHFSIKGS---QKATQLAAQCLSRDPKARPRMSEVVETLK 416
              ++L   +EG    K         +L   C   +PK RP   E++ ++K
Sbjct: 247 E--QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 134/291 (46%), Gaps = 43/291 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G  +  G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 55  LGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 110
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 248
           ++V+L+G   +    L++ E M RG L+++L  RSL           P   S  +++A  
Sbjct: 111 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQMAGE 168
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            A G+A+L+       ++RD    N ++  D+  K+ DFG+ +D  E        + +  
Sbjct: 169 IADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 225
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
             + +PE +  G  T+ SDV+SFGVVL E+ T               L E  +P+ G   
Sbjct: 226 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSN 268
Query: 369 RFYRLLDPRLEGHFSIKGSQ---KATQLAAQCLSRDPKARPRMSEVVETLK 416
              ++L   +EG    K         +L   C   +PK RP   E++ ++K
Sbjct: 269 E--QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 317

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 134/291 (46%), Gaps = 43/291 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G  +  G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 26  LGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 81
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 248
           ++V+L+G   +    L++ E M RG L+++L  RSL           P   S  +++A  
Sbjct: 82  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQMAGE 139
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            A G+A+L+       ++RD    N ++  D+  K+ DFG+ +D  E        + +  
Sbjct: 140 IADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 196
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
             + +PE +  G  T+ SDV+SFGVVL E+ T               L E  +P+ G   
Sbjct: 197 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSN 239
Query: 369 RFYRLLDPRLEGHFSIKGSQ---KATQLAAQCLSRDPKARPRMSEVVETLK 416
              ++L   +EG    K         +L   C   +PK RP   E++ ++K
Sbjct: 240 E--QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 288

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 136/291 (46%), Gaps = 43/291 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G  +  G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 33  LGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 248
           ++V+L+G   +    L++ E M RG L+++L  RSL           P   S  +++A  
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPAMANNPVLAPPSLSKMIQMAGE 146
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            A G+A+L+  A K  ++RD    N ++  D+  K+ DFG+ +D  E        + +  
Sbjct: 147 IADGMAYLN--ANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 203
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
             + +PE +  G  T+ SDV+SFGVVL E+ T               L E  +P+ G   
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSN 246
Query: 369 RFYRLLDPRLEGHFSIKGSQ---KATQLAAQCLSRDPKARPRMSEVVETLK 416
              ++L   +EG    K         +L   C   +PK RP   E++ ++K
Sbjct: 247 E--QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 122/293 (41%), Gaps = 42/293 (14%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEV 190
           NFR E  +G G F  V++     +G         + VA+K +    L   K   + + E+
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDG---------VPVALKKVQIFDLMDAKARADCIKEI 83
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLE---NHLFRRSLPLPWSIRMKIAL 247
           + L  L HPN++K     IED++  +V E    G L     H  ++   +P     K  +
Sbjct: 84  DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV 143
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
                L  +H    + V++RD K +N+ + A    KL D GL +      KT  +  ++G
Sbjct: 144 QLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVG 198
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  Y +PE +       KSD++S G +L EM                       P  GDK
Sbjct: 199 TPYYMSPERIHENGYNFKSDIWSLGCLLYEM------------------AALQSPFYGDK 240
Query: 368 RRFYRLLDPRLEGHF----SIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
              Y L     +  +    S   S++  QL   C++ DP+ RP ++ V +  K
Sbjct: 241 MNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK 293

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 116/297 (39%), Gaps = 45/297 (15%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE----VNFLGNL 196
           LG G FG V    VE      +K    +TVAVK L        +E L      +++LGN 
Sbjct: 54  LGAGAFGKV----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 108
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWS---------------- 240
            H N+V L+G C      L++ E+   G L N L R+      S                
Sbjct: 109 -HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 167
Query: 241 -IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
              +  +   AKG+AFL   A K  I+RD    NILL      K+ DFGLA+    D   
Sbjct: 168 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNY 224
Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 359
            V         + APE +     T +SDV+S+G+ L E+ +   S               
Sbjct: 225 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------------- 269
Query: 360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
             P +    +FY+++              +   +   C   DP  RP   ++V+ ++
Sbjct: 270 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 125/287 (43%), Gaps = 41/287 (14%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 194
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 16  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 59
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
              H N++  +GY     Q  +V ++    SL +HL            + IA   A+G+ 
Sbjct: 60  KTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           +LH    K +I+RD K++NI L  D   K+ DFGLA        +H   ++ G+  + AP
Sbjct: 119 YLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 315 EYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 371
           E +        + +SDVY+FG+VL E++TG+     N  N +  +    R +L       
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSKV 234
Query: 372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
           R   P+              +L A+CL +    RP   +++ +++ L
Sbjct: 235 RSNCPK-----------AMKRLMAECLKKKRDERPLFPQILASIELL 270

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 123/267 (46%), Gaps = 33/267 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 17  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 65
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L    +  +   ++ E+M  GSL + L   S + L  +  + +A   A+G+AF+ E 
Sbjct: 66  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 123
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             +  I+R+ + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 124 --RNYIHRNLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINY 180
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 181 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 229
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARP 406
                   ++  QL   C    P+ RP
Sbjct: 230 -----NCPEELYQLMRLCWKERPEDRP 251

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 124/295 (42%), Gaps = 44/295 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP     VAVK L  D  +    + ++E+  +  +  H
Sbjct: 36  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIR--------------M 243
            N++ L+G C +D    ++ E+  +G+L  +L  R  P L +S                +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
             A   A+G+ +L   A K  I+RD    N+L+  D   K++DFGLA+D         +T
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV+L E+ T   S     P  E          
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---------- 260
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETL 415
                  ++LL    EGH   K S    +L      C    P  RP   ++VE L
Sbjct: 261 ------LFKLLK---EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 16  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 63
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 249
           +  L H  LV+L    + ++   +V E+M +GSL + L     + L LP  + M   +  
Sbjct: 64  MKKLRHEKLVQLYA-VVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQI-- 120
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +           
Sbjct: 121 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEWTARQGAKFPI 176
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L    R
Sbjct: 177 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 227
Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            YR+  P        +  +    L  QC  ++P+ RP
Sbjct: 228 GYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 257

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 232
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 249
           +  L H  LV+L    + ++   +V E+M +GSL + L     + L LP  + M  A   
Sbjct: 233 MKKLRHEKLVQLYA-VVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDM--AAQI 289
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +           
Sbjct: 290 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPI 345
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L    R
Sbjct: 346 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 396
Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            YR+  P        +  +    L  QC  ++P+ RP
Sbjct: 397 GYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 426

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LGEG FG VF    E +   P +    + VAVK L        +++  E   L  L H +
Sbjct: 26  LGEGAFGKVFLA--ECHNLLPEQ--DKMLVAVKALKEASESARQDFQREAELLTMLQHQH 81
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL----------------PLPWSIRMK 244
           +V+  G C E    L+V+E+M  G L    F RS                 PL     + 
Sbjct: 82  IVRFFGVCTEGRPLLMVFEYMRHGDLNR--FLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 139
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           +A   A G+ +L   A    ++RD  T N L+      K+ DFG+++D        V  R
Sbjct: 140 VASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR 196
Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            M    +  PE ++    T++SDV+SFGVVL E+ T
Sbjct: 197 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 106/214 (49%), Gaps = 23/214 (10%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK--EWLAEVNFLGNLL 197
           +LGEG FG V +G +++      + GT L VAVKT+  D     +  E+L+E   + +  
Sbjct: 41  ILGEGEFGSVMEGNLKQ------EDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS 94
Query: 198 HPNLVKLVGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLP-----LPWSIRMKIAL 247
           HPN+++L+G CIE   +     +++  FM  G L  +L    L      +P    +K  +
Sbjct: 95  HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMV 154
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A G+ +L   + +  ++RD    N +L  D    ++DFGL+K     G  +   R+  
Sbjct: 155 DIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKI-YSGDYYRQGRIAK 210
Query: 308 T-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
               + A E +     TSKSDV++FGV + E+ T
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 16  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 63
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 249
           +  L H  LV+L    + ++   +V E+M +GSL + L     + L LP  + M   +  
Sbjct: 64  MKKLRHEKLVQLYA-VVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQI-- 120
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +           
Sbjct: 121 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPI 176
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L    R
Sbjct: 177 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 227
Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            YR+  P        +  +    L  QC  ++P+ RP
Sbjct: 228 GYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 257

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 124/295 (42%), Gaps = 44/295 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP     VAVK L  D  +    + ++E+  +  +  H
Sbjct: 25  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 82
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIR--------------M 243
            N++ L+G C +D    ++ E+  +G+L  +L  R  P L +S                +
Sbjct: 83  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 142
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
             A   A+G+ +L   A K  I+RD    N+L+  D   K++DFGLA+D         +T
Sbjct: 143 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 199
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV+L E+ T   S     P  E          
Sbjct: 200 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---------- 249
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETL 415
                  ++LL    EGH   K S    +L      C    P  RP   ++VE L
Sbjct: 250 ------LFKLLK---EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 295

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LGEG FG VF    E +   P +    + VAVK L        +++  E   L  L H +
Sbjct: 20  LGEGAFGKVFLA--ECHNLLPEQ--DKMLVAVKALKEASESARQDFQREAELLTMLQHQH 75
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL----------------PLPWSIRMK 244
           +V+  G C E    L+V+E+M  G L    F RS                 PL     + 
Sbjct: 76  IVRFFGVCTEGRPLLMVFEYMRHGDLNR--FLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 133
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           +A   A G+ +L   A    ++RD  T N L+      K+ DFG+++D        V  R
Sbjct: 134 VASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR 190
Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            M    +  PE ++    T++SDV+SFGVVL E+ T
Sbjct: 191 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LGEG FG VF    E +   P +    + VAVK L        +++  E   L  L H +
Sbjct: 49  LGEGAFGKVFLA--ECHNLLPEQ--DKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL----------------PLPWSIRMK 244
           +V+  G C E    L+V+E+M  G L    F RS                 PL     + 
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNR--FLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           +A   A G+ +L   A    ++RD  T N L+      K+ DFG+++D        V  R
Sbjct: 163 VASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR 219
Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            M    +  PE ++    T++SDV+SFGVVL E+ T
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 124/295 (42%), Gaps = 44/295 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP     VAVK L  D  +    + ++E+  +  +  H
Sbjct: 36  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIR--------------M 243
            N++ L+G C +D    ++ E+  +G+L  +L  R  P L +S                +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
             A   A+G+ +L   A K  I+RD    N+L+  D   K++DFGLA+D         +T
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV+L E+ T   S     P  E          
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---------- 260
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETL 415
                  ++LL    EGH   K S    +L      C    P  RP   ++VE L
Sbjct: 261 ------LFKLLK---EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 124/295 (42%), Gaps = 44/295 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP     VAVK L  D  +    + ++E+  +  +  H
Sbjct: 29  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 86
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIR--------------M 243
            N++ L+G C +D    ++ E+  +G+L  +L  R  P L +S                +
Sbjct: 87  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 146
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
             A   A+G+ +L   A K  I+RD    N+L+  D   K++DFGLA+D         +T
Sbjct: 147 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 203
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV+L E+ T   S     P  E          
Sbjct: 204 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---------- 253
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETL 415
                  ++LL    EGH   K S    +L      C    P  RP   ++VE L
Sbjct: 254 ------LFKLLK---EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 299

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 122/267 (45%), Gaps = 33/267 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G  G V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 21  LGAGQAGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 69
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L    +  +   ++ E+M  GSL + L   S + L  +  + +A   A+G+AF+ E 
Sbjct: 70  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 127
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 128 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDAEXTAREGAKFPIKWTAPEAINY 184
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 233
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARP 406
                   ++  QL   C    P+ RP
Sbjct: 234 -----NCPEELYQLMRLCWKERPEDRP 255

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 124/295 (42%), Gaps = 44/295 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP     VAVK L  D  +    + ++E+  +  +  H
Sbjct: 28  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 85
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIR--------------M 243
            N++ L+G C +D    ++ E+  +G+L  +L  R  P L +S                +
Sbjct: 86  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 145
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
             A   A+G+ +L   A K  I+RD    N+L+  D   K++DFGLA+D         +T
Sbjct: 146 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 202
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV+L E+ T   S     P  E          
Sbjct: 203 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---------- 252
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETL 415
                  ++LL    EGH   K S    +L      C    P  RP   ++VE L
Sbjct: 253 ------LFKLLK---EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 298

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 133/291 (45%), Gaps = 43/291 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G  +  G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 20  LGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 75
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 248
           ++V+L+G   +    L++ E M RG L+++L  RSL           P   S  +++A  
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVLAPPSLSKMIQMAGE 133
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            A G+A+L+       ++RD    N  +  D+  K+ DFG+ +D  E        + +  
Sbjct: 134 IADGMAYLNA---NKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 190
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
             + +PE +  G  T+ SDV+SFGVVL E+ T               L E  +P+ G   
Sbjct: 191 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSN 233
Query: 369 RFYRLLDPRLEGHFSIKGSQ---KATQLAAQCLSRDPKARPRMSEVVETLK 416
              ++L   +EG    K         +L   C   +PK RP   E++ ++K
Sbjct: 234 E--QVLRFVMEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIK 282

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 83/270 (30%), Positives = 124/270 (45%), Gaps = 39/270 (14%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V+ G W   NG           VA+KTL   G    + +L E   +  L H 
Sbjct: 17  LGNGQFGEVWMGTW---NGNT--------KVAIKTLK-PGTMSPESFLEEAQIMKKLKHD 64
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
            LV+L    + ++   +V E+M +GSL + L     R+L LP  + M  A   A G+A++
Sbjct: 65  KLVQLYA-VVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDM--AAQVAAGMAYI 121
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
                   I+RD +++NIL+      K++DFGLA+   ED +            + APE 
Sbjct: 122 ER---MNYIHRDLRSANILVGNGLICKIADFGLAR-LIEDNEXTARQGAKFPIKWTAPEA 177
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP 376
            + G  T KSDV+SFG++L E++T  R       N         R  L    R YR+  P
Sbjct: 178 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---------REVLEQVERGYRMPCP 228
Query: 377 RLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
           + +   S+       +L   C  +DP+ RP
Sbjct: 229 Q-DCPISLH------ELMIHCWKKDPEERP 251

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 124/295 (42%), Gaps = 44/295 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP     VAVK L  D  +    + ++E+  +  +  H
Sbjct: 77  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIR--------------M 243
            N++ L+G C +D    ++ E+  +G+L  +L  R  P L +S                +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
             A   A+G+ +L   A K  I+RD    N+L+  D   K++DFGLA+D         +T
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV+L E+ T   S     P  E          
Sbjct: 252 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---------- 301
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETL 415
                  ++LL    EGH   K S    +L      C    P  RP   ++VE L
Sbjct: 302 ------LFKLLK---EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 122/295 (41%), Gaps = 44/295 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP     VAVK L  D  +    + ++E+  +  +  H
Sbjct: 21  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 243
            N++ L+G C +D    ++ E+  +G+L  +L  R  P               L     +
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 138
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
             A   A+G+ +L   A K  I+RD    N+L+  D   K++DFGLA+D         +T
Sbjct: 139 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV+L E+ T   S     P  E          
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---------- 245
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETL 415
                  ++LL    EGH   K S    +L      C    P  RP   ++VE L
Sbjct: 246 ------LFKLLK---EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 126/281 (44%), Gaps = 35/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V+ G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 40  LGGGQYGEVYVG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 89
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    +V E+MP G+L ++L   +   +   + + +A   +  + +L   
Sbjct: 90  LVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE-- 147
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 148 -KKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 204
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 205 YNTFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYDLLEKG 247
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                      K  +L   C    P  RP  +E  +  + +
Sbjct: 248 YRMEQPEGCPPKVYELMRACWKWSPADRPSFAETHQAFETM 288

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 122/295 (41%), Gaps = 44/295 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP     VAVK L  D  +    + ++E+  +  +  H
Sbjct: 36  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 243
            N++ L+G C +D    ++ E+  +G+L  +L  R  P               L     +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 153
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
             A   A+G+ +L   A K  I+RD    N+L+  D   K++DFGLA+D         +T
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV+L E+ T   S     P  E          
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---------- 260
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETL 415
                  ++LL    EGH   K S    +L      C    P  RP   ++VE L
Sbjct: 261 ------LFKLLK---EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 123/300 (41%), Gaps = 46/300 (15%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGNL-LH 198
           LG G FG V    VE       K    L VAVK L        KE L +E+  + +L  H
Sbjct: 39  LGAGAFGKV----VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 94
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL--------------------P 238
            N+V L+G C      L++ E+   G L N L R++  +                    P
Sbjct: 95  ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRP 154
Query: 239 WSIR--MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED 296
             +R  +  +   A+G+AFL   A K  I+RD    N+LL   + AK+ DFGLA+D   D
Sbjct: 155 LELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 211
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 356
               V         + APE +     T +SDV+S+G++L E+     S+  N        
Sbjct: 212 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLN-------- 259
Query: 357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
                P +    +FY+L+    +        +    +   C + +P  RP   ++   L+
Sbjct: 260 ---PYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 316

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 110/220 (50%), Gaps = 17/220 (7%)
Query: 128 LKLATRNFRPESL-----LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTL-NHDGL 180
           +K+  R F+   L     LG G FG V KG W+ E  +  +       V +K + +  G 
Sbjct: 3   MKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKI------PVCIKVIEDKSGR 56
Query: 181 QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWS 240
           Q  +     +  +G+L H ++V+L+G C     +L V +++P GSL +H+ +    L   
Sbjct: 57  QSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQ 115
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH 300
           + +   +  AKG+ +L E     +++R+    N+LL +    +++DFG+A   P D K  
Sbjct: 116 LLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL 172
Query: 301 VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           + +       + A E +  G  T +SDV+S+GV + E++T
Sbjct: 173 LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 105/209 (50%), Gaps = 12/209 (5%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLAEVN 191
             R   +LG G FG V KG W+ E  +  +       V +K + +  G Q  +     + 
Sbjct: 32  ELRKLKVLGSGVFGTVHKGVWIPEGESIKI------PVCIKVIEDKSGRQSFQAVTDHML 85
Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 251
            +G+L H ++V+L+G C     +L V +++P GSL +H+ +    L   + +   +  AK
Sbjct: 86  AIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAK 144
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+ +L E     +++R+    N+LL +    +++DFG+A   P D K  + +       +
Sbjct: 145 GMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 201
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            A E +  G  T +SDV+S+GV + E++T
Sbjct: 202 MALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 102/215 (47%), Gaps = 14/215 (6%)
Query: 130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW 186
           +  ++ R    LG+G FG V +G       AP   G  ++VAVK L  D L   +   ++
Sbjct: 9   IGEKDLRLLEKLGDGSFGVVRRG----EWDAP--SGKTVSVAVKCLKPDVLSQPEAMDDF 62
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
           + EVN + +L H NL++L G  +    ++ V E  P GSL + L +           + A
Sbjct: 63  IREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYA 121
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           +  A+G+ +L     K  I+RD    N+LL      K+ DFGL +  P++   +V     
Sbjct: 122 VQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 178
Query: 307 GT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + + APE + T   +  SD + FGV L EM T
Sbjct: 179 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 105/211 (49%), Gaps = 16/211 (7%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA--EVN 191
           +F    +LG+G FG VF            +P +G   A+K L    L+         E +
Sbjct: 29  HFELLKVLGQGSFGKVFLV------RKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERD 82
Query: 192 FLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 250
            L ++ HP +VKL  Y  + + +L L+ +F+  G L   L +  +     ++  +A   A
Sbjct: 83  ILADVNHPFVVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELA 140
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            GL  LH      +IYRD K  NILLD + + KL+DFGL+K+A +  K   S    GT  
Sbjct: 141 LGLDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS--FCGTVE 195
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           Y APE V     +  +D +S+GV++ EMLTG
Sbjct: 196 YMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 126/301 (41%), Gaps = 44/301 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 243
            N++ L+G C +D    ++ E+  +G+L  +L  R  P               + +   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLV 160
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 267
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 420
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 268 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 421 L 421
           L
Sbjct: 319 L 319

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 102/215 (47%), Gaps = 14/215 (6%)
Query: 130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW 186
           +  ++ R    LG+G FG V +G       AP   G  ++VAVK L  D L   +   ++
Sbjct: 9   IGEKDLRLLEKLGDGSFGVVRRG----EWDAP--SGKTVSVAVKCLKPDVLSQPEAMDDF 62
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
           + EVN + +L H NL++L G  +    ++ V E  P GSL + L +           + A
Sbjct: 63  IREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYA 121
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           +  A+G+ +L     K  I+RD    N+LL      K+ DFGL +  P++   +V     
Sbjct: 122 VQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 178
Query: 307 GT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + + APE + T   +  SD + FGV L EM T
Sbjct: 179 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 102/215 (47%), Gaps = 14/215 (6%)
Query: 130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW 186
           +  ++ R    LG+G FG V +G       AP   G  ++VAVK L  D L   +   ++
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRG----EWDAP--SGKTVSVAVKCLKPDVLSQPEAMDDF 68
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
           + EVN + +L H NL++L G  +    ++ V E  P GSL + L +           + A
Sbjct: 69  IREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYA 127
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           +  A+G+ +L     K  I+RD    N+LL      K+ DFGL +  P++   +V     
Sbjct: 128 VQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 184
Query: 307 GT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + + APE + T   +  SD + FGV L EM T
Sbjct: 185 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 116/282 (41%), Gaps = 35/282 (12%)
Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 186
           D ++    F    LLG+G FG V    V+E  T       G   A+K L  + +    E 
Sbjct: 4   DPRVTMNEFEYLKLLGKGTFGKVI--LVKEKAT-------GRYYAMKILKKEVIVAKDEV 54
Query: 187 ---LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM 243
              L E   L N  HP L  L       D+   V E+   G L  HL R  +      R 
Sbjct: 55  AHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF 114
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
             A      L +LH  +EK V+YRD K  N++LD D + K++DFGL K+  +DG T    
Sbjct: 115 YGA-EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MK 169
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
              GT  Y APE +         D +  GVV+ EM+ GR             L+      
Sbjct: 170 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------ 223
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           L ++ RF R L P            +A  L +  L +DPK R
Sbjct: 224 LMEEIRFPRTLGP------------EAKSLLSGLLKKDPKQR 253

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 85/280 (30%), Positives = 116/280 (41%), Gaps = 35/280 (12%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           ++    F    LLG+G FG V    V+E  T       G   A+K L  + +    E   
Sbjct: 147 RVTMNEFEYLKLLGKGTFGKVI--LVKEKAT-------GRYYAMKILKKEVIVAKDEVAH 197
Query: 187 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 245
            L E   L N  HP L  L       D+   V E+   G L  HL R  +      R   
Sbjct: 198 TLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYG 257
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
           A      L +LH  +EK V+YRD K  N++LD D + K++DFGL K+  +DG T  +   
Sbjct: 258 A-EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--F 312
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
            GT  Y APE +         D +  GVV+ EM+ GR             L+      L 
Sbjct: 313 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LM 366
Query: 366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           ++ RF R L P            +A  L +  L +DPK R
Sbjct: 367 EEIRFPRTLGP------------EAKSLLSGLLKKDPKQR 394

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 85/280 (30%), Positives = 116/280 (41%), Gaps = 35/280 (12%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           ++    F    LLG+G FG V    V+E  T       G   A+K L  + +    E   
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVI--LVKEKAT-------GRYYAMKILKKEVIVAKDEVAH 194
Query: 187 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 245
            L E   L N  HP L  L       D+   V E+   G L  HL R  +      R   
Sbjct: 195 TLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYG 254
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
           A      L +LH  +EK V+YRD K  N++LD D + K++DFGL K+  +DG T  +   
Sbjct: 255 A-EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--F 309
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
            GT  Y APE +         D +  GVV+ EM+ GR             L+      L 
Sbjct: 310 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LM 363
Query: 366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           ++ RF R L P            +A  L +  L +DPK R
Sbjct: 364 EEIRFPRTLGP------------EAKSLLSGLLKKDPKQR 391

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 126/301 (41%), Gaps = 44/301 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 243
            N++ L+G C +D    ++ E+  +G+L  +L  R  P               + +   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 267
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 420
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 268 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 421 L 421
           L
Sbjct: 319 L 319

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 102/215 (47%), Gaps = 14/215 (6%)
Query: 130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW 186
           +  ++ R    LG+G FG V +G       AP   G  ++VAVK L  D L   +   ++
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRG----EWDAP--SGKTVSVAVKCLKPDVLSQPEAMDDF 58
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
           + EVN + +L H NL++L G  +    ++ V E  P GSL + L +           + A
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYA 117
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           +  A+G+ +L     K  I+RD    N+LL      K+ DFGL +  P++   +V     
Sbjct: 118 VQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 174
Query: 307 GT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + + APE + T   +  SD + FGV L EM T
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V+ G+   N T          VAVKTL   G    + +L E N +  L H  
Sbjct: 21  LGAGQFGEVWMGYYN-NST---------KVAVKTLKP-GTMSVQAFLEEANLMKTLQHDK 69
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLH 257
           LV+L      ++   ++ E+M +GSL + L       + LP  I     +  A+G+A++ 
Sbjct: 70  LVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAYIE 127
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
               K  I+RD + +N+L+      K++DFGLA+   ED +            + APE +
Sbjct: 128 R---KNYIHRDLRAANVLVSESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAI 183
Query: 318 MTGHLTSKSDVYSFGVVLLEMLT 340
             G  T KSDV+SFG++L E++T
Sbjct: 184 NFGCFTIKSDVWSFGILLYEIVT 206

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 102/215 (47%), Gaps = 14/215 (6%)
Query: 130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW 186
           +  ++ R    LG+G FG V +G       AP   G  ++VAVK L  D L   +   ++
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRG----EWDAP--SGKTVSVAVKCLKPDVLSQPEAMDDF 58
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
           + EVN + +L H NL++L G  +    ++ V E  P GSL + L +           + A
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYA 117
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           +  A+G+ +L     K  I+RD    N+LL      K+ DFGL +  P++   +V     
Sbjct: 118 VQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 174
Query: 307 GT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + + APE + T   +  SD + FGV L EM T
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFL 193
            + E ++G G FG V  G ++  G   +       VA+KTL      +  +++L+E + +
Sbjct: 16  IKIEKVIGVGEFGEVCSGRLKVPGKREI------CVAIKTLKAGYTDKQRRDFLSEASIM 69
Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 253
           G   HPN++ L G   +    +++ E+M  GSL+  L +          + +  G   G+
Sbjct: 70  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGM 129
Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT-YGYA 312
            +L   ++   ++RD    NIL++++   K+SDFG+++   +D +   +TR       + 
Sbjct: 130 KYL---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWT 186
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           APE +     TS SDV+S+G+V+ E+++
Sbjct: 187 APEAIAYRKFTSASDVWSYGIVMWEVMS 214

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 105/232 (45%), Gaps = 47/232 (20%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           +GEG FG VF+      G  P +P T   VAVK L  +       ++  E   +    +P
Sbjct: 55  IGEGAFGRVFQA--RAPGLLPYEPFT--MVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL------------------------ 235
           N+VKL+G C       L++E+M  G L    F RS+                        
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNE--FLRSMSPHTVCSLSHSDLSTRARVSSPGP 168
Query: 236 -PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA- 293
            PL  + ++ IA   A G+A+L   +E+  ++RD  T N L+  +   K++DFGL+++  
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 225
Query: 294 -----PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                  DG   +  R M       PE +     T++SDV+++GVVL E+ +
Sbjct: 226 SADYYKADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/233 (30%), Positives = 114/233 (48%), Gaps = 30/233 (12%)
Query: 116 VASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL 175
           VA+Q  +F  +   L  +  +    +G+G FG V  G    N            VAVK +
Sbjct: 177 VAAQ-DEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGN-----------KVAVKCI 224
Query: 176 NHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRS 234
            +D     + +LAE + +  L H NLV+L+G  +E+   L +V E+M +GSL ++L  R 
Sbjct: 225 KNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG 282
Query: 235 LP-LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 293
              L     +K +L   + + +L        ++RD    N+L+  D  AK+SDFGL K+A
Sbjct: 283 RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339
Query: 294 P---EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 343
               + GK  V         + APE +     ++KSDV+SFG++L E+ +  R
Sbjct: 340 SSTQDTGKLPVK--------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 384

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 101/203 (49%), Gaps = 20/203 (9%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V+ G+   N T          VAVKTL   G    + +L E N +  L H  
Sbjct: 20  LGAGQFGEVWMGYYN-NST---------KVAVKTLK-PGTMSVQAFLEEANLMKTLQHDK 68
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLH 257
           LV+L     +++   ++ EFM +GSL + L       + LP  I     +  A+G+A++ 
Sbjct: 69  LVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAYIE 126
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
               K  I+RD + +N+L+      K++DFGLA+   ED +            + APE +
Sbjct: 127 R---KNYIHRDLRAANVLVSESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAI 182
Query: 318 MTGHLTSKSDVYSFGVVLLEMLT 340
             G  T KS+V+SFG++L E++T
Sbjct: 183 NFGCFTIKSNVWSFGILLYEIVT 205

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/233 (30%), Positives = 114/233 (48%), Gaps = 30/233 (12%)
Query: 116 VASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL 175
           VA+Q  +F  +   L  +  +    +G+G FG V  G    N            VAVK +
Sbjct: 5   VAAQ-DEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGN-----------KVAVKCI 52
Query: 176 NHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRS 234
            +D     + +LAE + +  L H NLV+L+G  +E+   L +V E+M +GSL ++L  R 
Sbjct: 53  KNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG 110
Query: 235 LP-LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 293
              L     +K +L   + + +L        ++RD    N+L+  D  AK+SDFGL K+A
Sbjct: 111 RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167
Query: 294 P---EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 343
               + GK  V         + APE +     ++KSDV+SFG++L E+ +  R
Sbjct: 168 SSTQDTGKLPVK--------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 212

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFL 193
            + E ++G G FG V  G ++  G   +       VA+KTL      +  +++L+E + +
Sbjct: 10  IKIEKVIGVGEFGEVCSGRLKVPGKREI------CVAIKTLKAGYTDKQRRDFLSEASIM 63
Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 253
           G   HPN++ L G   +    +++ E+M  GSL+  L +          + +  G   G+
Sbjct: 64  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGM 123
Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT-YGYA 312
            +L   ++   ++RD    NIL++++   K+SDFG+++   +D +   +TR       + 
Sbjct: 124 KYL---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWT 180
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           APE +     TS SDV+S+G+V+ E+++
Sbjct: 181 APEAIAYRKFTSASDVWSYGIVMWEVMS 208

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 105/215 (48%), Gaps = 35/215 (16%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           + + E  LG G FG V+     ++            VAVKT+   G    + +LAE N +
Sbjct: 183 SLKLEKKLGAGQFGEVWMATYNKHTK----------VAVKTMK-PGSMSVEAFLAEANVM 231
Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAA 250
             L H  LVKL    +  +   ++ EFM +GSL + L        PLP  I     +  A
Sbjct: 232 KTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--A 288
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY- 309
           +G+AF+ +   +  I+RD + +NIL+ A    K++DFGLA             RV   + 
Sbjct: 289 EGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLA-------------RVGAKFP 332
Query: 310 -GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 343
             + APE +  G  T KSDV+SFG++L+E++T  R
Sbjct: 333 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 367

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 126/301 (41%), Gaps = 44/301 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 243
            N++ L+G C +D    ++ E+  +G+L  +L  R  P               + +   +
Sbjct: 101 KNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 267
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 420
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 268 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 421 L 421
           L
Sbjct: 319 L 319

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 85/280 (30%), Positives = 115/280 (41%), Gaps = 35/280 (12%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           ++    F    LLG+G FG V    V+E  T       G   A+K L  + +    E   
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKVI--LVKEKAT-------GRYYAMKILKKEVIVAKDEVAH 54
Query: 187 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 245
            L E   L N  HP L  L       D+   V E+   G L  HL R  +      R   
Sbjct: 55  TLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYG 114
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
           A      L +LH  +EK V+YRD K  N++LD D + K++DFGL K+  +DG T      
Sbjct: 115 A-EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXF 169
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
            GT  Y APE +         D +  GVV+ EM+ GR             L+      L 
Sbjct: 170 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LM 223
Query: 366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           ++ RF R L P            +A  L +  L +DPK R
Sbjct: 224 EEIRFPRTLGP------------EAKSLLSGLLKKDPKQR 251

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 126/301 (41%), Gaps = 44/301 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKH 100
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 243
            N++ L+G C +D    ++ E+  +G+L  +L  R  P               + +   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 267
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 420
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 268 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 421 L 421
           L
Sbjct: 319 L 319

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 126/301 (41%), Gaps = 44/301 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 243
            N++ L+G C +D    ++ E+  +G+L  +L  R  P               + +   +
Sbjct: 101 KNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 267
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 420
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 268 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 421 L 421
           L
Sbjct: 319 L 319

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 85/280 (30%), Positives = 115/280 (41%), Gaps = 35/280 (12%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           ++    F    LLG+G FG V    V+E  T       G   A+K L  + +    E   
Sbjct: 5   RVTMNEFEYLKLLGKGTFGKVI--LVKEKAT-------GRYYAMKILKKEVIVAKDEVAH 55
Query: 187 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 245
            L E   L N  HP L  L       D+   V E+   G L  HL R  +      R   
Sbjct: 56  TLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYG 115
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
           A      L +LH  +EK V+YRD K  N++LD D + K++DFGL K+  +DG T      
Sbjct: 116 A-EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXF 170
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
            GT  Y APE +         D +  GVV+ EM+ GR             L+      L 
Sbjct: 171 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LM 224
Query: 366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           ++ RF R L P            +A  L +  L +DPK R
Sbjct: 225 EEIRFPRTLGP------------EAKSLLSGLLKKDPKQR 252

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 126/301 (41%), Gaps = 44/301 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 243
            N++ L+G C +D    ++ E+  +G+L  +L  R  P               + +   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTT 217
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 267
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 420
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 268 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 421 L 421
           L
Sbjct: 319 L 319

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 126/301 (41%), Gaps = 44/301 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 89  LGEGCFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 243
            N++ L+G C +D    ++ E+  +G+L  +L  R  P               + +   +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 264 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 313
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 420
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 314 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364
Query: 421 L 421
           L
Sbjct: 365 L 365

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 101/215 (46%), Gaps = 14/215 (6%)
Query: 130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW 186
           +  ++ R    LG+G FG V +G       AP   G  ++VAVK L  D L   +   ++
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRG----EWDAP--SGKTVSVAVKCLKPDVLSQPEAMDDF 68
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
           + EVN + +L H NL++L G  +    ++ V E  P GSL + L +           + A
Sbjct: 69  IREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYA 127
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           +  A+G+ +L     K  I+RD    N+LL      K+ DFGL +  P++    V     
Sbjct: 128 VQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHR 184
Query: 307 GT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + + APE + T   +  SD + FGV L EM T
Sbjct: 185 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 29/208 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G+G FG V  G    N            VAVK + +D     + +LAE + +  L H N
Sbjct: 20  IGKGEFGDVMLGDYRGN-----------KVAVKCIKNDATA--QAFLAEASVMTQLRHSN 66
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLAFLHE 258
           LV+L+G  +E+   L +V E+M +GSL ++L  R    L     +K +L   + + +L  
Sbjct: 67  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 126
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP---EDGKTHVSTRVMGTYGYAAPE 315
                 ++RD    N+L+  D  AK+SDFGL K+A    + GK  V         + APE
Sbjct: 127 ---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK--------WTAPE 175
Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGRR 343
            +     ++KSDV+SFG++L E+ +  R
Sbjct: 176 ALREAAFSTKSDVWSFGILLWEIYSFGR 203

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 101/215 (46%), Gaps = 14/215 (6%)
Query: 130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW 186
           +  ++ R    LG+G FG V +G       AP   G  ++VAVK L  D L   +   ++
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRG----EWDAP--SGKTVSVAVKCLKPDVLSQPEAMDDF 58
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
           + EVN + +L H NL++L G  +    ++ V E  P GSL + L +           + A
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYA 117
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           +  A+G+ +L     K  I+RD    N+LL      K+ DFGL +  P++    V     
Sbjct: 118 VQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHR 174
Query: 307 GT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + + APE + T   +  SD + FGV L EM T
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 141/294 (47%), Gaps = 39/294 (13%)
Query: 128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EW 186
           ++L   +F   S LG G  G VFK           KP +GL +A K ++ +     + + 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQI 51
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
           + E+  L     P +V   G    D +  +  E M  GSL + + +++  +P  I  K++
Sbjct: 52  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVS 110
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           +   KGL +L E+ +  +++RD K SNIL+++    KL DFG++    +     ++   +
Sbjct: 111 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFV 164
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           GT  Y +PE +   H + +SD++S G+ L+EM  GR  +    P+ +    E +RP +  
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP--PDAK----EDSRPPMA- 217
Query: 367 KRRFYRLLD-------PRL-EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
               + LLD       P+L  G FS+    +      +CL ++P  R  + +++
Sbjct: 218 ---IFELLDYIVNEPPPKLPSGVFSL----EFQDFVNKCLIKNPAERADLKQLM 264

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 126/301 (41%), Gaps = 44/301 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 30  LGEGCFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 87
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 243
            N++ L+G C +D    ++ E+  +G+L  +L  R  P               + +   +
Sbjct: 88  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 147
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 148 SCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTT 204
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 205 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 254
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 420
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 255 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 305
Query: 421 L 421
           L
Sbjct: 306 L 306

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 126/301 (41%), Gaps = 44/301 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 35  LGEGCFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 92
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 243
            N++ L+G C +D    ++ E+  +G+L  +L  R  P               + +   +
Sbjct: 93  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 152
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 153 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 209
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 210 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 259
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 420
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 260 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 310
Query: 421 L 421
           L
Sbjct: 311 L 311

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 126/301 (41%), Gaps = 44/301 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 32  LGEGCFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 89
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 243
            N++ L+G C +D    ++ E+  +G+L  +L  R  P               + +   +
Sbjct: 90  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 149
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 150 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 206
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 207 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 256
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 420
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 257 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 307
Query: 421 L 421
           L
Sbjct: 308 L 308

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 118/282 (41%), Gaps = 40/282 (14%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           K+   +F    LLG+G FG V    V E  T       G   A+K L  + +    E   
Sbjct: 4   KVTMNDFDYLKLLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAH 54
Query: 187 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
            + E   L N  HP L  L  Y  +   RL  V E+   G L  HL R  +      R  
Sbjct: 55  TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY 113
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
            A      L +LH    + V+YRD K  N++LD D + K++DFGL K+   DG T  +  
Sbjct: 114 GA-EIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-- 167
Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPH 363
             GT  Y APE +         D +  GVV+ EM+ GR        N +H  L E     
Sbjct: 168 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF----YNQDHERLFELI--- 220
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           L ++ RF R L P            +A  L A  L +DPK R
Sbjct: 221 LMEEIRFPRTLSP------------EAKSLLAGLLKKDPKQR 250

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 19/215 (8%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENG--TAPVKPGTGLTVAVKTLNHDGLQGHKEW 186
           K + ++F+    LG G FG V       NG   A       + V +K + H         
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTN------- 54
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
             E   L  + HP ++++ G   +  Q  ++ +++  G L + L R+S   P  +    A
Sbjct: 55  -DERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFS-LLRKSQRFPNPVAKFYA 112
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
                 L +LH    K +IYRD K  NILLD + + K++DFG AK  P+     V+  + 
Sbjct: 113 AEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYXLC 164
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           GT  Y APE V T       D +SFG+++ EML G
Sbjct: 165 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 126/301 (41%), Gaps = 44/301 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 243
            N++ L+G C +D    ++ E+  +G+L  +L  R  P               + +   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
                 A+G+ +L   A +  I+RD    N+L+  +   +++DFGLA+D         +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTT 217
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 267
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 420
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 268 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 421 L 421
           L
Sbjct: 319 L 319

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 118/282 (41%), Gaps = 40/282 (14%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           K+   +F    LLG+G FG V    V E  T       G   A+K L  + +    E   
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAH 51
Query: 187 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
            + E   L N  HP L  L  Y  +   RL  V E+   G L  HL R  +      R  
Sbjct: 52  TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY 110
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
            A      L +LH    + V+YRD K  N++LD D + K++DFGL K+   DG T  +  
Sbjct: 111 GA-EIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-- 164
Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPH 363
             GT  Y APE +         D +  GVV+ EM+ GR        N +H  L E     
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF----YNQDHERLFELI--- 217
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           L ++ RF R L P            +A  L A  L +DPK R
Sbjct: 218 LMEEIRFPRTLSP------------EAKSLLAGLLKKDPKQR 247

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 118/282 (41%), Gaps = 40/282 (14%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           K+   +F    LLG+G FG V    V E  T       G   A+K L  + +    E   
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAH 51
Query: 187 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
            + E   L N  HP L  L  Y  +   RL  V E+   G L  HL R  +      R  
Sbjct: 52  TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY 110
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
            A      L +LH    + V+YRD K  N++LD D + K++DFGL K+   DG T  +  
Sbjct: 111 GA-EIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-- 164
Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPH 363
             GT  Y APE +         D +  GVV+ EM+ GR        N +H  L E     
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF----YNQDHERLFELI--- 217
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           L ++ RF R L P            +A  L A  L +DPK R
Sbjct: 218 LMEEIRFPRTLSP------------EAKSLLAGLLKKDPKQR 247

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 107/219 (48%), Gaps = 29/219 (13%)
Query: 130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 189
           L  +  +    +G+G FG V  G              G  VAVK + +D     + +LAE
Sbjct: 3   LNMKELKLLQTIGKGEFGDVMLG-----------DYRGNKVAVKCIKNDATA--QAFLAE 49
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLP-LPWSIRMKIAL 247
            + +  L H NLV+L+G  +E+   L +V E+M +GSL ++L  R    L     +K +L
Sbjct: 50  ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 109
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP---EDGKTHVSTR 304
              + + +L        ++RD    N+L+  D  AK+SDFGL K+A    + GK  V   
Sbjct: 110 DVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-- 164
Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 343
                 + APE +     ++KSDV+SFG++L E+ +  R
Sbjct: 165 ------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 117/282 (41%), Gaps = 40/282 (14%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           K+   +F    LLG+G FG V    V E  T       G   A+K L  + +    E   
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAH 51
Query: 187 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
            + E   L N  HP L  L  Y  +   RL  V E+   G L  HL R  +      R  
Sbjct: 52  TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY 110
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
            A      L +LH    + V+YRD K  N++LD D + K++DFGL K+   DG T     
Sbjct: 111 GA-EIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKX 164
Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPH 363
             GT  Y APE +         D +  GVV+ EM+ GR        N +H  L E     
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF----YNQDHERLFELI--- 217
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           L ++ RF R L P            +A  L A  L +DPK R
Sbjct: 218 LMEEIRFPRTLSP------------EAKSLLAGLLKKDPKQR 247

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 118/239 (49%), Gaps = 24/239 (10%)
Query: 112 EELKVASQLRK----FMFNDLK---LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKP 164
           EEL++  Q RK    F+    K   L   +F   S LG G  G VFK           KP
Sbjct: 5   EELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFK--------VSHKP 56
Query: 165 GTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR 223
            +GL +A K ++ +     + + + E+  L     P +V   G    D +  +  E M  
Sbjct: 57  -SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 115
Query: 224 GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK 283
           GSL + + +++  +P  I  K+++   KGL +L E+ +  +++RD K SNIL+++    K
Sbjct: 116 GSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIK 172
Query: 284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           L DFG++    +     ++   +GT  Y +PE +   H + +SD++S G+ L+EM  GR
Sbjct: 173 LCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 87/283 (30%), Positives = 115/283 (40%), Gaps = 38/283 (13%)
Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 186
           D K+   +F    LLG+G FG V    V E  T       G   A+K L  + +    E 
Sbjct: 4   DPKVTMNDFDYLKLLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEV 54
Query: 187 ---LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR 242
              + E   L N  HP L  L  Y  +   RL  V E+   G L  HL R  +      R
Sbjct: 55  AHTVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERAR 113
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
              A      L +LH    + V+YRD K  N++LD D + K++DFGL K+   DG T   
Sbjct: 114 FYGA-EIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--M 167
Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 362
               GT  Y APE +         D +  GVV+ EM+ GR             L+     
Sbjct: 168 KXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI----- 222
Query: 363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
            L ++ RF R L P            +A  L A  L +DPK R
Sbjct: 223 -LMEEIRFPRTLSP------------EAKSLLAGLLKKDPKQR 252

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 117/282 (41%), Gaps = 40/282 (14%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           K+   +F    LLG+G FG V    V E  T       G   A+K L  + +    E   
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAH 51
Query: 187 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
            + E   L N  HP L  L  Y  +   RL  V E+   G L  HL R  +      R  
Sbjct: 52  TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY 110
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
            A      L +LH    + V+YRD K  N++LD D + K++DFGL K+   DG T     
Sbjct: 111 GA-EIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKX 164
Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPH 363
             GT  Y APE +         D +  GVV+ EM+ GR        N +H  L E     
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF----YNQDHERLFELI--- 217
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           L ++ RF R L P            +A  L A  L +DPK R
Sbjct: 218 LMEEIRFPRTLSP------------EAKSLLAGLLKKDPKQR 247

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 119/285 (41%), Gaps = 39/285 (13%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----- 188
           +F+  +LLG+G F  V++              TGL VA+K ++   +  +K  +      
Sbjct: 12  DFKVGNLLGKGSFAGVYRAE---------SIHTGLEVAIKMIDKKAM--YKAGMVQRVQN 60
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 248
           EV     L HP++++L  Y  + +   LV E    G +  +L  R  P   +        
Sbjct: 61  EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ 120
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
              G+ +LH      +++RD   SN+LL  + N K++DFGLA       + H +  + GT
Sbjct: 121 IITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGT 175
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
             Y +PE         +SDV+S G +   +L GR   D +      N V  A        
Sbjct: 176 PNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA-------- 227
Query: 369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                 D  +    SI    +A  L  Q L R+P  R  +S V++
Sbjct: 228 ------DYEMPSFLSI----EAKDLIHQLLRRNPADRLSLSSVLD 262

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 97/211 (45%), Gaps = 19/211 (9%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +    H 
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRM----KIALGAAKG 252
           N+V+ +G  ++   R ++ E M  G L++ L R + P    P S+ M     +A   A G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
             +L E      I+RD    N LL        AK+ DFG+A+D    G        M   
Sbjct: 194 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV 250
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            +  PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 97/211 (45%), Gaps = 19/211 (9%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +    H 
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 111
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRM----KIALGAAKG 252
           N+V+ +G  ++   R ++ E M  G L++ L R + P    P S+ M     +A   A G
Sbjct: 112 NIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACG 170
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
             +L E      I+RD    N LL        AK+ DFG+A+D    G        M   
Sbjct: 171 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV 227
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            +  PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 228 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 123/295 (41%), Gaps = 44/295 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 198
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 26  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 199 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHL-FRRSLPLPWSIR-------------- 242
            N+V L+G C +    L+V  EF   G+L  +L  +R+  +P+ +               
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
           +  +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D      
Sbjct: 142 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 198
Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 362
                   + APE +     T +SDV+SFGV+L E+ +                   A P
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASP 241
Query: 363 HLGDK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           + G K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 242 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 86/281 (30%), Positives = 114/281 (40%), Gaps = 38/281 (13%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           K+   +F    LLG+G FG V    V E  T       G   A+K L  + +    E   
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAH 51
Query: 187 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
            + E   L N  HP L  L  Y  +   RL  V E+   G L  HL R  +      R  
Sbjct: 52  TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY 110
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
            A      L +LH    + V+YRD K  N++LD D + K++DFGL K+   DG T     
Sbjct: 111 GA-EIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKX 164
Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
             GT  Y APE +         D +  GVV+ EM+ GR             L+      L
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------L 218
Query: 365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
            ++ RF R L P            +A  L A  L +DPK R
Sbjct: 219 MEEIRFPRTLSP------------EAKSLLAGLLKKDPKQR 247

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 116/278 (41%), Gaps = 30/278 (10%)
Query: 131 ATRN-FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 189
            T+N FR   +LG+GGFG V    V   G              K          K+ L +
Sbjct: 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK 240
Query: 190 VNFLGNLLHPNLVKLVGYCIE-DDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIAL 247
           VN          V  + Y  E  D   LV   M  G L+ H++       P +  +  A 
Sbjct: 241 VN-------SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
               GL  LH E    ++YRD K  NILLD   + ++SD GLA   PE G+T +  RV G
Sbjct: 294 EICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE-GQT-IKGRV-G 347
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T GY APE V     T   D ++ G +L EM+ G+    + +   +   VE         
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE--------- 398
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
               RL+    E  +S + S +A  L +Q L +DP  R
Sbjct: 399 ----RLVKEVPE-EYSERFSPQARSLCSQLLCKDPAER 431

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 116/278 (41%), Gaps = 30/278 (10%)
Query: 131 ATRN-FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 189
            T+N FR   +LG+GGFG V    V   G              K          K+ L +
Sbjct: 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK 240
Query: 190 VNFLGNLLHPNLVKLVGYCIE-DDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIAL 247
           VN          V  + Y  E  D   LV   M  G L+ H++       P +  +  A 
Sbjct: 241 VN-------SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
               GL  LH E    ++YRD K  NILLD   + ++SD GLA   PE G+T +  RV G
Sbjct: 294 EICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE-GQT-IKGRV-G 347
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T GY APE V     T   D ++ G +L EM+ G+    + +   +   VE         
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE--------- 398
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
               RL+    E  +S + S +A  L +Q L +DP  R
Sbjct: 399 ----RLVKEVPE-EYSERFSPQARSLCSQLLCKDPAER 431

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 123/295 (41%), Gaps = 44/295 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 198
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 26  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 199 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHL-FRRSLPLPWSIR-------------- 242
            N+V L+G C +    L+V  EF   G+L  +L  +R+  +P+ +               
Sbjct: 82  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
           +  +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D      
Sbjct: 142 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 198
Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 362
                   + APE +     T +SDV+SFGV+L E+ +                   A P
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASP 241
Query: 363 HLGDK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           + G K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 242 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 123/295 (41%), Gaps = 44/295 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 198
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 35  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 199 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHL-FRRSLPLPWSIR-------------- 242
            N+V L+G C +    L+V  EF   G+L  +L  +R+  +P+ +               
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
           +  +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D      
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 362
                   + APE +     T +SDV+SFGV+L E+ +                   A P
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASP 250
Query: 363 HLGDK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           + G K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 251 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 125/301 (41%), Gaps = 44/301 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 243
            N++ L+G C +D    ++  +  +G+L  +L  R  P               + +   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 267
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 420
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 268 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 421 L 421
           L
Sbjct: 319 L 319

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 105/213 (49%), Gaps = 20/213 (9%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTV----AVKTLNHDGLQGHKEWLAE 189
            F    +LG+G FG VF   V++   +  +    + V     +K  +    +  ++ L E
Sbjct: 26  QFELLKVLGQGSFGKVF--LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE 83
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 248
           VN      HP +VKL  Y  + + +L L+ +F+  G L   L +  +     ++  +A  
Sbjct: 84  VN------HPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-E 135
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            A  L  LH      +IYRD K  NILLD + + KL+DFGL+K++ +  K   S    GT
Sbjct: 136 LALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 190
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
             Y APE V     T  +D +SFGV++ EMLTG
Sbjct: 191 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 105/213 (49%), Gaps = 20/213 (9%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTV----AVKTLNHDGLQGHKEWLAE 189
            F    +LG+G FG VF   V++   +  +    + V     +K  +    +  ++ L E
Sbjct: 25  QFELLKVLGQGSFGKVF--LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE 82
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 248
           VN      HP +VKL  Y  + + +L L+ +F+  G L   L +  +     ++  +A  
Sbjct: 83  VN------HPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-E 134
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            A  L  LH      +IYRD K  NILLD + + KL+DFGL+K++ +  K   S    GT
Sbjct: 135 LALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 189
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
             Y APE V     T  +D +SFGV++ EMLTG
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/306 (26%), Positives = 135/306 (44%), Gaps = 37/306 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEVNFLGNLLHP 199
           +G+G FG VFKG   +N T  V       VA+K ++  +     ++   E+  L     P
Sbjct: 15  IGKGSFGEVFKGI--DNRTQKV-------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 65
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
            + K  G  ++D +  ++ E++  GS  + L     PL  +    I     KGL +LH E
Sbjct: 66  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSE 123
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
            +   I+RD K +N+LL      KL+DFG+A     D +   +T V GT  + APE +  
Sbjct: 124 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNTFV-GTPFWMAPEVIKQ 178
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
               SK+D++S G+  +E+  G     +  P     L+    P             P LE
Sbjct: 179 SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------PTLE 225
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQTMQADNT 439
           G++    S+   +    CL+++P  RP   E+++    L+N K    +SY  + +     
Sbjct: 226 GNY----SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK---KTSYLTELIDRYKR 278
Query: 440 WSIRNS 445
           W    S
Sbjct: 279 WKAEQS 284

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG+G FG V+K   +E         TG   A K +     +  ++++ E+  L    HP 
Sbjct: 27  LGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           +VKL+G    D +  ++ EF P G+++  +      L       +     + L FLH   
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH--- 134
Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG 320
            K +I+RD K  N+L+  + + +L+DFG++  A            +GT  + APE VM  
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYWMAPEVVMCE 192
Query: 321 HLTS-----KSDVYSFGVVLLEM 338
            +       K+D++S G+ L+EM
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEM 215

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 105/213 (49%), Gaps = 20/213 (9%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTV----AVKTLNHDGLQGHKEWLAE 189
            F    +LG+G FG VF   V++   +  +    + V     +K  +    +  ++ L E
Sbjct: 25  QFELLKVLGQGSFGKVF--LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE 82
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 248
           VN      HP +VKL  Y  + + +L L+ +F+  G L   L +  +     ++  +A  
Sbjct: 83  VN------HPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-E 134
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            A  L  LH      +IYRD K  NILLD + + KL+DFGL+K++ +  K   S    GT
Sbjct: 135 LALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 189
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
             Y APE V     T  +D +SFGV++ EMLTG
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 107/213 (50%), Gaps = 12/213 (5%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 16  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 69
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E   + ++ +P++ +L+G C+    +L++ + MP G L +++      +     +   +
Sbjct: 70  DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 128
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + +     
Sbjct: 129 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 185
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + A E ++    T +SDV+S+GV + E++T
Sbjct: 186 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 17/215 (7%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 187
           +L   +F   S LG G  G VFK           KP +GL +A K ++ +     + + +
Sbjct: 64  ELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQII 114
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E+  L     P +V   G    D +  +  E M  GSL + + +++  +P  I  K+++
Sbjct: 115 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSI 173
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
              KGL +L E+ +  +++RD K SNIL+++    KL DFG++    +     ++   +G
Sbjct: 174 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVG 227
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           T  Y +PE +   H + +SD++S G+ L+EM  GR
Sbjct: 228 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 102/213 (47%), Gaps = 15/213 (7%)
Query: 135 FRPES-----LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 189
            RPE      +LG+GG+G VF+  V +   A       + V  K +     +      AE
Sbjct: 14  IRPECFELLRVLGKGGYGKVFQ--VRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAE 71
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 248
            N L  + HP +V L+ Y  +   +L L+ E++  G L   L R  + +  +    +A  
Sbjct: 72  RNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA-E 129
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            +  L  LH+   K +IYRD K  NI+L+   + KL+DFGL K++  DG   V+    GT
Sbjct: 130 ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHXFCGT 184
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
             Y APE +M        D +S G ++ +MLTG
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +  L H 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQ 94
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIALGAAKGLAF- 255
           N+V+ +G  ++   R ++ E M  G L++ L R + P    P S+ M   L  A+ +A  
Sbjct: 95  NIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACG 153
Query: 256 LHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
                E   I+RD    N LL        AK+ DFG+A+D             M    + 
Sbjct: 154 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 213
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 123/295 (41%), Gaps = 44/295 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 198
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 26  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 199 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHL-FRRSLPLPWSIR-------------- 242
            N+V L+G C +    L+V  EF   G+L  +L  +R+  +P+ +               
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
           +  +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D      
Sbjct: 142 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 198
Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 362
                   + APE +     T +SDV+SFGV+L E+ +                   A P
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASP 241
Query: 363 HLGDK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           + G K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 242 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 123/295 (41%), Gaps = 44/295 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 198
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 35  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 199 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHL-FRRSLPLPWSIR-------------- 242
            N+V L+G C +    L+V  EF   G+L  +L  +R+  +P+ +               
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
           +  +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D      
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRK 207
Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 362
                   + APE +     T +SDV+SFGV+L E+ +                   A P
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASP 250
Query: 363 HLGDK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           + G K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 251 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 109/215 (50%), Gaps = 17/215 (7%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 187
           +L   +F   S LG G  G VFK           KP +GL +A K ++ +     + + +
Sbjct: 5   ELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQII 55
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E+  L     P +V   G    D +  +  E M  GSL + + +++  +P  I  K+++
Sbjct: 56  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSI 114
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
              KGL +L E+ +  +++RD K SNIL+++    KL DFG++    ++    ++   +G
Sbjct: 115 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDE----MANEFVG 168
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           T  Y +PE +   H + +SD++S G+ L+EM  GR
Sbjct: 169 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 123/295 (41%), Gaps = 44/295 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 198
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 26  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 199 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHL-FRRSLPLPWSIR-------------- 242
            N+V L+G C +    L+V  EF   G+L  +L  +R+  +P+ +               
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
           +  +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D      
Sbjct: 142 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 198
Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 362
                   + APE +     T +SDV+SFGV+L E+ +                   A P
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASP 241
Query: 363 HLGDK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           + G K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 242 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 128/290 (44%), Gaps = 43/290 (14%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +G G FG V+KG W   +G   VK      + V     +  Q  +    EV  L    H 
Sbjct: 44  IGSGSFGTVYKGKW---HGDVAVK-----ILKVVDPTPEQFQAFRN---EVAVLRKTRHV 92
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           N++  +GY  +D+   +V ++    SL  HL  +         + IA   A+G+ +LH  
Sbjct: 93  NILLFMGYMTKDN-LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA- 150
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             K +I+RD K++NI L      K+ DFGLA        +    +  G+  + APE +  
Sbjct: 151 --KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRM 208
Query: 320 GH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL-- 374
                 + +SDVYS+G+VL E++TG                E    H+ ++ +   ++  
Sbjct: 209 QDNNPFSFQSDVYSYGIVLYELMTG----------------ELPYSHINNRDQIIFMVGR 252
Query: 375 ---DPRLEGHFSIKGSQKATQ-LAAQCLSRDPKARPRMSEVVETLKPLQN 420
               P L   +  K   KA + L A C+ +  + RP   +++ +++ LQ+
Sbjct: 253 GYASPDLSKLY--KNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 102/213 (47%), Gaps = 15/213 (7%)
Query: 135 FRPES-----LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 189
            RPE      +LG+GG+G VF+  V +   A       + V  K +     +      AE
Sbjct: 14  IRPECFELLRVLGKGGYGKVFQ--VRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAE 71
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 248
            N L  + HP +V L+ Y  +   +L L+ E++  G L   L R  + +  +    +A  
Sbjct: 72  RNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA-E 129
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            +  L  LH+   K +IYRD K  NI+L+   + KL+DFGL K++  DG   V+    GT
Sbjct: 130 ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFCGT 184
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
             Y APE +M        D +S G ++ +MLTG
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 83/305 (27%), Positives = 132/305 (43%), Gaps = 53/305 (17%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTG--LTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           LGEG FG V K       TA    G     TVAVK L  +      ++ L+E N L  + 
Sbjct: 31  LGEGEFGKVVKA------TAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN 84
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLP------------------- 236
           HP+++KL G C +D   LL+ E+   GSL   L   R+  P                   
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 237 --LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 294
             L     +  A   ++G+ +L   AE  +++RD    NIL+      K+SDFGL++D  
Sbjct: 145 RALTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
           E+      ++      + A E +     T++SDV+SFGV+L E++T    +  N      
Sbjct: 202 EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT----LGGN------ 251
Query: 355 NLVEWARPHLG-DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                  P+ G    R + LL            S++  +L  QC  ++P  RP  +++ +
Sbjct: 252 -------PYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304
Query: 414 TLKPL 418
            L+ +
Sbjct: 305 DLEKM 309

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 107/213 (50%), Gaps = 12/213 (5%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 67
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E   + ++ +P++ +L+G C+    +L++ + MP G L +++      +     +   +
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 126
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + +     
Sbjct: 127 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 183
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + A E ++    T +SDV+S+GV + E++T
Sbjct: 184 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 107/213 (50%), Gaps = 12/213 (5%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 13  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 66
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E   + ++ +P++ +L+G C+    +L++ + MP G L +++      +     +   +
Sbjct: 67  DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 125
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + +     
Sbjct: 126 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 182
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + A E ++    T +SDV+S+GV + E++T
Sbjct: 183 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 107/213 (50%), Gaps = 12/213 (5%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 65
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E   + ++ +P++ +L+G C+    +L++ + MP G L +++      +     +   +
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + +     
Sbjct: 125 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + A E ++    T +SDV+S+GV + E++T
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 80/309 (25%), Positives = 135/309 (43%), Gaps = 39/309 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEVNFLGNLLHP 199
           +G+G FG VFKG   +N T  V       VA+K ++  +     ++   E+  L     P
Sbjct: 30  IGKGSFGEVFKGI--DNRTQKV-------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
            + K  G  ++D +  ++ E++  GS  + L     PL  +    I     KGL +LH E
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSE 138
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS-TRVMGTYGYAAPEYVM 318
            +   I+RD K +N+LL      KL+DFG+A    +   T +     +GT  + APE + 
Sbjct: 139 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD---TQIKRNXFVGTPFWMAPEVIK 192
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRL 378
                SK+D++S G+  +E+  G     +  P     L+    P             P L
Sbjct: 193 QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------PTL 239
Query: 379 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQTMQADN 438
           EG++    S+   +    CL+++P  RP   E+++    L+N K    +SY  + +    
Sbjct: 240 EGNY----SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK---KTSYLTELIDRYK 292
Query: 439 TWSIRNSKN 447
            W    S +
Sbjct: 293 RWKAEQSHD 301

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 107/213 (50%), Gaps = 12/213 (5%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 68
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E   + ++ +P++ +L+G C+    +L++ + MP G L +++      +     +   +
Sbjct: 69  DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 127
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + +     
Sbjct: 128 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 184
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + A E ++    T +SDV+S+GV + E++T
Sbjct: 185 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 83/305 (27%), Positives = 132/305 (43%), Gaps = 53/305 (17%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTG--LTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           LGEG FG V K       TA    G     TVAVK L  +      ++ L+E N L  + 
Sbjct: 31  LGEGEFGKVVKA------TAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN 84
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLP------------------- 236
           HP+++KL G C +D   LL+ E+   GSL   L   R+  P                   
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 237 --LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 294
             L     +  A   ++G+ +L   AE  +++RD    NIL+      K+SDFGL++D  
Sbjct: 145 RALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
           E+      ++      + A E +     T++SDV+SFGV+L E++T    +  N      
Sbjct: 202 EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT----LGGN------ 251
Query: 355 NLVEWARPHLG-DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                  P+ G    R + LL            S++  +L  QC  ++P  RP  +++ +
Sbjct: 252 -------PYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304
Query: 414 TLKPL 418
            L+ +
Sbjct: 305 DLEKM 309

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 106/213 (49%), Gaps = 12/213 (5%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 22  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 75
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++      +     +   +
Sbjct: 76  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 134
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + +     
Sbjct: 135 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 191
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + A E ++    T +SDV+S+GV + E++T
Sbjct: 192 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 123/295 (41%), Gaps = 44/295 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 198
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 35  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 199 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHL-FRRSLPLPWSIR-------------- 242
            N+V L+G C +    L+V  EF   G+L  +L  +R+  +P+ +               
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
           +  +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D      
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 362
                   + APE +     T +SDV+SFGV+L E+ +                   A P
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASP 250
Query: 363 HLGDK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           + G K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 251 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 128/301 (42%), Gaps = 45/301 (14%)
Query: 116 VASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL 175
           + S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L
Sbjct: 3   MESKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVL 46
Query: 176 NHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR 232
               L+      +   EV    +L HPN+++L GY  +  +  L+ E+ PRG +   L +
Sbjct: 47  FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQK 106
Query: 233 RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD 292
            S          I    A  L++ H    K VI+RD K  N+LL +    K++DFG +  
Sbjct: 107 LSKFDEQRTATYIT-ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH 162
Query: 293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG 352
           AP   +    T + GT  Y  PE +       K D++S GV+  E L G+   + N    
Sbjct: 163 APSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 218
Query: 353 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
            +  +                   R+E  F    ++ A  L ++ L  +P  RP + EV+
Sbjct: 219 TYKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 260
Query: 413 E 413
           E
Sbjct: 261 E 261

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 106/213 (49%), Gaps = 12/213 (5%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 18  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 71
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++      +     +   +
Sbjct: 72  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 130
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + +     
Sbjct: 131 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 187
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + A E ++    T +SDV+S+GV + E++T
Sbjct: 188 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 106/213 (49%), Gaps = 12/213 (5%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 68
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++      +     +   +
Sbjct: 69  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 127
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + +     
Sbjct: 128 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 184
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + A E ++    T +SDV+S+GV + E++T
Sbjct: 185 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 107/213 (50%), Gaps = 12/213 (5%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 13  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 66
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E   + ++ +P++ +L+G C+    +L++ + MP G L +++      +     +   +
Sbjct: 67  DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGXLLDYVREHKDNIGSQYLLNWCV 125
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + +     
Sbjct: 126 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 182
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + A E ++    T +SDV+S+GV + E++T
Sbjct: 183 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 106/213 (49%), Gaps = 12/213 (5%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 19  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 72
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++      +     +   +
Sbjct: 73  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 131
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + +     
Sbjct: 132 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 188
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + A E ++    T +SDV+S+GV + E++T
Sbjct: 189 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG+G FG V+K   +E         TG   A K +     +  ++++ E+  L    HP 
Sbjct: 19  LGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 69
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           +VKL+G    D +  ++ EF P G+++  +      L       +     + L FLH   
Sbjct: 70  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH--- 126
Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG 320
            K +I+RD K  N+L+  + + +L+DFG++  A            +GT  + APE VM  
Sbjct: 127 SKRIIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYWMAPEVVMCE 184
Query: 321 HLTS-----KSDVYSFGVVLLEM 338
            +       K+D++S G+ L+EM
Sbjct: 185 TMKDTPYDYKADIWSLGITLIEM 207

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 109/216 (50%), Gaps = 17/216 (7%)
Query: 128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EW 186
           ++L   +F   S LG G  G VFK           KP +GL +A K ++ +     + + 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQI 51
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
           + E+  L     P +V   G    D +  +  E M  GSL + + +++  +P  I  K++
Sbjct: 52  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVS 110
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           +   KGL +L E+ +  +++RD K SNIL+++    KL DFG++    +     ++   +
Sbjct: 111 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFV 164
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           GT  Y +PE +   H + +SD++S G+ L+EM  GR
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 125/301 (41%), Gaps = 44/301 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 243
            N++ L+G C +D    ++  +  +G+L  +L  R  P               + +   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 267
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 420
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 268 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 421 L 421
           L
Sbjct: 319 L 319

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 106/213 (49%), Gaps = 12/213 (5%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 37  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 90
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++      +     +   +
Sbjct: 91  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 149
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + +     
Sbjct: 150 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 206
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + A E ++    T +SDV+S+GV + E++T
Sbjct: 207 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +  L H 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQ 108
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIALGAAKGLAF- 255
           N+V+ +G  ++   R ++ E M  G L++ L R + P    P S+ M   L  A+ +A  
Sbjct: 109 NIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACG 167
Query: 256 LHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
                E   I+RD    N LL        AK+ DFG+A+D             M    + 
Sbjct: 168 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 227
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 106/213 (49%), Gaps = 12/213 (5%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 65
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++      +     +   +
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + +     
Sbjct: 125 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + A E ++    T +SDV+S+GV + E++T
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 122/293 (41%), Gaps = 42/293 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 198
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 37  LGRGAFGQV----IEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 92
Query: 199 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHL-FRRSLPLPWSIR------------MK 244
            N+V L+G C +    L+V  EF   G+L  +L  +R+  +P+               + 
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIX 152
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
            +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D        
Sbjct: 153 YSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
                 + APE +     T +SDV+SFGV+L E+ +                   A P+ 
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASPYP 252
Query: 365 GDK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           G K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 253 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 109/216 (50%), Gaps = 17/216 (7%)
Query: 128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EW 186
           ++L   +F   S LG G  G VFK           KP +GL +A K ++ +     + + 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQI 51
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
           + E+  L     P +V   G    D +  +  E M  GSL + + +++  +P  I  K++
Sbjct: 52  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVS 110
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           +   KGL +L E+ +  +++RD K SNIL+++    KL DFG++    +     ++   +
Sbjct: 111 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFV 164
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           GT  Y +PE +   H + +SD++S G+ L+EM  GR
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 106/213 (49%), Gaps = 12/213 (5%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 67
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++      +     +   +
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 126
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + +     
Sbjct: 127 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 183
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + A E ++    T +SDV+S+GV + E++T
Sbjct: 184 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 12/213 (5%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWL 187
           L     R   +LG G FG V+KG W+      P      + VA+K L  +   + +KE L
Sbjct: 14  LKETELRKVKVLGSGAFGTVYKGIWI------PDGENVKIPVAIKVLRENTSPKANKEIL 67
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E   +  +  P + +L+G C+    +L V + MP G L +H+      L     +   +
Sbjct: 68  DEAYVMAGVGSPYVSRLLGICLTSTVQL-VTQLMPYGCLLDHVRENRGRLGSQDLLNWCM 126
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             AKG+++L +     +++RD    N+L+ +  + K++DFGLA+    D   + +     
Sbjct: 127 QIAKGMSYLEDVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV 183
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + A E ++    T +SDV+S+GV + E++T
Sbjct: 184 PIKWMALESILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 122/291 (41%), Gaps = 40/291 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 198
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 35  LGRGAFGQV----IEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 199 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHL-FRRSLPLPWSIRMK----------IA 246
            N+V L+G C +    L+V  EF   G+L  +L  +R+  +P+    K           +
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYS 150
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
              AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D          
Sbjct: 151 FQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDAR 207
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
               + APE +     T +SDV+SFGV+L E+ +                   A P+ G 
Sbjct: 208 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASPYPGV 250
Query: 367 K--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 251 KIDEEFXRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 84/294 (28%), Positives = 122/294 (41%), Gaps = 43/294 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 198
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 36  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 91
Query: 199 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHL-FRRSLPLPWSI-------------RM 243
            N+V L+G C +    L+V  EF   G+L  +L  +R+  +P+                +
Sbjct: 92  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLI 151
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
             +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D       
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV+L E+ +                   A P+
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASPY 251
Query: 364 LGDK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
            G K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 252 PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 106/213 (49%), Gaps = 12/213 (5%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 65
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++      +     +   +
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + +     
Sbjct: 125 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + A E ++    T +SDV+S+GV + E++T
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 83/305 (27%), Positives = 132/305 (43%), Gaps = 53/305 (17%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTG--LTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           LGEG FG V K       TA    G     TVAVK L  +      ++ L+E N L  + 
Sbjct: 31  LGEGEFGKVVKA------TAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN 84
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLP------------------- 236
           HP+++KL G C +D   LL+ E+   GSL   L   R+  P                   
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 237 --LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 294
             L     +  A   ++G+ +L   AE  +++RD    NIL+      K+SDFGL++D  
Sbjct: 145 RALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
           E+      ++      + A E +     T++SDV+SFGV+L E++T    +  N      
Sbjct: 202 EEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT----LGGN------ 251
Query: 355 NLVEWARPHLG-DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                  P+ G    R + LL            S++  +L  QC  ++P  RP  +++ +
Sbjct: 252 -------PYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304
Query: 414 TLKPL 418
            L+ +
Sbjct: 305 DLEKM 309

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 122/291 (41%), Gaps = 40/291 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 198
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 35  LGRGAFGQV----IEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 199 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHL-FRRSLPLPWSIRMK----------IA 246
            N+V L+G C +    L+V  EF   G+L  +L  +R+  +P+    K           +
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYS 150
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
              AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D          
Sbjct: 151 FQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 207
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
               + APE +     T +SDV+SFGV+L E+ +                   A P+ G 
Sbjct: 208 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASPYPGV 250
Query: 367 K--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 251 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 109/216 (50%), Gaps = 17/216 (7%)
Query: 128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EW 186
           ++L   +F   S LG G  G VFK           KP +GL +A K ++ +     + + 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQI 51
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
           + E+  L     P +V   G    D +  +  E M  GSL + + +++  +P  I  K++
Sbjct: 52  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVS 110
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           +   KGL +L E+ +  +++RD K SNIL+++    KL DFG++    +     ++   +
Sbjct: 111 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFV 164
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           GT  Y +PE +   H + +SD++S G+ L+EM  GR
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 109/216 (50%), Gaps = 17/216 (7%)
Query: 128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EW 186
           ++L   +F   S LG G  G VFK           KP +GL +A K ++ +     + + 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQI 51
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
           + E+  L     P +V   G    D +  +  E M  GSL + + +++  +P  I  K++
Sbjct: 52  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVS 110
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           +   KGL +L E+ +  +++RD K SNIL+++    KL DFG++    +     ++   +
Sbjct: 111 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFV 164
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           GT  Y +PE +   H + +SD++S G+ L+EM  GR
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 106/213 (49%), Gaps = 12/213 (5%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 68
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++      +     +   +
Sbjct: 69  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 127
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + +     
Sbjct: 128 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 184
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + A E ++    T +SDV+S+GV + E++T
Sbjct: 185 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 123/295 (41%), Gaps = 44/295 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 198
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 72  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 127
Query: 199 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHL-FRRSLPLPWSIR-------------- 242
            N+V L+G C +    L+V  EF   G+L  +L  +R+  +P+ +               
Sbjct: 128 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 187
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
           +  +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D      
Sbjct: 188 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 244
Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 362
                   + APE +     T +SDV+SFGV+L E+ +                   A P
Sbjct: 245 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASP 287
Query: 363 HLGDK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           + G K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 288 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 342

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 106/213 (49%), Gaps = 12/213 (5%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 68
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++      +     +   +
Sbjct: 69  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 127
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + +     
Sbjct: 128 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 184
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + A E ++    T +SDV+S+GV + E++T
Sbjct: 185 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 106/213 (49%), Gaps = 12/213 (5%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 65
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++      +     +   +
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGXLLDYVREHKDNIGSQYLLNWCV 124
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + +     
Sbjct: 125 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + A E ++    T +SDV+S+GV + E++T
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 134/307 (43%), Gaps = 39/307 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEVNFLGNLLHP 199
           +G+G FG VFKG   +N T  V       VA+K ++  +     ++   E+  L     P
Sbjct: 15  IGKGSFGEVFKGI--DNRTQKV-------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 65
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
            + K  G  ++D +  ++ E++  GS  + L     PL  +    I     KGL +LH E
Sbjct: 66  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSE 123
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS-TRVMGTYGYAAPEYVM 318
            +   I+RD K +N+LL      KL+DFG+A    +   T +     +GT  + APE + 
Sbjct: 124 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD---TQIKRNXFVGTPFWMAPEVIK 177
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRL 378
                SK+D++S G+  +E+  G     +  P     L+    P             P L
Sbjct: 178 QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------PTL 224
Query: 379 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQTMQADN 438
           EG++    S+   +    CL+++P  RP   E+++    L+N K    +SY  + +    
Sbjct: 225 EGNY----SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK---KTSYLTELIDRYK 277
Query: 439 TWSIRNS 445
            W    S
Sbjct: 278 RWKAEQS 284

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 17/215 (7%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 187
           +L   +F   S LG G  G VFK           KP +GL +A K ++ +     + + +
Sbjct: 21  ELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQII 71
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E+  L     P +V   G    D +  +  E M  GSL + + +++  +P  I  K+++
Sbjct: 72  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSI 130
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
              KGL +L E+ +  +++RD K SNIL+++    KL DFG++    +     ++   +G
Sbjct: 131 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVG 184
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           T  Y +PE +   H + +SD++S G+ L+EM  GR
Sbjct: 185 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 95/208 (45%), Gaps = 13/208 (6%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +    H 
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 120
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIALGAAKGLAF- 255
           N+V+ +G  ++   R ++ E M  G L++ L R + P    P S+ M   L  A+ +A  
Sbjct: 121 NIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACG 179
Query: 256 LHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
                E   I+RD    N LL        AK+ DFG+A+D             M    + 
Sbjct: 180 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 239
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 240 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 106/213 (49%), Gaps = 12/213 (5%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 6   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 59
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++      +     +   +
Sbjct: 60  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 118
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + +     
Sbjct: 119 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 175
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + A E ++    T +SDV+S+GV + E++T
Sbjct: 176 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 95/208 (45%), Gaps = 13/208 (6%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +    H 
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 110
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIALGAAKGLAF- 255
           N+V+ +G  ++   R ++ E M  G L++ L R + P    P S+ M   L  A+ +A  
Sbjct: 111 NIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACG 169
Query: 256 LHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
                E   I+RD    N LL        AK+ DFG+A+D             M    + 
Sbjct: 170 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 229
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 230 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 95/208 (45%), Gaps = 13/208 (6%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +    H 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 94
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIALGAAKGLAF- 255
           N+V+ +G  ++   R ++ E M  G L++ L R + P    P S+ M   L  A+ +A  
Sbjct: 95  NIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACG 153
Query: 256 LHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
                E   I+RD    N LL        AK+ DFG+A+D             M    + 
Sbjct: 154 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 213
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 95/208 (45%), Gaps = 13/208 (6%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +    H 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIALGAAKGLAF- 255
           N+V+ +G  ++   R ++ E M  G L++ L R + P    P S+ M   L  A+ +A  
Sbjct: 94  NIVRCIGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 256 LHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
                E   I+RD    N LL        AK+ DFG+A+D             M    + 
Sbjct: 153 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 95/208 (45%), Gaps = 13/208 (6%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +    H 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 94
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIALGAAKGLAF- 255
           N+V+ +G  ++   R ++ E M  G L++ L R + P    P S+ M   L  A+ +A  
Sbjct: 95  NIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACG 153
Query: 256 LHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
                E   I+RD    N LL        AK+ DFG+A+D             M    + 
Sbjct: 154 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWM 213
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 95/208 (45%), Gaps = 13/208 (6%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +    H 
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 100
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIALGAAKGLAF- 255
           N+V+ +G  ++   R ++ E M  G L++ L R + P    P S+ M   L  A+ +A  
Sbjct: 101 NIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACG 159
Query: 256 LHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
                E   I+RD    N LL        AK+ DFG+A+D             M    + 
Sbjct: 160 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 219
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 220 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 95/208 (45%), Gaps = 13/208 (6%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +    H 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIALGAAKGLAF- 255
           N+V+ +G  ++   R ++ E M  G L++ L R + P    P S+ M   L  A+ +A  
Sbjct: 94  NIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 256 LHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
                E   I+RD    N LL        AK+ DFG+A+D             M    + 
Sbjct: 153 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 95/208 (45%), Gaps = 13/208 (6%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +    H 
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 85
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIALGAAKGLAF- 255
           N+V+ +G  ++   R ++ E M  G L++ L R + P    P S+ M   L  A+ +A  
Sbjct: 86  NIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACG 144
Query: 256 LHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
                E   I+RD    N LL        AK+ DFG+A+D             M    + 
Sbjct: 145 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 204
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 205 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 95/208 (45%), Gaps = 13/208 (6%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +    H 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 108
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIALGAAKGLAF- 255
           N+V+ +G  ++   R ++ E M  G L++ L R + P    P S+ M   L  A+ +A  
Sbjct: 109 NIVRCIGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACG 167
Query: 256 LHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
                E   I+RD    N LL        AK+ DFG+A+D             M    + 
Sbjct: 168 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 227
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 83/300 (27%), Positives = 135/300 (45%), Gaps = 40/300 (13%)
Query: 130 LATRNFRPESL------LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH 183
           L  ++  PE L      +G+G FG VFKG   +N T  V       VA+K ++ +  +  
Sbjct: 18  LYFQSMDPEELFTKLEKIGKGSFGEVFKGI--DNRTQKV-------VAIKIIDLEEAEDE 68
Query: 184 KEWLA-EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 242
            E +  E+  L     P + K  G  ++D +  ++ E++  GS  + L     PL  +  
Sbjct: 69  IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQI 126
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
             I     KGL +LH E +   I+RD K +N+LL      KL+DFG+A     D +   +
Sbjct: 127 ATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRN 182
Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 362
           T V GT  + APE +      SK+D++S G+  +E+  G     +  P     L+    P
Sbjct: 183 TFV-GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP 241
Query: 363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLK 422
                        P LEG++    S+   +    CL+++P  RP   E+++    L+N K
Sbjct: 242 -------------PTLEGNY----SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK 284

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 22/219 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAE 189
           ++  F+    LG G +  V+KG         +   TG+ VA+K +  D  +G     + E
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKG---------LNKTTGVYVALKEVKLDSEEGTPSTAIRE 53
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-----LPWSIRMK 244
           ++ +  L H N+V+L      +++  LV+EFM    L+ ++  R++      L  ++   
Sbjct: 54  ISLMKELKHENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKY 112
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
                 +GLAF HE     +++RD K  N+L++     KL DFGLA+       T  S  
Sbjct: 113 FQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEV 169
Query: 305 VMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
           V  T  Y AP+ +M     S S D++S G +L EM+TG+
Sbjct: 170 V--TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 95/208 (45%), Gaps = 13/208 (6%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +    H 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQ 108
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIALGAAKGLAF- 255
           N+V+ +G  ++   R ++ E M  G L++ L R + P    P S+ M   L  A+ +A  
Sbjct: 109 NIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACG 167
Query: 256 LHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
                E   I+RD    N LL        AK+ DFG+A+D             M    + 
Sbjct: 168 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 227
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 77/309 (24%), Positives = 131/309 (42%), Gaps = 38/309 (12%)
Query: 108 PKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTG 167
           P+ + E ++AS+ +       + A  +F     LG+G FG V+    ++         + 
Sbjct: 9   PENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQ---------SK 59
Query: 168 LTVAVKTLNHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRG 224
             +A+K L    L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G
Sbjct: 60  FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG 119
Query: 225 SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL 284
           ++   L + S          I    A  L++ H    K VI+RD K  N+LL +    K+
Sbjct: 120 TVYRELQKLSKFDEQRTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKI 175
Query: 285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRS 344
           +DFG +  AP   +    T + GT  Y  PE +       K D++S GV+  E L G+  
Sbjct: 176 ADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231
Query: 345 MDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA 404
            + N     +  +                   R+E  F    ++ A  L ++ L  +P  
Sbjct: 232 FEANTYQETYKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQ 273
Query: 405 RPRMSEVVE 413
           RP + EV+E
Sbjct: 274 RPMLREVLE 282

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 118/297 (39%), Gaps = 48/297 (16%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 198
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 37  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 92
Query: 199 PNLVKLVGYCIEDDQRLLVY------------------EFMPRGSLENHLFRRSLPLPWS 240
            N+V L+G C +    L+V                   EF+P       L++  L L   
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHL 152
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH 300
           I    +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D    
Sbjct: 153 I--CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 207
Query: 301 VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 360
                     + APE +     T +SDV+SFGV+L E+ +                   A
Sbjct: 208 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------A 250
Query: 361 RPHLGDK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
            P+ G K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 251 SPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 307

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 121/286 (42%), Gaps = 38/286 (13%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 187
           A  +F     LG+G FG V+    ++         +   +A+K L    L+      +  
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLR 57
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L + S          I  
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 116
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +T +S    G
Sbjct: 117 ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLS----G 169
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  Y  PE +       K D++S GV+  E L G+   + N     +  +          
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--------- 220
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                    R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 221 ---------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LGEG +G V+K   +E         TG  VA+K +  +     +E + E++ +     P+
Sbjct: 37  LGEGSYGSVYKAIHKE---------TGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPH 85
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           +VK  G   ++    +V E+   GS+ + +  R+  L       I     KGL +LH   
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG 320
           +   I+RD K  NILL+ + +AKL+DFG+A    +         V+GT  + APE +   
Sbjct: 146 K---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKR--NXVIGTPFWMAPEVIQEI 200
Query: 321 HLTSKSDVYSFGVVLLEMLTGR 342
                +D++S G+  +EM  G+
Sbjct: 201 GYNCVADIWSLGITAIEMAEGK 222

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 106/213 (49%), Gaps = 12/213 (5%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 67
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E   + ++ +P++ +L+G C+    +L++ + MP G L +++      +     +   +
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 126
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             AKG+ +L +   + +++RD    N+L+    + K++DFG AK    + K + +     
Sbjct: 127 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 183
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + A E ++    T +SDV+S+GV + E++T
Sbjct: 184 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 94/205 (45%), Gaps = 27/205 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGNLL 197
           +G G FG V+      N            VA+K +++ G Q +++W   + EV FL  L 
Sbjct: 62  IGHGSFGAVYFARDVRNSE---------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 257
           HPN ++  G  + +    LV E+   GS  + L     PL       +  GA +GLA+LH
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD-APEDGKTHVSTRVMGTYGYAAPEY 316
                 +I+RD K  NILL      KL DFG A   AP       +   +GT  + APE 
Sbjct: 172 SHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAPEV 221
Query: 317 VMT---GHLTSKSDVYSFGVVLLEM 338
           ++    G    K DV+S G+  +E+
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIEL 246

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 108/218 (49%), Gaps = 23/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 49
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+EF+    L++ +   +L  +P  +    
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSY 108
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 109 LFQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 23/215 (10%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 189
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 8   NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 56
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALG 248
           ++ L  L HPN+VKL+     +++  LV+EF+    L+  +   +L  +P  +       
Sbjct: 57  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 115
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
             +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  + T
Sbjct: 116 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 170
Query: 309 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 130/294 (44%), Gaps = 59/294 (20%)
Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNL 196
           + ++G+G FG V+ G   +     ++       A+K+L+    +Q  + +L E   +  L
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQ------CAIKSLSRITEMQQVEAFLREGLLMRGL 79
Query: 197 LHPNLVKLVGYCIEDD---QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAK 251
            HPN++ L+G  +  +     LL Y  M  G L    F RS     +++  I+ G   A+
Sbjct: 80  NHPNVLALIGIMLPPEGLPHVLLPY--MCHGDLLQ--FIRSPQRNPTVKDLISFGLQVAR 135
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE----DGKTHVSTRVMG 307
           G+ +L   AE+  ++RD    N +LD  +  K++DFGLA+D  +      + H   R+  
Sbjct: 136 GMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL-- 190
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
              + A E + T   T+KSDV+SFGV+L E+LT      +  P                 
Sbjct: 191 PVKWTALESLQTYRFTTKSDVWSFGVLLWELLT------RGAPP---------------- 228
Query: 368 RRFYRLLDPRLEGHFSIKGSQ---------KATQLAAQCLSRDPKARPRMSEVV 412
              YR +DP    HF  +G +            Q+  QC   DP  RP    +V
Sbjct: 229 ---YRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLV 279

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 127/301 (42%), Gaps = 45/301 (14%)
Query: 116 VASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL 175
           + S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L
Sbjct: 3   MESKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVL 46
Query: 176 NHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR 232
               L+      +   EV    +L HPN+++L GY  +  +  L+ E+ PRG +   L +
Sbjct: 47  FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQK 106
Query: 233 RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD 292
            S          I    A  L++ H    K VI+RD K  N+LL +    K++DFG +  
Sbjct: 107 LSKFDEQRTATYIT-ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH 162
Query: 293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG 352
           AP   +      + GT  Y  PE +       K D++S GV+  E L G+   + N    
Sbjct: 163 APSSRR----XXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 218
Query: 353 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
            +  +                   R+E  F    ++ A  L ++ L  +P  RP + EV+
Sbjct: 219 TYKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 260
Query: 413 E 413
           E
Sbjct: 261 E 261

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 106/213 (49%), Gaps = 12/213 (5%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +L  G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 19  LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 72
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E   + ++ +P++ +L+G C+    +L++ + MP G L +++      +     +   +
Sbjct: 73  DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 131
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + +     
Sbjct: 132 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 188
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + A E ++    T +SDV+S+GV + E++T
Sbjct: 189 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 118/286 (41%), Gaps = 39/286 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLHP 199
           +G G FG VF G +  + T          VAVK+         K ++L E   L    HP
Sbjct: 122 IGRGNFGEVFSGRLRADNT---------LVAVKSCRETLPPDLKAKFLQEARILKQYSHP 172
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           N+V+L+G C +     +V E +  G     L      L     +++   AA G+ +L   
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE-- 230
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT-YGYAAPEYVM 318
             K  I+RD    N L+      K+SDFG++++   DG    S  +      + APE + 
Sbjct: 231 -SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA-DGVXAASGGLRQVPVKWTAPEALN 288
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY----RLL 374
            G  +S+SDV+SFG++L E  +   S   N  N +              R F     RL 
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-------------TREFVEKGGRLP 335
Query: 375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN 420
            P L             +L  QC + +P  RP  S + + L+ ++ 
Sbjct: 336 CPEL-------CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 106/213 (49%), Gaps = 12/213 (5%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 9   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 62
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++      +     +   +
Sbjct: 63  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 121
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A+G+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + +     
Sbjct: 122 QIAEGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 178
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + A E ++    T +SDV+S+GV + E++T
Sbjct: 179 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 23/215 (10%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 189
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 3   NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 51
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALG 248
           ++ L  L HPN+VKL+     +++  LV+EF+    L+  +   +L  +P  +       
Sbjct: 52  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
             +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  + T
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 165
Query: 309 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 105/213 (49%), Gaps = 12/213 (5%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+  L      + +KE L
Sbjct: 46  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIMELREATSPKANKEIL 99
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++      +     +   +
Sbjct: 100 DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 158
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + +     
Sbjct: 159 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 215
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + A E ++    T +SDV+S+GV + E++T
Sbjct: 216 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 23/215 (10%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 189
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 4   NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 52
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALG 248
           ++ L  L HPN+VKL+     +++  LV+EF+    L+  +   +L  +P  +       
Sbjct: 53  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
             +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  + T
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 166
Query: 309 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 23/215 (10%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 189
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 3   NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 51
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALG 248
           ++ L  L HPN+VKL+     +++  LV+EF+    L+  +   +L  +P  +       
Sbjct: 52  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
             +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  + T
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 165
Query: 309 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 108/218 (49%), Gaps = 23/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 50
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +   +L  +P  +    
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 109
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  
Sbjct: 110 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THE 164
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
           + T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 165 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 106/213 (49%), Gaps = 12/213 (5%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 16  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 69
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E   + ++ +P++ +L+G C+    +L++ + MP G L +++      +     +   +
Sbjct: 70  DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 128
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             AKG+ +L +   + +++RD    N+L+    + K++DFG AK    + K + +     
Sbjct: 129 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 185
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + A E ++    T +SDV+S+GV + E++T
Sbjct: 186 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 106/213 (49%), Gaps = 12/213 (5%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 67
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E   + ++ +P++ +L+G C+    +L++ + MP G L +++      +     +   +
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 126
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             AKG+ +L +   + +++RD    N+L+    + K++DFG AK    + K + +     
Sbjct: 127 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 183
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + A E ++    T +SDV+S+GV + E++T
Sbjct: 184 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 127/299 (42%), Gaps = 45/299 (15%)
Query: 118 SQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH 177
           S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L  
Sbjct: 5   SKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVLFK 48
Query: 178 DGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS 234
             L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G++   L + S
Sbjct: 49  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 108
Query: 235 LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 294
                     I    A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP
Sbjct: 109 KFDEQRTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 164
Query: 295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
              +    T + GT  Y  PE +       K D++S GV+  E L G+   + N     +
Sbjct: 165 SSRR----TTLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY 220
Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
             +                   R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 221 KRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPXLREVLE 261

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 105/213 (49%), Gaps = 12/213 (5%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 67
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++      +     +   +
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 126
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             AKG+ +L +   + +++RD    N+L+    + K++DFG AK    + K + +     
Sbjct: 127 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 183
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + A E ++    T +SDV+S+GV + E++T
Sbjct: 184 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 23/215 (10%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 189
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 4   NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 52
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALG 248
           ++ L  L HPN+VKL+     +++  LV+EF+    L+  +   +L  +P  +       
Sbjct: 53  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
             +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  + T
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 166
Query: 309 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 167 LWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 123/304 (40%), Gaps = 68/304 (22%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           +F+   L+G GGFG VFK     +G          T  +K + ++  +  +E    V  L
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGK---------TYVIKRVKYNNEKAERE----VKAL 58
Query: 194 GNLLHPNLVKLVG------YCIEDDQR----------LLVYEFMPRGSLENHLF-RRSLP 236
             L H N+V   G      Y  E   +           +  EF  +G+LE  +  RR   
Sbjct: 59  AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 237 LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED 296
           L   + +++     KG+ ++H    K +I RD K SNI L      K+ DFGL      D
Sbjct: 119 LDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 356
           GK     R  GT  Y +PE + +     + D+Y+ G++L E+L                 
Sbjct: 176 GK---RXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL----------------- 215
Query: 357 VEWARPHLGD-----KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
                 H+ D      + F  L D  +   F     +K   L  + LS+ P+ RP  SE+
Sbjct: 216 ------HVCDTAFETSKFFTDLRDGIISDIF----DKKEKTLLQKLLSKKPEDRPNTSEI 265
Query: 412 VETL 415
           + TL
Sbjct: 266 LRTL 269

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 23/215 (10%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 189
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 4   NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 52
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALG 248
           ++ L  L HPN+VKL+     +++  LV+EF+    L+  +   +L  +P  +       
Sbjct: 53  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
             +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  + T
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 166
Query: 309 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 108/218 (49%), Gaps = 23/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 51
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+EF+    L++ +   +L  +P  +    
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSY 110
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 111 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 168 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 23/215 (10%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 189
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 11  NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 59
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALG 248
           ++ L  L HPN+VKL+     +++  LV+EF+    L+  +   +L  +P  +       
Sbjct: 60  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 118
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
             +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  + T
Sbjct: 119 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 173
Query: 309 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 174 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 105/213 (49%), Gaps = 12/213 (5%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +L  G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 19  LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 72
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++      +     +   +
Sbjct: 73  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 131
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + +     
Sbjct: 132 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 188
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + A E ++    T +SDV+S+GV + E++T
Sbjct: 189 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 94/205 (45%), Gaps = 27/205 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGNLL 197
           +G G FG V+      N            VA+K +++ G Q +++W   + EV FL  L 
Sbjct: 23  IGHGSFGAVYFARDVRNSE---------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 257
           HPN ++  G  + +    LV E+   GS  + L     PL       +  GA +GLA+LH
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD-APEDGKTHVSTRVMGTYGYAAPEY 316
                 +I+RD K  NILL      KL DFG A   AP       +   +GT  + APE 
Sbjct: 133 SHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAPEV 182
Query: 317 VMT---GHLTSKSDVYSFGVVLLEM 338
           ++    G    K DV+S G+  +E+
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIEL 207

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 49
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +   +L  +P  +    
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 108
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 109 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 108/218 (49%), Gaps = 23/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 52
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+EF+    L++ +   +L  +P  +    
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSY 111
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 112 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 118/286 (41%), Gaps = 39/286 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLHP 199
           +G G FG VF G +  + T          VAVK+         K ++L E   L    HP
Sbjct: 122 IGRGNFGEVFSGRLRADNT---------LVAVKSCRETLPPDLKAKFLQEARILKQYSHP 172
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           N+V+L+G C +     +V E +  G     L      L     +++   AA G+ +L   
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE-- 230
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT-YGYAAPEYVM 318
             K  I+RD    N L+      K+SDFG++++   DG    S  +      + APE + 
Sbjct: 231 -SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQVPVKWTAPEALN 288
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY----RLL 374
            G  +S+SDV+SFG++L E  +   S   N  N +              R F     RL 
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-------------TREFVEKGGRLP 335
Query: 375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN 420
            P L             +L  QC + +P  RP  S + + L+ ++ 
Sbjct: 336 CPEL-------CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 51
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +   +L  +P  +    
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 110
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 111 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 168 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 127/299 (42%), Gaps = 45/299 (15%)
Query: 118 SQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH 177
           S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L  
Sbjct: 17  SKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVLFK 60
Query: 178 DGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS 234
             L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G++   L + S
Sbjct: 61  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 120
Query: 235 LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 294
                     I    A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP
Sbjct: 121 KFDEQRTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 176
Query: 295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
              +    T + GT  Y  PE +       K D++S GV+  E L G+   + N     +
Sbjct: 177 SSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY 232
Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
             +                   R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 233 KRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 273

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 52
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +   +L  +P  +    
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 111
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 112 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 51
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +   +L  +P  +    
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 110
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 111 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 168 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 105/213 (49%), Gaps = 12/213 (5%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +L  G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 12  LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 65
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++      +     +   +
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + +     
Sbjct: 125 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + A E ++    T +SDV+S+GV + E++T
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 51
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +   +L  +P  +    
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 110
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 111 LFQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 168 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 23/215 (10%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 189
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 11  NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 59
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALG 248
           ++ L  L HPN+VKL+     +++  LV+EF+    L+  +   +L  +P  +       
Sbjct: 60  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 118
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
             +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  + T
Sbjct: 119 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 173
Query: 309 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 174 LWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 128/301 (42%), Gaps = 45/301 (14%)
Query: 116 VASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL 175
           + S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L
Sbjct: 1   MESKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVL 44
Query: 176 NHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR 232
               L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +
Sbjct: 45  FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK 104
Query: 233 RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD 292
            S          I    A  L++ H    K VI+RD K  N+LL +    K++DFG +  
Sbjct: 105 LSKFDEQRTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVH 160
Query: 293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG 352
           AP   +    T + GT  Y  PE +       K D++S GV+  E L G+   + N    
Sbjct: 161 APSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216
Query: 353 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
            +  +                   R+E  F    ++ A  L ++ L  +P  RP + EV+
Sbjct: 217 TYKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258
Query: 413 E 413
           E
Sbjct: 259 E 259

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 120/286 (41%), Gaps = 38/286 (13%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 187
           A  +F     LG+G FG V+    ++         +   +A+K L    L+      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLR 56
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L + S          I  
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 115
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +T +     G
Sbjct: 116 ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELC----G 168
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  Y  PE +       K D++S GV+  E L G+   + N     +  +          
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--------- 219
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                    R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 220 ---------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 52
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +   +L  +P  +    
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSY 111
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 112 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 52
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +   +L  +P  +    
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 111
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 112 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 49
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +   +L  +P  +    
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 108
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 109 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 49
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +   +L  +P  +    
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 108
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 109 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 105/213 (49%), Gaps = 12/213 (5%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 65
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++      +     +   +
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             AKG+ +L +   + +++RD    N+L+    + K++DFG AK    + K + +     
Sbjct: 125 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 181
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + A E ++    T +SDV+S+GV + E++T
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 53
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +   +L  +P  +    
Sbjct: 54  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 112
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 113 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 169
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 170 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 116/293 (39%), Gaps = 50/293 (17%)
Query: 140 LLGEGGFGCVFKGWVEENGTA--PVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGNL 196
           +LG G FG V       N TA    K G  + VAVK L        +E L +E+  +  L
Sbjct: 52  VLGSGAFGKVM------NATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 105
Query: 197 -LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP------------------- 236
             H N+V L+G C       L++E+   G L N+L  +                      
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 237 ---LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 293
              L +   +  A   AKG+ FL     K  ++RD    N+L+      K+ DFGLA+D 
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDI 222
Query: 294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 353
             D    V         + APE +  G  T KSDV+S+G++L E+     S+  N     
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF----SLGVN----- 273
Query: 354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
                   P +     FY+L+    +       +++   +   C + D + RP
Sbjct: 274 ------PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRP 320

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 105/213 (49%), Gaps = 12/213 (5%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 19  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 72
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++      +     +   +
Sbjct: 73  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 131
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             AKG+ +L +   + +++RD    N+L+    + K++DFG AK    + K + +     
Sbjct: 132 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 188
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + A E ++    T +SDV+S+GV + E++T
Sbjct: 189 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 50
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +   +L  +P  +    
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 109
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 110 LFQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 167 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 128/301 (42%), Gaps = 45/301 (14%)
Query: 116 VASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL 175
           + S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L
Sbjct: 3   MESKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVL 46
Query: 176 NHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR 232
               L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +
Sbjct: 47  FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK 106
Query: 233 RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD 292
            S          I    A  L++ H    K VI+RD K  N+LL +    K++DFG +  
Sbjct: 107 LSKFDEQRTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVH 162
Query: 293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG 352
           AP   +    T + GT  Y  PE +       K D++S GV+  E L G+   + N    
Sbjct: 163 APSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 218
Query: 353 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
            +  +                   R+E  F    ++ A  L ++ L  +P  RP + EV+
Sbjct: 219 TYKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 260
Query: 413 E 413
           E
Sbjct: 261 E 261

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 23/215 (10%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 189
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 3   NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 51
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALG 248
           ++ L  L HPN+VKL+     +++  LV+EF+    L+  +   +L  +P  +       
Sbjct: 52  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
             +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V  T
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 165
Query: 309 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 50
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +   +L  +P  +    
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 109
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 110 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 167 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 127/299 (42%), Gaps = 45/299 (15%)
Query: 118 SQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH 177
           S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L  
Sbjct: 1   SKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVLFK 44
Query: 178 DGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS 234
             L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G++   L + S
Sbjct: 45  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 104
Query: 235 LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 294
                     I    A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP
Sbjct: 105 KFDEQRTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160
Query: 295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
              +T +     GT  Y  PE +       K D++S GV+  E L G+   + N     +
Sbjct: 161 SSRRTDLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY 216
Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
             +                   R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 217 KRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 23/215 (10%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 189
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 3   NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 51
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALG 248
           ++ L  L HPN+VKL+     +++  LV+EF+    L+  +   +L  +P  +       
Sbjct: 52  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
             +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V  T
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 165
Query: 309 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 127/299 (42%), Gaps = 45/299 (15%)
Query: 118 SQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH 177
           S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L  
Sbjct: 5   SKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVLFK 48
Query: 178 DGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS 234
             L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G++   L + S
Sbjct: 49  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 108
Query: 235 LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 294
                     I    A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP
Sbjct: 109 KFDEQRTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 164
Query: 295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
              +T +     GT  Y  PE +       K D++S GV+  E L G+   + N     +
Sbjct: 165 SSRRTDLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY 220
Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
             +                   R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 221 KRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 261

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 49
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +   +L  +P  +    
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 108
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 109 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 85/324 (26%), Positives = 141/324 (43%), Gaps = 54/324 (16%)
Query: 125 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL-NHDGLQGH 183
           +ND+K        + ++GEG FG V K  ++       K G  +  A+K +  +     H
Sbjct: 24  WNDIKF-------QDVIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDH 69
Query: 184 KEWLAEVNFLGNL-LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 242
           +++  E+  L  L  HPN++ L+G C       L  E+ P G+L + L R+S  L     
Sbjct: 70  RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPA 128
Query: 243 MKIALGAAKGLA---FLHEEA----------EKPVIYRDFKTSNILLDADYNAKLSDFGL 289
             IA   A  L+    LH  A          +K  I+RD    NIL+  +Y AK++DFGL
Sbjct: 129 FAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 188
Query: 290 AKDAPEDGKTHVSTRVMGT--YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDK 347
           ++     G+     + MG     + A E +     T+ SDV+S+GV+L E++    S+  
Sbjct: 189 SR-----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV----SLGG 239
Query: 348 NRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR 407
               G      + +   G     YRL  P       +    +   L  QC    P  RP 
Sbjct: 240 TPYCGMTCAELYEKLPQG-----YRLEKP-------LNCDDEVYDLMRQCWREKPYERPS 287
Query: 408 MSEVVETL-KPLQNLKDMASSSYY 430
            ++++ +L + L+  K   +++ Y
Sbjct: 288 FAQILVSLNRMLEERKTYVNTTLY 311

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 85/324 (26%), Positives = 141/324 (43%), Gaps = 54/324 (16%)
Query: 125 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL-NHDGLQGH 183
           +ND+K        + ++GEG FG V K  ++       K G  +  A+K +  +     H
Sbjct: 14  WNDIKF-------QDVIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDH 59
Query: 184 KEWLAEVNFLGNL-LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 242
           +++  E+  L  L  HPN++ L+G C       L  E+ P G+L + L R+S  L     
Sbjct: 60  RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPA 118
Query: 243 MKIALGAAKGLA---FLHEEA----------EKPVIYRDFKTSNILLDADYNAKLSDFGL 289
             IA   A  L+    LH  A          +K  I+RD    NIL+  +Y AK++DFGL
Sbjct: 119 FAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 178
Query: 290 AKDAPEDGKTHVSTRVMGT--YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDK 347
           ++     G+     + MG     + A E +     T+ SDV+S+GV+L E++    S+  
Sbjct: 179 SR-----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV----SLGG 229
Query: 348 NRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR 407
               G      + +   G     YRL  P       +    +   L  QC    P  RP 
Sbjct: 230 TPYCGMTCAELYEKLPQG-----YRLEKP-------LNCDDEVYDLMRQCWREKPYERPS 277
Query: 408 MSEVVETL-KPLQNLKDMASSSYY 430
            ++++ +L + L+  K   +++ Y
Sbjct: 278 FAQILVSLNRMLEERKTYVNTTLY 301

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 52
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +   +L  +P  +    
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSY 111
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 112 LFQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 113/247 (45%), Gaps = 31/247 (12%)
Query: 113 ELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAV 172
           E+ + +Q ++    ++ L+   F  E  LGE  FG V+KG +   G AP +      VA+
Sbjct: 8   EMPLINQHKQAKLKEISLSAVRFMEE--LGEDRFGKVYKGHL--FGPAPGEQTQA--VAI 61
Query: 173 KTLNHDGLQG--HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL 230
           KTL  D  +G   +E+  E      L HPN+V L+G   +D    +++ +   G L   L
Sbjct: 62  KTLK-DKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFL 120
Query: 231 FRRS-----------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN 273
             RS                 L  P  + +   + A  G+ +L   +   V+++D  T N
Sbjct: 121 VMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAA--GMEYL---SSHHVVHKDLATRN 175
Query: 274 ILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGV 333
           +L+    N K+SD GL ++        +    +    + APE +M G  +  SD++S+GV
Sbjct: 176 VLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGV 235
Query: 334 VLLEMLT 340
           VL E+ +
Sbjct: 236 VLWEVFS 242

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 120/286 (41%), Gaps = 38/286 (13%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 187
           A  +F     LG+G FG V+    ++         +   +A+K L    L+      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLR 56
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L + S          I  
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 115
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +    T + G
Sbjct: 116 ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCG 168
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  Y  PE +       K D++S GV+  E L G+   + N     +  +          
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--------- 219
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                    R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 220 ---------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 50
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +   +L  +P  +    
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSY 109
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 110 LFQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 167 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 23/215 (10%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 189
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 5   NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 53
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALG 248
           ++ L  L HPN+VKL+     +++  LV+EF+    L+  +   +L  +P  +       
Sbjct: 54  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
             +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V  T
Sbjct: 113 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 167
Query: 309 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 107/235 (45%), Gaps = 20/235 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V  G          K      VA+K +  +G     E++ E   + NL H  
Sbjct: 32  LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 80
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           LV+L G C +     ++ E+M  G L N+L            +++     + + +L    
Sbjct: 81  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--- 137
Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG 320
            K  ++RD    N L++     K+SDFGL++   +D +T  S        ++ PE +M  
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETS-SVGSKFPVRWSPPEVLMYS 196
Query: 321 HLTSKSDVYSFGVVLLEMLT-GRRSMDK--NRPNGEHNL--VEWARPHLGDKRRF 370
             +SKSD+++FGV++ E+ + G+   ++  N    EH    +   RPHL  ++ +
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY 251

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 120/286 (41%), Gaps = 38/286 (13%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 187
           A  +F     LG+G FG V+    ++         +   +A+K L    L+      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLR 56
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L + S          I  
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 115
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +T +     G
Sbjct: 116 ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----G 168
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  Y  PE +       K D++S GV+  E L G+   + N     +  +          
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--------- 219
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                    R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 220 ---------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 122/280 (43%), Gaps = 30/280 (10%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 199
           +GEG FG V +G       +P  P   L VA+KT  +      +E +L E   +    HP
Sbjct: 21  IGEGQFGDVHQGIY----MSPENPA--LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 74
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           ++VKL+G  I ++   ++ E    G L + L  R   L  +  +  A   +  LA+L   
Sbjct: 75  HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES- 132
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             K  ++RD    N+L+ ++   KL DFGL++   ED   + +++      + APE +  
Sbjct: 133 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINF 189
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLLDPRL 378
              TS SDV+ FGV + E+L     M   +P  G  N     R   G++        P L
Sbjct: 190 RRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 244
Query: 379 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                         L  +C + DP  RPR +E+   L  +
Sbjct: 245 ------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 272

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 128/301 (42%), Gaps = 45/301 (14%)
Query: 116 VASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL 175
           + S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L
Sbjct: 1   MESKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVL 44
Query: 176 NHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR 232
               L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +
Sbjct: 45  FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK 104
Query: 233 RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD 292
            S          I    A  L++ H    K VI+RD K  N+LL +    K++DFG +  
Sbjct: 105 LSKFDEQRTATYIT-ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVH 160
Query: 293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG 352
           AP   +T +     GT  Y  PE +       K D++S GV+  E L G+   + N    
Sbjct: 161 APSSRRTTLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216
Query: 353 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
            +  +                   R+E  F    ++ A  L ++ L  +P  RP + EV+
Sbjct: 217 TYKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258
Query: 413 E 413
           E
Sbjct: 259 E 259

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 120/286 (41%), Gaps = 38/286 (13%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 187
           A  +F     LG+G FG V+    ++         +   +A+K L    L+      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLR 56
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L + S          I  
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 115
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +T +     G
Sbjct: 116 ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLC----G 168
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  Y  PE +       K D++S GV+  E L G+   + N     +  +          
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--------- 219
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                    R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 220 ---------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 23/215 (10%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 189
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 4   NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 52
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALG 248
           ++ L  L HPN+VKL+     +++  LV+EF+    L+  +   +L  +P  +       
Sbjct: 53  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
             +GL+F H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  + T
Sbjct: 112 LLQGLSFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 166
Query: 309 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 122/280 (43%), Gaps = 30/280 (10%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 199
           +GEG FG V +G       +P  P   L VA+KT  +      +E +L E   +    HP
Sbjct: 23  IGEGQFGDVHQGIY----MSPENPA--LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 76
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           ++VKL+G  I ++   ++ E    G L + L  R   L  +  +  A   +  LA+L   
Sbjct: 77  HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES- 134
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             K  ++RD    N+L+ ++   KL DFGL++   ED   + +++      + APE +  
Sbjct: 135 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINF 191
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLLDPRL 378
              TS SDV+ FGV + E+L     M   +P  G  N     R   G++        P L
Sbjct: 192 RRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 246
Query: 379 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                         L  +C + DP  RPR +E+   L  +
Sbjct: 247 ------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 274

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 122/280 (43%), Gaps = 30/280 (10%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 199
           +GEG FG V +G       +P  P   L VA+KT  +      +E +L E   +    HP
Sbjct: 46  IGEGQFGDVHQGIY----MSPENPA--LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 99
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           ++VKL+G  I ++   ++ E    G L + L  R   L  +  +  A   +  LA+L   
Sbjct: 100 HIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES- 157
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             K  ++RD    N+L+ ++   KL DFGL++   ED   + +++      + APE +  
Sbjct: 158 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINF 214
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLLDPRL 378
              TS SDV+ FGV + E+L     M   +P  G  N     R   G++        P L
Sbjct: 215 RRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 269
Query: 379 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                         L  +C + DP  RPR +E+   L  +
Sbjct: 270 ------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 297

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 97/217 (44%), Gaps = 19/217 (8%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           +L   NF    +LG+G FG V    V+E         TG   AVK L  D +    +   
Sbjct: 19  RLGIDNFEFIRVLGKGSFGKVMLARVKE---------TGDLYAVKVLKKDVILQDDDVEC 69
Query: 187 -LAEVNFLGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
            + E   L     HP L +L       D+   V EF+  G L  H+ ++S     +    
Sbjct: 70  TMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI-QKSRRFDEARARF 128
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
            A      L FLH+   K +IYRD K  N+LLD + + KL+DFG+ K+   +G T  +  
Sbjct: 129 YAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TAT 183
Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
             GT  Y APE +         D ++ GV+L EML G
Sbjct: 184 FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 122/280 (43%), Gaps = 30/280 (10%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 199
           +GEG FG V +G       +P  P   L VA+KT  +      +E +L E   +    HP
Sbjct: 20  IGEGQFGDVHQGIY----MSPENPA--LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 73
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           ++VKL+G  I ++   ++ E    G L + L  R   L  +  +  A   +  LA+L   
Sbjct: 74  HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES- 131
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             K  ++RD    N+L+ ++   KL DFGL++   ED   + +++      + APE +  
Sbjct: 132 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINF 188
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLLDPRL 378
              TS SDV+ FGV + E+L     M   +P  G  N     R   G++        P L
Sbjct: 189 RRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 243
Query: 379 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                         L  +C + DP  RPR +E+   L  +
Sbjct: 244 ------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 271

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 120/286 (41%), Gaps = 38/286 (13%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 187
           A  +F     LG+G FG V+    E+N        +   +A+K L    L+      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLA-REKN--------SKFILALKVLFKAQLEKAGVEHQLR 56
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L + S          I  
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 115
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +  +     G
Sbjct: 116 ELANALSYCH---SKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----G 168
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  Y  PE +       K D++S GV+  E L G+   + N     +  +          
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRIS--------- 219
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                    R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 220 ---------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 106/241 (43%), Gaps = 23/241 (9%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN---HDGLQGHKE 185
           K+    ++    LG GG   V   ++ E+    +K      VA+K +     +  +  K 
Sbjct: 7   KIINERYKIVDKLGGGGMSTV---YLAEDTILNIK------VAIKAIFIPPREKEETLKR 57
Query: 186 WLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 245
           +  EV+    L H N+V ++    EDD   LV E++   +L  ++     PL     +  
Sbjct: 58  FEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINF 116
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                 G+   H+     +++RD K  NIL+D++   K+ DFG+AK   E   T  +  V
Sbjct: 117 TNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHV 172
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
           +GT  Y +PE          +D+YS G+VL EML G         NGE   V  A  H+ 
Sbjct: 173 LGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPF-----NGE-TAVSIAIKHIQ 226
Query: 366 D 366
           D
Sbjct: 227 D 227

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 76/309 (24%), Positives = 130/309 (42%), Gaps = 38/309 (12%)
Query: 108 PKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTG 167
           P+ + E ++AS+ +       + A  +F     LG+G FG V+    ++         + 
Sbjct: 9   PENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQ---------SK 59
Query: 168 LTVAVKTLNHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRG 224
             +A+K L    L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G
Sbjct: 60  FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG 119
Query: 225 SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL 284
           ++   L + S          I    A  L++ H    K VI+RD K  N+LL +    K+
Sbjct: 120 TVYRELQKLSKFDEQRTATYIT-ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKI 175
Query: 285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRS 344
           +DFG +  AP   +  +     GT  Y  PE +       K D++S GV+  E L G+  
Sbjct: 176 ADFGWSVHAPSSRRDDLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231
Query: 345 MDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA 404
            + N     +  +                   R+E  F    ++ A  L ++ L  +P  
Sbjct: 232 FEANTYQETYKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQ 273
Query: 405 RPRMSEVVE 413
           RP + EV+E
Sbjct: 274 RPMLREVLE 282

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 120/286 (41%), Gaps = 38/286 (13%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 187
           A  +F     LG+G FG V+    ++         +   +A+K L    L+      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLR 56
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L + S          I  
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 115
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +T +     G
Sbjct: 116 ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----G 168
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  Y  PE +       K D++S GV+  E L G+   + N     +  +          
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--------- 219
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                    R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 220 ---------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 121/280 (43%), Gaps = 30/280 (10%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 199
           +GEG FG V +G       +P  P   + VA+KT  +      +E +L E   +    HP
Sbjct: 18  IGEGQFGDVHQGIY----MSPENPA--MAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           ++VKL+G  I ++   ++ E    G L + L  R   L  +  +  A   +  LA+L   
Sbjct: 72  HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES- 129
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             K  ++RD    N+L+ A    KL DFGL++   ED   + +++      + APE +  
Sbjct: 130 --KRFVHRDIAARNVLVSATDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINF 186
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLLDPRL 378
              TS SDV+ FGV + E+L     M   +P  G  N     R   G++        P L
Sbjct: 187 RRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 241
Query: 379 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                         L  +C + DP  RPR +E+   L  +
Sbjct: 242 ------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 120/286 (41%), Gaps = 38/286 (13%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 187
           A  +F     LG+G FG V+    ++         +   +A+K L    L+      +  
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLR 60
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L + S          I  
Sbjct: 61  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 119
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +    T + G
Sbjct: 120 ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCG 172
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  Y  PE +       K D++S GV+  E L G+   + N     +  +          
Sbjct: 173 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--------- 223
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                    R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 224 ---------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 260

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 121/280 (43%), Gaps = 30/280 (10%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 199
           +GEG FG V +G       +P  P   + VA+KT  +      +E +L E   +    HP
Sbjct: 398 IGEGQFGDVHQGIY----MSPENPA--MAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 451
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           ++VKL+G  I ++   ++ E    G L + L  R   L  +  +  A   +  LA+L   
Sbjct: 452 HIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES- 509
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             K  ++RD    N+L+ A    KL DFGL++   ED   + +++      + APE +  
Sbjct: 510 --KRFVHRDIAARNVLVSATDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINF 566
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLLDPRL 378
              TS SDV+ FGV + E+L     M   +P  G  N     R   G++        P L
Sbjct: 567 RRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 621
Query: 379 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                         L  +C + DP  RPR +E+   L  +
Sbjct: 622 ------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 649

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 120/286 (41%), Gaps = 38/286 (13%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 187
           A  +F     LG+G FG V+    ++         +   +A+K L    L+      +  
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLR 55
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L + S          I  
Sbjct: 56  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 114
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +T +     G
Sbjct: 115 ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----G 167
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  Y  PE +       K D++S GV+  E L G+   + N     +  +          
Sbjct: 168 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--------- 218
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                    R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 219 ---------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 255

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 118/292 (40%), Gaps = 37/292 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V  G          K      VA+K +  +G     E++ E   + NL H  
Sbjct: 17  LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 65
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           LV+L G C +     ++ E+M  G L N+L            +++     + + +L    
Sbjct: 66  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--- 122
Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG 320
            K  ++RD    N L++     K+SDFGL++   +D  T  S        ++ PE +M  
Sbjct: 123 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMYS 181
Query: 321 HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEG 380
             +SKSD+++FGV++ E+ +  +   +   N E         H+    R YR   P L  
Sbjct: 182 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQGLRLYR---PHL-- 230
Query: 381 HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQ 432
                 S+K   +   C       RP    +      L N+ D+   + Y Q
Sbjct: 231 -----ASEKVYTIMYSCWHEKADERPTFKIL------LSNILDVMDENLYGQ 271

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 106/235 (45%), Gaps = 20/235 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V  G          K      VA+K +  +G     E++ E   + NL H  
Sbjct: 16  LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 64
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           LV+L G C +     ++ E+M  G L N+L            +++     + + +L    
Sbjct: 65  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--- 121
Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG 320
            K  ++RD    N L++     K+SDFGL++   +D  T  S        ++ PE +M  
Sbjct: 122 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMYS 180
Query: 321 HLTSKSDVYSFGVVLLEMLT-GRRSMDK--NRPNGEHNL--VEWARPHLGDKRRF 370
             +SKSD+++FGV++ E+ + G+   ++  N    EH    +   RPHL  ++ +
Sbjct: 181 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY 235

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 122/280 (43%), Gaps = 30/280 (10%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 199
           +GEG FG V +G       +P  P   + VA+KT  +      +E +L E   +    HP
Sbjct: 398 IGEGQFGDVHQGIY----MSPENPA--MAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 451
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           ++VKL+G  I ++   ++ E    G L + L  R   L  +  +  A   +  LA+L   
Sbjct: 452 HIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES- 509
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             K  ++RD    N+L+ ++   KL DFGL++   ED   + +++      + APE +  
Sbjct: 510 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINF 566
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLLDPRL 378
              TS SDV+ FGV + E+L     M   +P  G  N     R   G++        P L
Sbjct: 567 RRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 621
Query: 379 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                         L  +C + DP  RPR +E+   L  +
Sbjct: 622 ------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 649

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 122/280 (43%), Gaps = 30/280 (10%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 199
           +GEG FG V +G       +P  P   L VA+KT  +      +E +L E   +    HP
Sbjct: 15  IGEGQFGDVHQGIY----MSPENPA--LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           ++VKL+G  I ++   ++ E    G L + L  R   L  +  +  A   +  LA+L   
Sbjct: 69  HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES- 126
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             K  ++RD    N+L+ ++   KL DFGL++   ED   + +++      + APE +  
Sbjct: 127 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINF 183
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLLDPRL 378
              TS SDV+ FGV + E+L     M   +P  G  N     R   G++        P L
Sbjct: 184 RRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 238
Query: 379 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                         L  +C + DP  RPR +E+   L  +
Sbjct: 239 ------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 106/235 (45%), Gaps = 20/235 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V  G          K      VA+K +  +G     E++ E   + NL H  
Sbjct: 12  LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 60
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           LV+L G C +     ++ E+M  G L N+L            +++     + + +L    
Sbjct: 61  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--- 117
Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG 320
            K  ++RD    N L++     K+SDFGL++   +D  T  S        ++ PE +M  
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMYS 176
Query: 321 HLTSKSDVYSFGVVLLEMLT-GRRSMDK--NRPNGEHNL--VEWARPHLGDKRRF 370
             +SKSD+++FGV++ E+ + G+   ++  N    EH    +   RPHL  ++ +
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY 231

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 122/280 (43%), Gaps = 30/280 (10%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 199
           +GEG FG V +G       +P  P   L VA+KT  +      +E +L E   +    HP
Sbjct: 18  IGEGQFGDVHQGIY----MSPENPA--LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           ++VKL+G  I ++   ++ E    G L + L  R   L  +  +  A   +  LA+L   
Sbjct: 72  HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES- 129
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             K  ++RD    N+L+ ++   KL DFGL++   ED   + +++      + APE +  
Sbjct: 130 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINF 186
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLLDPRL 378
              TS SDV+ FGV + E+L     M   +P  G  N     R   G++        P L
Sbjct: 187 RRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 241
Query: 379 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                         L  +C + DP  RPR +E+   L  +
Sbjct: 242 ------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 96/222 (43%), Gaps = 25/222 (11%)
Query: 128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL 187
           +KL   +F    +LG+G FG VF         A  K  T    A+K L  D +    +  
Sbjct: 13  IKLKIEDFELHKMLGKGSFGKVF--------LAEFK-KTNQFFAIKALKKDVVLMDDD-- 61
Query: 188 AEVNFLGNLL------HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI 241
            E   +   +      HP L  +       +    V E++  G L  H+ +       S 
Sbjct: 62  VECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSR 120
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD-APEDGKTH 300
               A     GL FLH    K ++YRD K  NILLD D + K++DFG+ K+    D KT+
Sbjct: 121 ATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN 177
Query: 301 VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
                 GT  Y APE ++        D +SFGV+L EML G+
Sbjct: 178 ---EFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 15/211 (7%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           NF+    +GEG +G V+K   +  G         L    + +    ++       E++ L
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-------EISLL 56
Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKG 252
             L HPN+VKL+     +++  LV+EF+    L+  +   +L  +P  +         +G
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           LAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  + T  Y 
Sbjct: 116 LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYR 170
Query: 313 APEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
           APE ++   + ++  D++S G +  EM+T R
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 15/211 (7%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           NF+    +GEG +G V+K   +  G         L    + +    ++       E++ L
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-------EISLL 55
Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKG 252
             L HPN+VKL+     +++  LV+EF+    L+  +   +L  +P  +         +G
Sbjct: 56  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           LAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  + T  Y 
Sbjct: 115 LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYR 169
Query: 313 APEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
           APE ++   + ++  D++S G +  EM+T R
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 106/235 (45%), Gaps = 20/235 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V  G          K      VA+K +  +G     E++ E   + NL H  
Sbjct: 32  LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 80
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           LV+L G C +     ++ E+M  G L N+L            +++     + + +L    
Sbjct: 81  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--- 137
Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG 320
            K  ++RD    N L++     K+SDFGL++   +D  T  S        ++ PE +M  
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMYS 196
Query: 321 HLTSKSDVYSFGVVLLEMLT-GRRSMDK--NRPNGEHNL--VEWARPHLGDKRRF 370
             +SKSD+++FGV++ E+ + G+   ++  N    EH    +   RPHL  ++ +
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY 251

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 82/317 (25%), Positives = 128/317 (40%), Gaps = 81/317 (25%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           +F+   L+G GGFG VFK     +G          T  ++ + ++  +  +E    V  L
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGK---------TYVIRRVKYNNEKAERE----VKAL 59
Query: 194 GNLLHPNLVKLVGYCIE---------DDQR---------------------LLVYEFMPR 223
             L H N+V   G C +         DD                        +  EF  +
Sbjct: 60  AKLDHVNIVHYNG-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDK 118
Query: 224 GSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA 282
           G+LE  +  RR   L   + +++     KG+ ++H    K +I+RD K SNI L      
Sbjct: 119 GTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQV 175
Query: 283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           K+ DFGL      DGK    TR  GT  Y +PE + +     + D+Y+ G++L E+L   
Sbjct: 176 KIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL--- 229
Query: 343 RSMDKNRPNGEHNLVEWARPHLGD----KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCL 398
                               H+ D      +F+   D R +G  S    +K   L  + L
Sbjct: 230 --------------------HVCDTAFETSKFF--TDLR-DGIISDIFDKKEKTLLQKLL 266
Query: 399 SRDPKARPRMSEVVETL 415
           S+ P+ RP  SE++ TL
Sbjct: 267 SKKPEDRPNTSEILRTL 283

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 105/229 (45%), Gaps = 33/229 (14%)
Query: 128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW- 186
           +KL   NF    +LG+G FG V             + GT    A+K L  D +    +  
Sbjct: 16  VKLTDFNFL--MVLGKGSFGKVMLA---------DRKGTEELYAIKILKKDVVIQDDDVE 64
Query: 187 --LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHL-----FRRSLPLP 238
             + E   L  L  P  +  +  C +   RL  V E++  G L  H+     F+    + 
Sbjct: 65  CTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVF 124
Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
           ++  + I      GL FLH+     +IYRD K  N++LD++ + K++DFG+ K+   DG 
Sbjct: 125 YAAEISI------GLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDG- 174
Query: 299 THVSTR-VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD 346
             V+TR   GT  Y APE +         D +++GV+L EML G+   D
Sbjct: 175 --VTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 15/214 (7%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 188
           +L   +F   S LG G  G V K     +G    +    L +     N        + + 
Sbjct: 12  ELKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRN--------QIIR 63
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 248
           E+  L     P +V   G    D +  +  E M  GSL + + + +  +P  I  K+++ 
Sbjct: 64  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKEAKRIPEEILGKVSIA 122
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
             +GLA+L E+ +  +++RD K SNIL+++    KL DFG++    +     ++   +GT
Sbjct: 123 VLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGT 176
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
             Y APE +   H + +SD++S G+ L+E+  GR
Sbjct: 177 RSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 127/299 (42%), Gaps = 45/299 (15%)
Query: 118 SQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH 177
           S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L  
Sbjct: 2   SKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVLFK 45
Query: 178 DGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS 234
             L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G++   L + S
Sbjct: 46  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 105
Query: 235 LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 294
                     I    A  L++ H    K VI+RD K  N+LL +    K+++FG +  AP
Sbjct: 106 KFDEQRTATYIT-ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAP 161
Query: 295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
              +    T + GT  Y  PE +       K D++S GV+  E L G+   + N     +
Sbjct: 162 SSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY 217
Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
             +                   R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 218 KRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 258

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 126/299 (42%), Gaps = 45/299 (15%)
Query: 118 SQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH 177
           S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L  
Sbjct: 2   SKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVLFK 45
Query: 178 DGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS 234
             L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G++   L + S
Sbjct: 46  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 105
Query: 235 LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 294
                     I    A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP
Sbjct: 106 KFDEQRTATYIT-ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 161
Query: 295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
              +  +     GT  Y  PE +       K D++S GV+  E L G+   + N     +
Sbjct: 162 SSRRXXLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY 217
Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
             +                   R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 218 KRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 258

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 121/280 (43%), Gaps = 30/280 (10%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 199
           +GEG FG V +G       +P  P   + VA+KT  +      +E +L E   +    HP
Sbjct: 18  IGEGQFGDVHQGIY----MSPENPA--MAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           ++VKL+G  I ++   ++ E    G L + L  R   L  +  +  A   +  LA+L   
Sbjct: 72  HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES- 129
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             K  ++RD    N+L+ ++   KL DFGL++   ED     +++      + APE +  
Sbjct: 130 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTXXKASKGKLPIKWMAPESINF 186
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLLDPRL 378
              TS SDV+ FGV + E+L     M   +P  G  N     R   G++        P L
Sbjct: 187 RRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 241
Query: 379 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                         L  +C + DP  RPR +E+   L  +
Sbjct: 242 ------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 106/235 (45%), Gaps = 20/235 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V  G          K      VA+K +  +G     E++ E   + NL H  
Sbjct: 23  LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 71
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           LV+L G C +     ++ E+M  G L N+L            +++     + + +L    
Sbjct: 72  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--- 128
Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG 320
            K  ++RD    N L++     K+SDFGL++   +D  T  S        ++ PE +M  
Sbjct: 129 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMYS 187
Query: 321 HLTSKSDVYSFGVVLLEMLT-GRRSMDK--NRPNGEHNL--VEWARPHLGDKRRF 370
             +SKSD+++FGV++ E+ + G+   ++  N    EH    +   RPHL  ++ +
Sbjct: 188 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY 242

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 119/286 (41%), Gaps = 38/286 (13%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 187
           A  +F     LG+G FG V+    ++             +A+K L    L+      +  
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRK---------FILALKVLFKAQLEKAGVEHQLR 53
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L + S          I  
Sbjct: 54  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 112
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +T +     G
Sbjct: 113 ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----G 165
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  Y  PE +       K D++S GV+  E L G+   + N     +  +          
Sbjct: 166 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--------- 216
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                    R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 217 ---------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 253

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 110/238 (46%), Gaps = 26/238 (10%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V  G          K      VA+K +  +G     E++ E   + NL H  
Sbjct: 17  LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 65
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           LV+L G C +     ++ E+M  G L N+L            +++     + + +L    
Sbjct: 66  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--- 122
Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT---YGYAAPEYV 317
            K  ++RD    N L++     K+SDFGL++   +D  T  S+R  G+     ++ PE +
Sbjct: 123 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT--SSR--GSKFPVRWSPPEVL 178
Query: 318 MTGHLTSKSDVYSFGVVLLEMLT-GRRSMDK--NRPNGEHNL--VEWARPHLGDKRRF 370
           M    +SKSD+++FGV++ E+ + G+   ++  N    EH    +   RPHL  ++ +
Sbjct: 179 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY 236

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 122/280 (43%), Gaps = 30/280 (10%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 199
           +GEG FG V +G       +P  P   + VA+KT  +      +E +L E   +    HP
Sbjct: 18  IGEGQFGDVHQGIY----MSPENPA--MAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           ++VKL+G  I ++   ++ E    G L + L  R   L  +  +  A   +  LA+L   
Sbjct: 72  HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES- 129
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             K  ++RD    N+L+ ++   KL DFGL++   ED   + +++      + APE +  
Sbjct: 130 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINF 186
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLLDPRL 378
              TS SDV+ FGV + E+L     M   +P  G  N     R   G++        P L
Sbjct: 187 RRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 241
Query: 379 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                         L  +C + DP  RPR +E+   L  +
Sbjct: 242 ------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 84/324 (25%), Positives = 141/324 (43%), Gaps = 54/324 (16%)
Query: 125 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL-NHDGLQGH 183
           +ND+K        + ++GEG FG V K  ++       K G  +  A+K +  +     H
Sbjct: 21  WNDIKF-------QDVIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDH 66
Query: 184 KEWLAEVNFLGNL-LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 242
           +++  E+  L  L  HPN++ L+G C       L  E+ P G+L + L R+S  L     
Sbjct: 67  RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPA 125
Query: 243 MKIALGAAKGLA---FLHEEA----------EKPVIYRDFKTSNILLDADYNAKLSDFGL 289
             IA   A  L+    LH  A          +K  I+R+    NIL+  +Y AK++DFGL
Sbjct: 126 FAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGL 185
Query: 290 AKDAPEDGKTHVSTRVMGT--YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDK 347
           ++     G+     + MG     + A E +     T+ SDV+S+GV+L E++    S+  
Sbjct: 186 SR-----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV----SLGG 236
Query: 348 NRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR 407
               G      + +   G     YRL  P       +    +   L  QC    P  RP 
Sbjct: 237 TPYCGMTCAELYEKLPQG-----YRLEKP-------LNCDDEVYDLMRQCWREKPYERPS 284
Query: 408 MSEVVETL-KPLQNLKDMASSSYY 430
            ++++ +L + L+  K   +++ Y
Sbjct: 285 FAQILVSLNRMLEERKTYVNTTLY 308

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 128/301 (42%), Gaps = 45/301 (14%)
Query: 116 VASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL 175
           + S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L
Sbjct: 1   MESKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVL 44
Query: 176 NHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR 232
               L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +
Sbjct: 45  FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK 104
Query: 233 RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD 292
            S          I    A  L++ H    K VI+RD K  N+LL +    K+++FG +  
Sbjct: 105 LSKFDEQRTATYIT-ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVH 160
Query: 293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG 352
           AP   +    T + GT  Y  PE +       K D++S GV+  E L G+   + N    
Sbjct: 161 APSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216
Query: 353 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
            +  +                   R+E  F    ++ A  L ++ L  +P  RP + EV+
Sbjct: 217 TYKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258
Query: 413 E 413
           E
Sbjct: 259 E 259

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 126/299 (42%), Gaps = 45/299 (15%)
Query: 118 SQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH 177
           S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L  
Sbjct: 1   SKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVLFK 44
Query: 178 DGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS 234
             L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G++   L + S
Sbjct: 45  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 104
Query: 235 LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 294
                     I    A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP
Sbjct: 105 KFDEQRTATYIT-ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160
Query: 295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
              +      + GT  Y  PE +       K D++S GV+  E L G+   + N     +
Sbjct: 161 SSRR----DTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY 216
Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
             +                   R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 217 KRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 198 HPNLVKLVGYCIEDDQRLL-VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 256
           HP LV L   C + + RL  V E++  G L  H+ +R   LP       +   +  L +L
Sbjct: 112 HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPEEHARFYSAEISLALNYL 169
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           HE   + +IYRD K  N+LLD++ + KL+D+G+ K+    G T  ++   GT  Y APE 
Sbjct: 170 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEI 224
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMD--KNRPNGEHNLVEWARPHLGDKRRFYRLL 374
           +         D ++ GV++ EM+ GR   D   +  N + N  ++          F  +L
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL---------FQVIL 275
Query: 375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           + ++    S+  S KA  +    L++DPK R
Sbjct: 276 EKQIRIPRSL--SVKAASVLKSFLNKDPKER 304

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 106/222 (47%), Gaps = 37/222 (16%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 189
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 3   NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 51
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYE--------FMPRGSLENHLFRRSLPLPWSI 241
           ++ L  L HPN+VKL+     +++  LV+E        FM   +L        +PLP  +
Sbjct: 52  ISLLKELNHPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTG------IPLP--L 103
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
                    +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+ 
Sbjct: 104 IKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY- 159
Query: 302 STRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
            T  + T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 160 -THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 119/286 (41%), Gaps = 38/286 (13%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 187
           A  +F     LG+G FG V+    ++         +   +A+K L    L+      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLR 56
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L + S          I  
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 115
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +  +     G
Sbjct: 116 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----G 168
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  Y  PE +       K D++S GV+  E L G+   + N     +  +          
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--------- 219
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                    R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 220 ---------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 127/301 (42%), Gaps = 45/301 (14%)
Query: 116 VASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL 175
           + S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L
Sbjct: 1   MESKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVL 44
Query: 176 NHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR 232
               L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +
Sbjct: 45  FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK 104
Query: 233 RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD 292
            S          I    A  L++ H    K VI+RD K  N+LL +    K++DFG +  
Sbjct: 105 LSKFDEQRTATYIT-ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH 160
Query: 293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG 352
           AP   +  +     GT  Y  PE +       K D++S GV+  E L G+   + N    
Sbjct: 161 APSSRRXXLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216
Query: 353 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
            +  +                   R+E  F    ++ A  L ++ L  +P  RP + EV+
Sbjct: 217 TYKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258
Query: 413 E 413
           E
Sbjct: 259 E 259

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 96/222 (43%), Gaps = 25/222 (11%)
Query: 128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL 187
           +KL   +F    +LG+G FG VF    ++         T    A+K L  D +    +  
Sbjct: 12  IKLKIEDFILHKMLGKGSFGKVFLAEFKK---------TNQFFAIKALKKDVVLMDDD-- 60
Query: 188 AEVNFLGNLL------HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI 241
            E   +   +      HP L  +       +    V E++  G L  H+ +       S 
Sbjct: 61  VECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSR 119
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD-APEDGKTH 300
               A     GL FLH    K ++YRD K  NILLD D + K++DFG+ K+    D KT+
Sbjct: 120 ATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN 176
Query: 301 VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
                 GT  Y APE ++        D +SFGV+L EML G+
Sbjct: 177 ---XFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 119/286 (41%), Gaps = 38/286 (13%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 187
           A  +F     LG+G FG V+    ++         +   +A+K L    L+      +  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLR 59
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L + S          I  
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 118
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +  +     G
Sbjct: 119 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC----G 171
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  Y  PE +       K D++S GV+  E L G+   + N     +  +          
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--------- 222
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                    R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 223 ---------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 119/286 (41%), Gaps = 38/286 (13%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 187
           A  +F     LG+G FG V+    ++         +   +A+K L    L+      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLR 56
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L + S          I  
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 115
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +  +     G
Sbjct: 116 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----G 168
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  Y  PE +       K D++S GV+  E L G+   + N     +  +          
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--------- 219
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                    R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 220 ---------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 119/286 (41%), Gaps = 38/286 (13%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 187
           A  +F     LG+G FG V+    ++         +   +A+K L    L+      +  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLR 59
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L + S          I  
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 118
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +  +     G
Sbjct: 119 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----G 171
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  Y  PE +       K D++S GV+  E L G+   + N     +  +          
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--------- 222
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                    R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 223 ---------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 107/221 (48%), Gaps = 16/221 (7%)
Query: 122 KFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ 181
           K ++ D KL T     +  LG G FG V KG+ +      V     + +     N   L+
Sbjct: 362 KEVYLDRKLLTLE---DKELGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALK 415
Query: 182 GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI 241
              E LAE N +  L +P +V+++G C E +  +LV E    G L  +L +       +I
Sbjct: 416 --DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI 472
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
            +++    + G+ +L E      ++RD    N+LL   + AK+SDFGL+K    D + + 
Sbjct: 473 -IELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYY 527
Query: 302 STRVMGTY--GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
             +  G +   + APE +     +SKSDV+SFGV++ E  +
Sbjct: 528 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 107/221 (48%), Gaps = 16/221 (7%)
Query: 122 KFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ 181
           K ++ D KL T     +  LG G FG V KG+ +      V     + +     N   L+
Sbjct: 361 KEVYLDRKLLTLE---DKELGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALK 414
Query: 182 GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI 241
              E LAE N +  L +P +V+++G C E +  +LV E    G L  +L +       +I
Sbjct: 415 --DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI 471
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
            +++    + G+ +L E      ++RD    N+LL   + AK+SDFGL+K    D + + 
Sbjct: 472 -IELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYY 526
Query: 302 STRVMGTY--GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
             +  G +   + APE +     +SKSDV+SFGV++ E  +
Sbjct: 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 115/257 (44%), Gaps = 31/257 (12%)
Query: 166 TGLTVAVKTLNHDG-LQGHKEWLAEVNF-LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR 223
           TG  +AVK +   G  + +K  L +++  L +   P +V+  G  I +    +  E M  
Sbjct: 49  TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-- 106
Query: 224 GSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA 282
           G+    L +R   P+P  I  K+ +   K L +L E+    VI+RD K SNILLD     
Sbjct: 107 GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQI 164
Query: 283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS-----KSDVYSFGVVLLE 337
           KL DFG++    +D       R  G   Y APE +     T      ++DV+S G+ L+E
Sbjct: 165 KLCDFGISGRLVDD---KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221
Query: 338 MLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQ 396
           + TG+      + + E    V    P             P L GH    G  ++      
Sbjct: 222 LATGQFPYKNCKTDFEVLTKVLQEEP-------------PLLPGHMGFSGDFQS--FVKD 266
Query: 397 CLSRDPKARPRMSEVVE 413
           CL++D + RP+ ++++E
Sbjct: 267 CLTKDHRKRPKYNKLLE 283

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 111/244 (45%), Gaps = 35/244 (14%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLA 188
           N++    LGEG FG V   +            TG  VA+K +N   L     QG  E   
Sbjct: 5   NYQIVKTLGEGSFGKVKLAY---------HTTTGQKVALKIINKKVLAKSDMQGRIE--R 53
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 248
           E+++L  L HP+++KL       D+ ++V E+      +  + R  +    + R    + 
Sbjct: 54  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQII 113
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
           +A      H+     +++RD K  N+LLD   N K++DFGL+    +      S    G+
Sbjct: 114 SAVEYCHRHK-----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GS 165
Query: 309 YGYAAPEYVMTGHLTS--KSDVYSFGVVLLEMLTGRRSMD--------KNRPNGEHNLVE 358
             YAAPE V++G L +  + DV+S GV+L  ML  R   D        KN  NG + L +
Sbjct: 166 PNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK 224
Query: 359 WARP 362
           +  P
Sbjct: 225 FLSP 228

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 111/244 (45%), Gaps = 35/244 (14%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLA 188
           N++    LGEG FG V   +            TG  VA+K +N   L     QG  E   
Sbjct: 15  NYQIVKTLGEGSFGKVKLAY---------HTTTGQKVALKIINKKVLAKSDMQGRIE--R 63
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 248
           E+++L  L HP+++KL       D+ ++V E+      +  + R  +    + R    + 
Sbjct: 64  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQII 123
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
           +A      H+     +++RD K  N+LLD   N K++DFGL+    +      S    G+
Sbjct: 124 SAVEYCHRHK-----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GS 175
Query: 309 YGYAAPEYVMTGHLTS--KSDVYSFGVVLLEMLTGRRSMD--------KNRPNGEHNLVE 358
             YAAPE V++G L +  + DV+S GV+L  ML  R   D        KN  NG + L +
Sbjct: 176 PNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK 234
Query: 359 WARP 362
           +  P
Sbjct: 235 FLSP 238

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 198 HPNLVKLVGYCIEDDQRLL-VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 256
           HP LV L   C + + RL  V E++  G L  H+ +R   LP       +   +  L +L
Sbjct: 80  HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPEEHARFYSAEISLALNYL 137
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           HE   + +IYRD K  N+LLD++ + KL+D+G+ K+    G T  ++   GT  Y APE 
Sbjct: 138 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPEI 192
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMD--KNRPNGEHNLVEWARPHLGDKRRFYRLL 374
           +         D ++ GV++ EM+ GR   D   +  N + N  ++          F  +L
Sbjct: 193 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL---------FQVIL 243
Query: 375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           + ++    S+  S KA  +    L++DPK R
Sbjct: 244 EKQIRIPRSM--SVKAASVLKSFLNKDPKER 272

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLHP 199
           LG G FG V +G               + VA+K L     +   +E + E   +  L +P
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQ-------IDVAIKVLKQGTEKADTEEMMREAQIMHQLDNP 70
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
            +V+L+G C + +  +LV E    G L   L  +   +P S   ++    + G+ +L E 
Sbjct: 71  YIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE- 128
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY--GYAAPEYV 317
             K  ++RD    N+LL   + AK+SDFGL+K    D  ++ + R  G +   + APE +
Sbjct: 129 --KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAGKWPLKWYAPECI 185
Query: 318 MTGHLTSKSDVYSFGVVLLEMLT 340
                +S+SDV+S+GV + E L+
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALS 208

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 198 HPNLVKLVGYCIEDDQRLL-VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 256
           HP LV L   C + + RL  V E++  G L  H+ +R   LP       +   +  L +L
Sbjct: 69  HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPEEHARFYSAEISLALNYL 126
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           HE     +IYRD K  N+LLD++ + KL+D+G+ K+    G T  ++   GT  Y APE 
Sbjct: 127 HERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPEI 181
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMD--KNRPNGEHNLVEWARPHLGDKRRFYRLL 374
           +         D ++ GV++ EM+ GR   D   +  N + N  ++          F  +L
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL---------FQVIL 232
Query: 375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           + ++    S+  S KA  +    L++DPK R
Sbjct: 233 EKQIRIPRSL--SVKAASVLKSFLNKDPKER 261

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 198 HPNLVKLVGYCIEDDQRLL-VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 256
           HP LV L   C + + RL  V E++  G L  H+ +R   LP       +   +  L +L
Sbjct: 65  HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPEEHARFYSAEISLALNYL 122
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           HE   + +IYRD K  N+LLD++ + KL+D+G+ K+    G T  ++   GT  Y APE 
Sbjct: 123 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPEI 177
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMD--KNRPNGEHNLVEWARPHLGDKRRFYRLL 374
           +         D ++ GV++ EM+ GR   D   +  N + N  ++          F  +L
Sbjct: 178 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL---------FQVIL 228
Query: 375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           + ++    S+  S KA  +    L++DPK R
Sbjct: 229 EKQIRIPRSL--SVKAASVLKSFLNKDPKER 257

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 106/225 (47%), Gaps = 37/225 (16%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 52
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYE--------FMPRGSLENHLFRRSLPLP 238
           + E++ L  L HPN+VKL+     +++  LV+E        FM   +L        +PLP
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTG------IPLP 106
Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
                   L   +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +
Sbjct: 107 LIKSYLFQL--LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 161
Query: 299 THVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
           T+    V  T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 162 TYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 111/244 (45%), Gaps = 35/244 (14%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLA 188
           N++    LGEG FG V   +            TG  VA+K +N   L     QG  E   
Sbjct: 14  NYQIVKTLGEGSFGKVKLAY---------HTTTGQKVALKIINKKVLAKSDMQGRIE--R 62
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 248
           E+++L  L HP+++KL       D+ ++V E+      +  + R  +    + R    + 
Sbjct: 63  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQII 122
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
           +A      H+     +++RD K  N+LLD   N K++DFGL+    +      S    G+
Sbjct: 123 SAVEYCHRHK-----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GS 174
Query: 309 YGYAAPEYVMTGHLTS--KSDVYSFGVVLLEMLTGRRSMD--------KNRPNGEHNLVE 358
             YAAPE V++G L +  + DV+S GV+L  ML  R   D        KN  NG + L +
Sbjct: 175 PNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK 233
Query: 359 WARP 362
           +  P
Sbjct: 234 FLSP 237

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/243 (29%), Positives = 108/243 (44%), Gaps = 35/243 (14%)
Query: 113 ELKVASQLRKFMFND----LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGL 168
           E K A+ + KF  N     +KL   NF    +LG+G FG V             + GT  
Sbjct: 319 EEKTANTISKFDNNGNRDRMKLTDFNFL--MVLGKGSFGKVM---------LSERKGTDE 367
Query: 169 TVAVKTLNHDGLQGHKE---WLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRG 224
             AVK L  D +    +    + E   L     P  +  +  C +   RL  V E++  G
Sbjct: 368 LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG 427
Query: 225 SLENHL-----FRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD 279
            L  H+     F+    + ++  + I      GL FL     K +IYRD K  N++LD++
Sbjct: 428 DLMYHIQQVGRFKEPHAVFYAAEIAI------GLFFLQS---KGIIYRDLKLDNVMLDSE 478
Query: 280 YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 339
            + K++DFG+ K+   DG T  +    GT  Y APE +         D ++FGV+L EML
Sbjct: 479 GHIKIADFGMCKENIWDGVT--TKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 536
Query: 340 TGR 342
            G+
Sbjct: 537 AGQ 539

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 111/244 (45%), Gaps = 35/244 (14%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLA 188
           N++    LGEG FG V   +            TG  VA+K +N   L     QG  E   
Sbjct: 9   NYQIVKTLGEGSFGKVKLAY---------HTTTGQKVALKIINKKVLAKSDMQGRIE--R 57
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 248
           E+++L  L HP+++KL       D+ ++V E+      +  + R  +    + R    + 
Sbjct: 58  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQII 117
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
           +A      H+     +++RD K  N+LLD   N K++DFGL+    +      S    G+
Sbjct: 118 SAVEYCHRHK-----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GS 169
Query: 309 YGYAAPEYVMTGHLTS--KSDVYSFGVVLLEMLTGRRSMD--------KNRPNGEHNLVE 358
             YAAPE V++G L +  + DV+S GV+L  ML  R   D        KN  NG + L +
Sbjct: 170 PNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK 228
Query: 359 WARP 362
           +  P
Sbjct: 229 FLSP 232

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 122/290 (42%), Gaps = 33/290 (11%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGNLL 197
           L+GEG +G V K   ++         TG  VA+K    + D     K  + E+  L  L 
Sbjct: 32  LVGEGSYGMVMKCRNKD---------TGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLEN-HLFRRSLPLPWSIRMKIALGAAKGLAFL 256
           H NLV L+  C +  +  LV+EF+    L++  LF   L   + +  K       G+ F 
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLD--YQVVQKYLFQIINGIGFC 140
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +I+RD K  NIL+      KL DFG A+     G+ +     + T  Y APE 
Sbjct: 141 HSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE--VATRWYRAPEL 195
Query: 317 VMTGHLTSKS-DVYSFGVVLLEMLTGRRSM--DKNRPNGEH------NLVEWARPHLGDK 367
           ++      K+ DV++ G ++ EM  G      D +     H      NL+   +      
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255
Query: 368 RRFYRLLDPRLEGHFSI-----KGSQKATQLAAQCLSRDPKARPRMSEVV 412
             F  +  P ++    +     K S+    LA +CL  DP  RP  +E++
Sbjct: 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELL 305

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 102/210 (48%), Gaps = 29/210 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAEVNFLGNL 196
           +GEG +G V+K           K   G  VA+K +  D    G+      + E++ L  L
Sbjct: 29  VGEGTYGVVYKA----------KDSQGRIVALKRIRLDAEDEGIPSTA--IREISLLKEL 76
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL-GAAKGLAF 255
            HPN+V L+     +    LV+EFM +  L+  L      L  S ++KI L    +G+A 
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDS-QIKIYLYQLLRGVAH 134
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTHVSTRVMGTYGYAA 313
            H+     +++RD K  N+L+++D   KL+DFGLA+    P    TH       T  Y A
Sbjct: 135 CHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TLWYRA 187
Query: 314 PEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
           P+ +M     S S D++S G +  EM+TG+
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 106/235 (45%), Gaps = 31/235 (13%)
Query: 125 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-- 182
             ++ L+   F  E  LGE  FG V+KG +   G AP +      VA+KTL  D  +G  
Sbjct: 3   LKEISLSAVRFMEE--LGEDRFGKVYKGHL--FGPAPGEQTQA--VAIKTLK-DKAEGPL 55
Query: 183 HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS-------- 234
            +E+  E      L HPN+V L+G   +D    +++ +   G L   L  RS        
Sbjct: 56  REEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGST 115
Query: 235 ---------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS 285
                    L  P  + +   + A  G+ +L   +   V+++D  T N+L+    N K+S
Sbjct: 116 DDDRTVKSALEPPDFVHLVAQIAA--GMEYL---SSHHVVHKDLATRNVLVYDKLNVKIS 170
Query: 286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           D GL ++        +    +    + APE +M G  +  SD++S+GVVL E+ +
Sbjct: 171 DLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 102/210 (48%), Gaps = 29/210 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAEVNFLGNL 196
           +GEG +G V+K           K   G  VA+K +  D    G+      + E++ L  L
Sbjct: 29  VGEGTYGVVYKA----------KDSQGRIVALKRIRLDAEDEGIPSTA--IREISLLKEL 76
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL-GAAKGLAF 255
            HPN+V L+     +    LV+EFM +  L+  L      L  S ++KI L    +G+A 
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDS-QIKIYLYQLLRGVAH 134
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD--APEDGKTHVSTRVMGTYGYAA 313
            H+     +++RD K  N+L+++D   KL+DFGLA+    P    TH       T  Y A
Sbjct: 135 CHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TLWYRA 187
Query: 314 PEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
           P+ +M     S S D++S G +  EM+TG+
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 13/202 (6%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V KG+ +      V     + +     N   L+   E LAE N +  L +P 
Sbjct: 35  LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPY 89
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           +V+++G C E +  +LV E    G L  +L +       +I +++    + G+ +L E  
Sbjct: 90  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEESN 147
Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY--GYAAPEYVM 318
               ++RD    N+LL   + AK+SDFGL+K    D + +   +  G +   + APE + 
Sbjct: 148 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECIN 203
Query: 319 TGHLTSKSDVYSFGVVLLEMLT 340
               +SKSDV+SFGV++ E  +
Sbjct: 204 YYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 13/202 (6%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V KG+ +      V     + +     N   L+   E LAE N +  L +P 
Sbjct: 35  LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPY 89
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           +V+++G C E +  +LV E    G L  +L +       +I +++    + G+ +L E  
Sbjct: 90  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEESN 147
Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY--GYAAPEYVM 318
               ++RD    N+LL   + AK+SDFGL+K    D + +   +  G +   + APE + 
Sbjct: 148 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECIN 203
Query: 319 TGHLTSKSDVYSFGVVLLEMLT 340
               +SKSDV+SFGV++ E  +
Sbjct: 204 YYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 13/202 (6%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V KG+ +      V     + +     N   L+   E LAE N +  L +P 
Sbjct: 33  LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLDNPY 87
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           +V+++G C E +  +LV E    G L  +L +       +I +++    + G+ +L E  
Sbjct: 88  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEESN 145
Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY--GYAAPEYVM 318
               ++RD    N+LL   + AK+SDFGL+K    D + +   +  G +   + APE + 
Sbjct: 146 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECIN 201
Query: 319 TGHLTSKSDVYSFGVVLLEMLT 340
               +SKSDV+SFGV++ E  +
Sbjct: 202 YYKFSSKSDVWSFGVLMWEAFS 223

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 36/275 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEVNFLGNLLHP 199
           +G+G FG V+KG   +N T  V       VA+K ++  +     ++   E+  L     P
Sbjct: 27  IGKGSFGEVYKGI--DNHTKEV-------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 77
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
            + +  G  ++  +  ++ E++  GS  + L  +  PL  +    I     KGL +LH E
Sbjct: 78  YITRYFGSYLKSTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSE 135
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS-TRVMGTYGYAAPEYVM 318
            +   I+RD K +N+LL    + KL+DFG+A    +   T +     +GT  + APE + 
Sbjct: 136 RK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD---TQIKRNXFVGTPFWMAPEVIK 189
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRL 378
                 K+D++S G+  +E+  G        P     L+    P             P L
Sbjct: 190 QSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------PTL 236
Query: 379 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
           EG    + S+   +    CL++DP+ RP   E+++
Sbjct: 237 EG----QHSKPFKEFVEACLNKDPRFRPTAKELLK 267

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 10/204 (4%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +LG GGFG VF   ++  G              K   + G    K+ LA+V       H 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HS 244
Query: 200 NLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 258
             +  + Y  E    L LV   M  G +  H++      P     +     A+ ++ L  
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
             ++ +IYRD K  N+LLD D N ++SD GLA +  + G+T       GT G+ APE ++
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL-KAGQTKTKGYA-GTPGFMAPELLL 362
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGR 342
                   D ++ GV L EM+  R
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLHP 199
           LG G FG V +G               + VA+K L     +   +E + E   +  L +P
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQ-------IDVAIKVLKQGTEKADTEEMMREAQIMHQLDNP 396
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
            +V+L+G C + +  +LV E    G L   L  +   +P S   ++    + G+ +L E 
Sbjct: 397 YIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE- 454
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY--GYAAPEYV 317
             K  ++R+    N+LL   + AK+SDFGL+K    D  ++ + R  G +   + APE +
Sbjct: 455 --KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAGKWPLKWYAPECI 511
Query: 318 MTGHLTSKSDVYSFGVVLLEMLT 340
                +S+SDV+S+GV + E L+
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALS 534

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 10/204 (4%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +LG GGFG VF   ++  G              K   + G    K+ LA+V       H 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HS 244
Query: 200 NLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 258
             +  + Y  E    L LV   M  G +  H++      P     +     A+ ++ L  
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
             ++ +IYRD K  N+LLD D N ++SD GLA +  + G+T       GT G+ APE ++
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL-KAGQTKTKGYA-GTPGFMAPELLL 362
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGR 342
                   D ++ GV L EM+  R
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 13/202 (6%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V KG+ +      V     + +     N   L+   E LAE N +  L +P 
Sbjct: 19  LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLDNPY 73
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           +V+++G C E +  +LV E    G L  +L +       +I +++    + G+ +L E  
Sbjct: 74  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEE-- 129
Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY--GYAAPEYVM 318
               ++RD    N+LL   + AK+SDFGL+K    D + +   +  G +   + APE + 
Sbjct: 130 -SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECIN 187
Query: 319 TGHLTSKSDVYSFGVVLLEMLT 340
               +SKSDV+SFGV++ E  +
Sbjct: 188 YYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 10/204 (4%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +LG GGFG VF   ++  G              K   + G    K+ LA+V       H 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HS 244
Query: 200 NLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 258
             +  + Y  E    L LV   M  G +  H++      P     +     A+ ++ L  
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
             ++ +IYRD K  N+LLD D N ++SD GLA +  + G+T       GT G+ APE ++
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL-KAGQTKTKGYA-GTPGFMAPELLL 362
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGR 342
                   D ++ GV L EM+  R
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 13/202 (6%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V KG+ +      V     + +     N   L+   E LAE N +  L +P 
Sbjct: 25  LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLDNPY 79
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           +V+++G C E +  +LV E    G L  +L +       +I +++    + G+ +L E  
Sbjct: 80  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEE-- 135
Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY--GYAAPEYVM 318
               ++RD    N+LL   + AK+SDFGL+K    D + +   +  G +   + APE + 
Sbjct: 136 -SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECIN 193
Query: 319 TGHLTSKSDVYSFGVVLLEMLT 340
               +SKSDV+SFGV++ E  +
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFS 215

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 13/202 (6%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V KG+ +      V     + +     N   L+   E LAE N +  L +P 
Sbjct: 13  LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLDNPY 67
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           +V+++G C E +  +LV E    G L  +L +       +I +++    + G+ +L E  
Sbjct: 68  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEE-- 123
Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY--GYAAPEYVM 318
               ++RD    N+LL   + AK+SDFGL+K    D + +   +  G +   + APE + 
Sbjct: 124 -SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECIN 181
Query: 319 TGHLTSKSDVYSFGVVLLEMLT 340
               +SKSDV+SFGV++ E  +
Sbjct: 182 YYKFSSKSDVWSFGVLMWEAFS 203

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 10/204 (4%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +LG GGFG VF   ++  G              K   + G    K+ LA+V       H 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HS 244
Query: 200 NLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 258
             +  + Y  E    L LV   M  G +  H++      P     +     A+ ++ L  
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
             ++ +IYRD K  N+LLD D N ++SD GLA +  + G+T       GT G+ APE ++
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL-KAGQTKTKGYA-GTPGFMAPELLL 362
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGR 342
                   D ++ GV L EM+  R
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 92/215 (42%), Gaps = 27/215 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 199
           LG GGFG V + W+ ++        TG  VA+K    +    ++E W  E+  +  L HP
Sbjct: 22  LGTGGFGYVLR-WIHQD--------TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 200 NLVKL------VGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAK 251
           N+V        +     +D  LL  E+   G L  +L  F     L       +    + 
Sbjct: 73  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLD---ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            L +LHE     +I+RD K  NI+L         K+ D G AK   E  +  + T  +GT
Sbjct: 133 ALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAK---ELDQGELCTEFVGT 186
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 343
             Y APE +     T   D +SFG +  E +TG R
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 92/215 (42%), Gaps = 27/215 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 199
           LG GGFG V + W+ ++        TG  VA+K    +    ++E W  E+  +  L HP
Sbjct: 23  LGTGGFGYVLR-WIHQD--------TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 73
Query: 200 NLVKL------VGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAK 251
           N+V        +     +D  LL  E+   G L  +L  F     L       +    + 
Sbjct: 74  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 133
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLD---ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            L +LHE     +I+RD K  NI+L         K+ D G AK   E  +  + T  +GT
Sbjct: 134 ALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAK---ELDQGELCTEFVGT 187
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 343
             Y APE +     T   D +SFG +  E +TG R
Sbjct: 188 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 222

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 119/283 (42%), Gaps = 51/283 (18%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +GEG  G V    V  +G           VAVK ++    Q  +    EV  + +  H N
Sbjct: 159 IGEGSTGIVCIATVRSSGK---------LVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 209
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK------IALGAAKGLA 254
           +V++    +  D+  +V EF+  G+L +        +    RM       + L   + L+
Sbjct: 210 VVEMYNSYLVGDELWVVMEFLEGGALTD--------IVTHTRMNEEQIAAVCLAVLQALS 261
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG----LAKDAPEDGKTHVSTRVMGTYG 310
            LH +    VI+RD K+ +ILL  D   KLSDFG    ++K+ P          ++GT  
Sbjct: 262 VLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR------RKXLVGTPY 312
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           + APE +       + D++S G++++EM+ G                 +  P L   +  
Sbjct: 313 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY-------------FNEPPLKAMKMI 359
Query: 371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
              L PRL+    +  S K      + L RDP  R   +E+++
Sbjct: 360 RDNLPPRLKNLHKVSPSLKG--FLDRLLVRDPAQRATAAELLK 400

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 13/202 (6%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V KG+ +      V     + +     N   L+   E LAE N +  L +P 
Sbjct: 15  LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLDNPY 69
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           +V+++G C E +  +LV E    G L  +L +       +I +++    + G+ +L E  
Sbjct: 70  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEE-- 125
Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY--GYAAPEYVM 318
               ++RD    N+LL   + AK+SDFGL+K    D + +   +  G +   + APE + 
Sbjct: 126 -SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECIN 183
Query: 319 TGHLTSKSDVYSFGVVLLEMLT 340
               +SKSDV+SFGV++ E  +
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFS 205

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 11/217 (5%)
Query: 124 MFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH 183
           M  D+K   + +     LGEG F  V+K    +  T  +     + +  ++   DG+  +
Sbjct: 1   MALDVKSRAKRYEKLDFLGEGQFATVYKA--RDKNTNQIVAIKKIKLGHRSEAKDGI--N 56
Query: 184 KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM 243
           +  L E+  L  L HPN++ L+          LV++FM    LE  +   SL L  S   
Sbjct: 57  RTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIK 115
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
              L   +GL +LH+     +++RD K +N+LLD +   KL+DFGLAK      + +   
Sbjct: 116 AYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQ 172
Query: 304 RVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEML 339
            V  T  Y APE +    +     D+++ G +L E+L
Sbjct: 173 VV--TRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 110/227 (48%), Gaps = 45/227 (19%)
Query: 144 GGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGN--LLHPNL 201
           G FGCV+K  +  +            VAVK      LQ  + W +E        + H NL
Sbjct: 26  GRFGCVWKAQLMND-----------FVAVKIFP---LQDKQSWQSEREIFSTPGMKHENL 71
Query: 202 VKLV-----GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 256
           ++ +     G  +E  +  L+  F  +GSL ++L  +   + W+    +A   ++GL++L
Sbjct: 72  LQFIAAEKRGSNLEV-ELWLITAFHDKGSLTDYL--KGNIITWNELCHVAETMSRGLSYL 128
Query: 257 HE-------EAEKPVI-YRDFKTSNILLDADYNAKLSDFGLA---KDAPEDGKTHVSTRV 305
           HE       E  KP I +RDFK+ N+LL +D  A L+DFGLA   +     G TH     
Sbjct: 129 HEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQ--- 185
Query: 306 MGTYGYAAPEYVMTGHLTS------KSDVYSFGVVLLEMLTGRRSMD 346
           +GT  Y APE V+ G +        + D+Y+ G+VL E+++  ++ D
Sbjct: 186 VGTRRYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G+G  G V+           +   TG  VA++ +N       +  + E+  +    +PN
Sbjct: 28  IGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           +V  +   +  D+  +V E++  GSL + +    +         +     + L FLH   
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQALEFLHS-- 134
Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
              VI+RD K+ NILL  D + KL+DFG  A+  PE  K    + ++GT  + APE V  
Sbjct: 135 -NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSEMVGTPYWMAPEVVTR 190
Query: 320 GHLTSKSDVYSFGVVLLEMLTGR 342
                K D++S G++ +EM+ G 
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 11/201 (5%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V KG+ +      V     + +     N   L+   E LAE N +  L +P 
Sbjct: 19  LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLDNPY 73
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           +V+++G C E +  +LV E    G L  +L +       +I +++    + G+ +L E  
Sbjct: 74  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEE-- 129
Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH-VSTRVMGTYGYAAPEYVMT 319
               ++RD    N+LL   + AK+SDFGL+K    D   +   T       + APE +  
Sbjct: 130 -SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINY 188
Query: 320 GHLTSKSDVYSFGVVLLEMLT 340
              +SKSDV+SFGV++ E  +
Sbjct: 189 YKFSSKSDVWSFGVLMWEAFS 209

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 127/297 (42%), Gaps = 44/297 (14%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNF 192
           ++  + ++G G    V   +      AP K      VA+K +N +  Q    E L E+  
Sbjct: 16  DYELQEVIGSGATAVVQAAY-----CAPKKE----KVAIKRINLEKCQTSMDELLKEIQA 66
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLEN---HLF----RRSLPLPWSIRMKI 245
           +    HPN+V      +  D+  LV + +  GS+ +   H+      +S  L  S    I
Sbjct: 67  MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG---KTHVS 302
                +GL +LH+  +   I+RD K  NILL  D + +++DFG++      G   +  V 
Sbjct: 127 LREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR 183
Query: 303 TRVMGTYGYAAPEYV--MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 360
              +GT  + APE +  + G+   K+D++SFG+  +E+ TG     K  P     L    
Sbjct: 184 KTFVGTPCWMAPEVMEQVRGY-DFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 242
Query: 361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKAT-----QLAAQCLSRDPKARPRMSEVV 412
            P             P LE     K   K       ++ + CL +DP+ RP  +E++
Sbjct: 243 DP-------------PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 118/285 (41%), Gaps = 52/285 (18%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 198
           +GEG FG        E+G   V         +K +N   +     +E   EV  L N+ H
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYV---------IKEINISRMSSKEREESRREVAVLANMKH 82
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSL-------ENHLFRRSLPLPWSIRMKIALGAAK 251
           PN+V+      E+    +V ++   G L       +  LF+    L W +++ +AL    
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
                    ++ +++RD K+ NI L  D   +L DFG+A+    +    ++   +GT  Y
Sbjct: 143 ---------DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARACIGTPYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 371
            +PE        +KSD+++ G VL E+ T + + +        NLV              
Sbjct: 192 LSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE---AGSMKNLVLKI----------- 237
Query: 372 RLLDPRLEGHF---SIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                 + G F   S+  S     L +Q   R+P+ RP ++ ++E
Sbjct: 238 ------ISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G+G  G V+           +   TG  VA++ +N       +  + E+  +    +PN
Sbjct: 28  IGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           +V  +   +  D+  +V E++  GSL + +    +         +     + L FLH   
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQALEFLHS-- 134
Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
              VI+RD K+ NILL  D + KL+DFG  A+  PE  K    + ++GT  + APE V  
Sbjct: 135 -NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSXMVGTPYWMAPEVVTR 190
Query: 320 GHLTSKSDVYSFGVVLLEMLTGR 342
                K D++S G++ +EM+ G 
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G+G  G V+           +   TG  VA++ +N       +  + E+  +    +PN
Sbjct: 28  IGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           +V  +   +  D+  +V E++  GSL + +    +         +     + L FLH   
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQALEFLHS-- 134
Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
              VI+RD K+ NILL  D + KL+DFG  A+  PE  K    + ++GT  + APE V  
Sbjct: 135 -NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTR 190
Query: 320 GHLTSKSDVYSFGVVLLEMLTGR 342
                K D++S G++ +EM+ G 
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 118/279 (42%), Gaps = 38/279 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGNLLHP 199
           LG G FG V    VEE  +       GL   +KT+N D  Q   E + AE+  L +L HP
Sbjct: 30  LGSGAFGDV--HLVEERSS-------GLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           N++K+     +     +V E    G L   +     R   L      ++       LA+ 
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 257 HEEAEKPVIYRDFKTSNILL-DADYNA--KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
           H +    V+++D K  NIL  D   ++  K+ DFGLA+    D     ST   GT  Y A
Sbjct: 141 HSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMA 194
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 373
           PE V    +T K D++S GVV+  +LTG                 +  P+   +    R 
Sbjct: 195 PE-VFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE---CRP 250
Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
           L P            +A  L  Q L++DP+ RP  ++V+
Sbjct: 251 LTP------------QAVDLLKQMLTKDPERRPSAAQVL 277

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G+G  G V+           +   TG  VA++ +N       +  + E+  +    +PN
Sbjct: 29  IGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 79
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           +V  +   +  D+  +V E++  GSL + +    +         +     + L FLH   
Sbjct: 80  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQALEFLHS-- 135
Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
              VI+RD K+ NILL  D + KL+DFG  A+  PE  K    + ++GT  + APE V  
Sbjct: 136 -NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSXMVGTPYWMAPEVVTR 191
Query: 320 GHLTSKSDVYSFGVVLLEMLTGR 342
                K D++S G++ +EM+ G 
Sbjct: 192 KAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 106/237 (44%), Gaps = 24/237 (10%)
Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGH 183
           ++ L   +F    ++G GGFG V+            K  TG   A+K L+   +   QG 
Sbjct: 182 NIHLTMNDFSVHRIIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGE 232
Query: 184 KEWLAEVNFLGNLLHPN--LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWS 240
              L E   L  +   +   +  + Y      +L  + + M  G L  HL +  +     
Sbjct: 233 TLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD 292
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH 300
           +R   A     GL  +H    + V+YRD K +NILLD   + ++SD GLA D  +  K H
Sbjct: 293 MRF-YAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPH 347
Query: 301 VSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 356
            S   +GT+GY APE +  G    S +D +S G +L ++L G     +++   +H +
Sbjct: 348 AS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 401

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 127/297 (42%), Gaps = 44/297 (14%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNF 192
           ++  + ++G G    V   +      AP K      VA+K +N +  Q    E L E+  
Sbjct: 11  DYELQEVIGSGATAVVQAAY-----CAPKKE----KVAIKRINLEKCQTSMDELLKEIQA 61
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLEN---HLF----RRSLPLPWSIRMKI 245
           +    HPN+V      +  D+  LV + +  GS+ +   H+      +S  L  S    I
Sbjct: 62  MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 121
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG---KTHVS 302
                +GL +LH+  +   I+RD K  NILL  D + +++DFG++      G   +  V 
Sbjct: 122 LREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR 178
Query: 303 TRVMGTYGYAAPEYV--MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 360
              +GT  + APE +  + G+   K+D++SFG+  +E+ TG     K  P     L    
Sbjct: 179 KTFVGTPCWMAPEVMEQVRGY-DFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 237
Query: 361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKAT-----QLAAQCLSRDPKARPRMSEVV 412
            P             P LE     K   K       ++ + CL +DP+ RP  +E++
Sbjct: 238 DP-------------PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 106/237 (44%), Gaps = 24/237 (10%)
Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGH 183
           ++ L   +F    ++G GGFG V+            K  TG   A+K L+   +   QG 
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGE 233
Query: 184 KEWLAEVNFLGNLLHPN--LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWS 240
              L E   L  +   +   +  + Y      +L  + + M  G L  HL +  +     
Sbjct: 234 TLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD 293
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH 300
           +R   A     GL  +H    + V+YRD K +NILLD   + ++SD GLA D  +  K H
Sbjct: 294 MRF-YAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPH 348
Query: 301 VSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 356
            S   +GT+GY APE +  G    S +D +S G +L ++L G     +++   +H +
Sbjct: 349 AS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 100/224 (44%), Gaps = 31/224 (13%)
Query: 128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW- 186
           +KL   NF    +LG+G FG V             + GT    AVK L  D +    +  
Sbjct: 17  MKLTDFNFL--MVLGKGSFGKV---------MLSERKGTDELYAVKILKKDVVIQDDDVE 65
Query: 187 --LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHL-----FRRSLPLP 238
             + E   L     P  +  +  C +   RL  V E++  G L  H+     F+    + 
Sbjct: 66  CTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF 125
Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
           ++  + I      GL FL     K +IYRD K  N++LD++ + K++DFG+ K+   DG 
Sbjct: 126 YAAEIAI------GLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 176
Query: 299 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           T  +    GT  Y APE +         D ++FGV+L EML G+
Sbjct: 177 T--TKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 36/211 (17%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +GEG  G V             +  TG  VAVK ++    Q  +    EV  + +  H N
Sbjct: 53  IGEGSTGIV---------CIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDN 103
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK------IALGAAKGLA 254
           +V +    +  D+  +V EF+  G+L +        +    RM       + L   + L+
Sbjct: 104 VVDMYSSYLVGDELWVVMEFLEGGALTD--------IVTHTRMNEEQIATVCLSVLRALS 155
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG----LAKDAPEDGKTHVSTRVMGTYG 310
           +LH +    VI+RD K+ +ILL +D   KLSDFG    ++K+ P+         ++GT  
Sbjct: 156 YLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK------RKXLVGTPY 206
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           + APE +      ++ D++S G++++EM+ G
Sbjct: 207 WMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 237

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 116/279 (41%), Gaps = 43/279 (15%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +GEG  G V    V  +G           VAVK ++    Q  +    EV  + +  H N
Sbjct: 82  IGEGSTGIVCIATVRSSGK---------LVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 132
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK------IALGAAKGLA 254
           +V++    +  D+  +V EF+  G+L +        +    RM       + L   + L+
Sbjct: 133 VVEMYNSYLVGDELWVVMEFLEGGALTD--------IVTHTRMNEEQIAAVCLAVLQALS 184
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
            LH +    VI+RD K+ +ILL  D   KLSDFG      ++        ++GT  + AP
Sbjct: 185 VLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMAP 239
Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL 374
           E +       + D++S G++++EM+ G                 +  P L   +     L
Sbjct: 240 ELISRLPYGPEVDIWSLGIMVIEMVDGEPPY-------------FNEPPLKAMKMIRDNL 286
Query: 375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
            PRL+    +  S K      + L RDP  R   +E+++
Sbjct: 287 PPRLKNLHKVSPSLKG--FLDRLLVRDPAQRATAAELLK 323

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 129/301 (42%), Gaps = 37/301 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEVNFLGNLLHP 199
           +G+G FG VFKG   +N T  V       VA+K ++  +     ++   E+  L      
Sbjct: 31  IGKGSFGEVFKGI--DNRTQQV-------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSS 81
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
            + K  G  ++  +  ++ E++  GS  + L  R+ P        +     KGL +LH E
Sbjct: 82  YVTKYYGSYLKGSKLWIIMEYLGGGSALDLL--RAGPFDEFQIATMLKEILKGLDYLHSE 139
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
            +   I+RD K +N+LL    + KL+DFG+A     D +   +T V GT  + APE +  
Sbjct: 140 KK---IHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNTFV-GTPFWMAPEVIQQ 194
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
               SK+D++S G+  +E+  G        P     L+    P             P L 
Sbjct: 195 SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP-------------PTLV 241
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQTMQADNT 439
           G F    ++   +    CL++DP  RP   E+   LK    +K+   +SY  + +     
Sbjct: 242 GDF----TKSFKEFIDACLNKDPSFRPTAKEL---LKHKFIVKNSKKTSYLTELIDRFKR 294
Query: 440 W 440
           W
Sbjct: 295 W 295

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 106/237 (44%), Gaps = 24/237 (10%)
Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGH 183
           ++ L   +F    ++G GGFG V+            K  TG   A+K L+   +   QG 
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGE 233
Query: 184 KEWLAEVNFLGNLLHPN--LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWS 240
              L E   L  +   +   +  + Y      +L  + + M  G L  HL +  +     
Sbjct: 234 TLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD 293
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH 300
           +R   A     GL  +H    + V+YRD K +NILLD   + ++SD GLA D  +  K H
Sbjct: 294 MRF-YAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPH 348
Query: 301 VSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 356
            S   +GT+GY APE +  G    S +D +S G +L ++L G     +++   +H +
Sbjct: 349 AS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 106/237 (44%), Gaps = 24/237 (10%)
Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGH 183
           ++ L   +F    ++G GGFG V+            K  TG   A+K L+   +   QG 
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGE 233
Query: 184 KEWLAEVNFLGNLLHPN--LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWS 240
              L E   L  +   +   +  + Y      +L  + + M  G L  HL +  +     
Sbjct: 234 TLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD 293
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH 300
           +R   A     GL  +H    + V+YRD K +NILLD   + ++SD GLA D  +  K H
Sbjct: 294 MRF-YAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPH 348
Query: 301 VSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 356
            S   +GT+GY APE +  G    S +D +S G +L ++L G     +++   +H +
Sbjct: 349 AS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 16/202 (7%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT-LNHDGLQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V+     ++     K    L V  KT L   G++   +   EV    +L HP
Sbjct: 20  LGKGKFGNVYLARERQS-----KFILALKVLFKTQLEKAGVE--HQLRREVEIQSHLRHP 72
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           N+++L GY  +  +  L+ E+ P G++   L + S          I    A  L++ H  
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYIT-ELANALSYCHS- 130
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             K VI+RD K  N+LL ++   K++DFG +  AP   +    T + GT  Y  PE +  
Sbjct: 131 --KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEG 184
Query: 320 GHLTSKSDVYSFGVVLLEMLTG 341
                K D++S GV+  E L G
Sbjct: 185 RMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 101/226 (44%), Gaps = 30/226 (13%)
Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLT--VAVKTLNHDGLQGHK 184
           DL++   ++    ++G G FG V    V    T  V     L+    +K  +       +
Sbjct: 63  DLRMKAEDYEVVKVIGRGAFGEV--QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 120
Query: 185 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW---- 239
           + +A  N       P +V+L  Y  +DD+ L +V E+MP G L N +    +P  W    
Sbjct: 121 DIMAFAN------SPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFY 173
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
           +  + +AL A   + F+H         RD K  N+LLD   + KL+DFG      ++G  
Sbjct: 174 TAEVVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224
Query: 300 HVSTRVMGTYGYAAPEYVMT----GHLTSKSDVYSFGVVLLEMLTG 341
              T V GT  Y +PE + +    G+   + D +S GV L EML G
Sbjct: 225 RCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 101/226 (44%), Gaps = 30/226 (13%)
Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLT--VAVKTLNHDGLQGHK 184
           DL++   ++    ++G G FG V    V    T  V     L+    +K  +       +
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEV--QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 125
Query: 185 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW---- 239
           + +A  N       P +V+L  Y  +DD+ L +V E+MP G L N +    +P  W    
Sbjct: 126 DIMAFAN------SPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFY 178
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
           +  + +AL A   + F+H         RD K  N+LLD   + KL+DFG      ++G  
Sbjct: 179 TAEVVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 229
Query: 300 HVSTRVMGTYGYAAPEYVMT----GHLTSKSDVYSFGVVLLEMLTG 341
              T V GT  Y +PE + +    G+   + D +S GV L EML G
Sbjct: 230 RCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 116/279 (41%), Gaps = 43/279 (15%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +GEG  G V    V  +G           VAVK ++    Q  +    EV  + +  H N
Sbjct: 39  IGEGSTGIVCIATVRSSGK---------LVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 89
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK------IALGAAKGLA 254
           +V++    +  D+  +V EF+  G+L +        +    RM       + L   + L+
Sbjct: 90  VVEMYNSYLVGDELWVVMEFLEGGALTD--------IVTHTRMNEEQIAAVCLAVLQALS 141
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
            LH +    VI+RD K+ +ILL  D   KLSDFG      ++        ++GT  + AP
Sbjct: 142 VLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMAP 196
Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL 374
           E +       + D++S G++++EM+ G                 +  P L   +     L
Sbjct: 197 ELISRLPYGPEVDIWSLGIMVIEMVDGEPPY-------------FNEPPLKAMKMIRDNL 243
Query: 375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
            PRL+    +  S K      + L RDP  R   +E+++
Sbjct: 244 PPRLKNLHKVSPSLKG--FLDRLLVRDPAQRATAAELLK 280

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 101/226 (44%), Gaps = 30/226 (13%)
Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLT--VAVKTLNHDGLQGHK 184
           DL++   ++    ++G G FG V    V    T  V     L+    +K  +       +
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEV--QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 125
Query: 185 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW---- 239
           + +A  N       P +V+L  Y  +DD+ L +V E+MP G L N +    +P  W    
Sbjct: 126 DIMAFAN------SPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFY 178
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
           +  + +AL A   + F+H         RD K  N+LLD   + KL+DFG      ++G  
Sbjct: 179 TAEVVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 229
Query: 300 HVSTRVMGTYGYAAPEYVMT----GHLTSKSDVYSFGVVLLEMLTG 341
              T V GT  Y +PE + +    G+   + D +S GV L EML G
Sbjct: 230 RCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 116/279 (41%), Gaps = 43/279 (15%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +GEG  G V    V  +G           VAVK ++    Q  +    EV  + +  H N
Sbjct: 37  IGEGSTGIVCIATVRSSGK---------LVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 87
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK------IALGAAKGLA 254
           +V++    +  D+  +V EF+  G+L +        +    RM       + L   + L+
Sbjct: 88  VVEMYNSYLVGDELWVVMEFLEGGALTD--------IVTHTRMNEEQIAAVCLAVLQALS 139
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
            LH +    VI+RD K+ +ILL  D   KLSDFG      ++        ++GT  + AP
Sbjct: 140 VLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMAP 194
Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL 374
           E +       + D++S G++++EM+ G                 +  P L   +     L
Sbjct: 195 ELISRLPYGPEVDIWSLGIMVIEMVDGEPPY-------------FNEPPLKAMKMIRDNL 241
Query: 375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
            PRL+    +  S K      + L RDP  R   +E+++
Sbjct: 242 PPRLKNLHKVSPSLKG--FLDRLLVRDPAQRATAAELLK 278

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 129/277 (46%), Gaps = 38/277 (13%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
            LG+GGF   F+  + +  T  V  G    +  K+L     Q  K  + E++   +L H 
Sbjct: 28  FLGKGGFAKCFE--ISDADTKEVFAGK---IVPKSLLLKPHQREKMSM-EISIHRSLAHQ 81
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSL-ENHLFRRSLPLP---WSIRMKIALGAAKGLAF 255
           ++V   G+  ++D   +V E   R SL E H  R++L  P   + +R +I LG      +
Sbjct: 82  HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----Y 136
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
           LH      VI+RD K  N+ L+ D   K+ DFGLA     DG+   +  + GT  Y APE
Sbjct: 137 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPE 191
Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 375
            +     + + DV+S G ++  +L G+       P  E + ++    +L  K+  Y +  
Sbjct: 192 VLSKKGHSFEVDVWSIGCIMYTLLVGK-------PPFETSCLKET--YLRIKKNEYSI-- 240
Query: 376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
           P+   H +      A  L  + L  DP ARP ++E++
Sbjct: 241 PK---HIN----PVAASLIQKMLQTDPTARPTINELL 270

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 129/277 (46%), Gaps = 38/277 (13%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
            LG+GGF   F+  + +  T  V  G    +  K+L     Q  K  + E++   +L H 
Sbjct: 24  FLGKGGFAKCFE--ISDADTKEVFAGK---IVPKSLLLKPHQREKMSM-EISIHRSLAHQ 77
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSL-ENHLFRRSLPLP---WSIRMKIALGAAKGLAF 255
           ++V   G+  ++D   +V E   R SL E H  R++L  P   + +R +I LG      +
Sbjct: 78  HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----Y 132
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
           LH      VI+RD K  N+ L+ D   K+ DFGLA     DG+   +  + GT  Y APE
Sbjct: 133 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPE 187
Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 375
            +     + + DV+S G ++  +L G+       P  E + ++    +L  K+  Y +  
Sbjct: 188 VLSKKGHSFEVDVWSIGCIMYTLLVGK-------PPFETSCLKET--YLRIKKNEYSI-- 236
Query: 376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
           P+   H +      A  L  + L  DP ARP ++E++
Sbjct: 237 PK---HIN----PVAASLIQKMLQTDPTARPTINELL 266

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 129/277 (46%), Gaps = 38/277 (13%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
            LG+GGF   F+  + +  T  V  G    +  K+L     Q  K  + E++   +L H 
Sbjct: 24  FLGKGGFAKCFE--ISDADTKEVFAGK---IVPKSLLLKPHQREKMSM-EISIHRSLAHQ 77
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSL-ENHLFRRSLPLP---WSIRMKIALGAAKGLAF 255
           ++V   G+  ++D   +V E   R SL E H  R++L  P   + +R +I LG      +
Sbjct: 78  HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----Y 132
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
           LH      VI+RD K  N+ L+ D   K+ DFGLA     DG+   +  + GT  Y APE
Sbjct: 133 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPE 187
Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 375
            +     + + DV+S G ++  +L G+       P  E + ++    +L  K+  Y +  
Sbjct: 188 VLSKKGHSFEVDVWSIGCIMYTLLVGK-------PPFETSCLKET--YLRIKKNEYSI-- 236
Query: 376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
           P+   H +      A  L  + L  DP ARP ++E++
Sbjct: 237 PK---HIN----PVAASLIQKMLQTDPTARPTINELL 266

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 116/279 (41%), Gaps = 43/279 (15%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +GEG  G V    V  +G           VAVK ++    Q  +    EV  + +  H N
Sbjct: 28  IGEGSTGIVCIATVRSSGK---------LVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 78
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK------IALGAAKGLA 254
           +V++    +  D+  +V EF+  G+L +        +    RM       + L   + L+
Sbjct: 79  VVEMYNSYLVGDELWVVMEFLEGGALTD--------IVTHTRMNEEQIAAVCLAVLQALS 130
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
            LH +    VI+RD K+ +ILL  D   KLSDFG      ++        ++GT  + AP
Sbjct: 131 VLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMAP 185
Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL 374
           E +       + D++S G++++EM+ G                 +  P L   +     L
Sbjct: 186 ELISRLPYGPEVDIWSLGIMVIEMVDGEPPY-------------FNEPPLKAMKMIRDNL 232
Query: 375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
            PRL+    +  S K      + L RDP  R   +E+++
Sbjct: 233 PPRLKNLHKVSPSLKG--FLDRLLVRDPAQRATAAELLK 269

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 128/277 (46%), Gaps = 38/277 (13%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
            LG+GGF   F+  + +  T  V  G    +  K+L     Q  K  + E++   +L H 
Sbjct: 46  FLGKGGFAKCFE--ISDADTKEVFAGK---IVPKSLLLKPHQREKMSM-EISIHRSLAHQ 99
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSL-ENHLFRRSLPLP---WSIRMKIALGAAKGLAF 255
           ++V   G+  ++D   +V E   R SL E H  R++L  P   + +R +I LG      +
Sbjct: 100 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----Y 154
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
           LH      VI+RD K  N+ L+ D   K+ DFGLA     DG+      + GT  Y APE
Sbjct: 155 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPE 209
Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 375
            +     + + DV+S G ++  +L G+       P  E + ++    +L  K+  Y +  
Sbjct: 210 VLSKKGHSFEVDVWSIGCIMYTLLVGK-------PPFETSCLKET--YLRIKKNEYSI-- 258
Query: 376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
           P+   H +      A  L  + L  DP ARP ++E++
Sbjct: 259 PK---HIN----PVAASLIQKMLQTDPTARPTINELL 288

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 116/279 (41%), Gaps = 43/279 (15%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +GEG  G V    V  +G           VAVK ++    Q  +    EV  + +  H N
Sbjct: 32  IGEGSTGIVCIATVRSSGK---------LVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 82
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK------IALGAAKGLA 254
           +V++    +  D+  +V EF+  G+L +        +    RM       + L   + L+
Sbjct: 83  VVEMYNSYLVGDELWVVMEFLEGGALTD--------IVTHTRMNEEQIAAVCLAVLQALS 134
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
            LH +    VI+RD K+ +ILL  D   KLSDFG      ++        ++GT  + AP
Sbjct: 135 VLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMAP 189
Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL 374
           E +       + D++S G++++EM+ G                 +  P L   +     L
Sbjct: 190 ELISRLPYGPEVDIWSLGIMVIEMVDGEPPY-------------FNEPPLKAMKMIRDNL 236
Query: 375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
            PRL+    +  S K      + L RDP  R   +E+++
Sbjct: 237 PPRLKNLHKVSPSLKG--FLDRLLVRDPAQRATAAELLK 273

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 128/277 (46%), Gaps = 38/277 (13%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
            LG+GGF   F+  + +  T  V  G    +  K+L     Q  K  + E++   +L H 
Sbjct: 48  FLGKGGFAKCFE--ISDADTKEVFAGK---IVPKSLLLKPHQREKMSM-EISIHRSLAHQ 101
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSL-ENHLFRRSLPLP---WSIRMKIALGAAKGLAF 255
           ++V   G+  ++D   +V E   R SL E H  R++L  P   + +R +I LG      +
Sbjct: 102 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----Y 156
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
           LH      VI+RD K  N+ L+ D   K+ DFGLA     DG+      + GT  Y APE
Sbjct: 157 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPE 211
Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 375
            +     + + DV+S G ++  +L G+       P  E + ++    +L  K+  Y +  
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLLVGK-------PPFETSCLKET--YLRIKKNEYSI-- 260
Query: 376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
           P+   H +      A  L  + L  DP ARP ++E++
Sbjct: 261 PK---HIN----PVAASLIQKMLQTDPTARPTINELL 290

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G+G  G V+           +   TG  VA++ +N       +  + E+  +    +PN
Sbjct: 29  IGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 79
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           +V  +   +  D+  +V E++  GSL + +    +         +     + L FLH   
Sbjct: 80  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQALEFLHS-- 135
Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
              VI+R+ K+ NILL  D + KL+DFG  A+  PE  K    + ++GT  + APE V  
Sbjct: 136 -NQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTR 191
Query: 320 GHLTSKSDVYSFGVVLLEMLTGR 342
                K D++S G++ +EM+ G 
Sbjct: 192 KAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/153 (33%), Positives = 75/153 (49%), Gaps = 22/153 (14%)
Query: 199 PNLVKLVGYC-IEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW----SIRMKIALGAAKG 252
           P +V+L  +C  +DD+ L +V E+MP G L N +    +P  W    +  + +AL A   
Sbjct: 135 PWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHS 192
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           +  +H         RD K  N+LLD   + KL+DFG      E G  H  T V GT  Y 
Sbjct: 193 MGLIH---------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV-GTPDYI 242
Query: 313 APEYVMT----GHLTSKSDVYSFGVVLLEMLTG 341
           +PE + +    G+   + D +S GV L EML G
Sbjct: 243 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 100/235 (42%), Gaps = 39/235 (16%)
Query: 121 RKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT-LNHDG 179
           RKF  +D  +     RP   LG+G FG V+    ++N     K    L V  K+ L  +G
Sbjct: 9   RKFTIDDFDIV----RP---LGKGKFGNVYLAREKQN-----KFIMALKVLFKSQLEKEG 56
Query: 180 LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 239
           ++   +   E+    +L HPN++++  Y  +  +  L+ EF PRG L   L +       
Sbjct: 57  VE--HQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG----- 109
Query: 240 SIRMKIALGAAKGLAFLHEEA-------EKPVIYRDFKTSNILLDADYNAKLSDFGLAKD 292
                      +   F+ E A       E+ VI+RD K  N+L+      K++DFG +  
Sbjct: 110 ------RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVH 163
Query: 293 APEDGKTHVSTRVM-GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD 346
           AP      +  R M GT  Y  PE +       K D++  GV+  E L G    D
Sbjct: 164 APS-----LRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 100/228 (43%), Gaps = 25/228 (10%)
Query: 121 RKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT-LNHDG 179
           RKF  +D  +     RP   LG+G FG V+    ++N     K    L V  K+ L  +G
Sbjct: 10  RKFTIDDFDIG----RP---LGKGKFGNVYLAREKQN-----KFIMALKVLFKSQLEKEG 57
Query: 180 LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 239
           ++   +   E+    +L HPN++++  Y  +  +  L+ EF PRG L   L +       
Sbjct: 58  VE--HQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR---- 111
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
               + A    +    LH   E+ VI+RD K  N+L+      K++DFG +  AP     
Sbjct: 112 FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS---- 167
Query: 300 HVSTRVM-GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD 346
            +  R M GT  Y  PE +       K D++  GV+  E L G    D
Sbjct: 168 -LRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 84/184 (45%), Gaps = 10/184 (5%)
Query: 166 TGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR 223
           TG  VA+K ++   L     ++   EV  +  L HPN+VKL      +    L+ E+   
Sbjct: 36  TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASG 95
Query: 224 GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK 283
           G + ++L           R K        + + H+   K +++RD K  N+LLDAD N K
Sbjct: 96  GEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIK 151
Query: 284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS-KSDVYSFGVVLLEMLTGR 342
           ++DFG + +    GK        G+  YAAPE          + DV+S GV+L  +++G 
Sbjct: 152 IADFGFSNEFTVGGKLDT---FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 208
Query: 343 RSMD 346
              D
Sbjct: 209 LPFD 212

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 135/308 (43%), Gaps = 47/308 (15%)
Query: 144 GGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL--AEVNFLGNLLHPNL 201
           G FGCV+K  +               VAVK      +Q  + W    EV  L  + H N+
Sbjct: 35  GRFGCVWKAQLLNE-----------YVAVKIFP---IQDKQSWQNEYEVYSLPGMKHENI 80
Query: 202 VKLVGY----CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 257
           ++ +G        D    L+  F  +GSL +  F ++  + W+    IA   A+GLA+LH
Sbjct: 81  LQFIGAEKRGTSVDVDLWLITAFHEKGSLSD--FLKANVVSWNELCHIAETMARGLAYLH 138
Query: 258 EE------AEKPVI-YRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR-VMGTY 309
           E+        KP I +RD K+ N+LL  +  A ++DFGLA    E GK+   T   +GT 
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF-EAGKSAGDTHGQVGTR 197
Query: 310 GYAAPEYVMTGHLTS------KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL----VEW 359
            Y APE V+ G +        + D+Y+ G+VL E+ +  R    + P  E+ L       
Sbjct: 198 RYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELAS--RCTAADGPVDEYMLPFEEEIG 254
Query: 360 ARPHLGDKRR--FYRLLDPRLEGHFSI-KGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
             P L D +    ++   P L  ++    G     +   +C   D +AR     V E + 
Sbjct: 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERIT 314
Query: 417 PLQNLKDM 424
            +Q L ++
Sbjct: 315 QMQRLTNI 322

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 128/277 (46%), Gaps = 38/277 (13%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
            LG+GGF   F+  + +  T  V  G    +  K+L     Q  K  + E++   +L H 
Sbjct: 22  FLGKGGFAKCFE--ISDADTKEVFAGK---IVPKSLLLKPHQREKMSM-EISIHRSLAHQ 75
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSL-ENHLFRRSLPLP---WSIRMKIALGAAKGLAF 255
           ++V   G+  ++D   +V E   R SL E H  R++L  P   + +R +I LG      +
Sbjct: 76  HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----Y 130
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
           LH      VI+RD K  N+ L+ D   K+ DFGLA     DG+      + GT  Y APE
Sbjct: 131 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPE 185
Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 375
            +     + + DV+S G ++  +L G+       P  E + ++    +L  K+  Y +  
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGK-------PPFETSCLKET--YLRIKKNEYSI-- 234
Query: 376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
           P+   H +      A  L  + L  DP ARP ++E++
Sbjct: 235 PK---HIN----PVAASLIQKMLQTDPTARPTINELL 264

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 93/214 (43%), Gaps = 23/214 (10%)
Query: 134 NFRPESLLGEGGFGCVF--KGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLA 188
           +F    ++G+G FG V   +   EE           +  AVK L    +   KE    ++
Sbjct: 39  DFHFLKVIGKGSFGKVLLARHKAEE-----------VFYAVKVLQKKAILKKKEEKHIMS 87
Query: 189 EVN-FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
           E N  L N+ HP LV L       D+   V +++  G L  HL R    L    R   A 
Sbjct: 88  ERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAA 146
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A  L +LH      ++YRD K  NILLD+  +  L+DFGL K+  E   T  ++   G
Sbjct: 147 EIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCG 201
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           T  Y APE +         D +  G VL EML G
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 101/231 (43%), Gaps = 37/231 (16%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 192
           +F P   LG GGFG VF+   + +             A+K +     +  +E  + EV  
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDC---------NYAIKRIRLPNRELAREKVMREVKA 56
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL--ENHLFRRSLPLPW----------- 239
           L  L HP +V+     +E +    +    P+  L  +  L R+     W           
Sbjct: 57  LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116
Query: 240 -SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL--AKDAPED 296
            S+ + I L  A+ + FLH    K +++RD K SNI    D   K+ DFGL  A D  E+
Sbjct: 117 RSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 173
Query: 297 GKTHVS--------TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 339
            +T ++        T  +GT  Y +PE +     + K D++S G++L E+L
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 83/184 (45%), Gaps = 10/184 (5%)
Query: 166 TGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR 223
           TG  VA+K ++   L     ++   EV  +  L HPN+VKL      +    L+ E+   
Sbjct: 39  TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASG 98
Query: 224 GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK 283
           G + ++L           R K        + + H+   K +++RD K  N+LLDAD N K
Sbjct: 99  GEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIK 154
Query: 284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS-KSDVYSFGVVLLEMLTGR 342
           ++DFG + +    GK        G   YAAPE          + DV+S GV+L  +++G 
Sbjct: 155 IADFGFSNEFTVGGKLDA---FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 211
Query: 343 RSMD 346
              D
Sbjct: 212 LPFD 215

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 22/208 (10%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGNLLH 198
            LG+GGF   ++  + +  T  V  G  +  ++    H      KE ++ E+    +L +
Sbjct: 49  FLGKGGFAKCYE--ITDMDTKEVFAGKVVPKSMLLKPH-----QKEKMSTEIAIHKSLDN 101
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSL-ENHLFRRSLPLP---WSIRMKIALGAAKGLA 254
           P++V   G+  +DD   +V E   R SL E H  R+++  P   + +R  I     +G+ 
Sbjct: 102 PHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQ 156
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           +LH      VI+RD K  N+ L+ D + K+ DFGLA     DG+      + GT  Y AP
Sbjct: 157 YLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKXLCGTPNYIAP 211
Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           E +     + + D++S G +L  +L G+
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGNLLH 198
            LG+GGF   ++  + +  T  V  G  +  ++    H      KE ++ E+    +L +
Sbjct: 49  FLGKGGFAKCYE--ITDMDTKEVFAGKVVPKSMLLKPH-----QKEKMSTEIAIHKSLDN 101
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSL-ENHLFRRSLPLP---WSIRMKIALGAAKGLA 254
           P++V   G+  +DD   +V E   R SL E H  R+++  P   + +R  I     +G+ 
Sbjct: 102 PHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQ 156
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           +LH      VI+RD K  N+ L+ D + K+ DFGLA     DG+   +  + GT  Y AP
Sbjct: 157 YLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT--LCGTPNYIAP 211
Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           E +     + + D++S G +L  +L G+
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 103/221 (46%), Gaps = 31/221 (14%)
Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 194
           F+ E + G+G FG V  G          +  TG++VA+K +  D    ++E L  +  L 
Sbjct: 25  FQVERMAGQGTFGTVQLGK---------EKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLA 74
Query: 195 NLLHPNLVKLVGYCI---EDDQRLL----VYEFMP---RGSLENHLFRRSLPLPWSIRMK 244
            L HPN+V+L  Y     E D+R +    V E++P        N+  R+  P P  I++ 
Sbjct: 75  VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV- 133
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILL-DADYNAKLSDFGLAK--DAPEDGKTHV 301
                 + +  LH  +   V +RD K  N+L+ +AD   KL DFG AK     E    ++
Sbjct: 134 FLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYI 192
Query: 302 STRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTG 341
            +R      Y APE +    H T+  D++S G +  EM+ G
Sbjct: 193 CSRY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 22/208 (10%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGNLLH 198
            LG+GGF   ++  + +  T  V  G  +  ++    H      KE ++ E+    +L +
Sbjct: 49  FLGKGGFAKCYE--ITDMDTKEVFAGKVVPKSMLLKPH-----QKEKMSTEIAIHKSLDN 101
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSL-ENHLFRRSLPLP---WSIRMKIALGAAKGLA 254
           P++V   G+  +DD   +V E   R SL E H  R+++  P   + +R  I     +G+ 
Sbjct: 102 PHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQ 156
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           +LH      VI+RD K  N+ L+ D + K+ DFGLA     DG+      + GT  Y AP
Sbjct: 157 YLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCGTPNYIAP 211
Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           E +     + + D++S G +L  +L G+
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT-LNHDGLQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V+     ++     K    L V  KT L   G++   +   EV    +L HP
Sbjct: 20  LGKGKFGNVYLARERQS-----KFILALKVLFKTQLEKAGVE--HQLRREVEIQSHLRHP 72
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           N+++L GY  +  +  L+ E+ P G++   L + S          I    A  L++ H  
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYIT-ELANALSYCHS- 130
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             K VI+RD K  N+LL ++   K++DFG +  AP   +      + GT  Y  PE +  
Sbjct: 131 --KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----DTLCGTLDYLPPEMIEG 184
Query: 320 GHLTSKSDVYSFGVVLLEMLTG 341
                K D++S GV+  E L G
Sbjct: 185 RMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 97/226 (42%), Gaps = 39/226 (17%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPG----TGLTVAVKTLNHDGLQ--GHKEWL 187
           N+R +  +G+G F             A VK      TG  VAVK ++   L     ++  
Sbjct: 16  NYRLQKTIGKGNF-------------AKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLF 62
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            EV  +  L HPN+VKL      +    LV E+   G + ++L           RMK   
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG-------RMKEKE 115
Query: 248 GAAK------GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
             AK       + + H+   K +++RD K  N+LLD D N K++DFG + +     K   
Sbjct: 116 ARAKFRQIVSAVQYCHQ---KYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT 172
Query: 302 STRVMGTYGYAAPEYVMTGHLTS-KSDVYSFGVVLLEMLTGRRSMD 346
                G+  YAAPE          + DV+S GV+L  +++G    D
Sbjct: 173 ---FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/312 (23%), Positives = 132/312 (42%), Gaps = 41/312 (13%)
Query: 112 EELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVA 171
           + L ++ +L++    D+ +  + F    +LG+G FG V +  +++      + G+ + VA
Sbjct: 3   DSLGISDELKE-KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQ------EDGSFVKVA 55
Query: 172 VKTLNHDGLQGH--KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQR------LLVYEFMPR 223
           VK L  D +     +E+L E   +    HP++ KLVG  +    +      +++  FM  
Sbjct: 56  VKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKH 115
Query: 224 GSLENHLFRRSL-----PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA 278
           G L   L    +      LP    ++  +  A G+ +L   + +  I+RD    N +L  
Sbjct: 116 GDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAE 172
Query: 279 DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 338
           D    ++DFGL++                   + A E +     T  SDV++FGV + E+
Sbjct: 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEI 232
Query: 339 LTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQC 397
           +T  ++      N E +N +      +G      RL  P        +  ++   L  QC
Sbjct: 233 MTRGQTPYAGIENAEIYNYL------IGGN----RLKQPP-------ECMEEVYDLMYQC 275
Query: 398 LSRDPKARPRMS 409
            S DPK RP  +
Sbjct: 276 WSADPKQRPSFT 287

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 22/208 (10%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGNLLH 198
            LG+GGF   ++  + +  T  V  G  +  ++    H      KE ++ E+    +L +
Sbjct: 33  FLGKGGFAKCYE--ITDMDTKEVFAGKVVPKSMLLKPH-----QKEKMSTEIAIHKSLDN 85
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSL-ENHLFRRSLPLP---WSIRMKIALGAAKGLA 254
           P++V   G+  +DD   +V E   R SL E H  R+++  P   + +R  I     +G+ 
Sbjct: 86  PHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQ 140
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           +LH      VI+RD K  N+ L+ D + K+ DFGLA     DG+      + GT  Y AP
Sbjct: 141 YLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCGTPNYIAP 195
Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           E +     + + D++S G +L  +L G+
Sbjct: 196 EVLCKKGHSFEVDIWSLGCILYTLLVGK 223

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGNLL 197
           LG G FG V  G  E          TG  VAVK LN   ++      +   E+  L    
Sbjct: 24  LGVGTFGKVKVGKHE---------LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR 74
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 257
           HP+++KL           +V E++  G L +++ +    L      ++      G+ + H
Sbjct: 75  HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCH 133
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
                 V++RD K  N+LLDA  NAK++DFGL+ +   DG+    +   G+  YAAPE V
Sbjct: 134 RHM---VVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRXS--CGSPNYAAPE-V 186
Query: 318 MTGHLTS--KSDVYSFGVVLLEMLTGRRSMDKN 348
           ++G L +  + D++S GV+L  +L G    D +
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD 219

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 22/207 (10%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNLL 197
           +LG+G FG V K              T    AVK +N    +       L EV  L  L 
Sbjct: 29  MLGKGSFGEVLKCK---------DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 257
           HPN++KL     +     +V E    G L + + +R          +I      G+ ++H
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH 138
Query: 258 EEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           +     +++RD K  NILL++   D + K+ DFGL+    ++  T +  R+ GT  Y AP
Sbjct: 139 KH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRI-GTAYYIAP 192
Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           E V+ G    K DV+S GV+L  +L+G
Sbjct: 193 E-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 86/190 (45%), Gaps = 22/190 (11%)
Query: 166 TGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR 223
           TG  VAVK ++   L     ++   EV  +  L HPN+VKL      +    LV E+   
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 224 GSLENHLFRRSLPLPWSIRMKIALGAAK------GLAFLHEEAEKPVIYRDFKTSNILLD 277
           G + ++L           RMK     AK       + + H+   K +++RD K  N+LLD
Sbjct: 98  GEVFDYLVAHG-------RMKEKEARAKFRQIVSAVQYCHQ---KFIVHRDLKAENLLLD 147
Query: 278 ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS-KSDVYSFGVVLL 336
           AD N K++DFG + +     K        G+  YAAPE          + DV+S GV+L 
Sbjct: 148 ADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILY 204
Query: 337 EMLTGRRSMD 346
            +++G    D
Sbjct: 205 TLVSGSLPFD 214

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 86/190 (45%), Gaps = 22/190 (11%)
Query: 166 TGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR 223
           TG  VAVK ++   L     ++   EV  +  L HPN+VKL      +    LV E+   
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 224 GSLENHLFRRSLPLPWSIRMKIALGAAK------GLAFLHEEAEKPVIYRDFKTSNILLD 277
           G + ++L           RMK     AK       + + H+   K +++RD K  N+LLD
Sbjct: 98  GEVFDYLVAHG-------RMKEKEARAKFRQIVSAVQYCHQ---KFIVHRDLKAENLLLD 147
Query: 278 ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS-KSDVYSFGVVLL 336
           AD N K++DFG + +     K        G+  YAAPE          + DV+S GV+L 
Sbjct: 148 ADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILY 204
Query: 337 EMLTGRRSMD 346
            +++G    D
Sbjct: 205 TLVSGSLPFD 214

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 90/180 (50%), Gaps = 15/180 (8%)
Query: 166 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGS 225
           +G  VAVK ++    Q  +    EV  + +  H N+V++    +  ++  ++ EF+  G+
Sbjct: 69  SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGA 128
Query: 226 LENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS 285
           L +      + L       +     + LA+LH +    VI+RD K+ +ILL  D   KLS
Sbjct: 129 LTD--IVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLS 183
Query: 286 DFG----LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           DFG    ++KD P+         ++GT  + APE +      ++ D++S G++++EM+ G
Sbjct: 184 DFGFCAQISKDVPK------RKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNL 196
            +LG+G FG V K              T    AVK +N    +       L EV  L  L
Sbjct: 28  CMLGKGSFGEVLKC---------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 256
            HPN++KL     +     +V E    G L + + +R          +I      G+ ++
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYM 137
Query: 257 HEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
           H+     +++RD K  NILL++   D + K+ DFGL+    ++  T +  R+ GT  Y A
Sbjct: 138 HKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRI-GTAYYIA 191
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           PE V+ G    K DV+S GV+L  +L+G
Sbjct: 192 PE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 59/109 (54%), Gaps = 4/109 (3%)
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
           +++   A + L F H+     +I+RD K +NIL+ A    K+ DFG+A+   + G +   
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQ 175
Query: 303 TR-VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           T  V+GT  Y +PE      + ++SDVYS G VL E+LTG      + P
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 60/110 (54%), Gaps = 4/110 (3%)
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
           +++   A + L F H+     +I+RD K +NI++ A    K+ DFG+A+   + G +   
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 303 TR-VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN 351
           T  V+GT  Y +PE      + ++SDVYS G VL E+LTG      + P+
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPD 225

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNL 196
            +LG+G FG V K              T    AVK +N    +       L EV  L  L
Sbjct: 28  CMLGKGSFGEVLKC---------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 256
            HPN++KL     +     +V E    G L + + +R          +I      G+ ++
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYM 137
Query: 257 HEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
           H+     +++RD K  NILL++   D + K+ DFGL+    ++  T +  R+ GT  Y A
Sbjct: 138 HKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRI-GTAYYIA 191
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           PE V+ G    K DV+S GV+L  +L+G
Sbjct: 192 PE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 89/191 (46%), Gaps = 16/191 (8%)
Query: 170 VAVKTLNHDGLQGHKEWLA---EVNFLGNLLHPNLVKLVGYCIEDDQR------LLVYEF 220
           VAVK L  D  +    +L    E      L HP +V +  Y   + +        +V E+
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV--YATGEAETPAGPLPYIVMEY 97
Query: 221 MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY 280
           +   +L + +     P+     +++   A + L F H+     +I+RD K +NI++ A  
Sbjct: 98  VDGVTLRD-IVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATN 153
Query: 281 NAKLSDFGLAKDAPEDGKTHVSTR-VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 339
             K+ DFG+A+   + G +   T  V+GT  Y +PE      + ++SDVYS G VL E+L
Sbjct: 154 AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL 213
Query: 340 TGRRSMDKNRP 350
           TG      + P
Sbjct: 214 TGEPPFTGDSP 224

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 85/190 (44%), Gaps = 22/190 (11%)
Query: 166 TGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR 223
           TG  VAVK ++   L     ++   EV  +  L HPN+VKL      +    LV E+   
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 224 GSLENHLFRRSLPLPWSIRMKIALGAAK------GLAFLHEEAEKPVIYRDFKTSNILLD 277
           G + ++L           RMK     AK       + + H+   K +++RD K  N+LLD
Sbjct: 98  GEVFDYLVAHG-------RMKEKEARAKFRQIVSAVQYCHQ---KFIVHRDLKAENLLLD 147
Query: 278 ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS-KSDVYSFGVVLL 336
           AD N K++DFG + +     K        G   YAAPE          + DV+S GV+L 
Sbjct: 148 ADMNIKIADFGFSNEFTFGNKLDA---FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILY 204
Query: 337 EMLTGRRSMD 346
            +++G    D
Sbjct: 205 TLVSGSLPFD 214

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 17/210 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 17/210 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 15  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 101/225 (44%), Gaps = 23/225 (10%)
Query: 123 FMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ- 181
           F+ +   + +  ++ + +LG+G FG V                TG   AVK ++   ++ 
Sbjct: 22  FVQHSTAIFSDRYKGQRVLGKGSFGEVI---------LCKDKITGQECAVKVISKRQVKQ 72
Query: 182 --GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 239
               +  L EV  L  L HPN++KL  +  +     LV E    G L + +  R      
Sbjct: 73  KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSE 131
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPED 296
               +I      G+ ++H+     +++RD K  N+LL++   D N ++ DFGL+      
Sbjct: 132 VDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 188
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            K       +GT  Y APE V+ G    K DV+S GV+L  +L+G
Sbjct: 189 KKMKDK---IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 94/220 (42%), Gaps = 27/220 (12%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPG----TGLTVAVKTLNHDGLQGH--KEWL 187
           N+R    +G+G F             A VK      TG  VAVK ++   L     ++  
Sbjct: 8   NYRLLKTIGKGNF-------------AKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLF 54
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            EV  +  L HPN+VKL      +    LV E+   G + ++L           R K   
Sbjct: 55  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR- 113
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
                + + H+   K +++RD K  N+LLDAD N K++DFG + +     K        G
Sbjct: 114 QIVSAVQYCHQ---KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCG 167
Query: 308 TYGYAAPEYVMTGHLTS-KSDVYSFGVVLLEMLTGRRSMD 346
           +  YAAPE          + DV+S GV+L  +++G    D
Sbjct: 168 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 101/225 (44%), Gaps = 23/225 (10%)
Query: 123 FMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ- 181
           F+ +   + +  ++ + +LG+G FG V                TG   AVK ++   ++ 
Sbjct: 39  FVQHSTAIFSDRYKGQRVLGKGSFGEVI---------LCKDKITGQECAVKVISKRQVKQ 89
Query: 182 --GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 239
               +  L EV  L  L HPN++KL  +  +     LV E    G L + +  R      
Sbjct: 90  KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSE 148
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPED 296
               +I      G+ ++H+     +++RD K  N+LL++   D N ++ DFGL+      
Sbjct: 149 VDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 205
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            K       +GT  Y APE V+ G    K DV+S GV+L  +L+G
Sbjct: 206 KKMKDK---IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 9/159 (5%)
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIE--DDQRLLVYEFMPRGSLENHLF-----RRSLPLPW 239
           ++EVN L  L HPN+V+     I+  +    +V E+   G L + +      R+ L   +
Sbjct: 53  VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF 112
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
            +R+   L  A        +    V++RD K +N+ LD   N KL DFGLA+    D  T
Sbjct: 113 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--T 170
Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 338
             +   +GT  Y +PE +       KSD++S G +L E+
Sbjct: 171 SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 59/109 (54%), Gaps = 4/109 (3%)
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
           +++   A + L F H+     +I+RD K +NI++ A    K+ DFG+A+   + G +   
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 303 TR-VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           T  V+GT  Y +PE      + ++SDVYS G VL E+LTG      + P
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 86/190 (45%), Gaps = 22/190 (11%)
Query: 166 TGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR 223
           TG  VAV+ ++   L     ++   EV  +  L HPN+VKL      +    LV E+   
Sbjct: 38  TGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 224 GSLENHLFRRSLPLPWSIRMKIALGAAK------GLAFLHEEAEKPVIYRDFKTSNILLD 277
           G + ++L           RMK     AK       + + H+   K +++RD K  N+LLD
Sbjct: 98  GEVFDYLVAHG-------RMKEKEARAKFRQIVSAVQYCHQ---KFIVHRDLKAENLLLD 147
Query: 278 ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS-KSDVYSFGVVLL 336
           AD N K++DFG + +     K        G+  YAAPE          + DV+S GV+L 
Sbjct: 148 ADMNIKIADFGFSNEFTFGNKL---DEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILY 204
Query: 337 EMLTGRRSMD 346
            +++G    D
Sbjct: 205 TLVSGSLPFD 214

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 59/109 (54%), Gaps = 4/109 (3%)
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
           +++   A + L F H+     +I+RD K +NI++ A    K+ DFG+A+   + G +   
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 303 TR-VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           T  V+GT  Y +PE      + ++SDVYS G VL E+LTG      + P
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 86/190 (45%), Gaps = 22/190 (11%)
Query: 166 TGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR 223
           TG  VAV+ ++   L     ++   EV  +  L HPN+VKL      +    LV E+   
Sbjct: 38  TGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 224 GSLENHLFRRSLPLPWSIRMKIALGAAK------GLAFLHEEAEKPVIYRDFKTSNILLD 277
           G + ++L           RMK     AK       + + H+   K +++RD K  N+LLD
Sbjct: 98  GEVFDYLVAHG-------RMKEKEARAKFRQIVSAVQYCHQ---KFIVHRDLKAENLLLD 147
Query: 278 ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS-KSDVYSFGVVLL 336
           AD N K++DFG + +     K        G+  YAAPE          + DV+S GV+L 
Sbjct: 148 ADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILY 204
Query: 337 EMLTGRRSMD 346
            +++G    D
Sbjct: 205 TLVSGSLPFD 214

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 9/159 (5%)
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIE--DDQRLLVYEFMPRGSLENHLF-----RRSLPLPW 239
           ++EVN L  L HPN+V+     I+  +    +V E+   G L + +      R+ L   +
Sbjct: 53  VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF 112
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
            +R+   L  A        +    V++RD K +N+ LD   N KL DFGLA+    D  T
Sbjct: 113 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--T 170
Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 338
             +   +GT  Y +PE +       KSD++S G +L E+
Sbjct: 171 SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 101/225 (44%), Gaps = 23/225 (10%)
Query: 123 FMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ- 181
           F+ +   + +  ++ + +LG+G FG V                TG   AVK ++   ++ 
Sbjct: 40  FVQHSTAIFSDRYKGQRVLGKGSFGEVI---------LCKDKITGQECAVKVISKRQVKQ 90
Query: 182 --GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 239
               +  L EV  L  L HPN++KL  +  +     LV E    G L + +  R      
Sbjct: 91  KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSE 149
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPED 296
               +I      G+ ++H+     +++RD K  N+LL++   D N ++ DFGL+      
Sbjct: 150 VDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 206
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            K       +GT  Y APE V+ G    K DV+S GV+L  +L+G
Sbjct: 207 KKMKDK---IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 102/225 (45%), Gaps = 35/225 (15%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           R    +  +G+G FG V++G              G  VAVK  +    +  + W  E   
Sbjct: 4   RTIVLQESIGKGRFGEVWRG-----------KWRGEEVAVKIFSS---REERSWFREAEI 49
Query: 193 LGNLL--HPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
              ++  H N++  +    +D+    Q  LV ++   GSL ++L R ++ +   I  K+A
Sbjct: 50  YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI--KLA 107
Query: 247 LGAAKGLAFLHEEAE----KPVI-YRDFKTSNILLDADYNAKLSDFGLA--KDAPEDGKT 299
           L  A GLA LH E      KP I +RD K+ NIL+  +    ++D GLA   D+  D   
Sbjct: 108 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 167
Query: 300 HVSTRVMGTYGYAAPEY----VMTGHLTS--KSDVYSFGVVLLEM 338
                 +GT  Y APE     +   H  S  ++D+Y+ G+V  E+
Sbjct: 168 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 35/226 (15%)
Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 191
            R    +  +G+G FG V++G              G  VAVK  +    +  + W  E  
Sbjct: 2   ARTIVLQESIGKGRFGEVWRG-----------KWRGEEVAVKIFSS---REERSWFREAE 47
Query: 192 FLGNLL--HPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 245
               ++  H N++  +    +D+    Q  LV ++   GSL ++L R ++ +   I  K+
Sbjct: 48  IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI--KL 105
Query: 246 ALGAAKGLAFLHEEAE----KPVI-YRDFKTSNILLDADYNAKLSDFGLA--KDAPEDGK 298
           AL  A GLA LH E      KP I +RD K+ NIL+  +    ++D GLA   D+  D  
Sbjct: 106 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 165
Query: 299 THVSTRVMGTYGYAAPEY----VMTGHLTS--KSDVYSFGVVLLEM 338
                  +GT  Y APE     +   H  S  ++D+Y+ G+V  E+
Sbjct: 166 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 81/184 (44%), Gaps = 10/184 (5%)
Query: 166 TGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR 223
           TG  VAVK ++   L     ++   EV     L HPN+VKL      +    LV E+   
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASG 97
Query: 224 GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK 283
           G + ++L           R K        + + H+   K +++RD K  N+LLDAD N K
Sbjct: 98  GEVFDYLVAHGRXKEKEARAKFR-QIVSAVQYCHQ---KFIVHRDLKAENLLLDADXNIK 153
Query: 284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS-KSDVYSFGVVLLEMLTGR 342
           ++DFG + +     K        G   YAAPE          + DV+S GV+L  +++G 
Sbjct: 154 IADFGFSNEFTFGNKLDA---FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 210
Query: 343 RSMD 346
              D
Sbjct: 211 LPFD 214

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 104/227 (45%), Gaps = 27/227 (11%)
Query: 123 FMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ- 181
           F+ +   + +  ++ + +LG+G FG V                TG   AVK ++   ++ 
Sbjct: 16  FVQHSTAIFSDRYKGQRVLGKGSFGEVI---------LCKDKITGQECAVKVISKRQVKQ 66
Query: 182 --GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 239
               +  L EV  L  L HPN++KL  +  +     LV E    G L + +  R      
Sbjct: 67  KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSE 125
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAK--DAP 294
               +I      G+ ++H+     +++RD K  N+LL++   D N ++ DFGL+   +A 
Sbjct: 126 VDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182
Query: 295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           +  K  +     GT  Y APE V+ G    K DV+S GV+L  +L+G
Sbjct: 183 KKMKDKI-----GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 17/210 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 15  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 17/210 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 15  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 17/210 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 15  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 17/210 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 13  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 121
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 122 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 208

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHK----E 185
           A + +   + +GEG +G VFK    +NG        G  VA+K +    G +G       
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTGEEGMPLSTIR 60
Query: 186 WLAEVNFLGNLLHPNLVKLVGYCI-----EDDQRLLVYEFMPRGSLENHLFRRSLP-LPW 239
            +A +  L    HPN+V+L   C       + +  LV+E + +  L  +L +   P +P 
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT 119
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
                +     +GL FLH      V++RD K  NIL+ +    KL+DFGLA+        
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQ 173
Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 339
              T V+ T  Y APE ++     +  D++S G +  EM 
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 59/109 (54%), Gaps = 4/109 (3%)
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
           +++   A + L F H+     +I+RD K +NI++ A    K+ DFG+A+   + G +   
Sbjct: 136 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 192
Query: 303 TR-VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           T  V+GT  Y +PE      + ++SDVYS G VL E+LTG      + P
Sbjct: 193 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 241

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 35/226 (15%)
Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 191
            R    +  +G+G FG V++G              G  VAVK  +    +  + W  E  
Sbjct: 5   ARTIVLQESIGKGRFGEVWRG-----------KWRGEEVAVKIFSS---REERSWFREAE 50
Query: 192 FLGNLL--HPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 245
               ++  H N++  +    +D+    Q  LV ++   GSL ++L R ++ +   I  K+
Sbjct: 51  IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI--KL 108
Query: 246 ALGAAKGLAFLHEEAE----KPVI-YRDFKTSNILLDADYNAKLSDFGLA--KDAPEDGK 298
           AL  A GLA LH E      KP I +RD K+ NIL+  +    ++D GLA   D+  D  
Sbjct: 109 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 168
Query: 299 THVSTRVMGTYGYAAPEY----VMTGHLTS--KSDVYSFGVVLLEM 338
                  +GT  Y APE     +   H  S  ++D+Y+ G+V  E+
Sbjct: 169 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 102/225 (45%), Gaps = 35/225 (15%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           R    +  +G+G FG V++G              G  VAVK  +    +  + W  E   
Sbjct: 42  RTIVLQESIGKGRFGEVWRG-----------KWRGEEVAVKIFSS---REERSWFREAEI 87
Query: 193 LGNLL--HPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
              ++  H N++  +    +D+    Q  LV ++   GSL ++L R ++ +   I  K+A
Sbjct: 88  YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI--KLA 145
Query: 247 LGAAKGLAFLHEEAE----KPVI-YRDFKTSNILLDADYNAKLSDFGLA--KDAPEDGKT 299
           L  A GLA LH E      KP I +RD K+ NIL+  +    ++D GLA   D+  D   
Sbjct: 146 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 205
Query: 300 HVSTRVMGTYGYAAPEY----VMTGHLTS--KSDVYSFGVVLLEM 338
                 +GT  Y APE     +   H  S  ++D+Y+ G+V  E+
Sbjct: 206 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 17/210 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 17/210 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 100/224 (44%), Gaps = 30/224 (13%)
Query: 130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA- 188
           +AT  + P + +G G +G V+K            P +G  VA+K++      G    L  
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKAR---------DPHSGHFVALKSVRVPNGGGGGGGLPI 56
Query: 189 ----EVNFLGNLL---HPNLVKLVGYCIED--DQRL---LVYEFMPRGSLENHLFRRSLP 236
               EV  L  L    HPN+V+L+  C     D+ +   LV+E + +  L  +L +   P
Sbjct: 57  STVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPP 115
Query: 237 -LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE 295
            LP      +     +GL FLH      +++RD K  NIL+ +    KL+DFGLA+    
Sbjct: 116 GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY-- 170
Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 339
                  T V+ T  Y APE ++     +  D++S G +  EM 
Sbjct: 171 -SYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 35/226 (15%)
Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 191
            R    +  +G+G FG V++G              G  VAVK  +    +  + W  E  
Sbjct: 8   ARTIVLQESIGKGRFGEVWRG-----------KWRGEEVAVKIFSS---REERSWFREAE 53
Query: 192 FLGNLL--HPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 245
               ++  H N++  +    +D+    Q  LV ++   GSL ++L R ++ +   I  K+
Sbjct: 54  IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI--KL 111
Query: 246 ALGAAKGLAFLHEEAE----KPVI-YRDFKTSNILLDADYNAKLSDFGLA--KDAPEDGK 298
           AL  A GLA LH E      KP I +RD K+ NIL+  +    ++D GLA   D+  D  
Sbjct: 112 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 171
Query: 299 THVSTRVMGTYGYAAPEY----VMTGHLTS--KSDVYSFGVVLLEM 338
                  +GT  Y APE     +   H  S  ++D+Y+ G+V  E+
Sbjct: 172 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 17/210 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 17/210 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 17/210 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 17/210 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 15  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 75/162 (46%), Gaps = 11/162 (6%)
Query: 183 HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 242
           H+E   E++ L +L HPN++KL     +     LV EF   G L   +  R         
Sbjct: 90  HEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDA 148
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD---YNAKLSDFGLAKDAPEDGKT 299
             I      G+ +LH+     +++RD K  NILL+      N K+ DFGL+    +D K 
Sbjct: 149 ANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL 205
Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
                 +GT  Y APE V+      K DV+S GV++  +L G
Sbjct: 206 RDR---LGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 102/225 (45%), Gaps = 35/225 (15%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           R    +  +G+G FG V++G              G  VAVK  +    +  + W  E   
Sbjct: 29  RTIVLQESIGKGRFGEVWRG-----------KWRGEEVAVKIFSS---REERSWFREAEI 74
Query: 193 LGNLL--HPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
              ++  H N++  +    +D+    Q  LV ++   GSL ++L R ++ +   I  K+A
Sbjct: 75  YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI--KLA 132
Query: 247 LGAAKGLAFLHEEAE----KPVI-YRDFKTSNILLDADYNAKLSDFGLA--KDAPEDGKT 299
           L  A GLA LH E      KP I +RD K+ NIL+  +    ++D GLA   D+  D   
Sbjct: 133 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 192
Query: 300 HVSTRVMGTYGYAAPEY----VMTGHLTS--KSDVYSFGVVLLEM 338
                 +GT  Y APE     +   H  S  ++D+Y+ G+V  E+
Sbjct: 193 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 17/210 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 15  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 180
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 17/210 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 94/212 (44%), Gaps = 18/212 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 38  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 88
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 249
           + +  L HP  VKL  +C +DD++L     +   G L  ++ R+      +         
Sbjct: 89  DVMSRLDHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 146
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
              L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT 
Sbjct: 147 VSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 203
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 204 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 17/210 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           LGEG +G V            V   T   VAVK ++    +   +    E+     L H 
Sbjct: 15  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 17/210 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 102/221 (46%), Gaps = 27/221 (12%)
Query: 130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHK-EWL 187
           +AT  + P + +G G +G V+K            P +G  VA+K++   +G +G     +
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKAR---------DPHSGHFVALKSVRVPNGEEGLPISTV 51
Query: 188 AEVNFLGNLL---HPNLVKLVGYCIED--DQRL---LVYEFMPRGSLENHLFRRSLP-LP 238
            EV  L  L    HPN+V+L+  C     D+ +   LV+E + +  L  +L +   P LP
Sbjct: 52  REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 110
Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
                 +     +GL FLH      +++RD K  NIL+ +    KL+DFGLA+       
Sbjct: 111 AETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SY 164
Query: 299 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 339
                 V+ T  Y APE ++     +  D++S G +  EM 
Sbjct: 165 QMALAPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 17/210 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 17/210 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHK----E 185
           A + +   + +GEG +G VFK    +NG        G  VA+K +    G +G       
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTGEEGMPLSTIR 60
Query: 186 WLAEVNFLGNLLHPNLVKLVGYCI-----EDDQRLLVYEFMPRGSLENHLFRRSLP-LPW 239
            +A +  L    HPN+V+L   C       + +  LV+E + +  L  +L +   P +P 
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT 119
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
                +     +GL FLH      V++RD K  NIL+ +    KL+DFGLA+        
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQ 173
Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 339
              T V+ T  Y APE ++     +  D++S G +  EM 
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 17/210 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 15  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 17/210 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHK----E 185
           A + +   + +GEG +G VFK    +NG        G  VA+K +    G +G       
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTGEEGMPLSTIR 60
Query: 186 WLAEVNFLGNLLHPNLVKLVGYCI-----EDDQRLLVYEFMPRGSLENHLFRRSLP-LPW 239
            +A +  L    HPN+V+L   C       + +  LV+E + +  L  +L +   P +P 
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT 119
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
                +     +GL FLH      V++RD K  NIL+ +    KL+DFGLA+        
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQ 173
Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 339
              T V+ T  Y APE ++     +  D++S G +  EM 
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 102/221 (46%), Gaps = 27/221 (12%)
Query: 130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHK-EWL 187
           +AT  + P + +G G +G V+K            P +G  VA+K++   +G +G     +
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKAR---------DPHSGHFVALKSVRVPNGEEGLPISTV 51
Query: 188 AEVNFLGNLL---HPNLVKLVGYCIED--DQRL---LVYEFMPRGSLENHLFRRSLP-LP 238
            EV  L  L    HPN+V+L+  C     D+ +   LV+E + +  L  +L +   P LP
Sbjct: 52  REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 110
Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
                 +     +GL FLH      +++RD K  NIL+ +    KL+DFGLA+       
Sbjct: 111 AETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SY 164
Query: 299 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 339
                 V+ T  Y APE ++     +  D++S G +  EM 
Sbjct: 165 QMALDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 97/222 (43%), Gaps = 32/222 (14%)
Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 194
           F    L+G G +G V+KG         VK  TG   A+K ++  G +  +E   E+N L 
Sbjct: 26  FELVELVGNGTYGQVYKG-------RHVK--TGQLAAIKVMDVTGDE-EEEIKQEINMLK 75
Query: 195 NLLHP-NLVKLVGYCIE------DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMK 244
              H  N+    G  I+      DDQ  LV EF   GS+ + +      +L   W     
Sbjct: 76  KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AY 133
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           I     +GL+ LH+     VI+RD K  N+LL  +   KL DFG++  A  D        
Sbjct: 134 ICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNT 188
Query: 305 VMGTYGYAAPEYVMTGH-----LTSKSDVYSFGVVLLEMLTG 341
            +GT  + APE +            KSD++S G+  +EM  G
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 27/227 (11%)
Query: 123 FMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ- 181
           F+ +   + +  ++ + +LG+G FG V                TG   AVK ++   ++ 
Sbjct: 16  FVQHSTAIFSDRYKGQRVLGKGSFGEVI---------LCKDKITGQECAVKVISKRQVKQ 66
Query: 182 --GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 239
               +  L EV  L  L HPN+ KL  +  +     LV E    G L + +  R      
Sbjct: 67  KTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSE 125
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAK--DAP 294
               +I      G+ + H+     +++RD K  N+LL++   D N ++ DFGL+   +A 
Sbjct: 126 VDAARIIRQVLSGITYXHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182
Query: 295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           +  K  +     GT  Y APE V+ G    K DV+S GV+L  +L+G
Sbjct: 183 KKXKDKI-----GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 96/224 (42%), Gaps = 27/224 (12%)
Query: 121 RKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL 180
           R F  +D ++     RP   LG+G FG V+            +  +   VA+K L    +
Sbjct: 18  RHFTIDDFEIG----RP---LGKGKFGNVYLAR---------EKKSHFIVALKVLFKSQI 61
Query: 181 QGH---KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL 237
           +      +   E+    +L HPN+++L  Y  +  +  L+ E+ PRG L   L ++S   
Sbjct: 62  EKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKEL-QKSCTF 120
Query: 238 PWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG 297
                  I    A  L + H    K VI+RD K  N+LL      K++DFG +  AP   
Sbjct: 121 DEQRTATIMEELADALMYCH---GKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLR 177
Query: 298 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           +      + GT  Y  PE +       K D++  GV+  E+L G
Sbjct: 178 R----KTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 75/159 (47%), Gaps = 9/159 (5%)
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIE--DDQRLLVYEFMPRGSLENHLF-----RRSLPLPW 239
           ++EVN L  L HPN+V+     I+  +    +V E+   G L + +      R+ L   +
Sbjct: 53  VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF 112
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
            +R+   L  A        +    V++RD K +N+ LD   N KL DFGLA+    D   
Sbjct: 113 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--E 170
Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 338
             +   +GT  Y +PE +       KSD++S G +L E+
Sbjct: 171 DFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 102/221 (46%), Gaps = 27/221 (12%)
Query: 130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHK-EWL 187
           +AT  + P + +G G +G V+K            P +G  VA+K++   +G +G     +
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKAR---------DPHSGHFVALKSVRVPNGEEGLPISTV 51
Query: 188 AEVNFLGNLL---HPNLVKLVGYCIED--DQRL---LVYEFMPRGSLENHLFRRSLP-LP 238
            EV  L  L    HPN+V+L+  C     D+ +   LV+E + +  L  +L +   P LP
Sbjct: 52  REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 110
Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
                 +     +GL FLH      +++RD K  NIL+ +    KL+DFGLA+       
Sbjct: 111 AETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SY 164
Query: 299 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 339
                 V+ T  Y APE ++     +  D++S G +  EM 
Sbjct: 165 QMALFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 85/189 (44%), Gaps = 30/189 (15%)
Query: 236 PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE 295
           P+     +  +   A+G+ FL   + +  I+RD    NILL  +   K+ DFGLA+D  +
Sbjct: 195 PITMEDLISYSFQVARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 251
Query: 296 D------GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR 349
           +      G T +  + M      APE +     ++KSDV+S+GV+L E+ +   S     
Sbjct: 252 NPDYVRKGDTRLPLKWM------APESIFDKIYSTKSDVWSYGVLLWEIFSLGGS---PY 302
Query: 350 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS 409
           P  + +    +R   G + R      P +             Q+   C  RDPK RPR +
Sbjct: 303 PGVQMDEDFCSRLREGMRMRAPEYSTPEI------------YQIMLDCWHRDPKERPRFA 350
Query: 410 EVVETLKPL 418
           E+VE L  L
Sbjct: 351 ELVEKLGDL 359

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 92/186 (49%), Gaps = 13/186 (6%)
Query: 166 TGLTVAVKTLNHDGLQGHK---EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMP 222
           TG  VAVK LN   ++      +   E+  L    HP+++KL           +V E++ 
Sbjct: 35  TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVS 94
Query: 223 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA 282
            G L +++ +         R ++       + + H      V++RD K  N+LLDA  NA
Sbjct: 95  GGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNA 150
Query: 283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS--KSDVYSFGVVLLEMLT 340
           K++DFGL+ +   DG+   ++   G+  YAAPE V++G L +  + D++S GV+L  +L 
Sbjct: 151 KIADFGLS-NMMSDGEFLRTS--CGSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLC 206
Query: 341 GRRSMD 346
           G    D
Sbjct: 207 GTLPFD 212

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 21/225 (9%)
Query: 122 KFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ 181
           +FM N     + N+  +  LG+G F  V +          V   TGL  A K +N   L 
Sbjct: 18  EFMMNASTKFSDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLS 68
Query: 182 GH--KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 239
               ++   E      L HPN+V+L     E+    LV++ +  G L   +  R      
Sbjct: 69  ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA 128
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN---AKLSDFGLAKDAPED 296
                I     + +A+ H      +++R+ K  N+LL +       KL+DFGLA +  + 
Sbjct: 129 DASHCIQ-QILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
              H      GT GY +PE +     +   D+++ GV+L  +L G
Sbjct: 185 EAWH---GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 25  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +        ++  
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 130
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR
Sbjct: 131 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 186
Query: 305 VMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
                 Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 -----WYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 17/210 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG  G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 14  LGEGAAGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 25  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +        ++  
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDDHVQFL 130
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR
Sbjct: 131 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR 186
Query: 305 VMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
                 Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 37/231 (16%)
Query: 134 NFRPESLLGEGGFGCVFKG---------WVEENGTAPVKPGTGLT--VAVKTLNHD-GLQ 181
           +F   ++LG+G FG V K           +++      K  T L+  + + +LNH   ++
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 182 GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI 241
            +  WL   NF         VK +    +     +  E+   G+L + +   +L      
Sbjct: 67  YYAAWLERRNF---------VKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE 117
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED----- 296
             ++     + L+++H +    +I+RD K  NI +D   N K+ DFGLAK+         
Sbjct: 118 YWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 297 -------GKTHVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEML 339
                  G +   T  +GT  Y A E +  TGH   K D+YS G++  EM+
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 19/205 (9%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +LG G FG V K   EE  T       GL +A K +   G++  +E   E++ +  L H 
Sbjct: 96  ILGGGRFGQVHK--CEETAT-------GLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHA 146
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           NL++L       +  +LV E++  G L + +   S  L     +       +G+  +H  
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH-- 204
Query: 260 AEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
            +  +++ D K  NIL    DA    K+ DFGLA+      K  V+    GT  + APE 
Sbjct: 205 -QMYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLKVN---FGTPEFLAPEV 259
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTG 341
           V    ++  +D++S GV+   +L+G
Sbjct: 260 VNYDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 25  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +        ++  
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDDHVQFL 130
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR
Sbjct: 131 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 186
Query: 305 VMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
                 Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 35  IGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 85
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
            N++ L+          E +   LV   M  G+  N++ +        ++  I     +G
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLI-YQILRG 142
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y 
Sbjct: 143 LKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYR 194
Query: 313 APEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           APE ++   H     D++S G ++ E+LTGR
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 91/186 (48%), Gaps = 13/186 (6%)
Query: 166 TGLTVAVKTLNHDGLQGHK---EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMP 222
           TG  VAVK LN   ++      +   E+  L    HP+++KL           +V E++ 
Sbjct: 35  TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVS 94
Query: 223 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA 282
            G L +++ +         R ++       + + H      V++RD K  N+LLDA  NA
Sbjct: 95  GGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNA 150
Query: 283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS--KSDVYSFGVVLLEMLT 340
           K++DFGL+ +   DG+    +   G+  YAAPE V++G L +  + D++S GV+L  +L 
Sbjct: 151 KIADFGLS-NMMSDGEFLRDS--CGSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLC 206
Query: 341 GRRSMD 346
           G    D
Sbjct: 207 GTLPFD 212

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 32  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 79
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +        ++  
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 137
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR
Sbjct: 138 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR 193
Query: 305 VMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
                 Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 194 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 103/221 (46%), Gaps = 20/221 (9%)
Query: 129 KLATRNFRPESLLGEGGFGCVF---KGWVEENGTA-PVKPGTGLTVAVKTLNHDGLQGHK 184
           K+   NF    +LG G +G VF   K    + G    +K     T+  K    +  +  +
Sbjct: 50  KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 109
Query: 185 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM 243
           + L  +        P LV L  Y  + + +L L+ +++  G L  HL +R       +++
Sbjct: 110 QVLEHIR-----QSPFLVTL-HYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQI 163
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
            +       L  LH+     +IYRD K  NILLD++ +  L+DFGL+K+   D +T  + 
Sbjct: 164 YVG-EIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD-ETERAY 218
Query: 304 RVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTG 341
              GT  Y AP+ V    +GH     D +S GV++ E+LTG
Sbjct: 219 DFCGTIEYMAPDIVRGGDSGH-DKAVDWWSLGVLMYELLTG 258

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 27/214 (12%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 49  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 99
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-------FRRSLPLPWSIRMKIALGAA 250
           H N++      I D  R    E M    L  HL         ++  L             
Sbjct: 100 HENIIG-----INDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQIL 154
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHVSTRVMGTY 309
           +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T   T  + T 
Sbjct: 155 RGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 211
Query: 310 GYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            Y APE ++     +KS D++S G +L EML+ R
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 32  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 79
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +        ++  
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 137
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR
Sbjct: 138 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR 193
Query: 305 VMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
                 Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 194 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 42  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 92
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
            N++ L+          E +   LV   M  G+  N++ +        ++  I     +G
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLI-YQILRG 149
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y 
Sbjct: 150 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYR 201
Query: 313 APEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           APE ++   H     D++S G ++ E+LTGR
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 32  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 79
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +        ++  
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 137
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR
Sbjct: 138 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR 193
Query: 305 VMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
                 Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 194 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 42  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 92
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
            N++ L+          E +   LV   M  G+  N++ +        ++  I     +G
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLI-YQILRG 149
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y 
Sbjct: 150 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYR 201
Query: 313 APEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           APE ++   H     D++S G ++ E+LTGR
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 35  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 85
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
            N++ L+          E +   LV   M  G+  N++ +        ++  I     +G
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLI-YQILRG 142
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y 
Sbjct: 143 LKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYR 194
Query: 313 APEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           APE ++   H     D++S G ++ E+LTGR
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 30  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
            N++ L+          E +   LV   M  G+  N++ +        ++  I     +G
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLI-YQILRG 137
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y 
Sbjct: 138 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYR 189
Query: 313 APEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           APE ++   H     D++S G ++ E+LTGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 117/261 (44%), Gaps = 26/261 (9%)
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL--PLPWSIRMK 244
           L EV  L  L HPN++KL  +  +     LV E    G L + +  R     +  ++ +K
Sbjct: 84  LEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK 143
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHV 301
             L    G+ +LH+     +++RD K  N+LL++   D   K+ DFGL+  A  + +  +
Sbjct: 144 QVLS---GVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLS--AVFENQKKM 195
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG--------RRSMDKNRPNGE 353
             R +GT  Y APE V+      K DV+S GV+L  +L G         + + +    G+
Sbjct: 196 KER-LGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGK 253
Query: 354 HNLV--EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR-PRMSE 410
           +     EW     G K    ++L    +   S + + +   +   C  ++     P ++ 
Sbjct: 254 YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLAN 313
Query: 411 VVETLKPLQNLKDMASSSYYF 431
            +E ++  QN + +A ++  +
Sbjct: 314 AIENMRKFQNSQKLAQAALLY 334

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 27  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 74
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +        ++  
Sbjct: 75  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 132
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR
Sbjct: 133 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 188
Query: 305 VMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
                 Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 36  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 83
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +        ++  
Sbjct: 84  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 141
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR
Sbjct: 142 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR 197
Query: 305 VMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
                 Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 198 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 25  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +        ++  
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 130
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR
Sbjct: 131 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 186
Query: 305 VMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
                 Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 27  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 74
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +        ++  
Sbjct: 75  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 132
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR
Sbjct: 133 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR 188
Query: 305 VMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
                 Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 37  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYREL 84
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +        ++  
Sbjct: 85  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 142
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR
Sbjct: 143 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 198
Query: 305 VMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
                 Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 199 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 27  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 74
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +        ++  
Sbjct: 75  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 132
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR
Sbjct: 133 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 188
Query: 305 VMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
                 Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 25  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +        ++  
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 130
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR
Sbjct: 131 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 186
Query: 305 VMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
                 Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 32  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 79
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +        ++  
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 137
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR
Sbjct: 138 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 193
Query: 305 VMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
                 Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 194 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 35  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 85
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
            N++ L+          E +   LV   M  G+  N++ +        ++  I     +G
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLI-YQILRG 142
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y 
Sbjct: 143 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYR 194
Query: 313 APEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           APE ++   H     D++S G ++ E+LTGR
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 29  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 79
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
            N++ L+          E +   LV   M  G+  N++ +        ++  I     +G
Sbjct: 80  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLI-YQILRG 136
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y 
Sbjct: 137 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYR 188
Query: 313 APEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 31  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 78
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +        ++  
Sbjct: 79  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 136
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR
Sbjct: 137 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 192
Query: 305 VMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
                 Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 193 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 25  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +        ++  
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 130
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR
Sbjct: 131 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 186
Query: 305 VMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
                 Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 32  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 82
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
            N++ L+          E +   LV   M  G+  N++ +        ++  I     +G
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLI-YQILRG 139
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y 
Sbjct: 140 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYR 191
Query: 313 APEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           APE ++   H     D++S G ++ E+LTGR
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 31  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 78
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +        ++  
Sbjct: 79  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 136
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR
Sbjct: 137 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 192
Query: 305 VMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
                 Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 193 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 30  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
            N++ L+          E +   LV   M  G+  N++ +        ++  I     +G
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLI-YQILRG 137
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y 
Sbjct: 138 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYR 189
Query: 313 APEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           APE ++   H     D++S G ++ E+LTGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/298 (24%), Positives = 121/298 (40%), Gaps = 45/298 (15%)
Query: 128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK----TLNHDGLQGH 183
           +++   +  P   LG G +G V     E+    P    +G  +AVK    T+N    Q  
Sbjct: 2   MEVKADDLEPIMELGRGAYGVV-----EKMRHVP----SGQIMAVKRIRATVNS---QEQ 49
Query: 184 KEWLAEVNF-LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRG--SLENHLFRRSLPLPWS 240
           K  L +++  +  +  P  V   G    +    +  E M          +  +   +P  
Sbjct: 50  KRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPED 109
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH 300
           I  KIA+   K L  LH +    VI+RD K SN+L++A    K+ DFG++    +D    
Sbjct: 110 ILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD 167
Query: 301 VSTRVMGTYGYAAPEYV-----MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 355
           +     G   Y APE +       G+ + KSD++S G+ ++E+   R   D         
Sbjct: 168 IDA---GCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYD--------- 214
Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
              W  P     ++      P+L      K S +     +QCL ++ K RP   E+++
Sbjct: 215 --SWGTP-FQQLKQVVEEPSPQLPAD---KFSAEFVDFTSQCLKKNSKERPTYPELMQ 266

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 86/321 (26%), Positives = 140/321 (43%), Gaps = 75/321 (23%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-- 197
           +G+G +G V++G W             G +VAVK  +    +  + W  E      +L  
Sbjct: 16  VGKGRYGEVWRGLW------------HGESVAVKIFSS---RDEQSWFRETEIYNTVLLR 60
Query: 198 HPNLVKLVGYCI----EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 253
           H N++  +   +       Q  L+  +   GSL + L R++L    ++R+  A+ AA GL
Sbjct: 61  HDNILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRL--AVSAACGL 118
Query: 254 AFLHEEA----EKPVI-YRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST----R 304
           A LH E      KP I +RDFK+ N+L+ ++    ++D GLA      G  ++      R
Sbjct: 119 AHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAV-MHSQGSDYLDIGNNPR 177
Query: 305 VMGTYGYAAPEY----VMTGHLTSK--SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 358
           V GT  Y APE     + T    S   +D+++FG+VL E+   RR++     NG   +VE
Sbjct: 178 V-GTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI--ARRTI----VNG---IVE 227
Query: 359 WARPHLGDKRRFYRLL--DPRLEGHFSIKGSQKAT-----------------QLAAQCLS 399
             RP       FY ++  DP  E    +    + T                 Q+  +C  
Sbjct: 228 DYRP------PFYDVVPNDPSFEDMKKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECWY 281
Query: 400 RDPKARPRMSEVVETLKPLQN 420
            +P AR     + +TL+ + N
Sbjct: 282 PNPSARLTALRIKKTLQKISN 302

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 49  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 99
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
            N++ L+          E +   LV   M  G+  N++ +        ++  I     +G
Sbjct: 100 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLI-YQILRG 156
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y 
Sbjct: 157 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYR 208
Query: 313 APEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           APE ++   H     D++S G ++ E+LTGR
Sbjct: 209 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 30  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
            N++ L+          E +   LV   M  G+  N++ +        ++  I     +G
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLI-YQILRG 137
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y 
Sbjct: 138 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYR 189
Query: 313 APEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           APE ++   H     D++S G ++ E+LTGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 31  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 78
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +        ++  
Sbjct: 79  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 136
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR
Sbjct: 137 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR 192
Query: 305 VMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
                 Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 193 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 45  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 92
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +        ++  
Sbjct: 93  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 150
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR
Sbjct: 151 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 206
Query: 305 VMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
                 Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 207 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 29  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 79
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
           H N++ +               Y ++D     +Y+ +    L N      L         
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 130
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHVST 303
                 +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T   T
Sbjct: 131 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 185
Query: 304 RVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
             + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 48  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 95
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +        ++  
Sbjct: 96  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 153
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR
Sbjct: 154 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVATR 209
Query: 305 VMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
                 Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 210 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 36  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 83
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +        ++  
Sbjct: 84  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 141
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR
Sbjct: 142 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 197
Query: 305 VMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
                 Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 198 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 29  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 79
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
           H N++ +               Y ++D     +Y+ +    L N      L         
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 130
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHVST 303
                 +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T   T
Sbjct: 131 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 185
Query: 304 RVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
             + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 31  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 81
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
           H N++ +               Y ++D     +Y+ +    L N      L         
Sbjct: 82  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 132
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHVST 303
                 +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T   T
Sbjct: 133 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 187
Query: 304 RVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
             + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 188 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 48  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 95
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +        ++  
Sbjct: 96  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 153
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR
Sbjct: 154 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 209
Query: 305 VMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
                 Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 210 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 33  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYXQRTLREIKILLRFR 83
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
           H N++ +               Y ++D     +Y+ +    L N      L         
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 134
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHVST 303
                 +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T   T
Sbjct: 135 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 189
Query: 304 RVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
             + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 30  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 77
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +        ++  
Sbjct: 78  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 135
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR
Sbjct: 136 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 191
Query: 305 VMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
                 Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 192 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 29  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 79
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
           H N++ +               Y ++D     +Y+ +    L N      L         
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 130
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHVST 303
                 +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T   T
Sbjct: 131 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 185
Query: 304 RVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
             + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 33  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 83
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
           H N++ +               Y ++D     +Y+ +    L N      L         
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 134
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHVST 303
                 +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T   T
Sbjct: 135 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 189
Query: 304 RVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
             + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 27  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 77
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
            N++ L+          E +   LV   M  G+  N++ +        ++  I     +G
Sbjct: 78  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLI-YQILRG 134
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y 
Sbjct: 135 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYR 186
Query: 313 APEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 23/211 (10%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGNLL 197
           LGEG FG V                T   VA+K ++   L+    H     E+++L  L 
Sbjct: 17  LGEGSFGKV---------KLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR 67
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 257
           HP+++KL          ++V E+   G L +++  +        R +        + + H
Sbjct: 68  HPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGR-RFFQQIICAIEYCH 125
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
                 +++RD K  N+LLD + N K++DFGL+    +      S    G+  YAAPE V
Sbjct: 126 RHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE-V 178
Query: 318 MTGHLTS--KSDVYSFGVVLLEMLTGRRSMD 346
           + G L +  + DV+S G+VL  ML GR   D
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 28  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 78
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
            N++ L+          E +   LV   M  G+  N++ +        ++  I     +G
Sbjct: 79  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLI-YQILRG 135
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y 
Sbjct: 136 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYR 187
Query: 313 APEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           APE ++   H     D++S G ++ E+LTGR
Sbjct: 188 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 26  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
            N++ L+          E +   LV   M  G+  N++ +        ++  I     +G
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLI-YQILRG 133
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y 
Sbjct: 134 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYR 185
Query: 313 APEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           APE ++   H     D++S G ++ E+LTGR
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 30  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
            N++ L+          E +   LV   M  G+  N++ +        ++  I     +G
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLI-YQILRG 137
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y 
Sbjct: 138 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYR 189
Query: 313 APEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           APE ++   H     D++S G ++ E+LTGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 49  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 99
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
           H N++ +               Y ++D     +Y+ +    L N      L         
Sbjct: 100 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 150
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHVST 303
                 +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T   T
Sbjct: 151 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 205
Query: 304 RVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
             + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 206 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 29  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 79
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
           H N++ +               Y ++D     +Y+ +    L N      L         
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 130
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHVST 303
                 +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T   T
Sbjct: 131 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLT 185
Query: 304 RVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
             + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 17/207 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLHP 199
           +GEG +G V   +     T          VA+K ++    Q + +  L E+  L    H 
Sbjct: 51  IGEGAYGMVSSAYDHVRKT---------RVAIKKISPFEHQTYCQRTLREIQILLRFRHE 101
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGLAFLH 257
           N++ +           +   ++ +  +E  L++  +S  L             +GL ++H
Sbjct: 102 NVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIH 161
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHVSTRVMGTYGYAAPEY 316
                 V++RD K SN+L++   + K+ DFGLA+ A PE   T   T  + T  Y APE 
Sbjct: 162 SAN---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEI 218
Query: 317 VMTGHLTSKS-DVYSFGVVLLEMLTGR 342
           ++     +KS D++S G +L EML+ R
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 34  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 84
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
           H N++ +               Y ++D     +Y+ +    L N      L         
Sbjct: 85  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 135
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHVST 303
                 +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T   T
Sbjct: 136 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 190
Query: 304 RVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
             + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 191 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 35  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 85
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
           H N++ +               Y ++D     +Y+ +    L N      L         
Sbjct: 86  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 136
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHVST 303
                 +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T   T
Sbjct: 137 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 191
Query: 304 RVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
             + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 192 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 26  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 76
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
           H N++ +               Y ++D     +Y+ +    L N      L         
Sbjct: 77  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 127
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHVST 303
                 +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T   T
Sbjct: 128 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 182
Query: 304 RVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
             + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 183 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 33  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 83
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
           H N++ +               Y ++D     +Y+ +    L N      L         
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 134
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHVST 303
                 +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T   T
Sbjct: 135 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 304 RVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
             + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 102/241 (42%), Gaps = 57/241 (23%)
Query: 134 NFRPESLLGEGGFGCVFKG---------WVEENGTAPVKPGTGLT--VAVKTLNHD-GLQ 181
           +F   ++LG+G FG V K           +++      K  T L+  + + +LNH   ++
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 182 GHKEWLAEVNFLGNLL----HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENH------LF 231
            +  WL   NF+  +        L   + YC   + R L Y+ +   +L         LF
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYC---ENRTL-YDLIHSENLNQQRDEYWRLF 122
Query: 232 RRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK 291
           R+ L               + L+++H +    +I+RD K  NI +D   N K+ DFGLAK
Sbjct: 123 RQIL---------------EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAK 164
Query: 292 DAPED------------GKTHVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEM 338
           +                G +   T  +GT  Y A E +  TGH   K D+YS G++  EM
Sbjct: 165 NVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224
Query: 339 L 339
           +
Sbjct: 225 I 225

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 27  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 77
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
           H N++ +               Y ++D     +Y+ +    L N      L         
Sbjct: 78  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 128
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHVST 303
                 +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T   T
Sbjct: 129 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 183
Query: 304 RVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
             + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 184 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 27  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 77
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
            N++ L+          E +   LV   M  G+  N++ +        ++  I     +G
Sbjct: 78  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLI-YQILRG 134
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y 
Sbjct: 135 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYR 186
Query: 313 APEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 37  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 87
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
           H N++ +               Y ++D     +Y+ +    L N      L         
Sbjct: 88  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 138
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHVST 303
                 +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T   T
Sbjct: 139 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 193
Query: 304 RVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
             + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 194 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 29  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 79
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
           H N++ +               Y ++D     +Y+ +    L N      L         
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 130
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHVST 303
                 +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T   T
Sbjct: 131 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 185
Query: 304 RVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
             + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 27  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 77
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
           H N++ +               Y ++D     +Y+ +    L N      L         
Sbjct: 78  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 128
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHVST 303
                 +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T   T
Sbjct: 129 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 183
Query: 304 RVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
             + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 184 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 31  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLAFR 81
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
           H N++ +               Y ++D     +Y+ +    L N      L         
Sbjct: 82  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 132
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHVST 303
                 +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T   T
Sbjct: 133 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 187
Query: 304 RVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
             + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 188 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 77/181 (42%), Gaps = 21/181 (11%)
Query: 237 LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED 296
           +P  I  KI L   K L  L E  +  +I+RD K SNILLD   N KL DFG++    + 
Sbjct: 122 IPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVD- 178
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGH----LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG 352
             +   TR  G   Y APE +           +SDV+S G+ L E+ TGR       P  
Sbjct: 179 --SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY----PKW 232
Query: 353 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
                +  +   GD         P+L      + S         CL++D   RP+  E++
Sbjct: 233 NSVFDQLTQVVKGDP--------PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELL 284
Query: 413 E 413
           +
Sbjct: 285 K 285

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 10  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 60
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ R+      +         
Sbjct: 61  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 118
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
              L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT 
Sbjct: 119 VSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 175
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 176 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 9   DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 59
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ R+      +         
Sbjct: 60  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 117
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
              L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT 
Sbjct: 118 VSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 174
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 30/218 (13%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 25  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 191 NFLGNLLHPNLVKLVGY-----CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 245
             L ++ H N++ L+        +E+   + +   +    L N    +S  L       +
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--IVKSQKLTDDHVQFL 130
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GL ++H      +I+RD K SN+ ++ D   K+ DFGL +   ++   +V+TR 
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVATR- 186
Query: 306 MGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 18/212 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 33  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ R+      +         
Sbjct: 84  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGCLLKYI-RKIGSFDETCTRFYTAEI 141
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
              L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT 
Sbjct: 142 VSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 198
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            Y +PE +     +  SD+++ G ++ +++ G
Sbjct: 199 QYVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 11  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 61
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ R+      +         
Sbjct: 62  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 119
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
              L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT 
Sbjct: 120 VSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 176
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 177 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 31  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLAFR 81
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
           H N++ +               Y ++D     +Y+ +    L N      L         
Sbjct: 82  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 132
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHVST 303
                 +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T   T
Sbjct: 133 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLT 187
Query: 304 RVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
             + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 188 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 33  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 83
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
           H N++ +               Y ++D     +Y+ +    L N      L         
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFL--------- 134
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHVST 303
                 +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T   T
Sbjct: 135 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 304 RVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
             + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 22/219 (10%)
Query: 134 NFRPESLLGEGGFG----CVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 189
           N+ P+ +LG G       C+ K   +E     +    G + + + +     +  +  L E
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQ----ELREATLKE 73
Query: 190 VNFLGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 248
           V+ L  +  HPN+++L      +    LV++ M +G L ++L  + + L      KI   
Sbjct: 74  VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRA 132
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
             + +  LH+     +++RD K  NILLD D N KL+DFG +       K      V GT
Sbjct: 133 LLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EVCGT 186
Query: 309 YGYAAPEYVMTGH------LTSKSDVYSFGVVLLEMLTG 341
             Y APE +             + D++S GV++  +L G
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 8   DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 58
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ R+      +         
Sbjct: 59  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 116
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
              L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT 
Sbjct: 117 VSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 173
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 174 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 22/220 (10%)
Query: 133 RNFRPESLLGEGGFG----CVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 188
            N+ P+ +LG G       C+ K   +E     +    G + + + +     +  +  L 
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQ----ELREATLK 59
Query: 189 EVNFLGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
           EV+ L  +  HPN+++L      +    LV++ M +G L ++L  + + L      KI  
Sbjct: 60  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMR 118
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
              + +  LH+     +++RD K  NILLD D N KL+DFG +       K      V G
Sbjct: 119 ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EVCG 172
Query: 308 TYGYAAPEYVMTGH------LTSKSDVYSFGVVLLEMLTG 341
           T  Y APE +             + D++S GV++  +L G
Sbjct: 173 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 25  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +        ++  
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 130
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           I     +GL ++H      +I+RD K SN+ ++ D   K+ D+GLA+   ++   +V+TR
Sbjct: 131 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVATR 186
Query: 305 VMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
                 Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 33  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ R+      +         
Sbjct: 84  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 141
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
              L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT 
Sbjct: 142 VSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 31  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 81
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ R+      +         
Sbjct: 82  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 139
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
              L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT 
Sbjct: 140 VSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 34  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 84
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ R+      +         
Sbjct: 85  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 142
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
              L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT 
Sbjct: 143 VSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 199
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 200 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 31  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 81
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ R+      +         
Sbjct: 82  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 139
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
              L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT 
Sbjct: 140 VSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 22/219 (10%)
Query: 134 NFRPESLLGEGGFG----CVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 189
           N+ P+ +LG G       C+ K   +E     +    G + + + +     +  +  L E
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQ----ELREATLKE 73
Query: 190 VNFLGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 248
           V+ L  +  HPN+++L      +    LV++ M +G L ++L  + + L      KI   
Sbjct: 74  VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRA 132
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
             + +  LH+     +++RD K  NILLD D N KL+DFG +       K      V GT
Sbjct: 133 LLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---SVCGT 186
Query: 309 YGYAAPEYVMTGH------LTSKSDVYSFGVVLLEMLTG 341
             Y APE +             + D++S GV++  +L G
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 33  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ R+      +         
Sbjct: 84  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 141
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
              L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT 
Sbjct: 142 VSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 34  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 84
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ R+      +         
Sbjct: 85  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 142
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
              L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT 
Sbjct: 143 VSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 199
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 200 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA++ ++    Q + +  L E+  L    
Sbjct: 33  SYIGEGAYGMVCSAYDNLNK---------VRVAIRKISPFEHQTYCQRTLREIKILLRFR 83
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
           H N++ +               Y ++D     +Y+ +    L N      L         
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 134
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHVST 303
                 +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T   T
Sbjct: 135 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 304 RVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
             + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 33  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ R+      +         
Sbjct: 84  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 141
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
              L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT 
Sbjct: 142 VSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 15  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 65
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ R+      +         
Sbjct: 66  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 123
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
              L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT 
Sbjct: 124 VSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 180
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 181 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 92/208 (44%), Gaps = 18/208 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVNFLGNLLH 198
           +GEG +G VFK    E         T   VA+K   L+ D        L E+  L  L H
Sbjct: 10  IGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 258
            N+V+L      D +  LV+EF  +  L+ +    +  L   I         KGL F H 
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
              + V++RD K  N+L++ +   KL+DFGLA+      + + +  V  T  Y  P+ + 
Sbjct: 120 ---RNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLF 174
Query: 319 TGHLTSKS-DVYSFGVVLLEMLTGRRSM 345
              L S S D++S G +  E+    R +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 31  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 81
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ R+      +         
Sbjct: 82  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 139
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
              L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT 
Sbjct: 140 VSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTA 196
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 36  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 86
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ R+      +         
Sbjct: 87  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 144
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
              L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT 
Sbjct: 145 VSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 201
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 202 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 29/211 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 30  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
            N++ L+          E +   LV   M  G+  N++ +        ++  I     +G
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLI-YQILRG 137
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++    V+TR      Y 
Sbjct: 138 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGXVATR-----WYR 189
Query: 313 APEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           APE ++   H     D++S G ++ E+LTGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 33  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ R+      +         
Sbjct: 84  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 141
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
              L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT 
Sbjct: 142 VSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 30  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 80
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ R+      +         
Sbjct: 81  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 138
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
              L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT 
Sbjct: 139 VSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 195
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 196 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 30  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 80
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ R+      +         
Sbjct: 81  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 138
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
              L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT 
Sbjct: 139 VSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 195
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 196 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/300 (23%), Positives = 120/300 (40%), Gaps = 45/300 (15%)
Query: 126 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK----TLNHDGLQ 181
            + ++   +  P   LG G +G V     E+    P    +G  +AVK    T+N    Q
Sbjct: 44  QNFEVKADDLEPIMELGRGAYGVV-----EKMRHVP----SGQIMAVKRIRATVNS---Q 91
Query: 182 GHKEWLAEVNF-LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRG--SLENHLFRRSLPLP 238
             K  L +++  +  +  P  V   G    +    +  E M          +  +   +P
Sbjct: 92  EQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIP 151
Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
             I  KIA+   K L  LH +    VI+RD K SN+L++A    K+ DFG++    +   
Sbjct: 152 EDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVA 209
Query: 299 THVSTRVMGTYGYAAPEYV-----MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 353
             +     G   Y APE +       G+ + KSD++S G+ ++E+   R   D       
Sbjct: 210 KTIDA---GCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYD------- 258
Query: 354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                W  P     ++      P+L      K S +     +QCL ++ K RP   E+++
Sbjct: 259 ----SWGTP-FQQLKQVVEEPSPQLPAD---KFSAEFVDFTSQCLKKNSKERPTYPELMQ 310

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 87/204 (42%), Gaps = 18/204 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGNLLH 198
           +GEG +G VFK    +         TG  VA+K    + D     K  L E+  L  L H
Sbjct: 11  IGEGSYGVVFKCRNRD---------TGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 258
           PNLV L+       +  LV+E+     L + L R    +P  +   I     + + F H+
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDHTVL-HELDRYQRGVPEHLVKSITWQTLQAVNFCHK 120
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                 I+RD K  NIL+      KL DFG A+     G +      + T  Y +PE ++
Sbjct: 121 HN---CIHRDVKPENILITKHSVIKLCDFGFARLL--TGPSDYYDDEVATRWYRSPELLV 175
Query: 319 -TGHLTSKSDVYSFGVVLLEMLTG 341
                    DV++ G V  E+L+G
Sbjct: 176 GDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 33  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ R+      +         
Sbjct: 84  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEI 141
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
              L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT 
Sbjct: 142 VSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            Y +PE +        SD+++ G ++ +++ G
Sbjct: 199 QYVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 100/228 (43%), Gaps = 34/228 (14%)
Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEV 190
           + +F+ +SLLGEG +G V         +A  KP TG  VA+K +   D        L E+
Sbjct: 10  SSDFQLKSLLGEGAYGVV--------CSATHKP-TGEIVAIKKIEPFDKPLFALRTLREI 60
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM------- 243
             L +  H N++ +        QR   +E      +   L +  L    S +M       
Sbjct: 61  KILKHFKHENIITIFNI-----QRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQ 115
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED------- 296
                  + +  LH      VI+RD K SN+L++++ + K+ DFGLA+   E        
Sbjct: 116 YFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 297 -GKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            G+    T  + T  Y APE ++T    S++ DV+S G +L E+   R
Sbjct: 173 TGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 100/228 (43%), Gaps = 34/228 (14%)
Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEV 190
           + +F+ +SLLGEG +G V         +A  KP TG  VA+K +   D        L E+
Sbjct: 10  SSDFQLKSLLGEGAYGVV--------CSATHKP-TGEIVAIKKIEPFDKPLFALRTLREI 60
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM------- 243
             L +  H N++ +        QR   +E      +   L +  L    S +M       
Sbjct: 61  KILKHFKHENIITIFNI-----QRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQ 115
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED------- 296
                  + +  LH      VI+RD K SN+L++++ + K+ DFGLA+   E        
Sbjct: 116 YFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 297 -GKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            G+    T  + T  Y APE ++T    S++ DV+S G +L E+   R
Sbjct: 173 TGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/249 (25%), Positives = 102/249 (40%), Gaps = 45/249 (18%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVN 191
           N+  + L+G G +G V+  + ++N            VA+K +N   + L   K  L E+ 
Sbjct: 29  NYEIKHLIGRGSYGYVYLAY-DKNANK--------NVAIKKVNRMFEDLIDCKRILREIT 79
Query: 192 FLGNLLHPNLVKLVGYCI-ED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
            L  L    +++L    I ED    D+  +V E     S    LF+  + L       I 
Sbjct: 80  ILNRLKSDYIIRLHDLIIPEDLLKFDELYIVLEIA--DSDLKKLFKTPIFLTEQHVKTIL 137
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS---- 302
                G  F+HE     +I+RD K +N LL+ D + K+ DFGLA+    D   H+     
Sbjct: 138 YNLLLGEKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLE 194
Query: 303 -------------------TRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
                              T  + T  Y APE ++   + T+  D++S G +  E+L   
Sbjct: 195 EKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMM 254
Query: 343 RSMDKNRPN 351
           +S   N  N
Sbjct: 255 KSHINNPTN 263

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 73/154 (47%), Gaps = 6/154 (3%)
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
           E + +  L HP  VKL  +  +DD++L     +   G L  ++ R+      +       
Sbjct: 80  ERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA 137
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
                L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +G
Sbjct: 138 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           T  Y +PE +        SD+++ G ++ +++ G
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 98/238 (41%), Gaps = 40/238 (16%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVN 191
           N+  + L+G G +G V+  +            T   VA+K +N   + L   K  L E+ 
Sbjct: 27  NYIIKHLIGRGSYGYVYLAY---------DKNTEKNVAIKKVNRMFEDLIDCKRILREIT 77
Query: 192 FLGNLLHPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            L  L    +++L    I DD      L +   +    L+  LF+  + L       I  
Sbjct: 78  ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKK-LFKTPIFLTEEHIKTILY 136
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS----- 302
               G  F+HE     +I+RD K +N LL+ D + K+ DFGLA+    +  T++      
Sbjct: 137 NLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEE 193
Query: 303 ---------------TRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRS 344
                          T  + T  Y APE ++     +KS D++S G +  E+L   +S
Sbjct: 194 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 29/217 (13%)
Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNF 192
           ++  S +G G +G V   +        VK  +GL +AVK L+     +   K    E+  
Sbjct: 53  YQTLSPVGSGAYGSVCSSY-------DVK--SGLKIAVKKLSRPFQSIIHAKRTYRELRL 103
Query: 193 LGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
           L ++ H N++ L+          E +   LV   M  G+  N++ +        ++  I 
Sbjct: 104 LKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLI- 160
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
               +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR  
Sbjct: 161 YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-- 215
Query: 307 GTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
               Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 216 ---WYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 42/228 (18%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNLL 197
           LG+G +G V+K          +   TG  VAVK +  D  Q   +      E+  L  L 
Sbjct: 17  LGKGAYGIVWKS---------IDRRTGEVVAVKKI-FDAFQNSTDAQRTFREIMILTELS 66
Query: 198 -HPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
            H N+V L+     D+ R   LV+++M     + H   R+  L    +  +     K + 
Sbjct: 67  GHENIVNLLNVLRADNDRDVYLVFDYM---ETDLHAVIRANILEPVHKQYVVYQLIKVIK 123
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE------------------- 295
           +LH      +++RD K SNILL+A+ + K++DFGL++                       
Sbjct: 124 YLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 296 DGKTHVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
           D    + T  + T  Y APE ++ +   T   D++S G +L E+L G+
Sbjct: 181 DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 76/160 (47%), Gaps = 15/160 (9%)
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL--PLPWSIRMK 244
           L EV  L  L HPN++KL  +  +     LV E    G L + +  R     +  ++ MK
Sbjct: 52  LDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK 111
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHV 301
             L    G  +LH+     +++RD K  N+LL++   D   K+ DFGL+      GK   
Sbjct: 112 QVLS---GTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKM-- 163
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
               +GT  Y APE V+      K DV+S GV+L  +L G
Sbjct: 164 -KERLGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 39/220 (17%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 33  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 83
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
           H N++ +               Y ++D     +Y+ +    L N      L         
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 134
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHVST 303
                 +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T    
Sbjct: 135 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLX 189
Query: 304 RVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
             + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 190 EXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 39/220 (17%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 34  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 84
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
           H N++ +               Y ++D     +Y+ +    L N      L         
Sbjct: 85  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--------- 135
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHVST 303
                 +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T    
Sbjct: 136 --YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLX 190
Query: 304 RVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
             + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 191 EXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TG  VAVK L+     +   K    E+  L ++ H
Sbjct: 26  VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
            N++ L+          E +   LV   M  G+  N++ + +      ++  I     +G
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCAKLTDDHVQFLI-YQILRG 133
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y 
Sbjct: 134 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYR 185
Query: 313 APEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           APE ++   H     D++S G ++ E+LTGR
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 128/293 (43%), Gaps = 52/293 (17%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQG      E+  +  L H 
Sbjct: 27  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQGKAFKNRELQIMRKLDHC 73
Query: 200 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFRRSLPLPWSIRMKIALGAA- 250
           N+V+L  +       +D+  L LV +++P     +  H  R    LP  I +K+ +    
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP-VIYVKLYMYQLF 132
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAP--EDGKTHVSTRVMG 307
           + LA++H      + +RD K  N+LLD D    KL DFG AK     E   +++ +R   
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 187
Query: 308 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
              Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +  LG 
Sbjct: 188 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIK-VLGT 241
Query: 367 KRR---------FYRLLDPRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
             R         +     P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 242 PTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 76/160 (47%), Gaps = 15/160 (9%)
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL--PLPWSIRMK 244
           L EV  L  L HPN++KL  +  +     LV E    G L + +  R     +  ++ MK
Sbjct: 69  LDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK 128
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHV 301
             L    G  +LH+     +++RD K  N+LL++   D   K+ DFGL+      GK   
Sbjct: 129 QVLS---GTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKM-- 180
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
               +GT  Y APE V+      K DV+S GV+L  +L G
Sbjct: 181 -KERLGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 129/291 (44%), Gaps = 48/291 (16%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQG      E+  +  L H 
Sbjct: 27  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQGKAFKNRELQIMRKLDHC 73
Query: 200 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFRRSLPLPWSIRMKIALGAA- 250
           N+V+L  +       +D+  L LV +++P     +  H  R    LP  I +K+ +    
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLP-VIYVKLYMYQLF 132
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + + 
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSX--ICSR 186
Query: 310 GYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
            Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +  LG   
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIK-VLGTPT 243
Query: 369 R---------FYRLLDPRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
           R         +     P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 244 REQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 29/211 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TG  VAVK L+     +   K    E+  L ++ H
Sbjct: 30  VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
            N++ L+          E +   LV   M  G+  N++ +        ++  I     +G
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLI-YQILRG 137
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y 
Sbjct: 138 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYR 189
Query: 313 APEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           APE ++   H     D++S G ++ E+LTGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TG  VAVK L+     +   K    E+
Sbjct: 45  QNLSP---VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 92
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +        ++  
Sbjct: 93  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 150
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR
Sbjct: 151 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 206
Query: 305 VMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
                 Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 207 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 29/211 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TG  VAVK L+     +   K    E+  L ++ H
Sbjct: 36  VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 86
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
            N++ L+          E +   LV   M  G+  N++ +        ++  I     +G
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLI-YQILRG 143
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y 
Sbjct: 144 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYR 195
Query: 313 APEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           APE ++   H     D++S G ++ E+LTGR
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 29/211 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TG  VAVK L+     +   K    E+  L ++ H
Sbjct: 40  VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 90
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
            N++ L+          E +   LV   M  G+  N++ +        ++  I     +G
Sbjct: 91  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLI-YQILRG 147
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y 
Sbjct: 148 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYR 199
Query: 313 APEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           APE ++   H     D++S G ++ E+LTGR
Sbjct: 200 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 128/292 (43%), Gaps = 50/292 (17%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQG      E+  +  L H 
Sbjct: 27  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQGKAFKNRELQIMRKLDHC 73
Query: 200 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFRRSLPLPWSIRMKIALGAA- 250
           N+V+L  +       +D+  L LV +++P     +  H  R    LP  I +K+ +    
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP-VIYVKLYMYQLF 132
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAP--EDGKTHVSTRVMG 307
           + LA++H      + +RD K  N+LLD D    KL DFG AK     E   +++ +R   
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 187
Query: 308 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
              Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +     
Sbjct: 188 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 242
Query: 367 KRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
            R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 84/181 (46%), Gaps = 18/181 (9%)
Query: 170 VAVKTLNH--DGLQGHKEWLAEVNFLGNLLHPNLVKLV-----GYCIEDDQRLLVYEFMP 222
           VAVK L+     L   +    E+  L +L H N++ L+        IED   + +   + 
Sbjct: 56  VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM 115
Query: 223 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA 282
              L N    +S  L       +     +GL ++H      +I+RD K SN+ ++ D   
Sbjct: 116 GADLNN--IVKSQALSDEHVQFLVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSEL 170
Query: 283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTG 341
           ++ DFGLA+ A E+   +V+TR      Y APE ++   H     D++S G ++ E+L G
Sbjct: 171 RILDFGLARQADEEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 225
Query: 342 R 342
           +
Sbjct: 226 K 226

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 29/211 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TG  VAVK L+     +   K    E+  L ++ H
Sbjct: 49  VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 99
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
            N++ L+          E +   LV   M  G+  N++ +        ++  I     +G
Sbjct: 100 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLI-YQILRG 156
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y 
Sbjct: 157 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYR 208
Query: 313 APEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           APE ++   H     D++S G ++ E+LTGR
Sbjct: 209 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 92/214 (42%), Gaps = 23/214 (10%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  Y  +D+  L +V E++P G + +HL R    S P       +I L       +L
Sbjct: 103 LVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEI 209
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +++       D ++ GV++ EM  G      ++P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 89/205 (43%), Gaps = 23/205 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  Y  +D+  L +V E++P G + +HL R    S P       +I L       +L
Sbjct: 103 LVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEI 209
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTG 341
           +++       D ++ GV++ EM  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 92/214 (42%), Gaps = 23/214 (10%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  Y  +D+  L +V E++P G + +HL R    S P       +I L       +L
Sbjct: 103 LVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEI 209
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +++       D ++ GV++ EM  G      ++P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 88/205 (42%), Gaps = 23/205 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  +  +D+  L +V E+MP G + +HL R    S P       +I L       +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+L+D     K++DFG AK     G+T     + GT  Y APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRT---WXLCGTPEYLAPEI 209
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTG 341
           +++       D ++ GV++ EM  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 105/236 (44%), Gaps = 50/236 (21%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           N +   L+G G +G V+KG ++E      +P     VAVK  +    Q    ++ E N  
Sbjct: 14  NLKLLELIGRGRYGAVYKGSLDE------RP-----VAVKVFSFANRQN---FINEKNIY 59
Query: 194 GNLL--HPNLVKLV--GYCIEDDQR---LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
              L  H N+ + +     +  D R   LLV E+ P GSL  +L   +    W    ++A
Sbjct: 60  RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD--WVSSCRLA 117
Query: 247 LGAAKGLAFLHEEA-----EKPVI-YRDFKTSNILLDADYNAKLSDFGLA---------K 291
               +GLA+LH E       KP I +RD  + N+L+  D    +SDFGL+         +
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLT--------SKSDVYSFGVVLLEML 339
              ED   + +   +GT  Y APE V+ G +          + D+Y+ G++  E+ 
Sbjct: 178 PGEED---NAAISEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 127/290 (43%), Gaps = 46/290 (15%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 61  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 107
Query: 200 NLVKLVGYCIEDDQRL------LVYEFMPRG--SLENHLFRRSLPLPWSIRMKIALGAA- 250
           N+V+L  +     ++       LV +++P     +  H  R    LP  I +K+ +    
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV-IYVKLYMYQLF 166
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + + 
Sbjct: 167 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSX--ICSR 220
Query: 310 GYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
            Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +      R
Sbjct: 221 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTPTR 278
Query: 369 RFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
              R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 328

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 92/220 (41%), Gaps = 48/220 (21%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGNLL 197
           +G G +G V          + +   +G  VA+K L+    Q     K    E+  L ++ 
Sbjct: 50  VGSGAYGSV---------CSAIDKRSGEKVAIKKLSRP-FQSEIFAKRAYRELLLLKHMQ 99
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKI----------- 245
           H N++ L+              F P  SL N   F   +P   +   KI           
Sbjct: 100 HENVIGLLDV------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQ 147
Query: 246 --ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
                  KGL ++H      V++RD K  N+ ++ D   K+ DFGLA+ A  +   +V T
Sbjct: 148 YLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVT 204
Query: 304 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           R      Y APE +++  H     D++S G ++ EMLTG+
Sbjct: 205 R-----WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 92/220 (41%), Gaps = 48/220 (21%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGNLL 197
           +G G +G V          + +   +G  VA+K L+    Q     K    E+  L ++ 
Sbjct: 32  VGSGAYGSV---------CSAIDKRSGEKVAIKKLSR-PFQSEIFAKRAYRELLLLKHMQ 81
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKI----------- 245
           H N++ L+              F P  SL N   F   +P   +   KI           
Sbjct: 82  HENVIGLLDV------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQ 129
Query: 246 --ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
                  KGL ++H      V++RD K  N+ ++ D   K+ DFGLA+ A  +   +V T
Sbjct: 130 YLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVT 186
Query: 304 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           R      Y APE +++  H     D++S G ++ EMLTG+
Sbjct: 187 R-----WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 29/211 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TG  VAVK L+     +   K    E+  L ++ H
Sbjct: 26  VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
            N++ L+          E +   LV   M  G+  N++ +        ++  I     +G
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLI-YQILRG 133
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y 
Sbjct: 134 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYR 185
Query: 313 APEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           APE ++   H     D++S G ++ E+LTGR
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 25  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +        ++  
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 130
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           I     +GL ++H      +I+RD K SN+ ++ D   K+  FGLA+   ++   +V+TR
Sbjct: 131 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVATR 186
Query: 305 VMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
                 Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 88/205 (42%), Gaps = 23/205 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  +  +D+  L +V E+MP G + +HL R    S P       +I L       +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+L+D     K++DFG AK     G+T     + GT  Y APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRT---WXLCGTPEYLAPEI 209
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTG 341
           +++       D ++ GV++ EM  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 88/203 (43%), Gaps = 17/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V +          V+  TG     K +N            E++ +  L HP 
Sbjct: 59  LGSGAFGVVHRC---------VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           L+ L     +  + +L+ EF+  G L + +      +  +  +     A +GL  +HE +
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 261 EKPVIYRDFKTSNILLDAD--YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
              +++ D K  NI+ +     + K+ DFGLA     D    V+T    T  +AAPE V 
Sbjct: 170 ---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVD 223
Query: 319 TGHLTSKSDVYSFGVVLLEMLTG 341
              +   +D+++ GV+   +L+G
Sbjct: 224 REPVGFYTDMWAIGVLGYVLLSG 246

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 127/290 (43%), Gaps = 46/290 (15%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 63  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 109
Query: 200 NLVKLVGYCIEDDQRL------LVYEFMPRG--SLENHLFRRSLPLPWSIRMKIALGAA- 250
           N+V+L  +     ++       LV +++P     +  H  R    LP  I +K+ +    
Sbjct: 110 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV-IYVKLYMYQLF 168
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + + 
Sbjct: 169 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVS--YICSR 222
Query: 310 GYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
            Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +      R
Sbjct: 223 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTPTR 280
Query: 369 RFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
              R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 281 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 330

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 89/213 (41%), Gaps = 21/213 (9%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVN 191
           N+  +  LG+G F  V +          V   TGL  A K +N   L     ++   E  
Sbjct: 6   NYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLEREAR 56
Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 251
               L HPN+V+L     E+    LV++ +  G L   +  R           I     +
Sbjct: 57  ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QILE 115
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYN---AKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            +A+ H      +++R+ K  N+LL +       KL+DFGLA +  +    H      GT
Sbjct: 116 SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGT 169
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            GY +PE +     +   D+++ GV+L  +L G
Sbjct: 170 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 127/290 (43%), Gaps = 46/290 (15%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 61  VIGNGSFGVVYQAKLCDSGEL---------VAIKKV----LQDKRFKNRELQIMRKLDHC 107
Query: 200 NLVKLVGYCIEDDQRL------LVYEFMPRG--SLENHLFRRSLPLPWSIRMKIALGAA- 250
           N+V+L  +     ++       LV +++P     +  H  R    LP  I +K+ +    
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP-VIYVKLYMYQLF 166
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + + 
Sbjct: 167 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVS--YICSR 220
Query: 310 GYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
            Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +      R
Sbjct: 221 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTPTR 278
Query: 369 RFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
              R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 328

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 25  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +        ++  
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 130
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           I     +GL ++H      +I+RD K SN+ ++ D   K+ D GLA+   ++   +V+TR
Sbjct: 131 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVATR 186
Query: 305 VMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
                 Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 129/290 (44%), Gaps = 46/290 (15%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 46  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 92
Query: 200 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFRRSLPLPWSIRMKIALGAA- 250
           N+V+L  +       +D+  L LV +++P     +  H  R    LP  I +K+ +    
Sbjct: 93  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP-VIYVKLYMYQLF 151
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + + 
Sbjct: 152 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSX--ICSR 205
Query: 310 GYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
            Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +      R
Sbjct: 206 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTPTR 263
Query: 369 RFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
              R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 264 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 313

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 89/213 (41%), Gaps = 21/213 (9%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVN 191
           N+  +  LG+G F  V +          V   TGL  A K +N   L     ++   E  
Sbjct: 7   NYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLEREAR 57
Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 251
               L HPN+V+L     E+    LV++ +  G L   +  R           I     +
Sbjct: 58  ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QILE 116
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYN---AKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            +A+ H      +++R+ K  N+LL +       KL+DFGLA +  +    H      GT
Sbjct: 117 SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGT 170
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            GY +PE +     +   D+++ GV+L  +L G
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 44/289 (15%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 65  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 111
Query: 200 NLVKLVGYCIEDDQRL------LVYEFMPRG--SLENHLFRRSLPLPWSIRMKIALGAAK 251
           N+V+L  +     ++       LV +++P     +  H  R    LP            +
Sbjct: 112 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 171
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + +  
Sbjct: 172 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVS--YICSRY 225
Query: 311 YAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
           Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +      R 
Sbjct: 226 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTPTRE 283
Query: 370 FYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
             R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 284 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 332

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 99/228 (43%), Gaps = 34/228 (14%)
Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEV 190
           + +F+ +SLLGEG +G V         +A  KP TG  VA+K +   D        L E+
Sbjct: 10  SSDFQLKSLLGEGAYGVV--------CSATHKP-TGEIVAIKKIEPFDKPLFALRTLREI 60
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM------- 243
             L +  H N++ +        QR   +E      +   L +  L    S +M       
Sbjct: 61  KILKHFKHENIITIFNI-----QRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQ 115
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED------- 296
                  + +  LH      VI+RD K SN+L++++ + K+ DFGLA+   E        
Sbjct: 116 YFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 297 -GKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            G+       + T  Y APE ++T    S++ DV+S G +L E+   R
Sbjct: 173 TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 121/291 (41%), Gaps = 48/291 (16%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 106 VIGNGSFGVVYQAKLCDSGEL---------VAIKKV----LQDKRFKNRELQIMRKLDHC 152
Query: 200 NLVKLVGYCIEDDQRL------LVYEFMPRG--SLENHLFRRSLPLPWSIRMKIALGAAK 251
           N+V+L  +     ++       LV +++P     +  H  R    LP            +
Sbjct: 153 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 212
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAP--EDGKTHVSTRVMGT 308
            LA++H      + +RD K  N+LLD D    KL DFG AK     E   +++ +R    
Sbjct: 213 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 266
Query: 309 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
             Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +      
Sbjct: 267 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTPT 322
Query: 368 RRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
           R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 323 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 373

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 129/290 (44%), Gaps = 46/290 (15%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 35  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 81
Query: 200 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFRRSLPLPWSIRMKIALGAA- 250
           N+V+L  +       +D+  L LV +++P     +  H  R    LP  I +K+ +    
Sbjct: 82  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP-VIYVKLYMYQLF 140
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + + 
Sbjct: 141 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSX--ICSR 194
Query: 310 GYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
            Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +      R
Sbjct: 195 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTPTR 252
Query: 369 RFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
              R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 253 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 302

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 44/289 (15%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 55  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 101
Query: 200 NLVKLVGYCIEDDQRL------LVYEFMPRGS--LENHLFRRSLPLPWSIRMKIALGAAK 251
           N+V+L  +     ++       LV +++P     +  H  R    LP            +
Sbjct: 102 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 161
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + +  
Sbjct: 162 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVS--YICSRY 215
Query: 311 YAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
           Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +      R 
Sbjct: 216 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTPTRE 273
Query: 370 FYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
             R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 274 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 322

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 28/223 (12%)
Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--- 183
           +++   R+ +P   +G G +G V          + V   TG  VA+K L +   Q     
Sbjct: 22  EVRAVYRDLQP---VGSGAYGAV---------CSAVDGRTGAKVAIKKL-YRPFQSELFA 68
Query: 184 KEWLAEVNFLGNLLHPNLVKLVGYCIED---DQRLLVYEFMPRGSLENHLFRRSLPLPWS 240
           K    E+  L ++ H N++ L+     D   D     Y  MP    +     +   L   
Sbjct: 69  KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGED 128
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH 300
               +     KGL ++H      +I+RD K  N+ ++ D   K+ DFGLA+ A  +    
Sbjct: 129 RIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGX 185
Query: 301 VSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           V TR      Y APE ++     T   D++S G ++ EM+TG+
Sbjct: 186 VVTR-----WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 29/211 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 30  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
            N++ L+          E +   LV   M  G+  N++ +        ++  I     +G
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLI-YQILRG 137
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L ++H      +I+RD K SN+ ++ D   K+ D GLA+   ++   +V+TR      Y 
Sbjct: 138 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVATR-----WYR 189
Query: 313 APEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           APE ++   H     D++S G ++ E+LTGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 124/289 (42%), Gaps = 44/289 (15%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 39  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 85
Query: 200 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFRRSLPLPWSIRMKIALGAAK 251
           N+V+L  +       +D+  L LV +++P     +  H  R    LP            +
Sbjct: 86  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 145
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + +  
Sbjct: 146 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSX--ICSRY 199
Query: 311 YAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
           Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +      R 
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTPTRE 257
Query: 370 FYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
             R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 258 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 306

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 89/213 (41%), Gaps = 21/213 (9%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVN 191
           N+  +  LG+G F  V +          V   TGL  A K +N   L     ++   E  
Sbjct: 7   NYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLEREAR 57
Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 251
               L HPN+V+L     E+    LV++ +  G L   +  R           I     +
Sbjct: 58  ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QILE 116
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYN---AKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            +A+ H      +++R+ K  N+LL +       KL+DFGLA +  +    H      GT
Sbjct: 117 SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGT 170
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            GY +PE +     +   D+++ GV+L  +L G
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 124/289 (42%), Gaps = 44/289 (15%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 40  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 86
Query: 200 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFRRSLPLPWSIRMKIALGAAK 251
           N+V+L  +       +D+  L LV +++P     +  H  R    LP            +
Sbjct: 87  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 146
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + +  
Sbjct: 147 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVS--YICSRY 200
Query: 311 YAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
           Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +      R 
Sbjct: 201 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTPTRE 258
Query: 370 FYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
             R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 259 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 307

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 129/290 (44%), Gaps = 46/290 (15%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 39  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 85
Query: 200 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFRRSLPLPWSIRMKIALGAA- 250
           N+V+L  +       +D+  L LV +++P     +  H  R    LP  I +K+ +    
Sbjct: 86  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP-VIYVKLYMYQLF 144
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + + 
Sbjct: 145 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSX--ICSR 198
Query: 310 GYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
            Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +      R
Sbjct: 199 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTPTR 256
Query: 369 RFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
              R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 257 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 306

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 29/211 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TG  VAVK L+     +   K    E+  L ++ H
Sbjct: 30  VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
            N++ L+          E +   LV   M  G+  N++ +        ++  I     +G
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLI-YQILRG 137
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++    V+TR      Y 
Sbjct: 138 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WYR 189
Query: 313 APEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           APE ++   H     D++S G ++ E+LTGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 29/211 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TG  VAVK L+     +   K    E+  L ++ H
Sbjct: 30  VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
            N++ L+          E +   LV   M  G+  N++ +        ++  I     +G
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLI-YQILRG 137
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++    V+TR      Y 
Sbjct: 138 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WYR 189
Query: 313 APEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           APE ++   H     D++S G ++ E+LTGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 18/208 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVNFLGNLLH 198
           +GEG +G VFK    E         T   VA+K   L+ D        L E+  L  L H
Sbjct: 10  IGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 258
            N+V+L      D +  LV+EF  +  L+ +    +  L   I         KGL F H 
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
              + V++RD K  N+L++ +   KL++FGLA+      + + +  V  T  Y  P+ + 
Sbjct: 120 ---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDVLF 174
Query: 319 TGHLTSKS-DVYSFGVVLLEMLTGRRSM 345
              L S S D++S G +  E+    R +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 124/289 (42%), Gaps = 44/289 (15%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 27  VIGNGSFGVVYQAKLCDSGEL---------VAIKKV----LQDKRFKNRELQIMRKLDHC 73
Query: 200 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFRRSLPLPWSIRMKIALGAAK 251
           N+V+L  +       +D+  L LV +++P     +  H  R    LP            +
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + +  
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSX--ICSRY 187
Query: 311 YAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
           Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +      R 
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTPTRE 245
Query: 370 FYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
             R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 86/181 (47%), Gaps = 18/181 (9%)
Query: 170 VAVKTLNH--DGLQGHKEWLAEVNFLGNLLHPNLVKLV-----GYCIEDDQRLLVYEFMP 222
           VAVK L+     L   +    E+  L +L H N++ L+        IED   + +   + 
Sbjct: 48  VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM 107
Query: 223 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA 282
              L N +  ++L       +   L   +GL ++H      +I+RD K SN+ ++ D   
Sbjct: 108 GADLNNIVKCQALSDEHVQFLVYQL--LRGLKYIHSAG---IIHRDLKPSNVAVNEDCEL 162
Query: 283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTG 341
           ++ DFGLA+ A E+   +V+TR      Y APE ++   H     D++S G ++ E+L G
Sbjct: 163 RILDFGLARQADEEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 217
Query: 342 R 342
           +
Sbjct: 218 K 218

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 25  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +        ++  
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 130
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           I     +GL ++H      +I+RD K SN+ ++ D   K+ D GLA+   ++   +V+TR
Sbjct: 131 I-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVATR 186
Query: 305 VMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
                 Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 129/290 (44%), Gaps = 46/290 (15%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 32  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 78
Query: 200 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFRRSLPLPWSIRMKIALGAA- 250
           N+V+L  +       +D+  L LV +++P     +  H  R    LP  I +K+ +    
Sbjct: 79  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP-VIYVKLYMYQLF 137
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + + 
Sbjct: 138 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVS--YICSR 191
Query: 310 GYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
            Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +      R
Sbjct: 192 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTPTR 249
Query: 369 RFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
              R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 250 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 299

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 124/289 (42%), Gaps = 44/289 (15%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 28  VIGNGSFGVVYQAKLCDSGEL---------VAIKKV----LQDKRFKNRELQIMRKLDHC 74
Query: 200 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFRRSLPLPWSIRMKIALGAAK 251
           N+V+L  +       +D+  L LV +++P     +  H  R    LP            +
Sbjct: 75  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 134
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + +  
Sbjct: 135 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSX--ICSRY 188
Query: 311 YAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
           Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +      R 
Sbjct: 189 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTPTRE 246
Query: 370 FYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
             R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 247 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 295

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 22/212 (10%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNF 192
           +FR   +LG G F  V     E+  T  +       VA+K +  + L+G +  +  E+  
Sbjct: 21  DFR--DVLGTGAFSEVILA--EDKRTQKL-------VAIKCIAKEALEGKEGSMENEIAV 69
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
           L  + HPN+V L           L+ + +  G L + +  +          ++       
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS-RLIFQVLDA 128
Query: 253 LAFLHEEAEKPVIYRDFKTSNIL---LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           + +LH+     +++RD K  N+L   LD D    +SDFGL+K   ED  + +ST   GT 
Sbjct: 129 VKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLST-ACGTP 182
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           GY APE +     +   D +S GV+   +L G
Sbjct: 183 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 129/290 (44%), Gaps = 46/290 (15%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 27  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 73
Query: 200 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFRRSLPLPWSIRMKIALGAA- 250
           N+V+L  +       +D+  L LV +++P     +  H  R    LP  I +K+ +    
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP-VIYVKLYMYQLF 132
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + + 
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSX--ICSR 186
Query: 310 GYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
            Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +      R
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTPTR 244
Query: 369 RFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
              R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 127/290 (43%), Gaps = 46/290 (15%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 27  VIGNGSFGVVYQAKLCDSGEL---------VAIKKV----LQDKRFKNRELQIMRKLDHC 73
Query: 200 NLVKLVGYCIEDDQRL------LVYEFMPRGS--LENHLFRRSLPLPWSIRMKIALGAA- 250
           N+V+L  +     ++       LV +++P     +  H  R    LP  I +K+ +    
Sbjct: 74  NIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLP-VIYVKLYMYQLF 132
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + + 
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSX--ICSR 186
Query: 310 GYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
            Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +      R
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTPTR 244
Query: 369 RFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
              R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 29/211 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TG  VAVK L+     +   K    E+  L ++ H
Sbjct: 50  VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 100
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
            N++ L+          E +   LV   M  G+  N++ +        ++  I     +G
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLI-YQILRG 157
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++    V+TR      Y 
Sbjct: 158 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXVATR-----WYR 209
Query: 313 APEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           APE ++   H     D++S G ++ E+LTGR
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 124/289 (42%), Gaps = 44/289 (15%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 31  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 77
Query: 200 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFRRSLPLPWSIRMKIALGAAK 251
           N+V+L  +       +D+  L LV +++P     +  H  R    LP            +
Sbjct: 78  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 137
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + +  
Sbjct: 138 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSX--ICSRY 191
Query: 311 YAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
           Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +      R 
Sbjct: 192 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTPTRE 249
Query: 370 FYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
             R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 250 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 298

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 86/181 (47%), Gaps = 18/181 (9%)
Query: 170 VAVKTLNH--DGLQGHKEWLAEVNFLGNLLHPNLVKLV-----GYCIEDDQRLLVYEFMP 222
           VAVK L+     L   +    E+  L +L H N++ L+        IED   + +   + 
Sbjct: 56  VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM 115
Query: 223 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA 282
              L N +  ++L       +   L   +GL ++H      +I+RD K SN+ ++ D   
Sbjct: 116 GADLNNIVKCQALSDEHVQFLVYQL--LRGLKYIHSAG---IIHRDLKPSNVAVNEDSEL 170
Query: 283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTG 341
           ++ DFGLA+ A E+   +V+TR      Y APE ++   H     D++S G ++ E+L G
Sbjct: 171 RILDFGLARQADEEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 225
Query: 342 R 342
           +
Sbjct: 226 K 226

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 22/212 (10%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNF 192
           +FR   +LG G F  V     E+  T  +       VA+K +  + L+G +  +  E+  
Sbjct: 21  DFR--DVLGTGAFSEVILA--EDKRTQKL-------VAIKCIAKEALEGKEGSMENEIAV 69
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
           L  + HPN+V L           L+ + +  G L + +  +          ++       
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS-RLIFQVLDA 128
Query: 253 LAFLHEEAEKPVIYRDFKTSNIL---LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           + +LH+     +++RD K  N+L   LD D    +SDFGL+K   ED  + +ST   GT 
Sbjct: 129 VKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLST-ACGTP 182
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           GY APE +     +   D +S GV+   +L G
Sbjct: 183 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 92/214 (42%), Gaps = 23/214 (10%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E G             VK    +     K  L  VNF      P 
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 123
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  +  +D+  L +V E++P G + +HL R    S P       +I L       +L
Sbjct: 124 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 178
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE 
Sbjct: 179 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRT---WXLCGTPEYLAPEI 230
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +++       D ++ GV++ EM  G      ++P
Sbjct: 231 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 92/214 (42%), Gaps = 23/214 (10%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E G             VK    +     K  L  VNF      P 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 103
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  +  +D+  L +V E++P G + +HL R    S P       +I L       +L
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 158
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE 
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEI 210
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +++       D ++ GV++ EM  G      ++P
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 22/212 (10%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNF 192
           +FR   +LG G F  V     E+  T  +       VA+K +    L+G +  +  E+  
Sbjct: 21  DFR--DVLGTGAFSEVI--LAEDKRTQKL-------VAIKCIAKKALEGKEGSMENEIAV 69
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
           L  + HPN+V L           L+ + +  G L + +  +          ++       
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS-RLIFQVLDA 128
Query: 253 LAFLHEEAEKPVIYRDFKTSNIL---LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           + +LH+     +++RD K  N+L   LD D    +SDFGL+K   ED  + +ST   GT 
Sbjct: 129 VKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLST-ACGTP 182
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           GY APE +     +   D +S GV+   +L G
Sbjct: 183 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 92/214 (42%), Gaps = 23/214 (10%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E G             VK    +     K  L  VNF      P 
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 95
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  +  +D+  L +V E++P G + +HL R    S P       +I L       +L
Sbjct: 96  LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 150
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE 
Sbjct: 151 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEI 202
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +++       D ++ GV++ EM  G      ++P
Sbjct: 203 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 236

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 92/214 (42%), Gaps = 23/214 (10%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E G             VK    +     K  L  VNF      P 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 103
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  +  +D+  L +V E++P G + +HL R    S P       +I L       +L
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 158
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE 
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEI 210
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +++       D ++ GV++ EM  G      ++P
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 92/214 (42%), Gaps = 23/214 (10%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E G             VK    +     K  L  VNF      P 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 103
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  +  +D+  L +V E++P G + +HL R    S P       +I L       +L
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 158
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE 
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEI 210
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +++       D ++ GV++ EM  G      ++P
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 29/211 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TG  VAVK L+     +   K    E+  L ++ H
Sbjct: 26  VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
            N++ L+          E +   LV   M  G+  N++ +        ++  I     +G
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLI-YQILRG 133
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++    V+TR      Y 
Sbjct: 134 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WYR 185
Query: 313 APEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           APE ++   H     D++S G ++ E+LTGR
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 129/290 (44%), Gaps = 46/290 (15%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 27  VIGNGSFGVVYQAKLCDSGEL---------VAIKKV----LQDKRFKNRELQIMRKLDHC 73
Query: 200 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFRRSLPLPWSIRMKIALGAA- 250
           N+V+L  +       +D+  L LV +++P     +  H  R    LP  I +K+ +    
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP-VIYVKLYMYQLF 132
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + + 
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVS--YICSR 186
Query: 310 GYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
            Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +      R
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTPTR 244
Query: 369 RFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
              R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 22/212 (10%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNF 192
           +FR   +LG G F  V     E+  T  +       VA+K +  + L+G +  +  E+  
Sbjct: 21  DFR--DVLGTGAFSEVILA--EDKRTQKL-------VAIKCIAKEALEGKEGSMENEIAV 69
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
           L  + HPN+V L           L+ + +  G L + +  +          ++       
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS-RLIFQVLDA 128
Query: 253 LAFLHEEAEKPVIYRDFKTSNIL---LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           + +LH+     +++RD K  N+L   LD D    +SDFGL+K   ED  + +ST   GT 
Sbjct: 129 VKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLST-ACGTP 182
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           GY APE +     +   D +S GV+   +L G
Sbjct: 183 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 88/205 (42%), Gaps = 23/205 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  +  +D+  L +V E+ P G + +HL R    S P       +I L       +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+++D     K++DFGLAK     G+T     + GT  Y APE 
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVK--GRT---WXLCGTPEYLAPEI 209
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTG 341
           +++       D ++ GV++ EM  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 88/205 (42%), Gaps = 23/205 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E G             VK    +     K  L  VNF      P 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 103
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  +  +D+  L +V E+ P G + +HL R    S P       +I L       +L
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 158
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+++D     K++DFG AK     G+T     + GT  Y APE 
Sbjct: 159 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRT---WXLCGTPEYLAPEI 210
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTG 341
           +++       D ++ GV++ EM  G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 78/182 (42%), Gaps = 26/182 (14%)
Query: 237 LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED 296
           +P  I  KIA+   K L  LH +    VI+RD K SN+L++A    K  DFG++    +D
Sbjct: 133 IPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDD 190
Query: 297 GKTHVSTRVMGTYGYAAPEYV-----MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN 351
               +     G   Y APE +       G+ + KSD++S G+  +E+   R   D     
Sbjct: 191 VAKDIDA---GCKPYXAPERINPELNQKGY-SVKSDIWSLGITXIELAILRFPYDS---- 242
Query: 352 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
                  W  P     ++      P+L      K S +     +QCL ++ K RP   E+
Sbjct: 243 -------WGTP-FQQLKQVVEEPSPQLPAD---KFSAEFVDFTSQCLKKNSKERPTYPEL 291
Query: 412 VE 413
            +
Sbjct: 292 XQ 293

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 84/203 (41%), Gaps = 17/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V +  V E  T       G   A K +        +    E+  +  L HP 
Sbjct: 59  LGTGAFGVVHR--VTERAT-------GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 109
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           LV L     +D++ +++YEFM  G L   +      +     ++      KGL  +HE  
Sbjct: 110 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 169
Query: 261 EKPVIYRDFKTSNILLDADYN--AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
               ++ D K  NI+     +   KL DFGL           V+T   GT  +AAPE   
Sbjct: 170 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAE 223
Query: 319 TGHLTSKSDVYSFGVVLLEMLTG 341
              +   +D++S GV+   +L+G
Sbjct: 224 GKPVGYYTDMWSVGVLSYILLSG 246

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 31/224 (13%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEV-- 190
           + + P+ ++G G    V +          V   TG   AVK +     +   E L EV  
Sbjct: 94  QKYDPKDVIGRGVSSVVRRC---------VHRATGHEFAVKIMEVTAERLSPEQLEEVRE 144
Query: 191 ------NFLGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM 243
                 + L  +  HP+++ L+          LV++ M +G L ++L  + + L      
Sbjct: 145 ATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETR 203
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
            I     + ++FLH      +++RD K  NILLD +   +LSDFG +       K     
Sbjct: 204 SIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR--- 257
Query: 304 RVMGTYGYAAPEYVMTGHLTS------KSDVYSFGVVLLEMLTG 341
            + GT GY APE +      +      + D+++ GV+L  +L G
Sbjct: 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 70/172 (40%), Gaps = 22/172 (12%)
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
           +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D         
Sbjct: 206 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 262
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
                + APE +     T +SDV+SFGV+L E+ +                   A P+ G
Sbjct: 263 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----------------LGASPYPG 305
Query: 366 DK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
            K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 306 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 357

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 89/211 (42%), Gaps = 17/211 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E G             VK    +     K  L  VNF      P 
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 95
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LVKL  +  +D+  L +V E++P G + +HL R         R   A        +LH  
Sbjct: 96  LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLHS- 152
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
               +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE +++
Sbjct: 153 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIILS 205
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
                  D ++ GV++ EM  G      ++P
Sbjct: 206 KGYNKAVDWWALGVLIYEMAAGYPPFFADQP 236

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 70/172 (40%), Gaps = 22/172 (12%)
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
           +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D         
Sbjct: 199 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
                + APE +     T +SDV+SFGV+L E+ +                   A P+ G
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASPYPG 298
Query: 366 DK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
            K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 299 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 350

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 91/214 (42%), Gaps = 23/214 (10%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  +  +D+  L +V E++P G + +HL R    S P       +I L       +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+L+D     K++DFG AK     G+T     + GT  Y APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRT---WXLCGTPEYLAPEI 209
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +++       D ++ GV++ EM  G      ++P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 70/172 (40%), Gaps = 22/172 (12%)
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
           +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D         
Sbjct: 204 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 260
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
                + APE +     T +SDV+SFGV+L E+ +                   A P+ G
Sbjct: 261 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASPYPG 303
Query: 366 DK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
            K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 304 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 355

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 28/212 (13%)
Query: 141 LGEGGFG--CVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGN 195
           +G+G FG  C+    V++N T  +        A+K +N        E      E+  +  
Sbjct: 23  IGKGSFGKVCI----VQKNDTKKM-------YAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 196 LLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
           L HP LV L  Y  +D++ + +V + +  G L  HL +       ++++ I       L 
Sbjct: 72  LEHPFLVNL-WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-ELVMALD 129
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           +L  +    +I+RD K  NILLD   +  ++DF +A   P + +    T + GT  Y AP
Sbjct: 130 YLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYMAP 183
Query: 315 EYVMT---GHLTSKSDVYSFGVVLLEMLTGRR 343
           E   +      +   D +S GV   E+L GRR
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 91/214 (42%), Gaps = 23/214 (10%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 103
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  +  +D+  L +V E++P G + +HL R    S P       +I L       +L
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 158
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE 
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWT---LCGTPEYLAPEI 210
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +++       D ++ GV++ EM  G      ++P
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 70/172 (40%), Gaps = 22/172 (12%)
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
           +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D         
Sbjct: 197 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 253
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
                + APE +     T +SDV+SFGV+L E+ +                   A P+ G
Sbjct: 254 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASPYPG 296
Query: 366 DK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
            K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 297 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 348

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 84/203 (41%), Gaps = 17/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V +  V E  T       G   A K +        +    E+  +  L HP 
Sbjct: 165 LGTGAFGVVHR--VTERAT-------GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           LV L     +D++ +++YEFM  G L   +      +     ++      KGL  +HE  
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 261 EKPVIYRDFKTSNILLDADYN--AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
               ++ D K  NI+     +   KL DFGL           V+T   GT  +AAPE   
Sbjct: 276 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAE 329
Query: 319 TGHLTSKSDVYSFGVVLLEMLTG 341
              +   +D++S GV+   +L+G
Sbjct: 330 GKPVGYYTDMWSVGVLSYILLSG 352

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 70/155 (45%), Gaps = 9/155 (5%)
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL--PWSIRMKIA 246
           E    G L  P++V +  +  E D +L V   +  G       RR  PL  P ++ +   
Sbjct: 84  EARTAGRLQEPHVVPIHDFG-EIDGQLYVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQ 142
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           +G+A               +RD K  NIL+ AD  A L DFG+A    ++  T +   V 
Sbjct: 143 IGSAL-----DAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV- 196
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           GT  Y APE     H T ++D+Y+   VL E LTG
Sbjct: 197 GTLYYXAPERFSESHATYRADIYALTCVLYECLTG 231

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 115/267 (43%), Gaps = 40/267 (14%)
Query: 165 GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD--QRLLVYEFMP 222
           G  + V V  +     +  +++  E   L    HPN++ ++G C         L+  +MP
Sbjct: 33  GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMP 92
Query: 223 RGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRD-FKTSNILLDADY 280
            GSL N L    +  +  S  +K AL  A+G+AFLH    +P+I R    + ++++D D 
Sbjct: 93  YGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH--TLEPLIPRHALNSRSVMIDEDM 150
Query: 281 NAKLS--DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSK---SDVYSFGVVL 335
            A++S  D   +  +P  G+       M    + APE +      +    +D++SF V+L
Sbjct: 151 TARISMADVKFSFQSP--GR-------MYAPAWVAPEALQKKPEDTNRRSADMWSFAVLL 201
Query: 336 LEMLTGRRSMD--KNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQL 393
            E++T         N   G    +E  RP           + P +  H S        +L
Sbjct: 202 WELVTREVPFADLSNMEIGMKVALEGLRP----------TIPPGISPHVS--------KL 243
Query: 394 AAQCLSRDPKARPRMSEVVETLKPLQN 420
              C++ DP  RP+   +V  L+ +Q+
Sbjct: 244 MKICMNEDPAKRPKFDMIVPILEKMQD 270

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 91/214 (42%), Gaps = 23/214 (10%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  +  +D+  L +V E++P G + +HL R    S P       +I L       +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEI 209
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +++       D ++ GV++ EM  G      ++P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 91/214 (42%), Gaps = 23/214 (10%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 103
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  +  +D+  L +V E++P G + +HL R    S P       +I L       +L
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 158
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE 
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEI 210
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +++       D ++ GV++ EM  G      ++P
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 92/220 (41%), Gaps = 26/220 (11%)
Query: 126 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 185
            ++  AT   R    LG G FG V +  +E+  T       G   AVK +  +  +    
Sbjct: 90  EEVHWATHQLR----LGRGSFGEVHR--MEDKQT-------GFQCAVKKVRLEVFRAE-- 134
Query: 186 WLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 245
              E+     L  P +V L G   E     +  E +  GSL   L +    LP    +  
Sbjct: 135 ---ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLVKEQGCLPEDRALYY 190
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDAPEDG---KTHV 301
              A +GL +LH    + +++ D K  N+LL +D  +A L DFG A     DG       
Sbjct: 191 LGQALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLT 247
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
              + GT  + APE V+     +K DV+S   ++L ML G
Sbjct: 248 GDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 91/214 (42%), Gaps = 23/214 (10%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  +  +D+  L +V E++P G + +HL R    S P       +I L       +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEI 209
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +++       D ++ GV++ EM  G      ++P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 91/214 (42%), Gaps = 23/214 (10%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 35  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 88
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  +  +D+  L +V E++P G + +HL R    S P       +I L       +L
Sbjct: 89  LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 143
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE 
Sbjct: 144 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWT---LCGTPEYLAPEI 195
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +++       D ++ GV++ EM  G      ++P
Sbjct: 196 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 229

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 91/214 (42%), Gaps = 23/214 (10%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  +  +D+  L +V E++P G + +HL R    S P       +I L       +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEI 209
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +++       D ++ GV++ EM  G      ++P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 118/282 (41%), Gaps = 50/282 (17%)
Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 194
           F  ES LG G    V++   ++ GT   KP   L V  KT++   ++       E+  L 
Sbjct: 55  FEVESELGRGATSIVYR--CKQKGTQ--KP-YALKVLKKTVDKKIVR------TEIGVLL 103
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK--- 251
            L HPN++KL        +  LV E +  G L + +  +     +S R   A  A K   
Sbjct: 104 RLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY---YSERD--AADAVKQIL 158
Query: 252 -GLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             +A+LHE     +++RD K  N+L      D   K++DFGL+K         +   V G
Sbjct: 159 EAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ---VLMKTVCG 212
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T GY APE +       + D++S G++   +L G       R               GD+
Sbjct: 213 TPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER---------------GDQ 257
Query: 368 RRFYRLLDPRLEGHFSI----KGSQKATQLAAQCLSRDPKAR 405
             F R+L+   E +F      + S  A  L  + +  DPK R
Sbjct: 258 FMFRRILN--CEYYFISPWWDEVSLNAKDLVRKLIVLDPKKR 297

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 23/210 (10%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +LG+G +G V+ G    N          + +A+K +     +  +    E+    +L H 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQ---------VRIAIKEIPERDSRYSQPLHEEIALHKHLKHK 79
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK---GLAFL 256
           N+V+ +G   E+    +  E +P GSL   L  +  PL  +    I     +   GL +L
Sbjct: 80  NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN-EQTIGFYTKQILEGLKYL 138
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNA--KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           H+     +++RD K  N+L++  Y+   K+SDFG +K     G    +    GT  Y AP
Sbjct: 139 HDNQ---IVHRDIKGDNVLINT-YSGVLKISDFGTSKRLA--GINPCTETFTGTLQYMAP 192
Query: 315 EYVMTG--HLTSKSDVYSFGVVLLEMLTGR 342
           E +  G       +D++S G  ++EM TG+
Sbjct: 193 EIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 92/220 (41%), Gaps = 26/220 (11%)
Query: 126 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 185
            ++  AT   R    LG G FG V +  +E+  T       G   AVK +  +  +    
Sbjct: 71  EEVHWATHQLR----LGRGSFGEVHR--MEDKQT-------GFQCAVKKVRLEVFRAE-- 115
Query: 186 WLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 245
              E+     L  P +V L G   E     +  E +  GSL   L +    LP    +  
Sbjct: 116 ---ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLVKEQGCLPEDRALYY 171
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDAPEDG---KTHV 301
              A +GL +LH    + +++ D K  N+LL +D  +A L DFG A     DG       
Sbjct: 172 LGQALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLT 228
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
              + GT  + APE V+     +K DV+S   ++L ML G
Sbjct: 229 GDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 87/205 (42%), Gaps = 23/205 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  +  +D+  L +V E+ P G + +HL R    S P       +I L       +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+++D     K++DFG AK     G+T     + GT  Y APE 
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRT---WXLCGTPEYLAPEI 209
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTG 341
           +++       D ++ GV++ EM  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 27/215 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V         ++  +  TG  VA+K + +  D +   K  L E+  L +  H
Sbjct: 63  IGNGAYGVV---------SSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKH 113
Query: 199 PNLVKL-------VGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 251
            N++ +       V Y  E     +V + M   S  + +   S PL             +
Sbjct: 114 DNIIAIKDILRPTVPYG-EFKSVYVVLDLM--ESDLHQIIHSSQPLTLEHVRYFLYQLLR 170
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH--VSTRVMGTY 309
           GL ++H      VI+RD K SN+L++ +   K+ DFG+A+        H    T  + T 
Sbjct: 171 GLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 227
Query: 310 GYAAPEYVMTGH-LTSKSDVYSFGVVLLEMLTGRR 343
            Y APE +++ H  T   D++S G +  EML  R+
Sbjct: 228 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 88/205 (42%), Gaps = 23/205 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  +  +D+  L +V E+ P G + +HL R    S P       +I L       +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+++D     +++DFGLAK     G+T     + GT  Y APE 
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVK--GRT---WXLCGTPEYLAPEI 209
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTG 341
           +++       D ++ GV++ EM  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 88/211 (41%), Gaps = 17/211 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LVKL  +  +D+  L +V E++P G + +HL R         R   A        +LH  
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLHS- 159
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
               +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE +++
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIILS 212
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
                  D ++ GV++ EM  G      ++P
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 92/232 (39%), Gaps = 39/232 (16%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           +F   ++LG+G FG V K     N             A+K + H   +     L+EV  L
Sbjct: 7   DFEEIAVLGQGAFGQVVKA---RNAL------DSRYYAIKKIRHTE-EKLSTILSEVXLL 56
Query: 194 GNLLHPNLVKLVGYCIE-------------DDQRLLVYEFMPRGSLENHLFRRSLPLPWS 240
            +L H  +V+     +E                  +  E+    +L + +   +L     
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRD 116
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED---- 296
              ++     + L+++H +    +I+R+ K  NI +D   N K+ DFGLAK+        
Sbjct: 117 EYWRLFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 297 --------GKTHVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEML 339
                   G +   T  +GT  Y A E +  TGH   K D YS G++  E +
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 17/204 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLHP 199
           LGEG +  V+KG             T   VA+K +  +  +G     + EV+ L +L H 
Sbjct: 10  LGEGTYATVYKG---------KSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 60
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           N+V L      +    LV+E++ +  L+ +L      +             +GLA+ H +
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM- 318
               V++RD K  N+L++     KL+DFGLA+      KT+ +  V  T  Y  P+ ++ 
Sbjct: 120 K---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDILLG 174
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGR 342
           +   +++ D++  G +  EM TGR
Sbjct: 175 STDYSTQIDMWGVGCIFYEMATGR 198

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 29/211 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TG  VAVK L+     +   K    E+  L ++ H
Sbjct: 30  VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
            N++ L+          E +   LV   M  G+  N++ +        ++  I     +G
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLI-YQILRG 137
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L ++H      +I+RD K SN+ ++ D   K+ DF LA+   ++   +V+TR      Y 
Sbjct: 138 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYVATR-----WYR 189
Query: 313 APEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           APE ++   H     D++S G ++ E+LTGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 88/211 (41%), Gaps = 17/211 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LVKL  +  +D+  L +V E++P G + +HL R         R   A        +LH  
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLHS- 159
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
               +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE +++
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIILS 212
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
                  D ++ GV++ EM  G      ++P
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 88/211 (41%), Gaps = 17/211 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 103
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LVKL  +  +D+  L +V E++P G + +HL R         R   A        +LH  
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLHS- 160
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
               +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE +++
Sbjct: 161 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIILS 213
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
                  D ++ GV++ EM  G      ++P
Sbjct: 214 KGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 87/205 (42%), Gaps = 23/205 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E G             VK    +     K     VNF      P 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF------PF 103
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  +  +D+  L +V E+ P G + +HL R    S P       +I L       +L
Sbjct: 104 LVKL-EFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 158
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+L+D     K++DFG AK     G+T     + GT  Y APE 
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRT---WXLCGTPEYLAPEI 210
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTG 341
           +++       D ++ GV++ EM  G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 27/208 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAEVNFLGNL 196
           +GEG +G V+K           +   G T A+K +      +G+      + E++ L  L
Sbjct: 10  IGEGTYGVVYKA----------QNNYGETFALKKIRLEKEDEGIPSTT--IREISILKEL 57
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 256
            H N+VKL        + +LV+E + +  L+  L      L         L    G+A+ 
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTHVSTRVMGTYGYAAP 314
           H+   + V++RD K  N+L++ +   K++DFGLA+    P    TH       T  Y AP
Sbjct: 117 HD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV----TLWYRAP 169
Query: 315 EYVM-TGHLTSKSDVYSFGVVLLEMLTG 341
           + +M +   ++  D++S G +  EM+ G
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 27/208 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAEVNFLGNL 196
           +GEG +G V+K           +   G T A+K +      +G+      + E++ L  L
Sbjct: 10  IGEGTYGVVYKA----------QNNYGETFALKKIRLEKEDEGIPSTT--IREISILKEL 57
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 256
            H N+VKL        + +LV+E + +  L+  L      L         L    G+A+ 
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTHVSTRVMGTYGYAAP 314
           H+   + V++RD K  N+L++ +   K++DFGLA+    P    TH       T  Y AP
Sbjct: 117 HD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV----TLWYRAP 169
Query: 315 EYVM-TGHLTSKSDVYSFGVVLLEMLTG 341
           + +M +   ++  D++S G +  EM+ G
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 27/215 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V         ++  +  TG  VA+K + +  D +   K  L E+  L +  H
Sbjct: 62  IGNGAYGVV---------SSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKH 112
Query: 199 PNLVKL-------VGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 251
            N++ +       V Y  E     +V + M   S  + +   S PL             +
Sbjct: 113 DNIIAIKDILRPTVPYG-EFKSVYVVLDLM--ESDLHQIIHSSQPLTLEHVRYFLYQLLR 169
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH--VSTRVMGTY 309
           GL ++H      VI+RD K SN+L++ +   K+ DFG+A+        H    T  + T 
Sbjct: 170 GLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 226
Query: 310 GYAAPEYVMTGH-LTSKSDVYSFGVVLLEMLTGRR 343
            Y APE +++ H  T   D++S G +  EML  R+
Sbjct: 227 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 84/202 (41%), Gaps = 17/202 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LVKL  +  +D+  L +V E+ P G + +HL R         R   A        +LH  
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLHS- 159
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
               +IYRD K  N+++D     K++DFG AK     G+T     + GT  Y APE +++
Sbjct: 160 --LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIILS 212
Query: 320 GHLTSKSDVYSFGVVLLEMLTG 341
                  D ++ GV++ EM  G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 97/234 (41%), Gaps = 49/234 (20%)
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-----ENHLFRRSLPLPWSIRM 243
           E+  L  L HP ++K+  +  + +   +V E M  G L      N   + +    +  +M
Sbjct: 71  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 129
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTH 300
            +A+       +LHE     +I+RD K  N+LL   + D   K++DFG +K     G+T 
Sbjct: 130 LLAV------QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETS 177
Query: 301 VSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 357
           +   + GT  Y APE ++   T       D +S GV+L   L+G                
Sbjct: 178 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG---------------- 221
Query: 358 EWARPHLGDKRRFYRLLDPRLEGHFSI------KGSQKATQLAAQCLSRDPKAR 405
               P   + R    L D    G ++       + S+KA  L  + L  DPKAR
Sbjct: 222 ---YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 272

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 89/213 (41%), Gaps = 24/213 (11%)
Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFL 193
           F  +  LG G F  V             +  TG   AVK +    L+G +  +  E+  L
Sbjct: 24  FEFKETLGTGAFSEV---------VLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVL 74
Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP--WSIRMKIALGAAK 251
             + H N+V L       +   LV + +  G L + +  +        S  ++  L A  
Sbjct: 75  RKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDA-- 132
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            + +LH      +++RD K  N+L    D +    +SDFGL+K    +GK  V +   GT
Sbjct: 133 -VYYLHRMG---IVHRDLKPENLLYYSQDEESKIMISDFGLSK---MEGKGDVMSTACGT 185
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            GY APE +     +   D +S GV+   +L G
Sbjct: 186 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 99/241 (41%), Gaps = 49/241 (20%)
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-----ENHLFRRSLPLPWSIRM 243
           E+  L  L HP ++K+  +  + +   +V E M  G L      N   + +    +  +M
Sbjct: 64  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 122
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTH 300
            +A+       +LHE     +I+RD K  N+LL   + D   K++DFG +K     G+T 
Sbjct: 123 LLAV------QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETS 170
Query: 301 VSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 357
           +   + GT  Y APE ++   T       D +S GV+L   L+G                
Sbjct: 171 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG---------------- 214
Query: 358 EWARPHLGDKRRFYRLLDPRLEGHFSI------KGSQKATQLAAQCLSRDPKARPRMSEV 411
               P   + R    L D    G ++       + S+KA  L  + L  DPKAR    E 
Sbjct: 215 ---YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 271
Query: 412 V 412
           +
Sbjct: 272 L 272

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 97/234 (41%), Gaps = 49/234 (20%)
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-----ENHLFRRSLPLPWSIRM 243
           E+  L  L HP ++K+  +  + +   +V E M  G L      N   + +    +  +M
Sbjct: 65  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTH 300
            +A+       +LHE     +I+RD K  N+LL   + D   K++DFG +K     G+T 
Sbjct: 124 LLAV------QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETS 171
Query: 301 VSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 357
           +   + GT  Y APE ++   T       D +S GV+L   L+G                
Sbjct: 172 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG---------------- 215
Query: 358 EWARPHLGDKRRFYRLLDPRLEGHFSI------KGSQKATQLAAQCLSRDPKAR 405
               P   + R    L D    G ++       + S+KA  L  + L  DPKAR
Sbjct: 216 ---YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 266

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 99/242 (40%), Gaps = 49/242 (20%)
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-----ENHLFRRSLPLPWSIR 242
            E+  L  L HP ++K+  +  + +   +V E M  G L      N   + +    +  +
Sbjct: 189 TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 247
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKT 299
           M +A+       +LHE     +I+RD K  N+LL   + D   K++DFG +K     G+T
Sbjct: 248 MLLAV------QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GET 295
Query: 300 HVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 356
            +   + GT  Y APE ++   T       D +S GV+L   L+G               
Sbjct: 296 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG--------------- 340
Query: 357 VEWARPHLGDKRRFYRLLDPRLEGHFSI------KGSQKATQLAAQCLSRDPKARPRMSE 410
                P   + R    L D    G ++       + S+KA  L  + L  DPKAR    E
Sbjct: 341 ----YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE 396
Query: 411 VV 412
            +
Sbjct: 397 AL 398

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAEVNFLGNL 196
           +GEG +G V+K           +   G T A+K +      +G+      + E++ L  L
Sbjct: 10  IGEGTYGVVYKA----------QNNYGETFALKKIRLEKEDEGIPSTT--IREISILKEL 57
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 256
            H N+VKL        + +LV+E + +  L+  L      L         L    G+A+ 
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTHVSTRVMGTYGYAAP 314
           H+   + V++RD K  N+L++ +   K++DFGLA+    P    TH     + T  Y AP
Sbjct: 117 HD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH----EIVTLWYRAP 169
Query: 315 EYVM-TGHLTSKSDVYSFGVVLLEMLTG 341
           + +M +   ++  D++S G +  EM+ G
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 82/312 (26%), Positives = 134/312 (42%), Gaps = 49/312 (15%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-- 197
           +G+G +G V+ G W             G  VAVK            W  E      +L  
Sbjct: 45  IGKGRYGEVWMGKW------------RGEKVAVKVF---FTTEEASWFRETEIYQTVLMR 89
Query: 198 HPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 253
           H N++  +   I+      Q  L+ ++   GSL ++L  +S  L     +K+A  +  GL
Sbjct: 90  HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGL 147
Query: 254 AFLHEEA----EKPVI-YRDFKTSNILLDADYNAKLSDFGLA-KDAPEDGKTHV--STRV 305
             LH E      KP I +RD K+ NIL+  +    ++D GLA K   +  +  +  +TRV
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV 207
Query: 306 MGTYGYAAPEYVMTG----HLTS--KSDVYSFGVVLLEM----LTGRRSMDKNRPNGEHN 355
            GT  Y  PE +       H  S   +D+YSFG++L E+    ++G    +   P   H+
Sbjct: 208 -GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY--HD 264
Query: 356 LVEWARPHLGDKRRFYRL--LDPRLEGHFSIKGS-QKATQLAAQCLSRDPKARPRMSEVV 412
           LV  + P   D R    +  L P     +S     ++  +L  +C + +P +R     V 
Sbjct: 265 LVP-SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323
Query: 413 ETLKPLQNLKDM 424
           +TL  +   +D+
Sbjct: 324 KTLAKMSESQDI 335

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 97/234 (41%), Gaps = 49/234 (20%)
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-----ENHLFRRSLPLPWSIRM 243
           E+  L  L HP ++K+  +  + +   +V E M  G L      N   + +    +  +M
Sbjct: 65  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTH 300
            +A+       +LHE     +I+RD K  N+LL   + D   K++DFG +K     G+T 
Sbjct: 124 LLAV------QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETS 171
Query: 301 VSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 357
           +   + GT  Y APE ++   T       D +S GV+L   L+G                
Sbjct: 172 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG---------------- 215
Query: 358 EWARPHLGDKRRFYRLLDPRLEGHFSI------KGSQKATQLAAQCLSRDPKAR 405
               P   + R    L D    G ++       + S+KA  L  + L  DPKAR
Sbjct: 216 ---YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 266

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 97/234 (41%), Gaps = 49/234 (20%)
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-----ENHLFRRSLPLPWSIRM 243
           E+  L  L HP ++K+  +  + +   +V E M  G L      N   + +    +  +M
Sbjct: 65  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTH 300
            +A+       +LHE     +I+RD K  N+LL   + D   K++DFG +K     G+T 
Sbjct: 124 LLAV------QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETS 171
Query: 301 VSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 357
           +   + GT  Y APE ++   T       D +S GV+L   L+G                
Sbjct: 172 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG---------------- 215
Query: 358 EWARPHLGDKRRFYRLLDPRLEGHFSI------KGSQKATQLAAQCLSRDPKAR 405
               P   + R    L D    G ++       + S+KA  L  + L  DPKAR
Sbjct: 216 ---YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 266

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 76/181 (41%), Gaps = 28/181 (15%)
Query: 202 VKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP------WSIRMKIALGAAKGLA 254
           +  + Y  +DD  L LV ++   G L   L +    LP      +   M IA+ +   L 
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           ++H         RD K  NIL+D + + +L+DFG      EDG    S  V GT  Y +P
Sbjct: 196 YVH---------RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISP 245
Query: 315 EYVMT-----GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
           E +       G    + D +S GV + EML G        P    +LVE     +  K R
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE------TPFYAESLVETYGKIMNHKER 299
Query: 370 F 370
           F
Sbjct: 300 F 300

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 87/210 (41%), Gaps = 29/210 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G G F  V+KG ++   T  V       +  + L     Q  KE   E   L  L HPN
Sbjct: 34  IGRGSFKTVYKG-LDTETTVEV---AWCELQDRKLTKSERQRFKE---EAEXLKGLQHPN 86
Query: 201 LVKLVGY---------CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 251
           +V+             CI     +LV E    G+L+ +L R  +     +R        K
Sbjct: 87  IVRFYDSWESTVKGKKCI-----VLVTELXTSGTLKTYLKRFKVXKIKVLR-SWCRQILK 140
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
           GL FLH     P+I+RD K  NI +     + K+ D GLA       +   +  V+GT  
Sbjct: 141 GLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPE 195
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           + APE     +  S  DVY+FG   LE  T
Sbjct: 196 FXAPEXYEEKYDES-VDVYAFGXCXLEXAT 224

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 23/210 (10%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +LG+G +G V+ G    N          + +A+K +     +  +    E+    +L H 
Sbjct: 15  VLGKGTYGIVYAGRDLSNQ---------VRIAIKEIPERDSRYSQPLHEEIALHKHLKHK 65
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK---GLAFL 256
           N+V+ +G   E+    +  E +P GSL   L  +  PL  +    I     +   GL +L
Sbjct: 66  NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN-EQTIGFYTKQILEGLKYL 124
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNA--KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           H+     +++RD K  N+L++  Y+   K+SDFG +K     G    +    GT  Y AP
Sbjct: 125 HDNQ---IVHRDIKGDNVLINT-YSGVLKISDFGTSKRLA--GINPCTETFTGTLQYMAP 178
Query: 315 EYVMTG--HLTSKSDVYSFGVVLLEMLTGR 342
           E +  G       +D++S G  ++EM TG+
Sbjct: 179 EIIDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 99/242 (40%), Gaps = 49/242 (20%)
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-----ENHLFRRSLPLPWSIR 242
            E+  L  L HP ++K+  +  + +   +V E M  G L      N   + +    +  +
Sbjct: 203 TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 261
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKT 299
           M +A+       +LHE     +I+RD K  N+LL   + D   K++DFG +K     G+T
Sbjct: 262 MLLAV------QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GET 309
Query: 300 HVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 356
            +   + GT  Y APE ++   T       D +S GV+L   L+G               
Sbjct: 310 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG--------------- 354
Query: 357 VEWARPHLGDKRRFYRLLDPRLEGHFSI------KGSQKATQLAAQCLSRDPKARPRMSE 410
                P   + R    L D    G ++       + S+KA  L  + L  DPKAR    E
Sbjct: 355 ----YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE 410
Query: 411 VV 412
            +
Sbjct: 411 AL 412

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 87/205 (42%), Gaps = 23/205 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  +  +D+  L +V E+ P G + +HL R    S P       +I L       +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+++D     +++DFG AK     G+T     + GT  Y APE 
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEI 209
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTG 341
           +++       D ++ GV++ EM  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 92/214 (42%), Gaps = 23/214 (10%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  +  +D+  L +V E++  G + +HL R    S P       +I L       +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEI 209
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +++       D ++ GV++ EM  G      ++P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 89/205 (43%), Gaps = 23/205 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  +  +D+  L +V E++  G + +HL R    S P       +I L       +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLXGTPEYLAPEI 209
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTG 341
           +++       D ++ GV++ EM  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 118/302 (39%), Gaps = 44/302 (14%)
Query: 124 MFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH 183
           M +D  L    +    ++G+G F  V +    E G    +    +    K  +  GL   
Sbjct: 15  MADDDVLFEDVYELCEVIGKGAFSVVRRCINRETGQ---QFAVKIVDVAKFTSSPGLST- 70
Query: 184 KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWS 240
           ++   E +    L HP++V+L+     D    +V+EFM    L   + +R+        +
Sbjct: 71  EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA 130
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA---KLSDFGLAKDAPEDG 297
           +         + L + H+     +I+RD K  N+LL +  N+   KL DFG+A    E G
Sbjct: 131 VASHYMRQILEALRYCHDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESG 187
Query: 298 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 357
              V+   +GT  + APE V         DV+  GV+L  +L+G                
Sbjct: 188 L--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG---------------- 229
Query: 358 EWARPHLGDKRRFYR-------LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 410
               P  G K R +         ++PR   H     S+ A  L  + L  DP  R  + E
Sbjct: 230 --CLPFYGTKERLFEGIIKGKYKMNPRQWSHI----SESAKDLVRRMLMLDPAERITVYE 283
Query: 411 VV 412
            +
Sbjct: 284 AL 285

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 89/205 (43%), Gaps = 23/205 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  +  +D+  L +V E++  G + +HL R    S P       +I L       +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLAGTPEYLAPEI 209
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTG 341
           +++       D ++ GV++ EM  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 89/205 (43%), Gaps = 23/205 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  +  +D+  L +V E++  G + +HL R    S P       +I L       +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEI 209
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTG 341
           +++       D ++ GV++ EM  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 89/205 (43%), Gaps = 23/205 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 50  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 103
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  +  +D+  L +V E++  G + +HL R    S P       +I L       +L
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 158
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE 
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEI 210
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTG 341
           +++       D ++ GV++ EM  G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 89/205 (43%), Gaps = 23/205 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  +  +D+  L +V E++  G + +HL R    S P       +I L       +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEI 209
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTG 341
           +++       D ++ GV++ EM  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 89/205 (43%), Gaps = 23/205 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  +  +D+  L +V E++  G + +HL R    S P       +I L       +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEI 209
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTG 341
           +++       D ++ GV++ EM  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 66/302 (21%), Positives = 121/302 (40%), Gaps = 44/302 (14%)
Query: 125 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK 184
           F  + +  R +     +G GG   VF+   E+     +K      V ++  ++  L  ++
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYR 74
Query: 185 EWLAEVNFLGNLLHPN-LVKLVGYCIEDDQRLLVYEFMPRGSLE-NHLFRRSLPL-PWSI 241
             +A +N L    H + +++L  Y I D     +Y  M  G+++ N   ++   + PW  
Sbjct: 75  NEIAYLNKLQQ--HSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE- 128
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           R        + +  +H+     +++ D K +N L+  D   KL DFG+A     D  + V
Sbjct: 129 RKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVV 184
Query: 302 STRVMGTYGYAAPEYV-----------MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
               +GT  Y  PE +               ++ KSDV+S G +L  M  G+    +   
Sbjct: 185 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-- 242
Query: 351 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 410
                        +    + + ++DP  E  F     +    +   CL RDPK R  + E
Sbjct: 243 -------------INQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPE 289
Query: 411 VV 412
           ++
Sbjct: 290 LL 291

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 86/205 (41%), Gaps = 23/205 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 103
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           L KL  +  +D+  L +V E+ P G + +HL R    S P       +I L       +L
Sbjct: 104 LTKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 158
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+++D     K++DFG AK     G+T     + GT  Y APE 
Sbjct: 159 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRT---WXLCGTPEYLAPEI 210
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTG 341
           +++       D ++ GV++ EM  G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 89/205 (43%), Gaps = 23/205 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  +  +D+  L +V E++  G + +HL R    S P       +I L       +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEI 209
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTG 341
           +++       D ++ GV++ EM  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 92/214 (42%), Gaps = 23/214 (10%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 36  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 89
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  +  +D+  L +V E++  G + +HL R    S P       +I L       +L
Sbjct: 90  LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 144
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE 
Sbjct: 145 HS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEI 196
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +++       D ++ GV++ EM  G      ++P
Sbjct: 197 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 230

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 86/205 (41%), Gaps = 23/205 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 103
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           L KL  +  +D+  L +V E+ P G + +HL R    S P       +I L       +L
Sbjct: 104 LTKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 158
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+++D     K++DFG AK     G+T     + GT  Y APE 
Sbjct: 159 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRT---WXLCGTPEYLAPEI 210
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTG 341
           +++       D ++ GV++ EM  G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 100/239 (41%), Gaps = 35/239 (14%)
Query: 198 HPNLVKLVGYCIED----DQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAA 250
           HPN+++LV YC+ +     +  L+  F  RG+L N + R   +   L     + + LG  
Sbjct: 85  HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGIC 144
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP---EDGKTHVSTRVMG 307
           +GL  +H    K   +RD K +NILL  +    L D G    A    E  +  ++ +   
Sbjct: 145 RGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWA 201
Query: 308 ----TYGYAAPE-YVMTGH--LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 360
               T  Y APE + +  H  +  ++DV+S G VL  M+ G    D     G+   +   
Sbjct: 202 AQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA-- 259
Query: 361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ 419
                        +  +L    S + S    QL    ++ DP  RP +  ++  L+ LQ
Sbjct: 260 -------------VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 6/90 (6%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            APE ++        D++S GV++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 6/90 (6%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            APE ++        D++S GV++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 79/180 (43%), Gaps = 13/180 (7%)
Query: 166 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGS 225
           TG   AVK +  +  +     + E+     L  P +V L G   E     +  E +  GS
Sbjct: 82  TGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136
Query: 226 LENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN-AKL 284
           L   L ++   LP    +     A +GL +LH    + +++ D K  N+LL +D + A L
Sbjct: 137 L-GQLIKQMGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAAL 192
Query: 285 SDFGLAKDAPEDG---KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            DFG A     DG          + GT  + APE VM     +K D++S   ++L ML G
Sbjct: 193 CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 86/202 (42%), Gaps = 17/202 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LVKL  +  +D+  L +V E++  G + +HL R         R   A        +LH  
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLHS- 159
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
               +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE +++
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIILS 212
Query: 320 GHLTSKSDVYSFGVVLLEMLTG 341
                  D ++ GV++ EM  G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 86/202 (42%), Gaps = 17/202 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 44  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 97
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LVKL  +  +D+  L +V E++  G + +HL R         R   A        +LH  
Sbjct: 98  LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLHS- 154
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
               +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE +++
Sbjct: 155 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIILS 207
Query: 320 GHLTSKSDVYSFGVVLLEMLTG 341
                  D ++ GV++ EM  G
Sbjct: 208 KGYNKAVDWWALGVLIYEMAAG 229

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 89/211 (42%), Gaps = 17/211 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 123
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LVKL  +  +D+  L +V E++  G + +HL R         R   A        +LH  
Sbjct: 124 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLHS- 180
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
               +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE +++
Sbjct: 181 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIILS 233
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
                  D ++ GV++ EM  G      ++P
Sbjct: 234 KGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 79/180 (43%), Gaps = 13/180 (7%)
Query: 166 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGS 225
           TG   AVK +  +  +     + E+     L  P +V L G   E     +  E +  GS
Sbjct: 96  TGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 150
Query: 226 LENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN-AKL 284
           L   L ++   LP    +     A +GL +LH    + +++ D K  N+LL +D + A L
Sbjct: 151 L-GQLIKQMGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAAL 206
Query: 285 SDFGLAKDAPEDG---KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            DFG A     DG          + GT  + APE VM     +K D++S   ++L ML G
Sbjct: 207 CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 57/109 (52%), Gaps = 13/109 (11%)
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL--AKDAPEDGK 298
           + + I +  A+ + FLH    K +++RD K SNI    D   K+ DFGL  A D  E+ +
Sbjct: 165 VCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 221
Query: 299 THVSTR--------VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 339
           T ++           +GT  Y +PE +   + + K D++S G++L E+L
Sbjct: 222 TVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 86/202 (42%), Gaps = 17/202 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LVKL  +  +D+  L +V E++  G + +HL R         R   A        +LH  
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLHS- 159
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
               +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE +++
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIILS 212
Query: 320 GHLTSKSDVYSFGVVLLEMLTG 341
                  D ++ GV++ EM  G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 23/205 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  +  +D+  L +V E++  G + +HL R    S P       +I L       +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+++D     +++DFG AK     G+T     + GT  Y APE 
Sbjct: 158 HS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEI 209
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTG 341
           +++       D ++ GV++ EM  G
Sbjct: 210 IISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 128 LKLATRNFRPESL------LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ 181
           + L T N   +S+      LG+G F  V +          VK   G   A K +N   L 
Sbjct: 11  VDLGTENLYFQSMYQLFEELGKGAFSVVRRC---------VKVLAGQEYAAKIINTKKLS 61
Query: 182 G--HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 239
              H++   E      L HPN+V+L     E+    L+++ +  G L   +  R     +
Sbjct: 62  ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE----Y 117
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN---AKLSDFGLAKDAPED 296
                 +    + L  +    +  V++RD K  N+LL +       KL+DFGLA +   +
Sbjct: 118 YSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEV--E 175
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           G+        GT GY +PE +         D+++ GV+L  +L G
Sbjct: 176 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 220

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 86/202 (42%), Gaps = 17/202 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LVKL  +  +D+  L +V E++  G + +HL R         R   A        +LH  
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLHS- 159
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
               +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE +++
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIILS 212
Query: 320 GHLTSKSDVYSFGVVLLEMLTG 341
                  D ++ GV++ EM  G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 83/202 (41%), Gaps = 17/202 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 103
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           L KL  +  +D+  L +V E+ P G + +HL R         R   A        +LH  
Sbjct: 104 LTKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLHS- 160
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
               +IYRD K  N+++D     K++DFG AK     G+T     + GT  Y APE +++
Sbjct: 161 --LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIILS 213
Query: 320 GHLTSKSDVYSFGVVLLEMLTG 341
                  D ++ GV++ EM  G
Sbjct: 214 KGYNKAVDWWALGVLIYEMAAG 235

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 91/214 (42%), Gaps = 23/214 (10%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 123
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  +  +D+  L +V E++  G + +HL R    S P       +I L       +L
Sbjct: 124 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 178
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+L+D     +++DFG AK     G T     + GT  Y APE 
Sbjct: 179 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GATWT---LCGTPEYLAPEI 230
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +++       D ++ GV++ EM  G      ++P
Sbjct: 231 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 86/202 (42%), Gaps = 17/202 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LVKL  +  +D+  L +V E++  G + +HL R         R   A        +LH  
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARF-YAAQIVLTFEYLHS- 159
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
               +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE +++
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIILS 212
Query: 320 GHLTSKSDVYSFGVVLLEMLTG 341
                  D ++ GV++ EM  G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 79/180 (43%), Gaps = 13/180 (7%)
Query: 166 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGS 225
           TG   AVK +  +  +     + E+     L  P +V L G   E     +  E +  GS
Sbjct: 98  TGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 152
Query: 226 LENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN-AKL 284
           L   L ++   LP    +     A +GL +LH    + +++ D K  N+LL +D + A L
Sbjct: 153 L-GQLIKQMGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAAL 208
Query: 285 SDFGLAKDAPEDG---KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            DFG A     DG          + GT  + APE VM     +K D++S   ++L ML G
Sbjct: 209 CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/302 (21%), Positives = 120/302 (39%), Gaps = 44/302 (14%)
Query: 125 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK 184
           F  + +  R +     +G GG   VF+   E+     +K      V ++  ++  L  ++
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYR 74
Query: 185 EWLAEVNFLGNLLHPN-LVKLVGYCIEDDQRLLVYEFMPRGSLE-NHLFRRSLPL-PWSI 241
             +A +N L    H + +++L  Y I D     +Y  M  G+++ N   ++   + PW  
Sbjct: 75  NEIAYLNKLQQ--HSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE- 128
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           R        + +  +H+     +++ D K +N L+  D   KL DFG+A     D    V
Sbjct: 129 RKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVV 184
Query: 302 STRVMGTYGYAAPEYV-----------MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
               +GT  Y  PE +               ++ KSDV+S G +L  M  G+    +   
Sbjct: 185 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-- 242
Query: 351 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 410
                        +    + + ++DP  E  F     +    +   CL RDPK R  + E
Sbjct: 243 -------------INQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPE 289
Query: 411 VV 412
           ++
Sbjct: 290 LL 291

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/286 (22%), Positives = 116/286 (40%), Gaps = 44/286 (15%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G GG   VF+   E+     +K      V ++  ++  L  ++  +A +N L    H +
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYRNEIAYLNKLQQ--HSD 116
Query: 201 -LVKLVGYCIEDDQRLLVYEFMPRGSLE-NHLFRRSLPL-PWSIRMKIALGAAKGLAFLH 257
            +++L  Y I D     +Y  M  G+++ N   ++   + PW  R        + +  +H
Sbjct: 117 KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIH 172
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
           +     +++ D K +N L+  D   KL DFG+A     D  + V    +GT  Y  PE +
Sbjct: 173 QHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 228
Query: 318 -----------MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
                          ++ KSDV+S G +L  M  G+    +                +  
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI---------------INQ 273
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
             + + ++DP  E  F     +    +   CL RDPK R  + E++
Sbjct: 274 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 37/230 (16%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL 187
           +   R+      +G+G +G V++G W  EN            VAVK  +    +  K W 
Sbjct: 4   RTVARDITLLECVGKGRYGEVWRGSWQGEN------------VAVKIFSS---RDEKSWF 48
Query: 188 AEVNFLGNLL--HPNLVKLVGYCI----EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI 241
            E      ++  H N++  +   +       Q  L+  +   GSL ++L   +L     +
Sbjct: 49  RETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCL 108
Query: 242 RMKIALGAAKGLAFLHEEA----EKPVI-YRDFKTSNILLDADYNAKLSDFGLA-KDAPE 295
           R  I L  A GLA LH E      KP I +RD K+ NIL+  +    ++D GLA   +  
Sbjct: 109 R--IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQS 166
Query: 296 DGKTHVSTR-VMGTYGYAAPEY----VMTGHLTS--KSDVYSFGVVLLEM 338
             +  V     +GT  Y APE     +      S  + D+++FG+VL E+
Sbjct: 167 TNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 23/205 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  +  +D+  L +V E++  G + +HL R    S P       +I L       +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEI 209
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTG 341
           +++       D ++ GV++ +M  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 98/230 (42%), Gaps = 37/230 (16%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL 187
           +   R       +G+G +G V++G W  EN            VAVK  +    +  K W 
Sbjct: 33  RTVARQITLLECVGKGRYGEVWRGSWQGEN------------VAVKIFSS---RDEKSWF 77
Query: 188 AEVNFLGNLL--HPNLVKLVGYCI----EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI 241
            E      ++  H N++  +   +       Q  L+  +   GSL ++L   +L     +
Sbjct: 78  RETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCL 137
Query: 242 RMKIALGAAKGLAFLHEEA----EKPVI-YRDFKTSNILLDADYNAKLSDFGLA-KDAPE 295
           R  I L  A GLA LH E      KP I +RD K+ NIL+  +    ++D GLA   +  
Sbjct: 138 R--IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQS 195
Query: 296 DGKTHVSTR-VMGTYGYAAPEY----VMTGHLTS--KSDVYSFGVVLLEM 338
             +  V     +GT  Y APE     +      S  + D+++FG+VL E+
Sbjct: 196 TNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 87/205 (42%), Gaps = 23/205 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  +  +D+  L +V E++  G + +HL R    S P       +I L       +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEI 209
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTG 341
           +++       D ++ GV++ EM  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/286 (22%), Positives = 116/286 (40%), Gaps = 44/286 (15%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G GG   VF+   E+     +K      V ++  ++  L  ++  +A +N L    H +
Sbjct: 20  IGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYRNEIAYLNKLQQ--HSD 72
Query: 201 -LVKLVGYCIEDDQRLLVYEFMPRGSLE-NHLFRRSLPL-PWSIRMKIALGAAKGLAFLH 257
            +++L  Y I D     +Y  M  G+++ N   ++   + PW  R        + +  +H
Sbjct: 73  KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIH 128
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
           +     +++ D K +N L+  D   KL DFG+A     D  + V    +GT  Y  PE +
Sbjct: 129 QHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 184
Query: 318 -----------MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
                          ++ KSDV+S G +L  M  G+    +                +  
Sbjct: 185 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ---------------IINQ 229
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
             + + ++DP  E  F     +    +   CL RDPK R  + E++
Sbjct: 230 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 275

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            APE ++        D++S G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 192
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            APE ++        D++S G ++ EM+ G
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            APE ++        D++S G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 40/218 (18%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG VF+  + E+            VA+K +    LQ  +    E+  +  + HP
Sbjct: 47  VIGNGSFGVVFQAKLVESD----------EVAIKKV----LQDKRFKNRELQIMRIVKHP 92
Query: 200 NLVKLVGYCIEDDQRL------LVYEFMP----RGSLENHLFRRSLPLPWSIRMKIAL-G 248
           N+V L  +   +  +       LV E++P    R S      ++++P+   + +K+ +  
Sbjct: 93  NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPM---LLIKLYMYQ 149
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAK--DAPEDGKTHVSTRV 305
             + LA++H      + +RD K  N+LLD      KL DFG AK   A E   + + +R 
Sbjct: 150 LLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY 206
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
                Y APE +    + T+  D++S G V+ E++ G+
Sbjct: 207 -----YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/286 (22%), Positives = 116/286 (40%), Gaps = 44/286 (15%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G GG   VF+   E+     +K      V ++  ++  L  ++  +A +N L    H +
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYRNEIAYLNKLQQ--HSD 116
Query: 201 -LVKLVGYCIEDDQRLLVYEFMPRGSLE-NHLFRRSLPL-PWSIRMKIALGAAKGLAFLH 257
            +++L  Y I D     +Y  M  G+++ N   ++   + PW  R        + +  +H
Sbjct: 117 KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIH 172
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
           +     +++ D K +N L+  D   KL DFG+A     D  + V    +GT  Y  PE +
Sbjct: 173 QHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 228
Query: 318 -----------MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
                          ++ KSDV+S G +L  M  G+    +                +  
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI---------------INQ 273
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
             + + ++DP  E  F     +    +   CL RDPK R  + E++
Sbjct: 274 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            APE ++        D++S G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 71/296 (23%), Positives = 113/296 (38%), Gaps = 62/296 (20%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
            +R   LLG+GGFG VF G      T  ++    +    + L    L        EV  L
Sbjct: 32  EYRLGPLLGKGGFGTVFAG---HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALL 88
Query: 194 GNLL----HPNLVKLVGYCIEDDQRLLVYEF-MPRGSLENHLFRRSLPLPWSIRMKIALG 248
             +     HP +++L+ +    +  +LV E  +P   L ++           I  K  LG
Sbjct: 89  WKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDY-----------ITEKGPLG 137
Query: 249 AAKGLAFLHEEA-------EKPVIYRDFKTSNILLDADYN-AKLSDFG---LAKDAPEDG 297
                 F  +          + V++RD K  NIL+D     AKL DFG   L  D P   
Sbjct: 138 EGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP--- 194
Query: 298 KTHVSTRVMGTYGYAAPEYVMTGHLTS-KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 356
                T   GT  Y+ PE++      +  + V+S G++L +M+ G    ++++   E  L
Sbjct: 195 ----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAEL 250
Query: 357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
                                   HF    S     L  +CL+  P +RP + E++
Sbjct: 251 ------------------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEIL 282

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/286 (22%), Positives = 116/286 (40%), Gaps = 44/286 (15%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G GG   VF+   E+     +K      V ++  ++  L  ++  +A +N L    H +
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYRNEIAYLNKLQQ--HSD 69
Query: 201 -LVKLVGYCIEDDQRLLVYEFMPRGSLE-NHLFRRSLPL-PWSIRMKIALGAAKGLAFLH 257
            +++L  Y I D     +Y  M  G+++ N   ++   + PW  R        + +  +H
Sbjct: 70  KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIH 125
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
           +     +++ D K +N L+  D   KL DFG+A     D  + V    +GT  Y  PE +
Sbjct: 126 QHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 318 -----------MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
                          ++ KSDV+S G +L  M  G+    +                +  
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI---------------INQ 226
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
             + + ++DP  E  F     +    +   CL RDPK R  + E++
Sbjct: 227 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 272

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            APE ++        D++S G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPEVVTRYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            APE ++        D++S G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            APE ++        D++S G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/286 (22%), Positives = 116/286 (40%), Gaps = 44/286 (15%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G GG   VF+   E+     +K      V ++  ++  L  ++  +A +N L    H +
Sbjct: 16  IGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYRNEIAYLNKLQQ--HSD 68
Query: 201 -LVKLVGYCIEDDQRLLVYEFMPRGSLE-NHLFRRSLPL-PWSIRMKIALGAAKGLAFLH 257
            +++L  Y I D     +Y  M  G+++ N   ++   + PW  R        + +  +H
Sbjct: 69  KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIH 124
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
           +     +++ D K +N L+  D   KL DFG+A     D  + V    +GT  Y  PE +
Sbjct: 125 QHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 180
Query: 318 -----------MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
                          ++ KSDV+S G +L  M  G+    +                +  
Sbjct: 181 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI---------------INQ 225
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
             + + ++DP  E  F     +    +   CL RDPK R  + E++
Sbjct: 226 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 271

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 37/218 (16%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-- 197
           +G+G +G V++G W  EN            VAVK  +    +  K W  E      ++  
Sbjct: 16  VGKGRYGEVWRGSWQGEN------------VAVKIFSS---RDEKSWFRETELYNTVMLR 60
Query: 198 HPNLVKLVGYCI----EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 253
           H N++  +   +       Q  L+  +   GSL ++L   +L     +R  I L  A GL
Sbjct: 61  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLR--IVLSIASGL 118
Query: 254 AFLHEEA----EKPVI-YRDFKTSNILLDADYNAKLSDFGLA-KDAPEDGKTHVSTR-VM 306
           A LH E      KP I +RD K+ NIL+  +    ++D GLA   +    +  V     +
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 307 GTYGYAAPEY------VMTGHLTSKSDVYSFGVVLLEM 338
           GT  Y APE       V       + D+++FG+VL E+
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            APE ++        D++S G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 118/294 (40%), Gaps = 52/294 (17%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG+G F  +FKG   E G       T   V +K L+       + +    + +  L H +
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHET--EVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           LV   G C+  D+ +LV EF+  GSL+ +L +    +    ++++A   A  + FL E  
Sbjct: 74  LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT 133
Query: 261 EKPVIYRDFKTSNILLDADYN--------AKLSDFGLAKDA-PEDGKTHVSTRVMGTYGY 311
              +I+ +    NILL  + +         KLSD G++    P+D    +  R+     +
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI---LQERI----PW 183
Query: 312 AAPEYVMT-GHLTSKSDVYSFGVVLLEMLTG----RRSMDKNRPNGEHNLVEWARPHLGD 366
             PE +    +L   +D +SFG  L E+ +G      ++D  R                 
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR----------------- 226
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKA--TQLAAQCLSRDPKARPRMSEVVETLKPL 418
           K +FY       E    +   + A    L   C+  +P  RP    ++  L  L
Sbjct: 227 KLQFY-------EDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK------EWLAEVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +      E   EV+ L 
Sbjct: 20  LGSGQFAIVKKCR---------EKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
            +LHPN++ L          +L+ E +  G L + L ++   L              G+ 
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVN 129
Query: 255 FLHEEAEKPVIYRDFKTSNI-LLDADY---NAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
           +LH    K + + D K  NI LLD +    + KL DFGLA +  EDG       + GT  
Sbjct: 130 YLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEF--KNIFGTPE 183
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           + APE V    L  ++D++S GV+   +L+G
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 88/205 (42%), Gaps = 23/205 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  +  +D+  L +V E++  G + +HL R    S P       +I L       +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y AP  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPAI 209
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTG 341
           +++       D ++ GV++ EM  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 92/221 (41%), Gaps = 28/221 (12%)
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 257
           HPN+VKL     +     LV E +  G L   + ++      +    I       ++ +H
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERI-KKKKHFSETEASYIMRKLVSAVSHMH 123
Query: 258 EEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           +     V++RD K  N+L    + +   K+ DFG A+  P D +  + T    T  YAAP
Sbjct: 124 DVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTPCF-TLHYAAP 178
Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL 374
           E +         D++S GV+L  ML+G+       P   H+        +   ++  +  
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLSGQ------VPFQSHDRSLTCTSAVEIMKKIKK-- 230
Query: 375 DPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMS 409
                G FS +G      SQ+A  L    L+ DP  R +MS
Sbjct: 231 -----GDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMS 266

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + +    + T  Y
Sbjct: 140 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMVPFVVTRYY 193
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            APE ++        D++S G ++ EM+ G
Sbjct: 194 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 355
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 356 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 406
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 310
Query: 407 RMSEVVE 413
            + + ++
Sbjct: 311 SVDDALQ 317

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 176 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 229
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 355
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289
Query: 356 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 406
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 348
Query: 407 RMSEVVE 413
            + + ++
Sbjct: 349 SVDDALQ 355

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 176 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 229
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 355
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289
Query: 356 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 406
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 348
Query: 407 RMSEVVE 413
            + + ++
Sbjct: 349 SVDDALQ 355

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 192
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 355
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 252
Query: 356 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 406
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 253 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 311
Query: 407 RMSEVVE 413
            + + ++
Sbjct: 312 SVDDALQ 318

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 355
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 356 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 406
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 310
Query: 407 RMSEVVE 413
            + + ++
Sbjct: 311 SVDDALQ 317

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 137 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 190
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 355
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 191 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 250
Query: 356 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 406
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 251 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 309
Query: 407 RMSEVVE 413
            + + ++
Sbjct: 310 SVDDALQ 316

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 355
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 356 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 406
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 310
Query: 407 RMSEVVE 413
            + + ++
Sbjct: 311 SVDDALQ 317

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYY 184
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 355
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 356 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 406
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 303
Query: 407 RMSEVVE 413
            + + ++
Sbjct: 304 SVDDALQ 310

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 184
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 355
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 356 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 406
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 303
Query: 407 RMSEVVE 413
            + + ++
Sbjct: 304 SVDDALQ 310

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 192
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 355
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 252
Query: 356 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 406
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 253 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 311
Query: 407 RMSEVVE 413
            + + ++
Sbjct: 312 SVDDALQ 318

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 132 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 185
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 355
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 245
Query: 356 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 406
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 246 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 304
Query: 407 RMSEVVE 413
            + + ++
Sbjct: 305 SVDDALQ 311

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 355
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 356 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 406
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 310
Query: 407 RMSEVVE 413
            + + ++
Sbjct: 311 SVDDALQ 317

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 132 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 185
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 355
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 245
Query: 356 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 406
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 246 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 304
Query: 407 RMSEVVE 413
            + + ++
Sbjct: 305 SVDDALQ 311

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 86/206 (41%), Gaps = 20/206 (9%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 198
           LG+G F  V +          +K  TG   A K +N   L    H++   E      L H
Sbjct: 12  LGKGAFSVVRRC---------MKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 258
           PN+V+L     E+    LV++ +  G L   +  R     +      +    + L  ++ 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE----YYSEADASHCIQQILESVNH 118
Query: 259 EAEKPVIYRDFKTSNILLDADYN---AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
                +++RD K  N+LL +       KL+DFGLA +   D +        GT GY +PE
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLSPE 176
Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTG 341
            +         D+++ GV+L  +L G
Sbjct: 177 VLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 355
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 356 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 406
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 310
Query: 407 RMSEVVE 413
            + + ++
Sbjct: 311 SVDDALQ 317

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 355
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 356 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 406
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 310
Query: 407 RMSEVVE 413
            + + ++
Sbjct: 311 SVDDALQ 317

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 76/178 (42%), Gaps = 20/178 (11%)
Query: 123 FMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG 182
           F+   ++L     R   +L EGGF  V++             G+G   A+K L  +  + 
Sbjct: 18  FVGQTVELGELRLRVRRVLAEGGFAFVYEAQ---------DVGSGREYALKRLLSNEEEK 68
Query: 183 HKEWLAEVNFLGNLL-HPNLVKLVGYCI----EDDQ---RLLVYEFMPRGSLENHLFRRS 234
           ++  + EV F+  L  HPN+V+          E D      L+   + +G L   L +  
Sbjct: 69  NRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKME 128
Query: 235 L--PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA 290
              PL     +KI     + +  +H + + P+I+RD K  N+LL      KL DFG A
Sbjct: 129 SRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 79/159 (49%), Gaps = 12/159 (7%)
Query: 189 EVNFLGNLLHPNLVKLVGYCIE--DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
           E+  L  L HPN+VKLV    +  +D   +V+E + +G +      +  PL         
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK--PLSEDQARFYF 143
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
               KG+ +LH +    +I+RD K SN+L+  D + K++DFG++ +    G   + +  +
Sbjct: 144 QDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEF--KGSDALLSNTV 198
Query: 307 GTYGYAAPEYVMTGH--LTSKS-DVYSFGVVLLEMLTGR 342
           GT  + APE +       + K+ DV++ GV L   + G+
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 104/250 (41%), Gaps = 41/250 (16%)
Query: 109 KFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVK-PGTG 167
           +F E  K  +QL K    +++L   +F    ++G G FG V          A VK   T 
Sbjct: 70  EFLEWAKPFTQLVK----EMQLHREDFEIIKVIGRGAFGEV----------AVVKMKNTE 115
Query: 168 LTVAVKTLNHDGLQGHKE---WLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPR 223
              A+K LN   +    E   +  E + L N      +  + Y  +D+  L LV ++   
Sbjct: 116 RIYAMKILNKWEMLKRAETACFREERDVLVNG-DCQWITALHYAFQDENHLYLVMDYYVG 174
Query: 224 GSLENHLFRRSLPLPWSI------RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD 277
           G L   L +    LP  +       M +A+ +   L ++H         RD K  N+LLD
Sbjct: 175 GDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVH---------RDIKPDNVLLD 225
Query: 278 ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-----GHLTSKSDVYSFG 332
            + + +L+DFG      +DG    S  V GT  Y +PE +       G    + D +S G
Sbjct: 226 VNGHIRLADFGSCLKMNDDGTVQSSVAV-GTPDYISPEILQAMEDGMGKYGPECDWWSLG 284
Query: 333 VVLLEMLTGR 342
           V + EML G 
Sbjct: 285 VCMYEMLYGE 294

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 104/250 (41%), Gaps = 41/250 (16%)
Query: 109 KFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVK-PGTG 167
           +F E  K  +QL K    +++L   +F    ++G G FG V          A VK   T 
Sbjct: 54  EFLEWAKPFTQLVK----EMQLHREDFEIIKVIGRGAFGEV----------AVVKMKNTE 99
Query: 168 LTVAVKTLNHDGLQGHKE---WLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPR 223
              A+K LN   +    E   +  E + L N      +  + Y  +D+  L LV ++   
Sbjct: 100 RIYAMKILNKWEMLKRAETACFREERDVLVNG-DCQWITALHYAFQDENHLYLVMDYYVG 158
Query: 224 GSLENHLFRRSLPLPWSI------RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD 277
           G L   L +    LP  +       M +A+ +   L ++H         RD K  N+LLD
Sbjct: 159 GDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVH---------RDIKPDNVLLD 209
Query: 278 ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-----GHLTSKSDVYSFG 332
            + + +L+DFG      +DG    S  V GT  Y +PE +       G    + D +S G
Sbjct: 210 VNGHIRLADFGSCLKMNDDGTVQSSVAV-GTPDYISPEILQAMEDGMGKYGPECDWWSLG 268
Query: 333 VVLLEMLTGR 342
           V + EML G 
Sbjct: 269 VCMYEMLYGE 278

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 88/205 (42%), Gaps = 23/205 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 256
           LVKL  +  +D+  L +V E++  G + +HL R    S P       +I L       +L
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYL 157
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +IYRD K  N+L+D     +++DFG AK     G+T     + GT    APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEALAPEI 209
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTG 341
           +++       D ++ GV++ EM  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 86/206 (41%), Gaps = 20/206 (9%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 198
           LG+G F  V +          +K  TG   A K +N   L    H++   E      L H
Sbjct: 12  LGKGAFSVVRRC---------MKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 258
           PN+V+L     E+    LV++ +  G L   +  R     +      +    + L  ++ 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE----YYSEADASHCIQQILESVNH 118
Query: 259 EAEKPVIYRDFKTSNILLDADYN---AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
                +++RD K  N+LL +       KL+DFGLA +   D +        GT GY +PE
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLSPE 176
Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTG 341
            +         D+++ GV+L  +L G
Sbjct: 177 VLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 63/286 (22%), Positives = 115/286 (40%), Gaps = 44/286 (15%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G GG   VF+   E+     +K      V ++  ++  L  ++  +A +N L    H +
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYRNEIAYLNKLQQ--HSD 116
Query: 201 -LVKLVGYCIEDDQRLLVYEFMPRGSLE-NHLFRRSLPL-PWSIRMKIALGAAKGLAFLH 257
            +++L  Y I D     +Y  M  G+++ N   ++   + PW  R        + +  +H
Sbjct: 117 KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIH 172
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
           +     +++ D K +N L+  D   KL DFG+A     D  + V    +G   Y  PE +
Sbjct: 173 QHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 318 -----------MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
                          ++ KSDV+S G +L  M  G+    +                +  
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI---------------INQ 273
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
             + + ++DP  E  F     +    +   CL RDPK R  + E++
Sbjct: 274 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 89/215 (41%), Gaps = 20/215 (9%)
Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAE 189
           T +++    LG+G F  V +          VK       A K +N   L    H++   E
Sbjct: 30  TDDYQLFEELGKGAFSVVRRC---------VKKTPTQEYAAKIINTKKLSARDHQKLERE 80
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 249
                 L HPN+V+L     E+    LV++ +  G L   +  R     +      +   
Sbjct: 81  ARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE----YYSEADASHCI 136
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYN---AKLSDFGLAKDAPEDGKTHVSTRVM 306
            + L  ++   +  +++RD K  N+LL +       KL+DFGLA +    G+        
Sbjct: 137 HQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEV--QGEQQAWFGFA 194
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           GT GY +PE +         D+++ GV+L  +L G
Sbjct: 195 GTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 117/294 (39%), Gaps = 52/294 (17%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG+G F  +FKG   E G       T   V +K L+       + +    + +  L H +
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHET--EVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
           LV   G C   D+ +LV EF+  GSL+ +L +    +    ++++A   A  + FL E  
Sbjct: 74  LVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLEENT 133
Query: 261 EKPVIYRDFKTSNILLDADYN--------AKLSDFGLAKDA-PEDGKTHVSTRVMGTYGY 311
              +I+ +    NILL  + +         KLSD G++    P+D    +  R+     +
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI---LQERI----PW 183
Query: 312 AAPEYVMT-GHLTSKSDVYSFGVVLLEMLTG----RRSMDKNRPNGEHNLVEWARPHLGD 366
             PE +    +L   +D +SFG  L E+ +G      ++D  R                 
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR----------------- 226
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKA--TQLAAQCLSRDPKARPRMSEVVETLKPL 418
           K +FY       E    +   + A    L   C+  +P  RP    ++  L  L
Sbjct: 227 KLQFY-------EDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 89/221 (40%), Gaps = 39/221 (17%)
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR--MKIALGAAKGLAF 255
           HPN++ L     +     +V E M  G L + + R+     +S R    +     K + +
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF---FSEREASAVLFTITKTVEY 131
Query: 256 LHEEAEKPVIYRDFKTSNIL-LDADYN---AKLSDFGLAKDA-PEDGKTHVSTRVMGTYG 310
           LH +    V++RD K SNIL +D   N    ++ DFG AK    E+G          T  
Sbjct: 132 LHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY---TAN 185
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           + APE +      +  D++S GV+L  MLTG         NG  +  E     +G     
Sbjct: 186 FVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPF----ANGPDDTPEEILARIG----- 236
Query: 371 YRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKAR 405
                    G FS+ G      S  A  L ++ L  DP  R
Sbjct: 237 --------SGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQR 269

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 39/137 (28%), Positives = 65/137 (47%), Gaps = 15/137 (10%)
Query: 212 DQRLLVYEFMPRGSL---ENHLF----RRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPV 264
           D+  ++YE+M   S+   + + F      +  +P  +   I        +++H E  K +
Sbjct: 116 DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE--KNI 173
Query: 265 IYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM--TGHL 322
            +RD K SNIL+D +   KLSDFG   +   D K   S    GTY +  PE+    + + 
Sbjct: 174 CHRDVKPSNILMDKNGRVKLSDFG-ESEYMVDKKIKGSR---GTYEFMPPEFFSNESSYN 229
Query: 323 TSKSDVYSFGVVLLEML 339
            +K D++S G+ L  M 
Sbjct: 230 GAKVDIWSLGICLYVMF 246

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 85/206 (41%), Gaps = 20/206 (9%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 198
           +G+G F  V +          VK  TG   A K +N   L    H++   E      L H
Sbjct: 12  IGKGAFSVVRRC---------VKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 258
            N+V+L     E+    LV++ +  G L   +  R     +      +    + L  +  
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLH 118
Query: 259 EAEKPVIYRDFKTSNILLDADYN---AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
             +  V++RD K  N+LL +       KL+DFGLA +   D +        GT GY +PE
Sbjct: 119 CHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLSPE 176
Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTG 341
            +         D+++ GV+L  +L G
Sbjct: 177 VLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 6/91 (6%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 143 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 196
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
            APE ++        D++S G ++ EM+  +
Sbjct: 197 RAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 132 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 185
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK 347
            APE ++        D++S G ++ EM+       GR  +D+
Sbjct: 186 RAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQ 227

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 24/214 (11%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + F    +LG G F  VF            +  TG   A+K +             E+  
Sbjct: 9   KTFIFMEVLGSGAFSEVF---------LVKQRLTGKLFALKCIKKSPAFRDSSLENEIAV 59
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP--WSIRMKIALGAA 250
           L  + H N+V L           LV + +  G L + +  R +      S+ ++  L A 
Sbjct: 60  LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAV 119
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNIL-LDADYNAKL--SDFGLAKDAPEDGKTHVSTRVMG 307
           K   +LHE     +++RD K  N+L L  + N+K+  +DFGL+K   ++G   + +   G
Sbjct: 120 K---YLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSK-MEQNG---IMSTACG 169
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           T GY APE +     +   D +S GV+   +L G
Sbjct: 170 TPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/262 (23%), Positives = 103/262 (39%), Gaps = 30/262 (11%)
Query: 165 GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD--QRLLVYEFMP 222
           G  + V V  +     +  +++  E   L    HPN++ ++G C         L+  + P
Sbjct: 33  GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWXP 92
Query: 223 RGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRD-FKTSNILLDADY 280
            GSL N L    +  +  S  +K AL  A+G AFLH    +P+I R    + ++ +D D 
Sbjct: 93  YGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLH--TLEPLIPRHALNSRSVXIDEDX 150
Query: 281 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            A++S   +       G+ +    V        PE          +D +SF V+L E++T
Sbjct: 151 TARISXADVKFSFQSPGRXYAPAWVAPEALQKKPEDTNR----RSADXWSFAVLLWELVT 206
Query: 341 GRRSMD--KNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCL 398
                    N   G    +E  RP           + P +  H S        +L   C 
Sbjct: 207 REVPFADLSNXEIGXKVALEGLRP----------TIPPGISPHVS--------KLXKICX 248
Query: 399 SRDPKARPRMSEVVETLKPLQN 420
           + DP  RP+   +V  L+  Q+
Sbjct: 249 NEDPAKRPKFDXIVPILEKXQD 270

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 96/233 (41%), Gaps = 47/233 (20%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGNLL 197
           L+G G +G V + + +              VA+K +    + L   K  L E+  L  L 
Sbjct: 60  LIGTGSYGHVCEAYDKLEKR---------VVAIKKILRVFEDLIDCKRILREIAILNRLN 110
Query: 198 HPNLVKLVGYCIEDD-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
           H ++VK++   I  D     +  +V E     S    LFR  + L       +      G
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTHVS-------- 302
           + ++H      +++RD K +N L++ D + K+ DFGLA+  D PE+G + +         
Sbjct: 169 VKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 303 ---------------TRVMGTYGYAAPEYV-MTGHLTSKSDVYSFGVVLLEML 339
                          T  + T  Y APE + +  + T   DV+S G +  E+L
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 113/288 (39%), Gaps = 50/288 (17%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           + GTG   A K +    L   +  ++      EVN L 
Sbjct: 13  LGSGQFAIVRKCR---------QKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
            + HPN++ L          +L+ E +  G L + L  +   L      +       G+ 
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVH 122
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           +LH    K + + D K  NI+L  D N      KL DFG+A    E G       + GT 
Sbjct: 123 YLHS---KRIAHFDLKPENIML-LDKNVPNPRIKLIDFGIAHKI-EAGNEF--KNIFGTP 175
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            + APE V    L  ++D++S GV+   +L+G                  A P LG+ ++
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGETKQ 217
Query: 370 F----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                   ++   +  +    S+ A     + L +DPK R  +++ +E
Sbjct: 218 ETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 92/229 (40%), Gaps = 39/229 (17%)
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK--IALGAAKGLAF 255
           HPN++ L     +     LV E M  G L + + R+     +S R    +     K + +
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF---FSEREASFVLHTIGKTVEY 136
Query: 256 LHEEAEKPVIYRDFKTSNIL-LDADYN---AKLSDFGLAKDA-PEDGKTHVSTRVMGTYG 310
           LH +    V++RD K SNIL +D   N    ++ DFG AK    E+G          T  
Sbjct: 137 LHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY---TAN 190
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           + APE +         D++S G++L  ML G         NG  +  E     +G     
Sbjct: 191 FVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPF----ANGPSDTPEEILTRIGS---- 242
Query: 371 YRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEVVE 413
                    G F++ G      S+ A  L ++ L  DP  R    +V++
Sbjct: 243 ---------GKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQ 282

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 113/288 (39%), Gaps = 50/288 (17%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           + GTG   A K +    L   +  ++      EVN L 
Sbjct: 20  LGSGQFAIVRKCR---------QKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 70
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
            + HPN++ L          +L+ E +  G L + L  +   L      +       G+ 
Sbjct: 71  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVH 129
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           +LH    K + + D K  NI+L  D N      KL DFG+A    E G       + GT 
Sbjct: 130 YLHS---KRIAHFDLKPENIML-LDKNVPNPRIKLIDFGIAHKI-EAGNEF--KNIFGTP 182
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            + APE V    L  ++D++S GV+   +L+G                  A P LG+ ++
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGETKQ 224
Query: 370 F----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                   ++   +  +    S+ A     + L +DPK R  +++ +E
Sbjct: 225 ETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLE 272

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 85/206 (41%), Gaps = 20/206 (9%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 198
           LG+G F  V +          VK   G   A   +N   L    H++   E      L H
Sbjct: 19  LGKGAFSVVRRC---------VKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 258
           PN+V+L     E+    L+++ +  G L   +  R     +      +    + L  +  
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLH 125
Query: 259 EAEKPVIYRDFKTSNILLDADYN---AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
             +  V++R+ K  N+LL +       KL+DFGLA +   +G+        GT GY +PE
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV--EGEQQAWFGFAGTPGYLSPE 183
Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTG 341
            +         D+++ GV+L  +L G
Sbjct: 184 VLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 113/288 (39%), Gaps = 50/288 (17%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           + GTG   A K +    L   +  ++      EVN L 
Sbjct: 34  LGSGQFAIVRKCR---------QKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILR 84
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
            + HPN++ L          +L+ E +  G L + L  +   L      +       G+ 
Sbjct: 85  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVH 143
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           +LH    K + + D K  NI+L  D N      KL DFG+A    E G       + GT 
Sbjct: 144 YLHS---KRIAHFDLKPENIML-LDKNVPNPRIKLIDFGIAHKI-EAGNEF--KNIFGTP 196
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            + APE V    L  ++D++S GV+   +L+G                  A P LG+ ++
Sbjct: 197 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGETKQ 238
Query: 370 ----FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                   ++   +  +    S+ A     + L +DPK R  +++ +E
Sbjct: 239 ETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLE 286

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 97/220 (44%), Gaps = 34/220 (15%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG GG G VF           V       VA+K +     Q  K  L E+  +  L H N
Sbjct: 19  LGCGGNGLVFSA---------VDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 201 LVKL--------------VGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
           +VK+              VG   E +   +V E+M    L N L +  L L    R+   
Sbjct: 70  IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPL-LEEHARL-FM 126
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYNAKLSDFGLAK--DAPEDGKTHVST 303
               +GL ++H      V++RD K +N+ ++  D   K+ DFGLA+  D     K H+S 
Sbjct: 127 YQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE 183
Query: 304 RVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGR 342
            ++ T  Y +P  +++  + T   D+++ G +  EMLTG+
Sbjct: 184 GLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 92/229 (40%), Gaps = 39/229 (17%)
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK--IALGAAKGLAF 255
           HPN++ L     +     LV E M  G L + + R+     +S R    +     K + +
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF---FSEREASFVLHTIGKTVEY 136
Query: 256 LHEEAEKPVIYRDFKTSNIL-LDADYN---AKLSDFGLAKDA-PEDGKTHVSTRVMGTYG 310
           LH +    V++RD K SNIL +D   N    ++ DFG AK    E+G          T  
Sbjct: 137 LHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY---TAN 190
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           + APE +         D++S G++L  ML G         NG  +  E     +G     
Sbjct: 191 FVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPF----ANGPSDTPEEILTRIG----- 241
Query: 371 YRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEVVE 413
                    G F++ G      S+ A  L ++ L  DP  R    +V++
Sbjct: 242 --------SGKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQ 282

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 125/305 (40%), Gaps = 49/305 (16%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGN 195
           +G+G FG VFK    +         TG  VA+K +    ++  KE      L E+  L  
Sbjct: 26  IGQGTFGEVFKARHRK---------TGQKVALKKV---LMENEKEGFPITALREIKILQL 73
Query: 196 LLHPNLVKLVGYCIEDDQ--------RLLVYEFMPR---GSLENHLFRRSLPLPWSIRMK 244
           L H N+V L+  C               LV++F      G L N L + +L    S   +
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL----SEIKR 129
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD---APEDGKTHV 301
           +      GL ++H      +++RD K +N+L+  D   KL+DFGLA+    A        
Sbjct: 130 VMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 302 STRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW- 359
             RV+ T  Y  PE ++         D++  G ++ EM T    M  N    +  L+   
Sbjct: 187 XNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 245
Query: 360 ---ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
                P +      Y L + +LE    +KG ++  +   +   RDP A   + +++  L 
Sbjct: 246 CGSITPEVWPNVDNYELYE-KLE---LVKGQKRKVKDRLKAYVRDPYALDLIDKLL-VLD 300
Query: 417 PLQNL 421
           P Q +
Sbjct: 301 PAQRI 305

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 96/221 (43%), Gaps = 36/221 (16%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLH 198
           +LG+G    VF+G  ++         TG   A+K  N+   L+     + E   L  L H
Sbjct: 16  ILGQGATANVFRGRHKK---------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH 66
Query: 199 PNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKG 252
            N+VKL  + IE++     ++L+ EF P GSL   L   S    LP S  + +      G
Sbjct: 67  KNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 253 LAFLHEEAEKPVIYRDFKTSNILL----DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
           +  L E     +++R+ K  NI+     D     KL+DFG A++  ED +  VS  + GT
Sbjct: 125 MNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVS--LYGT 178
Query: 309 YGYAAPEYVMTGHLT--------SKSDVYSFGVVLLEMLTG 341
             Y  P+      L         +  D++S GV      TG
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A       + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---CTNFMMTPYVVTRYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            APE ++     +  D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 85/214 (39%), Gaps = 18/214 (8%)
Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLAEVNF 192
           +  +  +  G +G V  G   E     +K         +T+N   D     K  L E+  
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC-KRVLREIRL 82
Query: 193 LGNLLHPNLVKLVGYCIEDDQ-----RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
           L +  HPN++ L    +  ++       LV E M R  L   +  + + +          
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMY 141
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK-DAPEDGKTHVSTRVM 306
               GL  LHE     V++RD    NILL  + +  + DF LA+ D  +  KTH  T   
Sbjct: 142 HILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH-- 196
Query: 307 GTYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEML 339
               Y APE VM     T   D++S G V+ EM 
Sbjct: 197 --RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 85/214 (39%), Gaps = 18/214 (8%)
Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLAEVNF 192
           +  +  +  G +G V  G   E     +K         +T+N   D     K  L E+  
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC-KRVLREIRL 82
Query: 193 LGNLLHPNLVKLVGYCIEDDQ-----RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
           L +  HPN++ L    +  ++       LV E M R  L   +  + + +          
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMY 141
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK-DAPEDGKTHVSTRVM 306
               GL  LHE     V++RD    NILL  + +  + DF LA+ D  +  KTH  T   
Sbjct: 142 HILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH-- 196
Query: 307 GTYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEML 339
               Y APE VM     T   D++S G V+ EM 
Sbjct: 197 --RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + +    + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMEPEVVTRYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
            APE ++        D++S G ++ EM+  +
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 91/217 (41%), Gaps = 29/217 (13%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-H 198
           LLGEG +  V            V    G   AVK +             EV  L     +
Sbjct: 20  LLGEGAYAKV---------QGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGN 70
Query: 199 PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 257
            N+++L+ +  EDD R  LV+E +  GS+  H+ ++          ++    A  L FLH
Sbjct: 71  KNILELIEF-FEDDTRFYLVFEKLQGGSILAHI-QKQKHFNEREASRVVRDVAAALDFLH 128
Query: 258 EEAEKPVIYRDFKTSNILLDADYN---AKLSDFGLAKDAP-EDGKTHVSTRVM----GTY 309
               K + +RD K  NIL ++       K+ DF L       +  T ++T  +    G+ 
Sbjct: 129 ---TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSA 185
Query: 310 GYAAPEY--VMTGHLT---SKSDVYSFGVVLLEMLTG 341
            Y APE   V T   T    + D++S GVVL  ML+G
Sbjct: 186 EYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 125/305 (40%), Gaps = 49/305 (16%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGN 195
           +G+G FG VFK    +         TG  VA+K +    ++  KE      L E+  L  
Sbjct: 25  IGQGTFGEVFKARHRK---------TGQKVALKKV---LMENEKEGFPITALREIKILQL 72
Query: 196 LLHPNLVKLVGYCIEDDQ--------RLLVYEFMPR---GSLENHLFRRSLPLPWSIRMK 244
           L H N+V L+  C               LV++F      G L N L + +L    S   +
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL----SEIKR 128
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD---APEDGKTHV 301
           +      GL ++H      +++RD K +N+L+  D   KL+DFGLA+    A        
Sbjct: 129 VMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 302 STRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW- 359
             RV+ T  Y  PE ++         D++  G ++ EM T    M  N    +  L+   
Sbjct: 186 XNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244
Query: 360 ---ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
                P +      Y L + +LE    +KG ++  +   +   RDP A   + +++  L 
Sbjct: 245 CGSITPEVWPNVDNYELYE-KLE---LVKGQKRKVKDRLKAYVRDPYALDLIDKLL-VLD 299
Query: 417 PLQNL 421
           P Q +
Sbjct: 300 PAQRI 304

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 71/305 (23%), Positives = 117/305 (38%), Gaps = 44/305 (14%)
Query: 121 RKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL 180
           R  M +D  L    +    ++G+G F  V +    E G    +    +    K  +  GL
Sbjct: 14  RGSMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQ---QFAVKIVDVAKFTSSPGL 70
Query: 181 QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPL 237
              ++   E +    L HP++V+L+     D    +V+EFM    L   + +R+      
Sbjct: 71  ST-EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY 129
Query: 238 PWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA---KLSDFGLAKDAP 294
             ++         + L + H+     +I+RD K   +LL +  N+   KL  FG+A    
Sbjct: 130 SEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG 186
Query: 295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
           E G   V+   +GT  + APE V         DV+  GV+L  +L+G             
Sbjct: 187 ESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG------------- 231
Query: 355 NLVEWARPHLGDKRRFYR-------LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR 407
                  P  G K R +         ++PR   H     S+ A  L  + L  DP  R  
Sbjct: 232 -----CLPFYGTKERLFEGIIKGKYKMNPRQWSHI----SESAKDLVRRMLMLDPAERIT 282
Query: 408 MSEVV 412
           + E +
Sbjct: 283 VYEAL 287

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 6/90 (6%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A       + T  + T  Y
Sbjct: 136 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---STNFMMTPYVVTRYY 189
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            APE ++        D++S G ++ E++ G
Sbjct: 190 RAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 125/305 (40%), Gaps = 49/305 (16%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGN 195
           +G+G FG VFK    +         TG  VA+K +    ++  KE      L E+  L  
Sbjct: 26  IGQGTFGEVFKARHRK---------TGQKVALKKV---LMENEKEGFPITALREIKILQL 73
Query: 196 LLHPNLVKLVGYCIEDDQ--------RLLVYEFMPR---GSLENHLFRRSLPLPWSIRMK 244
           L H N+V L+  C               LV++F      G L N L + +L    S   +
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTL----SEIKR 129
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD---APEDGKTHV 301
           +      GL ++H      +++RD K +N+L+  D   KL+DFGLA+    A        
Sbjct: 130 VMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 302 STRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW- 359
             RV+ T  Y  PE ++         D++  G ++ EM T    M  N    +  L+   
Sbjct: 187 XNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 245
Query: 360 ---ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
                P +      Y L + +LE    +KG ++  +   +   RDP A   + +++  L 
Sbjct: 246 CGSITPEVWPNVDNYELYE-KLE---LVKGQKRKVKDRLKAYVRDPYALDLIDKLL-VLD 300
Query: 417 PLQNL 421
           P Q +
Sbjct: 301 PAQRI 305

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 125/305 (40%), Gaps = 49/305 (16%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGN 195
           +G+G FG VFK    +         TG  VA+K +    ++  KE      L E+  L  
Sbjct: 26  IGQGTFGEVFKARHRK---------TGQKVALKKV---LMENEKEGFPITALREIKILQL 73
Query: 196 LLHPNLVKLVGYCIEDDQ--------RLLVYEFMPR---GSLENHLFRRSLPLPWSIRMK 244
           L H N+V L+  C               LV++F      G L N L + +L    S   +
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL----SEIKR 129
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD---APEDGKTHV 301
           +      GL ++H      +++RD K +N+L+  D   KL+DFGLA+    A        
Sbjct: 130 VMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 302 STRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW- 359
             RV+ T  Y  PE ++         D++  G ++ EM T    M  N    +  L+   
Sbjct: 187 XNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 245
Query: 360 ---ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
                P +      Y L + +LE    +KG ++  +   +   RDP A   + +++  L 
Sbjct: 246 CGSITPEVWPNVDNYELYE-KLE---LVKGQKRKVKDRLKAYVRDPYALDLIDKLL-VLD 300
Query: 417 PLQNL 421
           P Q +
Sbjct: 301 PAQRI 305

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 94/221 (42%), Gaps = 36/221 (16%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLH 198
           +LG+G    VF+G  ++         TG   A+K  N+   L+     + E   L  L H
Sbjct: 16  ILGQGATANVFRGRHKK---------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH 66
Query: 199 PNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKG 252
            N+VKL  + IE++     ++L+ EF P GSL   L   S    LP S  + +      G
Sbjct: 67  KNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 253 LAFLHEEAEKPVIYRDFKTSNILL----DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
           +  L E     +++R+ K  NI+     D     KL+DFG A++  +D +      + GT
Sbjct: 125 MNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VXLYGT 178
Query: 309 YGYAAPEYVMTGHLT--------SKSDVYSFGVVLLEMLTG 341
             Y  P+      L         +  D++S GV      TG
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 70/302 (23%), Positives = 116/302 (38%), Gaps = 44/302 (14%)
Query: 124 MFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH 183
           M +D  L    +    ++G+G F  V +    E G    +    +    K  +  GL   
Sbjct: 15  MADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQ---QFAVKIVDVAKFTSSPGLST- 70
Query: 184 KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWS 240
           ++   E +    L HP++V+L+     D    +V+EFM    L   + +R+        +
Sbjct: 71  EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA 130
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA---KLSDFGLAKDAPEDG 297
           +         + L + H+     +I+RD K   +LL +  N+   KL  FG+A    E G
Sbjct: 131 VASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 187
Query: 298 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 357
              V+   +GT  + APE V         DV+  GV+L  +L+G                
Sbjct: 188 L--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG---------------- 229
Query: 358 EWARPHLGDKRRFYR-------LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 410
               P  G K R +         ++PR   H     S+ A  L  + L  DP  R  + E
Sbjct: 230 --CLPFYGTKERLFEGIIKGKYKMNPRQWSHI----SESAKDLVRRMLMLDPAERITVYE 283
Query: 411 VV 412
            +
Sbjct: 284 AL 285

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + +    + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMEPEVVTRYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
            APE ++        D++S G ++ EM+  +
Sbjct: 192 RAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 97/221 (43%), Gaps = 40/221 (18%)
Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAEV 190
           +R  + LGEG +G V+K          +   T  TVA+K +      +G+ G    + EV
Sbjct: 36  YRRITKLGEGTYGEVYKA---------IDTVTNETVAIKRIRLEHEEEGVPGTA--IREV 84
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA---- 246
           + L  L H N+++L      + +  L++E+      EN L +     P  + M++     
Sbjct: 85  SLLKELQHRNIIELKSVIHHNHRLHLIFEYA-----ENDLKKYMDKNP-DVSMRVIKSFL 138
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAKD--APEDGKT 299
                G+ F H    +  ++RD K  N+LL     +     K+ DFGLA+    P    T
Sbjct: 139 YQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFT 195
Query: 300 HVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEML 339
           H     + T  Y  PE ++ + H ++  D++S   +  EML
Sbjct: 196 H----EIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 20  LGSGQFAIVKKCR---------EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
            +LH N++ L          +L+ E +  G L + L ++   L              G+ 
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVN 129
Query: 255 FLHEEAEKPVIYRDFKTSNI-LLDADY---NAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
           +LH    K + + D K  NI LLD +    + KL DFGLA +  EDG       + GT  
Sbjct: 130 YLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEF--KNIFGTPE 183
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           + APE V    L  ++D++S GV+   +L+G
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 20  LGSGQFAIVKKCR---------EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
            +LH N++ L          +L+ E +  G L + L ++   L              G+ 
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVN 129
Query: 255 FLHEEAEKPVIYRDFKTSNI-LLDADY---NAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
           +LH    K + + D K  NI LLD +    + KL DFGLA +  EDG       + GT  
Sbjct: 130 YLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEF--KNIFGTPE 183
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           + APE V    L  ++D++S GV+   +L+G
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 20  LGSGQFAIVKKCR---------EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
            +LH N++ L          +L+ E +  G L + L ++   L              G+ 
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVN 129
Query: 255 FLHEEAEKPVIYRDFKTSNI-LLDADY---NAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
           +LH    K + + D K  NI LLD +    + KL DFGLA +  EDG       + GT  
Sbjct: 130 YLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEF--KNIFGTPE 183
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           + APE V    L  ++D++S GV+   +L+G
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 20  LGSGQFAIVKKCR---------EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
            +LH N++ L          +L+ E +  G L + L ++   L              G+ 
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVN 129
Query: 255 FLHEEAEKPVIYRDFKTSNI-LLDADY---NAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
           +LH    K + + D K  NI LLD +    + KL DFGLA +  EDG       + GT  
Sbjct: 130 YLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEF--KNIFGTPE 183
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           + APE V    L  ++D++S GV+   +L+G
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 73/157 (46%), Gaps = 11/157 (7%)
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 248
           EV+ L  +LH N++ L          +L+ E +  G L + L ++   L           
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQ 123
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNI-LLDADY---NAKLSDFGLAKDAPEDGKTHVSTR 304
              G+ +LH    K + + D K  NI LLD +    + KL DFGLA +  EDG       
Sbjct: 124 ILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEF--KN 177
Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           + GT  + APE V    L  ++D++S GV+   +L+G
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 119/279 (42%), Gaps = 33/279 (11%)
Query: 147 GCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLV 205
           GC+  G +     A  +   G  V +K L H G  +     +AE  FL  ++HP++V++ 
Sbjct: 86  GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 206 GYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 260
            +    D+       +V E++   SL+     +   LP +  +   L     L++LH   
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRS---KGQKLPVAEAIAYLLEILPALSYLHSIG 202
Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG 320
              ++Y D K  NI+L  +   KL D G        G  +      GT G+ APE V TG
Sbjct: 203 ---LVYNDLKPENIML-TEEQLKLIDLGAVSRINSFGYLY------GTPGFQAPEIVRTG 252
Query: 321 HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLVEWARPHLGDKRRFYRLL----- 374
             T  +D+Y+ G  L  +     ++D    NG + + +    P L     + RLL     
Sbjct: 253 P-TVATDIYTVGRTLAAL-----TLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRRAID 306
Query: 375 -DPRLEGHFSIKGSQKATQLAAQCLSRDPKA-RPRMSEV 411
            DPR     + + S + T +  + +++D    RP +S +
Sbjct: 307 PDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGLSTI 345

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 68/282 (24%), Positives = 107/282 (37%), Gaps = 54/282 (19%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 19  LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
            + HPN++ L          +L+ E +  G L + L  +   L      +       G+ 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 128
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHVSTRVMG 307
           +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K      + G
Sbjct: 129 YLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-----IFG 179
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  + APE V    L  ++D++S GV+   +L+G                  A P LGD 
Sbjct: 180 TPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDT 221
Query: 368 RRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           ++        ++   E  +    S  A     + L +DPK R
Sbjct: 222 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 31/163 (19%)
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADY---NAKLSDFGLAKDAPEDGKTHVSTRVMG 307
           +G+ +LH+     +++ D K  NILL + Y   + K+ DFG+++     G       +MG
Sbjct: 142 EGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI---GHACELREIMG 195
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  Y APE +    +T+ +D+++ G++   +LT                     P +G+ 
Sbjct: 196 TPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH------------------TSPFVGED 237
Query: 368 RRFYRLLDPRLEGHFSIKG----SQKATQLAAQCLSRDPKARP 406
            +   L   ++   +S +     SQ AT      L ++P+ RP
Sbjct: 238 NQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRP 280

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 71/296 (23%), Positives = 110/296 (37%), Gaps = 78/296 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 15  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 65
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYEFM-----------PRGSLENHLFRRSLPLPWS 240
             +      +++L+ +    D  +L+ E M            RG+L+  L R      W 
Sbjct: 66  KKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFF---WQ 122
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPED 296
           +   +      G           V++RD K  NIL+D +    KL DFG   L KD    
Sbjct: 123 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 168
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 355
               V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +       
Sbjct: 169 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 218
Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
             E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 219 --EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 256

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 20/207 (9%)
Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL 197
           E+ +G G +G V            V+ GT +  A K +    ++    +  E+  + +L 
Sbjct: 31  ENTIGRGSWGEV---------KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 81
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 257
           HPN+++L     ++    LV E    G L   +  + +    S   +I       +A+ H
Sbjct: 82  HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRV-FRESDAARIMKDVLSAVAYCH 140
Query: 258 EEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           +     V +RD K  N L      D   KL DFGLA    + GK  + T+V GT  Y +P
Sbjct: 141 KLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-KPGKM-MRTKV-GTPYYVSP 194
Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           + V+ G    + D +S GV++  +L G
Sbjct: 195 Q-VLEGLYGPECDEWSAGVMMYVLLCG 220

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 20/207 (9%)
Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL 197
           E+ +G G +G V            V+ GT +  A K +    ++    +  E+  + +L 
Sbjct: 14  ENTIGRGSWGEV---------KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 64
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 257
           HPN+++L     ++    LV E    G L   +  + +    S   +I       +A+ H
Sbjct: 65  HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRV-FRESDAARIMKDVLSAVAYCH 123
Query: 258 EEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           +     V +RD K  N L      D   KL DFGLA    + GK  + T+V GT  Y +P
Sbjct: 124 KLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-KPGKM-MRTKV-GTPYYVSP 177
Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           + V+ G    + D +S GV++  +L G
Sbjct: 178 Q-VLEGLYGPECDEWSAGVMMYVLLCG 203

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 16  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 66
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 240
             +      +++L+ +    D  +L+ E              RG+L+  L R      W 
Sbjct: 67  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 123
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPED 296
           +   +      G           V++RD K  NIL+D +    KL DFG   L KD    
Sbjct: 124 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 169
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 355
               V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +       
Sbjct: 170 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 219
Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
             E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 220 --EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 257

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 87/221 (39%), Gaps = 39/221 (17%)
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR--MKIALGAAKGLAF 255
           HPN++ L     +     +V E    G L + + R+     +S R    +     K + +
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKF---FSEREASAVLFTITKTVEY 131
Query: 256 LHEEAEKPVIYRDFKTSNIL-LDADYN---AKLSDFGLAKDA-PEDGKTHVSTRVMGTYG 310
           LH +    V++RD K SNIL +D   N    ++ DFG AK    E+G          T  
Sbjct: 132 LHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY---TAN 185
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           + APE +      +  D++S GV+L   LTG         NG  +  E     +G     
Sbjct: 186 FVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPF----ANGPDDTPEEILARIG----- 236
Query: 371 YRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKAR 405
                    G FS+ G      S  A  L ++ L  DP  R
Sbjct: 237 --------SGKFSLSGGYWNSVSDTAKDLVSKXLHVDPHQR 269

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 30  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 80
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 240
             +      +++L+ +    D  +L+ E              RG+L+  L R      W 
Sbjct: 81  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 137
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPED 296
           +   +      G           V++RD K  NIL+D +    KL DFG   L KD    
Sbjct: 138 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 183
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 355
               V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +       
Sbjct: 184 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 233
Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
             E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 234 --EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 271

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 68/282 (24%), Positives = 107/282 (37%), Gaps = 54/282 (19%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 19  LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
            + HPN++ L          +L+ E +  G L + L  +   L      +       G+ 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 128
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHVSTRVMG 307
           +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K      + G
Sbjct: 129 YLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-----IFG 179
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  + APE V    L  ++D++S GV+   +L+G                  A P LGD 
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDT 221
Query: 368 RRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           ++        ++   E  +    S  A     + L +DPK R
Sbjct: 222 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 71/306 (23%), Positives = 119/306 (38%), Gaps = 56/306 (18%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 18  LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
            + HPN++ L          +L+ E +  G L + L  +   L      +       G+ 
Sbjct: 69  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 127
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHVSTRVMG 307
           +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K      + G
Sbjct: 128 YLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-----IFG 178
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  + APE V    L  ++D++S GV+   +L+G                  A P LGD 
Sbjct: 179 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDT 220
Query: 368 RRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPLQNL 421
           ++        ++   E  +    S  A     + L +DPK R  + + ++   +KP    
Sbjct: 221 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 280
Query: 422 KDMASS 427
           + ++S+
Sbjct: 281 QALSSA 286

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 71/306 (23%), Positives = 119/306 (38%), Gaps = 56/306 (18%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 18  LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
            + HPN++ L          +L+ E +  G L + L  +   L      +       G+ 
Sbjct: 69  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 127
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHVSTRVMG 307
           +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K      + G
Sbjct: 128 YLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-----IFG 178
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  + APE V    L  ++D++S GV+   +L+G                  A P LGD 
Sbjct: 179 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDT 220
Query: 368 RRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPLQNL 421
           ++        ++   E  +    S  A     + L +DPK R  + + ++   +KP    
Sbjct: 221 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 280
Query: 422 KDMASS 427
           + ++S+
Sbjct: 281 QALSSA 286

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 50  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 100
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 240
             +      +++L+ +    D  +L+ E              RG+L+  L R      W 
Sbjct: 101 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 157
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPED 296
           +   +      G           V++RD K  NIL+D +    KL DFG   L KD    
Sbjct: 158 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 203
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 355
               V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +       
Sbjct: 204 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 253
Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
             E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 254 --EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 291

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 30  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 80
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 240
             +      +++L+ +    D  +L+ E              RG+L+  L R      W 
Sbjct: 81  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 137
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPED 296
           +   +      G           V++RD K  NIL+D +    KL DFG   L KD    
Sbjct: 138 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 183
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 355
               V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +       
Sbjct: 184 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 233
Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
             E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 234 --EIIRGQVFFRQRV----------------SXECQHLIRWCLALRPSDRPTFEEI 271

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 15  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 65
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 240
             +      +++L+ +    D  +L+ E              RG+L+  L R      W 
Sbjct: 66  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 122
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPED 296
           +   +      G           V++RD K  NIL+D +    KL DFG   L KD    
Sbjct: 123 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 168
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 355
               V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +       
Sbjct: 169 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 218
Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
             E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 219 --EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 256

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 43  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 240
             +      +++L+ +    D  +L+ E              RG+L+  L R      W 
Sbjct: 94  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 150
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPED 296
           +   +      G           V++RD K  NIL+D +    KL DFG   L KD    
Sbjct: 151 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 196
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 355
               V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +       
Sbjct: 197 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 246
Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
             E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 247 --EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 284

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 31  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 81
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 240
             +      +++L+ +    D  +L+ E              RG+L+  L R      W 
Sbjct: 82  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 138
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPED 296
           +   +      G           V++RD K  NIL+D +    KL DFG   L KD    
Sbjct: 139 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 184
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 355
               V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +       
Sbjct: 185 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 234
Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
             E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 235 --EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 272

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 11  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 240
             +      +++L+ +    D  +L+ E              RG+L+  L R      W 
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 118
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPED 296
           +   +      G           V++RD K  NIL+D +    KL DFG   L KD    
Sbjct: 119 VLEAVRHCHNXG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 164
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 355
               V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +       
Sbjct: 165 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 214
Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
             E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 215 --EIIRGQVFFRQRV----------------SXECQHLIRWCLALRPSDRPTFEEI 252

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 31  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 81
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 240
             +      +++L+ +    D  +L+ E              RG+L+  L R      W 
Sbjct: 82  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 138
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPED 296
           +   +      G           V++RD K  NIL+D +    KL DFG   L KD    
Sbjct: 139 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 184
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 355
               V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +       
Sbjct: 185 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 234
Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
             E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 235 --EIIRGQVFFRQRV----------------SXECQHLIRWCLALRPSDRPTFEEI 272

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 16  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 66
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 240
             +      +++L+ +    D  +L+ E              RG+L+  L R      W 
Sbjct: 67  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 123
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPED 296
           +   +      G           V++RD K  NIL+D +    KL DFG   L KD    
Sbjct: 124 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 169
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 355
               V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +       
Sbjct: 170 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 219
Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
             E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 220 --EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 257

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 16  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 66
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 240
             +      +++L+ +    D  +L+ E              RG+L+  L R      W 
Sbjct: 67  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 123
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPED 296
           +   +      G           V++RD K  NIL+D +    KL DFG   L KD    
Sbjct: 124 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 169
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 355
               V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +       
Sbjct: 170 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 219
Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
             E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 220 --EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 257

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 71/306 (23%), Positives = 119/306 (38%), Gaps = 56/306 (18%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 19  LGSGKFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
            + HPN++ L          +L+ E +  G L + L  +   L      +       G+ 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 128
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHVSTRVMG 307
           +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K      + G
Sbjct: 129 YLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-----IFG 179
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  + APE V    L  ++D++S GV+   +L+G                  A P LGD 
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDT 221
Query: 368 RRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPLQNL 421
           ++        ++   E  +    S  A     + L +DPK R  + + ++   +KP    
Sbjct: 222 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 281
Query: 422 KDMASS 427
           + ++S+
Sbjct: 282 QALSSA 287

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 31  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 81
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 240
             +      +++L+ +    D  +L+ E              RG+L+  L R      W 
Sbjct: 82  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 138
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPED 296
           +   +      G           V++RD K  NIL+D +    KL DFG   L KD    
Sbjct: 139 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 184
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 355
               V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +       
Sbjct: 185 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 234
Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
             E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 235 --EIIRGQVFFRQRV----------------SXECQHLIRWCLALRPXDRPTFEEI 272

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 66/145 (45%), Gaps = 21/145 (14%)
Query: 212 DQRLLVYEFMPRGSLENHLFRRSL--PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDF 269
           D+  LV+E M  GS+ +H+ +R     L  S+   +    A  L FLH    K + +RD 
Sbjct: 84  DRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDFLH---NKGIAHRDL 137
Query: 270 KTSNILLDADYN---AKLSDFGLAKDAPEDGKTH-VSTRVM----GTYGYAAPEYV---- 317
           K  NIL +        K+ DFGL      +G    +ST  +    G+  Y APE V    
Sbjct: 138 KPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFS 197
Query: 318 -MTGHLTSKSDVYSFGVVLLEMLTG 341
                   + D++S GV+L  +L+G
Sbjct: 198 EEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 69/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 44  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 240
             +      +++L+ +    D  +L+ E              RG+L+  L R      W 
Sbjct: 95  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 151
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPED 296
           +   +      G           V++RD K  NIL+D +    KL DFG   L KD    
Sbjct: 152 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 197
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 355
               V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +       
Sbjct: 198 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 247
Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
                   +   + F+R            + S +   L   CL+  P  RP   E+
Sbjct: 248 -------EIIGGQVFFRQ-----------RVSSECQHLIRWCLALRPSDRPTFEEI 285

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 58  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 108
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 240
             +      +++L+ +    D  +L+ E              RG+L+  L R      W 
Sbjct: 109 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 165
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPED 296
           +   +      G           V++RD K  NIL+D +    KL DFG   L KD    
Sbjct: 166 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 211
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 355
               V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +       
Sbjct: 212 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 261
Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
             E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 262 --EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 299

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 14  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 64
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 240
             +      +++L+ +    D  +L+ E              RG+L+  L R      W 
Sbjct: 65  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 121
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPED 296
           +   +      G           V++RD K  NIL+D +    KL DFG   L KD    
Sbjct: 122 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 167
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 355
               V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +       
Sbjct: 168 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 217
Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
             E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 218 --EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 255

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 71/306 (23%), Positives = 119/306 (38%), Gaps = 56/306 (18%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 19  LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
            + HPN++ L          +L+ E +  G L + L  +   L      +       G+ 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 128
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHVSTRVMG 307
           +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K      + G
Sbjct: 129 YLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-----IFG 179
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  + APE V    L  ++D++S GV+   +L+G                  A P LGD 
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDT 221
Query: 368 RRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPLQNL 421
           ++        ++   E  +    S  A     + L +DPK R  + + ++   +KP    
Sbjct: 222 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 281
Query: 422 KDMASS 427
           + ++S+
Sbjct: 282 QALSSA 287

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 69/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 44  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 240
             +      +++L+ +    D  +L+ E              RG+L+  L R      W 
Sbjct: 95  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 151
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPED 296
           +   +      G           V++RD K  NIL+D +    KL DFG   L KD    
Sbjct: 152 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 197
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 355
               V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +       
Sbjct: 198 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 247
Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
                   +   + F+R            + S +   L   CL+  P  RP   E+
Sbjct: 248 -------EIIGGQVFFRQ-----------RVSSECQHLIRWCLALRPSDRPTFEEI 285

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 69/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 43  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 240
             +      +++L+ +    D  +L+ E              RG+L+  L R      W 
Sbjct: 94  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 150
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPED 296
           +   +      G           V++RD K  NIL+D +    KL DFG   L KD    
Sbjct: 151 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 196
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 355
               V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +       
Sbjct: 197 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 246
Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
                   +   + F+R            + S +   L   CL+  P  RP   E+
Sbjct: 247 -------EIIGGQVFFRQ-----------RVSSECQHLIRWCLALRPSDRPTFEEI 284

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 58  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 108
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 240
             +      +++L+ +    D  +L+ E              RG+L+  L R      W 
Sbjct: 109 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 165
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPED 296
           +   +      G           V++RD K  NIL+D +    KL DFG   L KD    
Sbjct: 166 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 211
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 355
               V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +       
Sbjct: 212 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 261
Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
             E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 262 --EIIRGQVFFRQRV----------------SXECQHLIRWCLALRPSDRPTFEEI 299

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 69/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 43  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 240
             +      +++L+ +    D  +L+ E              RG+L+  L R      W 
Sbjct: 94  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 150
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPED 296
           +   +      G           V++RD K  NIL+D +    KL DFG   L KD    
Sbjct: 151 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 196
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 355
               V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +       
Sbjct: 197 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 246
Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
                   +   + F+R            + S +   L   CL+  P  RP   E+
Sbjct: 247 -------EIIGGQVFFRQ-----------RVSSECQHLIRWCLALRPSDRPTFEEI 284

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 94/236 (39%), Gaps = 39/236 (16%)
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 248
           EV+ L  + HPN++ L          +L+ E +  G L + L  +   L      +    
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQ 122
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHV 301
              G+ +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K   
Sbjct: 123 ILNGVYYLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-- 176
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 361
              + GT  + APE V    L  ++D++S GV+   +L+G                  A 
Sbjct: 177 ---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------AS 215
Query: 362 PHLGDKRR----FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
           P LGD ++        ++   E  +    S  A     + L +DPK R  + + ++
Sbjct: 216 PFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 69/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 44  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 240
             +      +++L+ +    D  +L+ E              RG+L+  L R      W 
Sbjct: 95  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 151
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPED 296
           +   +      G           V++RD K  NIL+D +    KL DFG   L KD    
Sbjct: 152 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 197
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 355
               V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +       
Sbjct: 198 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 247
Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
                   +   + F+R            + S +   L   CL+  P  RP   E+
Sbjct: 248 -------EIIGGQVFFRQ-----------RVSXECQHLIRWCLALRPSDRPTFEEI 285

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 63  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 113
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 240
             +      +++L+ +    D  +L+ E              RG+L+  L R      W 
Sbjct: 114 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 170
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPED 296
           +   +      G           V++RD K  NIL+D +    KL DFG   L KD    
Sbjct: 171 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 216
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 355
               V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +       
Sbjct: 217 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 266
Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
             E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 267 --EIIRGQVFFRQRV----------------SXECQHLIRWCLALRPSDRPTFEEI 304

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 38  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 88
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 240
             +      +++L+ +    D  +L+ E              RG+L+  L R      W 
Sbjct: 89  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 145
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPED 296
           +   +      G           V++RD K  NIL+D +    KL DFG   L KD    
Sbjct: 146 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 191
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 355
               V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +       
Sbjct: 192 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 241
Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
             E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 242 --EIIRGQVFFRQRV----------------SXECQHLIRWCLALRPSDRPTFEEI 279

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 90/226 (39%), Gaps = 54/226 (23%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 44  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 240
             +      +++L+ +    D  +L+ E              RG+L+  L R      W 
Sbjct: 95  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 151
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPED 296
           +   +      G           V++RD K  NIL+D +    KL DFG   L KD    
Sbjct: 152 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 197
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTG 341
               V T   GT  Y+ PE++       +S  V+S G++L +M+ G
Sbjct: 198 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 69/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 43  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 240
             +      +++L+ +    D  +L+ E              RG+L+  L R      W 
Sbjct: 94  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 150
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPED 296
           +   +      G           V++RD K  NIL+D +    KL DFG   L KD    
Sbjct: 151 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 196
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 355
               V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +       
Sbjct: 197 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 246
Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
                   +   + F+R            + S +   L   CL+  P  RP   E+
Sbjct: 247 -------EIIGGQVFFRQ-----------RVSXECQHLIRWCLALRPSDRPTFEEI 284

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 68/282 (24%), Positives = 107/282 (37%), Gaps = 54/282 (19%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 19  LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
            + HPN++ L          +L+ E +  G L + L  +   L      +       G+ 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 128
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHVSTRVMG 307
           +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K      + G
Sbjct: 129 YLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-----IFG 179
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  + APE V    L  ++D++S GV+   +L+G                  A P LGD 
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDT 221
Query: 368 RRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           ++        ++   E  +    S  A     + L +DPK R
Sbjct: 222 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 68/282 (24%), Positives = 107/282 (37%), Gaps = 54/282 (19%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 19  LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
            + HPN++ L          +L+ E +  G L + L  +   L      +       G+ 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 128
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHVSTRVMG 307
           +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K      + G
Sbjct: 129 YLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-----IFG 179
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  + APE V    L  ++D++S GV+   +L+G                  A P LGD 
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDT 221
Query: 368 RRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           ++        ++   E  +    S  A     + L +DPK R
Sbjct: 222 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 60/252 (23%), Positives = 102/252 (40%), Gaps = 41/252 (16%)
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 248
           EV+ L  + HPN++ L          +L+ E +  G L + L  +   L      +    
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQ 122
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHV 301
              G+ +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K   
Sbjct: 123 ILNGVYYLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-- 176
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 361
              + GT  + APE V    L  ++D++S GV+   +L+G                  A 
Sbjct: 177 ---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------AS 215
Query: 362 PHLGDKRRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--L 415
           P LGD ++        ++   E  +    S  A     + L +DPK R  + + ++   +
Sbjct: 216 PFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275
Query: 416 KPLQNLKDMASS 427
           KP    + ++S+
Sbjct: 276 KPKDTQQALSSA 287

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 11  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 240
             +      +++L+ +    D  +L+ E              RG+L+  L R      W 
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 118
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPED 296
           +   +      G           V++RD K  NIL+D +    KL DFG   L KD    
Sbjct: 119 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 164
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 355
               V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +       
Sbjct: 165 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 214
Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
             E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 215 --EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 252

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEVN 191
           ++F+  S LG G +G VFK   +E+G         L    ++++   G +     LAEV 
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGR--------LYAVKRSMSPFRGPKDRARKLAEVG 108
Query: 192 FLGNL-LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 250
               +  HP  V+L     E+   L +   +   SL+ H       LP +          
Sbjct: 109 SHEKVGQHPCCVRLE-QAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTL 167
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
             LA LH +    +++ D K +NI L      KL DFGL  +    G   V     G   
Sbjct: 168 LALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPR 221
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEM 338
           Y APE ++ G   + +DV+S G+ +LE+
Sbjct: 222 YMAPE-LLQGSYGTAADVFSLGLTILEV 248

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 68/282 (24%), Positives = 107/282 (37%), Gaps = 54/282 (19%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 19  LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
            + HPN++ L          +L+ E +  G L + L  +   L      +       G+ 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 128
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHVSTRVMG 307
           +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K      + G
Sbjct: 129 YLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-----IFG 179
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  + APE V    L  ++D++S GV+   +L+G                  A P LGD 
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDT 221
Query: 368 RRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           ++        ++   E  +    S  A     + L +DPK R
Sbjct: 222 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 68/282 (24%), Positives = 107/282 (37%), Gaps = 54/282 (19%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 19  LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
            + HPN++ L          +L+ E +  G L + L  +   L      +       G+ 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 128
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHVSTRVMG 307
           +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K      + G
Sbjct: 129 YLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-----IFG 179
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  + APE V    L  ++D++S GV+   +L+G                  A P LGD 
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDT 221
Query: 368 RRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           ++        ++   E  +    S  A     + L +DPK R
Sbjct: 222 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 68/282 (24%), Positives = 107/282 (37%), Gaps = 54/282 (19%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 19  LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
            + HPN++ L          +L+ E +  G L + L  +   L      +       G+ 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 128
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHVSTRVMG 307
           +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K      + G
Sbjct: 129 YLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-----IFG 179
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  + APE V    L  ++D++S GV+   +L+G                  A P LGD 
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDT 221
Query: 368 RRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           ++        ++   E  +    S  A     + L +DPK R
Sbjct: 222 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 69/296 (23%), Positives = 109/296 (36%), Gaps = 78/296 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 11  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRRSLPLPWS 240
             +      +++L+ +    D  +L+ E              RG+L+  L R      W 
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF---WQ 118
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPED 296
           +   +      G           V++RD K  NIL+D +    KL DFG   L KD    
Sbjct: 119 VLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 164
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN 355
               V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +       
Sbjct: 165 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 214
Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
                   +   + F+R            + S +   L   CL+  P  RP   E+
Sbjct: 215 -------EIIGGQVFFRQ-----------RVSSECQHLIRWCLALRPSDRPTFEEI 252

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 76/169 (44%), Gaps = 20/169 (11%)
Query: 189 EVNFLGNLLHPNLVKL--VGYCIEDDQRLLVYEFMPRGSLENHLFRRS-------LPLPW 239
           E+  L  L HPN++ L  V     D +  L++++          F R+       + LP 
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY----NAKLSDFGLAK--DA 293
            +   +      G+ +LH      V++RD K +NIL+  +       K++D G A+  ++
Sbjct: 128 GMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
Query: 294 PEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTG 341
           P      +   V+ T+ Y APE ++   H T   D+++ G +  E+LT 
Sbjct: 185 PLKPLADLDP-VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 71/306 (23%), Positives = 119/306 (38%), Gaps = 56/306 (18%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 19  LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
            + HPN++ L          +L+ E +  G L + L  +   L      +       G+ 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 128
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHVSTRVMG 307
           +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K      + G
Sbjct: 129 YLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-----IFG 179
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  + APE V    L  ++D++S GV+   +L+G                  A P LGD 
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDT 221
Query: 368 RRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPLQNL 421
           ++        ++   E  +    S  A     + L +DPK R  + + ++   +KP    
Sbjct: 222 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 281
Query: 422 KDMASS 427
           + ++S+
Sbjct: 282 QALSSA 287

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 65/145 (44%), Gaps = 21/145 (14%)
Query: 212 DQRLLVYEFMPRGSLENHLFRRSL--PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDF 269
           D+  LV+E M  GS+ +H+ +R     L  S+   +    A  L FLH    K + +RD 
Sbjct: 84  DRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDFLH---NKGIAHRDL 137
Query: 270 KTSNILLDADYN---AKLSDFGLAKDAPEDGKTH-VSTRVM----GTYGYAAPEYV---- 317
           K  NIL +        K+ DF L      +G    +ST  +    G+  Y APE V    
Sbjct: 138 KPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFS 197
Query: 318 -MTGHLTSKSDVYSFGVVLLEMLTG 341
                   + D++S GV+L  +L+G
Sbjct: 198 EEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 57/242 (23%), Positives = 94/242 (38%), Gaps = 45/242 (18%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGNLL 197
           S LGEG FG V +      G        G  VA+K +    ++ +KE    E+N L  + 
Sbjct: 39  STLGEGTFGRVVQCVDHRRG--------GARVALKIIK--NVEKYKEAARLEINVLEKIN 88
Query: 198 HPN------LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 251
             +       V++  +        + +E +   + +       LP P      +A    +
Sbjct: 89  EKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQ 148
Query: 252 GLAFLHEEAEKPVIYRDFKTSNIL-LDADYN------------------AKLSDFGLAKD 292
            + FLH+     + + D K  NIL +++DY                    ++ DFG A  
Sbjct: 149 AVKFLHD---NKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATF 205
Query: 293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG 352
             E   T VSTR      Y APE ++    +   DV+S G ++ E   G  ++ +   N 
Sbjct: 206 DHEHHSTIVSTR-----HYRAPEVILELGWSQPCDVWSIGCIIFEYYVG-FTLFQTHDNR 259
Query: 353 EH 354
           EH
Sbjct: 260 EH 261
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	490
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	0.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	0.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-160
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-88
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	6e-67
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-66
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-65
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	6e-65
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-64
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-63
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	8e-62
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-61
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	9e-61
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-60
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-60
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-58
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-58
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-58
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-46
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-45
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-45
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-45
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-44
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-44
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	8e-43
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-42
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-41
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-41
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-41
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-41
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-40
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-40
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-40
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-40
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-40
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-40
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-40
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	9e-40
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-39
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-39
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-39
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-39
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-39
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-39
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-39
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	7e-39
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	8e-39
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	8e-39
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	8e-39
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-38
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-38
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-38
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-38
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-38
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	7e-38
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	9e-38
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	9e-38
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-37
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-37
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-37
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-37
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-37
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-37
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-37
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-37
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-37
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	7e-37
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-36
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-36
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-36
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-36
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	6e-36
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-36
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-35
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-35
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-35
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	5e-35
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	6e-35
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	8e-35
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	8e-35
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-34
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-34
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-34
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-33
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-33
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-33
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-33
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-33
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-33
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	7e-33
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-32
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-32
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-32
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-32
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-31
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-31
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-31
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-31
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-31
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	7e-31
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	7e-31
3ork_A	311	Serine/threonine protein kinase; structural genomi	9e-31
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-30
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-30
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-30
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-30
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-30
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-29
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-29
3fme_A	290	Dual specificity mitogen-activated protein kinase;	7e-29
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-28
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-28
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-28
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-28
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-27
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-27
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-27
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-27
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-27
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	7e-27
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-04
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	8e-27
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-26
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-26
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-26
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-26
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-26
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	9e-26
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-25
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-25
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-25
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-25
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-25
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	5e-25
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	8e-25
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-24
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-24
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-24
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-24
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-24
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-24
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-24
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-24
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	6e-24
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	7e-24
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	7e-24
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-23
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-23
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-23
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-23
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-23
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-23
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	5e-23
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	8e-23
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-22
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-22
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-22
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-22
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-22
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	8e-22
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	8e-22
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	9e-22
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-21
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-21
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-21
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-21
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-21
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-21
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-21
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-21
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-21
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	7e-21
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-21
3o0g_A	292	Cell division protein kinase 5; kinase activator c	8e-21
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-20
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-20
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-20
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-20
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-20
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-20
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-20
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-20
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	9e-20
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	9e-20
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-19
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-19
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-19
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-19
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-19
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-19
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-19
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-18
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-18
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-18
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-18
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-18
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-18
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-18
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-18
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	6e-18
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-17
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-17
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-17
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	7e-17
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	8e-17
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-16
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-16
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-16
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-16
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-15
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-15
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-14
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	5e-12
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	9e-12
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-11
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	8e-11
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	9e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	8e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-09
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-09
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	9e-09
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-08
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-08
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-08
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-08
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-07
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-06

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  534 bits (1377), Expect = 0.0
 Identities = 110/321 (34%), Positives = 174/321 (54%), Gaps = 31/321 (9%)

Query: 112 EELKVAS-QLRKFMFNDLKLATRNFRPE------SLLGEGGFGCVFKGWVEENGTAPVKP 164
           + L+V+  +   F F +LK  T NF         + +GEGGFG V+KG+V          
Sbjct: 3   KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT------- 55

Query: 165 GTGLTVAVKTL----NHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEF 220
               TVAVK L    +    +  +++  E+  +    H NLV+L+G+  + D   LVY +
Sbjct: 56  ----TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVY 111

Query: 221 MPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA 278
           MP GSL + L     + PL W +R KIA GAA G+ FLHE      I+RD K++NILLD 
Sbjct: 112 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168

Query: 279 DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 338
            + AK+SDFGLA+ + +  +T +++R++GT  Y APE  + G +T KSD+YSFGVVLLE+
Sbjct: 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEI 227

Query: 339 LTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCL 398
           +TG  ++D++R      L++       +++     +D ++         +    +A+QCL
Sbjct: 228 ITGLPAVDEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCL 284

Query: 399 SRDPKARPRMSEVVETLKPLQ 419
                 RP + +V + L+ + 
Sbjct: 285 HEKKNKRPDIKKVQQLLQEMT 305

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  517 bits (1333), Expect = 0.0
 Identities = 114/332 (34%), Positives = 182/332 (54%), Gaps = 17/332 (5%)

Query: 97  TTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEE 156
           +  +  + S     S    V  +  +    DL+ AT NF  + L+G G FG V+KG + +
Sbjct: 3   SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62

Query: 157 NGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLL 216
                     G  VA+K    +  QG +E+  E+  L    HP+LV L+G+C E ++ +L
Sbjct: 63  ----------GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112

Query: 217 VYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN 273
           +Y++M  G+L+ HL+     ++ + W  R++I +GAA+GL +LH      +I+RD K+ N
Sbjct: 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSIN 169

Query: 274 ILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGV 333
           ILLD ++  K++DFG++K   E  +TH+ST V GT GY  PEY + G LT KSDVYSFGV
Sbjct: 170 ILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGV 229

Query: 334 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQL 393
           VL E+L  R ++ ++ P    NL EWA     +  +  +++DP L      +  +K    
Sbjct: 230 VLFEVLCARSAIVQSLPREMVNLAEWAVESH-NNGQLEQIVDPNLADKIRPESLRKFGDT 288

Query: 394 AAQCLSRDPKARPRMSEVVETLKPLQNLKDMA 425
           A +CL+   + RP M +V+  L+    L++  
Sbjct: 289 AVKCLALSSEDRPSMGDVLWKLEYALRLQESV 320

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  455 bits (1172), Expect = e-160
 Identities = 120/304 (39%), Positives = 186/304 (61%), Gaps = 18/304 (5%)

Query: 119 QLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD 178
           QL++F   +L++A+ NF  +++LG GGFG V+KG +  +GT          VAVK L  +
Sbjct: 16  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGT---------LVAVKRLKEE 65

Query: 179 GLQGHK-EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRR---S 234
             QG + ++  EV  +   +H NL++L G+C+   +RLLVY +M  GS+ + L  R    
Sbjct: 66  RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 125

Query: 235 LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 294
            PL W  R +IALG+A+GLA+LH+  +  +I+RD K +NILLD ++ A + DFGLAK   
Sbjct: 126 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185

Query: 295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
               THV+T V GT G+ APEY+ TG  + K+DV+ +GV+LLE++TG+R+ D  R   + 
Sbjct: 186 -YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244

Query: 355 --NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
              L++W +  L +K +   L+D  L+G++  +  ++  Q+A  C    P  RP+MSEVV
Sbjct: 245 DVMLLDWVKGLLKEK-KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303

Query: 413 ETLK 416
             L+
Sbjct: 304 RMLE 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  273 bits (699), Expect = 1e-88
 Identities = 77/321 (23%), Positives = 127/321 (39%), Gaps = 39/321 (12%)

Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 186
           +L   +   +   +   G FGCV+K  +               VAVK      +Q  + W
Sbjct: 18  NLYFQSMPLQLLEVKARGRFGCVWKAQLL-----------NEYVAVKIFP---IQDKQSW 63

Query: 187 LAE--VNFLGNLLHPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWS 240
             E  V  L  + H N+++ +G             L+  F  +GSL + L      + W+
Sbjct: 64  QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWN 121

Query: 241 IRMKIALGAAKGLAFLHEE------AEKP-VIYRDFKTSNILLDADYNAKLSDFGLAKDA 293
               IA   A+GLA+LHE+        KP + +RD K+ N+LL  +  A ++DFGLA   
Sbjct: 122 ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181

Query: 294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS-----KSDVYSFGVVLLEMLTGRRSMDKN 348
                   +   +GT  Y APE +            + D+Y+ G+VL E+ +   + D  
Sbjct: 182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241

Query: 349 RPNGEHNLVE--WARPHLGDKRRF--YRLLDPRLEGHF-SIKGSQKATQLAAQCLSRDPK 403
                    E     P L D +    ++   P L  ++    G     +   +C   D +
Sbjct: 242 VDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAE 301

Query: 404 ARPRMSEVVETLKPLQNLKDM 424
           AR     V E +  +Q L ++
Sbjct: 302 ARLSAGCVGERITQMQRLTNI 322

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  216 bits (552), Expect = 6e-67
 Identities = 83/344 (24%), Positives = 130/344 (37%), Gaps = 70/344 (20%)

Query: 125 FNDLKLATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGH 183
           + ++++          +G G FG V K  W                VA+K +  +  +  
Sbjct: 7   YKEIEVEEV-------VGRGAFGVVCKAKW------------RAKDVAIKQIESESER-- 45

Query: 184 KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLEN--HLFRRSLPLPWSI 241
           K ++ E+  L  + HPN+VKL G C+      LV E+   GSL N  H          + 
Sbjct: 46  KAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAH 103

Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN-AKLSDFGLAKDAPEDGKTH 300
            M   L  ++G+A+LH    K +I+RD K  N+LL A     K+ DFG A D        
Sbjct: 104 AMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQT 158

Query: 301 VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 360
             T   G+  + APE     + + K DV+S+G++L E++T R      +P  E     + 
Sbjct: 159 HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR------KPFDEIGGPAFR 212

Query: 361 ---------RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
                    RP L         L   +E             L  +C S+DP  RP M E+
Sbjct: 213 IMWAVHNGTRPPLIKN------LPKPIE------------SLMTRCWSKDPSQRPSMEEI 254

Query: 412 VETLKPLQN-----LKDMASSSYYFQTMQADNTWSIRNSKNGIR 450
           V+ +  L        + +     +      D             
Sbjct: 255 VKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPYVDFAEFY 298

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  217 bits (553), Expect = 1e-66
 Identities = 65/336 (19%), Positives = 120/336 (35%), Gaps = 52/336 (15%)

Query: 123 FMFNDLKLATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQ 181
              ++  L   N +   L+G G +G V+KG   E              VAVK  +     
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDER------------PVAVKVFS---FA 47

Query: 182 GHKEWLAEVN--FLGNLLHPNLVKLVGYCIEDD-----QRLLVYEFMPRGSLENHLFRRS 234
             + ++ E N   +  + H N+ + +            + LLV E+ P GSL  +L   +
Sbjct: 48  NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT 107

Query: 235 LPLPWSIRMKIALGAAKGLAFLHEEAEK------PVIYRDFKTSNILLDADYNAKLSDFG 288
               W    ++A    +GLA+LH E  +       + +RD  + N+L+  D    +SDFG
Sbjct: 108 SD--WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165

Query: 289 LAK------DAPEDGKTHVSTRVMGTYGYAAPEYVM-------TGHLTSKSDVYSFGVVL 335
           L+             + + +   +GT  Y APE +              + D+Y+ G++ 
Sbjct: 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225

Query: 336 LEMLTGRRSMDKNRPNGEHNL----VEWARPHLGDKRRF--YRLLDPRLEGHFSI--KGS 387
            E+      +       E+ +         P   D +         P+    +       
Sbjct: 226 WEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAV 285

Query: 388 QKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKD 423
           +   +    C  +D +AR       E +  L  + +
Sbjct: 286 RSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  212 bits (541), Expect = 3e-65
 Identities = 74/306 (24%), Positives = 124/306 (40%), Gaps = 46/306 (15%)

Query: 133 RNFRPESL-----LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 186
           R FRP  L     LG+G FG   K               TG  + +K L     +  + +
Sbjct: 5   RIFRPSDLIHGEVLGKGCFGQAIKVTH----------RETGEVMVMKELIRFDEETQRTF 54

Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
           L EV  +  L HPN++K +G   +D +   + E++  G+L   +       PWS R+  A
Sbjct: 55  LKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFA 114

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT------- 299
              A G+A+LH      +I+RD  + N L+  + N  ++DFGLA+   ++          
Sbjct: 115 KDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSL 171

Query: 300 -----HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
                     V+G   + APE +       K DV+SFG+VL E++    +     P+   
Sbjct: 172 KKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA----DPDYLP 227

Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET 414
             +++      + R F     P                +  +C   DP+ RP   ++   
Sbjct: 228 RTMDFGL----NVRGFLDRYCPP-------NCPPSFFPITVRCCDLDPEKRPSFVKLEHW 276

Query: 415 LKPLQN 420
           L+ L+ 
Sbjct: 277 LETLRM 282

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  210 bits (537), Expect = 6e-65
 Identities = 86/317 (27%), Positives = 142/317 (44%), Gaps = 70/317 (22%)

Query: 125 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH- 183
            N+++        E  +G+GGFG V KG + ++ +          VA+K+L     +G  
Sbjct: 18  DNEIEY-------EKQIGKGGFGLVHKGRLVKDKS---------VVAIKSLILGDSEGET 61

Query: 184 ------KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL 237
                 +E+  EV  + NL HPN+VKL G         +V EF+P G L + L  ++ P+
Sbjct: 62  EMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHPI 119

Query: 238 PWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD-----ADYNAKLSDFGLAKD 292
            WS+++++ L  A G+ ++  +   P+++RD ++ NI L      A   AK++DFGL++ 
Sbjct: 120 KWSVKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ 178

Query: 293 APEDGKTHVSTRVMGTYGYAAPEYVMTG---HLTSKSDVYSFGVVLLEMLTGRR------ 343
                  H  + ++G + + APE  +       T K+D YSF ++L  +LTG        
Sbjct: 179 -----SVHSVSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232

Query: 344 --SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRD 401
              +       E  L    RP + +         PRL              +   C S D
Sbjct: 233 YGKIKFINMIREEGL----RPTIPED------CPPRLR------------NVIELCWSGD 270

Query: 402 PKARPRMSEVVETLKPL 418
           PK RP  S +V+ L  L
Sbjct: 271 PKKRPHFSYIVKELSEL 287

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  210 bits (537), Expect = 1e-64
 Identities = 82/309 (26%), Positives = 132/309 (42%), Gaps = 59/309 (19%)

Query: 125 FNDLKLATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGH 183
           + DL +  +       +G G FG V +  W   +G+          VAVK L        
Sbjct: 36  WCDLNIKEK-------IGAGSFGTVHRAEW---HGS---------DVAVKILMEQDFHAE 76

Query: 184 --KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS--LPLPW 239
              E+L EV  +  L HPN+V  +G   +     +V E++ RGSL   L +      L  
Sbjct: 77  RVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDE 136

Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
             R+ +A   AKG+ +LH     P+++R+ K+ N+L+D  Y  K+ DFGL++       +
Sbjct: 137 RRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS 195

Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 359
             S    GT  + APE +       KSDVYSFGV+L E+ T +      +P G  N  + 
Sbjct: 196 --SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ------QPWGNLNPAQV 247

Query: 360 A--------RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
                    R  +         L+P++              +   C + +P  RP  + +
Sbjct: 248 VAAVGFKCKRLEIPRN------LNPQVA------------AIIEGCWTNEPWKRPSFATI 289

Query: 412 VETLKPLQN 420
           ++ L+PL  
Sbjct: 290 MDLLRPLIK 298

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  204 bits (522), Expect = 6e-63
 Identities = 82/315 (26%), Positives = 129/315 (40%), Gaps = 70/315 (22%)

Query: 125 FNDLKLATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGH 183
           F +L L          +G GGFG V++  W    G           VAVK   HD  +  
Sbjct: 6   FAELTLEEI-------IGIGGFGKVYRAFW---IGD---------EVAVKAARHDPDEDI 46

Query: 184 ----KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 239
               +    E      L HPN++ L G C+++    LV EF   G L   L  +   +P 
Sbjct: 47  SQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK--RIPP 104

Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD--------ADYNAKLSDFGLAK 291
            I +  A+  A+G+ +LH+EA  P+I+RD K+SNIL+         ++   K++DFGLA+
Sbjct: 105 DILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164

Query: 292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN 351
           +     K        G Y + APE +     +  SDV+S+GV+L E+LTG        P 
Sbjct: 165 EWHRTTKMS----AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE------VPF 214

Query: 352 GEHNLVEWA--------RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPK 403
              + +  A           +                           +L   C + DP 
Sbjct: 215 RGIDGLAVAYGVAMNKLALPIPST------CPEPFA------------KLMEDCWNPDPH 256

Query: 404 ARPRMSEVVETLKPL 418
           +RP  + +++ L  +
Sbjct: 257 SRPSFTNILDQLTTI 271

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  202 bits (515), Expect = 8e-62
 Identities = 68/314 (21%), Positives = 119/314 (37%), Gaps = 70/314 (22%)

Query: 125 FNDLKLATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGH 183
           F  L   T+       L E   G ++KG W    G           + VK L        
Sbjct: 9   FKQLNFLTK-------LNENHSGELWKGRW---QGN---------DIVVKVLKVRDWSTR 49

Query: 184 --KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLL--VYEFMPRGSLENHLFR-RSLPLP 238
             +++  E   L    HPN++ ++G C          +  +MP GSL N L    +  + 
Sbjct: 50  KSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVD 109

Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
            S  +K AL  A+G+AFLH   E  +      + ++++D D  A++S   +         
Sbjct: 110 QSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVK-------F 161

Query: 299 THVSTRVMGTYGYAAPEYVMTG----HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
           +  S   M    + APE  +           +D++SF V+L E++T         P  + 
Sbjct: 162 SFQSPGRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTRE------VPFADL 214

Query: 355 NLVEWA--------RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
           + +E          RP +         + P +            ++L   C++ DP  RP
Sbjct: 215 SNMEIGMKVALEGLRPTIPPG------ISPHV------------SKLMKICMNEDPAKRP 256

Query: 407 RMSEVVETLKPLQN 420
           +   +V  L+ +Q+
Sbjct: 257 KFDMIVPILEKMQD 270

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  201 bits (513), Expect = 6e-61
 Identities = 60/344 (17%), Positives = 122/344 (35%), Gaps = 63/344 (18%)

Query: 103 SASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKG-WVEENGTAP 161
           SA S P+ + +  +  Q     F  L++          +G+G FG V+ G W   +G   
Sbjct: 10  SARSFPRKASQTSIFLQEWDIPFEQLEIGEL-------IGKGRFGQVYHGRW---HGE-- 57

Query: 162 VKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYE 219
                   VA++ ++ +       K +  EV       H N+V  +G C+      ++  
Sbjct: 58  --------VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109

Query: 220 FMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD 279
                +L + +    + L  +   +IA    KG+ +LH    K ++++D K+ N+  D +
Sbjct: 110 LCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-N 165

Query: 280 YNAKLSDFGLAK---DAPEDGKTHVSTRVMGTYGYAAPEYVMTG---------HLTSKSD 327
               ++DFGL           +        G   + APE +              +  SD
Sbjct: 166 GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSD 225

Query: 328 VYSFGVVLLEMLTGR---RSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSI 384
           V++ G +  E+       ++            + W            +    ++     I
Sbjct: 226 VFALGTIWYELHAREWPFKTQPAEA-------IIWQ------MGTGMKPNLSQIGMGKEI 272

Query: 385 KGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSS 428
                   +   C + + + RP  +++++ L+ L   K     S
Sbjct: 273 S------DILLFCWAFEQEERPTFTKLMDMLEKLP--KRNRRLS 308

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  199 bits (509), Expect = 9e-61
 Identities = 79/301 (26%), Positives = 126/301 (41%), Gaps = 42/301 (13%)

Query: 125 FNDLKLATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGH 183
              + +  R       +G G FG V+KG W   +G           VAVK LN       
Sbjct: 23  DGQITVGQR-------IGSGSFGTVYKGKW---HGD----------VAVKMLNVTAPTPQ 62

Query: 184 --KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI 241
             + +  EV  L    H N++  +GY     Q  +V ++    SL +HL           
Sbjct: 63  QLQAFKNEVGVLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKK 121

Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
            + IA   A+G+ +LH    K +I+RD K++NI L  D   K+ DFGLA +      +H 
Sbjct: 122 LIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178

Query: 302 STRVMGTYGYAAPE---YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 358
             ++ G+  + APE      +   + +SDVY+FG+VL E++TG+       P    N  +
Sbjct: 179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRD 232

Query: 359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                +G       L   R      +K      +L A+CL +    RP    ++  ++ L
Sbjct: 233 QIIEMVGRGSLSPDLSKVRSNCPKRMK------RLMAECLKKKRDERPSFPRILAEIEEL 286

Query: 419 Q 419
            
Sbjct: 287 A 287

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  196 bits (499), Expect = 1e-58
 Identities = 70/313 (22%), Positives = 122/313 (38%), Gaps = 45/313 (14%)

Query: 138 ESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL--AEVNFLG 194
              +G+G +G V+ G W  E             VAVK            W    E+    
Sbjct: 42  VKQIGKGRYGEVWMGKWRGE------------KVAVKVFFT---TEEASWFRETEIYQTV 86

Query: 195 NLLHPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 250
            + H N++  +   I+      Q  L+ ++   GSL ++L  +S  L     +K+A  + 
Sbjct: 87  LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSV 144

Query: 251 KGLAFLHEEAEK-----PVIYRDFKTSNILLDADYNAKLSDFGLA--KDAPEDGKTHVST 303
            GL  LH E         + +RD K+ NIL+  +    ++D GLA    +  +       
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPN 204

Query: 304 RVMGTYGYAAPEYVMTGHL-------TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE--H 354
             +GT  Y  PE V+   L          +D+YSFG++L E+   R          +  +
Sbjct: 205 TRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQLPY 262

Query: 355 NLVEWARPHLGDKRRF--YRLLDPRLEGHFSIKGSQKA-TQLAAQCLSRDPKARPRMSEV 411
           + +  + P   D R     + L P     +S     +   +L  +C + +P +R     V
Sbjct: 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322

Query: 412 VETLKPLQNLKDM 424
            +TL  +   +D+
Sbjct: 323 KKTLAKMSESQDI 335

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  194 bits (495), Expect = 2e-58
 Identities = 70/310 (22%), Positives = 117/310 (37%), Gaps = 51/310 (16%)

Query: 138 ESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE--VNFLG 194
              +G+G +G V++G W  E             VAVK  +    +  K W  E  +    
Sbjct: 13  LECVGKGRYGEVWRGSWQGE------------NVAVKIFSS---RDEKSWFRETELYNTV 57

Query: 195 NLLHPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 250
            L H N++  +   +       Q  L+  +   GSL ++L  +   L     ++I L  A
Sbjct: 58  MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIA 115

Query: 251 KGLAFLHEEAEK-----PVIYRDFKTSNILLDADYNAKLSDFGLA--KDAPEDGKTHVST 303
            GLA LH E         + +RD K+ NIL+  +    ++D GLA       +     + 
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175

Query: 304 RVMGTYGYAAPEYVMTGHL-------TSKSDVYSFGVVLLEMLTGRRSMDKNRP------ 350
             +GT  Y APE V+   +         + D+++FG+VL E+     S            
Sbjct: 176 PRVGTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234

Query: 351 --NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM 408
                    E  R  +   ++  R   P     FS        +L  +C  ++P AR   
Sbjct: 235 DVVPNDPSFEDMRKVVCVDQQ--RPNIP--NRWFSDPTLTSLAKLMKECWYQNPSARLTA 290

Query: 409 SEVVETLKPL 418
             + +TL  +
Sbjct: 291 LRIKKTLTKI 300

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  194 bits (495), Expect = 5e-58
 Identities = 74/316 (23%), Positives = 126/316 (39%), Gaps = 51/316 (16%)

Query: 138 ESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE--VNFLG 194
           +  +G+G FG V++G W  E             VAVK  +    +  + W  E  +    
Sbjct: 47  QESIGKGRFGEVWRGKWRGE------------EVAVKIFS---SREERSWFREAEIYQTV 91

Query: 195 NLLHPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 250
            L H N++  +    +D+    Q  LV ++   GSL ++L      +     +K+AL  A
Sbjct: 92  MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTA 149

Query: 251 KGLAFLHEEAE----KPVI-YRDFKTSNILLDADYNAKLSDFGLA--KDAPEDGKTHVST 303
            GLA LH E      KP I +RD K+ NIL+  +    ++D GLA   D+  D       
Sbjct: 150 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 209

Query: 304 RVMGTYGYAAPEYVMTGHL-------TSKSDVYSFGVVLLEMLTGRRSMDKNRP------ 350
             +GT  Y APE V+   +         ++D+Y+ G+V  E+         +        
Sbjct: 210 HRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268

Query: 351 --NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM 408
                   VE  R  + +++   R   P      S +  +   ++  +C   +  AR   
Sbjct: 269 DLVPSDPSVEEMRKVVCEQKL--RPNIP--NRWQSCEALRVMAKIMRECWYANGAARLTA 324

Query: 409 SEVVETLKPLQNLKDM 424
             + +TL  L   + +
Sbjct: 325 LRIKKTLSQLSQQEGI 340

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  164 bits (418), Expect = 2e-46
 Identities = 72/281 (25%), Positives = 115/281 (40%), Gaps = 31/281 (11%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           +G G FG VF G +  + T          VAVK+           ++L E   L    HP
Sbjct: 122 IGRGNFGEVFSGRLRADNT---------LVAVKSCRETLPPDLKAKFLQEARILKQYSHP 172

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           N+V+L+G C +     +V E +  G     L      L     +++   AA G+ +L   
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE-- 230

Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             K  I+RD    N L+      K+SDFG++++  +               + APE +  
Sbjct: 231 -SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY 289

Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRLLDPRL 378
           G  +S+SDV+SFG++L E  +   S   N  N +    VE          +  RL  P  
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE----------KGGRL--PCP 337

Query: 379 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ 419
           E            +L  QC + +P  RP  S + + L+ ++
Sbjct: 338 ELC-----PDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  160 bits (408), Expect = 1e-45
 Identities = 87/302 (28%), Positives = 121/302 (40%), Gaps = 38/302 (12%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVN 191
           R  +    LGEG FG V     +     P   GTG  VAVK L  D G Q    W  E++
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYD-----PTNDGTGEMVAVKALKADAGPQHRSGWKQEID 85

Query: 192 FLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 249
            L  L H +++K  G C +       LV E++P GSL ++L R S+ L   +    A   
Sbjct: 86  ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF--AQQI 143

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST------ 303
            +G+A+LH    +  I+RD    N+LLD D   K+ DFGLAK  PE  + +         
Sbjct: 144 CEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 200

Query: 304 -RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWAR 361
                     APE +        SDV+SFGV L E+LT    S        E   +   +
Sbjct: 201 VFWY------APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQ 254

Query: 362 PHLGDKRRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP 417
             +           RL  P        K   +   L   C   +   RP    ++  LK 
Sbjct: 255 MTVLRLTELLERGERLPRPD-------KCPAEVYHLMKNCWETEASFRPTFENLIPILKT 307

Query: 418 LQ 419
           + 
Sbjct: 308 VH 309

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  159 bits (405), Expect = 2e-45
 Identities = 76/306 (24%), Positives = 126/306 (41%), Gaps = 42/306 (13%)

Query: 133 RNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 191
           R+ +    LG+G FG V    +       P++  TG  VAVK L H   +  +++  E+ 
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYD------PLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 63

Query: 192 FLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 249
            L +L H N+VK  G C    +R   L+ E++P GSL ++L +    +     ++     
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST------ 303
            KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +           
Sbjct: 124 CKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180

Query: 304 -RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 362
                     APE +     +  SDV+SFGVVL E+ T         P  E   +     
Sbjct: 181 IFWY------APESLTESKFSVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRMIGNDK 232

Query: 363 HLGDK--------RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET 414
                        +   RL  PR +G        +   +  +C + +   RP   ++   
Sbjct: 233 QGQMIVFHLIELLKNNGRL--PRPDG-----CPDEIYMIMTECWNNNVNQRPSFRDLALR 285

Query: 415 LKPLQN 420
           +  +++
Sbjct: 286 VDQIRD 291

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  159 bits (405), Expect = 4e-45
 Identities = 75/309 (24%), Positives = 125/309 (40%), Gaps = 48/309 (15%)

Query: 133 RNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 191
           R+ +    LG+G FG V    +       P++  TG  VAVK L H   +  +++  E+ 
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYD------PLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 94

Query: 192 FLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 249
            L +L H N+VK  G C    +R   L+ E++P GSL ++L +    +     ++     
Sbjct: 95  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 154

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST------ 303
            KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D + +         
Sbjct: 155 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 211

Query: 304 -RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 362
                     APE +     +  SDV+SFGVVL E+ T         P  E   +     
Sbjct: 212 IFWY------APESLTESKFSVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRMIGNDK 263

Query: 363 HLGDK--------RRFYRLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
                        +   RL  P     E +           +  +C + +   RP   ++
Sbjct: 264 QGQMIVFHLIELLKNNGRLPRPDGCPDEIY----------MIMTECWNNNVNQRPSFRDL 313

Query: 412 VETLKPLQN 420
              +  +++
Sbjct: 314 ALRVDQIRD 322

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  157 bits (399), Expect = 3e-44
 Identities = 81/301 (26%), Positives = 123/301 (40%), Gaps = 37/301 (12%)

Query: 133 RNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 191
           R+ +  S LG+G FG V    +       P+   TG  VAVK L H G    +++  E+ 
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYD------PLGDNTGALVAVKQLQHSGPDQQRDFQREIQ 76

Query: 192 FLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 249
            L  L    +VK  G      ++   LV E++P G L + L R    L  S  +  +   
Sbjct: 77  ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQI 136

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST------ 303
            KG+ +L     +  ++RD    NIL++++ + K++DFGLAK  P D   +V        
Sbjct: 137 CKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193

Query: 304 -RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWAR 361
                     APE +     + +SDV+SFGVVL E+ T   +S   +         E   
Sbjct: 194 IFWY------APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV 247

Query: 362 PHLGDKRRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP 417
           P L           RL  P            +  +L   C +  P+ RP  S +   L  
Sbjct: 248 PALSRLLELLEEGQRL--PAPPA-----CPAEVHELMKLCWAPSPQDRPSFSALGPQLDM 300

Query: 418 L 418
           L
Sbjct: 301 L 301

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  155 bits (395), Expect = 6e-44
 Identities = 80/304 (26%), Positives = 122/304 (40%), Gaps = 42/304 (13%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVN 191
           R  +    LGEG FG V     +     P    TG  VAVK+L  + G     +   E+ 
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYD-----PEGDNTGEQVAVKSLKPESGGNHIADLKKEIE 75

Query: 192 FLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 249
            L NL H N+VK  G C ED      L+ EF+P GSL+ +L +    +    ++K A+  
Sbjct: 76  ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 135

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST------ 303
            KG+ +L     +  ++RD    N+L+++++  K+ DFGL K    D + +         
Sbjct: 136 CKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSP 192

Query: 304 -RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLV---E 358
                     APE +M       SDV+SFGV L E+LT             +       +
Sbjct: 193 VFWY------APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ 246

Query: 359 WARPHLGDK-RRFYRLLDPR---LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET 414
                L +  +   RL  P     E +          QL  +C    P  R     ++E 
Sbjct: 247 MTVTRLVNTLKEGKRLPCPPNCPDEVY----------QLMRKCWEFQPSNRTSFQNLIEG 296

Query: 415 LKPL 418
            + L
Sbjct: 297 FEAL 300

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  153 bits (389), Expect = 8e-43
 Identities = 68/300 (22%), Positives = 128/300 (42%), Gaps = 51/300 (17%)

Query: 132 TRNFRPESL-----LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHK 184
            R  +         LG G FG V+KG W+ E     +       VA+K L      + +K
Sbjct: 9   LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP------VAIKELREATSPKANK 62

Query: 185 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
           E L E   + ++ +P++ +L+G C+      L+ + MP G L +++      +     + 
Sbjct: 63  EILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN 121

Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
             +  AKG+ +L    ++ +++RD    N+L+    + K++DFGLAK    + K + +  
Sbjct: 122 WCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178

Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEW 359
                 + A E ++    T +SDV+S+GV + E++T G +    +    P  E  +++E 
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI----PASEISSILE- 233

Query: 360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKAT----QLAAQCLSRDPKARPRMSEVVETL 415
                    +  RL  P              T     +  +C   D  +RP+  E++   
Sbjct: 234 ---------KGERLPQP-----------PICTIDVYMIMRKCWMIDADSRPKFRELIIEF 273

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  152 bits (385), Expect = 2e-42
 Identities = 79/347 (22%), Positives = 108/347 (31%), Gaps = 59/347 (17%)

Query: 70  GTSTNYADGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLK 129
           GT   Y       + RR       S T  S     S    F ++                
Sbjct: 14  GTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQ---------------- 57

Query: 130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWL 187
               +F+  S LG G +G VFK               G   AVK       G +     L
Sbjct: 58  ----SFQRLSRLGHGSYGEVFKV---------RSKEDGRLYAVKRSMSPFRGPKDRARKL 104

Query: 188 AEVNFLGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
           AEV     +  HP  V+L     E     L  E     SL+ H       LP +      
Sbjct: 105 AEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYL 163

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
                 LA LH    + +++ D K +NI L      KL DFGL  +    G   V     
Sbjct: 164 RDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QE 217

Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           G   Y APE +   +  + +DV+S G+ +LE+               H    W    L  
Sbjct: 218 GDPRYMAPELLQGSY-GTAADVFSLGLTILEVACNMELP--------HGGEGW--QQLRQ 266

Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                  L P          S +   +    L  DPK R     ++ 
Sbjct: 267 GY-----LPPEFTAGL----SSELRSVLVMMLEPDPKLRATAEALLA 304

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  149 bits (378), Expect = 1e-41
 Identities = 63/294 (21%), Positives = 107/294 (36%), Gaps = 48/294 (16%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           LG+G F  +FKG   E      +       V +K L+       + +    + +  L H 
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHE---TEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 257
           +LV   G C+  D+ +LV EF+  GSL+ +L   +  + + W + +  A   A  + FL 
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV--AKQLAAAMHFL- 129

Query: 258 EEAEKPVIYRDFKTSNILLDADYN--------AKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
              E  +I+ +    NILL  + +         KLSD G++               +   
Sbjct: 130 --EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV--- 184

Query: 310 GYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDK 367
               PE +    +L   +D +SFG  L E+ +G         +       E         
Sbjct: 185 ---PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE--------- 232

Query: 368 RRFYRLLDPRL-EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN 420
              ++L  P+  E             L   C+  +P  RP    ++  L  L  
Sbjct: 233 -DRHQLPAPKAAELA----------NLINNCMDYEPDHRPSFRAIIRDLNSLFT 275

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  149 bits (378), Expect = 2e-41
 Identities = 74/315 (23%), Positives = 116/315 (36%), Gaps = 52/315 (16%)

Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 186
            + +  +++     LGEGGF  V    VE           G   A+K +     Q  +E 
Sbjct: 23  MVIIDNKHYLFIQKLGEGGFSYVDL--VEGLHD-------GHFYALKRILCHEQQDREEA 73

Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQR----LLVYEFMPRGSLENHLFRRSL---PLPW 239
             E +      HPN+++LV YC+ +        L+  F  RG+L N + R       L  
Sbjct: 74  QREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTE 133

Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
              + + LG  +GL  +H    K   +RD K +NILL  +    L D G    A    + 
Sbjct: 134 DQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190

Query: 300 HVSTRVM-------GTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEMLTGRRSMDKNR 349
                 +        T  Y APE         +  ++DV+S G VL  M+ G    D   
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF 250

Query: 350 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSI----KGSQKATQLAAQCLSRDPKAR 405
             G+                    +   ++   SI    + S    QL    ++ DP  R
Sbjct: 251 QKGD-------------------SVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQR 291

Query: 406 PRMSEVVETLKPLQN 420
           P +  ++  L+ LQ 
Sbjct: 292 PHIPLLLSQLEALQP 306

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  149 bits (377), Expect = 4e-41
 Identities = 70/311 (22%), Positives = 134/311 (43%), Gaps = 44/311 (14%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLH 198
           LG G FG V+KG W+ E     +       VA+K L      + +KE L E   + ++ +
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIP------VAIKELREATSPKANKEILDEAYVMASVDN 76

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 258
           P++ +L+G C+      L+ + MP G L +++      +     +   +  AKG+ +L  
Sbjct: 77  PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-- 133

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
             ++ +++RD    N+L+    + K++DFGLAK    + K + +        + A E ++
Sbjct: 134 -EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192

Query: 319 TGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPHLGDKRRFYRL 373
               T +SDV+S+GV + E++T G +    +    P  E  +++E          +  RL
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI----PASEISSILE----------KGERL 238

Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQT 433
             P          +     +  +C   D  +RP+  E++           MA     +  
Sbjct: 239 PQPP-------ICTIDVYMIMVKCWMIDADSRPKFRELIIE------FSKMARDPQRYLV 285

Query: 434 MQADNTWSIRN 444
           +Q D    + +
Sbjct: 286 IQGDERMHLPS 296

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  148 bits (375), Expect = 7e-41
 Identities = 78/311 (25%), Positives = 128/311 (41%), Gaps = 55/311 (17%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G     G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 33  LGQGSFGMVYEG--VAKGVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAA 250
           ++V+L+G   +    L++ E M RG L+++L              P   S  +++A   A
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED------GKTHVSTR 304
            G+A+L        ++RD    N ++  D+  K+ DFG+ +D  E       GK  +  R
Sbjct: 149 DGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205

Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVE----W 359
            M      +PE +  G  T+ SDV+SFGVVL E+ T      +   N +    V      
Sbjct: 206 WM------SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 259

Query: 360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ 419
            +P        + L+                      C   +PK RP   E++ ++K   
Sbjct: 260 DKPD-NCPDMLFELM--------------------RMCWQYNPKMRPSFLEIISSIKEEM 298

Query: 420 NLKDMASSSYY 430
                  S YY
Sbjct: 299 EPGFREVSFYY 309

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  146 bits (370), Expect = 1e-40
 Identities = 77/285 (27%), Positives = 119/285 (41%), Gaps = 45/285 (15%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V  G W    G   V        AVK +  +G     E+  E   +  L HP
Sbjct: 16  LGSGQFGVVKLGKW---KGQYDV--------AVKMIK-EGSMSEDEFFQEAQTMMKLSHP 63

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 257
            LVK  G C ++    +V E++  G L N+L    + L     + M       +G+AFL 
Sbjct: 64  KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM--CYDVCEGMAFL- 120

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT---YGYAAP 314
                  I+RD    N L+D D   K+SDFG+ +   +D         +GT     ++AP
Sbjct: 121 --ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD----QYVSSVGTKFPVKWSAP 174

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRL 373
           E       +SKSDV++FG+++ E+ +  +       N E    V           + +RL
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS----------QGHRL 224

Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
             P L        S    Q+   C    P+ RP   +++ +++PL
Sbjct: 225 YRPHL-------ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  145 bits (368), Expect = 2e-40
 Identities = 82/285 (28%), Positives = 123/285 (43%), Gaps = 45/285 (15%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +G G FG V  G W        V        A+KT+  +G    ++++ E   +  L HP
Sbjct: 16  IGSGQFGLVHLGYW---LNKDKV--------AIKTI-REGAMSEEDFIEEAEVMMKLSHP 63

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 257
            LV+L G C+E     LV EFM  G L ++L   R        + M   L   +G+A+L 
Sbjct: 64  KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGM--CLDVCEGMAYL- 120

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT---YGYAAP 314
              E  VI+RD    N L+  +   K+SDFG+ +   +D      T   GT     +A+P
Sbjct: 121 --EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD----QYTSSTGTKFPVKWASP 174

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRL 373
           E       +SKSDV+SFGV++ E+ +  +   +NR N E    +             +RL
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS----------TGFRL 224

Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
             PRL        S    Q+   C    P+ RP  S ++  L  +
Sbjct: 225 YKPRL-------ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  147 bits (372), Expect = 2e-40
 Identities = 72/296 (24%), Positives = 127/296 (42%), Gaps = 43/296 (14%)

Query: 132 TRNFRPESL-----LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHK 184
            R F+   L     LG G FG V KG W+ E  +  +       V +K +    G Q  +
Sbjct: 7   ARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIP------VCIKVIEDKSGRQSFQ 60

Query: 185 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
                +  +G+L H ++V+L+G C       LV +++P GSL +H+ +    L   + + 
Sbjct: 61  AVTDHMLAIGSLDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLN 119

Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
             +  AKG+ +L    E  +++R+    N+LL +    +++DFG+A   P D K  + + 
Sbjct: 120 WGVQIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE 176

Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEW 359
                 + A E +  G  T +SDV+S+GV + E++T G      +       E  +L+E 
Sbjct: 177 AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL----RLAEVPDLLE- 231

Query: 360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
                    +  RL  P++        +     +  +C   D   RP   E+    
Sbjct: 232 ---------KGERLAQPQI-------CTIDVYMVMVKCWMIDENIRPTFKELANEF 271

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  145 bits (369), Expect = 3e-40
 Identities = 75/302 (24%), Positives = 123/302 (40%), Gaps = 49/302 (16%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           +G G FGCV+ G      T     G  +  AVK+LN    +    ++L E   + +  HP
Sbjct: 33  IGRGHFGCVYHG------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 86

Query: 200 NLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 258
           N++ L+G C+  +   L+V  +M  G L N +   +        +   L  AKG+ +L  
Sbjct: 87  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL-- 144

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG------TYGYA 312
            A K  ++RD    N +LD  +  K++DFGLA+D  +     V  +              
Sbjct: 145 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM---- 199

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPHLGDK 367
           A E + T   T+KSDV+SFGV+L E++T G      ++      +    +          
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN----TFDITVYLL--------- 246

Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASS 427
            +  RLL P               ++  +C     + RP  SE+V  +  +         
Sbjct: 247 -QGRRLLQPE-------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI--FSTFIGE 296

Query: 428 SY 429
            Y
Sbjct: 297 HY 298

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  145 bits (369), Expect = 5e-40
 Identities = 83/310 (26%), Positives = 134/310 (43%), Gaps = 57/310 (18%)

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNL 196
           E ++G G  G V  G +   G   V       VA+K L     +  + ++L+E + +G  
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVP------VAIKALKAGYTERQRRDFLSEASIMGQF 107

Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 256
            HPN+++L G        ++V E+M  GSL+  L            + +  G   G+ +L
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL 167

Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG------ 310
              ++   ++RD    N+L+D++   K+SDFGL++   +D     +T      G      
Sbjct: 168 ---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT-----GGKIPIR 219

Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPHLG 365
           + APE +     +S SDV+SFGVV+ E+L  G R   +M     N +  + VE       
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT----NRDVISSVE------- 268

Query: 366 DKRRFYRLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL---- 418
                YRL  P       H          QL   C  +D   RPR S++V  L  L    
Sbjct: 269 ---EGYRLPAPMGCPHALH----------QLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315

Query: 419 QNLKDMASSS 428
           ++L+  A+ S
Sbjct: 316 ESLRATATVS 325

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  144 bits (366), Expect = 6e-40
 Identities = 78/309 (25%), Positives = 121/309 (39%), Gaps = 58/309 (18%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
            +F+   L+G GGFG VFK   +           G T  +K + ++  +  +E    V  
Sbjct: 11  MDFKEIELIGSGGFGQVFK--AKHRID-------GKTYVIKRVKYNNEKAERE----VKA 57

Query: 193 LGNLLHPNLVKLVGYCIEDDQRL----------------LVYEFMPRGSLENHL-FRRSL 235
           L  L H N+V   G     D                   +  EF  +G+LE  +  RR  
Sbjct: 58  LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117

Query: 236 PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE 295
            L   + +++     KG+ ++H    K +I RD K SNI L      K+ DFGL      
Sbjct: 118 KLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 174

Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 355
           DGK    TR  GT  Y +PE + +     + D+Y+ G++L E+L                
Sbjct: 175 DGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV-------------- 217

Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
                       + F  L D  +   F     +K   L  + LS+ P+ RP  SE++ TL
Sbjct: 218 ----CDTAFETSKFFTDLRDGIISDIF----DKKEKTLLQKLLSKKPEDRPNTSEILRTL 269

Query: 416 KPLQNLKDM 424
              +   + 
Sbjct: 270 TVWKKSPEK 278

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  145 bits (368), Expect = 8e-40
 Identities = 76/307 (24%), Positives = 119/307 (38%), Gaps = 57/307 (18%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LGEG FG VF    E +   P +      VAVK L        +++  E   L  L H +
Sbjct: 49  LGEGAFGKVFLA--ECHNLLPEQDKM--LVAVKALKEASESARQDFQREAELLTMLQHQH 104

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR--------------MKIA 246
           +V+  G C E    L+V+E+M  G L   L                          + +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED------GKTH 300
              A G+ +L   A    ++RD  T N L+      K+ DFG+++D          G+T 
Sbjct: 165 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221

Query: 301 VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGEHNL 356
           +  R M       PE ++    T++SDV+SFGVVL E+ T G++    +     N E   
Sbjct: 222 LPIRWM------PPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL----SNTE--A 269

Query: 357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
           ++          +   L  PR           +   +   C  R+P+ R  + +V   L+
Sbjct: 270 IDCI-------TQGRELERPR-------ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQ 315

Query: 417 PLQNLKD 423
            L     
Sbjct: 316 ALAQAPP 322

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  149 bits (377), Expect = 9e-40
 Identities = 71/281 (25%), Positives = 125/281 (44%), Gaps = 35/281 (12%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           LG G +G V++G W              LTVAVKTL  D ++  +E+L E   +  + HP
Sbjct: 228 LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 276

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLHE 258
           NLV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L  
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-- 334

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
             +K  I+R+    N L+  ++  K++DFGL++                   + APE + 
Sbjct: 335 -EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLA 392

Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S        + + L+E          + YR+  P 
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----------KDYRMERPE 442

Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 443 G-------CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  144 bits (366), Expect = 1e-39
 Identities = 72/261 (27%), Positives = 120/261 (45%), Gaps = 44/261 (16%)

Query: 100 NAESASSTPKFSEELKVASQLRKFMF--NDLKLATRNFRPESLLGEGGFGCVFKGWVEEN 157
           +  S+   P+ SEEL+  ++L   +   N L L         +LGEG FG V +G     
Sbjct: 8   HHHSSGLVPRGSEELQ--NKLEDVVIDRNLLIL-------GKILGEGEFGSVMEG----- 53

Query: 158 GTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQR- 214
                + GT L VAVKT+  D    +  +E+L+E   + +  HPN+++L+G CIE   + 
Sbjct: 54  -NLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112

Query: 215 ----LLVYEFMPRGSLENHL-FRRSLPLPWSIRMK----IALGAAKGLAFLHEEAEKPVI 265
               +++  FM  G L  +L + R    P  I ++      +  A G+ +L   + +  +
Sbjct: 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFL 169

Query: 266 YRDFKTSNILLDADYNAKLSDFGLAKDAPED------GKTHVSTRVMGTYGYAAPEYVMT 319
           +RD    N +L  D    ++DFGL+K               +  + +      A E +  
Sbjct: 170 HRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI------AIESLAD 223

Query: 320 GHLTSKSDVYSFGVVLLEMLT 340
              TSKSDV++FGV + E+ T
Sbjct: 224 RVYTSKSDVWAFGVTMWEIAT 244

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  143 bits (363), Expect = 1e-39
 Identities = 68/285 (23%), Positives = 115/285 (40%), Gaps = 45/285 (15%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V  G W    G   V        A+K +  +G     E++ E   + NL H 
Sbjct: 32  LGTGQFGVVKYGKW---RGQYDV--------AIKMIK-EGSMSEDEFIEEAKVMMNLSHE 79

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 257
            LV+L G C +     ++ E+M  G L N+L   R        + M       + + +L 
Sbjct: 80  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM--CKDVCEAMEYL- 136

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT---YGYAAP 314
               K  ++RD    N L++     K+SDFGL++   +D      T  +G+     ++ P
Sbjct: 137 --ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD----EYTSSVGSKFPVRWSPP 190

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRL 373
           E +M    +SKSD+++FGV++ E+ +  +   +   N E    +           +  RL
Sbjct: 191 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA----------QGLRL 240

Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
             P L        S+K   +   C       RP    ++  +  +
Sbjct: 241 YRPHL-------ASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  146 bits (369), Expect = 2e-39
 Identities = 81/377 (21%), Positives = 143/377 (37%), Gaps = 58/377 (15%)

Query: 66  SSMSGTSTNYADGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMF 125
           S       +  +  +S  K+     +      T + + ++  P+  + ++          
Sbjct: 31  SPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSS-- 88

Query: 126 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHK 184
             +           ++G G FGCV+ G      T     G  +  AVK+LN    +    
Sbjct: 89  LIVHF-------NEVIGRGHFGCVYHG------TLLDNDGKKIHCAVKSLNRITDIGEVS 135

Query: 185 EWLAEVNFLGNLLHPNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRM 243
           ++L E   + +  HPN++ L+G C+  +   L+V  +M  G L N +   +        +
Sbjct: 136 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 195

Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
              L  AKG+ FL   A K  ++RD    N +LD  +  K++DFGLA+D  +     V  
Sbjct: 196 GFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN 252

Query: 304 RVMG------TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE 353
           +              A E + T   T+KSDV+SFGV+L E++T G      ++      +
Sbjct: 253 KTGAKLPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN----TFD 304

Query: 354 -HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
               +           +  RLL P               ++  +C     + RP  SE+V
Sbjct: 305 ITVYLL----------QGRRLLQPE-------YCPDPLYEVMLKCWHPKAEMRPSFSELV 347

Query: 413 ETLKPLQNLKDMASSSY 429
             +  +          Y
Sbjct: 348 SRISAI--FSTFIGEHY 362

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  143 bits (363), Expect = 2e-39
 Identities = 69/309 (22%), Positives = 121/309 (39%), Gaps = 52/309 (16%)

Query: 138 ESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGN 195
           +  LG G FG V +G +        V        A+K L         +E + E   +  
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDV--------AIKVLKQGTEKADTEEMMREAQIMHQ 66

Query: 196 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 255
           L +P +V+L+G C + +  +LV E    G L   L  +   +P S   ++    + G+ +
Sbjct: 67  LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY 125

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG----- 310
           L    EK  ++RD    N+LL   + AK+SDFGL+K    D   + +             
Sbjct: 126 L---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPL 177

Query: 311 -YAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPHL 364
            + APE +     +S+SDV+S+GV + E L+ G++    M       E    +E      
Sbjct: 178 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM----KGPEVMAFIE------ 227

Query: 365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL-QNLKD 423
               +  R+  P        +   +   L + C     + RP    V + ++    +L  
Sbjct: 228 ----QGKRMECPP-------ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276

Query: 424 MASSSYYFQ 432
                ++  
Sbjct: 277 KVEGHHHHH 285

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  143 bits (363), Expect = 2e-39
 Identities = 83/305 (27%), Positives = 127/305 (41%), Gaps = 58/305 (19%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LGEG FG VF    E    +P K      VAVK L    L   K++  E   L NL H +
Sbjct: 23  LGEGAFGKVFLA--ECYNLSPTKDKM--LVAVKALKDPTLAARKDFQREAELLTNLQHEH 78

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---------------MKI 245
           +VK  G C + D  ++V+E+M  G L   L          +                + I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED------GKT 299
           A   A G+ +L   A +  ++RD  T N L+ A+   K+ DFG+++D          G T
Sbjct: 139 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195

Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGEHN 355
            +  R M       PE +M    T++SDV+SFGV+L E+ T G++    +     N E  
Sbjct: 196 MLPIRWM------PPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL----SNTE-- 243

Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           ++E          +   L  PR          ++   +   C  R+P+ R  + E+ + L
Sbjct: 244 VIECI-------TQGRVLERPR-------VCPKEVYDVMLGCWQREPQQRLNIKEIYKIL 289

Query: 416 KPLQN 420
             L  
Sbjct: 290 HALGK 294

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  142 bits (361), Expect = 4e-39
 Identities = 73/304 (24%), Positives = 126/304 (41%), Gaps = 53/304 (17%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           +G+G FG V+ G          +    +  A+K+L+    +Q  + +L E   +  L HP
Sbjct: 29  IGKGHFGVVYHG------EYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHP 82

Query: 200 NLVKLVGYCIEDD-QRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFL 256
           N++ L+G  +  +    ++  +M  G L   +   +R+  +   I     L  A+G+ +L
Sbjct: 83  NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF--GLQVARGMEYL 140

Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG------TYG 310
              AE+  ++RD    N +LD  +  K++DFGLA+D  +     V            T  
Sbjct: 141 ---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT-- 195

Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPHLG 365
             A E + T   T+KSDV+SFGV+L E+LT G      +D      +  + +        
Sbjct: 196 --ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID----PFDLTHFLA------- 242

Query: 366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMA 425
              +  RL  P               Q+  QC   DP  RP    +V  ++ +  +  + 
Sbjct: 243 ---QGRRLPQPE-------YCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI--VSALL 290

Query: 426 SSSY 429
              Y
Sbjct: 291 GDHY 294

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  146 bits (370), Expect = 4e-39
 Identities = 82/284 (28%), Positives = 123/284 (43%), Gaps = 37/284 (13%)

Query: 138 ESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL 196
           E  LG+G FG V+ G W   NGT  V        A+KTL   G    + +L E   +  L
Sbjct: 189 EVKLGQGCFGEVWMGTW---NGTTRV--------AIKTL-KPGTMSPEAFLQEAQVMKKL 236

Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAF 255
            H  LV+L     E+    +V E+M +GSL + L       L     + +A   A G+A+
Sbjct: 237 RHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
           +        ++RD + +NIL+  +   K++DFGLA+   ED +            + APE
Sbjct: 296 V---ERMNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE 351

Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRLL 374
             + G  T KSDV+SFG++L E+ T  R       N E  + VE          R YR+ 
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE----------RGYRMP 401

Query: 375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
            P           +    L  QC  ++P+ RP    +   L+  
Sbjct: 402 CPPE-------CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  142 bits (359), Expect = 7e-39
 Identities = 75/285 (26%), Positives = 119/285 (41%), Gaps = 41/285 (14%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGNL 196
           LG+G FG V +G W   +G         ++VAVK L  D L   +   +++ EVN + +L
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKT-------VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78

Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLA 254
            H NL++L G  +      +V E  P GSL + L   +    L    R   A+  A+G+ 
Sbjct: 79  DHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMG 135

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT---YGY 311
           +L     K  I+RD    N+LL      K+ DFGL +  P++   +V          + +
Sbjct: 136 YL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAW 190

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRF 370
            APE + T   +  SD + FGV L EM T  +         +  + ++         +  
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID---------KEG 241

Query: 371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
            RL  P           Q    +  QC +  P+ RP    + + L
Sbjct: 242 ERLPRPED-------CPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  141 bits (358), Expect = 8e-39
 Identities = 78/305 (25%), Positives = 133/305 (43%), Gaps = 61/305 (20%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLHP 199
           LGEG FG V++G            G  + VAVKT   D    +K ++++E   + NL HP
Sbjct: 20  LGEGFFGEVYEG------VYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHP 73

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 257
           ++VKL+G   E+    ++ E  P G L ++L   + SL +   +    +L   K +A+L 
Sbjct: 74  HIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLY--SLQICKAMAYL- 129

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED-----GKTHVSTRVMGTYGYA 312
                  ++RD    NIL+ +    KL DFGL++   ++       T +  + M      
Sbjct: 130 --ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM------ 181

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPHLGDK 367
           +PE +     T+ SDV+ F V + E+L+ G++    ++    N +   ++E         
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE----NKDVIGVLE--------- 228

Query: 368 RRFYRLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDM 424
            +  RL  P L     +           L  +C   DP  RPR +E+V +   L ++  M
Sbjct: 229 -KGDRLPKPDLCPPVLY----------TLMTRCWDYDPSDRPRFTELVCS---LSDVYQM 274

Query: 425 ASSSY 429
                
Sbjct: 275 EKDIA 279

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  143 bits (362), Expect = 8e-39
 Identities = 75/294 (25%), Positives = 127/294 (43%), Gaps = 54/294 (18%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLH 198
           +G G FG V+KG     +G   V       VA+KTL      +   ++L E   +G   H
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVP------VAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 105

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 258
            N+++L G   +    +++ E+M  G+L+  L  +         + +  G A G+ +L  
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL-- 163

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG------YA 312
            A    ++RD    NIL++++   K+SDFGL++   +D +   +T      G      + 
Sbjct: 164 -ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIPIRWT 217

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPHLGDK 367
           APE +     TS SDV+SFG+V+ E++T G R    +     N E    +          
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL----SNHEVMKAIN--------- 264

Query: 368 RRFYRLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
              +RL  P       +          QL  QC  ++   RP+ +++V  L  L
Sbjct: 265 -DGFRLPTPMDCPSAIY----------QLMMQCWQQERARRPKFADIVSILDKL 307

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  141 bits (359), Expect = 8e-39
 Identities = 73/307 (23%), Positives = 116/307 (37%), Gaps = 61/307 (19%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           LGE  FG V+KG     G AP +      VA+KTL         +E+  E      L HP
Sbjct: 17  LGEDRFGKVYKG--HLFGPAPGEQTQ--AVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---------------MK 244
           N+V L+G   +D    +++ +   G L   L  RS                       + 
Sbjct: 73  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132

Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED------GK 298
           +    A G+ +L   +   V+++D  T N+L+    N K+SD GL ++          G 
Sbjct: 133 LVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189

Query: 299 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE- 353
           + +  R M      APE +M G  +  SD++S+GVVL E+ + G +          N + 
Sbjct: 190 SLLPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY----SNQDV 239

Query: 354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
             ++               L  P                L  +C +  P  RPR  ++  
Sbjct: 240 VEMIR----------NRQVLPCPD-------DCPAWVYALMIECWNEFPSRRPRFKDIHS 282

Query: 414 TLKPLQN 420
            L+   N
Sbjct: 283 RLRAWGN 289

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  141 bits (357), Expect = 1e-38
 Identities = 65/282 (23%), Positives = 108/282 (38%), Gaps = 40/282 (14%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEV 190
           R  + +  +G G F  V+KG   E         T + VA   L    L     + +  E 
Sbjct: 26  RFLKFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEA 76

Query: 191 NFLGNLLHPNLVKLVGYCI---EDDQRLLVY-EFMPRGSLENHLFRRSLPLPWSIRMKIA 246
             L  L HPN+V+         +  + +++  E M  G+L+ +L +R   +   +     
Sbjct: 77  EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWC 135

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFGLAKDAPEDGKTHVSTRV 305
               KGL FLH     P+I+RD K  NI +     + K+ D GLA       +   +  V
Sbjct: 136 RQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAV 190

Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHL 364
           +GT  + APE     +     DVY+FG+ +LEM T         P +   N  +      
Sbjct: 191 IGTPEFMAPEMYEEKY-DESVDVYAFGMCMLEMATSE------YPYSECQNAAQI----- 238

Query: 365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
                + R+        F      +  ++   C+ ++   R 
Sbjct: 239 -----YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERY 275

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  141 bits (357), Expect = 2e-38
 Identities = 65/315 (20%), Positives = 111/315 (35%), Gaps = 73/315 (23%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 191
             +F   ++LG+G FG V K                   A+K + H   +     L+EV 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKA---------RNALDSRYYAIKKIRHTEEK-LSTILSEVM 54

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRL-------------LVYEFMPRGSLENHLFRRSLPLP 238
            L +L H  +V+     +E    +             +  E+   G+L + +   +L   
Sbjct: 55  LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQ 114

Query: 239 ----WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--- 291
               W +  +I       L+++H    + +I+RD K  NI +D   N K+ DFGLAK   
Sbjct: 115 RDEYWRLFRQILEA----LSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVH 167

Query: 292 ----------DAPEDGKTHVSTRVMGTYGYAAPEYVM--TGHLTSKSDVYSFGVVLLEML 339
                             ++++ + GT  Y A E V+  TGH   K D+YS G++  EM+
Sbjct: 168 RSLDILKLDSQNLPGSSDNLTSAI-GTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMI 225

Query: 340 TGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL---DPRLEGHFSIKGSQKATQLAAQ 396
                      +     V              + L          F     +   ++   
Sbjct: 226 YP--------FSTGMERVN-----------ILKKLRSVSIEFPPDFDDNKMKVEKKIIRL 266

Query: 397 CLSRDPKARPRMSEV 411
            +  DP  RP    +
Sbjct: 267 LIDHDPNKRPGARTL 281

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  140 bits (356), Expect = 2e-38
 Identities = 75/285 (26%), Positives = 127/285 (44%), Gaps = 43/285 (15%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  +     +E+L E   +  + HPN
Sbjct: 21  LGGGQYGEVYEG---------VWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPN 70

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--- 127

Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG-KTHVSTRV----MGTYGYAAP 314
            +K  I+RD    N L+  ++  K++DFGL++    D    H   +            AP
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT------AP 181

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRL 373
           E +     + KSDV++FGV+L E+ T   S        + + L+E          + YR+
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----------KDYRM 231

Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
              R EG       +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 232 --ERPEG-----CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  140 bits (356), Expect = 2e-38
 Identities = 78/322 (24%), Positives = 128/322 (39%), Gaps = 63/322 (19%)

Query: 126 NDLKLATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGL--QG 182
             L L  +       LG G FG V KG +  +     V        AVK L ++      
Sbjct: 16  KLLTLEDK------ELGSGNFGTVKKGYYQMKKVVKTV--------AVKILKNEANDPAL 61

Query: 183 HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSI 241
             E LAE N +  L +P +V+++G C E +  +LV E    G L  +L   R +     I
Sbjct: 62  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII 120

Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
            +      + G+ +L    E   ++RD    N+LL   + AK+SDFGL+K    D   + 
Sbjct: 121 EL--VHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 175

Query: 302 STRVMGTYG------YAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPN 351
           +              + APE +     +SKSDV+SFGV++ E  + G++    M      
Sbjct: 176 AQT-----HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM----KG 226

Query: 352 GE-HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 410
            E   ++E          +  R+  P           ++   L   C + D + RP  + 
Sbjct: 227 SEVTAMLE----------KGERMGCPAG-------CPREMYDLMNLCWTYDVENRPGFAA 269

Query: 411 VVETLKPLQNLKDMASSSYYFQ 432
           V   L+      D+ +  ++  
Sbjct: 270 VELRLRNY--YYDVVNEGHHHH 289

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  141 bits (357), Expect = 2e-38
 Identities = 71/329 (21%), Positives = 129/329 (39%), Gaps = 75/329 (22%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLH 198
           LG+G FG V +           + G+ + VAVK L  D +     +E+L E   +    H
Sbjct: 31  LGKGEFGSVREA------QLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH 84

Query: 199 PNLVKLVGYCIEDDQR------LLVYEFMPRGSLENHL-FRRSLPLPWSIRMK----IAL 247
           P++ KLVG  +    +      +++  FM  G L   L   R    P+++ ++      +
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED------GKTHV 301
             A G+ +L   + +  I+RD    N +L  D    ++DFGL++             + +
Sbjct: 145 DIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201

Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNL 356
             + +      A E +     T  SDV++FGV + E++T G+     ++    N E +N 
Sbjct: 202 PVKWL------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE----NAEIYNY 251

Query: 357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
           +              RL  P        +  ++   L  QC S DPK RP  + +   L+
Sbjct: 252 LI----------GGNRLKQPP-------ECMEEVYDLMYQCWSADPKQRPSFTCLRMELE 294

Query: 417 PL---------------QNLKDMASSSYY 430
            +                N++      ++
Sbjct: 295 NILGHLSVLSTSQDPLYINIERAHHHHHH 323

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  138 bits (351), Expect = 7e-38
 Identities = 74/291 (25%), Positives = 116/291 (39%), Gaps = 52/291 (17%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLHP 199
           +GEG FG V +G               L VA+KT  +      + ++L E   +    HP
Sbjct: 23  IGEGQFGDVHQG------IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 76

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 257
           ++VKL+G   E+    ++ E    G L + L   + SL L   I    A   +  LA+L 
Sbjct: 77  HIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILY--AYQLSTALAYL- 132

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED-----GKTHVSTRVMGTYGYA 312
               K  ++RD    N+L+ ++   KL DFGL++   +       K  +  + M      
Sbjct: 133 --ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM------ 184

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPHLGDK 367
           APE +     TS SDV+ FGV + E+L  G +    +     N +    +E         
Sbjct: 185 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV----KNNDVIGRIE--------- 231

Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
               RL  P                L  +C + DP  RPR +E+   L  +
Sbjct: 232 -NGERL--PMPPN-----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  141 bits (357), Expect = 9e-38
 Identities = 74/292 (25%), Positives = 130/292 (44%), Gaps = 51/292 (17%)

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL 196
           + ++G G FG V  G ++      +       VA+KTL      +  +++L E + +G  
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEIS------VAIKTLKVGYTEKQRRDFLGEASIMGQF 103

Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 256
            HPN+++L G   +    ++V E+M  GSL++ L +          + +  G A G+ +L
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163

Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT---YGYAA 313
              ++   ++RD    NIL++++   K+SDFGL +   +D +   +TR  G      + +
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWTS 218

Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPHLGDKR 368
           PE +     TS SDV+S+G+VL E+++ G R    M     N +    V+          
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS----NQDVIKAVD---------- 264

Query: 369 RFYRLLDPRLEG-----HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
             YRL  P         +          QL   C  +D   RP+  ++V  L
Sbjct: 265 EGYRL--PPPMDCPAALY----------QLMLDCWQKDRNNRPKFEQIVSIL 304

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  142 bits (361), Expect = 9e-38
 Identities = 76/285 (26%), Positives = 124/285 (43%), Gaps = 49/285 (17%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +G+G FG V  G +             G  VAVK + +D     + +LAE + +  L H 
Sbjct: 201 IGKGEFGDVMLGDY------------RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHS 246

Query: 200 NLVKLVGYCIEDDQRL-LVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLH 257
           NLV+L+G  +E+   L +V E+M +GSL ++L  R    L     +K +L   + + +L 
Sbjct: 247 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL- 305

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD---APEDGKTHVSTRVMGTYGYAAP 314
                  ++RD    N+L+  D  AK+SDFGL K+     + GK  V  +        AP
Sbjct: 306 --EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV--KWT------AP 355

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRL 373
           E +     ++KSDV+SFG++L E+ +  R      P  +    VE          + Y++
Sbjct: 356 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE----------KGYKM 405

Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
             P                +   C   D   RP   ++ E L+ +
Sbjct: 406 DAPDG-------CPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  138 bits (349), Expect = 2e-37
 Identities = 77/291 (26%), Positives = 128/291 (43%), Gaps = 57/291 (19%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +G+G FG V  G +             G  VAVK + +D     + +LAE + +  L H 
Sbjct: 29  IGKGEFGDVMLGDY------------RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHS 74

Query: 200 NLVKLVGYCIEDDQRL-LVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLH 257
           NLV+L+G  +E+   L +V E+M +GSL ++L  R    L     +K +L   + + +L 
Sbjct: 75  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL- 133

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD---APEDGKTHVSTRVMGTYGYAAP 314
                  ++RD    N+L+  D  AK+SDFGL K+     + GK  V  +        AP
Sbjct: 134 --EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV--KWT------AP 183

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPHLGDKRR 369
           E +     ++KSDV+SFG++L E+ + GR     +    P  +    VE          +
Sbjct: 184 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI----PLKDVVPRVE----------K 229

Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN 420
            Y++  P               ++   C   D   RP   ++ E L+ ++ 
Sbjct: 230 GYKMDAPDG-------CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  140 bits (354), Expect = 2e-37
 Identities = 81/314 (25%), Positives = 127/314 (40%), Gaps = 52/314 (16%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLL-H 198
           LGEG FG V     E  G    KP     VAVK L  D   +   + ++E+  +  +  H
Sbjct: 77  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-----------FRRSLPLPWSIRMK--- 244
            N++ L+G C +D    ++ E+  +G+L  +L           +  S      +  K   
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 245 -IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG--KTHV 301
             A   A+G+ +L   A K  I+RD    N+L+  D   K++DFGLA+D       K   
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251

Query: 302 STRV----MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNL 356
           + R+    M      APE +     T +SDV+SFGV+L E+ T   S     P  E   L
Sbjct: 252 NGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305

Query: 357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
           ++            +R+   +         + +   +   C    P  RP   ++VE L 
Sbjct: 306 LK----------EGHRM--DKPSNC-----TNELYMMMRDCWHAVPSQRPTFKQLVEDLD 348

Query: 417 PLQNLKDMASSSYY 430
            +  L       YY
Sbjct: 349 RIVALTSNQEMGYY 362

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  139 bits (353), Expect = 3e-37
 Identities = 91/400 (22%), Positives = 156/400 (39%), Gaps = 64/400 (16%)

Query: 45  IGCWVRFRFIESCMPSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPVSSTTTSNAESA 104
           +G            P+  K+   +          +SS+    + P+V +++  +S A++ 
Sbjct: 1   MGSSHHHHHHSQDPPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTP 60

Query: 105 SSTPKFSEELKVASQLRKFMF--NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPV 162
                   EL    +  K+ F  + L L          LGEG FG V     E  G    
Sbjct: 61  MLAGVSEYEL---PEDPKWEFPRDKLTL-------GKPLGEGCFGQVVMA--EAVGIDKD 108

Query: 163 KPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIEDDQRLLVYEF 220
           KP   +TVAVK L  D   +   + ++E+  +  +  H N++ L+G C +D    ++ E+
Sbjct: 109 KPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEY 168

Query: 221 MPRGSLENHLFRRSLPLPWSIR---------------MKIALGAAKGLAFLHEEAEKPVI 265
             +G+L  +L  R  P                     +      A+G+ +L   A +  I
Sbjct: 169 ASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCI 225

Query: 266 YRDFKTSNILLDADYNAKLSDFGLAKDAPEDG--KTHVSTRV----MGTYGYAAPEYVMT 319
           +RD    N+L+  +   K++DFGLA+D       K   + R+    M      APE +  
Sbjct: 226 HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM------APEALFD 279

Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRLLDPRL 378
              T +SDV+SFGV++ E+ T   S     P  E   L+          +  +R+  P  
Sbjct: 280 RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL----------KEGHRMDKPA- 328

Query: 379 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                   + +   +   C    P  RP   ++VE L  +
Sbjct: 329 ------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  142 bits (360), Expect = 3e-37
 Identities = 82/292 (28%), Positives = 124/292 (42%), Gaps = 40/292 (13%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V+ G W   NGT  V        A+KTL   G    + +L E   +  L H 
Sbjct: 275 LGQGCFGEVWMGTW---NGTTRV--------AIKTL-KPGTMSPEAFLQEAQVMKKLRHE 322

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLHE 258
            LV+L     E+    +V E+M +GSL + L       L     + +A   A G+A++  
Sbjct: 323 KLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-- 379

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                 ++RD + +NIL+  +   K++DFGLA+   ED +            + APE  +
Sbjct: 380 -ERMNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAAL 437

Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRLLDPR 377
            G  T KSDV+SFG++L E+ T  R       N E  + VE          R YR+  P 
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE----------RGYRMPCPP 487

Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSY 429
                     +    L  QC  ++P+ RP    +      L++        Y
Sbjct: 488 E-------CPESLHDLMCQCWRKEPEERPTFEYLQAF---LEDYFTSTEPQY 529

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  138 bits (349), Expect = 3e-37
 Identities = 75/292 (25%), Positives = 117/292 (40%), Gaps = 50/292 (17%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEV 190
           NFR E  +G G F  V++               G+ VA+K +    L   K     + E+
Sbjct: 33  NFRIEKKIGRGQFSEVYRA---------ACLLDGVPVALKKVQIFDLMDAKARADCIKEI 83

Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIAL 247
           + L  L HPN++K     IED++  +V E    G L   +    ++   +P     K  +
Sbjct: 84  DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV 143

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
                L  +H    + V++RD K +N+ + A    KL D GL +       T   + V G
Sbjct: 144 QLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLV-G 198

Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  Y +PE +       KSD++S G +L EM   +                   P  GDK
Sbjct: 199 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ------------------SPFYGDK 240

Query: 368 RRFYRLL--------DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
              Y L          P    H+    S++  QL   C++ DP+ RP ++ V
Sbjct: 241 MNLYSLCKKIEQCDYPPLPSDHY----SEELRQLVNMCINPDPEKRPDVTYV 288

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  137 bits (348), Expect = 3e-37
 Identities = 66/305 (21%), Positives = 112/305 (36%), Gaps = 56/305 (18%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 192
           +F P   LG GGFG VF+                   A+K +     +  +E  + EV  
Sbjct: 6   DFEPIQCLGRGGFGVVFEA---------KNKVDDCNYAIKRIRLPNRELAREKVMREVKA 56

Query: 193 LGNLLHPNLVKLVGYCIEDD---------QRLLVY---EFMPRGSLENHLFRR--SLPLP 238
           L  L HP +V+     +E +          ++ +Y   +   + +L++ +  R       
Sbjct: 57  LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116

Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK------- 291
            S+ + I L  A+ + FLH    K +++RD K SNI    D   K+ DFGL         
Sbjct: 117 RSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 173

Query: 292 ---DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN 348
                         T  +GT  Y +PE +     + K D++S G++L E+L         
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-------- 225

Query: 349 RPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM 408
             + +   V               + + +    F+ K       +    LS  P  RP  
Sbjct: 226 PFSTQMERVR----------TLTDVRNLKFPPLFTQK-YPCEYVMVQDMLSPSPMERPEA 274

Query: 409 SEVVE 413
             ++E
Sbjct: 275 INIIE 279

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  137 bits (347), Expect = 3e-37
 Identities = 81/284 (28%), Positives = 126/284 (44%), Gaps = 43/284 (15%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V+ G +   NG   V        AVK+L   G      +LAE N +  L H 
Sbjct: 21  LGAGQFGEVWMGYY---NGHTKV--------AVKSLK-QGSMSPDAFLAEANLMKQLQHQ 68

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLHE 258
            LV+L     ++    ++ E+M  GSL + L     + L  +  + +A   A+G+AF+  
Sbjct: 69  RLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI-- 125

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT---YGYAAPE 315
             E+  I+RD + +NIL+    + K++DFGLA+   ++      T   G      + APE
Sbjct: 126 -EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN----EYTAREGAKFPIKWTAPE 180

Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRLL 374
            +  G  T KSDV+SFG++L E++T  R       N E    +E          R YR+ 
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE----------RGYRM- 229

Query: 375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
             R +        ++  QL   C    P+ RP    +   L+  
Sbjct: 230 -VRPDN-----CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  144 bits (364), Expect = 3e-37
 Identities = 71/292 (24%), Positives = 115/292 (39%), Gaps = 48/292 (16%)

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNL 196
              +GEG FG V +G               + VA+KT  +       +++L E   +   
Sbjct: 395 GRCIGEGQFGDVHQG------IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF 448

Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 256
            HP++VKL+G   E+    ++ E    G L + L  R   L  +  +  A   +  LA+L
Sbjct: 449 DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL 507

Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED-----GKTHVSTRVMGTYGY 311
                K  ++RD    N+L+ ++   KL DFGL++   +       K  +  + M     
Sbjct: 508 ---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----- 559

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPHLGD 366
            APE +     TS SDV+ FGV + E+L  G +    +     N +    +E        
Sbjct: 560 -APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV----KNNDVIGRIE-------- 606

Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                RL  P                L  +C + DP  RPR +E+   L  +
Sbjct: 607 --NGERL--PMPPN-----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  138 bits (350), Expect = 3e-37
 Identities = 63/223 (28%), Positives = 101/223 (45%), Gaps = 34/223 (15%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLL-H 198
           LGEG FG V     E  G    KP   +TVAVK L  D   +   + ++E+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---------------M 243
            N++ L+G C +D    ++ E+  +G+L  +L  R  P                     +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG--KTHV 301
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D       K   
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217

Query: 302 STRV----MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           + R+    M      APE +     T +SDV+SFGV++ E+ T
Sbjct: 218 NGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 254

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  137 bits (347), Expect = 7e-37
 Identities = 79/314 (25%), Positives = 124/314 (39%), Gaps = 57/314 (18%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V++G V  +G           VAVKTL      Q   ++L E   +    H 
Sbjct: 38  LGHGAFGEVYEGQV--SGMPNDPSPL--QVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-------LPWSIRMKIALGAAKG 252
           N+V+ +G  ++   R ++ E M  G L++ L R + P       L     + +A   A G
Sbjct: 94  NIVRCIGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACG 152

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPED------GKTHVST 303
             +L    E   I+RD    N LL        AK+ DFG+A+D          G   +  
Sbjct: 153 CQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209

Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVE 358
           + M       PE  M G  TSK+D +SFGV+L E+ + G     S      N E    V 
Sbjct: 210 KWM------PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK----SNQEVLEFV- 258

Query: 359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                        R+  P+              ++  QC    P+ RP  + ++E ++  
Sbjct: 259 ---------TSGGRMDPPK-------NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302

Query: 419 QNLKDMASSSYYFQ 432
               D+ +++   +
Sbjct: 303 TQDPDVINTALPIE 316

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  139 bits (353), Expect = 1e-36
 Identities = 79/296 (26%), Positives = 125/296 (42%), Gaps = 42/296 (14%)

Query: 138 ESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL 196
           E  LG G FG V+   +   N    V        AVKT+   G    + +LAE N +  L
Sbjct: 193 EKKLGAGQFGEVWMATY---NKHTKV--------AVKTM-KPGSMSVEAFLAEANVMKTL 240

Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAF 255
            H  LVKL     ++    ++ EFM +GSL + L        P    +  +   A+G+AF
Sbjct: 241 QHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 299

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG-KTHVSTRVMGTYGYAAP 314
           +    ++  I+RD + +NIL+ A    K++DFGLA+   ++        +      + AP
Sbjct: 300 I---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP--IKWTAP 354

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRL 373
           E +  G  T KSDV+SFG++L+E++T  R       N E    +E          R YR+
Sbjct: 355 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE----------RGYRM 404

Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSY 429
             P           ++   +  +C    P+ RP    +      L +      S Y
Sbjct: 405 PRPEN-------CPEELYNIMMRCWKNRPEERPTFEYIQSV---LDDFYTATESQY 450

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  136 bits (345), Expect = 1e-36
 Identities = 76/308 (24%), Positives = 127/308 (41%), Gaps = 66/308 (21%)

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNL 196
           + ++GEG FG V K  ++       K G  +  A+K +        H+++  E+  L  L
Sbjct: 30  QDVIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 82

Query: 197 L-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR------------- 242
             HPN++ L+G C       L  E+ P G+L + L R+S  L                  
Sbjct: 83  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSS 141

Query: 243 ---MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
              +  A   A+G+ +L   ++K  I+RD    NIL+  +Y AK++DFGL++      K 
Sbjct: 142 QQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 198

Query: 300 HVSTRV----MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPN 351
               R+    M      A E +     T+ SDV+S+GV+L E+++ G      M      
Sbjct: 199 T-MGRLPVRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM----TC 247

Query: 352 GE-HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 410
            E +  +           + YRL  P            +   L  QC    P  RP  ++
Sbjct: 248 AELYEKLP----------QGYRLEKPL-------NCDDEVYDLMRQCWREKPYERPSFAQ 290

Query: 411 VVETLKPL 418
           ++ +L  +
Sbjct: 291 ILVSLNRM 298

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  141 bits (357), Expect = 2e-36
 Identities = 67/288 (23%), Positives = 115/288 (39%), Gaps = 43/288 (14%)

Query: 138 ESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGN 195
           +  LG G FG V +G +        V        A+K L         +E + E   +  
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDV--------AIKVLKQGTEKADTEEMMREAQIMHQ 392

Query: 196 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 255
           L +P +V+L+G C + +  +LV E    G L   L  +   +P S   ++    + G+ +
Sbjct: 393 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY 451

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT---YGYA 312
           L    EK  ++R+    N+LL   + AK+SDFGL+K    D   + +           + 
Sbjct: 452 L---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--AGKWPLKWY 506

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFY 371
           APE +     +S+SDV+S+GV + E L+  +   K     E    +E          +  
Sbjct: 507 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE----------QGK 556

Query: 372 RLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
           R+  P     E +           L + C     + RP    V + ++
Sbjct: 557 RMECPPECPPELY----------ALMSDCWIYKWEDRPDFLTVEQRMR 594

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  136 bits (345), Expect = 2e-36
 Identities = 65/358 (18%), Positives = 129/358 (36%), Gaps = 39/358 (10%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEV 190
            +     +GEG FG                   G    +K +N   +   KE      EV
Sbjct: 25  KYVRLQKIGEGSFGKAILV---------KSTEDGRQYVIKEINISRMS-SKEREESRREV 74

Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGA 249
             L N+ HPN+V+      E+    +V ++   G L   +  ++ +       +   +  
Sbjct: 75  AVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI 134

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
              L  +H+   + +++RD K+ NI L  D   +L DFG+A+    +    ++   +GT 
Sbjct: 135 CLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARACIGTP 189

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            Y +PE        +KSD+++ G VL E+ T + + +          +            
Sbjct: 190 YYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF------- 242

Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPLQNLKDMASS 427
                 P +  H+    S     L +Q   R+P+ RP ++ ++E   +            
Sbjct: 243 ------PPVSLHY----SYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQL 292

Query: 428 SYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPLRTLSHPNGPHASPYRHPQQSPK 485
                 ++  + +         R   G  + +  P + ++ P   +  P  + +   K
Sbjct: 293 IAEEFCLKTFSKFG-SQPIPAKRPASGQNSISVMPAQKITKPAAKYGIPLAYKKYGDK 349

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  135 bits (343), Expect = 6e-36
 Identities = 77/300 (25%), Positives = 119/300 (39%), Gaps = 57/300 (19%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V++G V  +G           VAVKTL      Q   ++L E   +    H 
Sbjct: 79  LGHGAFGEVYEGQV--SGMPNDPSPL--QVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-----PWSIR--MKIALGAAKG 252
           N+V+ +G  ++   R ++ E M  G L++ L R + P        ++   + +A   A G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACG 193

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPED------GKTHVST 303
             +L    E   I+RD    N LL        AK+ DFG+A+D          G   +  
Sbjct: 194 CQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV 250

Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVE 358
           + M       PE  M G  TSK+D +SFGV+L E+ + G     S      N E    V 
Sbjct: 251 KWM------PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK----SNQEVLEFV- 299

Query: 359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                        R+  P+              ++  QC    P+ RP  + ++E ++  
Sbjct: 300 ---------TSGGRMDPPK-------NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  135 bits (342), Expect = 6e-36
 Identities = 63/230 (27%), Positives = 100/230 (43%), Gaps = 43/230 (18%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           +GEG FG VF+      G  P +P T   VAVK L  +       ++  E   +    +P
Sbjct: 55  IGEGAFGRVFQA--RAPGLLPYEPFT--MVAVKMLKEEASADMQADFQREAALMAEFDNP 110

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR----------------- 242
           N+VKL+G C       L++E+M  G L   L   S     S+                  
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170

Query: 243 ------MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED 296
                 + IA   A G+A+L   +E+  ++RD  T N L+  +   K++DFGL+++    
Sbjct: 171 LSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227

Query: 297 ------GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                 G   +  R M       PE +     T++SDV+++GVVL E+ +
Sbjct: 228 DYYKADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 271

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  134 bits (339), Expect = 1e-35
 Identities = 69/341 (20%), Positives = 116/341 (34%), Gaps = 53/341 (15%)

Query: 78  GKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRP 137
           G  S+ +      +  + ++ S             E  + ++  K +  + +        
Sbjct: 3   GSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTH 62

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL 197
           +  +G G FG V +              TG   AVK +    L+  +    E+     L 
Sbjct: 63  QPRVGRGSFGEVHRM---------KDKQTGFQCAVKKVR---LEVFRV--EELVACAGLS 108

Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 257
            P +V L G   E     +  E +  GSL   L ++   LP    +     A +GL +LH
Sbjct: 109 SPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLIKQMGCLPEDRALYYLGQALEGLEYLH 167

Query: 258 EEAEKPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDAPEDGKTHVSTR---VMGTYGYAA 313
                 +++ D K  N+LL +D   A L DFG A     DG          + GT  + A
Sbjct: 168 TRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 224

Query: 314 PEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-------LVEWARPHLG 365
           PE VM      +K D++S   ++L ML G        P  ++        +     P   
Sbjct: 225 PEVVMGKPC-DAKVDIWSSCCMMLHMLNGC------HPWTQYFRGPLCLKIASEPPPI-- 275

Query: 366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
                       +        +    Q   + L ++P  R 
Sbjct: 276 ----------REIPPSC----APLTAQAIQEGLRKEPVHRA 302

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  133 bits (337), Expect = 1e-35
 Identities = 78/307 (25%), Positives = 117/307 (38%), Gaps = 61/307 (19%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLL-H 198
           LG G FG V +      G          TVAVK L     L   +  ++E+  L  L  H
Sbjct: 31  LGAGAFGKVVEA--TAYGLIKSDAAM--TVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---------------- 242
            N+V L+G C      L++ E+   G L N L R+      S                  
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 243 -MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED----- 296
            +  +   AKG+AFL   A K  I+RD    NILL      K+ DFGLA+D   D     
Sbjct: 147 LLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203

Query: 297 -GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPN 351
            G   +  + M      APE +     T +SDV+S+G+ L E+ + G      M  +   
Sbjct: 204 KGNARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-- 255

Query: 352 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
                 +     +   +  +R+L P            +   +   C   DP  RP   ++
Sbjct: 256 ---KFYK----MI---KEGFRMLSPE-------HAPAEMYDIMKTCWDADPLKRPTFKQI 298

Query: 412 VETLKPL 418
           V+ ++  
Sbjct: 299 VQLIEKQ 305

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  132 bits (334), Expect = 4e-35
 Identities = 79/307 (25%), Positives = 119/307 (38%), Gaps = 62/307 (20%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLL-H 198
           LG G FG V +   +  G          TVAVK L        H+  ++E+  L ++  H
Sbjct: 35  LGRGAFGQVIEA--DAFGIDKTATCR--TVAVKMLKEGATHSEHRALMSELKILIHIGHH 90

Query: 199 PNLVKLVGYCIEDDQ-RLLVYEFMPRGSLENHLFRRSLPLPWSIR--------------- 242
            N+V L+G C +     +++ EF   G+L  +L R         +               
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFLTLEH 149

Query: 243 -MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG--KT 299
            +  +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D     
Sbjct: 150 LICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206

Query: 300 HVSTRV----MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPN 351
               R+    M      APE +     T +SDV+SFGV+L E+ + G      +  +   
Sbjct: 207 KGDARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--- 257

Query: 352 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
                       L   +   R+  P          + +  Q    C   +P  RP  SE+
Sbjct: 258 --EEFCR----RL---KEGTRMRAPD-------YTTPEMYQTMLDCWHGEPSQRPTFSEL 301

Query: 412 VETLKPL 418
           VE L  L
Sbjct: 302 VEHLGNL 308

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  131 bits (333), Expect = 5e-35
 Identities = 67/231 (29%), Positives = 102/231 (44%), Gaps = 45/231 (19%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           LGEG FG V K              T  TVAVK L  +      ++ L+E N L  + HP
Sbjct: 31  LGEGEFGKVVKA--TAFHLKGRAGYT--TVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR----------------- 242
           +++KL G C +D   LL+ E+   GSL   L R S  +                      
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFL-RESRKVGPGYLGSGGSRNSSSLDHPDER 145

Query: 243 -------MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE 295
                  +  A   ++G+ +L   AE  +++RD    NIL+      K+SDFGL++D  E
Sbjct: 146 ALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202

Query: 296 D------GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +       +  +  + M      A E +     T++SDV+SFGV+L E++T
Sbjct: 203 EDSYVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  131 bits (332), Expect = 6e-35
 Identities = 68/322 (21%), Positives = 119/322 (36%), Gaps = 60/322 (18%)

Query: 94  SSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGW 153
           S  +T   +  S   ++  E                          +LG+G +G V+ G 
Sbjct: 1   SMRSTEEGDCESDLLEYDYEYD------------------ENGDRVVLGKGTYGIVYAG- 41

Query: 154 VEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQ 213
                         + +A+K +     +  +    E+    +L H N+V+ +G   E+  
Sbjct: 42  --------RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93

Query: 214 RLLVYEFMPRGSLENHLFRRSLPLPWS---IRMKIALGAAKGLAFLHEEAEKPVIYRDFK 270
             +  E +P GSL   L  +  PL  +   I         +GL +LH+     +++RD K
Sbjct: 94  IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG-FYTKQILEGLKYLHDNQ---IVHRDIK 149

Query: 271 TSNILLDA-DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV---MTGHLTSKS 326
             N+L++      K+SDFG +K          +    GT  Y APE +     G+    +
Sbjct: 150 GDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRGY-GKAA 206

Query: 327 DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP--HLGDKRRFYRLLDPRLEGHFSI 384
           D++S G  ++EM TG+       P   + L E       +G  +     + P +      
Sbjct: 207 DIWSLGCTIIEMATGK------PPF--YELGEPQAAMFKVGMFK-----VHPEIPESM-- 251

Query: 385 KGSQKATQLAAQCLSRDPKARP 406
             S +A     +C   DP  R 
Sbjct: 252 --SAEAKAFILKCFEPDPDKRA 271

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  133 bits (335), Expect = 8e-35
 Identities = 49/390 (12%), Positives = 85/390 (21%), Gaps = 64/390 (16%)

Query: 78  GKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRP 137
           G S       R    +        +  ++  +              + + L    R  + 
Sbjct: 7   GDSFMRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKL 66

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLG 194
              L  G    VF                    A+K           E            
Sbjct: 67  VEPLRVGDRSVVFLV---------RDVERLEDFALKVFTMGAENSRSELERLHEATFAAA 117

Query: 195 NLLHPNLVKLVGYC-----------------------IEDDQRLLVYEFMPR-------- 223
            LL  +  +                             +D         MP         
Sbjct: 118 RLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELL 177

Query: 224 GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK 283
            S  + ++             +     +  A L     K +++  F   N+ +  D    
Sbjct: 178 FSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLM 234

Query: 284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL--TSKSDVYSFGVVLLEMLTG 341
           L D          G             YA  E++       T   + +  G+ +  +   
Sbjct: 235 LGDVSALWKVGTRGPA-----SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289

Query: 342 RRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRD 401
                   P  +     W RP L             L              L  + L+ D
Sbjct: 290 FLPFGLVTPGIKG---SWKRPSLRVPGT------DSLAFGSCTPLPDFVKTLIGRFLNFD 340

Query: 402 PKARPRMSEVVET--LKPLQNLKDMASSSY 429
            + R    E +ET     LQN    + S+ 
Sbjct: 341 RRRRLLPLEAMETPEFLQLQNEISSSLSTG 370

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  132 bits (333), Expect = 8e-35
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 34/221 (15%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLL-H 198
           LG G FG V +           K    L VAVK L         +  ++E+  + +L  H
Sbjct: 54  LGAGAFGKVVEATAFG----LGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR-------------MKI 245
            N+V L+G C      L++ E+   G L N L R+S  L                  +  
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169

Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED------GKT 299
           +   A+G+AFL   A K  I+RD    N+LL   + AK+ DFGLA+D   D      G  
Sbjct: 170 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226

Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            +  + M      APE +     T +SDV+S+G++L E+ +
Sbjct: 227 RLPVKWM------APESIFDCVYTVQSDVWSYGILLWEIFS 261

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  130 bits (328), Expect = 1e-34
 Identities = 64/290 (22%), Positives = 111/290 (38%), Gaps = 37/290 (12%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEV 190
            ++     +G G +G   K  +            G  +  K L++  +     +  ++EV
Sbjct: 6   EDYEVLYTIGTGSYGRCQK--IRRKSD-------GKILVWKELDYGSMTEAEKQMLVSEV 56

Query: 191 NFLGNLLHPNLVKLVG-YCIEDDQRL-LVYEFMPRGSLENHL---FRRSLPLPWSIRMKI 245
           N L  L HPN+V+         +  L +V E+   G L + +    +    L     +++
Sbjct: 57  NLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV 116

Query: 246 ALGAAKGLAFLHE--EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
                  L   H   +    V++RD K +N+ LD   N KL DFGLA+       +   T
Sbjct: 117 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKT 175

Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
            V GT  Y +PE +       KSD++S G +L E+           P    +  E A   
Sbjct: 176 FV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELAGKI 228

Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
              K         R+   +    S +  ++  + L+     RP + E++E
Sbjct: 229 REGKF-------RRIPYRY----SDELNEIITRMLNLKDYHRPSVEEILE 267

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  130 bits (330), Expect = 2e-34
 Identities = 71/323 (21%), Positives = 117/323 (36%), Gaps = 68/323 (21%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLL-H 198
           LG G FG V        G +         VAVK L         +  ++E+  +  L  H
Sbjct: 53  LGSGAFGKVMNA--TAYGISKTGVSI--QVAVKMLKEKADSSEREALMSELKMMTQLGSH 108

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---------------- 242
            N+V L+G C       L++E+   G L N+L  +                         
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168

Query: 243 ------MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED 296
                 +  A   AKG+ FL     K  ++RD    N+L+      K+ DFGLA+D   D
Sbjct: 169 LTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225

Query: 297 ------GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMD 346
                 G   +  + M      APE +  G  T KSDV+S+G++L E+ + G      + 
Sbjct: 226 SNYVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279

Query: 347 KNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            +      N  +     +   +  +++  P          +++   +   C + D + RP
Sbjct: 280 VD-----ANFYK----LI---QNGFKMDQPF-------YATEEIYIIMQSCWAFDSRKRP 320

Query: 407 RMSEVVETLKPLQNLKDMASSSY 429
               +   L     L D   + Y
Sbjct: 321 SFPNLTSFLGCQ--LADAEEAMY 341

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  128 bits (324), Expect = 6e-34
 Identities = 73/291 (25%), Positives = 117/291 (40%), Gaps = 41/291 (14%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGL--TVAVKTLNHDGLQGHKEWLA---- 188
           ++    LG GG   V+               T L   VA+K +     +  +E L     
Sbjct: 13  YKIVDKLGGGGMSTVYLAE-----------DTILNIKVAIKAI-FIPPREKEETLKRFER 60

Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 248
           EV+    L H N+V ++    EDD   LV E++   +L  ++     PL     +     
Sbjct: 61  EVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQ 119

Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
              G+   H+     +++RD K  NIL+D++   K+ DFG+AK   E   T  +  V+GT
Sbjct: 120 ILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGT 175

Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDK 367
             Y +PE          +D+YS G+VL EML G        P NGE   V  A  H+ D 
Sbjct: 176 VQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE------PPFNGE-TAVSIAIKHIQDS 228

Query: 368 R-RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-MSEVVETLK 416
                  +   +         Q  + +  +   +D   R + + E+ + L 
Sbjct: 229 VPNVTTDVRKDI--------PQSLSNVILRATEKDKANRYKTIQEMKDDLS 271

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  128 bits (323), Expect = 1e-33
 Identities = 58/213 (27%), Positives = 84/213 (39%), Gaps = 19/213 (8%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----EV 190
           +R   L+G GG G V++                  VA+K +  + L     +      E 
Sbjct: 36  YRLRRLVGRGGMGDVYEA---------EDTVRERIVALKLM-SETLSSDPVFRTRMQREA 85

Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 250
              G L  P++V +  +   D Q  +    +    L   L RR  PL     + I     
Sbjct: 86  RTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIG 144

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
             L   H        +RD K  NIL+ AD  A L DFG+A    ++  T +    +GT  
Sbjct: 145 SALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLY 200

Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 343
           Y APE     H T ++D+Y+   VL E LTG  
Sbjct: 201 YMAPERFSESHATYRADIYALTCVLYECLTGSP 233

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  130 bits (328), Expect = 1e-33
 Identities = 72/360 (20%), Positives = 127/360 (35%), Gaps = 66/360 (18%)

Query: 69  SGTSTNYADGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDL 128
           SG     +  K +   + +R  +      T + + ASS+                    +
Sbjct: 8   SGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSAN----------------ECI 51

Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEW 186
            +  R +     +G GG   VF+          V        A+K +N +    Q    +
Sbjct: 52  SVKGRIYSILKQIGSGGSSKVFQ----------VLNEKKQIYAIKYVNLEEADNQTLDSY 101

Query: 187 LAEVNFLGNLLHPNL--VKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM 243
             E+ +L  L   +   ++L  Y    DQ + +V E      L + L ++   +    R 
Sbjct: 102 RNEIAYLNKLQQHSDKIIRLYDY-EITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERK 158

Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
                  + +  +H+     +++ D K +N L+  D   KL DFG+A     D  + V  
Sbjct: 159 SYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKD 214

Query: 304 RVMGTYGYAAPEYVM-----------TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-N 351
             +G   Y  PE +               ++ KSDV+S G +L  M  G+       P  
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------TPFQ 268

Query: 352 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
              N +           + + ++DP  E  F     +    +   CL RDPK R  + E+
Sbjct: 269 QIINQIS----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  128 bits (323), Expect = 2e-33
 Identities = 65/304 (21%), Positives = 113/304 (37%), Gaps = 50/304 (16%)

Query: 125 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH- 183
           F  + +  R +     +G GG   VF+  + E              A+K +N +      
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQV-LNEKKQ---------IYAIKYVNLEEADNQT 69

Query: 184 -KEWLAEVNFLGNLLHPNL--VKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW 239
              +  E+ +L  L   +   ++L  Y    DQ + +V E      L + L ++   +  
Sbjct: 70  LDSYRNEIAYLNKLQQHSDKIIRLYDY-EITDQYIYMVMECG-NIDLNSWLKKKK-SIDP 126

Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
             R        + +  +H+     +++ D K +N L+  D   KL DFG+A     D  +
Sbjct: 127 WERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 182

Query: 300 HVSTRVMGTYGYAAPEYVM-----------TGHLTSKSDVYSFGVVLLEMLTGRRSMDKN 348
            V    +GT  Y  PE +               ++ KSDV+S G +L  M  G+      
Sbjct: 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------ 236

Query: 349 RP-NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR 407
            P     N +           + + ++DP  E  F     +    +   CL RDPK R  
Sbjct: 237 TPFQQIINQIS----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRIS 286

Query: 408 MSEV 411
           + E+
Sbjct: 287 IPEL 290

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  128 bits (324), Expect = 2e-33
 Identities = 54/395 (13%), Positives = 109/395 (27%), Gaps = 99/395 (25%)

Query: 83  EKRRDRPVVPVSSTTTSNAESASSTPKFSEE--LKVASQLRKFMFNDLKLATRNFRPESL 140
            +     V   S    S A+S  ST  ++     +V S+L +          R     ++
Sbjct: 29  NRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGER--------PRTLVRGTV 80

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-------------------- 180
           LG+       +              TG +  V                            
Sbjct: 81  LGQEDPYAYLEA---------TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 131

Query: 181 --------QGHKEWLAEVNFLGNLLHPNLVKLVGYC--IEDDQRLLVYEFMP-----RGS 225
                   + H  ++   + + +     ++++      +    R  +Y  M       G 
Sbjct: 132 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 191

Query: 226 LENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS 285
           +          L    R+++ L   + LA LH      +++   +  +I+LD      L+
Sbjct: 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLT 248

Query: 286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-----------GHLTSKSDVYSFGVV 334
            F        DG   VS     + G+  PE                 +T   D ++ G+V
Sbjct: 249 GFEHLV---RDGARVVS---SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302

Query: 335 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLA 394
           +  +           P  +   +  +       +                   Q    L 
Sbjct: 303 IYWIWCAD------LPITKDAALGGSEWIFRSCKNI----------------PQPVRALL 340

Query: 395 AQCLSRDPKARPRMSEVVETLKP-LQNLKDMASSS 428
              L    + R    + +ET  P  + L+   S++
Sbjct: 341 EGFLRYPKEDRLLPLQAMET--PEYEQLRTELSAA 373

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  129 bits (326), Expect = 2e-33
 Identities = 68/340 (20%), Positives = 115/340 (33%), Gaps = 56/340 (16%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLH 198
           +LG+G    VF+G             TG   A+K  N+       +  + E   L  L H
Sbjct: 16  ILGQGATANVFRG---------RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH 66

Query: 199 PNLVKLVGYCIEDDQR----LLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKG 252
            N+VKL  + IE++      +L+ EF P GSL   L     +  LP S  + +      G
Sbjct: 67  KNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 253 LAFLHEEAEKPVIYRDFKTSNILL----DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
           +  L E     +++R+ K  NI+     D     KL+DFG A++  +D +    +   GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV--SLY-GT 178

Query: 309 YGYAAPEYVMTGHL--------TSKSDVYSFGVVLLEMLTGRR-------------SMDK 347
             Y  P+      L         +  D++S GV      TG                M K
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238

Query: 348 NRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR 407
                    +   +        +   +        S       T + A  L  D +    
Sbjct: 239 IITGKPSGAISGVQKAENGPIDWSGDMPV--SCSLSRGLQVLLTPVLANILEADQEKCWG 296

Query: 408 MSEVVETLKPLQNLK-----DMASSSYYFQTMQADNTWSI 442
             +       + +        +   + +   + + NT +I
Sbjct: 297 FDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATI 336

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  132 bits (332), Expect = 4e-33
 Identities = 78/388 (20%), Positives = 126/388 (32%), Gaps = 54/388 (13%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 192
            +  +  LG GGFG V +          +   TG  VA+K    +    ++E W  E+  
Sbjct: 15  PWEMKERLGTGGFGYVLRW---------IHQDTGEQVAIKQCRQELSPKNRERWCLEIQI 65

Query: 193 LGNLLHPNLVKLVGYCIEDDQR--------LLVYEFMPRGSLENHLFR--RSLPLPWSIR 242
           +  L HPN+V      + D  +        LL  E+   G L  +L +      L     
Sbjct: 66  MKKLNHPNVVSA--REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI 123

Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA---KLSDFGLAKDAPEDGKT 299
             +    +  L +LHE     +I+RD K  NI+L         K+ D G AK+  +    
Sbjct: 124 RTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC 180

Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR---------SMDKNRP 350
                V GT  Y APE +     T   D +SFG +  E +TG R                
Sbjct: 181 T--EFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237

Query: 351 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 410
              +  +       G  +    L  P    H S   + K  +     L    + R    +
Sbjct: 238 EKSNEHIVVYDDLTGAVKFSSVLPTPN---HLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294

Query: 411 V--------VETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRN--- 459
                    ++++  L+ L  M   S    T       +++N K+ ++   G        
Sbjct: 295 NPNVGCFQALDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPEEEQEL 354

Query: 460 GQPLRTLSHPNGPHASPYRHPQQSPKPN 487
            Q      +   P               
Sbjct: 355 LQASGLALNSAQPLTQYVIDCTVIDGRQ 382

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  126 bits (318), Expect = 7e-33
 Identities = 65/314 (20%), Positives = 108/314 (34%), Gaps = 49/314 (15%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLH 198
           +LG+G    VF+G             TG   A+K  N+       +  + E   L  L H
Sbjct: 16  ILGQGATANVFRG---------RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH 66

Query: 199 PNLVKLVGYCIEDDQR----LLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKG 252
            N+VKL  + IE++      +L+ EF P GSL   L     +  LP S  + +      G
Sbjct: 67  KNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 253 LAFLHEEAEKPVIYRDFKTSNILL----DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
           +  L E     +++R+ K  NI+     D     KL+DFG A++  +D +    +   GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV--SLY-GT 178

Query: 309 YGYAAPEYVMTGHL--------TSKSDVYSFGVVLLEMLTGR------------RSMDKN 348
             Y  P+      L         +  D++S GV      TG             + +   
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238

Query: 349 RPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM 408
              G+ +          +    +    P      S       T + A  L  D +     
Sbjct: 239 IITGKPSGAISGVQKAENGPIDWSGDMPV-SCSLSRGLQVLLTPVLANILEADQEKCWGF 297

Query: 409 SEVVETLKPLQNLK 422
            +       + +  
Sbjct: 298 DQFFAETSDILHRG 311

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  125 bits (317), Expect = 1e-32
 Identities = 62/289 (21%), Positives = 106/289 (36%), Gaps = 50/289 (17%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNLL 197
            +G GG   VF+                   A+K +N +         +  E+ +L  L 
Sbjct: 16  QIGSGGSSKVFQV----------LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 65

Query: 198 HPNL--VKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
             +   ++L  Y    DQ + +V E      L + L ++   +    R        + + 
Sbjct: 66  QHSDKIIRLYDY-EITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVH 122

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
            +H+     +++ D K +N L+  D   KL DFG+A     D  + V    +GT  Y  P
Sbjct: 123 TIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178

Query: 315 EYVM-----------TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARP 362
           E +               ++ KSDV+S G +L  M  G+       P     N +     
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------TPFQQIINQIS---- 228

Query: 363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
                 + + ++DP  E  F     +    +   CL RDPK R  + E+
Sbjct: 229 ------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  125 bits (315), Expect = 3e-32
 Identities = 79/329 (24%), Positives = 126/329 (38%), Gaps = 46/329 (13%)

Query: 92  PVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFK 151
           P  +          + P        A ++ + + +      R +     LG+GGF   F+
Sbjct: 2   PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSR--RRYVRGRFLGKGGFAKCFE 59

Query: 152 GWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGNLLHPNLVKLVGYC 208
                         T    A K +    L       +   E++   +L H ++V   G+ 
Sbjct: 60  I---------SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF- 109

Query: 209 IEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYR 267
            ED+  + +V E   R SL     RR        R         G  +LH      VI+R
Sbjct: 110 FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHR---NRVIHR 165

Query: 268 DFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM-GTYGYAAPEYVMTGHLTS-K 325
           D K  N+ L+ D   K+ DFGLA     DG+     +V+ GT  Y APE V++    S +
Sbjct: 166 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAPE-VLSKKGHSFE 221

Query: 326 SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE-WARPHLGDKRRFYRLLDPRLEGHFSI 384
            DV+S G ++  +L G+       P     L E + R    +    Y +  P+   H   
Sbjct: 222 VDVWSIGCIMYTLLVGK------PPFETSCLKETYLRIKKNE----YSI--PK---HI-- 264

Query: 385 KGSQKATQLAAQCLSRDPKARPRMSEVVE 413
             +  A  L  + L  DP ARP ++E++ 
Sbjct: 265 --NPVAASLIQKMLQTDPTARPTINELLN 291

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  126 bits (319), Expect = 3e-32
 Identities = 72/339 (21%), Positives = 119/339 (35%), Gaps = 54/339 (15%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           +F P+ +LG G  G +        G           VAVK +  +          EV  L
Sbjct: 25  SFCPKDVLGHGAEGTIVYR-----GMF-----DNRDVAVKRILPECFSFADR---EVQLL 71

Query: 194 GNLL-HPNLVKLVGYCIEDDQRL--LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 250
                HPN+++   +C E D++   +  E     +L+ ++ ++         + +     
Sbjct: 72  RESDEHPNVIRY--FCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTT 128

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILL-----DADYNAKLSDFGLAKD-APEDGKTHVSTR 304
            GLA LH      +++RD K  NIL+          A +SDFGL K  A         + 
Sbjct: 129 SGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185

Query: 305 VMGTYGYAAPEYV---MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 361
           V GT G+ APE +      + T   D++S G V   +++         P G+    +   
Sbjct: 186 VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS-----HPFGKSLQRQ--- 237

Query: 362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV------VETL 415
                      L     E H        A +L  + ++ DP+ RP    V          
Sbjct: 238 --ANILLGACSLDCLHPEKHE----DVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE 291

Query: 416 KPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGG 454
           K LQ  +D+   S   +    D     +  + G      
Sbjct: 292 KQLQFFQDV---SDRIEKESLDGPIVKQLERGGRAVVKM 327

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  125 bits (315), Expect = 4e-32
 Identities = 44/253 (17%), Positives = 79/253 (31%), Gaps = 24/253 (9%)

Query: 105 SSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKP 164
           SS P   E       ++     + +L ++      LLGEG F  V++    +      K 
Sbjct: 39  SSYPNTFEWQCKLPAIKPKT--EFQLGSKLVYVHHLLGEGAFAQVYE--ATQGDLNDAK- 93

Query: 165 GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRG 224
                  +K                +  L   +    +K     +  +  +LV E    G
Sbjct: 94  -NKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYG 152

Query: 225 SLENHLFRRSL----PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---- 276
           +L N +          +P  + +  A+     +  +H+     +I+ D K  N +L    
Sbjct: 153 TLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGF 209

Query: 277 -------DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVY 329
                  D      L D G + D     K  + T    T G+   E +       + D +
Sbjct: 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYF 269

Query: 330 SFGVVLLEMLTGR 342
                +  ML G 
Sbjct: 270 GVAATVYCMLFGT 282

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  123 bits (311), Expect = 1e-31
 Identities = 54/311 (17%), Positives = 107/311 (34%), Gaps = 65/311 (20%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------------ 188
           L +G F  +     E++             A+K      L+  +++              
Sbjct: 39  LNQGKFNKIIL--CEKDNK---------FYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87

Query: 189 -----EVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHL-------FRRSL 235
                E+  + ++ +   +   G  I +   + ++YE+M   S+              + 
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC 146

Query: 236 PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE 295
            +P  +   I        +++H   EK + +RD K SNIL+D +   KLSDFG ++    
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV- 203

Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLT---SKSDVYSFGVVLLEMLTGRRSMDKNRP-N 351
           D K   S    GTY +  PE   +   +   +K D++S G+ L  M           P +
Sbjct: 204 DKKIKGS---RGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV------VPFS 253

Query: 352 GEHNL---------VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDP 402
            + +L              P   +   +          +  +  S +        L ++P
Sbjct: 254 LKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFL--SNEDIDFLKLFLRKNP 311

Query: 403 KARPRMSEVVE 413
             R    + ++
Sbjct: 312 AERITSEDALK 322

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  122 bits (308), Expect = 1e-31
 Identities = 75/294 (25%), Positives = 116/294 (39%), Gaps = 56/294 (19%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAE 189
           R +     LG+GGF   F+              T    A K +    L       +   E
Sbjct: 15  RRYVRGRFLGKGGFAKCFEI---------SDADTKEVFAGKIVPKSLLLKPHQREKMSME 65

Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM----- 243
           ++   +L H ++V   G+  ED+  + +V E   R SL     RR         +     
Sbjct: 66  ISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRK-------ALTEPEA 117

Query: 244 -KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
                    G  +LH      VI+RD K  N+ L+ D   K+ DFGLA     DG+    
Sbjct: 118 RYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK-- 172

Query: 303 TRVM-GTYGYAAPEYVMTGHLTS-KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE-W 359
            +V+ GT  Y APE V++    S + DV+S G ++  +L G+       P     L E +
Sbjct: 173 -KVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGK------PPFETSCLKETY 224

Query: 360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
            R    +    Y +  P+   H     +  A  L  + L  DP ARP ++E++ 
Sbjct: 225 LRIKKNE----YSI--PK---HI----NPVAASLIQKMLQTDPTARPTINELLN 265

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  124 bits (311), Expect = 2e-31
 Identities = 56/393 (14%), Positives = 112/393 (28%), Gaps = 96/393 (24%)

Query: 83  EKRRDRPVVPVSSTTTSNAESASSTPKFSE--ELKVASQLRKFMFNDLKLATRNFRPESL 140
            +     V   S    S A+S  ST  ++     +V S+L +          R     ++
Sbjct: 34  NRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGER--------PRTLVRGTV 85

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD---------------------- 178
           LG+       +   +E         TG +  V                            
Sbjct: 86  LGQEDPYAYLEATDQE---------TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 136

Query: 179 GLQGHKEWLAEVNFLGN---LLHPNLVKLVGYCIEDDQRLLVYEF--MPRGSLENHLFRR 233
           G++  K+    + F+     +  P   K++   +++    ++  F   PR       F  
Sbjct: 137 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 196

Query: 234 SL--------PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS 285
            L         L    R+++ L   + LA LH      +++   +  +I+LD      L+
Sbjct: 197 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLT 253

Query: 286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM----------TGHLTSKSDVYSFGVVL 335
            F           +          G+A PE                +T   D ++ G+ +
Sbjct: 254 GFEHLVRDGASAVS------PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307

Query: 336 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA 395
             +           PN +   +  +       +                   Q    L  
Sbjct: 308 YWIWCAD------LPNTDDAALGGSEWIFRSCKNI----------------PQPVRALLE 345

Query: 396 QCLSRDPKARPRMSEVVETLKPLQNLKDMASSS 428
             L    + R    + +ET    + L+   S++
Sbjct: 346 GFLRYPKEDRLLPLQAMET-PEYEQLRTELSAA 377

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  121 bits (305), Expect = 3e-31
 Identities = 63/302 (20%), Positives = 100/302 (33%), Gaps = 66/302 (21%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK--TLNHDGLQGHKEWLAE 189
           T  F     +G G FG VFK          VK   G   A+K       G    +  L E
Sbjct: 10  TTEFHELEKIGSGEFGSVFKC---------VKRLDGCIYAIKRSKKPLAGSVDEQNALRE 60

Query: 190 VNFLGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKI 245
           V     L  H ++V+      EDD  L+  E+   GSL + +   +R       +    +
Sbjct: 61  VYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120

Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-------------------YNAKLSD 286
            L   +GL ++H  +   +++ D K SNI +                         K+ D
Sbjct: 121 LLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177

Query: 287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM--TGHLTSKSDVYSFGVVLLEMLTGRRS 344
            G            V     G   + A E +     HL  K+D+++  + ++        
Sbjct: 178 LGHVT---RISSPQVEE---GDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAEPL 230

Query: 345 MDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA 404
                P       +W     G          PR+        SQ+ T+L    +  DP+ 
Sbjct: 231 -----PRNGD---QWHEIRQGRL--------PRIPQVL----SQEFTELLKVMIHPDPER 270

Query: 405 RP 406
           RP
Sbjct: 271 RP 272

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  120 bits (303), Expect = 4e-31
 Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 22/207 (10%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGNL 196
            LG+G FG V+            +  +   +A+K L    L+      +   EV    +L
Sbjct: 16  PLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66

Query: 197 LHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 255
            HPN+++L GY   D  R+ L+ E+ P G++   L ++                A  L++
Sbjct: 67  RHPNILRLYGY-FHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSY 124

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
            H    K VI+RD K  N+LL +    K++DFG +  AP   +        GT  Y  PE
Sbjct: 125 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLC---GTLDYLPPE 177

Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGR 342
            +       K D++S GV+  E L G+
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  121 bits (305), Expect = 7e-31
 Identities = 66/329 (20%), Positives = 121/329 (36%), Gaps = 63/329 (19%)

Query: 128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKP-GTGLTVAVKTLNHDGLQGHKEW 186
           ++L     R   +L EGGF  V++           +  G+G   A+K L  +  + ++  
Sbjct: 23  VELGELRLRVRRVLAEGGFAFVYE----------AQDVGSGREYALKRLLSNEEEKNRAI 72

Query: 187 LAEVNFLGNLL-HPNLVKLVGYCIEDDQR-------LLVYEFMPRGSLENHLFRRSL--P 236
           + EV F+  L  HPN+V+         +         L+   + +G L   L +     P
Sbjct: 73  IQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP 132

Query: 237 LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA---KDA 293
           L     +KI     + +  +H   + P+I+RD K  N+LL      KL DFG A      
Sbjct: 133 LSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHY 191

Query: 294 PEDGKTHVSTRVM-------GTYGYAAPEYV-MTGHL--TSKSDVYSFGVVLLEMLTGRR 343
           P+   +     ++        T  Y  PE + +  +     K D+++ G +L  +   + 
Sbjct: 192 PDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ- 250

Query: 344 SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSI----KGSQKATQLAAQCLS 399
                 P  +   +                    + G +SI            L    L 
Sbjct: 251 -----HPFEDGAKLRI------------------VNGKYSIPPHDTQYTVFHSLIRAMLQ 287

Query: 400 RDPKARPRMSEVVETLKPLQNLKDMASSS 428
            +P+ R  ++EVV  L+ +   +++   S
Sbjct: 288 VNPEERLSIAEVVHQLQEIAAARNVNPKS 316

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  119 bits (301), Expect = 7e-31
 Identities = 76/296 (25%), Positives = 121/296 (40%), Gaps = 41/296 (13%)

Query: 124 MFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH 183
           +   +     +F+  +LLG+G F  V++              TGL VA+K ++   +   
Sbjct: 2   LATCIGEKIEDFKVGNLLGKGSFAGVYRA---------ESIHTGLEVAIKMIDKKAMYKA 52

Query: 184 K---EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW 239
                   EV     L HP++++L  Y  ED   + LV E    G +  +L  R  P   
Sbjct: 53  GMVQRVQNEVKIHCQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSE 111

Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
           +           G+ +LH      +++RD   SN+LL  + N K++DFGLA       + 
Sbjct: 112 NEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK 168

Query: 300 HVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 358
           H  T + GT  Y +PE    + H   +SDV+S G +   +L GR       P     +  
Sbjct: 169 H-YT-LCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGR------PPFDTDTVKN 219

Query: 359 -WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
              +  L D    Y +  P          S +A  L  Q L R+P  R  +S V++
Sbjct: 220 TLNKVVLAD----YEM--PS---FL----SIEAKDLIHQLLRRNPADRLSLSSVLD 262

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  120 bits (303), Expect = 9e-31
 Identities = 68/290 (23%), Positives = 114/290 (39%), Gaps = 44/290 (15%)

Query: 130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGL--TVAVKTLNHDGLQGHKEWL 187
           L+ R +    +LG GG   V                      VAVK L    L     + 
Sbjct: 10  LSDR-YELGEILGFGGMSEVHLAR-----------DLRDHRDVAVKVL-RADLARDPSFY 56

Query: 188 A----EVNFLGNLLHPNLVKLVGYCIEDDQRL----LVYEFMPRGSLENHLFRRSLPLPW 239
                E      L HP +V +      +        +V E++   +L + +     P+  
Sbjct: 57  LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTP 115

Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
              +++   A + L F H+     +I+RD K +NI++ A    K+ DFG+A+   + G +
Sbjct: 116 KRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172

Query: 300 HVST-RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLV 357
              T  V+GT  Y +PE      + ++SDVYS G VL E+LTG        P  G+ + V
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGD-SPV 225

Query: 358 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR 407
             A  H+ +           L        S     +  + L+++P+ R +
Sbjct: 226 SVAYQHVREDPIPPSARHEGL--------SADLDAVVLKALAKNPENRYQ 267

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  119 bits (300), Expect = 1e-30
 Identities = 56/207 (27%), Positives = 86/207 (41%), Gaps = 22/207 (10%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK--EWLA-EVNFLGNL 196
            LG+G FG V+            +      +A+K L    L+       L  E+    +L
Sbjct: 21  PLGKGKFGNVYLA---------REKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 71

Query: 197 LHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 255
            HPN++++  Y   D +R+ L+ EF PRG L   L ++                A  L +
Sbjct: 72  RHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHY 129

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
            HE   + VI+RD K  N+L+      K++DFG +  AP   +        GT  Y  PE
Sbjct: 130 CHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTMC---GTLDYLPPE 182

Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGR 342
            +       K D++  GV+  E L G 
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGM 209

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  123 bits (310), Expect = 2e-30
 Identities = 83/339 (24%), Positives = 124/339 (36%), Gaps = 49/339 (14%)

Query: 79  KSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPE 138
               E+   + +    +  T    S +    + + +     L+        +    FR  
Sbjct: 130 TQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQY 189

Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGN 195
            +LG+GGFG V     +          TG   A K L    ++  K     L E   L  
Sbjct: 190 RVLGKGGFGEVCA--CQ-------VRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK 240

Query: 196 LLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK-----IALGA 249
           +    +V L  Y  E    L LV   M  G L+ H++          R       I  G 
Sbjct: 241 VNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG- 298

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
              L  LH E    ++YRD K  NILLD   + ++SD GLA   PE        RV GT 
Sbjct: 299 ---LEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRV-GTV 349

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR---RSMDKNRPNGEHNLVEWARPHLGD 366
           GY APE V     T   D ++ G +L EM+ G+   +   + +      +          
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ--QRKKKIKREEV---------- 397

Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
                 + +   E  +S + S +A  L +Q L +DP  R
Sbjct: 398 ---ERLVKEVPEE--YSERFSPQARSLCSQLLCKDPAER 431

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  123 bits (311), Expect = 2e-30
 Identities = 62/292 (21%), Positives = 106/292 (36%), Gaps = 59/292 (20%)

Query: 135 FRPESLLGEGGFGCVFKGW---VEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEV 190
           +  +  +  GG G ++      V            G  V +K L H G    +   +AE 
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVN-----------GRPVVLKGLVHSGDAEAQAMAMAER 130

Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRL-----LVYEFMPRGSLENHLFRRSLPLPWSIRMKI 245
            FL  ++HP++V++  +    D+       +V E++   SL+     + LP+  +I    
Sbjct: 131 QFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-GQKLPVAEAIA--Y 187

Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
            L     L++LH      ++Y D K  NI+L  +   KL D G        G       +
Sbjct: 188 LLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFG------YL 237

Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
            GT G+ APE ++    T  +D+Y+ G  L  +                          G
Sbjct: 238 YGTPGFQAPE-IVRTGPTVATDIYTVGRTLAALTLDL------------------PTRNG 278

Query: 366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-MSEVVETLK 416
                    DP L+ + S        +L  + +  DP+ R     E+   L 
Sbjct: 279 RYVDGLPEDDPVLKTYDSYG------RLLRRAIDPDPRQRFTTAEEMSAQLT 324

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  119 bits (300), Expect = 4e-30
 Identities = 78/337 (23%), Positives = 135/337 (40%), Gaps = 54/337 (16%)

Query: 104 ASSTPKFSEELKVASQLRKFMFNDLK---LATRNFRPESLLGEGGFGCVFKGWVEENGTA 160
                +   + +   +L  F+    K   L   +F   S LG G  G VFK   +     
Sbjct: 1   GKKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKP---- 56

Query: 161 PVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYE 219
                +GL +A K ++ +       + + E+  L     P +V   G    D +  +  E
Sbjct: 57  -----SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111

Query: 220 FMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD 279
            M  GSL+  + +++  +P  I  K+++   KGL +L E+    +++RD K SNIL+++ 
Sbjct: 112 HMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSR 168

Query: 280 YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 339
              KL DFG++    +   +  ++ V GT  Y +PE +   H + +SD++S G+ L+EM 
Sbjct: 169 GEIKLCDFGVSG---QLIDSMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 224

Query: 340 TGR----------------------RSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD-- 375
            GR                       +    RP      +             + LLD  
Sbjct: 225 VGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYI 284

Query: 376 -----PRL-EGHFSIKGSQKATQLAAQCLSRDPKARP 406
                P+L  G F    S +      +CL ++P  R 
Sbjct: 285 VNEPPPKLPSGVF----SLEFQDFVNKCLIKNPAERA 317

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  120 bits (302), Expect = 4e-29
 Identities = 78/317 (24%), Positives = 116/317 (36%), Gaps = 38/317 (11%)

Query: 40  EEEEEIGCWVRFRFIESCMPSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPVSSTTTS 99
           E EEE     R  F    M          S ++  +  G    ++       P       
Sbjct: 96  ETEEERLVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQ 155

Query: 100 NAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGT 159
           N            +        K +  ++ L   +F    ++G GGFG V+         
Sbjct: 156 NLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYG--CR---- 209

Query: 160 APVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFL---GNLLHPNLVKLVGYCIEDDQ 213
              K  TG   A+K L+   ++  +     L E   L        P +V +  Y      
Sbjct: 210 ---KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS-YAFHTPD 265

Query: 214 RL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAEKPVIY 266
           +L  + + M  G L  HL +           M+     I LG    L  +H      V+Y
Sbjct: 266 KLSFILDLMNGGDLHYHLSQHGVFSEA---DMRFYAAEIILG----LEHMHNRF---VVY 315

Query: 267 RDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS 326
           RD K +NILLD   + ++SD GLA D  +  K H    V GT+GY APE +  G     S
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLACDFSKK-KPH--ASV-GTHGYMAPEVLQKGVAYDSS 371

Query: 327 -DVYSFGVVLLEMLTGR 342
            D +S G +L ++L G 
Sbjct: 372 ADWFSLGCMLFKLLRGH 388

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  119 bits (300), Expect = 4e-29
 Identities = 85/348 (24%), Positives = 122/348 (35%), Gaps = 61/348 (17%)

Query: 79  KSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDL---KLATRNF 135
             +  + R      +         +      F E L     LR   +  L    +    F
Sbjct: 128 AETVARARAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWF 187

Query: 136 RPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNF 192
               +LG GGFG VF    +          TG   A K LN   L+  K +   + E   
Sbjct: 188 LDFRVLGRGGFGEVFA--CQ-------MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI 238

Query: 193 LGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR-----RSLPLPWSIRMK-- 244
           L  +    +V L  Y  E    L LV   M  G +  H++           P   R    
Sbjct: 239 LAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP---RAIFY 294

Query: 245 ---IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
              I  G    L  LH+     +IYRD K  N+LLD D N ++SD GLA +         
Sbjct: 295 TAQIVSG----LEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-T 346

Query: 302 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR---RSMDKNRPNGEHNLV 357
                GT G+ APE ++ G     S D ++ GV L EM+  R   R+  +   N E    
Sbjct: 347 KGYA-GTPGFMAPE-LLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE---- 400

Query: 358 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
                         R+L+  +   +  K S  +       L +DP+ R
Sbjct: 401 -----------LKQRVLEQAVT--YPDKFSPASKDFCEALLQKDPEKR 435

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  114 bits (288), Expect = 7e-29
 Identities = 66/296 (22%), Positives = 108/296 (36%), Gaps = 55/296 (18%)

Query: 128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEW 186
           +++   +  P   LG G +G V K              +G  +AVK +      Q  K  
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVP---------SGQIMAVKRIRATVNSQEQKRL 52

Query: 187 LAEVNFLGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLEN---HLFRRSLPLPWSIR 242
           L +++     +  P  V   G    +    +  E M   SL+     +  +   +P  I 
Sbjct: 53  LMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDIL 111

Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
            KIA+   K L  LH +    VI+RD K SN+L++A    K+ DFG++            
Sbjct: 112 GKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAK 166

Query: 303 TRVMGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 358
               G   Y APE +         + KSD++S G+ ++E+   R                
Sbjct: 167 DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR---------------- 210

Query: 359 WARPHLGDKRRFYRLLD-------PRL-EGHFSIKGSQKATQLAAQCLSRDPKARP 406
                       ++ L        P+L    FS     +     +QCL ++ K RP
Sbjct: 211 ---FPYDSWGTPFQQLKQVVEEPSPQLPADKFS----AEFVDFTSQCLKKNSKERP 259

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  113 bits (285), Expect = 2e-28
 Identities = 77/313 (24%), Positives = 122/313 (38%), Gaps = 47/313 (15%)

Query: 103 SASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPV 162
           S+ S+ K +  L +  Q  +   NDL+           +G G  G V+K    +      
Sbjct: 2   SSGSSGKQTGYLTIGGQRYQAEINDLEN-------LGEMGSGTCGQVWKMRFRK------ 48

Query: 163 KPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIEDDQRLLVYEF 220
              TG  +AVK +   G  + +K  L +++ +      P +V+  G  I +    +  E 
Sbjct: 49  ---TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL 105

Query: 221 MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY 280
           M     E    R   P+P  I  K+ +   K L +L E+    VI+RD K SNILLD   
Sbjct: 106 M-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERG 162

Query: 281 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-----TSKSDVYSFGVVL 335
             KL DFG++             R  G   Y APE +            ++DV+S G+ L
Sbjct: 163 QIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISL 219

Query: 336 LEMLTGRRSMDKNRPNGE--HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQL 393
           +E+ TG+      + + E    +++   P L     F                S      
Sbjct: 220 VELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGF----------------SGDFQSF 263

Query: 394 AAQCLSRDPKARP 406
              CL++D + RP
Sbjct: 264 VKDCLTKDHRKRP 276

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  114 bits (287), Expect = 4e-28
 Identities = 61/225 (27%), Positives = 96/225 (42%), Gaps = 40/225 (17%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEV 190
           +F     +G+G FG V    V++N T           A+K +N        E      E+
Sbjct: 16  HFEILRAIGKGSFGKVCI--VQKNDT-------KKMYAMKYMNKQKCVERNEVRNVFKEL 66

Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK---- 244
             +  L HP LV L  Y  +D++ + +V + +  G L  HL +           +K    
Sbjct: 67  QIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE---TVKLFIC 122

Query: 245 -IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
            + +     L +L     + +I+RD K  NILLD   +  ++DF +A   P + +    T
Sbjct: 123 ELVMA----LDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---T 172

Query: 304 RVMGTYGYAAPEYVM----TGHLTSKS-DVYSFGVVLLEMLTGRR 343
            + GT  Y APE        G+  S + D +S GV   E+L GRR
Sbjct: 173 TMAGTKPYMAPEMFSSRKGAGY--SFAVDWWSLGVTAYELLRGRR 215

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  112 bits (282), Expect = 4e-28
 Identities = 74/312 (23%), Positives = 121/312 (38%), Gaps = 70/312 (22%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFL 193
           F     +G+G FG VFKG         +   T   VA+K ++ +  +   E +  E+  L
Sbjct: 24  FTKLEKIGKGSFGEVFKG---------IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVL 74

Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL---GAA 250
                P + K  G  ++D +  ++ E++  GS  + L    L         IA       
Sbjct: 75  SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ-----IATILREIL 129

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
           KGL +LH E     I+RD K +N+LL      KL+DFG+A               +GT  
Sbjct: 130 KGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPF 184

Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR---------RSM---DKNRPNGEHNLVE 358
           + APE +      SK+D++S G+  +E+  G          + +    KN P        
Sbjct: 185 WMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------- 236

Query: 359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE------VV 412
                            P LEG++    S+   +    CL+++P  RP   E      ++
Sbjct: 237 -----------------PTLEGNY----SKPLKEFVEACLNKEPSFRPTAKELLKHKFIL 275

Query: 413 ETLKPLQNLKDM 424
              K    L ++
Sbjct: 276 RNAKKTSYLTEL 287

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  112 bits (283), Expect = 7e-28
 Identities = 70/225 (31%), Positives = 102/225 (45%), Gaps = 32/225 (14%)

Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           K     F    +LG+G FG VF   V++              A+K L    L+       
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFL--VKKISG----SDARQLYAMKVLKKATLKVRDRVRT 73

Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK 244
             E + L  + HP +VKL  Y  + + +L L+ +F+  G L   L +           +K
Sbjct: 74  KMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE---DVK 129

Query: 245 -----IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
                +AL     L  LH      +IYRD K  NILLD + + KL+DFGL+K++ +  K 
Sbjct: 130 FYLAELALA----LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 182

Query: 300 HVSTRVM-GTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
                   GT  Y APE V+     ++S D +SFGV++ EMLTG 
Sbjct: 183 ---AYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGT 223

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  112 bits (281), Expect = 1e-27
 Identities = 68/297 (22%), Positives = 104/297 (35%), Gaps = 51/297 (17%)

Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKE 185
                  + +    +G G +G V K   +          +G  +AVK +      +  K+
Sbjct: 16  HWDFTAEDLKDLGEIGRGAYGSVNKMVHKP---------SGQIMAVKRIRSTVDEKEQKQ 66

Query: 186 WLAEVNFLGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL----FRRSLPLPWS 240
            L +++ +      P +V+  G    +    +  E M   S +             +P  
Sbjct: 67  LLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEE 125

Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH 300
           I  KI L   K L  L E     +I+RD K SNILLD   N KL DFG++    +   + 
Sbjct: 126 ILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSI 180

Query: 301 VSTRVMGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 356
             TR  G   Y APE +           +SDV+S G+ L E+ TGR              
Sbjct: 181 AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR-------------- 226

Query: 357 VEWARPHLGDKRRFYRLLD-------PRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
                         +  L        P+L      + S         CL++D   RP
Sbjct: 227 -----FPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRP 278

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  113 bits (285), Expect = 1e-27
 Identities = 87/346 (25%), Positives = 137/346 (39%), Gaps = 49/346 (14%)

Query: 5   PESVKVKNWEVNNSDNNNNSKSRKVKKKKDGGAEQEEEEEIGCWVRFRFIESCMPSRSKV 64
           P+ V  +   +NN         +  + + +    +  +     W         + +  + 
Sbjct: 42  PQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQ-----WTTVIERTFHVETPEER 96

Query: 65  DSSMSGTSTNYADGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFM 124
           +   +   T      +   K++    +   S + S+   A        E+ +A    +  
Sbjct: 97  EEWTTAIQT-----VADGLKKQAAAEMDFRSGSPSDNSGAEEM-----EVSLAKPKHRVT 146

Query: 125 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK 184
            N+       F    LLG+G FG V    V+E  T       G   A+K L  + +    
Sbjct: 147 MNE-------FEYLKLLGKGTFGKVIL--VKEKAT-------GRYYAMKILKKEVIVAKD 190

Query: 185 EW---LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPW 239
           E    L E   L N  HP L  L  Y  +   RL  V E+   G L  HL R R      
Sbjct: 191 EVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED- 248

Query: 240 SIRMKI-ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
             R +         L +LH  +EK V+YRD K  N++LD D + K++DFGL K+  +DG 
Sbjct: 249 --RARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 304

Query: 299 THVSTRVM-GTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
           T    +   GT  Y APE V+  +   ++ D +  GVV+ EM+ GR
Sbjct: 305 T---MKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  111 bits (280), Expect = 2e-27
 Identities = 73/226 (32%), Positives = 100/226 (44%), Gaps = 36/226 (15%)

Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           K+   +F    LLG+G FG V    V E  T       G   A+K L  + +    E   
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVIL--VREKAT-------GRYYAMKILRKEVIIAKDEVAH 51

Query: 187 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRM 243
            + E   L N  HP L  L  Y  +   RL  V E+   G L  HL R R        R 
Sbjct: 52  TVTESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE---RA 107

Query: 244 K-----IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
           +     I       L +LH    + V+YRD K  N++LD D + K++DFGL K+   DG 
Sbjct: 108 RFYGAEIVSA----LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160

Query: 299 THVSTRVM-GTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
           T    +   GT  Y APE V+  +   ++ D +  GVV+ EM+ GR
Sbjct: 161 T---MKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  110 bits (277), Expect = 3e-27
 Identities = 61/255 (23%), Positives = 101/255 (39%), Gaps = 39/255 (15%)

Query: 99  SNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENG 158
             A          +  +   Q RK    D       F+   +LGEG F  V      E  
Sbjct: 3   GTAAEPRPGAGSLQHAQPPPQPRKKRPED-------FKFGKILGEGSFSTVVL--ARELA 53

Query: 159 TAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGNLLHPNLVKLVGYCIEDDQRL 215
           T           A+K L    +    +      E + +  L HP  VKL  +  +DD++L
Sbjct: 54  T-------SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKL 105

Query: 216 -LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAEKPVIYRD 268
                +   G L  ++ +  S         +     I       L +LH    K +I+RD
Sbjct: 106 YFGLSYAKNGELLKYIRKIGSFDET---CTRFYTAEIVSA----LEYLHG---KGIIHRD 155

Query: 269 FKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-D 327
            K  NILL+ D + +++DFG AK    + K   +   +GT  Y +PE ++T     KS D
Sbjct: 156 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE-LLTEKSACKSSD 214

Query: 328 VYSFGVVLLEMLTGR 342
           +++ G ++ +++ G 
Sbjct: 215 LWALGCIIYQLVAGL 229

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  110 bits (277), Expect = 4e-27
 Identities = 67/227 (29%), Positives = 103/227 (45%), Gaps = 34/227 (14%)

Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---E 185
           K+    F    +LG+GG+G VF+  V +         TG   A+K L    +  +     
Sbjct: 13  KIRPECFELLRVLGKGGYGKVFQ--VRKVTG----ANTGKIFAMKVLKKAMIVRNAKDTA 66

Query: 186 W-LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIR 242
              AE N L  + HP +V L+ Y  +   +L L+ E++  G L   L R           
Sbjct: 67  HTKAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMED---T 122

Query: 243 MK-----IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG 297
                  I++     L  LH+   K +IYRD K  NI+L+   + KL+DFGL K++  DG
Sbjct: 123 ACFYLAEISMA----LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG 175

Query: 298 KTHVSTRVM-GTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
                T    GT  Y APE ++     +++ D +S G ++ +MLTG 
Sbjct: 176 TV---THTFCGTIEYMAPE-ILMRSGHNRAVDWWSLGALMYDMLTGA 218

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  109 bits (275), Expect = 7e-27
 Identities = 55/308 (17%), Positives = 109/308 (35%), Gaps = 44/308 (14%)

Query: 124 MFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH 183
                +   R  +  + L   G    F  W+E       +    + +  ++ +       
Sbjct: 44  RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPS 103

Query: 184 KEWLA--EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP--- 238
                  ++  +      N V  +          +  +   + +L++ + RR        
Sbjct: 104 PMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163

Query: 239 ---WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DA 293
                I ++IA      + FLH    K +++RD K SNI    D   K+ DFGL    D 
Sbjct: 164 GVCLHIFIQIAEA----VEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 216

Query: 294 PEDGKTHVS--------TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM 345
            E+ +T ++        T  +GT  Y +PE +   + + K D++S G++L E+L      
Sbjct: 217 DEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS---- 272

Query: 346 DKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
                + +   V               + + +    F+ K   +   +    LS  P  R
Sbjct: 273 ----FSTQMERVR----------IITDVRNLKFPLLFTQK-YPQEHMMVQDMLSPSPTER 317

Query: 406 PRMSEVVE 413
           P  ++++E
Sbjct: 318 PEATDIIE 325

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 20/82 (24%), Positives = 31/82 (37%), Gaps = 10/82 (12%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVN 191
            +F P   +G GGFG VF+                   A+K +     +  +E  + EV 
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAK---------NKVDDCNYAIKRIRLPNRELAREKVMREVK 56

Query: 192 FLGNLLHPNLVKLVGYCIEDDQ 213
            L  L HP +V+     +E   
Sbjct: 57  ALAKLEHPGIVRYFNAWLETPP 78

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  110 bits (278), Expect = 8e-27
 Identities = 59/256 (23%), Positives = 99/256 (38%), Gaps = 36/256 (14%)

Query: 106 STPKFSEELKVASQLRKF-----MFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTA 160
              + +++  VA  L+          +++L   +F    ++G G F  V    V+   T 
Sbjct: 29  GASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAV--VKMKQTG 86

Query: 161 PVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-L 216
            V        A+K +N   +    E   +  E + L N     + +L  +  +D+  L L
Sbjct: 87  QV-------YAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYL 138

Query: 217 VYEFMPRGSLENHLFR--RSLPLPWSIRMKIA-LGAAKGLAFLHEEAEKPVIYRDFKTSN 273
           V E+   G L   L +    +P   + R  +A +  A  +  +H       ++RD K  N
Sbjct: 139 VMEYYVGGDLLTLLSKFGERIPAEMA-RFYLAEIVMA--IDSVHR---LGYVHRDIKPDN 192

Query: 274 ILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVY---- 329
           ILLD   + +L+DFG       DG       V GT  Y +PE +        +  Y    
Sbjct: 193 ILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPEC 251

Query: 330 ---SFGVVLLEMLTGR 342
              + GV   EM  G+
Sbjct: 252 DWWALGVFAYEMFYGQ 267

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  108 bits (272), Expect = 1e-26
 Identities = 76/304 (25%), Positives = 125/304 (41%), Gaps = 48/304 (15%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 191
            + +     +G+G  G V+           +   TG  VA++ +N       +  + E+ 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEIL 69

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 251
            +    +PN+V  +   +  D+  +V E++  GSL + +    +     I   +     +
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ-I-AAVCRECLQ 127

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTYG 310
            L FLH      VI+RD K+ NILL  D + KL+DFG  A+  PE  K    T V GT  
Sbjct: 128 ALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMV-GTPY 181

Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK--R 368
           + APE V       K D++S G++ +EM+ G        P           P+L +   R
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG-------EP-----------PYLNENPLR 223

Query: 369 RFYRLLD---PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV-----VETLKPLQN 420
             Y +     P L+     K S        +CL  D + R    E+     ++  KPL +
Sbjct: 224 ALYLIATNGTPELQN--PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSS 281

Query: 421 LKDM 424
           L  +
Sbjct: 282 LTPL 285

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  111 bits (278), Expect = 1e-26
 Identities = 73/316 (23%), Positives = 107/316 (33%), Gaps = 78/316 (24%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 194
              E +LG G  G V                 G  VAVK +    +      L E+  L 
Sbjct: 17  VVSEKILGYGSSGTVVFQGSF----------QGRPVAVKRML---IDFCDIALMEIKLLT 63

Query: 195 NLL-HPNLVKLVGYCIEDDQRL--LVYEFMPRGSL-----ENHLFRRSLPLPWSIRMKIA 246
               HPN+++   YC E   R   +  E     +L       ++   +L L         
Sbjct: 64  ESDDHPNVIRY--YCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISL 120

Query: 247 L-GAAKGLAFLHEEAEKPVIYRDFKTSNILLD-------------ADYNAKLSDFGLAKD 292
           L   A G+A LH      +I+RD K  NIL+               +    +SDFGL K 
Sbjct: 121 LRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177

Query: 293 APED---GKTHVSTRVMGTYGYAAPE-------YVMTGHLTSKSDVYSFGVVLLEMLTG- 341
                   +T+++    GT G+ APE             LT   D++S G V   +L+  
Sbjct: 178 LDSGQSSFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236

Query: 342 ------RRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA 395
                 + S + N   G  +L E    H                         +AT L +
Sbjct: 237 KHPFGDKYSRESNIIRGIFSLDEMKCLHDRSL-------------------IAEATDLIS 277

Query: 396 QCLSRDPKARPRMSEV 411
           Q +  DP  RP   +V
Sbjct: 278 QMIDHDPLKRPTAMKV 293

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  109 bits (274), Expect = 1e-26
 Identities = 69/278 (24%), Positives = 110/278 (39%), Gaps = 36/278 (12%)

Query: 81  SNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESL 140
           ++           S      +       +    +K   +      +  K+   NF    +
Sbjct: 2   AHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKV 61

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW----LAEVNFLGNL 196
           LG G +G VF   V +         TG   A+K L    +    +       E   L ++
Sbjct: 62  LGTGAYGKVFL--VRKISG----HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115

Query: 197 LH-PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALG 248
              P LV L  Y  + + +L L+ +++  G L  HL +           ++     I L 
Sbjct: 116 RQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEH---EVQIYVGEIVLA 171

Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
               L  LH+     +IYRD K  NILLD++ +  L+DFGL+K+   D          GT
Sbjct: 172 ----LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GT 223

Query: 309 YGYAAPEYVM---TGHLTSKS-DVYSFGVVLLEMLTGR 342
             Y AP+ V    +GH   K+ D +S GV++ E+LTG 
Sbjct: 224 IEYMAPDIVRGGDSGH--DKAVDWWSLGVLMYELLTGA 259

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  107 bits (269), Expect = 3e-26
 Identities = 65/315 (20%), Positives = 124/315 (39%), Gaps = 69/315 (21%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 194
           +     LG+G FG V+K              TG   A K +     +  ++++ E+  L 
Sbjct: 21  WEIVGELGDGAFGKVYKA---------KNKETGALAAAKVIETKSEEELEDYIVEIEILA 71

Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
              HP +VKL+G    D +  ++ EF P G+++  +      L       +     + L 
Sbjct: 72  TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALN 131

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA---KDAPEDGKTHVSTRVMGTYGY 311
           FLH +    +I+RD K  N+L+  + + +L+DFG++       +   + +     GT  +
Sbjct: 132 FLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYW 183

Query: 312 AAPEYVMTGHLT-----SKSDVYSFGVVLLEMLTGR---------RSM---DKNRPNGEH 354
            APE VM   +       K+D++S G+ L+EM             R +    K+ P    
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP---- 239

Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV--- 411
                  P L    ++                S +        L ++P+ RP  +++   
Sbjct: 240 -------PTLLTPSKW----------------SVEFRDFLKIALDKNPETRPSAAQLLEH 276

Query: 412 --VETLKPLQNLKDM 424
             V ++   + L+++
Sbjct: 277 PFVSSITSNKALREL 291

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  107 bits (268), Expect = 5e-26
 Identities = 76/314 (24%), Positives = 129/314 (41%), Gaps = 54/314 (17%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 191
                    +GEG  G V             +  +G  VAVK ++    Q  +    EV 
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLA---------REKHSGRQVAVKMMDLRKQQRRELLFNEVV 94

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 251
            + +  H N+V++    +  ++  ++ EF+  G+L + +    + L       +     +
Sbjct: 95  IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQ 152

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTYG 310
            LA+LH +    VI+RD K+ +ILL  D   KLSDFG  A+ + +  K    + V GT  
Sbjct: 153 ALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK--SLV-GTPY 206

Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK--R 368
           + APE +      ++ D++S G++++EM+ G        P           P+  D   +
Sbjct: 207 WMAPEVISRSLYATEVDIWSLGIMVIEMVDG-------EP-----------PYFSDSPVQ 248

Query: 369 RFYRLLD---PRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----------RMSEVVET 414
              RL D   P+L+   S K S        + L RDP+ R              + + E 
Sbjct: 249 AMKRLRDSPPPKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPEC 306

Query: 415 LKPLQNLKDMASSS 428
           L PL  L    +S+
Sbjct: 307 LVPLIQLYRKQTST 320

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  106 bits (266), Expect = 9e-26
 Identities = 74/311 (23%), Positives = 125/311 (40%), Gaps = 62/311 (19%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 191
              F     LGEG +G V+K   +E         TG  VA+K +  +     +E + E++
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKE---------TGQIVAIKQVPVE--SDLQEIIKEIS 76

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 251
            +     P++VK  G   ++    +V E+   GS+ + +  R+  L       I     K
Sbjct: 77  IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLK 136

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTYG 310
           GL +LH       I+RD K  NILL+ + +AKL+DFG+  +      K +    V+GT  
Sbjct: 137 GLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT---VIGTPF 190

Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR---------RSM---DKNRPNGEHNLVE 358
           + APE +        +D++S G+  +EM  G+         R++     N P        
Sbjct: 191 WMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP-------- 242

Query: 359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV-----VE 413
              P       +                S   T    QCL + P+ R   +++     V 
Sbjct: 243 ---PTFRKPELW----------------SDNFTDFVKQCLVKSPEQRATATQLLQHPFVR 283

Query: 414 TLKPLQNLKDM 424
           + K +  L+D+
Sbjct: 284 SAKGVSILRDL 294

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  107 bits (270), Expect = 1e-25
 Identities = 63/229 (27%), Positives = 94/229 (41%), Gaps = 29/229 (12%)

Query: 126 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 185
             ++L   +F    ++G G FG V    V+      V        A+K LN   +    E
Sbjct: 67  KQMRLHREDFEILKVIGRGAFGEVAV--VKLKNADKV-------FAMKILNKWEMLKRAE 117

Query: 186 ---WLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHL--FRRSLPLPW 239
              +  E + L N     +  L  Y  +DD  L LV ++   G L   L  F   LP   
Sbjct: 118 TACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM 176

Query: 240 SIRMKIA-LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
           + R  +A +  A  +  +H+      ++RD K  NIL+D + + +L+DFG      EDG 
Sbjct: 177 A-RFYLAEMVIA--IDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230

Query: 299 THVSTRVMGTYGYAAPEYVMTGHLTSKS-----DVYSFGVVLLEMLTGR 342
              S  V GT  Y +PE +              D +S GV + EML G 
Sbjct: 231 VQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  107 bits (269), Expect = 1e-25
 Identities = 68/251 (27%), Positives = 109/251 (43%), Gaps = 31/251 (12%)

Query: 106 STPKFSEELKVASQLRKF-----MFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTA 160
             P   +   + + L ++        DL++   ++    ++G G FG V    V    T 
Sbjct: 37  DFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQL--VRHKSTR 94

Query: 161 PVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-L 216
            V        A+K L+   +    +   +  E + +     P +V+L  Y  +DD+ L +
Sbjct: 95  KV-------YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYM 146

Query: 217 VYEFMPRGSLENHLFRRSLPLPWSIRMKIA-LGAAKGLAFLHEEAEKPVIYRDFKTSNIL 275
           V E+MP G L N +    +P  W+ R   A +  A  L  +H       I+RD K  N+L
Sbjct: 147 VMEYMPGGDLVNLMSNYDVPEKWA-RFYTAEVVLA--LDAIHS---MGFIHRDVKPDNML 200

Query: 276 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT----GHLTSKSDVYSF 331
           LD   + KL+DFG      ++G     T V GT  Y +PE + +    G+   + D +S 
Sbjct: 201 LDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSV 259

Query: 332 GVVLLEMLTGR 342
           GV L EML G 
Sbjct: 260 GVFLYEMLVGD 270

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  107 bits (270), Expect = 2e-25
 Identities = 71/289 (24%), Positives = 111/289 (38%), Gaps = 61/289 (21%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGNLL 197
           LG+G FG V                TG   AVK ++   ++   +    L EV  L  L 
Sbjct: 34  LGKGSFGEVILC---------KDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 198 HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAK 251
           HPN++KL  +  ED     LV E    G L + +  R     +S       ++  L    
Sbjct: 85  HPNIMKLYEFF-EDKGYFYLVGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSG-- 138

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            + ++H   +  +++RD K  N+LL     D N ++ DFGL+               +GT
Sbjct: 139 -ITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS---KKMKDKIGT 191

Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
             Y APE V+ G    K DV+S GV+L  +L+G                    P  G   
Sbjct: 192 AYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC------------------PPFNGANE 232

Query: 369 RFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEV 411
               +L    +G ++ +       S+ A  L  + L+  P  R    + 
Sbjct: 233 Y--DILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDA 279

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  104 bits (262), Expect = 3e-25
 Identities = 62/298 (20%), Positives = 113/298 (37%), Gaps = 58/298 (19%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNF 192
           ++  + ++G G    V                    VA+K +N +  Q   + L  E+  
Sbjct: 16  DYELQEVIGSGATAVVQAA---------YCAPKKEKVAIKRINLEKCQTSMDELLKEIQA 66

Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK-----IAL 247
           +    HPN+V      +  D+  LV + +  GS+   + +  +              IA 
Sbjct: 67  MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIAT 125

Query: 248 ---GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA---KDAPEDGKTHV 301
                 +GL +LH+      I+RD K  NILL  D + +++DFG++       +  +  V
Sbjct: 126 ILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV 182

Query: 302 STRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGR---------RSM---DKN 348
               +GT  + APE +        K+D++SFG+  +E+ TG          + +    +N
Sbjct: 183 RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 242

Query: 349 RPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            P           P          L     +     K  +   ++ + CL +DP+ RP
Sbjct: 243 DP-----------P---------SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 280

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  107 bits (268), Expect = 4e-25
 Identities = 69/288 (23%), Positives = 108/288 (37%), Gaps = 60/288 (20%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 198
           LG G +G V                T +  A+K +    +    + + L EV  L  L H
Sbjct: 45  LGSGAYGEVLLC---------RDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95

Query: 199 PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAKG 252
           PN++KL  +  ED +   LV E    G L + +  R     ++       +K  L     
Sbjct: 96  PNIMKLYDFF-EDKRNYYLVMECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSG--- 148

Query: 253 LAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           + +LH   +  +++RD K  N+LL   + D   K+ DFGL+               +GT 
Sbjct: 149 VTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ---KKMKERLGTA 202

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            Y APE V+      K DV+S GV+L  +L G                    P  G   +
Sbjct: 203 YYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY------------------PPFGGQTDQ 243

Query: 370 FYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEV 411
              +L    +G ++         S+ A  L  Q L  D + R    + 
Sbjct: 244 --EILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQA 289

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  105 bits (264), Expect = 5e-25
 Identities = 56/306 (18%), Positives = 91/306 (29%), Gaps = 56/306 (18%)

Query: 142 GEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHP 199
           G      V                TG  V V+ +N +            E++      HP
Sbjct: 36  GFEDLMTVNLA---------RYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL---GAAKGLAFL 256
           N+V      I D++  +V  FM  GS +  L         +  + IA    G  K L ++
Sbjct: 87  NIVPYRATFIADNELWVVTSFMAYGSAK-DLICTHFMDGMN-ELAIAYILQGVLKALDYI 144

Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-----THVSTRVMGTYGY 311
           H       ++R  K S+IL+  D    LS           G+            +    +
Sbjct: 145 HHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201

Query: 312 AAPEYVMTGHL---TSKSDVYSFGVVLLEMLTGR-------------------------- 342
            +PE V+  +L    +KSD+YS G+   E+  G                           
Sbjct: 202 LSPE-VLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260

Query: 343 --RSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSR 400
                ++   +   ++                         +    S        QCL R
Sbjct: 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQR 320

Query: 401 DPKARP 406
           +P ARP
Sbjct: 321 NPDARP 326

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  104 bits (262), Expect = 8e-25
 Identities = 70/254 (27%), Positives = 103/254 (40%), Gaps = 43/254 (16%)

Query: 102 ESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAP 161
            + +  P  S+++ +                 +F    ++G+G FG V            
Sbjct: 13  ANPAPPPAPSQQINLGPSSNP------HAKPSDFHFLKVIGKGSFGKVLL--AR------ 58

Query: 162 VKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGNLL-HPNLVKLVGYCIEDDQRL-L 216
                 +  AVK L    +   KE    ++E N L   + HP LV L  +  +   +L  
Sbjct: 59  -HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYF 116

Query: 217 VYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAEKPVIYRDFK 270
           V +++  G L  HL R R    P   R +     IA      L +LH      ++YRD K
Sbjct: 117 VLDYINGGELFYHLQRERCFLEP---RARFYAAEIASA----LGYLHS---LNIVYRDLK 166

Query: 271 TSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM-GTYGYAAPEYVMTGHLTSKS-DV 328
             NILLD+  +  L+DFGL K+  E   T   T    GT  Y APE V+      ++ D 
Sbjct: 167 PENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEYLAPE-VLHKQPYDRTVDW 222

Query: 329 YSFGVVLLEMLTGR 342
           +  G VL EML G 
Sbjct: 223 WCLGAVLYEMLYGL 236

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  105 bits (265), Expect = 1e-24
 Identities = 72/340 (21%), Positives = 121/340 (35%), Gaps = 71/340 (20%)

Query: 100 NAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGT 159
           +    SS  +      +A     ++         ++     LG G +G V          
Sbjct: 3   HHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLC------- 55

Query: 160 APVKPGTGLTVAVKTLN------------HDGLQGHKEWLA-EVNFLGNLLHPNLVKLVG 206
              +       A+K +             +  ++   E +  E++ L +L HPN++KL  
Sbjct: 56  --KEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113

Query: 207 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAKGLAFLHEEA 260
              ED +   LV EF   G L   +  R     +        MK  L     + +LH   
Sbjct: 114 VF-EDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSG---ICYLH--- 163

Query: 261 EKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
           +  +++RD K  NILL   ++  N K+ DFGL+    +D   +     +GT  Y APE V
Sbjct: 164 KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD---YKLRDRLGTAYYIAPE-V 219

Query: 318 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPR 377
           +      K DV+S GV++  +L G                    P  G   +   ++   
Sbjct: 220 LKKKYNEKCDVWSCGVIMYILLCGY------------------PPFGGQNDQ--DIIKKV 259

Query: 378 LEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEV 411
            +G +          S +A +L    L+ D   R    E 
Sbjct: 260 EKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEA 299

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  105 bits (264), Expect = 1e-24
 Identities = 72/288 (25%), Positives = 109/288 (37%), Gaps = 60/288 (20%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 198
           LG+G FG V K              T    AVK +N    +       L EV  L  L H
Sbjct: 30  LGKGSFGEVLKC---------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 199 PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAKG 252
           PN++KL     ED     +V E    G L + + +R     +S       +K        
Sbjct: 81  PNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSG--- 133

Query: 253 LAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           + ++H   +  +++RD K  NILL   + D + K+ DFGL+    ++         +GT 
Sbjct: 134 ITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTA 187

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            Y APE V+ G    K DV+S GV+L  +L+G                    P  G    
Sbjct: 188 YYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT------------------PPFYGKNEY 228

Query: 370 FYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEV 411
              +L     G ++         S  A  L  + L+  P  R   ++ 
Sbjct: 229 --DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  103 bits (258), Expect = 2e-24
 Identities = 70/227 (30%), Positives = 96/227 (42%), Gaps = 37/227 (16%)

Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           KL   +F    +LG+G FG VF    E   T           A+K L  D +    +   
Sbjct: 13  KLKIEDFILHKMLGKGSFGKVFL--AEFKKT-------NQFFAIKALKKDVVLMDDDVEC 63

Query: 187 -LAEVN-FLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIR 242
            + E         HP L  +     +  + L  V E++  G L  H+       L    R
Sbjct: 64  TMVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS---R 119

Query: 243 MK-----IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG 297
                  I LG    L FLH    K ++YRD K  NILLD D + K++DFG+ K+     
Sbjct: 120 ATFYAAEIILG----LQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172

Query: 298 KTHVSTRVM-GTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
                T    GT  Y APE ++ G   + S D +SFGV+L EML G+
Sbjct: 173 AK---TNTFCGTPDYIAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  102 bits (257), Expect = 3e-24
 Identities = 78/294 (26%), Positives = 126/294 (42%), Gaps = 54/294 (18%)

Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
            L  ++F    ++G G +  V    V           T    A+K +  + +   ++   
Sbjct: 5   PLGLQDFDLLRVIGRGSYAKVLL--VR-------LKKTDRIYAMKVVKKELVNDDEDIDW 55

Query: 187 -LAEVNFLGNLL-HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIR 242
              E +       HP LV L   C + + RL  V E++  G L  H+ R R LP   + R
Sbjct: 56  VQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-R 113

Query: 243 M---KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
               +I+L     L +LHE   + +IYRD K  N+LLD++ + KL+D+G+ K+    G T
Sbjct: 114 FYSAEISLA----LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 166

Query: 300 HVSTRVM-GTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR----RSMDKNRPNGE 353
              T    GT  Y APE ++ G     S D ++ GV++ EM+ GR         + P+  
Sbjct: 167 ---TSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 222

Query: 354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKG--SQKATQLAAQCLSRDPKAR 405
                        +   ++++   LE    I    S KA  +    L++DPK R
Sbjct: 223 ------------TEDYLFQVI---LEKQIRIPRSLSVKAASVLKSFLNKDPKER 261

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  102 bits (257), Expect = 3e-24
 Identities = 70/227 (30%), Positives = 103/227 (45%), Gaps = 37/227 (16%)

Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           ++   +F    +LG+G FG V     E       + GT    AVK L  D +    +   
Sbjct: 16  RMKLTDFNFLMVLGKGSFGKVML--SE-------RKGTDELYAVKILKKDVVIQDDDVEC 66

Query: 187 -LAEVNFLGNLL-HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIR 242
            + E   L      P L +L   C +   RL  V E++  G L  H+ +      P    
Sbjct: 67  TMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP---H 122

Query: 243 MK-----IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG 297
                  IA+G    L FL     K +IYRD K  N++LD++ + K++DFG+ K+   DG
Sbjct: 123 AVFYAAEIAIG----LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175

Query: 298 KTHVSTRVM-GTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            T   T+   GT  Y APE ++      KS D ++FGV+L EML G+
Sbjct: 176 VT---TKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  101 bits (255), Expect = 3e-24
 Identities = 71/303 (23%), Positives = 112/303 (36%), Gaps = 52/303 (17%)

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL 197
           E +LGEG    V            +   T    AVK +             EV  L    
Sbjct: 18  EDVLGEGAHARVQTC---------INLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ 68

Query: 198 -HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAA 250
            H N+++L+ +  E++ R  LV+E M  GS+ +H+ +R     ++       ++    A 
Sbjct: 69  GHRNVLELIEF-FEEEDRFYLVFEKMRGGSILSHIHKRR---HFNELEASVVVQDVASA- 123

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKD-APEDGKTHVSTRVM 306
             L FLH    K + +RD K  NIL    +     K+ DF L          + +ST  +
Sbjct: 124 --LDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178

Query: 307 ----GTYGYAAPEYVMTGHLTSKS-----DVYSFGVVLLEMLTGRRSMDKNRP-NGEHNL 356
               G+  Y APE V      +       D++S GV+L  +L+G        P  G    
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY------PPFVGRCGS 232

Query: 357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSE 410
                           L +   EG +          S  A  L ++ L RD K R   ++
Sbjct: 233 DCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQ 292

Query: 411 VVE 413
           V++
Sbjct: 293 VLQ 295

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  101 bits (255), Expect = 3e-24
 Identities = 78/296 (26%), Positives = 122/296 (41%), Gaps = 63/296 (21%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----E 189
           N+R    +G+G F  V                TG  VA+K ++   L      L     E
Sbjct: 16  NYRLLKTIGKGNFAKVKLA---------RHILTGREVAIKIIDKTQLN--PTSLQKLFRE 64

Query: 190 VNFLGNLLHPNLVKLVGY-CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
           V  +  L HPN+VKL  +  IE ++ L L+ E+   G + ++L           RMK   
Sbjct: 65  VRIMKILNHPNIVKL--FEVIETEKTLYLIMEYASGGEVFDYLVAHG-------RMKEKE 115

Query: 248 GAAK------GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
             +K       + + H+   K +++RD K  N+LLDAD N K++DFG + +    GK   
Sbjct: 116 ARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA 172

Query: 302 STRVMGTYGYAAPEYVMTGHL--TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 359
                G   YAAPE +  G      + DV+S GV+L  +++G    D        NL E 
Sbjct: 173 FC---GAPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD------GQNLKE- 221

Query: 360 ARPHLGDKRRFYRLLDPRLEGHFSIKG--SQKATQLAAQCLSRDPKARPRMSEVVE 413
                        L +  L G + I    S     L  + L  +P  R  + ++++
Sbjct: 222 -------------LRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  103 bits (258), Expect = 4e-24
 Identities = 84/330 (25%), Positives = 133/330 (40%), Gaps = 52/330 (15%)

Query: 92  PVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFK 151
                TT N     +     EE K A   R+       L  ++F    ++G G +  V  
Sbjct: 11  DYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLL 70

Query: 152 GWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGNLL-HPNLVKLVGY 207
             V           T    A++ +  + +   ++      E +       HP LV L   
Sbjct: 71  --VR-------LKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-S 120

Query: 208 CIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEA 260
           C + + RL  V E++  G L  H+ R R LP       +     I+L     L +LHE  
Sbjct: 121 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE---HARFYSAEISLA----LNYLHE-- 171

Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM-GTYGYAAPEYVMT 319
            + +IYRD K  N+LLD++ + KL+D+G+ K+    G T   T    GT  Y APE ++ 
Sbjct: 172 -RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPE-ILR 226

Query: 320 GHLTSKS-DVYSFGVVLLEMLTGR---RSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 375
           G     S D ++ GV++ EM+ GR     +  +    ++      +  L  + R  R L 
Sbjct: 227 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL- 285

Query: 376 PRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
                      S KA  +    L++DPK R
Sbjct: 286 -----------SVKAASVLKSFLNKDPKER 304

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  101 bits (254), Expect = 6e-24
 Identities = 65/259 (25%), Positives = 106/259 (40%), Gaps = 35/259 (13%)

Query: 94  SSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGW 153
           ++          S  +F  + K     +    +        F     LG G FG V    
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVML-- 59

Query: 154 VEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGNLLHPNLVKLVGYCIE 210
           V+   +       G   A+K L+   +   K+    L E   L  +  P LVKL  +  +
Sbjct: 60  VKHKES-------GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFK 111

Query: 211 DDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRM---KIALGAAKGLAFLHEEAEKPVI 265
           D+  L +V E++  G + +HL R      P + R    +I L       +LH      +I
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-RFYAAQIVLT----FEYLHS---LDLI 163

Query: 266 YRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTS 324
           YRD K  N+L+D     +++DFG AK       T     + GT    APE +++ G+  +
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGY--N 216

Query: 325 KS-DVYSFGVVLLEMLTGR 342
           K+ D ++ GV++ EM  G 
Sbjct: 217 KAVDWWALGVLIYEMAAGY 235

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  101 bits (253), Expect = 7e-24
 Identities = 66/226 (29%), Positives = 106/226 (46%), Gaps = 39/226 (17%)

Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           K + ++F+    LG G FG V    +            G   A+K L  + +   K+   
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHL--IRSRHN-------GRYYAMKVLKKEIVVRLKQVEH 52

Query: 187 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRM 243
              E   L  + HP ++++     +D Q++ ++ +++  G L + L + +  P P     
Sbjct: 53  TNDERLMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP---VA 108

Query: 244 K-----IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
           K     + L     L +LH    K +IYRD K  NILLD + + K++DFG AK  P+   
Sbjct: 109 KFYAAEVCLA----LEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY 161

Query: 299 THVSTRVMGTYGYAAPEYVMT-GHLTSKS-DVYSFGVVLLEMLTGR 342
           T     + GT  Y APE V T  +  +KS D +SFG+++ EML G 
Sbjct: 162 T-----LCGTPDYIAPEVVSTKPY--NKSIDWWSFGILIYEMLAGY 200

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  102 bits (256), Expect = 7e-24
 Identities = 78/336 (23%), Positives = 120/336 (35%), Gaps = 87/336 (25%)

Query: 118 SQLRKFMFNDLKLATRNFRPESL---------LGEGGFGCVFKGWVEENGTAPVKPGTGL 168
           S+ + F+F DL +  ++  P++L         LG G  G V             +  T  
Sbjct: 111 SRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLA---------FERKTCK 161

Query: 169 TVAVKTLNHDGLQGHKEWLA--------EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEF 220
            VA++ ++           A        E+  L  L HP ++K+  +  + +   +V E 
Sbjct: 162 KVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLEL 220

Query: 221 MPRGSLENHLFRRSLPLPWSIRMKIALG---AAK-------GLAFLHEEAEKPVIYRDFK 270
           M  G  E  LF +       +     L               + +LH   E  +I+RD K
Sbjct: 221 MEGG--E--LFDK-------VVGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLK 266

Query: 271 TSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL----T 323
             N+LL   + D   K++DFG +K   E       T   GT  Y APE V+         
Sbjct: 267 PENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLC-GTPTYLAPE-VLVSVGTAGYN 322

Query: 324 SKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFS 383
              D +S GV+L   L+G                    P   + R    L D    G ++
Sbjct: 323 RAVDCWSLGVILFICLSG-------------------YPPFSEHRTQVSLKDQITSGKYN 363

Query: 384 IKG------SQKATQLAAQCLSRDPKARPRMSEVVE 413
                    S+KA  L  + L  DPKAR    E + 
Sbjct: 364 FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  103 bits (258), Expect = 1e-23
 Identities = 74/253 (29%), Positives = 108/253 (42%), Gaps = 29/253 (11%)

Query: 99  SNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENG 158
             A+    T    E+            N  ++   +F    +LG+G FG V     E   
Sbjct: 307 ERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVML--SE--- 361

Query: 159 TAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGNLL-HPNLVKLVGYCIEDDQR 214
               + GT    AVK L  D +    +    + E   L      P L +L   C +   R
Sbjct: 362 ----RKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDR 416

Query: 215 L-LVYEFMPRGSLENHLFR-RSLPLPWSIRMKI-ALGAAKGLAFLHEEAEKPVIYRDFKT 271
           L  V E++  G L  H+ +      P        A   A GL FL     K +IYRD K 
Sbjct: 417 LYFVMEYVNGGDLMYHIQQVGRFKEP---HAVFYAAEIAIGLFFLQS---KGIIYRDLKL 470

Query: 272 SNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM-GTYGYAAPEYVMTGHLTSKS-DVY 329
            N++LD++ + K++DFG+ K+   DG T   T+   GT  Y APE ++      KS D +
Sbjct: 471 DNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPE-IIAYQPYGKSVDWW 526

Query: 330 SFGVVLLEMLTGR 342
           +FGV+L EML G+
Sbjct: 527 AFGVLLYEMLAGQ 539

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  100 bits (251), Expect = 1e-23
 Identities = 59/211 (27%), Positives = 87/211 (41%), Gaps = 30/211 (14%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGN 195
           +GEG +G VFK    +         TG  VA+K                  L E+  L  
Sbjct: 11  IGEGSYGVVFKCRNRD---------TGQIVAIKKFL---ESEDDPVIKKIALREIRMLKQ 58

Query: 196 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 255
           L HPNLV L+       +  LV+E+    ++ + L R    +P  +   I     + + F
Sbjct: 59  LKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD--APEDGKTH-VSTRVMGTYGYA 312
            H+      I+RD K  NIL+      KL DFG A+    P D     V+TR      Y 
Sbjct: 118 CHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WYR 169

Query: 313 APEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
           +PE ++         DV++ G V  E+L+G 
Sbjct: 170 SPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  100 bits (252), Expect = 1e-23
 Identities = 74/318 (23%), Positives = 119/318 (37%), Gaps = 74/318 (23%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LA 188
            + F     +G G FG V+                   VA+K +++ G Q +++W   + 
Sbjct: 53  EKLFSDLREIGHGSFGAVYFA---------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIK 103

Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 248
           EV FL  L HPN ++  G  + +    LV E+   GS  + L     PL       +  G
Sbjct: 104 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHG 162

Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR--VM 306
           A +GLA+LH      +I+RD K  NILL      KL DFG A        + ++     +
Sbjct: 163 ALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPANSFV 211

Query: 307 GTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEMLTGR---------RSM---DKNRPN 351
           GT  + APE ++    G    K DV+S G+  +E+   +          ++    +N   
Sbjct: 212 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES- 270

Query: 352 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
                                   P L+       S+        CL + P+ RP    +
Sbjct: 271 ------------------------PALQSG---HWSEYFRNFVDSCLQKIPQDRPTSEVL 303

Query: 412 -----VETLKPLQNLKDM 424
                V   +P   + D+
Sbjct: 304 LKHRFVLRERPPTVIMDL 321

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  100 bits (252), Expect = 1e-23
 Identities = 72/227 (31%), Positives = 99/227 (43%), Gaps = 37/227 (16%)

Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           +L   NF    +LG+G FG V                TG   AVK L  D +    +   
Sbjct: 19  RLGIDNFEFIRVLGKGSFGKVML--AR-------VKETGDLYAVKVLKKDVILQDDDVEC 69

Query: 187 -LAEVNFLGNLL-HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIR 242
            + E   L     HP L +L   C +   RL  V EF+  G L  H+ + R        R
Sbjct: 70  TMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA---R 125

Query: 243 MK-----IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG 297
            +     I       L FLH+   K +IYRD K  N+LLD + + KL+DFG+ K+   +G
Sbjct: 126 ARFYAAEIISA----LMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178

Query: 298 KTHVSTRVM-GTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            T   T    GT  Y APE ++   L   + D ++ GV+L EML G 
Sbjct: 179 VT---TATFCGTPDYIAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 99.7 bits (249), Expect = 3e-23
 Identities = 71/295 (24%), Positives = 111/295 (37%), Gaps = 62/295 (21%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGN 195
           +G+G F  V +          +   TG   AVK ++                 E +    
Sbjct: 32  IGKGPFSVVRRC---------INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 196 LLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW------SIRMKIALG 248
           L HP++V+L+      D  L +V+EFM    L   + +R+           S  M+  L 
Sbjct: 83  LKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141

Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
           A   L + H   +  +I+RD K   +LL   +     KL  FG+A    E G      RV
Sbjct: 142 A---LRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV-AGGRV 194

Query: 306 MGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
            GT  + APE V+      K  DV+  GV+L  +L+G                    P  
Sbjct: 195 -GTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGC------------------LPFY 234

Query: 365 GDKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEVVE 413
           G K R +  +   ++G + +        S+ A  L  + L  DP  R  + E + 
Sbjct: 235 GTKERLFEGI---IKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 98.5 bits (246), Expect = 5e-23
 Identities = 72/290 (24%), Positives = 117/290 (40%), Gaps = 55/290 (18%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHP 199
           LGEG F    K          V   +    AVK ++       ++   E+  L     HP
Sbjct: 19  LGEGSFSICRKC---------VHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHP 66

Query: 200 NLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAKGL 253
           N+VKL      D     LV E +  G L   + ++     +S       M+  + A   +
Sbjct: 67  NIVKLHEVF-HDQLHTFLVMELLNGGELFERIKKKK---HFSETEASYIMRKLVSA---V 119

Query: 254 AFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
           + +H   +  V++RD K  N+L    + +   K+ DFG A+  P D +  + T    T  
Sbjct: 120 SHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTPC-FTLH 174

Query: 311 YAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
           YAAPE ++  +   +S D++S GV+L  ML+G+       P         +         
Sbjct: 175 YAAPE-LLNQNGYDESCDLWSLGVILYTMLSGQ------VPF-------QSHDRSLTCTS 220

Query: 370 FYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEVVE 413
              ++    +G FS +G      SQ+A  L    L+ DP  R +MS +  
Sbjct: 221 AVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 97.7 bits (244), Expect = 5e-23
 Identities = 78/291 (26%), Positives = 114/291 (39%), Gaps = 64/291 (21%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGNLLHP 199
           LG G FG V             +  +GL   +KT+N D  Q   E +  E+  L +L HP
Sbjct: 30  LGSGAFGDVHLV---------EERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 200 NLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR----------MKIALG 248
           N++K+     ED   + +V E    G  E  L  R +      +          MK  + 
Sbjct: 81  NIIKIFEV-FEDYHNMYIVMETCEGG--E--LLERIVSAQARGKALSEGYVAELMKQMMN 135

Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
           A   LA+ H    + V+++D K  NIL          K+ DFGLA+    D     ST  
Sbjct: 136 A---LAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD---EHSTNA 186

Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
            GT  Y APE V    +T K D++S GVV+  +LTG                    P  G
Sbjct: 187 AGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGC------------------LPFTG 227

Query: 366 DKRRFYRLLDPRLEGHFSIKG-----SQKATQLAAQCLSRDPKARPRMSEV 411
                  +         +        + +A  L  Q L++DP+ RP  ++V
Sbjct: 228 TSLE--EVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQV 276

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 97.8 bits (244), Expect = 8e-23
 Identities = 78/325 (24%), Positives = 121/325 (37%), Gaps = 80/325 (24%)

Query: 117 ASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN 176
           A  L +   + L+     F    L+G G +G V+KG   +         TG   A+K ++
Sbjct: 8   ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVK---------TGQLAAIKVMD 58

Query: 177 HDGLQGHKEWLAEVNFLGNLL-HPNLVK-----LVGYCIEDDQRL-LVYEFMPRGSLE-- 227
             G    +E   E+N L     H N+       +       D +L LV EF   GS+   
Sbjct: 59  VTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL 117

Query: 228 -NHLFRRSLPLPWSIRMKIAL---GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK 283
             +    +L   W     IA       +GL+ LH+     VI+RD K  N+LL  +   K
Sbjct: 118 IKNTKGNTLKEEW-----IAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169

Query: 284 LSDFGL-AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLT-----SKSDVYSFGVVLLE 337
           L DFG+ A+     G+ +     +GT  + APE +            KSD++S G+  +E
Sbjct: 170 LVDFGVSAQLDRTVGRRNT---FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226

Query: 338 MLTGR---------RSM---DKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIK 385
           M  G          R++    +N                           PRL+     K
Sbjct: 227 MAEGAPPLCDMHPMRALFLIPRNPA-------------------------PRLKSK---K 258

Query: 386 GSQKATQLAAQCLSRDPKARPRMSE 410
            S+K       CL ++   RP   +
Sbjct: 259 WSKKFQSFIESCLVKNHSQRPATEQ 283

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 96.5 bits (241), Expect = 1e-22
 Identities = 68/294 (23%), Positives = 107/294 (36%), Gaps = 74/294 (25%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G G +G V            V+ GT +  A K +    ++    +  E+  + +L HPN
Sbjct: 17  IGRGSWGEVKIA---------VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67

Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-------------MKIA 246
           +++L     ED+  + LV E    G  E  LF R       +              MK  
Sbjct: 68  IIRLYET-FEDNTDIYLVMELCTGG--E--LFER-------VVHKRVFRESDAARIMKDV 115

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVST 303
           L A   +A+ H+     V +RD K  N L      D   KL DFGLA          +  
Sbjct: 116 LSA---VAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG---KMMR 166

Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
             +GT  Y +P+ V+ G    + D +S GV++  +L G                    P 
Sbjct: 167 TKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGY------------------PPF 207

Query: 364 LGDKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEV 411
                    ++    EG F+         S +A  L  + L++ PK R    + 
Sbjct: 208 SAPTDS--EVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQA 259

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 60/218 (27%), Positives = 93/218 (42%), Gaps = 30/218 (13%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LA 188
            +    L+GEG +G V K   ++         TG  VA+K           +      + 
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKD---------TGRIVAIKKFL---ESDDDKMVKKIAMR 73

Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 248
           E+  L  L H NLV L+  C +  +  LV+EF+   ++ + L      L + +  K    
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQ 132

Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD--APEDGKTH-VSTRV 305
              G+ F H      +I+RD K  NIL+      KL DFG A+   AP +     V+TR 
Sbjct: 133 IINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR- 188

Query: 306 MGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
                Y APE ++      K+ DV++ G ++ EM  G 
Sbjct: 189 ----WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 96.6 bits (241), Expect = 2e-22
 Identities = 67/341 (19%), Positives = 112/341 (32%), Gaps = 80/341 (23%)

Query: 94  SSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGW 153
           S      +  A      + +L    +               ++   LLG GGFG V+ G 
Sbjct: 12  SGLVPRGSHMAPCNDLHATKLAPGKEKEPLE--------SQYQVGPLLGSGGFGSVYSG- 62

Query: 154 VEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLGNLLH--PNLVKLV 205
                   ++    L VA+K +  D +    E         EV  L  +      +++L+
Sbjct: 63  --------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114

Query: 206 GYCIEDDQRL-LVYEF-MPRGSLENHLFRRSLPLPWSIRMKIALGAAK------GLAFLH 257
            +  E      L+ E   P   L + +  R         ++  L  +        +   H
Sbjct: 115 DW-FERPDSFVLILERPEPVQDLFDFITERG-------ALQEELARSFFWQVLEAVRHCH 166

Query: 258 EEAEKPVIYRDFKTSNILLDADY-NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
                 V++RD K  NIL+D +    KL DFG      +D          GT  Y+ PE+
Sbjct: 167 N---CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYSPPEW 219

Query: 317 VMTGHL--TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL 374
           +   H      + V+S G++L +M+ G                    P   D+       
Sbjct: 220 IR-YHRYHGRSAAVWSLGILLYDMVCGD------------------IPFEHDEE------ 254

Query: 375 DPRLEGHFSIKG--SQKATQLAAQCLSRDPKARPRMSEVVE 413
              + G    +   S +   L   CL+  P  RP   E+  
Sbjct: 255 --IIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 95.8 bits (239), Expect = 4e-22
 Identities = 58/217 (26%), Positives = 88/217 (40%), Gaps = 32/217 (14%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----EVNFLGN 195
           LLGEG +G V +    E         T    AVK L    L+      A    E+  L  
Sbjct: 12  LLGEGSYGKVKEVLDSE---------TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62

Query: 196 LLHPNLVKL--VGYCIEDDQRLLVYEFMPRGSLE--NHLFRRSLPLPWSIRMKIALGAAK 251
           L H N+++L  V Y  E  +  +V E+   G  E  + +  +  P+  +      L    
Sbjct: 63  LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQL--ID 120

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA---KDAPEDGKTHVSTRVMGT 308
           GL +LH    + ++++D K  N+LL      K+S  G+A        D     S    G+
Sbjct: 121 GLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ---GS 174

Query: 309 YGYAAPEYVMTGHLT---SKSDVYSFGVVLLEMLTGR 342
             +  PE +  G  T    K D++S GV L  + TG 
Sbjct: 175 PAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 96.3 bits (240), Expect = 5e-22
 Identities = 68/294 (23%), Positives = 116/294 (39%), Gaps = 40/294 (13%)

Query: 59  PSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVAS 118
             +S  +S    + + + + K           +PV S  TS        P    + ++ +
Sbjct: 20  YFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVT 79

Query: 119 QLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD 178
             ++   N             +LG G FG V K   EE  T       GL +A K +   
Sbjct: 80  -AKQGAVNSFY----TVSKTEILGGGRFGQVHK--CEETAT-------GLKLAAKIIKTR 125

Query: 179 GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSL------ENHLF 231
           G++  +E   E++ +  L H NL++L     E    + LV E++  G L      E++  
Sbjct: 126 GMKDKEEVKNEISVMNQLDHANLIQLYDA-FESKNDIVLVMEYVDGGELFDRIIDESYNL 184

Query: 232 --RRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL--DADYNAKLSDF 287
               ++       MK       G+  +H   +  +++ D K  NIL         K+ DF
Sbjct: 185 TELDTILF-----MKQICE---GIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDF 233

Query: 288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           GLA+      K  V     GT  + APE V    ++  +D++S GV+   +L+G
Sbjct: 234 GLARRYKPREKLKV---NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 94.2 bits (235), Expect = 8e-22
 Identities = 76/298 (25%), Positives = 110/298 (36%), Gaps = 76/298 (25%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 198
           LG+G FG V K              T    AVK +N    +       L EV  L  L H
Sbjct: 30  LGKGSFGEVLKC---------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 199 PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-------------MK 244
           PN++KL     ED     +V E    G  E  LF         I              +K
Sbjct: 81  PNIMKLFEIL-EDSSSFYIVGELYTGG--E--LFDE-------IIKRKRFSEHDAARIIK 128

Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHV 301
                   + ++H+     +++RD K  NILL   + D + K+ DFGL+    ++ K   
Sbjct: 129 QVFSG---ITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-- 180

Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 361
             R+ GT  Y APE V+ G    K DV+S GV+L  +L+G                    
Sbjct: 181 KDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT------------------P 220

Query: 362 PHLGDKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEVVE 413
           P  G       +L     G ++         S  A  L  + L+  P  R   ++ +E
Sbjct: 221 PFYGKNEY--DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 95.3 bits (237), Expect = 8e-22
 Identities = 66/330 (20%), Positives = 106/330 (32%), Gaps = 94/330 (28%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-----EVNFLGN 195
           +G+G +G V            ++  T    A+K +N + ++            EV  +  
Sbjct: 34  IGQGSYGVVRVA---------IENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 196 LLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG------ 248
           L HPN+ +L     ED+Q + LV E    G L + L            M +         
Sbjct: 85  LHHPNIARLYE-VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143

Query: 249 --------------------------AAK-------GLAFLHEEAEKPVIYRDFKTSNIL 275
                                      +         L +LH    + + +RD K  N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFL 200

Query: 276 LDADYNA--KLSDFGLAK--DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS---KSDV 328
              + +   KL DFGL+K      +G+ +  T   GT  + APE V+     S   K D 
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE-VLNTTNESYGPKCDA 259

Query: 329 YSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKG- 386
           +S GV+L  +L G        P  G ++                  +   L      +  
Sbjct: 260 WSAGVLLHLLLMGA------VPFPGVND---------------ADTISQVLNKKLCFENP 298

Query: 387 -----SQKATQLAAQCLSRDPKARPRMSEV 411
                S  A  L +  L+R+   R      
Sbjct: 299 NYNVLSPLARDLLSNLLNRNVDERFDAMRA 328

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 95.1 bits (237), Expect = 9e-22
 Identities = 72/304 (23%), Positives = 105/304 (34%), Gaps = 78/304 (25%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA--------EVNF 192
           LG G  G V             +  T   VA+K ++           A        E+  
Sbjct: 18  LGSGACGEVKLA---------FERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG---A 249
           L  L HP ++K+  +  + +   +V E M  G  E  LF +       +     L     
Sbjct: 69  LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG--E--LFDK-------VVGNKRLKEATC 116

Query: 250 AK-------GLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKT 299
                     + +LHE     +I+RD K  N+LL   + D   K++DFG +K   E    
Sbjct: 117 KLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 173

Query: 300 HVSTRVMGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 355
              T   GT  Y APE V+            D +S GV+L   L+G              
Sbjct: 174 --RTLC-GTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSG-------------- 215

Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMS 409
                 P   + R    L D    G ++         S+KA  L  + L  DPKAR    
Sbjct: 216 -----YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTE 270

Query: 410 EVVE 413
           E + 
Sbjct: 271 EALR 274

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 95.6 bits (238), Expect = 1e-21
 Identities = 77/381 (20%), Positives = 134/381 (35%), Gaps = 84/381 (22%)

Query: 61  RSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQL 120
           R +    +        + + +  +         ++      +   + PK +E L   S  
Sbjct: 19  RRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMG 78

Query: 121 RKFMFNDLKLA---TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH 177
            +    D   A    + + P+ ++G G    V +          V   TG   AVK +  
Sbjct: 79  PEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRC---------VHRATGHEFAVKIMEV 129

Query: 178 DGLQGHKEWLA--------EVNFLGNLL-HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLE 227
              +   E L         E + L  +  HP+++ L+    E    + LV++ M +G  E
Sbjct: 130 TAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKG--E 186

Query: 228 NHLFRRSLPLPWSIRMKIALG---AAK-------GLAFLHEEAEKPVIYRDFKTSNILLD 277
             LF         +  K+AL               ++FLH      +++RD K  NILLD
Sbjct: 187 --LFDY-------LTEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLD 234

Query: 278 ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS-------KSDVYS 330
            +   +LSDFG +       K        GT GY APE ++   +         + D+++
Sbjct: 235 DNMQIRLSDFGFSCHLEPGEKL--RELC-GTPGYLAPE-ILKCSMDETHPGYGKEVDLWA 290

Query: 331 FGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKG---- 386
            GV+L  +L G                    P    ++    +L   +EG +        
Sbjct: 291 CGVILFTLLAGS------------------PPFWHRRQ--ILMLRMIMEGQYQFSSPEWD 330

Query: 387 --SQKATQLAAQCLSRDPKAR 405
             S     L ++ L  DP+AR
Sbjct: 331 DRSSTVKDLISRLLQVDPEAR 351

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 93.8 bits (234), Expect = 1e-21
 Identities = 73/289 (25%), Positives = 113/289 (39%), Gaps = 60/289 (20%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EVNFLGNL 196
            LG G FG V  G             TG  VAVK LN   ++          E+  L   
Sbjct: 18  TLGVGTFGKVKIG---------EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF 68

Query: 197 LHPNLVKLVGY-CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK--- 251
            HP+++KL  Y  I       +V E++  G L +++ +         R++          
Sbjct: 69  RHPHIIKL--YQVISTPTDFFMVMEYVSGGELFDYICKHG-------RVEEMEARRLFQQ 119

Query: 252 ---GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
               + + H      V++RD K  N+LLDA  NAK++DFGL+    +      S    G+
Sbjct: 120 ILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GS 173

Query: 309 YGYAAPEYVMTGHL--TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
             YAAPE V++G L    + D++S GV+L  +L G    D      + ++          
Sbjct: 174 PNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLPFD------DEHVPT-------- 218

Query: 367 KRRFYRLLDPRLEGHFSIKG--SQKATQLAAQCLSRDPKARPRMSEVVE 413
                 L      G F I    ++    L    L  DP  R  + ++ E
Sbjct: 219 ------LFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 95.6 bits (238), Expect = 2e-21
 Identities = 76/406 (18%), Positives = 136/406 (33%), Gaps = 85/406 (20%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G G +G V+K   ++              A+K +   G+        E+  L  L HPN
Sbjct: 29  VGRGTYGHVYKAKRKD-------GKDDKDYALKQIEGTGI--SMSACREIALLRELKHPN 79

Query: 201 LVKLVGYCIED-DQRL-LVYEFMP---RGSLENH----LFRRSLPLPWSIRMKIALGAAK 251
           ++ L    +   D+++ L++++        ++ H      ++ + LP  +   +      
Sbjct: 80  VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNA----KLSDFGLAK--DAPEDGKTHVSTRV 305
           G+ +LH      V++RD K +NIL+  +       K++D G A+  ++P      +   V
Sbjct: 140 GIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196

Query: 306 MGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGR-----RSMDKNRPNGEH---- 354
           + T+ Y APE ++ G  H T   D+++ G +  E+LT       R  D    N  H    
Sbjct: 197 V-TFWYRAPE-LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254

Query: 355 ----------NLVEW-----------ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQL 393
                        +W                         L   +E H   K   KA  L
Sbjct: 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV-KPDSKAFHL 313

Query: 394 AAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQT---------MQADNTWSIRN 444
             + L+ DP  R    +              A    YF                 +  R 
Sbjct: 314 LQKLLTMDPIKRITSEQ--------------AMQDPYFLEDPLPTSDVFAGCQIPYPKRE 359

Query: 445 SKNGIRTQGGFMTRNGQPLRTLSHPNGPHASPYRHPQQSPKPNGKQ 490
                        +N Q  +  +H NG      +    +  P  K+
Sbjct: 360 FLTEEEPDDKGDKKNQQQQQGNNHTNGTGHPGNQDSSHTQGPPLKK 405

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 70/341 (20%), Positives = 110/341 (32%), Gaps = 80/341 (23%)

Query: 95  STTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWV 154
           S  T   +   + P              F           +R   LLG+GGFG VF G  
Sbjct: 1   SMLTKPLQGPPAPPGTPTPPPGGKDREAFE--------AEYRLGPLLGKGGFGTVFAG-- 50

Query: 155 EENGTAPVKPGTGLTVAVKTLN------HDGLQGHKEWLAEVNFL----GNLLHPNLVKL 204
                   +    L VA+K +          L        EV  L        HP +++L
Sbjct: 51  -------HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103

Query: 205 VGYCIEDDQRL-LVYEF-MPRGSLENHLFRRSLPLPWSIRMKIALGAAK------GLAFL 256
           + +  E  +   LV E  +P   L +++  +         +               +   
Sbjct: 104 LDW-FETQEGFMLVLERPLPAQDLFDYITEKG-------PLGEGPSRCFFGQVVAAIQHC 155

Query: 257 HEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
           H    + V++RD K  NIL+D      KL DFG       D          GT  Y+ PE
Sbjct: 156 HS---RGVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYTDFD---GTRVYSPPE 208

Query: 316 YVMTGHLT-SKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL 374
           ++         + V+S G++L +M+ G                    P   D+       
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGD------------------IPFERDQE------ 244

Query: 375 DPRLEGHFSIKG--SQKATQLAAQCLSRDPKARPRMSEVVE 413
              LE         S     L  +CL+  P +RP + E++ 
Sbjct: 245 --ILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 93.0 bits (232), Expect = 2e-21
 Identities = 60/214 (28%), Positives = 86/214 (40%), Gaps = 33/214 (15%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGNLLH 198
            LGEG +G V            V   T   VAVK ++        E +  E+     L H
Sbjct: 14  TLGEGAYGEVQLA---------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64

Query: 199 PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK------ 251
            N+VK  G    +     L  E+   G L + +          I M     A +      
Sbjct: 65  ENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPD-------IGMPEPD-AQRFFHQLM 115

Query: 252 -GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            G+ +LH      + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  
Sbjct: 116 AGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172

Query: 311 YAAPEYVMTGHL--TSKSDVYSFGVVLLEMLTGR 342
           Y APE ++          DV+S G+VL  ML G 
Sbjct: 173 YVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 94.8 bits (236), Expect = 3e-21
 Identities = 68/276 (24%), Positives = 111/276 (40%), Gaps = 37/276 (13%)

Query: 81  SNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESL 140
           S   R              +A  +    +  +  KV + +        +    ++    +
Sbjct: 2   SGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKV 61

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G G FG V++  + +         +G  VA+K +    LQ  +    E+  +  L H N
Sbjct: 62  IGNGSFGVVYQAKLCD---------SGELVAIKKV----LQDKRFKNRELQIMRKLDHCN 108

Query: 201 LVKLVGYCI------EDDQRL-LVYEFMPR--GSLENHLFRRSLPLPWSIRMKIALGAAK 251
           +V+L  Y        +D+  L LV +++P     +  H  R    LP            +
Sbjct: 109 IVRLR-YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKD-APEDGKTH-VSTRVMGT 308
            LA++H      + +RD K  N+LLD D    KL DFG AK     +     + +R    
Sbjct: 168 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---- 220

Query: 309 YGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGR 342
           Y Y APE ++ G    TS  DV+S G VL E+L G+
Sbjct: 221 Y-YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 92.9 bits (231), Expect = 5e-21
 Identities = 60/300 (20%), Positives = 101/300 (33%), Gaps = 70/300 (23%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----- 188
            +   S LG G FG V+           V       V VK +  + +             
Sbjct: 25  KYSTMSPLGSGAFGFVWTA---------VDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGK 75

Query: 189 ---EVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGS-LENHLFRRSLPLPWSIRM 243
              E+  L  + H N++K++    E+     LV E    G  L   + R         R+
Sbjct: 76  VTLEIAILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHP-------RL 127

Query: 244 KIALGAAK------GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG 297
              L +         + +L     K +I+RD K  NI++  D+  KL DFG A       
Sbjct: 128 DEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK 184

Query: 298 KTHVSTRVMGTYGYAAPEYVMTGHL--TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 355
             +      GT  Y APE V+ G+     + +++S GV L  ++       +        
Sbjct: 185 LFYTFC---GTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE-------- 232

Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKG--SQKATQLAAQCLSRDPKARPRMSEVVE 413
                             L+  +E         S++   L +  L   P+ R  + ++V 
Sbjct: 233 ------------------LEETVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 94.9 bits (236), Expect = 5e-21
 Identities = 69/364 (18%), Positives = 116/364 (31%), Gaps = 52/364 (14%)

Query: 60  SRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQ 119
                 S     +          ++RR   V             +S+   +  ++     
Sbjct: 85  ENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYY 144

Query: 120 LRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG 179
            +        +   ++     LG G FG V +  V E  T       G   A K +    
Sbjct: 145 PQPVEIKHDHV-LDHYDIHEELGTGAFGVVHR--VTERAT-------GNNFAAKFVMTPH 194

Query: 180 LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 239
               +    E+  +  L HP LV L     +D++ +++YEFM  G  E  LF +      
Sbjct: 195 ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG--E--LFEKVADEHN 250

Query: 240 SIRMKIALGAAK----GLAFLHEEAEKPVIYRDFKTSNILL--DADYNAKLSDFGLAKDA 293
            +    A+   +    GL  +H   E   ++ D K  NI+         KL DFGL    
Sbjct: 251 KMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307

Query: 294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 353
                  V     GT  +AAPE      +   +D++S GV+   +L+G            
Sbjct: 308 DPKQSVKV---TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG------------ 352

Query: 354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPR 407
                   P  G+       L       +++        S+       + L  DP  R  
Sbjct: 353 ------LSPFGGENDD--ETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT 404

Query: 408 MSEV 411
           + + 
Sbjct: 405 IHQA 408

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 91.8 bits (229), Expect = 6e-21
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 31/211 (14%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGN 195
           +GEG +G V+K           +   G T A+K +    L+   E      + E++ L  
Sbjct: 10  IGEGTYGVVYKA----------QNNYGETFALKKIR---LEKEDEGIPSTTIREISILKE 56

Query: 196 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 255
           L H N+VKL        + +LV+E + +  L+  L      L         L    G+A+
Sbjct: 57  LKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD--APEDGKTHVSTRVMGTYGYAA 313
            H+   + V++RD K  N+L++ +   K++DFGLA+    P    TH    ++ T  Y A
Sbjct: 116 CHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-TLWYRA 168

Query: 314 PEYVMTG--HLTSKSDVYSFGVVLLEMLTGR 342
           P+ V+ G    ++  D++S G +  EM+ G 
Sbjct: 169 PD-VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 93.1 bits (232), Expect = 7e-21
 Identities = 65/225 (28%), Positives = 103/225 (45%), Gaps = 31/225 (13%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 191
              F+ E + G+G FG V  G  +          TG++VA+K +  D    ++E L  + 
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKS---------TGMSVAIKKVIQDPRFRNRE-LQIMQ 71

Query: 192 FLGNLLHPNLVKL------VGYCIEDDQRL-LVYEFMPR--GSLENHLFRRSLPLPWSIR 242
            L  L HPN+V+L      +G     D  L +V E++P        + +RR +  P  + 
Sbjct: 72  DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILI 131

Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD-ADYNAKLSDFGLAKDA-PEDGKTH 300
                   + +  LH  +   V +RD K  N+L++ AD   KL DFG AK   P +    
Sbjct: 132 KVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190

Query: 301 -VSTRVMGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGR 342
            + +R    Y Y APE ++ G  H T+  D++S G +  EM+ G 
Sbjct: 191 YICSR----Y-YRAPE-LIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 91.9 bits (229), Expect = 7e-21
 Identities = 56/219 (25%), Positives = 85/219 (38%), Gaps = 48/219 (21%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +LG G F  VF            +  TG   A+K +             E+  L  + H 
Sbjct: 16  VLGSGAFSEVFLV---------KQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHE 66

Query: 200 NLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG------AAK- 251
           N+V L     E      LV + +  G  E  LF R       I   +  G      A+  
Sbjct: 67  NIVTLEDI-YESTTHYYLVMQLVSGG--E--LFDR-------I---LERGVYTEKDASLV 111

Query: 252 ------GLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVS 302
                  + +LHE     +++RD K  N+L    + +    ++DFGL+K   ++G    S
Sbjct: 112 IQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSK-MEQNGIM--S 165

Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           T   GT GY APE +     +   D +S GV+   +L G
Sbjct: 166 TAC-GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 91.4 bits (228), Expect = 8e-21
 Identities = 59/212 (27%), Positives = 92/212 (43%), Gaps = 30/212 (14%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGN 195
           +GEG +G VFK    E         T   VA+K +    L    E      L E+  L  
Sbjct: 10  IGEGTYGTVFKAKNRE---------THEIVALKRVR---LDDDDEGVPSSALREICLLKE 57

Query: 196 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 255
           L H N+V+L      D +  LV+EF  +  L+ +    +  L   I         KGL F
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD--APEDGKTHVSTRVMGTYGYAA 313
            H    + V++RD K  N+L++ +   KL++FGLA+    P    +     V+ T  Y  
Sbjct: 117 CHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-TLWYRP 169

Query: 314 PEYVMTG--HLTSKSDVYSFGVVLLEMLTGRR 343
           P+ V+ G    ++  D++S G +  E+    R
Sbjct: 170 PD-VLFGAKLYSTSIDMWSAGCIFAELANAGR 200

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 91.6 bits (228), Expect = 1e-20
 Identities = 60/214 (28%), Positives = 86/214 (40%), Gaps = 33/214 (15%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGNLLH 198
            LGEG +G V            V   T   VAVK ++        E +  E+     L H
Sbjct: 14  TLGEGAYGEVQLA---------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64

Query: 199 PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK------ 251
            N+VK  G    +     L  E+   G L + +          I M     A +      
Sbjct: 65  ENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPD-------IGMPEPD-AQRFFHQLM 115

Query: 252 -GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            G+ +LH      + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  
Sbjct: 116 AGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172

Query: 311 YAAPEYVMTGHL--TSKSDVYSFGVVLLEMLTGR 342
           Y APE ++          DV+S G+VL  ML G 
Sbjct: 173 YVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 91.5 bits (228), Expect = 1e-20
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 31/211 (14%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGN 195
           +GEG +G V+K           K   G  VA+K +    L    E      + E++ L  
Sbjct: 29  VGEGTYGVVYKA----------KDSQGRIVALKRIR---LDAEDEGIPSTAIREISLLKE 75

Query: 196 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 255
           L HPN+V L+     +    LV+EFM +  L+  L      L  S          +G+A 
Sbjct: 76  LHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD--APEDGKTHVSTRVMGTYGYAA 313
            H+     +++RD K  N+L+++D   KL+DFGLA+    P    TH    V+ T  Y A
Sbjct: 135 CHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV-TLWYRA 187

Query: 314 PEYVMTG--HLTSKSDVYSFGVVLLEMLTGR 342
           P+ V+ G    ++  D++S G +  EM+TG+
Sbjct: 188 PD-VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 92.1 bits (229), Expect = 2e-20
 Identities = 53/207 (25%), Positives = 83/207 (40%), Gaps = 25/207 (12%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V +          V+  TG     K +N            E++ +  L HP 
Sbjct: 59  LGSGAFGVVHRC---------VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109

Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP---WSIRMKIALGAAKGLAFL 256
           L+ L     ED   + L+ EF+  G L + +      +        M+ A     GL  +
Sbjct: 110 LINLHDA-FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE---GLKHM 165

Query: 257 HEEAEKPVIYRDFKTSNILL--DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           H   E  +++ D K  NI+       + K+ DFGLA     D    V      T  +AAP
Sbjct: 166 H---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAP 219

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           E V    +   +D+++ GV+   +L+G
Sbjct: 220 EIVDREPVGFYTDMWAIGVLGYVLLSG 246

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 70/315 (22%), Positives = 113/315 (35%), Gaps = 80/315 (25%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--------HDGLQGH 183
             N+ P+ +LG G    V +          +   T    AVK ++         + +Q  
Sbjct: 16  YENYEPKEILGRGVSSVVRRC---------IHKPTCKEYAVKIIDVTGGGSFSAEEVQEL 66

Query: 184 KEWLA-EVNFLGNL-LHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWS 240
           +E    EV+ L  +  HPN+++L     E +    LV++ M +G  E  LF         
Sbjct: 67  REATLKEVDILRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKG--E--LFDY------- 114

Query: 241 IRMKIALG---AAK-------GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA 290
           +  K+ L      K        +  LH+     +++RD K  NILLD D N KL+DFG +
Sbjct: 115 LTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 171

Query: 291 KDAPEDGKTHVSTRVMGTYGYAAPE------YVMTGHLTSKSDVYSFGVVLLEMLTGRRS 344
                  K        GT  Y APE               + D++S GV++  +L G   
Sbjct: 172 CQLDPGEKL--REVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS-- 226

Query: 345 MDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQCL 398
                            P    K+    +L   + G++          S     L ++ L
Sbjct: 227 ----------------PPFWHRKQ--MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFL 268

Query: 399 SRDPKARPRMSEVVE 413
              P+ R    E + 
Sbjct: 269 VVQPQKRYTAEEALA 283

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 90.7 bits (226), Expect = 2e-20
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 31/218 (14%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLA 188
            +     LGEG +  V+KG  +          T   VA+K +  +    H+E      + 
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKL---------TDNLVALKEIRLE----HEEGAPCTAIR 49

Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 248
           EV+ L +L H N+V L      +    LV+E++ +  L+ +L      +           
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQ 108

Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA--KDAPEDGKTHVSTRVM 306
             +GLA+ H    + V++RD K  N+L++     KL+DFGLA  K  P     +    V+
Sbjct: 109 LLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV 162

Query: 307 GTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGR 342
            T  Y  P+ ++ G    +++ D++  G +  EM TGR
Sbjct: 163 -TLWYRPPD-ILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 91.6 bits (228), Expect = 3e-20
 Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 38/222 (17%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 194
           +    ++G G FG VF+  + E+            VA+K +    LQ  +    E+  + 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDE----------VAIKKV----LQDKRFKNRELQIMR 87

Query: 195 NLLHPNLVKLVGYCI------EDDQRL-LVYEFMPR--GSLENHLFRRSLPLPWSIRMKI 245
            + HPN+V L           +D+  L LV E++P        H  +    +P  +    
Sbjct: 88  IVKHPNVVDLK-AFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLY 146

Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKD-APEDGKTH-VS 302
                + LA++H      + +RD K  N+LLD      KL DFG AK     +     + 
Sbjct: 147 MYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC 203

Query: 303 TRVMGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGR 342
           +R    Y Y APE ++ G  + T+  D++S G V+ E++ G+
Sbjct: 204 SR----Y-YRAPE-LIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 89.6 bits (223), Expect = 5e-20
 Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 34/215 (15%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGN 195
           LG G +  V+KG  +          TG+ VA+K +  D     +E      + E++ +  
Sbjct: 13  LGNGTYATVYKGLNKT---------TGVYVALKEVKLD----SEEGTPSTAIREISLMKE 59

Query: 196 LLHPNLVKLVGYCIEDDQRLLVYEFMP---RGSLENHLFRRS-LPLPWSIRMKIALGAAK 251
           L H N+V+L      +++  LV+EFM    +  +++     +   L  ++         +
Sbjct: 60  LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA--KDAPEDGKTHVSTRVMGTY 309
           GLAF HE     +++RD K  N+L++     KL DFGLA     P +  +     V+ T 
Sbjct: 120 GLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TL 172

Query: 310 GYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGR 342
            Y AP+ V+ G    ++  D++S G +L EM+TG+
Sbjct: 173 WYRAPD-VLMGSRTYSTSIDIWSCGCILAEMITGK 206

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 89.9 bits (224), Expect = 7e-20
 Identities = 69/229 (30%), Positives = 102/229 (44%), Gaps = 29/229 (12%)

Query: 124 MFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH 183
           M  D+K   + +     LGEG F  V+K   +          T   VA+K +        
Sbjct: 1   MALDVKSRAKRYEKLDFLGEGQFATVYKARDKN---------TNQIVAIKKIKLGHRSEA 51

Query: 184 KE-----WLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP 238
           K+      L E+  L  L HPN++ L+          LV++FM    LE  +   SL L 
Sbjct: 52  KDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLT 110

Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPED 296
            S      L   +GL +LH+     +++RD K +N+LLD +   KL+DFGLAK   +P  
Sbjct: 111 PSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 167

Query: 297 GKTH-VSTRVMGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGR 342
             TH V TR      Y APE ++ G        D+++ G +L E+L   
Sbjct: 168 AYTHQVVTR-----WYRAPE-LLFGARMYGVGVDMWAVGCILAELLLRV 210

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 88.4 bits (220), Expect = 9e-20
 Identities = 69/300 (23%), Positives = 113/300 (37%), Gaps = 77/300 (25%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAE 189
           + N+  +  LG+G F  V +          V   TGL  A K +N   L     ++   E
Sbjct: 5   SDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLERE 55

Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 248
                 L HPN+V+L    I+++    LV++ +  G  E  LF         I   +A  
Sbjct: 56  ARICRKLQHPNIVRLHDS-IQEESFHYLVFDLVTGG--E--LFED-------I---VARE 100

Query: 249 ------AAK-------GLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKD 292
                 A+         +A+ H      +++R+ K  N+LL         KL+DFGLA +
Sbjct: 101 FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157

Query: 293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPN 351
             +    H      GT GY +PE V+     +   D+++ GV+L  +L G          
Sbjct: 158 VNDSEAWH--GFA-GTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVG---------- 203

Query: 352 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKAR 405
                     P   + +  +RL      G +          + +A  L    L+ +PK R
Sbjct: 204 --------YPPFWDEDQ--HRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKR 253

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 69/316 (21%), Positives = 122/316 (38%), Gaps = 59/316 (18%)

Query: 115 KVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT 174
           +   +  +FM N     + N+  +  LG+G F  V +          V   TGL  A K 
Sbjct: 11  QQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKI 61

Query: 175 LNHDGLQG--HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLF 231
           +N   L     ++   E      L HPN+V+L    I+++    LV++ +  G L   + 
Sbjct: 62  INTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-IQEESFHYLVFDLVTGGELFEDIV 120

Query: 232 RRSLPLPWSIR-----MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAK 283
            R     +S       ++  L +   +A+ H      +++R+ K  N+LL         K
Sbjct: 121 ARE---FYSEADASHCIQQILES---IAYCHS---NGIVHRNLKPENLLLASKAKGAAVK 171

Query: 284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 343
           L+DFGLA +  +    H      GT GY +PE +     +   D+++ GV+L  +L G  
Sbjct: 172 LADFGLAIEVNDSEAWH--GFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY- 227

Query: 344 SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQC 397
                             P   + +  +RL      G +          + +A  L    
Sbjct: 228 -----------------PPFWDEDQ--HRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSM 268

Query: 398 LSRDPKARPRMSEVVE 413
           L+ +PK R    + ++
Sbjct: 269 LTVNPKKRITADQALK 284

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 90.2 bits (224), Expect = 1e-19
 Identities = 63/222 (28%), Positives = 97/222 (43%), Gaps = 38/222 (17%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EV 190
           ++     LG G FG V  G             TG  VAVK LN   ++          E+
Sbjct: 17  HYILGDTLGVGTFGKVKVG---------KHELTGHKVAVKILNRQKIRSLDVVGKIRREI 67

Query: 191 NFLGNLLHPNLVKLVGY-CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 248
             L    HP+++KL  Y  I     + +V E++  G L +++ +         R+     
Sbjct: 68  QNLKLFRHPHIIKL--YQVISTPSDIFMVMEYVSGGELFDYICKNG-------RLDEKES 118

Query: 249 AAK------GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
                    G+ + H      V++RD K  N+LLDA  NAK++DFGL+    +      S
Sbjct: 119 RRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS 175

Query: 303 TRVMGTYGYAAPEYVMTGHL--TSKSDVYSFGVVLLEMLTGR 342
               G+  YAAPE V++G L    + D++S GV+L  +L G 
Sbjct: 176 C---GSPNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGT 213

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 87.7 bits (218), Expect = 3e-19
 Identities = 68/295 (23%), Positives = 108/295 (36%), Gaps = 69/295 (23%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           +G G +    +          +   T +  AVK ++        E   E+  L     HP
Sbjct: 30  IGVGSYSVCKRC---------IHKATNMEFAVKIIDKSKRDP-TE---EIEILLRYGQHP 76

Query: 200 NLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAKGL 253
           N++ L     +D + + +V E M  G L + + R+     +S R     +         +
Sbjct: 77  NIITLKDVY-DDGKYVYVVTELMKGGELLDKILRQK---FFSEREASAVLFTITKT---V 129

Query: 254 AFLHEEAEKPVIYRDFKTSNILL-DADYNA---KLSDFGLAKDAPEDGKTHVSTRVMGTY 309
            +LH    + V++RD K SNIL  D   N    ++ DFG AK    +    + T    T 
Sbjct: 130 EYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL-LMTPC-YTA 184

Query: 310 GYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTG----RRSMDKNRPNGEHNLVEWARPHL 364
            + APE V+       + D++S GV+L  MLTG        D                  
Sbjct: 185 NFVAPE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE-------------- 229

Query: 365 GDKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEVVE 413
                   +L     G FS+ G      S  A  L ++ L  DP  R   + V+ 
Sbjct: 230 -------EILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 87.7 bits (218), Expect = 3e-19
 Identities = 71/295 (24%), Positives = 114/295 (38%), Gaps = 61/295 (20%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EV 190
            +     LGEG FG V                T   VA+K ++   L+     +    E+
Sbjct: 10  PYIIRETLGEGSFGKVKLA---------THYKTQQKVALKFISRQLLKKSDMHMRVEREI 60

Query: 191 NFLGNLLHPNLVKLVGY-CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 248
           ++L  L HP+++KL  Y  I     + +V E+   G L +++  +        RM    G
Sbjct: 61  SYLKLLRHPHIIKL--YDVITTPTDIVMVIEYAG-GELFDYIVEKK-------RMTEDEG 110

Query: 249 AAK------GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
                     + + H      +++RD K  N+LLD + N K++DFGL+    +      S
Sbjct: 111 RRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS 167

Query: 303 TRVMGTYGYAAPEYVMTGHL--TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 360
               G+  YAAPE V+ G L    + DV+S G+VL  ML GR   D      +  +    
Sbjct: 168 C---GSPNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD------DEFIPN-- 215

Query: 361 RPHLGDKRRFYRLLDPRLEGHFSIKG--SQKATQLAAQCLSRDPKARPRMSEVVE 413
                       L        + +    S  A  L  + +  DP  R  + E+  
Sbjct: 216 ------------LFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 87.4 bits (217), Expect = 4e-19
 Identities = 62/295 (21%), Positives = 103/295 (34%), Gaps = 64/295 (21%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-H 198
           +LG G  G V +              TG   A+K L         +   EV+        
Sbjct: 36  VLGLGVNGKVLEC---------FHRRTGQKCALKLLYD-----SPKARQEVDHHWQASGG 81

Query: 199 PNLVKLVGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALG 248
           P++V ++    E+        L++ E M  G L + +  R     ++ R     M+    
Sbjct: 82  PHIVCILDVY-ENMHHGKRCLLIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGT 139

Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
           A   + FLH      + +RD K  N+L    + D   KL+DFG AK+  ++    + T  
Sbjct: 140 A---IQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN---ALQTPC 190

Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHL 364
             T  Y APE +         D++S GV++  +L G        P               
Sbjct: 191 -YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGF------PPFYSNT---------- 233

Query: 365 GDKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEVVE 413
             +     +      G +          S+ A QL    L  DP  R  +++ + 
Sbjct: 234 -GQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 88.5 bits (220), Expect = 5e-19
 Identities = 64/291 (21%), Positives = 110/291 (37%), Gaps = 60/291 (20%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 198
           LG+G F  V +          VK   G   A   +N   L    H++   E      L H
Sbjct: 19  LGKGAFSVVRRC---------VKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69

Query: 199 PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAKG 252
           PN+V+L    I ++    L+++ +  G L   +  R     +S       ++  L A   
Sbjct: 70  PNIVRLHDS-ISEEGHHYLIFDLVTGGELFEDIVARE---YYSEADASHCIQQILEA--- 122

Query: 253 LAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           +   H+     V++R+ K  N+LL         KL+DFGLA +   + +        GT 
Sbjct: 123 VLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA-WFGFA-GTP 177

Query: 310 GYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
           GY +PE V+         D+++ GV+L  +L G                    P   + +
Sbjct: 178 GYLSPE-VLRKDPYGKPVDLWACGVILYILLVGY------------------PPFWDEDQ 218

Query: 369 RFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEVVE 413
             +RL      G +          + +A  L  + L+ +P  R   +E ++
Sbjct: 219 --HRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 84.8 bits (210), Expect = 1e-18
 Identities = 37/280 (13%), Positives = 75/280 (26%), Gaps = 59/280 (21%)

Query: 130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW 186
              R +R     G       ++                  VA+  ++  G+      +E 
Sbjct: 29  ANGR-YRLLIFHGGVPPLQFWQALDTA---------LDRQVALTFVDPQGVLPDDVLQET 78

Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
           L+    L  +  P + +++         L+V E++  GSL+      + P P    ++  
Sbjct: 79  LSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGA-IRAM 135

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
              A      H      V       S + +  D +  L+                     
Sbjct: 136 QSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------------------ 174

Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
                             + D+   G  L  +L  R  + +    G  + +  A      
Sbjct: 175 ----TMPDA-------NPQDDIRGIGASLYALLVNRWPLPE---AGVRSGLAPAERDTAG 220

Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
           +      +D  +    S         +AA+ +  D   R 
Sbjct: 221 QPIEPADIDRDIPFQIS--------AVAARSVQGDGGIRS 252

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 85.9 bits (213), Expect = 2e-18
 Identities = 56/218 (25%), Positives = 90/218 (41%), Gaps = 40/218 (18%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  +       EV+ L 
Sbjct: 20  LGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 195 NLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSL------ENHLFRRSLPLPWSIRMKIAL 247
            +LHPN++ L     E+   + L+ E +  G L      +  L         +  +K  L
Sbjct: 71  QVLHPNIITLHDV-YENRTDVVLILELVSGGELFDFLAQKESLSEEEA----TSFIKQIL 125

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILL----DADYNAKLSDFGLAKDAPEDGKTHVST 303
               G+ +LH    K + + D K  NI+L        + KL DFGLA +  +  +     
Sbjct: 126 D---GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-- 177

Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            + GT  + APE V    L  ++D++S GV+   +L+G
Sbjct: 178 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 85.0 bits (211), Expect = 2e-18
 Identities = 55/218 (25%), Positives = 90/218 (41%), Gaps = 40/218 (18%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 20  LGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 195 NLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSL------ENHLFRRSLPLPWSIRMKIAL 247
            +LH N++ L     E+   + L+ E +  G L      +  L         +  +K  L
Sbjct: 71  QVLHHNVITLHDV-YENRTDVVLILELVSGGELFDFLAQKESLSEEEA----TSFIKQIL 125

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILL----DADYNAKLSDFGLAKDAPEDGKTHVST 303
               G+ +LH    K + + D K  NI+L        + KL DFGLA +  +  +     
Sbjct: 126 D---GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-- 177

Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            + GT  + APE V    L  ++D++S GV+   +L+G
Sbjct: 178 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 51/236 (21%), Positives = 89/236 (37%), Gaps = 51/236 (21%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----------- 188
            +G+G +G V                     A+K L+   L     +             
Sbjct: 20  EIGKGSYGVVKLA---------YNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAP 70

Query: 189 ---------------EVNFLGNLLHPNLVKL--VGYCIEDDQRLLVYEFMPRGSLENHLF 231
                          E+  L  L HPN+VKL  V     +D   +V+E + +G +     
Sbjct: 71  GGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT 130

Query: 232 RRSLPLPWSIRM--KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL 289
            + L    +      +      G+ +LH    + +I+RD K SN+L+  D + K++DFG+
Sbjct: 131 LKPLSEDQARFYFQDLIK----GIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGV 183

Query: 290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLT---SKSDVYSFGVVLLEMLTGR 342
           + +  +     +S  V GT  + APE +            DV++ GV L   + G+
Sbjct: 184 SNE-FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 85.5 bits (212), Expect = 3e-18
 Identities = 64/297 (21%), Positives = 100/297 (33%), Gaps = 60/297 (20%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNF 192
            +     +G G FG                  T   VAVK +         E +  E+  
Sbjct: 21  RYDFVKDIGSGNFGVARLM---------RDKLTKELVAVKYIERGAAI--DENVQREIIN 69

Query: 193 LGNLLHPNLVKLVGY-CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 250
             +L HPN+V+      I     L ++ E+   G L   +           R        
Sbjct: 70  HRSLRHPNIVRF--KEVILTPTHLAIIMEYASGGELYERICNAG-------RFSEDEARF 120

Query: 251 K------GLAFLHEEAEKPVIYRDFKTSNILLDADY--NAKLSDFGLAKDAPEDGKTHVS 302
                  G+++ H      + +RD K  N LLD       K+ DFG +K +    +    
Sbjct: 121 FFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-- 175

Query: 303 TRVMGTYGYAAPEYVMTGHL--TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 360
           + V GT  Y APE V+         +DV+S GV L  ML G    +   P          
Sbjct: 176 STV-GTPAYIAPE-VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE--DPE--------- 222

Query: 361 RPHLGDKRRFYRLLDPRLEGHFSIKG----SQKATQLAAQCLSRDPKARPRMSEVVE 413
                + R + + +   L   +SI      S +   L ++    DP  R  + E+  
Sbjct: 223 -----EPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 83.8 bits (208), Expect = 3e-18
 Identities = 58/222 (26%), Positives = 90/222 (40%), Gaps = 48/222 (21%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           + GTG   A K +    L   +  ++      EVN L 
Sbjct: 13  LGSGQFAIVRKC---------RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 195 NLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG---AA 250
            + HPN++ L     E+   + L+ E +  G  E  LF         +  K +L    A 
Sbjct: 64  EIRHPNIITLHDIF-ENKTDVVLILELVSGG--E--LFDF-------LAEKESLTEDEAT 111

Query: 251 K-------GLAFLHEEAEKPVIYRDFKTSNILL----DADYNAKLSDFGLAKDAPEDGKT 299
           +       G+ +LH    K + + D K  NI+L      +   KL DFG+A       + 
Sbjct: 112 QFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF 168

Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
                + GT  + APE V    L  ++D++S GV+   +L+G
Sbjct: 169 KN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 84.2 bits (209), Expect = 4e-18
 Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 36/216 (16%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGN 195
           LGEG +G V+K              T  TVA+K +    L+  +E      + EV+ L  
Sbjct: 42  LGEGTYGEVYKAIDTV---------TNETVAIKRIR---LEHEEEGVPGTAIREVSLLKE 89

Query: 196 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 255
           L H N+++L      + +  L++E+     L+ ++  ++  +   +          G+ F
Sbjct: 90  LQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM-DKNPDVSMRVIKSFLYQLINGVNF 147

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAKD--APEDGKTHVSTRVMGT 308
            H    +  ++RD K  N+LL     +     K+ DFGLA+    P    TH    ++ T
Sbjct: 148 CH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH---EII-T 200

Query: 309 YGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGR 342
             Y  PE ++ G  H ++  D++S   +  EML   
Sbjct: 201 LWYRPPE-ILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 83.8 bits (208), Expect = 5e-18
 Identities = 40/207 (19%), Positives = 79/207 (38%), Gaps = 26/207 (12%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V +          V+  +  T   K +   G         E++ L    H N
Sbjct: 13  LGRGEFGIVHRC---------VETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRN 62

Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP---WSIRMKIALGAAKGLAFL 256
           ++ L     E  + L +++EF+    +   +   +  L        +       + L FL
Sbjct: 63  ILHLHESF-ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC---EALQFL 118

Query: 257 HEEAEKPVIYRDFKTSNILLDADYNA--KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           H      + + D +  NI+     ++  K+ +FG A+         +   +     Y AP
Sbjct: 119 H---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAP 172

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           E      +++ +D++S G ++  +L+G
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSG 199

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 84.3 bits (209), Expect = 6e-18
 Identities = 81/369 (21%), Positives = 123/369 (33%), Gaps = 87/369 (23%)

Query: 68  MSGTSTNYADGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFND 127
           M     + +      E    +     S T ++   +AS  P +  +      L  F    
Sbjct: 1   MHHHHHHSSGVDLGTENLYFQS--MSSVTASAAPGTASLVPDYWIDGSNRDALSDF---- 54

Query: 128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL 187
                  F  ES LG G    V++           + GT    A+K L        K   
Sbjct: 55  -------FEVESELGRGATSIVYRC---------KQKGTQKPYALKVLKKT--VDKKIVR 96

Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
            E+  L  L HPN++KL     E    + LV E +  G L    F R       I   + 
Sbjct: 97  TEIGVLLRLSHPNIIKLKEIF-ETPTEISLVLELVTGGEL----FDR-------I---VE 141

Query: 247 LG------AAK-------GLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLA 290
            G      AA         +A+LHE     +++RD K  N+L      D   K++DFGL+
Sbjct: 142 KGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLS 198

Query: 291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           K             V GT GY APE +       + D++S G++   +L G         
Sbjct: 199 KIVEHQVLM---KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG--------- 246

Query: 351 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKA 404
                          D+R    +    L   +          S  A  L  + +  DPK 
Sbjct: 247 ----------FEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKK 296

Query: 405 RPRMSEVVE 413
           R    + ++
Sbjct: 297 RLTTFQALQ 305

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 82.7 bits (205), Expect = 1e-17
 Identities = 52/218 (23%), Positives = 85/218 (38%), Gaps = 40/218 (18%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 19  LGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 195 NLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSL------ENHLFRRSLPLPWSIRMKIAL 247
            + HPN++ L     E+   + L+ E +  G L      +  L         +  +K  L
Sbjct: 70  EIQHPNVITLHEV-YENKTDVILILELVAGGELFDFLAEKESLTEEEA----TEFLKQIL 124

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILL----DADYNAKLSDFGLAKDAPEDGKTHVST 303
                + +LH      + + D K  NI+L          K+ DFGLA       +     
Sbjct: 125 NG---VYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN-- 176

Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            + GT  + APE V    L  ++D++S GV+   +L+G
Sbjct: 177 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 82.7 bits (204), Expect = 2e-17
 Identities = 76/350 (21%), Positives = 106/350 (30%), Gaps = 98/350 (28%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFL------ 193
           LG G FG V +           K  T  TVAVK L        H+  ++E+  L      
Sbjct: 30  LGRGAFGQVIEADAFG----IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85

Query: 194 --------------------------GNLLH-------------------PNLVKLVGYC 208
                                     GNL                           VG  
Sbjct: 86  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145

Query: 209 IEDDQRLLVYEFMPRGS----------------LENHLFRRSLPLPWSIRMKIALGAAKG 252
             D +R L      + S                 E         L     +  +   AKG
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           + FL   A +  I+RD    NILL      K+ DFGLA+D  +D              + 
Sbjct: 206 MEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 262

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGEHNLVEWARPHLGDKR 368
           APE +     T +SDV+SFGV+L E+ + G      +  +                   +
Sbjct: 263 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-----EEFCRRL-------K 310

Query: 369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
              R+  P          + +  Q    C   +P  RP  SE+VE L  L
Sbjct: 311 EGTRMRAPDY-------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 82.5 bits (204), Expect = 3e-17
 Identities = 68/357 (19%), Positives = 115/357 (32%), Gaps = 64/357 (17%)

Query: 79  KSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFR-P 137
             S       P  P    T +     +  P    +      ++  +         +++  
Sbjct: 7   GQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVT 66

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL 197
             +LG G  G V +              T    A+K L         +   EV       
Sbjct: 67  SQVLGLGINGKVLQI---------FNKRTQEKFALKMLQD-----CPKARREVELHWRAS 112

Query: 198 -HPNLVKLVGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIA 246
             P++V++V    E+        L+V E +  G L + +  R     ++ R     MK  
Sbjct: 113 QCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSI 170

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILL-DADYNA--KLSDFGLAKDAPEDGKTHVST 303
             A   + +LH      + +RD K  N+L      NA  KL+DFG AK+        ++T
Sbjct: 171 GEA---IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTT 222

Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARP 362
               T  Y APE +         D++S GV++  +L G        P    H        
Sbjct: 223 PC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY------PPFYSNH-------G 268

Query: 363 HLGDKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEVVE 413
                    R+      G +          S++   L    L  +P  R  ++E + 
Sbjct: 269 LAISPGMKTRI----RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 81.1 bits (201), Expect = 4e-17
 Identities = 51/216 (23%), Positives = 85/216 (39%), Gaps = 38/216 (17%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 198
           LG G F  V +          +   TG   A K L           E L E+  L     
Sbjct: 37  LGRGKFAVVRQC---------ISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87

Query: 199 -PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW--------SIRMKIALG 248
            P ++ L     E+   + L+ E+   G  E  +F   LP              +K  L 
Sbjct: 88  CPRVINLHEV-YENTSEIILILEYAAGG--E--IFSLCLPELAEMVSENDVIRLIKQILE 142

Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
              G+ +LH   +  +++ D K  NILL       + K+ DFG+++      +      +
Sbjct: 143 ---GVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---I 193

Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           MGT  Y APE +    +T+ +D+++ G++   +LT 
Sbjct: 194 MGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 81.1 bits (201), Expect = 4e-17
 Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 38/219 (17%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGN 195
           +GEG +G VFK    +N         G  VA+K +    +Q  +E      + EV  L +
Sbjct: 19  IGEGAYGKVFKARDLKN--------GGRFVALKRVR---VQTGEEGMPLSTIREVAVLRH 67

Query: 196 L---LHPNLVKL----VGYCIEDDQRL-LVYEFMP---RGSLENHLFRRSLPLPWSIRMK 244
           L    HPN+V+L         + + +L LV+E +       L+         +P      
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKD 124

Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVST 303
           +     +GL FLH      V++RD K  NIL+ +    KL+DFGLA+        T    
Sbjct: 125 MMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--- 178

Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
            V+ T  Y APE ++     +  D++S G +  EM   +
Sbjct: 179 VVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 81.2 bits (201), Expect = 5e-17
 Identities = 50/219 (22%), Positives = 87/219 (39%), Gaps = 35/219 (15%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           +++    LG G +  VF+     N            V VK L        K+   E+  L
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITNNE---------KVVVKILK---PVKKKKIKREIKIL 84

Query: 194 GNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL--PWSIR--MKIALG 248
            NL   PN++ L     +   R     F     + N  F++       + IR  M   L 
Sbjct: 85  ENLRGGPNIITLADIVKDPVSRTPALVFEH---VNNTDFKQLYQTLTDYDIRFYMYEIL- 140

Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAK-DAPEDGKTH-VSTRV 305
             K L + H      +++RD K  N+++D ++   +L D+GLA+   P       V++R 
Sbjct: 141 --KALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 195

Query: 306 MGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRR 343
                +  PE ++   +   S D++S G +L  M+  + 
Sbjct: 196 -----FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 81.8 bits (202), Expect = 7e-17
 Identities = 53/222 (23%), Positives = 88/222 (39%), Gaps = 33/222 (14%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 189
            + ++    +G G  G V                    VA+K L+         K    E
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAA---------YDAVLDRNVAIKKLSRPFQNQTHAKRAYRE 111

Query: 190 VNFLGNLLHPNLVKLV-----GYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM 243
           +  +  + H N++ L+        +E+ Q + LV E M   +    + +  L      RM
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQMEL---DHERM 166

Query: 244 KIAL-GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT--H 300
              L     G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A        +
Sbjct: 167 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 223

Query: 301 VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           V TR      Y APE ++        D++S G ++ EM+  +
Sbjct: 224 VVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 80.8 bits (200), Expect = 8e-17
 Identities = 55/231 (23%), Positives = 88/231 (38%), Gaps = 40/231 (17%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW----- 186
              +  +  +  G +G V                 G+ VA+K + +    G         
Sbjct: 21  QSPYTVQRFISSGSYGAVCA----------GVDSEGIPVAIKRVFNTVSDGRTVNILSDS 70

Query: 187 ------LAEVNFLGNLLHPNLVKL----VGYCIEDDQRL-LVYEFMPRGSLENHLFRRSL 235
                 L E+  L +  HPN++ L    V +      +L LV E M    L   +  + +
Sbjct: 71  FLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRI 129

Query: 236 PLPWSIRMK-IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 294
            +     ++        GL  LHE A   V++RD    NILL  + +  + DF LA++  
Sbjct: 130 VIS-PQHIQYFMYHILLGLHVLHE-AG--VVHRDLHPGNILLADNNDITICDFNLAREDT 185

Query: 295 EDGKT--HVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGR 342
            D     +V+ R      Y APE VM     T   D++S G V+ EM   +
Sbjct: 186 ADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 79.5 bits (197), Expect = 1e-16
 Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 42/222 (18%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA--------EVNF 192
           +G G +G V+K              +G  VA+K++    +                EV  
Sbjct: 17  IGVGAYGTVYKARDPH---------SGHFVALKSVR---VPNGGGGGGGLPISTVREVAL 64

Query: 193 LGNL---LHPNLVKL----VGYCIEDDQRL-LVYEFMP---RGSLENHLFRRSLPLPWSI 241
           L  L    HPN+V+L         + + ++ LV+E +    R  L+         LP   
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA---PPPGLPAET 121

Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-TH 300
              +     +GL FLH      +++RD K  NIL+ +    KL+DFGLA+        T 
Sbjct: 122 IKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP 178

Query: 301 VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
               V+ T  Y APE ++     +  D++S G +  EM   +
Sbjct: 179 ---VVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 80.0 bits (198), Expect = 1e-16
 Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 38/221 (17%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGN 195
           +G+G FG VFK    +         TG  VA+K +    ++  KE      L E+  L  
Sbjct: 25  IGQGTFGEVFKARHRK---------TGQKVALKKVL---MENEKEGFPITALREIKILQL 72

Query: 196 LLHPNLVKLVGYCIEDDQRL--------LVYEFMP---RGSLENHLFRRSLPLPWSIRMK 244
           L H N+V L+  C               LV++F      G L N L + +L     + M+
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV-MQ 131

Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTHVS 302
           + L    GL ++H      +++RD K +N+L+  D   KL+DFGLA+     ++ + +  
Sbjct: 132 MLL---NGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185

Query: 303 TRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
           T  + T  Y  PE ++         D++  G ++ EM T  
Sbjct: 186 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 79.3 bits (196), Expect = 3e-16
 Identities = 56/231 (24%), Positives = 98/231 (42%), Gaps = 52/231 (22%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 189
            + +   + +G G +G V            +   +G  VA+K L+         K    E
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSA---------IDKRSGEKVAIKKLSRPFQSEIFAKRAYRE 73

Query: 190 VNFLGNLLHPNLVKLV-----GYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM 243
           +  L ++ H N++ L+        + +     LV  FM     +  L +        + +
Sbjct: 74  LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQK-------IMGL 121

Query: 244 KIA-----------LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD 292
           K +           L   KGL ++H  A   V++RD K  N+ ++ D   K+ DFGLA+ 
Sbjct: 122 KFSEEKIQYLVYQML---KGLKYIHS-AG--VVHRDLKPGNLAVNEDCELKILDFGLARH 175

Query: 293 APEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGR 342
           A  +   +V TR    + Y APE +++  H     D++S G ++ EMLTG+
Sbjct: 176 ADAEMTGYVVTR----W-YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 79.3 bits (196), Expect = 3e-16
 Identities = 55/222 (24%), Positives = 90/222 (40%), Gaps = 33/222 (14%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 189
            + ++    +G G  G V                    VA+K L+         K    E
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAA---------YDAILERNVAIKKLSRPFQNQTHAKRAYRE 74

Query: 190 VNFLGNLLHPNLVKLV-----GYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM 243
           +  +  + H N++ L+        +E+ Q + +V E M   +L   + +  L      RM
Sbjct: 75  LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANL-CQVIQMEL---DHERM 129

Query: 244 KIAL-GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT--H 300
              L     G+  LH  A   +I+RD K SNI++ +D   K+ DFGLA+ A        +
Sbjct: 130 SYLLYQMLCGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 186

Query: 301 VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           V TR      Y APE ++        D++S G ++ EM+ G 
Sbjct: 187 VVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 78.9 bits (195), Expect = 3e-16
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 33/222 (14%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 189
              ++  S +G G +G V   +  +         TGL VAVK L+     +   K    E
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRE 78

Query: 190 VNFLGNLLHPNLVKLV-----GYCIEDDQRL-LVYEFMPRGSLENHLFR--RSLPLPWSI 241
           +  L ++ H N++ L+        +E+   + LV   M        L    +   L    
Sbjct: 79  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDH 133

Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
              +     +GL ++H  A+  +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V
Sbjct: 134 VQFLIYQILRGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV 190

Query: 302 STRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGR 342
           +TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 191 ATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 77.9 bits (192), Expect = 1e-15
 Identities = 54/258 (20%), Positives = 96/258 (37%), Gaps = 71/258 (27%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK-TLNHDGLQGHKEWLAEV 190
           ++ +     LG G FG V + +  E         +G   A+K  L        +    E+
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIE---------SGKRFALKKVLQDP-----RYKNREL 51

Query: 191 NFLGNLLHPNLVKL-------------------------------------VGYCIEDDQ 213
           + +  L H N++KL                                     V      ++
Sbjct: 52  DIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNK 111

Query: 214 RL-LVYEFMPR--GSLENHLFRRSLPLPWSIRMKIAL-GAAKGLAFLHEEAEKPVIYRDF 269
            L ++ E++P     +     R    +P    + I +    + + F+H      + +RD 
Sbjct: 112 YLNVIMEYVPDTLHKVLKSFIRSGRSIP-MNLISIYIYQLFRAVGFIHSLG---ICHRDI 167

Query: 270 KTSNILLDA-DYNAKLSDFGLAKDA-PEDGKTH-VSTRVMGTYGYAAPEYVMTG--HLTS 324
           K  N+L+++ D   KL DFG AK   P +     + +R    + Y APE +M G    T 
Sbjct: 168 KPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPE-LMLGATEYTP 221

Query: 325 KSDVYSFGVVLLEMLTGR 342
             D++S G V  E++ G+
Sbjct: 222 SIDLWSIGCVFGELILGK 239

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 58/222 (26%), Positives = 92/222 (41%), Gaps = 33/222 (14%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 189
              +R    +G G +G V            V   TG  VA+K L          K    E
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSA---------VDGRTGAKVAIKKLYRPFQSELFAKRAYRE 74

Query: 190 VNFLGNLLHPNLVKLV-----GYCIEDDQRL-LVYEFMPRGSLENHLFR--RSLPLPWSI 241
           +  L ++ H N++ L+        ++D     LV  FM        L +  +   L    
Sbjct: 75  LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDR 129

Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
              +     KGL ++H  A   +I+RD K  N+ ++ D   K+ DFGLA+ A  +   +V
Sbjct: 130 IQFLVYQMLKGLRYIHA-AG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV 186

Query: 302 STRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGR 342
            TR      Y APE ++     T   D++S G ++ EM+TG+
Sbjct: 187 VTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 75.4 bits (186), Expect = 3e-15
 Identities = 54/236 (22%), Positives = 92/236 (38%), Gaps = 48/236 (20%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 191
              +     LG GG G VF           V       VA+K +     Q  K  L E+ 
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSA---------VDNDCDKRVAIKKIVLTDPQSVKHALREIK 60

Query: 192 FLGNLLHPNLVKL-------------VGYCIEDDQRL-LVYEFMPRGSLENHLFR--RSL 235
            +  L H N+VK+                 + +   + +V E+M     E  L       
Sbjct: 61  IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQG 115

Query: 236 PLPWSIRMK-IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDA 293
           PL      +       +GL ++H  A   V++RD K +N+ ++  D   K+ DFGLA+  
Sbjct: 116 PLL-EEHARLFMYQLLRGLKYIHS-AN--VLHRDLKPANLFINTEDLVLKIGDFGLARIM 171

Query: 294 PEDGKT------HVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
                        + T+      Y +P  +++ +  +K+ D+++ G +  EMLTG+
Sbjct: 172 DPHYSHKGHLSEGLVTK-----WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 75.4 bits (186), Expect = 5e-15
 Identities = 60/230 (26%), Positives = 102/230 (44%), Gaps = 45/230 (19%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEV 190
              +   S +GEG +G V   +   N            VA+K ++  +     +  L E+
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKV---------RVAIKKISPFEHQTYCQRTLREI 76

Query: 191 NFLGNLLHPNLVKLVG----YCIEDDQRL-LVYEFMPRGSLENHLFR--RSLPLPWSIRM 243
             L    H N++ +        IE  + + +V + M     E  L++  ++  L  +  +
Sbjct: 77  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLS-NDHI 130

Query: 244 KI----ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
                  L   +GL ++H  A   V++RD K SN+LL+   + K+ DFGLA+ A  D   
Sbjct: 131 CYFLYQIL---RGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184

Query: 300 ------HVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
                 +V+TR      Y APE ++     +KS D++S G +L EML+ R
Sbjct: 185 TGFLTEYVATR-----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 74.2 bits (183), Expect = 1e-14
 Identities = 57/232 (24%), Positives = 101/232 (43%), Gaps = 42/232 (18%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEV 190
           + +F+ +SLLGEG +G V     +  G           VA+K +   D        L E+
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGE---------IVAIKKIEPFDKPLFALRTLREI 60

Query: 191 NFLGNLLHPNLVKLV----GYCIEDDQRL-LVYEFMPRGSLENHLFR--RSLPLPWSIRM 243
             L +  H N++ +         E+   + ++ E M     +  L R   +  L     +
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLS-DDHI 114

Query: 244 KI----ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA----KDAPE 295
           +      L   + +  LH  +   VI+RD K SN+L++++ + K+ DFGLA    + A +
Sbjct: 115 QYFIYQTL---RAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168

Query: 296 DGKTHVSTRVMGTY----GYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
           + +       M  +     Y APE ++T    S++ DV+S G +L E+   R
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 71.4 bits (175), Expect = 2e-13
 Identities = 49/318 (15%), Positives = 97/318 (30%), Gaps = 74/318 (23%)

Query: 81  SNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESL 140
           S+ +          +  T +        +        +       +D ++  R +    L
Sbjct: 2   SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDR-YEIRHL 60

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-----EVNFLGN 195
           +G G +G V +                  VA+K +                  E+  L  
Sbjct: 61  IGTGSYGHVCEA---------YDKLEKRVVAIKKILRVF---EDLIDCKRILREIAILNR 108

Query: 196 LLHPNLVKLV----GYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 250
           L H ++VK++       +E    L +V E       ++   +         R  + L   
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDFKK-------LFRTPVYLTEL 156

Query: 251 ----------KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA---------K 291
                      G+ ++H  A   +++RD K +N L++ D + K+ DFGLA          
Sbjct: 157 HIKTLLYNLLVGVKYVHS-AG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGN 213

Query: 292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGH------------LTSKS-----DVYSFGVV 334
                        ++        +  +TGH            L  ++     DV+S G +
Sbjct: 214 SQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCI 273

Query: 335 LLEMLTGRRSMDKNRPNG 352
             E+L   +       + 
Sbjct: 274 FAELLNMIKENVAYHADR 291

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 54/258 (20%), Positives = 95/258 (36%), Gaps = 62/258 (24%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 189
             N+  + L+G G +G V+  + +              VA+K +N   + L   K  L E
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEK---------NVAIKKVNRMFEDLIDCKRILRE 75

Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRL-----LVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
           +  L  L    +++L    I DD        +V E       ++ L +         +  
Sbjct: 76  ITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKK-------LFKTP 123

Query: 245 IALGAA----------KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 294
           I L              G  F+HE +   +I+RD K +N LL+ D + K+ DFGLA+   
Sbjct: 124 IFLTEEHIKTILYNLLLGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180

Query: 295 EDGKTHVSTRVMGTYGYAAP---------EYVMT------------GHLTSKSDVYSFGV 333
            +  T++   +                   +V+T             + T   D++S G 
Sbjct: 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGC 240

Query: 334 VLLEMLTGRRSMDKNRPN 351
           +  E+L   +S   +  N
Sbjct: 241 IFAELLNMLQSHINDPTN 258

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 66.6 bits (163), Expect = 5e-12
 Identities = 56/239 (23%), Positives = 97/239 (40%), Gaps = 46/239 (19%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 189
            R +     LG+G +G V+K              TG  VAVK +          +    E
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRR---------TGEVVAVKKIFDAFQNSTDAQRTFRE 58

Query: 190 VNFLGNL-LHPNLVKLVGYCI-EDDQRL-LVYEFMPRGSLENHLFR--RSLPLPWSIRMK 244
           +  L  L  H N+V L+     ++D+ + LV+++M     E  L    R+  L   +  +
Sbjct: 59  IMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILE-PVHKQ 112

Query: 245 -IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
            +     K + +LH      +++RD K SNILL+A+ + K++DFGL++      +   + 
Sbjct: 113 YVVYQLIKVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169

Query: 304 RVMGTYGYAAP--------EYVMT------------GHLTSKSDVYSFGVVLLEMLTGR 342
            +                 +YV T               T   D++S G +L E+L G+
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 65.5 bits (160), Expect = 9e-12
 Identities = 46/247 (18%), Positives = 85/247 (34%), Gaps = 53/247 (21%)

Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH 198
             LG G F  V+      N T          VA+K +  D     +    E+  L  +  
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNT---------HVAMKIVRGDK-VYTEAAEDEIKLLQRVND 74

Query: 199 PNLVKLVG----YCIEDDQRLLVYEFMPRGSLENHLF------RRSL----------PLP 238
            +  K       + +    +LL + F  +G    H+         +L           +P
Sbjct: 75  ADNTKEDSMGANHIL----KLLDH-FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP 129

Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD------ADYNAKLSDFGLAKD 292
                +I+     GL ++H      +I+ D K  N+L++           K++D G A  
Sbjct: 130 LIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187

Query: 293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR-----RSMDK 347
             E     + TR      Y +PE ++       +D++S   ++ E++TG           
Sbjct: 188 YDEHYTNSIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 242

Query: 348 NRPNGEH 354
              + +H
Sbjct: 243 YTKDDDH 249

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 54/302 (17%), Positives = 90/302 (29%), Gaps = 100/302 (33%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LG G  G V +              T    A+K L         +   EV         P
Sbjct: 26  LGLGINGKVLQI---------FNKRTQEKFALKMLQD-----CPKARREVELHWRASQCP 71

Query: 200 NLVKLVGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG-----A 249
           ++V++V    E+        L+V E +  G  E  LF R       I+ +         A
Sbjct: 72  HIVRIVDVY-ENLYAGRKCLLIVMECLDGG--E--LFSR-------IQDRGDQAFTEREA 119

Query: 250 A-------KGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKT 299
           +       + + +LH      + +RD K  N+L      +   KL+DFG    A E    
Sbjct: 120 SEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF---AKE---- 169

Query: 300 HVSTRVMGT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRS-MDKNRPNGEHNLV 357
                  G  Y  +              D++S GV++  +L G       +         
Sbjct: 170 -----TTGEKYDKSC-------------DMWSLGVIMYILLCGYPPFYSNHGLAISP--- 208

Query: 358 EWARPHLGDKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEV 411
                          +      G +          S++   L    L  +P  R  ++E 
Sbjct: 209 --------------GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 254

Query: 412 VE 413
           + 
Sbjct: 255 MN 256

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 63.2 bits (154), Expect = 5e-11
 Identities = 42/237 (17%), Positives = 79/237 (33%), Gaps = 40/237 (16%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG----------LQG 182
           R ++ +S       G +++     +             ++K    DG             
Sbjct: 42  RQWKLKSFQTRDNQGILYEA-APTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAA 100

Query: 183 HKEWLAEVNFLGNLLHPNLVKLVGY-CIEDDQRLLVYEFMPR--GSLENHLFRRSLPLPW 239
               + +   L +     +   +G+   +D  R LV   +P    SL+      S     
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLV---LPSLGRSLQ-SALDVSPKHVL 156

Query: 240 SIRM--KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK--LSDFGLAKDAPE 295
           S R   ++A      L FLH   E   ++ +    NI +D +  ++  L+ +G A     
Sbjct: 157 SERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYC- 212

Query: 296 DGKTHVSTR------VMGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEMLTGR 342
               HV+          G   + +    M  H     + +SD+ S G  +L+ L G 
Sbjct: 213 PSGKHVAYVEGSRSPHEGDLEFIS----MDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 62.8 bits (153), Expect = 8e-11
 Identities = 57/235 (24%), Positives = 90/235 (38%), Gaps = 53/235 (22%)

Query: 130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLA 188
              R +  +SL+G+G FG V K +                VA+K + N        +   
Sbjct: 52  WMDR-YEIDSLIGKGSFGQVVKAYDRVEQE---------WVAIKIIKNKKAF--LNQAQI 99

Query: 189 EVNFLGNLLHP------NLVKLVGY-------CI--EDDQRLL---VYEFMPRGSLENHL 230
           EV  L  +          +V L  +       C+  E    +L   +Y+      L N  
Sbjct: 100 EVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE----MLSYNLYDL-----LRNTN 150

Query: 231 FRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA--KLSDFG 288
           FR    +  ++  K A      L FL    E  +I+ D K  NILL     +  K+ DFG
Sbjct: 151 FR---GVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG 206

Query: 289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGR 342
            +    +    ++ +R      Y +PE V+ G       D++S G +L+EM TG 
Sbjct: 207 SSCQLGQRIYQYIQSRF-----YRSPE-VLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 62.8 bits (153), Expect = 9e-11
 Identities = 54/225 (24%), Positives = 92/225 (40%), Gaps = 52/225 (23%)

Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLAEVNFLGNLL 197
            ++G+G FG V K +  +             VA+K + N      H++   E+  L +L 
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQ---------HVALKMVRNEKRF--HRQAAEEIRILEHLR 151

Query: 198 H------PNLVKLVGY-------CI--EDDQRLL---VYEFMPRGSLENHLFRRSLPLPW 239
                   N++ ++         C+  E    LL   +YE + +         +   LP 
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFE----LLSMNLYELIKKNKF------QGFSLP- 200

Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL-DADYNA-KLSDFGLAKDAPEDG 297
            +R K A    + L  LH+     +I+ D K  NILL     +  K+ DFG +    +  
Sbjct: 201 LVR-KFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV 256

Query: 298 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
            T++ +R      Y APE ++        D++S G +L E+LTG 
Sbjct: 257 YTYIQSRF-----YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 59.4 bits (144), Expect = 8e-10
 Identities = 46/238 (19%), Positives = 87/238 (36%), Gaps = 42/238 (17%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----L 187
             ++    +G+GGFGC++   +  +       G+     VK    D      E       
Sbjct: 35  AAWKVGLPIGQGGFGCIYLADMNSSE----SVGSDAPCVVKVEPSDNGPLFTELKFYQRA 90

Query: 188 AEVNFLGNLLHPNLVKLVG-----YCIEDDQRLLVYEF--MPR-G-SLENHLFR---RSL 235
           A+   +   +    +K +G          D+    Y F  M R G  L+  ++    +  
Sbjct: 91  AKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQ-KIYEANAKRF 149

Query: 236 PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK--LSDFGLAKD- 292
               ++   ++L     L ++H   E   ++ D K SN+LL+     +  L D+GLA   
Sbjct: 150 SRK-TVLQ-LSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204

Query: 293 APEDGKTHVSTR----VMGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEMLTGR 342
            PE      +        GT  + +    +  H     + + D+   G  +++ LTG 
Sbjct: 205 CPEGVHKAYAADPKRCHDGTIEFTS----IDAHNGVAPSRRGDLEILGYCMIQWLTGH 258

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 51/230 (22%), Positives = 85/230 (36%), Gaps = 46/230 (20%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVN 191
           +++    +GEG FG +F+G                 VA+K      D  Q   E+     
Sbjct: 11  HYKVGRRIGEGSFGVIFEG---------TNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKL 61

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALG 248
             G      +  +  +  E    +LV + +   SLE  L     R   +  ++ M  A  
Sbjct: 62  LAGC---TGIPNVYYFGQEGLHNVLVIDLLGP-SLE-DLLDLCGRKFSVK-TVAM-AAKQ 114

Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK-----LSDFGLAK---DAPEDGKTH 300
               +  +H   EK ++YRD K  N L+    +       + DFG+ K   D     K H
Sbjct: 115 MLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP--VTKQH 169

Query: 301 VSTR----VMGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEMLTGR 342
           +  R    + GT  Y +    +  HL    + + D+ + G V +  L G 
Sbjct: 170 IPYREKKNLSGTARYMS----INTHLGREQSRRDDLEALGHVFMYFLRGS 215

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 52/225 (23%), Positives = 82/225 (36%), Gaps = 38/225 (16%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
            +R    +G G FG ++ G     G           VA+K         H +   E    
Sbjct: 10  RYRLGRKIGSGSFGDIYLGTDIAAGE---------EVAIKLECVK--TKHPQLHIESKIY 58

Query: 194 GNLLH-PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGA 249
             +     +  +     E D  ++V E +   SLE  LF    R   L  ++ + +A   
Sbjct: 59  KMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLE-DLFNFCSRKFSLK-TVLL-LADQM 114

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK---LSDFGLAKD-APEDGKTHVSTR- 304
              + ++H    K  I+RD K  N L+          + DFGLAK         H+  R 
Sbjct: 115 ISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE 171

Query: 305 ---VMGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEMLTGR 342
              + GT  YA+    +  HL    + + D+ S G VL+    G 
Sbjct: 172 NKNLTGTARYAS----INTHLGIEQSRRDDLESLGYVLMYFNLGS 212

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 55.8 bits (135), Expect = 9e-09
 Identities = 55/230 (23%), Positives = 87/230 (37%), Gaps = 46/230 (20%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK--TLNHDGLQGHKEWLAEVN 191
           NFR    +G G FG +  G             T   VA+K   +     Q H E+     
Sbjct: 10  NFRVGKKIGCGNFGELRLG---------KNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQ 60

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALG 248
                    + ++  +        +V E +   SLE  LF    R+  L  ++ M IA+ 
Sbjct: 61  LGSG---DGIPQVYYFGPCGKYNAMVLELLGP-SLE-DLFDLCDRTFSLK-TVLM-IAIQ 113

Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK-----LSDFGLAK---DAPEDGKTH 300
               + ++H    K +IYRD K  N L+    N       + DF LAK   D   + K H
Sbjct: 114 LISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP--ETKKH 168

Query: 301 VSTR----VMGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEMLTGR 342
           +  R    + GT  Y +    +  HL    + + D+ + G + +  L G 
Sbjct: 169 IPYREHKSLTGTARYMS----INTHLGKEQSRRDDLEALGHMFMYFLRGS 214

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 60/259 (23%), Positives = 87/259 (33%), Gaps = 72/259 (27%)

Query: 122 KFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL-NHDGL 180
                D  L  R +     LGEG FG V +                  VA+K + N    
Sbjct: 10  VCRIGDW-LQER-YEIVGNLGEGTFGKVVECLDHAR--------GKSQVALKIIRNVGKY 59

Query: 181 QGHKEWLAEVNFLGNLLHP------NLVKLVGY-------CI--EDDQRLL---VYEFMP 222
              +    E+N L  +           V +  +       CI  E    LL    +EF  
Sbjct: 60  --REAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFE----LLGKNTFEF-- 111

Query: 223 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL-DADYN 281
              L+ + F+   P P      +A      L FLHE     + + D K  NIL  ++++ 
Sbjct: 112 ---LKENNFQ---PYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFE 162

Query: 282 A------------------KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL- 322
                              +++DFG A    E   T V+TR      Y  PE V+     
Sbjct: 163 TLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRH-----YRPPE-VILELGW 216

Query: 323 TSKSDVYSFGVVLLEMLTG 341
               DV+S G +L E   G
Sbjct: 217 AQPCDVWSIGCILFEYYRG 235

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 54.1 bits (129), Expect = 3e-08
 Identities = 39/225 (17%), Positives = 57/225 (25%), Gaps = 63/225 (28%)

Query: 114 LKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK 173
           +   SQ     F+   L T   +    +GEG FG VF+                  VA+K
Sbjct: 2   MGECSQKGPVPFSHC-LPTEKLQRCEKIGEGVFGEVFQTIA-----------DHTPVAIK 49

Query: 174 TLNHDGLQGH--------KEWLAEVNFLGNLL---------HPNLVKLVGYCI------- 209
            +  +G            +E L E+     L              + L            
Sbjct: 50  IIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPP 109

Query: 210 -----------------------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
                                  +DDQ  +V EF   G     +  +      +    I 
Sbjct: 110 LLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK--LSSLATAKSIL 167

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK 291
                 LA           +RD    N+LL      KL      K
Sbjct: 168 HQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGK 210

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 54.2 bits (131), Expect = 4e-08
 Identities = 67/259 (25%), Positives = 96/259 (37%), Gaps = 72/259 (27%)

Query: 122 KFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL-NHDGL 180
                D+ L+ R +     LGEG FG V +    + G        G  VAVK + N D  
Sbjct: 5   ICQSGDV-LSAR-YEIVDTLGEGAFGKVVECIDHKAG--------GRHVAVKIVKNVDRY 54

Query: 181 QGHKEWLAEVNFLGNLLHP------NLVKLVGY-------CI--EDDQRLL---VYEFMP 222
              +   +E+  L +L           V+++ +       CI  E    LL    Y+F  
Sbjct: 55  --CEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE----LLGLSTYDF-- 106

Query: 223 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL-DADYN 281
              ++ + F    P       K+A    K + FLH      + + D K  NIL   +DY 
Sbjct: 107 ---IKENGFL---PFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYT 157

Query: 282 A------------------KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL- 322
                              K+ DFG A    E   T VSTR      Y APE V+     
Sbjct: 158 EAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRH-----YRAPE-VILALGW 211

Query: 323 TSKSDVYSFGVVLLEMLTG 341
           +   DV+S G +L+E   G
Sbjct: 212 SQPCDVWSIGCILIEYYLG 230

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 54.1 bits (130), Expect = 4e-08
 Identities = 42/278 (15%), Positives = 77/278 (27%), Gaps = 88/278 (31%)

Query: 216 LVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI 274
           +V+E +    L   + +     LP     KI     +GL +LH +    +I+ D K  NI
Sbjct: 122 MVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENI 178

Query: 275 LLDAD-------------------------------------------------YNAKLS 285
           LL  +                                                    K++
Sbjct: 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIA 238

Query: 286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM 345
           D G A    +     + TR      Y + E ++     + +D++S   +  E+ TG    
Sbjct: 239 DLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLF 293

Query: 346 DKNRPNGEHN-------------------LVEWARPHL-----GDKRRFYRLLDPRLEG- 380
           + +                          +V            GD +   +L    L   
Sbjct: 294 EPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEV 353

Query: 381 -----HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                 +S + +   T      L   P+ R   +E + 
Sbjct: 354 LVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 53.6 bits (129), Expect = 5e-08
 Identities = 39/239 (16%), Positives = 78/239 (32%), Gaps = 47/239 (19%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----L 187
             +     +G GGFG ++  +                  VK    +      E      +
Sbjct: 37  NQWVLGKKIGSGGFGLIYLAFPTNKP------EKDARHVVKVEYQENGPLFSELKFYQRV 90

Query: 188 AEVNFLGNLLHPNLVKLVG-----YC-----IEDDQRLLVYEFMPR--GSLENHLFRRSL 235
           A+ + +   +    +  +G                 R +V   M R    L+  +  ++ 
Sbjct: 91  AKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMV---MERLGIDLQ-KISGQNG 146

Query: 236 PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK--LSDFGLAKDA 293
               S  +++ +     L ++H   E   ++ D K +N+LL      +  L+D+GL+   
Sbjct: 147 TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203

Query: 294 PEDGKTHV------STRVMGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEMLTGR 342
                 H            GT  + +    +  H     + +SDV   G  +L  L G+
Sbjct: 204 -CPNGNHKQYQENPRKGHNGTIEFTS----LDAHKGVALSRRSDVEILGYCMLRWLCGK 257

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 54/247 (21%), Positives = 83/247 (33%), Gaps = 76/247 (30%)

Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLAEVNFLGNL- 196
             +G+G FG V      +N             AVK + N       +    E + L  + 
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKK---------YYAVKVVRNIKKY--TRSAKIEADILKKIQ 89

Query: 197 ----LHPNLVKLVGY-------CI--EDDQRLL---VYEFMPRGSLENHLFRRSLPLPWS 240
                + N+VK  G        C+  E     L   +YE      +  + +         
Sbjct: 90  NDDINNNNIVKYHGKFMYYDHMCLIFE----PLGPSLYEI-----ITRNNYN---GFHIE 137

Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL-DADYNA----------------- 282
                 +   K L +L + +   + + D K  NILL D  +                   
Sbjct: 138 DIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIY 194

Query: 283 -------KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVV 334
                  KL DFG A    +   + ++TR      Y APE V+        SD++SFG V
Sbjct: 195 RTKSTGIKLIDFGCATFKSDYHGSIINTRQ-----YRAPE-VILNLGWDVSSDMWSFGCV 248

Query: 335 LLEMLTG 341
           L E+ TG
Sbjct: 249 LAELYTG 255

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 56/224 (25%), Positives = 86/224 (38%), Gaps = 36/224 (16%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
            FR    +G G FG ++ G   +             VA+K  N      H + L E    
Sbjct: 8   KFRLGRKIGSGSFGEIYLGTNIQTNE---------EVAIKLENVK--TKHPQLLYESKIY 56

Query: 194 GNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM--KIALGAA 250
             L     +  +  + +E D  +LV + +   SLE  LF        S++    +A    
Sbjct: 57  RILQGGTGIPNVRWFGVEGDYNVLVMDLLGP-SLE-DLF-NFCSRKLSLKTVLMLADQMI 113

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK---LSDFGLAKD-APEDGKTHVSTR-- 304
             + F+H    K  ++RD K  N L+     A    + DFGLAK         H+  R  
Sbjct: 114 NRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170

Query: 305 --VMGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEMLTGR 342
             + GT  YA+    +  HL    + + D+ S G VL+  L G 
Sbjct: 171 KNLTGTARYAS----VNTHLGIEQSRRDDLESLGYVLMYFLRGS 210

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 48.7 bits (115), Expect = 4e-06
 Identities = 62/418 (14%), Positives = 110/418 (26%), Gaps = 141/418 (33%)

Query: 49  VRFRFIESCMPSRSKVDSSMSGT-STNYADGKSSNEKRRDRPVVPVSSTTTSNAESASST 107
               F          V   +      NY    S  +  + +P +             +  
Sbjct: 64  TLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDN 123

Query: 108 PKFSEELKVASQLRKFMFNDLKLATRNFRPESLL---GEGGFGCVFKGWVEENGTAPVKP 164
             F++   V+   R   +  L+ A    RP   +   G  G G   K W           
Sbjct: 124 QVFAK-YNVS---RLQPYLKLRQALLELRPAKNVLIDGVLGSG---KTW----------- 165

Query: 165 GTGLTVAVKTLNHDGLQGHKE----WLAEVNFLGNLLHPNLVKLVGYCIEDDQRL----- 215
                VA+       +Q   +    WL                 +  C   +  L     
Sbjct: 166 -----VALDVCLSYKVQCKMDFKIFWLN----------------LKNCNSPETVLEMLQK 204

Query: 216 LVYEFMPRG-SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI 274
           L+Y+  P   S  +H     L +                  +  E  + +  + ++   +
Sbjct: 205 LLYQIDPNWTSRSDHSSNIKLRIHS----------------IQAELRRLLKSKPYENCLL 248

Query: 275 LLDADYNAK-LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGV 333
           +L    NAK  + F L        K  ++TR                       V  F  
Sbjct: 249 VLLNVQNAKAWNAFNL------SCKILLTTR--------------------FKQVTDF-- 280

Query: 334 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQL 393
            L    T   S+D +                         L P            +   L
Sbjct: 281 -LSAATTTHISLDHHSMT----------------------LTPD-----------EVKSL 306

Query: 394 AAQCLSRDPKARPRMSEVVETLKPL------QNLKDMASSSYYFQTMQADNTWSIRNS 445
             + L   P+  PR  EV+ T  P       ++++D  ++   ++ +  D   +I  S
Sbjct: 307 LLKYLDCRPQDLPR--EVLTTN-PRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIES 361

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	490
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.75
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.46
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.31
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.23
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.14
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.77
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.6
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.56
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.53
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.52
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.51
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.41
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.35
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.04
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.96
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.75
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.71
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.58
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.56
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.55
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.54
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.52
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.43
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.26
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.25
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.18
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.87
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.92
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.3
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	91.63
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	89.22
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	87.76

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.5e-59  Score=471.15  Aligned_cols=251  Identities=25%  Similarity=0.397  Sum_probs=205.7

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ++|++++.||+|+||+||+|++..         +|+.||||++.....  ...+.+.+|+.+|+.|+|||||++++++.+
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~   94 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTE---------DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE   94 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETT---------TCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECC---------CCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE
Confidence            579999999999999999999876         677999999976543  334678999999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      ++.+|||||||+||+|.++|... ...+++..++.|+.||+.||+|||+++   ||||||||+||||+.++.+||+|||+
T Consensus        95 ~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGl  171 (350)
T 4b9d_A           95 NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGI  171 (350)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTE
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEccccc
Confidence            99999999999999999999654 346899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      |+.....  .......+||+.|||||++.+..|+.++|||||||+||||++|++||......   .+....   ....  
T Consensus       172 a~~~~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~~~i---~~~~--  241 (350)
T 4b9d_A          172 ARVLNST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK---NLVLKI---ISGS--  241 (350)
T ss_dssp             ESCCCHH--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHH---HHTC--
T ss_pred             ceeecCC--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHH---HcCC--
Confidence            9876432  11234578999999999999999999999999999999999999999754321   111111   0000  


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                          . +    .++...+.++.+||.+||+.||.+|||+.|++++
T Consensus       242 ----~-~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          242 ----F-P----PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             ----C-C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ----C-C----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                0 0    1223347889999999999999999999999975

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=9.4e-60  Score=465.27  Aligned_cols=265  Identities=29%  Similarity=0.440  Sum_probs=218.6

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      .++|.+.+.||+|+||+||+|++....    ...++..||||+++.......++|.+|+++|++|+|||||+++++|.++
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~----~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~   87 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLC----PEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   87 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC--------CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcc----cCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence            357889999999999999999986421    1125789999999877666678899999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcC------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRS------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD  279 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~  279 (490)
                      +.+|||||||++|+|.++|...+            ..+++..++.|+.||+.||.|||+++   ||||||||+||||+.+
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~  164 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGEN  164 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGG
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCC
Confidence            99999999999999999996532            46999999999999999999999988   9999999999999999


Q ss_pred             CCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhH
Q 011250          280 YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVE  358 (490)
Q Consensus       280 ~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~  358 (490)
                      +.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |+.||......   .+..
T Consensus       165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~  241 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIE  241 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHH
T ss_pred             CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH
Confidence            9999999999987654444333445679999999999999999999999999999999998 89999764321   1111


Q ss_pred             hhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                      .....              .....+..++.++.+||.+||+.||++|||+.+|++.|+.+..
T Consensus       242 ~i~~~--------------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          242 CITQG--------------RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             HHHHT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHcC--------------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            11100              0112334567899999999999999999999999999987643

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.7e-59  Score=467.13  Aligned_cols=264  Identities=27%  Similarity=0.429  Sum_probs=211.0

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      ++|.+.+.||+|+||+||+|++...    ....++..||||+++.......++|.+|+++|++|+|||||+++++|.+.+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~  116 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNL----LPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR  116 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSS----CC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCc----ccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            4678889999999999999998641    112367899999998776666788999999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcC--------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC
Q 011250          213 QRLLVYEFMPRGSLENHLFRRS--------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA  278 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~  278 (490)
                      .+|||||||++|+|.++|....              .++++..++.|+.||+.||+|||+.+   ||||||||+||||+.
T Consensus       117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~  193 (329)
T 4aoj_A          117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQ  193 (329)
T ss_dssp             SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEET
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECC
Confidence            9999999999999999996532              35999999999999999999999988   999999999999999


Q ss_pred             CCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhh
Q 011250          279 DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLV  357 (490)
Q Consensus       279 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~  357 (490)
                      ++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |+.||......   .+.
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~  270 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT---EAI  270 (329)
T ss_dssp             TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH---HHH
T ss_pred             CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH---HHH
Confidence            99999999999997755544444456789999999999999999999999999999999999 89999754321   111


Q ss_pred             HhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          358 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                      ......              .....+..++.++.+||.+||+.||++|||+.||+++|+.+.+
T Consensus       271 ~~i~~g--------------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          271 DCITQG--------------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             HHHHHT--------------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHcC--------------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence            111100              0112334557899999999999999999999999999987754

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.3e-59  Score=461.16  Aligned_cols=263  Identities=26%  Similarity=0.430  Sum_probs=208.8

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhccCCCCeeceeeE
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~  207 (490)
                      +..++|.+.+.||+|+||+||+|++..            .||||+++...  ....++|.+|+.+|++|+|||||+++++
T Consensus        33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~------------~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~  100 (307)
T 3omv_A           33 IEASEVMLSTRIGSGSFGTVYKGKWHG------------DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY  100 (307)
T ss_dssp             CCTTSCCEEEECCCCSSSEEEEEESSS------------EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             EcHHHeEEeeEEeeCCCcEEEEEEECC------------cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            344678899999999999999998643            59999987543  2345679999999999999999999998


Q ss_pred             EEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecc
Q 011250          208 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DF  287 (490)
                      +.+ +.++||||||++|+|.++|......+++..++.|+.||+.||+|||+.+   ||||||||+||||++++.+||+||
T Consensus       101 ~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DF  176 (307)
T 3omv_A          101 MTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDF  176 (307)
T ss_dssp             ECS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCC
T ss_pred             EEC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeec
Confidence            754 5789999999999999999877778999999999999999999999988   999999999999999999999999


Q ss_pred             cCcccCCCCCcceeeeccccCCCccCcchhcc---CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc
Q 011250          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~---~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      |+|+..............+||+.|||||++.+   +.|+.++|||||||+||||+||+.||........  +....... 
T Consensus       177 Gla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~--~~~~~~~~-  253 (307)
T 3omv_A          177 GLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ--IIFMVGRG-  253 (307)
T ss_dssp             SSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HHHHHHTT-
T ss_pred             cCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH--HHHHHhcC-
Confidence            99987654433334455789999999999864   4689999999999999999999999975432111  11111100 


Q ss_pred             CCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                              ...|.+ ...+..++..+.+||.+||+.||.+|||+.+|+++|+.|+.
T Consensus       254 --------~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          254 --------YASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             --------CCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             --------CCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence                    011111 12334567899999999999999999999999999987653

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=6.1e-59  Score=466.07  Aligned_cols=251  Identities=27%  Similarity=0.386  Sum_probs=212.8

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      ..|++.+.||+|+||+||+|++..         +|+.||||++........+.+.+|+.+|+.|+|||||+++++|.+++
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~---------tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  144 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRS---------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD  144 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             HhcEEeEEeecCcCeEEEEEEECC---------CCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            569999999999999999999986         67899999997665555567889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      .+|||||||+||+|.+++.+  ..+++..+..|+.||+.||+|||+++   ||||||||+||||+.+|.+||+|||+|+.
T Consensus       145 ~~~ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~  219 (346)
T 4fih_A          145 ELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ  219 (346)
T ss_dssp             EEEEEECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCcee
Confidence            99999999999999999865  36999999999999999999999988   99999999999999999999999999987


Q ss_pred             CCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhh
Q 011250          293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR  372 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (490)
                      ......  .....+||+.|||||++.+..|+.++|||||||+||||++|++||......   .+.......         
T Consensus       220 ~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~~i~~~---------  285 (346)
T 4fih_A          220 VSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRDN---------  285 (346)
T ss_dssp             CCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHS---------
T ss_pred             cCCCCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHHHcC---------
Confidence            754322  234579999999999999999999999999999999999999999754321   111111111         


Q ss_pred             ccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       373 ~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                       ..+.+  ......+.++.+||.+||+.||.+|||+.|+++|
T Consensus       286 -~~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          286 -LPPRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             -SCCCC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -CCCCC--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             11111  1122347899999999999999999999999875

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1e-58  Score=459.84  Aligned_cols=264  Identities=27%  Similarity=0.388  Sum_probs=215.7

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      ++++.+.||+|+||+||+|++....    ...+++.||||+++... ....++|.+|+.+|++|+|||||+++|+|.+++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~----~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~  102 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPA----PGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ  102 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-----------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCc----cCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence            4677889999999999999975311    11256789999997543 234578999999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD  277 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~  277 (490)
                      .++||||||++|+|.++|..+.               ..+++..++.|+.||+.||+|||+.+   ||||||||+||||+
T Consensus       103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~  179 (308)
T 4gt4_A          103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVY  179 (308)
T ss_dssp             SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred             EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEEC
Confidence            9999999999999999996432               35899999999999999999999988   99999999999999


Q ss_pred             CCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchh
Q 011250          278 ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNL  356 (490)
Q Consensus       278 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~  356 (490)
                      +++.+||+|||+|+..............+||+.|||||++.++.|+.++|||||||+||||+| |..||.....   ..+
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~~  256 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDV  256 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HHH
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HHH
Confidence            999999999999987654433334455789999999999999999999999999999999998 8999976432   122


Q ss_pred             hHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccc
Q 011250          357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~~  421 (490)
                      .......              .....+..++.++.+|+.+||+.||.+|||+.+|+++|+.+.++
T Consensus       257 ~~~i~~~--------------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~nl  307 (308)
T 4gt4_A          257 VEMIRNR--------------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGNL  307 (308)
T ss_dssp             HHHHHTT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC-
T ss_pred             HHHHHcC--------------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccCC
Confidence            2221110              01123445688999999999999999999999999999987653

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.3e-59  Score=462.48  Aligned_cols=251  Identities=23%  Similarity=0.302  Sum_probs=213.0

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|++++.||+|+||+||+|++..         +|+.||||++.+..   ....+.+.+|+++|+.|+|||||+++++|.
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~---------~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  102 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELA---------TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ  102 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECC---------CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            469999999999999999999886         67899999997542   234567899999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +++.+|||||||+||+|.++|.+. ..+++..+..|+.||+.||+|||+++   ||||||||+||||+.++.+||+|||+
T Consensus       103 ~~~~~yivmEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGl  178 (311)
T 4aw0_A          103 DDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGT  178 (311)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             eCCEEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCC
Confidence            999999999999999999999655 47999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      |+.+............+||+.|||||++.+..|+.++|||||||+||||++|++||......   .+....   ...   
T Consensus       179 a~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~~i---~~~---  249 (311)
T 4aw0_A          179 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG---LIFAKI---IKL---  249 (311)
T ss_dssp             CEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---HHT---
T ss_pred             ceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH---HcC---
Confidence            99876544444445689999999999999999999999999999999999999999754221   111111   100   


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                               ...++...+.++.+||.+||+.||.+|||++|++.+
T Consensus       250 ---------~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~  285 (311)
T 4aw0_A          250 ---------EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  285 (311)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred             ---------CCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence                     012233447889999999999999999999987543

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.1e-58  Score=458.71  Aligned_cols=253  Identities=24%  Similarity=0.273  Sum_probs=209.4

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      +.|.+.++||+|+||+||+|++..         +|+.||||+++.....     .+|+.+|+.|+|||||++++++.+++
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~---------~g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~  123 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQ---------TGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGP  123 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETT
T ss_pred             hheEeCcEeccCCCeEEEEEEECC---------CCCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            468888999999999999999876         6789999999865432     46999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-CeEEecccCcc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFGLAK  291 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-~vkL~DFG~a~  291 (490)
                      .+|||||||+||+|.++|.+. ..+++..+..|+.||+.||+|||+++   ||||||||+||||+.+| .+||+|||+|+
T Consensus       124 ~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~  199 (336)
T 4g3f_A          124 WVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHAL  199 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCE
T ss_pred             EEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCe
Confidence            999999999999999999655 47999999999999999999999988   99999999999999987 69999999998


Q ss_pred             cCCCCCcc---eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          292 DAPEDGKT---HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       292 ~~~~~~~~---~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ........   ......+||+.|||||++.+..|+.++|||||||+||||++|++||...........+..      ...
T Consensus       200 ~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~------~~~  273 (336)
T 4g3f_A          200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS------EPP  273 (336)
T ss_dssp             EC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH------SCC
T ss_pred             EccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc------CCC
Confidence            77543221   112346899999999999999999999999999999999999999976544332221111      000


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                      .         ...++..++..+.+||.+||+.||.+|||+.||+++|...
T Consensus       274 ~---------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~  314 (336)
T 4g3f_A          274 P---------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA  314 (336)
T ss_dssp             G---------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C---------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            0         0122334578999999999999999999999999998653

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=7e-58  Score=469.40  Aligned_cols=251  Identities=27%  Similarity=0.388  Sum_probs=213.4

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      +.|++.+.||+|+||+||+|++..         +|+.||||++........+.+.+|+.+|+.|+|||||+++++|.+++
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~---------tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  221 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRS---------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD  221 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             HhcEeeeEeccCcCcEEEEEEECC---------CCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECC
Confidence            569999999999999999999986         67899999998776666677899999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      .+|||||||+||+|.+++...  .+++..+..|+.||+.||+|||+++   ||||||||+||||+.+|.+||+|||+|+.
T Consensus       222 ~~~iVmEy~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~  296 (423)
T 4fie_A          222 ELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ  296 (423)
T ss_dssp             EEEEEEECCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEEeCCCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceE
Confidence            999999999999999998543  5999999999999999999999988   99999999999999999999999999987


Q ss_pred             CCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhh
Q 011250          293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR  372 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (490)
                      +.....  .....+||+.|||||++.+..|+.++|||||||+||||++|++||......   .+.......         
T Consensus       297 ~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~~i~~~---------  362 (423)
T 4fie_A          297 VSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRDN---------  362 (423)
T ss_dssp             CCSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHS---------
T ss_pred             CCCCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHHHcC---------
Confidence            754322  234579999999999999999999999999999999999999999754321   111111111         


Q ss_pred             ccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       373 ~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                       ..+.+  ......+.++.+||.+||+.||.+|||+.|+|+|
T Consensus       363 -~~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          363 -LPPRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             -CCCCC--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -CCCCC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             11111  1112347899999999999999999999999875

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.2e-57  Score=443.68  Aligned_cols=249  Identities=25%  Similarity=0.398  Sum_probs=201.4

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEe--
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE--  210 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--  210 (490)
                      |++.+.||+|+||+||+|.+..         ++..||||++.....  ...+.|.+|+.+|+.|+|||||+++++|.+  
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~   98 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV   98 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECC---------CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc
Confidence            4677889999999999999876         677999999975432  334678999999999999999999999875  


Q ss_pred             --CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-CCCCeEEecc
Q 011250          211 --DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD-ADYNAKLSDF  287 (490)
Q Consensus       211 --~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~-~~~~vkL~DF  287 (490)
                        ++.+|||||||+||+|.++|.+. ..+++..+..|+.||+.||+|||+++ .+||||||||+||||+ .++.+||+||
T Consensus        99 ~~~~~~~lvmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DF  176 (290)
T 3fpq_A           99 KGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDL  176 (290)
T ss_dssp             TTEEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCT
T ss_pred             CCCcEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeC
Confidence              34589999999999999999654 47999999999999999999999876 4599999999999997 4799999999


Q ss_pred             cCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011250          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      |+|+.....    .....+||+.|||||++. +.|+.++|||||||+||||+||+.||......  ..+.......    
T Consensus       177 Gla~~~~~~----~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~--~~~~~~i~~~----  245 (290)
T 3fpq_A          177 GLATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRVTSG----  245 (290)
T ss_dssp             TGGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHHHTTT----
T ss_pred             cCCEeCCCC----ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH--HHHHHHHHcC----
Confidence            999865332    224578999999999886 46999999999999999999999999643211  1111111100    


Q ss_pred             chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                               .....++...++++.+||.+||+.||.+|||+.|+++|
T Consensus       246 ---------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          246 ---------VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             ---------CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ---------CCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                     00011122236789999999999999999999999975

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.8e-57  Score=440.36  Aligned_cols=247  Identities=26%  Similarity=0.365  Sum_probs=194.6

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|++.+.||+|+||+||+|++..         +|+.||||++.+...   ...+.+.+|+.+|+.|+|||||++++++.
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~   83 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTT---------TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK   83 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTT---------TCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence            479999999999999999999876         678999999976532   23467899999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +++.+||||||| +|+|.+++.+. ..+++..+..++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+
T Consensus        84 ~~~~~~ivmEy~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGl  158 (275)
T 3hyh_A           84 SKDEIIMVIEYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGL  158 (275)
T ss_dssp             CSSEEEEEEECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSC
T ss_pred             ECCEEEEEEeCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCC
Confidence            999999999999 78999998665 47999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCC-CccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      |+......   .....+||+.|||||++.+..| +.++|||||||+||||++|+.||.....   ..+......   .. 
T Consensus       159 a~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~---~~~~~~i~~---~~-  228 (275)
T 3hyh_A          159 SNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI---PVLFKNISN---GV-  228 (275)
T ss_dssp             C------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH---TC-
T ss_pred             CeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHc---CC-
Confidence            98764432   2245789999999999988776 5799999999999999999999975321   111111110   00 


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                                 ..++...+.++.+||.+||+.||.+|||+.|+++|
T Consensus       229 -----------~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          229 -----------YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             -----------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             -----------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                       01223347889999999999999999999999975

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.8e-57  Score=456.35  Aligned_cols=270  Identities=27%  Similarity=0.378  Sum_probs=221.2

Q ss_pred             hHHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhccCC-CCeece
Q 011250          127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLH-PNLVKL  204 (490)
Q Consensus       127 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~Ei~il~~l~H-pnIv~l  204 (490)
                      ++++..++|++.+.||+|+||+||+|.+...+.    ..+++.||||.+...... ..++|.+|+.+|.++.| ||||++
T Consensus        58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~----~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDK----TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSS----TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCc----ccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            344556789999999999999999999875322    125678999999765433 35679999999999975 999999


Q ss_pred             eeEEEeC-CceEEEEEecCCCChhHHhhhc---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecC
Q 011250          205 VGYCIED-DQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRD  268 (490)
Q Consensus       205 ~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrD  268 (490)
                      +++|.+. +.+|||||||++|+|.++|...               ...+++..++.|+.||+.||+|||+++   |||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence            9999765 5689999999999999999643               235899999999999999999999988   99999


Q ss_pred             CCCCcEEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCC
Q 011250          269 FKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDK  347 (490)
Q Consensus       269 lkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~  347 (490)
                      |||+||||++++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |+.||..
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999998765544444556789999999999999999999999999999999998 9999976


Q ss_pred             CCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011250          348 NRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~  419 (490)
                      ......  +......              ......+..++.++.+||.+||+.||.+|||+.+|+++|+.+.
T Consensus       291 ~~~~~~--~~~~i~~--------------g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll  346 (353)
T 4ase_A          291 VKIDEE--FCRRLKE--------------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  346 (353)
T ss_dssp             CCCSHH--HHHHHHH--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCHHHH--HHHHHHc--------------CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            432211  1111110              0111233445789999999999999999999999999998764

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.2e-57  Score=449.79  Aligned_cols=252  Identities=29%  Similarity=0.359  Sum_probs=201.9

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ++|++++.||+|+||+||+|++..+..      +++.||||++++...  .....+.+|+.+|+.|+|||||++++++.+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~------~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~   97 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSD------ARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT   97 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTT------TTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCC------CCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence            469999999999999999998864322      678999999976532  223467889999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      ++.+|||||||+||+|.++|.+. ..+++..+..|+.||+.||+|||+++   ||||||||+|||++.++.+||+|||+|
T Consensus        98 ~~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla  173 (304)
T 3ubd_A           98 EGKLYLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLS  173 (304)
T ss_dssp             TTEEEEEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEE
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccc
Confidence            99999999999999999999665 47999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      +.......  .....+||+.|||||++.+..|+.++|||||||+||||++|+.||......   .+....   ...    
T Consensus       174 ~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~~~i---~~~----  241 (304)
T 3ubd_A          174 KESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK---ETMTMI---LKA----  241 (304)
T ss_dssp             EC-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---HHC----
T ss_pred             eeccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH---HHHHHH---HcC----
Confidence            87543322  224578999999999999999999999999999999999999999754321   111111   000    


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  414 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt-----~~evl~~  414 (490)
                              ...++...+.++.+||.+||+.||.+|||     ++|+++|
T Consensus       242 --------~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          242 --------KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             --------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             --------CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence                    01123344788999999999999999998     4677654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.1e-55  Score=434.74  Aligned_cols=273  Identities=25%  Similarity=0.313  Sum_probs=201.6

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      ++|.+.+.||+|+||+||+|++           +|+.||||+++..... ...+..|+..+..|+|||||++++++.+++
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-----------~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~   70 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDN   70 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-----------TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-----------CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecC
Confidence            4688889999999999999987           3568999999754321 122345666777899999999999998764


Q ss_pred             ----ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCCeeecCCCCCcEEEcCCCCeE
Q 011250          213 ----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA-----EKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       213 ----~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-----~~~iiHrDlkp~NILl~~~~~vk  283 (490)
                          .+|||||||++|+|.++|...  .+++..+..|+.|++.||+|||++.     .++||||||||+||||+.++++|
T Consensus        71 ~~~~~~~lV~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~K  148 (303)
T 3hmm_A           71 GTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  148 (303)
T ss_dssp             SSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             CCceEEEEEecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEE
Confidence                579999999999999999654  6999999999999999999999861     23499999999999999999999


Q ss_pred             EecccCcccCCCCCcce--eeeccccCCCccCcchhccC------CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcch
Q 011250          284 LSDFGLAKDAPEDGKTH--VSTRVMGTYGYAAPEYVMTG------HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN  355 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~--~~~~~~Gt~~y~aPE~l~~~------~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~  355 (490)
                      |+|||+|+.........  .....+||+.|||||++.+.      .|+.++|||||||+||||+||.+||......... 
T Consensus       149 i~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p-  227 (303)
T 3hmm_A          149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP-  227 (303)
T ss_dssp             ECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT-
T ss_pred             EEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc-
Confidence            99999998765433221  22346899999999998754      3678999999999999999999887543221110 


Q ss_pred             hhHhhhcccCCcchh-----hhccCCccCCC-CChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccc
Q 011250          356 LVEWARPHLGDKRRF-----YRLLDPRLEGH-FSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       356 ~~~~~~~~~~~~~~~-----~~~~~~~l~~~-~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~~  421 (490)
                      ..... +.......+     ...++|.+... .+..++..+.+|+.+||+.||.+|||+.||++.|+++...
T Consensus       228 ~~~~~-~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          228 YYDLV-PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             TTTTS-CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             chhcc-cccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            00000 000000000     01112222111 1234567899999999999999999999999999887654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.7e-54  Score=428.14  Aligned_cols=247  Identities=26%  Similarity=0.420  Sum_probs=189.0

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      +|++++.||+|+||+||+|++..         +|+.||||++...... ..+.+.+|+.+|+.|+|||||+++++|.+.+
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~   76 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKV---------DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKN   76 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETT---------TCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC
T ss_pred             hCEEeeEEecCCCeEEEEEEECC---------CCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecC
Confidence            59999999999999999999876         6779999999765433 3467899999999999999999999997654


Q ss_pred             c------------eEEEEEecCCCChhHHhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC
Q 011250          213 Q------------RLLVYEFMPRGSLENHLFRRSL--PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA  278 (490)
Q Consensus       213 ~------------~~lV~E~~~~gsL~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~  278 (490)
                      .            +|||||||++|+|.+++.....  ..++..++.|+.||+.||+|||+++   ||||||||+||||+.
T Consensus        77 ~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~  153 (299)
T 4g31_A           77 TTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTM  153 (299)
T ss_dssp             ----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECT
T ss_pred             ccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECC
Confidence            3            6899999999999999965432  3556778899999999999999988   999999999999999


Q ss_pred             CCCeEEecccCcccCCCCCcc----------eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCC
Q 011250          279 DYNAKLSDFGLAKDAPEDGKT----------HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN  348 (490)
Q Consensus       279 ~~~vkL~DFG~a~~~~~~~~~----------~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~  348 (490)
                      ++.+||+|||+|+........          ...+..+||+.|||||++.+..|+.++|||||||+||||++   ||...
T Consensus       154 ~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~  230 (299)
T 4g31_A          154 DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ  230 (299)
T ss_dssp             TCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred             CCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence            999999999999876543221          11234689999999999999999999999999999999996   66421


Q ss_pred             CCCCcchhhHhhhcccCCcchhhhccCCccCCCCC---hhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          349 RPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFS---IKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~---~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                           .........          +.    ...++   ...++.+.+||.+||+.||.+|||+.|++++
T Consensus       231 -----~~~~~~~~~----------~~----~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          231 -----MERVRTLTD----------VR----NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             -----HHHHHHHHH----------HH----TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -----cHHHHHHHH----------Hh----cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                 111110000          00    01111   1224567899999999999999999999874

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.2e-53  Score=433.78  Aligned_cols=268  Identities=23%  Similarity=0.314  Sum_probs=205.6

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ++|++++.||+|+||+||+|++..         +|+.||||++.....  ...+.+.+|+++|+.|+|||||++++++..
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~---------t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  124 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRL---------TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRP  124 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECC---------CCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeec
Confidence            579999999999999999999876         678999999976532  334678899999999999999999998764


Q ss_pred             ------CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 011250          211 ------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       211 ------~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL  284 (490)
                            .+.+|||||||+ |+|.+++.+. ..+++..+..|+.||+.||.|||+++   ||||||||+|||++.++.+||
T Consensus       125 ~~~~~~~~~~~ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki  199 (398)
T 4b99_A          125 TVPYGEFKSVYVVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKI  199 (398)
T ss_dssp             SSCTTTCCCEEEEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEE
T ss_pred             ccccccCCEEEEEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEE
Confidence                  357899999995 6899998554 57999999999999999999999988   999999999999999999999


Q ss_pred             ecccCcccCCCCCc--ceeeeccccCCCccCcchhccC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011250          285 SDFGLAKDAPEDGK--THVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       285 ~DFG~a~~~~~~~~--~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~  361 (490)
                      +|||+|+.+.....  .......+||+.|||||++.+. .|+.++|||||||+||||++|++||.+.........+....
T Consensus       200 ~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~  279 (398)
T 4b99_A          200 GDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVL  279 (398)
T ss_dssp             CCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHH
T ss_pred             eecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhc
Confidence            99999987643211  1223457999999999998865 57999999999999999999999997654322221111100


Q ss_pred             cccCC----------cchhhhccCCccCCC---CChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          362 PHLGD----------KRRFYRLLDPRLEGH---FSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       362 ~~~~~----------~~~~~~~~~~~l~~~---~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .....          ...+...+.+.....   .....+.++.+||.+||..||.+|||+.|+|+|
T Consensus       280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          280 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             CCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             CCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            00000          000000011100000   011236789999999999999999999999986

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.6e-52  Score=423.12  Aligned_cols=271  Identities=23%  Similarity=0.299  Sum_probs=204.7

Q ss_pred             hHHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcc-CCCCeecee
Q 011250          127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLV  205 (490)
Q Consensus       127 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~  205 (490)
                      .+....++|++.+.||+|+||+||+|+++.+      .++++.||||.+....  ....+.+|+++|..+ .|||||+++
T Consensus        15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~------~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~   86 (361)
T 4f9c_A           15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQ------VGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVK   86 (361)
T ss_dssp             HSGGGGGTCEEEEEEEECSSEEEEEEEEEBT------TSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCS
T ss_pred             hcCCccCcEEEEEEEecccCcEEEEEEEccc------CCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEE
Confidence            3334567899999999999999999988632      1267899999987653  345688999999998 599999999


Q ss_pred             eEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-CCeEE
Q 011250          206 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAKL  284 (490)
Q Consensus       206 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~-~~vkL  284 (490)
                      ++|.+.+.+|||||||++|+|.+++.    .+++..+..++.||+.||+|||+++   ||||||||+||||+.+ +.+||
T Consensus        87 ~~~~~~~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl  159 (361)
T 4f9c_A           87 YCFRKNDHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYAL  159 (361)
T ss_dssp             EEEEETTEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEE
T ss_pred             EEEEECCEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEE
Confidence            99999999999999999999999882    5899999999999999999999988   9999999999999877 79999


Q ss_pred             ecccCcccCCCCCcc--------------------------eeeeccccCCCccCcchhccC-CCCccchhhHHHHHHHH
Q 011250          285 SDFGLAKDAPEDGKT--------------------------HVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLE  337 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~--------------------------~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGv~l~e  337 (490)
                      +|||+|+........                          ...+..+||+.|||||++.+. .|+.++||||+||+|||
T Consensus       160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~e  239 (361)
T 4f9c_A          160 VDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLS  239 (361)
T ss_dssp             CCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHH
T ss_pred             CcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHH
Confidence            999999865432110                          112346899999999999875 58999999999999999


Q ss_pred             HHhCCCCCCCCCCCCcchhhHhhhcccC------------------------Ccchhhhc---c---CCcc---------
Q 011250          338 MLTGRRSMDKNRPNGEHNLVEWARPHLG------------------------DKRRFYRL---L---DPRL---------  378 (490)
Q Consensus       338 lltG~~pf~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~---~---~~~l---------  378 (490)
                      |++|+.||........ .+.... ..++                        +.......   .   .+.+         
T Consensus       240 ll~G~~Pf~~~~~~~~-~l~~I~-~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  317 (361)
T 4f9c_A          240 LLSGRYPFYKASDDLT-ALAQIM-TIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHAT  317 (361)
T ss_dssp             HHHTCSSSSCCSSHHH-HHHHHH-HHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC------------------
T ss_pred             HHHCCCCCCCCCCHHH-HHHHHH-HhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccc
Confidence            9999999964332110 000000 0000                        00000000   0   0000         


Q ss_pred             CCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          379 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       379 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ........+.++.+||.+||+.||.+|||++|+|+|
T Consensus       318 ~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~H  353 (361)
T 4f9c_A          318 NLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLH  353 (361)
T ss_dssp             ----CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             cccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            001112346789999999999999999999999975

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.9e-52  Score=445.45  Aligned_cols=253  Identities=23%  Similarity=0.316  Sum_probs=214.4

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      ++|++.+.||+|+||+||+|+++.         +|+.||||++........+.+.+|+.+|+.|+|||||+++++|.+++
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~---------tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  227 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERA---------TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN  227 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS
T ss_pred             cccEEEEEEeeccCeEEEEEEECC---------CCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            579999999999999999999876         67899999998776666678899999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC--CCeEEecccCc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD--YNAKLSDFGLA  290 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~--~~vkL~DFG~a  290 (490)
                      .+|||||||+||+|.++|......+++..+..|+.||+.||.|||+++   |+||||||+||||+.+  +.+||+|||+|
T Consensus       228 ~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a  304 (573)
T 3uto_A          228 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLT  304 (573)
T ss_dssp             EEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSC
T ss_pred             EEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccce
Confidence            999999999999999999766668999999999999999999999988   9999999999999854  89999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      +.+.....   ....+||+.|||||++.+..|+.++|||||||+||||++|.+||.......   +.....   ...   
T Consensus       305 ~~~~~~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~---~~~~i~---~~~---  372 (573)
T 3uto_A          305 AHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---TLRNVK---SCD---  372 (573)
T ss_dssp             EECCTTSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHH---TTC---
T ss_pred             eEccCCCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHHHH---hCC---
Confidence            98754322   234689999999999999999999999999999999999999997543211   111110   000   


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                           ..+........+.++.+||.+||+.||.+|||+.|+|+|
T Consensus       373 -----~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          373 -----WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             -----CCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -----CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 001111112337889999999999999999999999986

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=8.3e-52  Score=443.07  Aligned_cols=251  Identities=27%  Similarity=0.370  Sum_probs=206.0

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHH---HHHHHHHhccCCCCeecee
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW---LAEVNFLGNLLHPNLVKLV  205 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~---~~Ei~il~~l~HpnIv~l~  205 (490)
                      -++|+++++||+|+||+||+|++..         +|..||||++.+...   .....+   ..++.+++.++|||||+++
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~---------tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~  258 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS  258 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECC---------CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEE
Confidence            3689999999999999999999876         678999999975421   122223   3446777888999999999


Q ss_pred             eEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEe
Q 011250          206 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       206 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~  285 (490)
                      ++|.+.+.+|||||||+||+|.++|.+. ..+++..+..|+.||+.||.|||+++   ||||||||+||||+.+|.+||+
T Consensus       259 ~~f~~~~~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~  334 (689)
T 3v5w_A          259 YAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRIS  334 (689)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred             EEEEECCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEec
Confidence            9999999999999999999999999665 47999999999999999999999988   9999999999999999999999


Q ss_pred             cccCcccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc
Q 011250          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      |||+|+......    ....+||+.|||||++.. ..|+.++|||||||+||||++|++||..........+....   +
T Consensus       335 DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i---~  407 (689)
T 3v5w_A          335 DLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---L  407 (689)
T ss_dssp             CCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH---H
T ss_pred             ccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh---c
Confidence            999998765432    234789999999999975 57999999999999999999999999754333222211111   0


Q ss_pred             CCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011250          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  414 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt-----~~evl~~  414 (490)
                      ..            ...++...+.++.+||.+||+.||.+|++     ++||++|
T Consensus       408 ~~------------~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          408 TM------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             HC------------CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             CC------------CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence            00            11223344789999999999999999998     7888875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.9e-50  Score=400.81  Aligned_cols=285  Identities=39%  Similarity=0.690  Sum_probs=239.7

Q ss_pred             hhhhhHHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCee
Q 011250          123 FMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLV  202 (490)
Q Consensus       123 ~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv  202 (490)
                      +.+.++...+++|++.+.||+|+||.||+|.+.          ++..||||++........+.+.+|+.+++.++||||+
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   98 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR----------DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLV   98 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT----------TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBC
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEEC----------CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEe
Confidence            344455567789999999999999999999864          4668999998877666678899999999999999999


Q ss_pred             ceeeEEEeCCceEEEEEecCCCChhHHhhhcC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC
Q 011250          203 KLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD  279 (490)
Q Consensus       203 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~  279 (490)
                      ++++++.+.+..++||||+++|+|.+++....   ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.+
T Consensus        99 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~  175 (321)
T 2qkw_B           99 SLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDEN  175 (321)
T ss_dssp             CEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTT
T ss_pred             eEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCC
Confidence            99999999999999999999999999986543   35899999999999999999999988   9999999999999999


Q ss_pred             CCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 011250          280 YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW  359 (490)
Q Consensus       280 ~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~  359 (490)
                      +.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||....+........|
T Consensus       176 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~  255 (321)
T 2qkw_B          176 FVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW  255 (321)
T ss_dssp             CCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHH
T ss_pred             CCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHH
Confidence            99999999999875443333333456799999999999999999999999999999999999999987766665555555


Q ss_pred             hhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccc
Q 011250          360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~~  421 (490)
                      ...... ...+...+++.+...+....+..+.+|+.+||+.||.+|||+.+|+++|+.+...
T Consensus       256 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          256 AVESHN-NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             THHHHT-TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             hhhccc-cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            432211 1223345566666677788899999999999999999999999999999876543

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.3e-48  Score=390.18  Aligned_cols=289  Identities=40%  Similarity=0.738  Sum_probs=235.7

Q ss_pred             hhhchhhhhhHHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcc
Q 011250          118 SQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNL  196 (490)
Q Consensus       118 ~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~Ei~il~~l  196 (490)
                      ..++.+.+.++....++|++.+.||+|+||.||+|.+.          ++..||||++...... ....+.+|+.+++.+
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l   84 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA----------DGTLVAVKRLKEERTQGGELQFQTEVEMISMA   84 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS----------SSCCEEEEECCC-----CCCHHHHHHHGGGTC
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEec----------CCCEEEEEEeccccCchHHHHHHHHHHHHHhc
Confidence            34567888999999999999999999999999999753          4668999999765322 223688999999999


Q ss_pred             CCCCeeceeeEEEeCCceEEEEEecCCCChhHHhhhcC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 011250          197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN  273 (490)
Q Consensus       197 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~N  273 (490)
                      +||||+++++++.+.+..++||||+++|+|.+++....   ..+++..+..++.||+.||.|||+....+|+||||||+|
T Consensus        85 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~N  164 (326)
T 3uim_A           85 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAAN  164 (326)
T ss_dssp             CCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGG
T ss_pred             cCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhh
Confidence            99999999999999999999999999999999996543   349999999999999999999999811129999999999


Q ss_pred             EEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCC--CC
Q 011250          274 ILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR--PN  351 (490)
Q Consensus       274 ILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~--~~  351 (490)
                      ||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||+...  ..
T Consensus       165 il~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  243 (326)
T 3uim_A          165 ILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND  243 (326)
T ss_dssp             EEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTT
T ss_pred             EEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccc
Confidence            9999999999999999987654322 22344679999999999998899999999999999999999999996321  11


Q ss_pred             CcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          352 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                      .......|...... ........+..+...++...+..+.+|+.+||+.||.+|||+.+|+++|+..
T Consensus       244 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          244 DDVMLLDWVKGLLK-EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             SCSBHHHHHTTTTS-SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             cchhHHHHHHHHhh-chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            22233334333222 2234455566667777888899999999999999999999999999999864

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.4e-48  Score=387.52  Aligned_cols=261  Identities=26%  Similarity=0.413  Sum_probs=216.7

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      ++|.+.++||+|+||+||+|.+..         ++..||+|++........+.+.+|+.+++.++||||+++++++.+++
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~---------~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   80 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRE---------TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK   80 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETT---------TCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             hHeeccceecCCCCEEEEEEEECC---------CCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC
Confidence            579999999999999999999876         57789999997766666778999999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      ..++||||+++|+|.+++......+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  157 (310)
T 3s95_A           81 RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARL  157 (310)
T ss_dssp             EEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEE
T ss_pred             eeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeeccccee
Confidence            999999999999999999876778999999999999999999999988   99999999999999999999999999987


Q ss_pred             CCCCCcce------------eeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011250          293 APEDGKTH------------VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       293 ~~~~~~~~------------~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~  360 (490)
                      ........            .....+||+.|+|||++.+..++.++|||||||++|||++|..||.............  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~--  235 (310)
T 3s95_A          158 MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN--  235 (310)
T ss_dssp             CC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC--
T ss_pred             cccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh--
Confidence            64432211            0114679999999999999999999999999999999999999987543322111000  


Q ss_pred             hcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                               .....+    ...+..++..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus       236 ---------~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~  282 (310)
T 3s95_A          236 ---------VRGFLD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM  282 (310)
T ss_dssp             ---------HHHHHH----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------hhcccc----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                     000000    11122336778999999999999999999999999988754

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.1e-48  Score=383.35  Aligned_cols=252  Identities=25%  Similarity=0.374  Sum_probs=211.7

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      .++|++.+.||+|+||.||+|.+..         ++..||||++........+.+.+|+.+++.++||||+++++++...
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVA---------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG   89 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTT---------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             hhceeeeeeeccCCCeEEEEEEECC---------CCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC
Confidence            4579999999999999999998765         6779999999766656667889999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      +..++||||+++|+|.+++...  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        90 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~  164 (297)
T 3fxz_A           90 DELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA  164 (297)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CEEEEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCce
Confidence            9999999999999999998654  5899999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhh
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  371 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (490)
                      .......  .....+||+.|+|||++.+..++.++|||||||++|||++|..||...........  .....        
T Consensus       165 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--~~~~~--------  232 (297)
T 3fxz_A          165 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL--IATNG--------  232 (297)
T ss_dssp             ECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH--HHHHC--------
T ss_pred             ecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHhCC--------
Confidence            7654322  22346899999999999999999999999999999999999999965432111100  00000        


Q ss_pred             hccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       372 ~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                         .+  ....+...+..+.+||.+||+.||.+|||+.+++++
T Consensus       233 ---~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          233 ---TP--ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             ---SC--CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ---CC--CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence               00  111123347889999999999999999999999975

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.4e-48  Score=396.21  Aligned_cols=267  Identities=25%  Similarity=0.388  Sum_probs=217.6

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcc-CCCCeeceeeEEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~  209 (490)
                      .++|.+.+.||+|+||.||+|.+...+.  ....++..||||+++.... ...+.+.+|+.+|+.+ +||||+++++++.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  157 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  157 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCST--TCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccC--cCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence            4679999999999999999999853211  1123567899999976533 3346789999999999 8999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcE
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI  274 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NI  274 (490)
                      +.+..||||||+++|+|.+++....               ..+++..++.++.||+.||.|||+.+   |+||||||+||
T Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NI  234 (370)
T 2psq_A          158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV  234 (370)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGE
T ss_pred             cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhE
Confidence            9999999999999999999997643               34899999999999999999999988   99999999999


Q ss_pred             EEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCc
Q 011250          275 LLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGE  353 (490)
Q Consensus       275 Ll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~  353 (490)
                      ||+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||+||||++ |..||....... 
T Consensus       235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~-  313 (370)
T 2psq_A          235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-  313 (370)
T ss_dssp             EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-
T ss_pred             EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-
Confidence            999999999999999987654433333334567899999999999999999999999999999999 999997543211 


Q ss_pred             chhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                        +......              ......+..++.++.+||.+||+.||.+||++.++++.|+.+..
T Consensus       314 --~~~~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~  364 (370)
T 2psq_A          314 --LFKLLKE--------------GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  364 (370)
T ss_dssp             --HHHHHHT--------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHHHHhc--------------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence              1111110              01112233457889999999999999999999999999987654

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.3e-48  Score=387.96  Aligned_cols=249  Identities=25%  Similarity=0.366  Sum_probs=208.8

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      .++|++.+.||+|+||.||+|.+..         +|..||||++....  ....+.+.+|+.+|+.++||||+++++++.
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~   84 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHIL---------TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE   84 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            3579999999999999999999876         67799999997553  234567889999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      ..+..|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~  160 (328)
T 3fe3_A           85 TEKTLYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGF  160 (328)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTC
T ss_pred             ECCEEEEEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccC
Confidence            999999999999999999999665 46999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCC-ccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLT-SKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~-~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +........   ....+||+.|+|||++.+..++ .++|||||||+||+|++|+.||......   .+......   .  
T Consensus       161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~---~--  229 (328)
T 3fe3_A          161 SNEFTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK---ELRERVLR---G--  229 (328)
T ss_dssp             CGGGSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHH---C--
T ss_pred             ceecCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHh---C--
Confidence            987654322   2456899999999999887765 7999999999999999999999754321   11111100   0  


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                                ...++...+.++.+|+.+||..||.+|||+.+++++
T Consensus       230 ----------~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          230 ----------KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             ----------CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                      001222347889999999999999999999999976

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=7.4e-48  Score=385.59  Aligned_cols=263  Identities=26%  Similarity=0.434  Sum_probs=214.6

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .++|++.+.||+|+||.||+|.+...+.      .+..||||++.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  121 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQ------RDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR  121 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTS------CCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCC------CCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            3579999999999999999999875432      45579999997653 3345678999999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      .+..+|||||+++|+|.+++......+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  198 (325)
T 3kul_A          122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLS  198 (325)
T ss_dssp             GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred             CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcc
Confidence            99999999999999999999776678999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcc-eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          291 KDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       291 ~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +........ .......||+.|+|||++.+..++.++|||||||++|||++ |..||......   .+......      
T Consensus       199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~~~~------  269 (325)
T 3kul_A          199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DVISSVEE------  269 (325)
T ss_dssp             EECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHHHHHT------
T ss_pred             cccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHc------
Confidence            876543221 12233456889999999999999999999999999999999 99999654221   11111110      


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                              ......+..++..+.+||.+||..||.+|||+.+|++.|+.+..
T Consensus       270 --------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~  313 (325)
T 3kul_A          270 --------GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR  313 (325)
T ss_dssp             --------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                    01112233457889999999999999999999999999987754

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.9e-48  Score=386.96  Aligned_cols=273  Identities=26%  Similarity=0.350  Sum_probs=211.3

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ..++|++.++||+|+||+||+|++.           +..||||++.... .....+..|+.++..++||||+++++++.+
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   89 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL-----------NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKR   89 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET-----------TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC-----------CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceecc
Confidence            3467999999999999999999874           4689999997543 223456679999999999999999999988


Q ss_pred             CCc----eEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhc----------CCCCeeecCCCCCcEEE
Q 011250          211 DDQ----RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE----------AEKPVIYRDFKTSNILL  276 (490)
Q Consensus       211 ~~~----~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~----------~~~~iiHrDlkp~NILl  276 (490)
                      ...    ++|||||+++|+|.+++...  .+++..++.++.||+.||.|||+.          +   |+||||||+||||
T Consensus        90 ~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill  164 (322)
T 3soc_A           90 GTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLL  164 (322)
T ss_dssp             ECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEE
T ss_pred             CCCCCceEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEE
Confidence            553    69999999999999999654  599999999999999999999997          6   9999999999999


Q ss_pred             cCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccC-----CCCccchhhHHHHHHHHHHhCCCCCCCCCCC
Q 011250          277 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-----HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN  351 (490)
Q Consensus       277 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-----~~~~~sDvwSlGv~l~elltG~~pf~~~~~~  351 (490)
                      +.++.+||+|||+++..............+||+.|+|||++.+.     .++.++|||||||++|||++|+.||......
T Consensus       165 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~  244 (322)
T 3soc_A          165 KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE  244 (322)
T ss_dssp             CTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCC
T ss_pred             CCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcch
Confidence            99999999999999876544333333446799999999998763     4567899999999999999999999765443


Q ss_pred             CcchhhHhhhcccCCcchhh-----hccCCccCCCC-ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccc
Q 011250          352 GEHNLVEWARPHLGDKRRFY-----RLLDPRLEGHF-SIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~~~-~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~~  421 (490)
                      ............ .....+.     ....+.+...+ ...++.++.+||.+||+.||.+|||+.+|++.|+.+++.
T Consensus       245 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          245 YMLPFEEEIGQH-PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             CCCTTHHHHCSS-CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hccchhhhhccC-CchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            322221111000 0000000     01111111111 123467799999999999999999999999999988654

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.6e-47  Score=385.28  Aligned_cols=250  Identities=32%  Similarity=0.396  Sum_probs=209.2

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|++.+.||+|+||.||+|++..         +|..||||++.+..   ......+.+|+.+|+.++||||+++++++.
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~   75 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKA---------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ   75 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE
Confidence            579999999999999999999876         67799999997542   234567889999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +.+..||||||+++|+|..++.+. ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus        76 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~  151 (337)
T 1o6l_A           76 THDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGL  151 (337)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccc
Confidence            999999999999999999998654 47999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      ++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|..||......   .+....   ...   
T Consensus       152 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i---~~~---  220 (337)
T 1o6l_A          152 CKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFELI---LME---  220 (337)
T ss_dssp             CBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---HHC---
T ss_pred             hhhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH---HHHHHH---HcC---
Confidence            986433222  224578999999999999999999999999999999999999999653211   111111   000   


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHh
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVETL  415 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----t~~evl~~L  415 (490)
                               ...++...+.++.+||.+||+.||.+||     ++.+|++|-
T Consensus       221 ---------~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~  262 (337)
T 1o6l_A          221 ---------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR  262 (337)
T ss_dssp             ---------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence                     0112333478899999999999999999     899998763

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=9.1e-48  Score=382.30  Aligned_cols=262  Identities=29%  Similarity=0.462  Sum_probs=205.4

Q ss_pred             HHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceee
Q 011250          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVG  206 (490)
Q Consensus       129 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~  206 (490)
                      .+..++|++.+.||+|+||+||+|.+           ++..||||++.....  ...+.+.+|+.+++.++||||+++++
T Consensus        33 ~i~~~~y~i~~~lG~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~  101 (309)
T 3p86_A           33 DIPWCDLNIKEKIGAGSFGTVHRAEW-----------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG  101 (309)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cCChhHceeeeEeecCCCeEEEEEEE-----------CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            34456799999999999999999976           356899999976543  23457899999999999999999999


Q ss_pred             EEEeCCceEEEEEecCCCChhHHhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 011250          207 YCIEDDQRLLVYEFMPRGSLENHLFRRSL--PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL  284 (490)
                      ++.+.+..++||||+++|+|.+++.....  .+++..++.++.||+.||+|||+.+ .+|+||||||+|||++.++.+||
T Consensus       102 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL  180 (309)
T 3p86_A          102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKV  180 (309)
T ss_dssp             EECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEE
T ss_pred             EEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEE
Confidence            99999999999999999999999965432  3899999999999999999999865 45999999999999999999999


Q ss_pred             ecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc
Q 011250          285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      +|||+++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   .......  
T Consensus       181 ~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---~~~~~~~--  253 (309)
T 3p86_A          181 CDFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ---VVAAVGF--  253 (309)
T ss_dssp             CCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH---HHHHHHH--
T ss_pred             CCCCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHh--
Confidence            9999998654321  12234679999999999999999999999999999999999999997543211   1111000  


Q ss_pred             CCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                                 ......++...+..+.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus       254 -----------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~  298 (309)
T 3p86_A          254 -----------KCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK  298 (309)
T ss_dssp             -----------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             -----------cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                       000112233447889999999999999999999999999987754

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=7.8e-48  Score=389.61  Aligned_cols=272  Identities=28%  Similarity=0.382  Sum_probs=218.8

Q ss_pred             hhHHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcc-CCCCeec
Q 011250          126 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVK  203 (490)
Q Consensus       126 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~  203 (490)
                      .++....++|++.+.||+|+||.||+|++....    ...+++.||||++..... ...+.+.+|+.++..+ +||||++
T Consensus        15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSS----STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccccccccceeeceeecCCCCceEEEEEecccc----ccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            344556778999999999999999999875421    123678999999976533 3346789999999999 7999999


Q ss_pred             eeeEEEeCCc-eEEEEEecCCCChhHHhhhcCC-----------------------------------------------
Q 011250          204 LVGYCIEDDQ-RLLVYEFMPRGSLENHLFRRSL-----------------------------------------------  235 (490)
Q Consensus       204 l~~~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~-----------------------------------------------  235 (490)
                      +++++.+.+. .++|||||++|+|.+++.....                                               
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            9999988654 8999999999999999965432                                               


Q ss_pred             ------------------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCCC
Q 011250          236 ------------------PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG  297 (490)
Q Consensus       236 ------------------~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~  297 (490)
                                        .+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++......
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                              1899999999999999999999988   9999999999999999999999999998765544


Q ss_pred             cceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCC
Q 011250          298 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP  376 (490)
Q Consensus       298 ~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (490)
                      .........||+.|+|||++.+..++.++|||||||++|||++ |..||........  +......              
T Consensus       248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~~~~~--------------  311 (359)
T 3vhe_A          248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRRLKE--------------  311 (359)
T ss_dssp             TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HHHHHHH--------------
T ss_pred             cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--HHHHHHc--------------
Confidence            4444455778999999999999999999999999999999998 9999976433211  1111110              


Q ss_pred             ccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          377 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       377 ~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                      ......+...+.++.+||.+||+.||.+|||+.+|+++|+.+.+
T Consensus       312 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          312 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            00111223346789999999999999999999999999987653

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=6.9e-47  Score=384.08  Aligned_cols=254  Identities=24%  Similarity=0.342  Sum_probs=209.3

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc------cHHHHHHHHHHHhccCCCCeecee
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGNLLHPNLVKLV  205 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~  205 (490)
                      .++|.+.+.||+|+||.||+|.+..         +|..||||++......      ..+.+.+|+.+|+.+.||||++++
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~---------~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~   81 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKS---------TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLH   81 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECC---------CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEE
Confidence            4579999999999999999999876         6779999999765332      356789999999999999999999


Q ss_pred             eEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC----C
Q 011250          206 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY----N  281 (490)
Q Consensus       206 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~----~  281 (490)
                      +++.+.+..+|||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    .
T Consensus        82 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~  157 (361)
T 2yab_A           82 DVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPH  157 (361)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCC
T ss_pred             EEEEeCCEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccC
Confidence            9999999999999999999999999554 57999999999999999999999988   99999999999998776    7


Q ss_pred             eEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011250          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       282 vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~  361 (490)
                      +||+|||++........   ....+||+.|+|||++.+..++.++|||||||++|+|++|..||......   .......
T Consensus       158 vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~---~~~~~i~  231 (361)
T 2yab_A          158 IKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANIT  231 (361)
T ss_dssp             EEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHH
T ss_pred             EEEEecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH
Confidence            99999999987654322   23467999999999999889999999999999999999999999754221   1111110


Q ss_pred             cccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                      .   ....+    ++    .+....+..+.+||.+||..||.+|||+.+++++-
T Consensus       232 ~---~~~~~----~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp  274 (361)
T 2yab_A          232 A---VSYDF----DE----EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHP  274 (361)
T ss_dssp             T---TCCCC----CH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred             h---cCCCC----Cc----hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            0   00000    00    00112367899999999999999999999999863

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5.5e-48  Score=394.51  Aligned_cols=262  Identities=24%  Similarity=0.397  Sum_probs=214.6

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      +..++|.+.+.||+|+||.||+|.+..         ++..||||++..... ...+.+.+|+.+|+.++||||+++++++
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  181 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRA---------DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC  181 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEE
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEec---------CCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            345679999999999999999999875         567899999975532 2234688999999999999999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      .+.+..+|||||+++|+|.+++......+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||
T Consensus       182 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG  258 (377)
T 3cbl_A          182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFG  258 (377)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGG
T ss_pred             ecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCC
Confidence            9999999999999999999999776667999999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCc
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      +++...............+++.|+|||++....++.++|||||||+||||++ |..||......   ........     
T Consensus       259 ~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---~~~~~~~~-----  330 (377)
T 3cbl_A          259 MSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ---QTREFVEK-----  330 (377)
T ss_dssp             GCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH---HHHHHHHT-----
T ss_pred             CceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHc-----
Confidence            9986543221111112345778999999999999999999999999999998 99999754221   11111110     


Q ss_pred             chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                               ......+..++..+.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus       331 ---------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          331 ---------GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             ---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence                     00112233457889999999999999999999999999987754

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-47  Score=379.71  Aligned_cols=254  Identities=19%  Similarity=0.252  Sum_probs=210.5

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      .++|.+.+.||+|+||.||+|.+..         ++..||+|.+.... .....+.+|+.+|+.++||||+++++++.+.
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~   73 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETS---------SKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESM   73 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred             hhceEeeeEEecCCCeEEEEEEECC---------CCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecC
Confidence            4579999999999999999999876         67799999997553 3345688999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC--CCCeEEecccC
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA--DYNAKLSDFGL  289 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~--~~~vkL~DFG~  289 (490)
                      +..+||||||++|+|.+++......+++..++.++.||+.||.|||+.+   |+||||||+|||++.  ++.+||+|||+
T Consensus        74 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~  150 (321)
T 1tki_A           74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQ  150 (321)
T ss_dssp             TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred             CEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCC
Confidence            9999999999999999999766667999999999999999999999988   999999999999987  78999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      ++.......   ....+||+.|+|||++.+..++.++|||||||++|+|++|..||......   .........   ...
T Consensus       151 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~---~~~  221 (321)
T 1tki_A          151 ARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QIIENIMNA---EYT  221 (321)
T ss_dssp             CEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHHT---CCC
T ss_pred             CeECCCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH---HHHHHHHcC---CCC
Confidence            987754322   23467999999999999888999999999999999999999999754321   111111000   000


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                      +    +..    .....+.++.+||.+||..||.+|||+.|++++-
T Consensus       222 ~----~~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp  259 (321)
T 1tki_A          222 F----DEE----AFKEISIEAMDFVDRLLVKERKSRMTASEALQHP  259 (321)
T ss_dssp             C----CHH----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             C----Chh----hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence            0    000    0012367899999999999999999999999864

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=6.3e-47  Score=378.60  Aligned_cols=255  Identities=25%  Similarity=0.345  Sum_probs=206.8

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      ++|++.+.||+|+||+||+|++..         +++.||||++..... ...+.+.+|+.+++.++||||+++++++.++
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~   77 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRV---------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG   77 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhceeeeEEecCCCEEEEEEEECC---------CCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            579999999999999999999876         577899999865533 2235688999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      +..|||||||++|+|.+++.. ...+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  153 (323)
T 3tki_A           78 NIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLAT  153 (323)
T ss_dssp             SEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CeEEEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccc
Confidence            999999999999999999854 346999999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhccCCC-CccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ..............+||+.|+|||++.+..+ +.++|||||||+||+|++|+.||........ ....+....       
T Consensus       154 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~-------  225 (323)
T 3tki_A          154 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKK-------  225 (323)
T ss_dssp             ECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHHTTC-------
T ss_pred             eeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhccc-------
Confidence            6643333333345789999999999987765 7799999999999999999999975433211 111111100       


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                             .........+..+.+||.+||+.||.+|||+.|++++-
T Consensus       226 -------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~  263 (323)
T 3tki_A          226 -------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR  263 (323)
T ss_dssp             -------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred             -------ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence                   00000123367889999999999999999999998753

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.9e-47  Score=381.41  Aligned_cols=262  Identities=24%  Similarity=0.399  Sum_probs=208.2

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      ++|++.+.||+|+||.||+|++...+..     ....||+|.+.... ....+++.+|+.+++.++||||+++++++.+.
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   89 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC---------CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCce-----EEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence            5799999999999999999998753321     23357889886443 34557899999999999999999999999875


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      . .++||||+.+|+|.+++......+++..++.|+.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus        90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~  165 (327)
T 3poz_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred             C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCccee
Confidence            4 78999999999999999887778999999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ...............||+.|+|||++.+..++.++|||||||++|||++ |+.||...........+.   .        
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~---~--------  234 (327)
T 3poz_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---K--------  234 (327)
T ss_dssp             HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH---T--------
T ss_pred             EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH---c--------
Confidence            7654443333344567889999999999999999999999999999999 999997643322111111   0        


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                            ......+..++..+.+|+.+||+.||.+||++.+++++|+.+..
T Consensus       235 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          235 ------GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             ------TCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             ------CCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                  01112233447789999999999999999999999999987644

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4.4e-46  Score=368.64  Aligned_cols=282  Identities=38%  Similarity=0.626  Sum_probs=226.6

Q ss_pred             hchhhhhhHHHhhcCCCCC------cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC----cccHHHHHHH
Q 011250          120 LRKFMFNDLKLATRNFRPE------SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG----LQGHKEWLAE  189 (490)
Q Consensus       120 ~~~~~~~~~~~~~~~y~~~------~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~E  189 (490)
                      ...|.+.++..++++|...      +.||+|+||.||+|.+           ++..||||++....    ....+.+.+|
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~E   80 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-----------NNTTVAVKKLAAMVDITTEELKQQFDQE   80 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-----------SSCEEEEEEECCCTTSCTTTHHHHHHHH
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-----------CCceEEEEEEecccCcchHHHHHHHHHH
Confidence            3567778888888888776      8999999999999976           34589999986532    2335678999


Q ss_pred             HHHHhccCCCCeeceeeEEEeCCceEEEEEecCCCChhHHhhhc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeec
Q 011250          190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYR  267 (490)
Q Consensus       190 i~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHr  267 (490)
                      +.+++.++||||+++++++.+.+..++||||+++++|.+++...  ...+++..++.++.||+.||.|||+.+   |+||
T Consensus        81 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~  157 (307)
T 2nru_A           81 IKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHR  157 (307)
T ss_dssp             HHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred             HHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecC
Confidence            99999999999999999999999999999999999999998642  346999999999999999999999988   9999


Q ss_pred             CCCCCcEEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCC
Q 011250          268 DFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDK  347 (490)
Q Consensus       268 Dlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~  347 (490)
                      ||||+|||++.++.+||+|||++................||+.|+|||++.+ .++.++|||||||++|+|++|..||..
T Consensus       158 dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~  236 (307)
T 2nru_A          158 DIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDE  236 (307)
T ss_dssp             CCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCT
T ss_pred             CCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCccc
Confidence            9999999999999999999999987655433333445689999999998764 588999999999999999999999976


Q ss_pred             CCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011250          348 NRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~  419 (490)
                      ........  .+..........+...++..+ ...+...+..+.+|+.+||+.||.+|||+.+|+++|+++.
T Consensus       237 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          237 HREPQLLL--DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             TBSSSBTT--HHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             CcchHHHH--HHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            54332211  111111111122223333333 2345567889999999999999999999999999998764

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.3e-47  Score=368.53  Aligned_cols=259  Identities=27%  Similarity=0.391  Sum_probs=214.5

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ..++|++.+.||+|+||.||+|.+.          ++..||||++..... ..+++.+|+.++..++||||+++++++.+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   74 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK----------GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSK   74 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheeeeeeeccCCCceEEEEEec----------CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            4467999999999999999999775          355799999976543 34678999999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      .+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~  151 (268)
T 3sxs_A           75 EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMT  151 (268)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCE
T ss_pred             CCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccc
Confidence            99999999999999999999776667999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      ......... ......||+.|+|||++.+..++.++||||||+++|+|++ |..||........   .......      
T Consensus       152 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~~~~------  221 (268)
T 3sxs_A          152 RYVLDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV---VLKVSQG------  221 (268)
T ss_dssp             EECCTTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---HHHHHTT------
T ss_pred             eecchhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH---HHHHHcC------
Confidence            876544322 2233456788999999998899999999999999999999 9999965432111   1100000      


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccc
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~~  421 (490)
                              .....+...+..+.+|+.+||+.||.+|||+.+++++|+.+.+.
T Consensus       222 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          222 --------HRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             --------CCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             --------CCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence                    00111222367899999999999999999999999999988654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.2e-47  Score=388.47  Aligned_cols=251  Identities=29%  Similarity=0.415  Sum_probs=203.9

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcc-CCCCeeceee
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNL-LHPNLVKLVG  206 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~~  206 (490)
                      ..++|++.++||+|+||.||+|++..         ++..||||++....   ....+.+.+|+.++..+ .||||+++++
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~   91 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKE---------TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFC   91 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcC---------CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEE
Confidence            34689999999999999999999876         67799999997542   22345678899999988 6999999999


Q ss_pred             EEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEec
Q 011250          207 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~D  286 (490)
                      ++.+.+..|||||||++|+|..++.+. ..+++..++.++.||+.||+|||+.+   ||||||||+||||+.++.+||+|
T Consensus        92 ~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~D  167 (353)
T 3txo_A           92 CFQTPDRLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLAD  167 (353)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECC
T ss_pred             EEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEcc
Confidence            999999999999999999999998654 46999999999999999999999988   99999999999999999999999


Q ss_pred             ccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011250          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      ||+++.......  .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||......   .+....   ...
T Consensus       168 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~~i---~~~  239 (353)
T 3txo_A          168 FGMCKEGICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED---DLFEAI---LND  239 (353)
T ss_dssp             CTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---HHC
T ss_pred             ccceeecccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH---HHHHHH---HcC
Confidence            999986433222  234578999999999999889999999999999999999999999754321   111111   000


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM------SEVVET  414 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~------~evl~~  414 (490)
                                  ...++...+..+.+||.+||+.||.+||++      .+|++|
T Consensus       240 ------------~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          240 ------------EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             ------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             ------------CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence                        011223347889999999999999999998      777765

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5e-47  Score=368.46  Aligned_cols=257  Identities=28%  Similarity=0.446  Sum_probs=213.6

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      .++|++.+.||+|+||.||+|.+..          +..||+|++..... ..+++.+|+.+++.++||||+++++++.+.
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   77 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLN----------KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ   77 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             hhhceeeheecCCCccEEEEEEecC----------CCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            4579999999999999999998863          45799999986543 456799999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      +..++||||+++++|.+++......+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~  154 (269)
T 4hcu_A           78 APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTR  154 (269)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGG
T ss_pred             CceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccc
Confidence            9999999999999999999777677999999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ....... .......||+.|+|||++.+..++.++||||||+++|+|++ |..||......   .........       
T Consensus       155 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~---~~~~~~~~~-------  223 (269)
T 4hcu_A          155 FVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVEDISTG-------  223 (269)
T ss_dssp             GBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHTT-------
T ss_pred             ccccccc-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHHhcC-------
Confidence            7643221 12233557888999999999999999999999999999999 99999754221   111111100       


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                             .....+...+..+.+|+.+||+.||.+||++.+++++|+++.+
T Consensus       224 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          224 -------FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             -------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence                   0111122336789999999999999999999999999987754

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.6e-46  Score=368.89  Aligned_cols=263  Identities=24%  Similarity=0.353  Sum_probs=209.4

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      .++|++.+.||+|+||.||+|++..         ++..||+|++.....   ...+.+.+|+.++..++||||+++++++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~   80 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTI---------LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD   80 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETT---------TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECC---------CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee
Confidence            4579999999999999999999876         577899999865432   3346788999999999999999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      .+.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg  156 (294)
T 4eqm_A           81 EEDDCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFG  156 (294)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCS
T ss_pred             eeCCeEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCC
Confidence            9999999999999999999999655 47999999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +++....... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||........  .........    
T Consensus       157 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~--~~~~~~~~~----  229 (294)
T 4eqm_A          157 IAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI--AIKHIQDSV----  229 (294)
T ss_dssp             SSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH--HHHHHSSCC----
T ss_pred             Cccccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHhhccC----
Confidence            9987644322 222346799999999999999999999999999999999999999975432110  001000000    


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCC-CHHHHHHHhhcCccc
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-RMSEVVETLKPLQNL  421 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-t~~evl~~L~~l~~~  421 (490)
                             +.+...+....+..+.++|.+||+.||.+|| ++.++++.|..+...
T Consensus       230 -------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          230 -------PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             -------CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             -------CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence                   0011112223478899999999999999998 899999999876543

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.8e-47  Score=387.03  Aligned_cols=263  Identities=25%  Similarity=0.443  Sum_probs=203.6

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ..+|.+.+.||+|+||.||+|++...+      .++..||||++.... ....+++.+|+.+|+.++||||+++++++.+
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  117 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPS------KKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK  117 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTT------SCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCC------CCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence            357999999999999999999876322      156789999997653 2344679999999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      .+..+|||||+++|+|.+++......+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  194 (373)
T 2qol_A          118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLG  194 (373)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccc
Confidence            99999999999999999999877778999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcce-eeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          291 KDAPEDGKTH-VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       291 ~~~~~~~~~~-~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +......... ......+|+.|+|||++.+..++.++|||||||+||||++ |+.||......   .+......      
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~---~~~~~i~~------  265 (373)
T 2qol_A          195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ---DVIKAVDE------  265 (373)
T ss_dssp             -------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH---HHHHHHHT------
T ss_pred             cccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHc------
Confidence            8765432211 1122346789999999999999999999999999999998 99999654221   11111110      


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                              ......+..++..+.+||.+||+.||.+||++.+|++.|+.+..
T Consensus       266 --------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  309 (373)
T 2qol_A          266 --------GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR  309 (373)
T ss_dssp             --------TEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------CCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence                    01111223447889999999999999999999999999987644

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.5e-47  Score=386.31  Aligned_cols=271  Identities=26%  Similarity=0.379  Sum_probs=220.0

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcc-CCCCeeceeeEE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKLVGYC  208 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~  208 (490)
                      ..++|.+.+.||+|+||.||+|++...+.  .....+..||||++..... ...+.+.+|+.+++.+ +||||+++++++
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDK--DKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSST--TCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccc--cccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            34579999999999999999999864221  1122556899999976533 3346789999999999 899999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN  273 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~N  273 (490)
                      .+.+..+|||||+++|+|.+++....               ..+++..++.|+.||+.||.|||+.+   |+||||||+|
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N  221 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN  221 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcce
Confidence            99999999999999999999997643               35999999999999999999999988   9999999999


Q ss_pred             EEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCC
Q 011250          274 ILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNG  352 (490)
Q Consensus       274 ILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~  352 (490)
                      |||+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||...... 
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~-  300 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-  300 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence            9999999999999999987655433333344567899999999999999999999999999999999 99999654221 


Q ss_pred             cchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccccc
Q 011250          353 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKD  423 (490)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~~~~  423 (490)
                        .+......              ......+..++.++.+||.+||+.||.+|||+.+|+++|+.+.....
T Consensus       301 --~~~~~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  355 (382)
T 3tt0_A          301 --ELFKLLKE--------------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS  355 (382)
T ss_dssp             --HHHHHHHT--------------TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             --HHHHHHHc--------------CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence              11111111              01111223447889999999999999999999999999998765443

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.1e-47  Score=378.05  Aligned_cols=277  Identities=25%  Similarity=0.376  Sum_probs=212.8

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      .++|++.+.||+|+||.||+|++...     ...++..||||++........+.+.+|+.+++.++||||+++++++...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   83 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPL-----QDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA   83 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTT-----CSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecc-----cCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            45799999999999999999986431     1226789999999877666667899999999999999999999998654


Q ss_pred             --CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          212 --DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       212 --~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                        ...+|||||+++|+|.+++......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~  160 (295)
T 3ugc_A           84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGL  160 (295)
T ss_dssp             HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred             CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcc
Confidence              4589999999999999999776667999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcc-eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc-
Q 011250          290 AKDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK-  367 (490)
Q Consensus       290 a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~-  367 (490)
                      ++........ .......||..|+|||++.+..++.++|||||||++|||++|..||.....    ............. 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~----~~~~~~~~~~~~~~  236 (295)
T 3ugc_A          161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA----EFMRMIGNDKQGQM  236 (295)
T ss_dssp             CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH----HHHHHHCTTCCTHH
T ss_pred             cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH----HHHhhhcCccccch
Confidence            9876543221 122334577889999999999999999999999999999999998854210    0000000000000 


Q ss_pred             --chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          368 --RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       368 --~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                        ......+........+..++.++.+||.+||+.||.+|||+.+|++.|+.+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~  291 (295)
T 3ugc_A          237 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  291 (295)
T ss_dssp             HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence              00001111111222344557899999999999999999999999999987753

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-47  Score=390.25  Aligned_cols=266  Identities=27%  Similarity=0.392  Sum_probs=212.7

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .++|++.+.||+|+||+||+|++...+    ...++..||||++.... ......+.+|+.+++.++||||+++++++.+
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  145 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMP----NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  145 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCC----CCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            357999999999999999999975421    11267789999997543 3344578899999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcC------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC---C
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRS------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY---N  281 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~---~  281 (490)
                      ....+||||||++|+|.+++....      ..+++..++.++.||+.||.|||+.+   |+||||||+||||+.++   .
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~  222 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRV  222 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCC
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCce
Confidence            999999999999999999997543      35899999999999999999999988   99999999999998554   5


Q ss_pred             eEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 011250          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       282 vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~  360 (490)
                      +||+|||+++...............||+.|+|||++.+..++.++|||||||+||||++ |..||......   .+....
T Consensus       223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~---~~~~~i  299 (367)
T 3l9p_A          223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEFV  299 (367)
T ss_dssp             EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHH
T ss_pred             EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH
Confidence            99999999975432222222234678999999999999999999999999999999998 99999754321   111111


Q ss_pred             hcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccc
Q 011250          361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~~  421 (490)
                      ...              .....+..++..+.+||.+||+.||.+||++.+|+++|+.+...
T Consensus       300 ~~~--------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          300 TSG--------------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             HTT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HcC--------------CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence            110              01112234477899999999999999999999999999877553

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2e-46  Score=374.63  Aligned_cols=250  Identities=26%  Similarity=0.389  Sum_probs=209.1

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCCce
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQR  214 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  214 (490)
                      |...+.||+|+||.||+|++..         +|+.||||++........+.+.+|+.+++.++||||+++++++...+..
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~---------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  117 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKH---------SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL  117 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             hhccEEeccCCCeEEEEEEECC---------CCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence            6777899999999999999875         5779999999877666677899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCC
Q 011250          215 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~  294 (490)
                      +|||||+++++|.+++..  ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       118 ~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  192 (321)
T 2c30_A          118 WVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQIS  192 (321)
T ss_dssp             EEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecc
Confidence            999999999999998854  46999999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhcc
Q 011250          295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  374 (490)
Q Consensus       295 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (490)
                      ....  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......   ........          ..
T Consensus       193 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~---~~~~~~~~----------~~  257 (321)
T 2c30_A          193 KDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMKRLRD----------SP  257 (321)
T ss_dssp             SSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHH----------SS
T ss_pred             cCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhc----------CC
Confidence            4322  123468999999999999999999999999999999999999999654221   11111110          01


Q ss_pred             CCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       375 ~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                      .+.+  ......+..+.+||.+||+.||.+|||+.+++++-
T Consensus       258 ~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp  296 (321)
T 2c30_A          258 PPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHP  296 (321)
T ss_dssp             CCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             CCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence            1111  11123467899999999999999999999999864

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.4e-46  Score=373.93  Aligned_cols=267  Identities=24%  Similarity=0.319  Sum_probs=205.5

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      .++|++.+.||+|+||+||+|++.          ++..||||++.....  .....+.+|+.+++.++||||+++++++.
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   89 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDS----------QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH   89 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEET----------TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HhhhHhhhhccCCCCeEEEEEEEC----------CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc
Confidence            357999999999999999999874          466899999975532  22467889999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +++..+|||||++ |+|.+++......+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        90 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~  165 (311)
T 3niz_A           90 SERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGL  165 (311)
T ss_dssp             CSSCEEEEEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             cCCEEEEEEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcC
Confidence            9999999999996 5888888777777999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh-hcccC-C
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-RPHLG-D  366 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~-~~~~~-~  366 (490)
                      ++.......  .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+... ..... .
T Consensus       166 a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  243 (311)
T 3niz_A          166 ARAFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPRE  243 (311)
T ss_dssp             CEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTT
T ss_pred             ceecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHH
Confidence            987643322  1234578999999999876 56899999999999999999999999865544322211110 00000 0


Q ss_pred             c---chhh-------hccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          367 K---RRFY-------RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       367 ~---~~~~-------~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .   ..+.       ..+............+.++.+||.+||+.||.+|||+.|++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          244 WPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             SGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            0   0000       0000000000112236789999999999999999999999975

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-47  Score=380.95  Aligned_cols=268  Identities=25%  Similarity=0.383  Sum_probs=216.7

Q ss_pred             HHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeE
Q 011250          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (490)
Q Consensus       129 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~  207 (490)
                      ....++|++.+.||+|+||.||+|++.....    ..++..||||++..... ...+.+.+|+.+++.++||||++++++
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~  118 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLP----YEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV  118 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSST----TSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCC----CCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            3456789999999999999999999864211    12567899999976543 334678999999999999999999999


Q ss_pred             EEeCCceEEEEEecCCCChhHHhhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 011250          208 CIEDDQRLLVYEFMPRGSLENHLFRRS-----------------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPV  264 (490)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~i  264 (490)
                      +.+.+..+|||||+++|+|.+++....                       ..+++..++.++.||+.||.|||+.+   |
T Consensus       119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---i  195 (343)
T 1luf_A          119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F  195 (343)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred             EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            999999999999999999999997632                       56999999999999999999999988   9


Q ss_pred             eecCCCCCcEEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCC
Q 011250          265 IYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR  343 (490)
Q Consensus       265 iHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~  343 (490)
                      +||||||+||||+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..
T Consensus       196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  275 (343)
T 1luf_A          196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  275 (343)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence            9999999999999999999999999986543322222334578999999999999999999999999999999999 999


Q ss_pred             CCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          344 SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       344 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                      ||......   .+......             .. ...++..++..+.+||.+||+.||.+||++.+|+++|+.+..
T Consensus       276 p~~~~~~~---~~~~~~~~-------------~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          276 PYYGMAHE---EVIYYVRD-------------GN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             TTTTSCHH---HHHHHHHT-------------TC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             cCCCCChH---HHHHHHhC-------------CC-cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            99653211   11111100             00 011223447889999999999999999999999999998754

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=6.4e-47  Score=375.39  Aligned_cols=267  Identities=28%  Similarity=0.397  Sum_probs=217.7

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      ...++|.+.+.||+|+||.||+|.+.....    ..++..||||++.... ....+.+.+|+.+++.++||||+++++++
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   95 (314)
T 2ivs_A           20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKG----RAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC   95 (314)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEETGGG----CSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cchhheeeeeeecccCCeeEEEEEEeccCc----ccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence            345679999999999999999998853210    1256789999997653 23446789999999999999999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRS-----------------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVI  265 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ii  265 (490)
                      .+.+..++||||+++|+|.+++....                       ..+++..++.++.||+.||.|||+.+   |+
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iv  172 (314)
T 2ivs_A           96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LV  172 (314)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cc
Confidence            99999999999999999999997543                       23889999999999999999999988   99


Q ss_pred             ecCCCCCcEEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCC
Q 011250          266 YRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRS  344 (490)
Q Consensus       266 HrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~p  344 (490)
                      ||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..|
T Consensus       173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  252 (314)
T 2ivs_A          173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP  252 (314)
T ss_dssp             CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999987755433333344567899999999999999999999999999999999 9999


Q ss_pred             CCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          345 MDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       345 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                      |........   ......              ......+...+..+.+||.+||+.||.+||++.+|+++|+.+..
T Consensus       253 ~~~~~~~~~---~~~~~~--------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          253 YPGIPPERL---FNLLKT--------------GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             STTCCGGGH---HHHHHT--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCHHHH---HHHhhc--------------CCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            975433211   111110              00112223447889999999999999999999999999987643

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=9.8e-47  Score=376.48  Aligned_cols=246  Identities=27%  Similarity=0.398  Sum_probs=207.2

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|++.+.||+|+||.||+|++..         +|..||+|++....   ....+.+.+|+.+++.+.||||+++++++.
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~   76 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRH---------NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ   76 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE
Confidence            579999999999999999999876         67799999997542   234467889999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +.+..||||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus        77 ~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~  152 (318)
T 1fot_A           77 DAQQIFMIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGF  152 (318)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             eCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCc
Confidence            999999999999999999999654 47999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      ++.....     ....+||+.|+|||++.+..++.++|||||||++|||++|..||......   .....   .+     
T Consensus       153 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~---i~-----  216 (318)
T 1fot_A          153 AKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---KTYEK---IL-----  216 (318)
T ss_dssp             CEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHH---HH-----
T ss_pred             ceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHH---HH-----
Confidence            9876432     23468999999999999999999999999999999999999999653211   11110   00     


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----t~~evl~~  414 (490)
                           ...  ..++...+.++.+||.+||..||.+||     ++++|++|
T Consensus       217 -----~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          217 -----NAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             -----HCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -----hCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence                 000  112233478899999999999999999     88888865

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.5e-46  Score=368.08  Aligned_cols=265  Identities=24%  Similarity=0.297  Sum_probs=205.8

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ++|++.+.||+|+||+||+|.+..         ++..||||++.....  .....+.+|+.+++.++||||+++++++.+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   72 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS   72 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECC---------CCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe
Confidence            479999999999999999999876         577899999975533  234678899999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      ++..+|||||+++ +|.+.+......+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        73 ~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~  148 (292)
T 3o0g_A           73 DKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLA  148 (292)
T ss_dssp             TTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccc
Confidence            9999999999965 777777666678999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCC-CCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc-----
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL-----  364 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~-----  364 (490)
                      +.......  ......||+.|+|||++.+.. ++.++|||||||++|||++|..||......  ...........     
T Consensus       149 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~--~~~~~~i~~~~~~~~~  224 (292)
T 3o0g_A          149 RAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTE  224 (292)
T ss_dssp             EECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCCCT
T ss_pred             eecCCccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHHhCCCCh
Confidence            87643222  223467899999999987765 899999999999999999988886432211  11111110000     


Q ss_pred             CCcchhhhccC---------CccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          365 GDKRRFYRLLD---------PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       365 ~~~~~~~~~~~---------~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ..........+         ...........+..+.+||.+||+.||.+|||++|++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            00000000000         000111223457889999999999999999999999975

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-46  Score=385.41  Aligned_cols=254  Identities=22%  Similarity=0.310  Sum_probs=211.6

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      ++|++.+.||+|+||.||+|.+..         ++..||+|++..........+.+|+.+|+.++||||+++++++.+..
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~  121 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKA---------TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY  121 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred             cceEEEEEEecCCCEEEEEEEECC---------CCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC
Confidence            579999999999999999999876         67799999998765555667899999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC--CCCeEEecccCc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA--DYNAKLSDFGLA  290 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~--~~~vkL~DFG~a  290 (490)
                      ..+|||||+++|+|.+++......+++..++.++.||+.||.|||+.+   |+||||||+|||++.  ++.+||+|||++
T Consensus       122 ~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a  198 (387)
T 1kob_A          122 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLA  198 (387)
T ss_dssp             EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred             EEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccc
Confidence            999999999999999999766667999999999999999999999988   999999999999974  478999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      +.......   ....+||+.|+|||++.+..++.++|||||||++|||++|..||......   .........       
T Consensus       199 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~i~~~-------  265 (387)
T 1kob_A          199 TKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQNVKRC-------  265 (387)
T ss_dssp             EECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHHC-------
T ss_pred             eecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH---HHHHHHHhC-------
Confidence            87754322   23357999999999999999999999999999999999999999754211   111111000       


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                          ............+.++.+||.+||+.||.+|||+.+++++-
T Consensus       266 ----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp  306 (387)
T 1kob_A          266 ----DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP  306 (387)
T ss_dssp             ----CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred             ----CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCc
Confidence                00011111123478899999999999999999999999863

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.5e-47  Score=383.92  Aligned_cols=253  Identities=28%  Similarity=0.416  Sum_probs=207.3

Q ss_pred             HHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcc-CCCCeece
Q 011250          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNL-LHPNLVKL  204 (490)
Q Consensus       129 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l  204 (490)
                      ....++|.+.+.||+|+||.||+|++..         +++.||||+++...   ....+.+..|..++..+ +||||+++
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l   83 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKK---------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM   83 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcE
Confidence            3455789999999999999999999876         67799999997542   13345678899999877 89999999


Q ss_pred             eeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 011250          205 VGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       205 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL  284 (490)
                      ++++.+.+..||||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||
T Consensus        84 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL  159 (345)
T 1xjd_A           84 FCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKI  159 (345)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEE
T ss_pred             EEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEE
Confidence            99999999999999999999999998654 46999999999999999999999988   999999999999999999999


Q ss_pred             ecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc
Q 011250          285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      +|||+++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|..||......   .+......  
T Consensus       160 ~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i~~--  232 (345)
T 1xjd_A          160 ADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHSIRM--  232 (345)
T ss_dssp             CCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHH--
T ss_pred             eEChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHh--
Confidence            99999986533221  234578999999999999999999999999999999999999999754321   11111100  


Q ss_pred             CCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHH-HHHHH
Q 011250          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS-EVVET  414 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~-evl~~  414 (490)
                       .        .    ..++...+.++.+||.+||..||.+||++. +|++|
T Consensus       233 -~--------~----~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h  270 (345)
T 1xjd_A          233 -D--------N----PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  270 (345)
T ss_dssp             -C--------C----CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             -C--------C----CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence             0        0    112233478899999999999999999997 66543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-46  Score=375.51  Aligned_cols=253  Identities=23%  Similarity=0.330  Sum_probs=208.1

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc------cHHHHHHHHHHHhccCCCCeeceee
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGNLLHPNLVKLVG  206 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~~  206 (490)
                      ++|.+.+.||+|+||.||+|.+..         ++..||||++......      ..+.+.+|+.+|+.++||||+++++
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~   81 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKS---------TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE   81 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETT---------TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECC---------CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            469999999999999999999876         6779999999765322      3577899999999999999999999


Q ss_pred             EEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC----Ce
Q 011250          207 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY----NA  282 (490)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~----~v  282 (490)
                      ++.+.+..+|||||+++|+|.+++... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++    .+
T Consensus        82 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~  157 (326)
T 2y0a_A           82 VYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRI  157 (326)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCE
T ss_pred             EEEeCCEEEEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCE
Confidence            999999999999999999999998543 57999999999999999999999988   99999999999998877    89


Q ss_pred             EEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011250          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      ||+|||+++.......   ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.......   .......
T Consensus       158 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~~~~  231 (326)
T 2y0a_A          158 KIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANVSA  231 (326)
T ss_dssp             EECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHHH
T ss_pred             EEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHHHh
Confidence            9999999987653322   234679999999999998999999999999999999999999996542211   1111000


Q ss_pred             ccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                      .           .......+....+..+.+||.+||+.||.+|||+.+++++-
T Consensus       232 ~-----------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  273 (326)
T 2y0a_A          232 V-----------NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP  273 (326)
T ss_dssp             T-----------CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred             c-----------CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence            0           00000001112367899999999999999999999999864

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=6e-47  Score=378.69  Aligned_cols=262  Identities=25%  Similarity=0.400  Sum_probs=210.0

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      ++|++.+.||+|+||.||+|.+...+..     ....||+|.+.... ......+.+|+.+++.++||||+++++++. +
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-----~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~   86 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGES-----IKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G   86 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCS-----CCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCce-----EEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence            5799999999999999999998764321     22358888885443 223356778999999999999999999886 5


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      +..++||||+++|+|.+++......+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  163 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVAD  163 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred             CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccc
Confidence            6789999999999999999766567999999999999999999999988   9999999999999999999999999999


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ...............||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+...          
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~----------  233 (325)
T 3kex_A          164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG----------  233 (325)
T ss_dssp             GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT----------
T ss_pred             ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC----------
Confidence            8765544444455678899999999999999999999999999999999 99999765433221111110          


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                             .....+..++..+.+||.+||..||.+||++.+++++|+.+..
T Consensus       234 -------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          234 -------ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             -------CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             -------CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                   0011122235567899999999999999999999999987643

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.9e-47  Score=380.20  Aligned_cols=268  Identities=25%  Similarity=0.393  Sum_probs=215.8

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcc-CCCCeeceeeE
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGY  207 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~  207 (490)
                      ...++|.+.+.||+|+||.||+|.+....    ..+++..||||++.... ....+.+.+|+.++..+ .||||++++++
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  117 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGIS----KTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA  117 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCS----SSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccc----cCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            34568999999999999999999985321    12356789999997543 23346789999999999 89999999999


Q ss_pred             EEeCCceEEEEEecCCCChhHHhhhcCC----------------------CCCHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 011250          208 CIEDDQRLLVYEFMPRGSLENHLFRRSL----------------------PLPWSIRMKIALGAAKGLAFLHEEAEKPVI  265 (490)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~----------------------~l~~~~~~~i~~qi~~aL~yLH~~~~~~ii  265 (490)
                      +...+..+|||||+++|+|.+++.....                      .+++..++.++.||+.||.|||+.+   |+
T Consensus       118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iv  194 (344)
T 1rjb_A          118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CV  194 (344)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence            9999999999999999999999975432                      3789999999999999999999988   99


Q ss_pred             ecCCCCCcEEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCC
Q 011250          266 YRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRS  344 (490)
Q Consensus       266 HrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~p  344 (490)
                      ||||||+||||+.++.+||+|||++................||+.|+|||++.+..++.++|||||||+||+|++ |..|
T Consensus       195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  274 (344)
T 1rjb_A          195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP  274 (344)
T ss_dssp             ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence            999999999999999999999999987654444334445678999999999999999999999999999999998 9999


Q ss_pred             CCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          345 MDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       345 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                      |........  .......              ......+...+..+.+||.+||..||.+|||+.+|+++|+.+..
T Consensus       275 ~~~~~~~~~--~~~~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  334 (344)
T 1rjb_A          275 YPGIPVDAN--FYKLIQN--------------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA  334 (344)
T ss_dssp             STTCCCSHH--HHHHHHT--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             cccCCcHHH--HHHHHhc--------------CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            976532211  1111111              11112233447889999999999999999999999999987644

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.9e-46  Score=384.84  Aligned_cols=256  Identities=25%  Similarity=0.386  Sum_probs=206.2

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcc-CCCCeeceeeEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNL-LHPNLVKLVGYC  208 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~Ei~il~~l-~HpnIv~l~~~~  208 (490)
                      ++|++.++||+|+||+||+|++..         ++..||||++++....   ..+.+..|+.+|..+ +|||||++++++
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~---------~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~  122 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKK---------TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF  122 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE
Confidence            479999999999999999999876         6779999999765322   224578899999887 799999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      .+.+.+|||||||++|+|..++.+. ..+++..+..++.||+.||.|||+.+   ||||||||+||||+.++.+||+|||
T Consensus       123 ~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG  198 (396)
T 4dc2_A          123 QTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG  198 (396)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EECCEEEEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecc
Confidence            9999999999999999999998654 47999999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcc--hhhHhhhcccCC
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH--NLVEWARPHLGD  366 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~--~~~~~~~~~~~~  366 (490)
                      +++.......  .....+||+.|+|||++.+..|+.++|||||||+||||++|+.||.........  .......     
T Consensus       199 la~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~-----  271 (396)
T 4dc2_A          199 MCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF-----  271 (396)
T ss_dssp             TCBCCCCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHH-----
T ss_pred             eeeecccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHH-----
Confidence            9986433222  234578999999999999999999999999999999999999999643221110  0000000     


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM------SEVVET  414 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~------~evl~~  414 (490)
                          ..+...  ...++...+.++.+||.+||+.||.+||++      .+|++|
T Consensus       272 ----~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          272 ----QVILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             ----HHHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             ----HHHhcc--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence                001110  112333447889999999999999999985      677765

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.5e-46  Score=374.92  Aligned_cols=264  Identities=19%  Similarity=0.187  Sum_probs=213.2

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcc-CCCCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~  210 (490)
                      .++|++.+.||+|+||.||+|++..         ++..||||++.....  .+.+.+|+.+++.| .||||+++++++..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   76 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLY---------TNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPC   76 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETT---------TTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECC---------CCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEec
Confidence            4579999999999999999999865         677999999875532  23578999999999 89999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCC-----eEEe
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN-----AKLS  285 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~-----vkL~  285 (490)
                      .+..+|||||+ +++|.+++......+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.     +||+
T Consensus        77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~  152 (330)
T 2izr_A           77 GKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHII  152 (330)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEEC
T ss_pred             CCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEE
Confidence            99999999999 99999999776678999999999999999999999988   999999999999998887     9999


Q ss_pred             cccCcccCCCCCcce-----eeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011250          286 DFGLAKDAPEDGKTH-----VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       286 DFG~a~~~~~~~~~~-----~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~  360 (490)
                      |||+++.........     .....+||+.|+|||++.+..++.++|||||||+||||++|+.||...............
T Consensus       153 DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i  232 (330)
T 2izr_A          153 DFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI  232 (330)
T ss_dssp             CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHH
T ss_pred             EcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHH
Confidence            999998764432211     123568999999999999999999999999999999999999999875433322222111


Q ss_pred             hcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccc
Q 011250          361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~~  421 (490)
                      ...   ...   .....+    ....+ ++.+|+.+||+.||.+||++.+|++.|+.+...
T Consensus       233 ~~~---~~~---~~~~~~----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~  282 (330)
T 2izr_A          233 GDT---KRA---TPIEVL----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR  282 (330)
T ss_dssp             HHH---HHH---SCHHHH----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             Hhh---hcc---CCHHHH----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence            100   000   000000    01125 899999999999999999999999999876543

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.9e-46  Score=383.46  Aligned_cols=252  Identities=25%  Similarity=0.344  Sum_probs=209.0

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      .++|++.+.||+|+||.||+|++..         ++..||||++....   ....+.+.+|+.+|+.++|||||+++++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~---------~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~   84 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKND---------TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF   84 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            3579999999999999999999876         67799999986542   23346788999999999999999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      .+.+..|+||||+.+|+|..++.. ...+++..+..++.||+.||.|||+.+   ||||||||+||||+.++.+||+|||
T Consensus        85 ~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG  160 (384)
T 4fr4_A           85 QDEEDMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFN  160 (384)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EeCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccc
Confidence            999999999999999999999855 457999999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhcc---CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~---~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      ++........   ....+||+.|+|||++..   ..|+.++|||||||+||||++|+.||..........+.......  
T Consensus       161 ~a~~~~~~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~--  235 (384)
T 4fr4_A          161 IAAMLPRETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT--  235 (384)
T ss_dssp             TCEECCTTCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC--
T ss_pred             eeeeccCCCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc--
Confidence            9987654322   245789999999999864   45899999999999999999999999755433322222211110  


Q ss_pred             CcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCC-HHHHHHH
Q 011250          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-MSEVVET  414 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt-~~evl~~  414 (490)
                                   ...++...+..+.+||.+||+.||.+||+ +.+|+++
T Consensus       236 -------------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h  272 (384)
T 4fr4_A          236 -------------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF  272 (384)
T ss_dssp             -------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred             -------------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence                         11223344788999999999999999998 7777653

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.2e-46  Score=380.82  Aligned_cols=253  Identities=26%  Similarity=0.354  Sum_probs=205.6

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-----cccHHHHHHHHHHHhccCCCCeeceeeE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~l~~~  207 (490)
                      ++|++.+.||+|+||+||+|.+..         ++..||||++....     ....+.+.+|+.+++.++||||++++++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~   94 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRE---------TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLET   94 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECC---------CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            469999999999999999999876         67799999986431     1245778999999999999999999999


Q ss_pred             EEeCCceEEEEEecCCCChhHHhhhc---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCC---
Q 011250          208 CIEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN---  281 (490)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~---  281 (490)
                      +.+++..|||||||++|+|.+++...   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.   
T Consensus        95 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~  171 (351)
T 3c0i_A           95 YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAP  171 (351)
T ss_dssp             EEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCC
T ss_pred             EEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCc
Confidence            99999999999999999998887543   345899999999999999999999988   999999999999986654   


Q ss_pred             eEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011250          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       282 vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~  361 (490)
                      +||+|||+++.......  .....+||+.|+|||++.+..++.++|||||||+||+|++|..||....    ..+.....
T Consensus       172 vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~i~  245 (351)
T 3c0i_A          172 VKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLFEGII  245 (351)
T ss_dssp             EEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHHHHHH
T ss_pred             EEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHHHHHH
Confidence            99999999987654322  2234679999999999999899999999999999999999999997531    11111110


Q ss_pred             cccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ..   ...    +.+...    ...+.++.+||.+||+.||.+|||+.+++++
T Consensus       246 ~~---~~~----~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          246 KG---KYK----MNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             HT---CCC----CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cC---CCC----CCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            00   000    000000    1236789999999999999999999999975

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=8.3e-47  Score=369.46  Aligned_cols=262  Identities=24%  Similarity=0.376  Sum_probs=202.8

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ..++|++.+.||+|+||.||+|.+...+.      .+..||||.+..... ...+.+.+|+.+++.++||||+++++++.
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   86 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPEN------PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT   86 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCC------CceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence            34579999999999999999999865322      456899999876432 33467899999999999999999999974


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                       ++..++||||+++++|.+++......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~  162 (281)
T 1mp8_A           87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL  162 (281)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---
T ss_pred             -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccc
Confidence             56789999999999999999777668999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ++........ ......||+.|+|||++....++.++|||||||++|||++ |..||.......   ........     
T Consensus       163 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~~~i~~~-----  233 (281)
T 1mp8_A          163 SRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIENG-----  233 (281)
T ss_dssp             -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHHTT-----
T ss_pred             ccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HHHHHHcC-----
Confidence            9876543221 2233567889999999999999999999999999999997 999997543221   11111100     


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                               ....++..++..+.+||.+||+.||.+|||+.++++.|+.+.+
T Consensus       234 ---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  276 (281)
T 1mp8_A          234 ---------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  276 (281)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                     0011233447889999999999999999999999999987643

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-46  Score=370.83  Aligned_cols=251  Identities=24%  Similarity=0.349  Sum_probs=199.1

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--------------------------cHHH
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--------------------------GHKE  185 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------------------------~~~~  185 (490)
                      .++|++.+.||+|+||.||+|++..         ++..||||++......                          ..+.
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNEN---------DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQ   82 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETT---------TTEEEEEEEEECC-------------------------------CH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECC---------CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHH
Confidence            3579999999999999999999876         6779999999755321                          1246


Q ss_pred             HHHHHHHHhccCCCCeeceeeEEEe--CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 011250          186 WLAEVNFLGNLLHPNLVKLVGYCIE--DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKP  263 (490)
Q Consensus       186 ~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~  263 (490)
                      +.+|+.+|+.++||||+++++++.+  .+..+|||||+++++|.+++.  ...+++..++.++.||+.||.|||+.+   
T Consensus        83 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---  157 (298)
T 2zv2_A           83 VYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQK---  157 (298)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             HHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence            8899999999999999999999987  567899999999999988653  347999999999999999999999988   


Q ss_pred             eeecCCCCCcEEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCC---CCccchhhHHHHHHHHHHh
Q 011250          264 VIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH---LTSKSDVYSFGVVLLEMLT  340 (490)
Q Consensus       264 iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~---~~~~sDvwSlGv~l~ellt  340 (490)
                      |+||||||+|||++.++.+||+|||+++.......  ......||+.|+|||++.+..   ++.++|||||||++|+|++
T Consensus       158 ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~  235 (298)
T 2zv2_A          158 IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF  235 (298)
T ss_dssp             EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHH
T ss_pred             eeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHH
Confidence            99999999999999999999999999987654322  223467999999999987654   4788999999999999999


Q ss_pred             CCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          341 GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       341 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      |+.||......   .+.......   .          +........+..+.+||.+||+.||.+|||+.+++++
T Consensus       236 g~~pf~~~~~~---~~~~~~~~~---~----------~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          236 GQCPFMDERIM---CLHSKIKSQ---A----------LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             SSCSSCCSSHH---HHHHHHHHC---C----------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             CCCCCCCccHH---HHHHHHhcc---c----------CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            99999653211   111111000   0          0000112236789999999999999999999999864

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.7e-47  Score=396.11  Aligned_cols=265  Identities=22%  Similarity=0.281  Sum_probs=214.1

Q ss_pred             hhhhHHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCC
Q 011250          124 MFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPN  200 (490)
Q Consensus       124 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~Hpn  200 (490)
                      .+.++....++|++.++||+|+||+||+|++..         +++.||||++.+...   .....+.+|+.++..++|||
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~---------~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~  135 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKN---------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW  135 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTT
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcC---------CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCC
Confidence            345566777899999999999999999999876         677999999975321   11234788999999999999


Q ss_pred             eeceeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC
Q 011250          201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY  280 (490)
Q Consensus       201 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~  280 (490)
                      |++++++|.+.+.+|||||||++|+|.+++.+....+++..+..++.||+.||.|||+.+   ||||||||+||||+.++
T Consensus       136 Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g  212 (437)
T 4aw2_A          136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNG  212 (437)
T ss_dssp             BCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTS
T ss_pred             EEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCC
Confidence            999999999999999999999999999999776678999999999999999999999988   99999999999999999


Q ss_pred             CeEEecccCcccCCCCCcceeeeccccCCCccCcchhc-----cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcch
Q 011250          281 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN  355 (490)
Q Consensus       281 ~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~  355 (490)
                      .+||+|||+++....... ......+||+.|+|||++.     ...|+.++|||||||+||||++|+.||..........
T Consensus       213 ~vkL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~  291 (437)
T 4aw2_A          213 HIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG  291 (437)
T ss_dssp             CEEECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred             CEEEcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHH
Confidence            999999999987654332 2234468999999999987     4678999999999999999999999997543211111


Q ss_pred             hhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 011250          356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA--RPRMSEVVET  414 (490)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~--RPt~~evl~~  414 (490)
                      .+      +.....   ..-|.    .....+.++.+||++||..+|++  ||+++|+++|
T Consensus       292 ~i------~~~~~~---~~~p~----~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          292 KI------MNHKER---FQFPT----QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             HH------HTHHHH---CCCCS----SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             hh------hhcccc---ccCCc----ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            10      000000   00000    01123788999999999988888  9999999976

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.2e-46  Score=370.10  Aligned_cols=272  Identities=24%  Similarity=0.292  Sum_probs=213.3

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .++|.+.++||+|+||.||+|++..         ++..||||++.... ....+.+.+|+.+++.++||||+++++++..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   78 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKK---------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE   78 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECC---------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec
Confidence            3579999999999999999999876         57799999997543 2345678899999999999999999999987


Q ss_pred             CC--ceEEEEEecCCCChhHHhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE----cCCCCe
Q 011250          211 DD--QRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL----DADYNA  282 (490)
Q Consensus       211 ~~--~~~lV~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl----~~~~~v  282 (490)
                      ..  ..+|||||+++++|.+++....  ..+++..++.++.||+.||.|||+.+   |+||||||+||||    +.++.+
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~  155 (319)
T 4euu_A           79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVY  155 (319)
T ss_dssp             TTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEE
T ss_pred             CCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceE
Confidence            65  7799999999999999996543  23999999999999999999999988   9999999999999    778889


Q ss_pred             EEecccCcccCCCCCcceeeeccccCCCccCcchhc--------cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcc
Q 011250          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM--------TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH  354 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~--------~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~  354 (490)
                      ||+|||+++.......   ....+||+.|+|||++.        +..++.++|||||||++|||++|+.||.........
T Consensus       156 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  232 (319)
T 4euu_A          156 KLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN  232 (319)
T ss_dssp             EECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC
T ss_pred             EEccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh
Confidence            9999999987654332   23467999999999886        478899999999999999999999999754322211


Q ss_pred             -hhhHhhhcccCCc--chhhhc------c--CCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          355 -NLVEWARPHLGDK--RRFYRL------L--DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       355 -~~~~~~~~~~~~~--~~~~~~------~--~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                       .............  ......      .  .......++...+..+.+||.+||+.||.+|||++|++++....
T Consensus       233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence             1111111000000  000000      0  01112244566788999999999999999999999999998643

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.7e-46  Score=364.84  Aligned_cols=256  Identities=30%  Similarity=0.556  Sum_probs=208.2

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-------HHHHHHHHHHHhccCCCCeece
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-------HKEWLAEVNFLGNLLHPNLVKL  204 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~Ei~il~~l~HpnIv~l  204 (490)
                      .++|++.+.||+|+||.||+|++..         ++..||||++.......       .+.+.+|+.+++.++||||+++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~   88 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVK---------DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKL   88 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETT---------TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCE
T ss_pred             hccceehhccccCCceeEEEEEEcC---------CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhh
Confidence            3579999999999999999999876         56789999986543221       1578899999999999999999


Q ss_pred             eeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCC---
Q 011250          205 VGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN---  281 (490)
Q Consensus       205 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~---  281 (490)
                      ++++.+..  ++||||+++|+|.+++......+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.   
T Consensus        89 ~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~  165 (287)
T 4f0f_A           89 YGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAP  165 (287)
T ss_dssp             EEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCS
T ss_pred             heeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCc
Confidence            99986554  7999999999999999777778999999999999999999999865 45999999999999988776   


Q ss_pred             --eEEecccCcccCCCCCcceeeeccccCCCccCcchhc--cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 011250          282 --AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM--TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV  357 (490)
Q Consensus       282 --vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~--~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~  357 (490)
                        +||+|||+++.....     .....||+.|+|||++.  ...++.++|||||||++|||++|+.||............
T Consensus       166 ~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~  240 (287)
T 4f0f_A          166 VCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN  240 (287)
T ss_dssp             CCEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHH
T ss_pred             eeEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHH
Confidence              999999999854331     23467999999999984  456789999999999999999999999754332211111


Q ss_pred             HhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          358 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                      ...              .......++..++..+.+||.+||+.||.+|||+.+|++.|+++
T Consensus       241 ~~~--------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          241 MIR--------------EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHH--------------HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             HHh--------------ccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            100              01111223334578899999999999999999999999999864

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=9.6e-47  Score=369.00  Aligned_cols=258  Identities=22%  Similarity=0.374  Sum_probs=210.3

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ..++|++.+.||+|+||.||+|.+.          ++..||||++..... ..+++.+|+.++..++||||+++++++.+
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   90 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTK   90 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEET----------TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEc----------CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEec
Confidence            3457999999999999999999875          355799999986543 35678999999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      .+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~  167 (283)
T 3gen_A           91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLS  167 (283)
T ss_dssp             SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGG
T ss_pred             CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccc
Confidence            99999999999999999999765667999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +....... .......||+.|+|||++.+..++.++||||||+++|+|++ |+.||......   .........      
T Consensus       168 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~~~------  237 (283)
T 3gen_A          168 RYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAEHIAQG------  237 (283)
T ss_dssp             GGBCCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHHHTT------
T ss_pred             cccccccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh---HHHHHHhcc------
Confidence            87643221 11223457888999999999999999999999999999998 99999754321   111111100      


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                              .....+...+..+.+||.+||+.||.+|||+.+++++|..+.+
T Consensus       238 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~  280 (283)
T 3gen_A          238 --------LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD  280 (283)
T ss_dssp             --------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence                    1111122336789999999999999999999999999987643

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=9.8e-47  Score=376.20  Aligned_cols=267  Identities=24%  Similarity=0.375  Sum_probs=198.3

Q ss_pred             HHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhccCCCCeecee
Q 011250          128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLV  205 (490)
Q Consensus       128 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~  205 (490)
                      +.+..++|++.+.||+|+||.||+|++...+.      ....||||++....  ....+.+.+|+.+++.++||||++++
T Consensus        18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   91 (323)
T 3qup_A           18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDG------SFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLV   91 (323)
T ss_dssp             TBCC---CEEEEEEEEETTEEEEEEEC-------------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCC
T ss_pred             cccChhHeEEeceecccCCeEEEEEEEcccCC------cceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhh
Confidence            33456789999999999999999998875321      22379999997653  33457799999999999999999999


Q ss_pred             eEEEeCCce------EEEEEecCCCChhHHhhhcC-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcE
Q 011250          206 GYCIEDDQR------LLVYEFMPRGSLENHLFRRS-----LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI  274 (490)
Q Consensus       206 ~~~~~~~~~------~lV~E~~~~gsL~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NI  274 (490)
                      +++......      ++||||+++|+|.+++....     ..+++..++.++.||+.||.|||+.+   |+||||||+||
T Consensus        92 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NI  168 (323)
T 3qup_A           92 GVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNC  168 (323)
T ss_dssp             EEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred             ceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceE
Confidence            999887655      99999999999999986432     25999999999999999999999988   99999999999


Q ss_pred             EEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCc
Q 011250          275 LLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGE  353 (490)
Q Consensus       275 Ll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~  353 (490)
                      ||+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus       169 li~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~  248 (323)
T 3qup_A          169 MLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI  248 (323)
T ss_dssp             EECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred             EEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH
Confidence            999999999999999987655433333334567889999999999999999999999999999999 9999975432211


Q ss_pred             chhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                         .......              .....+...+..+.+||.+||+.||.+|||+.++++.|+++..
T Consensus       249 ---~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~  298 (323)
T 3qup_A          249 ---YNYLIGG--------------NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG  298 (323)
T ss_dssp             ---HHHHHTT--------------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---HHHHhcC--------------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence               1111000              0111223346889999999999999999999999999987754

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.5e-46  Score=372.49  Aligned_cols=267  Identities=26%  Similarity=0.396  Sum_probs=218.0

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcc-CCCCeeceeeE
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKLVGY  207 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~  207 (490)
                      ...++|++.+.||+|+||.||+|++...    ....++..||||++..... ...+.+.+|+.++..+ +||||++++++
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   95 (313)
T 1t46_A           20 FPRNRLSFGKTLGAGAFGKVVEATAYGL----IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA   95 (313)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cChhhhhHHHhhCccCCcceEEEEEeec----cccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence            3446799999999999999999987431    1123678999999976543 3446789999999999 89999999999


Q ss_pred             EEeCCceEEEEEecCCCChhHHhhhcCC-----------------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 011250          208 CIEDDQRLLVYEFMPRGSLENHLFRRSL-----------------PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFK  270 (490)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~-----------------~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlk  270 (490)
                      +.+++..++||||+++|+|.+++.....                 .+++..++.++.||+.||.|||+.+   |+|||||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlk  172 (313)
T 1t46_A           96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLA  172 (313)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred             EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCc
Confidence            9999999999999999999999976532                 4899999999999999999999988   9999999


Q ss_pred             CCcEEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCC
Q 011250          271 TSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNR  349 (490)
Q Consensus       271 p~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~  349 (490)
                      |+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus       173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  252 (313)
T 1t46_A          173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (313)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence            9999999999999999999988765544433445678899999999999999999999999999999999 999997543


Q ss_pred             CCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011250          350 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~  419 (490)
                      ....  .......              ......+...+..+.+||.+||+.||.+|||+.+++++|+.+.
T Consensus       253 ~~~~--~~~~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  306 (313)
T 1t46_A          253 VDSK--FYKMIKE--------------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (313)
T ss_dssp             SSHH--HHHHHHH--------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             chhH--HHHHhcc--------------CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            2211  1111110              0111112234788999999999999999999999999998654

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.6e-46  Score=381.66  Aligned_cols=253  Identities=24%  Similarity=0.351  Sum_probs=207.7

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      .++|.+.+.||+|+||.||+|.+..         ++..||||++.....  ...+.+.+|+.+++.|+||||+++++++.
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~   98 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKT---------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ   98 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECC---------CCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            4579999999999999999999876         677999999976543  33467889999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC---CCeEEec
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD---YNAKLSD  286 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~---~~vkL~D  286 (490)
                      +.+..||||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.+   +.+||+|
T Consensus        99 ~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~D  174 (362)
T 2bdw_A           99 EESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLAD  174 (362)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECC
T ss_pred             eCCEEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEee
Confidence            999999999999999999988654 47999999999999999999999988   9999999999999765   4599999


Q ss_pred             ccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011250          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      ||++........   ....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.....   ..+........  
T Consensus       175 fG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---~~~~~~i~~~~--  246 (362)
T 2bdw_A          175 FGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYAQIKAGA--  246 (362)
T ss_dssp             CTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTC--
T ss_pred             cCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhCC--
Confidence            999987654322   2346899999999999988999999999999999999999999975421   11111111000  


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                       ..        .........+.++.+||.+||+.||.+||++.+++++
T Consensus       247 -~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          247 -YD--------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             -CC--------CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             -CC--------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             00        0000112336889999999999999999999999976

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.1e-46  Score=388.33  Aligned_cols=255  Identities=22%  Similarity=0.297  Sum_probs=208.0

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      .++|++.+.||+|+||+||+|.+..         +|..||+|++......  ..+.+.+|+.+++.++||||+++++++.
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~---------~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~   80 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVL---------AGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS   80 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETT---------TTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECC---------CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE
Confidence            4579999999999999999999876         6789999999766432  3456889999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc---CCCCeEEec
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD---ADYNAKLSD  286 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~---~~~~vkL~D  286 (490)
                      +++..|||||||.+|+|.+++... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++   .++.+||+|
T Consensus        81 ~~~~~~lv~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~D  156 (444)
T 3soa_A           81 EEGHHYLIFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLAD  156 (444)
T ss_dssp             CSSEEEEEECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECC
T ss_pred             ECCEEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEcc
Confidence            999999999999999999998665 46999999999999999999999988   99999999999998   467899999


Q ss_pred             ccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011250          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      ||+++.......  .....+||+.|+|||++.+..|+.++|||||||+||+|++|.+||......   .+.......   
T Consensus       157 FG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~---~~~~~i~~~---  228 (444)
T 3soa_A          157 FGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH---RLYQQIKAG---  228 (444)
T ss_dssp             CSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHT---
T ss_pred             CceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH---HHHHHHHhC---
Confidence            999987654322  223468999999999999889999999999999999999999999654211   111111100   


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                      ..        .+........+.++.+||.+||+.||.+|||+.++|++-
T Consensus       229 ~~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp  269 (444)
T 3soa_A          229 AY--------DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHP  269 (444)
T ss_dssp             CC--------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSC
T ss_pred             CC--------CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence            00        000011123378899999999999999999999999863

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.5e-46  Score=373.80  Aligned_cols=263  Identities=23%  Similarity=0.394  Sum_probs=207.3

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC-CcccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .++|++.+.||+|+||.||+|++...+..     ....||+|.+... .....+.+.+|+.+++.++||||+++++++..
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-----~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   88 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT   88 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCS-----CCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCce-----EEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence            45799999999999999999998764321     1235688887644 33456789999999999999999999999987


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      .. .++||||+.+|+|.+++......+++..++.|+.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus        89 ~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a  164 (327)
T 3lzb_A           89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             SS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred             CC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcce
Confidence            64 78999999999999999877778999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +...............||+.|+|||++.+..++.++|||||||++|||++ |..||...........+   ..       
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~---~~-------  234 (327)
T 3lzb_A          165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL---EK-------  234 (327)
T ss_dssp             ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---HT-------
T ss_pred             eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH---Hc-------
Confidence            87654433333334567889999999999999999999999999999999 99999764332211111   10       


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                             ......+..++.++.+||.+||..||.+||++.++++.|+.+..
T Consensus       235 -------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          235 -------GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             -------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             -------CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                   01111223347789999999999999999999999999987754

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=9.5e-47  Score=369.93  Aligned_cols=261  Identities=23%  Similarity=0.353  Sum_probs=209.6

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      .++|.+.+.||+|+||.||+|.+...+...  ...+..||+|++........+.+.+|+.+++.++||||+++++++.++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~--~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYG--QLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG   84 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGG--CEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccc--cccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence            457999999999999999999987633210  001257999999776666678899999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCC--------eE
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN--------AK  283 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~--------vk  283 (490)
                      +..+|||||+++|+|.+++......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.        +|
T Consensus        85 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           85 DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence            9999999999999999999776666999999999999999999999988   999999999999998887        99


Q ss_pred             EecccCcccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011250          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      |+|||++......      ....||+.|+|||++.+ ..++.++|||||||++|||++|..|+......  .........
T Consensus       162 l~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~--~~~~~~~~~  233 (289)
T 4fvq_A          162 LSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS--QRKLQFYED  233 (289)
T ss_dssp             ECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHHHHHT
T ss_pred             eccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch--HHHHHHhhc
Confidence            9999998765321      23568999999999987 67999999999999999999965544322111  011110000


Q ss_pred             ccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccc
Q 011250          363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~~  421 (490)
                          .            ..++...+.++.+||.+||+.||.+|||+.+++++|+.+...
T Consensus       234 ----~------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          234 ----R------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             ----T------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             ----c------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence                0            011112245688999999999999999999999999988653

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.8e-46  Score=379.45  Aligned_cols=247  Identities=25%  Similarity=0.317  Sum_probs=208.2

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      .++|++.+.||+|+||.||+|++..         +|..||||++....   ....+.+.+|+.+|+.+.||||+++++++
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  110 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKE---------SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF  110 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECC---------CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            3579999999999999999999876         67799999996542   23456788999999999999999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      .+.+..||||||+++|+|.+++.+. ..+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||
T Consensus       111 ~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg  186 (350)
T 1rdq_E          111 KDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFG  186 (350)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccc
Confidence            9999999999999999999999655 46999999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +++.....     ....+||+.|+|||++.+..++.++|||||||+||||++|..||......   .+.....       
T Consensus       187 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i~-------  251 (350)
T 1rdq_E          187 FAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---QIYEKIV-------  251 (350)
T ss_dssp             TCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH-------
T ss_pred             cceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH---HHHHHHH-------
Confidence            99876432     23468999999999999999999999999999999999999999754221   1111110       


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  414 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt-----~~evl~~  414 (490)
                            ..  ...++...+..+.+||.+||+.||.+||+     +.+|++|
T Consensus       252 ------~~--~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          252 ------SG--KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             ------HC--CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ------cC--CCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence                  00  01122334788999999999999999998     8888765

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.2e-46  Score=366.72  Aligned_cols=266  Identities=17%  Similarity=0.159  Sum_probs=215.3

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcc-CCCCeeceeeEEE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  209 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~  209 (490)
                      ..++|++.+.||+|+||.||+|.+..         ++..||||++.....  .+.+.+|+.++..+ .|+||+++++++.
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~   76 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLL---------NNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQ   76 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETT---------TTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECC---------CCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecC
Confidence            34679999999999999999999865         677999999865432  24578899999999 7999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCC-----eEE
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN-----AKL  284 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~-----vkL  284 (490)
                      +....++||||+ +++|.+++......+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.     +||
T Consensus        77 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl  152 (298)
T 1csn_A           77 EGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYV  152 (298)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred             CCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEE
Confidence            999999999999 99999999877677999999999999999999999988   999999999999987766     999


Q ss_pred             ecccCcccCCCCCcc-----eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 011250          285 SDFGLAKDAPEDGKT-----HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW  359 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~  359 (490)
                      +|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||..............
T Consensus       153 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  232 (298)
T 1csn_A          153 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER  232 (298)
T ss_dssp             CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred             EECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHH
Confidence            999999876543221     112346799999999999999999999999999999999999999987543332222211


Q ss_pred             hhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccc
Q 011250          360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~~  421 (490)
                      ......      ....+.+    ....+..+.+|+.+||+.||.+||++.+|++.|+.+...
T Consensus       233 ~~~~~~------~~~~~~~----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~  284 (298)
T 1csn_A          233 IGEKKQ------STPLREL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  284 (298)
T ss_dssp             HHHHHH------HSCHHHH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHhhcc------CccHHHH----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence            110000      0000000    112367899999999999999999999999999877543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1e-46  Score=379.09  Aligned_cols=248  Identities=25%  Similarity=0.323  Sum_probs=206.0

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|.+.+.||+|+||.||+|.+..         ++..||||++.....   .....+.+|+.+++.++||||+++++++.
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~   79 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYK---------TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT   79 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            579999999999999999999876         677999999864321   22357889999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +.+..+|||||+ +|+|.+++... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        80 ~~~~~~lv~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~  154 (336)
T 3h4j_B           80 TPTDIVMVIEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGL  154 (336)
T ss_dssp             CSSEEEEEECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSC
T ss_pred             eCCEEEEEEECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEecc
Confidence            999999999999 78999988655 46999999999999999999999998   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCC-CccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +........   ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...........+.          
T Consensus       155 s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~----------  221 (336)
T 3h4j_B          155 SNIMTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVN----------  221 (336)
T ss_dssp             TBTTTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCC----------
T ss_pred             ceeccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHH----------
Confidence            987654322   234689999999999987766 689999999999999999999997543221111000          


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                            .  ....++...+..+.+||.+||+.||.+|||+.|++++-
T Consensus       222 ------~--~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  260 (336)
T 3h4j_B          222 ------S--CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP  260 (336)
T ss_dssp             ------S--SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred             ------c--CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence                  0  00112233478899999999999999999999998753

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.9e-46  Score=379.62  Aligned_cols=251  Identities=26%  Similarity=0.364  Sum_probs=207.5

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcc-CCCCeeceee
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNL-LHPNLVKLVG  206 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~~  206 (490)
                      ..++|++.+.||+|+||.||+|++..         ++..||||++....   ....+.+..|..+|..+ .||||+++++
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~   88 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKG---------TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS   88 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETT---------EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEE
Confidence            34689999999999999999999875         57799999997542   23446688999999988 7999999999


Q ss_pred             EEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEec
Q 011250          207 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~D  286 (490)
                      ++.+.+..||||||++||+|.+++... ..+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|
T Consensus        89 ~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~D  164 (353)
T 2i0e_A           89 CFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIAD  164 (353)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECC
T ss_pred             EEEcCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEe
Confidence            999999999999999999999999654 36999999999999999999999988   99999999999999999999999


Q ss_pred             ccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011250          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      ||+++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+....   +  
T Consensus       165 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~~i---~--  234 (353)
T 2i0e_A          165 FGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQSI---M--  234 (353)
T ss_dssp             CTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---H--
T ss_pred             CCcccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH---HHHHHH---H--
Confidence            999986433222  234578999999999999999999999999999999999999999754211   111111   0  


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  414 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt-----~~evl~~  414 (490)
                              ..  ...++...+.++.+||.+||..||.+||+     +.+|++|
T Consensus       235 --------~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          235 --------EH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             --------HC--CCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             --------hC--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                    00  01123344788999999999999999995     5777765

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4e-46  Score=366.07  Aligned_cols=265  Identities=23%  Similarity=0.328  Sum_probs=202.5

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ++|++.+.||+|+||.||+|++.          ++..||||++......  ..+.+.+|+.+++.++||||+++++++.+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~----------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   71 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT   71 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcC----------CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc
Confidence            47999999999999999999873          4678999999755322  23678899999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      .+..++||||+++ +|.+++......+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        72 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~  147 (288)
T 1ob3_A           72 KKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLA  147 (288)
T ss_dssp             SSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHH
T ss_pred             CCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccc
Confidence            9999999999965 999998776678999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhh-Hhhhc-c---c
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWARP-H---L  364 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~-~~~~~-~---~  364 (490)
                      +.......  ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+ ..... .   .
T Consensus       148 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  225 (288)
T 1ob3_A          148 RAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW  225 (288)
T ss_dssp             HHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             cccCcccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhc
Confidence            86543211  1234578999999999875 46899999999999999999999999754321111000 00000 0   0


Q ss_pred             CCcchhhhccCCcc-------CCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          365 GDKRRFYRLLDPRL-------EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       365 ~~~~~~~~~~~~~l-------~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ...... ...++.+       ...+....+.++.+||.+||+.||.+|||+.+++++
T Consensus       226 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          226 PNVTEL-PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             TTGGGS-TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhhcc-cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            000000 0001110       011122347889999999999999999999999875

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.1e-46  Score=396.26  Aligned_cols=261  Identities=25%  Similarity=0.403  Sum_probs=218.0

Q ss_pred             HHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       129 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      .+...+|.+.+.||+|+||.||+|.+..         ++..||||++.... ...+++.+|+.+|+.++|||||++++++
T Consensus       216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~---------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~  285 (495)
T 1opk_A          216 EMERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVC  285 (495)
T ss_dssp             BCCGGGEEEEEESGGGTTSSEEEEEEGG---------GTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCHHHceeeeEecCCCCeEEEEEEEcC---------CCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            3445678999999999999999999876         56789999997654 3467899999999999999999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DF  287 (490)
                      .+.+..+||||||++|+|.+++... ...+++..++.|+.||+.||.|||+.+   |+||||||+||||+.++.+||+||
T Consensus       286 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DF  362 (495)
T 1opk_A          286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADF  362 (495)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCT
T ss_pred             ecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeec
Confidence            9999999999999999999999764 346999999999999999999999988   999999999999999999999999


Q ss_pred             cCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCC
Q 011250          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      |+++...... ........+++.|+|||++....++.++|||||||+||||++ |..||.......   +.....     
T Consensus       363 G~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~~~~-----  433 (495)
T 1opk_A          363 GLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLE-----  433 (495)
T ss_dssp             TCEECCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHHH-----
T ss_pred             ccceeccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH-----
Confidence            9998765432 222233456789999999999999999999999999999999 999997543221   111111     


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                               .......+..++..+.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus       434 ---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          434 ---------KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             ---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             ---------cCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence                     111122334457899999999999999999999999999998754

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.3e-46  Score=376.91  Aligned_cols=256  Identities=25%  Similarity=0.388  Sum_probs=206.2

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcc-CCCCeeceeeEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNL-LHPNLVKLVGYC  208 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l-~HpnIv~l~~~~  208 (490)
                      ++|++.+.||+|+||.||+|++..         ++..||||++.....   ...+.+.+|+.++..+ +||||+++++++
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~   79 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKK---------TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF   79 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE
Confidence            469999999999999999999876         677999999976532   2345678899999987 799999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      .+.+..||||||+++|+|.+++.+. ..+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||
T Consensus        80 ~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG  155 (345)
T 3a8x_A           80 QTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG  155 (345)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGG
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecc
Confidence            9999999999999999999998654 47999999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcc--hhhHhhhcccCC
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH--NLVEWARPHLGD  366 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~--~~~~~~~~~~~~  366 (490)
                      +++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.........  .......     
T Consensus       156 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-----  228 (345)
T 3a8x_A          156 MCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF-----  228 (345)
T ss_dssp             GCBCSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHH-----
T ss_pred             ccccccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHH-----
Confidence            9986433222  234578999999999999999999999999999999999999999653221110  0000000     


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM------SEVVET  414 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~------~evl~~  414 (490)
                          ..+...  ...++...+.++.+||.+||+.||.+||++      .++++|
T Consensus       229 ----~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          229 ----QVILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             ----HHHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             ----HHHHcC--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence                000110  112233447889999999999999999995      666654

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.6e-46  Score=366.68  Aligned_cols=263  Identities=25%  Similarity=0.398  Sum_probs=219.3

Q ss_pred             hHHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceee
Q 011250          127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVG  206 (490)
Q Consensus       127 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  206 (490)
                      ++....++|++.+.||+|+||.||+|.+..         ++..||||++.... ...+.+.+|+.+++.++||||+++++
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~   76 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLG   76 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGG---------GTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecC---------CCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            344456789999999999999999999976         56789999997654 34577899999999999999999999


Q ss_pred             EEEeCCceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEe
Q 011250          207 YCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~  285 (490)
                      ++.+++..++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        77 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~  153 (288)
T 3kfa_A           77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVA  153 (288)
T ss_dssp             EECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEEC
T ss_pred             EEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEc
Confidence            999999999999999999999999763 346999999999999999999999998   9999999999999999999999


Q ss_pred             cccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhccc
Q 011250          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      |||++........ .......||+.|+|||++.+..++.++||||||+++|+|++ |..||........   .....   
T Consensus       154 Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~---~~~~~---  226 (288)
T 3kfa_A          154 DFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YELLE---  226 (288)
T ss_dssp             CCCGGGTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHHHH---
T ss_pred             cCccceeccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHh---
Confidence            9999987654332 22334567899999999999999999999999999999999 9999975432211   11111   


Q ss_pred             CCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                                 .......+...+..+.+|+.+||..||.+|||+.++++.|+.+..
T Consensus       227 -----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~  271 (288)
T 3kfa_A          227 -----------KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  271 (288)
T ss_dssp             -----------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----------ccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence                       011112223447889999999999999999999999999987654

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=5.1e-46  Score=370.81  Aligned_cols=267  Identities=24%  Similarity=0.348  Sum_probs=192.5

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      ++|++.+.||+|+||.||+|.+..         ++..||||++..... ...+.+.+|+.+++.++||||+++++++.++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   75 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKT---------TGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTE   75 (317)
T ss_dssp             --------------CEEEEEECSS---------SCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCT
T ss_pred             cceeEeeEECCCCCEEEEEEEECC---------CCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEEC
Confidence            579999999999999999998865         577999999975532 2346788999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcC-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEec
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRS-----LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~D  286 (490)
                      +..+|||||++ |+|.+++....     ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        76 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~D  151 (317)
T 2pmi_A           76 NKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGD  151 (317)
T ss_dssp             TEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECC
T ss_pred             CeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECc
Confidence            99999999997 69999886432     45899999999999999999999988   99999999999999999999999


Q ss_pred             ccCcccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011250          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      ||+++.......  .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+........
T Consensus       152 fg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  229 (317)
T 2pmi_A          152 FGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN  229 (317)
T ss_dssp             CSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred             CccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            999987643221  1234579999999999876 4689999999999999999999999975432211111100000000


Q ss_pred             --Ccchhhh--ccCCcc------------CCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          366 --DKRRFYR--LLDPRL------------EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 --~~~~~~~--~~~~~l------------~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                        .......  ...+.+            ........+.++.+||.+||+.||.+|||+.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          230 ESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             TTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence              0000000  000000            001111236789999999999999999999999865

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=5.5e-46  Score=361.10  Aligned_cols=254  Identities=31%  Similarity=0.515  Sum_probs=197.9

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc----ccHHHHHHHHHHHhccCCCCeeceeeE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~  207 (490)
                      .++|++.+.||+|+||.||+|.+.           +..||||++.....    ...+.+.+|+.+++.++||||++++++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   74 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-----------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV   74 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-----------TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-----------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            357999999999999999999873           55899999875432    234678899999999999999999999


Q ss_pred             EEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC--------C
Q 011250          208 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA--------D  279 (490)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~--------~  279 (490)
                      +.+++..++||||+++++|.+++.  ...+++..++.++.||+.||.|||+.+..+|+||||||+|||++.        +
T Consensus        75 ~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~  152 (271)
T 3dtc_A           75 CLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSN  152 (271)
T ss_dssp             ECCC--CEEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred             EecCCceEEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccC
Confidence            999999999999999999999884  347999999999999999999999987445899999999999986        6


Q ss_pred             CCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 011250          280 YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW  359 (490)
Q Consensus       280 ~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~  359 (490)
                      +.+||+|||++........    ....||+.|+|||++.+..++.++||||||+++|+|++|+.||.......   ... 
T Consensus       153 ~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~-  224 (271)
T 3dtc_A          153 KILKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA---VAY-  224 (271)
T ss_dssp             CCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH---HHH-
T ss_pred             cceEEccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH-
Confidence            7899999999986543322    23579999999999999999999999999999999999999996532111   000 


Q ss_pred             hhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                                  ...........+..++..+.+||.+||+.||.+|||+.+++++|+.+
T Consensus       225 ------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          225 ------------GVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             ------------HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             ------------hhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                        01111111223344578899999999999999999999999999864

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=4.7e-46  Score=365.76  Aligned_cols=262  Identities=28%  Similarity=0.472  Sum_probs=199.1

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeE
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~  207 (490)
                      +..++|++.+.||+|+||.||+|.+..            .||||+++....  ...+.+.+|+.+++.++||||++++++
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~------------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   88 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWHG------------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY   88 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESSS------------EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEcC------------ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEee
Confidence            345689999999999999999997643            599999976533  334678999999999999999999996


Q ss_pred             EEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecc
Q 011250          208 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DF  287 (490)
                      + .....++||||+++++|.+++......+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+||
T Consensus        89 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Df  164 (289)
T 3og7_A           89 S-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDF  164 (289)
T ss_dssp             E-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCC
T ss_pred             c-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccc
Confidence            5 556789999999999999999777778999999999999999999999988   999999999999999999999999


Q ss_pred             cCcccCCCCCcceeeeccccCCCccCcchhc---cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc
Q 011250          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      |+++...............||+.|+|||++.   ...++.++|||||||++|+|++|+.||.......  .+....... 
T Consensus       165 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~~-  241 (289)
T 3og7_A          165 GLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIEMVGRG-  241 (289)
T ss_dssp             C------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHHHHHHT-
T ss_pred             eeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHHHhccc-
Confidence            9998664433333334567999999999986   5678899999999999999999999997543211  111111110 


Q ss_pred             CCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011250          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~  419 (490)
                              ...+. ...+...++..+.+||.+||+.||.+|||+.++++.|+.+.
T Consensus       242 --------~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          242 --------SLSPD-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             --------SCCCC-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             --------ccCcc-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence                    00010 11122344788999999999999999999999999998774

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=7.2e-46  Score=376.69  Aligned_cols=254  Identities=22%  Similarity=0.284  Sum_probs=197.0

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      ++|++.+.||+|+||+||+|++..         ++..||||++...... .+.+.+|+.+++.++||||+++++++.+.+
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   89 (361)
T 3uc3_A           20 DRYDFVKDIGSGNFGVARLMRDKL---------TKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPT   89 (361)
T ss_dssp             TTEEEEEEESSSTTSSEEEEEETT---------TCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CcEEEEEEeccCCCEEEEEEEECC---------CCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCC
Confidence            579999999999999999999876         6779999999765432 356889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCC--eEEecccCc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN--AKLSDFGLA  290 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~--vkL~DFG~a  290 (490)
                      ..+|||||+++|+|.+++... ..+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.  +||+|||++
T Consensus        90 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a  165 (361)
T 3uc3_A           90 HLAIIMEYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYS  165 (361)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC
T ss_pred             EEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcc
Confidence            999999999999999998654 46999999999999999999999988   999999999999987765  999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCcc-chhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSK-SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~-sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +......   .....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...........  ....       
T Consensus       166 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~--~~~~-------  233 (361)
T 3uc3_A          166 KSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRK--TIQR-------  233 (361)
T ss_dssp             ------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHH--HHHH-------
T ss_pred             ccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHH--HHHH-------
Confidence            7543221   1234679999999999988877655 8999999999999999999976443222111  1110       


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                         +.............+..+.+||.+||+.||.+|||+.++++|-
T Consensus       234 ---~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp  276 (361)
T 3uc3_A          234 ---ILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHS  276 (361)
T ss_dssp             ---HHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred             ---HhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence               0111111111112368899999999999999999999999863

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.2e-46  Score=388.30  Aligned_cols=261  Identities=25%  Similarity=0.305  Sum_probs=210.7

Q ss_pred             hhHHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCee
Q 011250          126 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLV  202 (490)
Q Consensus       126 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv  202 (490)
                      .++....++|++.++||+|+||.||+|++..         ++..||+|++.+...   ...+.+.+|+.++..++|||||
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~---------~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv  132 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---------TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV  132 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBC
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECC---------CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCC
Confidence            4455667899999999999999999999876         677999999865321   1223478899999999999999


Q ss_pred             ceeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCe
Q 011250          203 KLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       203 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~v  282 (490)
                      ++++++.+.+.+|||||||+||+|.+++...  .+++..+..++.||+.||.|||+.+   ||||||||+||||+.++.+
T Consensus       133 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~i  207 (410)
T 3v8s_A          133 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHL  207 (410)
T ss_dssp             CEEEEEECSSEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCE
T ss_pred             eEEEEEEECCEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCE
Confidence            9999999999999999999999999998653  6899999999999999999999988   9999999999999999999


Q ss_pred             EEecccCcccCCCCCcceeeeccccCCCccCcchhccCC----CCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhH
Q 011250          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH----LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE  358 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~----~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~  358 (490)
                      ||+|||+++....... ......+||+.|+|||++.+..    |+.++|||||||+||||++|+.||........   ..
T Consensus       208 kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~~  283 (410)
T 3v8s_A          208 KLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---YS  283 (410)
T ss_dssp             EECCCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HH
T ss_pred             EEeccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH---HH
Confidence            9999999987654332 2234578999999999998655    88999999999999999999999975432111   11


Q ss_pred             hhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCC--CCCHHHHHHHh
Q 011250          359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA--RPRMSEVVETL  415 (490)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~--RPt~~evl~~L  415 (490)
                      ..   +.....        +.-......+.++.+||.+||..+|.+  ||++.||++|-
T Consensus       284 ~i---~~~~~~--------~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp  331 (410)
T 3v8s_A          284 KI---MNHKNS--------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  331 (410)
T ss_dssp             HH---HTHHHH--------CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred             HH---Hhcccc--------ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence            10   000000        000001123788999999999999988  99999999874

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-46  Score=388.83  Aligned_cols=265  Identities=22%  Similarity=0.266  Sum_probs=212.4

Q ss_pred             hhhhhHHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCC
Q 011250          123 FMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHP  199 (490)
Q Consensus       123 ~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~Hp  199 (490)
                      +.+.+.....++|++.++||+|+||.||+|++..         +|+.||||++.+...   ...+.+.+|+.++..++||
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~---------~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp  121 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---------TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRR  121 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTT
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCC
Confidence            3445566677899999999999999999999876         677999999975322   1223478899999999999


Q ss_pred             CeeceeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC
Q 011250          200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD  279 (490)
Q Consensus       200 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~  279 (490)
                      ||+++++++.+.+.+||||||+++|+|.+++.+.+..+++..++.++.||+.||.|||+.+   ||||||||+||||+.+
T Consensus       122 ~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~  198 (412)
T 2vd5_A          122 WITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRC  198 (412)
T ss_dssp             TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT
T ss_pred             CeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCC
Confidence            9999999999999999999999999999999776668999999999999999999999988   9999999999999999


Q ss_pred             CCeEEecccCcccCCCCCcceeeeccccCCCccCcchhc-------cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCC
Q 011250          280 YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM-------TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG  352 (490)
Q Consensus       280 ~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-------~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~  352 (490)
                      +.+||+|||+++....... ......+||+.|+|||++.       ...|+.++|||||||++|||++|+.||.......
T Consensus       199 g~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~  277 (412)
T 2vd5_A          199 GHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE  277 (412)
T ss_dssp             SCEEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred             CCEEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH
Confidence            9999999999987654332 2223468999999999987       3578999999999999999999999997543211


Q ss_pred             cchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCC---CCHHHHHHH
Q 011250          353 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR---PRMSEVVET  414 (490)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~R---Pt~~evl~~  414 (490)
                      ....+      +.....   ..-+.    ++...+.++.+||.+||. +|.+|   |++++|++|
T Consensus       278 ~~~~i------~~~~~~---~~~p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          278 TYGKI------VHYKEH---LSLPL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             HHHHH------HTHHHH---CCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             HHHHH------HhcccC---cCCCc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            11100      000000   00010    112237889999999999 99998   599999876

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=5.1e-46  Score=372.56  Aligned_cols=253  Identities=28%  Similarity=0.382  Sum_probs=198.9

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc----ccHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      ++|++.+.||+|+||.||+|+.....      .++..||||++.....    .....+.+|+.+|+.++||||+++++++
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   90 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGA------NTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF   90 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSST------TTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccC------CCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence            47999999999999999999885321      2678999999976532    2335578899999999999999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      .+.+..||||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg  166 (327)
T 3a62_A           91 QTGGKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFG  166 (327)
T ss_dssp             ECSSCEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCS
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCC
Confidence            9999999999999999999998654 46899999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......   ........   .  
T Consensus       167 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~---~--  236 (327)
T 3a62_A          167 LCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK---KTIDKILK---C--  236 (327)
T ss_dssp             CC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHH---T--
T ss_pred             cccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHh---C--
Confidence            9976433221  223468999999999999999999999999999999999999999754211   11111100   0  


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHh
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVETL  415 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----t~~evl~~L  415 (490)
                                ...++...+..+.+||.+||..||.+||     ++.++++|-
T Consensus       237 ----------~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp  278 (327)
T 3a62_A          237 ----------KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP  278 (327)
T ss_dssp             ----------CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence                      0112233478899999999999999999     788988763

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=5.8e-46  Score=379.04  Aligned_cols=249  Identities=25%  Similarity=0.331  Sum_probs=201.8

Q ss_pred             CCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCCceEE
Q 011250          137 PESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLL  216 (490)
Q Consensus       137 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  216 (490)
                      ..+.||+|+||.||+|.+..         +|..||||++........+.+.+|+.+|+.|+||||+++++++.+.+..+|
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~---------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  163 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETA---------TGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL  163 (373)
T ss_dssp             EEEECC-----CEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cceEEecCcCEEEEEEEEcC---------CCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            35789999999999999876         577999999987766667789999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE--cCCCCeEEecccCcccCC
Q 011250          217 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL--DADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       217 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl--~~~~~vkL~DFG~a~~~~  294 (490)
                      ||||+++++|.+++......+++..++.++.||+.||.|||+.+   |+||||||+|||+  +.++.+||+|||+++...
T Consensus       164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~  240 (373)
T 2x4f_A          164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYK  240 (373)
T ss_dssp             EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECC
T ss_pred             EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecC
Confidence            99999999999999776667999999999999999999999988   9999999999999  567889999999998765


Q ss_pred             CCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhcc
Q 011250          295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  374 (490)
Q Consensus       295 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (490)
                      ....   ....+||+.|+|||++.+..++.++|||||||+||||++|..||........  +.........         
T Consensus       241 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~i~~~~~~---------  306 (373)
T 2x4f_A          241 PREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET--LNNILACRWD---------  306 (373)
T ss_dssp             TTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHHTCCC---------
T ss_pred             Cccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCC---------
Confidence            4322   2235799999999999988999999999999999999999999975432111  1111110000         


Q ss_pred             CCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       375 ~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                         +........+.++.+||.+||+.||.+|||+.+++++
T Consensus       307 ---~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          307 ---LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             ---SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ---CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence               0000011236889999999999999999999999985

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.7e-46  Score=372.60  Aligned_cols=270  Identities=25%  Similarity=0.407  Sum_probs=216.5

Q ss_pred             hHHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeecee
Q 011250          127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLV  205 (490)
Q Consensus       127 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~  205 (490)
                      ++.+..++|++.+.||+|+||.||+|.+...    ....++..||||++..... .....+.+|+.+++.+.||||++++
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEE----ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCc----cCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            4445567899999999999999999987631    0111467899999976533 3345688999999999999999999


Q ss_pred             eEEEeCCceEEEEEecCCCChhHHhhhcC---------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE
Q 011250          206 GYCIEDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL  276 (490)
Q Consensus       206 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl  276 (490)
                      +++.+.+..++||||+++|+|.+++....         ..+++..++.++.||+.||.|||+.+   |+||||||+|||+
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli  171 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV  171 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEE
Confidence            99999999999999999999999986432         45789999999999999999999988   9999999999999


Q ss_pred             cCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcch
Q 011250          277 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHN  355 (490)
Q Consensus       277 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~  355 (490)
                      +.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||......   .
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~  248 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---Q  248 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---H
T ss_pred             cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH---H
Confidence            9999999999999986644332222334567899999999999999999999999999999999 88998653211   1


Q ss_pred             hhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                      .......             .. ....+..++..+.+||.+||+.||.+|||+.+++++|+.+..
T Consensus       249 ~~~~~~~-------------~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          249 VLRFVME-------------GG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHHHHT-------------TC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHHHc-------------CC-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            1111100             00 011223447889999999999999999999999999987644

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.3e-46  Score=374.56  Aligned_cols=276  Identities=28%  Similarity=0.384  Sum_probs=217.9

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEe--
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE--  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--  210 (490)
                      ++|++.+.||+|+||.||+|++...+     ..++..||||++........+.+.+|+.+++.++||||+++++++..  
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   97 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLG-----DNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG   97 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTS-----SSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCC-----CCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence            57999999999999999999864321     12678999999987766666789999999999999999999999874  


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      ....+|||||+++++|.+++......+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~  174 (327)
T 3lxl_A           98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLA  174 (327)
T ss_dssp             SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred             CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccc
Confidence            45689999999999999999775567999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcc-eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh--hcccCCc
Q 011250          291 KDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA--RPHLGDK  367 (490)
Q Consensus       291 ~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~--~~~~~~~  367 (490)
                      ......... .......||+.|+|||++.+..++.++|||||||++|+|++|..||......    .....  .......
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~----~~~~~~~~~~~~~~  250 (327)
T 3lxl_A          175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE----FLRMMGCERDVPAL  250 (327)
T ss_dssp             EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHCC----CCHH
T ss_pred             eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch----hhhhcccccccccH
Confidence            876543322 1223356889999999999999999999999999999999999998542110    00000  0000000


Q ss_pred             chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                      ......+........+..++..+.+||.+||+.||.+|||+.+|+++|+.+..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  303 (327)
T 3lxl_A          251 SRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS  303 (327)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred             HHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            11111112222223344567899999999999999999999999999987754

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.6e-46  Score=377.06  Aligned_cols=254  Identities=25%  Similarity=0.374  Sum_probs=201.3

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCC--CCeeceee
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLH--PNLVKLVG  206 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~H--pnIv~l~~  206 (490)
                      ..++|++.+.||+|+||.||+|.+.          ++..||||++.....  ...+.+.+|+.+|..+.|  +||+++++
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~   76 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD   76 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECT----------TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeC----------CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEee
Confidence            4567999999999999999999774          466899999875533  334678899999999986  99999999


Q ss_pred             EEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEec
Q 011250          207 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~D  286 (490)
                      ++.+++..+||||+ .+++|.+++... ..+++..+..++.||+.||.|||+.+   |+||||||+||||+ ++.+||+|
T Consensus        77 ~~~~~~~~~lv~e~-~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~D  150 (343)
T 3dbq_A           77 YEITDQYIYMVMEC-GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLID  150 (343)
T ss_dssp             EEECSSEEEEEECC-CSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECC
T ss_pred             eEeeCCEEEEEEeC-CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEee
Confidence            99999999999995 588999999664 57999999999999999999999988   99999999999997 67899999


Q ss_pred             ccCcccCCCCCcceeeeccccCCCccCcchhcc-----------CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcch
Q 011250          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-----------GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN  355 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----------~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~  355 (490)
                      ||+++..............+||+.|+|||++.+           ..++.++|||||||+||||++|+.||......    
T Consensus       151 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----  226 (343)
T 3dbq_A          151 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----  226 (343)
T ss_dssp             CSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----
T ss_pred             cccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH----
Confidence            999987755433333345689999999999865           67899999999999999999999999643210    


Q ss_pred             hhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                       .          ..+...+++.....++...+..+.+||.+||+.||.+|||+.+++++.
T Consensus       227 -~----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          227 -I----------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             -H----------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             -H----------HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence             0          011122223333334444467899999999999999999999999874

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.2e-46  Score=371.21  Aligned_cols=246  Identities=26%  Similarity=0.296  Sum_probs=197.6

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcc-CCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~  209 (490)
                      ++|++.++||+|+||+||+|++..         ++..||||++.....  .....+..|+..+..+ .||||+++++++.
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~  127 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKE---------DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE  127 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETT---------TSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECC---------CCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE
Confidence            469999999999999999999876         577999999865432  2234456666666555 8999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +.+..+|||||+ +++|.+++......+++..++.|+.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus       128 ~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~  203 (311)
T 3p1a_A          128 EGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGL  203 (311)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTT
T ss_pred             eCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEcccee
Confidence            999999999999 77999999877778999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +........   .....||+.|+|||++.+ .++.++|||||||++|||++|..+|....     .......        
T Consensus       204 a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-----~~~~~~~--------  266 (311)
T 3p1a_A          204 LVELGTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-----GWQQLRQ--------  266 (311)
T ss_dssp             CEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----HHHHHTT--------
T ss_pred             eeecccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHhc--------
Confidence            987644322   234579999999998875 79999999999999999999977664311     1110000        


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                            ..+...++...+.++.+||.+||+.||.+|||+.+++++
T Consensus       267 ------~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          267 ------GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             ------TCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ------cCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence                  000011112236889999999999999999999999975

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.2e-46  Score=391.09  Aligned_cols=250  Identities=30%  Similarity=0.391  Sum_probs=199.2

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC---CcccHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD---GLQGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      .++|++.+.||+|+||.||+|.+..         +|..||||++...   .......+.+|+.+++.++||||+++++++
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~  217 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKA---------TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF  217 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcC---------CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEE
Confidence            4579999999999999999999876         6779999999754   223345678899999999999999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEEcCCCCeEEecc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlkp~NILl~~~~~vkL~DF  287 (490)
                      .+.+..+|||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+   ||||||||+||||+.++.+||+||
T Consensus       218 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DF  293 (446)
T 4ejn_A          218 QTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDF  293 (446)
T ss_dssp             EETTEEEEEECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCC
T ss_pred             eeCCEEEEEEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccC
Confidence            9999999999999999999998654 479999999999999999999998 77   999999999999999999999999


Q ss_pred             cCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011250          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      |+++.......  .....+||+.|+|||++.+..|+.++|||||||+||||++|+.||......   .+.....   .. 
T Consensus       294 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i~---~~-  364 (446)
T 4ejn_A          294 GLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELIL---ME-  364 (446)
T ss_dssp             CCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH---HC-
T ss_pred             CCceeccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHHHHH---hC-
Confidence            99986543322  224478999999999999999999999999999999999999999654221   1111110   00 


Q ss_pred             chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011250          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  414 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----t~~evl~~  414 (490)
                                 ...++...+.++.+||.+||+.||.+||     ++.++++|
T Consensus       365 -----------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          365 -----------EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             -----------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -----------CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence                       0112233478899999999999999999     99999875

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.6e-46  Score=367.39  Aligned_cols=274  Identities=29%  Similarity=0.421  Sum_probs=213.1

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      ++|++.+.||+|+||.||+|++...+.     .++..||||++.... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGD-----NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED   95 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSS-----SCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccC-----ccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence            358899999999999999998643221     268899999997543 23457789999999999999999999999877


Q ss_pred             --CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          212 --DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       212 --~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                        ...++||||+++|+|.+++......+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~  172 (302)
T 4e5w_A           96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGL  172 (302)
T ss_dssp             --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccc
Confidence              6689999999999999999777678999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcc-eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC--
Q 011250          290 AKDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD--  366 (490)
Q Consensus       290 a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~--  366 (490)
                      +......... .......||..|+|||++.+..++.++|||||||++|+|++|..|+.....    .......+....  
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~  248 (302)
T 4e5w_A          173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA----LFLKMIGPTHGQMT  248 (302)
T ss_dssp             CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH----HHHHHHCSCCGGGH
T ss_pred             cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh----HHhhccCCcccccC
Confidence            9877544322 223346788999999999999999999999999999999999988642210    000000000000  


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                      ...+...+........+...+..+.+||.+||+.||.+|||+.++++.|+.+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          249 VTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            0001111111112223345578999999999999999999999999999865

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=8.3e-46  Score=387.18  Aligned_cols=254  Identities=28%  Similarity=0.429  Sum_probs=210.6

Q ss_pred             HHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       129 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      .+..++|++.+.||+|+||.||+|.+.           +..||||+++...  ..+.+.+|+.+|+.++||||+++++++
T Consensus       189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~  255 (450)
T 1k9a_A          189 ALNMKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVI  255 (450)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccChHHeEEEeeecCcCCeeEEEEEec-----------CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEE
Confidence            345568999999999999999999874           4589999998654  446799999999999999999999998


Q ss_pred             EeCC-ceEEEEEecCCCChhHHhhhcCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEec
Q 011250          209 IEDD-QRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       209 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~D  286 (490)
                      .+.+ ..+||||||++|+|.+++..... .+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|
T Consensus       256 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~D  332 (450)
T 1k9a_A          256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSD  332 (450)
T ss_dssp             ECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECC
T ss_pred             EcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEee
Confidence            7765 78999999999999999976543 4799999999999999999999988   99999999999999999999999


Q ss_pred             ccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccC
Q 011250          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      ||+++......     ....+++.|+|||++.+..++.++|||||||+||||++ |+.||...........+   ..   
T Consensus       333 fG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i---~~---  401 (450)
T 1k9a_A          333 FGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV---EK---  401 (450)
T ss_dssp             CTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH---HT---
T ss_pred             CCCcccccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---Hc---
Confidence            99998653221     22367899999999999999999999999999999998 99999765432221111   10   


Q ss_pred             CcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                                 ......+..++..+.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus       402 -----------~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          402 -----------GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             -----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence                       01112234457899999999999999999999999999987654

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.2e-45  Score=370.56  Aligned_cols=268  Identities=25%  Similarity=0.392  Sum_probs=215.6

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcc-CCCCeeceeeEE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKLVGYC  208 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~  208 (490)
                      ..++|++.+.||+|+||.||+|.+...+.  ....++..||||++..... ...+.+.+|+.+++.+ +||||+++++++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  110 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  110 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCST--TCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccc--cccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence            34679999999999999999999864211  1123567899999976533 3346788999999999 899999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN  273 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~N  273 (490)
                      .+.+..+|||||+++|+|.+++....               ..+++..++.++.||+.||.|||+.+   |+||||||+|
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N  187 (334)
T 2pvf_A          111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN  187 (334)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred             ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccce
Confidence            99999999999999999999996543               24899999999999999999999988   9999999999


Q ss_pred             EEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCC
Q 011250          274 ILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNG  352 (490)
Q Consensus       274 ILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~  352 (490)
                      |||+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||...... 
T Consensus       188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-  266 (334)
T 2pvf_A          188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-  266 (334)
T ss_dssp             EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred             EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH-
Confidence            9999999999999999987755433333344567899999999998899999999999999999999 99999654211 


Q ss_pred             cchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          353 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                        .+.......              .....+..++..+.+||.+||..||.+||++.+|++.|+.+..
T Consensus       267 --~~~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~  318 (334)
T 2pvf_A          267 --ELFKLLKEG--------------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  318 (334)
T ss_dssp             --HHHHHHHHT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHHHHHhcC--------------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence              111111100              0111223447889999999999999999999999999987754

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=6.9e-46  Score=368.41  Aligned_cols=268  Identities=26%  Similarity=0.409  Sum_probs=203.8

Q ss_pred             hHHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeece
Q 011250          127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKL  204 (490)
Q Consensus       127 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l  204 (490)
                      ++....++|.+.+.||+|+||.||+|.+.....      ++..||||++.....  ...+.+.+|+.+++.++||||+++
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~  101 (313)
T 3brb_A           28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDG------TSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL  101 (313)
T ss_dssp             TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTS------CEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCC
T ss_pred             hcccCHHHeeeccceeecCCeEEEEEEEeccCC------ceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeee
Confidence            334456789999999999999999998875322      567899999976532  334678999999999999999999


Q ss_pred             eeEEEeCCc-----eEEEEEecCCCChhHHhhh-----cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcE
Q 011250          205 VGYCIEDDQ-----RLLVYEFMPRGSLENHLFR-----RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI  274 (490)
Q Consensus       205 ~~~~~~~~~-----~~lV~E~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NI  274 (490)
                      ++++.+.+.     .++||||+++|+|.+++..     ....+++..++.++.||+.||.|||+.+   |+||||||+||
T Consensus       102 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NI  178 (313)
T 3brb_A          102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNC  178 (313)
T ss_dssp             CEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGE
T ss_pred             eEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceE
Confidence            999987653     4999999999999999843     2356999999999999999999999988   99999999999


Q ss_pred             EEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCc
Q 011250          275 LLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGE  353 (490)
Q Consensus       275 Ll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~  353 (490)
                      |++.++.+||+|||+++...............|++.|+|||++.+..++.++|||||||++|+|++ |..||....... 
T Consensus       179 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-  257 (313)
T 3brb_A          179 MLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-  257 (313)
T ss_dssp             EECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-
T ss_pred             EEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH-
Confidence            999999999999999987654433333334567889999999999999999999999999999999 889986543221 


Q ss_pred             chhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                        ........              ....++...+..+.+||.+||..||.+|||+.+|+++|+.+..
T Consensus       258 --~~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~  308 (313)
T 3brb_A          258 --MYDYLLHG--------------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE  308 (313)
T ss_dssp             --HHHHHHTT--------------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHHHHHcC--------------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence              11111000              0011223346889999999999999999999999999987643

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.3e-46  Score=373.94  Aligned_cols=266  Identities=26%  Similarity=0.388  Sum_probs=215.5

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcc-CCCCeeceeeEE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKLVGYC  208 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~  208 (490)
                      ..++|.+.+.||+|+||.||+|.+...+..    .....||+|.+..... ...+.+.+|+.++..+ .||||+++++++
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKE----DAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSS----CCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcc----cchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            346799999999999999999998753221    1345899999976543 3446789999999999 899999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhc-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRR-------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  275 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~-------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NIL  275 (490)
                      .+.+..+|||||+++|+|.+++...             ...+++..++.++.||+.||.|||+.+   |+||||||+|||
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl  196 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL  196 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence            9999999999999999999998643             246899999999999999999999988   999999999999


Q ss_pred             EcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcc
Q 011250          276 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEH  354 (490)
Q Consensus       276 l~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~  354 (490)
                      ++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||........ 
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-  275 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-  275 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-
Confidence            99999999999999987654433333344668899999999999999999999999999999998 9999975432211 


Q ss_pred             hhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011250          355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~  419 (490)
                       .......              ......+...+..+.+||.+||+.||.+|||+.+|+++|+.+.
T Consensus       276 -~~~~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          276 -FYKLVKD--------------GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             -HHHHHHH--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHHHHhc--------------CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence             1111110              0111122233678999999999999999999999999998664

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=5.6e-46  Score=368.91  Aligned_cols=271  Identities=28%  Similarity=0.383  Sum_probs=217.6

Q ss_pred             hHHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcc-CCCCeece
Q 011250          127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKL  204 (490)
Q Consensus       127 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l  204 (490)
                      .+....++|++.+.||+|+||.||+|.+....    ...++..||||++..... ...+.+.+|+.++..+ +||||+++
T Consensus        21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSS----STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ceecchhheeeeeEEcCCCceeEEEEEEecCC----ccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            33445678999999999999999999875321    122678999999976543 3346789999999999 69999999


Q ss_pred             eeEEEeCC-ceEEEEEecCCCChhHHhhhcCC---------------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecC
Q 011250          205 VGYCIEDD-QRLLVYEFMPRGSLENHLFRRSL---------------PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRD  268 (490)
Q Consensus       205 ~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~---------------~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrD  268 (490)
                      ++++...+ ..++||||+++|+|.+++.....               .+++..++.++.||+.||.|||+.+   |+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence            99988765 48999999999999999975432               2889999999999999999999988   99999


Q ss_pred             CCCCcEEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCC
Q 011250          269 FKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDK  347 (490)
Q Consensus       269 lkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~  347 (490)
                      |||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            999999999999999999999987755444334445678999999999999999999999999999999998 9999975


Q ss_pred             CCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          348 NRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                      ......  ........              .....+...+..+.+||.+||+.||.+|||+.+|+++|+.+..
T Consensus       254 ~~~~~~--~~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  310 (316)
T 2xir_A          254 VKIDEE--FCRRLKEG--------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  310 (316)
T ss_dssp             CCCSHH--HHHHHHHT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cchhHH--HHHHhccC--------------ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            432211  11111100              0011122346789999999999999999999999999987643

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.2e-45  Score=384.74  Aligned_cols=268  Identities=23%  Similarity=0.324  Sum_probs=189.6

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      .++|++.+.||+|+||+||+|++..         ++..||||++....  ....+.+.+|+.+|+.|+|||||++++++.
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  122 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKL---------EKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVI  122 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC-----------CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECC---------CCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence            3579999999999999999999876         67799999996542  334567899999999999999999999985


Q ss_pred             eC-----CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 011250          210 ED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       210 ~~-----~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL  284 (490)
                      ..     ..+||||||+ +++|.+++.. ...+++..+..|+.||+.||+|||+.+   ||||||||+||||+.++.+||
T Consensus       123 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl  197 (458)
T 3rp9_A          123 PKDVEKFDELYVVLEIA-DSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKV  197 (458)
T ss_dssp             CSCTTTCCCEEEEECCC-SEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEE
T ss_pred             cCCcccCceEEEEEecc-ccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEee
Confidence            43     4689999998 6799998854 457999999999999999999999988   999999999999999999999


Q ss_pred             ecccCcccCCCCCcc-------------------------eeeeccccCCCccCcchh-ccCCCCccchhhHHHHHHHHH
Q 011250          285 SDFGLAKDAPEDGKT-------------------------HVSTRVMGTYGYAAPEYV-MTGHLTSKSDVYSFGVVLLEM  338 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~-------------------------~~~~~~~Gt~~y~aPE~l-~~~~~~~~sDvwSlGv~l~el  338 (490)
                      +|||+++........                         ...+..+||+.|+|||++ ....|+.++|||||||+||||
T Consensus       198 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~el  277 (458)
T 3rp9_A          198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL  277 (458)
T ss_dssp             CCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred             cccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHH
Confidence            999999876432110                         123446899999999976 456799999999999999999


Q ss_pred             Hh-----------CCCCCCCCCCCCc-----------------chhhHhhhcccCCc-------------chhhhccCC-
Q 011250          339 LT-----------GRRSMDKNRPNGE-----------------HNLVEWARPHLGDK-------------RRFYRLLDP-  376 (490)
Q Consensus       339 lt-----------G~~pf~~~~~~~~-----------------~~~~~~~~~~~~~~-------------~~~~~~~~~-  376 (490)
                      ++           |+++|.+......                 ..........++..             ..+...+.. 
T Consensus       278 ltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~  357 (458)
T 3rp9_A          278 LNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKR  357 (458)
T ss_dssp             HTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCC
T ss_pred             HHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCC
Confidence            99           6666654331100                 00000000000000             000000000 


Q ss_pred             ---ccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          377 ---RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       377 ---~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                         .+... ....+.++.+||.+||..||.+|||++|+|+|
T Consensus       358 ~~~~~~~~-~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H  397 (458)
T 3rp9_A          358 EGTDLAER-FPASSADAIHLLKRMLVFNPNKRITINECLAH  397 (458)
T ss_dssp             CCCCGGGG-STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCCHHHH-CCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence               00111 12337889999999999999999999999986

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.7e-45  Score=362.89  Aligned_cols=261  Identities=26%  Similarity=0.380  Sum_probs=201.0

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhc--cCCCCeeceeeEEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGN--LLHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~  209 (490)
                      .++|++.+.||+|+||.||+|.+           ++..||||++...   ....+..|.+++..  ++||||+++++++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~   72 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-----------QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDM   72 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-----------CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeec
Confidence            45799999999999999999987           3568999998654   34556667777666  78999999999876


Q ss_pred             eC----CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhh--------hcCCCCeeecCCCCCcEEEc
Q 011250          210 ED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH--------EEAEKPVIYRDFKTSNILLD  277 (490)
Q Consensus       210 ~~----~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH--------~~~~~~iiHrDlkp~NILl~  277 (490)
                      ..    ...++||||+++|+|.+++..  ..+++..++.++.||+.||.|||        +.+   |+||||||+||||+
T Consensus        73 ~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~  147 (301)
T 3q4u_A           73 TSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVK  147 (301)
T ss_dssp             EEETTEEEEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEEC
T ss_pred             cccCCCceeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEc
Confidence            53    457999999999999999943  46999999999999999999999        666   99999999999999


Q ss_pred             CCCCeEEecccCcccCCCCCcce--eeeccccCCCccCcchhccC------CCCccchhhHHHHHHHHHHhC--------
Q 011250          278 ADYNAKLSDFGLAKDAPEDGKTH--VSTRVMGTYGYAAPEYVMTG------HLTSKSDVYSFGVVLLEMLTG--------  341 (490)
Q Consensus       278 ~~~~vkL~DFG~a~~~~~~~~~~--~~~~~~Gt~~y~aPE~l~~~------~~~~~sDvwSlGv~l~elltG--------  341 (490)
                      .++.+||+|||+++.........  .....+||+.|+|||++.+.      .++.++|||||||++|||++|        
T Consensus       148 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~  227 (301)
T 3q4u_A          148 KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE  227 (301)
T ss_dssp             TTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred             CCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccc
Confidence            99999999999997654432221  12235799999999999876      455799999999999999999        


Q ss_pred             --CCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCcc-CCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          342 --RRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRL-EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       342 --~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                        ..||............ ........      ...+.+ ...++...+..+.+|+.+||+.||.+|||+.+|++.|+.+
T Consensus       228 ~~~~pf~~~~~~~~~~~~-~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          228 DYKPPFYDVVPNDPSFED-MRKVVCVD------QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CCCCTTTTTSCSSCCHHH-HHHHHTTS------CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccccccccCCCCcchhh-hhHHHhcc------CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence              7787654333221111 00000000      000111 1112234578999999999999999999999999999865

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=9.1e-46  Score=361.89  Aligned_cols=262  Identities=27%  Similarity=0.388  Sum_probs=210.9

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ..++|.+.+.||+|+||.||+|.+....      +++..||||.+.... ....+.+.+|+.+++.++||||+++++++.
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   83 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHK------GEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE   83 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTT------CCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCC------CCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence            3457999999999999999999886532      245679999997653 334567899999999999999999999976


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      + +..++||||+++++|.+++......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        84 ~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~  159 (281)
T 3cc6_A           84 E-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGL  159 (281)
T ss_dssp             S-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCG
T ss_pred             C-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCC
Confidence            5 4678999999999999999877777999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +......... ......||+.|+|||++.+..++.++|||||||++|+|++ |+.||........   .......     
T Consensus       160 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~---~~~~~~~-----  230 (281)
T 3cc6_A          160 SRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV---IGVLEKG-----  230 (281)
T ss_dssp             GGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH---HHHHHHT-----
T ss_pred             Cccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH---HHHHhcC-----
Confidence            9876543221 1233567889999999999999999999999999999998 9999965432211   1111100     


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                               .....+...+..+.+||.+||..||.+||++.+++++|+.+..
T Consensus       231 ---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          231 ---------DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence                     0011122346789999999999999999999999999987754

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=7.5e-46  Score=370.06  Aligned_cols=251  Identities=24%  Similarity=0.423  Sum_probs=198.1

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      ++|++.+.||+|+||.||+|++..         ++..||||++..... ...+.+.+|+.+|+.|+||||++++++|.+.
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   76 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKV---------DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLET   76 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETT---------TCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEEC
T ss_pred             hcCceeeEecCCCCeEEEEEEEcC---------CCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEe
Confidence            469999999999999999999876         577999999975433 3456789999999999999999999998765


Q ss_pred             Cc---------------------------------------------------------eEEEEEecCCCChhHHhhhcC
Q 011250          212 DQ---------------------------------------------------------RLLVYEFMPRGSLENHLFRRS  234 (490)
Q Consensus       212 ~~---------------------------------------------------------~~lV~E~~~~gsL~~~l~~~~  234 (490)
                      ..                                                         .++|||||++|+|.+++....
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~  156 (332)
T 3qd2_B           77 PPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC  156 (332)
T ss_dssp             CSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC
T ss_pred             ccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc
Confidence            42                                                         799999999999999996543


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCCCcc----------eee
Q 011250          235 --LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT----------HVS  302 (490)
Q Consensus       235 --~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~----------~~~  302 (490)
                        ...++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++........          ...
T Consensus       157 ~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T 3qd2_B          157 SLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH  233 (332)
T ss_dssp             SGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CC
T ss_pred             CccchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccc
Confidence              23566778999999999999999988   999999999999999999999999999876543211          112


Q ss_pred             eccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCC
Q 011250          303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHF  382 (490)
Q Consensus       303 ~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  382 (490)
                      ...+||+.|+|||++.+..++.++|||||||++|||++|..|+...     ........             ...+ ...
T Consensus       234 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~~~~~~~~-------------~~~~-~~~  294 (332)
T 3qd2_B          234 TGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----VRIITDVR-------------NLKF-PLL  294 (332)
T ss_dssp             CSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----HHHHHHHH-------------TTCC-CHH
T ss_pred             cccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----HHHHHHhh-------------ccCC-Ccc
Confidence            3457999999999999999999999999999999999987664210     00000000             0000 000


Q ss_pred             ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          383 SIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       383 ~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ....+..+.+||.+||+.||.+|||+.+++++
T Consensus       295 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          295 FTQKYPQEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             cccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence            12235677999999999999999999999975

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1e-45  Score=375.74  Aligned_cols=274  Identities=17%  Similarity=0.235  Sum_probs=210.0

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccH-----------HHHHHHHHHHhccCCCC
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-----------KEWLAEVNFLGNLLHPN  200 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~Ei~il~~l~Hpn  200 (490)
                      .++|++.+.||+|+||.||+|.+.....    ...+..||||++........           ..+..|+..+..+.|||
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~  109 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSES----VGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLG  109 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSC----CCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCC
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccc----cccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCC
Confidence            4579999999999999999998875322    12457899999876542211           23455677788889999


Q ss_pred             eeceeeEEEeC----CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE
Q 011250          201 LVKLVGYCIED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL  276 (490)
Q Consensus       201 Iv~l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl  276 (490)
                      |+++++++...    ...+|||||+ +++|.+++......+++..++.|+.||+.||.|||+.+   |+||||||+||||
T Consensus       110 iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill  185 (364)
T 3op5_A          110 VPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLL  185 (364)
T ss_dssp             SCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred             CCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEE
Confidence            99999998875    4589999999 99999999877678999999999999999999999988   9999999999999


Q ss_pred             c--CCCCeEEecccCcccCCCCCcce-----eeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCC
Q 011250          277 D--ADYNAKLSDFGLAKDAPEDGKTH-----VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR  349 (490)
Q Consensus       277 ~--~~~~vkL~DFG~a~~~~~~~~~~-----~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~  349 (490)
                      +  .++.+||+|||+++.........     .....+||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus       186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~  265 (364)
T 3op5_A          186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL  265 (364)
T ss_dssp             ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence            8  88999999999998764322111     1123569999999999999999999999999999999999999997533


Q ss_pred             CCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          350 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                      ....  .........  ...+..++++.+.   ...++.++.+|+.+||..||.+||++.+|++.|+.+..
T Consensus       266 ~~~~--~~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  329 (364)
T 3op5_A          266 KDPK--YVRDSKIRY--RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK  329 (364)
T ss_dssp             TCHH--HHHHHHHHH--HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             cCHH--HHHHHHHHh--hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence            2211  111111100  0011112221111   11236889999999999999999999999999987644

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4e-46  Score=390.02  Aligned_cols=260  Identities=27%  Similarity=0.413  Sum_probs=212.9

Q ss_pred             HHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeE
Q 011250          128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (490)
Q Consensus       128 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  207 (490)
                      +.+..++|.+.+.||+|+||.||+|.+.          .+..||||+++... ...+.+.+|+.+|+.|+|||||+++++
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~----------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~  251 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYN----------KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV  251 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEET----------TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEEC----------CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEE
Confidence            3445568999999999999999999885          35579999998654 456789999999999999999999999


Q ss_pred             EEeCCceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEec
Q 011250          208 CIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~D  286 (490)
                      +. .+..+||||||++|+|.+++... ...+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|
T Consensus       252 ~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~D  327 (454)
T 1qcf_A          252 VT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIAD  327 (454)
T ss_dssp             EC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECS
T ss_pred             Ee-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEee
Confidence            86 66789999999999999999643 236889999999999999999999988   99999999999999999999999


Q ss_pred             ccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccC
Q 011250          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      ||+++....... .......+|+.|+|||++....++.++|||||||+||||++ |+.||......   .+.......  
T Consensus       328 FG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i~~~--  401 (454)
T 1qcf_A          328 FGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRALERG--  401 (454)
T ss_dssp             TTGGGGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHHHHT--
T ss_pred             CCCceEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcC--
Confidence            999987643211 11223456889999999999999999999999999999999 99999754221   111111100  


Q ss_pred             CcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                                  .....+..++..+.+||.+||..||.+|||+.+|++.|+.+..
T Consensus       402 ------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          402 ------------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             ------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             ------------CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence                        0111223457889999999999999999999999999998754

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.3e-46  Score=359.62  Aligned_cols=257  Identities=28%  Similarity=0.437  Sum_probs=213.1

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      .++|++.+.||+|+||.||+|.+.          ++..||+|++..... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   75 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ   75 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             hhheeeeeEecCCCceeEEEEEec----------CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            457999999999999999999885          345799999986643 346789999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      +..++||||+++++|.+++......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        76 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~  152 (267)
T 3t9t_A           76 APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTR  152 (267)
T ss_dssp             SSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGG
T ss_pred             CCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccc
Confidence            9999999999999999999877677999999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ...... ........||..|+|||++.+..++.++||||||+++|+|++ |..||......   .........       
T Consensus       153 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~i~~~-------  221 (267)
T 3t9t_A          153 FVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVEDISTG-------  221 (267)
T ss_dssp             GBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHTT-------
T ss_pred             cccccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH---HHHHHHhcC-------
Confidence            764321 111223567889999999998999999999999999999999 89999754211   111111100       


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                             .....+...+..+.+|+.+||+.||.+||++.+++++|+.+..
T Consensus       222 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          222 -------FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             -------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                   0011122336789999999999999999999999999987754

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=6.8e-46  Score=368.61  Aligned_cols=256  Identities=24%  Similarity=0.340  Sum_probs=196.8

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      .++|++.+.||+|+||.||+|++..         ++..||||++......   ....+.+|+.++..++||||+++++++
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   81 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLR---------DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG   81 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECC---------CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEee
Confidence            3579999999999999999999876         6779999999765332   235688999999999999999999998


Q ss_pred             EeCCce----EEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 011250          209 IEDDQR----LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       209 ~~~~~~----~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL  284 (490)
                      ......    ||||||+++++|.+++... ..+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||
T Consensus        82 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl  157 (311)
T 3ork_A           82 EAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKV  157 (311)
T ss_dssp             EEEETTEEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEE
T ss_pred             eccCCCCcccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEE
Confidence            876543    9999999999999999654 47999999999999999999999988   999999999999999999999


Q ss_pred             ecccCcccCCCCCcc-eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011250          285 SDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      +|||+++........ ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........  ....... 
T Consensus       158 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~--~~~~~~~-  234 (311)
T 3ork_A          158 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--AYQHVRE-  234 (311)
T ss_dssp             CCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHC-
T ss_pred             eeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHhcC-
Confidence            999999876543221 122346799999999999999999999999999999999999999975432111  0000000 


Q ss_pred             cCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                         .......        .....+.++.+||.+||+.||.+||+..+++.+
T Consensus       235 ---~~~~~~~--------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~  274 (311)
T 3ork_A          235 ---DPIPPSA--------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRA  274 (311)
T ss_dssp             ---CCCCHHH--------HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             ---CCCCccc--------ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence               0000000        011236789999999999999999977766643

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-45  Score=368.63  Aligned_cols=264  Identities=25%  Similarity=0.424  Sum_probs=207.3

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ..+|.+.+.||+|+||.||+|.+...+.     ..+..||||++..... .....+.+|+.+++.++||||+++++++.+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  117 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSG-----KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK  117 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCC-----CccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence            4578889999999999999999875321     1345799999976532 334578899999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      .+..+|||||+++|+|.+++......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~  194 (333)
T 1mqb_A          118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLS  194 (333)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcc
Confidence            99999999999999999999877678999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcce-eeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          291 KDAPEDGKTH-VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       291 ~~~~~~~~~~-~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +......... ......||+.|+|||++.+..++.++|||||||++|||++ |+.||......   .+.......     
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~~~~~~~-----  266 (333)
T 1mqb_A          195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EVMKAINDG-----  266 (333)
T ss_dssp             ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHTT-----
T ss_pred             hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHCC-----
Confidence            8765432211 1123456889999999999999999999999999999999 99999653221   111111100     


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                               .....+..++..+.+||.+||+.||.+||++.+|++.|+.+..
T Consensus       267 ---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  309 (333)
T 1mqb_A          267 ---------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  309 (333)
T ss_dssp             ---------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ---------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                     0111223447889999999999999999999999999987654

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.9e-45  Score=376.88  Aligned_cols=268  Identities=21%  Similarity=0.269  Sum_probs=206.2

Q ss_pred             cCCCCCcccccC--CceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          133 RNFRPESLLGEG--GFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       133 ~~y~~~~~LG~G--~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      ++|++.++||+|  +||.||+|++..         ++..||||++.....  ...+.+.+|+.+++.++|||||++++++
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~   95 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLARYKP---------TGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF   95 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CcEEEEecccCCcCCceEEEEEEEcC---------CCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEE
Confidence            479999999999  999999999876         677999999976532  3345688899999999999999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DF  287 (490)
                      .+++..+||||||++|+|.+++... ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+||
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~df  172 (389)
T 3gni_B           96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGL  172 (389)
T ss_dssp             EETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCG
T ss_pred             EECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccc
Confidence            9999999999999999999998654 356999999999999999999999988   999999999999999999999999


Q ss_pred             cCcccCCCCCcc-----eeeeccccCCCccCcchhcc--CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011250          288 GLAKDAPEDGKT-----HVSTRVMGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       288 G~a~~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~--~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~  360 (490)
                      |++.........     ......+||+.|+|||++.+  ..++.++|||||||++|||++|+.||..........  ...
T Consensus       173 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~  250 (389)
T 3gni_B          173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL--EKL  250 (389)
T ss_dssp             GGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH--HC-
T ss_pred             ccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHh
Confidence            998654322111     11123479999999999987  579999999999999999999999997643322111  100


Q ss_pred             hcccC---Ccch------------------hhhcc---------CCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHH
Q 011250          361 RPHLG---DKRR------------------FYRLL---------DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE  410 (490)
Q Consensus       361 ~~~~~---~~~~------------------~~~~~---------~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~e  410 (490)
                      .....   +...                  +...+         .......++...+..+.+||.+||+.||.+|||+.+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e  330 (389)
T 3gni_B          251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAST  330 (389)
T ss_dssp             -------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred             cCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHH
Confidence            00000   0000                  00000         000001122334678999999999999999999999


Q ss_pred             HHHH
Q 011250          411 VVET  414 (490)
Q Consensus       411 vl~~  414 (490)
                      ++++
T Consensus       331 ll~h  334 (389)
T 3gni_B          331 LLNH  334 (389)
T ss_dssp             HTTS
T ss_pred             HhcC
Confidence            9976

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.6e-46  Score=360.93  Aligned_cols=250  Identities=27%  Similarity=0.415  Sum_probs=187.7

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|++.+.||+|+||.||+|.+..         ++..||||++.....   ...+.+.+|+.+++.++||||+++++++.
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   81 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIH---------TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE   81 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEcc---------CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc
Confidence            469999999999999999999865         577899999864321   22467889999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +.+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        82 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~  158 (278)
T 3cok_A           82 DSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGL  158 (278)
T ss_dssp             CSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTT
T ss_pred             cCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecc
Confidence            999999999999999999999776678999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +.........  .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........      ..     
T Consensus       159 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------~~-----  225 (278)
T 3cok_A          159 ATQLKMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK------VV-----  225 (278)
T ss_dssp             CEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CC-----
T ss_pred             eeeccCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH------Hh-----
Confidence            9876432221  2235799999999999988999999999999999999999999975432211100      00     


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                           ...  ...+...+.++.+||.+||+.||.+|||+.+++++
T Consensus       226 -----~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          226 -----LAD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             -----SSC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             -----hcc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence                 000  01122346789999999999999999999999875

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.3e-45  Score=378.58  Aligned_cols=252  Identities=25%  Similarity=0.375  Sum_probs=200.5

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccC--CCCeeceeeEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLL--HPNLVKLVGYC  208 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~--HpnIv~l~~~~  208 (490)
                      ++|++.+.||+|+||.||+|.+.          ++..||||++.....  ...+.+.+|+.+|..|.  ||||+++++++
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~----------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~  125 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE  125 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECT----------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcC----------CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEE
Confidence            46999999999999999999864          356899999976532  34467899999999997  59999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      ..++.+||||| +.+++|.+++... ..+++..+..|+.||+.||.|||+.+   |+||||||+||||+ ++.+||+|||
T Consensus       126 ~~~~~~~lv~E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG  199 (390)
T 2zmd_A          126 ITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFG  199 (390)
T ss_dssp             ECSSEEEEEEE-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCS
T ss_pred             ecCCEEEEEEe-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecC
Confidence            99999999999 5588999999665 47899999999999999999999988   99999999999995 5899999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhcc-----------CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-----------GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV  357 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----------~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~  357 (490)
                      +++..............+||+.|+|||++.+           ..++.++|||||||+||||++|+.||......     .
T Consensus       200 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~  274 (390)
T 2zmd_A          200 IANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----I  274 (390)
T ss_dssp             SSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----H
T ss_pred             ccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----H
Confidence            9987754433333345689999999999865           46899999999999999999999999643211     0


Q ss_pred             HhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          358 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                      .          .+..++++.....++...+..+.+||.+||+.||.+|||+.+|+++.
T Consensus       275 ~----------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp  322 (390)
T 2zmd_A          275 S----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  322 (390)
T ss_dssp             H----------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             H----------HHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence            0          11122222222233333467899999999999999999999999764

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=4.1e-45  Score=363.16  Aligned_cols=266  Identities=26%  Similarity=0.315  Sum_probs=201.0

Q ss_pred             cCCCCC-cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcc-CCCCeeceeeEEEe
Q 011250          133 RNFRPE-SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~-~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~  210 (490)
                      +.|.+. ++||+|+||.||+|.+..         ++..||||++..........+.+|+.++.++ .||||+++++++.+
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~   82 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLI---------TSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE   82 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSS---------SCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcC---------CCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            468884 789999999999998765         5779999999876656677899999999985 69999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCC---eEEecc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN---AKLSDF  287 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~---vkL~DF  287 (490)
                      ++..+|||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.   +||+||
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Df  158 (316)
T 2ac3_A           83 EDRFYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDF  158 (316)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCT
T ss_pred             CCEEEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEc
Confidence            99999999999999999999665 46999999999999999999999988   999999999999988765   999999


Q ss_pred             cCcccCCCCCc-----ceeeeccccCCCccCcchhcc-----CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 011250          288 GLAKDAPEDGK-----THVSTRVMGTYGYAAPEYVMT-----GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV  357 (490)
Q Consensus       288 G~a~~~~~~~~-----~~~~~~~~Gt~~y~aPE~l~~-----~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~  357 (490)
                      |++........     .......+||+.|+|||++..     ..++.++|||||||++|||++|+.||............
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~  238 (316)
T 2ac3_A          159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR  238 (316)
T ss_dssp             TCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC--
T ss_pred             cCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc
Confidence            99976542211     111223569999999999875     56889999999999999999999999765433211000


Q ss_pred             HhhhcccCCcchhhhccCCccCCCCC----hhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          358 EWARPHLGDKRRFYRLLDPRLEGHFS----IKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~l~~~~~----~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ....+.. ....+..+.....  .++    ...+..+.+||.+||+.||.+|||+.+++++
T Consensus       239 ~~~~~~~-~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          239 GEACPAC-QNMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             --CCHHH-HHHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             cccchhH-HHHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            0000000 0000000000000  111    1236789999999999999999999999986

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.3e-45  Score=379.86  Aligned_cols=252  Identities=22%  Similarity=0.265  Sum_probs=195.1

Q ss_pred             cCCCCC-cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHh-ccCCCCeeceeeEEEe
Q 011250          133 RNFRPE-SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG-NLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~-~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~  210 (490)
                      ++|.+. ++||+|+||+||+|++..         ++..||||++...     ..+.+|+.++. .++||||+++++++..
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~---------~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~  126 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKR---------TQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYEN  126 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECC---------CCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEee
Confidence            457666 789999999999999876         6779999998632     45678888874 4579999999999876


Q ss_pred             ----CCceEEEEEecCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CCCe
Q 011250          211 ----DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNA  282 (490)
Q Consensus       211 ----~~~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~---~~~v  282 (490)
                          ...+|||||||++|+|.+++.... ..+++..+..|+.||+.||.|||+.+   ||||||||+||||+.   ++.+
T Consensus       127 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~  203 (400)
T 1nxk_A          127 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAIL  203 (400)
T ss_dssp             EETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCE
T ss_pred             cccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccE
Confidence                567899999999999999997643 46999999999999999999999988   999999999999987   7899


Q ss_pred             EEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcch-hhHhhh
Q 011250          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWAR  361 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~-~~~~~~  361 (490)
                      ||+|||+++......   .....+||+.|+|||++.+..|+.++|||||||+||||++|+.||.......... ......
T Consensus       204 kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~  280 (400)
T 1nxk_A          204 KLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR  280 (400)
T ss_dssp             EECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH
T ss_pred             EEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH
Confidence            999999998764322   1234689999999999999999999999999999999999999997654322110 111110


Q ss_pred             cccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                      ..   .        ..+........+.++.+||.+||+.||.+|||+.+|+++-
T Consensus       281 ~~---~--------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  323 (400)
T 1nxk_A          281 MG---Q--------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  323 (400)
T ss_dssp             HT---C--------CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             cC---c--------ccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            00   0        0000001123478899999999999999999999999874

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-45  Score=362.40  Aligned_cols=261  Identities=25%  Similarity=0.382  Sum_probs=212.0

Q ss_pred             hcCCCCCc-ccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          132 TRNFRPES-LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~-~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      .++|.+.+ .||+|+||.||+|.+....       ++..||||++..... ...+.+.+|+.+++.++||||+++++++ 
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-   79 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRK-------KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-   79 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCC-------CcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-
Confidence            34566766 9999999999999875321       567899999987532 3456789999999999999999999998 


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      ..+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~  156 (287)
T 1u59_A           80 QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGL  156 (287)
T ss_dssp             ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTT
T ss_pred             cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccc
Confidence            556789999999999999999776677999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcc-eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCc
Q 011250          290 AKDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       290 a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      +......... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||......   .........    
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~i~~~----  229 (287)
T 1u59_A          157 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIEQG----  229 (287)
T ss_dssp             CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHHHHTT----
T ss_pred             eeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHhcC----
Confidence            9876543222 11223457899999999998899999999999999999998 99999754321   111111100    


Q ss_pred             chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                                ....++..++..+.+||.+||..||.+||++.+++++|+.+..
T Consensus       230 ----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  272 (287)
T 1u59_A          230 ----------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  272 (287)
T ss_dssp             ----------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----------CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                      0112233457899999999999999999999999999987643

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.8e-46  Score=380.75  Aligned_cols=268  Identities=23%  Similarity=0.329  Sum_probs=195.6

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC--CcccHHHHHHHHHHHhccC-CCCeeceeeE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLL-HPNLVKLVGY  207 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~  207 (490)
                      ..++|++.+.||+|+||.||+|.+..         ++..||||++...  .....+.+.+|+.+|..+. ||||++++++
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~   77 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRR---------TGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNV   77 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETT---------TCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECC---------CCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeE
Confidence            34689999999999999999999876         6779999998654  2334567889999999997 9999999999


Q ss_pred             EEeCC--ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEe
Q 011250          208 CIEDD--QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       208 ~~~~~--~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~  285 (490)
                      +...+  .+|||||||+ ++|..++..  ..+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+
T Consensus        78 ~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~  151 (388)
T 3oz6_A           78 LRADNDRDVYLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVA  151 (388)
T ss_dssp             EECTTSSCEEEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEEC
T ss_pred             EecCCCCEEEEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEec
Confidence            98654  6899999996 699998855  36999999999999999999999988   9999999999999999999999


Q ss_pred             cccCcccCCCCC-------------------cceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCC
Q 011250          286 DFGLAKDAPEDG-------------------KTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSM  345 (490)
Q Consensus       286 DFG~a~~~~~~~-------------------~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf  345 (490)
                      |||+++......                   .....+..+||+.|+|||++.+ ..|+.++|||||||+||||++|++||
T Consensus       152 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf  231 (388)
T 3oz6_A          152 DFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF  231 (388)
T ss_dssp             CCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             CCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC
Confidence            999998653211                   1112244689999999999876 67999999999999999999999999


Q ss_pred             CCCCCCCcchhhHhhhcccCCcchhhhcc------------------CCccCCC------------CChhhHHHHHHHHH
Q 011250          346 DKNRPNGEHNLVEWARPHLGDKRRFYRLL------------------DPRLEGH------------FSIKGSQKATQLAA  395 (490)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~l~~~------------~~~~~~~~l~~Li~  395 (490)
                      ...........+.... ..+....+..+.                  .......            ....++.++.+||.
T Consensus       232 ~~~~~~~~~~~i~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~  310 (388)
T 3oz6_A          232 PGSSTMNQLERIIGVI-DFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLD  310 (388)
T ss_dssp             CCSSHHHHHHHHHHHH-CCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHhc-CCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHH
Confidence            7653221111110000 000000000000                  0000000            01133678999999


Q ss_pred             HhhhcCCCCCCCHHHHHHH
Q 011250          396 QCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       396 ~cL~~dP~~RPt~~evl~~  414 (490)
                      +||+.||.+|||+.|+++|
T Consensus       311 ~~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          311 KLLQFNPNKRISANDALKH  329 (388)
T ss_dssp             HHCCSSGGGSCCHHHHTTS
T ss_pred             HhhccCcccCCCHHHHhCC
Confidence            9999999999999999987

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=6.1e-46  Score=378.69  Aligned_cols=247  Identities=28%  Similarity=0.369  Sum_probs=195.6

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHH-HhccCCCCeeceeeEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNF-LGNLLHPNLVKLVGYC  208 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~  208 (490)
                      ++|++.+.||+|+||.||+|++..         ++..||||++.+...   .....+..|..+ ++.++||||+++++++
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~  108 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKA---------EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF  108 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETT---------TCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE
Confidence            469999999999999999999876         677899999976543   223456777776 5778999999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      .+.+.+||||||++||+|.+++.+. ..+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||
T Consensus       109 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG  184 (373)
T 2r5t_A          109 QTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFG  184 (373)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCc
Confidence            9999999999999999999998654 46899999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|..||......   .+..   ..     
T Consensus       185 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~---~i-----  251 (373)
T 2r5t_A          185 LCKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYD---NI-----  251 (373)
T ss_dssp             BCGGGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH---HHHH---HH-----
T ss_pred             cccccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---HHHH---HH-----
Confidence            9986433221  234578999999999999999999999999999999999999999653211   1111   10     


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV  412 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl  412 (490)
                           +...  ..++...+..+.+||.+||+.||.+||++.+.+
T Consensus       252 -----~~~~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          252 -----LNKP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             -----HHSC--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             -----Hhcc--cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence                 0000  012233478899999999999999999985433

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.6e-45  Score=371.50  Aligned_cols=253  Identities=23%  Similarity=0.339  Sum_probs=204.2

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcc-CCCCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~  210 (490)
                      .++|++.+.||+|+||.||+|.+..         ++..||||++......    ..+|++++.++ .||||+++++++.+
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~   87 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKA---------TNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDD   87 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEc
Confidence            3569999999999999999999876         6789999999765432    34688888888 69999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC----CCeEEec
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD----YNAKLSD  286 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~----~~vkL~D  286 (490)
                      ++..|||||||++|+|.+++... ..+++..+..++.||+.||.|||+.+   |+||||||+|||+..+    +.+||+|
T Consensus        88 ~~~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~D  163 (342)
T 2qr7_A           88 GKYVYVVTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICD  163 (342)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEE
Confidence            99999999999999999998654 47999999999999999999999988   9999999999998433    3599999


Q ss_pred             ccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011250          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      ||+++.......  .....+||+.|+|||++.+..|+.++|||||||++|||++|..||..........+.......   
T Consensus       164 fg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~---  238 (342)
T 2qr7_A          164 FGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG---  238 (342)
T ss_dssp             CTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC---
T ss_pred             CCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC---
Confidence            999987644322  223468999999999998888999999999999999999999999754322222222111100   


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                              ...+...+....+.++.+||.+||..||.+||++.+++++
T Consensus       239 --------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          239 --------KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             --------CCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             --------CcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                    0011112223347889999999999999999999999875

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.1e-45  Score=356.28  Aligned_cols=254  Identities=24%  Similarity=0.334  Sum_probs=206.6

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      .++|.+.+.||+|+||.||+|++.           +..||||++.....  ...+.+.+|+.+++.++||||+++++++.
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   77 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-----------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ   77 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEEC
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-----------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEc
Confidence            357999999999999999999874           45799999976542  33467899999999999999999999998


Q ss_pred             eC--CceEEEEEecCCCChhHHhhhcCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEec
Q 011250          210 ED--DQRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       210 ~~--~~~~lV~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~D  286 (490)
                      +.  ...++||||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.++|+|
T Consensus        78 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~  156 (271)
T 3kmu_A           78 SPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISM  156 (271)
T ss_dssp             TTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEG
T ss_pred             cCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEe
Confidence            87  788999999999999999976543 5899999999999999999999865 4599999999999999999999999


Q ss_pred             ccCcccCCCCCcceeeeccccCCCccCcchhccCCCCc---cchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011250          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS---KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~---~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      ||++.....       ....||+.|+|||++.+..++.   ++|||||||++|||++|+.||........   ...    
T Consensus       157 ~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~----  222 (271)
T 3kmu_A          157 ADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI---GMK----  222 (271)
T ss_dssp             GGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH---HHH----
T ss_pred             ccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH---HHH----
Confidence            998765322       2346899999999998765544   89999999999999999999965421111   000    


Q ss_pred             cCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                               .........++...+..+.+|+.+||+.||.+|||+.++++.|+.+.+
T Consensus       223 ---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          223 ---------VALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             ---------HHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             ---------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                     000111112233447889999999999999999999999999987753

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=364.85  Aligned_cols=269  Identities=25%  Similarity=0.329  Sum_probs=202.0

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-----ccHHHHHHHHHHHhccC---CCCe
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLAEVNFLGNLL---HPNL  201 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~Ei~il~~l~---HpnI  201 (490)
                      ...++|++.+.||+|+||+||+|++..         ++..||||++.....     .....+.+|+.+++.+.   ||||
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni   76 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPH---------SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV   76 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTT---------TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTB
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCe
Confidence            345789999999999999999998765         677999999864321     12245677888777765   9999


Q ss_pred             eceeeEEEeCC-----ceEEEEEecCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 011250          202 VKLVGYCIEDD-----QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  275 (490)
Q Consensus       202 v~l~~~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NIL  275 (490)
                      +++++++....     ..++||||+. ++|.+++.... ..+++..++.++.||+.||+|||+.+   |+||||||+|||
T Consensus        77 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil  152 (308)
T 3g33_A           77 VRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENIL  152 (308)
T ss_dssp             CCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEE
T ss_pred             EEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEE
Confidence            99999998765     4799999996 69999986654 24999999999999999999999988   999999999999


Q ss_pred             EcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcch
Q 011250          276 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN  355 (490)
Q Consensus       276 l~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~  355 (490)
                      ++.++.+||+|||+++.......   ....+||+.|+|||++.+..++.++|||||||++|||++|++||..........
T Consensus       153 ~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  229 (308)
T 3g33_A          153 VTSGGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG  229 (308)
T ss_dssp             ECTTSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHH
T ss_pred             EcCCCCEEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999999987643322   244689999999999999999999999999999999999999997643221111


Q ss_pred             hhHhhhcccC-----Ccchhh-hccCC---ccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          356 LVEWARPHLG-----DKRRFY-RLLDP---RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       356 ~~~~~~~~~~-----~~~~~~-~~~~~---~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .+........     ....+. ..+.+   ..........+..+.+||.+||+.||.+|||+.|++++
T Consensus       230 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          230 KIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             HHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            1100000000     000000 00000   00000112336889999999999999999999999976

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.1e-45  Score=374.34  Aligned_cols=276  Identities=23%  Similarity=0.266  Sum_probs=213.3

Q ss_pred             hchhhhhhHHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccC--
Q 011250          120 LRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL--  197 (490)
Q Consensus       120 ~~~~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~--  197 (490)
                      ...+.+.+.....++|.+.+.||+|+||.||+|++..         ++..||||++.... .....+..|+.+++.+.  
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~   91 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHID---------NKKYYAVKVVRNIK-KYTRSAKIEADILKKIQND   91 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECC---------CCeEEEEEEeccch-hhhhhhHHHHHHHHHhccc
Confidence            3456666777778899999999999999999999876         56789999997432 33456778999999986  


Q ss_pred             ---CCCeeceeeEEEeCCceEEEEEecCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 011250          198 ---HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN  273 (490)
Q Consensus       198 ---HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~N  273 (490)
                         ||||+++++++...+..+|||||+ +++|.+++.... ..+++..+..++.||+.||+|||+.+   |+||||||+|
T Consensus        92 ~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~N  167 (360)
T 3llt_A           92 DINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPEN  167 (360)
T ss_dssp             STTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred             CCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCccc
Confidence               999999999999999999999999 999999997653 35999999999999999999999988   9999999999


Q ss_pred             EEEcC-------------------------CCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchh
Q 011250          274 ILLDA-------------------------DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDV  328 (490)
Q Consensus       274 ILl~~-------------------------~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDv  328 (490)
                      |||+.                         ++.+||+|||+++.....     ....+||+.|+|||++.+..++.++||
T Consensus       168 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di  242 (360)
T 3llt_A          168 ILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDM  242 (360)
T ss_dssp             EEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHH
T ss_pred             EEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccch
Confidence            99975                         789999999999865432     134679999999999999999999999


Q ss_pred             hHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch-------hhhcc-CCccCCCC------------------
Q 011250          329 YSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR-------FYRLL-DPRLEGHF------------------  382 (490)
Q Consensus       329 wSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~-~~~l~~~~------------------  382 (490)
                      |||||+||+|++|+.||...........+............       ....+ ...+...+                  
T Consensus       243 wslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  322 (360)
T 3llt_A          243 WSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP  322 (360)
T ss_dssp             HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCC
T ss_pred             HHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccc
Confidence            99999999999999999764322211111111100000000       00000 00000000                  


Q ss_pred             --ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          383 --SIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       383 --~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                        ....+..+.+||.+||+.||.+|||+.|+|++
T Consensus       323 ~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          323 LYKIIKHELFCDFLYSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             HHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             ccccchHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence              01113678899999999999999999999865

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.5e-45  Score=360.02  Aligned_cols=249  Identities=27%  Similarity=0.425  Sum_probs=204.8

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      .++|++.+.||+|+||.||+|.+..         ++..||||++.....   .....+.+|+.+++.++||||+++++++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   78 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF   78 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEcc---------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE
Confidence            4579999999999999999999876         567899999865422   2345688999999999999999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      .+.+..++||||+++|+|.+++... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        79 ~~~~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg  154 (279)
T 3fdn_A           79 HDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFG  154 (279)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCC
T ss_pred             ecCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEecc
Confidence            9999999999999999999998654 46999999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ++.......    .....||+.|+|||++.+..++.++||||||+++|+|++|..||........   ......      
T Consensus       155 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~------  221 (279)
T 3fdn_A          155 WSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET---YKRISR------  221 (279)
T ss_dssp             EESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHH------
T ss_pred             ccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH---HHHHHh------
Confidence            987654322    2346799999999999999999999999999999999999999975422111   110000      


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                               ....++...+..+.+||.+||+.||.+|||+.+|+++-
T Consensus       222 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~  259 (279)
T 3fdn_A          222 ---------VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP  259 (279)
T ss_dssp             ---------TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred             ---------CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence                     01112223467899999999999999999999999863

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.8e-45  Score=361.26  Aligned_cols=263  Identities=26%  Similarity=0.409  Sum_probs=207.6

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEE-
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCI-  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-  209 (490)
                      ..+|++.+.||+|+||.||+|.+...+.      +...||+|.+..... ...+.+.+|+.+++.++||||+++++++. 
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   97 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDG------KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR   97 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCC------ceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc
Confidence            3468999999999999999999765322      445799999876432 34467899999999999999999999865 


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      .++..++||||+++|+|.+++......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        98 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~  174 (298)
T 3f66_A           98 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGL  174 (298)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGG
T ss_pred             CCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccc
Confidence            456789999999999999999776778999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcc--eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCC
Q 011250          290 AKDAPEDGKT--HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       290 a~~~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      ++........  .......||+.|+|||++.+..++.++|||||||++|+|++ |.+||............   ...   
T Consensus       175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~---~~~---  248 (298)
T 3f66_A          175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL---LQG---  248 (298)
T ss_dssp             GCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH---HTT---
T ss_pred             cccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH---hcC---
Confidence            9876543221  12234567889999999999999999999999999999999 55666543322211111   000   


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                                 .....+...+..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus       249 -----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          249 -----------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             -----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                       0011122336789999999999999999999999999987654

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.1e-45  Score=385.73  Aligned_cols=249  Identities=27%  Similarity=0.357  Sum_probs=207.8

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      .++|.+.+.||+|+||.||+|++..         +|..||||++.....   .....+.+|+.+|+.++||||+++++++
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~---------~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~   85 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHEL---------TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI   85 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETT---------TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            3579999999999999999999876         677999999975422   2345788999999999999999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      .+.+..||||||+++|+|.+++... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        86 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG  161 (476)
T 2y94_A           86 STPSDIFMVMEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFG  161 (476)
T ss_dssp             ECSSEEEEEEECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCS
T ss_pred             EECCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEecc
Confidence            9999999999999999999998544 57999999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhccCCC-CccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      ++........   ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||......   .+.....      
T Consensus       162 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~~~~i~------  229 (476)
T 2y94_A          162 LSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---TLFKKIC------  229 (476)
T ss_dssp             SCEECCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---HHHHHHH------
T ss_pred             chhhcccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---HHHHHHh------
Confidence            9987654322   234689999999999987765 68999999999999999999999754321   1111110      


Q ss_pred             chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                             +...  ..+...+.++.+||.+||+.||.+|||+.+|+++
T Consensus       230 -------~~~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          230 -------DGIF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             -------TTCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             -------cCCc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence                   0000  1122336789999999999999999999999985

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.3e-45  Score=371.18  Aligned_cols=254  Identities=25%  Similarity=0.308  Sum_probs=193.0

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ..++|++.+.||+|+||.||+|++..         +++.||||++....  ..+.+.+|+.+|+.++||||+++++++.+
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~  119 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKG---------TQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFET  119 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECC---------CCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEec
Confidence            34679999999999999999999875         56789999997653  34568899999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CCCeEEecc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDF  287 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~---~~~vkL~DF  287 (490)
                      .+..+|||||+++|+|.+++... ..+++..++.++.||+.||.|||+.+   |+||||||+||||+.   ++.+||+||
T Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Df  195 (349)
T 2w4o_A          120 PTEISLVLELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADF  195 (349)
T ss_dssp             SSEEEEEECCCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             CCeEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccC
Confidence            99999999999999999998654 46999999999999999999999988   999999999999975   889999999


Q ss_pred             cCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011250          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      |+++......   .....+||+.|+|||++.+..++.++|||||||+||||++|..||.......  ......   ....
T Consensus       196 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~i---~~~~  267 (349)
T 2w4o_A          196 GLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FMFRRI---LNCE  267 (349)
T ss_dssp             C-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HHHHHH---HTTC
T ss_pred             ccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HHHHHH---HhCC
Confidence            9998764321   2234679999999999999899999999999999999999999996543211  011110   0000


Q ss_pred             chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                      .        .....+....+.++.+||.+||..||.+|||+.+++++-
T Consensus       268 ~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  307 (349)
T 2w4o_A          268 Y--------YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHP  307 (349)
T ss_dssp             C--------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred             C--------ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence            0        001111223478899999999999999999999999863

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.5e-45  Score=362.81  Aligned_cols=267  Identities=25%  Similarity=0.325  Sum_probs=201.8

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ++|++.+.||+|+||.||+|.+..         +|..||||++......  ..+.+.+|+.+++.++||||+++++++.+
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   73 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRD---------TGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR   73 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCC---------CCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec
Confidence            579999999999999999999876         5779999998665432  24568899999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      .+..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        74 ~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~  149 (311)
T 4agu_A           74 KRRLHLVFEYCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFA  149 (311)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCeEEEEEEeCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCc
Confidence            9999999999999999887743 457999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC----
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG----  365 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~----  365 (490)
                      ........  .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+........    
T Consensus       150 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  227 (311)
T 4agu_A          150 RLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQ  227 (311)
T ss_dssp             EECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             hhccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccc
Confidence            87653322  1234579999999999876 6789999999999999999999999976533222111111000000    


Q ss_pred             ----Ccchhh--hccCCccCCC---CChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          366 ----DKRRFY--RLLDPRLEGH---FSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 ----~~~~~~--~~~~~~l~~~---~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                          ....+.  ...++.....   .....+..+.+||.+||+.||.+|||+.+++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          228 QVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             HHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence                000000  0000000000   001246789999999999999999999999976

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-45  Score=375.21  Aligned_cols=261  Identities=26%  Similarity=0.431  Sum_probs=201.1

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEEEe-C
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE-D  211 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~  211 (490)
                      .|.+.+.||+|+||.||+|++...+.      .+..||||.+.... ....+.+.+|+.+++.++||||+++++++.+ +
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~  163 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDG------KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE  163 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTT------EEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCC------cEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence            47788999999999999999865321      34579999987543 3445779999999999999999999998764 4


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      +..++||||+++|+|.+++......+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus       164 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~  240 (373)
T 3c1x_A          164 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR  240 (373)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccc
Confidence            5789999999999999999777677999999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCcc--eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          292 DAPEDGKT--HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       292 ~~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ........  .......||+.|+|||++.+..++.++|||||||+||||++ |.+||...........+   ...   . 
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~---~~~---~-  313 (373)
T 3c1x_A          241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL---LQG---R-  313 (373)
T ss_dssp             -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH---HTT---C-
T ss_pred             cccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH---HcC---C-
Confidence            66433221  11233567889999999999999999999999999999999 67777654332211111   000   0 


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                                ....+..++..+.+||.+||+.||.+||++.++++.|+.+..
T Consensus       314 ----------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~  355 (373)
T 3c1x_A          314 ----------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  355 (373)
T ss_dssp             ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                      001122346789999999999999999999999999987643

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=9.8e-46  Score=370.27  Aligned_cols=251  Identities=26%  Similarity=0.332  Sum_probs=182.1

Q ss_pred             CcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccC-CCCeeceeeEEEeCCceEE
Q 011250          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIEDDQRLL  216 (490)
Q Consensus       138 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~l  216 (490)
                      .+.||+|+||.||+|.+..         ++..||||++...   ....+.+|+.++..+. ||||+++++++.++...||
T Consensus        16 ~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l   83 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKK---------SNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL   83 (325)
T ss_dssp             SCCSEEETTEEEEEEEETT---------TCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCccccCCCeEEEEEEECC---------CCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence            4789999999999999876         5779999999653   3456789999999997 9999999999999999999


Q ss_pred             EEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC---CeEEecccCcccC
Q 011250          217 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY---NAKLSDFGLAKDA  293 (490)
Q Consensus       217 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~---~vkL~DFG~a~~~  293 (490)
                      ||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++   .+||+|||+++..
T Consensus        84 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~  159 (325)
T 3kn6_A           84 VMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLK  159 (325)
T ss_dssp             EECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred             EEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence            99999999999999654 57999999999999999999999988   99999999999997665   8999999999866


Q ss_pred             CCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcc-hhhHhhhcccCCcchhhh
Q 011250          294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLVEWARPHLGDKRRFYR  372 (490)
Q Consensus       294 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~  372 (490)
                      .....  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||......... ...+.........     
T Consensus       160 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~-----  232 (325)
T 3kn6_A          160 PPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD-----  232 (325)
T ss_dssp             CC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC-----
T ss_pred             CCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC-----
Confidence            44322  223467899999999999999999999999999999999999999764332111 1111111000000     


Q ss_pred             ccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       373 ~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                         ..+........+.++.+||.+||+.||.+|||+.+++++
T Consensus       233 ---~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          233 ---FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             ---CCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             ---CCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence               000000011237889999999999999999999998865

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-45  Score=359.19  Aligned_cols=262  Identities=24%  Similarity=0.368  Sum_probs=209.4

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      .|.+.++||+|+||.||+|.+.....      ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   95 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQ------NRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE   95 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSS------CEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred             EEccCceeccCCCceEEEEEEecCCC------ceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC
Confidence            46677999999999999999865332      445799999976433 34567899999999999999999999998776


Q ss_pred             ce-EEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          213 QR-LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       213 ~~-~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      .. ++||||+.+|+|.+++......+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        96 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~  172 (298)
T 3pls_A           96 GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLAR  172 (298)
T ss_dssp             SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSC
T ss_pred             CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcc
Confidence            65 9999999999999999776778999999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCcc--eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          292 DAPEDGKT--HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       292 ~~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      ........  .......||+.|+|||.+.+..++.++|||||||++|+|++|..|+......  ..+.......      
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~------  244 (298)
T 3pls_A          173 DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLTHFLAQG------  244 (298)
T ss_dssp             TTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--GGHHHHHHTT------
T ss_pred             cccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--HHHHHHhhcC------
Confidence            66433211  1123356889999999999999999999999999999999965554322111  1111111100      


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                              .....+...+..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus       245 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  287 (298)
T 3pls_A          245 --------RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS  287 (298)
T ss_dssp             --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                    0111222346789999999999999999999999999987644

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=6.7e-45  Score=378.33  Aligned_cols=201  Identities=29%  Similarity=0.421  Sum_probs=168.7

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC--CcccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      .++|++.+.||+|+||.||+|++..         ++..||||++...  .....+.+.+|+.+|+.++||||+++++++.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~   95 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKN---------TEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLII   95 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECC---------CCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEe
Confidence            4579999999999999999999876         6779999999754  2334567899999999999999999999998


Q ss_pred             eC-----CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 011250          210 ED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       210 ~~-----~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL  284 (490)
                      ..     ...||||||+. |+|.+++.. ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||
T Consensus        96 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL  170 (432)
T 3n9x_A           96 PDDLLKFDELYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKV  170 (432)
T ss_dssp             CSCTTTCCCEEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred             cCCCCcCCeEEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEE
Confidence            76     56899999995 699998854 457999999999999999999999988   999999999999999999999


Q ss_pred             ecccCcccCCCCCcc--------------------eeeeccccCCCccCcchh-ccCCCCccchhhHHHHHHHHHHhCCC
Q 011250          285 SDFGLAKDAPEDGKT--------------------HVSTRVMGTYGYAAPEYV-MTGHLTSKSDVYSFGVVLLEMLTGRR  343 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~--------------------~~~~~~~Gt~~y~aPE~l-~~~~~~~~sDvwSlGv~l~elltG~~  343 (490)
                      +|||+++........                    ...+..+||+.|+|||++ ....|+.++|||||||+||||++|..
T Consensus       171 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~  250 (432)
T 3n9x_A          171 CDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ  250 (432)
T ss_dssp             CCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCT
T ss_pred             ccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccc
Confidence            999999876543221                    122457899999999986 45679999999999999999998655


Q ss_pred             CCC
Q 011250          344 SMD  346 (490)
Q Consensus       344 pf~  346 (490)
                      ||.
T Consensus       251 p~~  253 (432)
T 3n9x_A          251 SHI  253 (432)
T ss_dssp             TTC
T ss_pred             ccc
Confidence            543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.7e-45  Score=356.59  Aligned_cols=252  Identities=23%  Similarity=0.290  Sum_probs=206.6

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      .++|++.+.||+|+||.||+|.+..         ++..||+|++........+.+.+|+.+++.++||||+++++++.+.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   78 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKG---------TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDN   78 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCC---------CCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            3469999999999999999999876         5678999999876556678899999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---cCCCCeEEeccc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFG  288 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl---~~~~~vkL~DFG  288 (490)
                      +..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+|||
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg  154 (277)
T 3f3z_A           79 TDIYLVMELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFG  154 (277)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             CeEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecc
Confidence            9999999999999999988654 46999999999999999999999988   9999999999999   788999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ++........   .....||+.|+|||++.+ .++.++||||||+++|+|++|..||......   ..........   .
T Consensus       155 ~~~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~---~  224 (277)
T 3f3z_A          155 LAARFKPGKM---MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS---EVMLKIREGT---F  224 (277)
T ss_dssp             TCEECCTTSC---BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCC---C
T ss_pred             cceeccCccc---hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhCC---C
Confidence            9987654322   234579999999998765 5999999999999999999999999754221   1111110000   0


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .+...        .....+..+.+||.+||+.||.+|||+.+++++
T Consensus       225 ~~~~~--------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          225 TFPEK--------DWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             CCCHH--------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             CCCch--------hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00000        001236789999999999999999999999864

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=6.6e-45  Score=363.14  Aligned_cols=253  Identities=24%  Similarity=0.321  Sum_probs=208.0

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc------cHHHHHHHHHHHhccCCCCeeceee
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGNLLHPNLVKLVG  206 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~~  206 (490)
                      ++|++.+.||+|+||.||+|++..         +|..||||++......      ..+.+.+|+.+++.+.||||+++++
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   82 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKS---------TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHD   82 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECC---------CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEE
Confidence            469999999999999999999876         5779999999764322      3577999999999999999999999


Q ss_pred             EEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC----Ce
Q 011250          207 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY----NA  282 (490)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~----~v  282 (490)
                      ++.+.+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++    .+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~  158 (321)
T 2a2a_A           83 VYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHI  158 (321)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCE
T ss_pred             EEecCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCE
Confidence            99999999999999999999999854 457999999999999999999999988   99999999999999887    79


Q ss_pred             EEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011250          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      ||+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||......   ........
T Consensus       159 kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~  232 (321)
T 2a2a_A          159 KLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANITS  232 (321)
T ss_dssp             EECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHT
T ss_pred             EEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHh
Confidence            9999999987654322   23467999999999999999999999999999999999999999654221   11111100


Q ss_pred             ccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                      ..   ..    +++    .+....+..+.+||.+||..||.+|||+.+++++-
T Consensus       233 ~~---~~----~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp  274 (321)
T 2a2a_A          233 VS---YD----FDE----EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHP  274 (321)
T ss_dssp             TC---CC----CCH----HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHST
T ss_pred             cc---cc----cCh----hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence            00   00    000    00112367899999999999999999999999863

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.2e-44  Score=355.93  Aligned_cols=266  Identities=19%  Similarity=0.229  Sum_probs=212.2

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEE-Ee
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYC-IE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~  210 (490)
                      .++|++.+.||+|+||.||+|++..         ++..||||++......  ..+.+|+.+++.+.|++++..+.++ ..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~   76 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIA---------AGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAE   76 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcC---------CCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCC
Confidence            4679999999999999999999865         6779999998765432  4688999999999988877666655 56


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---cCCCCeEEecc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDF  287 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl---~~~~~vkL~DF  287 (490)
                      .+..++||||+ +++|.+++......+++..++.++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+||
T Consensus        77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df  152 (296)
T 3uzp_A           77 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDF  152 (296)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred             CCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeC
Confidence            67789999999 99999999766678999999999999999999999988   9999999999999   48899999999


Q ss_pred             cCcccCCCCCcce-----eeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011250          288 GLAKDAPEDGKTH-----VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       288 G~a~~~~~~~~~~-----~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      |++..........     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.................
T Consensus       153 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  232 (296)
T 3uzp_A          153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE  232 (296)
T ss_dssp             TTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH
T ss_pred             CCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc
Confidence            9998765432211     12346799999999999999999999999999999999999999986544332222211110


Q ss_pred             -ccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccccc
Q 011250          363 -HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKD  423 (490)
Q Consensus       363 -~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~~~~  423 (490)
                       .....       .+.+    ....+..+.+|+.+||+.||.+|||+.+|++.|+.+.....
T Consensus       233 ~~~~~~-------~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  283 (296)
T 3uzp_A          233 KKMSTP-------IEVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             HHHHSC-------HHHH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             cccCCc-------hHHH----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence             00000       0000    11236789999999999999999999999999987755433

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=4.9e-45  Score=382.62  Aligned_cols=265  Identities=23%  Similarity=0.285  Sum_probs=198.3

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC--CcccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      .++|++.+.||+|+||+||+|++..         ++..||||++...  .....+.+.+|+.+|+.++||||+++++++.
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  131 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAV---------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT  131 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETT---------TTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECC---------CCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEc
Confidence            4689999999999999999999876         6779999999754  2234567889999999999999999999997


Q ss_pred             eCC------ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeE
Q 011250          210 EDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       210 ~~~------~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vk  283 (490)
                      ...      ..||||||+++ +|.+.+..   .+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+|
T Consensus       132 ~~~~~~~~~~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~k  204 (464)
T 3ttj_A          132 PQKTLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK  204 (464)
T ss_dssp             SCCSTTTCCEEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEE
T ss_pred             cCCccccCCeEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEE
Confidence            653      56999999965 57666632   4899999999999999999999988   99999999999999999999


Q ss_pred             EecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhh-Hhhhc
Q 011250          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWARP  362 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~-~~~~~  362 (490)
                      |+|||+++......   ..+..+||+.|+|||++.+..|+.++|||||||+||||++|+.||...........+ .....
T Consensus       205 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~  281 (464)
T 3ttj_A          205 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT  281 (464)
T ss_dssp             ECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred             EEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99999998764322   234478999999999999999999999999999999999999999764322111110 00000


Q ss_pred             -------cc--------C-----CcchhhhccCCccCC---CCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          363 -------HL--------G-----DKRRFYRLLDPRLEG---HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       363 -------~~--------~-----~~~~~~~~~~~~l~~---~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                             .+        .     ....+...+...+..   ......+.++.+||.+||..||.+|||++|+++|-
T Consensus       282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp  357 (464)
T 3ttj_A          282 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP  357 (464)
T ss_dssp             CCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred             CCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence                   00        0     000000111000000   00011267899999999999999999999999873

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=9.8e-46  Score=370.02  Aligned_cols=262  Identities=23%  Similarity=0.330  Sum_probs=193.7

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccC-CCCeeceeeEEE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCI  209 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~  209 (490)
                      ...+|++.++||+|+||.||+|++..         ++..||||++........+.+.+|+.++..+. ||||+++++++.
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~   96 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVG---------SGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAAS   96 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETT---------TCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             cCceEEEEEEEccCCceEEEEEEECC---------CCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccc
Confidence            34579999999999999999999876         57789999997666566678899999999996 999999999985


Q ss_pred             e--------CCceEEEEEecCCCChhHHhhh--cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC
Q 011250          210 E--------DDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD  279 (490)
Q Consensus       210 ~--------~~~~~lV~E~~~~gsL~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~  279 (490)
                      .        ....++||||+. |+|.+++..  ....+++..++.++.||+.||.|||+.+ .+|+||||||+||||+.+
T Consensus        97 ~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~  174 (337)
T 3ll6_A           97 IGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQ  174 (337)
T ss_dssp             ECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTT
T ss_pred             ccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCC
Confidence            3        335799999995 799998864  3457999999999999999999999865 459999999999999999


Q ss_pred             CCeEEecccCcccCCCCCcce----------eeeccccCCCccCcchh---ccCCCCccchhhHHHHHHHHHHhCCCCCC
Q 011250          280 YNAKLSDFGLAKDAPEDGKTH----------VSTRVMGTYGYAAPEYV---MTGHLTSKSDVYSFGVVLLEMLTGRRSMD  346 (490)
Q Consensus       280 ~~vkL~DFG~a~~~~~~~~~~----------~~~~~~Gt~~y~aPE~l---~~~~~~~~sDvwSlGv~l~elltG~~pf~  346 (490)
                      +.+||+|||+++.........          ......||+.|+|||++   .+..++.++|||||||++|+|++|+.||.
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~  254 (337)
T 3ll6_A          175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE  254 (337)
T ss_dssp             SCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred             CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence            999999999998765432211          11135699999999998   56678999999999999999999999996


Q ss_pred             CCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccccc
Q 011250          347 KNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKD  423 (490)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~~~~  423 (490)
                      .......   ..                 ...........+..+.+||.+||+.||.+|||+.+++++|+.+.....
T Consensus       255 ~~~~~~~---~~-----------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~  311 (337)
T 3ll6_A          255 DGAKLRI---VN-----------------GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN  311 (337)
T ss_dssp             -------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             chhHHHh---hc-----------------CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence            4322110   00                 000001111224567899999999999999999999999988765443

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.7e-45  Score=390.98  Aligned_cols=256  Identities=31%  Similarity=0.430  Sum_probs=212.2

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhccCCCCeeceee
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVG  206 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~  206 (490)
                      ...++|++.++||+|+||.||+|++..         +|..||||++....   ......+.+|+.+|..++|||||++++
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~---------tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~  251 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY  251 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEE
Confidence            345679999999999999999999876         67799999996542   223456889999999999999999999


Q ss_pred             EEEeCCceEEEEEecCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEe
Q 011250          207 YCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~  285 (490)
                      ++.+.+..||||||++||+|.+++.... ..+++..++.++.||+.||.|||+.+   ||||||||+||||+.++.+||+
T Consensus       252 ~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~  328 (576)
T 2acx_A          252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRIS  328 (576)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEEC
T ss_pred             EEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEE
Confidence            9999999999999999999999986543 35999999999999999999999988   9999999999999999999999


Q ss_pred             cccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011250          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      |||+++.......   ....+||+.|+|||++.+..|+.++|||||||+||||++|+.||...........+......  
T Consensus       329 DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~--  403 (576)
T 2acx_A          329 DLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE--  403 (576)
T ss_dssp             CCTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH--
T ss_pred             ecccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc--
Confidence            9999987654322   23468999999999999989999999999999999999999999765432211111100000  


Q ss_pred             CcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011250          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  414 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----t~~evl~~  414 (490)
                                  ....++...+.++.+||.+||+.||.+||     ++.||++|
T Consensus       404 ------------~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          404 ------------VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             ------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             ------------ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence                        01122334478999999999999999999     78999876

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.6e-45  Score=355.27  Aligned_cols=254  Identities=26%  Similarity=0.354  Sum_probs=207.3

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      ++|++.+.||+|+||.||+|.+..         ++..||||++.... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   77 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRV---------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG   77 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             cceEEEEEeecCCCcEEEEEEECC---------CCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC
Confidence            469999999999999999999875         56789999986543 23456788999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      +..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~  153 (276)
T 2yex_A           78 NIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLAT  153 (276)
T ss_dssp             TEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CEEEEEEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCcc
Confidence            999999999999999998854 347999999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhccCCC-CccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ...............||+.|+|||++.+..+ +.++||||||+++|+|++|..||........ ....+....     . 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~-----~-  226 (276)
T 2yex_A          154 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKK-----T-  226 (276)
T ss_dssp             ECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHTTC-----T-
T ss_pred             ccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhhcc-----c-
Confidence            6543332223345679999999999987665 7799999999999999999999976433211 111111100     0 


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                              ........+..+.+||.+||+.||.+|||+.+++++
T Consensus       227 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          227 --------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             --------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --------ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence                    000012336789999999999999999999999865

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.4e-45  Score=358.35  Aligned_cols=261  Identities=27%  Similarity=0.426  Sum_probs=211.8

Q ss_pred             hHHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceee
Q 011250          127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVG  206 (490)
Q Consensus       127 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  206 (490)
                      ++.+..++|++.+.||+|+||.||+|.+.          ++..||||.+.... ...+.+.+|+.+++.++||||+++++
T Consensus         7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~   75 (279)
T 1qpc_A            7 EWEVPRETLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA   75 (279)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hcccCHHhhhheeeecCCCCeEEEEEEEc----------CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEE
Confidence            44455678999999999999999999875          35579999997654 34578899999999999999999999


Q ss_pred             EEEeCCceEEEEEecCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEe
Q 011250          207 YCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~  285 (490)
                      ++. .+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        76 ~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~  151 (279)
T 1qpc_A           76 VVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIA  151 (279)
T ss_dssp             EEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEEC
T ss_pred             EEc-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEEC
Confidence            876 456899999999999999986432 26999999999999999999999988   9999999999999999999999


Q ss_pred             cccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhccc
Q 011250          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      |||++........ .......|+..|+|||++.+..++.++||||||+++|||++ |+.||......   ......... 
T Consensus       152 Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~~~~-  226 (279)
T 1qpc_A          152 DFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQNLERG-  226 (279)
T ss_dssp             CCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHHTT-
T ss_pred             CCcccccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHHHHHhcc-
Confidence            9999987654322 22233557889999999998899999999999999999999 99999654221   111111100 


Q ss_pred             CCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                                   .....+...+..+.+|+.+||..||.+|||+.++++.|+.+..
T Consensus       227 -------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  269 (279)
T 1qpc_A          227 -------------YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (279)
T ss_dssp             -------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------------cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence                         0111223347889999999999999999999999999987643

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=9e-45  Score=356.62  Aligned_cols=265  Identities=19%  Similarity=0.232  Sum_probs=208.8

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEE-Ee
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYC-IE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~  210 (490)
                      .++|++.+.||+|+||.||+|++..         ++..||||++......  ..+.+|+.+++.+.|++++..+.++ ..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~   76 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIA---------AGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAE   76 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcC---------CCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCC
Confidence            4679999999999999999999865         6779999987654322  3578899999999988877776655 56


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---cCCCCeEEecc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDF  287 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl---~~~~~vkL~DF  287 (490)
                      .+..+|||||+ +++|.+++......+++..++.++.||+.||.|||+.+   |+||||||+||||   +.++.+||+||
T Consensus        77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Df  152 (296)
T 4hgt_A           77 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDF  152 (296)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCC
T ss_pred             CCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecC
Confidence            67889999999 99999999766678999999999999999999999988   9999999999999   78899999999


Q ss_pred             cCcccCCCCCcc-----eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh-
Q 011250          288 GLAKDAPEDGKT-----HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR-  361 (490)
Q Consensus       288 G~a~~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~-  361 (490)
                      |+++........     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||................ 
T Consensus       153 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  232 (296)
T 4hgt_A          153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE  232 (296)
T ss_dssp             TTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH
T ss_pred             ccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhc
Confidence            999876543221     12234679999999999999999999999999999999999999998654433322222111 


Q ss_pred             cccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcccc
Q 011250          362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLK  422 (490)
Q Consensus       362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~~~  422 (490)
                      .......   .    .+    ....+..+.+||.+||+.||.+|||+.+|++.|+.+....
T Consensus       233 ~~~~~~~---~----~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~  282 (296)
T 4hgt_A          233 KKMSTPI---E----VL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             HHHHSCH---H----HH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ccccchh---h----hh----hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence            0000000   0    00    0122678999999999999999999999999998775543

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=7.4e-45  Score=360.48  Aligned_cols=263  Identities=25%  Similarity=0.368  Sum_probs=202.1

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|++.+.||+|+||.||+|.+..         +|..||||++....   ......+.+|+.+++.++||||+++++++.
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~  102 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLL---------DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI  102 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETT---------TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcC---------CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            469999999999999999999876         56789999997543   233467889999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEec
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~D  286 (490)
                      +.+..++||||+++++|.+++..   ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~D  179 (310)
T 2wqm_A          103 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGD  179 (310)
T ss_dssp             ETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECC
T ss_pred             cCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEe
Confidence            99999999999999999998864   3457999999999999999999999988   99999999999999999999999


Q ss_pred             ccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011250          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      ||++........  ......||+.|+|||++.+..++.++||||||+++|+|++|..||....... ..+.......   
T Consensus       180 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~---  253 (310)
T 2wqm_A          180 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKIEQC---  253 (310)
T ss_dssp             C--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-HHHHHHHHTT---
T ss_pred             ccceeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-HHHHHHhhcc---
Confidence            999987643321  1234579999999999999999999999999999999999999996542211 1111111000   


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccccc
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKD  423 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~~~~  423 (490)
                                ..........+.++.+||.+||..||.+|||+.+|++.|+.+.....
T Consensus       254 ----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~  300 (310)
T 2wqm_A          254 ----------DYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA  300 (310)
T ss_dssp             ----------CSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             ----------cCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence                      00000112336789999999999999999999999999998876544

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.7e-45  Score=358.78  Aligned_cols=251  Identities=28%  Similarity=0.375  Sum_probs=199.8

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      ++|.+.+.||+|+||.||+|.+..         ++..||+|++.... ....+.+.+|+++++.++||||+++++++.+.
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   92 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERS---------SGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY   92 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hheeecceeccCCCeEEEEEEEcc---------CCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecC
Confidence            368999999999999999999876         56789999987653 33457889999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---cCCCCeEEe
Q 011250          212 DQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLS  285 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl---~~~~~vkL~  285 (490)
                      +..++||||+++|+|.+++..   ....+++..++.++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+
T Consensus        93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~  169 (285)
T 3is5_A           93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKII  169 (285)
T ss_dssp             SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEEC
T ss_pred             CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEE
Confidence            999999999999999998854   2467999999999999999999999988   9999999999999   456789999


Q ss_pred             cccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011250          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      |||++........   .....||+.|+|||++. ..++.++|||||||++|||++|+.||................    
T Consensus       170 Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~----  241 (285)
T 3is5_A          170 DFGLAELFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE----  241 (285)
T ss_dssp             CCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----
T ss_pred             eeecceecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCC----
Confidence            9999987644321   23467999999999875 578999999999999999999999997543211111110000    


Q ss_pred             CcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                                +.... .....+..+.+||.+||+.||.+|||+.||+++
T Consensus       242 ----------~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          242 ----------PNYAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             ----------CCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             ----------ccccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                      00000 001126788999999999999999999999964

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=6.4e-45  Score=364.02  Aligned_cols=257  Identities=26%  Similarity=0.439  Sum_probs=206.8

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcE--EEEEEecCCC-cccHHHHHHHHHHHhcc-CCCCeeceeeEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLT--VAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGYC  208 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~--vaiK~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~  208 (490)
                      ++|++.+.||+|+||.||+|++..         ++..  ||||.+.... ....+.+.+|+.++..+ +||||+++++++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~   95 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKK---------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC   95 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEE---------TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEcc---------CCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceee
Confidence            469999999999999999999876         3443  5999987532 23345688999999999 899999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN  273 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~N  273 (490)
                      .+.+..+|||||+++|+|.+++....               ..+++..++.++.||+.||.|||+.+   |+||||||+|
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~N  172 (327)
T 1fvr_A           96 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARN  172 (327)
T ss_dssp             EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred             eeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccce
Confidence            99999999999999999999996543               46999999999999999999999988   9999999999


Q ss_pred             EEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCC
Q 011250          274 ILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNG  352 (490)
Q Consensus       274 ILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~  352 (490)
                      ||++.++.+||+|||+++.....   .......+++.|+|||++.+..++.++|||||||++|||++ |+.||...... 
T Consensus       173 Il~~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-  248 (327)
T 1fvr_A          173 ILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-  248 (327)
T ss_dssp             EEECGGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-
T ss_pred             EEEcCCCeEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-
Confidence            99999999999999999754321   11223467889999999998899999999999999999998 99999654221 


Q ss_pred             cchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccc
Q 011250          353 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~~  421 (490)
                        .+......              ......+...+..+.+||.+||..||.+|||+.+++++|..+...
T Consensus       249 --~~~~~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  301 (327)
T 1fvr_A          249 --ELYEKLPQ--------------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  301 (327)
T ss_dssp             --HHHHHGGG--------------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             --HHHHHhhc--------------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence              11111100              011122334478899999999999999999999999999876543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.7e-45  Score=368.91  Aligned_cols=259  Identities=23%  Similarity=0.271  Sum_probs=201.0

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC-----CcccHHHHHHHHHHHhccCCCCeece
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-----GLQGHKEWLAEVNFLGNLLHPNLVKL  204 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~Ei~il~~l~HpnIv~l  204 (490)
                      ...++|++.+.||+|+||.||+|.+..         ++..||||++...     .....+.+.+|+.+++.++||||+++
T Consensus        23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~   93 (345)
T 3hko_A           23 ELQKKYHLKGAIGQGSYGVVRVAIENQ---------TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL   93 (345)
T ss_dssp             HHHHHEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             hhhhheeecceeeecCCeEEEEEEECC---------CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCccee
Confidence            345679999999999999999998876         5778999998653     22345678999999999999999999


Q ss_pred             eeEEEeCCceEEEEEecCCCChhHHhhhc---------------------------------------CCCCCHHHHHHH
Q 011250          205 VGYCIEDDQRLLVYEFMPRGSLENHLFRR---------------------------------------SLPLPWSIRMKI  245 (490)
Q Consensus       205 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~---------------------------------------~~~l~~~~~~~i  245 (490)
                      ++++.+.+..+||||||++|+|.+++...                                       ...+++..++.+
T Consensus        94 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  173 (345)
T 3hko_A           94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNI  173 (345)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHH
T ss_pred             ehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHH
Confidence            99999999999999999999999988421                                       112357778899


Q ss_pred             HHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC--CeEEecccCcccCCCCC--cceeeeccccCCCccCcchhcc--
Q 011250          246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY--NAKLSDFGLAKDAPEDG--KTHVSTRVMGTYGYAAPEYVMT--  319 (490)
Q Consensus       246 ~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~--~vkL~DFG~a~~~~~~~--~~~~~~~~~Gt~~y~aPE~l~~--  319 (490)
                      +.||+.||+|||+.+   |+||||||+||||+.++  .+||+|||+++......  .........||+.|+|||++.+  
T Consensus       174 ~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  250 (345)
T 3hko_A          174 MRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN  250 (345)
T ss_dssp             HHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSS
T ss_pred             HHHHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCC
Confidence            999999999999988   99999999999998776  89999999998653221  1112234679999999999875  


Q ss_pred             CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhh
Q 011250          320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLS  399 (490)
Q Consensus       320 ~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~  399 (490)
                      ..++.++|||||||+||||++|+.||.........  ........    .        +........+..+.+||.+||+
T Consensus       251 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~----~--------~~~~~~~~~~~~~~~li~~~l~  316 (345)
T 3hko_A          251 ESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTI--SQVLNKKL----C--------FENPNYNVLSPLARDLLSNLLN  316 (345)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHCCC----C--------TTSGGGGGSCHHHHHHHHHHSC
T ss_pred             CCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHH--HHHHhccc----c--------cCCcccccCCHHHHHHHHHHcC
Confidence            67899999999999999999999999754321111  11110000    0        0000011236789999999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 011250          400 RDPKARPRMSEVVET  414 (490)
Q Consensus       400 ~dP~~RPt~~evl~~  414 (490)
                      .||.+||++.+++++
T Consensus       317 ~~p~~Rps~~~~l~h  331 (345)
T 3hko_A          317 RNVDERFDAMRALQH  331 (345)
T ss_dssp             SCTTTSCCHHHHHHS
T ss_pred             CChhHCCCHHHHhcC
Confidence            999999999999975

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.7e-45  Score=370.58  Aligned_cols=249  Identities=29%  Similarity=0.408  Sum_probs=205.0

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      +.|.+.+.||+|+||.||+|++..         ++..||||++......   ..+.+.+|+.+++.++||||+++++++.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  124 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL  124 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEcc---------CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            358899999999999999999865         6779999999755322   2356889999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +++..+|||||+. |+|.+++......+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus       125 ~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~  200 (348)
T 1u5q_A          125 REHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGS  200 (348)
T ss_dssp             ETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred             ECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccC
Confidence            9999999999996 6888888766678999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhc---cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      +......      ...+||+.|+|||++.   ...++.++|||||||++|||++|+.||........  +......    
T Consensus       201 a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~~~~~~----  268 (348)
T 1u5q_A          201 ASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQN----  268 (348)
T ss_dssp             CBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHS----
T ss_pred             ceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHhc----
Confidence            9876432      2357999999999985   56789999999999999999999999965321110  0000000    


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~  416 (490)
                             ..+.   ..+...+..+.+||.+||+.||.+|||+.+++++..
T Consensus       269 -------~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~  308 (348)
T 1u5q_A          269 -------ESPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  308 (348)
T ss_dssp             -------CCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred             -------CCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence                   0010   111233678999999999999999999999997643

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.8e-45  Score=369.70  Aligned_cols=269  Identities=17%  Similarity=0.207  Sum_probs=202.3

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-----------HHHHHHHHHHHhccCCCC
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-----------HKEWLAEVNFLGNLLHPN  200 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~Ei~il~~l~Hpn  200 (490)
                      .++|.+.+.||+|+||.||+|.+...+.      ++..||||++.......           ...+.+|+.++..+.|||
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~n  109 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPE------KDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLG  109 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCG------GGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCC
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCC------ccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccC
Confidence            3579999999999999999999875322      45689999987654221           124678889999999999


Q ss_pred             eeceeeEEEe----CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE
Q 011250          201 LVKLVGYCIE----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL  276 (490)
Q Consensus       201 Iv~l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl  276 (490)
                      |+++++++..    ....+|||||+ +++|.+++.... .+++..++.++.||+.||+|||+.+   |+||||||+||||
T Consensus       110 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  184 (345)
T 2v62_A          110 IPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLL  184 (345)
T ss_dssp             CCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred             cceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEE
Confidence            9999999988    67899999999 999999986554 7999999999999999999999988   9999999999999


Q ss_pred             cCCC--CeEEecccCcccCCCCCcc-----eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCC
Q 011250          277 DADY--NAKLSDFGLAKDAPEDGKT-----HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR  349 (490)
Q Consensus       277 ~~~~--~vkL~DFG~a~~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~  349 (490)
                      +.++  .+||+|||+++........     .......||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus       185 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~  264 (345)
T 2v62_A          185 GYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNL  264 (345)
T ss_dssp             ESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGT
T ss_pred             ccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence            8887  9999999999876432111     11134579999999999999999999999999999999999999996432


Q ss_pred             CCCcchhhHhhhcccCCc-chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011250          350 PNGEHNLVEWARPHLGDK-RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~  419 (490)
                      ..... ............ ..+.....       ....+.++.+||.+||..||.+||++.+|++.|+.+.
T Consensus       265 ~~~~~-~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          265 KDPVA-VQTAKTNLLDELPQSVLKWAP-------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             TCHHH-HHHHHHHHHHTTTHHHHHHSC-------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             cccHH-HHHHHHhhcccccHHHHhhcc-------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            21111 110000000000 00000000       0123678999999999999999999999999998753

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2e-45  Score=367.67  Aligned_cols=266  Identities=27%  Similarity=0.388  Sum_probs=207.2

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .++|++.+.||+|+||.||+|++....    ...++..||||++.... ......+.+|+.+++.+.||||+++++++.+
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMP----NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  104 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC------------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCC----CCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence            357999999999999999999864311    11267789999997543 3345678899999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcC------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CCC
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRS------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYN  281 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~---~~~  281 (490)
                      .+..+|||||+++++|.+++....      ..+++..++.++.||+.||.|||+.+   |+||||||+||||+.   +..
T Consensus       105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~  181 (327)
T 2yfx_A          105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRV  181 (327)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCC
T ss_pred             CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcce
Confidence            999999999999999999997653      35899999999999999999999988   999999999999984   456


Q ss_pred             eEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 011250          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       282 vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~  360 (490)
                      +||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||......   ......
T Consensus       182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~  258 (327)
T 2yfx_A          182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEFV  258 (327)
T ss_dssp             EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHH
T ss_pred             EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HHHHHH
Confidence            99999999976543332222334678999999999999999999999999999999998 99999654211   111111


Q ss_pred             hcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccc
Q 011250          361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~~  421 (490)
                      ...              .....+..++..+.+||.+||+.||.+||++.+|+++|+.+...
T Consensus       259 ~~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          259 TSG--------------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             HTT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hcC--------------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence            100              00112233477899999999999999999999999999877553

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.3e-45  Score=359.13  Aligned_cols=261  Identities=27%  Similarity=0.385  Sum_probs=208.5

Q ss_pred             hhcCCCCCc-ccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeE
Q 011250          131 ATRNFRPES-LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (490)
Q Consensus       131 ~~~~y~~~~-~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~  207 (490)
                      ..++|.+.+ .||+|+||.||+|.+....       ++..||||++.....  ...+++.+|+.+++.++||||++++++
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   86 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKK-------VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI   86 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSS-------SEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCC-------ceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            345788888 9999999999999765321       567899999976532  224678999999999999999999999


Q ss_pred             EEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecc
Q 011250          208 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DF  287 (490)
                      + ..+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        87 ~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Df  161 (291)
T 1xbb_A           87 C-EAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDF  161 (291)
T ss_dssp             E-ESSSEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCC
T ss_pred             E-CCCCcEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccC
Confidence            8 667889999999999999999654 46999999999999999999999988   999999999999999999999999


Q ss_pred             cCcccCCCCCcce-eeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccC
Q 011250          288 GLAKDAPEDGKTH-VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       288 G~a~~~~~~~~~~-~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      |++.......... ......||+.|+|||++.+..++.++||||||+++|+|++ |+.||......   ........   
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~~---  235 (291)
T 1xbb_A          162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAMLEK---  235 (291)
T ss_dssp             TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHHT---
T ss_pred             CcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHc---
Confidence            9998765433221 1223456789999999998889999999999999999999 99999754321   11111110   


Q ss_pred             CcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                                 .....++..++..+.+||.+||+.||.+||++.+|++.|+.+..
T Consensus       236 -----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  279 (291)
T 1xbb_A          236 -----------GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  279 (291)
T ss_dssp             -----------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -----------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                       00112233447889999999999999999999999999987643

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.5e-45  Score=365.84  Aligned_cols=274  Identities=31%  Similarity=0.420  Sum_probs=212.3

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEeC--
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED--  211 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--  211 (490)
                      |++.+.||+|+||.||+|.+....     ..++..||||++..... ...+.+.+|+.+++.++||||+++++++.+.  
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTN-----DGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA  107 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC-------CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred             HhhhheecCCCCeEEEEEEEccCC-----CCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence            589999999999999999765322     23788999999986643 3346789999999999999999999999884  


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      ...+|||||+++|+|.+++...  .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  182 (318)
T 3lxp_A          108 ASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK  182 (318)
T ss_dssp             TEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             ceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccc
Confidence            5789999999999999999654  4999999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCcc-eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          292 DAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       292 ~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ........ .......||..|+|||++.+..++.++|||||||++|+|++|..||....... .....+.... .....+
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~-~~~~~~  260 (318)
T 3lxp_A          183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQ-MTVLRL  260 (318)
T ss_dssp             ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHH-HHHHHH
T ss_pred             cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccc-hhHHHH
Confidence            77554322 22334568899999999999899999999999999999999999986421100 0000000000 000011


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                      ...+........+..++..+.+||.+||+.||.+|||+.++++.|+.+.+
T Consensus       261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  310 (318)
T 3lxp_A          261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE  310 (318)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            11122222223344557899999999999999999999999999987754

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-44  Score=360.23  Aligned_cols=266  Identities=24%  Similarity=0.372  Sum_probs=201.7

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcc--CCCCeeceeeEE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL--LHPNLVKLVGYC  208 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~~~~  208 (490)
                      ..++|++.+.||+|+||.||+|++.           +..||||++...   ....+..|.+++..+  +||||+++++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~  100 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR-----------GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAAD  100 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC-----------CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEE
Confidence            3457999999999999999999873           568999998643   234455666666554  899999999999


Q ss_pred             EeC----CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhc--------CCCCeeecCCCCCcEEE
Q 011250          209 IED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE--------AEKPVIYRDFKTSNILL  276 (490)
Q Consensus       209 ~~~----~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--------~~~~iiHrDlkp~NILl  276 (490)
                      ...    ...+|||||+++|+|.+++...  .+++..++.++.|++.||.|||+.        +   |+||||||+||||
T Consensus       101 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill  175 (337)
T 3mdy_A          101 IKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILV  175 (337)
T ss_dssp             EESCGGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEE
T ss_pred             ccCCCCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEE
Confidence            887    6789999999999999999554  699999999999999999999987        6   9999999999999


Q ss_pred             cCCCCeEEecccCcccCCCCCcce--eeeccccCCCccCcchhccCCCCcc------chhhHHHHHHHHHHhC-------
Q 011250          277 DADYNAKLSDFGLAKDAPEDGKTH--VSTRVMGTYGYAAPEYVMTGHLTSK------SDVYSFGVVLLEMLTG-------  341 (490)
Q Consensus       277 ~~~~~vkL~DFG~a~~~~~~~~~~--~~~~~~Gt~~y~aPE~l~~~~~~~~------sDvwSlGv~l~elltG-------  341 (490)
                      +.++.+||+|||+++.........  .....+||+.|+|||++.+..++..      +|||||||++|||++|       
T Consensus       176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~  255 (337)
T 3mdy_A          176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV  255 (337)
T ss_dssp             CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence            999999999999997664432221  1124579999999999987766655      9999999999999999       


Q ss_pred             ---CCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCC-ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011250          342 ---RRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHF-SIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  417 (490)
Q Consensus       342 ---~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~  417 (490)
                         ..||............ .. ....     .....+.+...+ ...++.++.+||.+||+.||.+|||+.+|+++|+.
T Consensus       256 ~~~~~p~~~~~~~~~~~~~-~~-~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  328 (337)
T 3mdy_A          256 EEYQLPYHDLVPSDPSYED-MR-EIVC-----IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK  328 (337)
T ss_dssp             CCCCCTTTTTSCSSCCHHH-HH-HHHT-----TSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             ccccccHhhhcCCCCchhh-hH-HHHh-----hhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence               5555433222211100 00 0000     000111111111 12568889999999999999999999999999998


Q ss_pred             Ccccc
Q 011250          418 LQNLK  422 (490)
Q Consensus       418 l~~~~  422 (490)
                      +.+..
T Consensus       329 l~~~~  333 (337)
T 3mdy_A          329 MSESQ  333 (337)
T ss_dssp             HHHTT
T ss_pred             HHhhc
Confidence            76543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.3e-45  Score=363.98  Aligned_cols=262  Identities=27%  Similarity=0.356  Sum_probs=207.3

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEe-
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE-  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-  210 (490)
                      .++|++.+.||+|+||.||+|.+..         ++..||||++........+.+.+|+.+++.++||||+++++++.. 
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   98 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLH---------DGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRE   98 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETT---------TCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecC---------CCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec
Confidence            4579999999999999999999865         577999999876665666789999999999999999999999873 


Q ss_pred             ---CCceEEEEEecCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 011250          211 ---DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       211 ---~~~~~lV~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL  284 (490)
                         ....++||||+++|+|.+++..   ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||
T Consensus        99 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl  175 (317)
T 2buj_A           99 RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVL  175 (317)
T ss_dssp             ETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEE
T ss_pred             cCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEE
Confidence               3478999999999999999865   3567999999999999999999999988   999999999999999999999


Q ss_pred             ecccCcccCCCCCcce-------eeeccccCCCccCcchhccCC---CCccchhhHHHHHHHHHHhCCCCCCCCCCCCcc
Q 011250          285 SDFGLAKDAPEDGKTH-------VSTRVMGTYGYAAPEYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH  354 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~-------~~~~~~Gt~~y~aPE~l~~~~---~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~  354 (490)
                      +|||++..........       ......||+.|+|||++....   ++.++|||||||++|+|++|+.||.........
T Consensus       176 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~  255 (317)
T 2buj_A          176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS  255 (317)
T ss_dssp             CCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC
T ss_pred             EecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch
Confidence            9999987653211000       012246799999999987543   688999999999999999999999531111100


Q ss_pred             hhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                       .......              ..........+..+.+||.+||+.||.+|||+.+|+++|+.+..
T Consensus       256 -~~~~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          256 -VALAVQN--------------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             -HHHHHHC--------------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             -hhHHhhc--------------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence             0000000              00111122346789999999999999999999999999998754

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.2e-44  Score=380.68  Aligned_cols=265  Identities=21%  Similarity=0.255  Sum_probs=212.6

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCC-CCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH-PNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~  210 (490)
                      .++|++.++||+|+||.||+|++..         ++..||||++......  .++..|+.+++.|.| ++|..+..++..
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~---------~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~   74 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQ---------TNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVE   74 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETT---------TCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECC---------CCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence            4679999999999999999999875         5779999998755332  357899999999986 566666667778


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---cCCCCeEEecc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDF  287 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl---~~~~~vkL~DF  287 (490)
                      .+..+|||||+ +++|.+++......+++..++.|+.||+.||.|||+.+   ||||||||+||||   +.++.+||+||
T Consensus        75 ~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DF  150 (483)
T 3sv0_A           75 GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDF  150 (483)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCC
T ss_pred             CCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeC
Confidence            88899999999 99999999766678999999999999999999999988   9999999999999   68899999999


Q ss_pred             cCcccCCCCCcc-----eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011250          288 GLAKDAPEDGKT-----HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       288 G~a~~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      |+++........     ......+||+.|+|||++.+..++.++|||||||+||||++|+.||.................
T Consensus       151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~  230 (483)
T 3sv0_A          151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE  230 (483)
T ss_dssp             TTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH
T ss_pred             CcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh
Confidence            999876543321     112357899999999999999999999999999999999999999987554333222221111


Q ss_pred             c-cCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcccc
Q 011250          363 H-LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLK  422 (490)
Q Consensus       363 ~-~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~~~  422 (490)
                      . +...  ..     .+    ...++.++.+||.+||+.||.+||++.+|++.|+.+....
T Consensus       231 ~~~~~~--~~-----~l----~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          231 KKVATS--IE-----AL----CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             HHHHSC--HH-----HH----HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             cccccc--HH-----HH----hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence            0 0000  00     00    0122678999999999999999999999999998775543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.8e-45  Score=367.36  Aligned_cols=265  Identities=22%  Similarity=0.297  Sum_probs=195.8

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ++|++.+.||+|+||.||+|++..         ++..||||++......  ..+.+.+|+.+++.++||||+++++++.+
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (329)
T 3gbz_A           34 DRYRRITKLGEGTYGEVYKAIDTV---------TNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH  104 (329)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE
T ss_pred             hhEEEEEEEEecCCeEEEEEEECC---------CCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec
Confidence            469999999999999999999876         6779999999765432  23567899999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-----CCCCeEEe
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD-----ADYNAKLS  285 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~-----~~~~vkL~  285 (490)
                      ++..+|||||++ |+|.+++... ..+++..++.|+.||+.||.|||+.+   |+||||||+||||+     .++.+||+
T Consensus       105 ~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~  179 (329)
T 3gbz_A          105 NHRLHLIFEYAE-NDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIG  179 (329)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEEC
T ss_pred             CCEEEEEEecCC-CCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEEC
Confidence            999999999996 5999998654 46999999999999999999999988   99999999999994     45569999


Q ss_pred             cccCcccCCCCCcceeeeccccCCCccCcchhccC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc
Q 011250          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      |||+++.......  .....+||+.|+|||++.+. .++.++|||||||++|||++|..||...........+.... ..
T Consensus       180 Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~  256 (329)
T 3gbz_A          180 DFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL-GL  256 (329)
T ss_dssp             CTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH-CC
T ss_pred             cCCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHh-CC
Confidence            9999986643221  22345789999999999864 58999999999999999999999997543221111100000 00


Q ss_pred             CCcch-------------hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          365 GDKRR-------------FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       365 ~~~~~-------------~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .....             +.......+...+....+.++.+||.+||+.||.+|||+.|++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence            00000             000000000000111236789999999999999999999999975

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=8.7e-45  Score=355.07  Aligned_cols=253  Identities=23%  Similarity=0.346  Sum_probs=206.8

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      .++|++.+.||+|+||.||+|.+..         ++..||+|++.....  ...+.+.+|+.+++.++||||+++++++.
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   75 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKT---------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ   75 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcC---------CCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence            4679999999999999999999876         577899999975432  33467889999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCC---eEEec
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN---AKLSD  286 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~---vkL~D  286 (490)
                      +.+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.   +||+|
T Consensus        76 ~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~D  151 (284)
T 3kk8_A           76 EESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLAD  151 (284)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECC
T ss_pred             cCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEee
Confidence            999999999999999999988655 46999999999999999999999988   999999999999976655   99999


Q ss_pred             ccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011250          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      ||++........   .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......   ..........  
T Consensus       152 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~~--  223 (284)
T 3kk8_A          152 FGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQIKAGA--  223 (284)
T ss_dssp             CTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHTC--
T ss_pred             ceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh---HHHHHHHhcc--
Confidence            999987654322   23467999999999999999999999999999999999999999653221   1111110000  


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                       .        ..........+.++.+||.+||+.||.+|||+.+++++
T Consensus       224 -~--------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          224 -Y--------DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             -C--------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             -c--------cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence             0        00000112336789999999999999999999999975

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.9e-45  Score=383.32  Aligned_cols=259  Identities=27%  Similarity=0.404  Sum_probs=207.1

Q ss_pred             HHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       129 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      .+..++|++.+.||+|+||.||+|.+..          +..||||+++... ...+++.+|+.+|+.|+||||+++++++
T Consensus       180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~  248 (452)
T 1fmk_A          180 EIPRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV  248 (452)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccChhHceeeeeecCCCCeEEEEEEECC----------CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            3445679999999999999999998863          3469999998654 3457899999999999999999999998


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DF  287 (490)
                      .+ +..+|||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+||
T Consensus       249 ~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~Df  324 (452)
T 1fmk_A          249 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADF  324 (452)
T ss_dssp             CS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCC
T ss_pred             cC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCC
Confidence            76 6789999999999999999643 346999999999999999999999988   999999999999999999999999


Q ss_pred             cCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCC
Q 011250          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      |+++....... .......+++.|+|||++....++.++|||||||+||||++ |+.||......   ........    
T Consensus       325 G~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i~~----  396 (452)
T 1fmk_A          325 GLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQVER----  396 (452)
T ss_dssp             CTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHHT----
T ss_pred             ccceecCCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHc----
Confidence            99987654322 12233457889999999999999999999999999999999 99999754221   11111110    


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                                ......+..++..+.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus       397 ----------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          397 ----------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             ----------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             ----------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence                      01112233457889999999999999999999999999998754

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.3e-45  Score=368.01  Aligned_cols=244  Identities=23%  Similarity=0.302  Sum_probs=204.4

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--------cHHHHHHHHHHHhccCCCCeec
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--------GHKEWLAEVNFLGNLLHPNLVK  203 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~Ei~il~~l~HpnIv~  203 (490)
                      .++|++.+.||+|+||.||+|++..         ++..||||++......        ....+.+|+.+|+.++||||++
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~   93 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKE---------KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIK   93 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETT---------TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCC
T ss_pred             ccceEEEeEEEecCCEEEEEEEECC---------CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEee
Confidence            3579999999999999999999876         6779999999765321        2235678999999999999999


Q ss_pred             eeeEEEeCCceEEEEEecCCC-ChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCe
Q 011250          204 LVGYCIEDDQRLLVYEFMPRG-SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       204 l~~~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~v  282 (490)
                      +++++.+.+..++||||+.+| +|.+++... ..+++..++.|+.||+.||.|||+.+   |+||||||+||||+.++.+
T Consensus        94 ~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~  169 (335)
T 3dls_A           94 VLDIFENQGFFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTI  169 (335)
T ss_dssp             EEEEEECSSEEEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCE
T ss_pred             EEEEEeeCCEEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcE
Confidence            999999999999999999777 999988544 47999999999999999999999988   9999999999999999999


Q ss_pred             EEecccCcccCCCCCcceeeeccccCCCccCcchhccCCC-CccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011250          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~  361 (490)
                      ||+|||+++.......   ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.....        ...
T Consensus       170 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~  238 (335)
T 3dls_A          170 KLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------TVE  238 (335)
T ss_dssp             EECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------GTT
T ss_pred             EEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------HHh
Confidence            9999999987654322   234679999999999988776 7899999999999999999999964210        000


Q ss_pred             cccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                      .          ..      ..+...+.++.+||.+||+.||.+|||+.+++++-
T Consensus       239 ~----------~~------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp  276 (335)
T 3dls_A          239 A----------AI------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDP  276 (335)
T ss_dssp             T----------CC------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred             h----------cc------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence            0          00      01112367899999999999999999999999874

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.1e-45  Score=367.48  Aligned_cols=267  Identities=22%  Similarity=0.319  Sum_probs=199.2

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccH-HHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      ++|++.+.||+|+||.||+|++..         ++..||||++........ ..+.+|+.+++.++||||+++++++.+.
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   72 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKL---------TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE   72 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS
T ss_pred             CceEEEEEEcCCCCEEEEEEEECC---------CCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC
Confidence            479999999999999999999876         567899999975432211 2356799999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      +..+|||||++ |+|.+++......+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        73 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  148 (324)
T 3mtl_A           73 KSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLAR  148 (324)
T ss_dssp             SCEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEE
T ss_pred             CEEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccc
Confidence            99999999996 6999999877778999999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc-------
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH-------  363 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~-------  363 (490)
                      .......  .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+......       
T Consensus       149 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  226 (324)
T 3mtl_A          149 AKSIPTK--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP  226 (324)
T ss_dssp             CC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             cccCCcc--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhch
Confidence            6543222  2234578999999999876 57899999999999999999999999764322211111000000       


Q ss_pred             -cCCcchhhhccCCccCC----CCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          364 -LGDKRRFYRLLDPRLEG----HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       364 -~~~~~~~~~~~~~~l~~----~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                       ......+.....+....    ......+.++.+||.+||+.||.+|||+.|++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          227 GILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             TGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence             00000000000000000    0011236788999999999999999999999975

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=5.9e-45  Score=370.10  Aligned_cols=260  Identities=17%  Similarity=0.185  Sum_probs=208.0

Q ss_pred             HHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccC---CCCeecee
Q 011250          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL---HPNLVKLV  205 (490)
Q Consensus       129 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~  205 (490)
                      ....++|.+.+.||+|+||+||+|.+....    ...++..||||++....   ..++..|++++..+.   |+||+.++
T Consensus        61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~  133 (365)
T 3e7e_A           61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLN----DAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFY  133 (365)
T ss_dssp             ECSSSEEEEEEEEEECSSEEEEEEEC-----------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred             EECCEEEEEEEEeeccCCEEEEEEEecCCc----ccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence            345678999999999999999999643211    11267789999997653   456777888888776   99999999


Q ss_pred             eEEEeCCceEEEEEecCCCChhHHhhh----cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---
Q 011250          206 GYCIEDDQRLLVYEFMPRGSLENHLFR----RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---  278 (490)
Q Consensus       206 ~~~~~~~~~~lV~E~~~~gsL~~~l~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~---  278 (490)
                      +++...+..|||||||++|+|.+++..    ....+++..++.|+.||+.||+|||+.+   ||||||||+||||+.   
T Consensus       134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~  210 (365)
T 3e7e_A          134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFL  210 (365)
T ss_dssp             EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGT
T ss_pred             eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEeccccc
Confidence            999999999999999999999999964    3457999999999999999999999988   999999999999998   


Q ss_pred             --------CCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCC
Q 011250          279 --------DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP  350 (490)
Q Consensus       279 --------~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~  350 (490)
                              ++.+||+|||+|+..............+||+.|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus       211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~  290 (365)
T 3e7e_A          211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG  290 (365)
T ss_dssp             CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred             CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence                    899999999999765432333344567899999999999999999999999999999999999999853221


Q ss_pred             CCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCC-CCHHHHHHHhhcCcc
Q 011250          351 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR-PRMSEVVETLKPLQN  420 (490)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~R-Pt~~evl~~L~~l~~  420 (490)
                      ...      .             +...+.. +  ..+..+.+++..||+.+|.+| |++.++.+.|+.+..
T Consensus       291 ~~~------~-------------~~~~~~~-~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~  339 (365)
T 3e7e_A          291 GEC------K-------------PEGLFRR-L--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ  339 (365)
T ss_dssp             TEE------E-------------ECSCCTT-C--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred             Cce------e-------------echhccc-c--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence            100      0             0000000 0  126788999999999999999 688888888876543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=8.6e-45  Score=385.83  Aligned_cols=255  Identities=27%  Similarity=0.390  Sum_probs=209.5

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      .++|.+.++||+|+||.||+|++..         +|+.||||++.....   .....+.+|+.+|+.++||||+++++++
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~---------tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~  254 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKA---------TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF  254 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECC---------CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            4689999999999999999999876         677999999975422   2346788999999999999999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhc---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEe
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~  285 (490)
                      .+.+.+||||||++||+|.+++...   ...+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+
T Consensus       255 ~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~  331 (543)
T 3c4z_A          255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRIS  331 (543)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEEC
T ss_pred             eeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEe
Confidence            9999999999999999999998654   346999999999999999999999988   9999999999999999999999


Q ss_pred             cccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011250          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      |||+++........  ....+||+.|+|||++.+..|+.++|||||||+||||++|+.||..........  +.....+ 
T Consensus       332 DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~--~~~~~i~-  406 (543)
T 3c4z_A          332 DLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELKQRVL-  406 (543)
T ss_dssp             CCTTCEECCTTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHH--HHHHHHH-
T ss_pred             ecceeeeccCCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHH--HHHHHHh-
Confidence            99999876543221  234689999999999999999999999999999999999999997653221111  1111111 


Q ss_pred             CcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 011250          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM-----SEVVET  414 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~-----~evl~~  414 (490)
                               ..  ...++...+..+.+||.+||+.||.+||++     .+|++|
T Consensus       407 ---------~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          407 ---------EQ--AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             ---------HC--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             ---------hc--ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence                     00  012233447899999999999999999975     666654

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=391.99  Aligned_cols=258  Identities=24%  Similarity=0.383  Sum_probs=206.8

Q ss_pred             cCCCCCc-ccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPES-LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~-~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ++|.+.+ .||+|+||.||+|.+...+       ++..||||+++... ....+++.+|+++|+.++|||||++++++..
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  407 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRK-------KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA  407 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSS-------CEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCC-------CcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence            3445555 7999999999999886422       45689999997653 2356789999999999999999999999876


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                       +..+||||||++|+|.+++......+++..++.|+.||+.||+|||+.+   ||||||||+||||+.++.+||+|||++
T Consensus       408 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla  483 (613)
T 2ozo_A          408 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLS  483 (613)
T ss_dssp             -SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTT
T ss_pred             -CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCc
Confidence             5689999999999999999777778999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcc-eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          291 KDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       291 ~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +........ .......+|+.|+|||++.+..++.++|||||||+||||++ |+.||.......   +......      
T Consensus       484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~~i~~------  554 (613)
T 2ozo_A          484 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIEQ------  554 (613)
T ss_dssp             TTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HHHHHHT------
T ss_pred             ccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHc------
Confidence            876433221 11122346789999999999999999999999999999998 999997643221   1111111      


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                              .....++..++.++.+||.+||..||.+||++.+|++.|+.+
T Consensus       555 --------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          555 --------GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             --------TCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             --------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                    011123344578999999999999999999999999999865

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.2e-45  Score=374.31  Aligned_cols=276  Identities=23%  Similarity=0.276  Sum_probs=214.8

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .++|.+.++||+|+||.||+|++..         ++..||||++.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~   78 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKK---------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE   78 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECC---------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc
Confidence            3579999999999999999999876         57799999997543 2345678899999999999999999999987


Q ss_pred             CC--ceEEEEEecCCCChhHHhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE----cCCCCe
Q 011250          211 DD--QRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL----DADYNA  282 (490)
Q Consensus       211 ~~--~~~lV~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl----~~~~~v  282 (490)
                      .+  ..+||||||++|+|.+++....  ..+++..++.++.||+.||.|||+.+   |+||||||+|||+    +.++.+
T Consensus        79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~  155 (396)
T 4eut_A           79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVY  155 (396)
T ss_dssp             TTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEE
T ss_pred             CCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeE
Confidence            65  6799999999999999996533  23999999999999999999999988   9999999999999    777889


Q ss_pred             EEecccCcccCCCCCcceeeeccccCCCccCcchhcc--------CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCc-
Q 011250          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT--------GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-  353 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--------~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~-  353 (490)
                      ||+|||+++.......   ....+||+.|+|||++..        ..++.++|||||||++|||++|+.||........ 
T Consensus       156 kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~  232 (396)
T 4eut_A          156 KLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN  232 (396)
T ss_dssp             EECCGGGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC
T ss_pred             EEecCCCceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch
Confidence            9999999987654321   234679999999999865        5678899999999999999999999975432221 


Q ss_pred             chhhHhhhcccCCc--chhhh--------ccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcccc
Q 011250          354 HNLVEWARPHLGDK--RRFYR--------LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLK  422 (490)
Q Consensus       354 ~~~~~~~~~~~~~~--~~~~~--------~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~~~  422 (490)
                      ..............  .....        ..+......++...+..+.+|+.+||+.||.+||++.++++.|..+.+.+
T Consensus       233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~  311 (396)
T 4eut_A          233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM  311 (396)
T ss_dssp             HHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred             HHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence            11111111000000  00000        00011122445667889999999999999999999999999998765543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6e-45  Score=367.51  Aligned_cols=270  Identities=25%  Similarity=0.317  Sum_probs=201.9

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-----HHHHHHHHHHHhccCCCCeecee
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-----HKEWLAEVNFLGNLLHPNLVKLV  205 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~Ei~il~~l~HpnIv~l~  205 (490)
                      ..++|++.+.||+|+||.||+|.+..         +|..||||++.......     .+.+.+|+.+++.++||||++++
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   78 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKN---------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLL   78 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSS---------CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEE
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECC---------CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEE
Confidence            45689999999999999999998875         57799999997543221     23678999999999999999999


Q ss_pred             eEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEe
Q 011250          206 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       206 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~  285 (490)
                      +++.+.+..++||||+++ +|.+++......+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        79 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~  154 (346)
T 1ua2_A           79 DAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLA  154 (346)
T ss_dssp             EEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             EEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEE
Confidence            999999999999999975 899988776677999999999999999999999988   9999999999999999999999


Q ss_pred             cccCcccCCCCCcceeeeccccCCCccCcchhccC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhh-Hhh-hc
Q 011250          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWA-RP  362 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~-~~~-~~  362 (490)
                      |||+++.......  .....+||+.|+|||++.+. .++.++|||||||++|||++|.+||...........+ ... .+
T Consensus       155 Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~  232 (346)
T 1ua2_A          155 DFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP  232 (346)
T ss_dssp             CCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             ecccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            9999987644322  22346799999999998754 5899999999999999999999999764321111100 000 00


Q ss_pred             ccCCcchhhhccCCccCCC--------CChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          363 HLGDKRRFYRLLDPRLEGH--------FSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~~--------~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                      ............+......        .....+.++.+||.+||..||.+|||+.|++++-
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~  293 (346)
T 1ua2_A          233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK  293 (346)
T ss_dssp             CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred             ChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence            0000000000000000000        0123368899999999999999999999999764

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.2e-45  Score=376.99  Aligned_cols=242  Identities=18%  Similarity=0.198  Sum_probs=191.4

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC---CcccHHHHHHHH---HHHhccCCCCeecee
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD---GLQGHKEWLAEV---NFLGNLLHPNLVKLV  205 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~Ei---~il~~l~HpnIv~l~  205 (490)
                      .++|.+.+.||+|+||.||+|++..         +|..||||++...   .....+.+.+|+   ++|+.++|||||+++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~  142 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQE---------TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH  142 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-C---------CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred             CceEEEcceeecCCCEEEEEEEECC---------CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHH
Confidence            4679999999999999999999865         5779999999743   233457788999   455556799999998


Q ss_pred             -------eEEEeCC-----------------ceEEEEEecCCCChhHHhhhcCC------CCCHHHHHHHHHHHHHHHHH
Q 011250          206 -------GYCIEDD-----------------QRLLVYEFMPRGSLENHLFRRSL------PLPWSIRMKIALGAAKGLAF  255 (490)
Q Consensus       206 -------~~~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~~------~l~~~~~~~i~~qi~~aL~y  255 (490)
                             +++.+.+                 ..||||||+ +|+|.+++.....      .+++..++.|+.||+.||+|
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~  221 (377)
T 3byv_A          143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS  221 (377)
T ss_dssp             HCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHH
Confidence                   6665553                 278999999 6899999965421      23358888999999999999


Q ss_pred             hhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccC-----------CCCc
Q 011250          256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-----------HLTS  324 (490)
Q Consensus       256 LH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-----------~~~~  324 (490)
                      ||+.+   |+||||||+||||+.++.+||+|||+++....     .....+| +.|+|||++.+.           .++.
T Consensus       222 LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~  292 (377)
T 3byv_A          222 LHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTF  292 (377)
T ss_dssp             HHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCH
T ss_pred             HHhCC---eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCCh
Confidence            99988   99999999999999999999999999986432     2234678 999999999887           8999


Q ss_pred             cchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCC
Q 011250          325 KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA  404 (490)
Q Consensus       325 ~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~  404 (490)
                      ++|||||||+||||++|+.||...........+                ..      .....+.++.+||.+||+.||.+
T Consensus       293 ~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~----------------~~------~~~~~~~~~~~li~~~L~~dp~~  350 (377)
T 3byv_A          293 SFDAWALGLVIYWIWCADLPITKDAALGGSEWI----------------FR------SCKNIPQPVRALLEGFLRYPKED  350 (377)
T ss_dssp             HHHHHHHHHHHHHHHHSSCCC------CCSGGG----------------GS------SCCCCCHHHHHHHHHHTCSSGGG
T ss_pred             hhhHHHHHHHHHHHHHCCCCCcccccccchhhh----------------hh------hccCCCHHHHHHHHHHcCCCchh
Confidence            999999999999999999999654322211110                00      00123678999999999999999


Q ss_pred             CCCHHHHHHH
Q 011250          405 RPRMSEVVET  414 (490)
Q Consensus       405 RPt~~evl~~  414 (490)
                      |||+.+++++
T Consensus       351 Rpt~~e~l~h  360 (377)
T 3byv_A          351 RLLPLQAMET  360 (377)
T ss_dssp             CCCHHHHHTS
T ss_pred             CCCHHHHhhC
Confidence            9999999974

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=9e-45  Score=359.07  Aligned_cols=251  Identities=23%  Similarity=0.327  Sum_probs=205.0

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      ++|.+.+.||+|+||.||+|++..         +|+.||||++........+.+.+|+.+++.++||||+++++++.+.+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   79 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRL---------TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTT   79 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             ccceeeeeccCCCCceEEEEEECC---------CCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCC
Confidence            469999999999999999999875         57789999998665445567889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---cCCCCeEEecccC
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGL  289 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl---~~~~~vkL~DFG~  289 (490)
                      ..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+|||+
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~  155 (304)
T 2jam_A           80 HYYLVMQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGL  155 (304)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCST
T ss_pred             EEEEEEEcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCc
Confidence            999999999999999998654 46999999999999999999999988   9999999999999   7889999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +.......    .....||+.|+|||++.+..++.++|||||||++|+|++|..||......   .+........     
T Consensus       156 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~-----  223 (304)
T 2jam_A          156 SKMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLFEKIKEGY-----  223 (304)
T ss_dssp             TCCCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHCC-----
T ss_pred             ceecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHcCC-----
Confidence            97654321    23357999999999999889999999999999999999999999654221   1111111000     


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                            ......+....+..+.+||.+||..||.+|||+.+++++
T Consensus       224 ------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          224 ------YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             ------CCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             ------CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                  001111222347889999999999999999999999975

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.9e-45  Score=362.65  Aligned_cols=277  Identities=25%  Similarity=0.374  Sum_probs=215.4

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      .++|++.+.||+|+||.||+|++...     ...++..||||++........+.+.+|+.+++.++||||+++++++...
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  114 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPL-----QDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA  114 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTT-----SSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccc-----cCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence            34689999999999999999986431     1226889999999877666667899999999999999999999998765


Q ss_pred             C--ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          212 D--QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       212 ~--~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +  ..++||||+++++|.+++......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~  191 (326)
T 2w1i_A          115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGL  191 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcc
Confidence            4  789999999999999999877667999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcce-eeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc-
Q 011250          290 AKDAPEDGKTH-VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK-  367 (490)
Q Consensus       290 a~~~~~~~~~~-~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~-  367 (490)
                      +.......... ......|+..|+|||++.+..++.++|||||||++|||++|..||.....    ............. 
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~----~~~~~~~~~~~~~~  267 (326)
T 2w1i_A          192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA----EFMRMIGNDKQGQM  267 (326)
T ss_dssp             CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH----HHHHHHCTTCCTHH
T ss_pred             hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH----HHHHhhccccchhh
Confidence            98775443221 12234678889999999988899999999999999999999998753210    0000000000000 


Q ss_pred             --chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          368 --RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       368 --~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                        ..+...+........+..++.++.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          268 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence              00001111111112234457899999999999999999999999999987653

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.2e-45  Score=370.25  Aligned_cols=266  Identities=25%  Similarity=0.365  Sum_probs=206.4

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .++|++.+.||+|+||.||+|.+..         ++..||+|++..... ...+.+.+|+.+++.++||||+++++++.+
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  102 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKP---------SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS  102 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECC---------CCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE
Confidence            4679999999999999999999876         577999999976532 334678999999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      ++..+|||||+++++|.+++... ..+++..+..++.||+.||.|||+. +   |+||||||+||||+.++.+||+|||+
T Consensus       103 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~  178 (360)
T 3eqc_A          103 DGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGV  178 (360)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred             CCEEEEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCC
Confidence            99999999999999999999654 3699999999999999999999995 7   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--------
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--------  361 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~--------  361 (490)
                      +......    ......||+.|+|||++.+..++.++|||||||++|+|++|+.||................        
T Consensus       179 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  254 (360)
T 3eqc_A          179 SGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP  254 (360)
T ss_dssp             CHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------
T ss_pred             Ccccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCC
Confidence            8754221    1234679999999999999999999999999999999999999997543211100000000        


Q ss_pred             --------------cccCCcchhhh----ccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          362 --------------PHLGDKRRFYR----LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       362 --------------~~~~~~~~~~~----~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                                    ...........    +.............+.++.+||.+||+.||.+|||+.+++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          255 PRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             -------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                          00000000000    000000111112246789999999999999999999999975

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.6e-44  Score=374.02  Aligned_cols=256  Identities=25%  Similarity=0.346  Sum_probs=196.0

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--------ccHHHHHHHHHHHhccCCCCe
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--------QGHKEWLAEVNFLGNLLHPNL  201 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~Ei~il~~l~HpnI  201 (490)
                      ...++|.+.+.||+|+||.||+|++..         ++..||||++.....        .....+.+|+.+|+.++||||
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  202 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERK---------TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI  202 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTB
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECC---------CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCE
Confidence            345789999999999999999999876         677999999875421        112347899999999999999


Q ss_pred             eceeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC--
Q 011250          202 VKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD--  279 (490)
Q Consensus       202 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~--  279 (490)
                      +++++++. .+..+|||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.+  
T Consensus       203 v~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~  277 (419)
T 3i6u_A          203 IKIKNFFD-AEDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEE  277 (419)
T ss_dssp             CCCCEEEE-SSEEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSS
T ss_pred             eeEEEEEe-cCceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCC
Confidence            99999975 45689999999999999988544 57999999999999999999999988   9999999999999654  


Q ss_pred             -CCeEEecccCcccCCCCCcceeeeccccCCCccCcchhcc---CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcch
Q 011250          280 -YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN  355 (490)
Q Consensus       280 -~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~---~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~  355 (490)
                       +.+||+|||+++......   .....+||+.|+|||++.+   ..++.++|||||||+||+|++|..||........  
T Consensus       278 ~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--  352 (419)
T 3i6u_A          278 DCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--  352 (419)
T ss_dssp             SCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--
T ss_pred             cceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--
Confidence             459999999998765432   2344689999999999853   6788999999999999999999999975432211  


Q ss_pred             hhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                      +..........   +    .+..    ....+..+.+||.+||+.||.+|||+.+++++-
T Consensus       353 ~~~~i~~~~~~---~----~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp  401 (419)
T 3i6u_A          353 LKDQITSGKYN---F----IPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRHP  401 (419)
T ss_dssp             HHHHHHTTCCC---C----CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             HHHHHhcCCCC---C----Cchh----hcccCHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence            11111110000   0    0000    012367899999999999999999999999863

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=358.41  Aligned_cols=253  Identities=31%  Similarity=0.502  Sum_probs=198.0

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      ++|++.+.||+|+||.||+|.+.           +..||||++...  ...+.+.+|+.+++.++||||+++++++.  +
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~   72 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-----------AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--N   72 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-----------TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--T
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-----------CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--C
Confidence            46899999999999999999873           457999999754  34567899999999999999999999876  4


Q ss_pred             ceEEEEEecCCCChhHHhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCC-eEEecccC
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSL--PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN-AKLSDFGL  289 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~-vkL~DFG~  289 (490)
                      ..+|||||+++|+|.+++.....  .+++..++.++.||+.||.|||+.+.++|+||||||+|||++.++. +||+|||+
T Consensus        73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~  152 (307)
T 2eva_A           73 PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT  152 (307)
T ss_dssp             TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred             CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence            58999999999999999965432  4788999999999999999999943233999999999999998887 79999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ... +... ..    
T Consensus       153 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~-~~~~-~~----  220 (307)
T 2eva_A          153 ACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-RIM-WAVH-NG----  220 (307)
T ss_dssp             -----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH-HHH-HHHH-TT----
T ss_pred             ccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH-HHH-HHHh-cC----
Confidence            9765332     1235699999999999999999999999999999999999999975422111 010 1000 00    


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                          .    ........+..+.+||.+||+.||.+|||+.++++.|+.+..
T Consensus       221 ----~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  263 (307)
T 2eva_A          221 ----T----RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR  263 (307)
T ss_dssp             ----C----CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred             ----C----CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence                0    011122346789999999999999999999999999987644

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.4e-44  Score=365.13  Aligned_cols=269  Identities=24%  Similarity=0.319  Sum_probs=204.5

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ++|++.+.||+|+||.||+|++..         +|..||||++.....  .....+.+|+.+++.++||||+++++++..
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   87 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRK---------TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT   87 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETT---------TCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             cceeEEEEEecCCCcEEEEEEECC---------CCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeec
Confidence            479999999999999999999876         577999999865532  223578899999999999999999999987


Q ss_pred             C--------CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCe
Q 011250          211 D--------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       211 ~--------~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~v  282 (490)
                      .        +..+|||||++ |+|.+.+......+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+
T Consensus        88 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~  163 (351)
T 3mi9_A           88 KASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVL  163 (351)
T ss_dssp             C--------CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCE
T ss_pred             cccccccCCceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCE
Confidence            4        46899999996 5888888776678999999999999999999999988   9999999999999999999


Q ss_pred             EEecccCcccCCCCCc--ceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 011250          283 KLSDFGLAKDAPEDGK--THVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW  359 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~--~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~  359 (490)
                      ||+|||+++.......  .......+||+.|+|||++.+ ..++.++|||||||++|||++|.+||...........+..
T Consensus       164 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~  243 (351)
T 3mi9_A          164 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ  243 (351)
T ss_dssp             EECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             EEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence            9999999987643221  122234678999999998876 4689999999999999999999999976433221111111


Q ss_pred             hhcccCC-----cc--hhhhccCCccCCCCCh-------hhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          360 ARPHLGD-----KR--RFYRLLDPRLEGHFSI-------KGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       360 ~~~~~~~-----~~--~~~~~~~~~l~~~~~~-------~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .......     ..  .....+..........       ..+..+.+||.+||+.||.+|||+.|++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             HHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            1000000     00  0000000000000000       014668999999999999999999999976

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2e-44  Score=357.86  Aligned_cols=259  Identities=23%  Similarity=0.276  Sum_probs=201.9

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|++.+.||+|+||.||+|.+..         ++..||||++......   ..+.+.+|+.++..++||||+++++++.
T Consensus        34 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~  104 (309)
T 2h34_A           34 GPYRLRRLVGRGGMGDVYEAEDTV---------RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGE  104 (309)
T ss_dssp             CCEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             ccEEEEEEEcCCCCeeEEEEEEcC---------CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe
Confidence            579999999999999999999875         5778999999765332   2367889999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      .++..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       105 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~  180 (309)
T 2h34_A          105 IDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGI  180 (309)
T ss_dssp             ETTEEEEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC
T ss_pred             eCCeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCcc
Confidence            999999999999999999998654 46999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +......... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......   .+..........   
T Consensus       181 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~---  253 (309)
T 2h34_A          181 ASATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---VMGAHINQAIPR---  253 (309)
T ss_dssp             -----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HHHHHHHSCCCC---
T ss_pred             Cccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---HHHHHhccCCCC---
Confidence            9876543221 223457999999999999899999999999999999999999999753211   111111000000   


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCC-CHHHHHHHhhcCcc
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-RMSEVVETLKPLQN  420 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-t~~evl~~L~~l~~  420 (490)
                               ...++...+..+.+||.+||+.||.+|| +++++++.|+.+..
T Consensus       254 ---------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~  296 (309)
T 2h34_A          254 ---------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA  296 (309)
T ss_dssp             ---------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred             ---------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence                     0112223467899999999999999999 99999999986644

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=7.4e-45  Score=365.20  Aligned_cols=250  Identities=26%  Similarity=0.377  Sum_probs=207.4

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      .++|.+.+.||+|+||.||+|.+..         ++..||+|++.....   ...+.+.+|+.+++.+.||||+++++++
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  110 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDAD---------TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF  110 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            3579999999999999999999876         567899999875432   3346788999999999999999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      .+.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg  186 (335)
T 2owb_A          111 EDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFG  186 (335)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCT
T ss_pred             ecCCeEEEEEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeecc
Confidence            9999999999999999999988654 47999999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ++.........  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   .......   .  
T Consensus       187 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~---~--  256 (335)
T 2owb_A          187 LATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---TYLRIKK---N--  256 (335)
T ss_dssp             TCEECCSTTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHH---T--
T ss_pred             CceecccCccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHHhc---C--
Confidence            99876433221  234679999999999998899999999999999999999999996532111   1100000   0  


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                            .    ..++...+..+.+||.+||+.||.+||++.+++++
T Consensus       257 ------~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          257 ------E----YSIPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             ------C----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ------C----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  0    01122336789999999999999999999999864

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.6e-45  Score=358.79  Aligned_cols=262  Identities=26%  Similarity=0.404  Sum_probs=202.2

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|++.+.||+|+||.||+|.+....      +.+..||||++....   ....+.+.+|+.+++.++||||+++++++.
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   91 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL   91 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTT------SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCC------CceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence            47999999999999999999875421      134479999987543   234567899999999999999999999988


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +.. .++||||+++++|.+++......+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        92 ~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~  167 (291)
T 1u46_A           92 TPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGL  167 (291)
T ss_dssp             SSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             cCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccc
Confidence            765 89999999999999999776667999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcce-eeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCc
Q 011250          290 AKDAPEDGKTH-VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       290 a~~~~~~~~~~-~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      +.......... ......||+.|+|||++.+..++.++||||||+++|+|++ |+.||......   .......   .. 
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~---~~-  240 (291)
T 1u46_A          168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILHKID---KE-  240 (291)
T ss_dssp             CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHH---TS-
T ss_pred             cccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH---HHHHHHH---cc-
Confidence            98775433221 2234567889999999998889999999999999999999 99999754321   1111110   00 


Q ss_pred             chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                               ......+...+..+.+||.+||..||.+|||+.++++.|++++.
T Consensus       241 ---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          241 ---------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             ---------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             ---------CCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence                     00111223347889999999999999999999999999987654

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=9.3e-45  Score=355.27  Aligned_cols=247  Identities=25%  Similarity=0.367  Sum_probs=206.4

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|.+.+.||+|+||.||+|.+..         ++..||||++....   ......+.+|+.+++.++||||+++++++.
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   84 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQ---------NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH   84 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcC---------CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE
Confidence            579999999999999999999875         56789999986532   123467889999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +.+..++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~  160 (284)
T 2vgo_A           85 DRKRIYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGW  160 (284)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             cCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccc
Confidence            999999999999999999998655 36999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +.......    .....||+.|+|||++.+..++.++||||||+++|+|++|..||.......   ...   ..      
T Consensus       161 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~---~~------  224 (284)
T 2vgo_A          161 SVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE---THR---RI------  224 (284)
T ss_dssp             CEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH---HH------
T ss_pred             cccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH---HHH---HH------
Confidence            97654322    233679999999999999899999999999999999999999997532111   110   00      


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                          ...  ...++...+..+.+||.+||+.||.+||++.+++++
T Consensus       225 ----~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          225 ----VNV--DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             ----HTT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             ----hcc--ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence                000  011223346789999999999999999999999875

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.1e-44  Score=356.46  Aligned_cols=250  Identities=26%  Similarity=0.369  Sum_probs=207.1

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      .++|.+.+.||+|+||.||+|.+..         ++..||+|++.....   ...+.+.+|+.+++.+.||||+++++++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   84 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDAD---------TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF   84 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECC---------CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence            3579999999999999999999876         567899999875432   3346688999999999999999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      .+.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg  160 (294)
T 2rku_A           85 EDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFG  160 (294)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred             ccCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEecc
Confidence            9999999999999999999988554 47999999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ++.........  .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.......   .....   .    
T Consensus       161 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~---~----  228 (294)
T 2rku_A          161 LATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---TYLRI---K----  228 (294)
T ss_dssp             TCEECCSTTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHH---H----
T ss_pred             CceecccCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH---h----
Confidence            99876433221  234679999999999998889999999999999999999999996532111   00000   0    


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                            ..  ...++...+..+.+||.+||+.||.+|||+.+++++
T Consensus       229 ------~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          229 ------KN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             ------TT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ------hc--cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                  00  001222346789999999999999999999999865

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=8.3e-45  Score=354.51  Aligned_cols=251  Identities=28%  Similarity=0.440  Sum_probs=200.4

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      .++|++.+.||+|+||.||+|.+           +|..||||++....  ..+.+.+|+.+++.++||||+++++++.+.
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   86 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE   86 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-----------TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred             hhhceEEeEEecCCCceEEEEEE-----------cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            45799999999999999999976           35689999997653  456789999999999999999999987655


Q ss_pred             -CceEEEEEecCCCChhHHhhhcCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          212 -DQRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       212 -~~~~lV~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                       +..++||||+++++|.+++..... .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~  163 (278)
T 1byg_A           87 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGL  163 (278)
T ss_dssp             --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred             CCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccc
Confidence             478999999999999999965432 3889999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +.......     ....+++.|+|||++.+..++.++||||||+++|+|++ |+.||......   ........      
T Consensus       164 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~~~------  229 (278)
T 1byg_A          164 TKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVEK------  229 (278)
T ss_dssp             -----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHHTT------
T ss_pred             cccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHhc------
Confidence            98654321     22467899999999999999999999999999999998 99999754321   11111100      


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                              ......+...+..+.+||.+||+.||.+||++.++++.|+.+..
T Consensus       230 --------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          230 --------GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             --------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------CCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence                    01112233447889999999999999999999999999987754

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.9e-45  Score=360.41  Aligned_cols=265  Identities=25%  Similarity=0.371  Sum_probs=189.4

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      +..++|++.+.||+|+||.||+|++..         ++..||||++..... ...+++.+|+.+++.++||||+++++++
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   82 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAP---------KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF   82 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC-------------CEEEEECCC----------------CCCCCCCTTBCCEEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECC---------CCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEE
Confidence            445789999999999999999998765         567899999875432 3346788999999999999999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhh-------cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCC
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFR-------RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~-------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                      ...+..++||||+++++|.+++..       ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus        83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~  159 (303)
T 2vwi_A           83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGS  159 (303)
T ss_dssp             ESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCC
T ss_pred             eecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCC
Confidence            999999999999999999999864       2456999999999999999999999988   999999999999999999


Q ss_pred             eEEecccCcccCCCCCc---ceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 011250          282 AKLSDFGLAKDAPEDGK---THVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV  357 (490)
Q Consensus       282 vkL~DFG~a~~~~~~~~---~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~  357 (490)
                      +||+|||++........   ........||+.|+|||++.. ..++.++|||||||++|+|++|+.||..........  
T Consensus       160 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--  237 (303)
T 2vwi_A          160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM--  237 (303)
T ss_dssp             EEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH--
T ss_pred             EEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH--
Confidence            99999999976643221   111234579999999999875 578999999999999999999999997643321111  


Q ss_pred             HhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          358 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ...........  ....++    ......+..+.+||.+||+.||.+||++.+++++
T Consensus       238 ~~~~~~~~~~~--~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          238 LTLQNDPPSLE--TGVQDK----EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             HHHTSSCCCTT--C---------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHhccCCCccc--cccccc----hhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            00000000000  000011    1112336789999999999999999999999975

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=8e-45  Score=364.10  Aligned_cols=267  Identities=27%  Similarity=0.402  Sum_probs=201.5

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ++|++.+.||+|+||.||+|++..         ++..||||++......  ..+.+.+|+.+++.++||||+++++++.+
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   95 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKD---------TGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK   95 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETT---------TCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECC---------CCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec
Confidence            469999999999999999999876         5779999998655332  24567899999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      .+..++||||+++++|.+++. ....+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus        96 ~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~  171 (331)
T 4aaa_A           96 KKRWYLVFEFVDHTILDDLEL-FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFA  171 (331)
T ss_dssp             TTEEEEEEECCSEEHHHHHHH-STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEecCCcchHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCc
Confidence            999999999999988887764 4457999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh-hcccC---
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-RPHLG---  365 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~-~~~~~---  365 (490)
                      +.......  ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+... .....   
T Consensus       172 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (331)
T 4aaa_A          172 RTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQ  249 (331)
T ss_dssp             --------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             eeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Confidence            87644322  22345799999999998865 7899999999999999999999999764322111100000 00000   


Q ss_pred             ----CcchhhhccCCccCCCC-----ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          366 ----DKRRFYRLLDPRLEGHF-----SIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 ----~~~~~~~~~~~~l~~~~-----~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                          ....+.....+.+....     ....+..+.+||.+||+.||.+|||+.|++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          250 ELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             HHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             hHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                00000000001111111     11347889999999999999999999999875

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-44  Score=367.82  Aligned_cols=262  Identities=24%  Similarity=0.333  Sum_probs=199.0

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      .++|++.+.||+|+||.||+|.+..         +|..||||++.....  ...+.+.+|+.+|+.++||||+++++++.
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~   94 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGR---------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT   94 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETT---------TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECC---------CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEe
Confidence            3579999999999999999999876         677999999965432  23467889999999999999999999998


Q ss_pred             eCC------ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeE
Q 011250          210 EDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       210 ~~~------~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vk  283 (490)
                      ...      .+||||||+ +++|.+++..  ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+|
T Consensus        95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~k  168 (367)
T 1cm8_A           95 PDETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELK  168 (367)
T ss_dssp             SCSSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEE
T ss_pred             cCCccccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEE
Confidence            763      459999999 8899998865  46999999999999999999999988   99999999999999999999


Q ss_pred             EecccCcccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011250          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      |+|||+++.....     ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.....
T Consensus       169 l~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g  243 (367)
T 1cm8_A          169 ILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG  243 (367)
T ss_dssp             ECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             EEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            9999999876432     234679999999999887 6899999999999999999999999976432211111000000


Q ss_pred             --------ccCC--cchhhhccC----CccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          363 --------HLGD--KRRFYRLLD----PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       363 --------~~~~--~~~~~~~~~----~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                              .+..  ...+...+.    ..+ ..+....+..+.+||.+||..||.+|||+.++++|
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          244 TPPAEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             CCCHHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCHHHHHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence                    0000  000000000    001 11122347889999999999999999999999986

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=8.3e-45  Score=397.05  Aligned_cols=252  Identities=26%  Similarity=0.372  Sum_probs=208.5

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcc-CCCCeecee
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNL-LHPNLVKLV  205 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~  205 (490)
                      ...++|++.++||+|+||.||+|++..         +++.||||++++..   ....+.+..|..+|..+ +||||+.++
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~---------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~  408 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKG---------TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH  408 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESS---------SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEE
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECC---------CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence            345689999999999999999999876         67789999997542   12345678899999988 699999999


Q ss_pred             eEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEe
Q 011250          206 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       206 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~  285 (490)
                      +++.+.+.+||||||+++|+|.+++... ..+++..++.|+.||+.||.|||+.+   ||||||||+||||+.++.+||+
T Consensus       409 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~  484 (674)
T 3pfq_A          409 SCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIA  484 (674)
T ss_dssp             EECBCSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEEC
T ss_pred             EEEEeCCEEEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEe
Confidence            9999999999999999999999999665 46999999999999999999999988   9999999999999999999999


Q ss_pred             cccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011250          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      |||+++.......  .....+||+.|+|||++.+..|+.++|||||||+||||++|+.||......   .+...      
T Consensus       485 DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~---~~~~~------  553 (674)
T 3pfq_A          485 DFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQS------  553 (674)
T ss_dssp             CCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH------
T ss_pred             ecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH---HHHHH------
Confidence            9999986443322  234578999999999999999999999999999999999999999754221   11111      


Q ss_pred             CcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 011250          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM-----SEVVET  414 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~-----~evl~~  414 (490)
                             ++...  ..++...+.++.+||.+||+.||.+||++     .+|++|
T Consensus       554 -------i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          554 -------IMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             -------HHSSC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             -------HHhCC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence                   11111  12333457899999999999999999997     777654

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.7e-44  Score=352.59  Aligned_cols=246  Identities=22%  Similarity=0.264  Sum_probs=201.2

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcc-CCCCeeceeeEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNL-LHPNLVKLVGYC  208 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~  208 (490)
                      .++|++.+.||+|+||.||+|.+..         ++..||||++....  .....++.+|+.++..+ .||||+++++++
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~   80 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRL---------DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAW   80 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcC---------CCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeee
Confidence            3569999999999999999999876         56799999997643  23456788999999999 899999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhc---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC------
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD------  279 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~------  279 (490)
                      .+.+..+|||||+++++|.+++...   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.+      
T Consensus        81 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~  157 (289)
T 1x8b_A           81 AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAA  157 (289)
T ss_dssp             EETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------
T ss_pred             ecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccc
Confidence            9999999999999999999999653   256999999999999999999999988   9999999999999844      


Q ss_pred             -------------CCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccC-CCCccchhhHHHHHHHHHHhCCCCC
Q 011250          280 -------------YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSM  345 (490)
Q Consensus       280 -------------~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGv~l~elltG~~pf  345 (490)
                                   ..+||+|||++.......      ...||+.|+|||++.+. .++.++|||||||++|+|++|.+++
T Consensus       158 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~  231 (289)
T 1x8b_A          158 SEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP  231 (289)
T ss_dssp             ------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             ccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCC
Confidence                         479999999998765432      24599999999999765 6678999999999999999999876


Q ss_pred             CCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          346 DKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                      ....     .........               ...++...+..+.+||.+||+.||.+|||+.+++++-
T Consensus       232 ~~~~-----~~~~~~~~~---------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~  281 (289)
T 1x8b_A          232 RNGD-----QWHEIRQGR---------------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHS  281 (289)
T ss_dssp             SSSH-----HHHHHHTTC---------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred             cchh-----HHHHHHcCC---------------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence            4321     111111000               0112223478899999999999999999999999763

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.6e-44  Score=357.02  Aligned_cols=253  Identities=27%  Similarity=0.388  Sum_probs=204.2

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ..++|++.+.||+|+||.||+|.+..         +|..||||++....  ..+.+.+|+.++..+.||||+++++++..
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   95 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKE---------TGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFK   95 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETT---------TCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECC---------CCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence            34679999999999999999999875         57799999997653  34678899999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      .+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        96 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~  172 (314)
T 3com_A           96 NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVA  172 (314)
T ss_dssp             TTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccc
Confidence            99999999999999999999766678999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ........  ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......   .......        
T Consensus       173 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~--------  239 (314)
T 3com_A          173 GQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR---AIFMIPT--------  239 (314)
T ss_dssp             EECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHH--------
T ss_pred             hhhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHhc--------
Confidence            77643221  1234579999999999998899999999999999999999999996532111   0000000        


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                        ...+.  ...+...+..+.+||.+||..||.+|||+.+++++
T Consensus       240 --~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          240 --NPPPT--FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             --SCCCC--CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             --CCCcc--cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence              00000  01122336789999999999999999999999874

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.5e-45  Score=367.90  Aligned_cols=259  Identities=28%  Similarity=0.356  Sum_probs=206.3

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc----ccHHHHHHHHHHHhcc-CCCCeeceeeE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGNL-LHPNLVKLVGY  207 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~Ei~il~~l-~HpnIv~l~~~  207 (490)
                      ++|++.+.||+|+||.||+|++....      .++..||||+++....    ...+.+.+|+.+|..+ .||||++++++
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  127 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGH------DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA  127 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSST------TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccC------CCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEE
Confidence            46999999999999999999985321      2678999999875421    2234567899999999 69999999999


Q ss_pred             EEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecc
Q 011250          208 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DF  287 (490)
                      +...+..+|||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+||
T Consensus       128 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Df  203 (355)
T 1vzo_A          128 FQTETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDF  203 (355)
T ss_dssp             EEETTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCS
T ss_pred             EeeCceEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeC
Confidence            99999999999999999999999655 46999999999999999999999988   999999999999999999999999


Q ss_pred             cCcccCCCCCcceeeeccccCCCccCcchhcc--CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011250          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      |+++....... ......+||+.|+|||++.+  ..++.++|||||||+||||++|+.||...........  .......
T Consensus       204 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~--~~~~~~~  280 (355)
T 1vzo_A          204 GLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE--ISRRILK  280 (355)
T ss_dssp             SEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH--HHHHHHH
T ss_pred             CCCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHH--HHHHHhc
Confidence            99986643222 22334689999999999985  3578999999999999999999999975433222111  1111000


Q ss_pred             CcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHhh
Q 011250          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVETLK  416 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----t~~evl~~L~  416 (490)
                              .    ...++...+..+.+||.+||..||.+||     ++.+++++..
T Consensus       281 --------~----~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~  324 (355)
T 1vzo_A          281 --------S----EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF  324 (355)
T ss_dssp             --------C----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred             --------c----CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence                    0    1122334477899999999999999999     9999997753

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5.1e-45  Score=389.18  Aligned_cols=259  Identities=27%  Similarity=0.403  Sum_probs=212.1

Q ss_pred             HHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       129 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      .+..++|++.+.||+|+||.||+|.+..          +..||||+++... ...++|.+|+.+|+.|+||||+++++++
T Consensus       263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~  331 (535)
T 2h8h_A          263 EIPRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV  331 (535)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEETT----------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ecchhhhhhheecccCCCeEEEEEEECC----------CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            3455678999999999999999998863          3479999998654 3457899999999999999999999998


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DF  287 (490)
                      .+ +..+||||||++|+|.++|... ...+++..++.|+.||+.||.|||+.+   ||||||||+||||+.++.+||+||
T Consensus       332 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DF  407 (535)
T 2h8h_A          332 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADF  407 (535)
T ss_dssp             CS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCT
T ss_pred             ee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEccc
Confidence            76 6789999999999999999643 346999999999999999999999988   999999999999999999999999


Q ss_pred             cCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCC
Q 011250          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      |+++...... ........++..|+|||++....++.++|||||||+||||++ |+.||......   .+.......   
T Consensus       408 G~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~~~~i~~~---  480 (535)
T 2h8h_A          408 GLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQVERG---  480 (535)
T ss_dssp             TSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HHHHHHHTT---
T ss_pred             ccceecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcC---
Confidence            9998764321 111223457889999999999999999999999999999999 99999654221   111111100   


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                                 .....+..++..+.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus       481 -----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          481 -----------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             -----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             -----------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence                       0111233457889999999999999999999999999998754

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.1e-44  Score=381.00  Aligned_cols=251  Identities=25%  Similarity=0.354  Sum_probs=200.5

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ++|++.+.||+|+||+||+|++..         ++..||||++....  ......+.+|+.+|+.++||||+++++++.+
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  107 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKV---------THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED  107 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETT---------TCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             cCeEEeeEEecCCCEEEEEEEECC---------CCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence            469999999999999999999876         57789999997653  2334678999999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC---CCeEEecc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD---YNAKLSDF  287 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~---~~vkL~DF  287 (490)
                      ....|||||||++|+|.+++... ..+++..+..++.||+.||.|||+.+   |+||||||+||||+..   +.+||+||
T Consensus       108 ~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Df  183 (494)
T 3lij_A          108 KRNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDF  183 (494)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred             CCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEEC
Confidence            99999999999999999988655 46999999999999999999999988   9999999999999764   55999999


Q ss_pred             cCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011250          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      |++.......   .....+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.......   +.......   .
T Consensus       184 G~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~---~  253 (494)
T 3lij_A          184 GLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE---ILRKVEKG---K  253 (494)
T ss_dssp             TTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHT---C
T ss_pred             CCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhC---C
Confidence            9998765432   223467999999999876 579999999999999999999999997643221   11111100   0


Q ss_pred             chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ..    ++.    ......+..+.+||.+||+.||.+|||+.+++++
T Consensus       254 ~~----~~~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          254 YT----FDS----PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             CC----CCS----GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             CC----CCc----hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            00    000    0011236789999999999999999999999975

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.9e-44  Score=350.27  Aligned_cols=252  Identities=24%  Similarity=0.346  Sum_probs=203.8

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc------ccHHHHHHHHHHHhccCCCCeeceee
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL------QGHKEWLAEVNFLGNLLHPNLVKLVG  206 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~~  206 (490)
                      ++|++.+.||+|+||.||+|++..         ++..||+|++.....      ...+.+.+|+.+++.++||||+++++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   75 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKG---------TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHD   75 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcC---------CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhh
Confidence            469999999999999999999876         567999999875432      13578999999999999999999999


Q ss_pred             EEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC----Ce
Q 011250          207 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY----NA  282 (490)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~----~v  282 (490)
                      ++.+.+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    .+
T Consensus        76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~  151 (283)
T 3bhy_A           76 IFENKTDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRI  151 (283)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCE
T ss_pred             eecCCCeEEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCce
Confidence            999999999999999999999998654 47999999999999999999999988   99999999999998877    89


Q ss_pred             EEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011250          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      ||+|||++........   .....||+.|+|||++.+..++.++||||||+++|+|++|..||......   ........
T Consensus       152 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~  225 (283)
T 3bhy_A          152 KLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ---ETLTNISA  225 (283)
T ss_dssp             EECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHT
T ss_pred             EEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH---HHHHHhHh
Confidence            9999999987644322   23457999999999999899999999999999999999999999754221   11111000


Q ss_pred             ccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .   .        ...........+..+.+|+.+||..||.+||++.+++++
T Consensus       226 ~---~--------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          226 V---N--------YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             T---C--------CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             c---c--------cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence            0   0        000000011236789999999999999999999999974

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=5.2e-45  Score=371.46  Aligned_cols=255  Identities=15%  Similarity=0.070  Sum_probs=186.7

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcc--CCCCeecee--
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNL--LHPNLVKLV--  205 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~Ei~il~~l--~HpnIv~l~--  205 (490)
                      .+|.+.+.||+|+||.||+|++..         ++..||||++.....   ...+.+.+|+.++..|  .||||++++  
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~  132 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVE---------RLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRR  132 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------C
T ss_pred             eeeeeeeeccCCCCEEEEEEEECC---------CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhcee
Confidence            458999999999999999999876         677999999987643   2234567785544444  699988755  


Q ss_pred             -----eEEEeCC-----------------ceEEEEEecCCCChhHHhhhcCCCCCHHHH------HHHHHHHHHHHHHhh
Q 011250          206 -----GYCIEDD-----------------QRLLVYEFMPRGSLENHLFRRSLPLPWSIR------MKIALGAAKGLAFLH  257 (490)
Q Consensus       206 -----~~~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~------~~i~~qi~~aL~yLH  257 (490)
                           +++...+                 ..|||||||+ |+|.+++......+++..+      ..++.||+.||+|||
T Consensus       133 ~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH  211 (371)
T 3q60_A          133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ  211 (371)
T ss_dssp             BCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH
Confidence                 4544332                 3799999998 8999999765445566666      788899999999999


Q ss_pred             hcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhcc--CCCCccchhhHHHHHH
Q 011250          258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT--GHLTSKSDVYSFGVVL  335 (490)
Q Consensus       258 ~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~~~~sDvwSlGv~l  335 (490)
                      +.+   ||||||||+||||+.++.+||+|||+++.....     .....||+.|+|||++.+  ..++.++|||||||+|
T Consensus       212 ~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il  283 (371)
T 3q60_A          212 SKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSI  283 (371)
T ss_dssp             HTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHH
T ss_pred             HCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHH
Confidence            988   999999999999999999999999999876421     124567899999999987  6899999999999999


Q ss_pred             HHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          336 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       336 ~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      |||++|+.||............   ....      .......+........+..+.+||.+||+.||.+|||+.+++++
T Consensus       284 ~elltg~~Pf~~~~~~~~~~~~---~~~~------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          284 YRVWCLFLPFGLVTPGIKGSWK---RPSL------RVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             HHHHHSSCSTTBCCTTCTTCCC---BCCT------TSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             HHHHhCCCCCCCcCcccccchh---hhhh------hhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            9999999999765432211100   0000      00000011111112347899999999999999999999999864

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=7.9e-45  Score=358.53  Aligned_cols=254  Identities=26%  Similarity=0.417  Sum_probs=203.2

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      .++|++.+.||+|+||.||+|.+..         ++..||+|++........+.+.+|+.+++.++||||+++++++.+.
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD   88 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETT---------TCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC
T ss_pred             ccceeecceeccCCCeEEEEEEEcC---------CCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC
Confidence            3579999999999999999999875         5678999999877666678899999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      +..++||||+++++|.+++......+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        89 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  165 (302)
T 2j7t_A           89 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSA  165 (302)
T ss_dssp             -CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHH
T ss_pred             CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCc
Confidence            9999999999999999998776678999999999999999999999988   9999999999999999999999999875


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhc-----cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      .....  ........||+.|+|||++.     ...++.++|||||||++|+|++|..||........  ........   
T Consensus       166 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~---  238 (302)
T 2j7t_A          166 KNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIAKSD---  238 (302)
T ss_dssp             HHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHSC---
T ss_pred             ccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--HHHHhccC---
Confidence            42111  11122357999999999884     56789999999999999999999999975432110  00110000   


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                              .+  ....+...+..+.+||.+||+.||.+|||+.+++++
T Consensus       239 --------~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          239 --------PP--TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             --------CC--CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             --------Cc--ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                    00  001122346789999999999999999999999875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.3e-44  Score=353.25  Aligned_cols=248  Identities=30%  Similarity=0.450  Sum_probs=206.0

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEe-
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE-  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-  210 (490)
                      ..+|++.+.||+|+||.||+|.+..         ++..||||++....    +.+.+|+.+++.++||||+++++++.. 
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~   76 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRI---------DGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGF   76 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETT---------TCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEE
T ss_pred             ccccceeeeeccCCceEEEEEEEcC---------CCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEecc
Confidence            3469999999999999999999875         56789999997653    356789999999999999999998864 


Q ss_pred             ---------------CCceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcE
Q 011250          211 ---------------DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI  274 (490)
Q Consensus       211 ---------------~~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NI  274 (490)
                                     ....++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+   |+||||||+||
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Ni  153 (284)
T 2a19_B           77 DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNI  153 (284)
T ss_dssp             EEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred             ccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHE
Confidence                           34579999999999999999654 357999999999999999999999988   99999999999


Q ss_pred             EEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcc
Q 011250          275 LLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH  354 (490)
Q Consensus       275 Ll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~  354 (490)
                      |++.++.+||+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||...     .
T Consensus       154 l~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~  225 (284)
T 2a19_B          154 FLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----S  225 (284)
T ss_dssp             EEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----H
T ss_pred             EEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----H
Confidence            999999999999999987654322   23357999999999999999999999999999999999999886321     0


Q ss_pred             hhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                      ....             .+....    ++...+..+.+||.+||..||.+|||+.+++++|+.+..
T Consensus       226 ~~~~-------------~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          226 KFFT-------------DLRDGI----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             HHHH-------------HHHTTC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             HHHH-------------Hhhccc----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence            0000             011111    112236778999999999999999999999999987754

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.4e-44  Score=380.25  Aligned_cols=253  Identities=26%  Similarity=0.348  Sum_probs=203.4

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-------------ccHHHHHHHHHHHhccC
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-------------QGHKEWLAEVNFLGNLL  197 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~Ei~il~~l~  197 (490)
                      ..++|.+.+.||+|+||+||+|.+..         ++..||||++.....             ...+.+.+|+.+|+.++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  104 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKN---------GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD  104 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETT---------TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC
T ss_pred             cccceEEEeEecccCCeEEEEEEECC---------CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC
Confidence            34679999999999999999999876         577899999976432             23467889999999999


Q ss_pred             CCCeeceeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc
Q 011250          198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD  277 (490)
Q Consensus       198 HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~  277 (490)
                      ||||+++++++.+....|||||||++|+|.+++... ..+++..++.++.||+.||.|||+.+   |+||||||+||||+
T Consensus       105 hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~  180 (504)
T 3q5i_A          105 HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLE  180 (504)
T ss_dssp             CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEES
T ss_pred             CCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEe
Confidence            999999999999999999999999999999998655 46999999999999999999999988   99999999999998


Q ss_pred             CCC---CeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcc
Q 011250          278 ADY---NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH  354 (490)
Q Consensus       278 ~~~---~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~  354 (490)
                      .++   .+||+|||++........   ....+||+.|+|||++. +.++.++|||||||++|+|++|..||.......  
T Consensus       181 ~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--  254 (504)
T 3q5i_A          181 NKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD--  254 (504)
T ss_dssp             STTCCSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--
T ss_pred             cCCCCccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--
Confidence            775   699999999987654322   23467999999999876 569999999999999999999999997643221  


Q ss_pred             hhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                       +........   ..+    +..    .....+.++.+||.+||+.||.+|||+.+++++
T Consensus       255 -~~~~i~~~~---~~~----~~~----~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          255 -IIKKVEKGK---YYF----DFN----DWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             -HHHHHHHCC---CCC----CHH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -HHHHHHcCC---CCC----Ccc----ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence             111111000   000    000    001236789999999999999999999999976

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1e-44  Score=382.18  Aligned_cols=251  Identities=26%  Similarity=0.372  Sum_probs=206.6

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|++.+.||+|+||.||+|++..         ++..||||++....   ....+.+.+|+.+|+.++||||+++++++.
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   96 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKI---------TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE   96 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECC---------CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            469999999999999999999876         67799999996553   234677999999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---cCCCCeEEec
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSD  286 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl---~~~~~vkL~D  286 (490)
                      +.+..++|||||.+|+|.+++... ..+++..++.++.||+.||.|||+.+   |+||||||+||||   +.++.+||+|
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~D  172 (484)
T 3nyv_A           97 DKGYFYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIID  172 (484)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred             eCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEe
Confidence            999999999999999999988654 47999999999999999999999988   9999999999999   5678999999


Q ss_pred             ccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011250          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      ||+++.......   ....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.......   .........  
T Consensus       173 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~--  243 (484)
T 3nyv_A          173 FGLSTHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD---ILKKVEKGK--  243 (484)
T ss_dssp             TTHHHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCC--
T ss_pred             eeeeEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHcCC--
Confidence            999987654322   234679999999998865 79999999999999999999999997643211   111111000  


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                       .        ..........+..+.+||.+||+.||.+|||+.++++|
T Consensus       244 -~--------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          244 -Y--------TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             -C--------CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -C--------CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence             0        00000112347889999999999999999999999975

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=8e-45  Score=354.41  Aligned_cols=258  Identities=24%  Similarity=0.338  Sum_probs=205.8

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ++|++.+.||+|+||.||+|.+..         +++.||+|++.....  ...+.+.+|+.+++.++||||+++++++.+
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   76 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRKS---------DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID   76 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             hheeeehhccCCCCcEEEEEEECC---------CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEec
Confidence            579999999999999999999876         577999999976543  334678899999999999999999998854


Q ss_pred             --CCceEEEEEecCCCChhHHhhhc---CCCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeeecCCCCCcEEEcCCCCeE
Q 011250          211 --DDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEA--EKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       211 --~~~~~lV~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~--~~~iiHrDlkp~NILl~~~~~vk  283 (490)
                        ....++||||+++++|.+++...   ...+++..++.++.||+.||.|||+.+  ..+|+||||||+|||++.++.+|
T Consensus        77 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~k  156 (279)
T 2w5a_A           77 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK  156 (279)
T ss_dssp             GGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEE
T ss_pred             CCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEE
Confidence              56789999999999999998643   345999999999999999999999976  23499999999999999999999


Q ss_pred             EecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011250          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      |+|||+++.......  ......||+.|+|||++.+..++.++||||||+++|+|++|..||.....   ..+.......
T Consensus       157 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~i~~~  231 (279)
T 2w5a_A          157 LGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGKIREG  231 (279)
T ss_dssp             ECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHT
T ss_pred             EecCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHHHHHhhc
Confidence            999999987644321  12335799999999999988999999999999999999999999975421   1111111100


Q ss_pred             cCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                                .    ...++...+.++.+||.+||+.||.+||++.+|++++..-
T Consensus       232 ----------~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~  272 (279)
T 2w5a_A          232 ----------K----FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL  272 (279)
T ss_dssp             ----------C----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred             ----------c----cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence                      0    0112233478899999999999999999999999887643

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.2e-44  Score=380.05  Aligned_cols=251  Identities=27%  Similarity=0.372  Sum_probs=203.8

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ++|++.+.||+|+||+||+|++..         ++..||||++....  ......+.+|+.+|+.++||||+++++++.+
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   92 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRI---------TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED   92 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETT---------TCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECC---------CCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc
Confidence            469999999999999999999876         57799999986432  2345678999999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc---CCCCeEEecc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD---ADYNAKLSDF  287 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~---~~~~vkL~DF  287 (490)
                      ....|+|||||.+|+|.+++... ..+++..+..++.||+.||.|||+.+   |+||||||+||||+   .++.+||+||
T Consensus        93 ~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Df  168 (486)
T 3mwu_A           93 SSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDF  168 (486)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEEC
Confidence            99999999999999999988665 47999999999999999999999988   99999999999995   4567999999


Q ss_pred             cCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011250          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      |+++.......   ....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.......   ........   .
T Consensus       169 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~---~  238 (486)
T 3mwu_A          169 GLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---ILKRVETG---K  238 (486)
T ss_dssp             SCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHT---C
T ss_pred             CcCeECCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhC---C
Confidence            99987644322   234679999999998865 69999999999999999999999997543211   11111000   0


Q ss_pred             chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .        ..........+.++.+||.+||+.||.+|||+.+++++
T Consensus       239 ~--------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          239 Y--------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             C--------CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             C--------CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0        00000112337889999999999999999999999986

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.7e-44  Score=354.28  Aligned_cols=251  Identities=26%  Similarity=0.395  Sum_probs=208.8

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      +.|++.+.||+|+||.||+|.+..         ++..||||++.... ....+.+.+|+.+++.+.||||+++++++.+.
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   92 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNR---------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD   92 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             HHHHHhhhhcccCCeEEEEEEECC---------CCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence            468999999999999999998865         57789999997654 23457889999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      ...++||||+++++|.+++..  ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        93 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~  167 (303)
T 3a7i_A           93 TKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAG  167 (303)
T ss_dssp             TEEEEEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccce
Confidence            999999999999999998854  46999999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhh
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  371 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (490)
                      .......  ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......   ......          
T Consensus       168 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~----------  232 (303)
T 3a7i_A          168 QLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK---VLFLIP----------  232 (303)
T ss_dssp             ECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHH----------
T ss_pred             ecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH---HHHHhh----------
Confidence            7644321  1234679999999999999999999999999999999999999996542211   111100          


Q ss_pred             hccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011250          372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       372 ~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~  416 (490)
                      ....+    .++...+..+.+||.+||..||.+|||+.+++++..
T Consensus       233 ~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~  273 (303)
T 3a7i_A          233 KNNPP----TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF  273 (303)
T ss_dssp             HSCCC----CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred             cCCCC----CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence            00011    112233678999999999999999999999998654

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=5.6e-44  Score=350.80  Aligned_cols=251  Identities=25%  Similarity=0.384  Sum_probs=201.4

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      +.|++.+.||+|+||.||+|.+..         ++..||+|++....  ....+.+.+|+.+++.++||||+++++++..
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   96 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES   96 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecC---------CceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecc
Confidence            458888999999999999998876         56789999987543  2344678899999999999999999999876


Q ss_pred             ----CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-CCCCeEEe
Q 011250          211 ----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD-ADYNAKLS  285 (490)
Q Consensus       211 ----~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~-~~~~vkL~  285 (490)
                          ....++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ .+|+||||||+|||++ .++.+||+
T Consensus        97 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~  174 (290)
T 1t4h_A           97 TVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIG  174 (290)
T ss_dssp             ESSSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred             ccCCCceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEe
Confidence                34589999999999999999654 46999999999999999999999865 4599999999999997 78999999


Q ss_pred             cccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011250          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      |||++.......    .....||+.|+|||++. +.++.++|||||||++|+|++|+.||.......  .........  
T Consensus       175 Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~--  245 (290)
T 1t4h_A          175 DLGLATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRVTSG--  245 (290)
T ss_dssp             CTTGGGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHHTTT--
T ss_pred             eCCCcccccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH--HHHHHHhcc--
Confidence            999997654332    23357999999999776 569999999999999999999999996532211  111111000  


Q ss_pred             CcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                                 .....++...+.++.+||.+||+.||.+|||+.+++++
T Consensus       246 -----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          246 -----------VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             -----------CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -----------CCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                       00011112235789999999999999999999999975

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=6.2e-44  Score=350.71  Aligned_cols=252  Identities=23%  Similarity=0.338  Sum_probs=201.8

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCCc
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQ  213 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  213 (490)
                      +|....+||+|+||.||+|.+..         ++..||||.+........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   93 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLS---------NQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF   93 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETT---------TCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             CCCCcEEEeecCcEEEEEEEECC---------CCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence            45666699999999999999876         567899999987665566789999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhHHhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-CCCeEEecccCc
Q 011250          214 RLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYNAKLSDFGLA  290 (490)
Q Consensus       214 ~~lV~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~-~~~vkL~DFG~a  290 (490)
                      .++||||+++++|.+++....  ..+++..+..++.||+.||.|||+.+   |+||||||+|||++. ++.+||+|||++
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~  170 (295)
T 2clq_A           94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTS  170 (295)
T ss_dssp             EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTC
T ss_pred             EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccc
Confidence            999999999999999997653  35678899999999999999999988   999999999999987 899999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccC--CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~--~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ........  ......||+.|+|||++.+.  .++.++||||||+++|+|++|+.||........ .....  ..     
T Consensus       171 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~--~~-----  240 (295)
T 2clq_A          171 KRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA-AMFKV--GM-----  240 (295)
T ss_dssp             EESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH-HHHHH--HH-----
T ss_pred             cccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH-HHHhh--cc-----
Confidence            87643221  12346799999999998764  388999999999999999999999964221100 00000  00     


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                         ..    ....++...+.++.+||.+||+.||.+||++.+++++
T Consensus       241 ---~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          241 ---FK----VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             ---HC----CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             ---cc----ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence               00    1112233447889999999999999999999999865

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=5e-44  Score=357.47  Aligned_cols=259  Identities=21%  Similarity=0.276  Sum_probs=202.3

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccC-CCCeeceeeEEEe-
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIE-  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~-  210 (490)
                      ++|++.+.||+|+||.||+|++..         ++..||||++...   ..+.+.+|+.+++.+. ||||+++++++.+ 
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~  103 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINIT---------NNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDP  103 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred             CceEEEEEecccCCeEEEEEEECC---------CCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccC
Confidence            579999999999999999999876         5678999999754   3467889999999997 9999999999988 


Q ss_pred             -CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-CeEEeccc
Q 011250          211 -DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG  288 (490)
Q Consensus       211 -~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-~vkL~DFG  288 (490)
                       ....++||||+.+++|.+++.    .+++..+..++.||+.||+|||+.+   |+||||||+||||+.++ .+||+|||
T Consensus       104 ~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg  176 (330)
T 3nsz_A          104 VSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWG  176 (330)
T ss_dssp             TTCCEEEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             CCCceEEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCC
Confidence             567899999999999998873    4889999999999999999999988   99999999999999776 89999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh------
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR------  361 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~------  361 (490)
                      +++.......   .....||..|+|||++.+ ..++.++|||||||+||+|++|+.||........ .+.....      
T Consensus       177 ~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~~~~~~~~~~~  252 (330)
T 3nsz_A          177 LAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVLGTED  252 (330)
T ss_dssp             TCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHHHCHHH
T ss_pred             CceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHHHHHHhcCCch
Confidence            9987654322   233579999999999877 6799999999999999999999999954322111 0000000      


Q ss_pred             ------c-ccCCcchhhhccC--------CccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          362 ------P-HLGDKRRFYRLLD--------PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       362 ------~-~~~~~~~~~~~~~--------~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                            . .......+.....        ...........+.++.+||.+||+.||.+|||+++++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          253 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             HHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             hhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                  0 0000000000000        001111122247889999999999999999999999975

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.8e-44  Score=361.16  Aligned_cols=262  Identities=20%  Similarity=0.287  Sum_probs=207.9

Q ss_pred             hhhhHHHhhcCCCCC-cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhccC-CC
Q 011250          124 MFNDLKLATRNFRPE-SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLL-HP  199 (490)
Q Consensus       124 ~~~~~~~~~~~y~~~-~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~Ei~il~~l~-Hp  199 (490)
                      .+.......++|.+. +.||+|+||.||+|.+..         ++..||||++....  ......+.+|+.++..+. ||
T Consensus        19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~   89 (327)
T 3lm5_A           19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKS---------TGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCP   89 (327)
T ss_dssp             CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCT
T ss_pred             HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECC---------CCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCC
Confidence            344445555678887 899999999999999876         57799999987542  334678899999999995 69


Q ss_pred             CeeceeeEEEeCCceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC
Q 011250          200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA  278 (490)
Q Consensus       200 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~  278 (490)
                      ||+++++++.+.+..++||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+   |+||||||+||||+.
T Consensus        90 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~  166 (327)
T 3lm5_A           90 RVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSS  166 (327)
T ss_dssp             TBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESC
T ss_pred             CEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEec
Confidence            9999999999999999999999999999988543 357999999999999999999999988   999999999999987


Q ss_pred             ---CCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcch
Q 011250          279 ---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN  355 (490)
Q Consensus       279 ---~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~  355 (490)
                         ++.+||+|||+++.......   ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||..........
T Consensus       167 ~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  243 (327)
T 3lm5_A          167 IYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL  243 (327)
T ss_dssp             BTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             CCCCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH
Confidence               78999999999987644322   234679999999999999999999999999999999999999996543211100


Q ss_pred             hhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .+  ...            ............+..+.+||.+||+.||.+|||+.+++++
T Consensus       244 ~i--~~~------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          244 NI--SQV------------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             HH--HHT------------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             HH--Hhc------------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            00  000            0001111122347889999999999999999999999875

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=5.2e-44  Score=353.20  Aligned_cols=252  Identities=23%  Similarity=0.286  Sum_probs=200.9

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC----cccHHHHHHHHHHHhccCCCCeeceeeE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG----LQGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~  207 (490)
                      .++|++.+.||+|+||.||+|.+..         ++..||||++....    ....+.+.+|+.+++.++||||++++++
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   74 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSE---------TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDV   74 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTT---------TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECC---------CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEE
Confidence            3689999999999999999998865         57789999997542    2335678999999999999999999999


Q ss_pred             EE--eCCceEEEEEecCCCChhHHhhh-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 011250          208 CI--EDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       208 ~~--~~~~~~lV~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL  284 (490)
                      +.  +....+|||||++++ |.+++.. ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||
T Consensus        75 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl  150 (305)
T 2wtk_C           75 LYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKI  150 (305)
T ss_dssp             EECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred             EEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEe
Confidence            84  445789999999776 7776654 3457999999999999999999999988   999999999999999999999


Q ss_pred             ecccCcccCCCCCcceeeeccccCCCccCcchhccCC--CCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011250          285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH--LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~--~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      +|||++................||+.|+|||++.+..  ++.++|||||||++|||++|+.||......   ........
T Consensus       151 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~i~~  227 (305)
T 2wtk_C          151 SALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY---KLFENIGK  227 (305)
T ss_dssp             CCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHH
T ss_pred             eccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH---HHHHHHhc
Confidence            9999998765433333334567999999999987643  377999999999999999999999753211   11111000


Q ss_pred             ccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .               ...++..++..+.+||.+||..||.+|||+.+++++
T Consensus       228 ~---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          228 G---------------SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             C---------------CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             C---------------CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0               001222346789999999999999999999999975

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.6e-44  Score=349.20  Aligned_cols=250  Identities=26%  Similarity=0.342  Sum_probs=198.8

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhccCCCCeeceeeE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~  207 (490)
                      ..++|.+.+.||+|+||.||+|.+..         ++..||||++....   ....+.+.+|+.+++.++||||++++++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   79 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQL---------TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV   79 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECC---------CCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEE
Confidence            34679999999999999999999875         56789999986542   2234678899999999999999999999


Q ss_pred             EEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecc
Q 011250          208 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DF  287 (490)
                      +.+.+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        80 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~df  155 (276)
T 2h6d_A           80 ISTPTDFFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADF  155 (276)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCC
T ss_pred             EecCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeec
Confidence            99999999999999999999999655 46899999999999999999999998   999999999999999999999999


Q ss_pred             cCcccCCCCCcceeeeccccCCCccCcchhccCCC-CccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011250          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      |++........   .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||......   ..........  
T Consensus       156 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~--  227 (276)
T 2h6d_A          156 GLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---TLFKKIRGGV--  227 (276)
T ss_dssp             CGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCC--
T ss_pred             ccccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHHHHhhcCc--
Confidence            99987654321   234578999999999987665 68999999999999999999999653211   1111111000  


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                                   ..++...+..+.+||.+||+.||.+|||+.+++++
T Consensus       228 -------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          228 -------------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             -------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -------------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                         01122336789999999999999999999999985

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.2e-44  Score=368.48  Aligned_cols=262  Identities=25%  Similarity=0.351  Sum_probs=199.7

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ...++|++.+.||+|+||+||+|++..         +|..||||++..+...    ..+|+.+|+.++||||+++++++.
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~   70 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIE---------SGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFY   70 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETT---------TCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECC---------CCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheee
Confidence            456789999999999999999999876         6779999998655322    237999999999999999999985


Q ss_pred             eC--------------------------------------CceEEEEEecCCCChhHHhh---hcCCCCCHHHHHHHHHH
Q 011250          210 ED--------------------------------------DQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALG  248 (490)
Q Consensus       210 ~~--------------------------------------~~~~lV~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~q  248 (490)
                      ..                                      ...+|||||++ |+|.+.+.   .....+++..+..++.|
T Consensus        71 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~q  149 (383)
T 3eb0_A           71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQ  149 (383)
T ss_dssp             EC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHH
T ss_pred             ecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHH
Confidence            43                                      34789999997 58877765   34567999999999999


Q ss_pred             HHHHHHHhhhcCCCCeeecCCCCCcEEEc-CCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccC-CCCccc
Q 011250          249 AAKGLAFLHEEAEKPVIYRDFKTSNILLD-ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKS  326 (490)
Q Consensus       249 i~~aL~yLH~~~~~~iiHrDlkp~NILl~-~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~s  326 (490)
                      |+.||.|||+.+   |+||||||+|||++ .++.+||+|||+++.......   .....||+.|+|||++.+. .++.++
T Consensus       150 i~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~  223 (383)
T 3eb0_A          150 LFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSI  223 (383)
T ss_dssp             HHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHH
T ss_pred             HHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcch
Confidence            999999999988   99999999999997 688999999999987644322   2345789999999988764 599999


Q ss_pred             hhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc--------------chhhhccCCccCCCCChhhHHHHHH
Q 011250          327 DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK--------------RRFYRLLDPRLEGHFSIKGSQKATQ  392 (490)
Q Consensus       327 DvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~l~~~~~~~~~~~l~~  392 (490)
                      |||||||++|||++|+.||........  +..... .++..              ..+...........++...+.++.+
T Consensus       224 DiwslG~il~ell~g~~pf~~~~~~~~--~~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (383)
T 3eb0_A          224 DLWSIGCVFGELILGKPLFSGETSIDQ--LVRIIQ-IMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAID  300 (383)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH-HHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHH
T ss_pred             hhhhHHHHHHHHHhCCCCCCCCChHHH--HHHHHH-HhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHH
Confidence            999999999999999999976432211  111110 00000              0000000111111133345788999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHH
Q 011250          393 LAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       393 Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ||.+||+.||.+|||+.|+++|
T Consensus       301 li~~~L~~dP~~R~t~~e~l~h  322 (383)
T 3eb0_A          301 LLEQILRYEPDLRINPYEAMAH  322 (383)
T ss_dssp             HHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHHccCChhhCCCHHHHhcC
Confidence            9999999999999999999975

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=361.82  Aligned_cols=270  Identities=23%  Similarity=0.372  Sum_probs=196.9

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHH--HhccCCCCeeceeeEEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF--LGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~i--l~~l~HpnIv~l~~~~~  209 (490)
                      .++|++.+.||+|+||.||+|++           ++..||||++....   ...+..|..+  +..+.||||+++++++.
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~   77 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-----------DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDE   77 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-----------CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheeccc
Confidence            35799999999999999999976           35689999997543   3344444444  55589999999998654


Q ss_pred             e-----CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhc---------CCCCeeecCCCCCcEE
Q 011250          210 E-----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE---------AEKPVIYRDFKTSNIL  275 (490)
Q Consensus       210 ~-----~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---------~~~~iiHrDlkp~NIL  275 (490)
                      .     ...++||||||++|+|.+++...  .+++..++.++.||+.||.|||+.         +   |+||||||+|||
T Consensus        78 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nil  152 (336)
T 3g2f_A           78 RVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVL  152 (336)
T ss_dssp             EECTTSCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEE
T ss_pred             ccccCCCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEE
Confidence            3     22568999999999999999654  458999999999999999999998         6   999999999999


Q ss_pred             EcCCCCeEEecccCcccCCCCCc------ceeeeccccCCCccCcchhcc-------CCCCccchhhHHHHHHHHHHhCC
Q 011250          276 LDADYNAKLSDFGLAKDAPEDGK------THVSTRVMGTYGYAAPEYVMT-------GHLTSKSDVYSFGVVLLEMLTGR  342 (490)
Q Consensus       276 l~~~~~vkL~DFG~a~~~~~~~~------~~~~~~~~Gt~~y~aPE~l~~-------~~~~~~sDvwSlGv~l~elltG~  342 (490)
                      |+.++.+||+|||+++.......      .......+||+.|+|||++.+       ..++.++|||||||+||||++|.
T Consensus       153 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~  232 (336)
T 3g2f_A          153 VKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC  232 (336)
T ss_dssp             ECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred             EcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcC
Confidence            99999999999999987643221      112234579999999999876       35667899999999999999997


Q ss_pred             CCCCCCCCCCcchh-hHhhhcccCCcchhh-----hccCCccCCCC--ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          343 RSMDKNRPNGEHNL-VEWARPHLGDKRRFY-----RLLDPRLEGHF--SIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       343 ~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~-----~~~~~~l~~~~--~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .||........... ...............     ....+.+...+  ...++..+.+||.+||+.||.+|||+.+|++.
T Consensus       233 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~  312 (336)
T 3g2f_A          233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER  312 (336)
T ss_dssp             GGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHH
Confidence            77643322221111 000000000000000     00111111111  12357789999999999999999999999999


Q ss_pred             hhcCcc
Q 011250          415 LKPLQN  420 (490)
Q Consensus       415 L~~l~~  420 (490)
                      |+.+..
T Consensus       313 L~~ll~  318 (336)
T 3g2f_A          313 MAELMM  318 (336)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            987653

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.6e-44  Score=389.48  Aligned_cols=251  Identities=27%  Similarity=0.394  Sum_probs=201.2

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEeCCceEE
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLL  216 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  216 (490)
                      +.||+|+||.||+|.+...       .++..||||+++....  ...+++.+|+.+|+.|+|||||++++++.. +..+|
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l  446 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML  446 (635)
T ss_dssp             EEEEECSSEEEEEEEEECS-------SCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             CEeccCCCEEEEEEEEcCC-------CcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence            4799999999999977542       1567899999976432  335789999999999999999999999864 56899


Q ss_pred             EEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCC
Q 011250          217 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  296 (490)
Q Consensus       217 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~  296 (490)
                      |||||++|+|.+++... ..+++..++.|+.||+.||+|||+.+   ||||||||+||||+.++.+||+|||+++.....
T Consensus       447 v~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~  522 (635)
T 4fl3_A          447 VMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  522 (635)
T ss_dssp             EEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred             EEEccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence            99999999999999544 57999999999999999999999988   999999999999999999999999999876543


Q ss_pred             Cc-ceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcchhhhcc
Q 011250          297 GK-THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  374 (490)
Q Consensus       297 ~~-~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (490)
                      .. ........||+.|+|||++.+..++.++|||||||+||||++ |+.||.......   +......            
T Consensus       523 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~~i~~------------  587 (635)
T 4fl3_A          523 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAMLEK------------  587 (635)
T ss_dssp             ------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHT------------
T ss_pred             ccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc------------
Confidence            22 122233567889999999999999999999999999999998 999997543211   1111110            


Q ss_pred             CCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       375 ~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                        ......+..++.++.+||.+||+.||.+||++.+|++.|+.+
T Consensus       588 --~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          588 --GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             --TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             --CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence              011122334578999999999999999999999999999865

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=7.9e-44  Score=369.91  Aligned_cols=199  Identities=22%  Similarity=0.333  Sum_probs=173.8

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcc------CCCCeecee
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL------LHPNLVKLV  205 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l------~HpnIv~l~  205 (490)
                      ..+|++.+.||+|+||.||+|.+..         ++..||||++.... .....+.+|+.++..+      .|+||++++
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~---------~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~  165 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHK---------VHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHML  165 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETT---------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECC---------CCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEE
Confidence            3579999999999999999999876         67799999997542 3345677888888877      577999999


Q ss_pred             eEEEeCCceEEEEEecCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCC--e
Q 011250          206 GYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN--A  282 (490)
Q Consensus       206 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~--v  282 (490)
                      +++...+..+|||||+. ++|.+++.... ..+++..++.|+.||+.||.|||+.+   ||||||||+||||+.++.  +
T Consensus       166 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~v  241 (429)
T 3kvw_A          166 ENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGI  241 (429)
T ss_dssp             EEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCE
T ss_pred             eecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcce
Confidence            99999999999999995 69999887654 45999999999999999999999998   999999999999999887  9


Q ss_pred             EEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCC
Q 011250          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR  349 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~  349 (490)
                      ||+|||+++.....     ....+||+.|+|||++.+..++.++|||||||+||||++|.+||....
T Consensus       242 kL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          242 KVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             EECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            99999999765432     223579999999999999999999999999999999999999997653

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=360.01  Aligned_cols=259  Identities=29%  Similarity=0.419  Sum_probs=201.5

Q ss_pred             hhhHHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcc-CCCCeec
Q 011250          125 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVK  203 (490)
Q Consensus       125 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~  203 (490)
                      +.++....++|++.+.||+|+||.||+|++..         ++..||||++.... ...+.+.+|+.+++.+ .||||++
T Consensus        16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~   85 (326)
T 2x7f_A           16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVK---------TGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIAT   85 (326)
T ss_dssp             CCCCCCCTTTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCC
T ss_pred             chhccCCCCcEEEEEEeccCCCEEEEEEEECC---------CCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeee
Confidence            34444556789999999999999999999875         56789999987553 2346788999999999 7999999


Q ss_pred             eeeEEEe------CCceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE
Q 011250          204 LVGYCIE------DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL  276 (490)
Q Consensus       204 l~~~~~~------~~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl  276 (490)
                      +++++..      .+..+|||||+++|+|.+++... ...+++..++.++.||+.||.|||+.+   |+||||||+|||+
T Consensus        86 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~  162 (326)
T 2x7f_A           86 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLL  162 (326)
T ss_dssp             EEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEE
T ss_pred             eeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEE
Confidence            9999987      46789999999999999999754 357999999999999999999999988   9999999999999


Q ss_pred             cCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhc-----cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCC
Q 011250          277 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN  351 (490)
Q Consensus       277 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~  351 (490)
                      +.++.+||+|||++........  ......||+.|+|||++.     ...++.++|||||||++|+|++|..||......
T Consensus       163 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~  240 (326)
T 2x7f_A          163 TENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM  240 (326)
T ss_dssp             CTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred             cCCCCEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH
Confidence            9999999999999987643211  123457999999999987     567899999999999999999999999653221


Q ss_pred             CcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          352 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ..  ......           ...+.   ......+..+.+||.+||..||.+||++.+++++
T Consensus       241 ~~--~~~~~~-----------~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          241 RA--LFLIPR-----------NPAPR---LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             HH--HHHHHH-----------SCCCC---CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HH--HHHhhc-----------Ccccc---CCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            11  000000           00000   1112236789999999999999999999999985

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.6e-44  Score=368.02  Aligned_cols=264  Identities=20%  Similarity=0.259  Sum_probs=205.0

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccC--------CCCeec
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL--------HPNLVK  203 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~--------HpnIv~  203 (490)
                      .++|++.+.||+|+||+||+|++..         ++..||||++.... ...+.+.+|+.+|+.+.        |+||++
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~  105 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQ---------GKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQ  105 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecC---------CCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence            3579999999999999999998876         67799999997542 33467889999999986        788999


Q ss_pred             eeeEEE----eCCceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEc
Q 011250          204 LVGYCI----EDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEE-AEKPVIYRDFKTSNILLD  277 (490)
Q Consensus       204 l~~~~~----~~~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiHrDlkp~NILl~  277 (490)
                      +++++.    .....+|||||+ +++|.+.+... ...+++..++.|+.||+.||.|||+. +   |+||||||+||||+
T Consensus       106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~  181 (397)
T 1wak_A          106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLS  181 (397)
T ss_dssp             EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEEC
T ss_pred             eecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEe
Confidence            999988    456789999999 66777766554 35799999999999999999999997 7   99999999999998


Q ss_pred             CCC-------------------------------------------------CeEEecccCcccCCCCCcceeeeccccC
Q 011250          278 ADY-------------------------------------------------NAKLSDFGLAKDAPEDGKTHVSTRVMGT  308 (490)
Q Consensus       278 ~~~-------------------------------------------------~vkL~DFG~a~~~~~~~~~~~~~~~~Gt  308 (490)
                      .++                                                 .+||+|||+++.....     ....+||
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt  256 (397)
T 1wak_A          182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQT  256 (397)
T ss_dssp             CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSC
T ss_pred             ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCC
Confidence            775                                                 8999999999876432     2335799


Q ss_pred             CCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhH---hhhcccCCc------------------
Q 011250          309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE---WARPHLGDK------------------  367 (490)
Q Consensus       309 ~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~---~~~~~~~~~------------------  367 (490)
                      +.|+|||++.+..++.++|||||||+||||++|+.||.............   .....++..                  
T Consensus       257 ~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  336 (397)
T 1wak_A          257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKK  336 (397)
T ss_dssp             GGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTT
T ss_pred             CcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCc
Confidence            99999999999999999999999999999999999997654433211110   000000000                  


Q ss_pred             chhhhccCCc---------cCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          368 RRFYRLLDPR---------LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       368 ~~~~~~~~~~---------l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ..+..+.+..         -...++...+..+.+||.+||+.||.+|||+.+|+++
T Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          337 GDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             SSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             cccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence            0000000000         0012345668889999999999999999999999975

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.7e-44  Score=352.42  Aligned_cols=253  Identities=25%  Similarity=0.324  Sum_probs=189.5

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cH-HHHHHHHHHHhccCCCCeeceeeEE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GH-KEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~-~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      ..++|++.+.||+|+||.||+|.+..         ++..||||++...... .. +.+..+...++.+.||||+++++++
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~   75 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVP---------SGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGAL   75 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecC---------CCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeee
Confidence            34679999999999999999999876         6779999999765322 22 2344555568888999999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEcCCCCeEE
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEE-AEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiHrDlkp~NILl~~~~~vkL  284 (490)
                      .+++..+|||||++ |+|.+++..   ....+++..++.++.||+.||.|||+. +   |+||||||+|||++.++.+||
T Consensus        76 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl  151 (290)
T 3fme_A           76 FREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKM  151 (290)
T ss_dssp             ECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEB
T ss_pred             eccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEE
Confidence            99999999999996 588777653   456899999999999999999999998 8   999999999999999999999


Q ss_pred             ecccCcccCCCCCcceeeeccccCCCccCcchh----ccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011250          285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV----MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l----~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~  360 (490)
                      +|||++........   .....||+.|+|||++    .+..++.++|||||||++|+|++|+.||........ .+....
T Consensus       152 ~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~  227 (290)
T 3fme_A          152 CDFGISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-QLKQVV  227 (290)
T ss_dssp             CCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-HHHHHH
T ss_pred             eecCCccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-HHHHHh
Confidence            99999987644322   2234799999999996    456789999999999999999999999974321110 111111


Q ss_pred             hcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ..              ..........+.++.+||.+||+.||.+|||+.+++++
T Consensus       228 ~~--------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          228 EE--------------PSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             HS--------------CCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             cc--------------CCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence            00              00011112336789999999999999999999999874

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=8.9e-44  Score=354.95  Aligned_cols=253  Identities=26%  Similarity=0.365  Sum_probs=199.3

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--------ccHHHHHHHHHHHhccCCCCeec
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--------QGHKEWLAEVNFLGNLLHPNLVK  203 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~Ei~il~~l~HpnIv~  203 (490)
                      .++|.+.+.||+|+||.||+|++..         ++..||||++.....        .....+.+|+.+|+.+.||||++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~   79 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERK---------TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK   79 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCC
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcC---------CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCce
Confidence            3579999999999999999999876         677999999975432        12235789999999999999999


Q ss_pred             eeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCC--
Q 011250          204 LVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN--  281 (490)
Q Consensus       204 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~--  281 (490)
                      +++++..++ .++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.  
T Consensus        80 ~~~~~~~~~-~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~  154 (322)
T 2ycf_A           80 IKNFFDAED-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDC  154 (322)
T ss_dssp             EEEEEESSS-EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSC
T ss_pred             EeeEEcCCc-eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCC
Confidence            999987654 8999999999999998854 457999999999999999999999988   999999999999987654  


Q ss_pred             -eEEecccCcccCCCCCcceeeeccccCCCccCcchhc---cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 011250          282 -AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV  357 (490)
Q Consensus       282 -vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~  357 (490)
                       +||+|||+++......   ......||+.|+|||++.   ...++.++|||||||++|+|++|..||........  +.
T Consensus       155 ~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~  229 (322)
T 2ycf_A          155 LIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LK  229 (322)
T ss_dssp             CEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HH
T ss_pred             eEEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HH
Confidence             9999999998764321   123467999999999874   46789999999999999999999999975443221  11


Q ss_pred             HhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          358 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ........   .+    .+..    ....+..+.+||.+||..||.+||++.+++++
T Consensus       230 ~~~~~~~~---~~----~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          230 DQITSGKY---NF----IPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             HHHHHTCC---CC----CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHhCcc---cc----Cchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            11110000   00    0000    01236789999999999999999999999975

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.1e-43  Score=361.01  Aligned_cols=255  Identities=24%  Similarity=0.374  Sum_probs=205.2

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--------cHHHHHHHHHHHhcc-CCCC
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--------GHKEWLAEVNFLGNL-LHPN  200 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~Ei~il~~l-~Hpn  200 (490)
                      ...++|.+.+.||+|+||.||+|++..         +|..||||++......        ..+.+.+|+.++..+ .|||
T Consensus        91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~---------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~  161 (365)
T 2y7j_A           91 EFYQKYDPKDVIGRGVSSVVRRCVHRA---------TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH  161 (365)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTT
T ss_pred             hhhhhcccceEEecCCCEEEEEEEECC---------CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            344679999999999999999999875         5779999998754311        134578899999999 7999


Q ss_pred             eeceeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC
Q 011250          201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY  280 (490)
Q Consensus       201 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~  280 (490)
                      |+++++++......+|||||+++++|.+++... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++
T Consensus       162 iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~  237 (365)
T 2y7j_A          162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNM  237 (365)
T ss_dssp             BCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTC
T ss_pred             EeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCC
Confidence            999999999999999999999999999998654 46999999999999999999999988   99999999999999999


Q ss_pred             CeEEecccCcccCCCCCcceeeeccccCCCccCcchhcc------CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcc
Q 011250          281 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT------GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH  354 (490)
Q Consensus       281 ~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~  354 (490)
                      .+||+|||++........   ....+||+.|+|||++.+      ..++.++|||||||++|+|++|..||......   
T Consensus       238 ~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---  311 (365)
T 2y7j_A          238 QIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI---  311 (365)
T ss_dssp             CEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---
T ss_pred             CEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH---
Confidence            999999999987654322   234689999999999864      35888999999999999999999999653211   


Q ss_pred             hhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .........   ...+   ..+.     ....+..+.+||.+||+.||.+|||+.+++++
T Consensus       312 ~~~~~i~~~---~~~~---~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          312 LMLRMIMEG---QYQF---SSPE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             HHHHHHHHT---CCCC---CHHH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHhC---CCCC---CCcc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            111111000   0000   0000     01225779999999999999999999999975

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=365.99  Aligned_cols=272  Identities=19%  Similarity=0.248  Sum_probs=206.5

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeec---------
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVK---------  203 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~---------  203 (490)
                      ++|.+.+.||+|+||.||+|++...... .....+..||||++...     +.+.+|+.+++.++||||++         
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~-~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTC-DSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC------------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccc-cccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            5799999999999999999998752110 00113668999998754     35789999999999999988         


Q ss_pred             ------eeeEEEe-CCceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 011250          204 ------LVGYCIE-DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  275 (490)
Q Consensus       204 ------l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NIL  275 (490)
                            +++++.. +...+|||||+ +++|.+++... ...+++..++.++.||+.||.|||+.+   |+||||||+|||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl  191 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIF  191 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEE
Confidence                  6777776 67889999999 99999999764 357999999999999999999999988   999999999999


Q ss_pred             EcCCC--CeEEecccCcccCCCCCcc-----eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCC
Q 011250          276 LDADY--NAKLSDFGLAKDAPEDGKT-----HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN  348 (490)
Q Consensus       276 l~~~~--~vkL~DFG~a~~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~  348 (490)
                      ++.++  .+||+|||+++........     .......||+.|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  9999999999876432211     1113357999999999999989999999999999999999999999754


Q ss_pred             CCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccc
Q 011250          349 RPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~~  421 (490)
                      ..... .+............   ...+..   ......+..+.+||.+||..||.+||++.+|++.|+.+...
T Consensus       272 ~~~~~-~~~~~~~~~~~~~~---~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  337 (352)
T 2jii_A          272 LPNTE-DIMKQKQKFVDKPG---PFVGPC---GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD  337 (352)
T ss_dssp             TTCHH-HHHHHHHHHHHSCC---CEECTT---SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             CcCHH-HHHHHHHhccCChh---hhhhhc---cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence            32211 11111110000000   000000   00012368899999999999999999999999999876543

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.1e-43  Score=360.63  Aligned_cols=268  Identities=23%  Similarity=0.304  Sum_probs=204.4

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .++|++.+.||+|+||.||+|++..         ++..||||++..... ...+.+.+|+.+|..++||||+++++++..
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   96 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNL---------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA   96 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred             cccEEEEEEeecCCCeEEEEEEECC---------CCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEec
Confidence            4579999999999999999999876         677899999975433 334678899999999999999999999976


Q ss_pred             C-----CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEe
Q 011250          211 D-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       211 ~-----~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~  285 (490)
                      .     ...++||||+. |+|.+++...  .+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+
T Consensus        97 ~~~~~~~~~~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~  170 (364)
T 3qyz_A           97 PTIEQMKDVYIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKIC  170 (364)
T ss_dssp             SSTTTCCCEEEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEEC
T ss_pred             CCccccceEEEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEE
Confidence            5     36899999996 6999988543  6999999999999999999999988   9999999999999999999999


Q ss_pred             cccCcccCCCCCcc-eeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011250          286 DFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       286 DFG~a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      |||+++........ ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+......
T Consensus       171 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  250 (364)
T 3qyz_A          171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS  250 (364)
T ss_dssp             CCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCS
T ss_pred             eCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCC
Confidence            99999876432211 11234689999999998764 45899999999999999999999999765433222111100000


Q ss_pred             cC--------Cc--chhhhccCCcc---CCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          364 LG--------DK--RRFYRLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       364 ~~--------~~--~~~~~~~~~~l---~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ..        ..  ..+...+....   ...+....+.++.+||.+||+.||.+|||+.+++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00        00  00000000000   000112236789999999999999999999999976

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=6.8e-44  Score=369.42  Aligned_cols=260  Identities=27%  Similarity=0.356  Sum_probs=196.8

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      .+|++.+.||+|+||+||+|++..         ++..||||++.....    .+.+|+++|+.|+|||||+++++|....
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~---------~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~  120 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCD---------SGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSG  120 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECC---------CCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccC
Confidence            368999999999999999999876         577999999865432    2347999999999999999999886421


Q ss_pred             ------ceEEEEEecCCCChhHHhh---hcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-CCe
Q 011250          213 ------QRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNA  282 (490)
Q Consensus       213 ------~~~lV~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~-~~v  282 (490)
                            .++|||||+++ +|.+++.   .....+++..++.++.||+.||.|||+.+   |+||||||+||||+.+ +.+
T Consensus       121 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~  196 (420)
T 1j1b_A          121 EKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL  196 (420)
T ss_dssp             TTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEE
T ss_pred             CCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeE
Confidence                  36799999965 6766654   34567999999999999999999999988   9999999999999965 568


Q ss_pred             EEecccCcccCCCCCcceeeeccccCCCccCcchhccC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011250          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~  361 (490)
                      ||+|||+++.......   ....+||+.|+|||++.+. .|+.++|||||||+||||++|+.||.......  .+.+...
T Consensus       197 kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~  271 (420)
T 1j1b_A          197 KLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIK  271 (420)
T ss_dssp             EECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH
T ss_pred             EeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH
Confidence            9999999987644322   2346799999999998764 79999999999999999999999997643211  1111111


Q ss_pred             cccCCcchhhhccCC--------cc-----CCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          362 PHLGDKRRFYRLLDP--------RL-----EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       362 ~~~~~~~~~~~~~~~--------~l-----~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ..-.........+++        .+     ...++...+.++.+||.+||..||.+|||+.|+++|
T Consensus       272 ~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          272 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence            000000000000011        00     011223447889999999999999999999999976

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.6e-43  Score=355.39  Aligned_cols=265  Identities=26%  Similarity=0.388  Sum_probs=206.5

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhc--cCCCCeeceeeEE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGN--LLHPNLVKLVGYC  208 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~  208 (490)
                      ..++|.+.+.||+|+||.||+|.+           ++..||||++...   ....+.+|++++..  ++||||+++++++
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~  105 (342)
T 1b6c_B           40 IARTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAAD  105 (342)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEE-----------TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEE
T ss_pred             ccccEEEEeeecCCCCcEEEEEEE-----------cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeee
Confidence            345799999999999999999987           3568999999643   34567889998887  7899999999999


Q ss_pred             EeCC----ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhh--------hcCCCCeeecCCCCCcEEE
Q 011250          209 IEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH--------EEAEKPVIYRDFKTSNILL  276 (490)
Q Consensus       209 ~~~~----~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH--------~~~~~~iiHrDlkp~NILl  276 (490)
                      ....    ..++||||+++|+|.+++.+.  .+++..++.++.||+.||.|||        +.+   |+||||||+||||
T Consensus       106 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll  180 (342)
T 1b6c_B          106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILV  180 (342)
T ss_dssp             ECCCSSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEE
T ss_pred             cccCCccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEE
Confidence            8876    789999999999999999653  6999999999999999999999        666   9999999999999


Q ss_pred             cCCCCeEEecccCcccCCCCCcce--eeeccccCCCccCcchhccC------CCCccchhhHHHHHHHHHHhC-------
Q 011250          277 DADYNAKLSDFGLAKDAPEDGKTH--VSTRVMGTYGYAAPEYVMTG------HLTSKSDVYSFGVVLLEMLTG-------  341 (490)
Q Consensus       277 ~~~~~vkL~DFG~a~~~~~~~~~~--~~~~~~Gt~~y~aPE~l~~~------~~~~~sDvwSlGv~l~elltG-------  341 (490)
                      +.++.+||+|||++..........  ......||+.|+|||++.+.      .++.++|||||||+||||++|       
T Consensus       181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~  260 (342)
T 1b6c_B          181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH  260 (342)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence            999999999999998764433221  12345799999999998765      233689999999999999999       


Q ss_pred             ---CCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCC-CChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011250          342 ---RRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGH-FSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  417 (490)
Q Consensus       342 ---~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~  417 (490)
                         ..||......... ...+......      ..+.+.+... .+..++..+.+||.+||+.||.+|||+.+|+++|+.
T Consensus       261 ~~~~~p~~~~~~~~~~-~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~  333 (342)
T 1b6c_B          261 EDYQLPYYDLVPSDPS-VEEMRKVVCE------QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  333 (342)
T ss_dssp             CCCCCTTTTTSCSSCC-HHHHHHHHTT------SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             cccccCccccCcCccc-HHHHHHHHHH------HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence               6777654332211 1111100000      0111111111 123557889999999999999999999999999998


Q ss_pred             Cccc
Q 011250          418 LQNL  421 (490)
Q Consensus       418 l~~~  421 (490)
                      +...
T Consensus       334 i~~~  337 (342)
T 1b6c_B          334 LSQQ  337 (342)
T ss_dssp             HHHT
T ss_pred             HHHH
Confidence            7553

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=6.6e-44  Score=363.07  Aligned_cols=263  Identities=25%  Similarity=0.367  Sum_probs=187.1

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      .++|++.+.||+|+||.||+|.+..         +|..||||++....  ....+.+.+|+.+|+.++||||+++++++.
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~   98 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT   98 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETT---------TTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECC---------CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence            3689999999999999999998876         67899999997542  234567889999999999999999999987


Q ss_pred             eC------CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeE
Q 011250          210 ED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       210 ~~------~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vk  283 (490)
                      ..      ...|+||||+ +++|.+++..  ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+|
T Consensus        99 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~k  172 (367)
T 2fst_X           99 PARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK  172 (367)
T ss_dssp             SCSSGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred             cCCccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEE
Confidence            54      5679999999 7899998854  47999999999999999999999988   99999999999999999999


Q ss_pred             EecccCcccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011250          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      |+|||+++.....     ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.....
T Consensus       173 L~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g  247 (367)
T 2fst_X          173 ILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG  247 (367)
T ss_dssp             ECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             Eeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            9999999875432     234679999999999876 6899999999999999999999999976432211111100000


Q ss_pred             --------ccCCc--chhhhccCCccCCC---CChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          363 --------HLGDK--RRFYRLLDPRLEGH---FSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       363 --------~~~~~--~~~~~~~~~~l~~~---~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                              .+...  ..+...+.......   .....+..+.+||.+||..||.+|||+.+++++
T Consensus       248 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             SCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence                    00000  00000000000000   001236789999999999999999999999976

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=6.9e-44  Score=363.33  Aligned_cols=261  Identities=23%  Similarity=0.289  Sum_probs=194.4

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      .++|++.+.||+|+||.||+|++..         ++..||||++....  ....+.+.+|+.+++.++||||+++++++.
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   94 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAI---------LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT   94 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECC---------CCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeec
Confidence            3579999999999999999999876         67789999997543  233467889999999999999999999998


Q ss_pred             eCC------ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeE
Q 011250          210 EDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       210 ~~~------~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vk  283 (490)
                      ..+      ..||||||++ |+|.+++.   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+|
T Consensus        95 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~k  167 (371)
T 2xrw_A           95 PQKSLEEFQDVYIVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK  167 (371)
T ss_dssp             SCCSTTTCCEEEEEEECCS-EEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred             cccccccccceEEEEEcCC-CCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEE
Confidence            765      6799999996 57888874   35899999999999999999999988   99999999999999999999


Q ss_pred             EecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011250          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      |+|||+++......   .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||........   .......
T Consensus       168 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~  241 (371)
T 2xrw_A          168 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ---WNKVIEQ  241 (371)
T ss_dssp             ECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHC-
T ss_pred             EEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHH
Confidence            99999998664321   22346799999999999999999999999999999999999999976432111   0000000


Q ss_pred             cCCc------------------------chhhhccCCccC---CCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          364 LGDK------------------------RRFYRLLDPRLE---GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       364 ~~~~------------------------~~~~~~~~~~l~---~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ++..                        ..+...+.....   .......+..+.+||.+||..||.+|||+.+++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          242 LGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             hCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence            0000                        000000000000   00011236789999999999999999999999976

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.8e-44  Score=364.29  Aligned_cols=275  Identities=23%  Similarity=0.321  Sum_probs=202.3

Q ss_pred             hhhhhHHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-----------cHHHHHHHHH
Q 011250          123 FMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-----------GHKEWLAEVN  191 (490)
Q Consensus       123 ~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~~~Ei~  191 (490)
                      ....++....++|.+.+.||+|+||.||+|.+.          ++..||||++......           ..+.+.+|+.
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~   81 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDS----------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR   81 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECT----------TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHH
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECC----------CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHH
Confidence            345677788899999999999999999999874          3668999998643221           1367899999


Q ss_pred             HHhccCCCCeeceeeEEEeC-----CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 011250          192 FLGNLLHPNLVKLVGYCIED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIY  266 (490)
Q Consensus       192 il~~l~HpnIv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH  266 (490)
                      +++.++||||+++++++...     ...||||||+. |+|.+++......+++..+..++.||+.||.|||+.+   |+|
T Consensus        82 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH  157 (362)
T 3pg1_A           82 LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVH  157 (362)
T ss_dssp             HHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred             HHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEe
Confidence            99999999999999998653     35799999996 6898888776668999999999999999999999988   999


Q ss_pred             cCCCCCcEEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCC
Q 011250          267 RDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSM  345 (490)
Q Consensus       267 rDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf  345 (490)
                      |||||+||||+.++.+||+|||+++......   ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus       158 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf  234 (362)
T 3pg1_A          158 RDLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF  234 (362)
T ss_dssp             CCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             cCCChHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCC
Confidence            9999999999999999999999997554322   2234679999999999876 67999999999999999999999999


Q ss_pred             CCCCCCCcchhh-Hhhh-cccC-----CcchhhhccCCcc-------CCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHH
Q 011250          346 DKNRPNGEHNLV-EWAR-PHLG-----DKRRFYRLLDPRL-------EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV  411 (490)
Q Consensus       346 ~~~~~~~~~~~~-~~~~-~~~~-----~~~~~~~~~~~~l-------~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~ev  411 (490)
                      ...........+ .... +...     ........+...+       ........+..+.+||.+||+.||.+|||+.++
T Consensus       235 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  314 (362)
T 3pg1_A          235 RGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQA  314 (362)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence            764321111100 0000 0000     0000000000000       001112336789999999999999999999999


Q ss_pred             HHH
Q 011250          412 VET  414 (490)
Q Consensus       412 l~~  414 (490)
                      +++
T Consensus       315 l~h  317 (362)
T 3pg1_A          315 LRH  317 (362)
T ss_dssp             HTS
T ss_pred             HcC
Confidence            976

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.9e-43  Score=348.02  Aligned_cols=253  Identities=26%  Similarity=0.349  Sum_probs=205.3

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---------ccHHHHHHHHHHHhccC-CCCe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---------QGHKEWLAEVNFLGNLL-HPNL  201 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~Ei~il~~l~-HpnI  201 (490)
                      .++|++.+.||+|+||.||+|.+..         ++..||||++.....         ...+.+.+|+.+++.+. ||||
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i   86 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKP---------TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI   86 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTB
T ss_pred             hhccceeeeecCCCceEEEEEEEcC---------cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCE
Confidence            3579999999999999999999876         677999999975531         12346789999999996 9999


Q ss_pred             eceeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCC
Q 011250          202 VKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       202 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                      +++++++...+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus        87 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~  162 (298)
T 1phk_A           87 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMN  162 (298)
T ss_dssp             CCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred             eeeeeeeccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCc
Confidence            99999999999999999999999999999654 47999999999999999999999988   999999999999999999


Q ss_pred             eEEecccCcccCCCCCcceeeeccccCCCccCcchhc------cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcch
Q 011250          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM------TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN  355 (490)
Q Consensus       282 vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~  355 (490)
                      +||+|||++........   .....||+.|+|||++.      ...++.++||||||+++|+|++|..||......   .
T Consensus       163 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~  236 (298)
T 1phk_A          163 IKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---L  236 (298)
T ss_dssp             EEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H
T ss_pred             EEEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH---H
Confidence            99999999987654322   23467999999999885      456889999999999999999999999653211   1


Q ss_pred             hhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .......   ...        ..........+..+.+||.+||+.||.+|||+.+++++
T Consensus       237 ~~~~~~~---~~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          237 MLRMIMS---GNY--------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             HHHHHHH---TCC--------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHhc---CCc--------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence            1111100   000        00001112347889999999999999999999999864

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=359.78  Aligned_cols=263  Identities=19%  Similarity=0.315  Sum_probs=203.4

Q ss_pred             HHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeecee
Q 011250          128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLV  205 (490)
Q Consensus       128 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~  205 (490)
                      +.+..++|++.+.||+|+||.||+|.+..            .||+|++.....  ...+.+.+|+.+++.++||||++++
T Consensus        28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~------------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~   95 (319)
T 2y4i_B           28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG------------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM   95 (319)
T ss_dssp             SSSCCSCEECCCBCCCSSSSEEEEEEESS------------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCC
T ss_pred             ccCCHHHeEEeeEeccCCceEEEEEEEcC------------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEE
Confidence            34456789999999999999999998753            499999875422  2234577899999999999999999


Q ss_pred             eEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEe
Q 011250          206 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       206 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~  285 (490)
                      +++.+.+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+   |+||||||+|||++ ++.+||+
T Consensus        96 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~  171 (319)
T 2y4i_B           96 GACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVIT  171 (319)
T ss_dssp             EEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEEC
T ss_pred             EEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEe
Confidence            9999999999999999999999999776667999999999999999999999988   99999999999998 6799999


Q ss_pred             cccCcccCCCCCc---ceeeeccccCCCccCcchhcc---------CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCc
Q 011250          286 DFGLAKDAPEDGK---THVSTRVMGTYGYAAPEYVMT---------GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE  353 (490)
Q Consensus       286 DFG~a~~~~~~~~---~~~~~~~~Gt~~y~aPE~l~~---------~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~  353 (490)
                      |||+++.......   ........||+.|+|||++..         ..++.++|||||||++|||++|+.||......  
T Consensus       172 Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--  249 (319)
T 2y4i_B          172 DFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE--  249 (319)
T ss_dssp             CCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH--
T ss_pred             ecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--
Confidence            9999876532111   111223568999999999864         45788999999999999999999999754221  


Q ss_pred             chhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcccc
Q 011250          354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLK  422 (490)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~~~  422 (490)
                       ........          ...+.+   .....+.++.+||.+||..||.+|||+.+|++.|+.+....
T Consensus       250 -~~~~~~~~----------~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          250 -AIIWQMGT----------GMKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             -HHHHHHHT----------TCCCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             -HHHHHhcc----------CCCCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence             11111000          000111   11123567899999999999999999999999999887654

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=5.4e-44  Score=354.93  Aligned_cols=263  Identities=24%  Similarity=0.365  Sum_probs=202.6

Q ss_pred             hhhhhhHHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccC--
Q 011250          122 KFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLL--  197 (490)
Q Consensus       122 ~~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~--  197 (490)
                      .+.+..+.+..++|++.+.||+|+||.||+|.+.          ++..||||++.....  ...+.+.+|+.++..+.  
T Consensus        17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~   86 (313)
T 3cek_A           17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH   86 (313)
T ss_dssp             ---CCEEEETTEEEEEEEEEECCSSEEEEEEECT----------TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGG
T ss_pred             CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcC----------CCcEEEEEEeccccccccchHHHHHHHHHHHhcccc
Confidence            4445555666778999999999999999999874          356899999975532  34467899999999997  


Q ss_pred             CCCeeceeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc
Q 011250          198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD  277 (490)
Q Consensus       198 HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~  277 (490)
                      |+||+++++++.+.+..+|||| +.+++|.+++... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++
T Consensus        87 ~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~  161 (313)
T 3cek_A           87 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV  161 (313)
T ss_dssp             CTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE
T ss_pred             CCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEE
Confidence            5999999999999999999999 5588999999654 47999999999999999999999988   99999999999996


Q ss_pred             CCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhcc-----------CCCCccchhhHHHHHHHHHHhCCCCCC
Q 011250          278 ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-----------GHLTSKSDVYSFGVVLLEMLTGRRSMD  346 (490)
Q Consensus       278 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----------~~~~~~sDvwSlGv~l~elltG~~pf~  346 (490)
                      + +.+||+|||++................||+.|+|||++.+           ..++.++|||||||++|||++|+.||.
T Consensus       162 ~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~  240 (313)
T 3cek_A          162 D-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ  240 (313)
T ss_dssp             T-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             C-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchh
Confidence            4 8999999999987654433223344679999999999875           478889999999999999999999996


Q ss_pred             CCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          347 KNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                      .....     ...          +....++.....++...+..+.+||.+||+.||.+||++.+++++-
T Consensus       241 ~~~~~-----~~~----------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~  294 (313)
T 3cek_A          241 QIINQ-----ISK----------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  294 (313)
T ss_dssp             TCCSH-----HHH----------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             hHHHH-----HHH----------HHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence            43211     000          1111222222233333467899999999999999999999999753

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.4e-43  Score=348.84  Aligned_cols=254  Identities=24%  Similarity=0.390  Sum_probs=197.0

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEe--
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE--  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--  210 (490)
                      ++|++.+.||+|+||.||+|++..         ++..||||++.... ...+.+.+|+.+++.++||||+++++++.+  
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   75 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNAL---------DSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERR   75 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECC
T ss_pred             ccchhhheeccCCcEEEEEEEEcC---------CCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhc
Confidence            469999999999999999999875         56789999996432 334678899999999999999999998865  


Q ss_pred             -----------CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC
Q 011250          211 -----------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD  279 (490)
Q Consensus       211 -----------~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~  279 (490)
                                 ....++||||+++|+|.+++......+++..++.++.||+.||+|||+.+   |+||||||+|||++.+
T Consensus        76 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~  152 (303)
T 1zy4_A           76 NFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDES  152 (303)
T ss_dssp             CCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTT
T ss_pred             chhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCC
Confidence                       34679999999999999999877667889999999999999999999988   9999999999999999


Q ss_pred             CCeEEecccCcccCCCCCc------------ceeeeccccCCCccCcchhccC-CCCccchhhHHHHHHHHHHhCCCCCC
Q 011250          280 YNAKLSDFGLAKDAPEDGK------------THVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMD  346 (490)
Q Consensus       280 ~~vkL~DFG~a~~~~~~~~------------~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGv~l~elltG~~pf~  346 (490)
                      +.+||+|||++........            ........||+.|+|||++.+. .++.++|||||||++|+|++   ||.
T Consensus       153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~  229 (303)
T 1zy4_A          153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFS  229 (303)
T ss_dssp             SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred             CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccC
Confidence            9999999999987643210            1112346799999999998754 78999999999999999998   443


Q ss_pred             CCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          347 KNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                      ...  ..........           .....+...++...+..+.+||.+||+.||.+|||+.+++++-
T Consensus       230 ~~~--~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~  285 (303)
T 1zy4_A          230 TGM--ERVNILKKLR-----------SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSG  285 (303)
T ss_dssp             SHH--HHHHHHHHHH-----------STTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSS
T ss_pred             Cch--hHHHHHHhcc-----------ccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCC
Confidence            210  0001111100           0111122234445577899999999999999999999999863

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=351.12  Aligned_cols=268  Identities=24%  Similarity=0.322  Sum_probs=197.5

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEE--
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI--  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--  209 (490)
                      .++|++.+.||+|+||.||+|.+..         +++.||||++........+.+.+|+.+++.++||||+++++++.  
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   80 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDND---------CDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPS   80 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETT---------TTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTT
T ss_pred             CCceeEEEEeccCCCeEEEEEEECC---------CCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccc
Confidence            3579999999999999999999876         67799999998776666678999999999999999999999874  


Q ss_pred             ------------eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc
Q 011250          210 ------------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD  277 (490)
Q Consensus       210 ------------~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~  277 (490)
                                  +....++||||+. |+|.+++..  ..+++..++.++.||+.||+|||+.+   |+||||||+|||++
T Consensus        81 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~  154 (320)
T 2i6l_A           81 GSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFIN  154 (320)
T ss_dssp             SCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEE
T ss_pred             ccccccccccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEc
Confidence                        3467899999997 699998843  46999999999999999999999988   99999999999997


Q ss_pred             -CCCCeEEecccCcccCCCCCc-ceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcc
Q 011250          278 -ADYNAKLSDFGLAKDAPEDGK-THVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH  354 (490)
Q Consensus       278 -~~~~vkL~DFG~a~~~~~~~~-~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~  354 (490)
                       .++.+||+|||+++....... ........||..|+|||++.. ..++.++|||||||++|||++|+.||.........
T Consensus       155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  234 (320)
T 2i6l_A          155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM  234 (320)
T ss_dssp             TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence             567999999999987643211 112234568999999998875 68899999999999999999999999764321111


Q ss_pred             hhhHhhhcccCC--cchhhhcc---------CCcc-CCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          355 NLVEWARPHLGD--KRRFYRLL---------DPRL-EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       355 ~~~~~~~~~~~~--~~~~~~~~---------~~~l-~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ..+....+....  ...+...+         .+.. ...+....+.++.+||.+||+.||.+|||+.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            111000000000  00000000         0000 000112247889999999999999999999999975

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.5e-43  Score=386.08  Aligned_cols=263  Identities=24%  Similarity=0.382  Sum_probs=211.3

Q ss_pred             HHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeE
Q 011250          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (490)
Q Consensus       129 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~  207 (490)
                      ....++|++.+.||+|+||.||+|.+...+.      .+..||||.+..... ...+.+.+|+.+|+.++||||++++++
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~  459 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPEN------PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV  459 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSS------CCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCC------ccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            3445679999999999999999999865332      456899999876433 334678999999999999999999999


Q ss_pred             EEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecc
Q 011250          208 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DF  287 (490)
                      +. ++..+|||||+++|+|.+++......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus       460 ~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DF  535 (656)
T 2j0j_A          460 IT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDF  535 (656)
T ss_dssp             EC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCC
T ss_pred             Ee-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEec
Confidence            85 56789999999999999999777667999999999999999999999988   999999999999999999999999


Q ss_pred             cCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCC
Q 011250          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      |+++........ ......||+.|+|||++.+..++.++|||||||++|||++ |..||......   .........   
T Consensus       536 G~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~~~i~~~---  608 (656)
T 2j0j_A          536 GLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRIENG---  608 (656)
T ss_dssp             CCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHHT---
T ss_pred             CCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHcC---
Confidence            999876543222 2233567889999999999999999999999999999997 99999754321   111111100   


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~  419 (490)
                                 ....++..++..+.+||.+||..||.+|||+.+|++.|+.+.
T Consensus       609 -----------~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          609 -----------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  650 (656)
T ss_dssp             -----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----------CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                       001123345788999999999999999999999999998764

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.9e-43  Score=351.13  Aligned_cols=266  Identities=23%  Similarity=0.305  Sum_probs=205.8

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCC------Ceece
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP------NLVKL  204 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~Hp------nIv~l  204 (490)
                      ..++|++.+.||+|+||.||+|.+...        ++..||||++.... ...+.+.+|+.+++.+.|+      +|+++
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~   82 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKA--------GGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQM   82 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCC--------CCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence            346899999999999999999988432        56789999997542 3346788899999988765      49999


Q ss_pred             eeEEEeCCceEEEEEecCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-----
Q 011250          205 VGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-----  278 (490)
Q Consensus       205 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~-----  278 (490)
                      ++++.+.+..+|||||+ +++|.+++.... ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.     
T Consensus        83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~  158 (339)
T 1z57_A           83 LEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTE  158 (339)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEE
T ss_pred             ecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEecccccc
Confidence            99999999999999999 889999987654 36899999999999999999999988   999999999999987     


Q ss_pred             --------------CCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCC
Q 011250          279 --------------DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRS  344 (490)
Q Consensus       279 --------------~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~p  344 (490)
                                    ++.+||+|||+++.....     ....+||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus       159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  233 (339)
T 1z57_A          159 AYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTV  233 (339)
T ss_dssp             EEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence                          678999999999875432     1345799999999999998999999999999999999999999


Q ss_pred             CCCCCCCCcchhhHhhhcccCCc-------ch------------------hhhccCCcc-CCCCChhhHHHHHHHHHHhh
Q 011250          345 MDKNRPNGEHNLVEWARPHLGDK-------RR------------------FYRLLDPRL-EGHFSIKGSQKATQLAAQCL  398 (490)
Q Consensus       345 f~~~~~~~~~~~~~~~~~~~~~~-------~~------------------~~~~~~~~l-~~~~~~~~~~~l~~Li~~cL  398 (490)
                      |......................       ..                  ......+.. ........+..+.+||.+||
T Consensus       234 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L  313 (339)
T 1z57_A          234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKML  313 (339)
T ss_dssp             CCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred             CCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHh
Confidence            97643222111111110000000       00                  000000000 01122345788999999999


Q ss_pred             hcCCCCCCCHHHHHHH
Q 011250          399 SRDPKARPRMSEVVET  414 (490)
Q Consensus       399 ~~dP~~RPt~~evl~~  414 (490)
                      +.||.+|||+.|++++
T Consensus       314 ~~dP~~Rpt~~ell~h  329 (339)
T 1z57_A          314 EYDPAKRITLREALKH  329 (339)
T ss_dssp             CSSTTTSCCHHHHTTS
T ss_pred             CcCcccccCHHHHhcC
Confidence            9999999999999865

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.7e-43  Score=356.51  Aligned_cols=262  Identities=24%  Similarity=0.351  Sum_probs=199.0

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      .++|.+.+.||+|+||.||+|.+..         +|..||||++.....  ...+.+.+|+.+++.++||||+++++++.
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  111 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKR---------SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT  111 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECC---------CCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhhee
Confidence            3579999999999999999999876         677999999976532  23467889999999999999999999998


Q ss_pred             eCCce------EEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeE
Q 011250          210 EDDQR------LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       210 ~~~~~------~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vk  283 (490)
                      ..+..      ++||||+. ++|.+++.   ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+|
T Consensus       112 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~k  184 (371)
T 4exu_A          112 PASSLRNFYDFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELK  184 (371)
T ss_dssp             SCSSSTTCCCCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEE
T ss_pred             ccCCcccceeEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEE
Confidence            87655      99999996 68888763   35999999999999999999999988   99999999999999999999


Q ss_pred             EecccCcccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011250          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      |+|||+++.....     ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.....
T Consensus       185 L~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~  259 (371)
T 4exu_A          185 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG  259 (371)
T ss_dssp             ECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             EEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            9999999865432     234678999999999887 6899999999999999999999999976432111110000000


Q ss_pred             --------ccCCc--chhhhccCCccCC---CCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          363 --------HLGDK--RRFYRLLDPRLEG---HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       363 --------~~~~~--~~~~~~~~~~l~~---~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                              .+...  ..+...+......   .+....+..+.+||.+||+.||.+|||+.+++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          260 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             CCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence                    00000  0000000000000   0112336889999999999999999999999976

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.4e-43  Score=353.94  Aligned_cols=268  Identities=25%  Similarity=0.324  Sum_probs=201.5

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .++|.+.+.||+|+||.||+|.+..         +|..||||++..... .....+.+|+.+++.++||||+++++++..
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   80 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKP---------TGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRP   80 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECC---------CCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecc
Confidence            4579999999999999999999875         677999999975432 334568899999999999999999998776


Q ss_pred             C-----CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEe
Q 011250          211 D-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       211 ~-----~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~  285 (490)
                      .     ...++||||+. ++|.+++..  ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        81 ~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~  154 (353)
T 2b9h_A           81 DSFENFNEVYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVC  154 (353)
T ss_dssp             SCSTTCCCEEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEEC
T ss_pred             cccCccceEEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEE
Confidence            4     67899999996 699998865  36999999999999999999999988   9999999999999999999999


Q ss_pred             cccCcccCCCCCcce--------eeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchh
Q 011250          286 DFGLAKDAPEDGKTH--------VSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL  356 (490)
Q Consensus       286 DFG~a~~~~~~~~~~--------~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~  356 (490)
                      |||+++.........        .....+||+.|+|||++.. ..++.++|||||||++|+|++|+.||...........
T Consensus       155 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  234 (353)
T 2b9h_A          155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL  234 (353)
T ss_dssp             CCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             ecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence            999998765322111        1223578999999998765 6789999999999999999999999976432111100


Q ss_pred             hHhhh--cccCC------cc---hhhhccCCccC---CCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          357 VEWAR--PHLGD------KR---RFYRLLDPRLE---GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       357 ~~~~~--~~~~~------~~---~~~~~~~~~l~---~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      +....  +....      ..   .+...+.....   .......+.++.+||.+||+.||.+|||+.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             HHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            00000  00000      00   00000000000   00012346789999999999999999999999975

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=9.2e-44  Score=358.19  Aligned_cols=263  Identities=19%  Similarity=0.282  Sum_probs=205.2

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-----------------HHHHHHHHHHHh
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-----------------HKEWLAEVNFLG  194 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----------------~~~~~~Ei~il~  194 (490)
                      .++|++.+.||+|+||.||+|.+           ++..||||++.......                 .+.+.+|+.+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   98 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-----------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT   98 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-----------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHT
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-----------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHH
Confidence            46899999999999999999987           25689999986442211                 178899999999


Q ss_pred             ccCCCCeeceeeEEEeCCceEEEEEecCCCChhHH------hhhc-CCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeee
Q 011250          195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENH------LFRR-SLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIY  266 (490)
Q Consensus       195 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~------l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiH  266 (490)
                      .++||||+++++++.+.+..++||||+++|+|.++      +... ...+++..++.++.||+.||.|||+ .+   |+|
T Consensus        99 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H  175 (348)
T 2pml_X           99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICH  175 (348)
T ss_dssp             TCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred             hCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---Eee
Confidence            99999999999999999999999999999999998      5432 4679999999999999999999999 88   999


Q ss_pred             cCCCCCcEEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccC-CCCc-cchhhHHHHHHHHHHhCCCC
Q 011250          267 RDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTS-KSDVYSFGVVLLEMLTGRRS  344 (490)
Q Consensus       267 rDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~-~sDvwSlGv~l~elltG~~p  344 (490)
                      |||||+|||++.++.+||+|||++......    ......||+.|+|||++.+. .++. ++|||||||++|||++|..|
T Consensus       176 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p  251 (348)
T 2pml_X          176 RDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP  251 (348)
T ss_dssp             CCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999876433    23446799999999999877 6666 99999999999999999999


Q ss_pred             CCCCCCCCcchhhHhhhcc---cCCc-chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          345 MDKNRPNGEHNLVEWARPH---LGDK-RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       345 f~~~~~~~~~~~~~~~~~~---~~~~-~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      |......  ..........   .... ..+................+..+.+||.+||+.||.+|||+.+++++
T Consensus       252 f~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          252 FSLKISL--VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             SCCSSCS--HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CCCCCcH--HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            9764331  1111111110   0000 00000000000001113347889999999999999999999999975

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3e-43  Score=362.76  Aligned_cols=269  Identities=22%  Similarity=0.349  Sum_probs=185.9

Q ss_pred             CCCC-CcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEe--
Q 011250          134 NFRP-ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE--  210 (490)
Q Consensus       134 ~y~~-~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--  210 (490)
                      .|.+ .++||+|+||.||+|++....       ++..||||++.....  ...+.+|+.+|+.|+||||+++++++..  
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~-------~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   91 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGK-------DDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHA   91 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSS-------CCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETT
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCC-------CCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCC
Confidence            4666 458999999999999976421       467899999976533  2468899999999999999999999965  


Q ss_pred             CCceEEEEEecCCCChhHHhhhc--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE----cC
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRR--------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL----DA  278 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~--------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl----~~  278 (490)
                      ....+|||||+. |+|.+++...        ...+++..++.|+.||+.||.|||+.+   |+||||||+||||    +.
T Consensus        92 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~  167 (405)
T 3rgf_A           92 DRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPE  167 (405)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTT
T ss_pred             CCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCC
Confidence            568899999995 5888877522        224999999999999999999999988   9999999999999    67


Q ss_pred             CCCeEEecccCcccCCCCCcc-eeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCc---
Q 011250          279 DYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE---  353 (490)
Q Consensus       279 ~~~vkL~DFG~a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~---  353 (490)
                      ++.+||+|||+++........ ......+||+.|+|||++.+ ..++.++|||||||+||||++|++||........   
T Consensus       168 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  247 (405)
T 3rgf_A          168 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN  247 (405)
T ss_dssp             TTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------C
T ss_pred             CCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccc
Confidence            789999999999876432211 22234689999999999887 4599999999999999999999999975433210   


Q ss_pred             ---chhhHhhhcccC--------------CcchhhhccCCccCC---------CCChhhHHHHHHHHHHhhhcCCCCCCC
Q 011250          354 ---HNLVEWARPHLG--------------DKRRFYRLLDPRLEG---------HFSIKGSQKATQLAAQCLSRDPKARPR  407 (490)
Q Consensus       354 ---~~~~~~~~~~~~--------------~~~~~~~~~~~~l~~---------~~~~~~~~~l~~Li~~cL~~dP~~RPt  407 (490)
                         ..........++              ....+...+......         ......+..+.+||.+||+.||.+|||
T Consensus       248 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t  327 (405)
T 3rgf_A          248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT  327 (405)
T ss_dssp             CCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC
T ss_pred             cchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC
Confidence               000000000000              000000000000000         001112567899999999999999999


Q ss_pred             HHHHHHHh
Q 011250          408 MSEVVETL  415 (490)
Q Consensus       408 ~~evl~~L  415 (490)
                      +.|+|+|-
T Consensus       328 a~e~L~hp  335 (405)
T 3rgf_A          328 SEQAMQDP  335 (405)
T ss_dssp             HHHHHTSG
T ss_pred             HHHHhcCh
Confidence            99999874

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4.8e-43  Score=354.62  Aligned_cols=266  Identities=27%  Similarity=0.383  Sum_probs=190.9

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ...++|++.+.||+|+||.||+|++..         ++..||||++..... ....+.+|++.+..++||||+++++++.
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~   89 (360)
T 3e3p_A           20 KEMDRFQVERMAGQGTFGTVQLGKEKS---------TGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFY   89 (360)
T ss_dssp             HHHTTEEEC----------CEEEEETT---------TCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             hhccceEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhh
Confidence            345689999999999999999999876         577899999865432 2245677888899999999999999997


Q ss_pred             eCCc-------eEEEEEecCCCChhHHhh---hcCCCCCHHHHHHHHHHHHHHHHHhh--hcCCCCeeecCCCCCcEEEc
Q 011250          210 EDDQ-------RLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLH--EEAEKPVIYRDFKTSNILLD  277 (490)
Q Consensus       210 ~~~~-------~~lV~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~qi~~aL~yLH--~~~~~~iiHrDlkp~NILl~  277 (490)
                      ..+.       .+|||||+++ +|...+.   .....+++..+..++.||+.||.|||  +.+   |+||||||+||||+
T Consensus        90 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~  165 (360)
T 3e3p_A           90 TLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVN  165 (360)
T ss_dssp             EECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEE
T ss_pred             ccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEe
Confidence            6443       7899999975 5555443   24567899999999999999999999  777   99999999999999


Q ss_pred             C-CCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcch
Q 011250          278 A-DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN  355 (490)
Q Consensus       278 ~-~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~  355 (490)
                      . ++.+||+|||+++.......   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..........
T Consensus       166 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  242 (360)
T 3e3p_A          166 EADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH  242 (360)
T ss_dssp             TTTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             CCCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHH
Confidence            6 89999999999987654322   2346789999999998654 48999999999999999999999997643221111


Q ss_pred             hhHhhhcccCCcchhhhccCC----------------ccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          356 LVEWARPHLGDKRRFYRLLDP----------------RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~----------------~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                        ................+++                ..........+.++.+||.+||+.||.+|||+.|++++
T Consensus       243 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          243 --EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             --HHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             --HHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence              1111000000000000000                00111223357899999999999999999999999975

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.2e-43  Score=364.50  Aligned_cols=259  Identities=24%  Similarity=0.340  Sum_probs=194.4

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      .+|++.++||+|+||+||+|++..         ++ .||+|++......    ..+|+.+|+.++||||+++++++...+
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~---------~~-~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~  105 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVE---------SD-EVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNG  105 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETT---------TE-EEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEES
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECC---------CC-eEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecC
Confidence            469999999999999999999864         33 4888887644321    236999999999999999999996644


Q ss_pred             c------eEEEEEecCCCChhHHhh---hcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-CCCCe
Q 011250          213 Q------RLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD-ADYNA  282 (490)
Q Consensus       213 ~------~~lV~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~-~~~~v  282 (490)
                      .      .+|||||++++ |...+.   .....+++..+..++.||+.||.|||+.+   |+||||||+||||+ .++.+
T Consensus       106 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~  181 (394)
T 4e7w_A          106 DKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVL  181 (394)
T ss_dssp             SSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEE
T ss_pred             CCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcE
Confidence            3      78999999764 444332   23567999999999999999999999988   99999999999999 78999


Q ss_pred             EEecccCcccCCCCCcceeeeccccCCCccCcchhccC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011250          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~  361 (490)
                      ||+|||+++.......   ....+||+.|+|||++.+. .++.++|||||||+||||++|+.||........  +.....
T Consensus       182 kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~i~~  256 (394)
T 4e7w_A          182 KLIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVEIIK  256 (394)
T ss_dssp             EECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH
T ss_pred             EEeeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHH
Confidence            9999999987644322   2346789999999998764 699999999999999999999999976432211  111111


Q ss_pred             ccc-CCcc------------hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          362 PHL-GDKR------------RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       362 ~~~-~~~~------------~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ... ....            .+.......+...++...+.++.+||.+||+.||.+|||+.++++|
T Consensus       257 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          257 VLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            000 0000            0000000011111223357899999999999999999999999986

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=5.1e-43  Score=349.34  Aligned_cols=269  Identities=25%  Similarity=0.360  Sum_probs=202.6

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcc---CCCCeecee
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNL---LHPNLVKLV  205 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l---~HpnIv~l~  205 (490)
                      ..++|++.+.||+|+||.||+|++...        ++..||||++.....  .....+.+|+.+++.+   .||||++++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~   80 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKN--------GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLF   80 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred             chhceeeeeeecccccEEEEEEEecCC--------CCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeee
Confidence            446899999999999999999998532        567899999864321  1123466777777766   899999999


Q ss_pred             eEEE-----eCCceEEEEEecCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC
Q 011250          206 GYCI-----EDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD  279 (490)
Q Consensus       206 ~~~~-----~~~~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~  279 (490)
                      +++.     .....++||||+. |+|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.+
T Consensus        81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~  156 (326)
T 1blx_A           81 DVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSS  156 (326)
T ss_dssp             EEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT
T ss_pred             eeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCC
Confidence            9987     4567899999997 69999987643 35999999999999999999999988   9999999999999999


Q ss_pred             CCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhh-H
Q 011250          280 YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-E  358 (490)
Q Consensus       280 ~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~-~  358 (490)
                      +.+||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+ .
T Consensus       157 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~  233 (326)
T 1blx_A          157 GQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD  233 (326)
T ss_dssp             CCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             CCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence            999999999998654321   223467999999999999999999999999999999999999999764322111100 0


Q ss_pred             hhh-c---ccCC----cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          359 WAR-P---HLGD----KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       359 ~~~-~---~~~~----~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ... +   .+..    ...............+....+..+.+||.+||..||.+|||+.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          234 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            000 0   0000    000000000000111223447889999999999999999999999964

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=7e-43  Score=349.06  Aligned_cols=255  Identities=27%  Similarity=0.368  Sum_probs=182.7

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHH-HHhccCCCCeeceeeEEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVN-FLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~  209 (490)
                      .++|++.+.||+|+||.||+|.+..         ++..||||++..... ....++..|+. +++.+.||||+++++++.
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~   91 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKP---------SGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF   91 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETT---------TTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcC---------CCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE
Confidence            4679999999999999999999875         677999999976532 23345666666 777889999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhh----cCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEcCCCCeEE
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFR----RSLPLPWSIRMKIALGAAKGLAFLHEE-AEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiHrDlkp~NILl~~~~~vkL  284 (490)
                      +.+..+|||||+++ +|.+++..    ....+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||
T Consensus        92 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl  167 (327)
T 3aln_A           92 REGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKL  167 (327)
T ss_dssp             CSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEE
T ss_pred             eCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEE
Confidence            99999999999974 88877753    246799999999999999999999998 8   999999999999999999999


Q ss_pred             ecccCcccCCCCCcceeeeccccCCCccCcchh----ccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011250          285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV----MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l----~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~  360 (490)
                      +|||+++.......   .....||+.|+|||++    .+..++.++|||||||++|+|++|+.||........     ..
T Consensus       168 ~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~  239 (327)
T 3aln_A          168 CDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QL  239 (327)
T ss_dssp             CCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------
T ss_pred             ccCCCceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HH
Confidence            99999987644321   2234799999999998    456789999999999999999999999975322110     00


Q ss_pred             hcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .....       ...+.+........+..+.+||.+||+.||.+||++.+|+++
T Consensus       240 ~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          240 TQVVK-------GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             CCCCC-------SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHhc-------CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence            00000       001111111222347889999999999999999999999875

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.9e-42  Score=349.86  Aligned_cols=262  Identities=24%  Similarity=0.351  Sum_probs=199.4

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      .++|.+.+.||+|+||.||+|.+..         +|..||||++.....  ...+.+.+|+.+++.++||||+++++++.
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   93 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKR---------SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT   93 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECC---------CCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEe
Confidence            3579999999999999999999876         678999999976432  23467889999999999999999999998


Q ss_pred             eCCc------eEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeE
Q 011250          210 EDDQ------RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       210 ~~~~------~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vk  283 (490)
                      ..+.      .++||||+. ++|.+++.   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+|
T Consensus        94 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~k  166 (353)
T 3coi_A           94 PASSLRNFYDFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELK  166 (353)
T ss_dssp             SCSSGGGCCCCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEE
T ss_pred             cccccccceeEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEE
Confidence            7654      499999996 68888763   35999999999999999999999988   99999999999999999999


Q ss_pred             EecccCcccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011250          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      |+|||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.....
T Consensus       167 l~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~  241 (353)
T 3coi_A          167 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG  241 (353)
T ss_dssp             ECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHC
T ss_pred             EeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            9999999865432     234578999999999876 6889999999999999999999999976432111110000000


Q ss_pred             --------ccCCc--chhhhccCCccC---CCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          363 --------HLGDK--RRFYRLLDPRLE---GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       363 --------~~~~~--~~~~~~~~~~l~---~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                              .+.+.  ..+...+.....   .......+..+.+||.+||..||.+|||+.+++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          242 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             BCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                    00000  000000000000   11123447899999999999999999999999975

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.1e-42  Score=353.70  Aligned_cols=203  Identities=24%  Similarity=0.299  Sum_probs=172.9

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccC-CC-----Ceec
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP-----NLVK  203 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~-Hp-----nIv~  203 (490)
                      ...++|++.+.||+|+||+||+|++..         ++..||||++.... ....++..|+.++..+. |+     +|++
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~  120 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRV---------EQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVH  120 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCC
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcC---------CCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEE
Confidence            345689999999999999999999876         67789999997542 33456778999988885 55     4999


Q ss_pred             eeeEEEeCCceEEEEEecCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc--CCC
Q 011250          204 LVGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD--ADY  280 (490)
Q Consensus       204 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~--~~~  280 (490)
                      +++++...+..+|||||+. |+|.+++.... ..+++..+..++.||+.||.|||.+. .+||||||||+||||+  .++
T Consensus       121 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~  198 (382)
T 2vx3_A          121 LKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRS  198 (382)
T ss_dssp             EEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSC
T ss_pred             eeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCC
Confidence            9999999999999999995 59999987653 46999999999999999999999532 3399999999999995  478


Q ss_pred             CeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCC
Q 011250          281 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR  349 (490)
Q Consensus       281 ~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~  349 (490)
                      .+||+|||+++.....     ....+||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus       199 ~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          199 AIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             CEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            8999999999876432     234679999999999999999999999999999999999999997643

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.3e-42  Score=340.72  Aligned_cols=252  Identities=27%  Similarity=0.376  Sum_probs=203.5

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      .++|++.+.||+|+||.||+|.+..         ++..||||++....  ....+.+.+|+.+++.++||||+++++++.
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   91 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRI---------TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE   91 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcC---------CCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe
Confidence            3579999999999999999999875         56789999986542  234578899999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC---CCeEEec
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD---YNAKLSD  286 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~---~~vkL~D  286 (490)
                      +.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.+   +.+||+|
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~D  167 (287)
T 2wei_A           92 DSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIID  167 (287)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECS
T ss_pred             CCCeEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEec
Confidence            999999999999999999988654 36999999999999999999999988   9999999999999754   4799999


Q ss_pred             ccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011250          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      ||++........   .....||+.|+|||++.+ .++.++||||||+++|+|++|..||......   .........   
T Consensus       168 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~---  237 (287)
T 2wei_A          168 FGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILKRVETG---  237 (287)
T ss_dssp             TTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHC---
T ss_pred             cCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHcC---
Confidence            999987644322   123568999999998765 5899999999999999999999999754321   111111100   


Q ss_pred             cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ...    .+.    ......+.++.+||.+||..||.+|||+.+++++
T Consensus       238 ~~~----~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          238 KYA----FDL----PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             CCC----CCS----GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             CCC----CCc----hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            000    000    0001236789999999999999999999999975

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=5e-43  Score=355.96  Aligned_cols=264  Identities=19%  Similarity=0.259  Sum_probs=201.4

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccC-----------CCC
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-----------HPN  200 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~-----------Hpn  200 (490)
                      .++|++.+.||+|+||.||+|++..         ++..||||++.... ...+.+.+|+.+++.+.           |||
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~   87 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMV---------NNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANH   87 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecC---------CCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccch
Confidence            3579999999999999999999876         67799999997543 33466888999999886           899


Q ss_pred             eeceeeEEEeCC----ceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcE
Q 011250          201 LVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEE-AEKPVIYRDFKTSNI  274 (490)
Q Consensus       201 Iv~l~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiHrDlkp~NI  274 (490)
                      |+++++++...+    ..++||||+ +++|.+++... ...+++..++.++.||+.||+|||+. +   |+||||||+||
T Consensus        88 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NI  163 (373)
T 1q8y_A           88 ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENV  163 (373)
T ss_dssp             BCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGE
T ss_pred             HHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHe
Confidence            999999998654    789999999 89999998763 34699999999999999999999997 8   99999999999


Q ss_pred             EEc------CCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCC
Q 011250          275 LLD------ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN  348 (490)
Q Consensus       275 Ll~------~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~  348 (490)
                      ||+      ..+.+||+|||++......     .....||+.|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus       164 ll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  238 (373)
T 1q8y_A          164 LMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD  238 (373)
T ss_dssp             EEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             EEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            994      3447999999999876432     23357999999999999999999999999999999999999999754


Q ss_pred             CCCCcc---hhhHhhhcccCCcc------------------hhhhccCC---------ccCCCCChhhHHHHHHHHHHhh
Q 011250          349 RPNGEH---NLVEWARPHLGDKR------------------RFYRLLDP---------RLEGHFSIKGSQKATQLAAQCL  398 (490)
Q Consensus       349 ~~~~~~---~~~~~~~~~~~~~~------------------~~~~~~~~---------~l~~~~~~~~~~~l~~Li~~cL  398 (490)
                      ......   .........++...                  .+..+...         .-...++...+.++.+||.+||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  318 (373)
T 1q8y_A          239 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML  318 (373)
T ss_dssp             ------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred             cccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHh
Confidence            322111   00000000000000                  00000000         0011345567889999999999


Q ss_pred             hcCCCCCCCHHHHHHH
Q 011250          399 SRDPKARPRMSEVVET  414 (490)
Q Consensus       399 ~~dP~~RPt~~evl~~  414 (490)
                      +.||.+|||+.+|+++
T Consensus       319 ~~dP~~Rpt~~ell~h  334 (373)
T 1q8y_A          319 QLDPRKRADAGGLVNH  334 (373)
T ss_dssp             CSSTTTCBCHHHHHTC
T ss_pred             ccCccccCCHHHHhhC
Confidence            9999999999999975

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.7e-42  Score=349.05  Aligned_cols=265  Identities=21%  Similarity=0.264  Sum_probs=202.8

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCC------eecee
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN------LVKLV  205 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~  205 (490)
                      .++|++.+.||+|+||.||+|.+...        .+..||||++.... ...+.+.+|+.+++.+.|++      |+.++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~   88 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHAR--------GKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMS   88 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCC--------CceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEee
Confidence            46899999999999999999998652        23689999997542 33467888999999997665      99999


Q ss_pred             eEEEeCCceEEEEEecCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE--------
Q 011250          206 GYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL--------  276 (490)
Q Consensus       206 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl--------  276 (490)
                      +++...+..+|||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+||||        
T Consensus        89 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~  164 (355)
T 2eu9_A           89 DWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETL  164 (355)
T ss_dssp             EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEE
T ss_pred             eeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccc
Confidence            9999999999999999 667777776543 57999999999999999999999988   9999999999999        


Q ss_pred             -----------cCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCC
Q 011250          277 -----------DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM  345 (490)
Q Consensus       277 -----------~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf  345 (490)
                                 +.++.+||+|||+++......     ...+||+.|+|||++.+..++.++|||||||+||||++|..||
T Consensus       165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  239 (355)
T 2eu9_A          165 YNEHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLF  239 (355)
T ss_dssp             ECCC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             ccccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCC
Confidence                       567899999999998654321     3357999999999999999999999999999999999999999


Q ss_pred             CCCCCCCcchhhHhhhcccCCc-------ch------------------hhhccCCc-cCCCCChhhHHHHHHHHHHhhh
Q 011250          346 DKNRPNGEHNLVEWARPHLGDK-------RR------------------FYRLLDPR-LEGHFSIKGSQKATQLAAQCLS  399 (490)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~-------~~------------------~~~~~~~~-l~~~~~~~~~~~l~~Li~~cL~  399 (490)
                      ......................       ..                  ......+. .........+..+.+||.+||+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  319 (355)
T 2eu9_A          240 QTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE  319 (355)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred             CCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence            7543221111111100000000       00                  00000000 0001122346789999999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 011250          400 RDPKARPRMSEVVET  414 (490)
Q Consensus       400 ~dP~~RPt~~evl~~  414 (490)
                      .||.+|||+.+++++
T Consensus       320 ~dP~~Rpt~~e~l~h  334 (355)
T 2eu9_A          320 FDPAQRITLAEALLH  334 (355)
T ss_dssp             SSTTTSCCHHHHTTS
T ss_pred             CChhhCcCHHHHhcC
Confidence            999999999999865

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.1e-42  Score=349.77  Aligned_cols=254  Identities=23%  Similarity=0.276  Sum_probs=175.5

Q ss_pred             hcCCCCCc-ccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          132 TRNFRPES-LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~-~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .++|.+.+ +||+|+||.||+|++..         ++..||||++....    .........+..+.||||+++++++..
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~   93 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRR---------TGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYEN   93 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECC---------CCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhh
Confidence            35788854 69999999999999876         57799999996531    222223334566789999999999876


Q ss_pred             ----CCceEEEEEecCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CCCe
Q 011250          211 ----DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNA  282 (490)
Q Consensus       211 ----~~~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~---~~~v  282 (490)
                          ....+|||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+||||+.   ++.+
T Consensus        94 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~  170 (336)
T 3fhr_A           94 MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVL  170 (336)
T ss_dssp             EETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCE
T ss_pred             ccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceE
Confidence                445899999999999999997653 46999999999999999999999988   999999999999976   4559


Q ss_pred             EEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011250          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      ||+|||+++......    ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.............  ..
T Consensus       171 kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~  244 (336)
T 3fhr_A          171 KLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK--RR  244 (336)
T ss_dssp             EECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------
T ss_pred             EEeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH--Hh
Confidence            999999998654321    234578999999999988889999999999999999999999996543221100000  00


Q ss_pred             ccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                      ..        .....+........+..+.+||.+||+.||.+|||+.+++++-
T Consensus       245 ~~--------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  289 (336)
T 3fhr_A          245 IR--------LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP  289 (336)
T ss_dssp             --------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             hh--------ccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            00        0000001111123478899999999999999999999999853

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.9e-43  Score=347.12  Aligned_cols=244  Identities=27%  Similarity=0.437  Sum_probs=194.8

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc------cHHHHHHHHHHHhcc----CCC
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGNL----LHP  199 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~Ei~il~~l----~Hp  199 (490)
                      ...++|++.+.||+|+||.||+|++..         ++..||||++......      ....+.+|+.++..+    .||
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~   98 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLT---------DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP   98 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTT---------TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCS
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEcc---------CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCC
Confidence            345679999999999999999998765         5678999999765432      223456799999988    899


Q ss_pred             CeeceeeEEEeCCceEEEEEe-cCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-
Q 011250          200 NLVKLVGYCIEDDQRLLVYEF-MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD-  277 (490)
Q Consensus       200 nIv~l~~~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~-  277 (490)
                      ||+++++++...+..++|||| +.+++|.+++... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++ 
T Consensus        99 ~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~  174 (312)
T 2iwi_A           99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDL  174 (312)
T ss_dssp             SBCCEEEEC-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEET
T ss_pred             CeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeC
Confidence            999999999999999999999 7899999999664 46999999999999999999999998   99999999999999 


Q ss_pred             CCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCC-ccchhhHHHHHHHHHHhCCCCCCCCCCCCcchh
Q 011250          278 ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLT-SKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL  356 (490)
Q Consensus       278 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~-~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~  356 (490)
                      .++.+||+|||++.......    .....||..|+|||++.+..+. .++|||||||++|+|++|+.||....     ..
T Consensus       175 ~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~  245 (312)
T 2iwi_A          175 RRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----EI  245 (312)
T ss_dssp             TTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH
T ss_pred             CCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----HH
Confidence            88999999999998765432    2345799999999998876664 58999999999999999999996321     00


Q ss_pred             hHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .   ..                ...++...+..+.+||.+||+.||.+|||+.+++++
T Consensus       246 ~---~~----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          246 L---EA----------------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             H---HT----------------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             h---hh----------------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0   00                011222346789999999999999999999999976

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.3e-42  Score=343.25  Aligned_cols=253  Identities=27%  Similarity=0.407  Sum_probs=184.2

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cH-HHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GH-KEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~-~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      .++|++.+.||+|+||.||+|.+..         +|..||||++...... .. +.+..+..+++.+.||||+++++++.
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~   94 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRK---------TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI   94 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETT---------TCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEec---------CCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Confidence            3578999999999999999999876         5679999999765432 22 23445556788889999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      +.+..+|||||+ ++.+..++......+++..++.++.||+.||.|||+. +   |+||||||+|||++.++.+||+|||
T Consensus        95 ~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg  170 (318)
T 2dyl_A           95 TNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFG  170 (318)
T ss_dssp             CSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCT
T ss_pred             cCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECC
Confidence            999999999999 6666666655566899999999999999999999995 8   9999999999999999999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhc-----cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      ++........   .....||+.|+|||++.     ...++.++|||||||++|||++|+.||......  ......... 
T Consensus       171 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~-  244 (318)
T 2dyl_A          171 ISGRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--FEVLTKVLQ-  244 (318)
T ss_dssp             TC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHHHHH-
T ss_pred             CchhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--HHHHHHHhc-
Confidence            9976644321   23457999999999984     457889999999999999999999999753211  111111100 


Q ss_pred             cCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                        ..       .+.+.  .....+..+.+||.+||+.||.+||++.+|+++
T Consensus       245 --~~-------~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          245 --EE-------PPLLP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             --SC-------CCCCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             --cC-------CCCCC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence              00       00010  011236789999999999999999999999875

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.2e-42  Score=346.95  Aligned_cols=244  Identities=25%  Similarity=0.386  Sum_probs=202.1

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc------cHHHHHHHHHHHhccC--CCCe
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGNLL--HPNL  201 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~Ei~il~~l~--HpnI  201 (490)
                      ...++|++.+.||+|+||.||+|.+..         ++..||||++......      ..+.+.+|+.+++.+.  |+||
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i  110 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVS---------DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV  110 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETT---------TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSB
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECC---------CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCc
Confidence            345689999999999999999998876         6779999999754321      1235678999999996  5999


Q ss_pred             eceeeEEEeCCceEEEEEecCC-CChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-CC
Q 011250          202 VKLVGYCIEDDQRLLVYEFMPR-GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD-AD  279 (490)
Q Consensus       202 v~l~~~~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~-~~  279 (490)
                      +++++++...+..++|||++.+ ++|.+++... ..+++..++.++.||+.||.|||+.+   |+||||||+||||+ .+
T Consensus       111 ~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~  186 (320)
T 3a99_A          111 IRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNR  186 (320)
T ss_dssp             CCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTT
T ss_pred             eEEEEEEecCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCC
Confidence            9999999999999999999976 8999998654 47999999999999999999999988   99999999999999 78


Q ss_pred             CCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCC-CccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhH
Q 011250          280 YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE  358 (490)
Q Consensus       280 ~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~  358 (490)
                      +.+||+|||+++......    .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||....        .
T Consensus       187 ~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------~  254 (320)
T 3a99_A          187 GELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------E  254 (320)
T ss_dssp             TEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------H
T ss_pred             CCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------h
Confidence            999999999998765432    234579999999999987665 688999999999999999999996421        0


Q ss_pred             hhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .....                ..++...+.++.+||.+||+.||.+|||+.+|+++
T Consensus       255 ~~~~~----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          255 IIRGQ----------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             HHHCC----------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhccc----------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00000                01112236789999999999999999999999875

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.1e-42  Score=355.91  Aligned_cols=251  Identities=23%  Similarity=0.317  Sum_probs=188.9

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcc-CCCCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~  210 (490)
                      ..+|.+.++||+|+||+||.....          +++.||||++......   .+.+|+.+|+.+ +|||||++++++.+
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~----------~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~   89 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMF----------DNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKD   89 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEES----------SSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEE
T ss_pred             cEEEecCCeeecCcCEEEEEEEEe----------CCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEec
Confidence            346899999999999996543222          4678999999765433   246899999999 79999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-----CCCeEEe
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-----DYNAKLS  285 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~-----~~~vkL~  285 (490)
                      ....|||||||. |+|.+++......+.+..++.++.||+.||.|||+.+   |+||||||+||||+.     ...+||+
T Consensus        90 ~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~  165 (432)
T 3p23_A           90 RQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMIS  165 (432)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEEC
T ss_pred             CCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEe
Confidence            999999999995 6999999776656666677899999999999999988   999999999999953     2368899


Q ss_pred             cccCcccCCCCCcc-eeeeccccCCCccCcchhc---cCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 011250          286 DFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       286 DFG~a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~---~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~  360 (490)
                      |||+++........ ......+||+.|+|||++.   ...++.++|||||||++|||++ |..||.......    ....
T Consensus       166 DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~----~~~~  241 (432)
T 3p23_A          166 DFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ----ANIL  241 (432)
T ss_dssp             CTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH----HHHH
T ss_pred             cccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH----HHHH
Confidence            99999876543211 2234467999999999987   4577889999999999999999 999985432110    0000


Q ss_pred             hcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .....    . .      ........+..+.+||.+||+.||.+|||+.+|++|
T Consensus       242 ~~~~~----~-~------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          242 LGACS----L-D------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             TTCCC----C-T------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hccCC----c-c------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence            00000    0 0      001112346778999999999999999999999965

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.9e-41  Score=351.15  Aligned_cols=253  Identities=25%  Similarity=0.310  Sum_probs=187.1

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcc-CCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~  211 (490)
                      +.|.+.++||+|+||+||.+...          +|..||||++..+   ..+.+.+|+.+|..+ +|||||++++++.++
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~----------~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~   81 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSF----------QGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTD   81 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEES----------SSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred             heeeccCeEeeCCCeEEEEEEEE----------CCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence            34666789999999999865332          5779999998653   235678999999876 799999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCC------CCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC------
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLP------LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD------  279 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~------l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~------  279 (490)
                      +..|||||||. |+|.+++......      .++..++.++.||+.||+|||+.+   |+||||||+||||+.+      
T Consensus        82 ~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~  157 (434)
T 2rio_A           82 RFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTAD  157 (434)
T ss_dssp             SEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSC
T ss_pred             CeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccc
Confidence            99999999995 6999999654321      123345789999999999999988   9999999999999654      


Q ss_pred             -------CCeEEecccCcccCCCCCcce--eeeccccCCCccCcchhcc-------CCCCccchhhHHHHHHHHHHh-CC
Q 011250          280 -------YNAKLSDFGLAKDAPEDGKTH--VSTRVMGTYGYAAPEYVMT-------GHLTSKSDVYSFGVVLLEMLT-GR  342 (490)
Q Consensus       280 -------~~vkL~DFG~a~~~~~~~~~~--~~~~~~Gt~~y~aPE~l~~-------~~~~~~sDvwSlGv~l~ellt-G~  342 (490)
                             +.+||+|||+++.........  .....+||+.|+|||++.+       ..++.++|||||||++|||++ |.
T Consensus       158 ~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~  237 (434)
T 2rio_A          158 QQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK  237 (434)
T ss_dssp             CTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSC
T ss_pred             cccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCC
Confidence                   489999999998765432211  1234679999999999875       678999999999999999999 99


Q ss_pred             CCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          343 RSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       343 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                      .||....... ..   .......         .+.+........+.++.+||.+||+.||.+|||+.+|+++-
T Consensus       238 ~Pf~~~~~~~-~~---i~~~~~~---------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp  297 (434)
T 2rio_A          238 HPFGDKYSRE-SN---IIRGIFS---------LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP  297 (434)
T ss_dssp             CTTCSTTTHH-HH---HHHTCCC---------CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             CCCCCchhhH-HH---HhcCCCC---------cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCC
Confidence            9996432211 11   1110000         00111112234578999999999999999999999999753

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=9.8e-41  Score=328.02  Aligned_cols=233  Identities=14%  Similarity=0.096  Sum_probs=186.6

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      .++|++.+.||+|+||.||+|++..         +++.||||++......   ..+.+.+|+.++..+.||||+++++++
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~  100 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTA---------LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV  100 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETT---------TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecC---------CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEE
Confidence            3579999999999999999999875         6779999999866432   236789999999999999999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      .+++..||||||++|++|.+++.. +  .....+..|+.||+.||+|||+.+   |+||||||+||||+.++.+||+++|
T Consensus       101 ~~~~~~~lv~e~~~g~~L~~~l~~-~--~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~  174 (286)
T 3uqc_A          101 HTRAGGLVVAEWIRGGSLQEVADT-S--PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA  174 (286)
T ss_dssp             EETTEEEEEEECCCEEEHHHHHTT-C--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC
T ss_pred             EECCcEEEEEEecCCCCHHHHHhc-C--CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc
Confidence            999999999999999999999843 2  355678889999999999999988   9999999999999999999998543


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                                            |++       .++.++|||||||+||||++|+.||............   ........
T Consensus       175 ----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---~~~~~~~~  222 (286)
T 3uqc_A          175 ----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---ERDTAGQP  222 (286)
T ss_dssp             ----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---CBCTTSCB
T ss_pred             ----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---HHHhccCC
Confidence                                  333       3688999999999999999999999865433211000   00000000


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                      ....        .+....+.++.+||.+||+.||.+| |+.++++.|+.+..
T Consensus       223 ~~~~--------~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          223 IEPA--------DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             CCHH--------HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             CChh--------hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence            0000        1112336789999999999999999 99999999987643

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.7e-41  Score=365.57  Aligned_cols=258  Identities=27%  Similarity=0.362  Sum_probs=199.9

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEEEe-
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE-  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-  210 (490)
                      ++|++.+.||+|+||.||+|.+..         +|..||||++.... ....+.+.+|+.+++.++||||+++++++.. 
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~---------tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~   84 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQD---------TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGL   84 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTT---------TTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTT
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECC---------CCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccc
Confidence            579999999999999999998765         57789999987652 3345678999999999999999999998765 


Q ss_pred             -----CCceEEEEEecCCCChhHHhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCC--
Q 011250          211 -----DDQRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN--  281 (490)
Q Consensus       211 -----~~~~~lV~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~--  281 (490)
                           .+..+||||||++|+|.+++....  ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.  
T Consensus        85 ~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~  161 (676)
T 3qa8_A           85 QKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRL  161 (676)
T ss_dssp             CCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSC
T ss_pred             ccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCce
Confidence                 667899999999999999996543  36899999999999999999999988   999999999999987765  


Q ss_pred             -eEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011250          282 -AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       282 -vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~  360 (490)
                       +||+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....     ...|.
T Consensus       162 ~vKL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~  233 (676)
T 3qa8_A          162 IHKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWH  233 (676)
T ss_dssp             EEEECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSS
T ss_pred             eEEEcccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhh
Confidence             99999999987654322   2346899999999999999999999999999999999999999964311     11111


Q ss_pred             hcc-------------cCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 011250          361 RPH-------------LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV  412 (490)
Q Consensus       361 ~~~-------------~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl  412 (490)
                      ...             ......+...  ......+....+..+.+||.+||..||.+|||+.+++
T Consensus       234 ~~i~~~~~~~~~~~~~l~g~~~~~~~--lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL  296 (676)
T 3qa8_A          234 GKVREKSNEHIVVYDDLTGAVKFSSV--LPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP  296 (676)
T ss_dssp             TTCC------CCSCCCCSSSCCCCSS--SCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred             hhhhcccchhhhhhhhhccccccccc--cCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence            000             0000000000  0112234455689999999999999999999998743

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.4e-41  Score=348.44  Aligned_cols=243  Identities=18%  Similarity=0.186  Sum_probs=184.7

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhccCC-CCeec---
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLH-PNLVK---  203 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~Ei~il~~l~H-pnIv~---  203 (490)
                      ..+.|.+.++||+|+||+||+|++..         +|..||||++......   ..+.+.+|+.+++.+.| .|+..   
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~---------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~  146 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQE---------TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV  146 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHH
T ss_pred             CceeEEEecccccCCCEEEEEEEecC---------CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHH
Confidence            34568888999999999999999876         5779999999844322   24678999999999987 32211   


Q ss_pred             ------------------eeeEEEe-----CCceEEEEEecCCCChhHHhh------hcCCCCCHHHHHHHHHHHHHHHH
Q 011250          204 ------------------LVGYCIE-----DDQRLLVYEFMPRGSLENHLF------RRSLPLPWSIRMKIALGAAKGLA  254 (490)
Q Consensus       204 ------------------l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~------~~~~~l~~~~~~~i~~qi~~aL~  254 (490)
                                        ++.++..     ....+++|+++ +++|.+++.      .....+++..++.++.||+.||+
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  225 (413)
T 3dzo_A          147 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLA  225 (413)
T ss_dssp             HTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHH
T ss_pred             hcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHH
Confidence                              1111111     12456777776 789999884      22345788899999999999999


Q ss_pred             HhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchh----------ccCCCCc
Q 011250          255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV----------MTGHLTS  324 (490)
Q Consensus       255 yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l----------~~~~~~~  324 (490)
                      |||+.+   ||||||||+||||+.++.+||+|||+++.....     ....+| +.|+|||++          ....++.
T Consensus       226 ~LH~~~---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~  296 (413)
T 3dzo_A          226 SLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTF  296 (413)
T ss_dssp             HHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECH
T ss_pred             HHHhCC---cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCc
Confidence            999988   999999999999999999999999998865332     344678 999999999          4556888


Q ss_pred             cchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCC
Q 011250          325 KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA  404 (490)
Q Consensus       325 ~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~  404 (490)
                      ++|||||||+||||++|+.||..........                .++...      ...+..+.+||.+||+.||.+
T Consensus       297 ~~DvwSlGvil~elltg~~Pf~~~~~~~~~~----------------~~~~~~------~~~~~~~~~li~~~l~~dP~~  354 (413)
T 3dzo_A          297 AFDTWTLGLAIYWIWCADLPNTDDAALGGSE----------------WIFRSC------KNIPQPVRALLEGFLRYPKED  354 (413)
T ss_dssp             HHHHHHHHHHHHHHHHSSCCCCTTGGGSCSG----------------GGGSSC------CCCCHHHHHHHHHHTCSSGGG
T ss_pred             hhhHHHHHHHHHHHHHCCCCCCCcchhhhHH----------------HHHhhc------ccCCHHHHHHHHHHccCChhh
Confidence            9999999999999999999997543211110                011100      122678999999999999999


Q ss_pred             CCCHHHHHHH
Q 011250          405 RPRMSEVVET  414 (490)
Q Consensus       405 RPt~~evl~~  414 (490)
                      ||++.+++++
T Consensus       355 Rpt~~~~l~~  364 (413)
T 3dzo_A          355 RLLPLQAMET  364 (413)
T ss_dssp             SCCHHHHTTS
T ss_pred             CcCHHHHHhC
Confidence            9999999864

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.3e-40  Score=365.10  Aligned_cols=241  Identities=24%  Similarity=0.409  Sum_probs=194.2

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .++|++.+.||+|+||.||+|++...        +++.||||++..... .....+.+|+.++..++||||+++++++..
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  150 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNV--------NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEH  150 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGG--------TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCC--------CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEee
Confidence            46899999999999999999998642        467899999875432 334578899999999999999999999988


Q ss_pred             CCc-----eEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEe
Q 011250          211 DDQ-----RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       211 ~~~-----~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~  285 (490)
                      .+.     .||||||++|++|.+++..   .+++..++.|+.||+.||.|||+.+   ||||||||+||||+.+ .+||+
T Consensus       151 ~~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~  223 (681)
T 2pzi_A          151 TDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLI  223 (681)
T ss_dssp             ECTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEEC
T ss_pred             cCCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEE
Confidence            766     7999999999999987643   6999999999999999999999988   9999999999999885 99999


Q ss_pred             cccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011250          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      |||+++.....      ...+||+.|+|||++.+. ++.++|||||||+||+|++|.+||........           .
T Consensus       224 DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-----------~  285 (681)
T 2pzi_A          224 DLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL-----------P  285 (681)
T ss_dssp             CCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC-----------C
T ss_pred             ecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc-----------c
Confidence            99999876443      335799999999988765 48999999999999999999988764211100           0


Q ss_pred             CcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCC-HHHHHHHhhcC
Q 011250          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-MSEVVETLKPL  418 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt-~~evl~~L~~l  418 (490)
                      .             .......+..+.+||.+||+.||.+||+ ++++...|..+
T Consensus       286 ~-------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          286 E-------------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             T-------------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             c-------------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence            0             0001123567899999999999999995 55565555543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=7.3e-40  Score=323.32  Aligned_cols=228  Identities=21%  Similarity=0.299  Sum_probs=180.4

Q ss_pred             cCCCCC-cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHH-hccCCCCeeceeeEEEe
Q 011250          133 RNFRPE-SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL-GNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~-~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~  210 (490)
                      ++|.+. ++||+|+||.||+|.+..         ++..||||++...     ..+.+|+.++ +.+.||||+++++++..
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~   82 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKR---------TQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYEN   82 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcC---------CCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence            357776 789999999999999876         5779999998642     4567888888 55689999999999887


Q ss_pred             ----CCceEEEEEecCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CCCe
Q 011250          211 ----DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNA  282 (490)
Q Consensus       211 ----~~~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~---~~~v  282 (490)
                          ....+|||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~  159 (299)
T 3m2w_A           83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAIL  159 (299)
T ss_dssp             EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCE
T ss_pred             hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcE
Confidence                677899999999999999997653 46999999999999999999999988   999999999999998   7899


Q ss_pred             EEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011250          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      ||+|||++....                        +..++.++|||||||++|||++|+.||............   ..
T Consensus       160 kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~---~~  212 (299)
T 3m2w_A          160 KLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KT  212 (299)
T ss_dssp             EECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS---CC
T ss_pred             EEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH---HH
Confidence            999999986432                        245678999999999999999999999654321110000   00


Q ss_pred             ccCCcchhhhccCCccCCCCC----hhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011250          363 HLGDKRRFYRLLDPRLEGHFS----IKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~~~~----~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L  415 (490)
                      ..         ...  ...++    ...+.++.+||.+||+.||.+|||+.+++++-
T Consensus       213 ~~---------~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp  258 (299)
T 3m2w_A          213 RI---------RMG--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  258 (299)
T ss_dssp             SS---------CTT--CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             HH---------hhc--cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence            00         000  00011    12378899999999999999999999999753

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=8e-41  Score=335.70  Aligned_cols=244  Identities=17%  Similarity=0.147  Sum_probs=184.3

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--------ccHHHHHHHHHHHhccC------
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--------QGHKEWLAEVNFLGNLL------  197 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~Ei~il~~l~------  197 (490)
                      .++|++.+.||+|+||+||+|++           +|..||||++.....        ...+.+.+|+.+|+.|+      
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-----------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~   87 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-----------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEV   87 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-----------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCS
T ss_pred             cccchheeeecccCceEEEEEEe-----------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccc
Confidence            34689999999999999999987           356899999976532        23467889999998886      


Q ss_pred             ---CCCeeceeeEE-----------------Ee-------------CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHH
Q 011250          198 ---HPNLVKLVGYC-----------------IE-------------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK  244 (490)
Q Consensus       198 ---HpnIv~l~~~~-----------------~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~  244 (490)
                         |||||++++++                 .+             .+..|||||||++|+|.+.+.+  ..+++..++.
T Consensus        88 ~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~  165 (336)
T 2vuw_A           88 CNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKS  165 (336)
T ss_dssp             SSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHH
T ss_pred             cccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHH
Confidence               66666666553                 32             6789999999999987777644  4689999999


Q ss_pred             HHHHHHHHHHHhh-hcCCCCeeecCCCCCcEEEcCCC--------------------CeEEecccCcccCCCCCcceeee
Q 011250          245 IALGAAKGLAFLH-EEAEKPVIYRDFKTSNILLDADY--------------------NAKLSDFGLAKDAPEDGKTHVST  303 (490)
Q Consensus       245 i~~qi~~aL~yLH-~~~~~~iiHrDlkp~NILl~~~~--------------------~vkL~DFG~a~~~~~~~~~~~~~  303 (490)
                      |+.||+.||.||| +.+   ||||||||+||||+.++                    .+||+|||+|+.....       
T Consensus       166 i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------  235 (336)
T 2vuw_A          166 ILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------  235 (336)
T ss_dssp             HHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------
T ss_pred             HHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------
Confidence            9999999999999 888   99999999999999887                    8999999999876432       


Q ss_pred             ccccCCCccCcchhccCCCCccchhhHHHHH-HHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCC
Q 011250          304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVV-LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHF  382 (490)
Q Consensus       304 ~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~-l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  382 (490)
                      ..+||+.|+|||++.+.. +.++||||||++ .+++++|..||....  ....+.+......        ..........
T Consensus       236 ~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~--~~~~~~~~~~~~~--------~~~~~~~~~~  304 (336)
T 2vuw_A          236 IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL--WLHYLTDKMLKQM--------TFKTKCNTPA  304 (336)
T ss_dssp             EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH--HHHHHHHHHHHTC--------CCSSCCCSHH
T ss_pred             cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh--hhhHHHHhhhhhh--------ccCcccchhh
Confidence            247999999999988655 899999998777 788999999884210  0000000000000        0000111112


Q ss_pred             ChhhHHHHHHHHHHhhhcCCCCCCCHHHHH-HH
Q 011250          383 SIKGSQKATQLAAQCLSRDPKARPRMSEVV-ET  414 (490)
Q Consensus       383 ~~~~~~~l~~Li~~cL~~dP~~RPt~~evl-~~  414 (490)
                      ....+.++.+||.+||+.|     |+.|++ +|
T Consensus       305 ~~~~s~~~~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          305 MKQIKRKIQEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred             hhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence            2346889999999999977     999998 65

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=7.3e-34  Score=304.44  Aligned_cols=185  Identities=18%  Similarity=0.107  Sum_probs=130.4

Q ss_pred             cccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc----------ccHHHHHHHHHHHhcc-CCCCeeceeeEEE
Q 011250          141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----------QGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  209 (490)
Q Consensus       141 LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~  209 (490)
                      ++.|++|.+..++...         .|..||+|++.....          ...++|.+|+++|+++ .|+||++++++++
T Consensus       242 ~~~~~~~~h~~~rr~~---------fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~e  312 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYF---------FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGE  312 (569)
T ss_dssp             -C--------CCEEEE---------ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEE
T ss_pred             cccCCccccccccccc---------ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Confidence            4455555555444333         566899999976531          1235689999999999 6999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +++..|||||||+|++|.++|.+. .+++..   .|+.||+.||+|||++|   ||||||||+||||+.+|.+||+|||+
T Consensus       313 d~~~~yLVMEyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGl  385 (569)
T 4azs_A          313 NAQSGWLVMEKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGS  385 (569)
T ss_dssp             CSSEEEEEEECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTT
T ss_pred             ECCEEEEEEecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeeccc
Confidence            999999999999999999999654 467654   58899999999999999   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCC
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRS  344 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~p  344 (490)
                      |+.......  .....+||+.|||||++.+ .+..++|+||+|+++|+|+++..+
T Consensus       386 Ar~~~~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          386 IVTTPQDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             EESCC---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CeeCCCCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            987654322  2345789999999998864 577889999999999988766543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=9.3e-30  Score=271.08  Aligned_cols=185  Identities=19%  Similarity=0.224  Sum_probs=146.4

Q ss_pred             CCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--------cHHHHHHHHHHHhccCCCCeeceeeE
Q 011250          136 RPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--------GHKEWLAEVNFLGNLLHPNLVKLVGY  207 (490)
Q Consensus       136 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~Ei~il~~l~HpnIv~l~~~  207 (490)
                      ...++||+|+||.||+|..           .+..+++|........        ..+.+.+|+++|+.++||||+++..+
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-----------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~  407 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-----------LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIF  407 (540)
T ss_dssp             ---------CCEEEEEEEC-----------SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-----------CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEE
Confidence            4457899999999999944           3557999987543221        12457899999999999999977777


Q ss_pred             EEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecc
Q 011250          208 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DF  287 (490)
                      +...+..|||||||++++|.+++..         +..++.||+.||.|||+++   |+||||||+|||++.  .+||+||
T Consensus       408 ~~~~~~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DF  473 (540)
T 3en9_A          408 DVDLDNKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDF  473 (540)
T ss_dssp             EEETTTTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCC
T ss_pred             EEeCCccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEEC
Confidence            7788888999999999999999854         5689999999999999988   999999999999998  9999999


Q ss_pred             cCcccCCCCCcce-----eeeccccCCCccCcchhcc--CCCCccchhhHHHHHHHHHHhCCCCC
Q 011250          288 GLAKDAPEDGKTH-----VSTRVMGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEMLTGRRSM  345 (490)
Q Consensus       288 G~a~~~~~~~~~~-----~~~~~~Gt~~y~aPE~l~~--~~~~~~sDvwSlGv~l~elltG~~pf  345 (490)
                      |+++.........     .....+||+.|||||++..  ..|+..+|+|+..+-..+.+.++.+|
T Consensus       474 Gla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          474 GLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             TTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            9999875432211     1235789999999999986  56888899999999999988887665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=6.5e-26  Score=221.86  Aligned_cols=163  Identities=15%  Similarity=0.083  Sum_probs=127.6

Q ss_pred             hHHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc------------------ccHHHHHH
Q 011250          127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL------------------QGHKEWLA  188 (490)
Q Consensus       127 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------------------~~~~~~~~  188 (490)
                      .+......|.+.+.||+|+||.||+|.+ .         +|..||||+++....                  .....+.+
T Consensus        84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~---------~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~  153 (282)
T 1zar_A           84 RLVRSGKVDAIGKLMGEGKESAVFNCYS-E---------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN  153 (282)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEEE-T---------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHH
T ss_pred             HHHhCCeEEEecCEeccCCCceEEEEEe-C---------CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHH
Confidence            3344455677889999999999999998 4         577999999965322                  12456889


Q ss_pred             HHHHHhccCCCCeeceeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecC
Q 011250          189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRD  268 (490)
Q Consensus       189 Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrD  268 (490)
                      |+.+|+.+.  | +++++++.. +..|+||||++|++|.+ +..       .....++.||+.||.|||+.+   |+|||
T Consensus       154 E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~g---iiHrD  218 (282)
T 1zar_A          154 EFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRG---IVHGD  218 (282)
T ss_dssp             HHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred             HHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCC---CEeCC
Confidence            999999998  5 777775544 56799999999999988 411       224579999999999999988   99999


Q ss_pred             CCCCcEEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhcc----------CCCCccchhhH
Q 011250          269 FKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT----------GHLTSKSDVYS  330 (490)
Q Consensus       269 lkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~----------~~~~~~sDvwS  330 (490)
                      |||+||||+ ++.+||+|||+|+.               +..|+|||++..          ..|+..+|+|.
T Consensus       219 lkp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          219 LSQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             CSTTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             CCHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence            999999999 99999999999863               345889998753          34555566654

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=3.4e-22  Score=192.86  Aligned_cols=137  Identities=18%  Similarity=0.067  Sum_probs=106.4

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcE--EEEEEecCCCcc------------------------cHHHHHH
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLT--VAVKTLNHDGLQ------------------------GHKEWLA  188 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~--vaiK~~~~~~~~------------------------~~~~~~~  188 (490)
                      |.+.+.||+|+||.||+|.+..         +|..  ||||+++.....                        ....+.+
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~---------~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  119 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVF---------DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEK  119 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEE---------TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcC---------CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHH
Confidence            6788999999999999999854         5668  999997543211                        0135788


Q ss_pred             HHHHHhccCCCCe--eceeeEEEeCCceEEEEEecCC-C----ChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhh-hcC
Q 011250          189 EVNFLGNLLHPNL--VKLVGYCIEDDQRLLVYEFMPR-G----SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH-EEA  260 (490)
Q Consensus       189 Ei~il~~l~HpnI--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH-~~~  260 (490)
                      |+.+|..|.|++|  ..++++    +..+|||||+.+ |    +|.+++..    .++..+..++.||+.+|.||| +.+
T Consensus       120 E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~g  191 (258)
T 1zth_A          120 EFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAE  191 (258)
T ss_dssp             HHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSC
T ss_pred             HHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999998864  333332    356899999942 4    66665432    234467889999999999999 888


Q ss_pred             CCCeeecCCCCCcEEEcCCCCeEEecccCcccC
Q 011250          261 EKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       261 ~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~  293 (490)
                         ||||||||+|||++.  .++|+|||+|...
T Consensus       192 ---ivHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          192 ---LVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             ---EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             ---EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence               999999999999988  9999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.75  E-value=5.5e-19  Score=178.31  Aligned_cols=138  Identities=13%  Similarity=0.094  Sum_probs=99.2

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--------------cHHH--------HHHHHH
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--------------GHKE--------WLAEVN  191 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------------~~~~--------~~~Ei~  191 (490)
                      -|.+.+.||.|+||.||+|.+.          +|+.||||+++.....              ....        ..+|..
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~----------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~  165 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADE----------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFA  165 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECT----------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHH
T ss_pred             EEEecCEeeeCCceEEEEEECC----------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHH
Confidence            3899999999999999999864          5779999997642110              1111        234666


Q ss_pred             HHhccCCCCeeceeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 011250          192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKT  271 (490)
Q Consensus       192 il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp  271 (490)
                      .|.+|.+.++....-+..  ...+|||||++|++|..+..     .  .....++.||+.+|.|||..|   ||||||||
T Consensus       166 nL~rL~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~-----~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp  233 (397)
T 4gyi_A          166 FMKALYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSS-----V--PDPASLYADLIALILRLAKHG---LIHGDFNE  233 (397)
T ss_dssp             HHHHHHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCC-----C--SCHHHHHHHHHHHHHHHHHTT---EECSCCST
T ss_pred             HHHHHHhcCCCCCeeeec--cCceEEEEecCCccHhhhcc-----c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCH
Confidence            666665444322221212  23479999999988866531     1  134567899999999999988   99999999


Q ss_pred             CcEEEcCCC----------CeEEecccCcccC
Q 011250          272 SNILLDADY----------NAKLSDFGLAKDA  293 (490)
Q Consensus       272 ~NILl~~~~----------~vkL~DFG~a~~~  293 (490)
                      .||||++++          .+.|+||+-+...
T Consensus       234 ~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          234 FNILIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             TSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             HHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence            999998776          3899999977654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.46  E-value=1.8e-13  Score=131.49  Aligned_cols=142  Identities=15%  Similarity=-0.004  Sum_probs=110.4

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccC-CCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~  211 (490)
                      ..|.+...++.|+++.||++...           +..+++|+...........+.+|+.+|+.|. +..+.++++++.+.
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~-----------~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~   82 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE-----------NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD   82 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS-----------SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred             ccceeEeeccCCCCCeEEEEECC-----------CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecC
Confidence            46888899999999999998642           4579999986532122245788999999885 67788999999888


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcC-------------------------------
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA-------------------------------  260 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-------------------------------  260 (490)
                      +..|+||||++|.+|.+.+.      +......++.+++++|..||+..                               
T Consensus        83 ~~~~lv~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T 3tm0_A           83 GWSNLLMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             TEEEEEEECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred             CceEEEEEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence            89999999999999987641      11223467889999999999810                               


Q ss_pred             -------------------------CCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          261 -------------------------EKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       261 -------------------------~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                                               ...++|+|+++.|||++.+..+.|+||+.+.
T Consensus       157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                     1349999999999999876556799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.31  E-value=4.2e-12  Score=121.08  Aligned_cols=137  Identities=17%  Similarity=0.046  Sum_probs=99.3

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCC--eeceeeEEEeC
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN--LVKLVGYCIED  211 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~  211 (490)
                      .|.+..+.+.|..+.||++...          +|..+++|+.....   ...+..|+.+++.+.+.+  +.++++++..+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~----------~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~   87 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQ----------GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEA   87 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECT----------TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred             CCceEecccCCCCceEEEEecC----------CCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence            4555444456677999998543          34579999976542   235678999999886545  45688888887


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcC-------------------------------
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA-------------------------------  260 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-------------------------------  260 (490)
                      +..++||||++|.+|.  +.    ...   ...++.+++..|..||...                               
T Consensus        88 ~~~~~v~e~i~G~~l~--~~----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (264)
T 1nd4_A           88 GRDWLLLGEVPGQDLL--SS----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDL  158 (264)
T ss_dssp             SCEEEEEECCSSEETT--TS----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSC
T ss_pred             CCCEEEEEecCCcccC--cC----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhh
Confidence            8899999999998884  21    112   2356777888888888743                               


Q ss_pred             ------------------------CCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          261 ------------------------EKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       261 ------------------------~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                                              ...++|+|++|.|||++.++.+.|+|||.+..
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          159 DEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                    12299999999999998776667999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.23  E-value=3.6e-11  Score=120.90  Aligned_cols=143  Identities=15%  Similarity=0.185  Sum_probs=106.1

Q ss_pred             CCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEec--CCC-cccHHHHHHHHHHHhccC--CCCeeceeeEEEeC
Q 011250          137 PESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDG-LQGHKEWLAEVNFLGNLL--HPNLVKLVGYCIED  211 (490)
Q Consensus       137 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~--~~~-~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~  211 (490)
                      ..+.|+.|.++.||+....           +..+++|+..  ... ......+.+|+.+++.|.  +..+.+++.++.+.
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-----------~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~  110 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-----------GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE  110 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-----------SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT
T ss_pred             eEEEcCCcccceEEEEEEC-----------CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC
Confidence            4567899999999998653           2368888876  332 122346788999999997  45578888888766


Q ss_pred             ---CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcC----------------------------
Q 011250          212 ---DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA----------------------------  260 (490)
Q Consensus       212 ---~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~----------------------------  260 (490)
                         +..|+||||++|..|.+..   ...++......++.++++.|..||...                            
T Consensus       111 ~~~g~~~~vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (359)
T 3dxp_A          111 SVIGRAFYIMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYK  187 (359)
T ss_dssp             TTTSSCEEEEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHH
T ss_pred             CccCCeEEEEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHH
Confidence               3479999999998875422   124778888899999999999999831                            


Q ss_pred             ---------------------------CCCeeecCCCCCcEEEcCCCC--eEEecccCcccC
Q 011250          261 ---------------------------EKPVIYRDFKTSNILLDADYN--AKLSDFGLAKDA  293 (490)
Q Consensus       261 ---------------------------~~~iiHrDlkp~NILl~~~~~--vkL~DFG~a~~~  293 (490)
                                                 ...+||+|+++.|||++.++.  +.|+||+.+...
T Consensus       188 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          188 LSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             hcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                       245999999999999987753  689999988653

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.14  E-value=9.2e-11  Score=115.16  Aligned_cols=183  Identities=21%  Similarity=0.208  Sum_probs=122.5

Q ss_pred             CcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccC-CCC--eeceeeEEEeCC--
Q 011250          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPN--LVKLVGYCIEDD--  212 (490)
Q Consensus       138 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~-Hpn--Iv~l~~~~~~~~--  212 (490)
                      .+.++.|.+..||+..              ..+++|+....  .....+.+|+.+|+.|. +..  +..++......+  
T Consensus        25 i~~~~~G~~n~v~~v~--------------~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~   88 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN--------------RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETY   88 (304)
T ss_dssp             CCEEEECSSEEEEEST--------------TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSC
T ss_pred             eEecCCCCcceEEEEC--------------CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCC
Confidence            4568999999999852              24889986533  33467889999998884 333  334444333332  


Q ss_pred             -ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcC-------------------------------
Q 011250          213 -QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA-------------------------------  260 (490)
Q Consensus       213 -~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-------------------------------  260 (490)
                       ..|+||++++|.+|.....   ..++...+..++.+++..|..||...                               
T Consensus        89 ~~~~~vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (304)
T 3sg8_A           89 QMSFAGFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSREL  165 (304)
T ss_dssp             SCSCEEEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTS
T ss_pred             CcceEEEcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccC
Confidence             3489999999988875432   24677788888899999999998621                               


Q ss_pred             ------------------------CCCeeecCCCCCcEEEcC--CCCeEEecccCcccCCCCCcceeeeccccCCCc---
Q 011250          261 ------------------------EKPVIYRDFKTSNILLDA--DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY---  311 (490)
Q Consensus       261 ------------------------~~~iiHrDlkp~NILl~~--~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y---  311 (490)
                                              ...++|+|+++.|||++.  +..+.|+||+.+.......      .......+   
T Consensus       166 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~------Dl~~~~~~~~~  239 (304)
T 3sg8_A          166 KGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN------DFISLMEDDEE  239 (304)
T ss_dssp             CHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH------HHHTTCCTTTS
T ss_pred             CcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH------HHHHHHhhccc
Confidence                                    134899999999999988  4568899999886543210      01111111   


Q ss_pred             cCcchhcc-----CCC---------CccchhhHHHHHHHHHHhCCCCC
Q 011250          312 AAPEYVMT-----GHL---------TSKSDVYSFGVVLLEMLTGRRSM  345 (490)
Q Consensus       312 ~aPE~l~~-----~~~---------~~~sDvwSlGv~l~elltG~~pf  345 (490)
                      ..|+....     +..         ....+.|+++.++|.+.+|..+|
T Consensus       240 ~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          240 YGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            23332211     111         12368999999999999998765

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.60  E-value=1.8e-07  Score=89.63  Aligned_cols=135  Identities=17%  Similarity=0.080  Sum_probs=94.2

Q ss_pred             cccCCce-EEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccC-CCCeeceeeEEEeCCceEEEE
Q 011250          141 LGEGGFG-CVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIEDDQRLLVY  218 (490)
Q Consensus       141 LG~G~fg-~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~  218 (490)
                      +..|..| .||+.....         .+..+++|+-...   ....+.+|..+|+.|. +--+.++++++.+.+..++||
T Consensus        32 ~~~G~S~~~v~rl~~~~---------~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvm   99 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKP---------NAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLT   99 (272)
T ss_dssp             EECSSSSCEEEEEECCT---------TCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             ccCCCcCCeEEEEEecC---------CCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEE
Confidence            4445554 689876543         3446889986532   3456788999998885 333677888888899999999


Q ss_pred             EecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcC--------------------------------------
Q 011250          219 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA--------------------------------------  260 (490)
Q Consensus       219 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--------------------------------------  260 (490)
                      |+++|.++.+.....     ......++.+++..|.-||...                                      
T Consensus       100 e~l~G~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (272)
T 4gkh_A          100 TAIPGKTAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW  174 (272)
T ss_dssp             ECCCSEEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred             EeeCCccccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence            999998887655321     1223345556666666666421                                      


Q ss_pred             -----------------CCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          261 -----------------EKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       261 -----------------~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                                       ...++|+|+.+.|||++.++.+-|+||+.+..
T Consensus       175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                             11289999999999999877778999997753

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.56  E-value=4.4e-07  Score=89.01  Aligned_cols=137  Identities=20%  Similarity=0.146  Sum_probs=94.3

Q ss_pred             CcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCC---CeeceeeEEE-eCCc
Q 011250          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP---NLVKLVGYCI-EDDQ  213 (490)
Q Consensus       138 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~~~~~-~~~~  213 (490)
                      .+.++.|....||+.              +..+++|+...  ......+.+|+.+|+.|.+.   .+.+++.++. ..+.
T Consensus        24 v~~l~~G~~n~v~~v--------------g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~   87 (306)
T 3tdw_A           24 VESLGEGFRNYAILV--------------NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGN   87 (306)
T ss_dssp             EEEEEECSSEEEEEE--------------TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSC
T ss_pred             eeecCCCcceeEEEE--------------CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCc
Confidence            456888998999986              12478888532  23345788999999999753   2555666654 3456


Q ss_pred             eEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcC---------------------------------
Q 011250          214 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA---------------------------------  260 (490)
Q Consensus       214 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---------------------------------  260 (490)
                      .++||||++|..|......   .++......++.++++.|..||...                                 
T Consensus        88 ~~~v~e~i~G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l  164 (306)
T 3tdw_A           88 PFVGYRKVQGQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLL  164 (306)
T ss_dssp             EEEEEECCCSEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGS
T ss_pred             eEEEEeccCCeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccccc
Confidence            7899999999888763211   2445555556666666666665432                                 


Q ss_pred             ------------------------CCCeeecCCCCCcEEEcC---CCCe-EEecccCcccC
Q 011250          261 ------------------------EKPVIYRDFKTSNILLDA---DYNA-KLSDFGLAKDA  293 (490)
Q Consensus       261 ------------------------~~~iiHrDlkp~NILl~~---~~~v-kL~DFG~a~~~  293 (490)
                                              ...++|+|+++.|||++.   ++.+ .|+||+.+...
T Consensus       165 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          165 DESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             CHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             chhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                                    224799999999999987   4554 89999987643

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.51  E-value=2.1e-07  Score=93.04  Aligned_cols=86  Identities=5%  Similarity=-0.069  Sum_probs=55.2

Q ss_pred             Cccc-ccCCceEEEEEEEcc--CCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhccC-C--CCeeceeeEE
Q 011250          138 ESLL-GEGGFGCVFKGWVEE--NGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLL-H--PNLVKLVGYC  208 (490)
Q Consensus       138 ~~~L-G~G~fg~Vy~~~~~~--~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~~l~-H--pnIv~l~~~~  208 (490)
                      .+.| +.|....+|+.....  ++.     ..+..+++|+.....   ......+.+|+.+|+.|. +  -.+.+++.++
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~-----~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~   99 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGR-----SIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIE   99 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTE-----EEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEE
T ss_pred             EEECCCCCccceEEEEEEecccCCC-----CCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEc
Confidence            3567 889899999886531  000     014468889865432   111235678888888885 3  3466777776


Q ss_pred             EeC---CceEEEEEecCCCChhH
Q 011250          209 IED---DQRLLVYEFMPRGSLEN  228 (490)
Q Consensus       209 ~~~---~~~~lV~E~~~~gsL~~  228 (490)
                      .+.   +..++||||++|..|.+
T Consensus       100 ~~~~~~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          100 TTGDVLGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             CSSTTTSSCEEEEECCCCBCCCB
T ss_pred             cCCCccCCceEEEEecCCCChhh
Confidence            655   35689999999876643

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.41  E-value=9.4e-07  Score=89.75  Aligned_cols=76  Identities=16%  Similarity=0.114  Sum_probs=49.2

Q ss_pred             CcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-------ccHHHHHHHHHHHhccCC--CCe-eceeeE
Q 011250          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-------QGHKEWLAEVNFLGNLLH--PNL-VKLVGY  207 (490)
Q Consensus       138 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~Ei~il~~l~H--pnI-v~l~~~  207 (490)
                      .+.||.|.++.||++....         .+..|+||.......       .....+..|+++|+.+..  +.+ .+++.+
T Consensus        35 ~~~lg~G~~n~vyrv~~~~---------~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~  105 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQE---------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS  105 (397)
T ss_dssp             EEECCSSSSEEEEEEEC-------------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred             EEECCCCceEEEEEEEECC---------CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE
Confidence            4679999999999997543         345799998643211       122456778898887742  333 345543


Q ss_pred             EEeCCceEEEEEecCCC
Q 011250          208 CIEDDQRLLVYEFMPRG  224 (490)
Q Consensus       208 ~~~~~~~~lV~E~~~~g  224 (490)
                        +.+..++||||+++.
T Consensus       106 --d~~~~~lvmE~l~g~  120 (397)
T 2olc_A          106 --DTEMAVTVMEDLSHL  120 (397)
T ss_dssp             --ETTTTEEEECCCTTS
T ss_pred             --cCCccEEEEEeCCCc
Confidence              455678999999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.35  E-value=3.5e-06  Score=83.17  Aligned_cols=139  Identities=17%  Similarity=0.243  Sum_probs=79.2

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccC-----CCCeecee-e--EEEe
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-----HPNLVKLV-G--YCIE  210 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l~-~--~~~~  210 (490)
                      +.|+.|..+.||+....          .| .+++|+....    ...+..|+.+++.|.     .|.++... +  +...
T Consensus        38 ~~l~gG~~n~~~~v~~~----------~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~  102 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTD----------SG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKH  102 (346)
T ss_dssp             EECC----CEEEEEEET----------TE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEE
T ss_pred             eeccccccCcEEEEEeC----------CC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEE
Confidence            45666788999998653          22 5889998752    234445666666553     24443311 1  2234


Q ss_pred             CCceEEEEEecCCCChh--------------HHhhhc--CC--C---------CCHHHH---------------------
Q 011250          211 DDQRLLVYEFMPRGSLE--------------NHLFRR--SL--P---------LPWSIR---------------------  242 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~--------------~~l~~~--~~--~---------l~~~~~---------------------  242 (490)
                      .+..++||+|++|..+.              ..++..  ..  +         ..|...                     
T Consensus       103 ~~~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  182 (346)
T 2q83_A          103 GSFLFVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKED  182 (346)
T ss_dssp             TTEEEEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSC
T ss_pred             CCEEEEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCC
Confidence            66789999999986542              111111  00  0         112110                     


Q ss_pred             ----------HHHHHHHHHHHHHhhh--------c--CCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          243 ----------MKIALGAAKGLAFLHE--------E--AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       243 ----------~~i~~qi~~aL~yLH~--------~--~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                                ..+..++..++.+|+.        .  ....+||+|+++.|||++.++.+.|+||+.+..
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          183 PFSQLYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             cHHHHHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence                      0111223445666763        1  234599999999999998888999999997753

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.04  E-value=2.8e-05  Score=76.20  Aligned_cols=75  Identities=19%  Similarity=0.099  Sum_probs=58.3

Q ss_pred             CcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccC---CCCeeceeeEEEeCCce
Q 011250          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL---HPNLVKLVGYCIEDDQR  214 (490)
Q Consensus       138 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~  214 (490)
                      .+.|+.|.+..+|+...           .+..+++|+....   ....+..|+..|+.|.   ...+.+++.+....+..
T Consensus        41 ~~~l~gG~~n~~y~v~~-----------~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~  106 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-----------EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHS  106 (312)
T ss_dssp             EEEECCSSSSEEEEEES-----------SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEE
T ss_pred             eEEeCCccceeeeEEEE-----------CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCce
Confidence            45689999999999764           2346888987543   2456788999998885   35678888888877889


Q ss_pred             EEEEEecCCCCh
Q 011250          215 LLVYEFMPRGSL  226 (490)
Q Consensus       215 ~lV~E~~~~gsL  226 (490)
                      ++||||+++..+
T Consensus       107 ~lvme~l~G~~~  118 (312)
T 3jr1_A          107 FLLLEALNKSKN  118 (312)
T ss_dssp             EEEEECCCCCCC
T ss_pred             EEEEEeccCCCC
Confidence            999999998765

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.96  E-value=3.8e-05  Score=78.52  Aligned_cols=76  Identities=13%  Similarity=0.121  Sum_probs=46.6

Q ss_pred             CCeeecCCCCCcEEEcCCCCeEEecccCcccCCCCCcceeeecccc--CCCccCcchhccC---CCCccchhhHHHHHHH
Q 011250          262 KPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG--TYGYAAPEYVMTG---HLTSKSDVYSFGVVLL  336 (490)
Q Consensus       262 ~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~G--t~~y~aPE~l~~~---~~~~~sDvwSlGv~l~  336 (490)
                      ..++|+|+++.|||++.++ ++|+||+.+.........  . ...+  ...|++|+.....   .-....++..+...+|
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl--a-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI--G-AYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH--H-HHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH--H-HHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            4599999999999998776 999999988754321000  0 0011  1345666544311   1112345567788888


Q ss_pred             HHHhC
Q 011250          337 EMLTG  341 (490)
Q Consensus       337 elltG  341 (490)
                      +.+++
T Consensus       308 ~~y~~  312 (420)
T 2pyw_A          308 NLFNK  312 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            87765

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.75  E-value=0.0002  Score=68.98  Aligned_cols=80  Identities=20%  Similarity=0.183  Sum_probs=56.0

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCC---CeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP---NLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~~~~~  209 (490)
                      ....-.+.+|.|..+.||+.+..          +|+.|.+|+...........+..|+..|+.|.--   -+.+++++  
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~----------DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--   82 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELA----------DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--   82 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEET----------TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--
T ss_pred             CCeEEEEecCCCCCeEEEEEEEC----------CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--
Confidence            34555677999999999999875          4678999987655444344577899999888522   23444443  


Q ss_pred             eCCceEEEEEecCCCCh
Q 011250          210 EDDQRLLVYEFMPRGSL  226 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL  226 (490)
                        +..++||||++++..
T Consensus        83 --~~~~lv~e~l~~~~~   97 (288)
T 3f7w_A           83 --DDRTLAMEWVDERPP   97 (288)
T ss_dssp             --ETTEEEEECCCCCCC
T ss_pred             --cCceEEEEeecccCC
Confidence              234899999987654

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.71  E-value=8.9e-05  Score=72.55  Aligned_cols=140  Identities=14%  Similarity=0.116  Sum_probs=77.1

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCC--eeceee------EEEe
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN--LVKLVG------YCIE  210 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~------~~~~  210 (490)
                      +.|+.|....+|+.....          | .+++|+.....  ....+..|+.++..|...+  +.+++.      +...
T Consensus        28 ~~i~~G~~n~~~~v~~~~----------g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~   94 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTK----------D-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL   94 (322)
T ss_dssp             EEECC---EEEEEEEESS----------C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred             eccCCCcccceEEEEeCC----------c-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEE
Confidence            456778888999986532          2 58899887531  1234556788877775222  233332      1223


Q ss_pred             CCceEEEEEecCCCChhH--------------HhhhcC----CC----CC---HHHHHH------------HHHHHHHHH
Q 011250          211 DDQRLLVYEFMPRGSLEN--------------HLFRRS----LP----LP---WSIRMK------------IALGAAKGL  253 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~--------------~l~~~~----~~----l~---~~~~~~------------i~~qi~~aL  253 (490)
                      .+..++||+|++|..+..              .++...    ..    ..   |.....            +...+...+
T Consensus        95 ~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~  174 (322)
T 2ppq_A           95 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI  174 (322)
T ss_dssp             TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred             CCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHH
Confidence            456789999998865421              011110    00    11   111000            001134445


Q ss_pred             HHhhhc----CCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          254 AFLHEE----AEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       254 ~yLH~~----~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      .+|+..    ....+||+|+.+.|||++.+..+.|+||+.+.
T Consensus       175 ~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          175 DYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            555532    12459999999999999877656899998764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.58  E-value=0.00013  Score=70.93  Aligned_cols=137  Identities=8%  Similarity=0.009  Sum_probs=75.4

Q ss_pred             CcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCe-eceeeEEEeCCceEE
Q 011250          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNL-VKLVGYCIEDDQRLL  216 (490)
Q Consensus       138 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~l  216 (490)
                      .+.|+.|....+|+.  .             .+++|+........ ....+|+.+++.+..-++ .+++++  +.+.-++
T Consensus        23 i~~l~gG~tN~~~~~--~-------------~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~   84 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA--G-------------DLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVM   84 (301)
T ss_dssp             CEEEESCSSEEEEEE--T-------------TEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCE
T ss_pred             eeEcCCcccccccee--e-------------eEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEE
Confidence            678989999999998  2             38889876432111 123468888777753233 344443  4445689


Q ss_pred             EEEec-CCCChhHHh------------------hhcCCCC----CH-HHHHHHHH--------------HHHHHHH----
Q 011250          217 VYEFM-PRGSLENHL------------------FRRSLPL----PW-SIRMKIAL--------------GAAKGLA----  254 (490)
Q Consensus       217 V~E~~-~~gsL~~~l------------------~~~~~~l----~~-~~~~~i~~--------------qi~~aL~----  254 (490)
                      |+||+ +|.+|....                  +.....+    .. .....+..              .+...+.    
T Consensus        85 v~e~i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~  164 (301)
T 3dxq_A           85 VTRYIAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRS  164 (301)
T ss_dssp             EEECCTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHH
T ss_pred             EEeecCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHH
Confidence            99999 665543210                  1111111    11 11111110              0111111    


Q ss_pred             Hhhh-cCCCCeeecCCCCCcEEEcCCCCeEEecccCcccC
Q 011250          255 FLHE-EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       255 yLH~-~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~  293 (490)
                      .|.. .....++|+|+.+.||| ..++.+.|+||..+...
T Consensus       165 ~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          165 ALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             HHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             HHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            1111 12244899999999999 56678899999987643

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.56  E-value=0.00051  Score=62.87  Aligned_cols=140  Identities=14%  Similarity=0.044  Sum_probs=92.5

Q ss_pred             CChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCCCcceeee
Q 011250          224 GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST  303 (490)
Q Consensus       224 gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~  303 (490)
                      -+|.+.|...+.+++++++|.++.|.+.+|.-+-... . -..+=+.|..|+|..+|.|-+.+ +.+.            
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRR-Q-PRHRVRSAAQIRVWRDGAVTLAP-AADD------------   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT-C-CCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcc-c-CCceecCCcceEEecCCceeccc-cccc------------
Confidence            3799999888999999999999999999987762111 0 11333457899999999988874 2110            


Q ss_pred             ccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCC
Q 011250          304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFS  383 (490)
Q Consensus       304 ~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  383 (490)
                        .....+.|||... ...+.+.=|||||++||.-+--..|-+                           ..+       
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~---------------------------eE~-------  140 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKEN---------------------------EER-------  140 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT---------------------------EEE-------
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcc---------------------------cch-------
Confidence              1123467888653 345677889999999999885332211                           001       


Q ss_pred             hhhHHHHHHHHHHhhhc-------------------------CCCCCCCHHHHHHHhh
Q 011250          384 IKGSQKATQLAAQCLSR-------------------------DPKARPRMSEVVETLK  416 (490)
Q Consensus       384 ~~~~~~l~~Li~~cL~~-------------------------dP~~RPt~~evl~~L~  416 (490)
                       ..++.+.+||..|...                         .+..|+++++|++.-.
T Consensus       141 -eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~  197 (229)
T 2yle_A          141 -ELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCA  197 (229)
T ss_dssp             -CCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHHH
T ss_pred             -hhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHH
Confidence             1167888888888765                         2468899999997654

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.55  E-value=0.00029  Score=70.85  Aligned_cols=148  Identities=15%  Similarity=0.109  Sum_probs=82.8

Q ss_pred             CcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccC-CCCeeceeeEEEeCCceEE
Q 011250          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIEDDQRLL  216 (490)
Q Consensus       138 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~l  216 (490)
                      .+.|..|-...+|++.......  -..+.+..|++|+... .......+.+|..+++.|. +.-..++++++.+    .+
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~--~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~  127 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLP--SVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR  127 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSC--CCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred             EEEcCCcccccEEEEEeCCCcc--ccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence            3457778889999987642100  0011345788998633 2234556778999998886 3333556665432    39


Q ss_pred             EEEecCCCChhHH----------h-------hhc----CCCCC--HHHHHHHHHHHHH-------------------HHH
Q 011250          217 VYEFMPRGSLENH----------L-------FRR----SLPLP--WSIRMKIALGAAK-------------------GLA  254 (490)
Q Consensus       217 V~E~~~~gsL~~~----------l-------~~~----~~~l~--~~~~~~i~~qi~~-------------------aL~  254 (490)
                      ||||++|..|...          +       +..    .....  +..+..+..++..                   .+.
T Consensus       128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~  207 (379)
T 3feg_A          128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG  207 (379)
T ss_dssp             EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred             EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence            9999998655311          0       111    11112  3444445443321                   223


Q ss_pred             Hhh----hc-CCCCeeecCCCCCcEEEcCC----CCeEEecccCccc
Q 011250          255 FLH----EE-AEKPVIYRDFKTSNILLDAD----YNAKLSDFGLAKD  292 (490)
Q Consensus       255 yLH----~~-~~~~iiHrDlkp~NILl~~~----~~vkL~DFG~a~~  292 (490)
                      .|.    .. ....++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            332    21 12359999999999999876    7899999987753

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.54  E-value=0.00048  Score=67.43  Aligned_cols=141  Identities=16%  Similarity=0.132  Sum_probs=79.4

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCC--eeceeeE-----EEeC
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN--LVKLVGY-----CIED  211 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~-----~~~~  211 (490)
                      ..|+ |....||+....          .|..+++|...... .....+..|+.++..|....  +++++..     ...+
T Consensus        32 ~~l~-g~~n~~y~v~~~----------~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~   99 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE----------DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQ   99 (328)
T ss_dssp             EEEC-CSSSEEEEECCT----------TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEET
T ss_pred             Eeec-CcccceEEEEcC----------CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEEC
Confidence            4566 888899986542          34468999986432 23456777888888775222  3444432     2234


Q ss_pred             CceEEEEEecCCCChh----HH----------hhh--cC------CCCCHHHH----HHH---------------HHHHH
Q 011250          212 DQRLLVYEFMPRGSLE----NH----------LFR--RS------LPLPWSIR----MKI---------------ALGAA  250 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~----~~----------l~~--~~------~~l~~~~~----~~i---------------~~qi~  250 (490)
                      +..++||+|++|..+.    +.          ++.  ..      ..+.+...    ..+               ...+.
T Consensus       100 g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  179 (328)
T 1zyl_A          100 GFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATD  179 (328)
T ss_dssp             TEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHH
T ss_pred             CEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHH
Confidence            5668899999875432    00          111  00      01121110    000               00111


Q ss_pred             HHHHHhhhc----CCCCeeecCCCCCcEEEcCCCCeEEecccCcccC
Q 011250          251 KGLAFLHEE----AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       251 ~aL~yLH~~----~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~  293 (490)
                      ..+..+...    ....+||+|+++.|||++ + .+.|+||+.+...
T Consensus       180 ~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          180 ELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             HHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             HHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence            122222221    234589999999999998 4 8999999987543

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.52  E-value=0.00025  Score=72.71  Aligned_cols=81  Identities=19%  Similarity=0.119  Sum_probs=50.7

Q ss_pred             CcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCe-eceeeEEEeCCceEE
Q 011250          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNL-VKLVGYCIEDDQRLL  216 (490)
Q Consensus       138 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~l  216 (490)
                      .+.|+.|-...||++........  ..+.+..|++|+.....  ....+..|+.+++.|...+| .++++.+.  +  .+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~--~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~  149 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPP--IRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G--GR  149 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCC--SSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EE
T ss_pred             EEEeCCCcccceEEEEeCCCccc--cCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CE
Confidence            45688888899999976421100  00124578899884321  12456689999988863334 56666543  2  38


Q ss_pred             EEEecCCCCh
Q 011250          217 VYEFMPRGSL  226 (490)
Q Consensus       217 V~E~~~~gsL  226 (490)
                      ||||++|.+|
T Consensus       150 v~e~l~G~~l  159 (429)
T 1nw1_A          150 LEEYIPSRPL  159 (429)
T ss_dssp             EECCCCEEEC
T ss_pred             EEEEeCCccc
Confidence            9999987444

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.43  E-value=0.0006  Score=70.37  Aligned_cols=75  Identities=13%  Similarity=0.026  Sum_probs=46.6

Q ss_pred             CcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCe-eceeeEEEeCCceEE
Q 011250          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNL-VKLVGYCIEDDQRLL  216 (490)
Q Consensus       138 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~l  216 (490)
                      .+.|+.|-...+|++....         .+..+++|+....... .-+..+|+.++..|...++ .++++++.  +  .+
T Consensus       113 i~~lsgG~tN~~y~v~~~~---------~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~  178 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMS---------KQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GR  178 (458)
T ss_dssp             EEEECC--CEEEEEEEETT---------TTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EE
T ss_pred             EEEcCCCeEeEEEEEEECC---------CCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eE
Confidence            3467788889999987642         2357889987543211 1112478999998875444 56676652  2  36


Q ss_pred             EEEecCCCCh
Q 011250          217 VYEFMPRGSL  226 (490)
Q Consensus       217 V~E~~~~gsL  226 (490)
                      ||||++|.+|
T Consensus       179 v~e~I~G~~l  188 (458)
T 2qg7_A          179 IEEFMDGYAL  188 (458)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEeeCCccC
Confidence            9999987544

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.26  E-value=0.0014  Score=64.42  Aligned_cols=32  Identities=28%  Similarity=0.318  Sum_probs=27.6

Q ss_pred             CCeeecCCCCCcEEEcCC----CCeEEecccCcccC
Q 011250          262 KPVIYRDFKTSNILLDAD----YNAKLSDFGLAKDA  293 (490)
Q Consensus       262 ~~iiHrDlkp~NILl~~~----~~vkL~DFG~a~~~  293 (490)
                      ..+||+|+.+.|||++.+    +.+.|+||+.+...
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            459999999999999874    67999999988754

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.25  E-value=0.0007  Score=67.63  Aligned_cols=83  Identities=10%  Similarity=0.023  Sum_probs=44.8

Q ss_pred             CcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCC-eeceeeEEEeCCceEE
Q 011250          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN-LVKLVGYCIEDDQRLL  216 (490)
Q Consensus       138 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~l  216 (490)
                      ...|+.|....+|+......+.. ..+..+..+++|+..... ....+...|+.+++.|...+ +.++++.+  .  -++
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~-~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~  111 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETAN-NYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGR  111 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHT-TCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcc-cccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcE
Confidence            34677888889999876431000 000112478888875432 11112357888888876333 34666543  2  378


Q ss_pred             EEEecCCCCh
Q 011250          217 VYEFMPRGSL  226 (490)
Q Consensus       217 V~E~~~~gsL  226 (490)
                      ||||++|..|
T Consensus       112 v~e~i~G~~l  121 (369)
T 3c5i_A          112 IEEWLYGDPL  121 (369)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEEecCCcC
Confidence            9999987544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.18  E-value=0.0025  Score=63.00  Aligned_cols=32  Identities=16%  Similarity=0.170  Sum_probs=27.9

Q ss_pred             CCeeecCCCCCcEEEcCCCCeEEecccCcccC
Q 011250          262 KPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       262 ~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~  293 (490)
                      ..++|+|+.+.|||++.++.+.|+||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            45999999999999998888999999877643

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.92  E-value=0.03  Score=57.00  Aligned_cols=82  Identities=9%  Similarity=-0.019  Sum_probs=47.8

Q ss_pred             CcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccC-CCCeeceeeEEEeCCceEE
Q 011250          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIEDDQRLL  216 (490)
Q Consensus       138 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~l  216 (490)
                      .+.|..|-...+|+.........  ....+..|++++..... ...-+..+|..+++.|. +.-..++++.+  .  -++
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~--~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~  147 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMS--LSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGR  147 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-------CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred             EEEcCCCcccceEEEEeCCCccc--ccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCE
Confidence            34577788899999887531100  00114678899865432 11112357888888875 33234555433  2  378


Q ss_pred             EEEecCCCCh
Q 011250          217 VYEFMPRGSL  226 (490)
Q Consensus       217 V~E~~~~gsL  226 (490)
                      ||||++|..|
T Consensus       148 I~efI~G~~l  157 (424)
T 3mes_A          148 IEEFIDGEPL  157 (424)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEEeCCccC
Confidence            9999998654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.30  E-value=0.089  Score=52.96  Aligned_cols=29  Identities=28%  Similarity=0.319  Sum_probs=24.6

Q ss_pred             eeecCCCCCcEEE------cCCCCeEEecccCccc
Q 011250          264 VIYRDFKTSNILL------DADYNAKLSDFGLAKD  292 (490)
Q Consensus       264 iiHrDlkp~NILl------~~~~~vkL~DFG~a~~  292 (490)
                      ++|+|+.+.|||+      +++..++|+||.+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999      4467799999988753

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=91.63  E-value=0.53  Score=42.78  Aligned_cols=123  Identities=9%  Similarity=0.082  Sum_probs=82.1

Q ss_pred             HHHHHhccCCCCeeceeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecC
Q 011250          189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRD  268 (490)
Q Consensus       189 Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrD  268 (490)
                      |+.+|. ..||+++.. .+-.+++.+.|.++.-+.+-=+..+    ..++...++.++.+|+....+++.     =+|--
T Consensus        36 el~LL~-~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i----k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~  104 (215)
T 4ann_A           36 LMYLLE-QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI----KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFV  104 (215)
T ss_dssp             GGGGGG-SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG----GGSCHHHHHHHHHHGGGGGGGGGS-----SEECC
T ss_pred             HHHHHh-ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHH----HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEE
Confidence            444443 358888877 4666667666666654322111222    357788999999999988876664     56788


Q ss_pred             CCCCcEEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCC
Q 011250          269 FKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD  346 (490)
Q Consensus       269 lkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~  346 (490)
                      |.|+||+++.++.++|.-.|+-..+.                   |.     .++...=+-.+=+++..+++++..|+
T Consensus       105 L~P~NL~f~~~~~p~i~~RGik~~l~-------------------P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          105 LAPDELFFTRDGLPIAKTRGLQNVVD-------------------PL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             CSGGGEEECTTSCEEESCCEETTTBS-------------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EecceEEEcCCCCEEEEEccCccCCC-------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999999999998777543221                   11     11222224467788899999988874

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=89.22  E-value=1  Score=41.12  Aligned_cols=115  Identities=10%  Similarity=0.111  Sum_probs=77.2

Q ss_pred             CCCCeeceeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHH-HhhhcCCCCeeecCCCCCcEE
Q 011250          197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA-FLHEEAEKPVIYRDFKTSNIL  275 (490)
Q Consensus       197 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~-yLH~~~~~~iiHrDlkp~NIL  275 (490)
                      .||++  -..+-.+++.+.|.++.-+++-=+..+    ..++...++.++.+|+.... +++.     -+|=-|.|+||+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~  116 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLM  116 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEE
Confidence            47877  333446667777777765443323333    25778899999999988777 6655     677889999999


Q ss_pred             EcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCC
Q 011250          276 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD  346 (490)
Q Consensus       276 l~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~  346 (490)
                      ++.++.++|.-.|+-..+                   +|.-     .+..-=+-.+=|++..++.++..|+
T Consensus       117 f~~~~~p~i~hRGi~~~l-------------------pP~e-----~~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          117 FNRALEPFFLHVGVKESL-------------------PPDE-----WDDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             ECTTCCEEESCCEETTTB-------------------SSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             EeCCCcEEEEEcCCcccC-------------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999987754322                   2221     1111123457778888888887764

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=87.76  E-value=0.083  Score=54.34  Aligned_cols=63  Identities=11%  Similarity=0.156  Sum_probs=18.7

Q ss_pred             CCCcccccCCceEEEEEEEccCCCccccCCCCcEEEE------EEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeE
Q 011250          136 RPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAV------KTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (490)
Q Consensus       136 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vai------K~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~  207 (490)
                      .+.+.||   ||+||+|.+..         +...|||      |.......  .....+.+|..++..+.|||+++.+++
T Consensus       145 ~l~~~lG---fG~v~~g~~~~---------~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f  212 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYK---------KHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNF  212 (463)
T ss_dssp             CSTTTSS---BCCC------------------CCBGGGC-----------------------------------CBCCCE
T ss_pred             cccccCC---chhhhcccccc---------cCCchhhhhccCccccccccccccccccccccccccccccccccCCCcce
Confidence            4566777   99999998864         2236777      66554322  223468889999999999999999987


Q ss_pred             EEe
Q 011250          208 CIE  210 (490)
Q Consensus       208 ~~~  210 (490)
                      ...
T Consensus       213 ~~~  215 (463)
T 3cxl_A          213 KVH  215 (463)
T ss_dssp             EEE
T ss_pred             EEe
Confidence            653

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	490
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-77
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-70
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-69
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-69
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-69
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-69
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-67
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-67
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	6e-67
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	9e-67
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-66
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-66
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-66
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	6e-66
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	9e-66
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-65
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-64
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	7e-64
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-63
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-63
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-62
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-62
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	9e-62
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-61
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	9e-61
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-60
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-60
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-59
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	9e-58
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-57
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-57
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-56
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-56
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-54
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-53
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	8e-52
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-51
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-50
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-50
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-49
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	6e-49
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-48
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-47
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-47
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	6e-47
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	8e-47
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-46
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-46
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-45
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-45
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-44
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-43
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-42
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-41
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	9e-41
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-39
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-38
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-36
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-34
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	7e-33
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-32
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-27
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-16

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  242 bits (619), Expect = 1e-77
 Identities = 76/291 (26%), Positives = 121/291 (41%), Gaps = 33/291 (11%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 191
                  +G G FG V+KG                 VAVK LN      Q  + +  EV 
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHG------------DVAVKMLNVTAPTPQQLQAFKNEVG 56

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 251
            L    H N++  +GY     Q  +V ++    SL +HL            + IA   A+
Sbjct: 57  VLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ 115

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+ +LH    K +I+RD K++NI L  D   K+ DFGLA        +H   ++ G+  +
Sbjct: 116 GMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172

Query: 312 AAPEYVMT---GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
            APE +        + +SDVY+FG+VL E++TG+       P    N  +     +G   
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGY 226

Query: 369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ 419
               L   R          +   +L A+CL +    RP   +++ +++ L 
Sbjct: 227 LSPDLSKVRSN------CPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (566), Expect = 5e-70
 Identities = 78/286 (27%), Positives = 123/286 (43%), Gaps = 31/286 (10%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
                  +G G FG V  G+                VA+KT+        ++++ E   +
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGA-MSEEDFIEEAEVM 54

Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 253
             L HP LV+L G C+E     LV+EFM  G L ++L  +         + + L   +G+
Sbjct: 55  MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGM 114

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
           A+L    E  VI+RD    N L+  +   K+SDFG+ +   +D +   ST       +A+
Sbjct: 115 AYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWAS 170

Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 373
           PE       +SKSDV+SFGV++ E+ +  +   +NR N E          + D    +RL
Sbjct: 171 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRL 221

Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ 419
             PRL        S    Q+   C    P+ RP  S ++  L  + 
Sbjct: 222 YKPRLA-------STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  220 bits (562), Expect = 1e-69
 Identities = 63/284 (22%), Positives = 109/284 (38%), Gaps = 31/284 (10%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           ++      LG G FG V  G                 VA+K +         E++ E   
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGS-MSEDEFIEEAKV 52

Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
           + NL H  LV+L G C +     ++ E+M  G L N+L            +++     + 
Sbjct: 53  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 112

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           + +L     K  ++RD    N L++     K+SDFGL++   +D +   S        ++
Sbjct: 113 MEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWS 168

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR 372
            PE +M    +SKSD+++FGV++ E+ +  +      P       E A        +  R
Sbjct: 169 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK-----MPYERFTNSETAE----HIAQGLR 219

Query: 373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
           L  P L        S+K   +   C       RP    ++  + 
Sbjct: 220 LYRPHLA-------SEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  221 bits (564), Expect = 2e-69
 Identities = 76/309 (24%), Positives = 130/309 (42%), Gaps = 38/309 (12%)

Query: 123 FMFNDLKLATRNFRPE---------SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK 173
           F F D   A R F  E          ++G G FG V  G ++  G         + VA+K
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPG------KREIFVAIK 60

Query: 174 TLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR 232
           TL      +  +++L+E + +G   HPN++ L G   +    +++ EFM  GSL++ L +
Sbjct: 61  TLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ 120

Query: 233 RSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD 292
                     + +  G A G+ +L    +   ++RD    NIL++++   K+SDFGL++ 
Sbjct: 121 NDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177

Query: 293 APEDGKTHVSTRV---MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR 349
             +D      T          + APE +     TS SDV+S+G+V+ E+++        R
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE-----R 232

Query: 350 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS 409
           P  +    +       D R               +       QL   C  +D   RP+  
Sbjct: 233 PYWDMTNQDVINAIEQDYRL-----------PPPMDCPSALHQLMLDCWQKDRNHRPKFG 281

Query: 410 EVVETLKPL 418
           ++V TL  +
Sbjct: 282 QIVNTLDKM 290

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (565), Expect = 2e-69
 Identities = 79/294 (26%), Positives = 126/294 (42%), Gaps = 31/294 (10%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 198
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 34  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87

Query: 199 PNLVKLVGYCIEDDQR-LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 257
           PN++ L+G C+  +   L+V  +M  G L N +   +        +   L  AKG+ FL 
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 147

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG--KTHVSTRVMGTYGYAAPE 315
               K  ++RD    N +LD  +  K++DFGLA+D  +      H  T       + A E
Sbjct: 148 S---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204

Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 375
            + T   T+KSDV+SFGV+L E++T         P  + N  +     L    +  RLL 
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGA-----PPYPDVNTFDITVYLL----QGRRLLQ 255

Query: 376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSY 429
           P               ++  +C     + RP  SE+V  +  +          Y
Sbjct: 256 PEYC-------PDPLYEVMLKCWHPKAEMRPSFSELVSRISAI--FSTFIGEHY 300

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (565), Expect = 4e-69
 Identities = 69/313 (22%), Positives = 126/313 (40%), Gaps = 43/313 (13%)

Query: 128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEW 186
           ++L   +F   S LG G  G VFK              +GL +A K ++ +       + 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKV---------SHKPSGLVMARKLIHLEIKPAIRNQI 51

Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
           + E+  L     P +V   G    D +  +  E M  GSL+  L +    +P  I  K++
Sbjct: 52  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVS 110

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           +   KGL +L E+    +++RD K SNIL+++    KL DFG++    +     ++   +
Sbjct: 111 IAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFV 164

Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR----------------------- 343
           GT  Y +PE +   H + +SD++S G+ L+EM  GR                        
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 224

Query: 344 ---SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSR 400
                 +       +    +RP +        +++       S   S +      +CL +
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 284

Query: 401 DPKARPRMSEVVE 413
           +P  R  + +++ 
Sbjct: 285 NPAERADLKQLMV 297

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (555), Expect = 1e-67
 Identities = 72/307 (23%), Positives = 115/307 (37%), Gaps = 46/307 (14%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 192
           N     +LG G FG V             K G  + VAVK L        +E  ++E+  
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGIS----KTGVSIQVAVKMLKEKADSSEREALMSELKM 93

Query: 193 LGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL---------------- 235
           +  L  H N+V L+G C       L++E+   G L N+L  +                  
Sbjct: 94  MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153

Query: 236 ------PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL 289
                  L +   +  A   AKG+ FL     K  ++RD    N+L+      K+ DFGL
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGL 210

Query: 290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR 349
           A+D   D    V         + APE +  G  T KSDV+S+G++L E+ +   +     
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270

Query: 350 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS 409
           P   +               FY+L+    +       +++   +   C + D + RP   
Sbjct: 271 PVDAN---------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFP 315

Query: 410 EVVETLK 416
            +   L 
Sbjct: 316 NLTSFLG 322

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (547), Expect = 3e-67
 Identities = 76/286 (26%), Positives = 123/286 (43%), Gaps = 33/286 (11%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
             +    LG G FG V+ G+                VAVK+L          +LAE N +
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLM 62

Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKG 252
             L H  LV+L       +   ++ E+M  GSL + L   S + L  +  + +A   A+G
Sbjct: 63  KQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           +AF+    E+  I+RD + +NIL+    + K++DFGLA+   ++ +            + 
Sbjct: 122 MAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREGAKFPIKWT 177

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR 372
           APE +  G  T KSDV+SFG++L E++T  R       N E          + +  R YR
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYR 228

Query: 373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
           ++ P           ++  QL   C    P+ RP    +   L+  
Sbjct: 229 MVRPD-------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (547), Expect = 6e-67
 Identities = 68/310 (21%), Positives = 120/310 (38%), Gaps = 31/310 (10%)

Query: 127 DLKLATRNFRPESL-LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-K 184
            L L   N     + LG G FG V +G               + VA+K L     +   +
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKK-------QIDVAIKVLKQGTEKADTE 54

Query: 185 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
           E + E   +  L +P +V+L+G C + +  +LV E    G L   L  +   +P S   +
Sbjct: 55  EMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE 113

Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVST 303
           +    + G+ +L E   K  ++RD    N+LL   + AK+SDFGL+K    D       +
Sbjct: 114 LLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 170

Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     +S+SDV+S+GV + E L+  +     +P  +    E     
Sbjct: 171 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ-----KPYKKMKGPE----- 220

Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK-PLQNLK 422
                     ++         +   +   L + C     + RP    V + ++    +L 
Sbjct: 221 ------VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274

Query: 423 DMASSSYYFQ 432
                 ++  
Sbjct: 275 SKVEGHHHHH 284

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  214 bits (546), Expect = 9e-67
 Identities = 71/302 (23%), Positives = 130/302 (43%), Gaps = 31/302 (10%)

Query: 125 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK 184
           ++  ++   +   +  LG G +G V++G         V     LTVAVKTL  D ++  +
Sbjct: 9   YDKWEMERTDITMKHKLGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-E 58

Query: 185 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRM 243
           E+L E   +  + HPNLV+L+G C  +    ++ EFM  G+L ++L   +   +   + +
Sbjct: 59  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 118

Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
            +A   +  + +L +   K  I+RD    N L+  ++  K++DFGL++    D       
Sbjct: 119 YMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHA 174

Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     + KSDV++FGV+L E+ T   S        +          
Sbjct: 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------- 224

Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKD 423
                  Y LL+            +K  +L   C   +P  RP  +E+ +  + +     
Sbjct: 225 ------VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278

Query: 424 MA 425
           ++
Sbjct: 279 IS 280

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (545), Expect = 2e-66
 Identities = 69/313 (22%), Positives = 121/313 (38%), Gaps = 35/313 (11%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           R    +  +G+G FG V++G              G  VAVK  +    +      AE+  
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSREER-SWFREAEIYQ 50

Query: 193 LGNLLHPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 248
              L H N++  +    +D+    Q  LV ++   GSL ++L R    +     +K+AL 
Sbjct: 51  TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALS 108

Query: 249 AAKGLAFLHEEA-----EKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTHV 301
            A GLA LH E      +  + +RD K+ NIL+  +    ++D GLA   D+  D     
Sbjct: 109 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 168

Query: 302 STRVMGTYGYAAPEYVMT------GHLTSKSDVYSFGVVLLEMLTGRR----SMDKNRPN 351
               +GT  Y APE +             ++D+Y+ G+V  E+           D   P 
Sbjct: 169 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228

Query: 352 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
            +    + +   +       +L         S +  +   ++  +C   +  AR     +
Sbjct: 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288

Query: 412 VETLKPLQNLKDM 424
            +TL  L   + +
Sbjct: 289 KKTLSQLSQQEGI 301

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 2e-66
 Identities = 72/292 (24%), Positives = 122/292 (41%), Gaps = 43/292 (14%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           +  +    +G+G FG V  G              G  VAVK + +D     + +LAE + 
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKNDATA--QAFLAEASV 53

Query: 193 LGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAA 250
           +  L H NLV+L+G  +E+   L +V E+M +GSL ++L  R    L     +K +L   
Sbjct: 54  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 113

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
           + + +L        ++RD    N+L+  D  AK+SDFGL K+A     T           
Sbjct: 114 EAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVK 165

Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HNLVEWARPHLGDKR 368
           + APE +     ++KSDV+SFG++L E+ +  R      P  +    + +  +    D  
Sbjct: 166 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC 225

Query: 369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN 420
                                  ++   C   D   RP   ++ E L+ ++ 
Sbjct: 226 ------------------PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (545), Expect = 2e-66
 Identities = 78/314 (24%), Positives = 118/314 (37%), Gaps = 46/314 (14%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 192
                  LG G FG V +          +K    +TVAVK L        +E  ++E+  
Sbjct: 24  RLSFGKTLGAGAFGKVVEATA----YGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79

Query: 193 LGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRR-----------------S 234
           L  L  H N+V L+G C      L++ E+   G L N L R+                  
Sbjct: 80  LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139

Query: 235 LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 294
           L L     +  +   AKG+AFL     K  I+RD    NILL      K+ DFGLA+D  
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIK 196

Query: 295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
            D    V         + APE +     T +SDV+S+G+ L E+ +   S     P    
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256

Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET 414
                          FY+++              +   +   C   DP  RP   ++V+ 
Sbjct: 257 ---------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301

Query: 415 LKPLQNLKDMASSS 428
           ++     K ++ S+
Sbjct: 302 IE-----KQISEST 310

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (539), Expect = 6e-66
 Identities = 67/297 (22%), Positives = 128/297 (43%), Gaps = 26/297 (8%)

Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 187
           ++       + ++G G FG V+KG ++ +          + VA+KTL     +  + ++L
Sbjct: 3   EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGK-----KEVPVAIKTLKAGYTEKQRVDFL 57

Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
            E   +G   H N+++L G   +    +++ E+M  G+L+  L  +         + +  
Sbjct: 58  GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR 117

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG-KTHVSTRVM 306
           G A G+ +L        ++RD    NIL++++   K+SDFGL++   +D   T+ ++   
Sbjct: 118 GIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 174

Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
               + APE +     TS SDV+SFG+V+ E++T          N E             
Sbjct: 175 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------------- 221

Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKD 423
                + ++        +       QL  QC  ++   RP+ +++V  L  L    D
Sbjct: 222 ---VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (538), Expect = 9e-66
 Identities = 77/291 (26%), Positives = 122/291 (41%), Gaps = 29/291 (9%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAE 189
           ++ R    LG+G FG V +G  +         G  ++VAVK L  D L   +   +++ E
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDFIRE 61

Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 249
           VN + +L H NL++L G  +    ++ V E  P GSL + L +           + A+  
Sbjct: 62  VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 120

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV-STRVMGT 308
           A+G+ +L     K  I+RD    N+LL      K+ DFGL +  P++   +V        
Sbjct: 121 AEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177

Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
           + + APE + T   +  SD + FGV L EM T  +      P    N  +       +  
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILHKIDKEGE 232

Query: 369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ 419
           R      PR E        Q    +  QC +  P+ RP    + + L   Q
Sbjct: 233 RL-----PRPEDC-----PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (533), Expect = 7e-65
 Identities = 75/308 (24%), Positives = 127/308 (41%), Gaps = 47/308 (15%)

Query: 132 TRNFRPE------SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 185
           TR+  PE        LG+G FG V+K              T +  A K ++    +  ++
Sbjct: 5   TRDLNPEDFWEIIGELGDGAFGKVYKA---------QNKETSVLAAAKVIDTKSEEELED 55

Query: 186 WLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 245
           ++ E++ L +  HPN+VKL+     ++   ++ EF   G+++  +     PL  S    +
Sbjct: 56  YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVV 115

Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                  L +LH   +  +I+RD K  NIL   D + KL+DFG++       +       
Sbjct: 116 CKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSF 170

Query: 306 MGTYGYAAPEYVMT-----GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 360
           +GT  + APE VM           K+DV+S G+ L+EM           P+ E N +   
Sbjct: 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE------PPHHELNPMRVL 224

Query: 361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV-------VE 413
                 K     L  P        + S        +CL ++  AR   S++       V+
Sbjct: 225 LKIA--KSEPPTLAQPS-------RWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275

Query: 414 TLKPLQNL 421
           + KP++ L
Sbjct: 276 SNKPIREL 283

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  208 bits (531), Expect = 2e-64
 Identities = 69/318 (21%), Positives = 115/318 (36%), Gaps = 47/318 (14%)

Query: 125 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-H 183
              L+    N      +GEG FG VF+          +       VAVK L  +      
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQARA----PGLLPYEPFTMVAVKMLKEEASADMQ 60

Query: 184 KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-------- 235
            ++  E   +    +PN+VKL+G C       L++E+M  G L   L   S         
Sbjct: 61  ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120

Query: 236 ---------------PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY 280
                          PL  + ++ IA   A G+A+L E   +  ++RD  T N L+  + 
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENM 177

Query: 281 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
             K++DFGL+++                  +  PE +     T++SDV+++GVVL E+ +
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237

Query: 341 GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSR 400
                     + E                 Y + D  +          +   L   C S+
Sbjct: 238 YGLQPYYGMAHEE---------------VIYYVRDGNIL-ACPENCPLELYNLMRLCWSK 281

Query: 401 DPKARPRMSEVVETLKPL 418
            P  RP    +   L+ +
Sbjct: 282 LPADRPSFCSIHRILQRM 299

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 7e-64
 Identities = 73/296 (24%), Positives = 123/296 (41%), Gaps = 33/296 (11%)

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGN 195
           +  LG G FG V KG+ +             TVAVK L ++        E LAE N +  
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKV-------VKTVAVKILKNEANDPALKDELLAEANVMQQ 64

Query: 196 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 255
           L +P +V+++G C E +  +LV E    G L  +L +    +     +++    + G+ +
Sbjct: 65  LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKY 122

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH-VSTRVMGTYGYAAP 314
           L E      ++RD    N+LL   + AK+SDFGL+K    D   +   T       + AP
Sbjct: 123 LEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL 374
           E +     +SKSDV+SFGV++ E  +  +     +P       E              +L
Sbjct: 180 ECINYYKFSSKSDVWSFGVLMWEAFSYGQ-----KPYRGMKGSE-----------VTAML 223

Query: 375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYY 430
           +            ++   L   C + D + RP  + V   L+      D+ +  ++
Sbjct: 224 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY--YYDVVNEGHH 277

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 1e-63
 Identities = 62/285 (21%), Positives = 121/285 (42%), Gaps = 26/285 (9%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFL 193
           F+   +LG G FG V+KG     G         + VA+K L      + +KE L E   +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVM 65

Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 253
            ++ +P++ +L+G C+    +L + + MP G L +++      +     +   +  AKG+
Sbjct: 66  ASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 124

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
            +L +   + +++RD    N+L+    + K++DFGLAK    + K + +        + A
Sbjct: 125 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181

Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 373
            E ++    T +SDV+S+GV + E++T         P  E                   +
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSI 225

Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
           L+           +     +  +C   D  +RP+  E++     +
Sbjct: 226 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 6e-63
 Identities = 65/282 (23%), Positives = 109/282 (38%), Gaps = 30/282 (10%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEVNF 192
           ++     LGEG +G V            V   T   VAVK ++    +   +    E+  
Sbjct: 6   DWDLVQTLGEGAYGEVQLA---------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 56

Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
              L H N+VK  G+  E + + L  E+   G L + +      +P     +       G
Sbjct: 57  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAG 115

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           + +LH      + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y 
Sbjct: 116 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172

Query: 313 APEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 371
           APE +          DV+S G+VL  ML G    D+   + +                + 
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE---------------YS 217

Query: 372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
              + +   +   K       L  + L  +P AR  + ++ +
Sbjct: 218 DWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 1e-62
 Identities = 72/325 (22%), Positives = 131/325 (40%), Gaps = 50/325 (15%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNF 192
           + + + ++GEG FG V K  ++++G         +  A+K +        H+++  E+  
Sbjct: 11  DIKFQDVIGEGNFGQVLKARIKKDGLR-------MDAAIKRMKEYASKDDHRDFAGELEV 63

Query: 193 LGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL---------------P 236
           L  L  HPN++ L+G C       L  E+ P G+L + L +  +                
Sbjct: 64  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123

Query: 237 LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED 296
           L     +  A   A+G+ +L +   K  I+RD    NIL+  +Y AK++DFGL++     
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 180

Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 356
            K    T       + A E +     T+ SDV+S+GV+L E+++   +     P      
Sbjct: 181 VKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTC 232

Query: 357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
            E            Y  L         +    +   L  QC    P  RP  ++++ +L 
Sbjct: 233 AEL-----------YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281

Query: 417 PLQNLKDMASSSYYFQTMQADNTWS 441
            +   +     +Y   T+    T++
Sbjct: 282 RMLEER----KTYVNTTLYEKFTYA 302

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (516), Expect = 1e-62
 Identities = 65/289 (22%), Positives = 113/289 (39%), Gaps = 37/289 (12%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 191
           ++     +G G +G   K           +   G  +  K L++  +     +  ++EVN
Sbjct: 5   DYEVLYTIGTGSYGRCQKI---------RRKSDGKILVWKELDYGSMTEAEKQMLVSEVN 55

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLL--VYEFMPRGSLENHLFRRSL---PLPWSIRMKIA 246
            L  L HPN+V+     I+     L  V E+   G L + + + +     L     +++ 
Sbjct: 56  LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115

Query: 247 LGAAKGLAFLHE--EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
                 L   H   +    V++RD K +N+ LD   N KL DFGLA+    D  T  +  
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKA 173

Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
            +GT  Y +PE +       KSD++S G +L E+           P    +  E A    
Sbjct: 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELAGKIR 227

Query: 365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
             K         R+   +    S +  ++  + L+     RP + E++E
Sbjct: 228 EGKF-------RRIPYRY----SDELNEIITRMLNLKDYHRPSVEEILE 265

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 9e-62
 Identities = 69/283 (24%), Positives = 113/283 (39%), Gaps = 38/283 (13%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEV 190
           +F     LG+G FG V+            +  +   +A+K L    L       +   EV
Sbjct: 7   DFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRREV 57

Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 250
               +L HPN+++L GY  +  +  L+ E+ P G++   L + S               A
Sbjct: 58  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELA 116

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
             L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +T +     GT  
Sbjct: 117 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL----CGTLD 169

Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           Y  PE +       K D++S GV+  E L G+   + N     +  +        D    
Sbjct: 170 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV-- 227

Query: 371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                           ++ A  L ++ L  +P  RP + EV+E
Sbjct: 228 ----------------TEGARDLISRLLKHNPSQRPMLREVLE 254

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 4e-61
 Identities = 64/288 (22%), Positives = 108/288 (37%), Gaps = 38/288 (13%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEV 190
           R  + +  +G G F  V+KG         +   T + VA   L    L     + +  E 
Sbjct: 9   RFLKFDIEIGRGSFKTVYKG---------LDTETTVEVAWCELQDRKLTKSERQRFKEEA 59

Query: 191 NFLGNLLHPNLVKLVGYCIE----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
             L  L HPN+V+               +LV E M  G+L+ +L R    +   +     
Sbjct: 60  EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWC 118

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDAPEDGKTHVSTRV 305
               KGL FLH     P+I+RD K  NI +     + K+ D GLA       +   +  V
Sbjct: 119 RQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAV 173

Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
           +GT  + APE +         DVY+FG+ +LEM T      + +   +            
Sbjct: 174 IGTPEFMAPE-MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI----------- 221

Query: 366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
               + R+        F      +  ++   C+ ++   R  + +++ 
Sbjct: 222 ----YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 9e-61
 Identities = 71/286 (24%), Positives = 115/286 (40%), Gaps = 33/286 (11%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           + R E  LG+G FG V+ G                 VA+KTL        + +L E   +
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNGTTR----------VAIKTLKPG-TMSPEAFLQEAQVM 66

Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKG 252
             L H  LV+L      ++   +V E+M +GSL + L       L     + +A   A G
Sbjct: 67  KKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 125

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           +A++        ++RD + +NIL+  +   K++DFGLA+   ED +            + 
Sbjct: 126 MAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWT 181

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR 372
           APE  + G  T KSDV+SFG++L E+ T  R       N E                   
Sbjct: 182 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------------VLD 225

Query: 373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
            ++         +  +    L  QC  ++P+ RP    +   L+  
Sbjct: 226 QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  199 bits (507), Expect = 1e-60
 Identities = 70/308 (22%), Positives = 117/308 (37%), Gaps = 46/308 (14%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LA 188
            + F     +G G FG V+                   VA+K +++ G Q +++W   + 
Sbjct: 14  EKLFSDLREIGHGSFGAVYFA---------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIK 64

Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 248
           EV FL  L HPN ++  G  + +    LV E+    + +     +  PL       +  G
Sbjct: 65  EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHG 123

Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
           A +GLA+LH      +I+RD K  NILL      KL DFG A           +   +GT
Sbjct: 124 ALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGT 174

Query: 309 YGYAAPEYVMT---GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
             + APE ++    G    K DV+S G+  +E+   +       P    N +        
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK------PPLFNMNAMSALYHIAQ 228

Query: 366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE-----TLKPLQN 420
           ++     L             S+        CL + P+ RP    +++       +P   
Sbjct: 229 NESPA--LQSGHW--------SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTV 278

Query: 421 LKDMASSS 428
           + D+   +
Sbjct: 279 IMDLIQRT 286

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 4e-60
 Identities = 68/286 (23%), Positives = 114/286 (39%), Gaps = 28/286 (9%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 192
                  +GEG FG V +G               L VA+KT  +      +E +L E   
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPE------NPALAVAIKTCKNCTSDSVREKFLQEALT 61

Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 252
           +    HP++VKL+G    ++   ++ E    G L + L  R   L  +  +  A   +  
Sbjct: 62  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           LA+L     K  ++RD    N+L+ ++   KL DFGL++   ED   + +++      + 
Sbjct: 121 LAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWM 176

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR 372
           APE +     TS SDV+ FGV + E+L         +P       +        +R    
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGV-----KPFQGVKNNDVIGRIENGER---- 227

Query: 373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                +  +           L  +C + DP  RPR +E+   L  +
Sbjct: 228 ---LPMPPNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 2e-59
 Identities = 66/302 (21%), Positives = 119/302 (39%), Gaps = 36/302 (11%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 191
            + +     +G+G  G V+           +   TG  VA++ +N       +  + E+ 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEIL 69

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 251
            +    +PN+V  +   +  D+  +V E++  GSL + +      +       +     +
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQ 127

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
            L FLH      VI+RD K+ NILL  D + KL+DFG       +      + ++GT  +
Sbjct: 128 ALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYW 182

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 371
            APE V       K D++S G++ +EM+ G        P    N +              
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE------PPYLNENPLRALYLIA--TNGTP 234

Query: 372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE-----TLKPLQNLKDMAS 426
            L +P        K S        +CL  D + R    E+++       KPL +L  + +
Sbjct: 235 ELQNPE-------KLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIA 287

Query: 427 SS 428
           ++
Sbjct: 288 AA 289

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 9e-58
 Identities = 79/303 (26%), Positives = 116/303 (38%), Gaps = 40/303 (13%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNF 192
             +    LG G FG V +           K  T  TVAVK L        H+  ++E+  
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKI 69

Query: 193 LGNLLH-PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRR---------------SL 235
           L ++ H  N+V L+G C +    L ++ EF   G+L  +L  +                 
Sbjct: 70  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129

Query: 236 PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE 295
            L     +  +   AKG+ FL     +  I+RD    NILL      K+ DFGLA+D  +
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186

Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 355
           D              + APE +     T +SDV+SFGV+L E+ +   S     P     
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVK 241

Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           + E     L +  R                 + +  Q    C   +P  RP  SE+VE L
Sbjct: 242 IDEEFCRRLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291

Query: 416 KPL 418
             L
Sbjct: 292 GNL 294

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 1e-57
 Identities = 70/295 (23%), Positives = 122/295 (41%), Gaps = 37/295 (12%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNF 192
                  LG+G FG V++G         VK      VA+KT+N    ++   E+L E + 
Sbjct: 21  KITMSRELGQGSFGMVYEGVA----KGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 76

Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF---------RRSLPLPWSIRM 243
           +      ++V+L+G   +    L++ E M RG L+++L              P   S  +
Sbjct: 77  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136

Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
           ++A   A G+A+L+       ++RD    N ++  D+  K+ DFG+ +D  E        
Sbjct: 137 QMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 193

Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HNLVEWAR 361
           + +    + +PE +  G  T+ SDV+SFGVVL E+ T      +   N +    ++E   
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 253

Query: 362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
               D                         +L   C   +PK RP   E++ ++K
Sbjct: 254 LDKPDNC------------------PDMLFELMRMCWQYNPKMRPSFLEIISSIK 290

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 2e-57
 Identities = 77/305 (25%), Positives = 119/305 (39%), Gaps = 38/305 (12%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNF 192
                  LGEG FG V     E  G    KP     VAVK L  D  +    + ++E+  
Sbjct: 14  RLVLGKPLGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 71

Query: 193 LGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP--------------- 236
           +  +  H N++ L+G C +D    ++ E+  +G+L  +L  R  P               
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 237 LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED 296
           L     +  A   A+G+ +L     K  I+RD    N+L+  D   K++DFGLA+D    
Sbjct: 132 LSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188

Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 356
                +T       + APE +     T +SDV+SFGV+L E+ T   S     P  E   
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 245

Query: 357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
                         ++LL            + +   +   C    P  RP   ++VE L 
Sbjct: 246 -------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292

Query: 417 PLQNL 421
            +  L
Sbjct: 293 RIVAL 297

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 4e-56
 Identities = 60/296 (20%), Positives = 103/296 (34%), Gaps = 38/296 (12%)

Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKE 185
           K    +F+   +LGEG F  V             +  T    A+K L    +        
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLA---------RELATSREYAIKILEKRHIIKENKVPY 54

Query: 186 WLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 245
              E + +  L HP  VKL     +D++      +   G L  ++ +       +     
Sbjct: 55  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFY 113

Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   
Sbjct: 114 TAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 170

Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
           +GT  Y +PE +        SD+++ G ++ +++ G                    P   
Sbjct: 171 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL------------------PPFRA 212

Query: 366 DKRRFYRLLDPRLEGHFSI--KGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ 419
                Y +    ++  +    K   KA  L  + L  D   R    E+        
Sbjct: 213 GNE--YLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  188 bits (479), Expect = 4e-56
 Identities = 63/282 (22%), Positives = 100/282 (35%), Gaps = 31/282 (10%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           ++     LG G FG V +           +  TG   A K +        +    E+  +
Sbjct: 27  HYDIHEELGTGAFGVVHRV---------TERATGNNFAAKFVMTPHESDKETVRKEIQTM 77

Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 253
             L HP LV L     +D++ +++YEFM  G L   +      +     ++      KGL
Sbjct: 78  SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGL 137

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYN--AKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
             +H   E   ++ D K  NI+     +   KL DFGL           V     GT  +
Sbjct: 138 CHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEF 191

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 371
           AAPE      +   +D++S GV+   +L+G        P G  N  E  R          
Sbjct: 192 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGL------SPFGGENDDETLRNVKSCDWNMD 245

Query: 372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                 +        S+       + L  DP  R  + + +E
Sbjct: 246 DSAFSGI--------SEDGKDFIRKLLLADPNTRMTIHQALE 279

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  184 bits (469), Expect = 1e-54
 Identities = 58/282 (20%), Positives = 105/282 (37%), Gaps = 31/282 (10%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
            +     LG G FG V +          V+  TG     K +N            E++ +
Sbjct: 30  YYDILEELGSGAFGVVHRC---------VEKATGRVFVAKFINTPYPLDKYTVKNEISIM 80

Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 253
             L HP L+ L     +  + +L+ EF+  G L + +      +  +  +     A +GL
Sbjct: 81  NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGL 140

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNA--KLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
             +H   E  +++ D K  NI+ +    +  K+ DFGLA     D           T  +
Sbjct: 141 KHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAEF 194

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 371
           AAPE V    +   +D+++ GV+   +L+G        P    + +E  +        F 
Sbjct: 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGL------SPFAGEDDLETLQNVKRCDWEFD 248

Query: 372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                 +        S +A       L ++P+ R  + + +E
Sbjct: 249 EDAFSSV--------SPEAKDFIKNLLQKEPRKRLTVHDALE 282

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  178 bits (451), Expect = 6e-53
 Identities = 68/295 (23%), Positives = 117/295 (39%), Gaps = 36/295 (12%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVN 191
           +    +LG GG   V                    VAVK L  D  +    +  +  E  
Sbjct: 9   YELGEILGFGGMSEVHLA---------RDLRLHRDVAVKVLRADLARDPSFYLRFRREAQ 59

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRL----LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
               L HP +V +      +        +V E++   +L + +     P+     +++  
Sbjct: 60  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIA 118

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST-RVM 306
            A + L F H+     +I+RD K +NI++ A    K+ DFG+A+   + G +   T  V+
Sbjct: 119 DACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 175

Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           GT  Y +PE      + ++SDVYS G VL E+LTG        P    + V  A  H+ +
Sbjct: 176 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGDSPVSVAYQHVRE 229

Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-MSEVVETLKPLQN 420
                      L        S     +  + L+++P+ R +  +E+   L  + N
Sbjct: 230 DPIPPSARHEGL--------SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  174 bits (443), Expect = 8e-52
 Identities = 68/296 (22%), Positives = 111/296 (37%), Gaps = 46/296 (15%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---------QGHK 184
           N+ P+ +LG G    V +          +   T    AVK ++  G          +  +
Sbjct: 4   NYEPKEILGRGVSSVVRRC---------IHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 54

Query: 185 EWLAEVNFLGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM 243
             L EV+ L  +  HPN+++L      +    LV++ M +G L ++L  +   L      
Sbjct: 55  ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETR 113

Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
           KI     + +  LH+     +++RD K  NILLD D N KL+DFG +       K     
Sbjct: 114 KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---R 167

Query: 304 RVMGTYGYAAPEYVMTGHL------TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 357
            V GT  Y APE +             + D++S GV++  +L G        P      +
Sbjct: 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS------PPFWHRKQM 221

Query: 358 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
              R  +    +F                S     L ++ L   P+ R    E + 
Sbjct: 222 LMLRMIMSGNYQFGSPEWDDY--------SDTVKDLVSRFLVVQPQKRYTAEEALA 269

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 1e-51
 Identities = 54/336 (16%), Positives = 118/336 (35%), Gaps = 44/336 (13%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
            +     LG G FG V +          V+  +  T   K +   G         E++ L
Sbjct: 6   KYMIAEDLGRGEFGIVHRC---------VETSSKKTYMAKFVKVKGTD-QVLVKKEISIL 55

Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 253
               H N++ L       ++ ++++EF+    +   +   +  L     +       + L
Sbjct: 56  NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNA--KLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
            FLH      + + D +  NI+     ++  K+ +FG A+         +   +     Y
Sbjct: 116 QFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEY 169

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 371
            APE      +++ +D++S G ++  +L+G        P       +     +  +  F 
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGI------NPFLAETNQQIIENIMNAEYTFD 223

Query: 372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV------ETLKPLQN--LKD 423
                 +        S +A     + L ++ K+R   SE +      + ++ +    ++ 
Sbjct: 224 EEAFKEI--------SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRT 275

Query: 424 MASSSYYFQTMQADNTWSI----RNSKNGIRTQGGF 455
           +    YY   ++ D    +     +    IR+Q G 
Sbjct: 276 LKHRRYYHTLIKKDLNMVVSAARISCGGAIRSQKGV 311

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  172 bits (437), Expect = 2e-50
 Identities = 54/280 (19%), Positives = 93/280 (33%), Gaps = 28/280 (10%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFL 193
           +    +LG G F  V                T   VA+K +    L+G +     E+  L
Sbjct: 11  YDFRDVLGTGAFSEVILA---------EDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61

Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 253
             + HPN+V L           L+ + +  G L + +  +          ++       +
Sbjct: 62  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAV 120

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
            +LH+        +        LD D    +SDFGL+K           +   GT GY A
Sbjct: 121 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL---STACGTPGYVA 177

Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 373
           PE +     +   D +S GV+   +L G        P  + N  +     L  +  F   
Sbjct: 178 PEVLAQKPYSKAVDCWSIGVIAYILLCGY------PPFYDENDAKLFEQILKAEYEFDSP 231

Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
               +        S  A       + +DP+ R    + ++
Sbjct: 232 YWDDI--------SDSAKDFIRHLMEKDPEKRFTCEQALQ 263

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  173 bits (440), Expect = 2e-50
 Identities = 70/284 (24%), Positives = 108/284 (38%), Gaps = 39/284 (13%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEV 190
           +F    ++G GGFG V+            K  TG   A+K L+   +   QG    L E 
Sbjct: 5   DFSVHRIIGRGGFGEVYGC---------RKADTGKMYAMKCLDKKRIKMKQGETLALNER 55

Query: 191 N---FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 247
                +     P +V +       D+   + + M  G L  HL +  +     +R   A 
Sbjct: 56  IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR-FYAA 114

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
               GL  +H    + V+YRD K +NILLD   + ++SD GLA D  +          +G
Sbjct: 115 EIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVG 167

Query: 308 TYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           T+GY APE +  G    S +D +S G +L ++L G     +++   +H +          
Sbjct: 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--- 224

Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 410
                      L   F    S +   L    L RD   R     
Sbjct: 225 --------AVELPDSF----SPELRSLLEGLLQRDVNRRLGCLG 256

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  169 bits (429), Expect = 2e-49
 Identities = 50/298 (16%), Positives = 93/298 (31%), Gaps = 33/298 (11%)

Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 186
           +L++  R +R    +G G FG ++ G              G  VA+K         H + 
Sbjct: 2   ELRVGNR-YRLGRKIGSGSFGDIYLG---------TDIAAGEEVAIKLECVK--TKHPQL 49

Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
             E      +     +  + +C  +    ++   +   SLE+     S        + +A
Sbjct: 50  HIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLA 109

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNIL---LDADYNAKLSDFGLAKDAPEDG-----K 298
                 + ++H    K  I+RD K  N L           + DFGLAK   +        
Sbjct: 110 DQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP 166

Query: 299 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 358
              +  + GT  YA+    +    + + D+ S G VL+    G       +   +    E
Sbjct: 167 YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 226

Query: 359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
                     +        L   +      +       C S     +P  S + +  +
Sbjct: 227 R------ISEKKMSTPIEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 6e-49
 Identities = 72/277 (25%), Positives = 103/277 (37%), Gaps = 37/277 (13%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEV 190
           +F    +LG+G FG VF               T    A+K L  D +    +    + E 
Sbjct: 3   DFILHKMLGKGSFGKVFLA---------EFKKTNQFFAIKALKKDVVLMDDDVECTMVEK 53

Query: 191 NFLGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 249
             L     HP L  +       +    V E++  G L  H+         S     A   
Sbjct: 54  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEI 112

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
             GL FLH    K ++YRD K  NILLD D + K++DFG+ K+              GT 
Sbjct: 113 ILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTP 167

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            Y APE ++        D +SFGV+L EML G+       P    +  E       D   
Sbjct: 168 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ------SPFHGQDEEELFHSIRMDNPF 221

Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
           + R L             ++A  L  +   R+P+ R 
Sbjct: 222 YPRWL------------EKEAKDLLVKLFVREPEKRL 246

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 2e-48
 Identities = 68/290 (23%), Positives = 109/290 (37%), Gaps = 31/290 (10%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLG 194
            LGEG F  V+K              T   VA+K +        K+      L E+  L 
Sbjct: 5   FLGEGQFATVYKA---------RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 55

Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
            L HPN++ L+          LV++FM    LE  +   SL L  S      L   +GL 
Sbjct: 56  ELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLE 114

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           +LH   +  +++RD K +N+LLD +   KL+DFGLAK      + +  T  + T  Y AP
Sbjct: 115 YLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAP 169

Query: 315 EYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRP----------NGEHNLVEWARPH 363
           E +    +     D+++ G +L E+L     +  +             G     +W    
Sbjct: 170 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229

Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                  ++        H           L       +P AR   ++ ++
Sbjct: 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 1e-47
 Identities = 69/308 (22%), Positives = 124/308 (40%), Gaps = 32/308 (10%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 191
           NF+    +GEG +G V+K              TG  VA+K +  D          + E++
Sbjct: 3   NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 53

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 251
            L  L HPN+VKL+     +++  LV+EF+ +   +         +P  +         +
Sbjct: 54  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQ 113

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+ +  V+  +  
Sbjct: 114 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYR 169

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN----------GEHNLVEWAR 361
           A    +   + ++  D++S G +  EM+T R     +             G  + V W  
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229

Query: 362 P-HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV------ET 414
              + D +  +     +          +    L +Q L  DP  R      +      + 
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

Query: 415 LKPLQNLK 422
            KP+ +L+
Sbjct: 290 TKPVPHLR 297

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 3e-47
 Identities = 68/315 (21%), Positives = 118/315 (37%), Gaps = 37/315 (11%)

Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---- 186
           A + +   + +GEG +G VFK    +NG        G  VA+K +     +         
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTGEEGMPLSTIR 56

Query: 187 -LAEVNFLGNLLHPNLVKLVGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWS 240
            +A +  L    HPN+V+L   C            LV+E + +             +P  
Sbjct: 57  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE 116

Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH 300
               +     +GL FLH      V++RD K  NIL+ +    KL+DFGLA+         
Sbjct: 117 TIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---M 170

Query: 301 VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV--- 357
             T V+ T  Y APE ++     +  D++S G +  EM   +     +    +   +   
Sbjct: 171 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 230

Query: 358 -------EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 410
                  +W R     ++ F+      +E   +    +    L  +CL+ +P  R     
Sbjct: 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVT-DIDELGKDLLLKCLTFNPAKRISAYS 289

Query: 411 VVET--LKPLQNLKD 423
            +     + L+  K+
Sbjct: 290 ALSHPYFQDLERCKE 304

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 6e-47
 Identities = 60/300 (20%), Positives = 111/300 (37%), Gaps = 30/300 (10%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEV 190
              +   S +GEG +G V   +              + VA+K ++    Q + +  L E+
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAY---------DNVNKVRVAIKKISPFEHQTYCQRTLREI 57

Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALG 248
             L    H N++ +           +   ++    +   L++  ++  L           
Sbjct: 58  KILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQ 117

Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH-VSTRVMG 307
             +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A  D       T  + 
Sbjct: 118 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174

Query: 308 TYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           T  Y APE ++     +KS D++S G +L EML+ R          + N +         
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234

Query: 367 KRRFYRLLDPRLEGHFSIKG-------------SQKATQLAAQCLSRDPKARPRMSEVVE 413
           +     +         S+                 KA  L  + L+ +P  R  + + + 
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  162 bits (412), Expect = 8e-47
 Identities = 71/277 (25%), Positives = 112/277 (40%), Gaps = 39/277 (14%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAE 189
           ++F+    LG G FG V                 G   A+K L  + +   K+      E
Sbjct: 4   QDFQILRTLGTGSFGRVHLI---------RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDE 54

Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 249
              L  + HP ++++ G   +  Q  ++ +++  G     L R+S   P  +    A   
Sbjct: 55  RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYAAEV 113

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
              L +LH    K +IYRD K  NILLD + + K++DFG AK  P+   T       GT 
Sbjct: 114 CLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTP 165

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            Y APE V T       D +SFG+++ EML G        P  + N ++     L  + R
Sbjct: 166 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY------TPFYDSNTMKTYEKILNAELR 219

Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
           F                ++    L ++ ++RD   R 
Sbjct: 220 FPPFF------------NEDVKDLLSRLITRDLSQRL 244

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 2e-46
 Identities = 65/307 (21%), Positives = 110/307 (35%), Gaps = 43/307 (14%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------ 188
           +     LG G F  V K           +  TGL  A K +     +  +  ++      
Sbjct: 12  YDTGEELGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62

Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 248
           EV+ L  + HPN++ L          +L+ E +  G L + L  +   L      +    
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQ 121

Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDAD----YNAKLSDFGLAKDAPEDGKTHVSTR 304
              G+ +LH      + + D K  NI+L          K+ DFGLA       +      
Sbjct: 122 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KN 175

Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
           + GT  + APE V    L  ++D++S GV+   +L+G        P       E      
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA------SPFLGDTKQETLANVS 229

Query: 365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPLQNLK 422
                F                S  A     + L +DPK R  + + ++   +KP ++ +
Sbjct: 230 AVNYEFEDEYFSNT--------SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP-KDTQ 280

Query: 423 DMASSSY 429
              SS++
Sbjct: 281 QALSSAW 287

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  159 bits (403), Expect = 7e-46
 Identities = 45/295 (15%), Positives = 85/295 (28%), Gaps = 34/295 (11%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           +++    +GEG FG +F+G                 VA+K           +   E    
Sbjct: 6   HYKVGRRIGEGSFGVIFEG---------TNLLNNQQVAIKFEPRR--SDAPQLRDEYRTY 54

Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 253
             L     +  V Y  ++    ++   +   SLE+ L               A      +
Sbjct: 55  KLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARV 114

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYN-----AKLSDFGLAKDAPEDG-----KTHVST 303
             +HE   K ++YRD K  N L+    +       + DFG+ K   +             
Sbjct: 115 QSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 171

Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
            + GT  Y +    +    + + D+ + G V +  L G       +        E     
Sbjct: 172 NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI--- 228

Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                +        L   F     ++  +      +    A P    +      +
Sbjct: 229 ---GEKKQSTPLRELCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  157 bits (397), Expect = 5e-45
 Identities = 59/293 (20%), Positives = 110/293 (37%), Gaps = 28/293 (9%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 191
            +     +GEG +G V+K           +   G T A+K +  +          + E++
Sbjct: 3   KYHGLEKIGEGTYGVVYKA----------QNNYGETFALKKIRLEKEDEGIPSTTIREIS 52

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 251
            L  L H N+VKL        + +LV+E +    L+  L      L         L    
Sbjct: 53  ILKELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLN 111

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+A+ H+   + V++RD K  N+L++ +   K++DFGLA+      + +    ++  +  
Sbjct: 112 GIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYR 167

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN----------GEHNLVEWAR 361
           A    + +   ++  D++S G +  EM+ G                    G  N   W  
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227

Query: 362 -PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
              L      + + +P     F     +    L ++ L  DP  R    + +E
Sbjct: 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 5e-45
 Identities = 60/289 (20%), Positives = 101/289 (34%), Gaps = 50/289 (17%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE------WLA 188
           ++   LLG GGFG V+ G         ++    L VA+K +  D +    E         
Sbjct: 6   YQVGPLLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 56

Query: 189 EVNFLGNL--LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
           EV  L  +      +++L+ +    D  +L+ E                 L   +     
Sbjct: 57  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 116

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDAPEDGKTHVSTRV 305
               + +   H      V++RD K  NIL+D +    KL DFG      +   T      
Sbjct: 117 WQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD----F 169

Query: 306 MGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
            GT  Y+ PE++       +S  V+S G++L +M+ G    +      +  ++       
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEII------- 217

Query: 365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
               R       R+        S +   L   CL+  P  RP   E+  
Sbjct: 218 ----RGQVFFRQRV--------SSECQHLIRWCLALRPSDRPTFEEIQN 254

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 1e-44
 Identities = 80/283 (28%), Positives = 108/283 (38%), Gaps = 36/283 (12%)

Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           K+   +F    LLG+G FG V             +  TG   A+K L  + +    E   
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILV---------REKATGRYYAMKILRKEVIIAKDEVAH 51

Query: 187 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 245
            + E   L N  HP L  L       D+   V E+   G L  HL  R            
Sbjct: 52  TVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFY 110

Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                  L +LH    + V+YRD K  N++LD D + K++DFGL K+   DG T      
Sbjct: 111 GAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTF 165

Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
            GT  Y APE +         D +  GVV+ EM+ GR       P    +        L 
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHERLFELILM 219

Query: 366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM 408
           ++ RF R L P            +A  L A  L +DPK R   
Sbjct: 220 EEIRFPRTLSP------------EAKSLLAGLLKKDPKQRLGG 250

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 6e-43
 Identities = 64/300 (21%), Positives = 106/300 (35%), Gaps = 38/300 (12%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           ++    ++G G FG V++              +G  VA+K +  D     +    E+  +
Sbjct: 21  SYTDTKVIGNGSFGVVYQA---------KLCDSGELVAIKKVLQD----KRFKNRELQIM 67

Query: 194 GNLLHPNLVKLVGYCIEDDQR------LLVYEFMPRGSLEN--HLFRRSLPLPWSIRMKI 245
             L H N+V+L  +     ++       LV +++P        H  R    LP       
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 127

Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDAPEDGKTHVSTR 304
                + LA++H      + +RD K  N+LLD D    KL DFG AK           + 
Sbjct: 128 MYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SY 182

Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA---- 360
           +   Y  A          TS  DV+S G VL E+L G+     +    +   +       
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242

Query: 361 --RPHLGDKRRFYRLLDPRLEGH-----FSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                      +     P+++ H     F  +   +A  L ++ L   P AR    E   
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 1e-42
 Identities = 55/283 (19%), Positives = 92/283 (32%), Gaps = 39/283 (13%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-H 198
           +LG G  G V +              T    A+K L         +   EV         
Sbjct: 19  VLGLGINGKVLQI---------FNKRTQEKFALKMLQD-----CPKARREVELHWRASQC 64

Query: 199 PNLVKLVGYC----IEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGL 253
           P++V++V             L+V E +  G L + +  R           +I     + +
Sbjct: 65  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 124

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYN---AKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            +LH      + +RD K  N+L  +       KL+DFG AK+               T  
Sbjct: 125 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPY 178

Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           Y APE +         D++S GV++  +L G      N  +G              +  F
Sbjct: 179 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN--HGLAISPGMKTRIRMGQYEF 236

Query: 371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                  +        S++   L    L  +P  R  ++E + 
Sbjct: 237 PNPEWSEV--------SEEVKMLIRNLLKTEPTQRMTITEFMN 271

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 1e-41
 Identities = 61/307 (19%), Positives = 110/307 (35%), Gaps = 40/307 (13%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVN 191
            +   + +G+G FG VFK              TG  VA+K +  +  +       L E+ 
Sbjct: 11  KYEKLAKIGQGTFGEVFKA---------RHRKTGQKVALKKVLMENEKEGFPITALREIK 61

Query: 192 FLGNLLHPNLVKLVGYCIEDDQR--------LLVYEFMPRGSLENHLFRRSLPLPWSIRM 243
            L  L H N+V L+  C               LV++F                   S   
Sbjct: 62  ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-KFTLSEIK 120

Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTHV 301
           ++      GL ++H      +++RD K +N+L+  D   KL+DFGLA+     ++ + + 
Sbjct: 121 RVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 177

Query: 302 STRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRP--------NG 352
            T  + T  Y  PE ++         D++  G ++ EM T    M  N            
Sbjct: 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237

Query: 353 EHNLVEWARPHLGDKRRFYRLLDPR------LEGHFSIKGSQKATQLAAQCLSRDPKARP 406
             ++     P++ +   + +L   +       +   +      A  L  + L  DP  R 
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297

Query: 407 RMSEVVE 413
              + + 
Sbjct: 298 DSDDALN 304

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 9e-41
 Identities = 60/294 (20%), Positives = 101/294 (34%), Gaps = 28/294 (9%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 191
            +     +GEG +G VFK              T   VA+K +  D          L E+ 
Sbjct: 3   KYEKLEKIGEGTYGTVFKA---------KNRETHEIVALKRVRLDDDDEGVPSSALREIC 53

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 251
            L  L H N+V+L      D +  LV+EF  +   +             I         K
Sbjct: 54  LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLK 112

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL F H    + V++RD K  N+L++ +   KL++FGLA+      + + S  V+  +  
Sbjct: 113 GLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYR 168

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN-----------GEHNLVEWA 360
                      ++  D++S G +  E+    R +                 G     +W 
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228

Query: 361 R-PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
               L D + +          +   K +     L    L  +P  R    E ++
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 2e-39
 Identities = 69/323 (21%), Positives = 117/323 (36%), Gaps = 42/323 (13%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNF 192
           +R    +G G +G V            V   TG  VA+K L          K    E+  
Sbjct: 20  YRDLQPVGSGAYGAVCSA---------VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL 70

Query: 193 LGNLLHPNLVKLVGYCIEDDQR------LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 246
           L ++ H N++ L+     D+         LV  FM  G+    L +    L       + 
Sbjct: 71  LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE-KLGEDRIQFLV 127

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
               KGL ++H      +I+RD K  N+ ++ D   K+ DFGLA+ A       ++  V+
Sbjct: 128 YQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTGYVV 180

Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV--------- 357
             +  A    +     T   D++S G ++ EM+TG+     +    +   +         
Sbjct: 181 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 240

Query: 358 EWARPHLGDKRRFYRLLDPRLEG----HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
           E+ +    D+ + Y    P LE           S  A  L  + L  D + R    E + 
Sbjct: 241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300

Query: 414 T--LKPLQNLKDMASSSYYFQTM 434
               + L + +D      Y  + 
Sbjct: 301 HPYFESLHDTEDEPQVQKYDDSF 323

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  140 bits (354), Expect = 3e-38
 Identities = 70/316 (22%), Positives = 110/316 (34%), Gaps = 48/316 (15%)

Query: 103 SASSTPKFSEELKVASQL---RKFMFNDLKLATRN------FRPESLLGEGGFGCVFKGW 153
           +A++  K SE+  V   L   ++      +  ++N      F     LG G FG V    
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV- 60

Query: 154 VEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGNLLHPNLVKLVGYCIE 210
                       +G   A+K L+   +   K+    L E   L  +  P LVKL     +
Sbjct: 61  --------KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112

Query: 211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFK 270
           +    +V E++  G + +HL R             A        +LH      +IYRD K
Sbjct: 113 NSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLK 168

Query: 271 TSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYS 330
             N+L+D     +++DFG AK       T     + GT    APE +++       D ++
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYNKAVDWWA 223

Query: 331 FGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKA 390
            GV++ EM  G        P      ++     +  K RF                S   
Sbjct: 224 LGVLIYEMAAGY------PPFFADQPIQIYEKIVSGKVRFPSHF------------SSDL 265

Query: 391 TQLAAQCLSRDPKARP 406
             L    L  D   R 
Sbjct: 266 KDLLRNLLQVDLTKRF 281

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 2e-36
 Identities = 73/289 (25%), Positives = 114/289 (39%), Gaps = 32/289 (11%)

Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----QGHK 184
           K+   NF    +LG G +G VF               TG   A+K L    +    +  +
Sbjct: 20  KVGIENFELLKVLGTGAYGKVFLVRKISG------HDTGKLYAMKVLKKATIVQKAKTTE 73

Query: 185 EWLAEVNFLGNLLH-PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM 243
               E   L ++   P LV L      + +  L+ +++  G L  HL +R          
Sbjct: 74  HTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQ 132

Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
                    L  LH+     +IYRD K  NILLD++ +  L+DFGL+K+   D +T  + 
Sbjct: 133 IYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD-ETERAY 188

Query: 304 RVMGTYGYAAPEYVMTGH--LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 361
              GT  Y AP+ V  G        D +S GV++ E+LTG           +++  E +R
Sbjct: 189 DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT--VDGEKNSQAEISR 246

Query: 362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 410
             L  +  + + +            S  A  L  + L +DPK R     
Sbjct: 247 RILKSEPPYPQEM------------SALAKDLIQRLLMKDPKKRLGCGP 283

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  129 bits (326), Expect = 2e-34
 Identities = 53/305 (17%), Positives = 101/305 (33%), Gaps = 47/305 (15%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           +++    LG G +  VF+          +       V VK L        K+   E+  L
Sbjct: 36  DYQLVRKLGRGKYSEVFEA---------INITNNEKVVVKILKPVK---KKKIKREIKIL 83

Query: 194 GNL-LHPNLVKLVGYCIEDDQRL--LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 250
            NL   PN++ L     +   R   LV+E +     +         L             
Sbjct: 84  ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEIL 139

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           K L + H      +++RD K  N+++D +    +L D+GLA+      +       + + 
Sbjct: 140 KALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASR 193

Query: 310 GYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE--------------- 353
            +  PE ++         D++S G +L  M+  +        N +               
Sbjct: 194 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253

Query: 354 -----HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM 408
                +N+    R +    R   +  +  +        S +A     + L  D ++R   
Sbjct: 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 313

Query: 409 SEVVE 413
            E +E
Sbjct: 314 REAME 318

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 7e-33
 Identities = 59/313 (18%), Positives = 111/313 (35%), Gaps = 51/313 (16%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEV 190
           + ++    +G G  G V   +                VA+K L+         K    E+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAY---------DAVLDRNVAIKKLSRPFQNQTHAKRAYREL 67

Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
             +  + H N++ L+          E     LV E M     +                 
Sbjct: 68  VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSY 123

Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           +      G+  LH      +I+RD K SNI++ +D   K+ DFGLA+     G + + T 
Sbjct: 124 LLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTP 177

Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR----------------RSMDKN 348
            + T  Y APE ++        D++S G ++ EM+  +                  +   
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237

Query: 349 RPNGEHNLVEWARPHLGDKRRFYRLLDPRL--------EGHFSIKGSQKATQLAAQCLSR 400
            P     L    R ++ ++ ++  L  P+L        +   +   + +A  L ++ L  
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297

Query: 401 DPKARPRMSEVVE 413
           DP  R  + + ++
Sbjct: 298 DPAKRISVDDALQ 310

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 5e-32
 Identities = 63/300 (21%), Positives = 114/300 (38%), Gaps = 38/300 (12%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAE 189
              ++  S +G G +G V   +            TGL VAVK L+         K    E
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAF---------DTKTGLRVAVKKLSRPFQSIIHAKRTYRE 67

Query: 190 VNFLGNLLHPNLVKLVGYC-----IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 244
           +  L ++ H N++ L+        +E+   + +   +    L N +  +   L       
Sbjct: 68  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQF 125

Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           +     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR
Sbjct: 126 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 182

Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN----------RPNGEH 354
               +  A    +   H     D++S G ++ E+LTGR                R  G  
Sbjct: 183 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 238

Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFS---IKGSQKATQLAAQCLSRDPKARPRMSEV 411
                 +      R + + L    + +F+   I  +  A  L  + L  D   R   ++ 
Sbjct: 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  111 bits (277), Expect = 1e-27
 Identities = 54/325 (16%), Positives = 100/325 (30%), Gaps = 58/325 (17%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 194
           +     LG G F  V+      N T          VA+K +  D +   +    E+  L 
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNT---------HVAMKIVRGDKVY-TEAAEDEIKLLQ 64

Query: 195 NLLHPNLVKLVGYCIEDDQRLLVY---------------EFMPRGSLENHLFRRSLPLPW 239
            +   +  K          +LL +               E +    L          +P 
Sbjct: 65  RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPL 124

Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDAPEDGK 298
               +I+     GL ++H      +I+ D K  N+L++  D    L    +A        
Sbjct: 125 IYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 182

Query: 299 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR--------------- 343
               T  + T  Y +PE ++       +D++S   ++ E++TG                 
Sbjct: 183 DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242

Query: 344 --------------SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGH-FSIKGSQ 388
                          + +N                  K +F+ L D   E + FS   ++
Sbjct: 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAK 302

Query: 389 KATQLAAQCLSRDPKARPRMSEVVE 413
           + +   +  L  DP+ R     +V 
Sbjct: 303 EISDFLSPMLQLDPRKRADAGGLVN 327

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 74.4 bits (182), Expect = 4e-16
 Identities = 24/158 (15%), Positives = 50/158 (31%), Gaps = 16/158 (10%)

Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH 198
            L+GEG    VF  + E+ G   VK       + K +      G   +            
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 199 PNLVKLVGYCIED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 254
             L KL G  +      +   ++ E +    L                 ++     + +A
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV--------RVENPDEVLDMILEEVA 117

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD 292
             +    + +++ D    N+L+  +    + DF  + +
Sbjct: 118 KFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE 151

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	490
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.73
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.04
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.98
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.35
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.13
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.8

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-57  Score=442.09  Aligned_cols=263  Identities=28%  Similarity=0.445  Sum_probs=208.5

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhccCCCCeeceeeE
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~  207 (490)
                      +..++|++.+.||+|+||+||+|++..            .||||+++...  ....+.|.+|+.+|++++|||||+++++
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~~~------------~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~   72 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKWHG------------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY   72 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEESSS------------EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEECC------------EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEE
Confidence            445789999999999999999997642            59999997543  3445789999999999999999999998


Q ss_pred             EEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecc
Q 011250          208 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DF  287 (490)
                      +. ++.++||||||++|+|.+++......+++..+..|+.||+.||+|||+++   ||||||||+||||+.++.+||+||
T Consensus        73 ~~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DF  148 (276)
T d1uwha_          73 ST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDF  148 (276)
T ss_dssp             EC-SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCC
T ss_pred             Ee-ccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccc
Confidence            75 45789999999999999999777778999999999999999999999988   999999999999999999999999


Q ss_pred             cCcccCCCCCcceeeeccccCCCccCcchhcc---CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc
Q 011250          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~---~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      |+|+...............||+.|||||++.+   ..|+.++|||||||+||||+||+.||.........  ....... 
T Consensus       149 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~--~~~~~~~-  225 (276)
T d1uwha_         149 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI--IFMVGRG-  225 (276)
T ss_dssp             CCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH--HHHHHHT-
T ss_pred             cceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH--HHHHhcC-
Confidence            99987755444344456789999999999864   35899999999999999999999999764322111  1111100 


Q ss_pred             CCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                              ...+.+ ...+..++.++.+||.+||+.||.+|||+.+|+++|+.+.+
T Consensus       226 --------~~~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         226 --------YLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             --------SCCCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------CCCCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                    001111 12233457899999999999999999999999999987753

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-57  Score=440.57  Aligned_cols=254  Identities=26%  Similarity=0.351  Sum_probs=208.4

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      ++|++.+.||+|+||+||+|++..         +|+.||||++..... ...+.+.+|+.+|+.++|||||++++++.++
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~   75 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRV---------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG   75 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             cceEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC
Confidence            479999999999999999999876         677999999976543 2345689999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      +..|||||||++|+|.++|.. ...+++..++.++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+
T Consensus        76 ~~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~  151 (271)
T d1nvra_          76 NIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLAT  151 (271)
T ss_dssp             TEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             ceeEEEEeccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhhe
Confidence            999999999999999999854 457999999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhccCCC-CccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ..............+||+.|||||++.+..+ +.++|||||||+||||++|+.||......... .......        
T Consensus       152 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~~~~~--------  222 (271)
T d1nvra_         152 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEK--------  222 (271)
T ss_dssp             ECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHHHHTT--------
T ss_pred             eeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HHHHhcC--------
Confidence            7754444444456789999999999988775 57899999999999999999999754332211 1111100        


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                            ..........+.++.+||.+||+.||.+|||++|++++
T Consensus       223 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         223 ------KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             ------CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ------CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                  00001112336889999999999999999999999864

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-56  Score=440.15  Aligned_cols=251  Identities=25%  Similarity=0.362  Sum_probs=212.3

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      ++|++.+.||+|+||+||+|++..         +|+.||||++........+.+.+|+.+|+.++|||||++++++.+++
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~---------~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   90 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVA---------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD   90 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTT---------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             cccEEEEEEecCcCcEEEEEEECC---------CCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC
Confidence            479999999999999999999876         67799999998766566778999999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      .+|||||||+||+|.+++.+.  .+++..+..|+.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+.
T Consensus        91 ~~~ivmEy~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~  165 (293)
T d1yhwa1          91 ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ  165 (293)
T ss_dssp             EEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEEEecCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhhee
Confidence            999999999999999987553  6999999999999999999999988   99999999999999999999999999987


Q ss_pred             CCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhh
Q 011250          293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR  372 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (490)
                      ......  .....+||+.|||||++.+..|+.++|||||||+||||++|+.||........  +.......         
T Consensus       166 ~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~~~~~~---------  232 (293)
T d1yhwa1         166 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLIATNG---------  232 (293)
T ss_dssp             CCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHHC---------
T ss_pred             eccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH--HHHHHhCC---------
Confidence            754332  22456899999999999999999999999999999999999999965432111  10000000         


Q ss_pred             ccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       373 ~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                        .  .....+...+.++.+||.+||+.||.+|||+.|+++|
T Consensus       233 --~--~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         233 --T--PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             --S--CCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             --C--CCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              0  0111223447889999999999999999999999865

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-57  Score=434.76  Aligned_cols=247  Identities=27%  Similarity=0.420  Sum_probs=209.4

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|++.+.||+|+||+||+|++..         +++.||||++....   ....+.+.+|+.+|+.++|||||++++++.
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~   76 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH   76 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECC---------CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE
Confidence            469999999999999999999876         67799999986432   233567889999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +++..|||||||++|+|.+++.+. ..+++..+..|+.||+.||+|||+++   ||||||||+||||+.++.+||+|||+
T Consensus        77 ~~~~~~ivmEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~  152 (263)
T d2j4za1          77 DATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGW  152 (263)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCS
T ss_pred             ECCEEEEEEeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccce
Confidence            999999999999999999999654 47999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      |+......    ....+||+.|||||++.+..|+.++|||||||+||||++|+.||.......   +.....        
T Consensus       153 a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~~i~--------  217 (263)
T d2j4za1         153 SVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---TYKRIS--------  217 (263)
T ss_dssp             CSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHH--------
T ss_pred             eeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH---HHHHHH--------
Confidence            98765432    234689999999999999999999999999999999999999997543211   111100        


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                           ..  ...++...+.++.+||.+||+.||.+|||++|+++|
T Consensus       218 -----~~--~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         218 -----RV--EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             -----TT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             -----cC--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence                 00  111233347889999999999999999999999874

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-56  Score=438.75  Aligned_cols=253  Identities=26%  Similarity=0.400  Sum_probs=211.9

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      +.|++++.||+|+||+||+|++..         ++..||||++........+.+.+|+++|+.|+|||||++++++.+++
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~   82 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKE---------TSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN   82 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECC---------CCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence            468999999999999999999876         67799999998776666678999999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      ..+||||||++|+|.+++.+....+++..+..++.||+.||.|||+++   ||||||||+||||+.++.+||+|||+|+.
T Consensus        83 ~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~  159 (288)
T d2jfla1          83 NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAK  159 (288)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             eEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhc
Confidence            999999999999999998777778999999999999999999999988   99999999999999999999999999976


Q ss_pred             CCCCCcceeeeccccCCCccCcchhc-----cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011250          293 APEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      ....  .......+||+.|||||++.     ...|+.++|||||||+||||++|+.||..........  ......    
T Consensus       160 ~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~--~i~~~~----  231 (288)
T d2jfla1         160 NTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL--KIAKSE----  231 (288)
T ss_dssp             CHHH--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH--HHHHSC----
T ss_pred             cCCC--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH--HHHcCC----
Confidence            5321  11223468999999999984     4568999999999999999999999997653322111  111000    


Q ss_pred             chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                             .+  ....+...+.++.+||.+||+.||.+|||+.|+++|
T Consensus       232 -------~~--~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         232 -------PP--TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             -------CC--CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             -------CC--CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                   00  111223447899999999999999999999999875

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.3e-56  Score=437.15  Aligned_cols=263  Identities=25%  Similarity=0.386  Sum_probs=218.8

Q ss_pred             HHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       129 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      ++..++|++.+.||+|+||+||+|++..         ++..||||+++.+. ...+++.+|+.+|+.|+|||||+++++|
T Consensus        13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~   82 (287)
T d1opja_          13 EMERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVC   82 (287)
T ss_dssp             BCCGGGEEEEEETTTTTTSSEEEEEEGG---------GTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             EecHHHeEEeeEEeeCCCeEEEEEEECC---------CCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccE
Confidence            3445679999999999999999999976         57789999997654 3467899999999999999999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DF  287 (490)
                      .+++..+||||||++|+|.+++... ...+++..++.|+.||+.||+|||+++   ||||||||+||||+.++.+||+||
T Consensus        83 ~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DF  159 (287)
T d1opja_          83 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADF  159 (287)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCC
T ss_pred             eeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccc
Confidence            9999999999999999999998653 457999999999999999999999988   999999999999999999999999


Q ss_pred             cCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011250          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      |+|+....... .......||+.|||||++.+..|+.++|||||||+||||++|..||.....  ...+.+..       
T Consensus       160 G~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~~~~~~i-------  229 (287)
T d1opja_         160 GLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELL-------  229 (287)
T ss_dssp             CCTTTCCSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHHHH-------
T ss_pred             cceeecCCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--HHHHHHHH-------
Confidence            99987654432 233445689999999999999999999999999999999997776643221  11111111       


Q ss_pred             chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccc
Q 011250          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~~  421 (490)
                             .......++..++.++.+||.+||+.||.+|||+++|++.|+.+.+.
T Consensus       230 -------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         230 -------EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             -------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             -------hcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence                   11112233445578999999999999999999999999999877543

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-56  Score=430.30  Aligned_cols=255  Identities=28%  Similarity=0.438  Sum_probs=203.0

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      ++|++.+.||+|+||+||+|.+.          ++..||||+++... ...++|.+|+++++.++|||||++++++.+++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~   73 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA   73 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET----------TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC----------CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCC
Confidence            57899999999999999999875          34579999998654 34578999999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      ..+||||||++|+|.+++......+++..++.|+.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.
T Consensus        74 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~  150 (263)
T d1sm2a_          74 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF  150 (263)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC----
T ss_pred             ceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchhee
Confidence            999999999999999999777778999999999999999999999988   99999999999999999999999999987


Q ss_pred             CCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhC-CCCCCCCCCCCcchhhHhhhcccCCcchhh
Q 011250          293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG-RRSMDKNRPNGEHNLVEWARPHLGDKRRFY  371 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (490)
                      ....... ......||+.|||||++.+..|+.++|||||||+||||+|+ .+||....   ...+.......        
T Consensus       151 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~---~~~~~~~i~~~--------  218 (263)
T d1sm2a_         151 VLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVEDISTG--------  218 (263)
T ss_dssp             ---------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC---HHHHHHHHHHT--------
T ss_pred             ccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC---HHHHHHHHHhc--------
Confidence            6543322 22346799999999999999999999999999999999995 55554321   11111111110        


Q ss_pred             hccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011250          372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       372 ~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~  419 (490)
                            .....+..++.++.+||.+||+.||.+|||+++|+++|+++.
T Consensus       219 ------~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         219 ------FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             ------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence                  111222344788999999999999999999999999998764

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-56  Score=431.29  Aligned_cols=254  Identities=24%  Similarity=0.363  Sum_probs=197.8

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ++|++.+.||+|+||+||+|++..         +|+.||||++......  ..+.+.+|+++|++++|||||++++++.+
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~   74 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKS---------DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID   74 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC
T ss_pred             hhCEEeEEEecCCCeEEEEEEECC---------CCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe
Confidence            579999999999999999999876         6779999999766432  34568899999999999999999999875


Q ss_pred             --CCceEEEEEecCCCChhHHhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeeecCCCCCcEEEcCCCCeE
Q 011250          211 --DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEA--EKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       211 --~~~~~lV~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~--~~~iiHrDlkp~NILl~~~~~vk  283 (490)
                        ++.+|||||||++|+|.+++.+   ....+++..++.++.||+.||+|||+.+  ..+||||||||+||||+.++.+|
T Consensus        75 ~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vk  154 (269)
T d2java1          75 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK  154 (269)
T ss_dssp             ----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEE
T ss_pred             CCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEE
Confidence              4568999999999999999864   3457999999999999999999999865  23499999999999999999999


Q ss_pred             EecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011250          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      |+|||+|+.......  .....+||+.|||||++.+..|+.++|||||||+||||++|+.||......   .+...... 
T Consensus       155 l~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~~~~i~~-  228 (269)
T d2java1         155 LGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGKIRE-  228 (269)
T ss_dssp             ECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHH-
T ss_pred             EeeccceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HHHHHHHc-
Confidence            999999988754322  234578999999999999999999999999999999999999999754221   11111110 


Q ss_pred             cCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                                  ... ..++...+.++.+||.+||+.||.+|||+.||++|
T Consensus       229 ------------~~~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         229 ------------GKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             ------------TCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ------------CCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                        000 11223447889999999999999999999999865

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.7e-56  Score=435.21  Aligned_cols=260  Identities=26%  Similarity=0.445  Sum_probs=204.3

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      .+|++.++||+|+||+||+|++..++.      ....||||.+..... ...++|.+|+.+|++|+|||||++++++.++
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~   99 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGK------REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS   99 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCC------EEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence            468889999999999999999875432      334699999876533 3456799999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      +..+||||||++|+|.+++......+++..++.|+.||+.||.|||+.+   ||||||||+||||+.++.+||+|||+|+
T Consensus       100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~  176 (299)
T d1jpaa_         100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSR  176 (299)
T ss_dssp             SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccce
Confidence            9999999999999999998777778999999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCccee---eeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCc
Q 011250          292 DAPEDGKTHV---STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       292 ~~~~~~~~~~---~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      ..........   .....||+.|||||++.++.|+.++|||||||+||||+| |+.||......   .+......     
T Consensus       177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~~~i~~-----  248 (299)
T d1jpaa_         177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVINAIEQ-----  248 (299)
T ss_dssp             -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHT-----
T ss_pred             EccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHHHHHHc-----
Confidence            7654322211   122468999999999999999999999999999999998 89999754321   11111111     


Q ss_pred             chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                               ......+..++.++.+||.+||+.||.+|||+.+|++.|+++
T Consensus       249 ---------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         249 ---------DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             ---------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ---------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                     011123345578999999999999999999999999999875

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-56  Score=443.28  Aligned_cols=267  Identities=25%  Similarity=0.382  Sum_probs=208.6

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ..++|++++.||+|+||+||+|++..         +|..||+|+++.... ...+.+.+|+.+|+.++|||||+++++|.
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~   74 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKP---------SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY   74 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETT---------TTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            45689999999999999999999876         678999999976533 33467899999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      +++.+|||||||+||+|.+++.+.+ .+++..+..++.||+.||.|||+ ++   ||||||||+||||+.++.+||+|||
T Consensus        75 ~~~~~~iVmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFG  150 (322)
T d1s9ja_          75 SDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFG  150 (322)
T ss_dssp             CSSEEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCC
T ss_pred             ECCEEEEEEEcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCC
Confidence            9999999999999999999996654 69999999999999999999997 47   9999999999999999999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHh-hhcccC--
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW-ARPHLG--  365 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~-~~~~~~--  365 (490)
                      +|+.....    .....+||+.|||||++.+..|+.++|||||||+||||++|+.||.............. ......  
T Consensus       151 la~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  226 (322)
T d1s9ja_         151 VSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET  226 (322)
T ss_dssp             CCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------
T ss_pred             CccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccC
Confidence            99865322    22346899999999999999999999999999999999999999976432211000000 000000  


Q ss_pred             ----------------C---cchhhh----ccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          366 ----------------D---KRRFYR----LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 ----------------~---~~~~~~----~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                                      .   ......    ..............+.++.+||.+||+.||.+|||++|+|+|
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         227 PPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             -------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                            0   000000    000000000011236789999999999999999999999985

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-56  Score=437.08  Aligned_cols=251  Identities=23%  Similarity=0.302  Sum_probs=207.2

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|++++.||+|+||+||+|++..         +|+.||||++....   ....+.+.+|+++|++++|||||++++++.
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~   78 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELA---------TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ   78 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE
Confidence            469999999999999999999876         67799999997532   233467899999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +++.+|||||||+||+|.+++... ..+++..++.++.||+.||+|||+.+   ||||||||+||||++++.+||+|||+
T Consensus        79 ~~~~~~ivmEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~  154 (288)
T d1uu3a_          79 DDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGT  154 (288)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             ECCEEEEEEEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEeccccc
Confidence            999999999999999999988655 47999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      |+..............+||+.|||||++.+..|+.++|||||||+||||++|+.||......   .+....   ...   
T Consensus       155 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~i---~~~---  225 (288)
T d1uu3a_         155 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY---LIFQKI---IKL---  225 (288)
T ss_dssp             CEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---HTT---
T ss_pred             ceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH---HHHHHH---HcC---
Confidence            98876544443445578999999999999999999999999999999999999999754221   111110   000   


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                               ...++...+.++.+||.+||+.||.+|||++|++++
T Consensus       226 ---------~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         226 ---------EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             ---------CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence                     011233447889999999999999999999998654

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-54  Score=418.42  Aligned_cols=254  Identities=23%  Similarity=0.383  Sum_probs=215.4

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      ++|++.+.||+|+||+||+|+++          ++..||||+++.... ..++|.+|+.++++++|||||++++++.+++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~   72 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR   72 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET----------TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSS
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC----------CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Confidence            58999999999999999999985          456899999987654 4578999999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                      .+++||||+++|+|..++......+++..++.|+.||++||+|||+.+   |+||||||+||||+.++.+||+|||+++.
T Consensus        73 ~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~  149 (258)
T d1k2pa_          73 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRY  149 (258)
T ss_dssp             SEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCB
T ss_pred             ceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhhee
Confidence            999999999999999998777778999999999999999999999988   99999999999999999999999999987


Q ss_pred             CCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcchhh
Q 011250          293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  371 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (490)
                      ....... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||......   .+......         
T Consensus       150 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~~~~i~~---------  216 (258)
T d1k2pa_         150 VLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAEHIAQ---------  216 (258)
T ss_dssp             CSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHHHHHT---------
T ss_pred             ccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HHHHHHHh---------
Confidence            6543222 2334679999999999999999999999999999999998 89999765322   11111111         


Q ss_pred             hccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       372 ~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                           ......+..++.++.+||.+||+.||.+|||+++|+++|..+
T Consensus       217 -----~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         217 -----GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             -----TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             -----CCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence                 011122334478899999999999999999999999998653

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-55  Score=435.54  Aligned_cols=263  Identities=25%  Similarity=0.402  Sum_probs=214.1

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcc-CCCCeeceeeEE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGYC  208 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~  208 (490)
                      ..++|++.++||+|+||+||+|++...+.    .+....||+|.+.... ......+.+|+.+|.++ +|||||++++++
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~  110 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISK----TGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC  110 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSS----SSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCc----ccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence            34579999999999999999999875321    1234579999986543 23345789999999998 899999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcC----------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRS----------------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIY  266 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~----------------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH  266 (490)
                      .+.+..+||||||++|+|.++|....                      ..+++..++.|+.||+.||+|||+++   |||
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiH  187 (325)
T d1rjba_         111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVH  187 (325)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred             eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence            99999999999999999999996542                      24889999999999999999999988   999


Q ss_pred             cCCCCCcEEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCC
Q 011250          267 RDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSM  345 (490)
Q Consensus       267 rDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf  345 (490)
                      |||||+|||++.++.+||+|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |+.||
T Consensus       188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf  267 (325)
T d1rjba_         188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  267 (325)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence            99999999999999999999999987765544444456789999999999999999999999999999999998 89999


Q ss_pred             CCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011250          346 DKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~  416 (490)
                      ........  +.....              .......+..++.++.+||.+||+.||++|||++||+++|.
T Consensus       268 ~~~~~~~~--~~~~~~--------------~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         268 PGIPVDAN--FYKLIQ--------------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             TTCCCSHH--HHHHHH--------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCHHHH--HHHHHh--------------cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            75433211  111111              11112234455789999999999999999999999999985

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.9e-55  Score=438.92  Aligned_cols=253  Identities=23%  Similarity=0.324  Sum_probs=213.4

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      ++|++.+.||+|+||+||+|++..         +|..||||++........+.+.+|+.+|+.|+|||||++++++.+++
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~---------~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   96 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERA---------TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN   96 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT
T ss_pred             cCeEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            479999999999999999999876         67899999998776666678899999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc--CCCCeEEecccCc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD--ADYNAKLSDFGLA  290 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~--~~~~vkL~DFG~a  290 (490)
                      .+|||||||+||+|.+++.+....+++..+..|+.||+.||.|||+++   ||||||||+||||+  .++.+||+|||+|
T Consensus        97 ~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a  173 (350)
T d1koaa2          97 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLT  173 (350)
T ss_dssp             EEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchh
Confidence            999999999999999999766668999999999999999999999988   99999999999995  4678999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      +.......   ....+||+.|||||++.+..|+.++|||||||++|||++|+.||......   .+.......       
T Consensus       174 ~~~~~~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i~~~-------  240 (350)
T d1koaa2         174 AHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETLRNVKSC-------  240 (350)
T ss_dssp             EECCTTSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHT-------
T ss_pred             eecccccc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHHhC-------
Confidence            88754322   23468999999999999999999999999999999999999999754221   111111000       


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                          +..+........+.++.+||.+||+.||.+|||++|+++|
T Consensus       241 ----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         241 ----DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             ----CCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             ----CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                0001111112347889999999999999999999999987

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-55  Score=425.09  Aligned_cols=259  Identities=25%  Similarity=0.392  Sum_probs=211.9

Q ss_pred             hcCCCCCcc-cccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          132 TRNFRPESL-LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~~-LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      .++|.+.+. ||+|+||+||+|.++..+       ++..||||+++.... ...++|.+|+++|++++|||||++++++.
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~-------~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~   79 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRK-------KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ   79 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCC-------CcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeec
Confidence            346777775 999999999999886432       456899999976543 34577999999999999999999999986


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      + +.+|||||||++|+|.+++......+++..++.|+.||+.||+|||+++   ||||||||+||||+.++.+||+|||+
T Consensus        80 ~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGl  155 (285)
T d1u59a_          80 A-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGL  155 (285)
T ss_dssp             S-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTT
T ss_pred             c-CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchh
Confidence            5 5689999999999999998776678999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcc-eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCc
Q 011250          290 AKDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       290 a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      ++........ .......||+.|||||++.++.++.++|||||||+||||+| |+.||......   .+......     
T Consensus       156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~~i~~-----  227 (285)
T d1u59a_         156 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIEQ-----  227 (285)
T ss_dssp             CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHHHHT-----
T ss_pred             hhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHHHHHc-----
Confidence            9877544322 22234678999999999999999999999999999999998 99999764322   11111111     


Q ss_pred             chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                               .....++..++.++.+||.+||+.||++|||+.+|++.|+.+
T Consensus       228 ---------~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         228 ---------GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             ---------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                     001123345578999999999999999999999999998754

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=7.2e-55  Score=438.07  Aligned_cols=253  Identities=22%  Similarity=0.311  Sum_probs=214.2

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeCC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  212 (490)
                      ++|++++.||+|+||+||+|++..         +|..||||++........+.+.+|+.+|+.|+|||||+++++|.+++
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   99 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKA---------TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY   99 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred             cceEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            469999999999999999999876         67799999998776566677889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc--CCCCeEEecccCc
Q 011250          213 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD--ADYNAKLSDFGLA  290 (490)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~--~~~~vkL~DFG~a  290 (490)
                      .+|||||||+||+|.+++......+++..++.|+.||+.||.|||+++   ||||||||+||||+  .++.+||+|||+|
T Consensus       100 ~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla  176 (352)
T d1koba_         100 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLA  176 (352)
T ss_dssp             EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred             EEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccc
Confidence            999999999999999988777778999999999999999999999988   99999999999997  6789999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      +.......   ....+||+.|||||++.+..|+.++|||||||+||||++|+.||.......   +......        
T Consensus       177 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~~~i~~--------  242 (352)
T d1koba_         177 TKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TLQNVKR--------  242 (352)
T ss_dssp             EECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHHH--------
T ss_pred             eecCCCCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHh--------
Confidence            98755322   234679999999999999999999999999999999999999997543211   1111100        


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                         .+..+........+.++.+||.+||+.||.+|||+.|+++|
T Consensus       243 ---~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         243 ---CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             ---CCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ---CCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               00111112223347889999999999999999999999986

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-54  Score=420.66  Aligned_cols=249  Identities=25%  Similarity=0.391  Sum_probs=200.6

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhccCCCCeeceeeEEEe--
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE--  210 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--  210 (490)
                      |++.+.||+|+||+||+|++..         ++..||+|++....  ....+.+.+|+++|++++|||||++++++.+  
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~---------~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   81 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV   81 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred             EEeeeEEecCcCcEEEEEEECC---------CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc
Confidence            4677889999999999999876         67789999987543  2334678999999999999999999999875  


Q ss_pred             --CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-CCCCeEEecc
Q 011250          211 --DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD-ADYNAKLSDF  287 (490)
Q Consensus       211 --~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~-~~~~vkL~DF  287 (490)
                        +..+|||||||++|+|.+++.+. ..+++..++.|+.||+.||+|||+++ .+||||||||+||||+ +++.+||+||
T Consensus        82 ~~~~~~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DF  159 (270)
T d1t4ha_          82 KGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDL  159 (270)
T ss_dssp             SSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred             ccCCEEEEEEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeec
Confidence              34579999999999999999654 47999999999999999999999876 5599999999999996 5789999999


Q ss_pred             cCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011250          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      |+|+.....    .....+||+.|||||++.+ .|+.++|||||||+||||++|+.||......  ..+.......    
T Consensus       160 Gla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~--~~~~~~i~~~----  228 (270)
T d1t4ha_         160 GLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRVTSG----  228 (270)
T ss_dssp             TGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHHHTTT----
T ss_pred             CcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH--HHHHHHHHcC----
Confidence            999865332    1234689999999998864 6999999999999999999999999643211  1111111100    


Q ss_pred             chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                               .....++...++++.+||.+||+.||++|||++|+++|
T Consensus       229 ---------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         229 ---------VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             ---------CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ---------CCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence                     00011122236789999999999999999999999875

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-55  Score=424.87  Aligned_cols=258  Identities=27%  Similarity=0.418  Sum_probs=209.1

Q ss_pred             HHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       129 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      .+..++|++.+.||+|+||.||+|.+.          ++..||||+++... ...+.|.+|+.+|++++|||||++++++
T Consensus         9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~   77 (272)
T d1qpca_           9 EVPRETLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV   77 (272)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ecCHHHeEEeEEEecCCCcEEEEEEEC----------CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeee
Confidence            344567999999999999999999875          35689999997654 3457899999999999999999999987


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DF  287 (490)
                      .+ +..+||||||++|+|.+++... ...+++..++.|+.||+.||.|||+.+   |+||||||+||||++++.+||+||
T Consensus        78 ~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DF  153 (272)
T d1qpca_          78 TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADF  153 (272)
T ss_dssp             CS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred             cc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccc
Confidence            54 5679999999999999977543 236999999999999999999999988   999999999999999999999999


Q ss_pred             cCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011250          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      |+|+...... ........||+.|||||++.++.++.++|||||||+||||+||..|+.....  ...+......     
T Consensus       154 Gla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~~~i~~-----  225 (272)
T d1qpca_         154 GLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQNLER-----  225 (272)
T ss_dssp             TTCEECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHT-----
T ss_pred             cceEEccCCc-cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--HHHHHHHHHh-----
Confidence            9999875432 2233456799999999999999999999999999999999996655432211  1111111110     


Q ss_pred             chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                               ......+..++.++.+||.+||+.||++|||+++|++.|+.+
T Consensus       226 ---------~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         226 ---------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             ---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------cCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence                     011112234578899999999999999999999999998864

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.1e-55  Score=430.82  Aligned_cols=253  Identities=22%  Similarity=0.333  Sum_probs=194.3

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .+.|++.+.||+|+||+||+|++..         +++.||||++...... ..+.+.+|+.+|+.|+|||||++++++.+
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~   78 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKR---------TQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES   78 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETT---------TCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECC---------CCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            4569999999999999999999876         6779999999765433 23567899999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc---CCCCeEEecc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD---ADYNAKLSDF  287 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~---~~~~vkL~DF  287 (490)
                      ++.+|||||||+||+|.++|... ..+++..+..++.||+.||+|||+.+   ||||||||+|||+.   +++.+||+||
T Consensus        79 ~~~~~lvmE~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DF  154 (307)
T d1a06a_          79 GGHLYLIMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDF  154 (307)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC
T ss_pred             CCEEEEEEeccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEecc
Confidence            99999999999999999999654 57999999999999999999999988   99999999999994   5789999999


Q ss_pred             cCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011250          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      |+|+......   .....+||+.|||||++.+..|+.++|||||||+||||++|+.||......   .+....   ....
T Consensus       155 G~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~i---~~~~  225 (307)
T d1a06a_         155 GLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KLFEQI---LKAE  225 (307)
T ss_dssp             ---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHH---HTTC
T ss_pred             ceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHH---hccC
Confidence            9998764432   223468999999999999999999999999999999999999999753221   111111   0000


Q ss_pred             chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                              ..+........+.++.+||.+||+.||.+|||++|+++|
T Consensus       226 --------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         226 --------YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             --------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             --------CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                    011112223447889999999999999999999999986

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-54  Score=421.42  Aligned_cols=264  Identities=25%  Similarity=0.413  Sum_probs=207.1

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      ..|++.++||+|+||.||+|.++..+..     ....||||++...... ...+|.+|+.+|++++|||||+++|++.+.
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~   81 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGK-----KEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY   81 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---C-----CEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCE-----EEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence            4688899999999999999998753211     2357999999765333 345789999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      +..++|||||.+|+|.+++......+++..++.++.||+.||+|||+.+   ||||||||+||||+.++.+||+|||+++
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~  158 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSR  158 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhh
Confidence            9999999999999999988877778999999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCcc-eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          292 DAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       292 ~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ........ .......||+.|||||++.++.++.++|||||||+||||++|..||......  ..+....          
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~~~i----------  226 (283)
T d1mqba_         159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKAI----------  226 (283)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHH----------
T ss_pred             cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHHHHH----------
Confidence            76543222 2223457899999999999999999999999999999999976665432211  1111111          


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                          ........+..++..+.+||.+||+.||++|||+.+|++.|+.+..
T Consensus       227 ----~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         227 ----NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             ----HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ----hccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence                1111223344557889999999999999999999999999987643

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-54  Score=427.71  Aligned_cols=246  Identities=28%  Similarity=0.401  Sum_probs=203.9

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      .|++++.||+|+||+||+|++..         ++..||||++......   ..+.+.+|+.+|+.|+|||||++++++.+
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~   86 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR   86 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECC---------CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE
Confidence            48999999999999999999876         6789999999765433   23568899999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      ++..|||||||.+|+|..++.. ...+++..++.|+.||+.||.|||+++   ||||||||+||||+.++.+||+|||+|
T Consensus        87 ~~~~~iv~E~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a  162 (309)
T d1u5ra_          87 EHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA  162 (309)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTC
T ss_pred             CCEEEEEEEecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccc
Confidence            9999999999999998766543 457999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhcc---CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~---~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      +.....      ...+||+.|||||++.+   +.|+.++|||||||+||||++|+.||........  +......     
T Consensus       163 ~~~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~--~~~i~~~-----  229 (309)
T d1u5ra_         163 SIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQN-----  229 (309)
T ss_dssp             BSSSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHS-----
T ss_pred             cccCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHhC-----
Confidence            875432      34679999999999864   4689999999999999999999999965422111  0000000     


Q ss_pred             chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                            ..+.   ..+...+.++.+||.+||+.||.+|||++|+++|
T Consensus       230 ------~~~~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         230 ------ESPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             ------CCCC---CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             ------CCCC---CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence                  0000   1112347889999999999999999999999875

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-54  Score=417.41  Aligned_cols=250  Identities=28%  Similarity=0.398  Sum_probs=201.7

Q ss_pred             cccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEeCCceEE
Q 011250          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLL  216 (490)
Q Consensus       139 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  216 (490)
                      +.||+|+||+||+|.+...+       +++.||||+++....  ...+++.+|+.+|++++|||||++++++.. +..+|
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~l   84 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKK-------VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML   84 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSS-------SEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEE
T ss_pred             CCcccCCCeEEEEEEEccCC-------cCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEE
Confidence            46999999999999876432       467899999975432  234679999999999999999999999865 56789


Q ss_pred             EEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCCC
Q 011250          217 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  296 (490)
Q Consensus       217 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~  296 (490)
                      |||||++|+|.+++... ..+++..++.|+.||+.||+|||+.+   ||||||||+||||+.++.+||+|||+++.....
T Consensus        85 vmE~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~  160 (277)
T d1xbba_          85 VMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  160 (277)
T ss_dssp             EEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             EEEcCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccc
Confidence            99999999999998654 57999999999999999999999988   999999999999999999999999999876544


Q ss_pred             Ccc-eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcchhhhcc
Q 011250          297 GKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  374 (490)
Q Consensus       297 ~~~-~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (490)
                      ... .......||+.|||||++.+..++.++|||||||++|||++ |+.||......   .+......            
T Consensus       161 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~~~~i~~------------  225 (277)
T d1xbba_         161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAMLEK------------  225 (277)
T ss_dssp             CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHHT------------
T ss_pred             ccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HHHHHHHc------------
Confidence            332 22234679999999999999999999999999999999998 89999754321   11111111            


Q ss_pred             CCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011250          375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  417 (490)
Q Consensus       375 ~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~  417 (490)
                        .....++..++.++.+||.+||+.||.+|||+++|++.|+.
T Consensus       226 --~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         226 --GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             --TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             --CCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence              01112334457899999999999999999999999988864

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-54  Score=428.92  Aligned_cols=249  Identities=31%  Similarity=0.391  Sum_probs=210.7

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|++++.||+|+||.||+|++..         +|+.||||++++..   ....+.+.+|+.+|+.++|||||++++++.
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~---------~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~   75 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKA---------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ   75 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec
Confidence            579999999999999999999876         67899999997542   234567889999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +++.+|||||||+||+|.+++.+. ..+++..++.++.||+.||+|||+++   ||||||||+||||+.+|.+||+|||+
T Consensus        76 ~~~~~~iv~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~  151 (337)
T d1o6la_          76 THDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGL  151 (337)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             cccccccceeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccc
Confidence            999999999999999999998655 47999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      |+.......  .....+||+.|||||++.+..|+.++|||||||+||||++|++||......   .+.....   ..   
T Consensus       152 a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~---~~~~~i~---~~---  220 (337)
T d1o6la_         152 CKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFELIL---ME---  220 (337)
T ss_dssp             CBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH---HC---
T ss_pred             ccccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH---HHHHHHh---cC---
Confidence            987654322  234578999999999999999999999999999999999999999764321   1111110   00   


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt-----~~evl~~  414 (490)
                               ...++...+.++.+||.+||+.||.+|++     +.++++|
T Consensus       221 ---------~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         221 ---------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             ---------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ---------CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence                     01223344788999999999999999994     8888875

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-53  Score=418.65  Aligned_cols=253  Identities=23%  Similarity=0.328  Sum_probs=209.1

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc------ccHHHHHHHHHHHhccCCCCeecee
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL------QGHKEWLAEVNFLGNLLHPNLVKLV  205 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~  205 (490)
                      .++|++++.||+|+||+||+|++..         +|+.||||++.+...      ...+.+.+|+.+|+.|+|||||+++
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~---------~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~   79 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKS---------TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH   79 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECC---------CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence            3579999999999999999999876         677999999975432      2357799999999999999999999


Q ss_pred             eEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC----C
Q 011250          206 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY----N  281 (490)
Q Consensus       206 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~----~  281 (490)
                      +++.+++.+|||||||++|+|.++|... ..+++..++.++.||+.||+|||+.+   ||||||||+|||++.++    .
T Consensus        80 ~~~~~~~~~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~  155 (293)
T d1jksa_          80 EVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPR  155 (293)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCC
T ss_pred             EEEEECCEEEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccc
Confidence            9999999999999999999999998655 47999999999999999999999988   99999999999998776    5


Q ss_pred             eEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011250          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       282 vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~  361 (490)
                      +||+|||+|........   .....||+.|+|||++.+..++.++|||||||+||||++|+.||.......   ......
T Consensus       156 vkl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~i~  229 (293)
T d1jksa_         156 IKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANVS  229 (293)
T ss_dssp             EEECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH
T ss_pred             eEecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH---HHHHHH
Confidence            99999999987754322   234679999999999999999999999999999999999999997543211   111110


Q ss_pred             cccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .   ...        .....+....+.++.+||.+||+.||.+|||++|+++|
T Consensus       230 ~---~~~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         230 A---VNY--------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             T---TCC--------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             h---cCC--------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0   000        00001112236789999999999999999999999875

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-54  Score=418.87  Aligned_cols=261  Identities=25%  Similarity=0.377  Sum_probs=204.4

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ..++|++.+.||+|+||+||+|++...+.      .+..||||.++..... ..+.+.+|+.+|+.++|||||++++++.
T Consensus         5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~   78 (273)
T d1mp8a_           5 QRERIELGRCIGEGQFGDVHQGIYMSPEN------PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT   78 (273)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CHHHeEEEEEEeeCCCcEEEEEEEecCCc------eeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            34579999999999999999999875432      4567999998755333 3467899999999999999999999985


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                       ++..|||||||++|+|.+++......+++..++.++.||+.||.|||+.+   ||||||||+|||++.++.+||+|||+
T Consensus        79 -~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~  154 (273)
T d1mp8a_          79 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL  154 (273)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---
T ss_pred             -cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchh
Confidence             56789999999999999998777778999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      |+....... .......||+.|+|||++.+..|+.++|||||||+||||++ |.+||.......   +.......     
T Consensus       155 a~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~i~~~-----  225 (273)
T d1mp8a_         155 SRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIENG-----  225 (273)
T ss_dssp             -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHHTT-----
T ss_pred             heeccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHHHHcC-----
Confidence            987654322 22345678999999999999999999999999999999998 899997654322   11111110     


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~  419 (490)
                               ....++..++.++.+||.+||+.||.+|||+.+|+++|+.+.
T Consensus       226 ---------~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         226 ---------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                     011233445789999999999999999999999999998764

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-53  Score=423.07  Aligned_cols=261  Identities=23%  Similarity=0.386  Sum_probs=209.8

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC-CcccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      .+|+++++||+|+||+||+|.+..++..     ....||+|.++.. .....+++.+|+.+|++++|||||+++++|.++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~   83 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS   83 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC---------CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCE-----EEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            4699999999999999999998764321     2346999998654 334567899999999999999999999999865


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                       ..++||||+.+|+|.+++......+++..++.|+.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+
T Consensus        84 -~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~  159 (317)
T d1xkka_          84 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK  159 (317)
T ss_dssp             -SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred             -CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccce
Confidence             568889999999999999888888999999999999999999999988   9999999999999999999999999999


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ...............||+.|||||++.++.|+.++|||||||+||||+| |.+||........   ......        
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~---~~~i~~--------  228 (317)
T d1xkka_         160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SSILEK--------  228 (317)
T ss_dssp             HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH---HHHHHH--------
T ss_pred             ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH---HHHHHc--------
Confidence            8765444444445679999999999999999999999999999999998 7888875432221   111110        


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~  419 (490)
                            ......+..++.++.+||.+||+.||.+|||+.+|+++|..+.
T Consensus       229 ------~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         229 ------GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             ------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence                  0111223345788999999999999999999999999987654

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.9e-53  Score=421.77  Aligned_cols=246  Identities=28%  Similarity=0.400  Sum_probs=208.0

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|++++.||+|+||+||+|++..         +|+.||||+++...   ....+.+.+|+.+|+.++|||||++++++.
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~---------~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~   74 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRH---------NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ   74 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECC---------CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe
Confidence            469999999999999999999876         67799999997542   234567899999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +++.+|+|||||+||+|..++... ..+++..+..++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+
T Consensus        75 ~~~~~~ivmE~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~  150 (316)
T d1fota_          75 DAQQIFMIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGF  150 (316)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             eCCeeeeEeeecCCcccccccccc-ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCcc
Confidence            999999999999999999888544 57899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      |+.....     ....+||+.|||||++.+..|+.++|||||||+||||++|+.||.......   +...   ..     
T Consensus       151 a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~---i~-----  214 (316)
T d1fota_         151 AKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK---TYEK---IL-----  214 (316)
T ss_dssp             CEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHH---HH-----
T ss_pred             ceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH---HHHH---HH-----
Confidence            9886543     234689999999999999999999999999999999999999997542211   1110   00     


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----t~~evl~~  414 (490)
                           ..  ...++...+.++.+||.+||..||.+|+     |++++++|
T Consensus       215 -----~~--~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         215 -----NA--ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             -----HC--CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -----cC--CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence                 00  0122233478899999999999999996     89999876

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1e-52  Score=409.29  Aligned_cols=262  Identities=25%  Similarity=0.351  Sum_probs=205.2

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      .++|++.+.||+|+||+||+|++..         +|+.||||+++.....   ..+.+.+|+++|+.++|||||++++++
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~   76 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLR---------LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG   76 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECC---------CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCccccee
Confidence            3579999999999999999999876         6789999999765433   335689999999999999999999999


Q ss_pred             EeCC----ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 011250          209 IEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       209 ~~~~----~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL  284 (490)
                      ...+    ..|||||||+||+|.+++... ..+++..++.|+.||+.||.|||+.+   ||||||||+||||+.++.++|
T Consensus        77 ~~~~~~~~~~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l  152 (277)
T d1o6ya_          77 EAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKV  152 (277)
T ss_dssp             EEECSSSEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEE
T ss_pred             eeccCCCceEEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCcccccee
Confidence            8754    378999999999999988655 47999999999999999999999988   999999999999999999999


Q ss_pred             ecccCcccCCCCCc-ceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011250          285 SDFGLAKDAPEDGK-THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       285 ~DFG~a~~~~~~~~-~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      +|||++........ .......+||+.|||||++.+..|+.++|||||||+||||+||++||.......      .....
T Consensus       153 ~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~~  226 (277)
T d1o6ya_         153 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQH  226 (277)
T ss_dssp             CCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHH
T ss_pred             ehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH------HHHHH
Confidence            99999876543222 222345789999999999999999999999999999999999999997543211      11111


Q ss_pred             cCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCC-CHHHHHHHhhcCcc
Q 011250          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-RMSEVVETLKPLQN  420 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-t~~evl~~L~~l~~  420 (490)
                      +......        ........+.++.+||.+||+.||.+|| |++++++.|..+.+
T Consensus       227 ~~~~~~~--------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n  276 (277)
T d1o6ya_         227 VREDPIP--------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  276 (277)
T ss_dssp             HHCCCCC--------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred             HhcCCCC--------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence            1111100        1111123378899999999999999999 89999988876643

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.6e-53  Score=417.46  Aligned_cols=268  Identities=25%  Similarity=0.374  Sum_probs=216.3

Q ss_pred             HHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhccCCCCeeceee
Q 011250          128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVG  206 (490)
Q Consensus       128 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~  206 (490)
                      ++...++|++.+.||+|+||+||+|++....    ...++..||||+++..... ..+++.+|+.+|+.++||||+++++
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~----~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~   83 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLL----PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLG   83 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSS----TTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCc----cCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCccccee
Confidence            3345678999999999999999999986421    1125678999999765433 3467999999999999999999999


Q ss_pred             EEEeCCceEEEEEecCCCChhHHhhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 011250          207 YCIEDDQRLLVYEFMPRGSLENHLFRRS-----------------------LPLPWSIRMKIALGAAKGLAFLHEEAEKP  263 (490)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~  263 (490)
                      ++.+.+..++||||+++|+|.+++....                       ..+++..++.|+.||+.||+|||+.+   
T Consensus        84 ~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---  160 (301)
T d1lufa_          84 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---  160 (301)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             eeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---
Confidence            9999999999999999999999986432                       24889999999999999999999988   


Q ss_pred             eeecCCCCCcEEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCC-
Q 011250          264 VIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR-  342 (490)
Q Consensus       264 iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~-  342 (490)
                      ||||||||+||||+.++.+||+|||+|+..............+||+.|+|||++.+..|+.++|||||||+||||++|. 
T Consensus       161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~  240 (301)
T d1lufa_         161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL  240 (301)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCC
Confidence            9999999999999999999999999998765444444445578999999999999999999999999999999999996 


Q ss_pred             CCCCCCCCCCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011250          343 RSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       343 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~  419 (490)
                      +||......   .+.......             . ....+..++.++.+||.+||+.||.+||||.||++.|+++.
T Consensus       241 ~p~~~~~~~---e~~~~v~~~-------------~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         241 QPYYGMAHE---EVIYYVRDG-------------N-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             CTTTTSCHH---HHHHHHHTT-------------C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCCCCHH---HHHHHHHcC-------------C-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            567543221   111111100             0 01123345788999999999999999999999999998764

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-53  Score=417.81  Aligned_cols=253  Identities=18%  Similarity=0.246  Sum_probs=209.9

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      .++|++++.||+|+||+||+|++..         ++..||||+++.... ....+.+|+++|+.++|||||++++++.++
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~---------~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   73 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETS---------SKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESM   73 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred             ccceEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            4579999999999999999999876         678999999987643 345688999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC--CCeEEecccC
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD--YNAKLSDFGL  289 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~--~~vkL~DFG~  289 (490)
                      +.+|||||||+||+|.++|......+++..++.|+.||+.||+|||+.+   |+||||||+||||+.+  ..+||+|||+
T Consensus        74 ~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~  150 (321)
T d1tkia_          74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQ  150 (321)
T ss_dssp             TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccch
Confidence            9999999999999999999777668999999999999999999999988   9999999999999854  5899999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      ++.......   ....+||+.|+|||.+.+..|+.++|||||||+||+|++|..||.......   +....   ......
T Consensus       151 ~~~~~~~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~---~~~~i---~~~~~~  221 (321)
T d1tkia_         151 ARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---IIENI---MNAEYT  221 (321)
T ss_dssp             CEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHH---HHTCCC
T ss_pred             hhccccCCc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH---HHHHH---HhCCCC
Confidence            987654322   234679999999999999999999999999999999999999997643211   11111   000000


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      +...        .....+.++.+||.+||..||.+|||+.|+++|
T Consensus       222 ~~~~--------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         222 FDEE--------AFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             CCHH--------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CChh--------hccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000        001236789999999999999999999999985

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-53  Score=416.68  Aligned_cols=267  Identities=27%  Similarity=0.364  Sum_probs=204.9

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcc-CCCCeeceeeE
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKLVGY  207 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~  207 (490)
                      +..++|++.+.||+|+||.||+|++...+.    ..+++.||||+++.... ...+.+.+|+.++.++ +|+|||.++++
T Consensus        10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~----~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1          10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDK----TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEESTTS----SSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccHHHEEEeeEEeecCCeEEEEEEEcCCCc----ccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            344679999999999999999999865322    22567899999976533 3346688888888877 58999999998


Q ss_pred             EEeC-CceEEEEEecCCCChhHHhhhc---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 011250          208 CIED-DQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKT  271 (490)
Q Consensus       208 ~~~~-~~~~lV~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp  271 (490)
                      +.+. ..+++|||||++|+|.++|...               ...+++..++.++.||+.||.|||+++   ||||||||
T Consensus        86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp  162 (299)
T d1ywna1          86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA  162 (299)
T ss_dssp             ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred             eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCc
Confidence            8765 4689999999999999999643               235899999999999999999999988   99999999


Q ss_pred             CcEEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCC-CCCCCCCC
Q 011250          272 SNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR-RSMDKNRP  350 (490)
Q Consensus       272 ~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~-~pf~~~~~  350 (490)
                      +||||+.++.+||+|||+|+..............+||+.|||||++.+..++.++|||||||++|||++|. +||.....
T Consensus       163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~  242 (299)
T d1ywna1         163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  242 (299)
T ss_dssp             GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred             cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999998765544444444578999999999999999999999999999999999975 56754432


Q ss_pred             CCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011250          351 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~  419 (490)
                      ..  .+.......              .....+..++.++.+||.+||+.||.+|||+.||+++|+.+.
T Consensus       243 ~~--~~~~~~~~~--------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         243 DE--EFCRRLKEG--------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             SH--HHHHHHHHT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HH--HHHHHHhcC--------------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            21  111111100              011223344788999999999999999999999999998763

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-53  Score=411.79  Aligned_cols=260  Identities=26%  Similarity=0.403  Sum_probs=203.4

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|++.+.||+|+||+||+|++....      +....||||+++...   ....++|.+|+.+|+.++|||||++++++.
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~------~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~   81 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL   81 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTT------SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCC------CcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            57999999999999999999886532      134579999987653   233467999999999999999999999996


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      + ...++|||||++|+|.+++......+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+
T Consensus        82 ~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl  157 (273)
T d1u46a_          82 T-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGL  157 (273)
T ss_dssp             S-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             e-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchh
Confidence            5 5778999999999999998877778999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcce-eeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCc
Q 011250          290 AKDAPEDGKTH-VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       290 a~~~~~~~~~~-~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      ++......... ......||..|+|||++.+..++.++|||||||++|||+| |+.||......   .......      
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~---~~~~~i~------  228 (273)
T d1u46a_         158 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILHKID------  228 (273)
T ss_dssp             CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHH------
T ss_pred             hhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH---HHHHHHH------
Confidence            99875543332 2334568899999999999999999999999999999998 89999654222   1111111      


Q ss_pred             chhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                             ........+...+..+.+||.+||..||.+|||+.+|++.|++.
T Consensus       229 -------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         229 -------KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             -------TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------hCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                   01111122234478899999999999999999999999999865

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-53  Score=411.80  Aligned_cols=256  Identities=27%  Similarity=0.393  Sum_probs=203.7

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      .++|++++.||+|+||+||+|++..          +..||||+++... ...+.|.+|+.+|++++|||||++++++. +
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~----------~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~   83 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-E   83 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECC----------CCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-c
Confidence            4579999999999999999998863          3479999997654 44578999999999999999999999985 4


Q ss_pred             CceEEEEEecCCCChhHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      +..+||||||++|+|..++... ...+++..++.|+.||+.||+|||+++   |+||||||+||||+.++++||+|||++
T Consensus        84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla  160 (285)
T d1fmka3          84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLA  160 (285)
T ss_dssp             SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred             CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchh
Confidence            5689999999999999888643 346999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchh
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      +....... .......||+.|+|||++..+.++.++|||||||+||||++|..||......  ..+......        
T Consensus       161 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~i~~--------  229 (285)
T d1fmka3         161 RLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVER--------  229 (285)
T ss_dssp             C---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHT--------
T ss_pred             hhccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHHh--------
Confidence            87654322 2234467999999999999999999999999999999999976665433211  111111110        


Q ss_pred             hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011250          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~  419 (490)
                            ......+..++.++.+||.+||+.||++||++++|++.|+.+.
T Consensus       230 ------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         230 ------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             ------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             ------cCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence                  1111233445789999999999999999999999999998754

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.2e-53  Score=422.87  Aligned_cols=246  Identities=25%  Similarity=0.329  Sum_probs=208.2

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      ++|++++.||+|+||.||+|++..         +|+.||||++....   ....+.+.+|+++|+.++|||||++++++.
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~---------~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~  111 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKE---------SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK  111 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECC---------CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc
Confidence            579999999999999999999876         67799999986532   233467899999999999999999999999


Q ss_pred             eCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          210 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                      +....++||||+.+|+|..++.+.. .+++..++.|+.||+.||.|||+++   ||||||||+||||+.++.+||+|||+
T Consensus       112 ~~~~~~~v~e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~  187 (350)
T d1rdqe_         112 DNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGF  187 (350)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             cccccccccccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeecee
Confidence            9999999999999999999986654 7999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcch
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      |+.....     ....+||+.|||||++.+..|+.++|||||||+||||++|+.||......   .+......   .   
T Consensus       188 a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~i~~---~---  253 (350)
T d1rdqe_         188 AKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---QIYEKIVS---G---  253 (350)
T ss_dssp             CEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHH---C---
T ss_pred             eeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH---HHHHHHhc---C---
Confidence            9876432     23468999999999999999999999999999999999999999754221   11111100   0   


Q ss_pred             hhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011250          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----t~~evl~~  414 (490)
                               ...++...+.++.+||.+||+.||.+|+     |+++|++|
T Consensus       254 ---------~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         254 ---------KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ---------CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence                     0112233478899999999999999994     89999875

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.6e-52  Score=421.45  Aligned_cols=250  Identities=27%  Similarity=0.380  Sum_probs=204.7

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHH---HHHHHHhccCCCCeeceee
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWL---AEVNFLGNLLHPNLVKLVG  206 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~---~Ei~il~~l~HpnIv~l~~  206 (490)
                      ++|++.++||+|+||.||+|++..         +|+.||||++.....   .....+.   .|+.+++.++|||||++++
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~---------t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~   74 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY   74 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECC---------CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEE
Confidence            579999999999999999999876         677999999864322   1222333   4577788888999999999


Q ss_pred             EEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEec
Q 011250          207 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~D  286 (490)
                      ++.+++.+|||||||+||+|.++|.+. ..+++..++.|+.||+.||.|||+.+   ||||||||+||||+.++.+||+|
T Consensus        75 ~~~~~~~~~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~D  150 (364)
T d1omwa3          75 AFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISD  150 (364)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECC
T ss_pred             EEEECCEEEEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEee
Confidence            999999999999999999999999655 47899999999999999999999988   99999999999999999999999


Q ss_pred             ccCcccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011250          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      ||+|+......    ....+||+.|||||++.. ..|+.++|||||||+||||++|+.||..........+...   ...
T Consensus       151 FGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~---~~~  223 (364)
T d1omwa3         151 LGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLT  223 (364)
T ss_dssp             CTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH---SSS
T ss_pred             eceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---ccc
Confidence            99998765432    234689999999999975 5689999999999999999999999976543332222111   111


Q ss_pred             CcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011250          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  414 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt-----~~evl~~  414 (490)
                      .            ...++...+.++.+||.+||+.||.+|||     ++++++|
T Consensus       224 ~------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         224 M------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             C------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             C------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence            0            11122234788999999999999999999     6888876

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=405.44  Aligned_cols=251  Identities=28%  Similarity=0.442  Sum_probs=201.6

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      -++|++++.||+|+||.||+|.+.           |..||||+++.+.  ..+++.+|+.++++++|||||++++++.++
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-----------~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~   72 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE   72 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-----------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC-----------CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEec
Confidence            356889999999999999999873           4589999997653  446799999999999999999999998654


Q ss_pred             -CceEEEEEecCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccC
Q 011250          212 -DQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       212 -~~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~  289 (490)
                       +.++|||||+++|+|.++|.+.. ..+++..++.|+.||+.||.|||+.+   ||||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~  149 (262)
T d1byga_          73 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGL  149 (262)
T ss_dssp             --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred             CCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeeccccc
Confidence             56899999999999999996543 35899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ++.....     .....+|..|+|||++.+..++.++|||||||++|||+| |++||......   .+......      
T Consensus       150 s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i~~------  215 (262)
T d1byga_         150 TKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVEK------  215 (262)
T ss_dssp             -----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHHTT------
T ss_pred             ceecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHc------
Confidence            9875432     223568999999999999999999999999999999998 68777654222   22222111      


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                              .....++...+.++.+||.+||..||.+|||+.+|+++|+.++.
T Consensus       216 --------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         216 --------GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             --------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence                    11122344457899999999999999999999999999987754

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.3e-52  Score=404.38  Aligned_cols=252  Identities=26%  Similarity=0.345  Sum_probs=207.7

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---------cHHHHHHHHHHHhccC-CCCee
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---------GHKEWLAEVNFLGNLL-HPNLV  202 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~Ei~il~~l~-HpnIv  202 (490)
                      ++|++.+.||+|+||+||+|++..         +|+.||||++......         ..+.+.+|+.+|+.|. |||||
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~---------~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv   73 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKP---------TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII   73 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBC
T ss_pred             ccCEEceEEecCcCeEEEEEEECC---------CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeE
Confidence            579999999999999999999876         6779999999765321         1235789999999997 99999


Q ss_pred             ceeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCe
Q 011250          203 KLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       203 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~v  282 (490)
                      ++++++.+++..|||||||++|+|.++|... ..+++..++.++.||+.||+|||+++   ||||||||+||||+.++.+
T Consensus        74 ~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~  149 (277)
T d1phka_          74 QLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNI  149 (277)
T ss_dssp             CEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred             EEEeecccCcceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCe
Confidence            9999999999999999999999999999655 47999999999999999999999988   9999999999999999999


Q ss_pred             EEecccCcccCCCCCcceeeeccccCCCccCcchhcc------CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchh
Q 011250          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT------GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL  356 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~  356 (490)
                      ||+|||+++.......   ....+||+.|+|||++.+      ..++.++||||+||+||||++|+.||........   
T Consensus       150 kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~---  223 (277)
T d1phka_         150 KLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM---  223 (277)
T ss_dssp             EECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---
T ss_pred             EEccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH---
Confidence            9999999988754322   244689999999999863      3578899999999999999999999976432111   


Q ss_pred             hHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ....   +...        ...........++++.+||.+||+.||.+|||+.||++|
T Consensus       224 ~~~i---~~~~--------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         224 LRMI---MSGN--------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             HHHH---HHTC--------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHH---HhCC--------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            1110   0000        001111122447899999999999999999999999875

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-52  Score=410.37  Aligned_cols=268  Identities=26%  Similarity=0.381  Sum_probs=213.5

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcc-CCCCeeceeeEE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKLVGYC  208 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~  208 (490)
                      ..++|++++.||+|+||.||+|++...+..  ...++..||||+++.+.. ....++.+|+.++.++ +|||||+++++|
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~--~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~   88 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKD--KPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC   88 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC------CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcc--cccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence            346799999999999999999987653321  122456899999977643 3346788999999888 799999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN  273 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~N  273 (490)
                      .+++..++|||||++|+|.++|..+.               ..+++..++.++.||+.||+|||+.+   ||||||||+|
T Consensus        89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~N  165 (299)
T d1fgka_          89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN  165 (299)
T ss_dssp             CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred             ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccc
Confidence            99999999999999999999996543               35899999999999999999999988   9999999999


Q ss_pred             EEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCC
Q 011250          274 ILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNG  352 (490)
Q Consensus       274 ILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~~~  352 (490)
                      ||++.++.+||+|||+++...............||+.|+|||++.++.|+.++|||||||+||||++ |.+||...... 
T Consensus       166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~-  244 (299)
T d1fgka_         166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-  244 (299)
T ss_dssp             EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred             eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH-
Confidence            9999999999999999997765544444455789999999999999999999999999999999998 68888654321 


Q ss_pred             cchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          353 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                        .+.....              ......++...+.++.+||.+||+.||.+|||+.||++.|+.+..
T Consensus       245 --~~~~~i~--------------~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         245 --ELFKLLK--------------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             --HHHHHHH--------------TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHHHHHH--------------cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence              1111111              011112233447889999999999999999999999999987643

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=416.17  Aligned_cols=249  Identities=28%  Similarity=0.419  Sum_probs=206.3

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHh-ccCCCCeeceeeEE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLG-NLLHPNLVKLVGYC  208 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~Ei~il~-~l~HpnIv~l~~~~  208 (490)
                      ++|++++.||+|+||+||+|++..         +++.||||++++..   ....+.+..|+.++. .++|||||++++++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~---------t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~   72 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKK---------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF   72 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECC---------CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE
Confidence            479999999999999999999876         67899999997532   233456777777765 68999999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEeccc
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG  288 (490)
                      .+++..|||||||++|+|.+++... ..+++..+..++.||+.||+|||+++   ||||||||+|||++.++.+||+|||
T Consensus        73 ~~~~~~yivmEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG  148 (320)
T d1xjda_          73 QTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFG  148 (320)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             ccCCceeEEEeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccc
Confidence            9999999999999999999998654 47999999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +++.......  .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||......   .+......      
T Consensus       149 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~~~i~~------  217 (320)
T d1xjda_         149 MCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHSIRM------  217 (320)
T ss_dssp             TCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHH------
T ss_pred             hhhhcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHHc------
Confidence            9987644322  234468999999999999999999999999999999999999999754322   11111100      


Q ss_pred             hhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHH-HHHHH
Q 011250          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS-EVVET  414 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~-evl~~  414 (490)
                           ..+    .++...+.++.+||.+||+.||.+||++. ++++|
T Consensus       218 -----~~~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h  255 (320)
T d1xjda_         218 -----DNP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  255 (320)
T ss_dssp             -----CCC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             -----CCC----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence                 011    12233478899999999999999999985 67653

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-52  Score=407.48  Aligned_cols=268  Identities=25%  Similarity=0.350  Sum_probs=202.2

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ++|++++.||+|+||+||+|++..         +|+.||||+++.....  ..+.+.+|+++|+.++|||||++++++.+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~   72 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKL---------TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT   72 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECC---------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc
Confidence            479999999999999999999976         6779999999755322  24678999999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      ++.+|||||||.++.+..........+++..+..++.||+.||+|||+.+   ||||||||+|||++.++.+||+|||+|
T Consensus        73 ~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a  149 (298)
T d1gz8a_          73 ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLA  149 (298)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHH
T ss_pred             ccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcc
Confidence            99999999999654444333445567999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCC-CCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh--hcccCCc
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA--RPHLGDK  367 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~--~~~~~~~  367 (490)
                      +.......  ......||+.|+|||++.... ++.++|||||||++|+|++|+.||...........+...  .+.....
T Consensus       150 ~~~~~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  227 (298)
T d1gz8a_         150 RAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW  227 (298)
T ss_dssp             HHHCCCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             eeccCCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhc
Confidence            87644322  223467999999999877654 578999999999999999999999754321111000000  0000000


Q ss_pred             chhhhccC--Ccc----CC---CCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          368 RRFYRLLD--PRL----EG---HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       368 ~~~~~~~~--~~l----~~---~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .......+  ...    ..   ......+.++.+||.+||..||.+|||+.|+++|
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             TTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            00000000  000    00   0011236789999999999999999999999976

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-52  Score=409.56  Aligned_cols=265  Identities=27%  Similarity=0.408  Sum_probs=216.4

Q ss_pred             hhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcc-CCCCeeceeeEE
Q 011250          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKLVGYC  208 (490)
Q Consensus       131 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~  208 (490)
                      ..++|++.++||+|+||.||+|++...    ....+++.||||+++.... ....++.+|+.++..+ +|||||++++++
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~----~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~   96 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGL----IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEecc----ccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            345789999999999999999998542    1123678999999976543 3445789999999999 699999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhcC-----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRRS-----------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKT  271 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~-----------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp  271 (490)
                      .+.+..+||||||++|+|.+++.+..                 ..+++..+..|+.||+.||+|||+++   ||||||||
T Consensus        97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp  173 (311)
T d1t46a_          97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAA  173 (311)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred             eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccc
Confidence            99999999999999999999986542                 25899999999999999999999988   99999999


Q ss_pred             CcEEEcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHh-CCCCCCCCCC
Q 011250          272 SNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRP  350 (490)
Q Consensus       272 ~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~ellt-G~~pf~~~~~  350 (490)
                      +|||++.++.+||+|||+++..............+||+.|+|||++.++.++.++|||||||+||||+| |.+||.....
T Consensus       174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~  253 (311)
T d1t46a_         174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (311)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999998776555555566789999999999999999999999999999999999 5555544322


Q ss_pred             CCcchhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          351 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                      ...  +.....              .......+...+.++.+||.+||+.||.+|||+++|++.|++.
T Consensus       254 ~~~--~~~~i~--------------~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         254 DSK--FYKMIK--------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             SHH--HHHHHH--------------HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHH--HHHHHh--------------cCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            211  111111              1111122233478899999999999999999999999999754

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-52  Score=413.27  Aligned_cols=252  Identities=22%  Similarity=0.260  Sum_probs=200.6

Q ss_pred             cCCCCCc-ccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcc-CCCCeeceeeEEEe
Q 011250          133 RNFRPES-LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~-~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~  210 (490)
                      ++|.+.. +||+|+||+||+|++..         +++.||||+++..     ..+.+|+.++.++ +|||||+++++|.+
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~   76 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKR---------TQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYEN   76 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECC---------CCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence            5788875 69999999999999876         6779999998643     4577899987655 79999999999876


Q ss_pred             ----CCceEEEEEecCCCChhHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CCCe
Q 011250          211 ----DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNA  282 (490)
Q Consensus       211 ----~~~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~---~~~v  282 (490)
                          +..+|||||||+||+|.++|.+++ ..+++.+++.|+.||+.||+|||+.+   |+||||||+|||++.   ++.+
T Consensus        77 ~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~  153 (335)
T d2ozaa1          77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAIL  153 (335)
T ss_dssp             EETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCE
T ss_pred             cccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccc
Confidence                456899999999999999997653 57999999999999999999999988   999999999999975   5679


Q ss_pred             EEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011250          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      ||+|||+|+.......   ....+||+.|||||++.+..|+.++|||||||+||+|+||+.||.............  ..
T Consensus       154 Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~--~~  228 (335)
T d2ozaa1         154 KLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--TR  228 (335)
T ss_dssp             EECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------C
T ss_pred             cccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH--HH
Confidence            9999999987654322   234689999999999999999999999999999999999999997543322111100  00


Q ss_pred             ccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      .....        ..+........+.++.+||.+||+.||.+|||+.|+++|
T Consensus       229 i~~~~--------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         229 IRMGQ--------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             CCSCS--------SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HhcCC--------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            00000        000011112347889999999999999999999999985

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-51  Score=406.21  Aligned_cols=258  Identities=26%  Similarity=0.430  Sum_probs=206.6

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcc-CCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~  210 (490)
                      ++|++.++||+|+||+||+|++..++.       ...||||.+.... ....+++.+|+++|.++ +|||||++++++.+
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~   82 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGL-------RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH   82 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTE-------EEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCe-------EEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec
Confidence            578999999999999999999976321       2357888876442 23456799999999999 69999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhc---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  275 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NIL  275 (490)
                      ++..+|||||+++|+|.++|...               ...+++..++.++.||+.||.|||+.+   ||||||||+|||
T Consensus        83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL  159 (309)
T d1fvra_          83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNIL  159 (309)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred             CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEE
Confidence            99999999999999999998643               357999999999999999999999988   999999999999


Q ss_pred             EcCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCC-CCCCCCCCCcc
Q 011250          276 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR-SMDKNRPNGEH  354 (490)
Q Consensus       276 l~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~-pf~~~~~~~~~  354 (490)
                      ++.++.+||+|||+++.......   .....||..|+|||.+.++.|+.++|||||||++|||++|.. ||.....   .
T Consensus       160 ~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~---~  233 (309)
T d1fvra_         160 VGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---A  233 (309)
T ss_dssp             ECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---H
T ss_pred             EcCCCceEEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH---H
Confidence            99999999999999986543221   223578999999999999999999999999999999999764 5644321   1


Q ss_pred             hhhHhhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                      .+......              ......+..++.++.+||.+||+.||++|||+.||+++|+.+.+
T Consensus       234 ~~~~~i~~--------------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         234 ELYEKLPQ--------------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             HHHHHGGG--------------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHh--------------cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            11111110              01112334457899999999999999999999999999987654

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-51  Score=405.40  Aligned_cols=263  Identities=25%  Similarity=0.301  Sum_probs=197.6

Q ss_pred             CCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-----HHHHHHHHHHHhccCCCCeeceeeEEEeC
Q 011250          137 PESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-----HKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (490)
Q Consensus       137 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  211 (490)
                      .+++||+|+||+||+|++..         +|+.||||+++......     .+.+.+|+.+|+.++|||||++++++.++
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~   72 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKN---------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK   72 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSS---------CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             cceEeccCcCeEEEEEEECC---------CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC
Confidence            35789999999999999876         67799999997553322     24588999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      +..|||||||.++++..++ .....+++..+..++.||+.||+|||+++   ||||||||+|||++.++.+||+|||+|+
T Consensus        73 ~~~~ivmE~~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~  148 (299)
T d1ua2a_          73 SNISLVFDFMETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK  148 (299)
T ss_dssp             TCCEEEEECCSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             CceeehhhhhcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCcccc
Confidence            9999999999887666554 55567999999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh-h-cc---cC
Q 011250          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-R-PH---LG  365 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~-~-~~---~~  365 (490)
                      ........  ....+||+.|+|||++.. ..|+.++|||||||+||||++|.+||......+....+... . +.   ..
T Consensus       149 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~  226 (299)
T d1ua2a_         149 SFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP  226 (299)
T ss_dssp             TTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred             ccCCCccc--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence            76543322  234689999999998875 46899999999999999999999999754322111111000 0 00   00


Q ss_pred             CcchhhhccCC-ccC----CCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          366 DKRRFYRLLDP-RLE----GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 ~~~~~~~~~~~-~l~----~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ........... ...    .......+.++.+||.+||+.||++|||++|+|+|
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             chhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            00000000000 000    00011236789999999999999999999999865

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-51  Score=404.82  Aligned_cols=258  Identities=26%  Similarity=0.439  Sum_probs=207.5

Q ss_pred             CcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC-CcccHHHHHHHHHHHhccCCCCeeceeeEEEeC-CceE
Q 011250          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED-DQRL  215 (490)
Q Consensus       138 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-~~~~  215 (490)
                      .++||+|+||+||+|++...+.      +...||||+++.. .....++|.+|+++|++++|||||+++|++.+. ...+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~  105 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDG------KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  105 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCC------EEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence            5789999999999999875321      3457999999754 334457899999999999999999999998764 5789


Q ss_pred             EEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCcccCCC
Q 011250          216 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE  295 (490)
Q Consensus       216 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~~~~  295 (490)
                      +|||||++|+|.+++......+++..++.++.|++.||.|||+.+   |+||||||+||||++++.+||+|||+++....
T Consensus       106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~  182 (311)
T d1r0pa_         106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD  182 (311)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred             EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccc
Confidence            999999999999999877778899999999999999999999988   99999999999999999999999999987654


Q ss_pred             CCcc--eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcchhhhc
Q 011250          296 DGKT--HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  373 (490)
Q Consensus       296 ~~~~--~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (490)
                      ....  .......||+.|+|||.+.+..++.++|||||||+||||++|..||.......  ........   ..      
T Consensus       183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i~~---g~------  251 (311)
T d1r0pa_         183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQ---GR------  251 (311)
T ss_dssp             TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHT---TC------
T ss_pred             cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHHHc---CC------
Confidence            3222  12233578999999999999999999999999999999999888876432211  11111111   00      


Q ss_pred             cCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       374 ~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                           ....+..++.++.+||.+||+.||.+||++.||+++|+.+.+
T Consensus       252 -----~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         252 -----RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                 011223347889999999999999999999999999988754

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-51  Score=405.89  Aligned_cols=267  Identities=25%  Similarity=0.405  Sum_probs=215.2

Q ss_pred             HhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhccCCCCeeceeeEE
Q 011250          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (490)
Q Consensus       130 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  208 (490)
                      +..++|.+.+.||+|+||+||+|.+....    ...++..||||+++... ......+.+|+.++++++|||||++++++
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~----~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~   92 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVV----KDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   92 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEE----TTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCcc----cCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence            34467899999999999999999886311    11135689999997653 23345689999999999999999999999


Q ss_pred             EeCCceEEEEEecCCCChhHHhhhc---------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC
Q 011250          209 IEDDQRLLVYEFMPRGSLENHLFRR---------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD  279 (490)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~---------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~  279 (490)
                      ..++..++|||||++|+|.+++...         ...+++..+..++.||+.||.|||+.+   ||||||||+||||+.+
T Consensus        93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~  169 (308)
T d1p4oa_          93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED  169 (308)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTT
T ss_pred             ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCC
Confidence            9999999999999999999988642         135789999999999999999999988   9999999999999999


Q ss_pred             CCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCC-CCCCCCCCCCcchhhH
Q 011250          280 YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR-RSMDKNRPNGEHNLVE  358 (490)
Q Consensus       280 ~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~-~pf~~~~~~~~~~~~~  358 (490)
                      +++||+|||+|+...............||+.|+|||.+.+..++.++|||||||+||||+||. +||......   ....
T Consensus       170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~---~~~~  246 (308)
T d1p4oa_         170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---QVLR  246 (308)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---HHHH
T ss_pred             ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH---HHHH
Confidence            999999999998775544444445567999999999999999999999999999999999985 666543211   1111


Q ss_pred             hhhcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011250          359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~  420 (490)
                      ..             .+.. ....+..++..+.+||.+||+.||.+|||+.+|+++|++...
T Consensus       247 ~i-------------~~~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         247 FV-------------MEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HH-------------HTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HH-------------HhCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            11             1100 111223447889999999999999999999999999986533

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-51  Score=402.68  Aligned_cols=269  Identities=24%  Similarity=0.314  Sum_probs=203.6

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcc---CCCCeeceee
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNL---LHPNLVKLVG  206 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l---~HpnIv~l~~  206 (490)
                      .++|++++.||+|+||+||+|++...        +++.||||+++....  .....+.+|+.+|+.|   +||||+++++
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~--------~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~   77 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKN--------GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD   77 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEE
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECC--------CCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeee
Confidence            46899999999999999999998652        356799999865322  1223466788777766   7999999999


Q ss_pred             EEEe-----CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCC
Q 011250          207 YCIE-----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       207 ~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                      +|..     ....+++||||.++.+..........+++..++.++.||+.||+|||+++   ||||||||+|||++.++.
T Consensus        78 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~  154 (305)
T d1blxa_          78 VCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQ  154 (305)
T ss_dssp             EEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCC
T ss_pred             eecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCC
Confidence            9864     34679999999888776665566678999999999999999999999988   999999999999999999


Q ss_pred             eEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh-
Q 011250          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-  360 (490)
Q Consensus       282 vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~-  360 (490)
                      +||+|||+++.....   ......+||+.|||||++.+..|+.++|||||||+||||++|++||...........+... 
T Consensus       155 ~kl~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~  231 (305)
T d1blxa_         155 IKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI  231 (305)
T ss_dssp             EEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             eeecchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhh
Confidence            999999998865432   2234578999999999999999999999999999999999999999765322111111000 


Q ss_pred             hc----ccCC----cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          361 RP----HLGD----KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       361 ~~----~~~~----~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ..    ....    ...............+....+..+.+||.+||+.||.+|||+.|+|+|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            00    0000    000000000111112233447889999999999999999999999976

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-51  Score=397.22  Aligned_cols=241  Identities=25%  Similarity=0.400  Sum_probs=199.3

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc------cHHHHHHHHHHHhccC--CCCeece
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGNLL--HPNLVKL  204 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~Ei~il~~l~--HpnIv~l  204 (490)
                      ++|++.++||+|+||+||+|++..         +|..||||++......      ....+.+|+.+|+.++  |||||++
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~   74 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVS---------DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL   74 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECC---------CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEE
Confidence            579999999999999999999876         6779999998754221      1234678999999997  8999999


Q ss_pred             eeEEEeCCceEEEEEecCC-CChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-CCe
Q 011250          205 VGYCIEDDQRLLVYEFMPR-GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNA  282 (490)
Q Consensus       205 ~~~~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~-~~v  282 (490)
                      ++++.+++..++||||+.+ ++|.+++... ..+++..++.++.||+.||+|||+.+   ||||||||+||||+.+ +.+
T Consensus        75 ~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~v  150 (273)
T d1xwsa_          75 LDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL  150 (273)
T ss_dssp             EEEEECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEE
T ss_pred             EEEEeeCCeEEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeE
Confidence            9999999999999999976 5777777544 47999999999999999999999988   9999999999999854 799


Q ss_pred             EEecccCcccCCCCCcceeeeccccCCCccCcchhccCCC-CccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011250          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~  361 (490)
                      ||+|||+|+......    .+..+||+.|||||++.+..+ +.++|||||||+||||++|+.||....     ..   ..
T Consensus       151 kl~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i---~~  218 (273)
T d1xwsa_         151 KLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EI---IR  218 (273)
T ss_dssp             EECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH---HH
T ss_pred             EECccccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HH---hh
Confidence            999999998754332    234689999999999987665 677999999999999999999996421     11   00


Q ss_pred             cccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ..                ..++...+.++.+||.+||+.||.+|||++|++++
T Consensus       219 ~~----------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         219 GQ----------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             CC----------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             cc----------------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            00                01122337889999999999999999999999975

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-50  Score=397.95  Aligned_cols=272  Identities=25%  Similarity=0.359  Sum_probs=201.6

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHH--HHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL--AEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~--~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ++|.+.+.||+|+||.||+|++           +|..||||++....   .+.+.  .|+..+..++|||||++++++.+
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-----------~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~   68 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNK   68 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-----------TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-----------CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEe
Confidence            5688889999999999999986           46689999996542   23333  45556667899999999999987


Q ss_pred             CC----ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCCeeecCCCCCcEEEcCCCC
Q 011250          211 DD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA-----EKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       211 ~~----~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-----~~~iiHrDlkp~NILl~~~~~  281 (490)
                      ++    .+|||||||++|+|.++|.+.  .+++..++.++.|++.||.|||+..     .++||||||||+||||+.++.
T Consensus        69 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~  146 (303)
T d1vjya_          69 DNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT  146 (303)
T ss_dssp             ECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC
T ss_pred             CCCcceEEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC
Confidence            64    578999999999999999654  6999999999999999999999741     245999999999999999999


Q ss_pred             eEEecccCcccCCCCCcce--eeeccccCCCccCcchhccCC------CCccchhhHHHHHHHHHHhCCCCCCCCCCCCc
Q 011250          282 AKLSDFGLAKDAPEDGKTH--VSTRVMGTYGYAAPEYVMTGH------LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE  353 (490)
Q Consensus       282 vkL~DFG~a~~~~~~~~~~--~~~~~~Gt~~y~aPE~l~~~~------~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~  353 (490)
                      +||+|||+++.........  .....+||+.|||||++....      ++.++|||||||+||||+||..||........
T Consensus       147 ~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~  226 (303)
T d1vjya_         147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL  226 (303)
T ss_dssp             EEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred             eEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc
Confidence            9999999998765433221  223478999999999987542      57789999999999999999988754322211


Q ss_pred             chhhHhhh--cccCCc--chhhhccCCccCCCC-ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccc
Q 011250          354 HNLVEWAR--PHLGDK--RRFYRLLDPRLEGHF-SIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       354 ~~~~~~~~--~~~~~~--~~~~~~~~~~l~~~~-~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~~~  421 (490)
                      ... ....  ......  ......+.|.+...+ +......+.+|+.+||+.||.+|||+.||++.|+++.+.
T Consensus       227 ~~~-~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         227 PYY-DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             TTT-TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             chh-hcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence            000 0000  000000  000011122222211 223467799999999999999999999999999987654

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5.3e-50  Score=391.77  Aligned_cols=266  Identities=22%  Similarity=0.312  Sum_probs=201.7

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ++|++++.||+|+||+||+|++.          +|+.||||++......  ..+.+.+|+.+|+.++|||||++++++.+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~   71 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT   71 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeC----------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc
Confidence            57999999999999999999875          4678999999765432  24678999999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      ++..+++|||+.++.+..+. .....+++..+..|+.||+.||+|||+.+   ||||||||+||||+.++.+||+|||++
T Consensus        72 ~~~~~i~~e~~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a  147 (286)
T d1ob3a_          72 KKRLVLVFEHLDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLA  147 (286)
T ss_dssp             SSCEEEEEECCSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHH
T ss_pred             CCceeEEEEeehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccc
Confidence            99999999999776555544 55578999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--cccC--
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--PHLG--  365 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~--~~~~--  365 (490)
                      .........  .....|++.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+....  +...  
T Consensus       148 ~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~  225 (286)
T d1ob3a_         148 RAFGIPVRK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW  225 (286)
T ss_dssp             HHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             eecccCccc--cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhc
Confidence            876443221  233578999999999875 467899999999999999999999997543211111100000  0000  


Q ss_pred             -Ccchh------hhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          366 -DKRRF------YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 -~~~~~------~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                       .....      .....+.....+....+..+.+||.+||+.||++|||++|+++|
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             00000      00001111111223346889999999999999999999999865

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-48  Score=388.74  Aligned_cols=269  Identities=22%  Similarity=0.298  Sum_probs=199.8

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      +.+|++++.||+|+||+||+|++..         +|+.||||++..... ...+.+++|+.+|+.|+||||+++++++..
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~   77 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNV---------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA   77 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETT---------TCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECC---------CCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEee
Confidence            3479999999999999999999876         677999999976543 335678999999999999999999999876


Q ss_pred             CC----ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEec
Q 011250          211 DD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       211 ~~----~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~D  286 (490)
                      ..    ..+++|+|+.+|+|.+++...  .+++..++.++.||+.||+|||+++   ||||||||+||||+.++.+||+|
T Consensus        78 ~~~~~~~~~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~D  152 (345)
T d1pmea_          78 PTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICD  152 (345)
T ss_dssp             SSTTTCCCEEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECC
T ss_pred             ccccccceEEEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcc
Confidence            54    234555667799999998654  6999999999999999999999988   99999999999999999999999


Q ss_pred             ccCcccCCCCCcc-eeeeccccCCCccCcchhc-cCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc
Q 011250          287 FGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       287 FG~a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~-~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      ||+++........ ......+||+.|+|||++. ...++.++||||+||++|||++|+.||...................
T Consensus       153 fG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~  232 (345)
T d1pmea_         153 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP  232 (345)
T ss_dssp             CTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred             cCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCC
Confidence            9999876433221 1224467999999999985 4577899999999999999999999997653221111110000000


Q ss_pred             CC----------cchhhhccCCccCC---CCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          365 GD----------KRRFYRLLDPRLEG---HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       365 ~~----------~~~~~~~~~~~l~~---~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ..          ..............   ......+.++.+|+.+||+.||.+|||+.|+|+|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00          00000000000000   0011235689999999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.1e-48  Score=381.54  Aligned_cols=260  Identities=20%  Similarity=0.217  Sum_probs=203.0

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCee-ceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLV-KLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~~~~~~~  211 (490)
                      ++|++.+.||+|+||+||+|++..         +|+.||||++.....  .+++..|+++++.++|+|++ .+.+++.+.
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~---------~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~   75 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIA---------AGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEG   75 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEET
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECC---------CCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecC
Confidence            469999999999999999999876         677999999876532  24578899999999876655 455566777


Q ss_pred             CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc---CCCCeEEeccc
Q 011250          212 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD---ADYNAKLSDFG  288 (490)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~---~~~~vkL~DFG  288 (490)
                      +..++||||+ +++|.+.+......+++..+..++.|++.||+|||+++   ||||||||+|||++   .+..+||+|||
T Consensus        76 ~~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG  151 (299)
T d1ckia_          76 DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFG  151 (299)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCS
T ss_pred             CEEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccC
Confidence            8889999999 67888877777778999999999999999999999988   99999999999985   45679999999


Q ss_pred             CcccCCCCCcc-----eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh-hc
Q 011250          289 LAKDAPEDGKT-----HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-RP  362 (490)
Q Consensus       289 ~a~~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~-~~  362 (490)
                      +|+........     ......+||+.|||||++.+..++.++|||||||++|||++|+.||............... ..
T Consensus       152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~  231 (299)
T d1ckia_         152 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK  231 (299)
T ss_dssp             SCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH
T ss_pred             cceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc
Confidence            99876543221     1223468999999999999999999999999999999999999999765443332222111 10


Q ss_pred             ccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011250          363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l  418 (490)
                      .+...       .+.+    ...++.++.+||.+||+.||.+||+++++.+.|+.+
T Consensus       232 ~~~~~-------~~~~----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         232 KMSTP-------IEVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             HHHSC-------HHHH----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             cCCCC-------hhHh----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            00000       0001    112368899999999999999999999998888765

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-48  Score=389.05  Aligned_cols=268  Identities=24%  Similarity=0.323  Sum_probs=199.9

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      .++|++++.||+|+||+||+|++..         +|+.||||+++....  ...+.+.+|+++|+.++|||||+++++|.
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~   87 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGR---------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT   87 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETT---------TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEec
Confidence            4689999999999999999999876         677999999976432  23467889999999999999999999998


Q ss_pred             eCC------ceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeE
Q 011250          210 EDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       210 ~~~------~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vk  283 (490)
                      ..+      .+||||||| +.+|..++..  ..+++..++.++.||+.||.|||+++   ||||||||+|||++.++.+|
T Consensus        88 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~k  161 (346)
T d1cm8a_          88 PDETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELK  161 (346)
T ss_dssp             SCSSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEE
T ss_pred             cCccccccceEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccc
Confidence            765      469999999 6678776643  36999999999999999999999988   99999999999999999999


Q ss_pred             EecccCcccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011250          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      |+|||+|+.....     .+..+||+.|+|||++.+ ..++.++|||||||+||||++|++||.................
T Consensus       162 l~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~  236 (346)
T d1cm8a_         162 ILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG  236 (346)
T ss_dssp             ECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             cccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccC
Confidence            9999999876443     234679999999999876 4678999999999999999999999976532211111100000


Q ss_pred             c--------cCC--cchhhhccCCcc---CCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH--hhcCc
Q 011250          363 H--------LGD--KRRFYRLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPLQ  419 (490)
Q Consensus       363 ~--------~~~--~~~~~~~~~~~l---~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~--L~~l~  419 (490)
                      .        ...  .......+....   ........+.++.+||.+||..||.+|||+.|+|+|  |+.+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             CCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            0        000  000000000000   001112346789999999999999999999999986  55443

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=392.25  Aligned_cols=262  Identities=25%  Similarity=0.316  Sum_probs=196.6

Q ss_pred             CCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCeeceeeEEEeC--
Q 011250          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED--  211 (490)
Q Consensus       134 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--  211 (490)
                      +|+..++||+|+||+||+|++..         +|+.||||++..+...    +.+|+++|++|+|||||+++++|...  
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~   87 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCD---------SGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGE   87 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred             CcEeeeEEeeCcCeEEEEEEECC---------CCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCc
Confidence            58888999999999999999876         6779999999765322    34799999999999999999998653  


Q ss_pred             ----CceEEEEEecCCCChhHHhh--hcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-CeEE
Q 011250          212 ----DQRLLVYEFMPRGSLENHLF--RRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKL  284 (490)
Q Consensus       212 ----~~~~lV~E~~~~gsL~~~l~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-~vkL  284 (490)
                          ..+|||||||+++.+..+..  .....+++..++.|+.||+.||+|||+++   ||||||||+||||+.++ .+||
T Consensus        88 ~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl  164 (350)
T d1q5ka_          88 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKL  164 (350)
T ss_dssp             CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEE
T ss_pred             cCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeE
Confidence                24789999997654333322  34567999999999999999999999988   99999999999999775 8999


Q ss_pred             ecccCcccCCCCCcceeeeccccCCCccCcchhcc-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh---
Q 011250          285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA---  360 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~---  360 (490)
                      +|||+++.......   ....+||+.|+|||.+.+ ..|+.++|||||||++|||++|++||...........+...   
T Consensus       165 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~  241 (350)
T d1q5ka_         165 CDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT  241 (350)
T ss_dssp             CCCTTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             ecccchhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            99999987654322   234689999999998875 57899999999999999999999999754322111110000   


Q ss_pred             ------hcccCC--cchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          361 ------RPHLGD--KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       361 ------~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                            ......  ...+................+.++.+||.+||..||.+|||+.|+|+|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             CCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  000000  000000000011111223347889999999999999999999999975

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-48  Score=385.52  Aligned_cols=269  Identities=23%  Similarity=0.310  Sum_probs=197.9

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ++|++++.||+|+||+||+|++..         +|+.||||++.....  ...+.+.+|+.+|+.++||||+++++++..
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~   80 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRK---------TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT   80 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCEEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeec
Confidence            579999999999999999999876         677999999865432  234678899999999999999999998865


Q ss_pred             --------CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCe
Q 011250          211 --------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       211 --------~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~v  282 (490)
                              ++..|+|||||.++.+. .+......+++..++.++.||+.||.|||+.+   ||||||||+||||+.++.+
T Consensus        81 ~~~~~~~~~~~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~  156 (318)
T d3blha1          81 KASPYNRCKGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVL  156 (318)
T ss_dssp             ----------CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCE
T ss_pred             ccccccccCceEEEEEeccCCCccc-hhhhcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcE
Confidence                    34679999999776554 44455568999999999999999999999988   9999999999999999999


Q ss_pred             EEecccCcccCCCCCcc--eeeeccccCCCccCcchhccC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 011250          283 KLSDFGLAKDAPEDGKT--HVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW  359 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~  359 (490)
                      ||+|||+++........  ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||...........+..
T Consensus       157 kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~  236 (318)
T d3blha1         157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ  236 (318)
T ss_dssp             EECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             EeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHH
Confidence            99999999876543221  122336799999999998765 689999999999999999999999975432221111111


Q ss_pred             hhcccCCc-------chhhhccCCccCCCCC-------hhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          360 ARPHLGDK-------RRFYRLLDPRLEGHFS-------IKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       360 ~~~~~~~~-------~~~~~~~~~~l~~~~~-------~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ........       ................       ...+..+.+||.+||+.||++|||++|+++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            11000000       0000000000000000       1125677899999999999999999999976

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=7.7e-48  Score=377.69  Aligned_cols=263  Identities=17%  Similarity=0.183  Sum_probs=211.1

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCC-CCeeceeeEEEe
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH-PNLVKLVGYCIE  210 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~  210 (490)
                      .++|++++.||+|+||+||+|++..         +|+.||||++.....  ...+.+|++++..|.| +||+.+++++.+
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~---------~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~   72 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLL---------NNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQE   72 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETT---------TTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeec
Confidence            4689999999999999999999876         677999999865432  2356788999999975 899999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-----CCCeEEe
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-----DYNAKLS  285 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~-----~~~vkL~  285 (490)
                      +...++||||+ +++|.+++......+++..+..++.|++.||+|||+.+   ||||||||+||||+.     ++.+||+
T Consensus        73 ~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~  148 (293)
T d1csna_          73 GLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVV  148 (293)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred             CCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEc
Confidence            99999999999 78999999877778999999999999999999999988   999999999999964     5789999


Q ss_pred             cccCcccCCCCCcc-----eeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011250          286 DFGLAKDAPEDGKT-----HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       286 DFG~a~~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~  360 (490)
                      |||+|+........     ......+||+.|||||++.+..++.++|||||||++|||++|..||...............
T Consensus       149 DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i  228 (293)
T d1csna_         149 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI  228 (293)
T ss_dssp             CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred             ccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHH
Confidence            99999876433211     1223468999999999999999999999999999999999999999765444332222111


Q ss_pred             hcccCCcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011250          361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~L~~l~  419 (490)
                      .... ..... .    .+    ...++.++.+|+..|+..+|++||+++.+.+.|+++.
T Consensus       229 ~~~~-~~~~~-~----~l----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~  277 (293)
T d1csna_         229 GEKK-QSTPL-R----EL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  277 (293)
T ss_dssp             HHHH-HHSCH-H----HH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             Hhcc-CCCCh-H----Hh----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            1000 00000 0    01    1123678999999999999999999999998887653

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=375.75  Aligned_cols=265  Identities=23%  Similarity=0.286  Sum_probs=206.7

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ++|++++.||+|+||+||+|++..         +++.||||+++....  ...+.+.+|+.+|+.++|||||++++++.+
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   72 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS   72 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             CCCEeeeEEecCcCeEEEEEEECC---------CCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc
Confidence            479999999999999999999876         677899999975532  335678999999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecccCc
Q 011250          211 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DFG~a  290 (490)
                      ....++|||++.+++|..++ .....+++..+..++.|++.||+|||+++   ||||||||+||||+.++.+||+|||.+
T Consensus        73 ~~~~~iv~~~~~~~~l~~~~-~~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a  148 (292)
T d1unla_          73 DKKLTLVFEFCDQDLKKYFD-SCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLA  148 (292)
T ss_dssp             SSEEEEEEECCSEEHHHHHH-HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             ccceeEEeeecccccccccc-ccccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchh
Confidence            99999999999988887776 45567999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCcceeeeccccCCCccCcchhccCC-CCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC----
Q 011250          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG----  365 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~----  365 (490)
                      +........  .....+++.|+|||++.... ++.++|||||||++|||++|+.||.......  ...........    
T Consensus       149 ~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~  224 (292)
T d1unla_         149 RAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTE  224 (292)
T ss_dssp             EECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCT
T ss_pred             hcccCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCCCCh
Confidence            877544322  23356789999999887654 6899999999999999999999975432211  11111000000    


Q ss_pred             -Ccchhhhcc---------CCccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          366 -DKRRFYRLL---------DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 -~~~~~~~~~---------~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                       .........         ............+..+.+||.+||+.||.+|||++|||+|
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             000000000         0001111223346789999999999999999999999875

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=6.6e-48  Score=384.20  Aligned_cols=260  Identities=20%  Similarity=0.259  Sum_probs=200.7

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccC-CCCeeceeeEEEeC
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIED  211 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~  211 (490)
                      ++|+++++||+|+||+||+|++..         +|+.||||+++...   .+++.+|+.+|+.+. ||||++++++|...
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~  102 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINIT---------NNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDP  102 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred             cCeEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence            579999999999999999999876         67899999997543   467889999999996 99999999999854


Q ss_pred             --CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-CeEEeccc
Q 011250          212 --DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG  288 (490)
Q Consensus       212 --~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-~vkL~DFG  288 (490)
                        ...++|||||.+++|..+.    ..+++..+..++.||+.||.|||+++   ||||||||+||||+.++ .+||+|||
T Consensus       103 ~~~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG  175 (328)
T d3bqca1         103 VSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWG  175 (328)
T ss_dssp             TTCSEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGG
T ss_pred             CCCceeEEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccc
Confidence              5689999999999997654    36999999999999999999999998   99999999999998655 69999999


Q ss_pred             CcccCCCCCcceeeeccccCCCccCcchhccC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchh--hH-------
Q 011250          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL--VE-------  358 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~--~~-------  358 (490)
                      +|+.......   ....+||+.|+|||.+.+. .++.++|||||||++|||++|+.||...........  ..       
T Consensus       176 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~  252 (328)
T d3bqca1         176 LAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL  252 (328)
T ss_dssp             GCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred             cceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchh
Confidence            9987654322   2346799999999998765 579999999999999999999999975433211100  00       


Q ss_pred             --hhh-cccCCcchhhhccCC--------ccCCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          359 --WAR-PHLGDKRRFYRLLDP--------RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       359 --~~~-~~~~~~~~~~~~~~~--------~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                        +.. ........+......        ..........+.++.+||.+||..||.+|||++|+|+|
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             HHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              000 000000001001000        01111112346789999999999999999999999974

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-48  Score=386.22  Aligned_cols=257  Identities=28%  Similarity=0.367  Sum_probs=206.8

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc----ccHHHHHHHHHHHhccCC-CCeeceeeE
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGNLLH-PNLVKLVGY  207 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~Ei~il~~l~H-pnIv~l~~~  207 (490)
                      ++|++++.||+|+||+||+|++..+.      .+|..||||+++....    ...+.+.+|+++|++++| |||++++++
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~------~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~   97 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGH------DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA   97 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSST------TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccC------CCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeee
Confidence            46999999999999999999885432      2688999999875432    233567899999999976 899999999


Q ss_pred             EEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEEecc
Q 011250          208 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL~DF  287 (490)
                      +.+....++||||+.+|+|.+++.... .+++..+..++.||+.||+|||+.+   ||||||||+||||+.++.+||+||
T Consensus        98 ~~~~~~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DF  173 (322)
T d1vzoa_          98 FQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDF  173 (322)
T ss_dssp             EEETTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCS
T ss_pred             eccCCceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeec
Confidence            999999999999999999999986554 6788999999999999999999988   999999999999999999999999


Q ss_pred             cCcccCCCCCcceeeeccccCCCccCcchhccC--CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011250          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~--~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      |+++....... .......|++.|+|||.+.+.  .++.++|||||||+||||++|+.||...........+....  ..
T Consensus       174 G~a~~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~--~~  250 (322)
T d1vzoa_         174 GLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--LK  250 (322)
T ss_dssp             SEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--HH
T ss_pred             cchhhhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc--cc
Confidence            99987644322 223446899999999998754  46889999999999999999999997664443322211110  00


Q ss_pred             CcchhhhccCCccCCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011250          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  414 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----t~~evl~~  414 (490)
                                  ....++...+.++.+||.+||+.||.+||     |++|+++|
T Consensus       251 ------------~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         251 ------------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             ------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             ------------CCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence                        01112234578999999999999999999     58888864

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-47  Score=381.93  Aligned_cols=263  Identities=22%  Similarity=0.283  Sum_probs=192.2

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEEe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  210 (490)
                      ++|+++++||+|+||+||+|++..         +|..||||++.....  ...+.+.+|+.+|+.++|||||+++++|..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~---------t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~   87 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAV---------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP   87 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETT---------TTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred             CCeEEEEEeecCcCeEEEEEEECC---------CCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEec
Confidence            579999999999999999999876         688999999976532  334568899999999999999999999964


Q ss_pred             C------CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 011250          211 D------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       211 ~------~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL  284 (490)
                      .      ..+|+|||||.++ |.+.+.   ..+++..++.++.||+.||.|||+.|   |+||||||+|||++.++.+||
T Consensus        88 ~~~~~~~~~~~iv~Ey~~~~-l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl  160 (355)
T d2b1pa1          88 QKTLEEFQDVYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI  160 (355)
T ss_dssp             CCSTTTCCEEEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEE
T ss_pred             ccccccCceeEEEEeccchH-HHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceee
Confidence            3      5789999999654 444442   35899999999999999999999998   999999999999999999999


Q ss_pred             ecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhH------
Q 011250          285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE------  358 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~------  358 (490)
                      +|||+++......   ..+..+||+.|+|||++.+..++.++||||+||++|||++|+.||...........+.      
T Consensus       161 ~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~  237 (355)
T d2b1pa1         161 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP  237 (355)
T ss_dssp             CCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             echhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCC
Confidence            9999988765432   2344689999999999999999999999999999999999999997543211100000      


Q ss_pred             ---hh-----------hcc-cCCcchhhhccCCccC---CCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          359 ---WA-----------RPH-LGDKRRFYRLLDPRLE---GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       359 ---~~-----------~~~-~~~~~~~~~~~~~~l~---~~~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                         +.           ... ................   .......+.++.+||++||..||++|||++|||+|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             CHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence               00           000 0000000111110000   01112347889999999999999999999999976

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-47  Score=379.26  Aligned_cols=264  Identities=24%  Similarity=0.338  Sum_probs=198.2

Q ss_pred             hcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhccCCCCeeceeeEEE
Q 011250          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (490)
Q Consensus       132 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  209 (490)
                      .++|++++.||+|+||+||+|++..         +|+.||||++.....  ...+.+.+|+++|+.|+|||||++++++.
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~   87 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT   87 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETT---------TTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            4679999999999999999999876         678999999976532  33457889999999999999999999986


Q ss_pred             eC-----CceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 011250          210 ED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       210 ~~-----~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~vkL  284 (490)
                      ..     ...++||+|+.+|+|.+++..  ..+++..+..++.||+.||+|||+++   ||||||||+|||++.++.+||
T Consensus        88 ~~~~~~~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl  162 (348)
T d2gfsa1          88 PARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI  162 (348)
T ss_dssp             SCSSTTTCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred             eccccccCceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccc
Confidence            43     344677788889999998844  46999999999999999999999988   999999999999999999999


Q ss_pred             ecccCcccCCCCCcceeeeccccCCCccCcchhccC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011250          285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      +|||++......     .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+......
T Consensus       163 ~dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~  237 (348)
T d2gfsa1         163 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT  237 (348)
T ss_dssp             CCC----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cccchhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            999999765332     2346799999999987765 5689999999999999999999999754322111111000000


Q ss_pred             cC--------C--cchhhhccCCccCCC---CChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011250          364 LG--------D--KRRFYRLLDPRLEGH---FSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       364 ~~--------~--~~~~~~~~~~~l~~~---~~~~~~~~l~~Li~~cL~~dP~~RPt~~evl~~  414 (490)
                      ..        .  ...+...+.......   .....+.++.+||.+||..||.+|||+.|+|+|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             CCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence            00        0  000000000000000   001236789999999999999999999999975

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.5e-42  Score=347.88  Aligned_cols=264  Identities=20%  Similarity=0.253  Sum_probs=192.9

Q ss_pred             cCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccC-----------CCCe
Q 011250          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-----------HPNL  201 (490)
Q Consensus       133 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~-----------HpnI  201 (490)
                      .+|+++++||+|+||+||+|++..         +|+.||||+++.+.. ..+.+.+|+.+++.+.           |+||
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~---------~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i   82 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMV---------NNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHI   82 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence            359999999999999999999876         678999999986532 2456788999888875           5789


Q ss_pred             eceeeEEEeC--CceEEEEEecCCCChhHHh--hhcCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEE
Q 011250          202 VKLVGYCIED--DQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNILL  276 (490)
Q Consensus       202 v~l~~~~~~~--~~~~lV~E~~~~gsL~~~l--~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlkp~NILl  276 (490)
                      +++++++...  ...+++|+++..+......  ......+++..+..++.||+.||+|||+ .+   |+||||||+||||
T Consensus        83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll  159 (362)
T d1q8ya_          83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLM  159 (362)
T ss_dssp             CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEE
T ss_pred             EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeee
Confidence            9999988653  4667777776555433332  2344678999999999999999999998 66   9999999999999


Q ss_pred             cCCCC------eEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHHHHHHhCCCCCCCCCC
Q 011250          277 DADYN------AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP  350 (490)
Q Consensus       277 ~~~~~------vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l~elltG~~pf~~~~~  350 (490)
                      +.++.      ++|+|||.+......     ....+||+.|+|||++....|+.++|||||||++++|++|+.||.....
T Consensus       160 ~~~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~  234 (362)
T d1q8ya_         160 EIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG  234 (362)
T ss_dssp             EEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             eccCcccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcc
Confidence            86653      999999999865432     2346799999999999999999999999999999999999999975433


Q ss_pred             CCcchhhHhhh---cccCCc-----------chh------hhccCC----------ccCCCCChhhHHHHHHHHHHhhhc
Q 011250          351 NGEHNLVEWAR---PHLGDK-----------RRF------YRLLDP----------RLEGHFSIKGSQKATQLAAQCLSR  400 (490)
Q Consensus       351 ~~~~~~~~~~~---~~~~~~-----------~~~------~~~~~~----------~l~~~~~~~~~~~l~~Li~~cL~~  400 (490)
                      ...........   ..++..           ..+      ...+..          .....+....+.++.+||.+||..
T Consensus       235 ~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~  314 (362)
T d1q8ya_         235 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL  314 (362)
T ss_dssp             ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred             ccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCC
Confidence            22111100000   000000           000      000000          001123445688999999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 011250          401 DPKARPRMSEVVET  414 (490)
Q Consensus       401 dP~~RPt~~evl~~  414 (490)
                      ||.+|||++|+|+|
T Consensus       315 dP~~Rpta~e~L~H  328 (362)
T d1q8ya_         315 DPRKRADAGGLVNH  328 (362)
T ss_dssp             STTTCBCHHHHHTC
T ss_pred             ChhHCcCHHHHhcC
Confidence            99999999999875

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=6.2e-26  Score=206.85  Aligned_cols=170  Identities=15%  Similarity=0.121  Sum_probs=120.3

Q ss_pred             CCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc------------------cHHHHHHHHHHHhcc
Q 011250          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ------------------GHKEWLAEVNFLGNL  196 (490)
Q Consensus       135 y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------------------~~~~~~~Ei~il~~l  196 (490)
                      +.+.+.||+|+||+||+|++.          +|..||||+++.....                  .......|+..+.++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~----------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l   71 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE----------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL   71 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET----------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred             chhCCEeeeCcceEEEEEECC----------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc
Confidence            346789999999999999874          4678999987532110                  012345688999999


Q ss_pred             CCCCeeceeeEEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE
Q 011250          197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL  276 (490)
Q Consensus       197 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl  276 (490)
                      .|.+++..+++.    ..+|||||+++..+..        ++...+..++.|++.+|+|||+.+   |+||||||+|||+
T Consensus        72 ~~~~v~~~~~~~----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv  136 (191)
T d1zara2          72 QGLAVPKVYAWE----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV  136 (191)
T ss_dssp             TTSSSCCEEEEE----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred             cCCCcceEEEec----CCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheee
Confidence            999999887653    2379999998765533        333446688999999999999988   9999999999999


Q ss_pred             cCCCCeEEecccCcccCCCCCcceeeeccccCCCccCcchhccCCCCccchhhHHHHHH
Q 011250          277 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVL  335 (490)
Q Consensus       277 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGv~l  335 (490)
                      +++ .++|+|||+|+............+.+..    -.+ +....|+.++|+||+.--+
T Consensus       137 ~~~-~~~liDFG~a~~~~~~~~~~~l~rd~~~----~~~-~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         137 SEE-GIWIIDFPQSVEVGEEGWREILERDVRN----IIT-YFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             ETT-EEEECCCTTCEETTSTTHHHHHHHHHHH----HHH-HHHHHHCCCCCHHHHHHHH
T ss_pred             eCC-CEEEEECCCcccCCCCCcHHHHHHHHHH----HHH-HHcCCCCCcccHHHHHHHH
Confidence            865 5999999999876433211100000000    001 1235788999999986544

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.73  E-value=2.6e-08  Score=92.70  Aligned_cols=148  Identities=15%  Similarity=0.002  Sum_probs=99.1

Q ss_pred             HHHhhcCCCCCcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccC-CCCeeceee
Q 011250          128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVG  206 (490)
Q Consensus       128 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~  206 (490)
                      ++..-..|++.+..+.++.+.||+...           .+..++||+...........+.+|..++..|. +--+.+++.
T Consensus         9 l~~~~~~~~~~~~~~G~s~~~v~rv~~-----------~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~   77 (263)
T d1j7la_           9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-----------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLH   77 (263)
T ss_dssp             HHHHHTTSEEEECSCCCSSSEEEEEEC-----------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEE
T ss_pred             HHHhhhceEEEEcCCCCCCCcEEEEEe-----------CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEE
Confidence            344445677777666566678998753           34467889876543333345678888888775 333567788


Q ss_pred             EEEeCCceEEEEEecCCCChhHHhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcC--------------------------
Q 011250          207 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA--------------------------  260 (490)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--------------------------  260 (490)
                      +..+++..++||++++|.++.+.....   .   ....++.++++.|..||+..                          
T Consensus        78 ~~~~~~~~~lv~~~l~G~~~~~~~~~~---~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (263)
T d1j7la_          78 FERHDGWSNLLMSEADGVLCSEEYEDE---Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLA  151 (263)
T ss_dssp             EEEETTEEEEEEECCSSEEHHHHTTTC---S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCS
T ss_pred             EEecCCceEEEEEeccccccccccccc---c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhh
Confidence            888888899999999998876544211   1   12234445555555555421                          


Q ss_pred             ------------------------------CCCeeecCCCCCcEEEcCCCCeEEecccCccc
Q 011250          261 ------------------------------EKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       261 ------------------------------~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~~  292 (490)
                                                    ...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         152 DVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                          11279999999999999776667999997753

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.04  E-value=1.6e-05  Score=72.84  Aligned_cols=74  Identities=20%  Similarity=0.097  Sum_probs=50.6

Q ss_pred             cccCC-ceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCC--CCeeceeeEEEeCCceEEE
Q 011250          141 LGEGG-FGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH--PNLVKLVGYCIEDDQRLLV  217 (490)
Q Consensus       141 LG~G~-fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lV  217 (490)
                      +..|. -+.||+....          .+..+++|........   .+..|+..|+.|..  --+.+++.+..+++..++|
T Consensus        18 ~~~G~s~~~v~r~~~~----------~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v   84 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQ----------GRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL   84 (255)
T ss_dssp             CSCTTSSCEEEEEECT----------TSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred             cCCcccCCeEEEEEeC----------CCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEE
Confidence            34444 3678987653          3456888987654332   45678888877753  2356678888888889999


Q ss_pred             EEecCCCChh
Q 011250          218 YEFMPRGSLE  227 (490)
Q Consensus       218 ~E~~~~gsL~  227 (490)
                      |++++|.++.
T Consensus        85 ~~~i~G~~~~   94 (255)
T d1nd4a_          85 LGEVPGQDLL   94 (255)
T ss_dssp             EECCSSEETT
T ss_pred             EEeeeccccc
Confidence            9999886653

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.98  E-value=1.8e-05  Score=77.83  Aligned_cols=78  Identities=14%  Similarity=0.082  Sum_probs=48.5

Q ss_pred             CcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC------C-cccHHHHHHHHHHHhccC-C--CCeeceeeE
Q 011250          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD------G-LQGHKEWLAEVNFLGNLL-H--PNLVKLVGY  207 (490)
Q Consensus       138 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~------~-~~~~~~~~~Ei~il~~l~-H--pnIv~l~~~  207 (490)
                      .+.||.|....||+.....         .++.|+||.-...      . .....+...|+.+|+.+. +  ..+.+++. 
T Consensus        31 ~~eig~G~~N~vfrV~~~~---------~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~-  100 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQE---------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY-  100 (392)
T ss_dssp             EEECCSSSSEEEEEEEC-------------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE-
T ss_pred             EEEeCCCceEeEEEEEeCC---------CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE-
Confidence            3468999999999987654         4567889964321      1 112234556888887663 2  33455554 


Q ss_pred             EEeCCceEEEEEecCCCCh
Q 011250          208 CIEDDQRLLVYEFMPRGSL  226 (490)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL  226 (490)
                       .+++..++|||++.+..+
T Consensus       101 -~d~~~~~lvmE~L~~~~~  118 (392)
T d2pula1         101 -SDTEMAVTVMEDLSHLKI  118 (392)
T ss_dssp             -EETTTTEEEECCCTTSEE
T ss_pred             -EcCCCCEEEEeccCCccc
Confidence             356677899999976543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.35  E-value=0.00034  Score=68.32  Aligned_cols=81  Identities=17%  Similarity=0.065  Sum_probs=51.9

Q ss_pred             CcccccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccC-CCCeeceeeEEEeCCceEE
Q 011250          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIEDDQRLL  216 (490)
Q Consensus       138 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~l  216 (490)
                      ++.|+.|-.-.+|++.......  +.......|.+++....  .......+|..+++.+. +.-..++++++.+    .+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~--~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~  118 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYP--PIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GR  118 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSC--CSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred             EEEcCCccccceEEEEeCCCCc--cccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence            3568888889999988764321  11123446777776532  22345568999999886 4334567766532    68


Q ss_pred             EEEecCCCCh
Q 011250          217 VYEFMPRGSL  226 (490)
Q Consensus       217 V~E~~~~gsL  226 (490)
                      ||||++|..|
T Consensus       119 I~efi~g~~l  128 (395)
T d1nw1a_         119 LEEYIPSRPL  128 (395)
T ss_dssp             EECCCCEEEC
T ss_pred             EEEEeccccC
Confidence            9999987544

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.13  E-value=0.0012  Score=62.46  Aligned_cols=69  Identities=14%  Similarity=0.055  Sum_probs=45.0

Q ss_pred             ceEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhccCCCCe-----ecee--eEEEeCCceEEEE
Q 011250          146 FGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNL-----VKLV--GYCIEDDQRLLVY  218 (490)
Q Consensus       146 fg~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~Ei~il~~l~HpnI-----v~l~--~~~~~~~~~~lV~  218 (490)
                      --.||++...          +|..|++|+.+... ...+++..|...+..|...+|     +..-  ..+..++..+.|+
T Consensus        35 EN~vy~v~~~----------dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~  103 (325)
T d1zyla1          35 ENRVYQFQDE----------DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF  103 (325)
T ss_dssp             SSEEEEECCT----------TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred             cceeEEEEcC----------CCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEE
Confidence            3579998764          46679999986543 345678889988888753222     1111  1334556778999


Q ss_pred             EecCCCC
Q 011250          219 EFMPRGS  225 (490)
Q Consensus       219 E~~~~gs  225 (490)
                      ++++|..
T Consensus       104 ~~~~G~~  110 (325)
T d1zyla1         104 PSVGGRQ  110 (325)
T ss_dssp             ECCCCEE
T ss_pred             eecCCcC
Confidence            9997643

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.80  E-value=0.0024  Score=59.78  Aligned_cols=31  Identities=29%  Similarity=0.259  Sum_probs=27.1

Q ss_pred             CCCeeecCCCCCcEEEcCCCCeEEecccCcc
Q 011250          261 EKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       261 ~~~iiHrDlkp~NILl~~~~~vkL~DFG~a~  291 (490)
                      ..++||+|+.++||+++.+...-|+||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            3559999999999999988777899999775